-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2093-01-13 JJ JJ I-DATE
Team NNP NNP O
X NNP NNP O
Intern NNP NNP O
Admission NNP NNP O
Note VB VB O
Name NN NN O
: : : O
Hendrickson NNP NNP O
, , , O
Ora NNP NNP I-PATIENT
MR NNP NNP O
# # # O
7194334 CD CD I-MEDICALRECORD
Date NN NN O
: : : O
01/13/93 CD CD I-DATE
PCP NNP NNP O
: : : O
Oliveira NNP NNP O
, , , O
Keith NNP NNP I-DOCTOR
MD NNP NNP O
CC/RFA NNP NNP O
: : : O
SOB NNP NNP O
. . . O
   
HPI NNP NNP O
: : : O
Pt NNP NNP O
is VBZ VBZ O
a DT DT O
76 CD CD I-AGE
yo NN NN O
F NN NN O
with IN IN O
a DT DT O
h/o NN NN O
CAD NNP NNP O
, , , O
HTN NNP NNP O
, , , O
hypercholesterolemia NN NN O
, , , O
COPD NNP NNP O
, , , O
CHF NNP NNP O
who WP WP O
developed VBD VBD O
acute JJ JJ O
SOB NNP NNP O
while IN IN O
at IN IN O
home NN NN O
PM NNP NNP O
of IN IN O
admission NN NN O
. . . O
   
Pt NNP NNP O
reports NNS NNS O
no DT DT O
dietary JJ JJ O
discretions NNS NNS O
and CC CC O
excellent JJ JJ O
adherence NN NN O
to TO TO O
medications NNS NNS O
. . . O
   
She PRP PRP O
was VBD VBD O
out IN IN O
evening NN NN O
of IN IN O
admission NN NN O
at IN IN O
a DT DT O
social JJ JJ O
gathering NN NN O
and CC CC O
noticed VBD VBD O
symptoms NNS NNS O
when WRB WRB O
she PRP PRP O
returned VBD VBD O
home NN NN O
and CC CC O
had VBD VBD O
difficulty NN NN O
climbing VBG VBG O
an DT DT O
internal JJ JJ O
staircase NN NN O
in IN IN O
her PRP$ PRP$ O
home NN NN O
She PRP PRP O
ascended VBD VBD O
the DT DT O
staircase NN NN O
and CC CC O
was VBD VBD O
unable JJ JJ O
to TO TO O
regain VB VB O
her PRP$ PRP$ O
breath NN NN O
. . . O
   
She PRP PRP O
reports NNS NNS O
she PRP PRP O
developed VBD VBD O
profound JJ JJ O
dyspnea NN NN O
and CC CC O
tachycardia NNS NNS O
. . . O
   
She PRP PRP O
denies VBZ VBZ O
chest NN NN O
pain NN NN O
, , , O
diaphoresis NNS NNS O
, , , O
dizziness NN NN O
or CC CC O
LOC NNP NNP O
. . . O
   
She PRP PRP O
has VBZ VBZ O
had VBN VBN O
a DT DT O
cough NN NN O
productive JJ JJ O
of IN IN O
clear JJ JJ O
sputum NN NN O
x SYM SYM O
1 CD CD O
week NN NN O
with IN IN O
no DT DT O
fever NN NN O
, , , O
night NN NN O
sweats NNS NNS O
, , , O
rigors NNS NNS O
or CC CC O
chills NNS NNS O
during IN IN O
this DT DT O
time NN NN O
. . . O
   
She PRP PRP O
has VBZ VBZ O
had VBN VBN O
no DT DT O
vomiting VBG VBG O
or CC CC O
diarrhea NN NN O
. . . O
   
She PRP PRP O
does VBZ VBZ O
not RB RB O
recall VB VB O
wheezing VBG VBG O
, , , O
and CC CC O
asserts VBZ VBZ O
the DT DT O
only JJ JJ O
symptoms NNS NNS O
during IN IN O
the DT DT O
episode NN NN O
consisted VBD VBD O
in IN IN O
SOB NNP NNP O
and CC CC O
tachypnea NN NN O
. . . O
   
Of IN IN O
note NN NN O
, , , O
pt NN NN O
had VBD VBD O
2 CD CD O
vessel NN NN O
CABG NNP NNP O
in IN IN O
11/92 CD CD I-DATE
. . . O
   
Catheterization NNP NNP O
on IN IN O
11/18/92 CD CD I-DATE
revealed VBD VBD O
100 CD CD O
% NN NN O
obstruction NN NN O
of IN IN O
the DT DT O
left VBN VBN O
proximal NN NN O
circ NN NN O
, , , O
70 CD CD O
% NN NN O
proximal NN NN O
LAD NNP NNP O
obstruction NN NN O
, , , O
and CC CC O
100 CD CD O
% NN NN O
obstruction NN NN O
of IN IN O
the DT DT O
mid JJ JJ O
RCA NNP NNP O
. . . O
   
Course NN NN O
in IN IN O
ED NNP NNP O
: : : O
En NNP NNP O
route NN NN O
to TO TO O
BBH NNP NNP I-HOSPITAL
pt NN NN O
received VBD VBD O
Lasix NNP NNP O
40 CD CD O
mg NN NN O
, , , O
TNG NNP NNP O
x SYM SYM O
   
3 CD CD O
. . . O
She PRP PRP O
was VBD VBD O
described VBN VBN O
as IN IN O
pale JJ JJ O
, , , O
cool VB VB O
, , , O
and CC CC O
diaphoretic JJ JJ O
. . . O
   
She PRP PRP O
was VBD VBD O
unable JJ JJ O
to TO TO O
complete VB VB O
full JJ JJ O
sentences NNS NNS O
. . . O
   
She PRP PRP O
received VBD VBD O
Lasix NNP NNP O
40 CD CD O
mg NN NN O
IV NNP NNP O
and CC CC O
20 CD CD O
mg NN NN O
IV NNP NNP O
2 CD CD O
hours NNS NNS O
later RB RB O
, , , O
ASA NNP NNP O
325 CD CD O
x SYM SYM O
1 CD CD O
, , , O
Zofran NNP NNP O
8 CD CD O
mg NN NN O
IV NNP NNP O
, , , O
and CC CC O
0.5 CD CD O
nitropaste NN NN O
. . . O
   
Initial JJ JJ O
vitals NNS NNS O
were VBD VBD O
T NN NN O
98 CD CD O
P NN NN O
93 CD CD O
BP NNP NNP O
148/67 CD CD O
RR NNP NNP O
24 CD CD O
93 CD CD O
% NN NN O
on IN IN O
6 CD CD O
L NNP NNP O
and CC CC O
100 CD CD O
% NN NN O
on IN IN O
BiPap NNP NNP O
   
( ( ( O
brief JJ JJ O
) ) ) O
. . . O
   
PMHx NNP NNP O
: : : O
   
1 CD CD O
. . . O
HTN NNP NNP O
   
2 CD CD O
. . . O
CAD NNP NNP O
[ NN NN O
old JJ JJ O
MI NNP NNP O
by IN IN O
EKG/imaging VBG VBG O
] NN NN O
   
3 CD CD O
. . . O
COPD NNP NNP O
   
4 CD CD O
. . . O
Hypercholesterolemia NNP NNP O
   
5 CD CD O
. . . O
DM NNP NNP O
, , , O
type NN NN O
II NNP NNP O
   
6 CD CD O
. . . O
Recurrent NNP NNP O
UTIs NNP NNP O
[ NN NN O
cystocele/recurrent NN NN O
UTI NNP NNP O
] NN NN O
   
7 CD CD O
. . . O
Chronic NNP NNP O
LE NNP NNP O
edema NN NN O
[ NN NN O
Doppler NNP NNP O
NEG NNP NNP O
] NN NN O
   
8 CD CD O
. . . O
Anxiety NNP NNP O
   
9 CD CD O
. . . O
GERD NNP NNP O
ALLERGIES NNP NNP O
: : : O
Penicillin/Cephalosporins NNP NNP O
- - - O
hives NNS NNS O
MEDS NNP NNP O
: : : O
Atenolol NNP NNP O
100 CD CD O
mg NN NN O
PO NNP NNP O
qd NN NN O
Lipitor NNP NNP O
10 CD CD O
mg NN NN O
po NN NN O
qd NN NN O
Cozaar NNP NNP O
50 CD CD O
mg NN NN O
po NN NN O
qd NN NN O
Furosemide NNP NNP O
20 CD CD O
mg NN NN O
po NN NN O
qde NN NN O
Prilosec NNP NNP O
20 CD CD O
mg NN NN O
po NN NN O
qd NN NN O
ECASA NNP NNP O
325 CD CD O
mg NN NN O
po NN NN O
qd NN NN O
Nifedipine NNP NNP O
XL NNP NNP O
60 CD CD O
mg NN NN O
po NN NN O
bid NN NN O
Klonazepam NNP NNP O
0.5 CD CD O
mg NN NN O
po NN NN O
bid NN NN O
SHx NNP NNP O
: : : O
lives NNS NNS O
alone RB RB O
, , , O
independent JJ JJ O
with IN IN O
ADLs NNP NNP O
PTA NNP NNP O
FHx NNP NNP O
: : : O
no DT DT O
CAD NNP NNP O
, , , O
DM NNP NNP O
, , , O
stroke NN NN O
PHYSICAL JJ JJ O
EXAM NNP NNP O
: : : O
Gen NNP NNP O
: : : O
Supine NNP NNP O
, , , O
c/o NN NN O
nausea NN NN O
. . . O
   
Vitals NNP NNP O
: : : O
T NN NN O
96.8 CD CD O
P NN NN O
87 CD CD O
BP NNP NNP O
132/64 CD CD O
RR NNP NNP O
20 CD CD O
SaO2 NNP NNP O
93 CD CD O
% NN NN O
6 CD CD O
L NNP NNP O
NC NNP NNP O
. . . O
   
HEENT NNP NNP O
: : : O
PERRL NNP NNP O
. . . O
   
Sclerae NNP NNP O
anicteric JJ JJ O
, , , O
conj NN NN O
pale JJ JJ O
. . . O
   
MMM NNP NNP O
, , , O
no DT DT O
exudates NNS NNS O
. . . O
   
JVP NNP NNP O
7 CD CD O
cm NN NN O
. . . O
   
Chest NN NN O
: : : O
Fine NNP NNP O
inspiratory NN NN O
crackles NNS NNS O
inf NN NN O
of IN IN O
lung NN NN O
field NN NN O
; : : O
   
anterior RB RB O
end-expiratory JJ JJ O
wheeze NN NN O
. . . O
   
Heart NNP NNP O
: : : O
RRR NNP NNP O
. . . O
   
Nl NNP NNP O
S1/S2, NNP NNP O
I/VI NNP NNP O
SM NNP NNP O
. . . O
   
Carotid NNP NNP O
bruit NN NN O
on IN IN O
left VBD VBD O
, , , O
right NN NN O
clear JJ JJ O
. . . O
   
Left NNP NNP O
pedal NN NN O
pulses NNS NNS O
1 CD CD O
+ NN NN O
uniformly RB RB O
; : : O
   
right RB RB O
not RB RB O
palpable JJ JJ O
. . . O
   
Abd NNP NNP O
: : : O
NABS NNP NNP O
, , , O
obese NN NN O
, , , O
NT NNP NNP O
, , , O
no DT DT O
organomegaly NN NN O
. . . O
   
Extr NNP NNP O
: : : O
Trace NNP NNP O
pretib NN NN O
edema NN NN O
. . . O
   
DJD NNP NNP O
hands NNS NNS O
. . . O
   
Skin NNP NNP O
: : : O
No DT DT O
lesions NNS NNS O
. . . O
   
Neuro NNP NNP O
: : : O
No DT DT O
gross NN NN O
deficits NNS NNS O
. . . O
   
LABS NNP NNP O
: : : O
Calcium NNP NNP O
9.0 CD CD O
8.5-10.5 JJ JJ O
mg/dl NN NN O
Phosphorus NNP NNP O
3.7 CD CD O
2.6-4.5 JJ JJ O
mg/dl NN NN O
Magnesium NNP NNP O
1.6 CD CD O
1.4-2.0 JJ JJ O
meq/L NN NN O
Total NNP NNP O
Protein NNP NNP O
7.9 CD CD O
6.0-8.0 JJ JJ O
g/dl NN NN O
Albumin NNP NNP O
3.1 CD CD O
3.1-4.3 JJ JJ O
g/dl NN NN O
Globulin NNP NNP O
4.8 CD CD O
H NNP NNP O
2.6-4.1 JJ JJ O
g/dl NN NN O
Direct NNP NNP O
Bilirubin NNP NNP O
0.1 CD CD O
0-0.4 NN NN O
mg/dl NN NN O
Total NNP NNP O
Bilirubin NNP NNP O
0.4 CD CD O
0-1.0 NN NN O
mg/dl NN NN O
Alkaline NNP NNP O
Phosphatase NNP NNP O
293 CD CD O
H NNP NNP O
30-100 CD CD O
U/L NNP NNP O
Transaminase-SGPT NNP NNP O
17 CD CD O
7-30 NN NN O
U/L NNP NNP O
Amylase NNP NNP O
29 CD CD O
3-100 NN NN O
units/L NN NN O
Lipase NNP NNP O
1.8 CD CD O
1.3-6.0 JJ JJ O
U/dl NNP NNP O
Creatine NNP NNP O
Kinase NNP NNP O
Isoenzy NNP NNP O
2.4 CD CD O
0.0-6.9 NN NN O
ng/ml NN NN O
CPK NNP NNP O
Isoenzymes NNP NNP O
Index NNP NNP O
0.0-3.5 NN NN O
% NN NN O
Result NNP NNP O
Text NN NN O
: : : O
CPK NNP NNP O
and/or NN NN O
CKMB NNP NNP O
too RB RB O
low JJ JJ O
to TO TO O
calculate VB VB O
Relative NNP NNP O
Index NNP NNP O
. . . O
   
Troponin-T NNP NNP O
0.01 CD CD O
0.00-0.09 NN NN O
ng/ml NN NN O
Transaminase-SGOT NNP NNP O
33 CD CD O
H NNP NNP O
9-25 JJ JJ O
U/L NNP NNP O
Creatine NNP NNP O
Kinase NNP NNP O
40 CD CD O
40-150 JJ JJ O
U/L NNP NNP O
Sodium NNP NNP O
( ( ( O
Stat NNP NNP O
Lab NNP NNP O
) ) ) O
138 CD CD O
135-145 JJ JJ O
mmol/L NN NN O
Potassium NNP NNP O
( ( ( O
Stat NNP NNP O
Lab NNP NNP O
) ) ) O
3.8 CD CD O
3.4-4.8 CD CD O
mmol/L NN NN O
Chloride NNP NNP O
( ( ( O
Stat NNP NNP O
Lab NNP NNP O
) ) ) O
109 CD CD O
H NNP NNP O
100-108 JJ JJ O
mmol/L NN NN O
CO2 NNP NNP O
( ( ( O
Stat NNP NNP O
Lab NNP NNP O
) ) ) O
25.0 CD CD O
24.0-30.0 JJ JJ O
mmol/L NN NN O
BUN NNP NNP O
( ( ( O
Stat NNP NNP O
Lab NNP NNP O
) ) ) O
14 CD CD O
8-25 JJ JJ O
mg/dl NN NN O
Creatinine NNP NNP O
( ( ( O
Stat NNP NNP O
Lab NNP NNP O
) ) ) O
0.8 CD CD O
0.6-1.5 CD CD O
mg/dl NN NN O
Glucose NNP NNP O
( ( ( O
Stat NNP NNP O
Lab NNP NNP O
) ) ) O
222 CD CD O
H NNP NNP O
70-110 CD CD O
mg/dl NN NN O
WBC NNP NNP O
11.1 CD CD O
H NNP NNP O
4.5-11.0 JJ JJ O
th/cmm NN NN O
HCT NNP NNP O
36.7 CD CD O
36.0-46.0 CD CD O
% NN NN O
HGB NNP NNP O
11.2 CD CD O
L NNP NNP O
12.0-16.0 JJ JJ O
gm/dl NN NN O
RBC NNP NNP O
4.68 CD CD O
4.00-5.20 JJ JJ O
mil/cmm NN NN O
PLT NNP NNP O
313 CD CD O
150-350 JJ JJ O
th/cumm NN NN O
MCV NNP NNP O
78 CD CD O
L NNP NNP O
80-100 JJ JJ O
fl NN NN O
MCH NNP NNP O
23.8 CD CD O
L NNP NNP O
26.0-34.0 JJ JJ O
pg/rbc NN NN O
MCHC NNP NNP O
30.4 CD CD O
L NNP NNP O
31.0-37.0 JJ JJ O
g/dl NN NN O
RDW NNP NNP O
15.8 CD CD O
H NNP NNP O
11.5-14.5 CD CD O
% NN NN O
Superstat NNP NNP O
PT NNP NNP O
12.6 CD CD O
11.1-13.1 JJ JJ O
sec NN NN O
Superstat NNP NNP O
APTT NNP NNP O
29.4 CD CD O
22.1-35.1 JJ JJ O
sec NN NN O
DIFFERENTIAL NNP NNP O
REQUEST NNP NNP O
RECEIVED NNP NNP O
Diff NNP NNP O
Method NNP NNP O
Auto NNP NNP O
Poly NNP NNP O
73 CD CD O
H NNP NNP O
40-70 CD CD O
% NN NN O
Lymphs NNP NNP O
23 CD CD O
22-44 JJ JJ O
% NN NN O
Monos NNP NNP O
2 CD CD O
L NNP NNP O
4-11 CD CD O
% NN NN O
EOS NNP NNP O
1 CD CD O
0-8 NN NN O
% NN NN O
Basos NNP NNP O
1 CD CD O
0-3 NN NN O
% NN NN O
Absolute NNP NNP O
Neuts NNP NNP O
8.19 CD CD O
H NNP NNP O
1.8-7.7 JJ JJ O
th/cmm NN NN O
Absolute NNP NNP O
Lymphs NNP NNP O
2.48 CD CD O
1.0-4.8 JJ JJ O
th/cmm NN NN O
Absolute NNP NNP O
Monos NNP NNP O
0.26 CD CD O
0.2-0.4 NN NN O
th/cmm NN NN O
Absolute NNP NNP O
EOS NNP NNP O
0.09 CD CD O
L NNP NNP O
0.1-0.3 JJ JJ O
th/cmm NN NN O
Absolute NNP NNP O
Basos NNP NNP O
0.06 CD CD O
0.0-0.3 NN NN O
th/cmm NN NN O
Aniso NNP NNP O
None NN NN O
NORMAL NNP NNP O
Hypo NNP NNP O
3 CD CD O
+ NN NN O
NORMAL NNP NNP O
Macrocytes NNP NNP O
None NN NN O
Microcytes NNP NNP O
1 CD CD O
+ NN NN O
CXR NNP NNP O
: : : O
Bilateral NNP NNP O
effusions NNS NNS O
, , , O
left VBD VBD O
> NN NN O
right NN NN O
. . . O
   
Pulmonary NNP NNP O
edema NN NN O
. . . O
   
Cardiac NNP NNP O
US NNP NNP O
: : : O
11/17/92 CD CD I-DATE
ANATOMIC NNP NNP O
REGION NNP NNP O
STATUS NNP NNP O
ROUTINE NNP NNP O
DIMENSIONS NNP NNP O
REGIONAL NNP NNP O
WALL NNP NNP O
MOTION NNP NNP O
   
( ( ( O
normal JJ JJ O
) ) ) O
( ( ( O
completed VBD VBD O
only RB RB O
if IN IN O
abn NN NN O
. . . O
) ) ) O
MITRAL NNP NNP O
VALVE NNP NNP O
ABN NNP NNP O
SEGMENT NNP NNP O
BASE NNP NNP O
MID NNP NNP O
APEX NNP NNP O
LEFT NNP NNP O
ATRIUM NNP NNP O
ABN NNP NNP O
LA NNP NNP O
39 CD CD O
(25-38mm) JJ JJ O
AV NNP NNP O
. . . O
   
A0 NNP NNP O
. . . O
   
LVOT NNP NNP O
ABN NNP NNP O
AO NNP NNP O
33 CD CD O
(24-39mm) JJ JJ O
anterior NN NN O
LEFT NNP NNP O
VENT NNP NNP O
. . . O
   
ABN NNP NNP O
LVIDd NNP NNP O
50 CD CD O
(37-53mm) JJ JJ O
ant.sep NN NN O
. . . O
   
TV NN NN O
. . . O
   
RA NNP NNP O
. . . O
   
VC NNP NNP O
. . . O
   
NORM NNP NNP O
LVIDs NNP NNP O
39 CD CD O
mid.sep NN NN O
. . . O
   
H NNP NNP O
PV NNP NNP O
. . . O
   
INF NNP NNP O
. . . O
   
PA NNP NNP O
. . . O
   
NORM NNP NNP O
PWT NNP NNP O
13 CD CD O
( ( ( O
7-11mm) NNP NNP O
inf.sep NN NN O
. . . O
   
H NNP NNP O
H NNP NNP O
RIGHT RB RB O
VENT NNP NNP O
. . . O
   
NORM NNP NNP O
IVS NNP NNP O
13 CD CD O
( ( ( O
7-11mm) NNP NNP O
inferior NN NN O
A DT DT O
A DT DT O
A DT DT O
IAS NNP NNP O
. . . O
   
IVS NNP NNP O
. . . O
   
ABN NNP NNP O
inf.pos NN NN O
. . . O
   
A DT DT O
A DT DT O
COMPLEX NNP NNP O
CHD NNP NNP O
NORM NNP NNP O
EF NNP NNP O
33 CD CD O
% NN NN O
( ( ( O
> NN NN O
50 CD CD O
%) NN NN O
pos.lat NN NN O
. . . O
   
H NNP NNP O
CORONARIES NNP NNP O
UV NNP NNP O
lateral NN NN O
PERICARDIUM NNP NNP O
ABN NNP NNP O
Wall NNP NNP O
Motion NNP NNP O
Abbreviations NNP NNP O
: : : O
N=Normal NNP NNP O
H=Hypokinetic NNP NNP O
A=Akinetic NNP NNP O
D=Dyskinetic NNP NNP O
MITRAL NNP NNP O
VALVE NNP NNP O
There EX EX O
is VBZ VBZ O
calcification NN NN O
of IN IN O
the DT DT O
posterior NN NN O
mitral NN NN O
annulus NN NN O
. . . O
   
There EX EX O
is VBZ VBZ O
no DT DT O
evidence NN NN O
of IN IN O
mitral JJ JJ O
valve NN NN O
prolapse NN NN O
. . . O
   
There EX EX O
is VBZ VBZ O
mild JJ JJ O
mitral JJ JJ O
regurgitation NN NN O
by IN IN O
color NN NN O
and CC CC O
spectral JJ JJ O
Doppler NNP NNP O
. . . O
   
LEFT NNP NNP O
ATRIUM NNP NNP O
The DT DT O
left VBN VBN O
atrium NN NN O
is VBZ VBZ O
dilated VBN VBN O
. . . O
   
AORTIC NNP NNP O
VALVE NNP NNP O
, , , O
AORTA NNP NNP O
, , , O
LVOT NNP NNP O
There EX EX O
is VBZ VBZ O
thickening VBG VBG O
of IN IN O
the DT DT O
bases NNS NNS O
of IN IN O
multiple JJ JJ O
aortic JJ JJ O
leaflets NNS NNS O
. . . O
   
The DT DT O
aortic JJ JJ O
valve NN NN O
is VBZ VBZ O
tricuspid JJ JJ O
. . . O
   
There EX EX O
is VBZ VBZ O
no DT DT O
evidence NN NN O
of IN IN O
aortic JJ JJ O
insufficiency NN NN O
by IN IN O
color NN NN O
or CC CC O
spectral JJ JJ O
Doppler NNP NNP O
. . . O
   
There EX EX O
are VBP VBP O
irregular JJ JJ O
echoes NNS NNS O
along IN IN O
the DT DT O
aortic JJ JJ O
wall NN NN O
c/w NN NN O
atheroma NN NN O
. . . O
   
LEFT NNP NNP O
VENTRICLE NNP NNP O
The DT DT O
left VBN VBN O
ventricular NN NN O
cavity NN NN O
size NN NN O
is VBZ VBZ O
normal JJ JJ O
. . . O
   
The DT DT O
left VBN VBN O
ventricular JJ JJ O
systolic JJ JJ O
function NN NN O
is VBZ VBZ O
impaired VBN VBN O
. . . O
   
There EX EX O
is VBZ VBZ O
symmetric JJ JJ O
left VBN VBN O
ventricular NN NN O
hypertrophy NN NN O
. . . O
   
There EX EX O
is VBZ VBZ O
segmental JJ JJ O
left VBN VBN O
ventricular NN NN O
dysfunction NN NN O
( ( ( O
see VB VB O
wall NN NN O
motion NN NN O
plot NN NN O
) ) ) O
. . . O
   
This DT DT O
involves VBZ VBZ O
the DT DT O
lateral,inferior NN NN O
and CC CC O
apical JJ JJ O
territory NN NN O
. . . O
   
There EX EX O
is VBZ VBZ O
a DT DT O
false JJ JJ O
tendon NN NN O
within IN IN O
the DT DT O
LV NNP NNP O
cavity NN NN O
which WDT WDT O
is VBZ VBZ O
a DT DT O
normal JJ JJ O
variant NN NN O
. . . O
   
The DT DT O
estimated JJ JJ O
ejection NN NN O
fraction NN NN O
is VBZ VBZ O
33 CD CD O
%. NN NN O
   
TRICUSPID NNP NNP O
VALVE NNP NNP O
- : : O
IVC NNP NNP O
, , , O
SVC NNP NNP O
There EX EX O
is VBZ VBZ O
color NN NN O
and CC CC O
spectral JJ JJ O
Doppler NNP NNP O
evidence NN NN O
of IN IN O
trace NN NN O
tricuspid JJ JJ O
insufficiency NN NN O
. . . O
   
PULMONARY NNP NNP O
VALVE NNP NNP O
, , , O
INFUND NNP NNP O
. . . O
   
, , , O
P.A. NN NN O
   
There EX EX O
is VBZ VBZ O
evidence NN NN O
of IN IN O
trace NN NN O
pulmonary JJ JJ O
insufficiency NN NN O
by IN IN O
color NN NN O
and CC CC O
spectral JJ JJ O
Doppler NNP NNP O
. . . O
   
RIGHT RB RB O
VENTRICLE NNP NNP O
The DT DT O
right JJ JJ O
ventricle NN NN O
is VBZ VBZ O
not RB RB O
dilated VBN VBN O
. . . O
   
The DT DT O
right NN NN O
ventricular NN NN O
systolic JJ JJ O
function NN NN O
is VBZ VBZ O
within IN IN O
normal JJ JJ O
limits NNS NNS O
. . . O
   
PERICARDIAL NNP NNP O
DISEASE NNP NNP O
AND CC CC O
EXTRACARDIAC NNP NNP O
MASSES NNP NNP O
There EX EX O
is VBZ VBZ O
a DT DT O
small JJ JJ O
circumferential JJ JJ O
pericardial NN NN O
effusion NN NN O
. . . O
   
There EX EX O
is VBZ VBZ O
increased VBN VBN O
intrapericardial JJ JJ O
pressure NN NN O
without IN IN O
evidence NN NN O
of IN IN O
frank JJ JJ O
tamponade NN NN O
. . . O
   
There EX EX O
is VBZ VBZ O
diffuse NN NN O
fibrin NN NN O
deposition NN NN O
on IN IN O
the DT DT O
visceral JJ JJ O
pericardium NN NN O
. . . O
   
There EX EX O
is VBZ VBZ O
evidence NN NN O
of IN IN O
a DT DT O
pleural JJ JJ O
effusion NN NN O
. . . O
   
CONCLUSIONS NNP NNP O
Compared NNP NNP O
to TO TO O
the DT DT O
report NN NN O
of IN IN O
6/5/2089,the CD CD O
left VBN VBN O
ventricular JJ JJ O
systolic JJ JJ O
function NN NN O
is VBZ VBZ O
impaired VBN VBN O
with IN IN O
new JJ JJ O
wall NN NN O
motion NN NN O
abnormalities NNS NNS O
. . . O
   
Also RB RB O
a DT DT O
new JJ JJ O
pericardial JJ JJ O
effusion NN NN O
is VBZ VBZ O
visualized JJ JJ O
. . . O
   
EKG NNP NNP O
: : : O
NSR NNP NNP O
, , , O
90 CD CD O
bpm NN NN O
. . . O
   
ST NNP NNP O
elevations NNS NNS O
V1-V6. NNP NNP O
   
______________________________________ NN NN O
_ NN NN O
ASSESSMENT NNP NNP O
AND CC CC O
PLAN NNP NNP O
: : : O
76 CD CD I-AGE
yo NN NN O
F NN NN O
with IN IN O
PVD NNP NNP O
, , , O
CAD NNP NNP O
, , , O
s/p NN NN O
CABG NNP NNP O
, , , O
CHF NNP NNP O
, , , O
with IN IN O
acute JJ JJ O
onset NN NN O
SOB NNP NNP O
, , , O
likely JJ JJ O
CHF NNP NNP O
exacerbation NN NN O
. . . O
   
CV NNP NNP O
: : : O
Pt NNP NNP O
has VBZ VBZ O
diffuse NN NN O
CAD NNP NNP O
with IN IN O
propensity NN NN O
for IN IN O
failure NN NN O
, , , O
most RBS RBS O
likely JJ JJ O
etiology NN NN O
for IN IN O
SOB NNP NNP O
being VBG VBG O
CHF NNP NNP O
. . . O
   
Pump NNP NNP O
33 CD CD O
% NN NN O
. . . O
   
Continue NNP NNP O
beta NN NN O
blocker NN NN O
, , , O
CCB NNP NNP O
. . . O
   
Daily NNP NNP O
weights NNS NNS O
, , , O
Is VBZ VBZ O
and CC CC O
Os NNP NNP O
, , , O
diurese NN NN O
with IN IN O
goal NN NN O
of IN IN O
- - - O
0.5 CD CD O
liters NNS NNS O
QD NNP NNP O
. . . O
   
PT/OT NNP NNP O
for IN IN O
chronic JJ JJ O
deconditioning VBG VBG O
2/2 CD CD O
failure NN NN O
. . . O
   
Ischemia NNP NNP O
. . . O
   
H/o NNP NNP O
CABG NNP NNP O
, , , O
PVD NNP NNP O
. . . O
   
Cont NNP NNP O
ASA NNP NNP O
, , , O
statin NN NN O
. . . O
   
Cycle NNP NNP O
enzymes NNS NNS O
. . . O
   
Serial NNP NNP O
EKGs NNP NNP O
. . . O
   
AdenoMIBI NNP NNP O
to TO TO O
identify VB VB O
ischemia NN NN O
, , , O
assess NN NN O
CABG NNP NNP O
grafts NNS NNS O
, , , O
risk NN NN O
for IN IN O
failure NN NN O
. . . O
   
Rhythm NNP NNP O
: : : O
sinus NN NN O
. . . O
   
Place NN NN O
pt NN NN O
on IN IN O
monitor NN NN O
given VBN VBN O
hx NN NN O
. . . O
   
DM NNP NNP O
: : : O
Sliding NNP NNP O
scale NN NN O
insulin NN NN O
. . . O
   
HTN NNP NNP O
: : : O
Beta NNP NNP O
blockade NN NN O
. . . O
   
Anxiety NNP NNP O
: : : O
Uses NNP NNP O
Klonopin NNP NNP O
0.5 CD CD O
mg NN NN O
BID NNP NNP O
. . . O
   
GERD NNP NNP O
: : : O
Prilosec NNP NNP O
. . . O
   
FEN NNP NNP O
: : : O
Cardiac NNP NNP O
diet NN NN O
; : : O
   
follow VB VB O
electrolytes NNS NNS O
given VBN VBN O
active JJ JJ O
diuresis NNS NNS O
. . . O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2062-03-27 JJ JJ I-DATE
Hematology NNP NNP O
Clinic NNP NNP O
Progress NNP NNP O
Note VB VB O
Fellow NNP NNP O
: : : O
Inge NNP NNP I-DOCTOR
Logan NNP NNP I-DOCTOR
, , , O
MD NNP NNP O
Attending NNP NNP O
: : : O
Cole NNP NNP I-DOCTOR
Morgan NNP NNP I-DOCTOR
, , , O
MD NNP NNP O
, , , O
PhD NNP NNP O
Date NN NN O
of IN IN O
visit NN NN O
: : : O
March NNP NNP I-DATE
27 CD CD I-AGE
, , , O
2062 CD CD I-DATE
Diagnosis NNP NNP O
: : : O
Mr NNP NNP O
. . . O
Goins NNP NNP I-PATIENT
is VBZ VBZ O
a DT DT O
27 CD CD I-AGE
yoM NN NN O
with IN IN O
thrombocytosis NNS NNS O
here RB RB O
for IN IN O
interval NN NN O
follow-up JJ JJ O
on IN IN O
hydrea NN NN O
. . . O
   
Hematologic NNP NNP O
History NN NN O
: : : O
Mr NNP NNP O
. . . O
Goins NNP NNP I-PATIENT
is VBZ VBZ O
a DT DT O
27 CD CD I-AGE
yo NN NN O
male NN NN O
with IN IN O
history NN NN O
of IN IN O
type NN NN O
I PRP PRP O
DM NNP NNP O
formally RB RB O
without IN IN O
regular JJ JJ O
medical JJ JJ O
care NN NN O
who WP WP O
was VBD VBD O
visiting VBG VBG O
family NN NN O
in IN IN O
Maryland NNP NNP I-STATE
and CC CC O
had VBD VBD O
sudden VBN VBN O
witnessed VBN VBN O
seizure NN NN O
activity NN NN O
in IN IN O
late JJ JJ O
August NNP NNP I-DATE
. . . O
   
At IN IN O
the DT DT O
time NN NN O
, , , O
blood NN NN O
sugar NN NN O
was VBD VBD O
> NN NN O
500 CD CD O
. . . O
   
Upon IN IN O
initial JJ JJ O
arrival NN NN O
to TO TO O
the DT DT O
ER NNP NNP O
in IN IN O
Maryland NNP NNP I-STATE
, , , O
he PRP PRP O
has VBZ VBZ O
BP NNP NNP O
248/146 CD CD O
; : : O
   
plt NN NN O
count NN NN O
was VBD VBD O
in IN IN O
800's. CD CD O
   
The DT DT O
patient NN NN O
was VBD VBD O
intubated VBN VBN O
, , , O
treated VBN VBN O
for IN IN O
HTN NNP NNP O
with IN IN O
labetolol NN NN O
and CC CC O
placed VBN VBN O
on IN IN O
IV NNP NNP O
insulin NN NN O
and CC CC O
dilantin NN NN O
and CC CC O
transferred VBN VBN O
to TO TO O
BMH NNP NNP I-HOSPITAL
for IN IN O
further JJ JJ O
care NN NN O
. . . O
   
At IN IN O
BMH NNP NNP I-HOSPITAL
, , , O
brain NN NN O
MRI NNP NNP O
showed VBD VBD O
several JJ JJ O
small JJ JJ O
areas NNS NNS O
of IN IN O
infarct NN NN O
read NN NN O
as IN IN O
concerning VBG VBG O
for IN IN O
embolic JJ JJ O
CVA NNP NNP O
. . . O
   
Embolic NNP NNP O
work-up NN NN O
included VBD VBD O
an DT DT O
echo NN NN O
which WDT WDT O
showed VBD VBD O
no DT DT O
vegetations NNS NNS O
, , , O
no DT DT O
PFO NNP NNP O
, , , O
NL NNP NNP O
EF NNP NNP O
with IN IN O
LVH NNP NNP O
; : : O
   
TEE NNP NNP O
without IN IN O
vegetations NNS NNS O
as RB RB O
well RB RB O
. . . O
   
LP NNP NNP O
was VBD VBD O
done VBN VBN O
and CC CC O
sent VBN VBN O
for IN IN O
HSV NNP NNP O
which WDT WDT O
was VBD VBD O
negative JJ JJ O
. . . O
   
He PRP PRP O
underwent VBD VBD O
a DT DT O
renal NN NN O
workup NN NN O
which WDT WDT O
showed VBD VBD O
nephrotic JJ JJ O
range NN NN O
proteinuria NN NN O
with IN IN O
labs NNS NNS O
also RB RB O
notable JJ JJ O
for IN IN O
rhabdoymyolysis NNS NNS O
. . . O
   
Renal NNP NNP O
doppler NN NN O
US NNP NNP O
showed VBD VBD O
no DT DT O
sign NN NN O
of IN IN O
RAS NNP NNP O
. . . O
   
He PRP PRP O
was VBD VBD O
continued VBN VBN O
on IN IN O
abx NN NN O
for IN IN O
his PRP$ PRP$ O
aspiration NN NN O
PNA NNP NNP O
. . . O
   
Other JJ JJ O
parts NNS NNS O
of IN IN O
the DT DT O
secondary JJ JJ O
hypertensive JJ JJ O
work-up JJ JJ O
were VBD VBD O
done VBN VBN O
including VBG VBG O
evaluation NN NN O
for IN IN O
hyperaldosteronism NN NN O
and CC CC O
pheochromocytoma NN NN O
. . . O
   
The DT DT O
vent NN NN O
was VBD VBD O
weaned VBN VBN O
and CC CC O
he PRP PRP O
was VBD VBD O
extubated VBN VBN O
on IN IN O
the DT DT O
4th JJ JJ I-DATE
. . . O
   
HTN NNP NNP O
was VBD VBD O
controlled VBN VBN O
with IN IN O
labetolol NN NN O
drip NN NN O
with IN IN O
additional JJ JJ O
oral JJ JJ O
agents NNS NNS O
being VBG VBG O
added VBN VBN O
. . . O
   
He PRP PRP O
continued VBD VBD O
to TO TO O
have VB VB O
intermittent JJ JJ O
fevers NNS NNS O
and CC CC O
was VBD VBD O
on IN IN O
broad JJ JJ O
antibiotics NNS NNS O
which WDT WDT O
were VBD VBD O
originally RB RB O
weaned VBN VBN O
off RP RP O
. . . O
   
Hematologically RB RB O
, , , O
the DT DT O
hct NN NN O
and CC CC O
wbc NN NN O
fell VBD VBD O
as IN IN O
he PRP PRP O
was VBD VBD O
hydrated VBN VBN O
. . . O
   
Plt NNP NNP O
count NN NN O
stayed VBD VBD O
stable JJ JJ O
in IN IN O
the DT DT O
600's CD CD O
for IN IN O
several JJ JJ O
days NNS NNS O
before IN IN O
increasing VBG VBG O
on IN IN O
the DT DT O
3rd CD CD I-DATE
gradually RB RB O
up IN IN O
to TO TO O
the DT DT O
1000's. CD CD O
   
Retics NNP NNP O
were VBD VBD O
depressed VBN VBN O
at IN IN O
presentation NN NN O
and CC CC O
iron NN NN O
studies NNS NNS O
were VBD VBD O
c/w JJ JJ O
ACD NNP NNP O
and CC CC O
he PRP PRP O
was VBD VBD O
started VBN VBN O
on IN IN O
epogen NN NN O
. . . O
   
Initially RB RB O
it PRP PRP O
was VBD VBD O
felt VBN VBN O
that IN IN O
his PRP$ PRP$ O
thrombocytosis NN NN O
was VBD VBD O
most JJS JJS O
certainly RB RB O
reactive JJ JJ O
( ( ( O
CRP NNP NNP O
was VBD VBD O
> NN NN O
150 CD CD O
with IN IN O
ESR NNP NNP O
> NN NN O
100 CD CD O
) ) ) O
. . . O
   
He PRP PRP O
left VBD VBD O
the DT DT O
ICU NNP NNP O
and CC CC O
at IN IN O
this DT DT O
point NN NN O
his PRP$ PRP$ O
WBC NNP NNP O
trended VBD VBD O
down RB RB O
and CC CC O
he PRP PRP O
was VBD VBD O
afebrile JJ JJ O
and CC CC O
more RBR RBR O
clinically RB RB O
stable JJ JJ O
. . . O
   
But CC CC O
his PRP$ PRP$ O
platelets NNS NNS O
kept VBD VBD O
climbing VBG VBG O
to TO TO O
nearly RB RB O
1.5 CD CD O
million CD CD O
. . . O
   
A DT DT O
bone NN NN O
marrow NN NN O
biopsy NN NN O
was VBD VBD O
done VBN VBN O
showing VBG VBG O
normal JJ JJ O
cytogenetics NNS NNS O
and CC CC O
no DT DT O
evidence NN NN O
for IN IN O
CML NNP NNP O
. . . O
   
His PRP$ PRP$ O
bone NN NN O
marrow NN NN O
did VBD VBD O
demonstrate VB VB O
elevated VBD VBD O
megakaryocytes NNS NNS O
, , , O
concerning VBG VBG O
for IN IN O
a DT DT O
myeloproliferative JJ JJ O
process NN NN O
. . . O
   
As RB RB O
well RB RB O
, , , O
he PRP PRP O
suffered VBD VBD O
a DT DT O
DVT NNP NNP O
in IN IN O
his PRP$ PRP$ O
subclavian/IJ NN NN O
on IN IN O
the DT DT O
same JJ JJ O
side NN NN O
as IN IN O
a DT DT O
central JJ JJ O
venous JJ JJ O
catheter NN NN O
. . . O
   
Given VBN VBN O
his PRP$ PRP$ O
thrombocytosis NN NN O
and CC CC O
elevated VBD VBD O
plt NN NN O
count NN NN O
, , , O
he PRP PRP O
was VBD VBD O
platelet NN NN O
pheresed VBN VBN O
twice RB RB O
in IN IN O
the DT DT O
hospital NN NN O
. . . O
   
As RB RB O
well RB RB O
, , , O
hydrea NN NN O
was VBD VBD O
started VBN VBN O
at IN IN O
this DT DT O
time NN NN O
, , , O
initially RB RB O
at IN IN O
500mg CD CD O
bid NN NN O
and CC CC O
then RB RB O
escalated VBN VBN O
to TO TO O
1000mg CD CD O
bid NN NN O
when WRB WRB O
his PRP$ PRP$ O
counts NNS NNS O
were VBD VBD O
up IN IN O
to TO TO O
800-900 JJ JJ O
despite IN IN O
the DT DT O
medication NN NN O
. . . O
   
As RB RB O
well RB RB O
, , , O
he PRP PRP O
suffered VBD VBD O
a DT DT O
small JJ JJ O
GI NNP NNP O
bleed NN NN O
due JJ JJ O
to TO TO O
an DT DT O
ulcer NN NN O
. . . O
   
For IN IN O
this DT DT O
reason NN NN O
he PRP PRP O
was VBD VBD O
not RB RB O
anticoagulated VBN VBN O
but CC CC O
placed VBN VBN O
upon IN IN O
daily JJ JJ O
ASA NNP NNP O
. . . O
   
He PRP PRP O
was VBD VBD O
discharged VBN VBN O
from IN IN O
the DT DT O
hospital NN NN O
in IN IN O
September NNP NNP I-DATE
. . . O
   
Since IN IN O
then RB RB O
he PRP PRP O
has VBZ VBZ O
been VBN VBN O
followed VBN VBN O
in IN IN O
hematology NN NN O
clinic NN NN O
. . . O
   
Initially RB RB O
, , , O
his PRP$ PRP$ O
platelets NNS NNS O
were VBD VBD O
still RB RB O
in IN IN O
the DT DT O
hi NN NN O
500's CD CD O
despite IN IN O
hydrea NN NN O
at IN IN O
1000 CD CD O
bid NN NN O
. . . O
   
His PRP$ PRP$ O
hematocrit NN NN O
was VBD VBD O
mildly RB RB O
depressed VBN VBN O
at IN IN O
this DT DT O
point NN NN O
as RB RB O
well RB RB O
( ( ( O
29-31 NN NN O
% NN NN O
). NN NN O
   
He PRP PRP O
was VBD VBD O
re-evaluated JJ JJ O
on IN IN O
12/05/61 CD CD I-DATE
. . . O
   
His PRP$ PRP$ O
platelets NNS NNS O
were VBD VBD O
502,000 CD CD O
. . . O
   
An DT DT O
epo NN NN O
level NN NN O
was VBD VBD O
drawn VBN VBN O
and CC CC O
his PRP$ PRP$ O
hydrea NN NN O
was VBD VBD O
increased VBN VBN O
to TO TO O
1500/1000mg. CD CD O
   
He PRP PRP O
was VBD VBD O
re-evaluated JJ JJ O
on IN IN O
12/26/61 CD CD I-DATE
and CC CC O
found VBD VBD O
to TO TO O
have VB VB O
a DT DT O
hematocrit NN NN O
of IN IN O
26.2 CD CD O
% NN NN O
, , , O
WBC NNP NNP O
of IN IN O
2.7K, CD CD O
and CC CC O
platelets NNS NNS O
of IN IN O
508,000 CD CD O
. . . O
   
His PRP$ PRP$ O
hydrea NN NN O
was VBD VBD O
decreased VBN VBN O
to TO TO O
500mg CD CD O
bid NN NN O
. . . O
   
Interval NNP NNP O
History NN NN O
: : : O
Since IN IN O
his PRP$ PRP$ O
last JJ JJ O
visit NN NN O
, , , O
he PRP PRP O
left VBD VBD O
for IN IN O
Wynne NNP NNP I-CITY
for IN IN O
one CD CD O
month NN NN O
. . . O
   
When WRB WRB O
he PRP PRP O
returned VBD VBD O
, , , O
his PRP$ PRP$ O
creatinine NN NN O
had VBD VBD O
increased VBN VBN O
to TO TO O
4.0 CD CD O
. . . O
   
A DT DT O
renal JJ JJ O
biopsy NN NN O
performed VBN VBN O
last JJ JJ O
week NN NN O
showed VBD VBD O
diabetic JJ JJ O
nephropathy NN NN O
. . . O
   
He PRP PRP O
is VBZ VBZ O
being VBG VBG O
evaluated VBN VBN O
by IN IN O
Dr NNP NNP O
. . . O
Xing NNP NNP I-DOCTOR
for IN IN O
dialysis NNS NNS O
and CC CC O
renal JJ JJ O
transplant NN NN O
evaluation NN NN O
. . . O
   
In IN IN O
terms NNS NNS O
of IN IN O
his PRP$ PRP$ O
blood NN NN O
disorders NNS NNS O
, , , O
the DT DT O
patient NN NN O
has VBZ VBZ O
been VBN VBN O
at IN IN O
his PRP$ PRP$ O
baseline NN NN O
fatigue NN NN O
, , , O
slightly RB RB O
improving VBG VBG O
over IN IN O
the DT DT O
past JJ JJ O
few JJ JJ O
months NNS NNS O
. . . O
   
He PRP PRP O
has VBZ VBZ O
no DT DT O
fevers NNS NNS O
, , , O
chills NNS NNS O
, , , O
night NN NN O
sweats NNS NNS O
, , , O
or CC CC O
unexplained JJ JJ O
weight NN NN O
loss NN NN O
. . . O
   
He PRP PRP O
had VBD VBD O
one CD CD O
episode NN NN O
of IN IN O
transient NN NN O
global JJ JJ O
blurry NN NN O
vision NN NN O
3 CD CD O
weeks NNS NNS O
ago RB RB O
which WDT WDT O
resolved VBD VBD O
on IN IN O
its PRP$ PRP$ O
own JJ JJ O
and CC CC O
has VBZ VBZ O
not RB RB O
recurred VBN VBN O
. . . O
   
He PRP PRP O
has VBZ VBZ O
no DT DT O
headaches NNS NNS O
, , , O
other JJ JJ O
sensory NN NN O
deficits NNS NNS O
, , , O
or CC CC O
focal JJ JJ O
neurologic JJ JJ O
symptoms NNS NNS O
. . . O
   
He PRP PRP O
has VBZ VBZ O
no DT DT O
oral JJ JJ O
ulcers NNS NNS O
or CC CC O
skin NN NN O
lesions NNS NNS O
from IN IN O
his PRP$ PRP$ O
Hydrea NNP NNP O
. . . O
   
Problems NNS NNS O
Diabetes NNP NNP O
mellitus NN NN O
type NN NN O
1 CD CD O
Nephrotic NNP NNP O
syndrome NN NN O
malignant JJ JJ O
hypertension NN NN O
Thrombocytosis NNP NNP O
: : : O
unclear JJ JJ O
if IN IN O
secondary JJ JJ O
vs NNS NNS O
essential JJ JJ O
Renal NNP NNP O
insufficiency NN NN O
Cerebrovascular NNP NNP O
accident NN NN O
: : : O
embolic JJ JJ O
, , , O
unclear JJ JJ O
source NN NN O
. . . O
   
In IN IN O
setting NN NN O
of IN IN O
high JJ JJ O
platelet NN NN O
count NN NN O
Unspecified NNP NNP O
GI NNP NNP O
bleed NN NN O
Medications NNP NNP O
Hydrea NNP NNP O
( ( ( O
HYDROXYUREA NNP NNP O
) ) ) O
500 CD CD O
MG NNP NNP O
( ( ( O
500MG CD CD O
CAPSULE NNP NNP O
take NN NN O
1 CD CD O
) ) ) O
PO NNP NNP O
bid NN NN O
Asa NNP NNP O
( ( ( O
ACETYLSALICYLIC NNP NNP O
ACID NNP NNP O
) ) ) O
81 CD CD O
MG NNP NNP O
( ( ( O
81MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Nexium NNP NNP O
( ( ( O
ESOMEPRAZOLE NNP NNP O
) ) ) O
40 CD CD O
MG NNP NNP O
( ( ( O
40MG CD CD O
CAPSULE NNP NNP O
DR NNP NNP O
take NN NN O
1 CD CD O
) ) ) O
PO NNP NNP O
BID NNP NNP O
Nifedipine NNP NNP O
( ( ( O
SUSTAINED NNP NNP O
RELEASE NNP NNP O
) ) ) O
90 CD CD O
MG NNP NNP O
( ( ( O
90MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Humulin NNP NNP O
N NNP NNP O
( ( ( O
INSULIN NNP NNP O
NPH NNP NNP O
HUMAN NNP NNP O
) ) ) O
40 CD CD O
UNITS NNP NNP O
SC NNP NNP O
QAM NNP NNP O
Humulin NNP NNP O
N NNP NNP O
( ( ( O
INSULIN NNP NNP O
NPH NNP NNP O
HUMAN NNP NNP O
) ) ) O
36 CD CD O
UNITS NNP NNP O
SC NNP NNP O
QPM NNP NNP O
Insulin NNP NNP O
REGULAR NNP NNP O
HUMAN NNP NNP O
25 CD CD O
UNITS NNP NNP O
SC NNP NNP O
QAM NNP NNP O
Insulin NNP NNP O
REGULAR NNP NNP O
HUMAN NNP NNP O
20 CD CD O
UNITS NNP NNP O
SC NNP NNP O
QPM NNP NNP O
Lasix NNP NNP O
( ( ( O
FUROSEMIDE NNP NNP O
) ) ) O
40 CD CD O
MG NNP NNP O
( ( ( O
40MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Lisinopril NNP NNP O
40 CD CD O
MG NNP NNP O
( ( ( O
40MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Toprol NNP NNP O
XL NNP NNP O
( ( ( O
METOPROLOL NNP NNP O
SUCCINATE NNP NNP O
EXTENDED NNP NNP O
RELEASE NNP NNP O
) ) ) O
100 CD CD O
MG NNP NNP O
( ( ( O
100MG CD CD O
TAB.SR NNP NNP O
24H CD CD O
take NN NN O
1 CD CD O
) ) ) O
PO NNP NNP O
BID NNP NNP O
Allergies NNP NNP O
: : : O
NKDA NNP NNP O
Social NNP NNP O
History NN NN O
: : : O
Lives NNS NNS O
in IN IN O
Waycross NNP NNP I-CITY
; : : O
   
single JJ JJ O
worked VBD VBD O
in IN IN O
Geologist NNP NNP I-PROFESSION
; : : O
   
not RB RB O
working VBG VBG O
now RB RB O
Tobacco NNP NNP O
: : : O
Denies NNP NNP O
EtOH NNP NNP O
: : : O
Social NNP NNP O
Illicits NNP NNP O
: : : O
Denies NNS NNS O
Family NNP NNP O
History NN NN O
: : : O
Hypertension NNP NNP O
in IN IN O
mother NN NN O
and CC CC O
father NN NN O
. . . O
   
Father NNP NNP O
has VBZ VBZ O
severe JJ JJ O
HTN NNP NNP O
as RB RB O
well RB RB O
as IN IN O
renal JJ JJ O
disease NN NN O
, , , O
though RB RB O
not RB RB O
on IN IN O
dialysis NN NN O
. . . O
   
Review NNP NNP O
of IN IN O
Systems NNPS NNPS O
: : : O
Generalized NNP NNP O
weakness NN NN O
and CC CC O
fatigue NN NN O
, , , O
only RB RB O
able JJ JJ O
to TO TO O
walk VB VB O
short JJ JJ O
distances NNS NNS O
   
( ( ( O
stable JJ JJ O
) ) ) O
. . . O
   
Denies NNP NNP O
chills NNS NNS O
, , , O
night NN NN O
sweats NNS NNS O
. . . O
   
Negative NNP NNP O
for IN IN O
shortness NN NN O
of IN IN O
breath NN NN O
, , , O
chest NN NN O
pain NN NN O
, , , O
palpitations NNS NNS O
. . . O
   
No DT DT O
cough NN NN O
, , , O
sputum NN NN O
production NN NN O
, , , O
sore NN NN O
throat NN NN O
. . . O
   
No DT DT O
epistaxis NNS NNS O
, , , O
gingival NN NN O
bleeding VBG VBG O
. . . O
   
No DT DT O
nausea NN NN O
, , , O
vomiting VBG VBG O
, , , O
anorexia NN NN O
, , , O
diarrhea NN NN O
, , , O
constipation NN NN O
. . . O
   
No DT DT O
hematochezia NN NN O
, , , O
melena NN NN O
. . . O
   
No DT DT O
hematuria NN NN O
or CC CC O
other JJ JJ O
urinary JJ JJ O
symptoms NNS NNS O
. . . O
   
All DT DT O
other JJ JJ O
ROS NNP NNP O
are VBP VBP O
negative JJ JJ O
in IN IN O
detail NN NN O
. . . O
   
Physical JJ JJ O
Examination NNP NNP O
: : : O
Vital NNP NNP O
Signs NNP NNP O
BP NNP NNP O
128/84 CD CD O
, , , O
P NN NN O
68 CD CD O
, , , O
RR NNP NNP O
16 CD CD O
, , , O
Temp NNP NNP O
98.6 CD CD O
F NN NN O
, , , O
Wt NNP NNP O
218 CD CD O
lb NN NN O
Gen NNP NNP O
: : : O
Thin NNP NNP O
male NN NN O
, , , O
alert NN NN O
, , , O
conversant NN NN O
, , , O
nad NN NN O
Heent NNP NNP O
: : : O
supple NN NN O
, , , O
anicteric JJ JJ O
, , , O
no DT DT O
cervical/supraclav NN NN O
adenopathy NN NN O
, , , O
mild JJ JJ O
proptosis NNS NNS O
Chest NN NN O
: : : O
CTAP NNP NNP O
without IN IN O
wheeze NN NN O
or CC CC O
rub NN NN O
CV NNP NNP O
: : : O
RRR NNP NNP O
S1/S2 NNP NNP O
+ NN NN O
S4 NNP NNP O
no DT DT O
m/r/g NN NN O
Abd NNP NNP O
: : : O
benign NN NN O
with IN IN O
no DT DT O
hsm NN NN O
Ext NNP NNP O
: : : O
trace VB VB O
LE NNP NNP O
edema NN NN O
, , , O
no DT DT O
upper JJ JJ O
edema NN NN O
, , , O
no DT DT O
cyanosis/clubbing VBG VBG O
Skin NNP NNP O
: : : O
scattered JJ JJ O
ulcerations NNS NNS O
on IN IN O
his PRP$ PRP$ O
arms NNS NNS O
with IN IN O
granulation NN NN O
tissue-stable JJ JJ O
, , , O
scarred JJ JJ O
vesicular NN NN O
changes NNS NNS O
on IN IN O
his PRP$ PRP$ O
neck NN NN O
Neuro NNP NNP O
: : : O
AOx3 NNP NNP O
, , , O
able JJ JJ O
to TO TO O
ambulate VB VB O
without IN IN O
difficulty NN NN O
Data NNP NNP O
: : : O
See VB VB O
LMR NNP NNP O
. . . O
   
Assessment NNP NNP O
and CC CC O
Plan NNP NNP O
: : : O
Mr NNP NNP O
. . . O
Goins NNP NNP I-PATIENT
is VBZ VBZ O
a DT DT O
27 CD CD I-AGE
yo NN NN O
male NN NN O
with IN IN O
insulin NN NN O
dependent NN NN O
diabetes NNS NNS O
and CC CC O
apparent NN NN O
untreated JJ JJ O
HTN NNP NNP O
who WP WP O
presented VBD VBD O
with IN IN O
seizure NN NN O
in IN IN O
setting VBG VBG O
of IN IN O
hypertensive JJ JJ O
emergency NN NN O
, , , O
subsequently RB RB O
found VBD VBD O
to TO TO O
have VB VB O
nephrotic JJ JJ O
syndrome NN NN O
, , , O
renal JJ JJ O
insufficiency NN NN O
, , , O
and CC CC O
several JJ JJ O
small JJ JJ O
embolic-appearing JJ JJ O
strokes NNS NNS O
. . . O
   
In IN IN O
this DT DT O
setting VBG VBG O
, , , O
he PRP PRP O
has VBZ VBZ O
developed VBN VBN O
marked VBN VBN O
thrombocytosis NNS NNS O
to TO TO O
1.5 CD CD O
million CD CD O
and CC CC O
had VBD VBD O
subsequent JJ JJ O
provoked VBN VBN O
DVT NNP NNP O
. . . O
   
He PRP PRP O
was VBD VBD O
treated VBN VBN O
with IN IN O
platelet NN NN O
pheresis NN NN O
, , , O
then RB RB O
hydrea NN NN O
. . . O
   
It PRP PRP O
has VBZ VBZ O
been VBN VBN O
unclear JJ JJ O
if IN IN O
this DT DT O
is VBZ VBZ O
still RB RB O
a DT DT O
reactive JJ JJ O
thrombocytosis NN NN O
vs NNS NNS O
essential JJ JJ O
thrombocytosis NNS NNS O
. . . O
   
We PRP PRP O
are VBP VBP O
following VBG VBG O
his PRP$ PRP$ O
CBC NNP NNP O
on IN IN O
hydrea NN NN O
. . . O
   
His PRP$ PRP$ O
platelets NNS NNS O
are VBP VBP O
moderately RB RB O
elevated VBN VBN O
( ( ( O
757K CD CD O
) ) ) O
. . . O
   
He PRP PRP O
has VBZ VBZ O
no DT DT O
evidence NN NN O
of IN IN O
recurrent JJ JJ O
thrombosis NNS NNS O
. . . O
   
His PRP$ PRP$ O
current JJ JJ O
hydrea NN NN O
dosing VBG VBG O
cannot NN NN O
be VB VB O
increased VBN VBN O
due JJ JJ O
to TO TO O
his PRP$ PRP$ O
anemia NN NN O
. . . O
   
We PRP PRP O
would MD MD O
advise VB VB O
starting VBG VBG O
erythropoetin NN NN O
, , , O
monitoring VBG VBG O
his PRP$ PRP$ O
blood NN NN O
pressure NN NN O
closely RB RB O
. . . O
   
At IN IN O
his PRP$ PRP$ O
current JJ JJ O
platelet NN NN O
count NN NN O
, , , O
his PRP$ PRP$ O
risk NN NN O
of IN IN O
thrombosis NN NN O
is VBZ VBZ O
not RB RB O
greatly RB RB O
increased VBN VBN O
, , , O
especially RB RB O
as IN IN O
his PRP$ PRP$ O
platelets NNS NNS O
are VBP VBP O
dysfunctional JJ JJ O
due JJ JJ O
to TO TO O
uremia NN NN O
. . . O
   
We PRP PRP O
would MD MD O
advise VB VB O
continuing VBG VBG O
current JJ JJ O
hydrea NN NN O
. . . O
   
Continue NNP NNP O
current JJ JJ O
hydrea NN NN O
Monitor NNP NNP O
counts NNS NNS O
monthly RB RB O
Agree VBP VBP O
with IN IN O
starting VBG VBG O
erythropoetin NN NN O
in IN IN O
Internal NNP NNP O
Medicine NNP NNP O
. . . O
   
Return NN NN O
in IN IN O
4 CD CD O
months NNS NNS O
for IN IN O
follow-up JJ JJ O
of IN IN O
counts NNS NNS O
The DT DT O
patient NN NN O
was VBD VBD O
seen VBN VBN O
and CC CC O
discussed VBN VBN O
with IN IN O
Dr NNP NNP O
. . . O
Morgan NNP NNP I-DOCTOR
. . . O
   
____________________________________________ NN NN O
_ NN NN O
Inge NNP NNP I-DOCTOR
J. NN NN I-DOCTOR
Logan NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2084-01-07 NN NN I-DATE
Fellow/NP NNP NNP O
Xiang NNP NNP I-DOCTOR
Reason NNP NNP O
for IN IN O
Visit NNP NNP O
: : : O
taxotere EX EX O
weekly JJ JJ O
chemo NN NN O
Diagnosis/Treatment NNP NNP O
Summary NNP NNP O
: : : O
Stage NN NN O
IVB NNP NNP O
( ( ( O
axillary JJ JJ O
and CC CC O
retroperitoneal NN NN O
LN NNP NNP O
and CC CC O
very RB RB O
large JJ JJ O
celiac NN NN O
axis NNS NNS O
LN NNP NNP O
mass NN NN O
) ) ) O
s/p NN NN O
XRT NNP NNP O
to TO TO O
esophagus VB VB O
Renal NNP NNP O
vein NN NN O
thrombus NN NN O
on IN IN O
Coumadin NNP NNP O
History NN NN O
: : : O
Patient NNP NNP O
is VBZ VBZ O
a DT DT O
72 CD CD I-AGE
year NN NN O
old JJ JJ O
man NN NN O
who WP WP O
began VBD VBD O
having VBG VBG O
dysphagia NN NN O
6/83 CD CD I-DATE
. . . O
   
On IN IN O
8/01/83 CD CD I-DATE
he PRP PRP O
was VBD VBD O
scheduled VBN VBN O
for IN IN O
a DT DT O
Colonoscopy NNP NNP O
, , , O
so IN IN O
his PRP$ PRP$ O
PCP NNP NNP O
suggested VBD VBD O
he PRP PRP O
have VBP VBP O
an DT DT O
UGI NNP NNP O
Endoscopy NNP NNP O
at IN IN O
the DT DT O
same JJ JJ O
time NN NN O
. . . O
   
The DT DT O
Colonoscopy NNP NNP O
demonstrated JJ JJ O
Diverticulosis NNP NNP O
and CC CC O
the DT DT O
UGI NNP NNP O
Endoscopy NNP NNP O
demonstrated VBD VBD O
a DT DT O
partially RB RB O
obstructing VBG VBG O
esophageal/gastric JJ JJ O
cardia NN NN O
tumor NN NN O
which WDT WDT O
was VBD VBD O
biopsied VBN VBN O
. . . O
   
Pathology NNP NNP O
revealed VBD VBD O
moderately RB RB O
to TO TO O
poorly RB RB O
differentiated VBN VBN O
adenocarcinoma NN NN O
. . . O
   
On IN IN O
8/10/83 CD CD I-DATE
an DT DT O
Abd NNP NNP O
and CC CC O
Pelvic NNP NNP O
CT NNP NNP O
were VBD VBD O
done VBN VBN O
showing VBG VBG O
: : : O
marked VBD VBD O
thickening NN NN O
of IN IN O
the DT DT O
wall NN NN O
of IN IN O
the DT DT O
distal JJ JJ O
esophagus NN NN O
(35-40cm JJ JJ O
by IN IN O
endoscopy NN NN O
- : : O
partial JJ JJ O
obstruction NN NN O
and CC CC O
circumferential JJ JJ O
) ) ) O
extending VBG VBG O
into IN IN O
the DT DT O
gastric JJ JJ O
cardia NN NN O
, , , O
consistent JJ JJ O
with IN IN O
biopsy NN NN O
proven VBN VBN O
adenocarcinoma NN NN O
. . . O
   
Also RB RB O
felt VBD VBD O
to TO TO O
be VB VB O
bleeding VBG VBG O
silently RB RB O
so RB RB O
placed VBN VBN O
on IN IN O
Fe NNP NNP O
replacement NN NN O
. . . O
   
Also RB RB O
, , , O
enlarged JJ JJ O
gastroepiploic NN NN O
, , , O
celiac NN NN O
and CC CC O
aortocaval NN NN O
lymph NN NN O
nodes NNS NNS O
consistent JJ JJ O
with IN IN O
metastatic JJ JJ O
disease NN NN O
. . . O
   
On IN IN O
8/10/83 CD CD I-DATE
a DT DT O
Chest NN NN O
CT NNP NNP O
revealed VBD VBD O
thickening NN NN O
of IN IN O
the DT DT O
lower JJR JJR O
esophagus NN NN O
extending VBG VBG O
into IN IN O
the DT DT O
chest NN NN O
esophageal NN NN O
junction NN NN O
. . . O
   
This DT DT O
is VBZ VBZ O
associated VBN VBN O
with IN IN O
lymphadenopathy NN NN O
in IN IN O
the DT DT O
( ( ( O
L NNP NNP O
) ) ) O
axilla NN NN O
, , , O
gastrohepatic JJ JJ O
ligament NN NN O
, , , O
celiac NN NN O
axis NNS NNS O
and CC CC O
retrocrural JJ JJ O
space NN NN O
. . . O
   
The DT DT O
appearance NN NN O
is VBZ VBZ O
highly RB RB O
suspicious JJ JJ O
for IN IN O
esophageal NN NN O
cancer NN NN O
and CC CC O
nodal NN NN O
spread NN NN O
. . . O
   
There EX EX O
is VBZ VBZ O
a DT DT O
3mm CD CD O
nodule NN NN O
adjacent JJ JJ O
to TO TO O
the DT DT O
( ( ( O
R NN NN O
) ) ) O
major JJ JJ O
fissure NN NN O
in IN IN O
the DT DT O
lung NN NN O
. . . O
   
PET NNP NNP O
scan VB VB O
confirmed VBD VBD O
axillary JJ JJ O
and CC CC O
abdominal JJ JJ O
involvement NN NN O
with IN IN O
cancer NN NN O
. . . O
   
The DT DT O
lung NN NN O
nodule NN NN O
was VBD VBD O
too RB RB O
small JJ JJ O
for IN IN O
PET NNP NNP O
to TO TO O
evaluate VB VB O
. . . O
   
He PRP PRP O
remains VBZ VBZ O
quite RB RB O
asymptomatic JJ JJ O
with IN IN O
no DT DT O
weight NN NN O
loss NN NN O
or CC CC O
dysphagia NN NN O
. . . O
   
He PRP PRP O
denies VBZ VBZ O
nausea NN NN O
, , , O
vomiting VBG VBG O
, , , O
diarrhea NN NN O
, , , O
or CC CC O
constipation NN NN O
. . . O
   
He PRP PRP O
has VBZ VBZ O
mild JJ JJ O
intermittant JJ JJ O
esophageal NN NN O
pain NN NN O
, , , O
usually RB RB O
after IN IN O
eating VBG VBG O
. . . O
   
No DT DT O
bleeding NN NN O
. . . O
   
He PRP PRP O
does VBZ VBZ O
complain NN NN O
of IN IN O
baseline NN NN O
DOE NNP NNP O
, , , O
although IN IN O
no DT DT O
SOB NNP NNP O
at IN IN O
rest NN NN O
. . . O
   
He PRP PRP O
is VBZ VBZ O
fatigued VBN VBN O
. . . O
   
Dizziness NNP NNP O
is VBZ VBZ O
improved VBN VBN O
with IN IN O
decrease NN NN O
in IN IN O
hypertension NN NN O
meds NNS NNS O
Problems/PMH NNP NNP O
: : : O
Repair NNP NNP O
of IN IN O
Zenker NNP NNP O
's POS POS O
diverticulum NN NN O
in IN IN O
2080 CD CD I-DATE
Aterial NNP NNP O
stent NN NN O
was VBD VBD O
placed VBN VBN O
in IN IN O
the DT DT O
mid JJ JJ O
LAD NNP NNP O
in IN IN O
4/80 CD CD I-DATE
Hypercholesteremia NNP NNP O
Arthritis NNP NNP O
Borderline NNP NNP O
Diabetic NNP NNP O
Heart NNP NNP O
murmur NN NN O
for IN IN O
50 CD CD O
years NNS NNS O
FH/SH NNP NNP O
: : : O
Never RB RB O
married VBN VBN O
No DT DT O
children NNS NNS O
Never RB RB O
smoked VBD VBD O
Rare NNP NNP O
ETOH NNP NNP O
- : : O
6 CD CD O
beers NNS NNS O
per IN IN O
year NN NN O
Aerospace NNP NNP I-PROFESSION
engineer NN NN I-PROFESSION
for IN IN O
40 CD CD O
years NNS NNS O
No DT DT O
family NN NN O
history NN NN O
of IN IN O
cancer NN NN O
Here RB RB O
with IN IN O
sister NN NN O
. . . O
   
Review NNP NNP O
of IN IN O
Systems NNPS NNPS O
: : : O
General NNP NNP O
: : : O
20 CD CD O
lb NN NN O
weight NN NN O
loss NN NN O
weight NN NN O
stabilized JJ JJ O
, , , O
moderate JJ JJ O
fatigue NN NN O
, , , O
no DT DT O
fevers NNS NNS O
, , , O
no DT DT O
chills NNS NNS O
. . . O
   
Respiratory NNP NNP O
: : : O
No DT DT O
cough NN NN O
, , , O
no DT DT O
SOB NNP NNP O
, , , O
baseline NN NN O
DOE NNP NNP O
, , , O
no DT DT O
hemoptysis NN NN O
, , , O
no DT DT O
wheezing VBG VBG O
HEENT NNP NNP O
: : : O
No DT DT O
neck NN NN O
swelling VBG VBG O
, , , O
no DT DT O
hoarseness NN NN O
, , , O
no DT DT O
hearing VBG VBG O
loss NN NN O
Cardiac NNP NNP O
: : : O
No DT DT O
chest NN NN O
pain NN NN O
, , , O
no DT DT O
palpitations NNS NNS O
( ( ( O
heart NN NN O
murmur NN NN O
for IN IN O
50 CD CD O
yrs NN NN O
. . . O
) ) ) O
arrythmias NN NN O
, , , O
no DT DT O
valve NN NN O
disease NN NN O
Gastrointestinal NNP NNP O
: : : O
No DT DT O
nausea NN NN O
, , , O
no DT DT O
vomiting VBG VBG O
, , , O
no DT DT O
diarrhea NN NN O
, , , O
no DT DT O
constipation NN NN O
, , , O
no DT DT O
bleeding VBG VBG O
Neurologic NNP NNP O
: : : O
No DT DT O
seizures NNS NNS O
, , , O
no DT DT O
headache NN NN O
, , , O
no DT DT O
weakness NN NN O
, , , O
no DT DT O
numbness/tingling VBG VBG O
Lymph NNP NNP O
nodes NNS NNS O
: : : O
No DT DT O
enlarged JJ JJ O
lymph NN NN O
nodes NNS NNS O
Musculoskeletal NNP NNP O
: : : O
No DT DT O
back NN NN O
pain NN NN O
, , , O
no DT DT O
neck NN NN O
pain NN NN O
, , , O
no DT DT O
leg NN NN O
pain NN NN O
, , , O
no DT DT O
arm NN NN O
pain NN NN O
Urologic NNP NNP O
: : : O
No DT DT O
hematuria NN NN O
, , , O
no DT DT O
dysuria NN NN O
, , , O
or CC CC O
no DT DT O
obstruction NN NN O
Endocrine NNP NNP O
: : : O
No DT DT O
adrenal NN NN O
, , , O
no DT DT O
thyroid NN NN O
or CC CC O
no DT DT O
parathyroid NN NN O
disease NN NN O
Hematologic NNP NNP O
: : : O
No DT DT O
bruising VBG VBG O
, , , O
no DT DT O
clotting VBG VBG O
, , , O
no DT DT O
bleeding VBG VBG O
Medications NNP NNP O
: : : O
Atenolol NNP NNP O
25 CD CD O
mg NN NN O
QD NNP NNP O
Triamterene/HCTZ NNP NNP O
50/25 CD CD O
QD NNP NNP O
Three CD CD O
times NNS NNS O
a DT DT O
week NN NN O
Vitamin NNP NNP O
B NNP NNP O
Complex NNP NNP O
100 CD CD O
u NN NN O
QD NNP NNP O
Folic NNP NNP O
Acid NNP NNP O
1 CD CD O
mg NN NN O
QD NNP NNP O
Iron NNP NNP O
Sulfate NNP NNP O
1 CD CD O
tab NN NN O
BID NNP NNP O
Lipitor NNP NNP O
10 CD CD O
mg NN NN O
QHS NNP NNP O
Terazosin NNP NNP O
5 CD CD O
mg NN NN O
QD NNP NNP O
Lisinopril NNP NNP O
2.5 CD CD O
mg NN NN O
QHS NNP NNP O
Ducolax NNP NNP O
2 CD CD O
tabs NNS NNS O
QD NNP NNP O
Allergies NNP NNP O
: : : O
Codeine-dizzy NNP NNP O
Physical JJ JJ O
Examination NNP NNP O
: : : O
Vital NNP NNP O
Signs NNP NNP O
BP NNP NNP O
116/58 CD CD O
, , , O
P NN NN O
60 CD CD O
, , , O
RR NNP NNP O
20 CD CD O
, , , O
Temp NNP NNP O
96.6 CD CD O
F NN NN O
, , , O
Ht NNP NNP O
67 CD CD O
in IN IN O
, , , O
Wt NNP NNP O
231 CD CD O
lb NN NN O
PS=1 NNP NNP O
Neck NNP NNP O
: : : O
no DT DT O
nodes NNS NNS O
palpable JJ JJ O
HEENT NNP NNP O
: : : O
No DT DT O
thrush NN NN O
or CC CC O
mucositis NN NN O
; : : O
   
EOMI NNP NNP O
; : : O
   
PERRL NNP NNP O
Skin NNP NNP O
: : : O
no DT DT O
rash NN NN O
Ext NNP NNP O
: : : O
without IN IN O
edema NN NN O
, , , O
clubbing VBG VBG O
Cor NNP NNP O
: : : O
S1 NNP NNP O
S2 NNP NNP O
Chest NN NN O
: : : O
clear JJ JJ O
lungs NNS NNS O
without IN IN O
wheezing VBG VBG O
or CC CC O
crackles NNS NNS O
Abdomen NNP NNP O
: : : O
soft JJ JJ O
, , , O
NT NNP NNP O
no DT DT O
HSM NNP NNP O
Nodes NNS NNS O
: : : O
neg NN NN O
cerv NN NN O
, , , O
sc NN NN O
Neuro NNP NNP O
: : : O
grossly RB RB O
non-focal JJ JJ O
Data NNP NNP O
( ( ( O
laboratory NN NN O
and CC CC O
radiographs NNS NNS O
) ) ) O
Results NNS NNS O
01/07/2084 CD CD I-DATE
BUN NNP NNP O
14 CD CD O
, , , O
CRE NNP NNP O
1.3 CD CD O
01/07/2084 CD CD I-DATE
WBC NNP NNP O
4.5 CD CD O
, , , O
RBC NNP NNP O
4.72 CD CD O
, , , O
HGB NNP NNP O
10.7 CD CD O
( ( ( O
L NNP NNP O
) ) ) O
, , , O
HCT NNP NNP O
34.0 CD CD O
( ( ( O
L NNP NNP O
) ) ) O
, , , O
MCV NNP NNP O
72 CD CD I-AGE
( ( ( O
L NNP NNP O
) ) ) O
, , , O
MCH NNP NNP O
22.7 CD CD O
( ( ( O
L NNP NNP O
) ) ) O
, , , O
MCHC NNP NNP O
31.5 CD CD O
, , , O
PLT NNP NNP O
131 CD CD O
( ( ( O
L NNP NNP O
) ) ) O
01/07/2084 CD CD I-DATE
ANEUT NNP NNP O
3.52 CD CD O
, , , O
ALYMP NNP NNP O
0.57 CD CD O
( ( ( O
L NNP NNP O
) ) ) O
, , , O
AMONS NNP NNP O
0.31 CD CD O
, , , O
AEOSN NNP NNP O
0.05 CD CD O
( ( ( O
L NNP NNP O
) ) ) O
, , , O
ABASOP NNP NNP O
0.01 CD CD O
Assessment NNP NNP O
and CC CC O
Plan NNP NNP O
: : : O
72 CD CD I-AGE
year NN NN O
old JJ JJ O
man NN NN O
with IN IN O
Stage NN NN O
IVB NNP NNP O
metastatic JJ JJ O
esophageal NN NN O
cancer NN NN O
s/p NN NN O
XRT NNP NNP O
with IN IN O
growing VBG VBG O
LN NNP NNP O
outside IN IN O
the DT DT O
field NN NN O
of IN IN O
radiation NN NN O
. . . O
   
Doing VBG VBG O
great JJ JJ O
. . . O
   
Renal NNP NNP O
vein NN NN O
thrombosis NNS NNS O
- : : O
continue VB VB O
same JJ JJ O
coumadin NN NN O
regimen NN NN O
Anemia NNP NNP O
, , , O
and CC CC O
DOE NNP NNP O
- : : O
continue VB VB O
procrit NN NN O
Consider NNP NNP O
head NN NN O
MRI NNP NNP O
if IN IN O
dizziness NN NN O
continues VBZ VBZ O
after IN IN O
hypotension NN NN O
and CC CC O
anemia NN NN O
are VBP VBP O
resolved VBN VBN O
Cycle NNP NNP O
3 CD CD O
, , , O
Week NN NN O
3 CD CD O
of IN IN O
taxotere NN NN O
chemotherapy NN NN O
today NN NN O
. . . O
   
Scans NNPS NNPS O
this DT DT O
week NN NN O
RTC NNP NNP O
in IN IN O
one CD CD O
week NN NN O
for IN IN O
results NNS NNS O
and CC CC O
plan NN NN O
____________________________________________ NN NN O
_ NN NN O
Jayda NNP NNP I-DOCTOR
Una NNP NNP I-DOCTOR
Xiang,NP NNP NNP O
cc NN NN O
: : : O
Dr NNP NNP O
. . . O
Geno NNP NNP I-DOCTOR
Guidry NNP NNP I-DOCTOR
Dr NNP NNP O
. . . O
Gregory NNP NNP I-DOCTOR
Mcguire NNP NNP I-DOCTOR
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2079-11-09 JJ JJ I-DATE
Cocke NNP NNP I-HOSPITAL
County NNP NNP I-HOSPITAL
Baptist NNP NNP I-HOSPITAL
Hospital NNP NNP I-HOSPITAL
0295 CD CD I-STREET
Keats NNP NNP I-STREET
Street NNP NNP I-STREET
GLENN NNP NNP O
, , , O
OLIVIA NNP NNP I-PATIENT
Whitewater NNP NNP I-CITY
, , , O
NC NNP NNP I-STATE
13662 CD CD I-ZIP
10776605 CD CD I-MEDICALRECORD
( ( ( O
545 CD CD O
) ) ) O
266-9272 NN NN I-PHONE
11/09/79 CD CD I-DATE
HISTORY NN NN O
OF IN IN O
PRESENT NNP NNP O
ILLNESS NNP NNP O
: : : O
The DT DT O
patient NN NN O
is VBZ VBZ O
a DT DT O
65-year-old JJ JJ O
female JJ JJ O
who WP WP O
returns VBZ VBZ O
to TO TO O
the DT DT O
clinic NN NN O
for IN IN O
a DT DT O
complete JJ JJ O
physical JJ JJ O
examination NN NN O
. . . O
   
PAST NNP NNP O
MEDICAL NNP NNP O
HISTORY NN NN O
: : : O
   
1 CD CD O
. . . O
Stage NN NN O
IV NNP NNP O
chronic JJ JJ O
renal JJ JJ O
disease NN NN O
approximate JJ JJ O
GFR NNP NNP O
of IN IN O
20 CD CD O
, , , O
currently RB RB O
being VBG VBG O
followed VBN VBN O
by IN IN O
nephrology NN NN O
at IN IN O
Salvation NNP NNP I-HOSPITAL
Army NNP NNP I-HOSPITAL
Hospital NNP NNP I-HOSPITAL
and CC CC O
has VBZ VBZ O
been VBN VBN O
evaluated VBN VBN O
for IN IN O
possible JJ JJ O
dialysis NNS NNS O
and CC CC O
also RB RB O
at IN IN O
the DT DT O
transplant NN NN O
clinic NN NN O
. . . O
   
2 CD CD O
. . . O
Diabetes NNP NNP O
mellitus NN NN O
. . . O
   
3 CD CD O
. . . O
Hypertension NNP NNP O
. . . O
   
4 CD CD O
. . . O
Asthma NNP NNP O
. . . O
   
5 CD CD O
. . . O
One CD CD O
episode NN NN O
of IN IN O
congestive JJ JJ O
heart NN NN O
failure NN NN O
this DT DT O
year NN NN O
. . . O
   
6 CD CD O
. . . O
Anemia NNP NNP O
. . . O
   
7 CD CD O
. . . O
Osteoporosis NNP NNP O
. . . O
   
8 CD CD O
. . . O
Diabetic NNP NNP O
retinopathy NN NN O
. . . O
   
FAMILY NN NN O
HISTORY NN NN O
: : : O
The DT DT O
patient NN NN O
's POS POS O
parents NNS NNS O
are VBP VBP O
dead JJ JJ O
. . . O
   
She PRP PRP O
does VBZ VBZ O
not RB RB O
know VB VB O
at IN IN O
what WP WP O
age NN NN O
or CC CC O
why WRB WRB O
they PRP PRP O
died VBD VBD O
. . . O
   
She PRP PRP O
also RB RB O
has VBZ VBZ O
eight CD CD O
siblings NNS NNS O
, , , O
only RB RB O
three CD CD O
of IN IN O
whom WP WP O
remain VB VB O
alive JJ JJ O
. . . O
   
She PRP PRP O
does VBZ VBZ O
not RB RB O
know VB VB O
the DT DT O
causes NNS NNS O
of IN IN O
death NN NN O
of IN IN O
the DT DT O
other JJ JJ O
five CD CD O
siblings NNS NNS O
. . . O
   
SOCIAL NNP NNP O
HISTORY NN NN O
: : : O
The DT DT O
patient NN NN O
is VBZ VBZ O
single JJ JJ O
. . . O
   
She PRP PRP O
has VBZ VBZ O
3 CD CD O
children NNS NNS O
and CC CC O
lives NNS NNS O
with IN IN O
her PRP$ PRP$ O
2 CD CD O
daughters NNS NNS O
and CC CC O
one CD CD O
son NN NN O
who WP WP O
are VBP VBP O
30 CD CD I-AGE
, , , O
28 CD CD I-AGE
, , , O
and CC CC O
26 CD CD I-AGE
years NNS NNS O
old JJ JJ O
. . . O
   
She PRP PRP O
is VBZ VBZ O
a DT DT O
retired VBN VBN O
Firefighter NNP NNP I-PROFESSION
. . . O
   
She PRP PRP O
has VBZ VBZ O
health NN NN O
insurance NN NN O
through IN IN O
a DT DT O
pension NN NN O
plan NN NN O
but CC CC O
has VBZ VBZ O
some DT DT O
difficulty NN NN O
paying VBG VBG O
for IN IN O
prescriptions NNS NNS O
. . . O
   
The DT DT O
patient NN NN O
does VBZ VBZ O
not RB RB O
smoke NN NN O
, , , O
does VBZ VBZ O
not RB RB O
drink VB VB O
alcohol NN NN O
, , , O
and CC CC O
does VBZ VBZ O
not RB RB O
use VB VB O
any DT DT O
drugs NNS NNS O
. . . O
   
MEDICATIONS NNP NNP O
: : : O
None NN NN O
. . . O
   
REVIEW NNP NNP O
OF IN IN O
SYSTEMS NNP NNP O
: : : O
The DT DT O
patient NN NN O
denies NNS NNS O
any DT DT O
weight NN NN O
gain NN NN O
or CC CC O
loss NN NN O
. . . O
   
No DT DT O
fever NN NN O
, , , O
chills NNS NNS O
, , , O
fatigue NN NN O
, , , O
or CC CC O
body NN NN O
aches NNS NNS O
. . . O
   
No DT DT O
blurred JJ JJ O
vision NN NN O
or CC CC O
light JJ JJ O
flashes NNS NNS O
. . . O
   
No DT DT O
hearing NN NN O
loss NN NN O
. . . O
   
No DT DT O
tinnitus NN NN O
. . . O
   
No DT DT O
ear NN NN O
pain NN NN O
. . . O
   
No DT DT O
chest NN NN O
pain NN NN O
, , , O
leg NN NN O
cramps NNS NNS O
, , , O
or CC CC O
palpitations NNS NNS O
. . . O
   
No DT DT O
shortness NN NN O
of IN IN O
breath NN NN O
, , , O
cough NN NN O
or CC CC O
wheezing VBG VBG O
, , , O
no DT DT O
loss NN NN O
of IN IN O
appetite NN NN O
, , , O
heartburn NN NN O
, , , O
nausea NN NN O
, , , O
vomiting VBG VBG O
, , , O
or CC CC O
diarrhea NN NN O
. . . O
   
No DT DT O
dysuria NN NN O
, , , O
hot JJ JJ O
flashes NNS NNS O
, , , O
or CC CC O
discharge NN NN O
. . . O
   
No DT DT O
painful JJ JJ O
joint JJ JJ O
stiffness NNS NNS O
or CC CC O
back RB RB O
pain NN NN O
. . . O
   
No DT DT O
skin NN NN O
rashes NNS NNS O
, , , O
moles NNS NNS O
, , , O
itching VBG VBG O
, , , O
or CC CC O
dryness NN NN O
. . . O
   
No DT DT O
seizures NNS NNS O
, , , O
numbness NNS NNS O
, , , O
imbalance NN NN O
, , , O
dizziness NN NN O
, , , O
or CC CC O
fainting VBG VBG O
. . . O
   
No DT DT O
anxiety NN NN O
or CC CC O
depression NN NN O
. . . O
   
No DT DT O
sweating VBG VBG O
, , , O
heat NN NN O
intolerance NN NN O
, , , O
polyuria NN NN O
, , , O
polydipsia NN NN O
, , , O
no DT DT O
bruising VBG VBG O
or CC CC O
bleeding VBG VBG O
, , , O
no DT DT O
swollen NN NN O
glands NNS NNS O
. . . O
   
PHYSICAL JJ JJ O
EXAMINATION NNP NNP O
: : : O
Reveals NNP NNP O
an DT DT O
elderly JJ JJ O
female JJ JJ O
in IN IN O
no DT DT O
acute JJ JJ O
distress NN NN O
. . . O
   
Blood NNP NNP O
pressure NN NN O
is VBZ VBZ O
150/70 CD CD O
, , , O
weight NN NN O
is VBZ VBZ O
168 CD CD O
pounds NNS NNS O
, , , O
height NN NN O
is VBZ VBZ O
60 CD CD O
inches NNS NNS O
, , , O
and CC CC O
pulse NN NN O
is VBZ VBZ O
   
88 CD CD O
. . . O
Skin NNP NNP O
is VBZ VBZ O
soft JJ JJ O
, , , O
dry JJ JJ O
, , , O
normal JJ JJ O
turgor NN NN O
, , , O
not RB RB O
jaundiced JJ JJ O
. . . O
   
HEENT NNP NNP O
: : : O
Atraumatic NNP NNP O
, , , O
normocephalic JJ JJ O
, , , O
pupils NNS NNS O
equal JJ JJ O
, , , O
reactive JJ JJ O
to TO TO O
light VB VB O
and CC CC O
accommodation NN NN O
. . . O
   
Extraocular NNP NNP O
movements NNS NNS O
are VBP VBP O
intact JJ JJ O
. . . O
   
Neck NN NN O
is VBZ VBZ O
supple JJ JJ O
. . . O
   
Jugular NNP NNP O
venous JJ JJ O
are VBP VBP O
flat JJ JJ O
. . . O
   
Heart NNP NNP O
: : : O
Regular NNP NNP O
rate NN NN O
and CC CC O
rhythm NN NN O
, , , O
positive JJ JJ O
S1 NNP NNP O
, , , O
S2 NNP NNP O
, , , O
negative JJ JJ O
S3 NNP NNP O
, , , O
S4 NNP NNP O
, , , O
no DT DT O
murmur NN NN O
. . . O
   
Abdomen NNP NNP O
is VBZ VBZ O
soft JJ JJ O
, , , O
nontender NN NN O
, , , O
positive JJ JJ O
bowel NN NN O
sounds VBZ VBZ O
. . . O
   
There EX EX O
are VBP VBP O
no DT DT O
lymphadenopathies NNS NNS O
in IN IN O
groin NN NN O
, , , O
axillae NN NN O
, , , O
or CC CC O
neck NN NN O
. . . O
   
Normal NNP NNP O
pendular NN NN O
breasts NNS NNS O
, , , O
no DT DT O
masses NNS NNS O
, , , O
no DT DT O
nipple NN NN O
discharge NN NN O
. . . O
   
Genital NNP NNP O
Exam NNP NNP O
: : : O
Normal NNP NNP O
external JJ JJ O
genitals NNS NNS O
. . . O
   
Vaginal NNP NNP O
walls NNS NNS O
pink VBP VBP O
. . . O
   
No DT DT O
adnexal NN NN O
or CC CC O
cervical JJ JJ O
motion NN NN O
tenderness NN NN O
. . . O
   
Pap NNP NNP O
smear NN NN O
is VBZ VBZ O
done VBN VBN O
by IN IN O
me PRP PRP O
. . . O
   
Rectal NNP NNP O
Exam NNP NNP O
: : : O
No DT DT O
masses NNS NNS O
in IN IN O
rectosigmoid NN NN O
. . . O
   
Stool NNP NNP O
is VBZ VBZ O
guaiac JJ JJ O
negative JJ JJ O
. . . O
   
Lower JJR JJR O
Extremities NNP NNP O
: : : O
No DT DT O
edema NN NN O
, , , O
nontender NN NN O
. . . O
   
Pulses NNP NNP O
2 CD CD O
+ NN NN O
and CC CC O
symmetric JJ JJ O
. . . O
   
Neurologic NNP NNP O
Exam NNP NNP O
: : : O
The DT DT O
patient NN NN O
is VBZ VBZ O
alert NN NN O
and CC CC O
oriented JJ JJ O
x3 NN NN O
, , , O
nonfocal JJ JJ O
. . . O
   
Sensory NNP NNP O
: : : O
Strength NNP NNP O
, , , O
deep JJ JJ O
tendon NN NN O
reflexes NNS NNS O
, , , O
and CC CC O
cranial JJ JJ O
nerves NNS NNS O
II-XII NNP NNP O
are VBP VBP O
within IN IN O
normal JJ JJ O
limits NNS NNS O
. . . O
   
Funduscopic NNP NNP O
Exam NNP NNP O
: : : O
Disks NNP NNP O
are VBP VBP O
sharp JJ JJ O
. . . O
   
Some DT DT O
microaneurysms NNS NNS O
and CC CC O
cotton-wool JJ JJ O
spots NNS NNS O
. . . O
   
Normal NNP NNP O
mood NN NN O
and CC CC O
affect NN NN O
. . . O
   
LABORATORY NNP NNP O
DATA NNP NNP O
: : : O
Most JJS JJS O
recent JJ JJ O
labs NNS NNS O
done VBN VBN O
at IN IN O
Salvation NNP NNP I-HOSPITAL
Army NNP NNP I-HOSPITAL
Hospital NNP NNP I-HOSPITAL
on IN IN O
10/17/2079 CD CD I-DATE
included VBD VBD O
a DT DT O
hematocrit NN NN O
of IN IN O
30.1 CD CD O
, , , O
hemoglobin NN NN O
of IN IN O
9.8 CD CD O
, , , O
a DT DT O
white JJ JJ O
count NN NN O
of IN IN O
5.4 CD CD O
, , , O
and CC CC O
a DT DT O
platelet NN NN O
count NN NN O
338 CD CD O
. . . O
   
Sodium NNP NNP O
was VBD VBD O
143 CD CD O
, , , O
potassium NN NN O
4.5 CD CD O
, , , O
chloride NN NN O
106 CD CD O
, , , O
CO2 NNP NNP O
of IN IN O
27.5 CD CD O
, , , O
creatinine NN NN O
0.0 CD CD O
, , , O
BUN NNP NNP O
   
66 CD CD O
. . . O
Glucose NNP NNP O
was VBD VBD O
117 CD CD O
, , , O
PTH NNP NNP O
level NN NN O
was VBD VBD O
112 CD CD O
, , , O
calcium NN NN O
9.0 CD CD O
, , , O
magnesium NN NN O
2.5 CD CD O
, , , O
and CC CC O
phosphorus NN NN O
4.8 CD CD O
. . . O
   
IMPRESSION NNP NNP O
AND CC CC O
PLAN NNP NNP O
: : : O
   
1 CD CD O
. . . O
Chronic NNP NNP O
renal JJ JJ O
failure NN NN O
, , , O
current JJ JJ O
GFR NNP NNP O
is VBZ VBZ O
17-19 JJ JJ O
and CC CC O
has VBZ VBZ O
been VBN VBN O
stable JJ JJ O
over IN IN O
the DT DT O
last JJ JJ O
year NN NN O
or CC CC O
so RB RB O
. . . O
   
This DT DT O
patient NN NN O
is VBZ VBZ O
currently RB RB O
on IN IN O
furosemide NN NN O
, , , O
and CC CC O
sevelamer NN NN O
for IN IN O
hyperphosphatemia NN NN O
. . . O
   
She PRP PRP O
follows VBZ VBZ O
up RB RB O
with IN IN O
the DT DT O
renal JJ JJ O
department NN NN O
at IN IN O
Salvation NNP NNP I-HOSPITAL
Army NNP NNP I-HOSPITAL
Hospital NNP NNP I-HOSPITAL
regularly RB RB O
. . . O
   
2 CD CD O
. . . O
Anemia NNP NNP O
, , , O
her PRP$ PRP$ O
hematocrit NN NN O
has VBZ VBZ O
increased VBN VBN O
over IN IN O
the DT DT O
last JJ JJ O
several JJ JJ O
months NNS NNS O
from IN IN O
about IN IN O
20 CD CD O
to TO TO O
   
30 CD CD I-AGE
. . . O
The DT DT O
patient NN NN O
continues VBZ VBZ O
on IN IN O
darbepoetin NN NN O
injections NNS NNS O
. . . O
   
Also RB RB O
, , , O
continues VBZ VBZ O
on IN IN O
Niferex NNP NNP O
150 CD CD O
mg NN NN O
once RB RB O
daily JJ JJ O
. . . O
   
3 CD CD O
. . . O
Diabetes NNP NNP O
, , , O
this DT DT O
has VBZ VBZ O
recently RB RB O
has VBZ VBZ O
been VBN VBN O
under IN IN O
very RB RB O
good JJ JJ O
control NN NN O
with IN IN O
a DT DT O
hemoglobin NN NN O
of IN IN O
6.5 CD CD O
, , , O
done VBN VBN O
on IN IN O
05/25/2079 CD CD I-DATE
. . . O
   
4 CD CD O
. . . O
Hypertension NNP NNP O
. . . O
   
This DT DT O
also RB RB O
has VBZ VBZ O
been VBN VBN O
very RB RB O
well RB RB O
controlled VBN VBN O
on IN IN O
the DT DT O
patient NN NN O
's POS POS O
current JJ JJ O
regimen NNS NNS O
including VBG VBG O
nifedipine NN NN O
and CC CC O
lisinopril NN NN O
. . . O
   
5 CD CD O
. . . O
Osteoporosis NNP NNP O
. . . O
   
The DT DT O
patient NN NN O
is VBZ VBZ O
currently RB RB O
taking VBG VBG O
Fosamax NNP NNP O
, , , O
and CC CC O
we PRP PRP O
will MD MD O
repeat VB VB O
a DT DT O
bone NN NN O
densitometry NN NN O
on IN IN O
12/17/2079 CD CD I-DATE
. . . O
   
6 CD CD O
. . . O
Asthma NNP NNP O
. . . O
   
The DT DT O
patient NN NN O
is VBZ VBZ O
currently RB RB O
completely RB RB O
asymptomatic JJ JJ O
and CC CC O
is VBZ VBZ O
using VBG VBG O
albuterol NN NN O
inhaler NN NN O
only RB RB O
very RB RB O
rarely RB RB O
. . . O
   
7 CD CD O
. . . O
Regular NNP NNP O
healthcare NN NN O
maintenance NN NN O
. . . O
   
The DT DT O
patient NN NN O
had VBD VBD O
a DT DT O
normal JJ JJ O
mammogram NN NN O
on IN IN O
06/15/2079 CD CD I-DATE
. . . O
   
We PRP PRP O
will MD MD O
repeat VB VB O
a DT DT O
hemoglobin NN NN O
A1c NNP NNP O
when WRB WRB O
she PRP PRP O
returns VBZ VBZ O
for IN IN O
her PRP$ PRP$ O
next JJ JJ O
visit NN NN O
. . . O
   
_____________________________ NN NN O
_ NN NN O
Infant NNP NNP I-DOCTOR
Brewer NNP NNP I-DOCTOR
, , , O
MD NNP NNP O
Dictated NNP NNP O
By IN IN O
: : : O
Infant NNP NNP I-DOCTOR
Brewer NNP NNP I-DOCTOR
eScription NN NN O
document:1-8422557 JJ JJ O
EMSSten NNP NNP O
Tel NNP NNP O
DD NNP NNP O
: : : O
11/09/79 CD CD I-DATE
DT NNP NNP O
: : : O
11/09/79 CD CD I-DATE
DV NNP NNP O
: : : O
11/09/79 CD CD I-DATE
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2062-07-21 JJ JJ I-DATE
Halcyon NNP NNP I-HOSPITAL
House NNP NNP I-HOSPITAL
Intern NNP NNP O
Admission NNP NNP O
Note VB VB O
PATIENT NNP NNP O
: : : O
Ostrander NNP NNP O
, , , O
Pamela NNP NNP I-PATIENT
. . . O
   
MR NNP NNP O
: : : O
1612187 CD CD I-MEDICALRECORD
ADMIT NNP NNP O
DATE NN NN O
: : : O
07/21/2062 CD CD I-DATE
PCP NNP NNP O
: : : O
Jameson NNP NNP I-DOCTOR
CODE NNP NNP O
STATUS NNP NNP O
: : : O
Full NNP NNP O
Code NNP NNP O
PATIENT NNP NNP O
CONTACT NNP NNP O
: : : O
CC NNP NNP O
: : : O
Fatigue NNP NNP O
HPI NNP NNP O
: : : O
This DT DT O
is VBZ VBZ O
a DT DT O
59 CD CD I-AGE
female NN NN O
with IN IN O
PMH NNP NNP O
significant JJ JJ O
for IN IN O
HTN NNP NNP O
, , , O
DM NNP NNP O
, , , O
Mood NNP NNP O
disorder NN NN O
NOS NNP NNP O
, , , O
Breast NNP NNP O
lump NN NN O
. . . O
   
Who WP WP O
present JJ JJ O
to TO TO O
the DT DT O
EW NNP NNP O
with IN IN O
fatigue NN NN O
and CC CC O
BP NNP NNP O
in IN IN O
the DT DT O
200s CD CD O
. . . O
   
According VBG VBG O
to TO TO O
the DT DT O
patient NN NN O
, , , O
she PRP PRP O
had VBD VBD O
high JJ JJ O
blood NN NN O
pressure NN NN O
for IN IN O
years NNS NNS O
that WDT WDT O
was VBD VBD O
well RB RB O
controlled VBN VBN O
according VBG VBG O
to TO TO O
her PRP$ PRP$ O
up RP RP O
till NN NN O
Jan NNP NNP I-DATE
, , , O
when WRB WRB O
she PRP PRP O
lost VBD VBD O
her PRP$ PRP$ O
insurance NN NN O
and CC CC O
could MD MD O
not RB RB O
fill VB VB O
in IN IN O
her PRP$ PRP$ O
prescriptions NNS NNS O
. . . O
   
In IN IN O
Jan NNP NNP I-DATE
of IN IN O
this DT DT O
year NN NN O
, , , O
the DT DT O
patient NN NN O
stopped VBD VBD O
taking VBG VBG O
any DT DT O
BP NNP NNP O
meds NNS NNS O
up RB RB O
till IN IN O
she PRP PRP O
had VBD VBD O
a DT DT O
visit NN NN O
with IN IN O
her PRP$ PRP$ O
Psych NNP NNP O
nurse NN NN O
which WDT WDT O
found VBD VBD O
her PRP$ PRP$ O
BP NNP NNP O
to TO TO O
be VB VB O
in IN IN O
the DT DT O
200s CD CD O
sent VBD VBD O
her PRP PRP O
to TO TO O
EW NNP NNP O
, , , O
they PRP PRP O
controlled VBD VBD O
her PRP$ PRP$ O
BP NNP NNP O
and CC CC O
sent VBD VBD O
her PRP PRP O
out IN IN O
on IN IN O
Metoprolol NNP NNP O
50 CD CD O
BID NNP NNP O
, , , O
and CC CC O
Lisinopril NNP NNP O
10 CD CD O
mg NN NN O
QD NNP NNP O
. . . O
   
After IN IN O
which WDT WDT O
, , , O
the DT DT O
patient NN NN O
had VBD VBD O
a DT DT O
trip NN NN O
to TO TO O
Peru NNP NNP I-COUNTRY
and CC CC O
ran VBD VBD O
out IN IN O
of IN IN O
her PRP$ PRP$ O
medication NN NN O
2 CD CD O
days NNS NNS O
priory NN NN O
to TO TO O
her PRP$ PRP$ O
return NN NN O
. . . O
   
When WRB WRB O
she PRP PRP O
returned VBD VBD O
about IN IN O
a DT DT O
wk NN NN O
ago RB RB O
the DT DT O
patient NN NN O
presented VBN VBN O
to TO TO O
EW NNP NNP O
because IN IN O
of IN IN O
another DT DT O
episode NN NN O
of IN IN O
hypertensive JJ JJ O
emergency NN NN O
, , , O
for IN IN O
which WDT WDT O
, , , O
she PRP PRP O
was VBD VBD O
D/C NNP NNP O
with IN IN O
a DT DT O
follow VB VB O
up RB RB O
with IN IN O
one CD CD O
of IN IN O
the DT DT O
HGH NNP NNP I-HOSPITAL
PCPs NNP NNP O
. . . O
   
Patient NNP NNP O
could MD MD O
not RB RB O
get VB VB O
an DT DT O
appointment NN NN O
until IN IN O
later RB RB O
this DT DT O
month NN NN O
, , , O
and CC CC O
she PRP PRP O
was VBD VBD O
having VBG VBG O
a DT DT O
feeling NN NN O
of IN IN O
fatigue NN NN O
today NN NN O
, , , O
so IN IN O
she PRP PRP O
called VBD VBD O
her PRP$ PRP$ O
APS NNP NNP O
nurse NN NN O
which WDT WDT O
one CD CD O
more JJR JJR O
time NN NN O
found VBD VBD O
her PRP PRP O
to TO TO O
be VB VB O
in IN IN O
the DT DT O
200s NN NN O
and CC CC O
sent VBD VBD O
her PRP PRP O
to TO TO O
the DT DT O
EW NNP NNP O
. . . O
   
On IN IN O
ROS NNP NNP O
: : : O
Patient NNP NNP O
denies NNS NNS O
any DT DT O
HA NNP NNP O
, , , O
changes NNS NNS O
in IN IN O
vision NN NN O
, , , O
nausia NN NN O
, , , O
vomiting VBG VBG O
, , , O
chest NN NN O
pain NN NN O
, , , O
palpitation NN NN O
, , , O
SOB NNP NNP O
, , , O
Abd NNP NNP O
pain NN NN O
, , , O
syncope NN NN O
, , , O
palpitation NN NN O
, , , O
recent JJ JJ O
wt NN NN O
changes NNS NNS O
, , , O
change NN NN O
in IN IN O
her PRP$ PRP$ O
bowel NN NN O
or CC CC O
urinary JJ JJ O
habits NNS NNS O
. . . O
   
However RB RB O
she PRP PRP O
does VBZ VBZ O
describe VB VB O
feeling VBG VBG O
fatigued VBN VBN O
, , , O
episodes NNS NNS O
of IN IN O
flushing VBG VBG O
, , , O
history NN NN O
of IN IN O
hearing NN NN O
double JJ JJ O
messages NNS NNS O
when WRB WRB O
she PRP PRP O
communicate VBP VBP O
with IN IN O
other JJ JJ O
people NNS NNS O
. . . O
   
No DT DT O
feeling NN NN O
of IN IN O
hot JJ JJ O
or CC CC O
cold JJ JJ O
. . . O
   
Emergency NNP NNP O
room NN NN O
course NN NN O
: : : O
In IN IN O
the DT DT O
EW NNP NNP O
, , , O
the DT DT O
BP NNP NNP O
was VBD VBD O
210/109 CD CD O
, , , O
P NN NN O
: : : O
90 CD CD O
, , , O
RR:18, NNP NNP O
SAO2 NNP NNP O
100 CD CD O
% NN NN O
. . . O
   
The DT DT O
patient NN NN O
received VBD VBD O
5mg CD CD O
of IN IN O
lopressor NN NN O
IV NNP NNP O
and CC CC O
and CC CC O
50mg CD CD O
PO NNP NNP O
for IN IN O
which WDT WDT O
her PRP$ PRP$ O
BP NNP NNP O
had VBD VBD O
minimal JJ JJ O
response NN NN O
. . . O
   
She PRP PRP O
also RB RB O
received VBD VBD O
20 CD CD O
mg NN NN O
of IN IN O
IV NNP NNP O
Labetalol NNP NNP O
then RB RB O
200mg CD CD O
PO NNP NNP O
' POS POS O
after IN IN O
which WDT WDT O
her PRP$ PRP$ O
blood NN NN O
pressure NN NN O
was VBD VBD O
down RB RB O
to TO TO O
the DT DT O
180s NN NN O
, , , O
then RB RB O
it PRP PRP O
started VBD VBD O
climbing VBG VBG O
back RB RB O
up RB RB O
to TO TO O
the DT DT O
200s NN NN O
for IN IN O
which WDT WDT O
she PRP PRP O
received VBD VBD O
another DT DT O
10 CD CD O
mg NN NN O
IV NNP NNP O
, , , O
the DT DT O
highest JJS JJS O
reading NN NN O
the DT DT O
patient NN NN O
got VBD VBD O
was VBD VBD O
257/188 CD CD O
. . . O
   
The DT DT O
patient NN NN O
was VBD VBD O
also RB RB O
given VBN VBN O
a DT DT O
325 CD CD O
mg NN NN O
ASA NNP NNP O
, , , O
and CC CC O
the DT DT O
first JJ JJ O
2 CD CD O
cardiac JJ JJ O
enzymes NNS NNS O
were VBD VBD O
negative JJ JJ O
. . . O
   
Relative NNP NNP O
to TO TO O
a DT DT O
previous JJ JJ O
EKG NNP NNP O
, , , O
the DT DT O
EW NNP NNP O
EKG NNP NNP O
showed VBD VBD O
t-wave JJ JJ O
inversion NN NN O
in IN IN O
V5 NNP NNP O
and CC CC O
V6 NNP NNP O
. . . O
   
PMH NNP NNP O
: : : O
DM NNP NNP O
no DT DT O
insulin NN NN O
requirement NN NN O
. . . O
   
HTN NNP NNP O
mood NN NN O
disorder NN NN O
Breast NNP NNP O
lump NN NN O
MEDICATIONS NNP NNP O
ON IN IN O
ADMISSION NNP NNP O
Metforman NNP NNP O
1000mg CD CD O
BID NNP NNP O
Seroquel NNP NNP O
100 CD CD O
mg NN NN O
QHS NNP NNP O
Metoprolol NNP NNP O
50 CD CD O
mg NN NN O
BID NNP NNP O
Lisinopril NNP NNP O
10mg CD CD O
QD NNP NNP O
Neurontin NNP NNP O
500 CD CD O
QHS NNP NNP O
ALLERGIES NNP NNP O
: : : O
NKDA NNP NNP O
FAMILY NN NN O
HISTORY NN NN O
: : : O
HTN NNP NNP O
, , , O
DM NNP NNP O
, , , O
CAD NNP NNP O
SOCIAL NNP NNP O
HISTORY NN NN O
: : : O
PHYSICAL JJ JJ O
EXAM NNP NNP O
: : : O
Floor NNP NNP O
: : : O
HR NNP NNP O
: : : O
72 CD CD O
BP NNP NNP O
: : : O
203/109 CD CD O
Temp NNP NNP O
: : : O
98.3RR: CD CD O
18 CD CD O
I&amp NNP NNP O
; : : O
   
O NNP NNP O
: : : O
in IN IN O
out IN IN O
Gen NNP NNP O
: : : O
NAD NNP NNP O
Coop NNP NNP O
A&amp NNP NNP O
; : : O
   
OX NNP NNP O
HEENT NNP NNP O
: : : O
PERRL NNP NNP O
EOMI NNP NNP O
. . . O
   
oral JJ JJ O
dry JJ JJ O
. . . O
   
No DT DT O
thyromegally RB RB O
. . . O
   
Neck NNP NNP O
: : : O
supp NN NN O
NT NNP NNP O
, , , O
no DT DT O
bruit NN NN O
, , , O
JVD NNP NNP O
flat JJ JJ O
, , , O
no DT DT O
nodes NNS NNS O
Chest NN NN O
: : : O
CTA-B NNP NNP O
Cardiac NNP NNP O
: : : O
RRR NNP NNP O
. . . O
   
Nl NNP NNP O
S1/S2 NNP NNP O
no DT DT O
S3/S4, NNP NNP O
normal JJ JJ O
S1 NNP NNP O
. . . O
   
No DT DT O
rubs NN NN O
/ NN NN O
murmurs/thrill NN NN O
. . . O
   
Abd NNP NNP O
: : : O
S/NT/ND NNP NNP O
, , , O
no DT DT O
palpable JJ JJ O
masses NNS NNS O
, , , O
no DT DT O
hepatosplenomegaly NN NN O
, , , O
no DT DT O
bruits NNS NNS O
, , , O
no DT DT O
palpable JJ JJ O
AAA NNP NNP O
. . . O
   
Ext NNP NNP O
: : : O
Pulses NNP NNP O
+ NN NN O
2 CD CD O
symmetrical JJ JJ O
, , , O
palp NN NN O
PT/DT NNP NNP O
, , , O
No DT DT O
Edema NNP NNP O
, , , O
+ NN NN O
color NN NN O
capr NN NN O
, , , O
Nails NNP NNP O
normal JJ JJ O
, , , O
without IN IN O
clubbing VBG VBG O
, , , O
cyanosis NNS NNS O
, , , O
or CC CC O
deformities NNS NNS O
. . . O
   
Skin NNP NNP O
: : : O
Nl NNP NNP O
texture NN NN O
, , , O
no DT DT O
lesions NNS NNS O
or CC CC O
rashes NNS NNS O
. . . O
   
Neuro NNP NNP O
: : : O
- : : O
Alert NNP NNP O
, , , O
oriented JJ JJ O
X3 NN NN O
. . . O
   
Clear NNP NNP O
speech NN NN O
. . . O
   
- : : O
Cranial NNP NNP O
nerves NNS NNS O
II-XII NNP NNP O
intact JJ JJ O
by IN IN O
gross JJ JJ O
confrontation NN NN O
. . . O
   
- : : O
No DT DT O
abnormal NN NN O
movements NNS NNS O
seen VBN VBN O
. . . O
   
- - - O
Patellar NNP NNP O
, , , O
Achillies NNP NNP O
, , , O
symmetrical JJ JJ O
. . . O
   
Babinski NNP NNP O
neg NN NN O
. . . O
   
- : : O
Intact NNP NNP O
touch NN NN O
and CC CC O
vibratory NN NN O
sens NNS NNS O
. . . O
   
Nl NNP NNP O
Motor NNP NNP O
strength NN NN O
. . . O
   
ROM NNP NNP O
intact JJ JJ O
. . . O
   
LABS NNP NNP O
: : : O
137 CD CD O
107 CD CD O
16 CD CD O
122 CD CD O
3.3 CD CD O
28.6 CD CD O
.8 CD CD O
Ca:9.3 NNP NNP O
Mg:1.7 NNP NNP O
Ph:3.6 NNP NNP O
13.3 CD CD O
9.7 CD CD O
286 CD CD O
40 CD CD O
UA NNP NNP O
: : : O
UA-COLOR NNP NNP O
YELLOW NNP NNP O
UA-APP NNP NNP O
SLIGHT NNP NNP O
UA-GLUC NNP NNP O
Negative NNP NNP O
Negative NNP NNP O
NEG NNP NNP O
UA-BILI NNP NNP O
NEG NNP NNP O
UA-KET NNP NNP O
Negative NNP NNP O
Negative NNP NNP O
NEG NNP NNP O
UA-SPGR NNP NNP O
1.020 CD CD O
1.015 NN NN O
1.010 CD CD O
UA-BLD NNP NNP O
Negative NNP NNP O
Negative NNP NNP O
NEG NNP NNP O
UA-PH NNP NNP O
5.5 CD CD O
6.5 CD CD O
7 CD CD O
UA-ALB NNP NNP O
Negative NNP NNP O
Negative NNP NNP O
NEG NNP NNP O
UA-UROBI NNP NNP O
NEG NNP NNP O
UA-NIT NNP NNP O
Negative NNP NNP O
Negative NNP NNP O
NEG NNP NNP O
UA-WBC NNP NNP O
see VB VB O
detail NN NN O
see VB VB O
detail NN NN O
TRACE NNP NNP O
HCAST NNP NNP O
Negative NNP NNP O
0-2 JJ JJ O
UAS-RBC NNP NNP O
0-2 JJ JJ O
0-2 JJ JJ O
0-2 JJ JJ O
UAS-WBC NNP NNP O
20-50 JJ JJ O
5-10 JJ JJ O
0-2 JJ JJ O
UAS-BACT NNP NNP O
Few JJ JJ O
Negative JJ JJ O
UAS-MUC NNP NNP O
PRESENT NNP NNP O
UAS-SQHI NNP NNP O
Few JJ JJ O
Negative NNP NNP O
FEW JJ JJ O
UAS-AMOR NNP NNP O
FEW JJ JJ O
Cardiac NNP NNP O
: : : O
Neg NNP NNP O
X NNP NNP O
2 CD CD O
- : : O
Trop NNP NNP O
T NN NN O
: : : O
- : : O
CK-MB NNP NNP O
: : : O
- : : O
CPK NNP NNP O
: : : O
EKG NNP NNP O
: : : O
80 CD CD O
, , , O
LVH NNP NNP O
, , , O
LA NNP NNP O
enlarg NN NN O
, , , O
new JJ JJ O
t-wave JJ JJ O
inversion NN NN O
in IN IN O
V5/V6 NNP NNP O
comapred VBD VBD O
to TO TO O
a DT DT O
wk NN NN O
ago RB RB O
. . . O
   
ASSESSMENT NNP NNP O
& CC CC O
amp NN NN O
; : : O
   
PLAN NNP NNP O
: : : O
59 CD CD I-AGE
yo NN NN O
female JJ JJ O
with IN IN O
hypertensive JJ JJ O
emergency NN NN O
, , , O
fatigue NN NN O
, , , O
and CC CC O
hypokalemia NN NN O
, , , O
no DT DT O
other JJ JJ O
symtomes NNS NNS O
. . . O
   
EKG NNP NNP O
with IN IN O
new JJ JJ O
wave NN NN O
inversion NN NN O
in IN IN O
lateral NN NN O
leads VBZ VBZ O
and CC CC O
negative JJ JJ O
cardiac JJ JJ O
enzymes NNS NNS O
. . . O
   
1 CD CD O
- : : O
Hypertensive NNP NNP O
Emergency NNP NNP O
: : : O
patient NN NN O
received VBD VBD O
2 CD CD O
inch NN NN O
nitropaste NN NN O
on IN IN O
floor NN NN O
with IN IN O
no DT DT O
decrease NN NN O
in IN IN O
BP NNP NNP O
. . . O
   
10mg CD CD O
IV NNP NNP O
hydralizine NN NN O
got VBD VBD O
her PRP$ PRP$ O
down IN IN O
to TO TO O
the DT DT O
150s-160s. JJ JJ O
   
Goal NNP NNP O
is VBZ VBZ O
around IN IN O
160-170 JJ JJ O
. . . O
   
Will MD MD O
start VB VB O
Nicardipine NNP NNP O
PO NNP NNP O
20mg CD CD O
TID NNP NNP O
and CC CC O
Labetolol NNP NNP O
300mg CD CD O
PO NNP NNP O
and CC CC O
titrate VB VB O
up IN IN O
to TO TO O
BP NNP NNP O
goal NN NN O
. . . O
   
to TO TO O
maintain VB VB O
goal NN NN O
2 CD CD O
- : : O
Hypkalemia/fatigue/hypertension NNP NNP O
: : : O
worried VBD VBD O
about IN IN O
secondary JJ JJ O
casues NNS NNS O
of IN IN O
HTN NNP NNP O
, , , O
namely RB RB O
hyperaldo JJ JJ O
state NN NN O
or CC CC O
liddel NN NN O
syndrom NN NN O
. . . O
   
Will NNP NNP O
check VB VB O
an DT DT O
8am CD CD O
ambulating VBG VBG O
PAC NNP NNP O
to TO TO O
PRA NNP NNP O
ratio NN NN O
, , , O
will MD MD O
also RB RB O
check VB VB O
a DT DT O
spot NN NN O
urine NN NN O
to TO TO O
plasma VB VB O
K. NN NN O
Will NNP NNP O
check VB VB O
serum NN NN O
Metanephrine NNP NNP O
for IN IN O
pheo NN NN O
, , , O
and CC CC O
24 CD CD O
hrs NN NN O
urine NN NN O
for IN IN O
cortisol NN NN O
, , , O
lytes NNS NNS O
, , , O
VMA NNP NNP O
, , , O
metanephrines NNS NNS O
to TO TO O
check VB VB O
for IN IN O
cushings NNS NNS O
and CC CC O
pheochromoctoma NN NN O
. . . O
   
Will MD MD O
get VB VB O
a DT DT O
MRA NNP NNP O
to TO TO O
evaluate VB VB O
for IN IN O
renal JJ JJ O
artery NN NN O
stenosis NN NN O
. . . O
   
2 CD CD O
- : : O
Mood NNP NNP O
disorder NN NN O
: : : O
no DT DT O
active JJ JJ O
hallucination NN NN O
, , , O
will MD MD O
continue VB VB O
with IN IN O
Seroquel NNP NNP O
. . . O
   
3 CD CD O
- : : O
DM NNP NNP O
: : : O
insulin NN NN O
sliding VBG VBG O
scale NN NN O
, , , O
QID NNP NNP O
finger NN NN O
sticks VBZ VBZ O
. . . O
   
4 CD CD O
- : : O
UTI NNP NNP O
: : : O
urine NN NN O
with IN IN O
WBC NNP NNP O
, , , O
? . . O
starting VBG VBG O
Bactrim NNP NNP O
DS NNP NNP O
X3 NNP NNP O
days NNS NNS O
. . . O
   
5 CD CD O
- : : O
Prophy NNP NNP O
: : : O
Fragmin NNP NNP O
SC NNP NNP O
. . . O
   
Xavier NNP NNP I-DOCTOR
Aaron NNP NNP I-DOCTOR
Lowe NNP NNP I-DOCTOR
M.D. NN NN O
75059 CD CD I-PHONE
Name NN NN O
, , , O
Pager NNP NNP O
# # # O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2069-02-17 JJ JJ I-DATE
MD NNP NNP O
Connect NNP NNP O
Call NNP NNP O
11:59pm CD CD O
2/16/69 CD CD I-DATE
from IN IN O
Dr NNP NNP O
. . . O
Hale NNP NNP I-DOCTOR
at IN IN O
Senior NNP NNP I-HOSPITAL
Care NNP NNP I-HOSPITAL
Clinic NNP NNP I-HOSPITAL
Queen NNP NNP I-CITY
Creek NNP NNP I-CITY
, , , O
SD NNP NNP I-STATE
regarding VBG VBG O
Terri NNP NNP I-PATIENT
Bird NNP NNP I-PATIENT
. . . O
   
Patient NNP NNP O
admitted VBD VBD O
there EX EX O
2/12/69 CD CD I-DATE
with IN IN O
CHF NNP NNP O
exacerbation NN NN O
with IN IN O
some DT DT O
associated VBN VBN O
COPD NNP NNP O
exacerbation NN NN O
and CC CC O
associated VBN VBN O
pneumonia NN NN O
. . . O
   
All DT DT O
initially RB RB O
improved VBN VBN O
but CC CC O
then RB RB O
clinically RB RB O
worsening VBG VBG O
2/14-2/16 JJ JJ O
. . . O
   
Patient NNP NNP O
requiring VBG VBG O
100 CD CD O
% NN NN O
NRB NNP NNP O
mask NN NN O
to TO TO O
maintain VB VB O
normal JJ JJ O
saturation NN NN O
with IN IN O
rising VBG VBG O
BUN/CR NNP NNP O
( ( ( O
hx NN NN O
kidney NN NN O
transplant NN NN O
) ) ) O
. . . O
   
Clinically NNP NNP O
showing VBG VBG O
pulmonary JJ JJ O
edema NN NN O
but CC CC O
no DT DT O
urine NN NN O
output NN NN O
to TO TO O
IV NNP NNP O
lasix NN NN O
. . . O
   
Patient NNP NNP O
had VBD VBD O
established VBN VBN O
DNR NNP NNP O
status NN NN O
. . . O
   
Request NNP NNP O
by IN IN O
family NN NN O
to TO TO O
Dr NNP NNP O
. . . O
Hale NNP NNP I-DOCTOR
to TO TO O
transfer VB VB O
patient NN NN O
to TO TO O
GCM NNP NNP I-HOSPITAL
. . . O
   
I PRP PRP O
spoke VBD VBD O
to TO TO O
MD NNP NNP O
, , , O
nurse NN NN O
, , , O
and CC CC O
daughter-in-law JJ JJ O
and CC CC O
offered VBN VBN O
to TO TO O
accept VB VB O
patient NN NN O
when WRB WRB O
she PRP PRP O
was VBD VBD O
medically RB RB O
stabilized VBN VBN O
. . . O
   
I PRP PRP O
thought VBD VBD O
she PRP PRP O
was VBD VBD O
too RB RB O
ill JJ JJ O
to TO TO O
safely RB RB O
transfer VB VB O
at IN IN O
the DT DT O
time NN NN O
without IN IN O
intubation NN NN O
before-hand NN NN O
. . . O
   
I PRP PRP O
called VBD VBD O
RN NNP NNP O
back RB RB O
at IN IN O
6am CD CD O
and CC CC O
learned VBD VBD O
that IN IN O
patient NN NN O
had VBD VBD O
O2 NNP NNP O
saturation NN NN O
of IN IN O
70 CD CD O
% NN NN O
, , , O
pH=7.2 NN NN O
and CC CC O
covering VBG VBG O
MD NNP NNP O
had VBD VBD O
honored VBN VBN O
patient NN NN O
's POS POS O
established VBD VBD O
DNR NNP NNP O
order NN NN O
despite IN IN O
some DT DT O
family NN NN O
members NNS NNS O
desire VBP VBP O
to TO TO O
reverse VB VB O
it PRP PRP O
. . . O
   
Patient NNP NNP O
too RB RB O
ill JJ JJ O
to TO TO O
transfer VB VB O
safely RB RB O
; : : O
   
will MD MD O
contact VB VB O
me PRP PRP O
again RB RB O
if IN IN O
patient NN NN O
stabilized VBD VBD O
. . . O
   
Al NNP NNP I-DOCTOR
S. NN NN I-DOCTOR
Everhart NNP NNP I-DOCTOR
, , , O
MD NNP NNP O
Hospitalist NNP NNP O
Service NNP NNP O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2094-08-11 JJ JJ I-DATE
INTERNAL NNP NNP O
MEDICINE NNP NNP O
ASSOCIATES NNP NNP O
ROSELAND NNP NNP I-HOSPITAL
COMMUNITY NNP NNP I-HOSPITAL
HOSPITAL NNP NNP I-HOSPITAL
Major NNP NNP O
Problems NNS NNS O
Health NNP NNP O
maintenance NN NN O
Up-to-date NNP NNP O
. . . O
   
Pneumococcal NNP NNP O
vaccine NN NN O
given VBN VBN O
in IN IN O
2093 CD CD I-DATE
. . . O
   
Declines NNP NNP O
a DT DT O
sigmoidoscopy NN NN O
or CC CC O
colonoscopy NN NN O
. . . O
   
Diabetes NNP NNP O
mellitus JJ JJ O
Blood NNP NNP O
sugars NNS NNS O
have VBP VBP O
been VBN VBN O
very RB RB O
good JJ JJ O
. . . O
   
Here RB RB O
today NN NN O
, , , O
it PRP PRP O
is VBZ VBZ O
156 CD CD O
. . . O
   
She PRP PRP O
met VBD VBD O
with IN IN O
Camp NNP NNP I-DOCTOR
who WP WP O
discussed VBD VBD O
extensively RB RB O
about IN IN O
her PRP$ PRP$ O
diabetes NNS NNS O
. . . O
   
She PRP PRP O
found VBD VBD O
it PRP PRP O
very RB RB O
helpful JJ JJ O
. . . O
   
Diet NNP NNP O
issues NNS NNS O
reinforced VBD VBD O
. . . O
   
Sebaceous NNP NNP O
cyst NN NN O
Resolved NNP NNP O
. . . O
   
Hypertension NNP NNP O
Blood NNP NNP O
pressure NN NN O
much RB RB O
improved VBD VBD O
, , , O
130/60 CD CD O
after IN IN O
increasing VBG VBG O
her PRP$ PRP$ O
medications NNS NNS O
. . . O
   
This DT DT O
is VBZ VBZ O
a DT DT O
great JJ JJ O
improvement NN NN O
. . . O
   
When WRB WRB O
Camp NNP NNP I-DOCTOR
checked VBD VBD O
, , , O
her PRP$ PRP$ O
blood NN NN O
pressure NN NN O
was VBD VBD O
also RB RB O
considerably RB RB O
better JJR JJR O
at IN IN O
that DT DT O
visit NN NN O
, , , O
132/70 CD CD O
. . . O
   
Having VBG VBG O
her PRP PRP O
watch NN NN O
her PRP$ PRP$ O
salt NN NN O
and CC CC O
also RB RB O
her PRP$ PRP$ O
sugar NN NN O
in IN IN O
her PRP$ PRP$ O
diet NN NN O
. . . O
   
Active JJ JJ O
Medications NNP NNP O
glyburide NN NN O
5mg CD CD O
po NN NN O
2 CD CD O
tabs NNS NNS O
bid NN NN O
metformin NN NN O
hydrochloride NN NN O
500 CD CD O
mg NN NN O
po NN NN O
bid NN NN O
lisinopril NN NN O
20 CD CD O
mg NN NN O
po NN NN O
qd NN NN O
atenolol NN NN O
100mg CD CD O
po NN NN O
qd NN NN O
Ecotrin NNP NNP O
325 CD CD O
mg NN NN O
po NN NN O
qd NN NN O
hydrochlorothiazide NN NN O
25 CD CD O
mg NN NN O
po NN NN O
qd NN NN O
Norvasc NNP NNP O
5mg CD CD O
po NN NN O
qd NN NN O
Physical JJ JJ O
examination NN NN O
Blood NNP NNP O
pressure NN NN O
130/60 CD CD O
Weight NNP NNP O
171 CD CD O
pounds NNS NNS O
Chest NN NN O
Lungs NNP NNP O
are VBP VBP O
clear JJ JJ O
Cor NNP NNP O
Unremarkable NNP NNP O
Extrem NNP NNP O
Clear NNP NNP O
Disposition NNP NNP O
Return NNP NNP O
is VBZ VBZ O
to TO TO O
see VB VB O
me PRP PRP O
in IN IN O
the DT DT O
fall NN NN O
. . . O
   
Note NN NN O
transcribed VBN VBN O
by IN IN O
outside IN IN O
service NN NN O
Transcription NNP NNP O
errors NNS NNS O
may MD MD O
be VB VB O
present JJ JJ O
. . . O
   
Signed VBN VBN O
electronically RB RB O
by IN IN O
Ruba NNP NNP I-DOCTOR
M NNP NNP I-DOCTOR
Neil NNP NNP I-DOCTOR
on IN IN O
Aug NNP NNP I-DATE
14 CD CD O
, , , O
2094 CD CD I-DATE
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2083-07-09 JJ JJ I-DATE
Pt NNP NNP O
here RB RB O
for IN IN O
new JJ JJ O
PCP NNP NNP O
and CC CC O
f/u NN NN O
on IN IN O
multiple JJ JJ O
issues NNS NNS O
. . . O
   
Medications NNP NNP O
Premarin NNP NNP O
( ( ( O
CONJUGATED NNP NNP O
Estrogens NNP NNP O
) ) ) O
2 CD CD O
GM NNP NNP O
PV NNP NNP O
QHS NNP NNP O
: : : O
SIG NNP NNP O
ONE CD CD O
APPLICATOR NNP NNP O
FULL NNP NNP O
AT IN IN O
HSX NNP NNP O
1WK CD CD O
THEN RB RB O
TWICE RB RB O
PER IN IN O
WEEK NN NN O
Cozaar NNP NNP O
( ( ( O
LOSARTAN NNP NNP O
) ) ) O
50MG CD CD O
, , , O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
bid NN NN O
ATENOLOL NNP NNP O
50MG CD CD O
, , , O
0.5 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Ativan NNP NNP O
( ( ( O
LORAZEPAM NNP NNP O
) ) ) O
0.5MG, CD CD O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PNGT NNP NNP O
QD NNP NNP O
GLYBURIDE NNP NNP O
5MG CD CD O
, , , O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Allergies NNP NNP O
Codeine NNP NNP O
- : : O
GI NNP NNP O
upset VBD VBD O
Sulfa NNP NNP O
- : : O
Rash NNP NNP O
* NN NN O
lisinopril NN NN O
- : : O
cough NN NN O
Penicillins NNS NNS O
- : : O
Rash NNP NNP O
* NN NN O
hctz NN NN O
- : : O
cramps NNS NNS O
Problems NNS NNS O
Diabetes NNP NNP O
mellitus JJ JJ O
- - - O
cheated JJ JJ O
last JJ JJ O
weekend NN NN O
at IN IN O
a DT DT O
party NN NN O
, , , O
but CC CC O
mostly RB RB O
sugars VBZ VBZ O
60-150s. JJ JJ O
   
Last JJ JJ O
low-sugar JJ JJ O
rxn NN NN O
was VBD VBD O
a DT DT O
month NN NN O
ago RB RB O
, , , O
and CC CC O
her PRP$ PRP$ O
glyb NN NN O
. . . O
   
was VBD VBD O
decreased VBN VBN O
. . . O
   
She PRP PRP O
may MD MD O
have VB VB O
"""" '' '' O
polys NN NN O
"""" '' '' O
. . . O
   
She PRP PRP O
still RB RB O
has VBZ VBZ O
not RB RB O
called VBN VBN O
her PRP$ PRP$ O
eye NN NN O
doctor NN NN O
for IN IN O
an DT DT O
appt NN NN O
. . . O
   
b/c NN NN O
too RB RB O
busy JJ JJ O
. . . O
   
Urine NNP NNP O
microalbumin NN NN O
nl NN NN O
. . . O
   
HBA1C NNP NNP O
6.6 CD CD O
% NN NN O
Hypertension NNP NNP O
- : : O
did VBD VBD O
not RB RB O
increase VB VB O
atenolol NN NN O
as IN IN O
advised VBN VBN O
by IN IN O
Dr NNP NNP O
Buckley NNP NNP I-DOCTOR
. . . O
   
Her PRP$ PRP$ O
home NN NN O
BPs NNP NNP O
are VBP VBP O
150/70 CD CD O
, , , O
but CC CC O
her PRP$ PRP$ O
pulse NN NN O
is VBZ VBZ O
often RB RB O
in IN IN O
the DT DT O
50s NN NN O
, , , O
which WDT WDT O
is VBZ VBZ O
why WRB WRB O
she PRP PRP O
is VBZ VBZ O
taking VBG VBG O
only RB RB O
1/2 CD CD O
of IN IN O
atenolol NN NN O
. . . O
   
Renal NNP NNP O
cancer NN NN O
: : : O
incidentally RB RB O
discovered VBN VBN O
, , , O
s/p NN NN O
nephrectomy NN NN O
Hyperparathyroidism NNP NNP O
: : : O
? . . O
2/2 CD CD O
Vit NNP NNP O
D NNP NNP O
deficiency NN NN O
. . . O
   
Thyroid NNP NNP O
nodules NNS NNS O
. . . O
   
Being VBG VBG O
evaluated VBN VBN O
by IN IN O
Dr NNP NNP O
Lawson NNP NNP I-DOCTOR
, , , O
SH NNP NNP I-HOSPITAL
Endocrine NNP NNP O
. . . O
   
However RB RB O
, , , O
the DT DT O
last JJ JJ O
time NN NN O
she PRP PRP O
went VBD VBD O
to TO TO O
Endo NNP NNP O
. . . O
   
she PRP PRP O
was VBD VBD O
told VBN VBN O
she PRP PRP O
did VBD VBD O
not RB RB O
have VB VB O
an DT DT O
appt NN NN O
. . . O
   
She PRP PRP O
has VBZ VBZ O
not RB RB O
rec NN NN O
'd MD MD O
another DT DT O
in IN IN O
the DT DT O
mail NN NN O
. . . O
   
She PRP PRP O
never RB RB O
had VBD VBD O
the DT DT O
thyroid NN NN O
bx NN NN O
. . . O
   
Last JJ JJ O
Ca NNP NNP O
nl NN NN O
. . . O
   
but CC CC O
phos RB RB O
low JJ JJ O
. . . O
   
Dyspepsia NNP NNP O
/ NN NN O
H NNP NNP O
Pylori NNP NNP O
: : : O
unable JJ JJ O
to TO TO O
tolerate VB VB O
bismuth NN NN O
, , , O
TCN NNP NNP O
, , , O
metronidazole NN NN O
or CC CC O
clarithromycin NN NN O
and CC CC O
metronidazole NN NN O
. . . O
   
She PRP PRP O
has VBZ VBZ O
occ NN NN O
. . . O
   
dyspepsia NN NN O
, , , O
for IN IN O
which WDT WDT O
she PRP PRP O
takes VBZ VBZ O
prn JJ JJ O
ranitidine NN NN O
, , , O
none NN NN O
lately RB RB O
. . . O
   
Of IN IN O
note NN NN O
, , , O
recent JJ JJ O
guaiacs NN NN O
positive JJ JJ O
. . . O
   
She PRP PRP O
had VBD VBD O
a DT DT O
colonoscopy NN NN O
2079 CD CD I-DATE
, , , O
which WDT WDT O
showed VBD VBD O
a DT DT O
polyp NN NN O
and CC CC O
diverticulosis NN NN O
. . . O
   
Three CD CD O
year NN NN O
f/u NN NN O
rec NN NN O
. . . O
   
Pt NNP NNP O
has VBZ VBZ O
been VBN VBN O
afraid JJ JJ O
to TO TO O
reschedule VB VB O
b/c NN NN O
was VBD VBD O
not RB RB O
sufficiently RB RB O
anesthetised VBN VBN O
the DT DT O
last JJ JJ O
time NN NN O
and CC CC O
had VBD VBD O
a DT DT O
lot NN NN O
of IN IN O
pain NN NN O
. . . O
   
Plantar NNP NNP O
Fasciitis NNP NNP O
- : : O
resolved VBD VBD O
. . . O
   
RHM NNP NNP O
- : : O
UTD NNP NNP O
. . . O
   
SH NNP NNP I-HOSPITAL
- : : O
married JJ JJ O
. . . O
   
Husband NNP NNP O
has VBZ VBZ O
some DT DT O
medical JJ JJ O
problems NNS NNS O
, , , O
but CC CC O
is VBZ VBZ O
able JJ JJ O
to TO TO O
drive VB VB O
her PRP PRP O
on IN IN O
all DT DT O
her PRP$ PRP$ O
errands NNS NNS O
, , , O
as IN IN O
she PRP PRP O
does VBZ VBZ O
not RB RB O
dirve VB VB O
. . . O
   
No DT DT O
cigs NN NN O
, , , O
EtOH NNP NNP O
, , , O
sexual JJ JJ O
activity NN NN O
. . . O
   
She PRP PRP O
has VBZ VBZ O
4 CD CD O
children NNS NNS O
and CC CC O
9 CD CD O
grandchildren NNS NNS O
. . . O
   
Her PRP$ PRP$ O
son NN NN O
was VBD VBD O
hit VBN VBN O
by IN IN O
a DT DT O
car NN NN O
some DT DT O
years NNS NNS O
ago RB RB O
, , , O
and CC CC O
sustained VBD VBD O
head NN NN O
trauma NN NN O
, , , O
now RB RB O
in IN IN O
assisted VBN VBN O
living VBG VBG O
. . . O
   
She PRP PRP O
is VBZ VBZ O
very RB RB O
stressed VBN VBN O
all PDT PDT O
the DT DT O
time NN NN O
worrying VBG VBG O
about IN IN O
him PRP PRP O
. . . O
   
She PRP PRP O
became VBD VBD O
tearful JJ JJ O
telling VBG VBG O
me PRP PRP O
about IN IN O
this DT DT O
. . . O
   
Enjoys NNP NNP O
gardening VBG VBG O
and CC CC O
attending VBG VBG O
her PRP$ PRP$ O
quilting VBG VBG I-ORGANIZATION
group NN NN O
. . . O
   
ROS NNP NNP O
- : : O
+ NN NN O
for IN IN O
hearing NN NN O
loss NN NN O
, , , O
diff NN NN O
. . . O
   
w NN NN O
/ NN NN O
memory NN NN O
related VBN VBN O
to TO TO O
stress NN NN O
and CC CC O
anxiety NN NN O
about IN IN O
son NN NN O
, , , O
as IN IN O
above IN IN O
in IN IN O
specific JJ JJ O
items NNS NNS O
, , , O
occ NN NN O
. . . O
   
constip NN NN O
. . . O
   
Neg NNP NNP O
. . . O
   
otherwise RB RB O
. . . O
   
PLAN NNP NNP O
: : : O
Rev NNP NNP O
'd NNP NNP O
medical JJ JJ O
and CC CC O
SH NNP NNP I-HOSPITAL
. . . O
   
Re-refer NNP NNP O
to TO TO O
Dr NNP NNP O
Lawson NNP NNP I-DOCTOR
, , , O
emailed JJ JJ O
Dr NNP NNP O
Lawson NNP NNP I-DOCTOR
. . . O
   
Disc NNP NNP O
. . . O
   
pt NN NN O
's POS POS O
intent NN NN O
about IN IN O
cancer NN NN O
surveillance NN NN O
. . . O
   
She PRP PRP O
states VBZ VBZ O
that IN IN O
she PRP PRP O
would MD MD O
want VB VB O
to TO TO O
be VB VB O
treated VBN VBN O
if IN IN O
she PRP PRP O
had VBD VBD O
ca NN NN O
, , , O
and CC CC O
therefore RB RB O
agrees VBZ VBZ O
to TO TO O
upper VB VB O
and CC CC O
lower JJR JJR O
endo NN NN O
. . . O
   
if IN IN O
I PRP PRP O
request VBP VBP O
she PRP PRP O
receive JJ JJ O
adequate JJ JJ O
analgesia NN NN O
. . . O
   
F/U NNP NNP O
2 CD CD O
mo NN NN O
. . . O
   
BP NNP NNP O
not RB RB O
done VBN VBN O
today NN NN O
b/c NN NN O
she PRP PRP O
became VBD VBD O
upset VBN VBN O
. . . O
   
Prob NNP NNP O
. . . O
   
will MD MD O
need VB VB O
a DT DT O
third JJ JJ O
BP NNP NNP O
med VBD VBD O
, , , O
but CC CC O
not RB RB O
incr VB VB O
. . . O
   
bb NN NN O
. . . O
   
____________________________________________ NN NN O
_ NN NN O
Patricia NNP NNP I-DOCTOR
Lund NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2102-12-21 JJ JJ I-DATE
SECTIONS NNP NNP O
OF IN IN O
THIS DT DT O
NOTE NN NN O
WERE VBD VBD O
CREATED NNP NNP O
WITH IN IN O
A DT DT O
' POS POS O
COPY NNP NNP O
AND CC CC O
PASTE NNP NNP O
' POS POS O
ACTION NNP NNP O
. . . O
   
THESE DT DT O
SECTIONS NNP NNP O
MAY NNP NNP O
NOT RB RB O
HAVE NNP NNP O
COPIED NNP NNP O
COMPLETELY RB RB O
. . . O
   
PLEASE NNP NNP O
USE NNP NNP O
CAUTION NNP NNP O
WHEN WRB WRB O
RENDERING NNP NNP O
CLINICAL NNP NNP O
JUDGMENT NNP NNP O
BASED NNP NNP O
ON IN IN O
THE DT DT O
INFORMATION NNP NNP O
IN IN IN O
THIS DT DT O
NOTE NN NN O
. . . O
   
Keely NNP NNP I-HOSPITAL
Institute NNP NNP I-HOSPITAL
ADMISSION NNP NNP O
NOTE NNP NNP O
PATIENT NNP NNP O
: : : O
Xayarath NNP NNP O
, , , O
Nancy NNP NNP I-PATIENT
MRN NNP NNP O
: : : O
1116417 CD CD I-MEDICALRECORD
ADMIT NNP NNP O
DATE NN NN O
: : : O
December NNP NNP I-DATE
21 CD CD O
, , , O
2102 CD CD I-DATE
Attending NNP NNP O
: : : O
Townsend NNP NNP O
, , , O
Lawrence NNP NNP I-DOCTOR
PCP/Endocrinologist NNP NNP O
: : : O
Townsend NNP NNP O
, , , O
Lawrence NNP NNP I-DOCTOR
Cadiologist NNP NNP O
: : : O
Xanthos NNP NNP O
, , , O
Priscilla NNP NNP I-DOCTOR
Gasteroenterologist NNP NNP O
: : : O
Sanders NNP NNP O
, , , O
Olivia NNP NNP I-DOCTOR
Family NNP NNP O
Contact NNP NNP O
: : : O
HUSBAND-XAYARATH NNP NNP O
, , , O
KEEGAN NNP NNP I-PATIENT
; : : O
   
Home NNP NNP O
: : : O
( ( ( O
779)226-7473 JJ JJ O
Code NNP NNP O
status NN NN O
: : : O
presumed VBD VBD O
FULL NNP NNP O
Source NNP NNP O
: : : O
medical JJ JJ O
records NNS NNS O
CC NNP NNP O
: : : O
swollen NN NN O
left VBD VBD O
knee NN NN O
HPI NNP NNP O
: : : O
The DT DT O
patient NN NN O
is VBZ VBZ O
a DT DT O
60 CD CD I-AGE
year NN NN O
old JJ JJ O
female JJ JJ O
with IN IN O
a DT DT O
history NN NN O
of IN IN O
renal JJ JJ O
transplant NN NN O
, , , O
CAD NNP NNP O
s/p NN NN O
CABG NNP NNP O
, , , O
diabetes NNS NNS O
who WP WP O
present JJ JJ O
with IN IN O
with IN IN O
abrasion NN NN O
and CC CC O
swelling VBG VBG O
of IN IN O
her PRP$ PRP$ O
left JJ JJ O
knee NN NN O
. . . O
   
Patient NNP NNP O
was VBD VBD O
well RB RB O
until IN IN O
December NNP NNP I-DATE
12th JJ JJ I-DATE
when WRB WRB O
she PRP PRP O
slipped VBD VBD O
on IN IN O
ice NN NN O
and CC CC O
fell VBD VBD O
on IN IN O
her PRP$ PRP$ O
left JJ JJ O
knee NN NN O
. . . O
   
Patient NNP NNP O
initially RB RB O
noted VBD VBD O
an DT DT O
abrasion NN NN O
and CC CC O
some DT DT O
ecchymosis NN NN O
around IN IN O
the DT DT O
knee NN NN O
joint NN NN O
and CC CC O
been VBN VBN O
weight NN NN O
bearing VBG VBG O
without IN IN O
difficultly RB RB O
. . . O
   
Patient NNP NNP O
reports NNS NNS O
frequent NN NN O
falls VBZ VBZ O
at IN IN O
home NN NN O
due JJ JJ O
to TO TO O
her PRP$ PRP$ O
neuropathy NN NN O
but CC CC O
is VBZ VBZ O
ambulatory JJ JJ O
without IN IN O
assist NN NN O
. . . O
   
On IN IN O
December NNP NNP I-DATE
19th CD CD I-DATE
, , , O
she PRP PRP O
noted VBD VBD O
some DT DT O
erythema NN NN O
around IN IN O
the DT DT O
knee NN NN O
joint NN NN O
and CC CC O
the DT DT O
lateral NN NN O
aspect NN NN O
of IN IN O
her PRP$ PRP$ O
shin NN NN O
and CC CC O
started VBD VBD O
developing VBG VBG O
pain NN NN O
and CC CC O
swelling VBG VBG O
that IN IN O
slightly RB RB O
limited JJ JJ O
her PRP$ PRP$ O
range NN NN O
of IN IN O
motion NN NN O
. . . O
   
She PRP PRP O
also RB RB O
noted VBD VBD O
some DT DT O
knee NN NN O
stiffness NN NN O
. . . O
   
Denies NNP NNP O
any DT DT O
drainage NN NN O
from IN IN O
injury NN NN O
site NN NN O
. . . O
   
Patient NNP NNP O
did VBD VBD O
speak VB VB O
to TO TO O
the DT DT O
NP NNP NNP O
at IN IN O
her PRP$ PRP$ O
PCPs NNP NNP O
office NN NN O
and CC CC O
was VBD VBD O
advised VBN VBN O
to TO TO O
be VB VB O
evaluated VBN VBN O
in IN IN O
the DT DT O
ED NNP NNP O
. . . O
   
ED NNP NNP O
course NN NN O
: : : O
On IN IN O
arrival NN NN O
, , , O
the DT DT O
patient&#8217; NN NN O
   
s VBZ VBZ O
vitals NNS NNS O
were VBD VBD O
: : : O
99.2 CD CD O
80 CD CD O
109/66 CD CD O
97%/RA. CD CD O
   
Per IN IN O
report NN NN O
, , , O
a DT DT O
tap NN NN O
of IN IN O
the DT DT O
left VBN VBN O
knee NN NN O
was VBD VBD O
attempted VBN VBN O
but CC CC O
no DT DT O
fluid NN NN O
could MD MD O
be VB VB O
aspirated VBN VBN O
. . . O
   
Blood NNP NNP O
cultures NNS NNS O
yielded VBD VBD O
GPC NNP NNP O
in IN IN O
pairs NNS NNS O
in IN IN O
& CC CC O
#189 NN NN O
; : : O
   
bottles NNS NNS O
. . . O
   
Patient NNP NNP O
was VBD VBD O
started VBN VBN O
on IN IN O
vancomycin NN NN O
and CC CC O
developed VBD VBD O
an DT DT O
itchy NN NN O
rash NN NN O
at IN IN O
the DT DT O
infusion NN NN O
site NN NN O
( ( ( O
right JJ JJ O
arm NN NN O
) ) ) O
. . . O
   
Patient NNP NNP O
was VBD VBD O
switched VBN VBN O
to TO TO O
linezolid JJ JJ O
per IN IN O
discussion NN NN O
with IN IN O
transplant NN NN O
ID NNP NNP O
. . . O
   
Of IN IN O
note NN NN O
, , , O
she PRP PRP O
had VBD VBD O
new JJ JJ O
lateral NN NN O
V5-6 NNP NNP O
TWI NNP NNP O
but CC CC O
cardiac JJ JJ O
enzymes NNS NNS O
have VBP VBP O
been VBN VBN O
negative JJ JJ O
x2 NN NN O
. . . O
   
ROS NNP NNP O
: : : O
Missed NNP NNP O
last JJ JJ O
night&#8217; NN NN O
   
s VBZ VBZ O
dose NN NN O
of IN IN O
lantus NN NN O
. . . O
   
+ NN NN O
subjective JJ JJ O
fever NN NN O
, , , O
some DT DT O
nausea NN NN O
. . . O
   
gets VBZ VBZ O
short JJ JJ O
of IN IN O
breath NN NN O
with IN IN O
exertion NN NN O
   
( ( ( O
stable JJ JJ O
) ) ) O
. . . O
   
some DT DT O
blood NN NN O
mucus NN NN O
in IN IN O
osteomy NN NN O
last JJ JJ O
week NN NN O
. . . O
   
snores NNS NNS O
at IN IN O
night NN NN O
and CC CC O
wakes NNS NNS O
up RB RB O
from IN IN O
some DT DT O
sleep NN NN O
. . . O
   
intermittent NN NN O
blurry NN NN O
vision NN NN O
   
( ( ( O
stable JJ JJ O
) ) ) O
. . . O
   
Denies NNP NNP O
hitting VBG VBG O
her PRP$ PRP$ O
head NN NN O
. . . O
   
No DT DT O
chest NN NN O
discomfort/pain NN NN O
, , , O
abdominal JJ JJ O
pain NN NN O
, , , O
change NN NN O
in IN IN O
urinary JJ JJ O
habits NNS NNS O
. . . O
   
No DT DT O
vomiting VBG VBG O
. . . O
   
No DT DT O
change NN NN O
in IN IN O
frequency/consistency NN NN O
of IN IN O
stool NN NN O
PMH/PSH NNP NNP O
: : : O
ID:Multiple NNP NNP O
episodes NNS NNS O
of IN IN O
line NN NN O
infections NNS NNS O
, , , O
bacteremia NN NN O
, , , O
pneumonia NN NN O
, , , O
UTI NNP NNP O
in IN IN O
past JJ JJ O
; : : O
   
s/p JJ JJ O
sternal JJ JJ O
oseomyelitis NN NN O
w NN NN O
/ NN NN O
graft NN NN O
( ( ( O
2096 CD CD I-DATE
) ) ) O
; : : O
   
SVC NNP NNP O
thromobosis NNS NNS O
( ( ( O
2096 CD CD I-DATE
) ) ) O
Endo NNP NNP O
: : : O
Diabetes NNP NNP O
mellitus NN NN O
type NN NN O
1 CD CD O
x SYM SYM O
37 CD CD O
years NNS NNS O
( ( ( O
diabetic JJ JJ O
left VBD VBD O
midfoot NN NN O
charcot NN NN O
arthropathy NN NN O
) ) ) O
; : : O
   
osteoporosis NN NN O
, , , O
thyroid NN NN O
disease NN NN O
Psych/Neuro NNP NNP O
: : : O
h/o NN NN O
seizure NN NN O
disorder NN NN O
, , , O
depression NN NN O
, , , O
meningioma NN NN O
( ( ( O
jugular NN NN O
foramen NNS NNS O
& CC CC O
#8211 NN NN O
; : : O
   
stable JJ JJ O
as IN IN O
of IN IN O
April NNP NNP I-DATE
2102 CD CD I-DATE
) ) ) O
GI NNP NNP O
: : : O
GERD NNP NNP O
; : : O
   
s/p JJ JJ O
colectomy NN NN O
( ( ( O
2094 CD CD I-DATE
& CC CC O
#8211 NN NN O
; : : O
   
E NNP NNP O
coli NN NN O
( ( ( O
0157 CD CD O
) ) ) O
gastroenteritis NN NN O
& CC CC O
#224 NN NN O
; : : O
   
HUS NNP NNP O
complicated VBN VBN O
by IN IN O
pancolitis NNS NNS O
) ) ) O
; : : O
   
03/2101 CD CD I-DATE
: : : O
sigmoidoscopy NN NN O
showed VBD VBD O
some DT DT O
mild JJ JJ O
inflammation NN NN O
Renal NNP NNP O
: : : O
s/p NN NN O
Left NNP NNP O
kidney NN NN O
transplant NN NN O
( ( ( O
2094 CD CD I-DATE
HUS NNP NNP O
& CC CC O
#224 NN NN O
; : : O
   
dialysis NN NN O
& CC CC O
#224 NN NN O
; : : O
   
2097 CD CD I-DATE
living VBG VBG O
donor NN NN O
   
( ( ( O
husband NN NN O
) ) ) O
kidney NN NN O
transplant NN NN O
) ) ) O
; : : O
   
baseline NN NN O
Cr NNP NNP O
= SYM SYM O
1.1-1.2 JJ JJ O
Ortho NNP NNP O
: : : O
2 CD CD O
toes NNS NNS O
amputated VBD VBD O
2090 CD CD I-DATE
GU/GI NNP NNP O
: : : O
h/opost-menopausal NN NN O
bleeding NN NN O
with IN IN O
evidence NN NN O
of IN IN O
polyp NN NN O
, , , O
history NN NN O
of IN IN O
dyspareunia NN NN O
CV NNP NNP O
: : : O
hypertension NN NN O
SVC NNP NNP O
syndrome NN NN O
with IN IN O
SVC NNP NNP O
stent NN NN O
on IN IN O
warfarin NN NN O
INR NNP NNP O
goal NN NN O
2-3 NN NN O
, , , O
followed VBN VBN O
by IN IN O
AMS NNP NNP O
CAD NNP NNP O
s/p NN NN O
CABG NNP NNP O
2096 CD CD I-DATE
: : : O
Complicated VBN VBN O
by IN IN O
sternal JJ JJ O
osteomyelitis NNS NNS O
to TO TO O
LAD NNP NNP O
, , , O
SVG NNP NNP O
to TO TO O
the DT DT O
PLV-OM NNP NNP O
and CC CC O
diagonal JJ JJ O
Cath NNP NNP O
( ( ( O
09/09/2099 CD CD I-DATE
) ) ) O
: : : O
severe JJ JJ O
native JJ JJ O
three-vessel JJ JJ O
disease NN NN O
, , , O
the DT DT O
to TO TO O
the DT DT O
LAD NNP NNP O
was VBD VBD O
patent NN NN O
. . . O
   
The DT DT O
saphenous JJ JJ O
vein NN NN O
graft NN NN O
to TO TO O
the DT DT O
diagonal NN NN O
was VBD VBD O
patent NN NN O
. . . O
   
The DT DT O
skip NN NN O
saphenous JJ JJ O
vein NN NN O
graft NN NN O
from IN IN O
the DT DT O
diagonal NN NN O
was VBD VBD O
not RB RB O
visualized VBN VBN O
and CC CC O
seemed VBN VBN O
to TO TO O
be VB VB O
obstructed VBN VBN O
. . . O
   
The DT DT O
left NN NN O
circumflex NN NN O
was VBD VBD O
subtotally RB RB O
occluded VBN VBN O
and CC CC O
this DT DT O
territory NN NN O
was VBD VBD O
consistent JJ JJ O
with IN IN O
the DT DT O
area NN NN O
of IN IN O
ischemia NN NN O
on IN IN O
her PRP$ PRP$ O
stress NN NN O
test NN NN O
. . . O
   
not RB RB O
amenable JJ JJ O
to TO TO O
stenting VBG VBG O
and CC CC O
has VBZ VBZ O
been VBN VBN O
medically RB RB O
managed VBN VBN O
. . . O
   
TTE NNP NNP O
( ( ( O
07/27/2101 CD CD I-DATE
) ) ) O
: : : O
inferior JJ JJ O
posterior NN NN O
hypokinesis NN NN O
with IN IN O
an DT DT O
EF NNP NNP O
of IN IN O
47 CD CD O
% NN NN O
. . . O
   
no DT DT O
significant JJ JJ O
valvular JJ JJ O
heart NN NN O
disease NN NN O
. . . O
   
Mitral NNP NNP O
inflow NN NN O
patterns NNS NNS O
were VBD VBD O
restrictive JJ JJ O
consistent JJ JJ O
with IN IN O
elevated VBD VBD O
LA NNP NNP O
pressures NNS NNS O
and/or VBP VBP O
a DT DT O
non-compliant JJ JJ O
Adenosine NNP NNP O
stress NN NN O
test NN NN O
( ( ( O
8/04/01 CD CD I-DATE
) ) ) O
: : : O
fixed VBN VBN O
posterior NN NN O
, , , O
lateral NN NN O
and CC CC O
inferior JJ JJ O
defects NNS NNS O
without IN IN O
ischemia NN NN O
ALLERGIES NNP NNP O
: : : O
Erythromycin NNP NNP O
& CC CC O
#224 NN NN O
; : : O
   
unknown JJ JJ O
. . . O
   
Vancomcyin NNP NNP O
& CC CC O
#224 NN NN O
; : : O
   
rash NN NN O
MEDICATIONS NNP NNP O
ON IN IN O
ADMISSION NNP NNP O
: : : O
Prograf NNP NNP O
2 CD CD O
mg NN NN O
QAM NNP NNP O
and CC CC O
1mg CD CD O
QPM NNP NNP O
, , , O
ASA NNP NNP O
81 CD CD O
mg NN NN O
QD NNP NNP O
, , , O
Folate NNP NNP O
400 CD CD O
mcg NN NN O
QD NNP NNP O
, , , O
Prilosec NNP NNP O
40 CD CD O
mg NN NN O
QD NNP NNP O
, , , O
Imdur NNP NNP O
30 CD CD O
mg NN NN O
QD NNP NNP O
, , , O
Fludrocortisone NNP NNP O
.05 CD CD O
mg NN NN O
QD NNP NNP O
, , , O
Imuran NNP NNP O
100 CD CD O
mg NN NN O
QPM NNP NNP O
, , , O
Toprol NNP NNP O
XL NNP NNP O
25 CD CD O
mg NN NN O
QPM NNP NNP O
, , , O
Lipitor NNP NNP O
40 CD CD O
mg NN NN O
QPM NNP NNP O
, , , O
Celexa NNP NNP O
20 CD CD O
mg NN NN O
QPM NNP NNP O
, , , O
Coumadin NNP NNP O
4 CD CD O
mg NN NN O
QPM NNP NNP O
, , , O
MVI NNP NNP O
QD NNP NNP O
, , , O
Calcium NNP NNP O
+ NN NN O
Vit NNP NNP O
D NNP NNP O
600 CD CD O
mg NN NN O
QD NNP NNP O
, , , O
, , , O
Fosamax NNP NNP O
70 CD CD O
mg NN NN O
qweek NN NN O
, , , O
Lantus NNP NNP O
Insulin NNP NNP O
5 CD CD O
units NNS NNS O
qpm NN NN O
, , , O
Humalog NNP NNP O
Insulin NNP NNP O
1 CD CD O
- : : O
10 CD CD O
units NNS NNS O
   
( ( ( O
scale NN NN O
) ) ) O
w NN NN O
/ NN NN O
meals NNS NNS O
and CC CC O
snacks NNS NNS O
SH NNP NNP O
: : : O
Married NNP NNP O
. . . O
   
Former NNP NNP O
IT PRP PRP I-PROFESSION
specialist NN NN I-PROFESSION
, , , O
now RB RB O
on IN IN O
disability NN NN O
. . . O
   
70 CD CD O
ppy JJ JJ O
smoking NN NN O
history NN NN O
, , , O
quit NN NN O
2090 CD CD I-DATE
. . . O
   
PHYSICAL JJ JJ O
EXAM NNP NNP O
Vitals:T NNP NNP O
: : : O
96.8 CD CD O
HR NNP NNP O
: : : O
74 CD CD O
BP NNP NNP O
: : : O
90/53 CD CD O
RR NNP NNP O
: : : O
20 CD CD O
SaO2 NNP NNP O
: : : O
96.8 CD CD O
GEN&#8217; NNP NNP O
   
L NNP NNP O
NAD NNP NNP O
, , , O
pleasant JJ JJ O
HEENT NNP NNP O
MMM NNP NNP O
, , , O
no DT DT O
scleral NN NN O
icterus NN NN O
, , , O
no DT DT O
pale JJ JJ O
conjunctiva NN NN O
NECK NNP NNP O
supple NN NN O
, , , O
no DT DT O
thyromegaly NN NN O
, , , O
no DT DT O
LAD NNP NNP O
. . . O
   
JVP&lt NNP NNP O
; : : O
   
5 CD CD O
cm NN NN O
Heart NNP NNP O
: : : O
regular JJ JJ O
, , , O
normal JJ JJ O
S1 NNP NNP O
S2 NNP NNP O
; : : O
   
3/6 CD CD O
systolic JJ JJ O
murmur NN NN O
LUNG NNP NNP O
: : : O
CTA NNP NNP O
bilaterally RB RB O
ABD NNP NNP O
: : : O
Soft JJ JJ O
, , , O
non-tender NN NN O
, , , O
non-distended JJ JJ O
, , , O
+ NN NN O
BS NNP NNP O
. . . O
   
osteomy NN NN O
site NN NN O
is VBZ VBZ O
C/D/I NNP NNP O
EXT NNP NNP O
: : : O
wwp NN NN O
, , , O
good JJ JJ O
distal NN NN O
pulses NNS NNS O
. . . O
   
mild JJ JJ O
swelling VBG VBG O
over IN IN O
left VBD VBD O
prepatellar NN NN O
bursa NN NN O
with IN IN O
erythema NN NN O
. . . O
   
no DT DT O
fluctuant NN NN O
mass NN NN O
; : : O
   
erythema NN NN O
over IN IN O
left VBD VBD O
lateral NN NN O
shin NN NN O
. . . O
   
full JJ JJ O
ROM NNP NNP O
of IN IN O
left VBD VBD O
knee NN NN O
. . . O
   
NEURO NNP NNP O
: : : O
alert NN NN O
, , , O
orientedx3 NN NN O
. . . O
   
CN NNP NNP O
II-XII NNP NNP O
grossly RB RB O
intact JJ JJ O
; : : O
   
unable JJ JJ O
to TO TO O
fully RB RB O
flex VB VB O
first JJ JJ O
3 CD CD O
digits NNS NNS O
of IN IN O
hands NNS NNS O
bilaterally RB RB O
. . . O
   
decreased VBD VBD O
sensation NN NN O
on IN IN O
anterior NN NN O
left VBD VBD O
shift NN NN O
. . . O
   
Motor NNP NNP O
5/5 CD CD O
B NNP NNP O
UE/LE NNP NNP O
LABS NNP NNP O
NA NNP NNP O
135 CD CD O
K NNP NNP O
5.2 CD CD O
CL NNP NNP O
103 CD CD O
CO2 NNP NNP O
24.6 CD CD O
BUN NNP NNP O
18 CD CD O
CRE NNP NNP O
1.3 CD CD O
GLU NNP NNP O
374 CD CD O
CA NNP NNP O
10.1 CD CD O
PHOS NNP NNP O
3.7 CD CD O
MG NNP NNP O
1.6 CD CD O
CK-MB NNP NNP O
NEGATIVE NNP NNP O
NEGATIVE NNP NNP O
TROP-I NNP NNP O
NEGATIVE NNP NNP O
NEGATIVE NNP NNP O
TACRO NNP NNP O
9 CD CD O
- : : O
WBC NNP NNP O
7.8 CD CD O
( ( ( O
N70L14M7E8B1 NNP NNP O
) ) ) O
HCT NNP NNP O
33.8 CD CD O
(MCV=90) NN NN O
PLT NNP NNP O
246 CD CD O
PT NNP NNP O
26.8 CD CD O
PT-INR NNP NNP O
2.7 CD CD O
PTT NNP NNP O
30.9 CD CD O
Micro NNP NNP O
: : : O
UA NNP NNP O
: : : O
BACT NNP NNP O
Few JJ JJ O
, , , O
WBC NNP NNP O
0-2 NN NN O
, , , O
RBC NNP NNP O
0-2 JJ JJ O
UCx NNP NNP O
( ( ( O
12/21/02 CD CD I-DATE
) ) ) O
: : : O
pending VBG VBG O
BCx NNP NNP O
( ( ( O
12/21/02 CD CD I-DATE
) ) ) O
: : : O
GPC NNP NNP O
in IN IN O
pairs NNS NNS O
BCx NNP NNP O
( ( ( O
12/21/02 CD CD I-DATE
) ) ) O
: : : O
NTD NNP NNP O
& CC CC O
lt NN NN O
; : : O
   
24 CD CD O
hours NNS NNS O
- : : O
BCx NNP NNP O
( ( ( O
11/28/96 CD CD I-DATE
) ) ) O
: : : O
MR-CNS NNP NNP O
BCx NNP NNP O
( ( ( O
11/28/96 CD CD I-DATE
) ) ) O
: : : O
C. NN NN O
Perfringens NNP NNP O
BCx NNP NNP O
( ( ( O
11/27/96 CD CD I-DATE
) ) ) O
: : : O
MS-CNS NNP NNP O
BCx NNP NNP O
( ( ( O
11/01/94 CD CD I-DATE
) ) ) O
: : : O
MR-CNS NNP NNP O
BCx NNP NNP O
( ( ( O
10/17/94 CD CD I-DATE
) ) ) O
: : : O
MSSA NNP NNP O
BCx NNP NNP O
( ( ( O
10/17/94 CD CD I-DATE
) ) ) O
: : : O
MSSA NNP NNP O
BCx NNP NNP O
( ( ( O
08/30/94 CD CD I-DATE
) ) ) O
: : : O
MR-CNS NNP NNP O
BCx NNP NNP O
( ( ( O
08/30/94 CD CD I-DATE
) ) ) O
: : : O
MR-CNS NNP NNP O
UCx NNP NNP O
( ( ( O
06/01/99 CD CD I-DATE
) ) ) O
: : : O
& CC CC O
lt NN NN O
; : : O
   
100k CD CD O
pan-S JJ JJ O
E. NN NN O
coli NNS NNS O
UCx NNP NNP O
( ( ( O
05/31/99 CD CD I-DATE
) ) ) O
: : : O
& CC CC O
gt NN NN O
; : : O
   
100k CD CD O
pan-S JJ JJ O
E. NN NN O
coli NNS NNS O
Left NNP NNP O
Knee NNP NNP O
( ( ( O
12/20/2102 CD CD I-DATE
22:58 CD CD O
) ) ) O
: : : O
There EX EX O
is VBZ VBZ O
no DT DT O
joint JJ JJ O
effusion NN NN O
. . . O
   
There EX EX O
are VBP VBP O
no DT DT O
fractures NNS NNS O
or CC CC O
dislocations NNS NNS O
identified VBN VBN O
. . . O
   
There EX EX O
are VBP VBP O
scattered JJ JJ O
vascular NN NN O
calcification NN NN O
seen VBN VBN O
. . . O
   
ASSESSMENT NNP NNP O
& CC CC O
amp NN NN O
; : : O
   
PLAN NNP NNP O
: : : O
The DT DT O
patient NN NN O
is VBZ VBZ O
a DT DT O
60 CD CD I-AGE
year NN NN O
old JJ JJ O
female JJ JJ O
with IN IN O
a DT DT O
history NN NN O
of IN IN O
renal JJ JJ O
transplant NN NN O
, , , O
CAD NNP NNP O
s/p NN NN O
CABG NNP NNP O
, , , O
diabetes NNS NNS O
who WP WP O
present JJ JJ O
with IN IN O
with IN IN O
abrasion NN NN O
and CC CC O
swelling VBG VBG O
of IN IN O
her PRP$ PRP$ O
left JJ JJ O
knee NN NN O
. . . O
   
Positive JJ JJ O
blood NN NN O
culture NN NN O
may MD MD O
be VB VB O
contamination NN NN O
but CC CC O
given VBN VBN O
patient&#8217; NN NN O
   
s VBZ VBZ O
comorbidities NNS NNS O
, , , O
will MD MD O
proceed VB VB O
with IN IN O
course NN NN O
of IN IN O
antibiotics NNS NNS O
. . . O
   
Blood NNP NNP O
cultures NNS NNS O
are VBP VBP O
growing VBG VBG O
GPC NNP NNP O
in IN IN O
pairs NNS NNS O
and CC CC O
patient NN NN O
has VBZ VBZ O
history NN NN O
of IN IN O
MR-CNS NNP NNP O
and CC CC O
patient NN NN O
had VBD VBD O
rash NN NN O
with IN IN O
vancomycin NN NN O
so RB RB O
will MD MD O
keep VB VB O
on IN IN O
linezolid NN NN O
for IN IN O
now RB RB O
. . . O
   
Patient NNP NNP O
does VBZ VBZ O
have VB VB O
history NN NN O
of IN IN O
MR NNP NNP O
and CC CC O
? . . O
endocarditis NN NN O
but CC CC O
will MD MD O
hold VB VB O
off IN IN O
on IN IN O
echo NN NN O
given VBN VBN O
patient NN NN O
is VBZ VBZ O
afebrile JJ JJ O
and CC CC O
hemodynamically RB RB O
stable JJ JJ O
. . . O
   
If IN IN O
surveillance NN NN O
blood NN NN O
cultures NNS NNS O
continue VBP VBP O
to TO TO O
be VB VB O
positive JJ JJ O
, , , O
will MD MD O
consider VB VB O
adding VBG VBG O
gentamycin NN NN O
and CC CC O
checking NN NN O
echo NN NN O
. . . O
   
Cellulitis NNP NNP O
: : : O
Linezolid NNP NNP O
x SYM SYM O
14 CD CD O
days NNS NNS O
( ( ( O
12/21-1/03 JJ JJ O
) ) ) O
; : : O
   
f/u NN NN O
blood NN NN O
cultures NNS NNS O
; : : O
   
check NN NN O
surveillance NN NN O
blood NN NN O
cultures NNS NNS O
; : : O
   
PICC NNP NNP O
c/s NN NN O
after IN IN O
blood NN NN O
cx NN NN O
negative JJ JJ O
x48 NN NN O
hours NNS NNS O
. . . O
   
f/u NN NN O
ID NNP NNP O
recs NN NN O
. . . O
   
PT/OT NNP NNP O
consult NN NN O
. . . O
   
Renal/Lytes NNP NNP O
: : : O
continue VB VB O
tacrolimus NN NN O
and CC CC O
check NN NN O
daily JJ JJ O
levels NNS NNS O
per IN IN O
transplant NN NN O
. . . O
   
f/u NN NN O
transplant NN NN O
recommendations NNS NNS O
. . . O
   
slightly RB RB O
high JJ JJ O
K NNP NNP O
this DT DT O
am VBP VBP O
, , , O
likely JJ JJ O
due JJ JJ O
to TO TO O
missed VBN VBN O
insulin NN NN O
. . . O
   
Will NNP NNP O
monitor NN NN O
for IN IN O
now RB RB O
. . . O
   
CV NNP NNP O
: : : O
complete JJ JJ O
rule NN NN O
out IN IN O
; : : O
   
keep VB VB O
on IN IN O
telemetry NN NN O
for IN IN O
now RB RB O
given VBN VBN O
hyperkalemia NN NN O
and CC CC O
EKG NNP NNP O
changes NNS NNS O
; : : O
   
continue VB VB O
home NN NN O
regiment NN NN O
GI NNP NNP O
: : : O
continue VB VB O
omeprazole NN NN O
, , , O
will MD MD O
make VB VB O
outpatient NN NN O
GI NNP NNP O
aware JJ JJ O
Diabetes NNP NNP O
: : : O
continue VB VB O
outpatient JJ JJ O
regiment NN NN O
of IN IN O
lantus NN NN O
+ NN NN O
insulin NN NN O
SS NNP NNP O
with IN IN O
meals NNS NNS O
. . . O
   
Will NNP NNP O
check VB VB O
blood NN NN O
sugars NNS NNS O
AC NNP NNP O
+ NN NN O
10 CD CD O
pm NN NN O
+ NN NN O
2 CD CD O
am VBP VBP O
per IN IN O
endocrine NN NN O
Psych NNP NNP O
: : : O
will MD MD O
hold VB VB O
celexa NN NN O
while IN IN O
patient NN NN O
on IN IN O
linezolid NN NN O
given VBN VBN O
risk NN NN O
of IN IN O
serotonin NN NN O
syndrome NN NN O
F/E/N NNP NNP O
: : : O
diabetic JJ JJ O
diet NN NN O
Ppx NNP NNP O
: : : O
warfarin NN NN O
, , , O
omperazole NN NN O
Code NNP NNP O
status NN NN O
: : : O
presumed VBD VBD O
FULL NNP NNP O
_________________________________ NN NN O
_ NN NN O
Barry NNP NNP I-DOCTOR
R. NN NN I-DOCTOR
Lockhart NNP NNP I-DOCTOR
, , , O
MD NNP NNP O
PhD NNP NNP O
Keely NNP NNP I-HOSPITAL
Institute NNP NNP I-HOSPITAL
- : : O
PGY-1 NNP NNP O
Pager NNP NNP O
#45374 NN NN O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2078-05-10 JJ JJ I-DATE
Vital NNP NNP O
signs NNS NNS O
BP NNP NNP O
140/88 CD CD O
, , , O
P NN NN O
68 CD CD O
, , , O
Wt NNP NNP O
172 CD CD O
lb NN NN O
69 CD CD I-AGE
year NN NN O
old JJ JJ O
male NN NN O
returns NNS NNS O
with IN IN O
daughter NN NN O
and CC CC O
grandson NN NN O
for IN IN O
follow-up JJ JJ O
of IN IN O
diabetes NN NN O
and CC CC O
hypertension NN NN O
. . . O
   
he PRP PRP O
was VBD VBD O
seen VBN VBN O
here RB RB O
several JJ JJ O
weeks NNS NNS O
ago RB RB O
after IN IN O
a DT DT O
4 CD CD O
month NN NN O
absence NN NN O
when WRB WRB O
he PRP PRP O
was VBD VBD O
in IN IN O
the DT DT I-COUNTRY
UK NNP NNP I-COUNTRY
. . . O
   
hgba1c NN NN O
and CC CC O
creatinine NN NN O
were VBD VBD O
checked VBN VBN O
at IN IN O
the DT DT I-COUNTRY
time NN NN O
, , , O
and CC CC O
bp NN NN O
was VBD VBD O
to TO TO O
be VB VB O
rechecked VBN VBN O
as IN IN O
it PRP PRP O
was VBD VBD O
not RB RB O
optimally RB RB O
controlled VBN VBN O
. . . O
   
the DT DT I-COUNTRY
patient NN NN O
returns NNS NNS O
feeling NN NN O
well RB RB O
, , , O
denies NNS NNS O
chest NN NN O
pain NN NN O
, , , O
shortness NN NN O
of IN IN O
breath NN NN O
, , , O
PND NNP NNP O
, , , O
orthopnea NN NN O
, , , O
change NN NN O
in IN IN O
exercise NN NN O
tolerance NN NN O
. . . O
   
he PRP PRP O
is VBZ VBZ O
taking VBG VBG O
medications NNS NNS O
as IN IN O
directed VBN VBN O
. . . O
   
daughter NN NN O
states NNS NNS O
that IN IN O
he PRP PRP O
saw VBD VBD O
an DT DT O
eye NN NN O
doctor NN NN O
in IN IN O
Anchorage NNP NNP I-CITY
Northeast NNP NNP I-CITY
in IN IN O
11/77 CD CD I-DATE
, , , O
had VBD VBD O
his PRP$ PRP$ O
pupils NNS NNS O
dilated JJ JJ O
, , , O
was VBD VBD O
checked VBN VBN O
for IN IN O
DM NNP NNP O
, , , O
was VBD VBD O
told VBN VBN O
everything NN NN O
was VBD VBD O
fine NN NN O
and CC CC O
he PRP PRP O
should MD MD O
return VB VB O
in IN IN O
1 CD CD O
year NN NN O
VS NNP NNP O
as IN IN O
noted VBD VBD O
chest NN NN O
clear JJ JJ O
to TO TO O
ausc VB VB O
. . . O
   
RR NNP NNP O
12 CD CD O
cardiac JJ JJ O
normal JJ JJ O
s1/s2 NN NN O
no DT DT O
m/s3/s4 NN NN O
HR NNP NNP O
58 CD CD O
reg NN NN O
no DT DT O
peripheral NN NN O
edema NN NN O
hgba1c NN NN O
6.5 CD CD O
( ( ( O
decreased VBD VBD O
from IN IN O
8.9 CD CD O
in IN IN O
11/77 CD CD I-DATE
) ) ) O
creatinine NN NN O
stable JJ JJ O
at IN IN O
1.4 CD CD O
Assessment NNP NNP O
- : : O
improved VBN VBN O
diabetic JJ JJ O
control NN NN O
. . . O
   
renal NN NN O
function NN NN O
stable JJ JJ O
. . . O
   
suboptimal NN NN O
bp NN NN O
control NN NN O
for IN IN O
diabetic JJ JJ O
with IN IN O
history NN NN O
of IN IN O
CAD NNP NNP O
; : : O
   
already RB RB O
bradycardic NN NN O
on IN IN O
atenolol NN NN O
50 CD CD O
mg NN NN O
qd NN NN O
Plan NNP NNP O
- : : O
continue VB VB O
current JJ JJ O
regimen NNS NNS O
with IN IN O
the DT DT I-COUNTRY
exception NN NN O
of IN IN O
lisinopril NN NN O
- - - O
will MD MD O
increase VB VB O
to TO TO O
20mg CD CD O
qd NN NN O
. . . O
   
pt NN NN O
has VBZ VBZ O
PE NNP NNP O
scheduled VBN VBN O
5/31/78 CD CD I-DATE
. . . O
   
bp NN NN O
recheck NN NN O
at IN IN O
that DT DT O
time NN NN O
no DT DT O
ophthalmology NN NN O
referral NN NN O
was VBD VBD O
made VBN VBN O
as IN IN O
he PRP PRP O
appears VBZ VBZ O
to TO TO O
be VB VB O
up RP RP O
to TO TO O
date NN NN O
with IN IN O
eye NN NN O
care NN NN O
N. NN NN I-DOCTOR
levine NN NN I-DOCTOR
, , , O
MD NNP NNP O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2080-05-30 NN NN I-DATE
CC NNP NNP O
: : : O
fever NN NN O
HPI NNP NNP O
: : : O
70 CD CD I-AGE
y/o NN NN O
Chilean JJ JJ I-COUNTRY
woman NN NN O
with IN IN O
PMH NNP NNP O
DM NNP NNP O
, , , O
HTN NNP NNP O
, , , O
high JJ JJ O
cholesterol NN NN O
who WP WP O
was VBD VBD O
recently RB RB O
admitted VBN VBN O
to TO TO O
CMC NNP NNP I-HOSPITAL
ED NNP NNP O
obs JJ JJ O
unit NN NN O
( ( ( O
last JJ JJ O
week NN NN O
) ) ) O
for IN IN O
back RB RB O
pain NN NN O
. . . O
   
She PRP PRP O
has VBZ VBZ O
been VBN VBN O
taking VBG VBG O
oxycodone NN NN O
and CC CC O
muscle NN NN O
relaxants NNS NNS O
at IN IN O
home NN NN O
. . . O
   
The DT DT O
past JJ JJ O
few JJ JJ O
days NNS NNS O
, , , O
she PRP PRP O
has VBZ VBZ O
had VBN VBN O
fevers NNS NNS O
every DT DT O
afternoon NN NN O
and CC CC O
family NN NN O
is VBZ VBZ O
concerned VBN VBN O
about IN IN O
malaria NN NN O
. . . O
   
Fevers NNP NNP O
at IN IN O
home NN NN O
have VBP VBP O
been VBN VBN O
between IN IN O
103 CD CD O
and CC CC O
105 CD CD O
( ( ( O
measured VBN VBN O
with IN IN O
thermometer NN NN O
) ) ) O
. . . O
   
She PRP PRP O
continues VBZ VBZ O
to TO TO O
have VB VB O
back RB RB O
pain NN NN O
and CC CC O
also RB RB O
has VBZ VBZ O
abdominal JJ JJ O
pain NN NN O
, , , O
decreased VBD VBD O
appetite NN NN O
. . . O
   
Per IN IN O
family NN NN O
, , , O
she PRP PRP O
has VBZ VBZ O
not RB RB O
seemed VBN VBN O
confused VBN VBN O
at IN IN O
all DT DT O
. . . O
   
Of IN IN O
note NN NN O
, , , O
she PRP PRP O
has VBZ VBZ O
had VBN VBN O
malaria NN NN O
in IN IN O
the DT DT O
past NN NN O
, , , O
and CC CC O
she PRP PRP O
reports NNS NNS O
the DT DT O
symptoms NNS NNS O
are VBP VBP O
the DT DT O
same JJ JJ O
now RB RB O
as IN IN O
they PRP PRP O
were VBD VBD O
at IN IN O
that DT DT O
time NN NN O
. . . O
   
Problems NNS NNS O
( ( ( O
per IN IN O
LMR NNP NNP O
) ) ) O
Diabetes NNP NNP O
mellitus NN NN O
: : : O
dx NN NN O
late JJ JJ O
2060s NN NN I-DATE
. . . O
   
No DT DT O
h/o NN NN O
macro NN NN O
or CC CC O
microvascular NN NN O
complications NNS NNS O
. . . O
   
Hypertensive NNP NNP O
disorder NN NN O
: : : O
dx NN NN O
2060s CD CD I-DATE
, , , O
was VBD VBD O
taking VBG VBG O
atenolol NN NN O
, , , O
enalapril NN NN O
and CC CC O
isosorbide NN NN O
in IN IN O
UNITED NNP NNP I-COUNTRY
KINGDOM NNP NNP I-COUNTRY
Hypercholesterolemia NNP NNP O
Obesity NNP NNP O
Osteoarthritis NNP NNP O
: : : O
L NNP NNP O
knee NN NN O
worst JJS JJS O
spot NN NN O
Gastroesophageal NNP NNP O
reflux NN NN O
disease NN NN O
: : : O
x SYM SYM O
years NNS NNS O
, , , O
never RB RB O
had VBD VBD O
EGD NNP NNP O
. . . O
   
H. NN NN O
pylori NN NN O
serology NN NN O
+ NN NN O
Helicobacter NNP NNP O
pylori NN NN O
: : : O
serology NN NN O
positive NN NN O
2068 CD CD I-DATE
and CC CC O
re-check NN NN O
2/2080 CD CD I-DATE
, , , O
no DT DT O
Ag NNP NNP O
done VBN VBN O
. . . O
   
Given VBN VBN O
triple NN NN O
therapy NN NN O
Rx NNP NNP O
by IN IN O
Internal NNP NNP O
Medicine NNP NNP O
Vitamin NNP NNP O
D NNP NNP O
deficiency NN NN O
Hepatitis NNP NNP O
B NNP NNP O
antibody NN NN O
present JJ JJ O
: : : O
Had VBD VBD O
HbsAg NNP NNP O
+ NN NN O
and CC CC O
HbsAb NNP NNP O
+ NN NN O
in IN IN O
2067 CD CD I-DATE
. . . O
   
LFTs NNP NNP O
wnl NN NN O
2067 CD CD I-DATE
and CC CC O
2080 CD CD I-DATE
. . . O
   
Positive NNP NNP O
PPD NNP NNP O
: : : O
dx NN NN O
in IN IN O
Mississippi NNP NNP I-STATE
previously RB RB O
in IN IN O
2067 CD CD I-DATE
Osteoporosis NNP NNP O
Medications NNP NNP O
( ( ( O
per IN IN O
LMR NNP NNP O
) ) ) O
Aspirin NNP NNP O
( ( ( O
ACETYLSALICYLIC NNP NNP O
Acid NNP NNP O
) ) ) O
81 CD CD O
MG NNP NNP O
( ( ( O
81 CD CD O
MG NNP NNP O
TABLET NNP NNP O
Take NNP NNP O
1 CD CD O
) ) ) O
PO NNP NNP O
QD NNP NNP O
x SYM SYM O
30 CD CD O
days NNS NNS O
#30 NN NN O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
Atenolol NNP NNP O
50 CD CD O
MG NNP NNP O
( ( ( O
50MG CD CD O
TABLET NNP NNP O
Take NNP NNP O
1 CD CD O
) ) ) O
PO NNP NNP O
QD NNP NNP O
x SYM SYM O
30 CD CD O
days NNS NNS O
#30 NN NN O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
Calcium NNP NNP O
600mg CD CD O
+ NN NN O
Vitamin NNP NNP O
D(400IU) NNP NNP O
1 CD CD O
TAB NNP NNP O
PO NNP NNP O
BID NNP NNP O
#60 NN NN O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
Ergocalciferol NNP NNP O
50000 CD CD O
UNITS NNP NNP O
( ( ( O
50000 CD CD O
UNIT NNP NNP O
CAPSULE NNP NNP O
Take NNP NNP O
1 CD CD O
) ) ) O
PO NNP NNP O
QWEEK NNP NNP O
x SYM SYM O
42 CD CD O
days NNS NNS O
#6 NN NN O
Capsule NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
Lisinopril NNP NNP O
20 CD CD O
MG NNP NNP O
( ( ( O
20 CD CD O
MG NNP NNP O
TABLET NNP NNP O
Take NNP NNP O
1 CD CD O
) ) ) O
PO NNP NNP O
QD NNP NNP O
x SYM SYM O
30 CD CD O
days NNS NNS O
#30 NN NN O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
Metformin NNP NNP O
500 CD CD O
MG NNP NNP O
( ( ( O
500 CD CD O
MG NNP NNP O
TABLET NNP NNP O
Take NNP NNP O
1 CD CD O
) ) ) O
PO NNP NNP O
BID NNP NNP O
x SYM SYM O
30 CD CD O
days NNS NNS O
#60 NN NN O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
Motrin NNP NNP O
( ( ( O
IBUPROFEN NNP NNP O
) ) ) O
600 CD CD O
MG NNP NNP O
( ( ( O
600MG CD CD O
TABLET NNP NNP O
Take NNP NNP O
1 CD CD O
) ) ) O
PO NNP NNP O
Q6H NNP NNP O
PRN NNP NNP O
pain NN NN O
, , , O
Take VB VB O
with IN IN O
food NN NN O
x SYM SYM O
7 CD CD O
days NNS NNS O
#28 NN NN O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
Nulytely RB RB O
4000 CD CD O
ML NNP NNP O
PO NNP NNP O
as IN IN O
directed VBN VBN O
#1 NN NN O
Bottle NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
Oxycodone NNP NNP O
5 CD CD O
MG NNP NNP O
( ( ( O
5MG CD CD O
TABLET NNP NNP O
Take NNP NNP O
1 CD CD O
) ) ) O
PO NNP NNP O
Q6H NNP NNP O
PRN NNP NNP O
pain NN NN O
, , , O
pain NN NN O
not RB RB O
relieved VBN VBN O
by IN IN O
ibuprofen NN NN O
Simvastatin NNP NNP O
40 CD CD O
MG NNP NNP O
( ( ( O
40 CD CD O
MG NNP NNP O
TABLET NNP NNP O
Take NNP NNP O
1 CD CD O
) ) ) O
PO NNP NNP O
QPM NNP NNP O
x SYM SYM O
30 CD CD O
days NNS NNS O
#30 NN NN O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
Valium NNP NNP O
( ( ( O
DIAZEPAM NNP NNP O
) ) ) O
5 CD CD O
MG NNP NNP O
( ( ( O
5MG CD CD O
TABLET NNP NNP O
Take NNP NNP O
1 CD CD O
) ) ) O
PO NNP NNP O
Q8H NNP NNP O
, , , O
Take NNP NNP O
1 CD CD O
tablet NN NN O
every DT DT O
8 CD CD O
hours NNS NNS O
for IN IN O
muscle NN NN O
relaxation NN NN O
if IN IN O
awake/uncomfortable JJ JJ O
Allergies NNP NNP O
NKA NNP NNP O
Social NNP NNP O
History NN NN O
Here RB RB O
with IN IN O
several JJ JJ O
family NN NN O
members NNS NNS O
. . . O
   
Originally RB RB O
from IN IN O
Chile NNP NNP I-COUNTRY
, , , O
does VBZ VBZ O
not RB RB O
speak VB VB O
English NNP NNP O
. . . O
   
Physical JJ JJ O
Exam NNP NNP O
102.6 CD CD O
, , , O
HR NNP NNP O
102 CD CD O
, , , O
RR NNP NNP O
20 CD CD O
, , , O
99 CD CD O
% NN NN O
RA NNP NNP O
BP NNP NNP O
184/68 CD CD O
and CC CC O
178/69 CD CD O
General NNP NNP O
- : : O
Very RB RB O
uncomfortable JJ JJ O
in IN IN O
bed NN NN O
HEENT NNP NNP O
- : : O
MMMLungs NNP NNP O
- : : O
clear JJ JJ O
CV NNP NNP O
- : : O
tachy NN NN O
but CC CC O
regular JJ JJ O
, , , O
no DT DT O
murmurs NNS NNS O
Abdomen NNP NNP O
- : : O
soft JJ JJ O
, , , O
non-distended JJ JJ O
, , , O
reports NNS NNS O
some DT DT O
tenderness NN NN O
to TO TO O
palpation NN NN O
of IN IN O
RLQ NNP NNP O
Ext NNP NNP O
- - - O
no DT DT O
edema NN NN O
, , , O
no DT DT O
rash NN NN O
, , , O
w/w/p NN NN O
EKG NNP NNP O
Rate NNP NNP O
100 CD CD O
, , , O
sinus JJ JJ O
rhythm NN NN O
, , , O
normal JJ JJ O
axis NNS NNS O
. . . O
   
No DT DT O
acute JJ JJ O
ST NNP NNP O
changes NNS NNS O
, , , O
Q NNP NNP O
waves NNS NNS O
or CC CC O
T NN NN O
wave NN NN O
inversion NN NN O
. . . O
   
T NN NN O
wave NN NN O
flattening NN NN O
in IN IN O
lead NN NN O
II NNP NNP O
. . . O
   
No DT DT O
significant JJ JJ O
change NN NN O
compared VBN VBN O
to TO TO O
prior RB RB O
( ( ( O
2/2080 CD CD I-DATE
) ) ) O
. . . O
   
Urine NNP NNP O
dipstick JJ JJ O
- : : O
large JJ JJ O
WBCs NNP NNP O
, , , O
large JJ JJ O
RBCs NNP NNP O
FSBG NNP NNP O
143 CD CD O
Motrin NNP NNP O
X1 NNP NNP O
at IN IN O
triage NN NN O
A/P NNP NNP O
70 CD CD I-AGE
y/o NN NN O
woman NN NN O
with IN IN O
PMH NNP NNP O
DM NNP NNP O
, , , O
HTN NNP NNP O
, , , O
high JJ JJ O
cholesterol NN NN O
who WP WP O
was VBD VBD O
recently RB RB O
admitted VBN VBN O
to TO TO O
CMC NNP NNP I-HOSPITAL
ED NNP NNP O
obs JJ JJ O
unit NN NN O
( ( ( O
last JJ JJ O
week NN NN O
) ) ) O
for IN IN O
back RB RB O
pain NN NN O
now RB RB O
with IN IN O
documented VBN VBN O
high JJ JJ O
fevers NNS NNS O
. . . O
   
- - - O
Blood NNP NNP O
cultures NNS NNS O
( ( ( O
one CD CD O
set VBN VBN O
) ) ) O
with IN IN O
IV NNP NNP O
start VB VB O
, , , O
500cc CD CD O
NS NNP NNP O
bolus NN NN O
- : : O
Urine NNP NNP O
culture NN NN O
sent VBD VBD O
- : : O
Transfer NNP NNP O
to TO TO O
CMC NNP NNP I-HOSPITAL
ER NNP NNP O
for IN IN O
further JJ JJ O
work-up JJ JJ O
, , , O
likely JJ JJ O
admission NN NN O
; : : O
   
referral JJ JJ O
called VBN VBN O
to TO TO O
ED NNP NNP O
access NN NN O
nurse NN NN O
Guadalupe NNP NNP I-DOCTOR
Logan NNP NNP I-DOCTOR
, , , O
MD NNP NNP O
, , , O
PGY3 NNP NNP O
CC NNP NNP O
: : : O
Dr NNP NNP O
. . . O
Xue NNP NNP I-DOCTOR
Personally RB RB O
discussed VBD VBD O
differential JJ JJ O
diagnosis NN NN O
and CC CC O
treatment NN NN O
plan NN NN O
with IN IN O
patient NN NN O
. . . O
   
Pt NNP NNP O
agrees NNS NNS O
and CC CC O
demonstrated VBD VBD O
full JJ JJ O
understanding NN NN O
of IN IN O
recommendations NNS NNS O
before RB RB O
discharge NN NN O
. . . O
   
Discharge NNP NNP O
Time NNP NNP O
: : : O
8:30PM CD CD O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2068-12-05 JJ JJ I-DATE
Narrative NNP NNP O
History NN NN O
Patient NNP NNP O
presents VBZ VBZ O
for IN IN O
uri NN NN O
. . . O
   
Walks NNP NNP O
- : : O
in IN IN O
. . . O
   
Overdue NNP NNP O
for IN IN O
follow-up JJ JJ O
by IN IN O
3 CD CD O
months NNS NNS O
. . . O
   
Started VBD VBD O
last JJ JJ O
week NN NN O
. . . O
   
Sinus NNP NNP O
pressure NN NN O
, , , O
post NN NN O
nasal NN NN O
drip NN NN O
, , , O
headache NN NN O
, , , O
ears NNS NNS O
blocked VBN VBN O
. . . O
   
No DT DT O
fevers NNS NNS O
. . . O
   
Slight NNP NNP O
white JJ JJ O
nasal NN NN O
cdischarge NN NN O
. . . O
   
Taking VBG VBG O
advil JJ JJ O
sinus NNS NNS O
only RB RB O
helps VBZ VBZ O
transiently RB RB O
. . . O
   
Not RB RB O
getting VBG VBG O
better JJR JJR O
or CC CC O
worse JJR JJR O
. . . O
   
No DT DT O
chest NN NN O
symptoms NNS NNS O
- : : O
coughing VBG VBG O
etc FW FW O
. . . O
. . . O
   
Got NNP NNP O
flu NN NN O
shot NN NN O
already RB RB O
. . . O
   
Problems NNS NNS O
FH NNP NNP O
breast NN NN O
cancer NN NN O
: : : O
37 CD CD I-AGE
yo NN NN O
s VBZ VBZ O
FH NNP NNP O
myocardial NN NN O
infarction NN NN O
: : : O
mother NN NN O
died VBD VBD O
66 CD CD I-AGE
yo NN NN O
Hypertension NNP NNP O
Uterine NNP NNP O
fibroids NNS NNS O
: : : O
u/s NN NN O
2062 CD CD I-DATE
Smoking NNP NNP O
: : : O
quit VBD VBD O
2/67 CD CD I-DATE
s/p NN NN O
MI NNP NNP O
Hyperlipidemia NNP NNP O
: : : O
CRF NNP NNP O
mild NN NN O
chol NN NN O
, , , O
cigs NNS NNS O
, , , O
HTN NNP NNP O
, , , O
Fhx NNP NNP O
and CC CC O
known VBN VBN O
hx NN NN O
CAD NNP NNP O
in IN IN O
pt NN NN O
. . . O
   
borderline NN NN O
diabetes NN NN O
mellitus NN NN O
: : : O
4/63 CD CD I-DATE
125 CD CD O
, , , O
follow VBP VBP O
hgbaic NN NN O
VPB NNP NNP O
: : : O
2065 CD CD I-DATE
- : : O
ETT NNP NNP O
showed VBD VBD O
freq NN NN O
PVC NNP NNP O
's POS POS O
, , , O
bigeminy NN NN O
and CC CC O
couplets NNS NNS O
, , , O
nondx NN NN O
for IN IN O
ischemia NN NN O
Coronary JJ JJ O
artery NN NN O
disease NN NN O
: : : O
s/p NN NN O
ant NN NN O
SEMI NNP NNP O
+ NN NN O
stent NN NN O
LAD NNP NNP O
2/67 CD CD I-DATE
, , , O
Dr NNP NNP O
Oakley NNP NNP I-DOCTOR
, , , O
ETT NNP NNP O
Clarkfield NNP NNP I-HOSPITAL
3/67 CD CD I-DATE
- : : O
neg NN NN O
scan VB VB O
for IN IN O
ischemia NN NN O
. . . O
   
Thyroid NNP NNP O
nodule NN NN O
: : : O
2065 CD CD I-DATE
, , , O
thyroid NN NN O
scan JJ JJ O
2066 CD CD I-DATE
consistent JJ JJ O
with IN IN O
hot JJ JJ O
nodule NN NN O
and CC CC O
toxic JJ JJ O
multinodular JJ JJ O
goiter NN NN O
, , , O
saw VBD VBD O
Dr NNP NNP O
Dolan NNP NNP I-DOCTOR
, , , O
follow VB VB O
TSH NNP NNP O
. . . O
   
Medications NNP NNP O
Asa NNP NNP O
( ( ( O
ACETYLSALICYLIC NNP NNP O
Acid NNP NNP O
) ) ) O
325MG CD CD O
, , , O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Nitroglycerin NNP NNP O
1/150 CD CD O
( ( ( O
0.4 CD CD O
Mg NNP NNP O
) ) ) O
1 CD CD O
TAB NNP NNP O
SL NNP NNP O
x1 NN NN O
PRN NNP NNP O
prn NN NN O
CP NNP NNP O
Norvasc NNP NNP O
( ( ( O
AMLODIPINE NNP NNP O
) ) ) O
5MG CD CD O
, , , O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Plavix NNP NNP O
( ( ( O
CLOPIDOGREL NNP NNP O
) ) ) O
75 CD CD O
MG NNP NNP O
PO NNP NNP O
QD NNP NNP O
ATENOLOL NNP NNP O
50MG CD CD O
, , , O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Lipitor NNP NNP O
( ( ( O
ATORVASTATIN NNP NNP O
) ) ) O
10MG CD CD O
, , , O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Hctz NNP NNP O
( ( ( O
HYDROCHLOROTHIAZIDE NNP NNP O
) ) ) O
25MG CD CD O
, , , O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Zestril NNP NNP O
( ( ( O
LISINOPRIL NNP NNP O
) ) ) O
40MG CD CD O
, , , O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Allergies NNP NNP O
Ceclor NNP NNP O
( ( ( O
CEFACLOR NNP NNP O
) ) ) O
- : : O
Rash NNP NNP O
Physical JJ JJ O
Exam NNP NNP O
Vital NNP NNP O
signs NNS NNS O
140/82 CD CD O
98.2 CD CD O
Looks NNP NNP O
well RB RB O
, , , O
nontoxic NN NN O
Sinuses NNP NNP O
- : : O
nontender NN NN O
TM NNP NNP O
's POS POS O
clear JJ JJ O
OP NNP NNP O
- : : O
negative JJ JJ O
without IN IN O
exudates NNS NNS O
neck NN NN O
- : : O
supple NN NN O
without IN IN O
increased VBN VBN O
nodes NNS NNS O
lungs NNS NNS O
- : : O
clear JJ JJ O
without IN IN O
wheezing VBG VBG O
on IN IN O
forced VBN VBN O
exp NN NN O
CVS NNP NNP O
- : : O
rrrs2s2 NN NN O
Assessment NNP NNP O
and CC CC O
Plan NNP NNP O
   
1 CD CD O
. . . O
URI NNP NNP O
- : : O
no DT DT O
evidence NN NN O
of IN IN O
bact NN NN O
sinus NN NN O
infection NN NN O
. . . O
   
Needs NNP NNP O
decongestion NN NN O
but CC CC O
would MD MD O
like VB VB O
to TO TO O
avoid VB VB O
decong JJ JJ O
systemically RB RB O
given VBN VBN O
history NN NN O
CAD NNP NNP O
and CC CC O
ectopy NN NN O
in IN IN O
past JJ JJ O
. . . O
   
Will MD MD O
use VB VB O
steam NN NN O
, , , O
humidity NN NN O
, , , O
nasal NN NN O
decong JJ JJ O
spray NN NN O
for IN IN O
3 CD CD O
days NNS NNS O
. . . O
   
Call NN NN O
if IN IN O
fevers NNS NNS O
, , , O
worsens NNS NNS O
or CC CC O
persists NNS NNS O
. . . O
   
2 CD CD O
. . . O
Hot NNP NNP O
thyroid NN NN O
nodule NN NN O
- - - O
was VBD VBD O
slightly RB RB O
higher JJR JJR O
last JJ JJ O
visit NN NN O
- : : O
will MD MD O
refer VB VB O
to TO TO O
Dr NNP NNP O
Dolan NNP NNP I-DOCTOR
for IN IN O
discussion NN NN O
re NN NN O
treating VBG VBG O
this DT DT O
now RB RB O
especially RB RB O
given VBN VBN O
her PRP$ PRP$ O
history NN NN O
of IN IN O
cardiac JJ JJ O
ds NN NN O
in IN IN O
the DT DT O
last JJ JJ O
couple NN NN O
of IN IN O
years NNS NNS O
. . . O
   
3 CD CD O
. . . O
blood NN NN O
pressure NN NN O
- : : O
slightly RB RB O
elevated VBD VBD O
above IN IN O
what WP WP O
would MD MD O
want VB VB O
it PRP PRP O
. . . O
   
Will MD MD O
recheck VB VB O
on IN IN O
follow-up JJ JJ O
which WDT WDT O
will MD MD O
be VB VB O
soon RB RB O
   
4 CD CD O
. . . O
Chol NNP NNP O
- : : O
will MD MD O
check VB VB O
fastings NNS NNS O
next JJ JJ O
visit NN NN O
. . . O
   
Lfts NNP NNP O
okay JJ JJ O
in IN IN O
June NNP NNP I-DATE
Due NNP NNP O
for IN IN O
annual JJ JJ O
- : : O
will MD MD O
schedule VB VB O
next JJ JJ O
avail NN NN O
. . . O
   
Beverly NNP NNP I-DOCTOR
Thiel NNP NNP I-DOCTOR
MD NNP NNP O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2089-05-17 JJ JJ I-DATE
INFECTIOUS NNP NNP O
DISEASE NNP NNP O
UNIT NNP NNP O
NORTHERN NNP NNP I-HOSPITAL
STATE NNP NNP I-HOSPITAL
HOSPITAL NNP NNP I-HOSPITAL
Visit NNP NNP O
Note NN NN O
   
( ( ( O
unreviewed VBN VBN O
) ) ) O
Reason NNP NNP O
for IN IN O
visit NN NN O
f/u NN NN O
for IN IN O
inpatient NN NN O
consult NN NN O
- : : O
GBS NNP NNP O
AV NNP NNP O
endocarditis NN NN O
History NN NN O
of IN IN O
present JJ JJ O
illness NN NN O
See VB VB O
initial JJ JJ O
ID NNP NNP O
consult NN NN O
note NN NN O
for IN IN O
greater JJR JJR O
detail NN NN O
. . . O
   
Briefly NNP NNP O
, , , O
70 CD CD I-AGE
yo NN NN O
F NN NN O
w NN NN O
HTN NNP NNP O
, , , O
DM2 NNP NNP O
, , , O
stable JJ JJ O
angina NN NN O
who WP WP O
is VBZ VBZ O
transferred VBN VBN O
to TO TO O
NSH NNP NNP I-HOSPITAL
on IN IN O
4/3/89 CD CD I-DATE
with IN IN O
aortic JJ JJ O
valve NN NN O
endocarditis NNS NNS O
complicated VBN VBN O
by IN IN O
AI NNP NNP O
and CC CC O
CHF NNP NNP O
. . . O
   
She PRP PRP O
was VBD VBD O
in IN IN O
her PRP$ PRP$ O
USOH NNP NNP O
until IN IN O
~ NN NN O
2/8/89 CD CD I-DATE
when WRB WRB O
she PRP PRP O
had VBD VBD O
an DT DT O
episode NN NN O
of IN IN O
shingles NNS NNS O
on IN IN O
R NNP NNP O
arm NN NN O
for IN IN O
which WDT WDT O
she PRP PRP O
took VBD VBD O
Valtrex NNP NNP O
. . . O
   
Soon RB RB O
after IN IN O
she PRP PRP O
began VBD VBD O
to TO TO O
feel VB VB O
fatigued VBN VBN O
and CC CC O
febrile JJ JJ O
and CC CC O
was VBD VBD O
found VBN VBN O
to TO TO O
have VB VB O
a DT DT O
2/2 CD CD O
bottles NNS NNS O
positive JJ JJ O
for IN IN O
Group NNP NNP O
B NNP NNP O
streptococcus NN NN O
on IN IN O
2/21 CD CD I-DATE
( ( ( O
PCN NNP NNP O
MIC NNP NNP O
0.125 CD CD O
) ) ) O
for IN IN O
which WDT WDT O
her PRP$ PRP$ O
PCP NNP NNP O
treated VBD VBD O
her PRP PRP O
with IN IN O
2 CD CD O
week NN NN O
course NN NN O
of IN IN O
amoxicillin NN NN O
. . . O
   
On IN IN O
4/3 CD CD I-DATE
she PRP PRP O
presents VBZ VBZ O
with IN IN O
SOB NNP NNP O
, , , O
orthopnea NN NN O
, , , O
and CC CC O
PND NNP NNP O
. . . O
   
she PRP PRP O
developed VBD VBD O
DOE NNP NNP O
, , , O
PND NNP NNP O
, , , O
orthopnea NN NN O
, , , O
worsening VBG VBG O
fatigue NN NN O
and CC CC O
malaise NN NN O
. . . O
   
CXR NNP NNP O
at IN IN O
OSH NNP NNP O
notable JJ JJ O
for IN IN O
pulm NN NN O
edema NN NN O
and CC CC O
TTE NNP NNP O
demonstrated VBD VBD O
vegetation NN NN O
on IN IN O
the DT DT O
aortic JJ JJ O
valve NN NN O
. . . O
   
She PRP PRP O
was VBD VBD O
transferred VBN VBN O
to TO TO O
NSH NNP NNP I-HOSPITAL
where WRB WRB O
she PRP PRP O
was VBD VBD O
started VBN VBN O
on IN IN O
ampicillin NN NN O
1gm CD CD O
IV NNP NNP O
q8h NN NN O
and CC CC O
gentamicin NN NN O
120 CD CD O
mg NN NN O
TID NNP NNP O
. . . O
   
TTE NNP NNP O
4/4 CD CD I-DATE
showed VBD VBD O
a DT DT O
mobile JJ JJ O
mass NN NN O
of IN IN O
echoes NNS NNS O
attached VBN VBN O
to TO TO O
the DT DT O
valve NN NN O
c/w NN NN O
vegetation NN NN O
. . . O
   
The DT DT O
right NN NN O
coronary JJ JJ O
leaflet NN NN O
appears VBZ VBZ O
flail NN NN O
, , , O
and CC CC O
there EX EX O
was VBD VBD O
prolapse NN NN O
of IN IN O
the DT DT O
non-coronary JJ JJ O
cusp NN NN O
as RB RB O
well RB RB O
. . . O
   
There EX EX O
was VBD VBD O
evidence NN NN O
of IN IN O
at IN IN O
least JJS JJS O
moderate JJ JJ O
aortic JJ JJ O
insufficiency NN NN O
by IN IN O
color NN NN O
and CC CC O
spectral JJ JJ O
Doppler NNP NNP O
. . . O
   
She PRP PRP O
went VBD VBD O
to TO TO O
the DT DT O
OR CC CC O
on IN IN O
4/5 CD CD I-DATE
CABG NNP NNP O
, , , O
TEE NNP NNP O
, , , O
Homograft NNP NNP O
aortic JJ JJ O
root NN NN O
placement NN NN O
oIn NN NN O
the DT DT O
OR CC CC O
the DT DT O
aortic JJ JJ O
valve NN NN O
was VBD VBD O
severely RB RB O
damaged VBN VBN O
. . . O
   
There EX EX O
was VBD VBD O
perforation NN NN O
of IN IN O
the DT DT O
right NN NN O
coronary JJ JJ O
leaflet NN NN O
and CC CC O
there EX EX O
were VBD VBD O
numerous JJ JJ O
vegetations NNS NNS O
, , , O
which WDT WDT O
appeared VBD VBD O
to TO TO O
be VB VB O
rolled VBN VBN O
up RP RP O
aortic JJ JJ O
valve NN NN O
tissue NN NN O
on IN IN O
predominantly RB RB O
the DT DT O
right NN NN O
and CC CC O
noncoronary JJ JJ O
leaflets NNS NNS O
. . . O
   
Underneath IN IN O
the DT DT O
annulus NN NN O
of IN IN O
the DT DT O
right NN NN O
coronary JJ JJ O
, , , O
there EX EX O
was VBD VBD O
an DT DT O
area NN NN O
of IN IN O
early JJ JJ O
abscess JJ JJ O
formation NN NN O
. . . O
   
Gram NNP NNP O
stain VB VB O
of IN IN O
tissues NNS NNS O
was VBD VBD O
negative JJ JJ O
for IN IN O
organisms NNS NNS O
and CC CC O
cultures NNS NNS O
were VBD VBD O
negative JJ JJ O
. . . O
   
Pathology NNP NNP O
was VBD VBD O
notable JJ JJ O
for IN IN O
Numerous JJ JJ O
degenerated JJ JJ O
bacterial JJ JJ O
coccal JJ JJ O
forms NNS NNS O
present JJ JJ O
on IN IN O
silver NN NN O
stain VBP VBP O
consistent JJ JJ O
with IN IN O
Streptococcus NNP NNP O
. . . O
   
Occasional NNP NNP O
residual JJ JJ O
gram NN NN O
positive JJ JJ O
cocci NN NN O
present JJ JJ O
on IN IN O
Brown-Hopps NNP NNP O
stain VB VB O
. . . O
   
She PRP PRP O
was VBD VBD O
started VBN VBN O
on IN IN O
PCN NNP NNP O
3 CD CD O
million CD CD O
units NNS NNS O
q4h NN NN O
and CC CC O
Gentamicin NNP NNP O
60 CD CD O
mg NN NN O
q12h NN NN O
on IN IN O
4/6 CD CD I-DATE
. . . O
   
Her PRP$ PRP$ O
hospital NN NN O
course NN NN O
was VBD VBD O
c/b NN NN O
by IN IN O
heart NN NN O
block NN NN O
for IN IN O
which WDT WDT O
she PRP PRP O
received VBD VBD O
a DT DT O
PPM NNP NNP O
on IN IN O
4/12 CD CD I-DATE
. . . O
   
She PRP PRP O
has VBZ VBZ O
now RB RB O
completed VBN VBN O
6 CD CD O
weeks NNS NNS O
of IN IN O
PCN NNP NNP O
on IN IN O
5/20 CD CD I-DATE
and CC CC O
2 CD CD O
weeks NNS NNS O
of IN IN O
gentamicin NN NN O
( ( ( O
4/6-4/20 JJ JJ O
) ) ) O
. . . O
   
She PRP PRP O
is VBZ VBZ O
clinically RB RB O
doing VBG VBG O
well RB RB O
without IN IN O
fevers NNS NNS O
, , , O
chills NNS NNS O
, , , O
night NN NN O
sweats NNS NNS O
, , , O
drainage NN NN O
or CC CC O
erythema NN NN O
from IN IN O
sternal JJ JJ O
incision NN NN O
or CC CC O
from IN IN O
PICC NNP NNP O
site NN NN O
. . . O
   
She PRP PRP O
does VBZ VBZ O
note NN NN O
swelling VBG VBG O
of IN IN O
her PRP$ PRP$ O
R NNP NNP O
arm NN NN O
which WDT WDT O
is VBZ VBZ O
slightly RB RB O
worse RBR RBR O
since IN IN O
she PRP PRP O
has VBZ VBZ O
been VBN VBN O
unable JJ JJ O
to TO TO O
wear VB VB O
her PRP$ PRP$ O
sleeve NN NN O
for IN IN O
chronic JJ JJ O
lymphedema NN NN O
. . . O
   
She PRP PRP O
had VBD VBD O
a DT DT O
recent JJ JJ O
admission NN NN O
5/11-5/15 NN NN O
for IN IN O
chest NN NN O
pain NN NN O
. . . O
   
She PRP PRP O
was VBD VBD O
ruled VBN VBN O
out IN IN O
for IN IN O
MI NNP NNP O
by IN IN O
cardiac JJ JJ O
markers NNS NNS O
and CC CC O
underwent JJ JJ O
cardiac JJ JJ O
catheterization NN NN O
which WDT WDT O
showed VBD VBD O
patent NN NN O
graft NN NN O
. . . O
   
Past NNP NNP O
medical JJ JJ O
history NN NN O
   
1 CD CD O
. . . O
Stable JJ JJ O
Angina NNP NNP O
( ( ( O
prior RB RB O
cath NN NN O
in IN IN O
2073 CD CD I-DATE
reportedly RB RB O
normal JJ JJ O
) ) ) O
   
2 CD CD O
. . . O
HTN NNP NNP O
   
3 CD CD O
. . . O
DM2 NNP NNP O
   
4 CD CD O
. . . O
GERD NNP NNP O
   
5 CD CD O
. . . O
S/P NNP NNP O
Bilateral NNP NNP O
Mastectomy NNP NNP O
- : : O
R NN NN O
in IN IN O
2081 CD CD I-DATE
and CC CC O
L NNP NNP O
in IN IN O
2084 CD CD I-DATE
   
6 CD CD O
. . . O
S/P NNP NNP O
Right RB RB O
Carotid NNP NNP O
Endarterectomy NNP NNP O
   
7 CD CD O
. . . O
Back RB RB O
surgery NN NN O
with IN IN O
rods NNS NNS O
placed VBN VBN O
2088 CD CD I-DATE
at IN IN O
MSTMC NNP NNP I-HOSPITAL
8 CD CD O
/ NN NN O
GBS NNP NNP O
AV NNP NNP O
endocarditis NN NN O
2089 CD CD I-DATE
Family NNP NNP O
history NN NN O
CAD NNP NNP O
Social NNP NNP O
history NN NN O
Widowed NNP NNP O
lives NNS NNS O
alone RB RB O
. . . O
   
2 CD CD O
adult NN NN O
children NNS NNS O
Employment NN NN O
: : : O
. . . O
   
Worked NNP NNP O
as IN IN O
an DT DT O
Welder NNP NNP I-PROFESSION
, , , O
but CC CC O
has VBZ VBZ O
not RB RB O
worked VBN VBN O
since IN IN O
she PRP PRP O
had VBD VBD O
children NNS NNS O
. . . O
   
Travel/Regional NNP NNP O
exposures NNS NNS O
: : : O
Travels NNP NNP O
to TO TO O
Angola NNP NNP I-COUNTRY
yearly RB RB O
. . . O
   
Israel NNP NNP I-COUNTRY
in IN IN O
2083 CD CD I-DATE
TB/PPD NNP NNP O
hx NN NN O
: : : O
no DT DT O
Known VBN VBN O
exposures NNS NNS O
Sick NNP NNP O
exposures NNS NNS O
: : : O
None NN NN O
Pets NNS NNS O
: : : O
None NN NN O
Tobacco NNP NNP O
: : : O
Quit NNP NNP O
in IN IN O
2079 CD CD I-DATE
; : : O
   
30 CD CD O
pack NN NN O
year NN NN O
hx NN NN O
ETOH NNP NNP O
: : : O
rare JJ JJ O
ETOH NNP NNP O
IVDU/illicits NNP NNP O
: : : O
Negative NNP NNP O
. . . O
   
Dental NNP NNP O
work NN NN O
: : : O
Edentulous NNP NNP O
Allergies NNP NNP O
No DT DT O
known VBN VBN O
allergies NNS NNS O
Physical JJ JJ O
Exam NNP NNP O
Blood NNP NNP O
pressure NN NN O
90/54 CD CD O
Pulse NNP NNP O
60 CD CD O
weight NN NN O
126 CD CD O
temperature NN NN O
97.7 CD CD O
General NNP NNP O
appearance NN NN O
Well RB RB O
developed VBD VBD O
, , , O
well RB RB O
nourished VBN VBN O
, , , O
no DT DT O
acute JJ JJ O
distress NN NN O
. . . O
   
Chest NN NN O
Bibasilar NNP NNP O
crackles NNS NNS O
. . . O
   
Sternal NNP NNP O
incisionwithout NN NN O
erythema NN NN O
or CC CC O
drainage NN NN O
. . . O
   
Pacer NNP NNP O
pcoket NN NN O
without IN IN O
erythema NN NN O
or CC CC O
fluctuance NN NN O
Cor NNP NNP O
RRR NNP NNP O
nl NN NN O
s1 NN NN O
, , , O
s2 NN NN O
without IN IN O
m/r/g NN NN O
. . . O
   
Abdomen NNP NNP O
NT/ND NNP NNP O
, , , O
no DT DT O
HSM NNP NNP O
. . . O
   
Normal JJ JJ O
active JJ JJ O
bowel NN NN O
sounds VBZ VBZ O
. . . O
   
Extrem NNP NNP O
No DT DT O
LE NNP NNP O
edema NN NN O
. . . O
   
RUE NNP NNP O
edematous JJ JJ O
from IN IN O
wrist NN NN O
to TO TO O
upper JJ JJ O
arm NN NN O
. . . O
   
PICC NNP NNP O
site NN NN O
without IN IN O
erythema NN NN O
or CC CC O
drainage NN NN O
. . . O
   
Assessment NNP NNP O
and CC CC O
plan NN NN O
70 CD CD I-AGE
yo NN NN O
F NN NN O
w NN NN O
HTN NNP NNP O
, , , O
DM NNP NNP O
, , , O
stable JJ JJ O
angina NN NN O
who WP WP O
now RB RB O
s/p NN NN O
2 CD CD O
weeks NNS NNS O
of IN IN O
gent NN NN O
and CC CC O
6 CD CD O
weeks NNS NNS O
of IN IN O
PCN NNP NNP O
for IN IN O
Group NNP NNP O
B NNP NNP O
strep NN NN O
AV NNP NNP O
endocarditis NN NN O
. . . O
   
Clinically NNP NNP O
she PRP PRP O
is VBZ VBZ O
doing VBG VBG O
well RB RB O
, , , O
except IN IN O
for IN IN O
RUE NNP NNP O
swelling VBG VBG O
which WDT WDT O
is VBZ VBZ O
likely JJ JJ O
lymphedema NN NN O
. . . O
   
She PRP PRP O
is VBZ VBZ O
therapeutic JJ JJ O
on IN IN O
her PRP$ PRP$ O
INR NNP NNP O
making VBG VBG O
DVT NNP NNP O
unlikely JJ JJ O
. . . O
   
Plan NNP NNP O
: : : O
- : : O
d/c NN NN O
PICC NNP NNP O
- : : O
check NN NN O
CBC/diff NNP NNP O
, , , O
LFTs NNP NNP O
, , , O
ESR NNP NNP O
, , , O
CRP NNP NNP O
Follow NNP NNP O
up RP RP O
RTC NNP NNP O
prn NN NN O
Natashia NNP NNP I-DOCTOR
Rosa NNP NNP I-DOCTOR
, , , O
MD NNP NNP O
pager NN NN O
#27960 NN NN O
Signed NNP NNP O
electronically RB RB O
by IN IN O
Natashia NNP NNP I-DOCTOR
Rosa NNP NNP I-DOCTOR
, , , O
MD NNP NNP O
Document NNP NNP O
Status NNP NNP O
: : : O
Final NNP NNP O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2073-07-04 JJ JJ I-DATE
HPI NNP NNP O
: : : O
81 CD CD I-AGE
y.o.w. NN NN O
with IN IN O
multiple JJ JJ O
medical JJ JJ O
problems NNS NNS O
including VBG VBG O
DM NNP NNP O
, , , O
HTN NNP NNP O
, , , O
CAD NNP NNP O
, , , O
CHF NNP NNP O
, , , O
PE NNP NNP O
, , , O
depresion NN NN O
here RB RB O
for IN IN O
follow VB VB O
up RB RB O
post NN NN O
EDUCARE-FARGO NNP NNP I-HOSPITAL
admission NN NN O
chart NN NN O
reviewed VBD VBD O
since IN IN O
last JJ JJ O
visit NN NN O
she PRP PRP O
had VBD VBD O
3 CD CD O
admission NN NN O
to TO TO O
the DT DT O
hospital NN NN O
first JJ JJ O
due JJ JJ O
to TO TO O
CHF NNP NNP O
then RB RB O
to TO TO O
SEH NNP NNP I-HOSPITAL
RF NNP NNP O
and CC CC O
last JJ JJ O
month NN NN O
again RB RB O
to TO TO O
RSH NNP NNP I-HOSPITAL
b/o NN NN O
CHF NNP NNP O
she PRP PRP O
was VBD VBD O
in IN IN O
SNF NNP NNP O
between IN IN O
those DT DT O
hospitalisations NNS NNS O
however RB RB O
did VBD VBD O
not RB RB O
want VB VB O
to TO TO O
go VB VB O
back RB RB O
so RB RB O
now RB RB O
at IN IN O
home NN NN O
tells VBZ VBZ O
me PRP PRP O
doing VBG VBG O
well RB RB O
has VBZ VBZ O
support NN NN O
a DT DT O
women NNS NNS O
who WP WP O
cleans VBZ VBZ O
cooks NN NN O
shops NNS NNS O
for IN IN O
her PRP$ PRP$ O
2 CD CD O
times NNS NNS O
a DT DT O
week NN NN O
VN NNP NNP O
comes VBZ VBZ O
once RB RB O
a DT DT O
week NN NN O
her PRP$ PRP$ O
family NN NN O
is VBZ VBZ O
in IN IN O
Kansas NNP NNP I-STATE
she PRP PRP O
uses VBZ VBZ O
a DT DT O
walker NN NN O
at IN IN O
home NN NN O
came VBD VBD O
with IN IN O
Patriot NNP NNP I-ORGANIZATION
chair NN NN O
car NN NN O
occ NN NN O
still RB RB O
has VBZ VBZ O
sob NN NN O
and CC CC O
CP NNP NNP O
the DT DT O
same JJ JJ O
the DT DT O
rash NN NN O
under IN IN O
her PRP$ PRP$ O
L NNP NNP O
breast NN NN O
bothers NNS NNS O
her PRP$ PRP$ O
itching VBG VBG O
occ NN NN O
legs NNS NNS O
, , , O
ankles,back RB RB O
pain NN NN O
same JJ JJ O
as IN IN O
before IN IN O
takes VBZ VBZ O
tyl NN NN O
; : : O
   
enol NN NN O
was VBD VBD O
not RB RB O
helpful JJ JJ O
now RB RB O
uses VBZ VBZ O
ibuprofen NN NN O
200 CD CD O
mg NN NN O
prn NN NN O
only RB RB O
1-2 CD CD O
day NN NN O
BM NNP NNP O
normal JJ JJ O
oc NN NN O
constipation NN NN O
, , , O
no DT DT O
abdominal JJ JJ O
discomfort NN NN O
but CC CC O
has VBZ VBZ O
bloading VBG VBG O
according VBG VBG O
to TO TO O
record VB VB O
this DT DT O
Sunday NNP NNP I-DATE
her PRP$ PRP$ O
FS NNP NNP O
249 CD CD O
- : : O
checked VBN VBN O
by IN IN O
HA NNP NNP O
denies VBZ VBZ O
depression NN NN O
has VBZ VBZ O
diaper NN NN O
does VBZ VBZ O
not RB RB O
c/o VB VB O
dysuria NN NN O
, , , O
polyuria NN NN O
no DT DT O
headache NN NN O
, , , O
rash NN NN O
F/C NNP NNP O
other JJ JJ O
ros NNS NNS O
neg NN NN O
PMH NNP NNP O
: : : O
Hypertension NNP NNP O
Osteoarthritis NNP NNP O
Dizziness NNP NNP O
amputation NN NN O
: : : O
3rd CD CD O
left VBN VBN O
toe NN NN O
Depression NNP NNP O
: : : O
with IN IN O
psychotic JJ JJ O
features NNS NNS O
Lumbar NNP NNP O
disc NN NN O
disease NN NN O
: : : O
s/p NN NN O
discectomy NN NN O
Cholecystectomy NNP NNP O
: : : O
s/p NN NN O
open JJ JJ O
procedure NN NN O
H/O NNP NNP O
Atrial NNP NNP O
fibrillation NN NN O
: : : O
vs NNS NNS O
. . . O
atrial JJ JJ O
tachycardia NNS NNS O
-- : : O
s/p NN NN O
cardioversion NN NN O
2/68 CD CD I-DATE
Diabetes NNP NNP O
mellitus NN NN O
: : : O
type NN NN O
2 CD CD O
Pulmonary NNP NNP O
embolism NN NN O
: : : O
bilateral NN NN O
; : : O
   
tx NN NN O
'd MD MD O
at IN IN O
Buzan NNP NNP I-HOSPITAL
County NNP NNP I-HOSPITAL
Clinic NNP NNP I-HOSPITAL
Myocardial NNP NNP O
infarction NN NN O
: : : O
NQWMI NNP NNP O
with IN IN O
inferolateral/apical JJ JJ O
depressions NNS NNS O
5/31/69 CD CD I-DATE
- : : O
6/04/69 CD CD I-DATE
at IN IN O
Buzan NNP NNP I-HOSPITAL
County NNP NNP I-HOSPITAL
Clinic NNP NNP I-HOSPITAL
; : : O
   
no DT DT O
cath NN NN O
or CC CC O
f/u NN NN O
ETT NNP NNP O
done VBN VBN O
there RB RB O
as IN IN O
pt NN NN O
requested VBD VBD O
conservative JJ JJ O
management NN NN O
Pulmonary NNP NNP O
hypertension NN NN O
: : : O
echo NN NN O
05/70 CD CD I-DATE
MMSE NNP NNP O
26/29 CD CD O
( ( ( O
could MD MD O
not RB RB O
spell VB VB O
otherwise RB RB O
got VBD VBD O
everything NN NN O
else RB RB O
) ) ) O
01/72 CD CD I-DATE
SH NNP NNP O
: : : O
lives NNS NNS O
alone RB RB O
- : : O
niece RB RB O
lives NNS NNS O
down RB RB O
stairs NNS NNS O
has VBZ VBZ O
Ursula NNP NNP I-DOCTOR
Toth NNP NNP I-DOCTOR
from IN IN O
Gladwin NNP NNP I-CITY
VNA NNP NNP O
smoking NN NN O
no DT DT O
ETOH NNP NNP O
no DT DT O
Med NNP NNP O
: : : O
she PRP PRP O
brings VBZ VBZ O
some DT DT O
of IN IN O
her PRP$ PRP$ O
meds NNS NNS O
reviewed VBD VBD O
Hydrocortisone NNP NNP O
1 CD CD O
% NN NN O
- : : O
TOPICAL NNP NNP O
CREAM NNP NNP O
TOP NNP NNP O
BID NNP NNP O
Mvi NNP NNP O
( ( ( O
MULTIVITAMINS NNP NNP O
) ) ) O
1 CD CD O
CAPSULE NNP NNP O
PO NNP NNP O
QD NNP NNP O
Asa NNP NNP O
( ( ( O
CHILDRENS NNP NNP O
) ) ) O
( ( ( O
ACETYLSALICYLIC NNP NNP O
ACID NNP NNP O
( ( ( O
C. NN NN O
   
. . . O
   
. . . O
   
81MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Lasix NNP NNP O
( ( ( O
FUROSEMIDE NNP NNP O
) ) ) O
20 CD CD O
MG NNP NNP O
( ( ( O
20MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
) ) ) O
PO NNP NNP O
every DT DT O
Su,Tu,Th NNP NNP O
Celexa NNP NNP O
( ( ( O
CITALOPRAM NNP NNP O
) ) ) O
40MG CD CD O
TABLET NNP NNP O
take NN NN O
1.5 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
, , , O
PA#128310 NNP NNP O
Vitamin NNP NNP O
B12 NNP NNP O
( ( ( O
CYANOCOBALAMIN NNP NNP O
) ) ) O
1000MCG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Synthroid NNP NNP O
( ( ( O
LEVOTHYROXINE NNP NNP O
SODIUM NNP NNP O
) ) ) O
75 CD CD O
MCG NNP NNP O
( ( ( O
75MCG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
) ) ) O
PO NNP NNP O
QD NNP NNP O
x SYM SYM O
30 CD CD O
days NNS NNS O
Prilosec NNP NNP O
OTC NNP NNP O
( ( ( O
OMEPRAZOLE NNP NNP O
OTC NNP NNP O
) ) ) O
20 CD CD O
MG NNP NNP O
( ( ( O
20MG CD CD O
TABLET NNP NNP O
DR NNP NNP O
take NN NN O
1 CD CD O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Ferrous NNP NNP O
SULFATE NNP NNP O
325 CD CD O
MG NNP NNP O
(325(65)MG NNP NNP O
TABLET NNP NNP O
take NN NN O
1 CD CD O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Ipratropium NNP NNP O
INHALER NNP NNP O
2 CD CD O
PUFF NNP NNP O
INH NNP NNP O
QID NNP NNP O
PRN NNP NNP O
Tylenol NNP NNP O
( ( ( O
ACETAMINOPHEN NNP NNP O
) ) ) O
500MG CD CD O
TABLET NNP NNP O
take NN NN O
2 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
TID NNP NNP O
PRN NNP NNP O
arthritis NNS NNS O
pain NN NN O
Ritalin NNP NNP O
( ( ( O
METHYLPHENIDATE NNP NNP O
HCL NNP NNP O
) ) ) O
5MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
x SYM SYM O
30 CD CD O
days NNS NNS O
Lopressor NNP NNP O
( ( ( O
METOPROLOL NNP NNP O
TARTRATE NNP NNP O
) ) ) O
25 CD CD O
MG NNP NNP O
( ( ( O
25MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
) ) ) O
PO NNP NNP O
BID NNP NNP O
Colace NNP NNP O
( ( ( O
DOCUSATE NNP NNP O
SODIUM NNP NNP O
) ) ) O
100MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
TID NNP NNP O
PRN NNP NNP O
constip NN NN O
Ibuprofen NNP NNP O
200 CD CD O
MG NNP NNP O
( ( ( O
200MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
) ) ) O
PO NNP NNP O
BID NNP NNP O
PRN NNP NNP O
All:Haloperidol NNP NNP O
Lactate NNP NNP O
- : : O
Unknown JJ JJ O
FH NNP NNP O
: : : O
no DT DT O
hx NN NN O
of IN IN O
CAD NNP NNP O
, , , O
HTN NNP NNP O
, , , O
DM NNP NNP O
, , , O
CVA NNP NNP O
, , , O
no DT DT O
hx NN NN O
of IN IN O
colon NN NN O
, , , O
breast NN NN O
, , , O
prostate NN NN O
ca MD MD O
BP NNP NNP O
140/80 CD CD O
was VBD VBD O
120/80 CD CD O
was VBD VBD O
130/80 CD CD O
was VBD VBD O
105/70 CD CD O
was VBD VBD O
115/70 CD CD O
FS NNP NNP O
171 CD CD O
Weight NNP NNP O
: : : O
did VBD VBD O
not RB RB O
want VB VB O
to TO TO O
go VB VB O
on IN IN O
the DT DT O
scale NN NN O
last JJ JJ O
weight NN NN O
in IN IN O
chart NN NN O
168 CD CD O
[ NN NN O
Pounds NNS NNS O
] NN NN O
General NNP NNP O
: : : O
pleasant NN NN O
, , , O
communicative JJ JJ O
, , , O
looks VBZ VBZ O
stated JJ JJ O
age NN NN O
, , , O
has VBZ VBZ O
hair NN NN O
piece NN NN O
and CC CC O
make VB VB O
up RB RB O
, , , O
overweight NN NN O
in IN IN O
NAD NNP NNP O
hard JJ JJ O
of IN IN O
hearing NN NN O
exam NN NN O
preformed VBN VBN O
in IN IN O
chair NN NN O
HEENT NNP NNP O
: : : O
normocephalic JJ JJ O
and CC CC O
atraumatic JJ JJ O
, , , O
PERRLA NNP NNP O
, , , O
EOMI NNP NNP O
, , , O
no DT DT O
icterus NN NN O
, , , O
nose NN NN O
wnl NN NN O
, , , O
lips NNS NNS O
no DT DT O
cyanosis NN NN O
or CC CC O
pallor NN NN O
, , , O
dentures NNS NNS O
Neck NNP NNP O
: : : O
supple NN NN O
, , , O
full JJ JJ O
ROM NNP NNP O
, , , O
no DT DT O
lymphadenopathy NN NN O
, , , O
thyroid NN NN O
gland NN NN O
normal JJ JJ O
Lungs NNP NNP O
: : : O
clear JJ JJ O
to TO TO O
auscultation NN NN O
, , , O
no DT DT O
wheezes NNS NNS O
, , , O
rales NNS NNS O
or CC CC O
ronchi NN NN O
Heart NNP NNP O
: : : O
normal JJ JJ O
S1 NNP NNP O
S2 NNP NNP O
, , , O
RRR NNP NNP O
, , , O
no DT DT O
m/r/g NN NN O
skin NN NN O
under IN IN O
the DT DT O
breast NN NN O
erythema NN NN O
with IN IN O
escoriations NNS NNS O
Abdomen NNP NNP O
: : : O
obese NN NN O
BS NNP NNP O
+ NN NN O
, , , O
soft JJ JJ O
, , , O
nontender NN NN O
, , , O
nondistended VBD VBD O
Ext NNP NNP O
: : : O
no DT DT O
clubbing VBG VBG O
, , , O
cyanosis NNS NNS O
or CC CC O
edema NN NN O
Mood NNP NNP O
; : : O
   
appears VBZ VBZ O
in IN IN O
good JJ JJ O
spirits NNS NNS O
FS NNP NNP O
161 CD CD O
Labs NNP NNP O
: : : O
reviewed VBD VBD O
A/P NNP NNP O
81 CD CD I-AGE
y.o.w.with NN NN O
multiple JJ JJ O
medical JJ JJ O
problems NNS NNS O
including VBG VBG O
CAD NNP NNP O
, , , O
CHF NNP NNP O
, , , O
djd NN NN O
, , , O
DM NNP NNP O
, , , O
htn NN NN O
, , , O
depression NN NN O
, , , O
anemia NN NN O
, , , O
hypothyroid NN NN O
here RB RB O
for IN IN O
follow VB VB O
up RB RB O
   
1 CD CD O
. . . O
cvs NNS NNS O
seems VBZ VBZ O
stableno JJ JJ O
sign NN NN O
of IN IN O
CHF NNP NNP O
, , , O
BP NNP NNP O
bordeline NN NN O
but CC CC O
did VBD VBD O
not RB RB O
take VB VB O
her PRP$ PRP$ O
meds NNS NNS O
today NN NN O
will MD MD O
check VB VB O
BMP NNP NNP O
   
2 CD CD O
. . . O
DM NNP NNP O
will MD MD O
check VB VB O
HbA1c NNP NNP O
, , , O
mircroalbumin NN NN O
not RB RB O
taking VBG VBG O
any DT DT O
meds NNS NNS O
for IN IN O
it PRP PRP O
   
3 CD CD O
. . . O
depression NN NN O
better JJR JJR O
continue VB VB O
celexa NN NN O
and CC CC O
ritaline NN NN O
   
4 CD CD O
. . . O
hypothyroid NN NN O
TSH NNP NNP O
normal JJ JJ O
conitnue NN NN O
same JJ JJ O
management NN NN O
   
5 CD CD O
. . . O
anemia NN NN O
will MD MD O
check VB VB O
cbc NN NN O
and CC CC O
anemia NN NN O
studies NNS NNS O
   
6 CD CD O
. . . O
DJD NNP NNP O
taking VBG VBG O
only RB RB O
1-2 NN NN O
ibuproens VBZ VBZ O
a DT DT O
day NN NN O
( ( ( O
I NN NN O
tried VBD VBD O
to TO TO O
get VB VB O
her PRP PRP O
to TO TO O
take VB VB O
tylenol NN NN O
however RB RB O
she PRP PRP O
always RB RB O
said VBD VBD O
it PRP PRP O
did VBD VBD O
nto JJ JJ O
help NN NN O
) ) ) O
also RB RB O
   
7 CD CD O
. . . O
protonix NN NN O
for IN IN O
GI NNP NNP O
protection NN NN O
and CC CC O
her PRP$ PRP$ O
GERD NNP NNP O
that WDT WDT O
seems VBZ VBZ O
stable JJ JJ O
   
8 CD CD O
. . . O
rash NN NN O
fungal JJ JJ O
ketoconzole NN NN O
prescription NN NN O
given VBN VBN O
9 CD CD O
RI NNP NNP O
check NN NN O
BMP NNP NNP O
   
10 CD CD O
. . . O
HM NNP NNP O
check NN NN O
fasting VBG VBG O
lipid NN NN O
panel NN NN O
follow VB VB O
up RB RB O
in IN IN O
4-6 JJ JJ O
months NNS NNS O
or CC CC O
earlier RBR RBR O
prn NN NN O
( ( ( O
pt NN NN O
has VBZ VBZ O
weekly JJ JJ O
visit NN NN O
with IN IN O
VN NNP NNP O
who WP WP O
monitors NNS NNS O
her PRP$ PRP$ O
and CC CC O
is VBZ VBZ O
in IN IN O
touch NN NN O
with IN IN O
me PRP PRP O
) ) ) O
_____________________________ NN NN O
_ NN NN O
Opal NNP NNP I-DOCTOR
Carrie-Guerrero NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2075-09-26 JJ JJ I-DATE
Neurology NNP NNP O
MEDIQUIK NNP NNP I-HOSPITAL
Senior NNP NNP O
Note NN NN O
9/26/75 CD CD I-DATE
5:00AM CD CD O
Patient NNP NNP O
Name NN NN O
: : : O
Percy NNP NNP I-PATIENT
Carrillo NNP NNP I-PATIENT
MRN NNP NNP O
: : : O
1668727 CD CD I-MEDICALRECORD
HISTORY NN NN O
OF IN IN O
PRESENT NNP NNP O
ILLNESS NNP NNP O
: : : O
Please VB VB O
see VB VB O
neurology NN NN O
PGY2 NNP NNP O
note NN NN O
for IN IN O
full JJ JJ O
details NNS NNS O
. . . O
   
In IN IN O
brief JJ JJ O
the DT DT O
patient NN NN O
is VBZ VBZ O
a DT DT O
62 CD CD I-AGE
yo NN NN O
man NN NN O
with IN IN O
mental JJ JJ O
retardation NN NN O
, , , O
HTN NNP NNP O
, , , O
hyperlipidemia NN NN O
, , , O
head NN NN O
trauma NN NN O
with IN IN O
SDH NNP NNP O
with IN IN O
evacuation NN NN O
, , , O
DM NNP NNP O
who WP WP O
presents VBZ VBZ O
with IN IN O
gait NN NN O
instability NN NN O
and CC CC O
difficulty NN NN O
with IN IN O
speaking VBG VBG O
and CC CC O
swallowing VBG VBG O
. . . O
   
Per IN IN O
guardian NN NN O
the DT DT O
patient NN NN O
was VBD VBD O
in IN IN O
his PRP$ PRP$ O
USOH NNP NNP O
until IN IN O
9/24/75 CD CD I-DATE
evening NN NN O
at IN IN O
approximately RB RB O
8:30pm CD CD O
he PRP PRP O
was VBD VBD O
found VBN VBN O
to TO TO O
have VB VB O
mumbled VBN VBN O
speech NN NN O
and CC CC O
having VBG VBG O
difficulty NN NN O
with IN IN O
ambulation NN NN O
with IN IN O
leaning VBG VBG O
to TO TO O
the DT DT O
left NN NN O
. . . O
   
On IN IN O
9/25/75 CD CD I-DATE
in IN IN O
the DT DT O
morning NN NN O
he PRP PRP O
had VBD VBD O
a DT DT O
fall NN NN O
when WRB WRB O
getting VBG VBG O
out IN IN O
of IN IN O
bed NN NN O
and CC CC O
struck VBD VBD O
his PRP$ PRP$ O
head NN NN O
, , , O
and CC CC O
brought VBD VBD O
to TO TO O
the DT DT O
ED NNP NNP O
. . . O
   
No DT DT O
prior RB RB O
history NN NN O
of IN IN O
stroke NN NN O
or CC CC O
TIA NNP NNP O
. . . O
   
MEDS NNP NNP O
: : : O
ASA NNP NNP O
, , , O
Metformin NNP NNP O
, , , O
Glyberide NNP NNP O
, , , O
Tegretol NNP NNP O
, , , O
Fosinoperil NNP NNP O
, , , O
Lipitor NNP NNP O
, , , O
HCTZ NNP NNP O
PHYSICAL JJ JJ O
EXAMINATION NNP NNP O
VITALS NNP NNP O
: : : O
BP NNP NNP O
130/85 CD CD O
MS NNP NNP O
: : : O
AA&Ox3, NNP NNP O
speech NN NN O
fluent NN NN O
with IN IN O
slurring VBG VBG O
( ( ( O
unclear JJ JJ O
baseline NN NN O
) ) ) O
, , , O
repeats NNS NNS O
and CC CC O
names NNS NNS O
well RB RB O
. . . O
   
Comprehends NNP NNP O
simple JJ JJ O
commands NNS NNS O
. . . O
   
Names NNP NNP O
president NN NN O
CN NNP NNP O
: : : O
PERRL NNP NNP O
, , , O
VF NNP NNP O
full JJ JJ O
with IN IN O
BTT NNP NNP O
. . . O
   
EOMI NNP NNP O
but CC CC O
with IN IN O
nystagmus NN NN O
in IN IN O
all DT DT O
directions NNS NNS O
of IN IN O
gaze VBP VBP O
, , , O
even RB RB O
primary JJ JJ O
gaze VBP VBP O
. . . O
   
Facial NNP NNP O
sensation NN NN O
intact JJ JJ O
. . . O
   
Face NNP NNP O
asymmetric JJ JJ O
. . . O
   
Tongue NNP NNP O
, , , O
palate NN NN O
symmetric JJ JJ O
. . . O
   
SCM NNP NNP O
and CC CC O
traps NNS NNS O
5/5 CD CD O
. . . O
   
Motor NNP NNP O
: : : O
UMN NNP NNP O
pattern NN NN O
weakness NN NN O
in IN IN O
RUE NNP NNP O
(4-/5), NNP NNP O
most RBS RBS O
notable JJ JJ O
in IN IN O
hands NNS NNS O
. . . O
   
Mild NNP NNP O
proximal NN NN O
RLE NNP NNP O
weak JJ JJ O
(4+/5). NN NN O
   
Coord NNP NNP O
: : : O
Impaired NNP NNP O
FTN NNP NNP O
in IN IN O
LUE NNP NNP O
, , , O
intact JJ JJ O
in IN IN O
RUE NNP NNP O
. . . O
   
Refl NNP NNP O
: : : O
Deep JJ JJ O
tendon NN NN O
reflexes NNS NNS O
are VBP VBP O
2 CD CD O
+ NN NN O
at IN IN O
biceps NNS NNS O
, , , O
triceps NNS NNS O
, , , O
brachioradialis NNS NNS O
, , , O
patella NN NN O
, , , O
and CC CC O
ankles NNS NNS O
. . . O
   
Plantar NNP NNP O
response NN NN O
is VBZ VBZ O
flexor NN NN O
on IN IN O
right NN NN O
and CC CC O
extensor NN NN O
on IN IN O
left VBD VBD O
. . . O
   
Sens NNP NNP O
: : : O
Decreased NNP NNP O
PP NNP NNP O
but CC CC O
NOT RB RB O
LT NNP NNP O
in IN IN O
LUE NNP NNP O
and CC CC O
LLE NNP NNP O
Imaging NNP NNP O
: : : O
MRI NNP NNP O
Brain NNP NNP O
( ( ( O
9/25/75 CD CD I-DATE
) ) ) O
DWI NNP NNP O
bright JJ JJ O
ADC NNP NNP O
dark JJ JJ O
right NN NN O
lateral NN NN O
medullary JJ JJ O
pyramid NN NN O
with IN IN O
associated VBN VBN O
increased JJ JJ O
T2 NNP NNP O
signal NN NN O
. . . O
   
MRA NNP NNP O
Head/Neck NNP NNP O
( ( ( O
9/25/75 CD CD I-DATE
) ) ) O
Narrowing NNP NNP O
of IN IN O
basilar NN NN O
artery NN NN O
with IN IN O
flow NN NN O
signal NN NN O
throughout IN IN O
and CC CC O
no DT DT O
thrombosis NN NN O
CTA NNP NNP O
Head/Neck NNP NNP O
( ( ( O
9/25/75 CD CD I-DATE
) ) ) O
Diffuse NNP NNP O
atherosclerotic JJ JJ O
disease NN NN O
, , , O
occluded VBD VBD O
R-ICA NNP NNP O
with IN IN O
good JJ JJ O
collateralization NN NN O
of IN IN O
right NN NN O
hemisphere NN NN O
, , , O
severe JJ JJ O
irregular NN NN O
narrowing VBG VBG O
through IN IN O
out IN IN O
bilateral JJ JJ O
vertebral NN NN O
arteries NNS NNS O
and CC CC O
basilar NN NN O
arteries NNS NNS O
. . . O
   
IMPRESSION NNP NNP O
: : : O
The DT DT O
patient NN NN O
has VBZ VBZ O
numerous JJ JJ O
risk NN NN O
factors NNS NNS O
for IN IN O
stroke NN NN O
with IN IN O
HTN NNP NNP O
, , , O
DM2 NNP NNP O
, , , O
and CC CC O
HLP NNP NNP O
. . . O
   
His PRP$ PRP$ O
exam NN NN O
is VBZ VBZ O
consistent JJ JJ O
with IN IN O
lateral NN NN O
medullary JJ JJ O
pyramid NN NN O
lesion NN NN O
with IN IN O
involvement NN NN O
of IN IN O
spinalcortical JJ JJ O
tract NN NN O
prior RB RB O
to TO TO O
decussation NN NN O
explaining VBG VBG O
ipsilateral JJ JJ O
weakness NNS NNS O
and CC CC O
also RB RB O
involvement NN NN O
of IN IN O
the DT DT O
spinalthalamic JJ JJ O
tract NN NN O
explaining VBG VBG O
contralateral JJ JJ O
deficit NN NN O
in IN IN O
pain NN NN O
sensation NN NN O
. . . O
   
His PRP$ PRP$ O
vessel NN NN O
imaging VBG VBG O
is VBZ VBZ O
notable JJ JJ O
and CC CC O
concerning VBG VBG O
for IN IN O
diffuse NN NN O
atherosclerotic JJ JJ O
disease NN NN O
, , , O
specifically RB RB O
in IN IN O
posterior NN NN O
circulation NN NN O
in IN IN O
distribution NN NN O
of IN IN O
acute JJ JJ O
stroke NN NN O
. . . O
   
The DT DT O
patient NN NN O
was VBD VBD O
reportedly RB RB O
taking VBG VBG O
aspirin NN NN O
, , , O
though IN IN O
reports NNS NNS O
are VBP VBP O
mixed JJ JJ O
and CC CC O
this DT DT O
needs VBZ VBZ O
clarification NN NN O
. . . O
   
Vessel NNP NNP O
imaging VBG VBG O
did VBD VBD O
not RB RB O
implicate VB VB O
that IN IN O
the DT DT O
patient NN NN O
suffered VBD VBD O
from IN IN O
acute JJ JJ O
vertebro-basilar JJ JJ O
thrombo-embolism NN NN O
, , , O
but CC CC O
that IN IN O
his PRP$ PRP$ O
posterior NN NN O
circulation NN NN O
disease NN NN O
is VBZ VBZ O
a DT DT O
chronic JJ JJ O
issue NN NN O
and CC CC O
the DT DT O
stroke NN NN O
was VBD VBD O
more RBR RBR O
likely JJ JJ O
due JJ JJ O
to TO TO O
distal JJ JJ O
vessel NN NN O
thrombosis NN NN O
. . . O
   
Anticoagulation NNP NNP O
can MD MD O
be VB VB O
considered VBN VBN O
in IN IN O
acute JJ JJ O
setting NN NN O
of IN IN O
small JJ JJ O
sized JJ JJ O
posterior NN NN O
circulation NN NN O
stroke NN NN O
with IN IN O
vertebro-basilar JJ JJ O
disease NN NN O
, , , O
but CC CC O
in IN IN O
this DT DT O
case NN NN O
by IN IN O
the DT DT O
time NN NN O
the DT DT O
patient NN NN O
became VBD VBD O
known VBN VBN O
to TO TO O
neurology NN NN O
service NN NN O
and CC CC O
by IN IN O
the DT DT O
time NN NN O
it PRP PRP O
was VBD VBD O
known VBN VBN O
he PRP PRP O
had VBD VBD O
a DT DT O
stroke NN NN O
it PRP PRP O
was VBD VBD O
some DT DT O
24hrs CD CD O
after IN IN O
initial JJ JJ O
symptoms NNS NNS O
, , , O
and CC CC O
in IN IN O
this DT DT O
interval NN NN O
he PRP PRP O
did VBD VBD O
not RB RB O
show VB VB O
any DT DT O
signs NNS NNS O
or CC CC O
symptoms NNS NNS O
of IN IN O
stroke NN NN O
progression NN NN O
making VBG VBG O
unstable JJ JJ O
plaque NN NN O
unlikely RB RB O
. . . O
   
Given VBN VBN O
the DT DT O
findings NNS NNS O
of IN IN O
the DT DT O
WASID NNP NNP O
study NN NN O
that IN IN O
anticoagulation NN NN O
did VBD VBD O
not RB RB O
significantly RB RB O
improve VB VB O
recurrent NN NN O
stroke NN NN O
prevention NN NN O
benefits NNS NNS O
over IN IN O
aspirin NN NN O
for IN IN O
symptomatic JJ JJ O
vertebro-basilar JJ JJ O
disease NN NN O
( ( ( O
because IN IN O
warfarin NN NN O
benefits NNS NNS O
were VBD VBD O
offset VBN VBN O
by IN IN O
higher JJR JJR O
hemorrhage NN NN O
rates NNS NNS O
) ) ) O
, , , O
the DT DT O
decision NN NN O
to TO TO O
place VB VB O
this DT DT O
patient NN NN O
on IN IN O
aspirin NN NN O
is VBZ VBZ O
supported VBN VBN O
. . . O
   
The DT DT O
long JJ JJ O
term NN NN O
management NN NN O
of IN IN O
this DT DT O
patient NN NN O
requires VBZ VBZ O
aggressive JJ JJ O
control NN NN O
of IN IN O
atherosclerotic JJ JJ O
risk NN NN O
factors NNS NNS O
such JJ JJ O
as IN IN O
HTN NNP NNP O
, , , O
DM2 NNP NNP O
, , , O
and CC CC O
HLP NNP NNP O
. . . O
   
The DT DT O
patient NN NN O
is VBZ VBZ O
significantly RB RB O
at IN IN O
risk NN NN O
of IN IN O
major JJ JJ O
ischemic JJ JJ O
stroke NN NN O
due JJ JJ O
to TO TO O
occluded JJ JJ O
right JJ JJ O
carotid NN NN O
artery NN NN O
and CC CC O
diffuse NN NN O
posterior NN NN O
circulation NN NN O
disease NN NN O
, , , O
and CC CC O
it PRP PRP O
is VBZ VBZ O
conceivable JJ JJ O
that IN IN O
if IN IN O
he PRP PRP O
continues VBZ VBZ O
to TO TO O
have VB VB O
persistent JJ JJ O
symptoms NNS NNS O
in IN IN O
the DT DT O
future NN NN O
that IN IN O
a DT DT O
revascularization NN NN O
procedure NN NN O
may MD MD O
be VB VB O
necessary JJ JJ O
. . . O
   
RECOMMENDATIONS NNP NNP O
: : : O
   
1 CD CD O
. . . O
Aspirin NNP NNP O
325 CD CD O
mg NN NN O
po NN NN O
qd NN NN O
   
2 CD CD O
. . . O
Continue NNP NNP O
Lipitor NNP NNP O
   
3 CD CD O
. . . O
HTN NNP NNP O
management NN NN O
as IN IN O
an DT DT O
outpatient NN NN O
, , , O
autoregulate NN NN O
x SYM SYM O
24hrs CD CD O
for IN IN O
SBP<180 NNP NNP O
mmHg NN NN O
   
4 CD CD O
. . . O
DM2 NNP NNP O
management NN NN O
   
5 CD CD O
. . . O
Check NNP NNP O
lipids NNS NNS O
, , , O
homocysteine NN NN O
, , , O
lipoprotein NN NN O
a DT DT O
, , , O
hba1c NN NN O
   
6 CD CD O
. . . O
Check NNP NNP O
TCDs NNP NNP O
to TO TO O
obtain VB VB O
baseline NN NN O
data NNS NNS O
   
7 CD CD O
. . . O
Consider NNP NNP O
TTE/Holter NNP NNP O
as RB RB O
outpatient NN NN O
as IN IN O
unlikely JJ JJ O
this DT DT O
was VBD VBD O
a DT DT O
cardioembolic JJ JJ O
event NN NN O
_______________________________ NN NN O
_ NN NN O
Freddie NNP NNP I-DOCTOR
V. NN NN I-DOCTOR
Hickman NNP NNP I-DOCTOR
MD NNP NNP O
Mediquik NNP NNP I-HOSPITAL
Pager NNP NNP O
#02662 NN NN O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2075-08-08 JJ JJ I-DATE
Reason NNP NNP O
for IN IN O
Visit NNP NNP O
62 CD CD I-AGE
y.o. NN NN O
man NN NN O
, , , O
pt NN NN O
of IN IN O
Dr NNP NNP O
. . . O
Kidd NNP NNP I-DOCTOR
, , , O
presents VBZ VBZ O
w NN NN O
/ NN NN O
c/o NN NN O
R NN NN O
hand NN NN O
pain NN NN O
x SYM SYM O
1d CD CD O
. . . O
   
Has VBZ VBZ O
sharp JJ JJ O
pain NN NN O
, , , O
starts VBZ VBZ O
in IN IN O
thumb NN NN O
, , , O
radiates NNS NNS O
proximally RB RB O
up RB RB O
arm NN NN O
to TO TO O
biceps VB VB O
area NN NN O
. . . O
   
Pain NN NN O
lasts VBZ VBZ O
several JJ JJ O
minutes NNS NNS O
, , , O
resolves NNS NNS O
spontaneously RB RB O
. . . O
   
Occurs VBZ VBZ O
several JJ JJ O
times NNS NNS O
a DT DT O
day NN NN O
, , , O
not RB RB O
reated VBN VBN O
to TO TO O
arm DT DT O
movement NN NN O
. . . O
   
He PRP PRP O
denies VBZ VBZ O
trauma NN NN O
to TO TO O
area NN NN O
, , , O
recent JJ JJ O
falls NNS NNS O
, , , O
denies NNS NNS O
swelling VBG VBG O
, , , O
redness NN NN O
, , , O
rashes NNS NNS O
, , , O
weakness NNS NNS O
. . . O
   
Problems NNS NNS O
Diabetes NNP NNP O
mellitus JJ JJ O
Hypertension NNP NNP O
H/O NNP NNP O
Seizure NNP NNP O
disorder NN NN O
: : : O
Status NNP NNP O
post NN NN O
head NN NN O
trauma NN NN O
H/O NNP NNP O
Alcohol NNP NNP O
abuse NN NN O
Medications NNP NNP O
Aspirin NNP NNP O
( ( ( O
ACETYLSALICYLIC NNP NNP O
Acid NNP NNP O
) ) ) O
81MG CD CD O
TABLET NNP NNP O
CHEWABLE NNP NNP O
take NN NN O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
, , , O
Take NNP NNP O
as IN IN O
directed VBN VBN O
Glucophage NNP NNP O
( ( ( O
METFORMIN NNP NNP O
) ) ) O
500MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
TID NNP NNP O
x SYM SYM O
90 CD CD O
days NNS NNS O
Micronase NNP NNP O
( ( ( O
GLYBURIDE NNP NNP O
) ) ) O
10 CD CD O
MG NNP NNP O
( ( ( O
5MG CD CD O
TABLET NNP NNP O
take NN NN O
2 CD CD O
) ) ) O
PO NNP NNP O
BID NNP NNP O
x SYM SYM O
90 CD CD O
days NNS NNS O
Tegretol NNP NNP O
( ( ( O
CARBAMAZEPINE NNP NNP O
) ) ) O
200MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
TID NNP NNP O
x SYM SYM O
90 CD CD O
days NNS NNS O
Monopril NNP NNP O
( ( ( O
FOSINOPRIL NNP NNP O
Sodium NNP NNP O
) ) ) O
20MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
x SYM SYM O
90 CD CD O
days NNS NNS O
Lipitor NNP NNP O
( ( ( O
ATORVASTATIN NNP NNP O
) ) ) O
10MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
, , , O
Take NNP NNP O
as IN IN O
directed VBN VBN O
Hctz NNP NNP O
( ( ( O
HYDROCHLOROTHIAZIDE NNP NNP O
) ) ) O
25MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
x SYM SYM O
90 CD CD O
days NNS NNS O
, , , O
Take VB VB O
as IN IN O
directed VBN VBN O
Allergies NNP NNP O
NKA NNP NNP O
Social NNP NNP O
History NN NN O
legally RB RB O
blind JJ JJ O
, , , O
also RB RB O
has VBZ VBZ O
MR NNP NNP O
; : : O
   
lives NNS NNS O
w NN NN O
/ NN NN O
sister NN NN O
Urquiza NNP NNP I-PATIENT
who WP WP O
is VBZ VBZ O
his PRP$ PRP$ O
care NN NN O
taker NN NN O
. . . O
   
Vital NNP NNP O
Signs NNP NNP O
BLOOD NNP NNP O
PRESSURE NN NN O
118/74 CD CD O
PULSE NNP NNP O
72 CD CD O
WEIGHT NNP NNP O
192 CD CD O
lb NN NN O
Physical JJ JJ O
Exam NNP NNP O
Gen NNP NNP O
: : : O
WDWN NNP NNP O
man NN NN O
, , , O
NAD NNP NNP O
Extrem NNP NNP O
: : : O
no DT DT O
edema NN NN O
; : : O
   
radial JJ JJ O
and CC CC O
p.t. NN NN O
pulses NNS NNS O
2 CD CD O
+ NN NN O
bilat NN NN O
; : : O
   
R NNP NNP O
UE NNP NNP O
- : : O
no DT DT O
deformity NN NN O
, , , O
no DT DT O
edema NN NN O
; : : O
   
well RB RB O
healed VBN VBN O
surgical JJ JJ O
scar NN NN O
over IN IN O
R NNP NNP O
bicpes NNS NNS O
area NN NN O
; : : O
   
non-tender JJ JJ O
in IN IN O
biceps/triceps NNS NNS O
, , , O
forearm NN NN O
area NN NN O
; : : O
   
mild JJ JJ O
tenderness NNS NNS O
in IN IN O
distal JJ JJ O
thumb NN NN O
; : : O
   
full JJ JJ O
ROM NNP NNP O
of IN IN O
elbow NN NN O
, , , O
wrist NN NN O
, , , O
fingers NNS NNS O
, , , O
shoulder NN NN O
w/out NN NN O
pain NN NN O
; : : O
   
motor NN NN O
5/5 CD CD O
in IN IN O
all DT DT O
UE NNP NNP O
muscle NN NN O
groups NNS NNS O
. . . O
   
radial NN NN O
, , , O
brachial JJ JJ O
pulses NNS NNS O
2 CD CD O
+ NN NN O
; : : O
   
hand VB VB O
warm JJ JJ O
, , , O
good JJ JJ O
cap NN NN O
refill NN NN O
. . . O
   
Assessment NNP NNP O
and CC CC O
Plan NNP NNP O
62 CD CD I-AGE
y.o. NN NN O
man NN NN O
w NN NN O
/ NN NN O
sharp JJ JJ O
intermitent NN NN O
pain NN NN O
in IN IN O
R NNP NNP O
UE NNP NNP O
- : : O
etiology NN NN O
unclear NN NN O
given VBN VBN O
lack NN NN O
of IN IN O
trauma NN NN O
and CC CC O
lack NN NN O
of IN IN O
physical JJ JJ O
findings NNS NNS O
on IN IN O
exam NN NN O
; : : O
   
will MD MD O
do VB VB O
hand VB VB O
film NN NN O
to TO TO O
assess VB VB O
for IN IN O
occult NN NN O
fracture NN NN O
or CC CC O
other JJ JJ O
abnormality NN NN O
; : : O
   
for IN IN O
now RB RB O
, , , O
ibuprofen NN NN O
prn NN NN O
. . . O
   
I PRP PRP O
recommended VBD VBD O
pt NN NN O
f/u NN NN O
w NN NN O
/ NN NN O
Dr NNP NNP O
. . . O
Kidd NNP NNP I-DOCTOR
in IN IN O
next JJ JJ O
few JJ JJ O
weeks NNS NNS O
( ( ( O
no DT DT O
showed VBD VBD O
12/74 CD CD I-DATE
appt NN NN O
, , , O
next JJ JJ O
appt NN NN O
10/75 CD CD I-DATE
) ) ) O
. . . O
   
Sister NNP NNP O
Urquiza NNP NNP I-PATIENT
will MD MD O
call VB VB O
for IN IN O
appt NN NN O
. . . O
   
RTC NNP NNP O
if IN IN O
pain NN NN O
persists NNS NNS O
. . . O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2072-12-04 JJ JJ I-DATE
HPI NNP NNP O
: : : O
81 CD CD I-AGE
y.o.w. NN NN O
with IN IN O
multiple JJ JJ O
medical JJ JJ O
problems NNS NNS O
including VBG VBG O
DM NNP NNP O
, , , O
HTN NNP NNP O
, , , O
CAD NNP NNP O
, , , O
CHF NNP NNP O
, , , O
PE NNP NNP O
, , , O
depresion NN NN O
here RB RB O
for IN IN O
follow VB VB O
up RB RB O
accompanied VBN VBN O
by IN IN O
her PRP$ PRP$ O
great JJ JJ O
great JJ JJ O
niece NN NN O
who WP WP O
provides VBZ VBZ O
part NN NN O
of IN IN O
the DT DT O
hx NN NN O
missed VBD VBD O
few JJ JJ O
appointments NNS NNS O
- : : O
last JJ JJ O
time NN NN O
seen VBN VBN O
8 CD CD O
months NNS NNS O
ago RB RB O
says VBZ VBZ O
doing VBG VBG O
well RB RB O
does VBZ VBZ O
not RB RB O
walk VB VB O
much JJ JJ O
- - - O
does VBZ VBZ O
not RB RB O
go VB VB O
out IN IN O
of IN IN O
the DT DT O
house NN NN O
at IN IN O
all DT DT O
- - - O
at IN IN O
home NN NN O
walks VBZ VBZ O
with IN IN O
walker NN NN O
occ NN NN O
legs NNS NNS O
, , , O
ankles,back RB RB O
pain NN NN O
same JJ JJ O
as IN IN O
before IN IN O
takes VBZ VBZ O
ibuprofen NN NN O
prn NN NN O
less RBR RBR O
only RB RB O
1-2 CD CD O
day NN NN O
her PRP$ PRP$ O
breathing VBG VBG O
is VBZ VBZ O
o.k. NN NN O
occ NN NN O
has VBZ VBZ O
CP NNP NNP O
with IN IN O
exertion NN NN O
as IN IN O
always RB RB O
no DT DT O
change NN NN O
BM NNP NNP O
normal JJ JJ O
oc NN NN O
constipation NN NN O
, , , O
no DT DT O
more JJR JJR O
diarrhea NN NN O
, , , O
no DT DT O
abdominal JJ JJ O
discomfort NN NN O
does VBZ VBZ O
not RB RB O
check VB VB O
her PRP$ PRP$ O
FS NNP NNP O
- - - O
VN NNP NNP O
does VBZ VBZ O
says VBZ VBZ O
it PRP PRP O
is VBZ VBZ O
fine NN NN O
denies NNS NNS O
depression NN NN O
, , , O
niece NN NN O
does VBZ VBZ O
not RB RB O
coment VB VB O
on IN IN O
any DT DT O
new JJ JJ O
events NNS NNS O
- : : O
hallucinations NNS NNS O
screaming VBG VBG O
has VBZ VBZ O
diaper NN NN O
does VBZ VBZ O
not RB RB O
c/o VB VB O
dysuria NN NN O
, , , O
polyuria NN NN O
no DT DT O
headache NN NN O
, , , O
rash NN NN O
F/C NNP NNP O
other JJ JJ O
ros NNS NNS O
neg NN NN O
PMH NNP NNP O
: : : O
Hypertension NNP NNP O
Osteoarthritis NNP NNP O
Dizziness NNP NNP O
amputation NN NN O
: : : O
3rd CD CD O
left VBN VBN O
toe NN NN O
Depression NNP NNP O
: : : O
with IN IN O
psychotic JJ JJ O
features NNS NNS O
Lumbar NNP NNP O
disc NN NN O
disease NN NN O
: : : O
s/p NN NN O
discectomy NN NN O
Cholecystectomy NNP NNP O
: : : O
s/p NN NN O
open JJ JJ O
procedure NN NN O
H/O NNP NNP O
Atrial NNP NNP O
fibrillation NN NN O
: : : O
vs NNS NNS O
. . . O
atrial JJ JJ O
tachycardia NNS NNS O
-- : : O
s/p NN NN O
cardioversion NN NN O
2/68 CD CD I-DATE
Diabetes NNP NNP O
mellitus NN NN O
: : : O
type NN NN O
2 CD CD O
Pulmonary NNP NNP O
embolism NN NN O
: : : O
bilateral NN NN O
; : : O
   
tx NN NN O
'd MD MD O
at IN IN O
Buzan NNP NNP I-HOSPITAL
County NNP NNP I-HOSPITAL
Clinic NNP NNP I-HOSPITAL
Myocardial NNP NNP O
infarction NN NN O
: : : O
NQWMI NNP NNP O
with IN IN O
inferolateral/apical JJ JJ O
depressions NNS NNS O
5/31/69 CD CD I-DATE
- : : O
6/04/69 CD CD I-DATE
at IN IN O
Buzan NNP NNP I-HOSPITAL
County NNP NNP I-HOSPITAL
Clinic NNP NNP I-HOSPITAL
; : : O
   
no DT DT O
cath NN NN O
or CC CC O
f/u NN NN O
ETT NNP NNP O
done VBN VBN O
there RB RB O
as IN IN O
pt NN NN O
requested VBD VBD O
conservative JJ JJ O
management NN NN O
Pulmonary NNP NNP O
hypertension NN NN O
: : : O
echo NN NN O
05/70 CD CD I-DATE
MMSE NNP NNP O
26/29 CD CD O
( ( ( O
could MD MD O
not RB RB O
spell VB VB O
otherwise RB RB O
got VBD VBD O
everything NN NN O
else RB RB O
) ) ) O
01/72 CD CD I-DATE
SH NNP NNP O
: : : O
lives NNS NNS O
alone RB RB O
- : : O
niece RB RB O
lives NNS NNS O
down RB RB O
stairs NNS NNS O
has VBZ VBZ O
Ursula NNP NNP I-DOCTOR
Toth NNP NNP I-DOCTOR
from IN IN O
Gladwin NNP NNP I-CITY
VNA NNP NNP O
smoking NN NN O
no DT DT O
ETOH NNP NNP O
no DT DT O
Med NNP NNP O
: : : O
Hydrocortisone NNP NNP O
1 CD CD O
% NN NN O
- : : O
TOPICAL NNP NNP O
CREAM NNP NNP O
TOP NNP NNP O
BID NNP NNP O
Naproxen NNP NNP O
375 CD CD O
MG NNP NNP O
( ( ( O
375MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
) ) ) O
PO NNP NNP O
BID NNP NNP O
x SYM SYM O
30 CD CD O
days NNS NNS O
Ritalin NNP NNP O
( ( ( O
METHYLPHENIDATE NNP NNP O
HCL NNP NNP O
) ) ) O
5MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
x SYM SYM O
30 CD CD O
days NNS NNS O
Asa NNP NNP O
( ( ( O
CHILDRENS NNP NNP O
) ) ) O
( ( ( O
ACETYLSALICYLIC NNP NNP O
ACID NNP NNP O
( ( ( O
C. NN NN O
   
. . . O
   
. . . O
   
81MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Amiodarone NNP NNP O
200MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Lasix NNP NNP O
( ( ( O
FUROSEMIDE NNP NNP O
) ) ) O
80 CD CD O
MG NNP NNP O
( ( ( O
40MG CD CD O
TABLET NNP NNP O
take NN NN O
2 CD CD O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Zestril NNP NNP O
( ( ( O
LISINOPRIL NNP NNP O
) ) ) O
30MG CD CD O
TABLET NNP NNP O
PO NNP NNP O
QD NNP NNP O
Celexa NNP NNP O
( ( ( O
CITALOPRAM NNP NNP O
) ) ) O
40MG CD CD O
TABLET NNP NNP O
take NN NN O
1.5 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
, , , O
PA#128310 NNP NNP O
Protonix NNP NNP O
( ( ( O
PANTOPRAZOLE NNP NNP O
) ) ) O
40MG CD CD O
TABLET NNP NNP O
EC NNP NNP O
take VB VB O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
PRN NNP NNP O
Mvi NNP NNP O
( ( ( O
MULTIVITAMINS NNP NNP O
) ) ) O
1 CD CD O
CAPSULE NNP NNP O
PO NNP NNP O
QD NNP NNP O
Atenolol NNP NNP O
25MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Tylenol NNP NNP O
( ( ( O
ACETAMINOPHEN NNP NNP O
) ) ) O
500MG CD CD O
TABLET NNP NNP O
take NN NN O
2 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
TID NNP NNP O
PRN NNP NNP O
arthritis NNS NNS O
pain NN NN O
Colace NNP NNP O
( ( ( O
DOCUSATE NNP NNP O
SODIUM NNP NNP O
) ) ) O
100MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
TID NNP NNP O
PRN NNP NNP O
constip NN NN O
, , , O
please VB VB O
mail NN NN O
to TO TO O
pt VB VB O
Ibuprofen NNP NNP O
600MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
Q8H NNP NNP O
PRN NNP NNP O
pain NN NN O
, , , O
to TO TO O
be VB VB O
taken VBN VBN O
with IN IN O
food NN NN O
Vitamin NNP NNP O
B12 NNP NNP O
( ( ( O
CYANOCOBALAMIN NNP NNP O
) ) ) O
1000MCG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Synthroid NNP NNP O
( ( ( O
LEVOTHYROXINE NNP NNP O
SODIUM NNP NNP O
) ) ) O
50 CD CD O
MCG NNP NNP O
( ( ( O
50MCG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
) ) ) O
PO NNP NNP O
QD NNP NNP O
x SYM SYM O
30 CD CD O
days NNS NNS O
Glucophage NNP NNP O
( ( ( O
METFORMIN NNP NNP O
) ) ) O
500MG CD CD O
TABLET NNP NNP O
take NN NN O
2 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
BID NNP NNP O
, , , O
take NN NN O
2 CD CD O
tabs NN NN O
bid NN NN O
, , , O
and CC CC O
1 CD CD O
tab NN NN O
All:Haloperidol NNP NNP O
Lactate NNP NNP O
- : : O
Unknown JJ JJ O
FH NNP NNP O
: : : O
no DT DT O
hx NN NN O
of IN IN O
CAD NNP NNP O
, , , O
HTN NNP NNP O
, , , O
DM NNP NNP O
, , , O
CVA NNP NNP O
, , , O
no DT DT O
hx NN NN O
of IN IN O
colon NN NN O
, , , O
breast NN NN O
, , , O
prostate NN NN O
ca MD MD O
BP NNP NNP O
120/80 CD CD O
was VBD VBD O
130/80 CD CD O
was VBD VBD O
105/70 CD CD O
was VBD VBD O
115/70 CD CD O
Weight NNP NNP O
: : : O
did VBD VBD O
not RB RB O
want VB VB O
to TO TO O
go VB VB O
on IN IN O
the DT DT O
scale NN NN O
today NN NN O
168 CD CD O
[ NN NN O
Pounds NNP NNP O
] NN NN O
was VBD VBD O
170 CD CD O
General NNP NNP O
: : : O
pleasant NN NN O
, , , O
communicative JJ JJ O
, , , O
looks VBZ VBZ O
stated JJ JJ O
age NN NN O
, , , O
has VBZ VBZ O
hair NN NN O
piece NN NN O
and CC CC O
make VB VB O
up RB RB O
, , , O
overweight NN NN O
in IN IN O
NAD NNP NNP O
hard JJ JJ O
of IN IN O
hearing NN NN O
exam NN NN O
preformed VBN VBN O
in IN IN O
chair NN NN O
- : : O
as IN IN O
usual JJ JJ O
she PRP PRP O
said VBD VBD O
she PRP PRP O
could MD MD O
not RB RB O
get VB VB O
up RP RP O
to TO TO O
exam VB VB O
table NN NN O
however RB RB O
at IN IN O
the DT DT O
end NN NN O
of IN IN O
visit NN NN O
was VBD VBD O
able JJ JJ O
to TO TO O
get VB VB O
up RP RP O
herself PRP PRP O
( ( ( O
minimal JJ JJ O
help NN NN O
from IN IN O
niece NN NN O
) ) ) O
and CC CC O
walks VBZ VBZ O
well RB RB O
with IN IN O
her PRP$ PRP$ O
walker NN NN O
HEENT NNP NNP O
: : : O
normocephalic JJ JJ O
and CC CC O
atraumatic JJ JJ O
, , , O
PERRLA NNP NNP O
, , , O
EOMI NNP NNP O
, , , O
no DT DT O
icterus NN NN O
, , , O
nose NN NN O
wnl NN NN O
, , , O
lips NNS NNS O
no DT DT O
cyanosis NN NN O
or CC CC O
pallor NN NN O
, , , O
dentures NNS NNS O
Neck NNP NNP O
: : : O
supple NN NN O
, , , O
full JJ JJ O
ROM NNP NNP O
, , , O
no DT DT O
lymphadenopathy NN NN O
, , , O
thyroid NN NN O
gland NN NN O
normal JJ JJ O
Lungs NNP NNP O
: : : O
clear JJ JJ O
to TO TO O
auscultation NN NN O
, , , O
no DT DT O
wheezes NNS NNS O
, , , O
rales NNS NNS O
or CC CC O
ronchi NN NN O
Heart NNP NNP O
: : : O
normal JJ JJ O
S1 NNP NNP O
S2 NNP NNP O
, , , O
RRR NNP NNP O
, , , O
no DT DT O
m/r/g NN NN O
Abdomen NNP NNP O
: : : O
obese NN NN O
BS NNP NNP O
+ NN NN O
, , , O
soft JJ JJ O
, , , O
nontender NN NN O
, , , O
nondistended VBD VBD O
Ext NNP NNP O
: : : O
no DT DT O
clubbing VBG VBG O
, , , O
cyanosis NNS NNS O
or CC CC O
edema NN NN O
Mood NNP NNP O
; : : O
   
appears VBZ VBZ O
in IN IN O
good JJ JJ O
spirits NNS NNS O
FS NNP NNP O
161 CD CD O
Labs NNP NNP O
: : : O
reviewed VBD VBD O
A/P NNP NNP O
81 CD CD I-AGE
y.o.w.with NN NN O
multiple JJ JJ O
medical JJ JJ O
problems NNS NNS O
including VBG VBG O
CAD NNP NNP O
, , , O
CHF NNP NNP O
, , , O
djd NN NN O
, , , O
DM NNP NNP O
, , , O
htn NN NN O
, , , O
depression NN NN O
, , , O
anemia NN NN O
, , , O
hypothyroid NN NN O
here RB RB O
for IN IN O
follow VB VB O
up RB RB O
   
1 CD CD O
. . . O
cvs NNS NNS O
seems VBZ VBZ O
stable JJ JJ O
BP NNP NNP O
normal JJ JJ O
check NN NN O
BMP NNP NNP O
( ( ( O
Lasix NNP NNP O
dose NN NN O
was VBD VBD O
recently RB RB O
adjusted VBN VBN O
as RB RB O
well RB RB O
as IN IN O
her PRP$ PRP$ O
lisinopril NN NN O
   
2 CD CD O
. . . O
DM NNP NNP O
will MD MD O
check VB VB O
HbA1c NNP NNP O
, , , O
mircroalbumin NN NN O
   
3 CD CD O
. . . O
depression NN NN O
better JJR JJR O
continue VB VB O
celexa NN NN O
and CC CC O
ritaline NN NN O
   
4 CD CD O
. . . O
hypothyroid NN NN O
check NN NN O
TSH NNP NNP O
   
5 CD CD O
. . . O
anemia NN NN O
on IN IN O
B12 NNP NNP O
suppl NN NN O
will MD MD O
check VB VB O
cbc NN NN O
and CC CC O
anemia NN NN O
studies NNS NNS O
   
6 CD CD O
. . . O
DJD NNP NNP O
better JJR JJR O
takien NN NN O
only RB RB O
1-2 JJ JJ O
ibuproens NNS NNS O
a DT DT O
day NN NN O
( ( ( O
I NN NN O
tried VBD VBD O
to TO TO O
get VB VB O
her PRP PRP O
to TO TO O
take VB VB O
tylenol NN NN O
however RB RB O
she PRP PRP O
always RB RB O
said VBD VBD O
it PRP PRP O
did VBD VBD O
nto JJ JJ O
help NN NN O
) ) ) O
also RB RB O
on IN IN O
protonix NN NN O
for IN IN O
GI NNP NNP O
protection NN NN O
and CC CC O
her PRP$ PRP$ O
GERD NNP NNP O
that WDT WDT O
seems VBZ VBZ O
stable JJ JJ O
   
7 CD CD O
. . . O
HM NNP NNP O
check NN NN O
fasting VBG VBG O
lipid NN NN O
panel NN NN O
( ( ( O
last JJ JJ O
one CD CD O
in IN IN O
2070 CD CD I-DATE
o.k. NN NN O
but CC CC O
pt NN NN O
has VBZ VBZ O
CAD NNP NNP O
) ) ) O
influenza NN NN O
vaccine NN NN O
given VBN VBN O
follow VB VB O
up RB RB O
in IN IN O
4-6 JJ JJ O
months NNS NNS O
or CC CC O
earlier RBR RBR O
prn NN NN O
( ( ( O
pt NN NN O
has VBZ VBZ O
weekly JJ JJ O
visit NN NN O
with IN IN O
VN NNP NNP O
who WP WP O
monitors NNS NNS O
her PRP$ PRP$ O
and CC CC O
is VBZ VBZ O
in IN IN O
touch NN NN O
with IN IN O
me PRP PRP O
) ) ) O
_____________________________ NN NN O
_ NN NN O
Opal NNP NNP I-DOCTOR
Carrie-Guerrero NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2089-04-14 NN NN I-DATE
ID NNP NNP O
Sign NNP NNP O
off IN IN O
Note NNP NNP O
Kong NNP NNP O
, , , O
Catherine NNP NNP I-PATIENT
MR NNP NNP O
# # # O
6746781 CD CD I-MEDICALRECORD
Original NNP NNP O
ID NNP NNP O
Consult NNP NNP O
: : : O
4/6/89 CD CD I-DATE
Sign NNP NNP O
off IN IN O
Date NN NN O
: : : O
4/14/89 CD CD I-DATE
ID NNP NNP O
issues NNS NNS O
: : : O
GBS NNP NNP O
AV NNP NNP O
endocarditis NNS NNS O
Brief NNP NNP O
History NN NN O
: : : O
See VB VB O
initial JJ JJ O
ID NNP NNP O
consult NN NN O
note NN NN O
for IN IN O
greater JJR JJR O
detail NN NN O
. . . O
   
Briefly NNP NNP O
, , , O
70 CD CD I-AGE
yo NN NN O
F NN NN O
w NN NN O
HTN NNP NNP O
, , , O
DM2 NNP NNP O
, , , O
stable JJ JJ O
angina NN NN O
who WP WP O
is VBZ VBZ O
transferred VBN VBN O
to TO TO O
NSH NNP NNP I-HOSPITAL
on IN IN O
4/3/89 CD CD I-DATE
with IN IN O
aortic JJ JJ O
valve NN NN O
endocarditis NNS NNS O
complicated VBN VBN O
by IN IN O
AI NNP NNP O
and CC CC O
CHF NNP NNP O
. . . O
   
She PRP PRP O
was VBD VBD O
in IN IN O
her PRP$ PRP$ O
USOH NNP NNP O
until IN IN O
~ NN NN O
2/8/89 CD CD I-DATE
when WRB WRB O
she PRP PRP O
had VBD VBD O
an DT DT O
episode NN NN O
of IN IN O
shingles NNS NNS O
on IN IN O
R NNP NNP O
arm NN NN O
for IN IN O
which WDT WDT O
she PRP PRP O
took VBD VBD O
Valtrex NNP NNP O
. . . O
   
Soon RB RB O
after IN IN O
she PRP PRP O
began VBD VBD O
to TO TO O
feel VB VB O
fatigued VBN VBN O
and CC CC O
febrile JJ JJ O
and CC CC O
was VBD VBD O
found VBN VBN O
to TO TO O
have VB VB O
a DT DT O
2/2 CD CD O
bottles NNS NNS O
positive JJ JJ O
for IN IN O
Group NNP NNP O
B NNP NNP O
streptococcus NN NN O
on IN IN O
2/21 CD CD I-DATE
( ( ( O
PCN NNP NNP O
MIC NNP NNP O
0.125 CD CD O
) ) ) O
for IN IN O
which WDT WDT O
her PRP$ PRP$ O
PCP NNP NNP O
treated VBD VBD O
her PRP PRP O
with IN IN O
2 CD CD O
week NN NN O
course NN NN O
of IN IN O
amoxicillin NN NN O
. . . O
   
On IN IN O
4/3 CD CD I-DATE
she PRP PRP O
presents VBZ VBZ O
with IN IN O
SOB NNP NNP O
, , , O
orthopnea NN NN O
, , , O
and CC CC O
PND NNP NNP O
. . . O
   
she PRP PRP O
developed VBD VBD O
DOE NNP NNP O
, , , O
PND NNP NNP O
, , , O
orthopnea NN NN O
, , , O
worsening VBG VBG O
fatigue NN NN O
and CC CC O
malaise NN NN O
. . . O
   
CXR NNP NNP O
at IN IN O
OSH NNP NNP O
notable JJ JJ O
for IN IN O
pulm NN NN O
edema NN NN O
and CC CC O
TTE NNP NNP O
demonstrated VBD VBD O
vegetation NN NN O
on IN IN O
the DT DT O
aortic JJ JJ O
valve NN NN O
. . . O
   
She PRP PRP O
was VBD VBD O
transferred VBN VBN O
to TO TO O
NSH NNP NNP I-HOSPITAL
where WRB WRB O
she PRP PRP O
was VBD VBD O
started VBN VBN O
on IN IN O
ampicillin NN NN O
1gm CD CD O
IV NNP NNP O
q8h NN NN O
and CC CC O
gentamicin NN NN O
120 CD CD O
mg NN NN O
TID NNP NNP O
. . . O
   
TTE NNP NNP O
4/4 CD CD I-DATE
showed VBD VBD O
a DT DT O
mobile JJ JJ O
mass NN NN O
of IN IN O
echoes NNS NNS O
attached VBN VBN O
to TO TO O
the DT DT O
valve NN NN O
c/w NN NN O
vegetation NN NN O
. . . O
   
The DT DT O
right NN NN O
coronary JJ JJ O
leaflet NN NN O
appears VBZ VBZ O
flail NN NN O
, , , O
and CC CC O
there EX EX O
was VBD VBD O
prolapse NN NN O
of IN IN O
the DT DT O
non-coronary JJ JJ O
cusp NN NN O
as RB RB O
well RB RB O
. . . O
   
There EX EX O
was VBD VBD O
evidence NN NN O
of IN IN O
at IN IN O
least JJS JJS O
moderate JJ JJ O
aortic JJ JJ O
insufficiency NN NN O
by IN IN O
color NN NN O
and CC CC O
spectral JJ JJ O
Doppler NNP NNP O
. . . O
   
She PRP PRP O
went VBD VBD O
to TO TO O
the DT DT O
OR CC CC O
on IN IN O
4/5 CD CD I-DATE
CABG NNP NNP O
, , , O
TEE NNP NNP O
, , , O
Homograft NNP NNP O
aortic JJ JJ O
root NN NN O
placement NN NN O
oIn NN NN O
the DT DT O
OR CC CC O
the DT DT O
aortic JJ JJ O
valve NN NN O
was VBD VBD O
severely RB RB O
damaged VBN VBN O
. . . O
   
There EX EX O
was VBD VBD O
perforation NN NN O
of IN IN O
the DT DT O
right NN NN O
coronary JJ JJ O
leaflet NN NN O
and CC CC O
there EX EX O
were VBD VBD O
numerous JJ JJ O
vegetations NNS NNS O
, , , O
which WDT WDT O
appeared VBD VBD O
to TO TO O
be VB VB O
rolled VBN VBN O
up RP RP O
aortic JJ JJ O
valve NN NN O
tissue NN NN O
on IN IN O
predominantly RB RB O
the DT DT O
right NN NN O
and CC CC O
noncoronary JJ JJ O
leaflets NNS NNS O
. . . O
   
Underneath IN IN O
the DT DT O
annulus NN NN O
of IN IN O
the DT DT O
right NN NN O
coronary JJ JJ O
, , , O
there EX EX O
was VBD VBD O
an DT DT O
area NN NN O
of IN IN O
early JJ JJ O
abscess JJ JJ O
formation NN NN O
. . . O
   
Gram NNP NNP O
stain VB VB O
of IN IN O
tissues NNS NNS O
was VBD VBD O
negative JJ JJ O
for IN IN O
organisms NNS NNS O
and CC CC O
cultures NNS NNS O
were VBD VBD O
negative JJ JJ O
. . . O
   
Pathology NNP NNP O
was VBD VBD O
notable JJ JJ O
for IN IN O
Numerous JJ JJ O
degenerated JJ JJ O
bacterial JJ JJ O
coccal JJ JJ O
forms NNS NNS O
present JJ JJ O
on IN IN O
silver NN NN O
stain VBP VBP O
consistent JJ JJ O
with IN IN O
Streptococcus NNP NNP O
. . . O
   
Occasional NNP NNP O
residual JJ JJ O
gram NN NN O
positive JJ JJ O
cocci NN NN O
present JJ JJ O
on IN IN O
Brown-Hopps NNP NNP O
stain VB VB O
. . . O
   
She PRP PRP O
was VBD VBD O
started VBN VBN O
on IN IN O
PCN NNP NNP O
3 CD CD O
million CD CD O
units NNS NNS O
q4h NN NN O
and CC CC O
Gentamicin NNP NNP O
60 CD CD O
mg NN NN O
q12h NN NN O
on IN IN O
4/6 CD CD I-DATE
with IN IN O
plan NN NN O
to TO TO O
complete VB VB O
6 CD CD O
weeks NNS NNS O
of IN IN O
PCN NNP NNP O
, , , O
and CC CC O
2 CD CD O
weeks NNS NNS O
of IN IN O
genatmicin NN NN O
. . . O
   
Her PRP$ PRP$ O
hospital NN NN O
course NN NN O
was VBD VBD O
c/b NN NN O
by IN IN O
heart NN NN O
block NN NN O
for IN IN O
which WDT WDT O
she PRP PRP O
received VBD VBD O
a DT DT O
PPM NNP NNP O
on IN IN O
4/12 CD CD I-DATE
. . . O
   
Recommendations NNP NNP O
: : : O
Gentamicin NNP NNP O
60 CD CD O
mg NN NN O
IV NNP NNP O
q12h NN NN O
) ) ) O
will MD MD O
end VB VB O
on IN IN O
4/20 CD CD I-DATE
Please VB VB O
check NN NN O
gent NN NN O
peak/trough RB RB O
early JJ JJ O
next JJ JJ O
week NN NN O
. . . O
   
( ( ( O
goal NN NN O
peak NN NN O
3-5 NN NN O
, , , O
trough NN NN O
< NN NN O
1 CD CD O
) ) ) O
PCN NNP NNP O
3 CD CD O
million CD CD O
units NNS NNS O
q4h NN NN O
until IN IN O
5/18 CD CD I-DATE
ID NNP NNP O
f/u NN NN O
scheduled VBD VBD O
on IN IN O
5/22 CD CD I-DATE
with IN IN O
me PRP PRP O
on IN IN O
Beckett NNP NNP O
10 CD CD O
at IN IN O
10:00am CD CD O
Weekly NNP NNP O
safety NN NN O
labs NNS NNS O
: : : O
Lfts NNP NNP O
, , , O
Chem NNP NNP O
7 CD CD O
and CC CC O
CBC/diff NNP NNP O
. . . O
   
Fax NNP NNP O
labs NNS NNS O
to TO TO O
# # # O
below IN IN O
Attn NNP NNP O
: : : O
Natashia NNP NNP I-DOCTOR
Rosa NNP NNP I-DOCTOR
Will NNP NNP O
sign VB VB O
off RP RP O
for IN IN O
now RB RB O
. . . O
   
Please VB VB O
call NN NN O
with IN IN O
questions NNS NNS O
. . . O
   
_____________________ NN NN O
_ NN NN O
Natashia NNP NNP I-DOCTOR
Rosa NNP NNP I-DOCTOR
Infectious NNP NNP O
Disease NNP NNP O
Fellow NNP NNP O
Office NNP NNP O
# # # O
470-119-6124 NN NN I-PHONE
Fax NN NN O
# # # O
664-577-0339 NN NN I-FAX
Pager NNP NNP O
# # # O
27960 CD CD I-PHONE
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
Date NN NN O
: : : O
2070-12-01 JJ JJ I-DATE
Narrative NNP NNP O
History NN NN O
Patient NNP NNP O
presents VBZ VBZ O
for IN IN O
an DT DT O
annual JJ JJ O
exam NN NN O
. . . O
   
Seen VBN VBN O
few JJ JJ O
weeks NNS NNS O
ago RB RB O
for IN IN O
hair NN NN O
breaking VBG VBG O
. . . O
   
GYN NNP NNP O
- : : O
thinks VBZ VBZ O
about IN IN O
2 CD CD O
years NNS NNS O
since IN IN O
last JJ JJ O
period NN NN O
. . . O
   
Having VBG VBG O
some DT DT O
tolerable JJ JJ O
hot JJ JJ O
flashes NNS NNS O
. . . O
   
Last RB RB O
saw VBD VBD O
Dr NNP NNP O
Foust NNP NNP I-DOCTOR
of IN IN O
gyn NN NN O
in IN IN O
4/66 CD CD I-DATE
, , , O
Pap NNP NNP O
smear NN NN O
done VBN VBN O
then RB RB O
. . . O
   
Diff NNP NNP O
exam NN NN O
secondary JJ JJ O
to TO TO O
way NN NN O
uterus JJ JJ O
tipped VBD VBD O
. . . O
   
Exercise NNP NNP O
- - - O
Started NNP NNP O
walking VBG VBG O
at IN IN O
work NN NN O
again RB RB O
daily JJ JJ O
1 CD CD O
mile NN NN O
. . . O
   
also RB RB O
watching VBG VBG O
diet NN NN O
now RB RB O
. . . O
   
Problems NNS NNS O
FH NNP NNP O
breast NN NN O
cancer NN NN O
: : : O
37 CD CD I-AGE
yo NN NN O
s VBZ VBZ O
- - - O
died JJ JJ O
41 CD CD I-AGE
FH NNP NNP O
myocardial NN NN O
infarction NN NN O
: : : O
mother NN NN O
died VBD VBD O
66 CD CD I-AGE
yo NN NN O
Hypertension NNP NNP O
- : : O
excellent JJ JJ O
today NN NN O
- : : O
check NN NN O
chem NN NN O
7 CD CD O
, , , O
meds NNS NNS O
renewed VBN VBN O
Uterine NNP NNP O
fibroids NNS NNS O
: : : O
u/s NN NN O
2062 CD CD I-DATE
- : : O
to TO TO O
follow-up JJ JJ O
with IN IN O
gyn NN NN O
. . . O
   
Still RB RB O
seem VBP VBP O
unchanged JJ JJ O
Smoking NNP NNP O
: : : O
quit VBD VBD O
2/67 CD CD I-DATE
s/p NN NN O
MI NNP NNP O
- : : O
still RB RB O
not RB RB O
smoking NN NN O
! . . O
   
borderline NN NN O
diabetes NN NN O
mellitus NN NN O
: : : O
4/63 CD CD I-DATE
125 CD CD O
, , , O
follow VBP VBP O
hgbaic JJ JJ O
- : : O
was VBD VBD O
5.7 CD CD O
in IN IN O
3/67 CD CD I-DATE
, , , O
recheck NN NN O
glc NN NN O
and CC CC O
a1c NN NN O
today NN NN O
VPB NNP NNP O
: : : O
2065 CD CD I-DATE
- : : O
ETT NNP NNP O
showed VBD VBD O
freq NN NN O
PVC NNP NNP O
's POS POS O
, , , O
bigeminy NN NN O
and CC CC O
couplets NNS NNS O
, , , O
nondx NN NN O
for IN IN O
ischemia NN NN O
- - - O
denies NNS NNS O
palp NN NN O
or CC CC O
dizziness NN NN O
Coronary JJ JJ O
artery NN NN O
disease NN NN O
: : : O
s/p NN NN O
ant NN NN O
SEMI NNP NNP O
+ NN NN O
stent NN NN O
LAD NNP NNP O
2/67 CD CD I-DATE
, , , O
Dr NNP NNP O
Oakley NNP NNP I-DOCTOR
, , , O
ETT NNP NNP O
Clarkfield NNP NNP I-HOSPITAL
3/67 CD CD I-DATE
- : : O
neg NN NN O
scan VB VB O
for IN IN O
ischemia NN NN O
. . . O
   
No DT DT O
CP NNP NNP O
's POS POS O
, , , O
palp NN NN O
. . . O
   
Saw VBD VBD O
Dr NNP NNP O
Oakley NNP NNP I-DOCTOR
today NN NN O
. . . O
   
Off IN IN O
plavix NN NN O
for IN IN O
the DT DT O
last JJ JJ O
several JJ JJ O
months NNS NNS O
which WDT WDT O
was VBD VBD O
what WP WP O
Dr NNP NNP O
Oakley NNP NNP I-DOCTOR
intended VBD VBD O
. . . O
   
She PRP PRP O
was VBD VBD O
"""" '' '' O
pleased JJ JJ O
"""" '' '' O
with IN IN O
everything NN NN O
. . . O
   
thyroid NN NN O
nodule NN NN O
: : : O
2065 CD CD I-DATE
, , , O
hot JJ JJ O
, , , O
follow VB VB O
TSH NNP NNP O
. . . O
   
Will NNP NNP O
recheck VB VB O
today NN NN O
. . . O
   
Has VBZ VBZ O
appt NN NN O
with IN IN O
Dr NNP NNP O
Dolan NNP NNP I-DOCTOR
in IN IN O
April NNP NNP I-DATE
to TO TO O
discuss VB VB O
treatment NN NN O
of IN IN O
the DT DT O
subclinical JJ JJ O
hyperthyroidism NN NN O
- : : O
I PRP PRP O
would MD MD O
favor VB VB O
this DT DT O
given VBN VBN O
history NN NN O
of IN IN O
CAD NNP NNP O
, , , O
mild JJ JJ O
VEA NNP NNP O
in IN IN O
past JJ JJ O
. . . O
   
Hyperlipidemia NNP NNP O
: : : O
CRF NNP NNP O
mild NN NN O
chol NN NN O
, , , O
cigs NNS NNS O
, , , O
HTN NNP NNP O
, , , O
Fhx NNP NNP O
and CC CC O
known VBN VBN O
hx NN NN O
CAD NNP NNP O
in IN IN O
pt NN NN O
. . . O
   
Check NNP NNP O
lfts NNS NNS O
and CC CC O
cholesterol NN NN O
today NN NN O
. . . O
   
Went VBD VBD O
back RB RB O
on IN IN O
lipitor NN NN O
for IN IN O
the DT DT O
last JJ JJ O
3 CD CD O
weeks NNS NNS O
. . . O
   
Does VBZ VBZ O
note NN NN O
a DT DT O
bit NN NN O
of IN IN O
achiness NN NN O
in IN IN O
legs NNS NNS O
, , , O
not RB RB O
sure JJ JJ O
if IN IN O
related VBN VBN O
to TO TO O
it PRP PRP O
or CC CC O
not RB RB O
- - - O
will MD MD O
let VB VB O
us PRP PRP O
know VB VB O
if IN IN O
so RB RB O
. . . O
   
Medications NNP NNP O
Asa NNP NNP O
( ( ( O
ACETYLSALICYLIC NNP NNP O
Acid NNP NNP O
) ) ) O
325MG CD CD O
, , , O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Lipitor NNP NNP O
( ( ( O
ATORVASTATIN NNP NNP O
) ) ) O
10MG CD CD O
, , , O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Nitroglycerin NNP NNP O
1/150 CD CD O
( ( ( O
0.4 CD CD O
Mg NNP NNP O
) ) ) O
1 CD CD O
TAB NNP NNP O
SL NNP NNP O
x1 NN NN O
PRN NNP NNP O
prn NN NN O
CP NNP NNP O
Norvasc NNP NNP O
( ( ( O
AMLODIPINE NNP NNP O
) ) ) O
5MG CD CD O
, , , O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Zestril NNP NNP O
( ( ( O
LISINOPRIL NNP NNP O
) ) ) O
40MG CD CD O
, , , O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
ATENOLOL NNP NNP O
50MG CD CD O
, , , O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Hctz NNP NNP O
( ( ( O
HYDROCHLOROTHIAZIDE NNP NNP O
) ) ) O
25MG CD CD O
, , , O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Allergies NNP NNP O
Ceclor NNP NNP O
( ( ( O
CEFACLOR NNP NNP O
) ) ) O
- : : O
Rash NNP NNP O
Family NNP NNP O
History NN NN O
father NN NN O
- : : O
HTN NNP NNP O
, , , O
78 CD CD I-AGE
now RB RB O
mother-HTN NN NN O
, , , O
MI NNP NNP O
at IN IN O
58 CD CD I-AGE
and CC CC O
62 CD CD I-AGE
- : : O
died VBD VBD O
then RB RB O
siblings-sister NN NN O
finally RB RB O
died VBD VBD O
from IN IN O
breast NN NN O
CA NNP NNP O
after IN IN O
4 CD CD O
year NN NN O
battle NN NN O
, , , O
dx NN NN O
age NN NN O
   
37 CD CD I-AGE
. . . O
7 CD CD O
sisters NNS NNS O
- : : O
one CD CD O
with IN IN O
DM,and NNP NNP O
2 CD CD O
brothers NNS NNS O
- : : O
ok JJ JJ O
No DT DT O
change NN NN O
since IN IN O
previous JJ JJ O
annual JJ JJ O
. . . O
   
Social NNP NNP O
History NN NN O
working VBG VBG O
for IN IN O
Convergys NNP NNP I-ORGANIZATION
as IN IN O
Sculptor NNP NNP I-PROFESSION
, , , O
married VBN VBN O
, , , O
one CD CD O
son NN NN O
- : : O
26 CD CD I-AGE
yo NN NN O
who WP WP O
lives VBZ VBZ O
with IN IN O
them PRP PRP O
. . . O
   
Review NNP NNP O
of IN IN O
Systems NNPS NNPS O
The DT DT O
following VBG VBG O
systems NNS NNS O
were VBD VBD O
reviewed VBN VBN O
today NN NN O
and CC CC O
were VBD VBD O
negative JJ JJ O
unless IN IN O
indicated VBD VBD O
otherwise RB RB O
in IN IN O
the DT DT O
history NN NN O
noted VBD VBD O
above IN IN O
: : : O
Constitutional NNP NNP O
, , , O
HEENT NNP NNP O
, , , O
Breast,CVS NNP NNP O
, , , O
GI NNP NNP O
, , , O
GYN NNP NNP O
, , , O
Skin NNP NNP O
, , , O
Musculoskeletal NNP NNP O
, , , O
Neuro NNP NNP O
, , , O
Psych NNP NNP O
, , , O
Respiratory NNP NNP O
, , , O
and CC CC O
Allergic NNP NNP O
Physical JJ JJ O
Exam NNP NNP O
Vital NNP NNP O
signs NNS NNS O
134/86 CD CD O
65 CD CD O
inches NNS NNS O
weight NN NN O
- : : O
210 CD CD O
down RB RB O
2 CD CD O
lbs NN NN O
since IN IN O
last JJ JJ O
year NN NN O
. . . O
   
General NNP NNP O
: : : O
appears VBZ VBZ O
well RB RB O
HEENT NNP NNP O
: : : O
EOMI NNP NNP O
, , , O
PERRL NNP NNP O
, , , O
OP NNP NNP O
normal JJ JJ O
Skin NNP NNP O
: : : O
no DT DT O
suspicious JJ JJ O
lesions NNS NNS O
Neck NNP NNP O
: : : O
no DT DT O
thyromegaly NN NN O
, , , O
no DT DT O
bruits NNS NNS O
Nodes NNS NNS O
: : : O
no DT DT O
cervical JJ JJ O
, , , O
axillary JJ JJ O
, , , O
or CC CC O
supraclavicular JJ JJ O
lymphadenopathy JJ JJ O
Breast NNP NNP O
- : : O
no DT DT O
nipple NN NN O
discharge NN NN O
or CC CC O
retraction NN NN O
, , , O
no DT DT O
dominant JJ JJ O
masses NNS NNS O
Chest NN NN O
: : : O
clear JJ JJ O
to TO TO O
auscultation NN NN O
, , , O
no DT DT O
rhonchi NN NN O
or CC CC O
wheeze NN NN O
COR NNP NNP O
: : : O
regular JJ JJ O
S1 NNP NNP O
, , , O
S2 NNP NNP O
, , , O
no DT DT O
murmurs NNS NNS O
, , , O
rubs NNS NNS O
or CC CC O
gallops NNS NNS O
Abd NNP NNP O
: : : O
soft JJ JJ O
, , , O
NT NNP NNP O
, , , O
no DT DT O
HSM NNP NNP O
or CC CC O
masses NNS NNS O
Musculoskeletal NNP NNP O
: : : O
no DT DT O
erythema NN NN O
, , , O
swelling VBG VBG O
, , , O
or CC CC O
tenderness NN NN O
Ext NNP NNP O
: : : O
no DT DT O
CCE NNP NNP O
, , , O
Neuro NNP NNP O
: : : O
grossly RB RB O
non-focal JJ JJ O
Health NNP NNP O
maintenance NN NN O
Influenza NNP NNP O
Vaccine NNP NNP O
11/29/2067 CD CD I-DATE
Cholesterol NNP NNP O
11/29/2067 CD CD I-DATE
182 CD CD O
Mammogram NNP NNP O
03/01/64 CD CD I-DATE
BilScrMammo(MC NNP NNP O
) ) ) O
Pap NNP NNP O
Smear NNP NNP O
03/12/2066 CD CD I-DATE
See VB VB O
report NN NN O
in IN IN O
Results NNS NNS O
UA-Protein NNP NNP O
03/12/2066 CD CD I-DATE
NEGATIVE NNP NNP O
HBA1C NNP NNP O
06/15/2068 CD CD I-DATE
5.80 CD CD O
TD NNP NNP O
Booster NNP NNP O
12/28/59 CD CD I-DATE
Triglycerides NNP NNP O
11/29/2067 CD CD I-DATE
61 CD CD O
Cholesterol-LDL NNP NNP O
11/29/2067 CD CD I-DATE
119 NN NN O
Hct NNP NNP O
( ( ( O
Hematocrit NNP NNP O
) ) ) O
03/16/2067 CD CD I-DATE
40.0 CD CD O
Cholesterol-HDL NNP NNP O
11/29/2067 CD CD I-DATE
51 CD CD O
Hgb NNP NNP O
( ( ( O
Hemoglobin NNP NNP O
) ) ) O
03/16/2067 CD CD I-DATE
13.3 CD CD O
Assessment NNP NNP O
and CC CC O
Plan NNP NNP O
   
1 CD CD O
. . . O
Health NNP NNP O
Maintenance NNP NNP O
- : : O
Pap NNP NNP O
smear NN NN O
with IN IN O
gyn NN NN O
soon RB RB O
, , , O
mammo JJ JJ O
- - - O
very RB RB O
overdue JJ JJ O
- - - O
stressed JJ JJ O
needs VBZ VBZ O
to TO TO O
do VB VB O
this DT DT O
again RB RB O
and CC CC O
promises VBZ VBZ O
, , , O
Stool NNP NNP O
cards NNS NNS O
. . . O
   
Declined NNP NNP O
sig NN NN O
for IN IN O
now RB RB O
but CC CC O
promises VBZ VBZ O
to TO TO O
think VB VB O
about IN IN O
it PRP PRP O
. . . O
   
2 CD CD O
. . . O
Menopause NNP NNP O
- : : O
calcium NN NN O
, , , O
consider VB VB O
BD NNP NNP O
when WRB WRB O
not RB RB O
overwhelmed VBN VBN O
with IN IN O
everything NN NN O
else RB RB O
- : : O
much JJ JJ O
prefer NN NN O
she PRP PRP O
concentrate JJ JJ O
on IN IN O
the DT DT O
appts NNS NNS O
, , , O
Pap NNP NNP O
smear NN NN O
and CC CC O
mammo NN NN O
. . . O
   
Rest NNP NNP O
of IN IN O
issues NNS NNS O
- - - O
see VB VB O
above IN IN O
. . . O
   
follow-up JJ JJ O
6 CD CD O
months NNS NNS O
Beverly NNP NNP I-DOCTOR
Thiel NNP NNP I-DOCTOR
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2080-06-13 JJ JJ I-DATE
INFECTIOUS NNP NNP O
DISEASE NNP NNP O
ASSOCIATES NNP NNP O
CURTIS NNP NNP I-HOSPITAL
MEDICAL NNP NNP I-HOSPITAL
CENTER NNP NNP I-HOSPITAL
Reason NNP NNP O
for IN IN O
visit NN NN O
Brucellosis NNP NNP O
. . . O
   
History NN NN O
of IN IN O
present JJ JJ O
illness NN NN O
Ms NNP NNP O
. . . O
Iles NNP NNP I-PATIENT
is VBZ VBZ O
seen VBN VBN O
here RB RB O
two CD CD O
weeks NNS NNS O
after IN IN O
her PRP$ PRP$ O
discharge NN NN O
from IN IN O
the DT DT O
hospital NN NN O
. . . O
   
She PRP PRP O
has VBZ VBZ O
been VBN VBN O
treated VBN VBN O
for IN IN O
systemic JJ JJ O
brucellosis NN NN O
with IN IN O
suspicion NN NN O
of IN IN O
osteoarticular JJ JJ O
disease NN NN O
given VBN VBN O
her PRP$ PRP$ O
low JJ JJ O
back RB RB O
pain NN NN O
. . . O
   
She PRP PRP O
is VBZ VBZ O
taking VBG VBG O
rifampin NN NN O
, , , O
doxycycline NN NN O
and CC CC O
has VBZ VBZ O
been VBN VBN O
treated VBN VBN O
with IN IN O
streptomycin NN NN O
. . . O
   
She PRP PRP O
feels VBZ VBZ O
quite RB RB O
a DT DT O
bit NN NN O
better JJR JJR O
and CC CC O
has VBZ VBZ O
had VBN VBN O
resolution NN NN O
of IN IN O
her PRP$ PRP$ O
fevers NNS NNS O
and CC CC O
chills NNS NNS O
. . . O
   
She PRP PRP O
has VBZ VBZ O
diminished VBN VBN O
pain NN NN O
and CC CC O
is VBZ VBZ O
able JJ JJ O
to TO TO O
ambulate VB VB O
somewhat RB RB O
and CC CC O
goes VBZ VBZ O
to TO TO O
the DT DT O
bathroom NN NN O
more RBR RBR O
comfortably RB RB O
. . . O
   
She PRP PRP O
still RB RB O
has VBZ VBZ O
weakness NNS NNS O
and CC CC O
a DT DT O
poor JJ JJ O
appetite NN NN O
. . . O
   
There EX EX O
have VBP VBP O
been VBN VBN O
no DT DT O
change NN NN O
in IN IN O
her PRP$ PRP$ O
bowel NN NN O
habits NNS NNS O
and CC CC O
no DT DT O
fevers NNS NNS O
, , , O
chills NNS NNS O
or CC CC O
rash NN NN O
. . . O
   
Past NNP NNP O
medical JJ JJ O
history NN NN O
- : : O
DMII NNP NNP O
( ( ( O
dx NN NN O
late JJ JJ O
60s CD CD I-DATE
, , , O
last JJ JJ O
A1c NNP NNP O
= SYM SYM O
5.6 CD CD O
in IN IN O
2/80 CD CD I-DATE
) ) ) O
- : : O
HTN NNP NNP O
- : : O
Hyperlipidemia NNP NNP O
- : : O
Hep NNP NNP O
B NNP NNP O
sAb NN NN O
+ NN NN O
, , , O
sAg NN NN O
+ NN NN O
, , , O
and CC CC O
core NN NN O
Ab NNP NNP O
+ NN NN O
in IN IN O
2067 CD CD I-DATE
; : : O
   
now RB RB O
sAg NN NN O
- : : O
, , , O
sAb NN NN O
+ NN NN O
, , , O
and CC CC O
core NN NN O
Ab NNP NNP O
(+) NN NN O
in IN IN O
2/2080 CD CD I-DATE
( ( ( O
recovery NN NN O
) ) ) O
- : : O
H/o NNP NNP O
H. NN NN O
pylori NN NN O
(+) NN NN O
2068 CD CD I-DATE
and CC CC O
2080 CD CD I-DATE
s/p NN NN O
triple NN NN O
therapy NN NN O
- : : O
GERD NNP NNP O
- : : O
OA NNP NNP O
- : : O
H/o NNP NNP O
vitamin NN NN O
D NNP NNP O
deficiency NN NN O
- : : O
H/o NNP NNP O
chronic NN NN O
HAs VBZ VBZ O
( ( ( O
migraines NN NN O
vs NNS NNS O
. . . O
tension NN NN O
HAs VBZ VBZ O
) ) ) O
-+ : : O
PPD NNP NNP O
( ( ( O
in IN IN O
Mississippi NNP NNP I-STATE
in IN IN O
2067 CD CD I-DATE
) ) ) O
- : : O
H/o NNP NNP O
malaria NN NN O
Active JJ JJ O
Medications NNP NNP O
multivitamins NNS NNS O
liquid NN NN O
; : : O
   
Dir NNP NNP O
: : : O
One CD CD O
teaspoon NN NN O
daily JJ JJ O
metformin NN NN O
hydrochloride NN NN O
500 CD CD O
MG NNP NNP O
PO NNP NNP O
BID NNP NNP O
lisinopril NN NN O
20 CD CD O
MG NNP NNP O
PO NNP NNP O
daily JJ JJ O
atenolol NN NN O
50 CD CD O
MG NNP NNP O
PO NNP NNP O
daily JJ JJ O
Zofran NNP NNP O
4 CD CD O
MG NNP NNP O
PO NNP NNP O
Q8H NNP NNP O
aspirin NN NN O
81 CD CD O
MG NNP NNP O
PO NNP NNP O
daily JJ JJ O
morphine NN NN O
sulfate NN NN O
immediate JJ JJ O
release NN NN O
PO NNP NNP O
Q4H NNP NNP O
PRN NNP NNP O
Ms NNP NNP O
contin NN NN O
PO NNP NNP O
Q12H NNP NNP O
simvastatin NN NN O
40 CD CD O
MG NNP NNP O
PO NNP NNP O
QPM NNP NNP O
Review NNP NNP O
of IN IN O
systems NNS NNS O
Denies NNP NNP O
fever NN NN O
, , , O
rigor NN NN O
, , , O
night NN NN O
sweats NNS NNS O
, , , O
headache NN NN O
, , , O
SOB NNP NNP O
, , , O
cough NN NN O
, , , O
anorexia NN NN O
, , , O
nausea NN NN O
, , , O
vomiting VBG VBG O
, , , O
diarrhea NN NN O
, , , O
abdominal JJ JJ O
pain NN NN O
, , , O
paresthesias NNS NNS O
, , , O
or CC CC O
rash NN NN O
. . . O
   
Physical JJ JJ O
Exam NNP NNP O
Pulse NNP NNP O
120 CD CD O
Blood NNP NNP O
pressure NN NN O
160/70 CD CD O
respiratory NN NN O
rate NN NN O
16 CD CD O
weight NN NN O
181 CD CD O
lbs NN NN O
. . . O
   
, , , O
temperature NN NN O
98.6 CD CD O
. . . O
   
General NNP NNP O
appearance NN NN O
Well RB RB O
appearing VBG VBG O
. . . O
   
Skin NNP NNP O
No DT DT O
rash NN NN O
or CC CC O
jaundice NN NN O
. . . O
   
HEENT NNP NNP O
No DT DT O
thrush NN NN O
. . . O
   
Nodes NNS NNS O
None NN NN O
. . . O
   
Chest NN NN O
Clear NNP NNP O
. . . O
   
Cor NNP NNP O
Normal NNP NNP O
PMI NNP NNP O
. . . O
   
Regular NNP NNP O
rate NN NN O
and CC CC O
rhythm NN NN O
, , , O
1/6 CD CD O
systolic JJ JJ O
ejection NN NN O
murmur NN NN O
is VBZ VBZ O
unchanged JJ JJ O
. . . O
   
No DT DT O
rub NN NN O
, , , O
gallop NN NN O
or CC CC O
click NN NN O
. . . O
   
Abdomen NNP NNP O
Soft JJ JJ O
without IN IN O
hepatosplenomegaly NN NN O
, , , O
mass NN NN O
or CC CC O
ascites NNS NNS O
. . . O
   
Musc NNP NNP O
skel NN NN O
There EX EX O
is VBZ VBZ O
some DT DT O
persistent JJ JJ O
tenderness NN NN O
in IN IN O
the DT DT O
left NN NN O
sacroiliac JJ JJ O
region NN NN O
in IN IN O
her PRP$ PRP$ O
lower JJR JJR O
back RB RB O
. . . O
   
Selected NNP NNP O
recent JJ JJ O
labs NNS NNS O
Include NNP NNP O
, , , O
sodium NN NN O
134 CD CD O
, , , O
creatinine NN NN O
0.6 CD CD O
, , , O
glucose NN NN O
147 CD CD O
, , , O
calcium NN NN O
9.0 CD CD O
. . . O
   
SGOT NNP NNP O
86 CD CD O
, , , O
SGPT NNP NNP O
75 CD CD O
and CC CC O
these DT DT O
are VBP VBP O
both DT DT O
lower JJR JJR O
than IN IN O
in IN IN O
the DT DT O
hospital NN NN O
. . . O
   
Iron NNP NNP O
31 CD CD O
, , , O
TIBC NNP NNP O
164 CD CD O
. . . O
   
Hematocrit NNP NNP O
37 CD CD O
, , , O
white JJ JJ O
blood NN NN O
cell NN NN O
count NN NN O
4 CD CD O
, , , O
platelets NNS NNS O
411,000 CD CD O
. . . O
   
Followup NNP NNP O
blood NN NN O
cultures NNS NNS O
drawn VBN VBN O
in IN IN O
the DT DT O
hospital NN NN O
, , , O
sterilized VBN VBN O
on IN IN O
therapy NN NN O
. . . O
   
Assessment NNP NNP O
and CC CC O
plan NN NN O
. . . O
   
Continue NNP NNP O
with IN IN O
doxycycline NN NN O
and CC CC O
rifampin NN NN O
for IN IN O
brucellosis NNS NNS O
. . . O
   
Follow VB VB O
up RB RB O
with IN IN O
Dr NNP NNP O
. . . O
Tillman NNP NNP I-DOCTOR
skin NN NN O
in IN IN O
one CD CD O
month NN NN O
. . . O
   
Liver NNP NNP O
function NN NN O
test NN NN O
and CC CC O
CBC NNP NNP O
drawn NN NN O
today NN NN O
. . . O
   
Low NNP NNP O
suspicion NN NN O
of IN IN O
endocarditis NNS NNS O
. . . O
   
We PRP PRP O
anticipate VBP VBP O
therapy NN NN O
to TO TO O
be VB VB O
six CD CD O
months NNS NNS O
. . . O
   
FOLLOWUP NNP NNP O
: : : O
One CD CD O
month NN NN O
. . . O
   
Todd NNP NNP I-DOCTOR
Riley NNP NNP I-DOCTOR
, , , O
MD NNP NNP O
Signed NNP NNP O
electronically RB RB O
by IN IN O
Todd NNP NNP I-DOCTOR
Riley NNP NNP I-DOCTOR
, , , O
MD NNP NNP O
Document NNP NNP O
Status NNP NNP O
: : : O
Final NNP NNP O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2080-06-14 NN NN I-DATE
Johnsonville NNP NNP I-HOSPITAL
Family NNP NNP I-HOSPITAL
Clinic NNP NNP I-HOSPITAL
5388 CD CD I-STREET
Main NNP NNP I-STREET
Street NNP NNP I-STREET
OSBORNE NNP NNP O
, , , O
MATTISON NNP NNP I-PATIENT
Oroville NNP NNP I-CITY
, , , O
AL NNP NNP I-STATE
89389 CD CD I-ZIP
48423663 CD CD I-MEDICALRECORD
( ( ( O
468 CD CD O
) ) ) O
429-7459 NN NN I-PHONE
06/14/2080 CD CD I-DATE
HISTORY NN NN O
OF IN IN O
PRESENT NNP NNP O
ILLNESS NNP NNP O
: : : O
The DT DT O
patient NN NN O
is VBZ VBZ O
a DT DT O
71-year-old JJ JJ O
male NN NN O
who WP WP O
returns VBZ VBZ O
to TO TO O
the DT DT O
clinic NN NN O
for IN IN O
a DT DT O
followup NN NN O
visit NN NN O
. . . O
   
The DT DT O
patient NN NN O
has VBZ VBZ O
a DT DT O
history NN NN O
of IN IN O
diabetes NN NN O
mellitus NN NN O
and CC CC O
hypertension NN NN O
. . . O
   
He PRP PRP O
also RB RB O
had VBD VBD O
an DT DT O
episode NN NN O
of IN IN O
bronchitis NNS NNS O
about IN IN O
2 CD CD O
months NNS NNS O
ago RB RB O
, , , O
which WDT WDT O
was VBD VBD O
treated VBN VBN O
with IN IN O
antibiotics NNS NNS O
. . . O
   
The DT DT O
patient NN NN O
feels VBZ VBZ O
improved VBN VBN O
today NN NN O
PHYSICAL JJ JJ O
EXAMINATION NNP NNP O
: : : O
An DT DT O
elderly JJ JJ O
male NN NN O
in IN IN O
no DT DT O
acute JJ JJ O
distress NN NN O
. . . O
   
Blood NNP NNP O
pressure NN NN O
is VBZ VBZ O
142/90 CD CD O
and CC CC O
pulse NN NN O
is VBZ VBZ O
   
64 CD CD O
. . . O
Chest NN NN O
is VBZ VBZ O
clear JJ JJ O
bilaterally RB RB O
. . . O
   
Heart NNP NNP O
: : : O
Regular NNP NNP O
rate NN NN O
and CC CC O
rhythm NN NN O
. . . O
   
Positive JJ JJ O
S1 NNP NNP O
and CC CC O
S2 NNP NNP O
. . . O
   
Negative NNP NNP O
S3 NNP NNP O
and CC CC O
S4 NNP NNP O
. . . O
   
No DT DT O
murmur NN NN O
. . . O
   
Abdomen NNP NNP O
is VBZ VBZ O
soft JJ JJ O
, , , O
nontender NN NN O
, , , O
positive JJ JJ O
bowel NN NN O
sounds VBZ VBZ O
. . . O
   
Lower JJR JJR O
extremities NNS NNS O
, , , O
no DT DT O
edema NN NN O
, , , O
nontender NN NN O
. . . O
   
IMPRESSION NNP NNP O
AND CC CC O
PLAN NNP NNP O
: : : O
   
1 CD CD O
. . . O
Diabetes NNP NNP O
mellitus NN NN O
. . . O
   
The DT DT O
patient NN NN O
reports NNS NNS O
blood NN NN O
sugars NNS NNS O
which WDT WDT O
have VBP VBP O
ranged VBN VBN O
from IN IN O
106-158 JJ JJ O
and CC CC O
reports NNS NNS O
overall JJ JJ O
good JJ JJ O
control NN NN O
of IN IN O
his PRP$ PRP$ O
diabetes NNS NNS O
mellitus NN NN O
. . . O
   
We PRP PRP O
will MD MD O
continue VB VB O
current JJ JJ O
treatment NN NN O
, , , O
especially RB RB O
in IN IN O
view NN NN O
of IN IN O
the DT DT O
fact NN NN O
that IN IN O
his PRP$ PRP$ O
most RBS RBS O
recent JJ JJ O
hemoglobin NN NN O
A1c NNP NNP O
in IN IN O
February NNP NNP I-DATE
was VBD VBD O
6.1 CD CD O
and CC CC O
repeat NN NN O
hemoglobin NN NN O
A1c NNP NNP O
when WRB WRB O
he PRP PRP O
returns VBZ VBZ O
for IN IN O
his PRP$ PRP$ O
next JJ JJ O
visit NN NN O
. . . O
   
2 CD CD O
. . . O
Hypertension NNP NNP O
. . . O
   
The DT DT O
patient NN NN O
's POS POS O
atenolol NN NN O
was VBD VBD O
recently RB RB O
decreased VBN VBN O
from IN IN O
50 CD CD O
mg NN NN O
to TO TO O
25 CD CD O
mg NN NN O
because IN IN O
of IN IN O
bradycardia NNS NNS O
and CC CC O
lisinopril NN NN O
was VBD VBD O
increased VBN VBN O
to TO TO O
60 CD CD O
mg NN NN O
because IN IN O
of IN IN O
microalbuminuria NN NN O
. . . O
The DT DT O
patient NN NN O
's POS POS O
heart NN NN O
rate NN NN O
is VBZ VBZ O
appropriate JJ JJ O
at IN IN O
64 CD CD O
even RB RB O
though IN IN O
his PRP$ PRP$ O
blood NN NN O
pressure NN NN O
remains VBZ VBZ O
borderline NN NN O
elevated JJ JJ O
. . . O
   
We PRP PRP O
will MD MD O
check VB VB O
a DT DT O
microalbumin NN NN O
today NN NN O
. . . O
   
4 CD CD O
. . . O
Recent JJ JJ O
TSH NNP NNP O
was VBD VBD O
mildly RB RB O
suppressed VBN VBN O
and CC CC O
we PRP PRP O
will MD MD O
repeat VB VB O
this DT DT O
today NN NN O
. . . O
   
5 CD CD O
. . . O
Regular NNP NNP O
healthcare NN NN O
maintenance NN NN O
. . . O
   
A DT DT O
CT NNP NNP O
of IN IN O
the DT DT O
patient NN NN O
's POS POS O
chest NN NN O
will MD MD O
be VB VB O
repeated VBN VBN O
when WRB WRB O
he PRP PRP O
returns VBZ VBZ O
for IN IN O
his PRP$ PRP$ O
next JJ JJ O
visit NN NN O
as IN IN O
recommended VBN VBN O
by IN IN O
radiology NN NN O
. . . O
   
_____________________________ NN NN O
_ NN NN O
Willie NNP NNP I-DOCTOR
Knapp NNP NNP I-DOCTOR
, , , O
MD NNP NNP O
eScription NN NN O
document:9-3577639 JJ JJ O
HFFocus NNP NNP O
transcriptionists NNS NNS O
DD NNP NNP O
: : : O
06/17/80 CD CD I-DATE
DT NNP NNP O
: : : O
06/17/80 CD CD I-DATE
DV NNP NNP O
: : : O
06/14/80 CD CD I-DATE
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2094-08-24 JJ JJ I-DATE
BMH NNP NNP I-HOSPITAL
Senior NNP NNP O
Health NNP NNP O
Initial JJ JJ O
Visit NNP NNP O
CC NNP NNP O
: : : O
79 CD CD I-AGE
yo NN NN O
man NN NN O
hx NN NN O
depression NN NN O
, , , O
psychosis NN NN O
, , , O
insomnia NN NN O
, , , O
CAD NNP NNP O
, , , O
syncope NN NN O
, , , O
HTN NNP NNP O
, , , O
DMT2 NNP NNP O
, , , O
carotid NN NN O
stenosis NN NN O
, , , O
PVD NNP NNP O
, , , O
here RB RB O
for IN IN O
PCP NNP NNP O
and CC CC O
f/u NN NN O
of IN IN O
these DT DT O
and CC CC O
other JJ JJ O
chronic JJ JJ O
health NN NN O
problems NNS NNS O
HPI NNP NNP O
: : : O
Patient NNP NNP O
recently RB RB O
presented VBD VBD O
to TO TO O
BMH NNP NNP I-HOSPITAL
with IN IN O
syncope NN NN O
s/p NN NN O
standing NN NN O
abruptly RB RB O
leading VBG VBG O
to TO TO O
left VBD VBD O
forhead NN NN O
lac NN NN O
. . . O
   
No DT DT O
seizure NN NN O
activity NN NN O
. . . O
   
He PRP PRP O
was VBD VBD O
brought VBN VBN O
to TO TO O
BMH NNP NNP I-HOSPITAL
where WRB WRB O
he PRP PRP O
indicated VBD VBD O
he PRP PRP O
had VBD VBD O
had VBN VBN O
2 CD CD O
similar JJ JJ O
episodes NNS NNS O
in IN IN O
previous JJ JJ O
month NN NN O
. . . O
   
Concern NNP NNP O
for IN IN O
cardiac JJ JJ O
orig1n NN NN O
given VBN VBN O
lack NN NN O
of IN IN O
posterior NN NN O
fossa NN NN O
signs NNS NNS O
, , , O
orthostasis NN NN O
at IN IN O
BMH NNP NNP I-HOSPITAL
, , , O
hx NN NN O
of IN IN O
seizure NN NN O
symptoms NNS NNS O
, , , O
and CC CC O
significant JJ JJ O
trauma NN NN O
. . . O
   
He PRP PRP O
ruled VBD VBD O
out IN IN O
for IN IN O
MI NNP NNP O
, , , O
had VBD VBD O
TTE NNP NNP O
showing VBG VBG O
EF NNP NNP O
59 CD CD O
% NN NN O
but CC CC O
had VBD VBD O
inf NN NN O
. . . O
   
WMA NNP NNP O
and CC CC O
LA NNP NNP O
dilation NN NN O
. . . O
   
Cardiology NNP NNP O
was VBD VBD O
therefore RB RB O
consulted VBN VBN O
. . . O
   
An DT DT O
adenoMIBI NN NN O
stress NN NN O
test NN NN O
was VBD VBD O
later RB RB O
performed VBN VBN O
and CC CC O
revealed VBN VBN O
mild JJ JJ O
inf NN NN O
. . . O
   
lat NN NN O
reversible JJ JJ O
ischemia NN NN O
, , , O
therefore RB RB O
a DT DT O
LHCath NNP NNP O
was VBD VBD O
performed VBN VBN O
and CC CC O
showed VBD VBD O
moderate JJ JJ O
non-intervenable JJ JJ O
lesions NNS NNS O
in IN IN O
the DT DT O
RCA NNP NNP O
and CC CC O
distal JJ JJ O
PLV NNP NNP O
. . . O
   
The DT DT O
patient NN NN O
also RB RB O
underwent VBD VBD O
an DT DT O
EP NNP NNP O
study NN NN O
that WDT WDT O
was VBD VBD O
non-diagnostic JJ JJ O
. . . O
   
An DT DT O
implantable JJ JJ O
loop NN NN O
recorder NN NN O
was VBD VBD O
placed VBN VBN O
on IN IN O
6/21 CD CD I-DATE
. . . O
   
Other JJ JJ O
work NN NN O
up RB RB O
of IN IN O
syncope NN NN O
included VBD VBD O
CNIs NNP NNP O
showing VBG VBG O
mild JJ JJ O
RICA NNP NNP O
stenosis NNS NNS O
; : : O
   
neurology NN NN O
consult NN NN O
thought VBD VBD O
these DT DT O
findings NNS NNS O
were VBD VBD O
unlikely JJ JJ O
to TO TO O
be VB VB O
the DT DT O
cause NN NN O
of IN IN O
his PRP$ PRP$ O
syncope NN NN O
and CC CC O
agreed VBD VBD O
with IN IN O
continued VBD VBD O
evaluation NN NN O
of IN IN O
cardiac JJ JJ O
etiologies NNS NNS O
. . . O
   
In IN IN O
hospital NN NN O
, , , O
was VBD VBD O
noted VBN VBN O
that IN IN O
pt NN NN O
had VBD VBD O
had VBN VBN O
40 CD CD O
lb NN NN O
weight NN NN O
loss NN NN O
over IN IN O
previous JJ JJ O
months NNS NNS O
. . . O
   
Surgery NNP NNP O
was VBD VBD O
consulted VBN VBN O
regarding VBG VBG O
prompt NN NN O
need VBP VBP O
for IN IN O
intervention NN NN O
of IN IN O
a DT DT O
known VBN VBN O
hernia NN NN O
, , , O
their PRP$ PRP$ O
evaluation NN NN O
was VBD VBD O
that IN IN O
the DT DT O
hernia NN NN O
was VBD VBD O
benign NN NN O
without IN IN O
signs NNS NNS O
of IN IN O
obstruction NN NN O
and CC CC O
there EX EX O
was VBD VBD O
no DT DT O
need NN NN O
for IN IN O
inpatient JJ JJ O
intervention NN NN O
. . . O
   
Endocrine NNP NNP O
w/u NN NN O
included VBD VBD O
nl NN NN O
TSH NNP NNP O
and CC CC O
cortstim NN NN O
. . . O
   
The DT DT O
patient NN NN O
had VBD VBD O
had VBD VBD O
a DT DT O
recent JJ JJ O
Chest NN NN O
and CC CC O
Abd NNP NNP O
CT NNP NNP O
and CC CC O
colonoscopy NN NN O
that WDT WDT O
had VBD VBD O
no DT DT O
evidence NN NN O
of IN IN O
pancreatic JJ JJ O
or CC CC O
colonic JJ JJ O
massess NN NN O
. . . O
   
SPEP NNP NNP O
and CC CC O
BNP NNP NNP O
wnl NN NN O
and CC CC O
; : : O
   
his PRP$ PRP$ O
PSA NNP NNP O
was VBD VBD O
elevated VBN VBN O
at IN IN O
9.56 CD CD O
, , , O
however RB RB O
alk NN NN O
phos NN NN O
, , , O
bone NN NN O
survey NN NN O
, , , O
bone NN NN O
scan NN NN O
were VBD VBD O
all DT DT O
normal JJ JJ O
. . . O
   
The DT DT O
patient NN NN O
's POS POS O
nutrition NN NN O
and CC CC O
PO NNP NNP O
intake NN NN O
improved VBD VBD O
greatly RB RB O
s/p JJ JJ O
treatment NN NN O
for IN IN O
constipation NN NN O
with IN IN O
an DT DT O
aggressive JJ JJ O
bowel NN NN O
regimen NNS NNS O
. . . O
   
Just RB RB O
prior RB RB O
to TO TO O
d/c NN NN O
, , , O
after IN IN O
returning VBG VBG O
from IN IN O
an DT DT O
uncomplicated JJ JJ O
EP NNP NNP O
study NN NN O
the DT DT O
patient NN NN O
started VBD VBD O
to TO TO O
exhibit VB VB O
inappropriate JJ JJ O
behavior NN NN O
( ( ( O
showing VBG VBG O
stool NN NN O
when WRB WRB O
not RB RB O
requested VBN VBN O
to TO TO O
staff NN NN O
) ) ) O
and CC CC O
stating VBG VBG O
bizarre JJ JJ O
thoughts NNS NNS O
"(""" NN NN O
I PRP PRP O
lost VBD VBD O
my PRP$ PRP$ O
mortal NN NN O
soul NN NN O
"""" '' '' O
). NN NN O
   
Psychiatry NNP NNP O
was VBD VBD O
consulted VBN VBN O
and CC CC O
suspected VBN VBN O
the DT DT O
patient NN NN O
was VBD VBD O
having VBG VBG O
a DT DT O
psychotic JJ JJ O
episode NN NN O
in IN IN O
setting VBG VBG O
of IN IN O
prolonged JJ JJ O
hospitalization NN NN O
and CC CC O
multiple JJ JJ O
diagnostic JJ JJ O
interventions NNS NNS O
. . . O
   
It PRP PRP O
was VBD VBD O
concluded VBN VBN O
that IN IN O
an DT DT O
inpatient NN NN O
geri-psych JJ JJ O
hospitalization NN NN O
was VBD VBD O
required VBN VBN O
. . . O
   
Hospitalization NNP NNP O
done VBN VBN O
on IN IN O
Psych NNP NNP O
floor NN NN O
. . . O
   
Per IN IN O
psych NN NN O
eval NN NN O
, , , O
pt NN NN O
had VBD VBD O
been VBN VBN O
withdrawn VBN VBN O
and CC CC O
depressed VBN VBN O
for IN IN O
8 CD CD O
months NNS NNS O
with IN IN O
poor JJ JJ O
sleep NN NN O
, , , O
anhedonia NN NN O
, , , O
and CC CC O
decreased VBD VBD O
energy NN NN O
. . . O
   
The DT DT O
pt NN NN O
believed VBD VBD O
that IN IN O
he PRP PRP O
had VBD VBD O
died VBN VBN O
some DT DT O
time NN NN O
ago RB RB O
and CC CC O
was VBD VBD O
currently RB RB O
in IN IN O
hell NN NN O
. . . O
   
He PRP PRP O
stated VBD VBD O
that IN IN O
he PRP PRP O
had VBD VBD O
been VBN VBN O
feeling VBG VBG O
that IN IN O
he PRP PRP O
had VBD VBD O
sinned VBN VBN O
so RB RB O
horribly RB RB O
, , , O
that IN IN O
God NNP NNP O
could MD MD O
not RB RB O
forgive VB VB O
him PRP PRP O
. . . O
   
He PRP PRP O
stated VBD VBD O
that IN IN O
he PRP PRP O
had VBD VBD O
died VBN VBN O
, , , O
and CC CC O
then RB RB O
further RBR RBR O
stated JJ JJ O
that IN IN O
by IN IN O
this DT DT O
he PRP PRP O
meant VBD VBD O
that IN IN O
though IN IN O
he PRP PRP O
might MD MD O
be VB VB O
physically RB RB O
alive JJ JJ O
, , , O
because IN IN O
he PRP PRP O
could MD MD O
not RB RB O
be VB VB O
forgiven VBN VBN O
, , , O
he PRP PRP O
was VBD VBD O
for IN IN O
all DT DT O
intents NNS NNS O
and CC CC O
purposes NNS NNS O
, , , O
spiritually RB RB O
dead JJ JJ O
. . . O
   
He PRP PRP O
had VBD VBD O
been VBN VBN O
having VBG VBG O
vivid JJ JJ O
dreams NNS NNS O
and CC CC O
had VBD VBD O
been VBN VBN O
told VBN VBN O
that IN IN O
he PRP PRP O
had VBD VBD O
exalted VBN VBN O
himself PRP PRP O
above IN IN O
god NN NN O
and CC CC O
for IN IN O
that DT DT O
would MD MD O
be VB VB O
punished VBN VBN O
. . . O
   
On IN IN O
the DT DT O
inpt NN NN O
ward NN NN O
, , , O
Mr NNP NNP O
. . . O
Shepherd NNP NNP I-PATIENT
was VBD VBD O
started VBN VBN O
on IN IN O
zyprexa NN NN O
5 CD CD O
mg NN NN O
which WDT WDT O
was VBD VBD O
titrated VBN VBN O
up RP RP O
to TO TO O
a DT DT O
dose NN NN O
of IN IN O
20 CD CD O
mg NN NN O
qHS NN NN O
. . . O
   
Cymbalta NNP NNP O
was VBD VBD O
initiated VBN VBN O
and CC CC O
titrated VBN VBN O
up IN IN O
to TO TO O
60mg CD CD O
qDay NN NN O
with IN IN O
gradual JJ JJ O
and CC CC O
signficant JJ JJ O
improvement NN NN O
in IN IN O
his PRP$ PRP$ O
mood NN NN O
. . . O
   
The DT DT O
patient NN NN O
also RB RB O
expressed VBD VBD O
difficulty NN NN O
sleeping VBG VBG O
which WDT WDT O
responded VBD VBD O
to TO TO O
Remeron NNP NNP O
15mg CD CD O
. . . O
   
At IN IN O
the DT DT O
time NN NN O
of IN IN O
discharge NN NN O
, , , O
the DT DT O
patient NN NN O
reported VBD VBD O
good JJ JJ O
appetite NN NN O
, , , O
adequate JJ JJ O
sleep NN NN O
( ( ( O
about IN IN O
8 CD CD O
hours NNS NNS O
a DT DT O
night NN NN O
, , , O
occasional JJ JJ O
awakening VBG VBG O
with IN IN O
nocturia NN NN O
) ) ) O
, , , O
and CC CC O
significant JJ JJ O
improvement NN NN O
of IN IN O
his PRP$ PRP$ O
depression NN NN O
. . . O
   
He PRP PRP O
further RB RB O
noted VBD VBD O
that IN IN O
his PRP$ PRP$ O
thoughts NNS NNS O
of IN IN O
being VBG VBG O
doomed VBN VBN O
to TO TO O
hell NN NN O
were VBD VBD O
still RB RB O
occasionally RB RB O
present JJ JJ O
, , , O
though IN IN O
much RB RB O
less JJR JJR O
intense JJ JJ O
than IN IN O
upon IN IN O
admission NN NN O
, , , O
and CC CC O
he PRP PRP O
reported VBD VBD O
that IN IN O
he PRP PRP O
was VBD VBD O
able JJ JJ O
to TO TO O
challenge VB VB O
this DT DT O
belief NN NN O
"""" '' '' O
most JJS JJS O
of IN IN O
the DT DT O
time NN NN O
. . . O
   
Neuropsych NNP NNP O
testing NN NN O
performed VBN VBN O
during IN IN O
inpt NN NN O
stay NN NN O
showing VBG VBG O
significant JJ JJ O
cognitive JJ JJ O
impairment NN NN O
. . . O
   
He PRP PRP O
had VBD VBD O
global JJ JJ O
deficits NNS NNS O
in IN IN O
language NN NN O
, , , O
memory NN NN O
, , , O
visual-spatial JJ JJ O
abilities NNS NNS O
, , , O
executive NN NN O
functioning VBG VBG O
, , , O
and CC CC O
attention NN NN O
. . . O
   
He PRP PRP O
had VBD VBD O
very RB RB O
poor JJ JJ O
learning NN NN O
of IN IN O
new JJ JJ O
information NN NN O
. . . O
   
Pt NNP NNP O
was VBD VBD O
discharged VBN VBN O
to TO TO O
home NN NN O
with IN IN O
an DT DT O
intake NN NN O
appointment NN NN O
in IN IN O
the DT DT O
Jones NNP NNP I-HOSPITAL
Hospital NNP NNP I-HOSPITAL
Psychiatry NNP NNP O
scheduled VBD VBD O
for IN IN O
the DT DT O
following VBG VBG O
day NN NN O
. . . O
   
He PRP PRP O
has VBZ VBZ O
since IN IN O
followed VBN VBN O
up RP RP O
with IN IN O
Frances NNP NNP I-DOCTOR
Talley NNP NNP I-DOCTOR
, , , O
where WRB WRB O
Zyprexa NNP NNP O
dose VBD VBD O
slowly RB RB O
tapered VBN VBN O
to TO TO O
decrease VB VB O
grogginess NN NN O
. . . O
   
Today NN NN O
, , , O
patient NN NN O
reports NNS NNS O
improved VBN VBN O
mood NN NN O
, , , O
no RB RB O
longer RB RB O
feels VBZ VBZ O
down RB RB O
, , , O
no RB RB O
longer RB RB O
feels VBZ VBZ O
guilty JJ JJ O
, , , O
as IN IN O
though IN IN O
in IN IN O
hell NN NN O
. . . O
   
Has VBZ VBZ O
continued VBN VBN O
to TO TO O
taper VB VB O
down RB RB O
Zyprexa NNP NNP O
to TO TO O
3.75mg CD CD O
QHS NNP NNP O
. . . O
   
Saw VBD VBD O
Dr NNP NNP O
. . . O
Nobles NNP NNP I-DOCTOR
on IN IN O
Wednesday NNP NNP I-DATE
, , , O
felt VBD VBD O
that IN IN O
patient NN NN O
should MD MD O
continue VB VB O
to TO TO O
stay VB VB O
on IN IN O
low JJ JJ O
dose NN NN O
Zyprexa NNP NNP O
for IN IN O
now RB RB O
. . . O
   
Pt NNP NNP O
as IN IN O
fell VBD VBD O
has VBZ VBZ O
been VBN VBN O
tapering VBG VBG O
down RB RB O
Cymbalta NNP NNP O
as IN IN O
well RB RB O
, , , O
taking VBG VBG O
it PRP PRP O
QOD NNP NNP O
. . . O
   
Reports NNS NNS O
some DT DT O
intermittent JJ JJ O
aches NNS NNS O
in IN IN O
right NN NN O
groin NN NN O
secondary JJ JJ O
to TO TO O
inguinal JJ JJ O
hernia NN NN O
. . . O
   
Awaiting NNP NNP O
appt NN NN O
with IN IN O
Dr NNP NNP O
. . . O
Small JJ JJ I-DOCTOR
-- : : O
Sept NNP NNP I-DATE
15th CD CD I-DATE
. . . O
   
Bowel NNP NNP O
movements NNS NNS O
much RB RB O
better JJR JJR O
, , , O
going VBG VBG O
2-3 JJ JJ O
times NNS NNS O
per IN IN O
day NN NN O
. . . O
   
Taking VBG VBG O
lots NNS NNS O
of IN IN O
fruits NNS NNS O
and CC CC O
vegetables NNS NNS O
. . . O
   
Only RB RB O
occasional JJ JJ O
constipation NN NN O
. . . O
   
No DT DT O
abdominal JJ JJ O
pain NN NN O
No DT DT O
more JJR JJR O
syncopal JJ JJ O
episodes NNS NNS O
ROS NNP NNP O
: : : O
General NNP NNP O
: : : O
Energy NNP NNP O
level NN NN O
fair JJ JJ O
, , , O
has VBZ VBZ O
gained VBN VBN O
20 CD CD O
lbs NN NN O
since IN IN O
discharge NN NN O
Skin NNP NNP O
: : : O
No DT DT O
rashes NNS NNS O
, , , O
lesions NNS NNS O
HEENT NNP NNP O
: : : O
No DT DT O
eye NN NN O
pain NN NN O
, , , O
spots NNS NNS O
, , , O
flashes NNS NNS O
of IN IN O
light JJ JJ O
, , , O
no DT DT O
new JJ JJ O
ear JJ JJ O
pain NN NN O
Cardiac NNP NNP O
: : : O
no DT DT O
chest NN NN O
discomfort NN NN O
no DT DT O
palpitations NNS NNS O
Pulmonary NNP NNP O
: : : O
No DT DT O
DOE NNP NNP O
, , , O
no DT DT O
chronic JJ JJ O
cough NN NN O
GI NNP NNP O
: : : O
little JJ JJ O
constipation NN NN O
no UH UH O
, , , O
no DT DT O
diarrhea NN NN O
GU NNP NNP O
: : : O
4-5x JJ JJ O
nocturia NN NN O
. . . O
   
Not RB RB O
worsening VBG VBG O
. . . O
   
Will NNP NNP O
f/u VB VB O
at IN IN O
FHV NNP NNP I-HOSPITAL
with IN IN O
urologist NN NN O
. . . O
   
Musculoskeletal NNP NNP O
: : : O
no DT DT O
significant JJ JJ O
pains NNS NNS O
Neurological NNP NNP O
: : : O
no DT DT O
motor/sensory NN NN O
problems NNS NNS O
PMH NNP NNP O
: : : O
   
1 CD CD O
. . . O
NIDDM NNP NNP O
. . . O
   
Had NNP NNP O
had VBD VBD O
DM NNP NNP O
for IN IN O
> NN NN O
15 CD CD O
yrs NN NN O
   
2 CD CD O
. . . O
HTN NNP NNP O
x SYM SYM O
yrs NN NN O
   
3 CD CD O
. . . O
Hyperlipidemia NNP NNP O
   
4 CD CD O
. . . O
BPH NNP NNP O
   
5 CD CD O
. . . O
Diverticulosis NNP NNP O
( ( ( O
noted VBD VBD O
on IN IN O
abd NN NN O
CT NNP NNP O
) ) ) O
   
6 CD CD I-AGE
. . . O
Basal NNP NNP O
cell NN NN O
carcinoma NN NN O
excisions NNS NNS O
on IN IN O
chest NN NN O
: : : O
followed VBN VBN O
by IN IN O
dermatologist NN NN O
   
7 CD CD O
. . . O
Carotids NNP NNP O
Stenosis NNP NNP O
   
8 CD CD O
. . . O
Claudication NNP NNP O
: : : O
walks VBZ VBZ O
a DT DT O
couple NN NN O
blocks NNS NNS O
before IN IN O
begins VBZ VBZ O
feeling NN NN O
cramps NNS NNS O
in IN IN O
leg NN NN O
   
9 CD CD O
. . . O
Glaucoma NNP NNP O
   
10 CD CD O
. . . O
Inguinal NNP NNP O
Hernia NNP NNP O
: : : O
9/93 CD CD I-DATE
pending VBG VBG O
surgery NN NN O
   
11 CD CD O
. . . O
? . . O
Ventral NNP NNP O
hernia NN NN O
12 CD CD O
: : : O
Depression NNP NNP O
13 CD CD O
: : : O
Psychosis NNP NNP O
14 CD CD O
: : : O
Insomnia NNP NNP O
Medications NNP NNP O
: : : O
Acetylsalicylic JJ JJ O
Acid NNP NNP O
( ( ( O
Aspirin NNP NNP O
) ) ) O
325 CD CD O
MG NNP NNP O
PO NNP NNP O
QD NNP NNP O
Cilostazol NNP NNP O
100 CD CD O
MG NNP NNP O
PO NNP NNP O
QD NNP NNP O
Brimonidine NNP NNP O
Tartrate NNP NNP O
1 CD CD O
DROP NNP NNP O
OU NNP NNP O
BID NNP NNP O
Multivitamins NNP NNP O
( ( ( O
Mvi NNP NNP O
) ) ) O
1 CD CD O
TAB NNP NNP O
PO NNP NNP O
QD NNP NNP O
Simvastatin NNP NNP O
80 CD CD O
MG NNP NNP O
PO NNP NNP O
QD NNP NNP O
Lisinopril NNP NNP O
40 CD CD O
MG NNP NNP O
PO NNP NNP O
QD NNP NNP O
Docusate NNP NNP O
Sodium NNP NNP O
( ( ( O
Colace NNP NNP O
) ) ) O
100 CD CD O
MG NNP NNP O
PO NNP NNP O
TID NNP NNP O
Olanzapine NNP NNP O
( ( ( O
Zyprexa NNP NNP O
) ) ) O
3.75 CD CD O
MG NNP NNP O
PO NNP NNP O
QHS NNP NNP O
Polyethylene NNP NNP O
Glycol NNP NNP O
( ( ( O
Miralax NNP NNP O
) ) ) O
17 CD CD O
GM NNP NNP O
PO NNP NNP O
QD NNP NNP O
Bisacodyl NNP NNP O
Rectal NNP NNP O
( ( ( O
Dulcolax NNP NNP O
Rectal NNP NNP O
) ) ) O
10 CD CD O
MG NNP NNP O
PR NNP NNP O
QD NNP NNP O
prn NN NN O
[ NN NN O
constipation NN NN O
] NN NN O
Duloxetine NNP NNP O
60 CD CD O
MG NNP NNP O
PO NNP NNP O
QOD NNP NNP O
Metoprolol NNP NNP O
Succinate NNP NNP O
Extended NNP NNP O
Release NNP NNP O
( ( ( O
Toprol NNP NNP O
Xl NNP NNP O
) ) ) O
100 CD CD O
MG NNP NNP O
PO NNP NNP O
QD NNP NNP O
Amlodipine NNP NNP O
( ( ( O
Norvasc NNP NNP O
) ) ) O
2.5 CD CD O
MG NNP NNP O
PO NNP NNP O
QD NNP NNP O
Mirtazapine NNP NNP O
( ( ( O
Remeron NNP NNP O
) ) ) O
15 CD CD O
MG NNP NNP O
PO NNP NNP O
Q NNP NNP O
bedtime NN NN O
prn NN NN O
[ NN NN O
insomnia NN NN O
] NN NN O
Terazosin NNP NNP O
Hcl NNP NNP O
5 CD CD O
MG NNP NNP O
PO NNP NNP O
QD NNP NNP O
Metformin NNP NNP O
500 CD CD O
MG NNP NNP O
PO NNP NNP O
QD NNP NNP O
Allergies NNP NNP O
: : : O
NKDA NNP NNP O
Habits NNP NNP O
: : : O
Smoking NNP NNP O
: : : O
Not RB RB O
currently RB RB O
, , , O
former JJ JJ O
smoker NN NN O
6yo CD CD O
until IN IN O
age NN NN O
   
45 CD CD I-AGE
. . . O
1ppd CD CD O
EtOH NNP NNP O
: : : O
Not RB RB O
currently RB RB O
. . . O
   
Used VBN VBN O
to TO TO O
drink VB VB O
socially RB RB O
Illicits NNP NNP O
: : : O
None NN NN O
Diet NNP NNP O
: : : O
lots NNS NNS O
of IN IN O
fruits NNS NNS O
and CC CC O
vegetables NNS NNS O
Exercise NNP NNP O
: : : O
walks VBZ VBZ O
0.5 CD CD O
to TO TO O
1 CD CD O
mile/day NN NN O
Health NNP NNP O
Maintenance NNP NNP O
: : : O
Pneumovax NNP NNP O
: : : O
Have VBP VBP O
had VBN VBN O
in IN IN O
past JJ JJ O
Influenza NNP NNP O
Vaccine NNP NNP O
: : : O
Gets VBZ VBZ O
flu NN NN O
vaccine NN NN O
each DT DT O
year NN NN O
Colonoscopy NNP NNP O
: : : O
Done VBN VBN O
in IN IN O
2094 CD CD I-DATE
showing VBG VBG O
only RB RB O
mild NN NN O
sigmoid NN NN O
tics NNS NNS O
Pap NNP NNP O
test NN NN O
: : : O
n/a NN NN O
Mammograms NNP NNP O
: : : O
n/a NN NN O
Dex NNP NNP O
screening VBG VBG O
: : : O
never RB RB O
Dental NNP NNP O
: : : O
Sees VBZ VBZ O
dentist NN NN O
Dr NNP NNP O
. . . O
Uecker NNP NNP I-DOCTOR
every DT DT O
few JJ JJ O
years NNS NNS O
Opthalmologic NNP NNP O
: : : O
Sees VBZ VBZ O
yearly RB RB O
through IN IN O
FHV NNP NNP I-HOSPITAL
Functional NNP NNP O
Status NNP NNP O
: : : O
ADLs NNP NNP O
: : : O
independent JJ JJ O
IADLs NNP NNP O
: : : O
independent JJ JJ O
Mobility NNP NNP O
: : : O
independent JJ JJ O
HCP NNP NNP O
: : : O
Wife NN NN O
, , , O
Ernestine NNP NNP I-PATIENT
is VBZ VBZ O
primary JJ JJ O
proxy NN NN O
. . . O
   
Alternative NNP NNP O
is VBZ VBZ O
daughter NN NN O
, , , O
Teresa NNP NNP I-PATIENT
Berry NNP NNP I-PATIENT
. . . O
   
Code NNP NNP O
Status NNP NNP O
: : : O
Has VBZ VBZ O
not RB RB O
decided VBN VBN O
as IN IN O
of IN IN O
yet RB RB O
. . . O
   
FH NNP NNP O
: : : O
NC NNP NNP O
SH NNP NNP O
: : : O
Born VBN VBN O
in IN IN O
Bryan NNP NNP I-CITY
. . . O
   
Raised NNP NNP O
in IN IN O
Shirley NNP NNP I-CITY
, , , O
Il NNP NNP I-STATE
. . . O
   
Currently RB RB O
lives VBZ VBZ O
in IN IN O
Shirley NNP NNP I-CITY
. . . O
   
Married NNP NNP O
for IN IN O
53 CD CD O
years NNS NNS O
with IN IN O
6 CD CD I-AGE
children NNS NNS O
and CC CC O
7 CD CD O
grandchildren NNS NNS O
. . . O
   
PE NNP NNP O
: : : O
Vitals NNP NNP O
: : : O
96.4 CD CD O
, , , O
80 CD CD O
, , , O
120/60 CD CD O
, , , O
20 CD CD O
, , , O
195.8Gen: CD CD O
NAD NNP NNP O
, , , O
Ox3 NNP NNP O
, , , O
Alert NNP NNP O
, , , O
pleasant JJ JJ O
, , , O
normal JJ JJ O
affect NN NN O
, , , O
normal JJ JJ O
thought NN NN O
process NN NN O
and CC CC O
content NN NN O
, , , O
denies NNS NNS O
AH NNP NNP O
, , , O
VH NNP NNP O
, , , O
SI NNP NNP O
. . . O
   
Able JJ JJ O
to TO TO O
spell VB VB O
"""" '' '' O
world NN NN O
"""" '' '' O
backwards JJ JJ O
HEENT NNP NNP O
: : : O
PERRL NNP NNP O
, , , O
EOMI NNP NNP O
, , , O
OP NNP NNP O
clear JJ JJ O
, , , O
TM NNP NNP O
well RB RB O
visualized VBD VBD O
, , , O
minimal JJ JJ O
cerumen NNS NNS O
, , , O
no DT DT O
thyromegaly NN NN O
, , , O
JVP NNP NNP O
7cm CD CD O
Chest NN NN O
: : : O
CTA NNP NNP O
b/l NN NN O
Heart NNP NNP O
: : : O
RRR NNP NNP O
occasional JJ JJ O
premature NN NN O
beats NNS NNS O
, , , O
normal JJ JJ O
s1 NN NN O
an DT DT O
s2 NN NN O
, , , O
? . . O
S4 NNP NNP O
Abd NNP NNP O
: : : O
obese NN NN O
, , , O
distended VBD VBD O
, , , O
soft JJ JJ O
, , , O
umbilical/ventral JJ JJ O
hernia NN NN O
, , , O
reducible JJ JJ O
, , , O
no DT DT O
organomegaly NN NN O
Ext NNP NNP O
: : : O
1 CD CD O
+ NN NN O
edema NN NN O
b/l NN NN O
, , , O
no DT DT O
decreased VBN VBN O
sensation NN NN O
to TO TO O
pin VB VB O
prick NN NN O
, , , O
distal JJ JJ O
legs NNS NNS O
hairless NN NN O
, , , O
1 CD CD O
+ NN NN O
DP NNP NNP O
pulses NNS NNS O
b/l NN NN O
, , , O
venous JJ JJ O
stasis NN NN O
changes NNS NNS O
, , , O
no DT DT O
ulcers NNS NNS O
Skin NNP NNP O
: : : O
No DT DT O
rashes NNS NNS O
Neuro NNP NNP O
: : : O
CN NNP NNP O
2-12 JJ JJ O
intact JJ JJ O
. . . O
   
Mild NNP NNP O
left VBD VBD O
sided JJ JJ O
facial JJ JJ O
droop NN NN O
, , , O
mild NN NN O
left VBD VBD O
ptosis NNS NNS O
, , , O
mild NN NN O
left VBD VBD O
decrement JJ JJ O
on IN IN O
eyebrow NN NN O
raise NN NN O
, , , O
otherwise RB RB O
grossly RB RB O
WNL NNP NNP O
. . . O
   
Groin NNP NNP O
: : : O
right RB RB O
reducible JJ JJ O
inguinal JJ JJ O
hernia NN NN O
into IN IN O
scrotum NN NN O
. . . O
   
BS NNP NNP O
appreciated VBD VBD O
, , , O
NT NNP NNP O
. . . O
   
Rectal NNP NNP O
: : : O
large JJ JJ O
, , , O
soft JJ JJ O
prostate NN NN O
, , , O
heme NN NN O
neg NN NN O
stool NN NN O
Labs NNP NNP O
: : : O
Pending NNP NNP O
EKG NNP NNP O
: : : O
NSR NNP NNP O
with IN IN O
sinus NN NN O
arrhythmia NN NN O
, , , O
QRS NNP NNP O
widening VBG VBG O
, , , O
left VBD VBD O
axis NNS NNS O
, , , O
poor JJ JJ O
r LS LS O
wave JJ JJ O
progression NN NN O
, , , O
criteria NNS NNS O
for IN IN O
LVH NNP NNP O
Impression NNP NNP O
: : : O
78 CD CD I-AGE
yo NN NN O
man NN NN O
with IN IN O
psychosis NN NN O
, , , O
depression NN NN O
, , , O
syncopal JJ JJ O
episodes NNS NNS O
markedly RB RB O
improved VBN VBN O
s/p NN NN O
Psych NNP NNP O
stay VB VB O
with IN IN O
psychpharm NN NN O
, , , O
now RB RB O
with IN IN O
weight NN NN O
gain NN NN O
. . . O
   
Encouraged NNP NNP O
continued VBD VBD O
intake NN NN O
of IN IN O
psych NN NN O
medications NNS NNS O
, , , O
continued VBD VBD O
psych NN NN O
f/u NN NN O
Plan NNP NNP O
: : : O
   
1 CD CD O
. . . O
Depression NNP NNP O
: : : O
Continues NNP NNP O
on IN IN O
Remeron NNP NNP O
and CC CC O
CYmbalta NNP NNP O
. . . O
   
Encouraged NNP NNP O
not RB RB O
to TO TO O
completely RB RB O
d/c NN NN O
Cymbalta NNP NNP O
just RB RB O
b/c NN NN O
is VBZ VBZ O
feeling VBG VBG O
better JJR JJR O
. . . O
   
Dr NNP NNP O
. . . O
Nobles NNP NNP I-DOCTOR
to TO TO O
follow VB VB O
. . . O
   
Appears VBZ VBZ O
willing JJ JJ O
to TO TO O
take VB VB O
Remeron NNP NNP O
as IN IN O
he PRP PRP O
feels VBZ VBZ O
it PRP PRP O
helps VBZ VBZ O
him PRP PRP O
with IN IN O
sleep NN NN O
. . . O
   
I PRP PRP O
am VBP VBP O
concerned VBN VBN O
that DT DT O
patient NN NN O
feels VBZ VBZ O
as IN IN O
though IN IN O
his PRP$ PRP$ O
depression NN NN O
was VBD VBD O
"""" '' '' O
just RB RB O
a DT DT O
phase NN NN O
"""" '' '' O
and CC CC O
that IN IN O
his PRP$ PRP$ O
d/c'ing NN NN O
of IN IN O
medications NNS NNS O
will MD MD O
lead VB VB O
to TO TO O
symptom JJ JJ O
recurrence NN NN O
. . . O
   
Will NNP NNP O
reinforce VB VB O
this DT DT O
. . . O
   
Will NNP NNP O
call VB VB O
him PRP PRP O
in IN IN O
1-2 JJ JJ O
wks NN NN O
for IN IN O
f/u NN NN O
. . . O
   
2 CD CD O
. . . O
Psychosis NNP NNP O
: : : O
no RB RB O
longer RB RB O
feels VBZ VBZ O
guilty JJ JJ O
, , , O
does VBZ VBZ O
not RB RB O
think VB VB O
he PRP PRP O
is VBZ VBZ O
in IN IN O
hell NN NN O
. . . O
   
Again RB RB O
, , , O
have VBP VBP O
encouraged VBN VBN O
pt NN NN O
not RB RB O
to TO TO O
stop VB VB O
Zyprexa NNP NNP O
completely RB RB O
. . . O
   
He PRP PRP O
will MD MD O
try VB VB O
to TO TO O
get VB VB O
outpt NN NN O
f/u NN NN O
at IN IN O
the DT DT O
FHV NNP NNP I-HOSPITAL
as IN IN O
well RB RB O
   
3 CD CD O
. . . O
Insomnia NNP NNP O
: : : O
Improved NNP NNP O
vs NNS NNS O
b/l NN NN O
on IN IN O
Remeron NNP NNP O
. . . O
   
Goes VBZ VBZ O
to TO TO O
bed NN NN O
late JJ JJ O
~3-4am JJ JJ O
and CC CC O
wakes NNS NNS O
at IN IN O
12noon CD CD O
. . . O
   
Watches NNP NNP O
a DT DT O
lot NN NN O
of IN IN O
TV NN NN O
. . . O
   
This DT DT O
schedule NN NN O
not RB RB O
new JJ JJ O
. . . O
   
Encouraged NNP NNP O
going VBG VBG O
to TO TO O
bed NN NN O
earlier RBR RBR O
. . . O
   
4 CD CD O
. . . O
Syncope NNP NNP O
: : : O
no DT DT O
further JJ JJ O
episodes NNS NNS O
. . . O
   
No DT DT O
pre-syncopal JJ JJ O
episodes NNS NNS O
either CC CC O
. . . O
   
Saw VBD VBD O
cardiologist NN NN O
yesterday NN NN O
, , , O
Dr NNP NNP O
. . . O
Benjamin NNP NNP I-DOCTOR
. . . O
   
Event NN NN O
recorder NN NN O
just RB RB O
with IN IN O
one CD CD O
episode NN NN O
of IN IN O
sinus NN NN O
brady NN NN O
at IN IN O
40 CD CD O
during IN IN O
sleep NN NN O
. . . O
   
Cards NNP NNP O
to TO TO O
continue VB VB O
following VBG VBG O
   
5 CD CD O
. . . O
Constipation NNP NNP O
: : : O
much RB RB O
improved VBN VBN O
on IN IN O
bowel NN NN O
regimen NNS NNS O
with IN IN O
increased VBN VBN O
fiber NN NN O
intake NN NN O
   
6 CD CD I-AGE
. . . O
Hernia NNP NNP O
: : : O
To TO TO O
see VB VB O
Dr NNP NNP O
. . . O
Small JJ JJ I-DOCTOR
for IN IN O
repair NN NN O
of IN IN O
inguinal NN NN O
hernia NN NN O
   
7 CD CD O
. . . O
CAD NNP NNP O
: : : O
continue VB VB O
ASA NNP NNP O
, , , O
BB NNP NNP O
, , , O
ACEI NNP NNP O
. . . O
   
CP NNP NNP O
free JJ JJ O
. . . O
   
NTD NNP NNP O
for IN IN O
now RB RB O
   
8 CD CD O
. . . O
Hyperlipidemia NNP NNP O
: : : O
fasting VBG VBG O
lipid NN NN O
panel NN NN O
today NN NN O
   
9 CD CD O
. . . O
DM NNP NNP O
: : : O
Will NNP NNP O
get VB VB O
A1c NNP NNP O
today NN NN O
. . . O
   
Urine NNP NNP O
microalbumin NN NN O
and CC CC O
creatinine NN NN O
. . . O
   
Patient NNP NNP O
rarely RB RB O
checks NNS NNS O
blood NN NN O
sugars NNS NNS O
. . . O
   
No DT DT O
known VBN VBN O
retinal JJ JJ O
disease NN NN O
or CC CC O
nephropathy NN NN O
at IN IN O
this DT DT O
time NN NN O
. . . O
   
10 CD CD O
. . . O
HTN NNP NNP O
: : : O
BP NNP NNP O
today NN NN O
120/60 CD CD O
. . . O
   
No DT DT O
changes NNS NNS O
in IN IN O
medication NN NN O
today NN NN O
   
11 CD CD O
. . . O
Frequency NNP NNP O
: : : O
have VBP VBP O
recommended VBN VBN O
change NN NN O
to TO TO O
Flomax NNP NNP O
from IN IN O
Terazosin NNP NNP O
if IN IN O
patient NN NN O
desires NNS NNS O
. . . O
   
Also RB RB O
can MD MD O
add VB VB O
Proscar NNP NNP O
. . . O
   
Pt NNP NNP O
will MD MD O
discuss VB VB O
with IN IN O
FHV NNP NNP I-HOSPITAL
physician NN NN O
. . . O
   
12 CD CD O
. . . O
Elevated NNP NNP O
PSA NNP NNP O
: : : O
Hx NNP NNP O
of IN IN O
PSA NNP NNP O
~ NN NN O
9.5 CD CD O
. . . O
   
Has VBZ VBZ O
gotten VBN VBN O
biopsy NN NN O
at IN IN O
FHV NNP NNP I-HOSPITAL
, , , O
WNL NNP NNP O
. . . O
   
Bone NNP NNP O
scan JJ JJ O
WNL NNP NNP O
. . . O
   
Pt NNP NNP O
would MD MD O
like VB VB O
redraw NN NN O
today NN NN O
. . . O
   
Will NNP NNP O
follow VB VB O
PSA NNP NNP O
velocity NN NN O
   
13 CD CD O
. . . O
Health NNP NNP O
maintenance NN NN O
: : : O
Pneumovax NNP NNP O
gotten VBN VBN O
thru NN NN O
FHV NNP NNP I-HOSPITAL
. . . O
   
return NN NN O
in IN IN O
8 CD CD O
wks NN NN O
for IN IN O
flu NN NN O
shot NN NN O
. . . O
   
Has VBZ VBZ O
had VBN VBN O
colo NN NN O
14 CD CD O
: : : O
Social NNP NNP O
work NN NN O
visit NN NN O
today NN NN O
with IN IN O
Nikki NNP NNP I-DOCTOR
Devine NNP NNP I-DOCTOR
   
15 CD CD O
. . . O
RTC NNP NNP O
in IN IN O
10 CD CD O
weeks NNS NNS O
. . . O
   
To TO TO O
see VB VB O
Dr NNP NNP O
Nobles NNP NNP I-DOCTOR
in IN IN O
interim JJ JJ O
as RB RB O
well RB RB O
as IN IN O
cardiology NN NN O
. . . O
   
Yusuf NNP NNP I-DOCTOR
Lugo NNP NNP I-DOCTOR
, , , O
MD NNP NNP O
, , , O
42390 CD CD I-PHONE
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2091-06-12 NN NN I-DATE
Narrative NNP NNP O
History NN NN O
79 CD CD I-AGE
yo NN NN O
woman NN NN O
who WP WP O
presents VBZ VBZ O
for IN IN O
f/u NN NN O
of IN IN O
: : : O
   
1 CD CD O
. . . O
Urinary NNP NNP O
incontinence NN NN O
: : : O
She PRP PRP O
is VBZ VBZ O
s/p JJ JJ O
vaginal JJ JJ O
sling VBG VBG O
procedure NN NN O
by IN IN O
Dr NNP NNP O
. . . O
Xuereb NNP NNP I-DOCTOR
in IN IN O
April NNP NNP I-DATE
. . . O
   
She PRP PRP O
states VBZ VBZ O
that IN IN O
she PRP PRP O
did VBD VBD O
well RB RB O
for IN IN O
about IN IN O
2 CD CD O
weeks NNS NNS O
, , , O
but CC CC O
then RB RB O
the DT DT O
incontinence NN NN O
became VBD VBD O
worse JJR JJR O
than IN IN O
before IN IN O
. . . O
   
According VBG VBG O
to TO TO O
her PRP$ PRP$ O
son NN NN O
, , , O
she PRP PRP O
saw VBD VBD O
Dr NNP NNP O
. . . O
Xuereb NNP NNP I-DOCTOR
10 CD CD O
days NNS NNS O
ago RB RB O
who WP WP O
thought VBD VBD O
the DT DT O
procedure NN NN O
was VBD VBD O
a DT DT O
success NN NN O
but CC CC O
that IN IN O
the DT DT O
pt NN NN O
had VBD VBD O
a DT DT O
UTI NNP NNP O
. . . O
   
She PRP PRP O
started VBD VBD O
her PRP PRP O
on IN IN O
a DT DT O
month-long JJ JJ O
course NN NN O
of IN IN O
nitrofurantoin NN NN O
. . . O
   
2 CD CD O
. . . O
PAF NNP NNP O
: : : O
The DT DT O
pt NN NN O
has VBZ VBZ O
not RB RB O
noted VBN VBN O
any DT DT O
cardiac JJ JJ O
symptoms NNS NNS O
. . . O
   
3 CD CD O
. . . O
PMR NNP NNP O
: : : O
Her PRP$ PRP$ O
shoulder NN NN O
pain NN NN O
and CC CC O
weakness NN NN O
has VBZ VBZ O
disappeared VBN VBN O
since IN IN O
starting VBG VBG O
the DT DT O
Prednisone NNP NNP O
. . . O
   
She PRP PRP O
has VBZ VBZ O
noted VBN VBN O
some DT DT O
facial JJ JJ O
puffiness NN NN O
since IN IN O
the DT DT O
medication NN NN O
was VBD VBD O
begun VBN VBN O
. . . O
   
She PRP PRP O
is VBZ VBZ O
being VBG VBG O
followed VBN VBN O
in IN IN O
Rheum NNP NNP O
by IN IN O
Dr NNP NNP O
. . . O
Lisa NNP NNP I-DOCTOR
Inge NNP NNP I-DOCTOR
. . . O
   
4 CD CD O
. . . O
Mental NNP NNP O
status NN NN O
: : : O
She PRP PRP O
underwent JJ JJ O
neuropsychiatric JJ JJ O
testing NN NN O
at IN IN O
BMA NNP NNP I-HOSPITAL
3 CD CD O
days NNS NNS O
ago RB RB O
and CC CC O
the DT DT O
results NNS NNS O
have VBP VBP O
been VBN VBN O
faxed VBN VBN O
to TO TO O
BH NNP NNP I-HOSPITAL
. . . O
   
5 CD CD O
. . . O
Social NNP NNP O
: : : O
She PRP PRP O
is VBZ VBZ O
currently RB RB O
living VBG VBG O
in IN IN O
Forest NNP NNP I-HOSPITAL
Hills NNP NNP I-HOSPITAL
, , , O
an DT DT O
assisted VBN VBN O
living VBG VBG O
facility NN NN O
. . . O
   
She PRP PRP O
has VBZ VBZ O
her PRP$ PRP$ O
own JJ JJ O
bedroom NN NN O
and CC CC O
sitting VBG VBG O
room NN NN O
and CC CC O
can MD MD O
shut VB VB O
her PRP$ PRP$ O
door NN NN O
for IN IN O
privacy NN NN O
. . . O
   
All DT DT O
meals NNS NNS O
are VBP VBP O
provided VBN VBN O
for IN IN O
her PRP PRP O
. . . O
   
She PRP PRP O
enjoys VBZ VBZ O
the DT DT O
room NN NN O
but CC CC O
at IN IN O
times NNS NNS O
feels VBZ VBZ O
"""" '' '' O
confined VBN VBN O
. . . O
"""" '' '' O
She PRP PRP O
had VBD VBD O
befriended VBN VBN O
a DT DT O
90 CD CD I-AGE
yo NN NN O
male JJ JJ O
patient NN NN O
, , , O
but CC CC O
recently RB RB O
had VBD VBD O
a DT DT O
bad JJ JJ O
experience NN NN O
when WRB WRB O
he PRP PRP O
made VBD VBD O
sexual JJ JJ O
advances NNS NNS O
toward IN IN O
her PRP PRP O
. . . O
   
She PRP PRP O
states VBZ VBZ O
that IN IN O
she PRP PRP O
would MD MD O
like VB VB O
to TO TO O
move VB VB O
back RB RB O
into IN IN O
her PRP$ PRP$ O
apartment NN NN O
in IN IN O
Stow NNP NNP I-CITY
. . . O
   
Problems NNS NNS O
Urinary NNP NNP O
incontinence NN NN O
s/p NN NN O
sling VBG VBG O
procedure NN NN O
in IN IN O
4/91 CD CD I-DATE
; : : O
   
s/p NN NN O
3 CD CD O
prior RB RB O
bladder NN NN O
suspension NN NN O
surgeries NNS NNS O
Hypertension NNP NNP O
Depression NNP NNP O
Elevated NNP NNP O
cholesterol NN NN O
Diarrhea NNP NNP O
Polymyalgia NNP NNP O
rheumatica NN NN O
diagnosed VBD VBD O
in IN IN O
1/91 CD CD I-DATE
S/P NNP NNP O
rectocele NN NN O
repair NN NN O
Paroxysmal NNP NNP O
atrial JJ JJ O
fibrillation NN NN O
controlled VBN VBN O
with IN IN O
medication NN NN O
Peripheral NNP NNP O
neuropathy NN NN O
unclear JJ JJ O
etiology NN NN O
Hyperlipidemia NNP NNP O
H/O NNP NNP O
Alcohol NNP NNP O
abuse NN NN O
S/P NNP NNP O
urosepsis NN NN O
admission NN NN O
in IN IN O
9/90 CD CD I-DATE
chronic JJ JJ O
diarrhea NN NN O
colonoscopy NN NN O
attempted VBD VBD O
in IN IN O
9/90 CD CD I-DATE
but CC CC O
pt NN NN O
not RB RB O
able JJ JJ O
to TO TO O
tolerate VB VB O
procedure NN NN O
Dementia NNP NNP O
Mild-moderate NNP NNP O
; : : O
   
neuropsychiatric JJ JJ O
test NN NN O
done VBN VBN O
in IN IN O
5/91 CD CD I-DATE
Medications NNP NNP O
FOLIC NNP NNP O
ACID NNP NNP O
1MG CD CD O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
ECOTRIN NNP NNP O
( ( ( O
ASPIRIN NNP NNP O
ENTERIC NNP NNP O
COATED NNP NNP O
) ) ) O
325MG CD CD O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
REMERON NNP NNP O
( ( ( O
MIRTAZAPINE NNP NNP O
) ) ) O
15MG CD CD O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QHS NNP NNP O
METOPROLOL NNP NNP O
TARTRATE NNP NNP O
50MG CD CD O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
TID NNP NNP O
SOTALOL NNP NNP O
80MG CD CD O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
BID NNP NNP O
THIAMINE NNP NNP O
HCL NNP NNP O
100MG CD CD O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
PREDNISONE NNP NNP O
12.5MG CD CD O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QAM NNP NNP O
VIOXX NNP NNP O
( ( ( O
ROFECOXIB NNP NNP O
) ) ) O
12.5MG CD CD O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
PRN NNP NNP O
. . . O
   
DIGOXIN NNP NNP O
0.125MG CD CD O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
FERROUS NNP NNP O
SULFATE NNP NNP O
325MG CD CD O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
MVI NNP NNP O
( ( ( O
MULTIVITAMINS NNP NNP O
) ) ) O
1 CD CD O
CAPSULE NNP NNP O
PO NNP NNP O
QD NNP NNP O
CALCIUM NNP NNP O
CARBONATE NNP NNP O
VIT NNP NNP O
D(1TABLET=250MG NNP NNP O
E. NN NN O
   
. . . O
   
. . . O
   
500 CD CD O
MG NNP NNP O
PO NNP NNP O
TID NNP NNP O
FOSAMAX NNP NNP O
( ( ( O
ALENDRONATE NNP NNP O
) ) ) O
70MG CD CD O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QWEEK NNP NNP O
NITROFURANTOIN NNP NNP O
100MG CD CD O
1 CD CD O
Capsule NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Allergies NNP NNP O
NKDA NNP NNP O
Review NNP NNP O
of IN IN O
Systems NNPS NNPS O
No DT DT O
change NN NN O
in IN IN O
appetite NN NN O
. . . O
   
No DT DT O
F/C NNP NNP O
, , , O
cough NN NN O
, , , O
SOB NNP NNP O
, , , O
CP NNP NNP O
, , , O
abd NN NN O
pain NN NN O
, , , O
diarrhea NN NN O
, , , O
constipation NN NN O
, , , O
dysuria NN NN O
, , , O
or CC CC O
joint JJ JJ O
pains NNS NNS O
. . . O
   
Physical JJ JJ O
Exam NNP NNP O
BP NNP NNP O
: : : O
140/80 CD CD O
Weight NNP NNP O
: : : O
133 CD CD O
lbs NN NN O
( ( ( O
up RB RB O
15 CD CD O
lbs NN NN O
since IN IN O
12/90 CD CD I-DATE
) ) ) O
General NNP NNP O
Appearance NNP NNP O
Appears VBZ VBZ O
healthy JJ JJ O
; : : O
   
facial JJ JJ O
swelling VBG VBG O
. . . O
   
Cor/Cardiac NNP NNP O
RRR NNP NNP O
; : : O
   
S1S2 NNP NNP O
with IN IN O
II/VI NNP NNP O
SEM NNP NNP O
at IN IN O
LLSB NNP NNP O
; : : O
   
no DT DT O
rubs NN NN O
or CC CC O
gallops NNS NNS O
. . . O
   
Laboratory NNP NNP O
Data NNP NNP O
Neuropsychiatric NNP NNP O
testing NN NN O
( ( ( O
summary NN NN O
of IN IN O
results NNS NNS O
) ) ) O
: : : O
Dementia NNP NNP O
of IN IN O
mild NN NN O
to TO TO O
moderate VB VB O
severity NN NN O
; : : O
   
pattern NN NN O
of IN IN O
deficits NNS NNS O
is VBZ VBZ O
consistent JJ JJ O
with IN IN O
primary JJ JJ O
neurodegenerative JJ JJ O
process NN NN O
( ( ( O
i.e. NN NN O
, , , O
Alzheimer NNP NNP O
's POS POS O
) ) ) O
; : : O
   
will MD MD O
impact VB VB O
her PRP$ PRP$ O
ability NN NN O
to TO TO O
function NN NN O
independently RB RB O
. . . O
   
Assessment NNP NNP O
and CC CC O
Plan NNP NNP O
   
1 CD CD O
. . . O
Incontinence NNP NNP O
: : : O
F/u NNP NNP O
with IN IN O
Dr NNP NNP O
. . . O
Xuereb NNP NNP I-DOCTOR
after IN IN O
completing VBG VBG O
course NN NN O
of IN IN O
nitrofurantoin NN NN O
. . . O
   
2 CD CD O
. . . O
Cardiac NNP NNP O
: : : O
Stable JJ JJ O
on IN IN O
metoprolol NN NN O
, , , O
sotalol NN NN O
, , , O
and CC CC O
digoxin NN NN O
. . . O
   
3 CD CD O
. . . O
PMR NNP NNP O
: : : O
Continue NNP NNP O
low-dose JJ JJ O
prednisone NN NN O
. . . O
   
Discussed NNP NNP O
facial JJ JJ O
bloating NN NN O
as IN IN O
side NN NN O
effect NN NN O
. . . O
   
Plan NNP NNP O
according VBG VBG O
to TO TO O
Dr NNP NNP O
. . . O
Inge NNP NNP I-DOCTOR
is VBZ VBZ O
to TO TO O
taper VB VB O
prednisone NN NN O
slowly RB RB O
over IN IN O
a DT DT O
year NN NN O
. . . O
   
Will NNP NNP O
check VB VB O
ESR NNP NNP O
today NN NN O
. . . O
   
4 CD CD O
. . . O
Depression NNP NNP O
: : : O
Much JJ JJ O
better JJR JJR O
. . . O
   
No DT DT O
physical JJ JJ O
signs/sx NN NN O
of IN IN O
depression NN NN O
right RB RB O
now RB RB O
. . . O
   
Continue NNP NNP O
Remeron NNP NNP O
. . . O
   
5 CD CD O
. . . O
Dementia NNP NNP O
: : : O
It PRP PRP O
was VBD VBD O
suggested VBN VBN O
in IN IN O
the DT DT O
neuropsych NN NN O
evaluation NN NN O
that IN IN O
a DT DT O
cognitive JJ JJ O
enhancing VBG VBG O
medication NN NN O
may MD MD O
benefit VB VB O
the DT DT O
pt NN NN O
. . . O
   
Will NNP NNP O
discuss VB VB O
starting VBG VBG O
Aricept NNP NNP O
with IN IN O
pt NN NN O
's POS POS O
cardiologist NN NN O
, , , O
Dr NNP NNP O
. . . O
Jankowski NNP NNP I-DOCTOR
, , , O
to TO TO O
make VB VB O
sure JJ JJ O
it PRP PRP O
will MD MD O
not RB RB O
impact VB VB O
her PRP$ PRP$ O
Afib NNP NNP O
. . . O
   
6 CD CD O
. . . O
Hyperlipidemia NNP NNP O
: : : O
Lipitor NNP NNP O
was VBD VBD O
d/c'd NN NN O
at IN IN O
some DT DT O
point NN NN O
over IN IN O
past JJ JJ O
year NN NN O
. . . O
   
Will NNP NNP O
check VB VB O
chol/HDL NN NN O
today NN NN O
since IN IN O
she PRP PRP O
is VBZ VBZ O
not RB RB O
fasting VBG VBG O
. . . O
   
7 CD CD O
. . . O
Social NNP NNP O
: : : O
Discussed JJ JJ O
results NNS NNS O
of IN IN O
neuropsych NN NN O
evaluation NN NN O
with IN IN O
patient NN NN O
. . . O
   
Discussed NNP NNP O
issues NNS NNS O
of IN IN O
living VBG VBG O
alone RB RB O
and CC CC O
how WRB WRB O
she PRP PRP O
would MD MD O
need VB VB O
24 CD CD O
hour NN NN O
supervision NN NN O
. . . O
   
Pt NNP NNP O
not RB RB O
sure JJ JJ O
if IN IN O
this DT DT O
situation NN NN O
would MD MD O
be VB VB O
better JJR JJR O
than IN IN O
assisted VBN VBN O
living VBG VBG O
. . . O
   
Discussed VBD VBD O
these DT DT O
issues NNS NNS O
with IN IN O
pt NN NN O
's POS POS O
son NN NN O
, , , O
Villatoro NNP NNP I-PATIENT
, , , O
over IN IN O
the DT DT O
phone NN NN O
after IN IN O
the DT DT O
visit NN NN O
. . . O
   
Will NNP NNP O
fax NN NN O
him PRP PRP O
paperwork NN NN O
for IN IN O
health NN NN O
care NN NN O
proxy NN NN O
. . . O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2105-12-15 JJ JJ I-DATE
Mr NNP NNP O
. . . O
Bryan NNP NNP I-PATIENT
comes VBZ VBZ O
in IN IN O
tonight NN NN O
complaining VBG VBG O
of IN IN O
pains NNS NNS O
in IN IN O
his PRP$ PRP$ O
varicose NN NN O
veins NNS NNS O
- : : O
much RB RB O
worse JJR JJR O
yesterday NN NN O
- : : O
now RB RB O
better JJR JJR O
. . . O
   
No DT DT O
swelling VBG VBG O
. . . O
   
No DT DT O
pain NN NN O
with IN IN O
walking VBG VBG O
. . . O
   
Hip NNP NNP O
feels VBZ VBZ O
fine NN NN O
. . . O
   
Otherwise RB RB O
he PRP PRP O
's VBZ VBZ O
doing VBG VBG O
OK JJ JJ O
, , , O
no DT DT O
respir NN NN O
, , , O
GI NNP NNP O
or CC CC O
GU NNP NNP O
problems NNS NNS O
. . . O
   
No DT DT O
increase NN NN O
in IN IN O
BPH NNP NNP O
sx NN NN O
. . . O
   
No DT DT O
new JJ JJ O
skin NN NN O
lesions NNS NNS O
. . . O
   
No DT DT O
cp NN NN O
. . . O
   
habits NNS NNS O
: : : O
no DT DT O
smoking NN NN O
, , , O
sober JJ JJ O
MEDICATIONS NNP NNP O
ATENOLOL NNP NNP O
100MG CD CD O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Take NNP NNP O
as IN IN O
directed VBN VBN O
CAPTOPRIL NNP NNP O
50MG CD CD O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
BID NNP NNP O
Take NNP NNP O
as IN IN O
directed VBN VBN O
ASPIRIN NNP NNP O
( ( ( O
ACETYLSALICYLIC NNP NNP O
ACID NNP NNP O
) ) ) O
81MG CD CD O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Take NNP NNP O
as IN IN O
directed VBN VBN O
PE NNP NNP O
: : : O
150/80 CD CD O
p. NN NN O
68 CD CD O
rr NN NN O
16 CD CD O
afeb NN NN O
wgt NN NN O
: : : O
227 CD CD O
1 CD CD O
+ NN NN O
carotids NNS NNS O
, , , O
no DT DT O
bruits NNS NNS O
, , , O
nml NN NN O
thyroid NN NN O
, , , O
no DT DT O
nodes NNS NNS O
clear JJ JJ O
lunds NNS NNS O
RRR NNP NNP O
no DT DT O
s4 NN NN O
or CC CC O
murmur NN NN O
abd NN NN O
: : : O
obese NN NN O
, , , O
no DT DT O
masses NNS NNS O
or CC CC O
HSM NNP NNP O
, , , O
prominent JJ JJ O
varicosities NNS NNS O
on IN IN O
entire JJ JJ O
L>R NNP NNP O
leg NN NN O
non NN NN O
- : : O
tender NN NN O
. . . O
   
no DT DT O
calf NN NN O
swelling VBG VBG O
. . . O
   
Minimal NNP NNP O
pedal NN NN O
edema NN NN O
. . . O
   
PROBLEMS NNS NNS O
1 CD CD O
) ) ) O
Hypertension NNP NNP O
- : : O
increase VB VB O
captopril NN NN O
to TO TO O
50 CD CD O
bid NN NN O
. . . O
   
2 CD CD O
) ) ) O
S/P NNP NNP O
total JJ JJ O
hip NN NN O
replacement NN NN O
Shoemaker NNP NNP I-DOCTOR
11/99 CD CD I-DATE
- : : O
stable JJ JJ O
3 CD CD O
) ) ) O
Diabetes NNP NNP O
mellitus NN NN O
- : : O
counselled JJ JJ O
on IN IN O
wgt NN NN O
. . . O
   
loss NN NN O
, , , O
check NN NN O
hgbA1C NN NN O
. . . O
   
Eye NNP NNP O
exam NN NN O
OK JJ JJ O
earlier RBR RBR O
this DT DT O
year NN NN O
. . . O
   
4)Basal CD CD O
cell NN NN O
carcinoma NN NN O
no DT DT O
new JJ JJ O
ones NNS NNS O
visible JJ JJ O
5)Varicose CD CD O
veins NNS NNS O
reassured VBD VBD O
, , , O
recommend NN NN O
against IN IN O
further JJ JJ O
surgery NN NN O
6 CD CD O
) ) ) O
macular JJ JJ O
degeneration NN NN O
- - - O
f/u NN NN O
with IN IN O
optho NN NN O
. . . O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2080-12-12 NN NN I-DATE
FREDERICK NNP NNP I-PATIENT
JEFFERSON NNP NNP I-PATIENT
KRMC NNP NNP I-HOSPITAL
Unit NNP NNP O
No DT DT O
: : : O
887-09-86 JJ JJ I-MEDICALRECORD
ZUCKER NNP NNP I-HOSPITAL
HILLSIDE NNP NNP I-HOSPITAL
HOSPITAL NNP NNP I-HOSPITAL
ADULT NNP NNP O
MEDICINE NNP NNP O
Date NN NN O
: : : O
December NNP NNP I-DATE
12 CD CD O
, , , O
2080 CD CD I-DATE
84-year-old JJ JJ O
male NN NN O
for IN IN O
follow VB VB O
up RB RB O
of IN IN O
a DT DT O
recent JJ JJ O
hospitalization NN NN O
last JJ JJ O
weekend NN NN O
. . . O
   
Apparently RB RB O
, , , O
had VBD VBD O
some DT DT O
mild NN NN O
congestive JJ JJ O
heart NN NN O
failure NN NN O
, , , O
after IN IN O
eating VBG VBG O
some DT DT O
pizza NN NN O
. . . O
   
Apparently RB RB O
he PRP PRP O
ruled VBD VBD O
out IN IN O
, , , O
he PRP PRP O
was VBD VBD O
only RB RB O
in IN IN O
the DT DT O
hospital NN NN O
for IN IN O
24 CD CD O
hours NNS NNS O
. . . O
   
Since IN IN O
discharge NN NN O
, , , O
he PRP PRP O
has VBZ VBZ O
been VBN VBN O
doing VBG VBG O
well RB RB O
. . . O
   
He PRP PRP O
feels VBZ VBZ O
perhaps RB RB O
a DT DT O
slight JJ JJ O
tickle NN NN O
in IN IN O
his PRP$ PRP$ O
throat NN NN O
and CC CC O
occasional JJ JJ O
cough NN NN O
but CC CC O
no DT DT O
PND NNP NNP O
, , , O
orthopnea NN NN O
, , , O
dyspnea NN NN O
on IN IN O
exertion NN NN O
or CC CC O
chest NN NN O
pain NN NN O
. . . O
   
There EX EX O
were VBD VBD O
no DT DT O
changes NNS NNS O
of IN IN O
his PRP$ PRP$ O
medication NN NN O
. . . O
   
PAST NNP NNP O
MEDICAL NNP NNP O
HISTORY NN NN O
: : : O
( ( ( O
1 CD CD O
) ) ) O
CAD NNP NNP O
with IN IN O
CHF NNP NNP O
: : : O
EF NNP NNP O
of IN IN O
25 CD CD O
% NN NN O
. . . O
   
( ( ( O
2 CD CD O
) ) ) O
Hypertension NNP NNP O
. . . O
   
( ( ( O
3 CD CD O
) ) ) O
Peripheral NNP NNP O
vascular NN NN O
disease NN NN O
. . . O
   
( ( ( O
4 CD CD O
) ) ) O
Gout NNP NNP O
. . . O
   
( ( ( O
5 CD CD O
) ) ) O
DJD NNP NNP O
. . . O
   
( ( ( O
6 CD CD O
) ) ) O
Renal NNP NNP O
insufficiency NN NN O
. . . O
   
( ( ( O
7 CD CD O
) ) ) O
Hyperlipidemia NNP NNP O
. . . O
   
( ( ( O
8 CD CD O
) ) ) O
BPH NNP NNP O
. . . O
   
MEDICATIONS NNP NNP O
: : : O
Lasix NNP NNP O
40 CD CD O
mg NN NN O
b.i.d. NN NN O
, , , O
digoxin NN NN O
.125 CD CD O
mg NN NN O
q.o.d. NN NN O
, , , O
Colchicine NNP NNP O
.6 CD CD O
mg NN NN O
q.o.d. NN NN O
, , , O
Metoprolol NNP NNP O
50 CD CD O
mg NN NN O
twice RB RB O
a DT DT O
day NN NN O
, , , O
prednisone NN NN O
5 CD CD O
mg NN NN O
q.d. NN NN O
, , , O
Coumadin NNP NNP O
as IN IN O
per IN IN O
Anticoag NNP NNP O
Clinic NNP NNP O
, , , O
hydralazine NN NN O
10 CD CD O
mg NN NN O
q.i.d. NN NN O
, , , O
Isordil NNP NNP O
20 CD CD O
mg NN NN O
t.i.d. NN NN O
, , , O
K-DUR NNP NNP O
20 CD CD O
meq NN NN O
q.d. NN NN O
, , , O
Hydroxychloroquine NNP NNP O
200 CD CD O
mg NN NN O
q.d. NN NN O
, , , O
calcium NN NN O
and CC CC O
vitamin NN NN O
D NNP NNP O
twice RB RB O
a DT DT O
day NN NN O
, , , O
allopurinol NN NN O
100 CD CD O
mg NN NN O
q.d. NN NN O
, , , O
Celebrex NNP NNP O
200 CD CD O
mg NN NN O
q.d. NN NN O
and CC CC O
Azulfidine NNP NNP O
500 CD CD O
mg NN NN O
taken VBN VBN O
3 CD CD O
x SYM SYM O
per IN IN O
week NN NN O
. . . O
   
PHYSICAL JJ JJ O
EXAM NNP NNP O
: : : O
Weight NNP NNP O
: : : O
197 CD CD O
, , , O
down RB RB O
6 CD CD O
pounds NNS NNS O
from IN IN O
November NNP NNP I-DATE
. . . O
   
His PRP$ PRP$ O
blood NN NN O
pressure NN NN O
today NN NN O
is VBZ VBZ O
130/70 CD CD O
. . . O
   
His PRP$ PRP$ O
pulse NN NN O
is VBZ VBZ O
in IN IN O
the DT DT O
80's CD CD O
and CC CC O
slightly RB RB O
irregular JJ JJ O
. . . O
   
Neck NNP NNP O
: : : O
8 CD CD O
cm NN NN O
JVD NNP NNP O
. . . O
   
Lungs NNP NNP O
: : : O
Although IN IN O
diminished JJ JJ O
breath NN NN O
sounds VBZ VBZ O
, , , O
clear JJ JJ O
. . . O
   
Cardiac NNP NNP O
: : : O
Regularly RB RB O
irregular JJ JJ O
, , , O
S1 NNP NNP O
, , , O
S2 NNP NNP O
. . . O
   
Abdomen NNP NNP O
: : : O
Soft JJ JJ O
and CC CC O
nontender NN NN O
. . . O
   
Extremities NNP NNP O
: : : O
No DT DT O
edema NN NN O
on IN IN O
the DT DT O
right NN NN O
. . . O
   
Trace NNP NNP O
ankle NN NN O
edema NN NN O
on IN IN O
the DT DT O
left NN NN O
. . . O
   
A/P NNP NNP O
: : : O
Status NNP NNP O
post NN NN O
episode NN NN O
of IN IN O
congestive JJ JJ O
heart NN NN O
failure NN NN O
due JJ JJ O
to TO TO O
dietary JJ JJ O
noncompliance NN NN O
: : : O
Appears VBZ VBZ O
to TO TO O
be VB VB O
stable JJ JJ O
now RB RB O
with IN IN O
decrease NN NN O
in IN IN O
his PRP$ PRP$ O
weight NN NN O
. . . O
   
Continue NNP NNP O
present JJ JJ O
medical JJ JJ O
regimen NNS NNS O
. . . O
   
We PRP PRP O
had VBD VBD O
a DT DT O
discussion NN NN O
on IN IN O
the DT DT O
importance NN NN O
of IN IN O
diet NN NN O
compliance NN NN O
. . . O
   
Avoid NNP NNP O
salt JJ JJ O
products NNS NNS O
. . . O
   
Will MD MD O
otherwise RB RB O
see VB VB O
Mrs NNP NNP O
. . . O
   
Kang NNP NNP I-DOCTOR
later RB RB O
this DT DT O
month NN NN O
in IN IN O
December NNP NNP I-DATE
and CC CC O
I PRP PRP O
will MD MD O
see VB VB O
him PRP PRP O
again RB RB O
in IN IN O
January NNP NNP I-DATE
. . . O
   
David NNP NNP I-DOCTOR
Hale NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
   
DH/quiggle/nielsen NNP NNP O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2100-07-07 NN NN I-DATE
Humalog NNP NNP O
0-2/4-8/6-10 NN NN O
111-64-17 JJ JJ I-MEDICALRECORD
Lantus NNP NNP O
10 CD CD O
U NNP NNP O
hs NN NN O
Xayarath NN NN O
, , , O
Nancy NNP NNP I-PATIENT
Prograf NNP NNP O
2 CD CD O
mg NN NN O
bid NN NN O
Imuran NNP NNP O
100 CD CD O
mg NN NN O
qhs NN NN O
Prednisone NNP NNP O
2.5 CD CD O
mg NN NN O
qd NN NN O
starting VBG VBG O
last JJ JJ O
week NN NN O
Omeprazole NNP NNP O
20 CD CD O
mg NN NN O
qd NN NN O
Lipitor NNP NNP O
40 CD CD O
mg NN NN O
qd NN NN O
Toprol NNP NNP O
XL NNP NNP O
25 CD CD O
mg NN NN O
qPM NN NN O
Imdur NNP NNP O
30 CD CD O
mg NN NN O
qd NN NN O
Coumadin NNP NNP O
4 CD CD O
mg NN NN O
tablets NNS NNS O
( ( ( O
for IN IN O
SVC NNP NNP O
stent NN NN O
) ) ) O
: : : O
4 CD CD O
mg NN NN O
2/7 CD CD O
; : : O
   
6 CD CD O
mg NN NN O
5/7 CD CD O
ASA NNP NNP O
325 CD CD O
mg NN NN O
qd NN NN O
Caltrate NNP NNP O
with IN IN O
D NNP NNP O
1200-1500 JJ JJ O
mg NN NN O
per IN IN O
day NN NN O
in IN IN O
divided JJ JJ O
doses NNS NNS O
Fosamax NNP NNP O
70 CD CD O
mg NN NN O
qw NN NN O
Centrum NNP NNP O
QD NNP NNP O
Folate NNP NNP O
1 CD CD O
mg NN NN O
qd NN NN O
not RB RB O
taking VBG VBG O
Celexa NNP NNP O
20 CD CD O
mg NN NN O
qd NN NN O
July NNP NNP I-DATE
07 CD CD O
, , , O
2100 CD CD I-DATE
Interim NNP NNP O
History NN NN O
: : : O
Comes VBZ VBZ O
to TO TO O
review VB VB O
her PRP$ PRP$ O
medical JJ JJ O
problems NNS NNS O
. . . O
   
She PRP PRP O
had VBD VBD O
been VBN VBN O
losing VBG VBG O
weight NN NN O
and CC CC O
feeling NN NN O
fatigued VBD VBD O
. . . O
   
She PRP PRP O
has VBZ VBZ O
been VBN VBN O
at IN IN O
her PRP$ PRP$ O
current JJ JJ O
weight NN NN O
for IN IN O
several JJ JJ O
weeks NNS NNS O
and CC CC O
feels VBZ VBZ O
that IN IN O
she PRP PRP O
has VBZ VBZ O
stabilized VBN VBN O
. . . O
   
Appetite NNP NNP O
has VBZ VBZ O
been VBN VBN O
good JJ JJ O
. . . O
   
Home NNP NNP O
Blood NNP NNP O
Tests NNP NNP O
: : : O
No DT DT O
records NNS NNS O
. . . O
   
She PRP PRP O
reports NNS NNS O
that IN IN O
she PRP PRP O
drops VBZ VBZ O
from IN IN O
the DT DT O
200's CD CD O
to TO TO O
the DT DT O
normal JJ JJ O
range NN NN O
in IN IN O
the DT DT O
morning NN NN O
. . . O
   
Her PRP$ PRP$ O
bedtime NN NN O
test NN NN O
is VBZ VBZ O
about IN IN O
3-4 JJ JJ O
hours NNS NNS O
after IN IN O
summer NN NN O
. . . O
   
Retinopathy NNP NNP O
: : : O
Saw VBD VBD O
Dr NNP NNP O
. . . O
Xiques NNP NNP I-DOCTOR
in IN IN O
the DT DT O
Spring NNP NNP I-DATE
. . . O
   
May NNP NNP O
need VB VB O
laser NN NN O
for IN IN O
p-cataract JJ JJ O
film NN NN O
. . . O
   
Retinas NNP NNP O
stable JJ JJ O
. . . O
   
Nephropathy NNP NNP O
: : : O
Cr NNP NNP O
1.0 CD CD O
in IN IN O
September NNP NNP I-DATE
. . . O
   
Saw VBD VBD O
Dr NNP NNP O
. . . O
Caldwell NNP NNP I-DOCTOR
re NN NN O
her PRP$ PRP$ O
Charcot NNP NNP O
foot NN NN O
. . . O
   
He PRP PRP O
put VBP VBP O
her PRP PRP O
in IN IN O
a DT DT O
boot NN NN O
and CC CC O
wheelchair NN NN O
for IN IN O
3 CD CD O
weeks NNS NNS O
and CC CC O
it PRP PRP O
resolved VBD VBD O
well RB RB O
. . . O
   
Cardiac NNP NNP O
: : : O
Gets VBZ VBZ O
little JJ JJ O
tingling VBG VBG O
sensations NNS NNS O
in IN IN O
her PRP$ PRP$ O
anterior NN NN O
chest NN NN O
, , , O
occurring VBG VBG O
at IN IN O
any DT DT O
times NNS NNS O
. . . O
   
Not RB RB O
specifically RB RB O
at IN IN O
times NNS NNS O
of IN IN O
physical JJ JJ O
exercise NN NN O
. . . O
   
Vascular NNP NNP O
: : : O
No DT DT O
claudication NN NN O
Past JJ JJ O
Medical NNP NNP O
History NN NN O
: : : O
Medications NNP NNP O
: : : O
Prograf NNP NNP O
reduced VBD VBD O
. . . O
   
Review NNP NNP O
of IN IN O
Systems NNPS NNPS O
: : : O
GI NNP NNP O
: : : O
Feels VBZ VBZ O
that IN IN O
her PRP$ PRP$ O
abdomen NN NN O
is VBZ VBZ O
uncomfortable JJ JJ O
much JJ JJ O
of IN IN O
the DT DT O
time NN NN O
. . . O
   
Not RB RB O
precipitated JJ JJ O
or CC CC O
relieved VBN VBN O
by IN IN O
food NN NN O
. . . O
   
Upper NNP NNP O
and CC CC O
lower JJR JJR O
abdominal JJ JJ O
. . . O
   
No DT DT O
change NN NN O
in IN IN O
volume NN NN O
or CC CC O
nature NN NN O
of IN IN O
ileostomy NN NN O
output NN NN O
. . . O
   
She PRP PRP O
has VBZ VBZ O
dysphagia VBN VBN O
for IN IN O
liquids NNS NNS O
, , , O
sometimes RB RB O
with IN IN O
regurgitation NN NN O
. . . O
   
Had VBD VBD O
Pap NNP NNP O
and CC CC O
mammogram NN NN O
through IN IN O
ANC NNP NNP I-HOSPITAL
gynecologist NN NN O
. . . O
   
She PRP PRP O
saw VBD VBD O
Dr NNP NNP O
. . . O
Wilhelm NNP NNP I-DOCTOR
for IN IN O
sinus NN NN O
problems NNS NNS O
. . . O
   
He PRP PRP O
got VBD VBD O
an DT DT O
MRI NNP NNP O
. . . O
   
It PRP PRP O
showed VBD VBD O
a DT DT O
meningioma NN NN O
of IN IN O
the DT DT O
jugular NN NN O
foramen NNS NNS O
. . . O
   
Dr NNP NNP O
. . . O
Wilhelm NNP NNP I-DOCTOR
's POS POS O
note NN NN O
indicated VBD VBD O
that IN IN O
she PRP PRP O
would MD MD O
see VB VB O
Dr NNP NNP O
. . . O
New NNP NNP I-DOCTOR
for IN IN O
that DT DT O
and CC CC O
indeed RB RB O
she PRP PRP O
has VBZ VBZ O
seen VBN VBN O
Dr NNP NNP O
. . . O
New NNP NNP I-DOCTOR
, , , O
although IN IN O
she PRP PRP O
says VBZ VBZ O
it PRP PRP O
is VBZ VBZ O
for IN IN O
a DT DT O
tumor NN NN O
on IN IN O
the DT DT O
vocal JJ JJ O
cord NN NN O
. . . O
   
He PRP PRP O
also RB RB O
wanted VBD VBD O
her PRP PRP O
to TO TO O
see VB VB O
Dr NNP NNP O
. . . O
Carter NNP NNP I-DOCTOR
about IN IN O
a DT DT O
vocal JJ JJ O
cord NN NN O
paralysis NN NN O
, , , O
and CC CC O
that DT DT O
visit NN NN O
is VBZ VBZ O
upcoming JJ JJ O
. . . O
   
Physical JJ JJ O
Exam NNP NNP O
: : : O
Looks NNP NNP O
well RB RB O
. . . O
   
BP NNP NNP O
: : : O
118/70 CD CD O
P NN NN O
: : : O
72 CD CD O
, , , O
regular JJ JJ O
Wt NNP NNP O
: : : O
118.5 CD CD O
without IN IN O
shoes NNS NNS O
, , , O
down RB RB O
8.5 CD CD O
HEENT NNP NNP O
: : : O
Anicteric NNP NNP O
. . . O
   
Carotids NNP NNP O
: : : O
Normal JJ JJ O
pulses NNS NNS O
, , , O
without IN IN O
bruits NNS NNS O
Chest NN NN O
: : : O
Clear NNP NNP O
to TO TO O
auscultation NN NN O
Heart NNP NNP O
: : : O
Dyskinetic NNP NNP O
prominent NN NN O
apical JJ JJ O
impulse NN NN O
. . . O
   
Normal NNP NNP O
S1 NNP NNP O
; : : O
   
single JJ JJ O
S2 NNP NNP O
. . . O
   
S4 NNP NNP O
. . . O
   
2/6 CD CD O
systolic JJ JJ O
ejection NN NN O
murmur NN NN O
Abdomen NNP NNP O
: : : O
No DT DT O
hepatosplenomegaly NN NN O
. . . O
   
No DT DT O
masses NNS NNS O
. . . O
   
Small JJ JJ O
epigastric JJ JJ O
hernia NN NN O
with IN IN O
mild JJ JJ O
tenderness NNS NNS O
in IN IN O
that DT DT O
area NN NN O
. . . O
   
Ileostomy NNP NNP O
. . . O
   
No DT DT O
palpable JJ JJ O
AAA NNP NNP O
. . . O
   
Extremities NNP NNP O
: : : O
No DT DT O
edema NN NN O
. . . O
   
DP NNP NNP O
2 CD CD O
+ NN NN O
,=. NN NN O
   
PT NNP NNP O
absent NN NN O
. . . O
   
Prominent NNP NNP O
mound NN NN O
of IN IN O
tissue NN NN O
in IN IN O
the DT DT O
plantar NN NN O
aspect NN NN O
of IN IN O
L NNP NNP O
foot NN NN O
, , , O
from IN IN O
Charcot NNP NNP O
changes NNS NNS O
, , , O
but CC CC O
with IN IN O
very RB RB O
normal JJ JJ O
skin NN NN O
covering NN NN O
. . . O
   
Good JJ JJ O
foot NN NN O
care NN NN O
. . . O
   
Impressions NNP NNP O
and CC CC O
Plan NNP NNP O
: : : O
Many JJ JJ O
active JJ JJ O
issues NNS NNS O
. . . O
   
Hard NNP NNP O
to TO TO O
assess VB VB O
control NN NN O
without IN IN O
data NNS NNS O
. . . O
   
Must MD MD O
bring VB VB O
them PRP PRP O
to TO TO O
visits NNS NNS O
. . . O
   
For IN IN O
now RB RB O
, , , O
reduce VB VB O
the DT DT O
Lantus NNP NNP O
to TO TO O
8 CD CD O
U NNP NNP O
since IN IN O
she PRP PRP O
drops VBZ VBZ O
overnight VBN VBN O
by IN IN O
history NN NN O
. . . O
   
Will MD MD O
need VB VB O
to TO TO O
talk VB VB O
with IN IN O
Dr NNP NNP O
. . . O
Wilhelm NNP NNP I-DOCTOR
and CC CC O
Dr NNP NNP O
. . . O
New NNP NNP I-DOCTOR
about IN IN O
their PRP$ PRP$ O
respective JJ JJ O
perspectives NNS NNS O
and CC CC O
figure NN NN O
out IN IN O
who WP WP O
is VBZ VBZ O
addressing VBG VBG O
the DT DT O
meningioma NN NN O
and CC CC O
hydrocephalus NN NN O
. . . O
   
May NNP NNP O
need VB VB O
to TO TO O
see VB VB O
a DT DT O
neurologist NN NN O
. . . O
   
Refer VBP VBP O
to TO TO O
Dr NNP NNP O
. . . O
Sanders NNP NNP I-DOCTOR
for IN IN O
evaluation NN NN O
of IN IN O
her PRP$ PRP$ O
gastrointestinal JJ JJ O
discomfort NN NN O
and CC CC O
dysphagia NN NN O
for IN IN O
liquids NNS NNS O
. . . O
   
I PRP PRP O
suspect VBP VBP O
a DT DT O
motility NN NN O
disorder NN NN O
. . . O
   
She PRP PRP O
needs VBZ VBZ O
follow-up JJ JJ O
with IN IN O
Dr NNP NNP O
. . . O
Arndt NNP NNP I-DOCTOR
. . . O
   
1 CD CD O
hour NN NN O
; : : O
   
most JJS JJS O
counseling VBG VBG O
and CC CC O
coordination NN NN O
of IN IN O
care NN NN O
. . . O
   
A1c NNP NNP O
, , , O
Electrolytes NNP NNP O
, , , O
BUN/Creatinine NNP NNP O
, , , O
CBC NNP NNP O
, , , O
anti-gliadin JJ JJ O
antibodies NNS NNS O
, , , O
anti-transglutaminase JJ JJ O
antibodies NNS NNS O
, , , O
TSH NNP NNP O
. . . O
   
Appointments NNP NNP O
: : : O
1 CD CD O
month NN NN O
cc NN NN O
: : : O
Transplant NNP NNP O
Clinic NNP NNP O
Fredrich NNP NNP I-DOCTOR
van NN NN I-DOCTOR
Butler NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
   
Nicole NNP NNP I-DOCTOR
Arndt NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
   
Lawrence NNP NNP I-DOCTOR
Wilhelm NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
, , , O
Minnie NNP NNP I-HOSPITAL
Hamilton NNP NNP I-HOSPITAL
Health NNP NNP I-HOSPITAL
Care NNP NNP I-HOSPITAL
Center NNP NNP I-HOSPITAL
, , , O
727 CD CD I-STREET
Seneca NNP NNP I-STREET
Drive NNP NNP I-STREET
, , , O
Suite NNP NNP O
9B CD CD O
, , , O
Red NNP NNP I-CITY
Springs NNP NNP I-CITY
, , , O
WA NNP NNP I-STATE
77286 CD CD I-ZIP
Nicholas NNP NNP I-DOCTOR
New NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
, , , O
BKMC NNP NNP I-HOSPITAL
Ophelia NNP NNP I-DOCTOR
Sanders NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
   
Lawrence NNP NNP I-DOCTOR
K. NN NN I-DOCTOR
Townsend NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
, , , O
Ph.D NNP NNP O
. . . O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2079-12-12 JJ JJ I-DATE
Harper NNP NNP I-HOSPITAL
Hospital NNP NNP I-HOSPITAL
Physician NNP NNP O
Group NNP NNP O
787 CD CD I-STREET
Everett NNP NNP I-STREET
Street NNP NNP I-STREET
Lake NNP NNP I-CITY
Pocotopaug NNP NNP I-CITY
, , , O
ME PRP PRP I-STATE
15424 CD CD I-ZIP
281-223-9046 JJ JJ I-PHONE
AARON NNP NNP O
, , , O
JEAN NNP NNP I-PATIENT
42817774 CD CD I-MEDICALRECORD
12/12/2079 CD CD I-DATE
HISTORY NN NN O
OF IN IN O
PRESENT NNP NNP O
ILLNESS NNP NNP O
: : : O
A DT DT O
65-year-old JJ JJ O
female JJ JJ O
who WP WP O
presents VBZ VBZ O
today NN NN O
for IN IN O
hospital NN NN O
followup NN NN O
. . . O
   
I PRP PRP O
admitted VBD VBD O
her PRP PRP O
to TO TO O
the DT DT O
HH NNP NNP I-HOSPITAL
on IN IN O
10/03/79 CD CD I-DATE
with IN IN O
an DT DT O
episode NN NN O
of IN IN O
hypoxemia NN NN O
, , , O
which WDT WDT O
was VBD VBD O
felt VBN VBN O
to TO TO O
be VB VB O
secondary JJ JJ O
to TO TO O
CHF NNP NNP O
and CC CC O
diastolic JJ JJ O
dysfunction NN NN O
. . . O
   
She PRP PRP O
was VBD VBD O
discharged VBN VBN O
to TO TO O
johnson NN NN I-HOSPITAL
rest NN NN I-HOSPITAL
home NN NN I-HOSPITAL
on IN IN O
10/12/79 CD CD I-DATE
. . . O
   
Two CD CD O
hours NNS NNS O
after IN IN O
arrival NN NN O
, , , O
she PRP PRP O
had VBD VBD O
a DT DT O
respiratory JJ JJ O
arrest NN NN O
and CC CC O
was VBD VBD O
taken VBN VBN O
to TO TO O
the DT DT O
Intensive NNP NNP O
Care NNP NNP O
Unit NNP NNP O
at IN IN O
Clinica NNP NNP I-HOSPITAL
Rovira NNP NNP I-HOSPITAL
where WRB WRB O
she PRP PRP O
stayed VBD VBD O
until IN IN O
11/03/79 CD CD I-DATE
. . . O
   
She PRP PRP O
is VBZ VBZ O
extremely RB RB O
difficult JJ JJ O
to TO TO O
diurese NN NN O
because IN IN O
of IN IN O
her PRP$ PRP$ O
tenuous JJ JJ O
renal JJ JJ O
function NN NN O
, , , O
this DT DT O
required JJ JJ O
multiple JJ JJ O
adjustments NNS NNS O
of IN IN O
her PRP$ PRP$ O
medication NN NN O
. . . O
   
Stress NNP NNP O
test NN NN O
showed VBD VBD O
no DT DT O
ischemia NN NN O
and CC CC O
echocardiogram NN NN O
showed VBD VBD O
concentric RB RB O
left VBN VBN O
ventricular NN NN O
hypertrophy NN NN O
with IN IN O
normal JJ JJ O
chamber NN NN O
size NN NN O
and CC CC O
systolic JJ JJ O
function NN NN O
, , , O
estimated VBN VBN O
ejection NN NN O
fraction NN NN O
is VBZ VBZ O
65 CD CD I-AGE
% NN NN O
as RB RB O
well RB RB O
as IN IN O
biatrial JJ JJ O
enlargement NN NN O
. . . O
   
She PRP PRP O
did VBD VBD O
well RB RB O
acutely RB RB O
with IN IN O
BiPAP NNP NNP O
and CC CC O
remains VBZ VBZ O
on IN IN O
oxygen NN NN O
. . . O
   
As IN IN O
part NN NN O
of IN IN O
her PRP$ PRP$ O
workup NN NN O
, , , O
she PRP PRP O
had VBD VBD O
pulmonary JJ JJ O
function NN NN O
tests NNS NNS O
, , , O
which WDT WDT O
showed VBD VBD O
moderate JJ JJ O
obstruction NN NN O
without IN IN O
a DT DT O
bronchodilator NN NN O
response NN NN O
and CC CC O
some DT DT O
mild JJ JJ O
restriction NN NN O
likely JJ JJ O
due JJ JJ O
to TO TO O
her PRP$ PRP$ O
obesity NN NN O
. . . O
   
In IN IN O
addition NN NN O
, , , O
she PRP PRP O
was VBD VBD O
quite RB RB O
anemic JJ JJ O
with IN IN O
hematocrit NN NN O
of IN IN O
19 CD CD O
on IN IN O
presentation NN NN O
. . . O
   
There EX EX O
was VBD VBD O
no DT DT O
evidence NN NN O
of IN IN O
hemolysis NNS NNS O
. . . O
   
She PRP PRP O
is VBZ VBZ O
mildly RB RB O
iron NN NN O
deficient NN NN O
and CC CC O
colonoscopy NN NN O
showed VBD VBD O
a DT DT O
tubulovillous JJ JJ O
adenoma NN NN O
, , , O
which WDT WDT O
was VBD VBD O
excised VBN VBN O
as RB RB O
well RB RB O
as IN IN O
a DT DT O
short JJ JJ O
area NN NN O
of IN IN O
Barrett NNP NNP O
's POS POS O
esophagus NN NN O
. . . O
   
There EX EX O
was VBD VBD O
no DT DT O
evidence NN NN O
of IN IN O
active JJ JJ O
bleeding NN NN O
. . . O
   
She PRP PRP O
received VBD VBD O
multiple JJ JJ O
transfusions NNS NNS O
throughout IN IN O
her PRP$ PRP$ O
stay NN NN O
and CC CC O
was VBD VBD O
started VBN VBN O
on IN IN O
darbepoetin NN NN O
, , , O
for IN IN O
what WP WP O
was VBD VBD O
ultimately RB RB O
felt VBN VBN O
to TO TO O
be VB VB O
anemia NN NN O
of IN IN O
renal JJ JJ O
disease NN NN O
. . . O
   
She PRP PRP O
was VBD VBD O
discharged VBN VBN O
to TO TO O
Lahey NNP NNP I-HOSPITAL
Clinic NNP NNP I-HOSPITAL
and CC CC O
has VBZ VBZ O
just RB RB O
returned JJ JJ O
home NN NN I-HOSPITAL
. . . O
   
Her PRP$ PRP$ O
son NN NN O
, , , O
Brendon NNP NNP I-PATIENT
Ambrose NNP NNP I-PATIENT
who WP WP O
was VBD VBD O
the DT DT O
healthcare NN NN O
proxy NN NN O
, , , O
is VBZ VBZ O
here RB RB O
with IN IN O
her PRP$ PRP$ O
today NN NN O
. . . O
   
Today NN NN O
, , , O
she PRP PRP O
feels VBZ VBZ O
reasonably RB RB O
well RB RB O
. . . O
   
She PRP PRP O
is VBZ VBZ O
still RB RB O
somewhat RB RB O
weak JJ JJ O
from IN IN O
the DT DT O
prolonged JJ JJ O
hospitalization NN NN O
, , , O
but CC CC O
is VBZ VBZ O
quite RB RB O
enthusiastic JJ JJ O
about IN IN O
the DT DT O
fact NN NN O
that IN IN O
she PRP PRP O
lost VBD VBD O
30 CD CD O
pounds NNS NNS O
. . . O
   
She PRP PRP O
is VBZ VBZ O
taking VBG VBG O
her PRP$ PRP$ O
medications NNS NNS O
regularly RB RB O
and CC CC O
remains VBZ VBZ O
on IN IN O
2 CD CD O
liters NNS NNS O
of IN IN O
oxygen NN NN O
. . . O
   
She PRP PRP O
has VBZ VBZ O
no DT DT O
chest NN NN O
pain NN NN O
or CC CC O
shortness NN NN O
of IN IN O
breath NN NN O
. . . O
   
Her PRP$ PRP$ O
diabetes NN NN O
regimen NNS NNS O
was VBD VBD O
changed VBN VBN O
during IN IN O
the DT DT O
hospital NN NN O
, , , O
she PRP PRP O
is VBZ VBZ O
still RB RB O
taking VBG VBG O
70/30 CD CD O
insulin NN NN O
, , , O
but CC CC O
lower JJR JJR O
dose NN NN O
in IN IN O
the DT DT O
evenings NNS NNS O
and CC CC O
using VBG VBG O
a DT DT O
sliding VBG VBG O
scale NN NN O
of IN IN O
lispro NN NN O
insulin NN NN O
with IN IN O
meals NNS NNS O
. . . O
   
Hospital NNP NNP I-HOSPITAL
course NN NN O
was VBD VBD O
complicated VBN VBN O
by IN IN O
a DT DT O
hospital-acquired JJ JJ O
pneumonia NN NN O
and CC CC O
urinary JJ JJ O
tract NN NN O
infection NN NN O
as RB RB O
well RB RB O
. . . O
   
PAST NNP NNP O
MEDICAL NNP NNP O
HISTORY NN NN O
: : : O
Congestive JJ JJ O
heart NN NN O
failure NN NN O
secondary JJ JJ O
to TO TO O
diastolic JJ JJ O
dysfunction NN NN O
, , , O
type NN NN O
2 CD CD O
diabetes NNS NNS O
, , , O
renal JJ JJ O
insufficiency NN NN O
with IN IN O
baseline NN NN O
creatinine NN NN O
approximately RB RB O
3 CD CD O
, , , O
hyperlipidemia NN NN O
, , , O
atrial JJ JJ O
fibrillation NN NN O
, , , O
peripheral JJ JJ O
vascular NN NN O
disease NN NN O
, , , O
chronic JJ JJ O
obstructive JJ JJ O
pulmonary JJ JJ O
disease NN NN O
, , , O
peripheral JJ JJ O
neuropathy NN NN O
, , , O
Barrett NNP NNP O
's POS POS O
esophagus NN NN O
, , , O
colon NN NN O
polyps NN NN O
( ( ( O
tubulovillous JJ JJ O
adenoma NN NN O
2079 CD CD I-DATE
) ) ) O
, , , O
diverticulosis NN NN O
adenoid NN NN O
hypertrophy NN NN O
, , , O
humeral JJ JJ O
fracture NN NN O
, , , O
history NN NN O
of IN IN O
marijuana NN NN O
use NN NN O
, , , O
history NN NN O
of IN IN O
alcohol NN NN O
abuse NN NN O
. . . O
   
MEDICATIONS NNP NNP O
: : : O
Reconciled NNP NNP O
today NN NN O
, , , O
they PRP PRP O
include VBP VBP O
: : : O
   
1 CD CD O
. . . O
Aspirin NNP NNP O
81 CD CD O
mg NN NN O
daily JJ JJ O
. . . O
   
2 CD CD O
. . . O
Calcium NNP NNP O
plus CC CC O
D NNP NNP O
1 CD CD O
tablet NN NN O
b.i.d. NN NN O
   
3 CD CD O
. . . O
Darbepoetin NNP NNP O
is VBZ VBZ O
followed VBN VBN O
by IN IN O
Dr NNP NNP O
. . . O
Dougherty NNP NNP I-DOCTOR
at IN IN O
St NNP NNP O
. . . O
Mary NNP NNP O
's POS POS O
. . . O
   
4 CD CD O
. . . O
Iron NNP NNP O
sulfate NN NN O
325 CD CD O
mg NN NN O
b.i.d. NN NN O
   
5 CD CD O
. . . O
Hydralazine NNP NNP O
100 CD CD O
mg NN NN O
t.i.d. NN NN O
   
6 CD CD O
. . . O
Loratadine NNP NNP O
10 CD CD O
mg NN NN O
daily JJ JJ O
. . . O
   
7 CD CD O
. . . O
Metolazone NNP NNP O
100 CD CD O
mg NN NN O
daily JJ JJ O
. . . O
   
8 CD CD O
. . . O
Metoprolol NNP NNP O
succinate NN NN O
150 CD CD O
mg NN NN O
daily JJ JJ O
. . . O
   
9 CD CD O
. . . O
Multivitamin NNP NNP O
. . . O
   
10 CD CD O
. . . O
Nitroglycerin NNP NNP O
patch NN NN O
0.3 CD CD O
mg NN NN O
per IN IN O
hour NN NN O
( ( ( O
3 CD CD O
x SYM SYM O
0.1 CD CD O
mg NN NN O
patches NNS NNS O
) ) ) O
. . . O
   
11 CD CD O
. . . O
70/30 CD CD O
NovoLog NNP NNP O
60 CD CD O
units NNS NNS O
in IN IN O
the DT DT O
morning NN NN O
and CC CC O
35 CD CD O
in IN IN O
the DT DT O
evening NN NN O
. . . O
   
12 CD CD O
. . . O
Omeprazole NNP NNP O
20 CD CD O
mg NN NN O
b.i.d. NN NN O
   
13 CD CD O
. . . O
Potassium NNP NNP O
chloride NN NN O
40 CD CD O
mEq NN NN O
t.i.d. NN NN O
   
14 CD CD O
. . . O
Ropinirole NNP NNP O
0.25 CD CD O
mg NN NN O
daily JJ JJ O
. . . O
   
15 CD CD O
. . . O
Simvastatin NNP NNP O
40 CD CD O
mg NN NN O
daily JJ JJ O
. . . O
   
16 CD CD O
. . . O
Spiriva NNP NNP O
1 CD CD O
inhalation NN NN O
daily JJ JJ O
. . . O
   
17 CD CD O
. . . O
Spironolactone NNP NNP O
50 CD CD O
mg NN NN O
daily JJ JJ O
. . . O
   
18 CD CD O
. . . O
Torsemide NNP NNP O
100 CD CD O
mg NN NN O
b.i.d. NN NN O
   
19 CD CD O
. . . O
Trazodone NNP NNP O
25 CD CD O
mg NN NN O
nightly RB RB O
. . . O
   
20 CD CD O
. . . O
B-complex NNP NNP O
vitamin NN NN O
daily JJ JJ O
. . . O
   
21 CD CD O
. . . O
Vitamin NNP NNP O
D3 NNP NNP O
1000 CD CD O
units NNS NNS O
daily JJ JJ O
. . . O
   
22 CD CD O
. . . O
Coumadin NNP NNP O
as IN IN O
monitored VBN VBN O
by IN IN O
the DT DT O
Hematology NNP NNP O
Dept NNP NNP O
. . . O
. . . O
   
ALLERGIES NNP NNP O
TO TO TO O
MEDICATIONS NNP NNP O
: : : O
None NN NN O
. . . O
   
PHYSICAL JJ JJ O
EXAMINATION NNP NNP O
: : : O
Blood NNP NNP O
pressure NN NN O
is VBZ VBZ O
136/60 CD CD O
, , , O
pulse NN NN O
74 CD CD O
, , , O
temperature NN NN O
97 CD CD O
, , , O
and CC CC O
weight NN NN O
222 CD CD O
pounds NNS NNS O
. . . O
   
General NNP NNP O
appearance NN NN O
: : : O
She PRP PRP O
looks VBZ VBZ O
remarkably RB RB O
well RB RB O
given VBN VBN O
everything NN NN O
she PRP PRP O
has VBZ VBZ O
gone VBN VBN O
through IN IN O
. . . O
   
HEENT NNP NNP O
is VBZ VBZ O
unremarkable JJ JJ O
. . . O
   
Neck NN NN O
is VBZ VBZ O
supple JJ JJ O
. . . O
   
No DT DT O
lymphadenopathy NN NN O
, , , O
no DT DT O
JVD NNP NNP O
. . . O
   
Lungs NNP NNP O
are VBP VBP O
clear JJ JJ O
. . . O
   
Heart NNP NNP O
irregularly RB RB O
irregular NN NN O
without IN IN O
murmurs NNS NNS O
. . . O
   
Abdomen NNP NNP O
is VBZ VBZ O
soft JJ JJ O
, , , O
nontender NN NN O
, , , O
without IN IN O
organomegaly NN NN O
. . . O
   
Extremities NNP NNP O
without IN IN O
edema NN NN O
. . . O
   
LABORATORIES NNP NNP O
: : : O
Drawn VBN VBN O
by IN IN O
the DT DT O
VNA NNP NNP O
on IN IN O
01/04/80 CD CD I-DATE
shows VBZ VBZ O
hematocrit NN NN O
of IN IN O
28.6 CD CD O
, , , O
INR NNP NNP O
2.1 CD CD O
on IN IN O
December NNP NNP I-DATE
9 CD CD O
, , , O
2079 CD CD I-DATE
as RB RB O
well RB RB O
as IN IN O
potassium NN NN O
3.9 CD CD O
and CC CC O
creatinine NN NN O
3.2 CD CD O
. . . O
   
IMPRESSION NNP NNP O
AND CC CC O
PLAN NNP NNP O
: : : O
   
1 CD CD O
. . . O
Congestive NNP NNP O
heart NN NN O
failure NN NN O
, , , O
diastolic JJ JJ O
dysfunction NN NN O
. . . O
   
She PRP PRP O
is VBZ VBZ O
currently RB RB O
euvolemic JJ JJ O
with IN IN O
a DT DT O
weight NN NN O
of IN IN O
222 CD CD O
pounds NNS NNS O
. . . O
   
She PRP PRP O
will MD MD O
check VB VB O
daily JJ JJ O
weights NNS NNS O
. . . O
   
I PRP PRP O
will MD MD O
speak VB VB O
to TO TO O
Dr NNP NNP O
. . . O
Vandiver NNP NNP I-DOCTOR
, , , O
her PRP$ PRP$ O
cardiologist NN NN O
whom WP WP O
she PRP PRP O
is VBZ VBZ O
seeing VBG VBG O
next JJ JJ O
week NN NN O
about IN IN O
getting VBG VBG O
her PRP$ PRP$ O
enrolled JJ JJ O
in IN IN O
the DT DT O
HH NNP NNP I-HOSPITAL
Cardiac NNP NNP O
Rehab NNP NNP O
Center NNP NNP O
. . . O
   
Meanwhile NNP NNP O
, , , O
she PRP PRP O
will MD MD O
call VB VB O
me PRP PRP O
for IN IN O
any DT DT O
fluctuations NNS NNS O
in IN IN O
weight NN NN O
. . . O
   
2 CD CD O
. . . O
Atrial NNP NNP O
fibrillation NN NN O
, , , O
stable JJ JJ O
and CC CC O
rate NN NN O
controlled VBN VBN O
. . . O
   
Coumadin NNP NNP O
anticoagulation NN NN O
followed VBN VBN O
by IN IN O
the DT DT O
HH NNP NNP I-HOSPITAL
Hematology NNP NNP O
Department NNP NNP O
. . . O
   
3 CD CD O
. . . O
COPD NNP NNP O
, , , O
for IN IN O
now RB RB O
, , , O
she PRP PRP O
remains VBZ VBZ O
on IN IN O
Spiriva NNP NNP O
and CC CC O
Flovent NNP NNP O
as RB RB O
well RB RB O
as IN IN O
oxygen NN NN O
2 CD CD O
liters NNS NNS O
per IN IN O
minute NN NN O
. . . O
   
We PRP PRP O
will MD MD O
see VB VB O
how WRB WRB O
she PRP PRP O
does VBZ VBZ O
; : : O
   
she PRP PRP O
may MD MD O
benefit VB VB O
from IN IN O
a DT DT O
trial NN NN O
of IN IN O
Advair NNP NNP O
. . . O
   
4 CD CD O
. . . O
Chronic NNP NNP O
renal JJ JJ O
insufficiency NN NN O
. . . O
   
Creatinine NNP NNP O
at IN IN O
baseline NN NN O
of IN IN O
3.2 CD CD O
. . . O
   
She PRP PRP O
will MD MD O
need VB VB O
to TO TO O
be VB VB O
watched VBN VBN O
closely RB RB O
. . . O
   
She PRP PRP O
expressed VBD VBD O
interest NN NN O
in IN IN O
possibility NN NN O
of IN IN O
her PRP$ PRP$ O
renal JJ JJ O
transplant NN NN O
should MD MD O
that VB VB O
become VB VB O
necessary JJ JJ O
. . . O
   
There EX EX O
has VBZ VBZ O
been VBN VBN O
a DT DT O
question NN NN O
as IN IN O
to TO TO O
whether IN IN O
she PRP PRP O
has VBZ VBZ O
renal JJ JJ O
artery NN NN O
stenosis NN NN O
based VBN VBN O
on IN IN O
a DT DT O
Doppler NNP NNP O
ultrasound NN NN O
done VBN VBN O
during IN IN O
rehabilitation NN NN O
. . . O
   
I PRP PRP O
think VBP VBP O
this DT DT O
must MD MD O
have VB VB O
been VBN VBN O
done VBN VBN O
at IN IN O
Brookwood NNP NNP I-HOSPITAL
Hospital NNP NNP I-HOSPITAL
because IN IN O
no DT DT O
studies NNS NNS O
are VBP VBP O
available JJ JJ O
in IN IN O
the DT DT O
HH NNP NNP I-HOSPITAL
system NN NN O
. . . O
   
Dr NNP NNP O
. . . O
Dougherty NNP NNP I-DOCTOR
had VBD VBD O
done VBN VBN O
MRA NNP NNP O
a DT DT O
number NN NN O
of IN IN O
years NNS NNS O
ago RB RB O
, , , O
which WDT WDT O
showed VBD VBD O
no DT DT O
renal JJ JJ O
artery NN NN O
stenosis NN NN O
at IN IN O
that DT DT O
time NN NN O
, , , O
but CC CC O
her PRP$ PRP$ O
worsening VBG VBG O
renal NN NN O
function NN NN O
is VBZ VBZ O
new JJ JJ O
. . . O
   
She PRP PRP O
is VBZ VBZ O
scheduled VBN VBN O
to TO TO O
see VB VB O
Dr NNP NNP O
. . . O
Dougherty NNP NNP I-DOCTOR
next JJ JJ O
week NN NN O
and CC CC O
will MD MD O
follow VB VB O
up RB RB O
with IN IN O
her PRP$ PRP$ O
expressly RB RB O
raising VBG VBG O
this DT DT O
issue NN NN O
. . . O
   
Her PRP$ PRP$ O
son NN NN O
brought VBD VBD O
up RP RP O
the DT DT O
issue NN NN O
of IN IN O
perhaps RB RB O
consolidating VBG VBG O
all DT DT O
her PRP$ PRP$ O
care NN NN O
at IN IN O
the DT DT O
HH NNP NNP I-HOSPITAL
, , , O
in IN IN O
particular JJ JJ O
is VBZ VBZ O
seeing VBG VBG O
a DT DT O
nephrologist NN NN O
here RB RB O
. . . O
   
She PRP PRP O
is VBZ VBZ O
quite RB RB O
fond NN NN O
of IN IN O
Dr NNP NNP O
. . . O
Dougherty NNP NNP I-DOCTOR
who WP WP O
has VBZ VBZ O
cared VBN VBN O
for IN IN O
her PRP$ PRP$ O
for IN IN O
years NNS NNS O
, , , O
but CC CC O
I PRP PRP O
think VBP VBP O
given VBN VBN O
the DT DT O
complexity NN NN O
of IN IN O
medical JJ JJ O
care NN NN O
. . . O
   
this DT DT O
might MD MD O
not RB RB O
be VB VB O
a DT DT O
bad JJ JJ O
idea NN NN O
. . . O
   
She PRP PRP O
is VBZ VBZ O
going VBG VBG O
to TO TO O
discuss VB VB O
with IN IN O
Dr NNP NNP O
. . . O
Dougherty NNP NNP I-DOCTOR
and CC CC O
I PRP PRP O
will MD MD O
E-mail NNP NNP O
Dr NNP NNP O
. . . O
Dougherty NNP NNP I-DOCTOR
as RB RB O
well RB RB O
. . . O
   
5 CD CD O
. . . O
GI NNP NNP O
. . . O
   
She PRP PRP O
was VBD VBD O
noted VBN VBN O
to TO TO O
have VB VB O
Barrett NNP NNP O
's POS POS O
esophagus NN NN O
and CC CC O
tubulovillous JJ JJ O
adenoma NN NN O
on IN IN O
exam NN NN O
and CC CC O
she PRP PRP O
will MD MD O
need VB VB O
to TO TO O
have VB VB O
followup NN NN O
within IN IN O
1 CD CD O
year NN NN O
for IN IN O
this DT DT O
. . . O
   
6 CD CD O
. . . O
Heme NNP NNP O
. . . O
   
Her PRP$ PRP$ O
anemia NN NN O
is VBZ VBZ O
a DT DT O
combination NN NN O
of IN IN O
iron NN NN O
deficiency NN NN O
and CC CC O
anemia NN NN O
of IN IN O
renal JJ JJ O
disease NN NN O
. . . O
   
She PRP PRP O
needed VBD VBD O
several JJ JJ O
transfusions NNS NNS O
during IN IN O
the DT DT O
hospitalization NN NN O
. . . O
   
She PRP PRP O
is VBZ VBZ O
scheduled VBN VBN O
to TO TO O
see VB VB O
Hematology NNP NNP O
at IN IN O
Stone-Wheeling NNP NNP I-HOSPITAL
in IN IN O
January NNP NNP I-DATE
. . . O
   
In IN IN O
the DT DT O
meantime NN NN O
, , , O
I PRP PRP O
have VBP VBP O
spoken VBN VBN O
to TO TO O
Dr NNP NNP O
. . . O
Dougherty NNP NNP I-DOCTOR
who WP WP O
agrees VBZ VBZ O
to TO TO O
monitor VB VB O
her PRP PRP O
in IN IN O
the DT DT O
Renal NNP NNP O
Department NNP NNP O
at IN IN O
St NNP NNP O
. . . O
Mary NNP NNP O
's POS POS O
. . . O
   
If IN IN O
necessary JJ JJ O
, , , O
they PRP PRP O
can MD MD O
give VB VB O
her PRP$ PRP$ O
intravenous JJ JJ O
iron NN NN O
. . . O
   
I PRP PRP O
will MD MD O
check VB VB O
a DT DT O
hematocrit NN NN O
and CC CC O
iron NN NN O
stores NNS NNS O
today NN NN O
and CC CC O
fax NN NN O
them PRP PRP O
over IN IN O
to TO TO O
Dr NNP NNP O
. . . O
Dougherty NNP NNP I-DOCTOR
. . . O
   
7 CD CD O
. . . O
Health NNP NNP O
care NN NN O
maintenance NN NN O
. . . O
   
Labs NNP NNP O
today NN NN O
. . . O
   
H1N1 NNP NNP O
vaccine NN NN O
today NN NN O
. . . O
   
Son NNP NNP O
, , , O
Brendon NNP NNP I-PATIENT
Ambrose NNP NNP I-PATIENT
is VBZ VBZ O
her PRP$ PRP$ O
healthcare NN NN O
proxy NN NN O
and CC CC O
I PRP PRP O
have VBP VBP O
put VBN VBN O
his PRP$ PRP$ O
name NN NN O
in IN IN O
the DT DT O
Advanced NNP NNP O
directive JJ JJ O
file NN NN O
on IN IN O
the DT DT O
LMR NNP NNP O
. . . O
   
She PRP PRP O
wishes VBZ VBZ O
to TO TO O
be VB VB O
full JJ JJ O
code NN NN O
at IN IN O
present JJ JJ O
. . . O
   
I PRP PRP O
will MD MD O
see VB VB O
her PRP$ PRP$ O
again RB RB O
in IN IN O
4 CD CD O
weeks NNS NNS O
. . . O
   
Visit NNP NNP O
length NN NN O
60 CD CD O
minutes NNS NNS O
. . . O
   
_____________________________ NN NN O
_ NN NN O
Wendy NNP NNP I-DOCTOR
P NN NN I-DOCTOR
Nowak NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
eScription NN NN O
document:2-22566361 JJ JJ O
CSSten NNP NNP O
Tel NNP NNP O
DD NNP NNP O
: : : O
12/12/79 CD CD I-DATE
DT NNP NNP O
: : : O
12/12/79 CD CD I-DATE
DV NNP NNP O
: : : O
12/12/79 CD CD I-DATE
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2082-10-31 NN NN I-DATE
Team NNP NNP O
B NNP NNP O
Internal NNP NNP O
Medicine NNP NNP O
Intern NNP NNP O
Admission NNP NNP O
Note VB VB O
Louise NNP NNP I-PATIENT
Urquhart NNP NNP I-PATIENT
MR NNP NNP O
# # # O
2072665 CD CD I-MEDICALRECORD
Date NN NN O
of IN IN O
Admission NNP NNP O
: : : O
10/30/82 CD CD I-DATE
PCP NNP NNP O
: : : O
Dr NNP NNP O
. . . O
Tatyana NNP NNP I-DOCTOR
Butler NNP NNP I-DOCTOR
( ( ( O
Solemar NNP NNP I-HOSPITAL
Hospital NNP NNP I-HOSPITAL
) ) ) O
ID/CC NNP NNP O
: : : O
75 CD CD I-AGE
yo NN NN O
F NN NN O
with IN IN O
HTN NNP NNP O
, , , O
DM2 NNP NNP O
, , , O
RCC NNP NNP O
s/p NN NN O
right NN NN O
radical JJ JJ O
nephrectomy NN NN O
2079 CD CD I-DATE
presents NNS NNS O
with IN IN O
hypertensive JJ JJ O
urgency NN NN O
HPI NNP NNP O
: : : O
Has VBZ VBZ O
h/o NN NN O
HTN NNP NNP O
, , , O
saw VBD VBD O
her PRP$ PRP$ O
PCP NNP NNP O
in IN IN O
September NNP NNP I-DATE
, , , O
BP NNP NNP O
168/78 CD CD O
, , , O
supposed VBN VBN O
to TO TO O
be VB VB O
on IN IN O
cozaar NN NN O
50 CD CD O
mg NN NN O
BID NNP NNP O
, , , O
added VBD VBD O
HCTZ NNP NNP O
25 CD CD O
mg NN NN O
QD NNP NNP O
. . . O
   
However RB RB O
, , , O
patient NN NN O
has VBZ VBZ O
only RB RB O
been VBN VBN O
taking VBG VBG O
cozaar NN NN O
50 CD CD O
mg NN NN O
QD NNP NNP O
. . . O
   
Needed NNP NNP O
renewal NN NN O
of IN IN O
her PRP$ PRP$ O
prescription NN NN O
, , , O
was VBD VBD O
sent VBN VBN O
to TO TO O
medical JJ JJ O
walk NN NN O
in IN IN O
clinic JJ JJ O
prior NN NN O
to TO TO O
filling VBG VBG O
it PRP PRP O
, , , O
found VBD VBD O
BP NNP NNP O
to TO TO O
be VB VB O
230/110 CD CD O
. . . O
   
Had VBD VBD O
HA NNP NNP O
2 CD CD O
nights NNS NNS O
ago RB RB O
lasting JJ JJ O
couple NN NN O
hours NNS NNS O
, , , O
posterior NN NN O
neck NN NN O
across IN IN O
top NN NN O
of IN IN O
head NN NN O
. . . O
   
While IN IN O
in IN IN O
waiting VBG VBG O
room NN NN O
also RB RB O
had VBD VBD O
HA NNP NNP O
, , , O
4/10 CD CD O
from IN IN O
back RB RB O
of IN IN O
neck NN NN O
across IN IN O
top NN NN O
of IN IN O
head NN NN O
. . . O
   
No DT DT O
other JJ JJ O
sx JJ JJ O
- - - O
no DT DT O
CP NNP NNP O
, , , O
SOB NNP NNP O
, , , O
visual JJ JJ O
changes NNS NNS O
, , , O
abdominal JJ JJ O
pain NN NN O
, , , O
unilateral JJ JJ O
weakness NN NN O
, , , O
numbness NN NN O
, , , O
hematuria NN NN O
. . . O
   
Was VBD VBD O
stressed VBN VBN O
out IN IN O
over IN IN O
argument NN NN O
with IN IN O
granddaughter NN NN O
yesterday NN NN O
. . . O
   
In IN IN O
ED NNP NNP O
afebrile IN IN O
T NN NN O
96.5 CD CD O
, , , O
BP NNP NNP O
235/92 CD CD O
, , , O
HR NNP NNP O
91 CD CD O
, , , O
RR NNP NNP O
   
18 CD CD O
. . . O
No DT DT O
evidence NN NN O
papilledema NN NN O
, , , O
no DT DT O
focal JJ JJ O
neurologic JJ JJ O
signs NNS NNS O
. . . O
   
EKG NNP NNP O
with IN IN O
new JJ JJ O
TWI NNP NNP O
V1-V4, NNP NNP O
head NN NN O
CT NNP NNP O
and CC CC O
CXR NNP NNP O
unremarkable JJ JJ O
. . . O
   
Given VBN VBN O
hydralazine NN NN O
10 CD CD O
mg NN NN O
IV NNP NNP O
x SYM SYM O
2 CD CD O
, , , O
ativan NN NN O
1 CD CD O
mg NN NN O
IV NNP NNP O
x1 NN NN O
, , , O
and CC CC O
lopressor NN NN O
25 CD CD O
mg NN NN O
PO NNP NNP O
x1 NN NN O
, , , O
BP NNP NNP O
improved VBD VBD O
to TO TO O
160's/80's. CD CD O
   
ROS NNP NNP O
: : : O
No DT DT O
F/C/NS NNP NNP O
. . . O
   
No DT DT O
change NN NN O
in IN IN O
weight/appetite NN NN O
. . . O
   
No DT DT O
CP/Palpitations/Orthopnea/PND/LE NNP NNP O
edema/Claudication NN NN O
. . . O
   
No DT DT O
SOB/cough/hemoptysis/wheezing/sore NNP NNP O
throat/rash NN NN O
. . . O
   
No DT DT O
N/V/D/hematochezia/melena NNP NNP O
. . . O
   
No DT DT O
delta NN NN O
MS/LOC NNP NNP O
. . . O
   
No DT DT O
slurring NN NN O
of IN IN O
speech NN NN O
, , , O
unilateral JJ JJ O
weakness NN NN O
. . . O
   
No DT DT O
dysuria NN NN O
. . . O
   
+ NN NN O
Right RB RB O
heel NN NN O
pain NN NN O
since IN IN O
jumping VBG VBG O
to TO TO O
grab VB VB O
her PRP$ PRP$ O
dog NN NN O
2 CD CD O
weeks NNS NNS O
ago RB RB O
. . . O
   
Otherwise RB RB O
negative JJ JJ O
in IN IN O
detail NN NN O
. . . O
   
PMH NNP NNP O
: : : O
HTN NNP NNP O
DM2 NNP NNP O
- : : O
x SYM SYM O
5 CD CD O
yrs NN NN O
, , , O
no DT DT O
retinopathy NN NN O
, , , O
nephropathy NN NN O
, , , O
neuropathy NN NN O
, , , O
HBA1C NNP NNP O
7.2 CD CD O
7/26 CD CD I-DATE
RCC NNP NNP O
s/p NN NN O
right NN NN O
radical JJ JJ O
nephrectomy NN NN O
2079 CD CD I-DATE
, , , O
4 CD CD O
cm NN NN O
, , , O
grade NN NN O
II/IV NNP NNP O
, , , O
confined VBN VBN O
in IN IN O
capsule NN NN O
S/p NNP NNP O
colonoscopic NN NN O
polypectomy NN NN O
tubular NN NN O
adenoma NN NN O
2079 CD CD I-DATE
Diverticulosis NNP NNP O
Osteoporosis NNP NNP O
Medications NNP NNP O
: : : O
Cozaar NNP NNP O
50 CD CD O
mg NN NN O
PO NNP NNP O
BID NNP NNP O
( ( ( O
only RB RB O
taking VBG VBG O
50 CD CD O
QD NNP NNP O
) ) ) O
HCTZ NNP NNP O
25 CD CD O
mg NN NN O
PO NNP NNP O
QD NNP NNP O
( ( ( O
added VBD VBD O
9/82 CD CD I-DATE
, , , O
not RB RB O
taking VBG VBG O
) ) ) O
Glyburide NNP NNP O
5 CD CD O
mg NN NN O
PO NNP NNP O
QD NNP NNP O
Premarin NNP NNP O
PO NNP NNP O
QHS NNP NNP O
( ( ( O
not RB RB O
taking VBG VBG O
) ) ) O
Fosamax NNP NNP O
70 CD CD O
mg NN NN O
PO NNP NNP O
QWK NNP NNP O
( ( ( O
not RB RB O
taking VBG VBG O
) ) ) O
Ativan NNP NNP O
0.5 CD CD O
mg NN NN O
PO NNP NNP O
QD NNP NNP O
PRN NNP NNP O
Tums NNP NNP O
MVI NNP NNP O
Allergies NNP NNP O
: : : O
PCN NNP NNP O
, , , O
sulfa NN NN O
rash NN NN O
, , , O
ACE-I NNP NNP O
cough NN NN O
, , , O
codeine NN NN O
GI NNP NNP O
upset VBD VBD O
SH NNP NNP I-HOSPITAL
: : : O
Patient NNP NNP O
lives NNS NNS O
in IN IN O
Marianna NNP NNP I-CITY
with IN IN O
husband NN NN O
of IN IN O
54 CD CD O
yrs NNS NNS O
. . . O
   
Used VBN VBN O
to TO TO O
work VB VB O
at IN IN O
Filenesas NNP NNP O
a DT DT O
salesperson NN NN I-PROFESSION
. . . O
   
Son NNP NNP O
handicapped VBD VBD O
after IN IN O
hit NN NN O
by IN IN O
drunk JJ JJ O
driver NN NN O
9 CD CD O
yrs NNS NNS O
ago RB RB O
, , , O
this DT DT O
remains VBZ VBZ O
a DT DT O
significant JJ JJ O
stressor NN NN O
for IN IN O
her PRP PRP O
. . . O
   
Tob NNP NNP O
: : : O
Very RB RB O
rare JJ JJ O
, , , O
quit VBD VBD O
30 CD CD O
yrs NNS NNS O
ago RB RB O
EtOH NNP NNP O
: : : O
Used VBN VBN O
to TO TO O
drink VB VB O
occasional JJ JJ O
glass NN NN O
wine NN NN O
, , , O
none NN NN O
recently RB RB O
Illicits NNP NNP O
: : : O
Negative NNP NNP O
FH NNP NNP O
: : : O
No DT DT O
MI NNP NNP O
, , , O
cancer NN NN O
. . . O
   
Brother NNP NNP O
with IN IN O
poor JJ JJ O
circulation NN NN O
. . . O
   
Exam NNP NNP O
: : : O
VS NNP NNP O
: : : O
T NN NN O
= SYM SYM O
98.2 CD CD O
HR NNP NNP O
= SYM SYM O
68 CD CD O
BP NNP NNP O
= SYM SYM O
152/81 CD CD O
RR NNP NNP O
= SYM SYM O
18 CD CD O
General NNP NNP O
: : : O
NAD NNP NNP O
, , , O
well RB RB O
appearing VBG VBG O
HEENT NNP NNP O
: : : O
NC/AT NNP NNP O
, , , O
PERRL NNP NNP O
, , , O
anicteric JJ JJ O
. . . O
   
EOMI NNP NNP O
. . . O
   
Fundi NNP NNP O
poorly RB RB O
visualized JJ JJ O
. . . O
   
OP NNP NNP O
w NN NN O
/ NN NN O
MMM NNP NNP O
, , , O
no DT DT O
erythema NN NN O
or CC CC O
injection NN NN O
. . . O
   
Skin NNP NNP O
: : : O
No DT DT O
rashes NNS NNS O
Neck NNP NNP O
: : : O
Supple NNP NNP O
, , , O
full JJ JJ O
ROM NNP NNP O
, , , O
no DT DT O
JVD NNP NNP O
, , , O
2 CD CD O
+ NN NN O
carotids NNS NNS O
w/o NN NN O
bruits NNS NNS O
, , , O
no DT DT O
thyromegaly NN NN O
or CC CC O
nodules NNS NNS O
, , , O
no DT DT O
nodes NNS NNS O
Chest NN NN O
: : : O
CTA&P NNP NNP O
bilaterally RB RB O
CVS NNP NNP O
: : : O
RRR NNP NNP O
nl NN NN O
S1 NNP NNP O
S2 NNP NNP O
, , , O
no DT DT O
m/r/g NN NN O
Abd NNP NNP O
: : : O
nl NN NN O
BS NNP NNP O
, , , O
soft JJ JJ O
, , , O
non-tender JJ JJ O
, , , O
no DT DT O
HSM NNP NNP O
, , , O
no DT DT O
abdominal JJ JJ O
bruits NNS NNS O
Extr NNP NNP O
: : : O
no DT DT O
c/c/e NN NN O
2 CD CD O
+ NN NN O
DP NNP NNP O
's POS POS O
bilaterally RB RB O
Neuro NNP NNP O
: : : O
AAOX3 NNP NNP O
, , , O
MS NNP NNP O
nl NN NN O
, , , O
CN NNP NNP O
II NNP NNP O
through IN IN O
XII NNP NNP O
intact JJ JJ O
, , , O
Motor NNP NNP O
5/5 CD CD O
UE NNP NNP O
and CC CC O
LE NNP NNP O
, , , O
Sensory NNP NNP O
intact JJ JJ O
to TO TO O
LT NNP NNP O
, , , O
vibration NN NN O
sense NN NN O
distally RB RB O
. . . O
   
F NN NN O
to TO TO O
N NNP NNP O
nl NN NN O
, , , O
RAM NNP NNP O
nl NN NN O
. . . O
   
DATA NNP NNP O
: : : O
Chemistry NNP NNP O
: : : O
SH NNP NNP I-HOSPITAL
BLOOD NNP NNP O
30-Oct-2082 NN NN I-DATE
19:57 CD CD O
Plasma NNP NNP O
Sodium NNP NNP O
133 CD CD O
L NNP NNP O
135-145 JJ JJ O
mmol/L NN NN O
Plasma NNP NNP O
Potassium NNP NNP O
5.4 CD CD O
H NNP NNP O
3.4-4.8 JJ JJ O
mmol/L NN NN O
Plasma NNP NNP O
Chloride NNP NNP O
98 CD CD O
L NNP NNP O
100-108 JJ JJ O
mmol/L NN NN O
Plasma NNP NNP O
Carbon NNP NNP O
Dioxide NNP NNP O
26.6 CD CD O
24.0-30.0 JJ JJ O
mmol/L NN NN O
Calcium NNP NNP O
10.4 CD CD O
8.5-10.5 JJ JJ O
mg/dl NN NN O
Phosphorus NNP NNP O
2.4 CD CD O
L NNP NNP O
2.6-4.5 JJ JJ O
mg/dl NN NN O
Magnesium NNP NNP O
1.6 CD CD O
1.4-2.0 JJ JJ O
meq/L NN NN O
Plasma NNP NNP O
Urea NNP NNP O
Nitrogen NNP NNP O
18 CD CD O
8-25 JJ JJ O
mg/dl NN NN O
Plasma NNP NNP O
Creatinine NNP NNP O
1.1 CD CD O
0.6-1.5 NN NN O
mg/dl NN NN O
Plasma NNP NNP O
Glucose NNP NNP O
230 CD CD O
H NNP NNP O
70-110 CD CD O
mg/dl NN NN O
Total NNP NNP O
Protein NNP NNP O
8.2 CD CD O
H NNP NNP O
6.0-8.0 JJ JJ O
g/dl NN NN O
Albumin NNP NNP O
4.0 CD CD O
3.1-4.3 JJ JJ O
g/dl NN NN O
Globulin NNP NNP O
4.2 CD CD O
H NNP NNP O
2.6-4.1 JJ JJ O
g/dl NN NN O
Direct NNP NNP O
Bilirubin NNP NNP O
0.2 CD CD O
0-0.4 NN NN O
mg/dl NN NN O
Total NNP NNP O
Bilirubin NNP NNP O
0.4 CD CD O
0-1.0 NN NN O
mg/dl NN NN O
Alkaline NNP NNP O
Phosphatase NNP NNP O
94 CD CD O
30-100 JJ JJ O
U/L NNP NNP O
Transaminase-SGPT NNP NNP O
27 CD CD O
7-30 NN NN O
U/L NNP NNP O
Transaminase-SGOT NNP NNP O
53 CD CD O
H NNP NNP O
9-25 JJ JJ O
U/L NNP NNP O
Creatine NNP NNP O
Kinase NNP NNP O
108 CD CD O
40-150 JJ JJ O
U/L NNP NNP O
SH NNP NNP I-HOSPITAL
BLOOD NNP NNP O
30-Oct-2082 NN NN I-DATE
23:10 CD CD O
Creatine NNP NNP O
Kinase NNP NNP O
Isoenzy NNP NNP O
1.9 CD CD O
0.0-6.9 NN NN O
ng/ml NN NN O
Troponin-T NNP NNP O
< NN NN O
0.01 CD CD O
0.00-0.09 NN NN O
ng/ml NN NN O
Creatine NNP NNP O
Kinase NNP NNP O
203 CD CD O
H NNP NNP O
40-150 JJ JJ O
U/L NNP NNP O
Heme NNP NNP O
: : : O
SH NNP NNP I-HOSPITAL
BLOOD NNP NNP O
30-Oct-2082 NN NN I-DATE
19:52 CD CD O
WBC NNP NNP O
14.2 CD CD O
H NNP NNP O
4.5-11.0 JJ JJ O
th/cmm NN NN O
HCT NNP NNP O
42.0 CD CD O
36.0-46.0 CD CD O
% NN NN O
HGB NNP NNP O
14.2 CD CD O
12.0-16.0 JJ JJ O
gm/dl NN NN O
RBC NNP NNP O
4.78 CD CD O
4.00-5.20 JJ JJ O
mil/cmm NN NN O
PLT NNP NNP O
220 CD CD O
150-350 JJ JJ O
th/cumm NN NN O
MCV NNP NNP O
88 CD CD O
80-100 JJ JJ O
fl NN NN O
MCH NNP NNP O
29.7 CD CD O
26.0-34.0 JJ JJ O
pg/rbc NN NN O
MCHC NNP NNP O
33.8 CD CD O
31.0-37.0 JJ JJ O
g/dl NN NN O
RDW NNP NNP O
12.8 CD CD O
11.5-14.5 JJ JJ O
% NN NN O
DIFFERENTIAL NNP NNP O
REQUEST NNP NNP O
RECEIVED NNP NNP O
Diff NNP NNP O
Method NNP NNP O
Auto NNP NNP O
Poly NNP NNP O
71 CD CD O
H NNP NNP O
40-70 CD CD O
% NN NN O
Lymphs NNP NNP O
23 CD CD O
22-44 JJ JJ O
% NN NN O
Monos NNP NNP O
3 CD CD O
L NNP NNP O
4-11 CD CD O
% NN NN O
EOS NNP NNP O
2 CD CD O
0-8 NN NN O
% NN NN O
Basos NNP NNP O
1 CD CD O
0-3 NN NN O
% NN NN O
Absolute NNP NNP O
Neuts NNP NNP O
10.27 CD CD O
H NNP NNP O
1.8-7.7 JJ JJ O
th/cmm NN NN O
Absolute NNP NNP O
Lymphs NNP NNP O
3.20 CD CD O
1.0-4.8 JJ JJ O
th/cmm NN NN O
Absolute NNP NNP O
Monos NNP NNP O
0.46 CD CD O
H NNP NNP O
0.2-0.4 JJ JJ O
th/cmm NN NN O
Absolute NNP NNP O
EOS NNP NNP O
0.22 CD CD O
0.1-0.3 NN NN O
th/cmm NN NN O
Absolute NNP NNP O
Basos NNP NNP O
0.07 CD CD O
0.0-0.3 NN NN O
th/cmm NN NN O
Urinalysis NNP NNP O
: : : O
Pending NNP NNP O
Microbiology NNP NNP O
: : : O
None NN NN O
CXR NNP NNP O
: : : O
Official NNP NNP O
read NN NN O
pending VBG VBG O
, , , O
no DT DT O
infiltrates NNS NNS O
, , , O
CHF NNP NNP O
Head NNP NNP O
CT NNP NNP O
: : : O
FINDINGS NNS NNS O
: : : O
Dystrophic NNP NNP O
calcification NN NN O
in IN IN O
the DT DT O
basal NN NN O
ganglia NN NN O
bilaterally RB RB O
. . . O
   
Head NNP NNP O
CT NNP NNP O
otherwise RB RB O
negative JJ JJ O
. . . O
   
No DT DT O
intracranial JJ JJ O
hemorrhage NN NN O
, , , O
mass NN NN O
, , , O
mass NN NN O
effect NN NN O
, , , O
or CC CC O
edema NN NN O
. . . O
   
No DT DT O
gross JJ JJ O
evidence NN NN O
of IN IN O
acute JJ JJ O
infarction NN NN O
, , , O
although IN IN O
MRI NNP NNP O
with IN IN O
diffusion NN NN O
weighted JJ JJ O
imaging NN NN O
would MD MD O
be VB VB O
more RBR RBR O
sensitive JJ JJ O
. . . O
   
Intracranial NNP NNP O
arterial JJ JJ O
calcification NN NN O
. . . O
   
Bilateral NNP NNP O
lens VBZ VBZ O
implants NNS NNS O
. . . O
   
IMPRESSION NNP NNP O
: : : O
Essentially RB RB O
normal JJ JJ O
head NN NN O
CT NNP NNP O
. . . O
   
EKG NNP NNP O
: : : O
NSR NNP NNP O
90 CD CD O
BPM NNP NNP O
, , , O
nl NN NN O
intervals NNS NNS O
, , , O
nl NN NN O
axis NNS NNS O
, , , O
deepening VBG VBG O
of IN IN O
old JJ JJ O
TWI NNP NNP O
aVL NN NN O
, , , O
new JJ JJ O
TWI NNP NNP O
V1-V4, NNP NNP O
isolated VBD VBD O
q NN NN O
in IN IN O
III NNP NNP O
__________________________________________ NN NN O
_ NN NN O
Impression NNP NNP O
: : : O
75 CD CD I-AGE
yo NN NN O
F NN NN O
with IN IN O
HTN NNP NNP O
, , , O
DM2 NNP NNP O
, , , O
RCC NNP NNP O
s/p NN NN O
right NN NN O
radical JJ JJ O
nephrectomy NN NN O
2079 CD CD I-DATE
presents NNS NNS O
with IN IN O
hypertensive JJ JJ O
urgency NN NN O
. . . O
   
Not RB RB O
taking VBG VBG O
all DT DT O
of IN IN O
prescribed VBN VBN O
meds NNS NNS O
. . . O
   
Could MD MD O
have VB VB O
left VBN VBN O
sided VBN VBN O
renal JJ JJ O
artery NN NN O
stenosis NN NN O
exacerbating VBG VBG O
HTN NNP NNP O
in IN IN O
setting VBG VBG O
of IN IN O
unilateral JJ JJ O
kidney NN NN O
, , , O
K NNP NNP O
is VBZ VBZ O
elevated VBN VBN O
, , , O
although IN IN O
Cr NNP NNP O
normal JJ JJ O
on IN IN O
cozaar NN NN O
. . . O
   
Needs NNP NNP O
tight JJ JJ O
BP NNP NNP O
control NN NN O
esp NN NN O
in IN IN O
setting VBG VBG O
of IN IN O
DM NNP NNP O
to TO TO O
prevent VB VB O
nephrosclerosis NNS NNS O
. . . O
   
Plan NNP NNP O
: : : O
HTN NNP NNP O
- - - O
BP NNP NNP O
now RB RB O
better JJR JJR O
controlled JJ JJ O
, , , O
cont NN NN O
to TO TO O
cycle NN NN O
q1 NN NN O
hr NN NN O
for IN IN O
now RB RB O
. . . O
   
Will NNP NNP O
repeat VB VB O
EKG NNP NNP O
, , , O
ROMI NNP NNP O
with IN IN O
serial JJ JJ O
cardiac JJ JJ O
enzymes NNS NNS O
. . . O
   
ASA NNP NNP O
, , , O
monitor NN NN O
. . . O
   
Cont NNP NNP O
cozaar NN NN O
50 CD CD O
mg NN NN O
qd NN NN O
( ( ( O
may MD MD O
need VB VB O
to TO TO O
d/c VB VB O
or CC CC O
decrease VB VB O
dose NN NN O
if IN IN O
K NNP NNP O
remains VBZ VBZ O
elevated JJ JJ O
) ) ) O
and CC CC O
start VB VB O
lopressor NN NN O
25 CD CD O
TID NNP NNP O
and CC CC O
titrate VB VB O
up RB RB O
as IN IN O
needed VBN VBN O
for IN IN O
BP NNP NNP O
control NN NN O
. . . O
   
Will MD MD O
not RB RB O
attempt VB VB O
to TO TO O
lower JJR JJR O
BP NNP NNP O
beyond IN IN O
150-160's NN NN O
for IN IN O
now RB RB O
to TO TO O
prevent VB VB O
drop NN NN O
in IN IN O
cerebral JJ JJ O
perfusion NN NN O
pressure NN NN O
. . . O
   
Cont NNP NNP O
ativan NN NN O
0.5-1 NN NN O
mg NN NN O
PO NNP NNP O
BID NNP NNP O
PRN NNP NNP O
. . . O
   
Consider NNP NNP O
MRI/MRA NNP NNP O
to TO TO O
assess VB VB O
for IN IN O
RAS NNP NNP O
given VBN VBN O
such JJ JJ O
severe JJ JJ O
BP NNP NNP O
elevation NN NN O
. . . O
   
Strict NNP NNP O
I/O's NNP NNP O
. . . O
   
F/E/N NNP NNP O
- : : O
Kayexalate NNP NNP O
30g CD CD O
x SYM SYM O
1 CD CD O
, , , O
recheck NN NN O
K NNP NNP O
in IN IN O
AM NNP NNP O
, , , O
consider NN NN O
lasix NN NN O
. . . O
   
DM NNP NNP O
- : : O
Cont NNP NNP O
glyburide NN NN O
, , , O
check NN NN O
QID NNP NNP O
FS NNP NNP O
with IN IN O
insulin NN NN O
SS NNP NNP O
. . . O
   
Diabetic NNP NNP O
diet NN NN O
Proph NNP NNP O
- : : O
Nexium NNP NNP O
, , , O
SC NNP NNP O
heparin NN NN O
________________________________ NN NN O
_ NN NN O
Xander NNP NNP I-DOCTOR
H. NN NN I-DOCTOR
Leonard NNP NNP I-DOCTOR
, , , O
MD NNP NNP O
Pager NNP NNP O
#77615 NN NN O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2097-08-21 JJ JJ I-DATE
Neil NNP NNP I-DOCTOR
, , , O
Ruba NNP NNP I-DOCTOR
Internal NNP NNP O
Medicine NNP NNP O
Associates NNPS NNPS O
, , , O
Suite NNP NNP O
M NNP NNP O
Shady NNP NNP I-HOSPITAL
Rest NNP NNP I-HOSPITAL
Care NNP NNP I-HOSPITAL
Center NNP NNP I-HOSPITAL
, , , O
4th JJ JJ O
Floor NNP NNP O
, , , O
Room NNP NNP O
483 CD CD O
Arroyo NNP NNP I-CITY
Grande NNP NNP I-CITY
, , , O
KS NNP NNP I-STATE
, , , O
19741-6273 NN NN I-ZIP
RE NNP NNP O
: : : O
ALAINA NNP NNP I-PATIENT
ROJAS NNP NNP I-PATIENT
08/21/2097 CD CD I-DATE
Admission NNP NNP O
Note NN NN O
87 CD CD I-AGE
yo NN NN O
woman NN NN O
with IN IN O
bilat NN NN O
leg NN NN O
swelling VBG VBG O
for IN IN O
several JJ JJ O
weeks NNS NNS O
; : : O
   
now RB RB O
with IN IN O
1 CD CD O
week NN NN O
of IN IN O
redness NN NN O
L NNP NNP O
> NN NN O
R. NN NN O
Problems NNS NNS O
: : : O
Diabetes NNP NNP O
mellitus NN NN O
- : : O
HgB NNP NNP O
A1c7.6 NNP NNP O
Hypertension NNP NNP O
- : : O
adequate JJ JJ O
control NN NN O
Hyperlipidemia NNP NNP O
Chronic NNP NNP O
renal JJ JJ O
failure NN NN O
Iron NNP NNP O
deficiency NN NN O
anemia NN NN O
Allergies NNP NNP O
: : : O
No DT DT O
known VBN VBN O
drug NN NN O
allergy NN NN O
Medications NNP NNP O
: : : O
vitamin NN NN O
d SYM SYM O
1000 CD CD O
units NNS NNS O
po NN NN O
daily JJ JJ O
glipizide NN NN O
10 CD CD O
mg NN NN O
po NN NN O
bid NN NN O
take NN NN O
30min CD CD O
before IN IN O
meals NNS NNS O
Prandin NNP NNP O
2 CD CD O
mg NN NN O
before IN IN O
each DT DT O
meal NN NN O
2 CD CD O
week NN NN O
supply NN NN O
til NN NN O
mail NN NN O
order NN NN O
arrives VBZ VBZ O
ferrous JJ JJ O
sulfate NN NN O
325mg CD CD O
po NN NN O
bid NN NN O
lisinopril NN NN O
40 CD CD O
mg NN NN O
po NN NN O
daily JJ JJ O
Norvasc NNP NNP O
10mg CD CD O
po NN NN O
daily JJ JJ O
metoprolol NN NN O
25mg CD CD O
po NN NN O
take NN NN O
3 CD CD O
tabs NNS NNS O
twice RB RB O
a DT DT O
day NN NN O
lovastatin NN NN O
10mg CD CD O
po NN NN O
qpm NN NN O
take NN NN O
with IN IN O
food NN NN O
furosemide NN NN O
20 CD CD O
mg NN NN O
po NN NN O
daily JJ JJ O
Ecotrin NNP NNP O
325 CD CD O
mg NN NN O
po NN NN O
daily JJ JJ O
Family NNP NNP O
history NN NN O
: : : O
She PRP PRP O
was VBD VBD O
born VBN VBN O
in IN IN O
Arroyo NNP NNP I-CITY
Grande NNP NNP I-CITY
. . . O
   
She PRP PRP O
had VBD VBD O
five CD CD O
children NNS NNS O
; : : O
   
four CD CD O
of IN IN O
them PRP PRP O
are VBP VBP O
alive JJ JJ O
, , , O
all DT DT O
living VBG VBG O
in IN IN O
the DT DT O
area NN NN O
. . . O
   
Husband NNP NNP O
died VBD VBD O
in IN IN O
2080 CD CD I-DATE
. . . O
   
Mother NNP NNP O
had VBD VBD O
Parkinson NNP NNP O
's POS POS O
disease NN NN O
. . . O
   
Sister NNP NNP O
had VBD VBD O
breast NN NN O
cancer NN NN O
at IN IN O
the DT DT O
age NN NN O
of IN IN O
   
72 CD CD I-AGE
. . . O
Social NNP NNP O
history NN NN O
: : : O
Continues NNP NNP O
to TO TO O
get VB VB O
out IN IN O
to TO TO O
the DT DT O
American NNP NNP I-ORGANIZATION
Senior NNP NNP I-ORGANIZATION
Center NNP NNP I-HOSPITAL
, , , O
except IN IN O
on IN IN O
one CD CD O
day NN NN O
. . . O
   
In IN IN O
the DT DT O
spring NN NN I-DATE
, , , O
she PRP PRP O
continues VBZ VBZ O
to TO TO O
get VB VB O
out IN IN O
, , , O
goes VBZ VBZ O
to TO TO O
bingo VB VB O
and CC CC O
continues VBZ VBZ O
to TO TO O
be VB VB O
very RB RB O
active JJ JJ O
. . . O
   
She PRP PRP O
gets VBZ VBZ O
out IN IN O
everyday JJ JJ O
. . . O
   
She PRP PRP O
is VBZ VBZ O
very RB RB O
active JJ JJ O
. . . O
   
Daughters NNS NNS O
are VBP VBP O
very RB RB O
involved VBN VBN O
with IN IN O
her PRP PRP O
. . . O
   
We PRP PRP O
have VBP VBP O
gone VBN VBN O
over IN IN O
in IN IN O
detail NN NN O
on IN IN O
this DT DT O
visit NN NN O
managing VBG VBG O
all DT DT O
of IN IN O
her PRP$ PRP$ O
issues NNS NNS O
. . . O
   
Continues NNP NNP O
to TO TO O
go VB VB O
to TO TO O
the DT DT O
club NN NN O
at IN IN O
Dekalb NNP NNP I-CITY
three CD CD O
times NNS NNS O
a DT DT O
week NN NN O
. . . O
   
Review NNP NNP O
of IN IN O
systems NNS NNS O
: : : O
No DT DT O
change NN NN O
in IN IN O
bowel NN NN O
habits NNS NNS O
, , , O
although IN IN O
she PRP PRP O
is VBZ VBZ O
a DT DT O
little JJ JJ O
bit NN NN O
constipated JJ JJ O
. . . O
   
Urine NNP NNP O
, , , O
no DT DT O
hematuria NN NN O
or CC CC O
urinary JJ JJ O
tract NN NN O
symptoms NNS NNS O
. . . O
   
Cardiac NNP NNP O
: : : O
No DT DT O
chest NN NN O
pain NN NN O
, , , O
shortness NN NN O
of IN IN O
breath NN NN O
, , , O
PND NNP NNP O
, , , O
or CC CC O
orthopnea NN NN O
. . . O
   
Pulmonary NNP NNP O
, , , O
no DT DT O
wheezes NNS NNS O
or CC CC O
asthma NN NN O
symptoms NNS NNS O
. . . O
   
HEENT NNP NNP O
: : : O
No DT DT O
ear NN NN O
or CC CC O
throat NN NN O
symptoms NNS NNS O
. . . O
   
Allergies NNP NNP O
: : : O
No DT DT O
new JJ JJ O
issues NNS NNS O
with IN IN O
that DT DT O
. . . O
   
Neurologic NNP NNP O
: : : O
No DT DT O
new JJ JJ O
issues NNS NNS O
. . . O
   
Psychiatric NNP NNP O
: : : O
Very RB RB O
anxious JJ JJ O
about IN IN O
all DT DT O
of IN IN O
the DT DT O
medications NNS NNS O
she PRP PRP O
has VBZ VBZ O
to TO TO O
take VB VB O
it PRP PRP O
as IN IN O
she PRP PRP O
was VBD VBD O
someone NN NN O
, , , O
who WP WP O
never RB RB O
needed VBN VBN O
pills NNS NNS O
. . . O
   
We PRP PRP O
tried VBD VBD O
to TO TO O
reassure VB VB O
her PRP$ PRP$ O
and CC CC O
spent VBD VBD O
the DT DT O
majority NN NN O
of IN IN O
this DT DT O
45-minute JJ JJ O
visit NN NN O
on IN IN O
that DT DT O
coordinating VBG VBG O
her PRP$ PRP$ O
care NN NN O
. . . O
   
Physical JJ JJ O
Exam NNP NNP O
: : : O
Blood NNP NNP O
pressure NN NN O
: : : O
130/82 CD CD O
Pulse NNP NNP O
: : : O
57 CD CD O
Weight NNP NNP O
: : : O
167 CD CD O
pounds NNS NNS O
Office NNP NNP O
blood NN NN O
glucose NN NN O
fingerstick NN NN O
: : : O
221 CD CD O
at IN IN O
noon NN NN O
Skin NNP NNP O
: : : O
Warm NNP NNP O
and CC CC O
dry JJ JJ O
. . . O
   
No DT DT O
rashes NNS NNS O
Neck NNP NNP O
: : : O
Carotids NNP NNP O
, , , O
normal JJ JJ O
upstroke NN NN O
without IN IN O
bruits NNS NNS O
Nodes NNS NNS O
: : : O
Lymph NNP NNP O
nodes NNS NNS O
, , , O
no DT DT O
lymphadenopathy NN NN O
Breasts NNP NNP O
: : : O
No DT DT O
masses NNS NNS O
, , , O
discharge NN NN O
, , , O
or CC CC O
tenderness NN NN O
Chest NN NN O
: : : O
Lungs NNS NNS O
are VBP VBP O
entirely RB RB O
clear JJ JJ O
with IN IN O
no DT DT O
wheezes NNS NNS O
, , , O
rales NNS NNS O
, , , O
or CC CC O
rhonchi NN NN O
Cor NNP NNP O
: : : O
No DT DT O
murmurs NNS NNS O
, , , O
rubs NNS NNS O
, , , O
or CC CC O
gallops NNS NNS O
, , , O
regular JJ JJ O
rate NN NN O
Abdomen NNP NNP O
: : : O
Nontender NNP NNP O
without IN IN O
masses NNS NNS O
Extrem NNP NNP O
: : : O
violaceous JJ JJ O
L NNP NNP O
shin NN NN O
without IN IN O
obvious JJ JJ O
streaking NN NN O
; : : O
   
swollen VBN VBN O
without IN IN O
tenderness NNS NNS O
. . . O
   
R NN NN O
shin JJ JJ O
present JJ JJ O
but CC CC O
not RB RB O
as IN IN O
severe JJ JJ O
Labs NNP NNP O
: : : O
pending VBG VBG O
Assessment NNP NNP O
and CC CC O
plan NN NN O
: : : O
Admit NNP NNP O
for IN IN O
antibiotics NNS NNS O
IV NNP NNP O
Ruba NNP NNP I-DOCTOR
Neil NNP NNP I-DOCTOR
, , , O
MD NNP NNP O
pager NN NN O
#34596 NN NN O
Signed NNP NNP O
electronically RB RB O
by IN IN O
Ruba NNP NNP I-DOCTOR
Neil NNP NNP I-DOCTOR
, , , O
MD NNP NNP O
Document NNP NNP O
Status NNP NNP O
: : : O
Final NNP NNP O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2066-10-14 JJ JJ I-DATE
HPI NNP NNP O
; : : O
   
pt NN NN O
was VBD VBD O
seen VBN VBN O
at IN IN O
her PRP$ PRP$ O
pulmonary JJ JJ O
specialist NN NN O
yesterday NN NN O
& CC CC O
amp NN NN O
; : : O
   
noted VBN VBN O
to TO TO O
have VB VB O
high JJ JJ O
BP NNP NNP O
188/100 CD CD O
. . . O
   
She PRP PRP O
denies VBZ VBZ O
any DT DT O
headache NN NN O
, , , O
change NN NN O
in IN IN O
vision NN NN O
, , , O
lightheadedness NN NN O
or CC CC O
dizziness NN NN O
. . . O
   
She PRP PRP O
reports NNS NNS O
that IN IN O
she PRP PRP O
has VBZ VBZ O
been VBN VBN O
hospitalized VBN VBN O
twice RB RB O
for IN IN O
hypertension NN NN O
& CC CC O
amp NN NN O
; : : O
   
both DT DT O
times NNS NNS O
she PRP PRP O
was VBD VBD O
asymptomatic JJ JJ O
. . . O
   
Is VBZ VBZ O
on IN IN O
avapro NN NN O
300mg CD CD O
, , , O
labetalol NN NN O
300mg CD CD O
bid NN NN O
& CC CC O
amp NN NN O
; : : O
   
norvasc NN NN O
10mg CD CD O
. . . O
   
Dr NNP NNP O
. . . O
Rosas NNP NNP I-DOCTOR
her PRP$ PRP$ O
PCP NNP NNP O
has VBZ VBZ O
tried VBN VBN O
diuretic JJ JJ O
& CC CC O
amp NN NN O
; : : O
   
pt NN NN O
developed VBN VBN O
hyponatremia NN NN O
. . . O
   
Pt NNP NNP O
has VBZ VBZ O
been VBN VBN O
advised VBN VBN O
in IN IN O
the DT DT O
past JJ JJ O
to TO TO O
restrict VB VB O
her PRP$ PRP$ O
intake NN NN O
of IN IN O
free JJ JJ O
water NN NN O
. . . O
   
VS NNP NNP O
BP NNP NNP O
R NNP NNP O
arm NN NN O
168/84 CD CD O
168/78 CD CD O
, , , O
L NNP NNP O
arm NN NN O
150/88 CD CD O
HR NNP NNP O
80 CD CD O
PE NNP NNP O
Lungs NNP NNP O
ctab NN NN O
Cardiac NNP NNP O
rrr NN NN O
no DT DT O
r/m/g NN NN O
LE NNP NNP O
some DT DT O
edema NN NN O
Assessment/Plan NNP NNP O
HTN NNP NNP O
, , , O
repeat NN NN O
chem NN NN O
7 CD CD O
, , , O
referred VBD VBD O
back RB RB O
to TO TO O
Dr NNP NNP O
. . . O
Marvin NNP NNP I-DOCTOR
Zigler NNP NNP I-DOCTOR
pt NN NN O
discussed VBD VBD O
with IN IN O
Dr NNP NNP O
. . . O
Gregory NNP NNP I-DOCTOR
Rosas NNP NNP I-DOCTOR
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2080-01-13 JJ JJ I-DATE
EDVISIT^10776605^Glenn, NNP NNP O
Olivia^01/14/80^WOODRUFF, NNP NNP O
FERNE NNP NNP I-DOCTOR
I PRP PRP O
saw VBD VBD O
this DT DT O
patient NN NN O
in IN IN O
conjunction NN NN O
with IN IN O
Dr NNP NNP O
. . . O
Leyva NNP NNP I-DOCTOR
and CC CC O
Dr NNP NNP O
. . . O
Forrest NNP NNP I-DOCTOR
. . . O
   
I PRP PRP O
confirm VBP VBP O
that IN IN O
I PRP PRP O
have VBP VBP O
interviewed VBN VBN O
and CC CC O
examined VBD VBD O
the DT DT O
patient NN NN O
, , , O
reviewed VBD VBD O
the DT DT O
resident NN NN O
's POS POS O
documentation NN NN O
on IN IN O
the DT DT O
patient NN NN O
's POS POS O
chart NN NN O
, , , O
and CC CC O
discussed VBD VBD O
the DT DT O
evaluation NN NN O
, , , O
plan NN NN O
of IN IN O
care NN NN O
, , , O
and CC CC O
disposition NN NN O
with IN IN O
the DT DT O
patient NN NN O
. . . O
   
CHIEF NNP NNP O
COMPLAINT NNP NNP O
: : : O
A DT DT O
65-year-old JJ JJ O
female JJ JJ O
with IN IN O
difficulty NN NN O
breathing VBG VBG O
. . . O
   
HISTORY NN NN O
OF IN IN O
PRESENT NNP NNP O
ILLNESS NNP NNP O
: : : O
The DT DT O
patient NN NN O
with IN IN O
known VBN VBN O
multiple JJ JJ O
medical JJ JJ O
problems NNS NNS O
presents VBZ VBZ O
with IN IN O
difficulty NN NN O
breathing NN NN O
. . . O
   
At IN IN O
her PRP$ PRP$ O
rehabilitation NN NN O
facility NN NN O
was VBD VBD O
noted VBN VBN O
to TO TO O
be VB VB O
hypoxic JJ JJ O
and CC CC O
thus RB RB O
was VBD VBD O
sent VBN VBN O
here RB RB O
. . . O
   
The DT DT O
patient NN NN O
's POS POS O
recent JJ JJ O
past JJ JJ O
medical JJ JJ O
history NN NN O
is VBZ VBZ O
remarkable JJ JJ O
for IN IN O
a DT DT O
fall NN NN O
with IN IN O
cervical JJ JJ O
fractures NNS NNS O
, , , O
rib NN NN O
fractures NNS NNS O
, , , O
and CC CC O
subsequent JJ JJ O
hemothorax NN NN O
for IN IN O
which WDT WDT O
she PRP PRP O
was VBD VBD O
admitted VBN VBN O
to TO TO O
the DT DT O
Educare-Pullman NNP NNP I-HOSPITAL
ICU NNP NNP O
over IN IN O
the DT DT O
end NN NN O
of IN IN O
December NNP NNP I-DATE
through IN IN O
the DT DT O
beginning NN NN O
of IN IN O
January NNP NNP I-DATE
. . . O
   
The DT DT O
patient NN NN O
's POS POS O
chest NN NN O
tube NN NN O
was VBD VBD O
withdrawn VBN VBN O
approximately RB RB O
10 CD CD O
days NNS NNS O
ago RB RB O
and CC CC O
the DT DT O
patient NN NN O
has VBZ VBZ O
been VBN VBN O
doing VBG VBG O
well RB RB O
at IN IN O
rehab NN NN O
since IN IN O
. . . O
   
However RB RB O
, , , O
today NN NN O
was VBD VBD O
noted VBN VBN O
to TO TO O
have VB VB O
desaturations NNS NNS O
to TO TO O
80 CD CD O
% NN NN O
on IN IN O
room NN NN O
air NN NN O
. . . O
   
She PRP PRP O
had VBD VBD O
shortness NNS NNS O
of IN IN O
breath NN NN O
as RB RB O
well RB RB O
. . . O
   
Her PRP$ PRP$ O
oxygen NN NN O
saturations NNS NNS O
improved VBN VBN O
marginally RB RB O
on IN IN O
oxygenation NN NN O
and CC CC O
have VBP VBP O
been VBN VBN O
responsive JJ JJ O
to TO TO O
nonrebreather DT DT O
treatment NN NN O
in IN IN O
the DT DT O
transport NN NN O
here RB RB O
. . . O
   
The DT DT O
patient NN NN O
was VBD VBD O
treated VBN VBN O
with IN IN O
nebulizers NNS NNS O
and CC CC O
Lasix NNP NNP O
without IN IN O
significant JJ JJ O
improvement NN NN O
and CC CC O
is VBZ VBZ O
noted VBN VBN O
to TO TO O
be VB VB O
quite RB RB O
tachypneic JJ JJ O
. . . O
   
PAST NNP NNP O
MEDICAL NNP NNP O
HISTORY NN NN O
: : : O
Remarkable NNP NNP O
for IN IN O
hypertension NN NN O
, , , O
CHF NNP NNP O
, , , O
diabetes NN NN O
, , , O
asthma NN NN O
, , , O
chronic JJ JJ O
renal JJ JJ O
insufficiency NN NN O
, , , O
osteoporosis NN NN O
, , , O
anemia NN NN O
, , , O
and CC CC O
cervical JJ JJ O
fracture NN NN O
. . . O
   
SOCIAL NNP NNP O
HISTORY NN NN O
, , , O
FAMILY NN NN O
HISTORY NN NN O
, , , O
AND CC CC O
REVIEW NNP NNP O
OF IN IN O
SYSTEMS NNP NNP O
: : : O
Limited NNP NNP O
by IN IN O
the DT DT O
severity NN NN O
of IN IN O
the DT DT O
patient NN NN O
's POS POS O
presentation NN NN O
. . . O
   
MEDICATIONS NNP NNP O
: : : O
Insulin NNP NNP O
, , , O
Zocor NNP NNP O
, , , O
PhosLo NNP NNP O
, , , O
calcium NN NN O
carbonate NN NN O
, , , O
Protonix NNP NNP O
, , , O
Niferex NNP NNP O
, , , O
Norvasc NNP NNP O
, , , O
Fosamax NNP NNP O
, , , O
Epogen NNP NNP O
, , , O
Lasix NNP NNP O
, , , O
lisinopril NN NN O
, , , O
Colace NNP NNP O
, , , O
and CC CC O
Xalatan NNP NNP O
. . . O
   
ALLERGIES NNP NNP O
: : : O
Morphine NNP NNP O
and CC CC O
aspirin NN NN O
. . . O
   
PHYSICAL JJ JJ O
EXAMINATION NNP NNP O
: : : O
The DT DT O
patient NN NN O
is VBZ VBZ O
awake JJ JJ O
and CC CC O
alert NN NN O
, , , O
in IN IN O
some DT DT O
degree NN NN O
of IN IN O
respiratory NN NN O
distress NN NN O
, , , O
however RB RB O
, , , O
able JJ JJ O
to TO TO O
interact VB VB O
and CC CC O
answer VB VB O
questions NNS NNS O
in IN IN O
1-2 JJ JJ O
word NN NN O
sentences NNS NNS O
. . . O
   
Vital NNP NNP O
signs NNS NNS O
are VBP VBP O
as IN IN O
documented VBN VBN O
with IN IN O
an DT DT O
elevated JJ JJ O
blood NN NN O
pressure NN NN O
of IN IN O
176/96 CD CD O
, , , O
pulse NN NN O
76 CD CD O
, , , O
and CC CC O
oxygen NN NN O
saturation NN NN O
is VBZ VBZ O
98 CD CD O
% NN NN O
on IN IN O
nonrebreather NN NN O
. . . O
   
HEENT NNP NNP O
exam NN NN O
is VBZ VBZ O
atraumatic JJ JJ O
, , , O
normal JJ JJ O
to TO TO O
inspection NN NN O
. . . O
   
The DT DT O
patient NN NN O
has VBZ VBZ O
a DT DT O
large JJ JJ O
tongue NN NN O
and CC CC O
her PRP$ PRP$ O
uvula NN NN O
is VBZ VBZ O
not RB RB O
visible JJ JJ O
at IN IN O
all DT DT O
. . . O
   
Neck NN NN O
is VBZ VBZ O
immobilized VBN VBN O
in IN IN O
a DT DT O
C-collar NNP NNP O
and CC CC O
is VBZ VBZ O
obese NN NN O
. . . O
   
Respiratory NNP NNP O
exam NN NN O
reveals VBZ VBZ O
decreased VBN VBN O
breath NN NN O
sounds VBZ VBZ O
diffusely RB RB O
with IN IN O
tachypnea NN NN O
and CC CC O
respiratory JJ JJ O
muscle NN NN O
accessory JJ JJ O
use NN NN O
. . . O
   
Cardiovascular NNP NNP O
exam NN NN O
: : : O
Regular NNP NNP O
rate NN NN O
and CC CC O
rhythm NN NN O
without IN IN O
murmur NN NN O
. . . O
   
Pulses NNP NNP O
are VBP VBP O
palpable JJ JJ O
in IN IN O
all DT DT O
four CD CD O
extremities NNS NNS O
. . . O
   
Abdomen NNP NNP O
is VBZ VBZ O
soft JJ JJ O
and CC CC O
nontender NN NN O
, , , O
obese NN NN O
, , , O
but CC CC O
without IN IN O
any DT DT O
organomegaly NN NN O
or CC CC O
masses NNS NNS O
, , , O
or CC CC O
guarding VBG VBG O
, , , O
or CC CC O
rebound NN NN O
. . . O
   
Skin NNP NNP O
is VBZ VBZ O
intact JJ JJ O
, , , O
warm JJ JJ O
, , , O
and CC CC O
dry JJ JJ O
without IN IN O
any DT DT O
lesions NNS NNS O
or CC CC O
rash NN NN O
. . . O
   
Musculoskeletal NNP NNP O
exam NN NN O
reveals VBZ VBZ O
tenderness NN NN O
over IN IN O
the DT DT O
right JJ JJ O
ribs NNS NNS O
where WRB WRB O
the DT DT O
patient NN NN O
has VBZ VBZ O
known VBN VBN O
rib NN NN O
fractures NNS NNS O
. . . O
   
Neurologically RB RB O
, , , O
she PRP PRP O
is VBZ VBZ O
oriented VBN VBN O
with IN IN O
difficulty NN NN O
speaking VBG VBG O
due JJ JJ O
to TO TO O
respiratory JJ JJ O
distress NN NN O
but CC CC O
no DT DT O
focal JJ JJ O
neurologic JJ JJ O
deficit NN NN O
. . . O
   
LABORATORY NNP NNP O
STUDIES NNP NNP O
: : : O
BNP NNP NNP O
is VBZ VBZ O
elevated VBN VBN O
in IN IN O
the DT DT O
500-600 JJ JJ O
range NN NN O
. . . O
   
White NNP NNP O
blood NN NN O
count NN NN O
is VBZ VBZ O
slightly RB RB O
elevated VBN VBN O
at IN IN O
10 CD CD O
, , , O
hematocrit NN NN O
26.3 CD CD O
, , , O
which WDT WDT O
is VBZ VBZ O
at IN IN O
the DT DT O
patient NN NN O
's POS POS O
baseline NN NN O
, , , O
and CC CC O
creatinine NN NN O
of IN IN O
2.2 CD CD O
. . . O
   
LFTs NNP NNP O
within IN IN O
normal JJ JJ O
limit NN NN O
. . . O
   
INR NNP NNP O
1.2 CD CD O
. . . O
   
D-dimer NNP NNP O
significantly RB RB O
elevated VBD VBD O
. . . O
   
EKG NNP NNP O
demonstrates VBZ VBZ O
sinus JJ JJ O
rhythm NN NN O
with IN IN O
nonspecific JJ JJ O
ST-T NNP NNP O
wave NN NN O
changes NNS NNS O
. . . O
   
IMAGING NNP NNP O
STUDIES NNP NNP O
: : : O
Chest NN NN O
x-ray NN NN O
shows VBZ VBZ O
bilateral JJ JJ O
effusions NNS NNS O
, , , O
which WDT WDT O
are VBP VBP O
present JJ JJ O
previously RB RB O
but CC CC O
possibly RB RB O
slightly RB RB O
increased VBN VBN O
. . . O
   
EMERGENCY NNP NNP O
DEPARTMENT NNP NNP O
COURSE NN NN O
: : : O
The DT DT O
patient NN NN O
was VBD VBD O
initially RB RB O
given VBN VBN O
Lasix NNP NNP O
and CC CC O
nitro NN NN O
with IN IN O
improvement NN NN O
in IN IN O
her PRP$ PRP$ O
blood NN NN O
pressure NN NN O
and CC CC O
was VBD VBD O
also RB RB O
started VBN VBN O
on IN IN O
CPAP NNP NNP O
. . . O
   
She PRP PRP O
seemed VBD VBD O
to TO TO O
be VB VB O
improving VBG VBG O
clinically RB RB O
for IN IN O
some DT DT O
period NN NN O
of IN IN O
time NN NN O
but CC CC O
then RB RB O
began VBD VBD O
to TO TO O
decline VB VB O
in IN IN O
her PRP$ PRP$ O
mental JJ JJ O
status NN NN O
. . . O
   
At IN IN O
that DT DT O
time NN NN O
an DT DT O
ABG NNP NNP O
was VBD VBD O
sent VBN VBN O
demonstrating VBG VBG O
hypoxia NN NN O
. . . O
   
Prior RB RB O
to TO TO O
those DT DT O
results NNS NNS O
, , , O
the DT DT O
decision NN NN O
was VBD VBD O
made VBN VBN O
that IN IN O
the DT DT O
patient NN NN O
likely JJ JJ O
needed VBN VBN O
intubation NN NN O
. . . O
   
We PRP PRP O
had VBD VBD O
hope VBN VBN O
to TO TO O
hold VB VB O
off IN IN O
to TO TO O
do VB VB O
a DT DT O
thoracentesis NN NN O
; : : O
   
however RB RB O
, , , O
the DT DT O
patient NN NN O
's POS POS O
clinical JJ JJ O
course NN NN O
declines VBZ VBZ O
such JJ JJ O
that IN IN O
it PRP PRP O
was VBD VBD O
not RB RB O
possible JJ JJ O
for IN IN O
her PRP PRP O
to TO TO O
sit VB VB O
up RP RP O
for IN IN O
the DT DT O
procedure NN NN O
. . . O
On IN IN O
CPAP NNP NNP O
, , , O
the DT DT O
patient NN NN O
's POS POS O
oxygen NN NN O
saturations NNS NNS O
were VBD VBD O
stable JJ JJ O
throughout IN IN O
in IN IN O
the DT DT O
90s NN NN O
, , , O
but CC CC O
she PRP PRP O
developed VBD VBD O
increasing VBG VBG O
respiratory JJ JJ O
distress NN NN O
. . . O
   
Intubation NNP NNP O
was VBD VBD O
complicated VBN VBN O
by IN IN O
her PRP$ PRP$ O
inability NN NN O
to TO TO O
flex VB VB O
her PRP$ PRP$ O
neck NN NN O
, , , O
her PRP$ PRP$ O
large JJ JJ O
tongue NN NN O
, , , O
and CC CC O
her PRP$ PRP$ O
body NN NN O
habitus NN NN O
; : : O
   
was VBD VBD O
successful JJ JJ O
in IN IN O
two CD CD O
attempts NNS NNS O
with IN IN O
one CD CD O
episode NN NN O
of IN IN O
bag NN NN O
mask NN NN O
ventilation NN NN O
in IN IN O
between IN IN O
those DT DT O
attempts NNS NNS O
. . . O
   
For IN IN O
full JJ JJ O
details NNS NNS O
of IN IN O
the DT DT O
procedure NN NN O
, , , O
please VB VB O
see VB VB O
the DT DT O
attached JJ JJ O
procedure NN NN O
note NN NN O
. . . O
   
Thoracic NNP NNP O
Surgery NNP NNP O
was VBD VBD O
consulted VBN VBN O
. . . O
   
They PRP PRP O
arrived VBD VBD O
as IN IN O
the DT DT O
patient NN NN O
was VBD VBD O
being VBG VBG O
intubated VBN VBN O
. . . O
   
At IN IN O
this DT DT O
time NN NN O
their PRP$ PRP$ O
recommendation NN NN O
is VBZ VBZ O
for IN IN O
a DT DT O
CT NNP NNP O
scan NN NN O
of IN IN O
the DT DT O
chest NN NN O
to TO TO O
determine VB VB O
whether IN IN O
this DT DT O
is VBZ VBZ O
more RBR RBR O
likely JJ JJ O
a DT DT O
hemothorax NN NN O
or CC CC O
a DT DT O
pleural JJ JJ O
effusion NN NN O
and CC CC O
whether IN IN O
it PRP PRP O
is VBZ VBZ O
loculated VBN VBN O
. . . O
   
This DT DT O
study NN NN O
will MD MD O
be VB VB O
performed VBN VBN O
and CC CC O
then RB RB O
patient NN NN O
will MD MD O
be VB VB O
admitted VBN VBN O
to TO TO O
her PRP$ PRP$ O
ready JJ JJ O
bed NN NN O
in IN IN O
the DT DT O
ICU NNP NNP O
. . . O
   
A DT DT O
bedside NN NN O
ultrasound NN NN O
was VBD VBD O
also RB RB O
performed VBN VBN O
by IN IN O
myself PRP PRP O
and CC CC O
the DT DT O
resident NN NN O
demonstrating VBG VBG O
no DT DT O
obvious JJ JJ O
pericardial JJ JJ O
effusion NN NN O
. . . O
   
******** NN NN O
Not RB RB O
reviewed VBN VBN O
by IN IN O
Attending NNP NNP O
Physician NNP NNP O
******** NN NN O
PRIMARY JJ JJ O
DIAGNOSIS NNP NNP O
: : : O
Bilateral NNP NNP O
pleural NN NN O
effusions NNS NNS O
. . . O
   
SECONDARY JJ JJ O
DIAGNOSIS NNP NNP O
: : : O
Respiratory NNP NNP O
distress NN NN O
. . . O
   
TERTIARY NNP NNP O
DIAGNOSIS NNP NNP O
: : : O
Question NNP NNP O
recurrent NN NN O
hemothorax NN NN O
versus CC CC O
pleural JJ JJ O
effusion NN NN O
. . . O
   
FOURTH NNP NNP O
DIAGNOSIS NNP NNP O
: : : O
Question NNP NNP O
CHF NNP NNP O
. . . O
   
DISPOSITION NNP NNP O
: : : O
Admitted NNP NNP O
to TO TO O
the DT DT O
ICU NNP NNP O
. . . O
   
CRITICAL JJ JJ O
CARE NNP NNP O
TIME NNP NNP O
: : : O
75 CD CD O
minutes NNS NNS O
. . . O
   
_____________________________ NN NN O
_ NN NN O
WOODRUFF NNP NNP O
, , , O
FERNE NNP NNP I-DOCTOR
MD NNP NNP O
D NNP NNP O
: : : O
01/14/80 CD CD I-DATE
T NN NN O
: : : O
01/14/80 CD CD I-DATE
Dictated NNP NNP O
By IN IN O
: : : O
WOODRUFF NNP NNP O
, , , O
FERNE NNP NNP I-DOCTOR
eScription NN NN O
document:9-3389642 JJ JJ O
BFFocus NNP NNP O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2067-01-12 NN NN I-DATE
( ( ( O
550 CD CD O
) ) ) O
659-5187 CD CD I-PHONE
GRANITE NNP NNP I-HOSPITAL
COUNTY NNP NNP I-HOSPITAL
MEMORIAL NNP NNP I-HOSPITAL
HOSPITAL NNP NNP I-HOSPITAL
January NNP NNP I-DATE
13 CD CD O
, , , O
2067 CD CD I-DATE
Gwendolyn NNP NNP I-DOCTOR
Irvine NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
   
Houghton NNP NNP I-HOSPITAL
Community NNP NNP I-HOSPITAL
Health NNP NNP I-HOSPITAL
Center NNP NNP I-HOSPITAL
Lyons NNP NNP I-STREET
Street NNP NNP I-STREET
Queen NNP NNP I-CITY
Creek NNP NNP I-CITY
, , , O
SD NNP NNP I-STATE
89544 CD CD I-ZIP
RE NNP NNP O
: : : O
Bird NNP NNP I-PATIENT
, , , O
Terri NNP NNP I-PATIENT
MRN NNP NNP O
: : : O
80910690 CD CD I-MEDICALRECORD
Dear RB RB O
Dr NNP NNP O
. . . O
Irvine NNP NNP I-DOCTOR
: : : O
I PRP PRP O
had VBD VBD O
the DT DT O
chance NN NN O
today NN NN O
to TO TO O
see VB VB O
Terri NNP NNP I-PATIENT
Bird NNP NNP I-PATIENT
in IN IN O
follow-up JJ JJ O
, , , O
as IN IN O
her PRP$ PRP$ O
primary JJ JJ O
care NN NN O
physician NN NN O
. . . O
   
As IN IN O
you PRP PRP O
are VBP VBP O
well RB RB O
aware JJ JJ O
, , , O
she PRP PRP O
is VBZ VBZ O
71-year-old JJ JJ O
female JJ JJ O
who WP WP O
resides VBZ VBZ O
currently RB RB O
at IN IN O
the DT DT O
Elm NNP NNP I-HOSPITAL
Hills NNP NNP I-HOSPITAL
Nursing NNP NNP I-HOSPITAL
Home NNP NNP I-HOSPITAL
where WRB WRB O
you PRP PRP O
have VBP VBP O
been VBN VBN O
taking VBG VBG O
care NN NN O
of IN IN O
her PRP PRP O
. . . O
   
I PRP PRP O
have VBP VBP O
not RB RB O
seen VBN VBN O
her PRP$ PRP$ O
now RB RB O
for IN IN O
the DT DT O
past JJ JJ O
ten CD CD O
months NNS NNS O
. . . O
   
For IN IN O
my PRP$ PRP$ O
records NNS NNS O
, , , O
I PRP PRP O
am VBP VBP O
going VBG VBG O
to TO TO O
summarize VB VB O
her PRP$ PRP$ O
medical JJ JJ O
history NN NN O
briefly NN NN O
. . . O
   
It PRP PRP O
includes VBZ VBZ O
a DT DT O
history NN NN O
of IN IN O
atrial JJ JJ O
fibrillation NN NN O
. . . O
   
She PRP PRP O
is VBZ VBZ O
status NN NN O
post NN NN O
an DT DT O
MVR NNP NNP O
with IN IN O
Duluth NNP NNP I-HOSPITAL
Clinic NNP NNP I-HOSPITAL
. . . O
   
She PRP PRP O
is VBZ VBZ O
on IN IN O
chronic JJ JJ O
anti-coagulation JJ JJ O
. . . O
   
She PRP PRP O
is VBZ VBZ O
status JJ JJ O
post NN NN O
a DT DT O
renal JJ JJ O
allograft NN NN O
for IN IN O
what WP WP O
is VBZ VBZ O
believed VBN VBN O
to TO TO O
be VB VB O
a DT DT O
history NN NN O
of IN IN O
strep NN NN O
glomerular NN NN O
nephritis NNS NNS O
. . . O
   
She PRP PRP O
has VBZ VBZ O
been VBN VBN O
on IN IN O
Imuran NNP NNP O
and CC CC O
Prednisone NNP NNP O
for IN IN O
several JJ JJ O
decades NNS NNS O
with IN IN O
no DT DT O
history NN NN O
of IN IN O
rejection NN NN O
. . . O
   
She PRP PRP O
also RB RB O
has VBZ VBZ O
a DT DT O
history NN NN O
of IN IN O
a DT DT O
CABG NNP NNP O
in IN IN O
the DT DT O
setting VBG VBG O
of IN IN O
her PRP$ PRP$ O
valve NN NN O
replacement NN NN O
. . . O
   
As RB RB O
well RB RB O
, , , O
she PRP PRP O
has VBZ VBZ O
a DT DT O
history NN NN O
of IN IN O
spinal JJ JJ O
stenosis NNS NNS O
, , , O
for IN IN O
which WDT WDT O
she PRP PRP O
has VBZ VBZ O
been VBN VBN O
treated VBN VBN O
intermittently RB RB O
with IN IN O
epidural JJ JJ O
steroid NN NN O
injection NN NN O
. . . O
   
About IN IN O
a DT DT O
year NN NN O
ago RB RB O
, , , O
she PRP PRP O
had VBD VBD O
an DT DT O
abdominal JJ JJ O
aortic JJ JJ O
aneurysm NN NN O
repair NN NN O
and CC CC O
in IN IN O
this DT DT O
setting VBG VBG O
developed VBN VBN O
some DT DT O
delirium NN NN O
and CC CC O
at IN IN O
that DT DT O
point NN NN O
was VBD VBD O
sent VBN VBN O
to TO TO O
rehab VB VB O
where WRB WRB O
she PRP PRP O
had VBD VBD O
a DT DT O
ankle NN NN O
fracture NN NN O
and CC CC O
a DT DT O
long JJ JJ O
recovery NN NN O
and CC CC O
she PRP PRP O
spent VBD VBD O
time NN NN O
at IN IN O
several JJ JJ O
different JJ JJ O
nursing NN NN O
homes NNS NNS O
and CC CC O
had VBD VBD O
a DT DT O
hip NN NN O
fracture NN NN O
as RB RB O
well RB RB O
as IN IN O
a DT DT O
recurrent JJ JJ O
ankle NN NN O
fracture NN NN O
and CC CC O
most RBS RBS O
recently RB RB O
has VBZ VBZ O
been VBN VBN O
with IN IN O
you PRP PRP O
at IN IN O
Elm NNP NNP I-HOSPITAL
Hills NNP NNP I-HOSPITAL
Nursing NNP NNP I-HOSPITAL
Home NNP NNP I-HOSPITAL
. . . O
   
I PRP PRP O
also RB RB O
have VBP VBP O
a DT DT O
discharge NN NN O
summary NN NN O
from IN IN O
a DT DT O
recent JJ JJ O
hospitalization NN NN O
where WRB WRB O
she PRP PRP O
had VBD VBD O
a DT DT O
pneumonia NN NN O
, , , O
a DT DT O
right JJ JJ O
middle NN NN O
lobe NN NN O
which WDT WDT O
was VBD VBD O
successfully RB RB O
treated VBN VBN O
with IN IN O
levofloxacin NN NN O
. . . O
   
MEDICATIONS NNP NNP O
: : : O
Her PRP$ PRP$ O
current JJ JJ O
medications NNS NNS O
from IN IN O
the DT DT O
notes NNS NNS O
that IN IN O
I PRP PRP O
received VBD VBD O
include VBP VBP O
Premarin NNP NNP O
.3mg, CD CD O
Neurontin NNP NNP O
300mg CD CD O
each DT DT O
day NN NN O
, , , O
Miacalcin NNP NNP O
nasal NN NN O
spray NN NN O
, , , O
Provera NNP NNP O
2.5mg, CD CD O
Synthroid NNP NNP O
25mcg CD CD O
, , , O
Digoxin NNP NNP O
125mcg CD CD O
, , , O
Cardizem NNP NNP O
CD NNP NNP O
180mg CD CD O
a DT DT O
day NN NN O
, , , O
Imuran NNP NNP O
100mg CD CD O
a DT DT O
day NN NN O
, , , O
Lopressor NNP NNP O
50mg CD CD O
twice RB RB O
a DT DT O
day NN NN O
, , , O
calcium NN NN O
carbonate NN NN O
500mg CD CD O
three CD CD O
times NNS NNS O
a DT DT O
day NN NN O
, , , O
Isordil NNP NNP O
3 CD CD O
times NNS NNS O
a DT DT O
day NN NN O
as RB RB O
well RB RB O
as IN IN O
Coumadin NNP NNP O
based VBN VBN O
on IN IN O
her PRP$ PRP$ O
INR NNP NNP O
. . . O
   
ALLERGIES NNP NNP O
: : : O
She PRP PRP O
has VBZ VBZ O
an DT DT O
allergy NN NN O
to TO TO O
penicillin VB VB O
as RB RB O
well RB RB O
as IN IN O
sulfur NN NN O
and CC CC O
cephalosporins NNS NNS O
and CC CC O
of IN IN O
note NN NN O
she PRP PRP O
had VBD VBD O
been VBN VBN O
on IN IN O
a DT DT O
tapering VBG VBG O
Prednisone NNP NNP O
dose NN NN O
which WDT WDT O
seems VBZ VBZ O
to TO TO O
have VB VB O
been VBN VBN O
stopped VBN VBN O
. . . O
   
As RB RB O
well RB RB O
, , , O
she PRP PRP O
is VBZ VBZ O
on IN IN O
sliding VBG VBG O
scale NN NN O
insulin NN NN O
and CC CC O
Humulin NNP NNP O
N NNP NNP O
, , , O
which WDT WDT O
seems VBZ VBZ O
to TO TO O
have VB VB O
been VBN VBN O
adjusted VBN VBN O
recently RB RB O
. . . O
   
RE NNP NNP O
: : : O
Bird NNP NNP I-PATIENT
, , , O
Terri NNP NNP I-PATIENT
MRN NNP NNP O
: : : O
80910690 CD CD I-MEDICALRECORD
January NNP NNP I-DATE
13 CD CD O
, , , O
2067 CD CD I-DATE
Page NNP NNP O
2 CD CD O
The DT DT O
patient NN NN O
was VBD VBD O
brought VBN VBN O
to TO TO O
me PRP PRP O
today NN NN O
by IN IN O
her PRP$ PRP$ O
family NN NN O
, , , O
because IN IN O
they PRP PRP O
were VBD VBD O
concerned VBN VBN O
that IN IN O
she PRP PRP O
was VBD VBD O
not RB RB O
getting VBG VBG O
optimal JJ JJ O
care NN NN O
. . . O
   
In IN IN O
talking VBG VBG O
to TO TO O
her PRP$ PRP$ O
, , , O
she PRP PRP O
says VBZ VBZ O
she PRP PRP O
feels VBZ VBZ O
quite RB RB O
well RB RB O
. . . O
   
She PRP PRP O
has VBZ VBZ O
no DT DT O
pain NN NN O
. . . O
   
She PRP PRP O
has VBZ VBZ O
no DT DT O
pain NN NN O
in IN IN O
her PRP$ PRP$ O
buttocks NNS NNS O
or CC CC O
her PRP$ PRP$ O
legs NNS NNS O
. . . O
   
She PRP PRP O
says VBZ VBZ O
her PRP$ PRP$ O
breathing VBG VBG O
feels VBZ VBZ O
well RB RB O
. . . O
   
She PRP PRP O
has VBZ VBZ O
no DT DT O
productive JJ JJ O
cough NN NN O
. . . O
   
She PRP PRP O
has VBZ VBZ O
no DT DT O
chest NN NN O
pain NN NN O
. . . O
   
She PRP PRP O
denies VBZ VBZ O
any DT DT O
peripheral JJ JJ O
edema NN NN O
. . . O
   
She PRP PRP O
notes NNS NNS O
that IN IN O
she PRP PRP O
is VBZ VBZ O
concerned VBN VBN O
that IN IN O
she PRP PRP O
is VBZ VBZ O
not RB RB O
getting VBG VBG O
enough RB RB O
exercise NN NN O
at IN IN O
Elm NNP NNP I-HOSPITAL
Hill NNP NNP I-HOSPITAL
Nursing NNP NNP I-HOSPITAL
Home NNP NNP I-HOSPITAL
, , , O
but CC CC O
otherwise RB RB O
feels VBZ VBZ O
like IN IN O
she PRP PRP O
is VBZ VBZ O
getting VBG VBG O
reasonable JJ JJ O
care NN NN O
. . . O
   
However RB RB O
, , , O
she PRP PRP O
does VBZ VBZ O
breakdown NN NN O
and CC CC O
cry NN NN O
about IN IN O
her PRP$ PRP$ O
current JJ JJ O
situation NN NN O
in IN IN O
that DT DT O
she PRP PRP O
is VBZ VBZ O
depressed VBN VBN O
about IN IN O
living VBG VBG O
in IN IN O
a DT DT O
nursing VBG VBG O
home NN NN O
. . . O
   
PHYSICAL JJ JJ O
EXAMINATION NNP NNP O
: : : O
On IN IN O
the DT DT O
exam NN NN O
today NN NN O
, , , O
her PRP$ PRP$ O
blood NN NN O
pressure NN NN O
is VBZ VBZ O
122/70 CD CD O
. . . O
   
She PRP PRP O
has VBZ VBZ O
a DT DT O
regular JJ JJ O
rate NN NN O
and CC CC O
rhythm NN NN O
on IN IN O
heart NN NN O
exam NN NN O
with IN IN O
a DT DT O
pulse NN NN O
of IN IN O
   
72 CD CD O
. . . O
She PRP PRP O
has VBZ VBZ O
sharp JJ JJ O
clicks NNS NNS O
over IN IN O
her PRP$ PRP$ O
chest NN NN O
. . . O
   
She PRP PRP O
has VBZ VBZ O
a DT DT O
soft JJ JJ O
abdomen NN NN O
with IN IN O
no DT DT O
organomegaly NN NN O
and CC CC O
a DT DT O
well RB RB O
healed VBN VBN O
scar NN NN O
. . . O
   
She PRP PRP O
has VBZ VBZ O
equal JJ JJ O
pulses NNS NNS O
bilaterally RB RB O
. . . O
   
She PRP PRP O
has VBZ VBZ O
got VBN VBN O
a DT DT O
normal JJ JJ O
skin NN NN O
exam NN NN O
with IN IN O
multiple JJ JJ O
skin NN NN O
tags NNS NNS O
. . . O
   
She PRP PRP O
has VBZ VBZ O
a DT DT O
full JJ JJ O
range NN NN O
of IN IN O
motion NN NN O
in IN IN O
her PRP$ PRP$ O
upper JJ JJ O
extremities NNS NNS O
as RB RB O
well RB RB O
as IN IN O
her PRP$ PRP$ O
hips NNS NNS O
, , , O
knees NNS NNS O
and CC CC O
ankles NNS NNS O
. . . O
   
She PRP PRP O
has VBZ VBZ O
a DT DT O
stooped JJ JJ O
gate NN NN O
and CC CC O
I PRP PRP O
watch VBP VBP O
her PRP$ PRP$ O
walk NN NN O
with IN IN O
her PRP$ PRP$ O
walker NN NN O
and CC CC O
she PRP PRP O
seems VBZ VBZ O
relatively RB RB O
stable JJ JJ O
. . . O
   
She PRP PRP O
is VBZ VBZ O
somewhat RB RB O
confused VBN VBN O
about IN IN O
the DT DT O
date NN NN O
and CC CC O
the DT DT O
place NN NN O
, , , O
but CC CC O
recognizes VBZ VBZ O
me PRP PRP O
and CC CC O
is VBZ VBZ O
able JJ JJ O
to TO TO O
articulate VB VB O
very RB RB O
clearly RB RB O
about IN IN O
her PRP$ PRP$ O
current JJ JJ O
situation NN NN O
at IN IN O
Elm NNP NNP I-HOSPITAL
Hills NNP NNP I-HOSPITAL
. . . O
   
I PRP PRP O
have VBP VBP O
no DT DT O
laboratory NN NN O
data NNS NNS O
to TO TO O
speak VB VB O
of IN IN O
. . . O
   
I PRP PRP O
had VBD VBD O
a DT DT O
long JJ JJ O
conversation NN NN O
with IN IN O
her PRP$ PRP$ O
and CC CC O
her PRP$ PRP$ O
husband NN NN O
as RB RB O
well RB RB O
as IN IN O
her PRP$ PRP$ O
son NN NN O
and CC CC O
daughter-in-law JJ JJ O
and CC CC O
explained VBD VBD O
my PRP$ PRP$ O
concerns NNS NNS O
with IN IN O
her PRP$ PRP$ O
overall JJ JJ O
safety NN NN O
and CC CC O
I PRP PRP O
thought VBD VBD O
that WDT WDT O
currently RB RB O
it PRP PRP O
would MD MD O
be VB VB O
unwise RB RB O
for IN IN O
her PRP PRP O
to TO TO O
be VB VB O
in IN IN O
an DT DT O
unsupervised JJ JJ O
setting NN NN O
. . . O
   
I PRP PRP O
thought VBD VBD O
that IN IN O
a DT DT O
nursing VBG VBG O
home NN NN O
is VBZ VBZ O
a DT DT O
reasonable JJ JJ O
place NN NN O
for IN IN O
her PRP PRP O
to TO TO O
be VB VB O
and CC CC O
suggested VBD VBD O
quite RB RB O
strongly RB RB O
to TO TO O
consider VB VB O
an DT DT O
antidepressant NN NN O
. . . O
   
It PRP PRP O
looks VBZ VBZ O
like IN IN O
you PRP PRP O
have VBP VBP O
had VBN VBN O
a DT DT O
psychiatrist NN NN O
evaluate NN NN O
her PRP$ PRP$ O
recently RB RB O
and CC CC O
I PRP PRP O
think VBP VBP O
it PRP PRP O
would MD MD O
be VB VB O
worthwhile JJ JJ O
, , , O
at IN IN O
least JJS JJS O
a DT DT O
month NN NN O
trial NN NN O
of IN IN O
SSRI NNP NNP O
, , , O
gradually RB RB O
titrating VBG VBG O
up RP RP O
the DT DT O
dose NN NN O
based VBN VBN O
on IN IN O
her PRP$ PRP$ O
side NN NN O
effects NNS NNS O
. . . O
   
I PRP PRP O
am VBP VBP O
more JJR JJR O
than IN IN O
happy JJ JJ O
to TO TO O
see VB VB O
her PRP$ PRP$ O
intermittently RB RB O
to TO TO O
give VB VB O
her PRP$ PRP$ O
reassurance NN NN O
, , , O
but CC CC O
it PRP PRP O
seems VBZ VBZ O
like IN IN O
your PRP$ PRP$ O
care NN NN O
has VBZ VBZ O
been VBN VBN O
excellent JJ JJ O
and CC CC O
feel VBP VBP O
free JJ JJ O
to TO TO O
contact VB VB O
me PRP PRP O
with IN IN O
questions NNS NNS O
about IN IN O
her PRP$ PRP$ O
past JJ JJ O
history NN NN O
. . . O
   
Sincerely NNP NNP O
, , , O
Steve NNP NNP I-DOCTOR
George NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
lb:TT:1489 NN NN I-IDNUM
DD:1-13-67 NNP NNP O
DT:1-13-67 NNP NNP O
******** NN NN O
Not RB RB O
reviewed VBN VBN O
by IN IN O
Attending NNP NNP O
Physician NNP NNP O
******** NN NN O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2084-03-17 JJ JJ I-DATE
Mediquik NNP NNP I-HOSPITAL
Team NNP NNP O
3 CD CD O
Medical NNP NNP O
Student NNP NNP O
Admission NNP NNP O
Note VB VB O
Pt NNP NNP O
: : : O
Vollmer NNP NNP I-PATIENT
, , , O
Ulyses NNP NNP I-PATIENT
MR NNP NNP O
# # # O
: : : O
8740465 CD CD I-MEDICALRECORD
Date NN NN O
of IN IN O
Admission NNP NNP O
: : : O
03/17/84 CD CD I-DATE
Attending NNP NNP O
Oncologist NNP NNP O
: : : O
Dr NNP NNP O
. . . O
Xavier NNP NNP I-DOCTOR
Otero NNP NNP I-DOCTOR
PCP NNP NNP O
: : : O
Dr NNP NNP O
. . . O
Geno NNP NNP I-DOCTOR
Guidry NNP NNP I-DOCTOR
Code NNP NNP O
Status NNP NNP O
: : : O
Full NNP NNP O
Code NNP NNP O
ID/CC NNP NNP O
: : : O
73-year-old JJ JJ O
man NN NN O
with IN IN O
stage NN NN O
IV-B NNP NNP O
metastatic JJ JJ O
esophageal NN NN O
adenocarcinoma NN NN O
presents VBZ VBZ O
complaining VBG VBG O
of IN IN O
three CD CD O
days NNS NNS O
of IN IN O
constant JJ JJ O
dizziness NN NN O
. . . O
   
Source NNP NNP O
: : : O
Patient NNP NNP O
, , , O
who WP WP O
is VBZ VBZ O
a DT DT O
good JJ JJ O
historian NN NN O
. . . O
   
Past NNP NNP O
medical JJ JJ O
records NNS NNS O
. . . O
   
History NN NN O
of IN IN O
Present JJ JJ O
Illness NNP NNP O
Mr NNP NNP O
. . . O
Vollmer NNP NNP I-PATIENT
is VBZ VBZ O
a DT DT O
pleasant JJ JJ O
73-year-old JJ JJ O
man NN NN O
with IN IN O
a DT DT O
past JJ JJ O
medical JJ JJ O
history NN NN O
significant JJ JJ O
for IN IN O
metastatic JJ JJ O
esophageal NN NN O
adenocarcinoma NN NN O
s/p NN NN O
XRT NNP NNP O
and CC CC O
chemotherapy NN NN O
, , , O
CAD NNP NNP O
s/p NN NN O
LAD NNP NNP O
stent NN NN O
placement NN NN O
, , , O
and CC CC O
borderline NN NN O
DM NNP NNP O
who WP WP O
presents VBZ VBZ O
to TO TO O
the DT DT O
Health NNP NNP I-HOSPITAL
Care NNP NNP I-HOSPITAL
Center NNP NNP I-HOSPITAL
complaining NN NN O
of IN IN O
48-hour JJ JJ O
history NN NN O
of IN IN O
dizziness NN NN O
and CC CC O
subjective JJ JJ O
fevers NNS NNS O
. . . O
   
He PRP PRP O
was VBD VBD O
in IN IN O
his PRP$ PRP$ O
usual JJ JJ O
state NN NN O
of IN IN O
health NN NN O
until IN IN O
three CD CD O
days NNS NNS O
prior RB RB O
to TO TO O
admission NN NN O
, , , O
when WRB WRB O
he PRP PRP O
awoke VBD VBD O
in IN IN O
the DT DT O
morning NN NN O
with IN IN O
a DT DT O
severe JJ JJ O
headache NN NN O
. . . O
   
As IN IN O
he PRP PRP O
got VBD VBD O
out IN IN O
of IN IN O
bed NN NN O
, , , O
he PRP PRP O
felt VBD VBD O
extremely RB RB O
lightheaded VBN VBN O
. . . O
   
He PRP PRP O
describes VBZ VBZ O
the DT DT O
dizziness NN NN O
as IN IN O
internal JJ JJ O
, , , O
and CC CC O
not RB RB O
like IN IN O
the DT DT O
room NN NN O
was VBD VBD O
spinning JJ JJ O
. . . O
   
He PRP PRP O
laid VBD VBD O
down RB RB O
, , , O
with IN IN O
some DT DT O
resolution NN NN O
of IN IN O
the DT DT O
symptoms NNS NNS O
. . . O
   
Of IN IN O
note NN NN O
, , , O
he PRP PRP O
reports NNS NNS O
that IN IN O
the DT DT O
dizziness NN NN O
is VBZ VBZ O
less RBR RBR O
severe JJ JJ O
when WRB WRB O
he PRP PRP O
lies VBZ VBZ O
down RB RB O
and CC CC O
comes VBZ VBZ O
on IN IN O
with IN IN O
standing NN NN O
or CC CC O
sitting VBG VBG O
up RP RP O
. . . O
   
Throughout IN IN O
the DT DT O
day NN NN O
, , , O
he PRP PRP O
developed VBD VBD O
a DT DT O
cough JJ JJ O
productive JJ JJ O
of IN IN O
green JJ JJ O
sputum NN NN O
, , , O
a DT DT O
subjective JJ JJ O
fever NN NN O
, , , O
continued VBD VBD O
headache NN NN O
, , , O
and CC CC O
nausea NN NN O
without IN IN O
vomiting VBG VBG O
. . . O
   
He PRP PRP O
denied VBD VBD O
any DT DT O
chills NNS NNS O
, , , O
shortness NNS NNS O
of IN IN O
breath NN NN O
, , , O
chest NN NN O
pain NN NN O
, , , O
palpitations NNS NNS O
, , , O
or CC CC O
pain NN NN O
upon IN IN O
deep JJ JJ O
breathing VBG VBG O
. . . O
   
That DT DT O
evening NN NN O
, , , O
two CD CD O
nights NNS NNS O
prior RB RB O
to TO TO O
admission NN NN O
, , , O
he PRP PRP O
developed JJ JJ O
night NN NN O
sweats NNS NNS O
but CC CC O
had VBD VBD O
no DT DT O
rigors NNS NNS O
. . . O
   
He PRP PRP O
continued VBD VBD O
to TO TO O
feel VB VB O
similarly RB RB O
throughout IN IN O
the DT DT O
day NN NN O
prior RB RB O
to TO TO O
admission NN NN O
, , , O
and CC CC O
presented VBD VBD O
to TO TO O
the DT DT O
emergency NN NN O
room NN NN O
for IN IN O
further JJ JJ O
evaluation NN NN O
. . . O
   
The DT DT O
current JJ JJ O
presentation NN NN O
is VBZ VBZ O
in IN IN O
the DT DT O
context NN NN O
of IN IN O
increasingly RB RB O
poor JJ JJ O
PO NNP NNP O
intake NN NN O
secondary JJ JJ O
to TO TO O
chemotherapy NN NN O
and CC CC O
treatment NN NN O
for IN IN O
esophageal NN NN O
cancer NN NN O
. . . O
   
He PRP PRP O
reports VBZ VBZ O
a DT DT O
four-to-five JJ JJ O
month NN NN O
history NN NN O
of IN IN O
poor JJ JJ O
appetite NN NN O
, , , O
eating VBG VBG O
chicken NN NN O
soup NN NN O
. . . O
   
He PRP PRP O
denies VBZ VBZ O
any DT DT O
trouble NN NN O
swallowing VBG VBG O
solids NNS NNS O
or CC CC O
liquids NNS NNS O
. . . O
   
Of IN IN O
note NN NN O
, , , O
the DT DT O
day NN NN O
prior RB RB O
to TO TO O
the DT DT O
onset NN NN O
of IN IN O
symptoms NNS NNS O
, , , O
he PRP PRP O
was VBD VBD O
NPO NNP NNP O
for IN IN O
a DT DT O
restaging VBG VBG O
CT NNP NNP O
scan VB VB O
. . . O
   
He PRP PRP O
reports NNS NNS O
eating VBG VBG O
two CD CD O
scrambled JJ JJ O
eggs NNS NNS O
after IN IN O
the DT DT O
scan NN NN O
, , , O
and CC CC O
a DT DT O
chicken NN NN O
potpie NN NN O
for IN IN O
dinner NN NN O
the DT DT O
night NN NN O
prior RB RB O
to TO TO O
symptoms NNS NNS O
starting VBG VBG O
. . . O
   
In IN IN O
the DT DT O
emergency NN NN O
room NN NN O
, , , O
vitals NNS NNS O
were VBD VBD O
temperature NN NN O
of IN IN O
95.6 CD CD O
, , , O
pulse NN NN O
52 CD CD O
, , , O
blood NN NN O
pressure NN NN O
132/68 CD CD O
, , , O
RR=20, NNP NNP O
95 CD CD O
% NN NN O
on IN IN O
room NN NN O
air NN NN O
. . . O
   
He PRP PRP O
received VBD VBD O
Zofran NNP NNP O
4 CD CD O
mg NN NN O
IV NNP NNP O
once RB RB O
, , , O
levofloxacin NN NN O
500 CD CD O
mg NN NN O
PO NNP NNP O
once RB RB O
, , , O
and CC CC O
a DT DT O
NS NNP NNP O
500 CD CD O
cc NN NN O
bolus NN NN O
. . . O
   
CXR NNP NNP O
showed VBD VBD O
bibasilar JJ JJ O
infiltrate NN NN O
and CC CC O
bilateral JJ JJ O
pleural JJ JJ O
effusions NNS NNS O
. . . O
   
Oncology NNP NNP O
History NN NN O
( ( ( O
per IN IN O
attending VBG VBG O
notes NNS NNS O
) ) ) O
Patient NNP NNP O
is VBZ VBZ O
a DT DT O
72 CD CD I-AGE
year NN NN O
old JJ JJ O
man NN NN O
who WP WP O
began VBD VBD O
having VBG VBG O
dysphagia NN NN O
6/83 CD CD I-DATE
. . . O
   
On IN IN O
8/01/83 CD CD I-DATE
he PRP PRP O
was VBD VBD O
scheduled VBN VBN O
for IN IN O
a DT DT O
Colonoscopy NNP NNP O
, , , O
so IN IN O
his PRP$ PRP$ O
PCP NNP NNP O
suggested VBD VBD O
he PRP PRP O
have VBP VBP O
an DT DT O
UGI NNP NNP O
Endoscopy NNP NNP O
at IN IN O
the DT DT O
same JJ JJ O
time NN NN O
. . . O
   
The DT DT O
Colonoscopy NNP NNP O
demonstrated JJ JJ O
Diverticulosis NNP NNP O
and CC CC O
the DT DT O
UGI NNP NNP O
Endoscopy NNP NNP O
demonstrated VBD VBD O
a DT DT O
partially RB RB O
obstructing VBG VBG O
esophageal/gastric JJ JJ O
cardia NN NN O
tumor NN NN O
which WDT WDT O
was VBD VBD O
biopsied VBN VBN O
. . . O
   
Pathology NNP NNP O
revealed VBD VBD O
moderately RB RB O
to TO TO O
poorly RB RB O
differentiated VBN VBN O
adenocarcinoma NN NN O
. . . O
   
On IN IN O
8/10/83 CD CD I-DATE
an DT DT O
Abd NNP NNP O
and CC CC O
Pelvic NNP NNP O
CT NNP NNP O
were VBD VBD O
done VBN VBN O
showing VBG VBG O
: : : O
marked VBD VBD O
thickening NN NN O
of IN IN O
the DT DT O
wall NN NN O
of IN IN O
the DT DT O
distal JJ JJ O
esophagus NN NN O
(35-40cm JJ JJ O
by IN IN O
endoscopy NN NN O
- : : O
partial JJ JJ O
obstruction NN NN O
and CC CC O
circumferential JJ JJ O
) ) ) O
extending VBG VBG O
into IN IN O
the DT DT O
gastric JJ JJ O
cardia NN NN O
, , , O
consistent JJ JJ O
with IN IN O
biopsy NN NN O
proven VBN VBN O
adenocarcinoma NN NN O
. . . O
   
Also RB RB O
felt VBD VBD O
to TO TO O
be VB VB O
bleeding VBG VBG O
silently RB RB O
so RB RB O
placed VBN VBN O
on IN IN O
Fe NNP NNP O
replacement NN NN O
. . . O
   
Also RB RB O
, , , O
enlarged JJ JJ O
gastroepiploic NN NN O
, , , O
celiac NN NN O
and CC CC O
aortocaval NN NN O
lymph NN NN O
nodes NNS NNS O
consistent JJ JJ O
with IN IN O
metastatic JJ JJ O
disease NN NN O
. . . O
   
On IN IN O
8/10/83 CD CD I-DATE
a DT DT O
Chest NN NN O
CT NNP NNP O
revealed VBD VBD O
thickening NN NN O
of IN IN O
the DT DT O
lower JJR JJR O
esophagus NN NN O
extending VBG VBG O
into IN IN O
the DT DT O
chest NN NN O
esophageal NN NN O
junction NN NN O
. . . O
   
This DT DT O
is VBZ VBZ O
associated VBN VBN O
with IN IN O
lymphadenopathy NN NN O
in IN IN O
the DT DT O
( ( ( O
L NNP NNP O
) ) ) O
axilla NN NN O
, , , O
gastrohepatic JJ JJ O
ligament NN NN O
, , , O
celiac NN NN O
axis NNS NNS O
and CC CC O
retrocrural JJ JJ O
space NN NN O
. . . O
   
The DT DT O
appearance NN NN O
is VBZ VBZ O
highly RB RB O
suspicious JJ JJ O
for IN IN O
esophageal NN NN O
cancer NN NN O
and CC CC O
nodal NN NN O
spread NN NN O
. . . O
   
There EX EX O
is VBZ VBZ O
a DT DT O
3mm CD CD O
nodule NN NN O
adjacent JJ JJ O
to TO TO O
the DT DT O
( ( ( O
R NN NN O
) ) ) O
major JJ JJ O
fissure NN NN O
in IN IN O
the DT DT O
lung NN NN O
. . . O
   
PET NNP NNP O
scan VB VB O
confirmed VBD VBD O
axillary JJ JJ O
and CC CC O
abdominal JJ JJ O
involvement NN NN O
with IN IN O
cancer NN NN O
. . . O
   
The DT DT O
lung NN NN O
nodule NN NN O
was VBD VBD O
too RB RB O
small JJ JJ O
for IN IN O
PET NNP NNP O
to TO TO O
evaluate VB VB O
. . . O
   
3/14/84 CD CD I-DATE
Restaging NNP NNP O
work-up JJ JJ O
revealed VBD VBD O
progressive JJ JJ O
disease NN NN O
( ( ( O
see VB VB O
imaging VBG VBG O
below IN IN O
) ) ) O
. . . O
   
His PRP$ PRP$ O
last JJ JJ O
Taxotere NNP NNP O
treatment NN NN O
was VBD VBD O
February NNP NNP I-DATE
17 CD CD I-DATE
; : : O
   
further JJ JJ O
treatment NN NN O
was VBD VBD O
stopped VBN VBN O
secondary JJ JJ O
to TO TO O
a DT DT O
chemotherapy NN NN O
burn NN NN O
on IN IN O
the DT DT O
right JJ JJ O
arm NN NN O
. . . O
   
Past NNP NNP O
Medical NNP NNP O
History NN NN O
: : : O
   
1 CD CD O
. . . O
Metastatic NNP NNP O
esophageal NN NN O
adenocarcinoma NN NN O
: : : O
Stage NN NN O
IV-B NNP NNP O
s/p NN NN O
Taxotere NNP NNP O
therapy NN NN O
. . . O
   
2 CD CD O
. . . O
Diabetes NNP NNP O
mellitus NN NN O
: : : O
Not RB RB O
taking VBG VBG O
any DT DT O
medications NNS NNS O
for IN IN O
sugar NN NN O
control NN NN O
. . . O
   
Last JJ JJ O
HgBA1c NNP NNP O
( ( ( O
06/19/83 CD CD I-DATE
) ) ) O
was VBD VBD O
5.30 CD CD O
. . . O
   
3 CD CD O
. . . O
HTN NNP NNP O
: : : O
On IN IN O
multiple JJ JJ O
medications NNS NNS O
for IN IN O
blood NN NN O
pressure NN NN O
control NN NN O
. . . O
   
No DT DT O
evidence NN NN O
of IN IN O
end-stage JJ JJ O
renal NN NN O
damage NN NN O
. . . O
   
4 CD CD O
. . . O
Hypercholesterolemia NNP NNP O
: : : O
Being VBG VBG O
treated VBN VBN O
with IN IN O
Lipitor NNP NNP O
10 CD CD O
mg NN NN O
daily JJ JJ O
. . . O
   
Last JJ JJ O
total JJ JJ O
cholesterol NN NN O
( ( ( O
06/18/83 CD CD I-DATE
) ) ) O
was VBD VBD O
139 CD CD O
; : : O
   
HDL=38, NNP NNP O
LDL=72. NNP NNP O
   
5 CD CD O
. . . O
CAD NNP NNP O
s/p NN NN O
LAD NNP NNP O
stent NN NN O
placement NN NN O
04/12/83 CD CD I-DATE
   
6 CD CD O
. . . O
Renal NNP NNP O
vein NN NN O
thrombosis NN NN O
, , , O
on IN IN O
coumadin NN NN O
. . . O
   
7 CD CD O
. . . O
s/p NN NN O
Zenker NNP NNP O
diverticulum NN NN O
repair NN NN O
in IN IN O
2080 CD CD I-DATE
   
8 CD CD O
. . . O
Chronic NNP NNP O
renal JJ JJ O
insufficiency NN NN O
: : : O
Baseline NNP NNP O
creatinine NN NN O
of IN IN O
1.2-1.5 JJ JJ O
. . . O
   
Medications NNP NNP O
: : : O
Atenolol NNP NNP O
25 CD CD O
mg NN NN O
QD NNP NNP O
Triamterene/HCTZ NNP NNP O
50/25 CD CD O
QD NNP NNP O
Three CD CD O
times NNS NNS O
a DT DT O
week NN NN O
Vitamin NNP NNP O
B NNP NNP O
Complex NNP NNP O
100 CD CD O
u NN NN O
QD NNP NNP O
Folic NNP NNP O
Acid NNP NNP O
1 CD CD O
mg NN NN O
QD NNP NNP O
Iron NNP NNP O
Sulfate NNP NNP O
1 CD CD O
tab NN NN O
BID NNP NNP O
Lipitor NNP NNP O
10 CD CD O
mg NN NN O
QHS NNP NNP O
Terazosin NNP NNP O
5 CD CD O
mg NN NN O
QD NNP NNP O
Ducolax NNP NNP O
2 CD CD O
tabs NNS NNS O
QD NNP NNP O
Warfarin NNP NNP O
5 CD CD O
mg NN NN O
QD NNP NNP O
Zantac NNP NNP O
75 CD CD O
mg NN NN O
QD NNP NNP O
PRN NNP NNP O
heartburn NN NN O
. . . O
   
Allergies NNP NNP O
: : : O
Codeine NNP NNP O
. . . O
   
Reaction-dizziness JJ JJ O
Family NNP NNP O
History NN NN O
: : : O
Mother NNP NNP O
and CC CC O
maternal NN NN O
grandmother NN NN O
died VBD VBD O
from IN IN O
heart NN NN O
disease NN NN O
. . . O
   
Father NNP NNP O
died VBD VBD O
from IN IN O
renal JJ JJ O
failure NN NN O
. . . O
   
No DT DT O
family NN NN O
history NN NN O
of IN IN O
cancer NN NN O
. . . O
   
Social NNP NNP O
History NN NN O
: : : O
Smoking NNP NNP O
: : : O
Denies NNP NNP O
history NN NN O
of IN IN O
smoking NN NN O
. . . O
   
Alcohol NNP NNP O
use NN NN O
: : : O
Drinks NNS NNS O
rarely RB RB O
, , , O
approximately RB RB O
six CD CD O
beers NNS NNS O
each DT DT O
year NN NN O
. . . O
   
Substance NNP NNP O
Abuse NNP NNP O
: : : O
Not RB RB O
assessed VBN VBN O
. . . O
   
Occupation NNP NNP O
: : : O
Retired NNP NNP O
. . . O
   
Former NNP NNP O
aerospace NN NN I-PROFESSION
engineer NN NN I-PROFESSION
of IN IN O
forty NN NN O
years NNS NNS O
. . . O
   
Marital NNP NNP O
Status NNP NNP O
: : : O
Never RB RB O
married VBN VBN O
Living NNP NNP O
Situation NNP NNP O
: : : O
Lives NNP NNP O
alone RB RB O
at IN IN O
home NN NN O
. . . O
   
Independent NNP NNP O
ADLs NNP NNP O
. . . O
   
ROS NNP NNP O
: : : O
General NNP NNP O
: : : O
Reports NNP NNP O
anorexia NN NN O
, , , O
20-pound JJ JJ O
weight NN NN O
loss NN NN O
over IN IN O
the DT DT O
last JJ JJ O
year NN NN O
. . . O
   
Head NNP NNP O
: : : O
As IN IN O
per IN IN O
HPI NNP NNP O
. . . O
   
Reports NNP NNP O
dizziness NN NN O
, , , O
headache NN NN O
, , , O
h/o NN NN O
head NN NN O
injury NN NN O
, , , O
and CC CC O
lightheadedness NN NN O
. . . O
   
Eyes NNS NNS O
: : : O
Denies NNP NNP O
vision NN NN O
changes NNS NNS O
. . . O
   
Ears NNS NNS O
: : : O
Denies NNP NNP O
hearing NN NN O
loss NN NN O
, , , O
tinnitus NN NN O
, , , O
vertigo NN NN O
, , , O
or CC CC O
earaches/discharge NN NN O
. . . O
   
Nose NN NN O
and CC CC O
Sinuses NNP NNP O
: : : O
Reports NNP NNP O
nosebleeds NNS NNS O
secondary JJ JJ O
to TO TO O
Coumadin NNP NNP O
. . . O
   
Denies NNP NNP O
frequent JJ JJ O
colds NNS NNS O
, , , O
stuffiness NNS NNS O
, , , O
itching VBG VBG O
, , , O
hayfever NN NN O
, , , O
or CC CC O
other JJ JJ O
sinus JJ JJ O
troubles NNS NNS O
. . . O
   
Mouth NN NN O
and CC CC O
Throat NNP NNP O
: : : O
Denies NNS NNS O
dry JJ JJ O
mouth NN NN O
. . . O
   
Neck NN NN O
: : : O
Denies NNP NNP O
lumps NNS NNS O
, , , O
pain NN NN O
, , , O
swollen NN NN O
glands NNS NNS O
, , , O
or CC CC O
stiffness NN NN O
in IN IN O
the DT DT O
neck NN NN O
. . . O
   
Respiratory NNP NNP O
: : : O
Denies NNP NNP O
SOB NNP NNP O
, , , O
, , , O
wheezing VBG VBG O
, , , O
and CC CC O
asthma NN NN O
. . . O
   
Cardiovascular NNP NNP O
: : : O
Denies NNP NNP O
palpitations NNS NNS O
, , , O
tachycardia NNS NNS O
. . . O
   
GI NNP NNP O
: : : O
Mild NNP NNP O
heartburn NN NN O
. . . O
   
Denies NNP NNP O
dysphagia NN NN O
, , , O
hematemasis NN NN O
, , , O
BRBPR NNP NNP O
, , , O
diarrhea NN NN O
, , , O
constipation NN NN O
. . . O
   
Urinary NNP NNP O
Tract NNP NNP O
: : : O
Denies NNP NNP O
pain/burning VBG VBG O
upon IN IN O
urination NN NN O
, , , O
discharge NN NN O
. . . O
   
Peripheral NNP NNP O
Vascular NNP NNP O
: : : O
Denies NNP NNP O
claudication NN NN O
, , , O
varicose NN NN O
veins NNS NNS O
, , , O
cold JJ JJ O
limbs NNS NNS O
. . . O
   
Endocrine NNP NNP O
: : : O
Reports NNS NNS O
some DT DT O
cold JJ JJ O
intolerance NN NN O
. . . O
   
Denies NNP NNP O
excessive JJ JJ O
sweating NN NN O
, , , O
thirst NN NN O
, , , O
and CC CC O
hunger NN NN O
. . . O
   
Neurological NNP NNP O
: : : O
One CD CD O
episode NN NN O
of IN IN O
syncope NN NN O
one CD CD O
year NN NN O
ago RB RB O
because IN IN O
of IN IN O
hypotension NN NN O
secondary JJ JJ O
to TO TO O
too RB RB O
many JJ JJ O
blood NN NN O
pressure NN NN O
medications NNS NNS O
. . . O
   
Denies NNP NNP O
generalized VBD VBD O
weakness NN NN O
, , , O
numbness/sensation NN NN O
loss NN NN O
, , , O
or CC CC O
memory NN NN O
loss NN NN O
. . . O
   
Psychiatric NNP NNP O
: : : O
Denies NNP NNP O
depression NN NN O
, , , O
suicidal JJ JJ O
ideation NN NN O
. . . O
   
Exam NNP NNP O
: : : O
Pt NNP NNP O
is VBZ VBZ O
a DT DT O
pleasant JJ JJ O
, , , O
well-appearing JJ JJ O
man NN NN O
who WP WP O
is VBZ VBZ O
in IN IN O
no DT DT O
acute JJ JJ O
distress NN NN O
. . . O
   
Patient NNP NNP O
is VBZ VBZ O
cooperative JJ JJ O
to TO TO O
interview VB VB O
. . . O
   
VS NNP NNP O
: : : O
Temperature=97.5; NNP NNP O
   
BP=140/70; NNP NNP O
   
HR=74; NNP NNP O
   
RR=18. NNP NNP O
   
HEENT NNP NNP O
: : : O
NC/AT NNP NNP O
, , , O
PERRL NNP NNP O
, , , O
nonicteric JJ JJ O
. . . O
   
EOMI NNP NNP O
. . . O
   
No DT DT O
temporal JJ JJ O
tenderness NNS NNS O
. . . O
   
MMM NNP NNP O
, , , O
w/o NN NN O
exudates NNS NNS O
or CC CC O
evidence NN NN O
of IN IN O
mucocitis NNS NNS O
or CC CC O
thrush NN NN O
. . . O
   
Neck NN NN O
: : : O
Supple NNP NNP O
, , , O
NT NNP NNP O
, , , O
full JJ JJ O
ROM NNP NNP O
, , , O
2 CD CD O
+ NN NN O
carotids NNS NNS O
w/o NN NN O
bruits NNS NNS O
, , , O
no DT DT O
LAD NNP NNP O
. . . O
   
JVP NNP NNP O
< NN NN O
5cm CD CD O
Lungs NNS NNS O
: : : O
Decreased NNP NNP O
bibasilar JJ JJ O
breath NN NN O
sounds VBZ VBZ O
, , , O
R>L NNP NNP O
. . . O
   
Fine NNP NNP O
crackles NNS NNS O
at IN IN O
the DT DT O
right JJ JJ O
base NN NN O
. . . O
   
Without IN IN O
wheezes NNS NNS O
. . . O
   
Cor NNP NNP O
: : : O
RRR NNP NNP O
; : : O
   
normal JJ JJ O
S1S2 NNP NNP O
, , , O
3/6 CD CD O
systolic JJ JJ O
ejection NN NN O
murmur NN NN O
heard VBN VBN O
best JJS JJS O
at IN IN O
the DT DT O
right JJ JJ O
sternal JJ JJ O
base NN NN O
, , , O
radiating VBG VBG O
to TO TO O
the DT DT O
axilla NN NN O
, , , O
consistent JJ JJ O
with IN IN O
AS NNP NNP O
. . . O
   
Abd NNP NNP O
: : : O
BS NNP NNP O
active JJ JJ O
. . . O
   
Abdomen NNP NNP O
mildly RB RB O
distended VBD VBD O
. . . O
   
Tympanic NNP NNP O
to TO TO O
percussion NN NN O
over IN IN O
all DT DT O
quadrants NNS NNS O
. . . O
   
Soft JJ JJ O
, , , O
nontender NN NN O
to TO TO O
palpation NN NN O
in IN IN O
all DT DT O
areas NNS NNS O
. . . O
   
Liver NNP NNP O
spanned VBD VBD O
10 CD CD O
cm NN NN O
at IN IN O
the DT DT O
midclavicular NN NN O
line NN NN O
. . . O
   
NO DT DT O
hepatosplenomegaly NN NN O
, , , O
liver NN NN O
edge NN NN O
not RB RB O
felt VBD VBD O
. . . O
   
G/R NNP NNP O
: : : O
Brown NNP NNP O
stool NN NN O
. . . O
   
Non-tender NNP NNP O
prostate NN NN O
. . . O
   
Extr NNP NNP O
: : : O
1 CD CD O
+ NN NN O
edema NN NN O
bilateral NN NN O
lower JJR JJR O
extremities NNS NNS O
. . . O
   
2 CD CD O
+ NN NN O
DP NNP NNP O
, , , O
radial JJ JJ O
pulses NNS NNS O
bilaterally RB RB O
. . . O
   
Skin NNP NNP O
: : : O
Large JJ JJ O
, , , O
sharply RB RB O
demarcated VBN VBN O
erythematous JJ JJ O
patch NN NN O
over IN IN O
right NN NN O
wrist NN NN O
. . . O
   
Neuro NNP NNP O
: : : O
AOx3 NNP NNP O
, , , O
MS NNP NNP O
nl NN NN O
, , , O
CN NNP NNP O
II NNP NNP O
through IN IN O
XII NNP NNP O
intact JJ JJ O
, , , O
some DT DT O
nystagmus NN NN O
on IN IN O
lateral NN NN O
and CC CC O
vertical JJ JJ O
gaze VBP VBP O
, , , O
motor NN NN O
and CC CC O
sensory JJ JJ O
nonfocal-5/5 JJ JJ O
plantarflexion NN NN O
, , , O
dorsiflexion NN NN O
, , , O
grip NN NN O
strength NN NN O
, , , O
hip NN NN O
flexors NNS NNS O
and CC CC O
extensors NNS NNS O
; : : O
   
DTR NNP NNP O
's POS POS O
2 CD CD O
+ NN NN O
and CC CC O
symmetric JJ JJ O
throughout IN IN O
in IN IN O
biceps NNS NNS O
and CC CC O
patellar JJ JJ O
tendons NNS NNS O
. . . O
   
Babinski NNP NNP O
down RB RB O
. . . O
   
Labs NNP NNP O
: : : O
Chemistry NNP NNP O
: : : O
03/17/84 CD CD I-DATE
08:51 CD CD O
NA NNP NNP O
139 CD CD O
K NNP NNP O
3.8 CD CD O
CL NNP NNP O
112(H) CD CD O
CO2 NNP NNP O
24.4 CD CD O
BUN NNP NNP O
14 CD CD O
CRE NNP NNP O
1.3 CD CD O
GLU NNP NNP O
145(H) CD CD O
CA NNP NNP O
8.8 CD CD O
PHOS NNP NNP O
2.5(L) CD CD O
MG NNP NNP O
1.8 CD CD O
TP NNP NNP O
6.4 CD CD O
ALB NNP NNP O
3.3 CD CD O
GLOB NNP NNP O
3.1 CD CD O
ALT/SGPT NNP NNP O
19 CD CD O
AST/SGOT NNP NNP O
29 CD CD O
ALKP NNP NNP O
47 CD CD O
TBILI NNP NNP O
0.8 CD CD O
DBILI NNP NNP O
0.3 CD CD O
Cardiac NNP NNP O
markers NNS NNS O
03/17/84 CD CD I-DATE
09:51 CD CD O
CK-MB NNP NNP O
Negative NNP NNP O
TROP-I NNP NNP O
Negative NNP NNP O
Hematology NNP NNP O
: : : O
03/17/84 CD CD I-DATE
08:47 CD CD O
WBC NNP NNP O
4.5 CD CD O
RBC NNP NNP O
5.27 CD CD O
HGB NNP NNP O
11.9(L) CD CD O
HCT NNP NNP O
38.4(L) CD CD O
MCV NNP NNP O
73(L) CD CD O
MCH NNP NNP O
22.6(L) CD CD O
MCHC NNP NNP O
31.0 CD CD O
PLT NNP NNP O
168 CD CD O
RDW NNP NNP O
17.1(H) CD CD O
DIFFR NNP NNP O
Received NNP NNP O
METHOD NNP NNP O
Auto NNP NNP O
% NN NN O
NEUT NNP NNP O
84(H) CD CD O
% NN NN O
LYMPH NNP NNP O
11(L) CD CD O
% NN NN O
MONO NNP NNP O
4 CD CD O
% NN NN O
EOS NNP NNP O
1 CD CD O
% NN NN O
BASO NNP NNP O
0 CD CD O
ANEUT NNP NNP O
3.81 CD CD O
ALYMP NNP NNP O
0.51(L) CD CD O
AMONS NNP NNP O
0.18(L) CD CD O
AEOSN NNP NNP O
0.02(L) CD CD O
ABASOP NNP NNP O
0.01 CD CD O
ANISO NNP NNP O
1 CD CD O
+ NN NN O
HYPO NNP NNP O
2 CD CD O
+ NN NN O
MACRO NNP NNP O
None NN NN O
MICRO NNP NNP O
3 CD CD O
+ NN NN O
Coagulation NNP NNP O
: : : O
03/17/84 CD CD I-DATE
08:47 CD CD O
PT NNP NNP O
22.9(H) CD CD O
PTT NNP NNP O
29.2 CD CD O
Miscellaneous NNP NNP O
Labs NNP NNP O
: : : O
03/17/84 CD CD I-DATE
08:47 CD CD O
ESR NNP NNP O
24(H) CD CD O
UA NNP NNP O
: : : O
Pending NNP NNP O
. . . O
   
EKG NNP NNP O
: : : O
NSR NNP NNP O
with IN IN O
ventricular NN NN O
rate NN NN O
of IN IN O
   
83 CD CD O
. . . O
PR NNP NNP O
interval=180 NN NN O
ms NN NN O
; : : O
   
QRS NNP NNP O
interval=92 NN NN O
ms NN NN O
; : : O
   
QT=383 NNP NNP O
ms NN NN O
. . . O
Axis NNP NNP O
normal JJ JJ O
. . . O
   
Good JJ JJ O
R-wave NNP NNP O
progression NN NN O
V3-V4. NNP NNP O
   
No DT DT O
evidence NN NN O
of IN IN O
atrial JJ JJ O
enlargement NN NN O
or CC CC O
ventricular NN NN O
hypertrophy NN NN O
. . . O
   
No DT DT O
evidence NN NN O
of IN IN O
bundle NN NN O
branch NN NN O
blocks NNS NNS O
. . . O
   
No DT DT O
ST NNP NNP O
segment NN NN O
changes NNS NNS O
or CC CC O
Q NNP NNP O
waves NNS NNS O
. . . O
   
Mild NNP NNP O
T NN NN O
wave NN NN O
flattening NN NN O
in IN IN O
III NNP NNP O
, , , O
aVF NN NN O
. . . O
   
IMAGING NNP NNP O
: : : O
CXR NNP NNP O
03/17/84 CD CD I-DATE
. . . O
   
IMPRESSION NNP NNP O
: : : O
Bibasilar NNP NNP O
pneumonia NN NN O
with IN IN O
bilateral JJ JJ O
pleural JJ JJ O
effusions NNS NNS O
, , , O
greater NN NN O
on IN IN O
the DT DT O
left NN NN O
. . . O
   
In IN IN O
patient NN NN O
of IN IN O
this DT DT O
age NN NN O
group NN NN O
, , , O
follow VB VB O
up RB RB O
chest NN NN O
films NNS NNS O
are VBP VBP O
recommended VBN VBN O
to TO TO O
clearing VBG VBG O
. . . O
   
Chest NN NN O
CT NNP NNP O
03/14/84 CD CD I-DATE
. . . O
   
IMPRESSION NNP NNP O
: : : O
   
1 CD CD O
. . . O
Increasing NNP NNP O
mediastinal JJ JJ O
lymphadenopathy NN NN O
suspicious JJ JJ O
for IN IN O
metastatic JJ JJ O
disease NN NN O
. . . O
   
Stable JJ JJ O
left VBD VBD O
axillary JJ JJ O
lymphadenopathy NN NN O
. . . O
   
2 CD CD O
. . . O
New NNP NNP O
small JJ JJ O
pericardial JJ JJ O
effusion NN NN O
and CC CC O
left VBD VBD O
pleural JJ JJ O
effusion NN NN O
. . . O
   
There EX EX O
is VBZ VBZ O
partial JJ JJ O
loculation NN NN O
of IN IN O
the DT DT O
left VBN VBN O
effusion NN NN O
. . . O
   
There EX EX O
is VBZ VBZ O
significant JJ JJ O
increase NN NN O
in IN IN O
size NN NN O
in IN IN O
the DT DT O
right NN NN O
pleural JJ JJ O
effusion NN NN O
. . . O
   
3 CD CD O
. . . O
Interval NNP NNP O
increase NN NN O
in IN IN O
size NN NN O
in IN IN O
lingular NN NN O
and CC CC O
right JJ JJ O
upper JJ JJ O
lobe NN NN O
subpleural JJ JJ O
nodules NNS NNS O
suspicious JJ JJ O
for IN IN O
metastatic JJ JJ O
disease NN NN O
. . . O
   
4 CD CD O
. . . O
Stable JJ JJ O
bronchiectasis NN NN O
and CC CC O
bronchial JJ JJ O
wall NN NN O
thickening VBG VBG O
at IN IN O
both DT DT O
bases NNS NNS O
likely JJ JJ O
due JJ JJ O
to TO TO O
aspiration NN NN O
or CC CC O
radiation NN NN O
changes NNS NNS O
. . . O
   
Abdominal/Pelvic NNP NNP O
CT NNP NNP O
: : : O
IMPRESSION NNP NNP O
: : : O
Evidence NN NN O
of IN IN O
interval NN NN O
progression NN NN O
of IN IN O
disease NN NN O
, , , O
with IN IN O
worsening VBG VBG O
lymphadenopathy NN NN O
at IN IN O
the DT DT O
celiac NN NN O
axis NNS NNS O
and CC CC O
in IN IN O
the DT DT O
upper JJ JJ O
retroperitoneum NN NN O
and CC CC O
small JJ JJ O
amount NN NN O
of IN IN O
perihepatic JJ JJ O
ascites NNS NNS O
. . . O
   
____________________________________________________________________________________ NN NN O
_ NN NN O
I/P NNP NNP O
: : : O
73-year-old JJ JJ O
man NN NN O
with IN IN O
metastatic JJ JJ O
esophageal NN NN O
adenocarcinoma NN NN O
presents VBZ VBZ O
with IN IN O
bibasilar NN NN O
pneumonia NN NN O
and CC CC O
small JJ JJ O
bilateral JJ JJ O
pleural NN NN O
effusions NNS NNS O
. . . O
   
1 CD CD O
. . . O
Pneumonia NNP NNP O
: : : O
The DT DT O
patient NN NN O
presents VBZ VBZ O
with IN IN O
a DT DT O
two-day JJ JJ O
history NN NN O
of IN IN O
dizziness NN NN O
, , , O
subjective JJ JJ O
fevers NNS NNS O
, , , O
and CC CC O
productive JJ JJ O
cough NN NN O
of IN IN O
green JJ JJ O
sputum NN NN O
. . . O
   
Physical JJ JJ O
exam NN NN O
reveals VBZ VBZ O
decreased VBN VBN O
bibasilar JJ JJ O
breath NN NN O
sounds VBZ VBZ O
, , , O
right NN NN O
greater JJR JJR O
than IN IN O
left VBD VBD O
. . . O
   
The DT DT O
constellation NN NN O
of IN IN O
symptoms NNS NNS O
can MD MD O
be VB VB O
attributed VBN VBN O
to TO TO O
the DT DT O
pneumonia NN NN O
found VBD VBD O
on IN IN O
chest NN NN O
imaging VBG VBG O
. . . O
   
The DT DT O
possible JJ JJ O
causes NNS NNS O
of IN IN O
the DT DT O
pneumonia NN NN O
include VBP VBP O
aspiration NN NN O
, , , O
infectious JJ JJ O
, , , O
and CC CC O
post-obstructive JJ JJ O
causes NNS NNS O
. . . O
   
The DT DT O
patient NN NN O
reports NNS NNS O
no DT DT O
problems NNS NNS O
with IN IN O
swallowing VBG VBG O
and CC CC O
has VBZ VBZ O
not RB RB O
vomited VBN VBN O
, , , O
making VBG VBG O
aspiration NN NN O
pneumonia NN NN O
lower NN NN O
on IN IN O
the DT DT O
differential NN NN O
. . . O
   
The DT DT O
chest NN NN O
CT NNP NNP O
does VBZ VBZ O
not RB RB O
show VB VB O
any DT DT O
evidence NN NN O
of IN IN O
tumor NN NN O
obstruction NN NN O
around IN IN O
the DT DT O
bronchi NN NN O
. . . O
   
Further RB RB O
, , , O
the DT DT O
pneumonia NN NN O
and CC CC O
pleural JJ JJ O
effusions NNS NNS O
are VBP VBP O
bilateral JJ JJ O
, , , O
meaning VBG VBG O
that IN IN O
the DT DT O
obstruction NN NN O
would MD MD O
have VB VB O
to TO TO O
be VB VB O
higher JJR JJR O
in IN IN O
the DT DT O
bronchial JJ JJ O
tree NN NN O
, , , O
making VBG VBG O
obstruction NN NN O
less RBR RBR O
likely JJ JJ O
. . . O
   
In IN IN O
this DT DT O
case NN NN O
the DT DT O
most RBS RBS O
likely JJ JJ O
cause NN NN O
is VBZ VBZ O
infectious JJ JJ O
in IN IN O
nature NN NN O
; : : O
   
the DT DT O
agents NNS NNS O
most RBS RBS O
likely JJ JJ O
to TO TO O
cause VB VB O
pneumonia NN NN O
in IN IN O
this DT DT O
patient NN NN O
are VBP VBP O
the DT DT O
typical JJ JJ O
bacteria NN NN O
, , , O
such JJ JJ O
as IN IN O
pneumococcus NN NN O
, , , O
H. NN NN O
influenza NN NN O
, , , O
Staphalococcus NNP NNP O
, , , O
and CC CC O
other JJ JJ O
gram-negative JJ JJ O
bugs NNS NNS O
, , , O
atypical JJ JJ O
bacteria NN NN O
such JJ JJ O
as IN IN O
Legionella NNP NNP O
sp NN NN O
, , , O
Mycoplasma NNP NNP O
pneumoniae NN NN O
, , , O
and CC CC O
Chlamydia NNP NNP O
pneumoniae NN NN O
, , , O
and CC CC O
viral JJ JJ O
causes NNS NNS O
. . . O
   
Based VBN VBN O
upon IN IN O
imaging VBG VBG O
findings NNS NNS O
, , , O
pneumonia NN NN O
most RBS RBS O
consistent JJ JJ O
with IN IN O
a DT DT O
bacterial JJ JJ O
infectious JJ JJ O
agent NN NN O
. . . O
   
a. NN NN O
   
Start NNP NNP O
Levofloxacin NNP NNP O
750 CD CD O
mg NN NN O
daily JJ JJ O
for IN IN O
antibacterial JJ JJ O
coverage NN NN O
. . . O
   
b. NN NN O
   
Sputum NNP NNP O
gram NN NN O
stain VB VB O
and CC CC O
culture NN NN O
c. NN NN O
   
Blood NNP NNP O
cultures NNS NNS O
d. NN NN O
   
Pneumococcus NNP NNP O
antigen NN NN O
screening NN NN O
e. NN NN O
   
U/A NNP NNP O
, , , O
urine NN NN O
Legionella NNP NNP O
f. NN NN O
   
NS NNP NNP O
at IN IN O
75 CD CD O
cc/hour NN NN O
. . . O
   
If IN IN O
PO NNP NNP O
intake NN NN O
is VBZ VBZ O
not RB RB O
increased VBN VBN O
, , , O
will MD MD O
switch VB VB O
fluids NNS NNS O
to TO TO O
D5 NNP NNP O
NS NNP NNP O
. . . O
   
g. NN NN O
   
Tylenol NNP NNP O
for IN IN O
fever NN NN O
, , , O
Zofran NNP NNP O
for IN IN O
nausea NN NN O
. . . O
   
h. NN NN O
   
Incentive NNP NNP O
spirometry NN NN O
every DT DT O
two CD CD O
hours NNS NNS O
while IN IN O
awake NN NN O
. . . O
   
2 CD CD O
. . . O
Dizziness NNP NNP O
: : : O
The DT DT O
patient NN NN O
presents VBZ VBZ O
with IN IN O
a DT DT O
two-day JJ JJ O
history NN NN O
of IN IN O
dizziness NN NN O
. . . O
   
Potential NNP NNP O
causes NNS NNS O
include VBP VBP O
orthostatic JJ JJ O
causes NNS NNS O
secondary JJ JJ O
to TO TO O
hypotension NN NN O
, , , O
dehydration NN NN O
, , , O
or CC CC O
poor JJ JJ O
sympthathetic JJ JJ O
tone NN NN O
; : : O
   
anxiety NN NN O
; : : O
   
cardiac JJ JJ O
causes NNS NNS O
( ( ( O
dysrhythmias NN NN O
, , , O
CAD NNP NNP O
) ) ) O
, , , O
anemia NN NN O
, , , O
and CC CC O
electrolyte NN NN O
abnormalities NNS NNS O
( ( ( O
e.g. NN NN O
hypoglycemia NN NN O
) ) ) O
. . . O
   
This DT DT O
patient NN NN O
has VBZ VBZ O
a DT DT O
history NN NN O
of IN IN O
CAD NNP NNP O
, , , O
but CC CC O
EKG NNP NNP O
findings NNS NNS O
and CC CC O
cardiac JJ JJ O
enzymes NNS NNS O
do VBP VBP O
not RB RB O
suggest VB VB O
cardiac JJ JJ O
insult NN NN O
. . . O
   
The DT DT O
patient NN NN O
has VBZ VBZ O
not RB RB O
had VBN VBN O
an DT DT O
increase NN NN O
in IN IN O
the DT DT O
BUN NNP NNP O
or CC CC O
creatinine NN NN O
from IN IN O
baseline NN NN O
, , , O
making VBG VBG O
dehydration NN NN O
less RBR RBR O
likely JJ JJ O
. . . O
   
Labs NNP NNP O
did VBD VBD O
not RB RB O
show VB VB O
any DT DT O
electrolyte NN NN O
abnormalities NNS NNS O
; : : O
   
therefore RB RB O
hypoglycemia NN NN O
is VBZ VBZ O
low JJ JJ O
on IN IN O
the DT DT O
differential JJ JJ O
diagnosis NN NN O
. . . O
   
The DT DT O
dizziness NN NN O
was VBD VBD O
positional JJ JJ O
in IN IN O
nature NN NN O
. . . O
   
The DT DT O
patient NN NN O
reports NNS NNS O
long-standing JJ JJ O
poor JJ JJ O
PO NNP NNP O
intake NN NN O
, , , O
particularly RB RB O
because IN IN O
he PRP PRP O
was VBD VBD O
NPO NNP NNP O
for IN IN O
much JJ JJ O
of IN IN O
the DT DT O
day NN NN O
prior RB RB O
to TO TO O
the DT DT O
start NN NN O
of IN IN O
symptoms NNS NNS O
. . . O
   
In IN IN O
this DT DT O
patient NN NN O
, , , O
the DT DT O
cause NN NN O
of IN IN O
the DT DT O
dizziness NN NN O
is VBZ VBZ O
most RBS RBS O
likely JJ JJ O
orthostatic JJ JJ O
in IN IN O
nature NN NN O
, , , O
secondary JJ JJ O
to TO TO O
poor JJ JJ O
PO NNP NNP O
intake NN NN O
and CC CC O
decreased VBD VBD O
sympathetic JJ JJ O
tone NN NN O
. . . O
   
a. NN NN O
   
NS NNP NNP O
at IN IN O
75 CD CD O
cc/hour NN NN O
. . . O
   
If IN IN O
PO NNP NNP O
intake NN NN O
is VBZ VBZ O
not RB RB O
increased VBN VBN O
, , , O
will MD MD O
switch VB VB O
fluids NNS NNS O
to TO TO O
D5 NNP NNP O
NS NNP NNP O
. . . O
   
b. NN NN O
   
Check NNP NNP O
orthostatics NNS NNS O
daily VBP VBP O
. . . O
   
3 CD CD O
. . . O
Metastatic NNP NNP O
esophageal NN NN O
adenocarcinoma NN NN O
: : : O
Patient NNP NNP O
presents VBZ VBZ O
with IN IN O
known VBN VBN O
Stage NN NN O
IV-B NNP NNP O
metastatic JJ JJ O
esophageal NN NN O
adenocarcinoma NN NN O
with IN IN O
new JJ JJ O
CT NNP NNP O
findings NNS NNS O
suggestive JJ JJ O
of IN IN O
disease NN NN O
progression NN NN O
, , , O
particularly RB RB O
in IN IN O
the DT DT O
retroperitoneum NN NN O
. . . O
   
Has VBZ VBZ O
been VBN VBN O
on IN IN O
Taxotere NNP NNP O
for IN IN O
the DT DT O
last JJ JJ O
six CD CD O
months NNS NNS O
. . . O
   
a. NN NN O
   
Patient NNP NNP O
does VBZ VBZ O
not RB RB O
know VB VB O
of IN IN O
new JJ JJ O
findings NNS NNS O
, , , O
to TO TO O
discuss VB VB O
with IN IN O
Dr NNP NNP O
. . . O
Otero NNP NNP I-DOCTOR
in IN IN O
AM NNP NNP O
. . . O
   
b. NN NN O
   
Consider NNP NNP O
alternative NN NN O
therapies NNS NNS O
. . . O
   
4 CD CD O
. . . O
Anemia NNP NNP O
: : : O
Patient NNP NNP O
presents VBZ VBZ O
with IN IN O
microcytic JJ JJ O
anemia NN NN O
(MCV=73). NN NN O
   
Not RB RB O
known VBN VBN O
to TO TO O
be VB VB O
iron-deficient JJ JJ O
. . . O
   
a. NN NN O
   
Iron NNP NNP O
studies NNS NNS O
( ( ( O
Iron NNP NNP O
, , , O
Ferritin NNP NNP O
, , , O
TIBC NNP NNP O
) ) ) O
to TO TO O
assess VB VB O
iron NN NN O
deficiency NN NN O
versus CC CC O
anemia NN NN O
of IN IN O
chronic JJ JJ O
disease NN NN O
. . . O
   
b. NN NN O
   
Guaiac NNP NNP O
stool NN NN O
for IN IN O
evidence NN NN O
of IN IN O
occult NN NN O
blood NN NN O
. . . O
   
5 CD CD O
. . . O
HTN NNP NNP O
: : : O
a. NN NN O
   
Check VB VB O
orthostatics NNS NNS O
daily RB RB O
. . . O
   
b. NN NN O
   
Patient NNP NNP O
is VBZ VBZ O
stable JJ JJ O
on IN IN O
current JJ JJ O
regimen NNS NNS O
. . . O
   
No DT DT O
changes NNS NNS O
to TO TO O
medications NNS NNS O
. . . O
   
6 CD CD O
. . . O
CAD/hypercholesterolemia NNP NNP O
: : : O
a. NN NN O
   
Continue VB VB O
with IN IN O
Lipitor NNP NNP O
10 CD CD O
mg NN NN O
daily JJ JJ O
b. NN NN O
   
Cardiac NNP NNP O
enzymes VBZ VBZ O
negative JJ JJ O
times NNS NNS O
one CD CD O
. . . O
   
Per IN IN O
Oncology NNP NNP O
fellow NN NN O
, , , O
no DT DT O
need NN NN O
to TO TO O
cycle NN NN O
given VBN VBN O
stability NN NN O
of IN IN O
TW NNP NNP O
changes NNS NNS O
in IN IN O
EKG NNP NNP O
and CC CC O
lack NN NN O
of IN IN O
anginal JJ JJ O
symptoms NNS NNS O
c. NN NN O
   
Low NNP NNP O
fat JJ JJ O
diet NN NN O
   
7 CD CD O
. . . O
Renal NNP NNP O
vein NN NN O
thrombosis NNS NNS O
: : : O
a. NN NN O
   
Stable JJ JJ O
on IN IN O
Coumadin NNP NNP O
. . . O
   
b. NN NN O
   
Clarify NNP NNP O
goal NN NN O
INR NNP NNP O
level NN NN O
. . . O
   
Currently RB RB O
INR=3.4. NNP NNP O
   
8 CD CD O
. . . O
Prophylaxis NNP NNP O
: : : O
a. NN NN O
   
Nexium NNP NNP O
for IN IN O
GI NNP NNP O
prophylaxis NNS NNS O
b. NN NN O
   
Colace/Mylanta NNP NNP O
for IN IN O
constipation NN NN O
. . . O
   
c. NN NN O
   
Low-fat NNP NNP O
, , , O
no DT DT O
added VBD VBD O
salt NN NN O
, , , O
no DT DT O
concentrated JJ JJ O
sugar NN NN O
diet NN NN O
. . . O
   
d. NN NN O
   
Finger NNP NNP O
sticks VBZ VBZ O
after IN IN O
each DT DT O
meal NN NN O
. . . O
   
______________________________ NN NN O
_ NN NN O
Nathan NNP NNP I-DOCTOR
Altman NNP NNP I-DOCTOR
, , , O
HCC NNP NNP I-HOSPITAL
III NNP NNP O
Pager NNP NNP O
#74972 NN NN O
Team NNP NNP O
3 CD CD O
Intern NNP NNP O
Addendum NNP NNP O
: : : O
The DT DT O
patient NN NN O
was VBD VBD O
seen VBN VBN O
and CC CC O
examined VBN VBN O
. . . O
   
Agree NNP NNP O
with IN IN O
above IN IN O
excellent JJ JJ O
HCC3 NNP NNP O
note NN NN O
. . . O
   
Briefly NNP NNP O
, , , O
the DT DT O
patient NN NN O
is VBZ VBZ O
a DT DT O
73 CD CD I-AGE
year-old JJ JJ O
male NN NN O
with IN IN O
h/o NN NN O
esophageal NN NN O
CA NNP NNP O
( ( ( O
Stage NN NN O
4B CD CD O
) ) ) O
, , , O
DM NNP NNP O
, , , O
HTN NNP NNP O
, , , O
CAD NNP NNP O
s/p NN NN O
LAD NNP NNP O
stent NN NN O
, , , O
renal JJ JJ O
v. NN NN O
   
thrombosis NNS NNS O
on IN IN O
Coumadin NNP NNP O
. . . O
   
He PRP PRP O
presents VBZ VBZ O
today NN NN O
with IN IN O
2 CD CD O
days NNS NNS O
of IN IN O
malaise NN NN O
, , , O
nausea NN NN O
, , , O
and CC CC O
dizziness NN NN O
, , , O
which WDT WDT O
he PRP PRP O
states VBZ VBZ O
does VBZ VBZ O
not RB RB O
consist VB VB O
of IN IN O
"""" '' '' O
room NN NN O
spinning JJ JJ O
"""" '' '' O
but CC CC O
that IN IN O
he PRP PRP O
does VBZ VBZ O
feel NN NN O
off-balance NN NN O
and CC CC O
is VBZ VBZ O
associated VBN VBN O
with IN IN O
nausea NN NN O
. . . O
   
His PRP$ PRP$ O
PO NNP NNP O
intake NN NN O
has VBZ VBZ O
been VBN VBN O
decreased VBN VBN O
due JJ JJ O
to TO TO O
nausea NN NN O
. . . O
   
Has VBZ VBZ O
has VBZ VBZ O
had VBN VBN O
a DT DT O
cough NN NN O
productive JJ JJ O
of IN IN O
green JJ JJ O
sputum NN NN O
, , , O
and CC CC O
CXR NNP NNP O
evidence NN NN O
of IN IN O
bibasilar JJ JJ O
consolidations NNS NNS O
and CC CC O
decreased VBD VBD O
breath NN NN O
sounds VBZ VBZ O
on IN IN O
exam NN NN O
R NN NN O
> NN NN O
L. NN NN O
He PRP PRP O
was VBD VBD O
admitted VBN VBN O
to TO TO O
medicine VB VB O
for IN IN O
treatment NN NN O
of IN IN O
PNA NNP NNP O
in IN IN O
the DT DT O
setting VBG VBG O
of IN IN O
multiple JJ JJ O
comorbidities NNS NNS O
, , , O
and CC CC O
for IN IN O
lightheadedness NN NN O
on IN IN O
standing NN NN O
which WDT WDT O
is VBZ VBZ O
likely JJ JJ O
orthostatic JJ JJ O
. . . O
   
Will NNP NNP O
treat VB VB O
with IN IN O
Levofloxacin NNP NNP O
750 CD CD O
PO NNP NNP O
QD NNP NNP O
to TO TO O
cover VB VB O
CAP NNP NNP O
. . . O
   
Send VB VB O
legionella NN NN O
urinary JJ JJ O
Agn NNP NNP O
, , , O
and CC CC O
sputum NN NN O
cx NN NN O
( ( ( O
blood NN NN O
cx NN NN O
sent VBD VBD O
in IN IN O
ED NNP NNP O
) ) ) O
. . . O
   
Check NNP NNP O
orthostatics NNS NNS O
. . . O
   
IVF NNP NNP O
gentle JJ JJ O
hydration NN NN O
. . . O
   
Need MD MD O
to TO TO O
clarify VB VB O
goal NN NN O
INR NNP NNP O
in IN IN O
setting VBG VBG O
of IN IN O
Coumadin NNP NNP O
use NN NN O
for IN IN O
renal JJ JJ O
vein NN NN O
thrombosis NNS NNS O
. . . O
   
Microcytic NNP NNP O
anemia-will JJ JJ O
check NN NN O
anemia NN NN O
labs NNS NNS O
; : : O
   
already RB RB O
on IN IN O
iron NN NN O
supplementation NN NN O
. . . O
   
EKG NNP NNP O
and CC CC O
1 CD CD O
set NN NN O
of IN IN O
cardiac JJ JJ O
enzymes NNS NNS O
do VBP VBP O
not RB RB O
suggest VB VB O
an DT DT O
acute JJ JJ O
cardiac JJ JJ O
event NN NN O
. . . O
   
Will NNP NNP O
treat VB VB O
nausea NN NN O
symptomatically RB RB O
. . . O
   
Discussed VBN VBN O
with IN IN O
onc JJ JJ O
fellow NN NN O
( ( ( O
Dr NNP NNP O
. . . O
Kramer NNP NNP I-DOCTOR
) ) ) O
. . . O
   
___________________________ NN NN O
_ NN NN O
Gerald NNP NNP I-DOCTOR
Echols NNP NNP I-DOCTOR
MD NNP NNP O
Pager NNP NNP O
69793 CD CD I-PHONE
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2076-11-11 JJ JJ I-DATE
OFFICE NNP NNP O
NOTE VB VB O
Esposito NNP NNP O
, , , O
Perla NNP NNP I-PATIENT
#146-55-23-5 NN NN O
November NNP NNP I-DATE
11 CD CD O
, , , O
2076 CD CD I-DATE
Has VBZ VBZ O
had VBN VBN O
no DT DT O
exertional NN NN O
chest NN NN O
pains NNS NNS O
. . . O
   
Urinates NNP NNP O
two CD CD O
to TO TO O
three CD CD O
times NNS NNS O
a DT DT O
night NN NN O
but CC CC O
not RB RB O
very RB RB O
frequently RB RB O
during IN IN O
the DT DT O
day NN NN O
. . . O
   
Ran VBD VBD O
out IN IN O
of IN IN O
her PRP$ PRP$ O
Lopressor NNP NNP O
yesterday NN NN O
. . . O
   
Continues NNP NNP O
to TO TO O
have VB VB O
some DT DT O
discomfort NN NN O
in IN IN O
her PRP$ PRP$ O
right JJ JJ O
buttock NN NN O
radiating VBG VBG O
down RP RP O
the DT DT O
side NN NN O
of IN IN O
her PRP$ PRP$ O
leg NN NN O
. . . O
   
Not RB RB O
happy JJ JJ O
with IN IN O
the DT DT O
orthotics NNS NNS O
that WDT WDT O
were VBD VBD O
given VBN VBN O
her PRP$ PRP$ O
for IN IN O
her PRP$ PRP$ O
arch NN NN O
pain NN NN O
because IN IN O
she PRP PRP O
can MD MD O
only RB RB O
use VB VB O
them PRP PRP O
with IN IN O
bulkier NN NN O
shoes NNS NNS O
. . . O
   
Has VBZ VBZ O
had VBD VBD O
some DT DT O
right JJ JJ O
shoulder NN NN O
discomfort NN NN O
. . . O
   
Meds NNP NNP O
: : : O
Procardia NNP NNP O
XL NNP NNP O
120 CD CD O
mg NN NN O
. . . O
   
q.d. NN NN O
   
Aspirin NNP NNP O
325 CD CD O
mg NN NN O
. . . O
   
q.d. NN NN O
   
Lopressor NNP NNP O
100 CD CD O
mg NN NN O
. . . O
   
b.i.d. NN NN O
   
Micronase NNP NNP O
5 CD CD O
mg NN NN O
. . . O
   
q.d. NN NN O
   
W. NN NN O
141 CD CD O
. . . O
   
176/90 CD CD O
in IN IN O
the DT DT O
left VBN VBN O
arm NN NN O
, , , O
178/90 CD CD O
in IN IN O
the DT DT O
right NN NN O
. . . O
   
80 CD CD O
. . . O
Good JJ JJ O
range NN NN O
of IN IN O
motion NN NN O
of IN IN O
the DT DT O
right JJ JJ O
shoulder NN NN O
. . . O
   
There EX EX O
is VBZ VBZ O
some DT DT O
crepitance NN NN O
over IN IN O
the DT DT O
AC NNP NNP O
joint NN NN O
. . . O
   
No DT DT O
subdeltoid NN NN O
or CC CC O
bicipital JJ JJ O
tendon NN NN O
tenderness NN NN O
. . . O
   
Full NNP NNP O
range NN NN O
of IN IN O
motion NN NN O
. . . O
   
Lungs NNP NNP O
are VBP VBP O
clear JJ JJ O
. . . O
   
Soft JJ JJ O
, , , O
positive JJ JJ O
S4 NNP NNP O
. . . O
   
No DT DT O
pedal NN NN O
edema NN NN O
. . . O
   
1 CD CD O
. . . O
CAD NNP NNP O
. . . O
   
Doing VBG VBG O
well RB RB O
without IN IN O
angina NN NN O
. . . O
   
2 CD CD O
. . . O
Hypertension NNP NNP O
. . . O
   
I PRP PRP O
renewed VBD VBD O
her PRP$ PRP$ O
Lopressor NNP NNP O
. . . O
   
Will MD MD O
recheck VB VB O
this DT DT O
after IN IN O
she PRP PRP O
has VBZ VBZ O
been VBN VBN O
taking VBG VBG O
both DT DT O
medications NNS NNS O
faithfully RB RB O
. . . O
   
3 CD CD O
. . . O
Diabetes NNP NNP O
. . . O
   
Will NNP NNP O
check VB VB O
a DT DT O
glucose NN NN O
today NN NN O
and CC CC O
I PRP PRP O
renewed VBD VBD O
her PRP$ PRP$ O
Micronase NNP NNP O
. . . O
   
4 CD CD O
. . . O
Question NNP NNP O
right RB RB O
sciatica NN NN O
. . . O
   
She PRP PRP O
is VBZ VBZ O
not RB RB O
interested JJ JJ O
in IN IN O
any DT DT O
invasive JJ JJ O
therapy NN NN O
so IN IN O
we PRP PRP O
will MD MD O
not RB RB O
pursue VB VB O
imaging VBG VBG O
at IN IN O
this DT DT O
time NN NN O
. . . O
   
She PRP PRP O
had VBD VBD O
a DT DT O
negative JJ JJ O
CT NNP NNP O
in IN IN O
2073 CD CD I-DATE
. . . O
   
I PRP PRP O
put VBP VBP O
her PRP PRP O
on IN IN O
400 CD CD O
mg NN NN O
. . . O
   
of IN IN O
Motrin NNP NNP O
three CD CD O
times NNS NNS O
a DT DT O
day NN NN O
. . . O
   
5 CD CD O
. . . O
Arch NNP NNP O
pain NN NN O
. . . O
   
This DT DT O
is VBZ VBZ O
clearly RB RB O
not RB RB O
that IN IN O
bothersome NN NN O
that IN IN O
she PRP PRP O
feels VBZ VBZ O
that IN IN O
it PRP PRP O
is VBZ VBZ O
more RBR RBR O
important JJ JJ O
to TO TO O
wear VB VB O
lighter JJR JJR O
shoes NNS NNS O
. . . O
   
6 CD CD O
. . . O
Right RB RB O
shoulder NN NN O
pain NN NN O
. . . O
   
She PRP PRP O
may MD MD O
have VB VB O
some DT DT O
mild JJ JJ O
rotator NN NN O
cuff NN NN O
tendinitis NNS NNS O
. . . O
   
We PRP PRP O
discussed VBD VBD O
the DT DT O
importance NN NN O
of IN IN O
not RB RB O
overusing VBG VBG O
this DT DT O
shoulder NN NN O
and CC CC O
avoiding VBG VBG O
lifting VBG VBG O
anything NN NN O
heavier JJR JJR O
than IN IN O
a DT DT O
coffee NN NN O
cup NN NN O
. . . O
   
Motrin NNP NNP O
400 CD CD O
mg NN NN O
. . . O
   
t.i.d. NN NN O
on IN IN O
a DT DT O
full JJ JJ O
stomach NN NN O
. . . O
   
I PRP PRP O
showed VBD VBD O
her PRP$ PRP$ O
some DT DT O
range NN NN O
of IN IN O
motion NN NN O
exercises NNS NNS O
. . . O
   
Ulises NNP NNP I-DOCTOR
J. NN NN I-DOCTOR
Kelley NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
/ NN NN O
dalton NN NN I-DOCTOR
Esposito NNP NNP O
, , , O
Perla NNP NNP I-PATIENT
#146-55-23-5 NN NN O
- - - O
2 CD CD O
- : : O
November NNP NNP I-DATE
11 CD CD O
, , , O
2076 CD CD I-DATE
DD NNP NNP O
: : : O
11/11/76 CD CD I-DATE
DT NNP NNP O
: : : O
11/19/76 CD CD I-DATE
DV NNP NNP O
: : : O
11/11/76 CD CD I-DATE
******** NN NN O
Approved NNP NNP O
but CC CC O
not RB RB O
reviewed VBN VBN O
by IN IN O
Attending NNP NNP O
Provider NNP NNP O
******** NN NN O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2061-10-03 JJ JJ I-DATE
BMH NNP NNP I-HOSPITAL
Cancer NNP NNP O
Center NNP NNP O
Hematology NNP NNP O
Note NNP NNP O
Fellow NNP NNP O
: : : O
James NNP NNP I-DOCTOR
Tyler NNP NNP I-DOCTOR
Attending NNP NNP O
: : : O
Cole NNP NNP I-DOCTOR
Morgan NNP NNP I-DOCTOR
Date NN NN O
of IN IN O
consultation NN NN O
: : : O
October NNP NNP I-DATE
04 CD CD O
, , , O
2061 CD CD I-DATE
Diagnosis NNP NNP O
: : : O
thrombocytosis NN NN O
, , , O
reactive JJ JJ O
vs NNS NNS O
. . . O
essential JJ JJ O
thrombocytosis NN NN O
HPI NNP NNP O
: : : O
27 CD CD I-AGE
yo NN NN O
African NNP NNP O
American JJ JJ O
male NN NN O
with IN IN O
recent JJ JJ O
complicated JJ JJ O
hospital NN NN O
stay NN NN O
at IN IN O
BMH NNP NNP I-HOSPITAL
presents VBZ VBZ O
to TO TO O
hematology NN NN O
clinic NN NN O
for IN IN O
first JJ JJ O
time NN NN O
for IN IN O
follow VB VB O
up RB RB O
of IN IN O
his PRP$ PRP$ O
thrombocytosis NN NN O
. . . O
   
This DT DT O
27 CD CD I-AGE
yo NN NN O
male NN NN O
with IN IN O
history NN NN O
of IN IN O
type NN NN O
I PRP PRP O
DM NNP NNP O
who WP WP O
does VBZ VBZ O
not RB RB O
get VB VB O
regular JJ JJ O
medical JJ JJ O
care NN NN O
in IN IN O
late JJ JJ O
August NNP NNP I-DATE
was VBD VBD O
visiting VBG VBG O
family NN NN O
in IN IN O
Maryland NNP NNP I-STATE
and CC CC O
had VBD VBD O
sudden VBN VBN O
witnessed VBN VBN O
seizure JJ JJ O
activity NN NN O
. . . O
   
At IN IN O
the DT DT O
time NN NN O
, , , O
blood NN NN O
sugar NN NN O
was VBD VBD O
> NN NN O
500 CD CD O
. . . O
   
Upon IN IN O
initial JJ JJ O
arrival NN NN O
to TO TO O
the DT DT O
ER NNP NNP O
in IN IN O
Maryland NNP NNP I-STATE
, , , O
he PRP PRP O
has VBZ VBZ O
BP NNP NNP O
248/146 CD CD O
; : : O
   
plt NN NN O
count NN NN O
was VBD VBD O
in IN IN O
800's. CD CD O
   
The DT DT O
patient NN NN O
was VBD VBD O
intubated VBN VBN O
, , , O
treated VBN VBN O
for IN IN O
HTN NNP NNP O
with IN IN O
labetolol NN NN O
and CC CC O
placed VBN VBN O
on IN IN O
IV NNP NNP O
insulin NN NN O
and CC CC O
dilantin NN NN O
and CC CC O
transferred VBN VBN O
to TO TO O
BMH NNP NNP I-HOSPITAL
for IN IN O
further JJ JJ O
care NN NN O
. . . O
   
At IN IN O
BMH NNP NNP I-HOSPITAL
, , , O
MRI NNP NNP O
showed VBD VBD O
several JJ JJ O
small JJ JJ O
areas NNS NNS O
of IN IN O
infarct NN NN O
read NN NN O
as IN IN O
concerning VBG VBG O
for IN IN O
embolic JJ JJ O
CVA NNP NNP O
- : : O
echo NN NN O
was VBD VBD O
done VBN VBN O
showing VBG VBG O
no DT DT O
vegetations NNS NNS O
, , , O
no DT DT O
PFO NNP NNP O
, , , O
NL NNP NNP O
EF NNP NNP O
with IN IN O
LVH NNP NNP O
; : : O
   
TEE NNP NNP O
without IN IN O
vegetations NNS NNS O
as RB RB O
well RB RB O
. . . O
   
LP NNP NNP O
was VBD VBD O
done VBN VBN O
and CC CC O
sent VBN VBN O
for IN IN O
HSV NNP NNP O
which WDT WDT O
was VBD VBD O
negative JJ JJ O
. . . O
   
He PRP PRP O
underent JJ JJ O
a DT DT O
renal NN NN O
workup NN NN O
which WDT WDT O
showed VBD VBD O
nephrotic JJ JJ O
range NN NN O
proteinuria NN NN O
; : : O
   
labs NNS NNS O
also RB RB O
showed VBD VBD O
rhabdoymyolysis NNS NNS O
. . . O
   
Renal NNP NNP O
doppler NN NN O
US NNP NNP O
showed VBD VBD O
no DT DT O
sign NN NN O
of IN IN O
RAS NNP NNP O
. . . O
   
He PRP PRP O
was VBD VBD O
continued VBN VBN O
on IN IN O
abx NN NN O
for IN IN O
his PRP$ PRP$ O
aspiration NN NN O
PNA NNP NNP O
. . . O
   
Other JJ JJ O
parts NNS NNS O
of IN IN O
the DT DT O
secondary JJ JJ O
htn NN NN O
workup NN NN O
were VBD VBD O
done VBN VBN O
including VBG VBG O
evaluation NN NN O
for IN IN O
hyper NN NN O
aldo NN NN O
, , , O
pheo NN NN O
. . . O
   
The DT DT O
vent NN NN O
was VBD VBD O
weaned VBN VBN O
and CC CC O
he PRP PRP O
was VBD VBD O
extubated VBN VBN O
on IN IN O
the DT DT O
4th JJ JJ I-DATE
. . . O
   
HTN NNP NNP O
was VBD VBD O
controlled VBN VBN O
with IN IN O
labetolol NN NN O
drip NN NN O
with IN IN O
additional JJ JJ O
oral JJ JJ O
agents NNS NNS O
being VBG VBG O
added VBN VBN O
. . . O
   
He PRP PRP O
continued VBD VBD O
to TO TO O
have VB VB O
intermittent JJ JJ O
fevers NNS NNS O
and CC CC O
was VBD VBD O
on IN IN O
broad JJ JJ O
antibiotics NNS NNS O
which WDT WDT O
were VBD VBD O
originally RB RB O
weaned VBN VBN O
off RP RP O
. . . O
   
Hematologically RB RB O
, , , O
the DT DT O
hct NN NN O
and CC CC O
wbc NN NN O
fell VBD VBD O
as IN IN O
he PRP PRP O
was VBD VBD O
hydrated VBN VBN O
. . . O
   
Plt NNP NNP O
count NN NN O
stayed VBD VBD O
stable JJ JJ O
in IN IN O
the DT DT O
600's CD CD O
for IN IN O
several JJ JJ O
days NNS NNS O
before IN IN O
increasing VBG VBG O
on IN IN O
the DT DT O
3rd CD CD I-DATE
gradually RB RB O
up IN IN O
to TO TO O
the DT DT O
1000's. CD CD O
   
Retics NNP NNP O
were VBD VBD O
depressed VBN VBN O
at IN IN O
presentation NN NN O
and CC CC O
iron NN NN O
studies NNS NNS O
were VBD VBD O
c/w JJ JJ O
ACD NNP NNP O
and CC CC O
he PRP PRP O
was VBD VBD O
started VBN VBN O
on IN IN O
epogen NN NN O
. . . O
   
Initially RB RB O
it PRP PRP O
was VBD VBD O
felt VBN VBN O
that IN IN O
his PRP$ PRP$ O
thrombocytosis NN NN O
was VBD VBD O
most JJS JJS O
certainly RB RB O
reactive JJ JJ O
; : : O
   
CRP NNP NNP O
was VBD VBD O
> NN NN O
150 CD CD O
with IN IN O
ESR NNP NNP O
> NN NN O
100 CD CD O
. . . O
   
He PRP PRP O
left VBD VBD O
the DT DT O
ICU NNP NNP O
and CC CC O
at IN IN O
this DT DT O
point NN NN O
his PRP$ PRP$ O
WBC NNP NNP O
trended VBD VBD O
down RB RB O
and CC CC O
he PRP PRP O
was VBD VBD O
afebrile JJ JJ O
and CC CC O
more RBR RBR O
clinically RB RB O
stable JJ JJ O
. . . O
   
But CC CC O
his PRP$ PRP$ O
platelets NNS NNS O
kept VBD VBD O
climbing VBG VBG O
to TO TO O
nearly RB RB O
1.5 CD CD O
million CD CD O
. . . O
   
A DT DT O
bone NN NN O
marrow NN NN O
biopsy NN NN O
was VBD VBD O
done VBN VBN O
showing VBG VBG O
no DT DT O
cytogenetics NNS NNS O
to TO TO O
suggest VB VB O
CML NNP NNP O
and CC CC O
there EX EX O
were VBD VBD O
elevated JJ JJ O
megakaryocytes NNS NNS O
read VBP VBP O
as IN IN O
concerning VBG VBG O
for IN IN O
a DT DT O
myeloproliferative JJ JJ O
process NN NN O
. . . O
   
As RB RB O
well RB RB O
, , , O
he PRP PRP O
suffered VBD VBD O
a DT DT O
DVT NNP NNP O
in IN IN O
his PRP$ PRP$ O
subclavian/IJ NN NN O
on IN IN O
the DT DT O
same JJ JJ O
side NN NN O
as IN IN O
a DT DT O
central JJ JJ O
venous JJ JJ O
catheter NN NN O
. . . O
   
Given VBN VBN O
his PRP$ PRP$ O
thrombocytosis NN NN O
and CC CC O
elevated VBD VBD O
plt NN NN O
count NN NN O
, , , O
he PRP PRP O
was VBD VBD O
platelet NN NN O
pheresed VBN VBN O
twice RB RB O
in IN IN O
the DT DT O
hospital NN NN O
. . . O
   
As RB RB O
well RB RB O
, , , O
hydrea NN NN O
was VBD VBD O
started VBN VBN O
at IN IN O
this DT DT O
time NN NN O
, , , O
initially RB RB O
at IN IN O
500mg CD CD O
bid NN NN O
and CC CC O
then RB RB O
escalated VBN VBN O
to TO TO O
1000mg CD CD O
bid NN NN O
when WRB WRB O
his PRP$ PRP$ O
counts NNS NNS O
were VBD VBD O
up IN IN O
to TO TO O
800-900 JJ JJ O
despite IN IN O
the DT DT O
medication NN NN O
. . . O
   
As RB RB O
well RB RB O
, , , O
he PRP PRP O
suffered VBD VBD O
a DT DT O
small JJ JJ O
GI NNP NNP O
bleed NN NN O
due JJ JJ O
to TO TO O
an DT DT O
ulcer NN NN O
. . . O
   
For IN IN O
this DT DT O
reason NN NN O
he PRP PRP O
was VBD VBD O
not RB RB O
anticoagulated VBN VBN O
but CC CC O
placed VBN VBN O
upon IN IN O
daily JJ JJ O
ASA NNP NNP O
. . . O
   
He PRP PRP O
was VBD VBD O
discharged VBN VBN O
from IN IN O
the DT DT O
hospital NN NN O
two CD CD O
weeks NNS NNS O
ago RB RB O
and CC CC O
has VBZ VBZ O
done VBN VBN O
fairly RB RB O
well RB RB O
since IN IN O
then RB RB O
. . . O
   
His PRP$ PRP$ O
energy NN NN O
has VBZ VBZ O
been VBN VBN O
good JJ JJ O
. . . O
   
He PRP PRP O
denies VBZ VBZ O
any DT DT O
fevers/chills/sweats NNS NNS O
. . . O
   
No DT DT O
bleeding/bruising VBG VBG O
. . . O
   
No DT DT O
further RB RB O
swelling VBG VBG O
in IN IN O
his PRP$ PRP$ O
arms/legs NN NN O
. . . O
   
He PRP PRP O
does VBZ VBZ O
have VB VB O
some DT DT O
occasionally RB RB O
blurryness NN NN O
in IN IN O
eyes NNS NNS O
immediately RB RB O
after IN IN O
taking VBG VBG O
his PRP$ PRP$ O
anti-hypertensives JJ JJ O
but CC CC O
no DT DT O
numnbess/weakness/dizziness NN NN O
. . . O
   
Problems/PMH NNP NNP O
: : : O
DM NNP NNP O
type NN NN O
1 CD CD O
since IN IN O
age NN NN O
12 CD CD I-AGE
no DT DT O
recollection NN NN O
of IN IN O
any DT DT O
abnormal JJ JJ O
blood NN NN O
counts NNS NNS O
prior RB RB O
to TO TO O
this DT DT O
admit NN NN O
New NNP NNP O
diagnoses NNS NNS O
on IN IN O
this DT DT O
admit NN NN O
renal JJ JJ O
insufficiency NN NN O
nephrotic JJ JJ O
proteinuria NN NN O
malignant JJ JJ O
hypertension NN NN O
thrombocytosis NN NN O
GI NNP NNP O
bleed NN NN O
- : : O
upper JJ JJ O
with IN IN O
ulcer NN NN O
visualized JJ JJ O
on IN IN O
EGD NNP NNP O
small JJ JJ O
embolic JJ JJ O
appearing VBG VBG O
CVA NNP NNP O
's POS POS O
Medications NNP NNP O
: : : O
Diovan NNP NNP O
lisinopril NN NN O
Hydrea NNP NNP O
1000 CD CD O
bid NN NN O
ASA NNP NNP O
81 CD CD O
qod NN NN O
lopressor NN NN O
procardia NNS NNS O
clonidine NN NN O
nexium NN NN O
insulin NN NN O
: : : O
am VBP VBP O
25 CD CD O
regular/34 NN NN O
NPH NNP NNP O
, , , O
pm NN NN O
20 CD CD O
regular/28 NN NN O
NPH NNP NNP O
Allergies NNP NNP O
: : : O
nkda NN NN O
Social NNP NNP O
History NN NN O
: : : O
lives NNS NNS O
in IN IN O
waycross NN NN I-CITY
; : : O
   
single JJ JJ O
works NNS NNS O
in IN IN O
Geologist NNP NNP I-PROFESSION
no DT DT O
tob NN NN O
reports NNS NNS O
social JJ JJ O
etoh NN NN O
Family NNP NNP O
History NN NN O
: : : O
htn NN NN O
Physical JJ JJ O
Examination NNP NNP O
: : : O
Vital NNP NNP O
Signs NNP NNP O
BP NNP NNP O
101/63 CD CD O
, , , O
P NN NN O
64 CD CD O
, , , O
RR NNP NNP O
16 CD CD O
, , , O
Temp NNP NNP O
98.1 CD CD O
F NN NN O
, , , O
Wt NNP NNP O
202 CD CD O
lb NN NN O
gen NN NN O
: : : O
well-appearing JJ JJ O
male NN NN O
, , , O
alert NN NN O
, , , O
conversant NN NN O
, , , O
nad NN NN O
heent NN NN O
: : : O
supple NN NN O
, , , O
non-icteric JJ JJ O
, , , O
no DT DT O
cervical/supraclav NN NN O
adenopathy JJ JJ O
chest NN NN O
: : : O
clear JJ JJ O
cv NN NN O
: : : O
reg NN NN O
abd NN NN O
; : : O
   
benign NN NN O
with IN IN O
no DT DT O
hsm NN NN O
ext JJ JJ O
: : : O
trace NN NN O
LE NNP NNP O
edema NN NN O
, , , O
no DT DT O
upper JJ JJ O
edema NN NN O
skin NN NN O
: : : O
scattered VBN VBN O
ulcerations NNS NNS O
on IN IN O
his PRP$ PRP$ O
arms NNS NNS O
with IN IN O
granulation NN NN O
tissue NN NN O
, , , O
scarred JJ JJ O
vesicular NN NN O
changes NNS NNS O
on IN IN O
his PRP$ PRP$ O
neck NN NN O
Data NNP NNP O
: : : O
10/03/2061 CD CD I-DATE
WBC NNP NNP O
4.1 CD CD O
( ( ( O
L NNP NNP O
) ) ) O
, , , O
RBC NNP NNP O
3.95 CD CD O
( ( ( O
L NNP NNP O
) ) ) O
, , , O
HGB NNP NNP O
12.0 CD CD O
( ( ( O
L NNP NNP O
) ) ) O
, , , O
HCT NNP NNP O
35.5 CD CD O
( ( ( O
L NNP NNP O
) ) ) O
, , , O
MCV NNP NNP O
90 CD CD O
, , , O
MCH NNP NNP O
30.4 CD CD O
, , , O
MCHC NNP NNP O
33.8 CD CD O
, , , O
PLT NNP NNP O
601 CD CD O
( ( ( O
H NNP NNP O
) ) ) O
10/03/2061 CD CD I-DATE
RDW NNP NNP O
17.2 CD CD O
( ( ( O
H NNP NNP O
) ) ) O
10/03/2061 CD CD I-DATE
DIFFR NNP NNP O
RECEIVED NNP NNP O
, , , O
METHOD NNP NNP O
, , , O
% NN NN O
NEUT NNP NNP O
57 CD CD O
, , , O
% NN NN O
LYMPH NNP NNP O
36 CD CD O
, , , O
% NN NN O
MONO NNP NNP O
3 CD CD O
( ( ( O
L NNP NNP O
) ) ) O
, , , O
% NN NN O
EOS NNP NNP O
3 CD CD O
, , , O
% NN NN O
BASO NNP NNP O
1 CD CD O
10/03/2061 CD CD I-DATE
ANEUT NNP NNP O
2.35 CD CD O
, , , O
ALYMP NNP NNP O
1.48 CD CD O
, , , O
AMONS NNP NNP O
0.10 CD CD O
( ( ( O
L NNP NNP O
) ) ) O
, , , O
AEOSN NNP NNP O
0.10 CD CD O
, , , O
ABASOP NNP NNP O
0.02 CD CD O
10/03/2061 CD CD I-DATE
RETIC NNP NNP O
1.0 CD CD O
Assessment NNP NNP O
and CC CC O
Plan NNP NNP O
: : : O
Interesting JJ JJ O
case NN NN O
of IN IN O
a DT DT O
27 CD CD I-AGE
yo NN NN O
male NN NN O
with IN IN O
insulin NN NN O
dependent NN NN O
diabetes NNS NNS O
and CC CC O
apparent NN NN O
untreated JJ JJ O
HTN NNP NNP O
who WP WP O
presented VBD VBD O
with IN IN O
seizure NN NN O
in IN IN O
setting VBG VBG O
of IN IN O
hypertensive JJ JJ O
emergency NN NN O
and CC CC O
is VBZ VBZ O
found VBN VBN O
with IN IN O
nephrotic JJ JJ O
syndrome NN NN O
, , , O
renal JJ JJ O
insufficiency NN NN O
, , , O
several JJ JJ O
small JJ JJ O
embolic-appearing JJ JJ O
strokes NNS NNS O
and CC CC O
has VBZ VBZ O
developed VBN VBN O
marked VBN VBN O
thrombocytopenia IN IN O
to TO TO O
1.5 CD CD O
million CD CD O
and CC CC O
had VBD VBD O
subsequent JJ JJ O
provoked VBN VBN O
DVT NNP NNP O
. . . O
   
He PRP PRP O
was VBD VBD O
treated VBN VBN O
for IN IN O
concern NN NN O
of IN IN O
essential JJ JJ O
thrombocytosis NNS NNS O
in IN IN O
hospital NN NN O
with IN IN O
platelet NN NN O
pheresis NN NN O
then RB RB O
hydrea NN NN O
. . . O
   
Today NN NN O
, , , O
he PRP PRP O
presents VBZ VBZ O
looking VBG VBG O
well RB RB O
and CC CC O
still RB RB O
has VBZ VBZ O
a DT DT O
thrombocytosis NN NN O
despite IN IN O
the DT DT O
hydrea NN NN O
. . . O
   
It PRP PRP O
is VBZ VBZ O
still RB RB O
not RB RB O
possible JJ JJ O
to TO TO O
tell VB VB O
for IN IN O
sure JJ JJ O
if IN IN O
this DT DT O
is VBZ VBZ O
still RB RB O
a DT DT O
reactive JJ JJ O
thrombocytosis NN NN O
vs NNS NNS O
Essential NNP NNP O
thrombocytosis NN NN O
. . . O
   
At IN IN O
the DT DT O
moment NN NN O
, , , O
we PRP PRP O
will MD MD O
continue VB VB O
to TO TO O
treat VB VB O
this DT DT O
as IN IN O
ET NNP NNP O
and CC CC O
will MD MD O
continue VB VB O
hydrea NN NN O
at IN IN O
the DT DT O
current JJ JJ O
dose NN NN O
and CC CC O
ask VB VB O
him PRP PRP O
to TO TO O
take VB VB O
aspirin NN NN O
81 CD CD O
mg NN NN O
qd NN NN O
. . . O
   
If IN IN O
this DT DT O
is VBZ VBZ O
a DT DT O
reactive JJ JJ O
process NN NN O
, , , O
time NN NN O
should MD MD O
be VB VB O
a DT DT O
good JJ JJ O
diagnostic JJ JJ O
test NN NN O
at IN IN O
this DT DT O
should MD MD O
improve VB VB O
after IN IN O
he PRP PRP O
is VBZ VBZ O
further RB RB O
from IN IN O
his PRP$ PRP$ O
complicated JJ JJ O
hospital/icu NN NN O
stay NN NN O
. . . O
   
At IN IN O
his PRP$ PRP$ O
next JJ JJ O
visit NN NN O
with IN IN O
us PRP PRP O
next JJ JJ O
month NN NN O
we PRP PRP O
will MD MD O
recheck VB VB O
his PRP$ PRP$ O
C-reactive JJ JJ O
protein NN NN O
, , , O
ESR NNP NNP O
, , , O
iron NN NN O
studies/ferritin NN NN O
for IN IN O
some DT DT O
idea NN NN O
of IN IN O
whether IN IN O
his PRP$ PRP$ O
body NN NN O
could MD MD O
still RB RB O
be VB VB O
mounting VBG VBG O
an DT DT O
inflammatory JJ JJ O
response NN NN O
to TO TO O
drive VB VB O
a DT DT O
reactive JJ JJ O
thrombocytosis NNS NNS O
. . . O
   
If IN IN O
his PRP$ PRP$ O
plt NN NN O
count NN NN O
comes VBZ VBZ O
down RB RB O
, , , O
we PRP PRP O
will MD MD O
be VB VB O
able JJ JJ O
to TO TO O
start VB VB O
tapering VBG VBG O
his PRP$ PRP$ O
hydrea NN NN O
at IN IN O
that DT DT O
time NN NN O
. . . O
   
Of IN IN O
note NN NN O
, , , O
in IN IN O
the DT DT O
near JJ JJ O
future NN NN O
, , , O
we PRP PRP O
may MD MD O
be VB VB O
able JJ JJ O
to TO TO O
help VB VB O
determine VB VB O
between IN IN O
reactive JJ JJ O
and CC CC O
essential JJ JJ O
process NN NN O
with IN IN O
measurement NN NN O
of IN IN O
the DT DT O
JAK2 NNP NNP O
kinase NN NN O
level NN NN O
. . . O
   
In IN IN O
the DT DT O
meantime NN NN O
, , , O
he PRP PRP O
will MD MD O
be VB VB O
meeting VBG VBG O
with IN IN O
his PRP$ PRP$ O
new JJ JJ O
PCP NNP NNP O
and CC CC O
renal JJ JJ O
physician NN NN O
next JJ JJ O
week NN NN O
. . . O
   
____________________________________________ NN NN O
_ NN NN O
James NNP NNP I-DOCTOR
B. NN NN I-DOCTOR
Tyler NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2092-11-16 JJ JJ I-DATE
Team NNP NNP O
D NNP NNP O
Intern NNP NNP O
Admission NNP NNP O
Note VB VB O
Date NN NN O
: : : O
11/16/92 CD CD I-DATE
______________________________________________________________________ NN NN O
_ NN NN O
CC/HPI NNP NNP O
: : : O
Pt NNP NNP O
is VBZ VBZ O
76 CD CD I-AGE
yo NN NN O
F NN NN O
with IN IN O
h/o NN NN O
CAD NNP NNP O
, , , O
HTN NNP NNP O
, , , O
hypercholesterolemia NN NN O
, , , O
COPD NNP NNP O
, , , O
many JJ JJ O
pack-years JJ JJ O
of IN IN O
smoking NN NN O
, , , O
and CC CC O
anxiety NN NN O
who WP WP O
presents VBZ VBZ O
with IN IN O
c/o NN NN O
SOB NNP NNP O
. . . O
   
Pt NNP NNP O
was VBD VBD O
in IN IN O
her PRP$ PRP$ O
usual JJ JJ O
state NN NN O
of IN IN O
health NN NN O
about IN IN O
1 CD CD O
week NN NN O
PTA NNP NNP O
, , , O
when WRB WRB O
she PRP PRP O
noticed VBD VBD O
gradually RB RB O
worsening VBG VBG O
SOB NNP NNP O
and CC CC O
developing VBG VBG O
cough RB RB O
productive JJ JJ O
of IN IN O
scant JJ JJ O
whitish NN NN O
sputum NN NN O
. . . O
   
She PRP PRP O
had VBD VBD O
no DT DT O
fevers/chills NNS NNS O
, , , O
prior RB RB O
URI NNP NNP O
symptoms/sick JJ JJ O
contacts NNS NNS O
, , , O
CP/lightheadedness NNP NNP O
, , , O
N/V/abdominal NNP NNP O
pain NN NN O
, , , O
diaphoresis NNS NNS O
, , , O
increasing VBG VBG O
leg NN NN O
swelling VBG VBG O
, , , O
or CC CC O
orthopnea/PND NN NN O
symptoms NNS NNS O
. . . O
   
She PRP PRP O
thought VBD VBD O
she PRP PRP O
might MD MD O
be VB VB O
developing VBG VBG O
bronchitis NNS NNS O
, , , O
discontinued VBD VBD O
smoking NN NN O
and CC CC O
called VBD VBD O
her PRP$ PRP$ O
PCP NNP NNP O
to TO TO O
ask VB VB O
for IN IN O
antibiotics NNS NNS O
. . . O
   
She PRP PRP O
was VBD VBD O
told VBN VBN O
to TO TO O
come VB VB O
to TO TO O
the DT DT O
clinic NN NN O
but CC CC O
her PRP$ PRP$ O
SOB NNP NNP O
progressively RB RB O
worsened VBD VBD O
in IN IN O
the DT DT O
few JJ JJ O
hours NNS NNS O
PTA NNP NNP O
, , , O
and CC CC O
she PRP PRP O
called VBD VBD O
for IN IN O
EMS NNP NNP O
to TO TO O
go VB VB O
to TO TO O
the DT DT O
ED NNP NNP O
. . . O
   
In IN IN O
ED NNP NNP O
: : : O
a. NN NN O
   
Lasix NNP NNP O
40 CD CD O
mg NN NN O
IV NNP NNP O
x2 NN NN O
, , , O
NTG NNP NNP O
paste NN NN O
initial JJ JJ O
SOB NNP NNP O
improvement NN NN O
, , , O
small JJ JJ O
UO NNP NNP O
; : : O
   
b. NN NN O
   
Lasix NNP NNP O
40 CD CD O
mg NN NN O
IV NNP NNP O
x SYM SYM O
2 CD CD O
improved VBN VBN O
, , , O
ready JJ JJ O
for IN IN O
floor NN NN O
transfer NN NN O
but CC CC O
develops VBZ VBZ O
an DT DT O
episode NN NN O
of IN IN O
worsening VBG VBG O
SOB/flush NNP NNP O
pulmonary JJ JJ O
edema NN NN O
on IN IN O
CXR NNP NNP O
; : : O
   
c. NN NN O
   
Lasix NNP NNP O
160mg CD CD O
IV NNP NNP O
Morphine NNP NNP O
3mg CD CD O
IV NNP NNP O
+ NN NN O
CPAP NNP NNP O
Atrovent/Albuterol NNP NNP O
Zaroxylin NNP NNP O
5mg CD CD O
+ NN NN O
Lasix NNP NNP O
200mg CD CD O
IV NNP NNP O
improved VBD VBD O
, , , O
on IN IN O
Hi-Flow NNP NNP O
O2 NNP NNP O
; : : O
   
total JJ JJ O
UO NNP NNP O
: : : O
1,100cc. CD CD O
   
Also RB RB O
received VBN VBN O
: : : O
ASA NNP NNP O
, , , O
CTX NNP NNP O
1gm CD CD O
IV NNP NNP O
, , , O
Azithromax NNP NNP O
500mg CD CD O
po NN NN O
, , , O
Atrovent/Albuterol NNP NNP O
nebs NN NN O
. . . O
   
PMHx NNP NNP O
: : : O
   
1 CD CD O
. . . O
HTN NNP NNP O
   
2 CD CD O
. . . O
CAD NNP NNP O
[ NN NN O
old JJ JJ O
MI NNP NNP O
by IN IN O
EKG/imaging VBG VBG O
] NN NN O
   
3 CD CD O
. . . O
COPD NNP NNP O
   
4 CD CD O
. . . O
Hypercholesterolemia NNP NNP O
   
5 CD CD O
. . . O
DM NNP NNP O
, , , O
type NN NN O
II NNP NNP O
   
6 CD CD O
. . . O
Recurrent NNP NNP O
UTIs NNP NNP O
[ NN NN O
cystocele/recurrent NN NN O
UTI NNP NNP O
] NN NN O
   
7 CD CD O
. . . O
Chronic NNP NNP O
LE NNP NNP O
edema NN NN O
[ NN NN O
Doppler NNP NNP O
NEG NNP NNP O
] NN NN O
   
8 CD CD O
. . . O
Anxiety NNP NNP O
   
9 CD CD O
. . . O
GERD NNP NNP O
ALLERGIES NNP NNP O
: : : O
Penicillin/Cephalosporins NNP NNP O
- - - O
hives NNS NNS O
MEDS NNP NNP O
: : : O
Atenolol NNP NNP O
100 CD CD O
mg NN NN O
PO NNP NNP O
qd NN NN O
Lipitor NNP NNP O
10 CD CD O
mg NN NN O
po NN NN O
qd NN NN O
Cozaar NNP NNP O
50 CD CD O
mg NN NN O
po NN NN O
qd NN NN O
Furosemide NNP NNP O
20 CD CD O
mg NN NN O
po NN NN O
qde NN NN O
Prilosec NNP NNP O
20 CD CD O
mg NN NN O
po NN NN O
qd NN NN O
ECASA NNP NNP O
325 CD CD O
mg NN NN O
po NN NN O
qd NN NN O
Nifedipine NNP NNP O
XL NNP NNP O
60 CD CD O
mg NN NN O
po NN NN O
bid NN NN O
Klonazepam NNP NNP O
0.5 CD CD O
mg NN NN O
po NN NN O
bid NN NN O
SHx NNP NNP O
: : : O
lives NNS NNS O
alone RB RB O
, , , O
independent JJ JJ O
with IN IN O
ADLs NNP NNP O
PTA NNP NNP O
FHx NNP NNP O
: : : O
no DT DT O
CAD NNP NNP O
, , , O
DM NNP NNP O
, , , O
stroke NN NN O
VS NNP NNP O
: : : O
T NN NN O
97 CD CD O
HR NNP NNP O
84 CD CD O
BP NNP NNP O
128/80 CD CD O
RR NNP NNP O
22 CD CD O
Sat NNP NNP O
97 CD CD O
% NN NN O
O2 NNP NNP O
HF NNP NNP O
PE NNP NNP O
: : : O
GEN NNP NNP O
: : : O
slightly RB RB O
anxious JJ JJ O
, , , O
with IN IN O
O2 NNP NNP O
mask NN NN O
on IN IN O
SKIN NNP NNP O
: : : O
pale JJ JJ O
, , , O
no DT DT O
ecchymoses NNS NNS O
HEENT NNP NNP O
: : : O
supple NN NN O
; : : O
   
JVP NNP NNP O
~ NN NN O
8cm CD CD O
; : : O
   
no DT DT O
carotid NN NN O
bruits NNS NNS O
CHEST NN NN O
: : : O
bibasilar NN NN O
crackles NNS NNS O
, , , O
few JJ JJ O
scattered JJ JJ O
wheezes NNS NNS O
HEART NNP NNP O
: : : O
RRR NNP NNP O
, , , O
(+) NN NN O
2/6 CD CD O
SEM NNP NNP O
ABD NNP NNP O
: : : O
soft JJ JJ O
, , , O
ND NNP NNP O
, , , O
active JJ JJ O
bowel NN NN O
sounds VBZ VBZ O
EXT NNP NNP O
: : : O
trace VB VB O
pitting VBG VBG O
edema NN NN O
bilat NN NN O
NEURO NNP NNP O
: : : O
alert NN NN O
, , , O
appropriate JJ JJ O
; : : O
   
CNs NNP NNP O
intact JJ JJ O
. . . O
   
Strength/sensation NNP NNP O
symmetric JJ JJ O
. . . O
   
LABS NNP NNP O
: : : O
Sodium NNP NNP O
( ( ( O
Stat NNP NNP O
Lab NNP NNP O
) ) ) O
132 CD CD O
L NNP NNP O
135-145 JJ JJ O
mmol/L NN NN O
Potassium NNP NNP O
( ( ( O
Stat NNP NNP O
Lab NNP NNP O
) ) ) O
4.0 CD CD O
3.4-4.8 CD CD O
mmol/L NN NN O
Chloride NNP NNP O
( ( ( O
Stat NNP NNP O
Lab NNP NNP O
) ) ) O
103 CD CD O
100-108 JJ JJ O
mmol/L NN NN O
CO2 NNP NNP O
( ( ( O
Stat NNP NNP O
Lab NNP NNP O
) ) ) O
19.8 CD CD O
L NNP NNP O
24.0-30.0 JJ JJ O
mmol/L NN NN O
BUN NNP NNP O
( ( ( O
Stat NNP NNP O
Lab NNP NNP O
) ) ) O
26 CD CD O
H NNP NNP O
8-25 JJ JJ O
mg/dl NN NN O
Creatinine NNP NNP O
( ( ( O
Stat NNP NNP O
Lab NNP NNP O
) ) ) O
1.1 CD CD O
0.6-1.5 CD CD O
mg/dl NN NN O
Glucose NNP NNP O
( ( ( O
Stat NNP NNP O
Lab NNP NNP O
) ) ) O
262 CD CD O
H NNP NNP O
70-110 CD CD O
mg/dl NN NN O
Calcium NNP NNP O
9.0 CD CD O
8.5-10.5 JJ JJ O
mg/dl NN NN O
Phosphorus NNP NNP O
3.9 CD CD O
2.6-4.5 JJ JJ O
mg/dl NN NN O
Magnesium NNP NNP O
1.9 CD CD O
1.4-2.0 JJ JJ O
meq/L NN NN O
Total NNP NNP O
Protein NNP NNP O
8.6 CD CD O
H NNP NNP O
6.0-8.0 JJ JJ O
g/dl NN NN O
Albumin NNP NNP O
3.6 CD CD O
3.1-4.3 JJ JJ O
g/dl NN NN O
Globulin NNP NNP O
5.0 CD CD O
H NNP NNP O
2.6-4.1 JJ JJ O
g/dl NN NN O
Direct NNP NNP O
Bilirubin NNP NNP O
0.0 CD CD O
0-0.4 NN NN O
mg/dl NN NN O
Total NNP NNP O
Bilirubin NNP NNP O
0.8 CD CD O
0-1.0 NN NN O
mg/dl NN NN O
Alkaline NNP NNP O
Phosphatase NNP NNP O
319 CD CD O
H NNP NNP O
30-100 CD CD O
U/L NNP NNP O
Transaminase-SGPT NNP NNP O
24 CD CD O
7-30 NN NN O
U/L NNP NNP O
Creatine NNP NNP O
Kinase NNP NNP O
Isoenzy NNP NNP O
0.7 CD CD O
0.0-6.9 NN NN O
ng/ml NN NN O
Troponin-T NNP NNP O
< NN NN O
0.01 CD CD O
0.00-0.09 JJ JJ O
ng/ml NN NN O
Transaminase-SGOT NNP NNP O
60 CD CD O
H NNP NNP O
9-25 JJ JJ O
U/L NNP NNP O
Creatine NNP NNP O
Kinase NNP NNP O
91 CD CD O
40-150 JJ JJ O
U/L NNP NNP O
WBC NNP NNP O
11.9 CD CD O
H NNP NNP O
4.5-11.0 JJ JJ O
th/cmm NN NN O
HCT NNP NNP O
41.1 CD CD O
36.0-46.0 CD CD O
% NN NN O
HGB NNP NNP O
13.9 CD CD O
12.0-16.0 JJ JJ O
gm/dl NN NN O
RBC NNP NNP O
4.81 CD CD O
4.00-5.20 JJ JJ O
mil/cmm NN NN O
PLT NNP NNP O
332 CD CD O
150-350 JJ JJ O
th/cumm NN NN O
MCV NNP NNP O
86 CD CD O
80-100 JJ JJ O
fl NN NN O
MCH NNP NNP O
28.8 CD CD O
26.0-34.0 JJ JJ O
pg/rbc NN NN O
MCHC NNP NNP O
33.7 CD CD O
31.0-37.0 JJ JJ O
g/dl NN NN O
RDW NNP NNP O
14.3 CD CD O
11.5-14.5 JJ JJ O
% NN NN O
Superstat NNP NNP O
PT NNP NNP O
12.4 CD CD O
11.1-13.1 JJ JJ O
sec NN NN O
Superstat NNP NNP O
PT-INR NNP NNP O
1.1 CD CD O
Superstat NNP NNP O
APTT NNP NNP O
29.3 CD CD O
22.1-35.1 JJ JJ O
sec NN NN O
Poly NNP NNP O
85 CD CD O
H NNP NNP O
40-70 CD CD O
% NN NN O
Lymphs NNP NNP O
11 CD CD O
L NNP NNP O
22-44 JJ JJ O
% NN NN O
Monos NNP NNP O
3 CD CD O
L NNP NNP O
4-11 CD CD O
% NN NN O
EOS NNP NNP O
1 CD CD O
0-8 NN NN O
% NN NN O
Basos NNP NNP O
0 CD CD O
0-3 NN NN O
% NN NN O
Absolute NNP NNP O
Neuts NNP NNP O
10.05 CD CD O
H NNP NNP O
1.8-7.7 JJ JJ O
th/cmm NN NN O
Absolute NNP NNP O
Lymphs NNP NNP O
1.33 CD CD O
1.0-4.8 JJ JJ O
th/cmm NN NN O
Absolute NNP NNP O
Monos NNP NNP O
0.40 CD CD O
0.2-0.4 NN NN O
th/cmm NN NN O
Absolute NNP NNP O
EOS NNP NNP O
0.10 CD CD O
0.1-0.3 NN NN O
th/cmm NN NN O
Absolute NNP NNP O
Basos NNP NNP O
0.04 CD CD O
0.0-0.3 NN NN O
th/cmm NN NN O
RBC NNP NNP O
Morph NNP NNP O
on IN IN O
Smear NNP NNP O
NORMAL NNP NNP O
NORMAL NNP NNP O
EKG NNP NNP O
: : : O
old JJ JJ O
LBBB NNP NNP O
, , , O
no DT DT O
acute JJ JJ O
ischemic JJ JJ O
changes NNS NNS O
CXR NNP NNP O
: : : O
cardiomegaly NN NN O
, , , O
bilateral JJ JJ O
pleural NN NN O
effusions NNS NNS O
ADENOSINE NNP NNP O
MIBI NNP NNP O
( ( ( O
6/89 CD CD I-DATE
) ) ) O
: : : O
The DT DT O
ECG NNP NNP O
response NN NN O
to TO TO O
pharmacological JJ JJ O
stress NN NN O
was VBD VBD O
negative JJ JJ O
for IN IN O
ischemia NN NN O
. . . O
   
Images NNPS NNPS O
demonstrated VBD VBD O
a DT DT O
small JJ JJ O
posterobasal NN NN O
infarction NN NN O
associated VBN VBN O
with IN IN O
mild JJ JJ O
to TO TO O
moderate JJ JJ O
inferior JJ JJ O
ischemia NN NN O
. . . O
   
Comparison NNP NNP O
to TO TO O
2084 CD CD I-DATE
is VBZ VBZ O
difficult JJ JJ O
due JJ JJ O
to TO TO O
the DT DT O
difference NN NN O
of IN IN O
technique NN NN O
. . . O
   
However RB RB O
, , , O
septal JJ JJ O
ischemia NN NN O
is VBZ VBZ O
no DT DT O
longer RB RB O
present JJ JJ O
in IN IN O
the DT DT O
current JJ JJ O
study NN NN O
and CC CC O
inferior JJ JJ O
ischemia NN NN O
is VBZ VBZ O
still RB RB O
present JJ JJ O
. . . O
   
ECHO NNP NNP O
( ( ( O
6/89 CD CD I-DATE
) ) ) O
: : : O
mild JJ JJ O
mitral JJ JJ O
regurgitation NN NN O
; : : O
   
LA NNP NNP O
dilated VBD VBD O
; : : O
   
- : : O
trans-aortic JJ JJ O
gradient NN NN O
~ NN NN O
13 CD CD O
mm NN NN O
HG/no NNP NNP O
stenosis NN NN O
; : : O
   
- : : O
LV NNP NNP O
imildly RB RB O
dilated VBD VBD O
, , , O
w/segmental JJ JJ O
LV NNP NNP O
dysfunction NN NN O
[ NN NN O
inferior JJ JJ O
wall NN NN O
] NN NN O
; : : O
   
EF NNP NNP O
68 CD CD O
%; NN NN O
   
- : : O
trace VB VB O
tricuspid JJ JJ O
insufficiency NN NN O
- : : O
trace VB VB O
pulmonary JJ JJ O
insufficiency NN NN O
; : : O
   
RV NNP NNP O
34 CD CD O
mmHg NN NN O
/ NN NN O
not RB RB O
dilated JJ JJ O
A/P NNP NNP O
: : : O
Pt NNP NNP O
is VBZ VBZ O
a DT DT O
76 CD CD I-AGE
yo NN NN O
F NN NN O
with IN IN O
multiple JJ JJ O
cardiac JJ JJ O
risk NN NN O
factors NNS NNS O
who WP WP O
presents VBZ VBZ O
with IN IN O
CHF NNP NNP O
exacerbation NN NN O
. . . O
   
Ddx NNP NNP O
of IN IN O
precipitants NNS NNS O
include VBP VBP O
new JJ JJ O
myocardial NN NN O
ischemia NN NN O
, , , O
hypertensive JJ JJ O
crisis NN NN O
, , , O
medication NN NN O
non-compliance/misadministration NN NN O
, , , O
arrhythmia NN NN O
, , , O
or CC CC O
infection NN NN O
. . . O
   
Even RB RB O
though IN IN O
MI NNP NNP O
would MD MD O
be VB VB O
the DT DT O
most RBS RBS O
worrisome VBN VBN O
to TO TO O
follow VB VB O
through IN IN O
with IN IN O
, , , O
a DT DT O
simple JJ JJ O
trigger NN NN O
such JJ JJ O
as IN IN O
COPD NNP NNP O
exacerbation NN NN O
cannot NN NN O
be VB VB O
excluded VBN VBN O
. . . O
   
- - - O
continue VB VB O
HF NNP NNP O
O2 NNP NNP O
, , , O
ASA NNP NNP O
, , , O
cardiac JJ JJ O
enzymes NNS NNS O
to TO TO O
r/o VB VB O
MI NNP NNP O
- : : O
tight JJ JJ O
BP NNP NNP O
control NN NN O
w NN NN O
/ NN NN O
CCB NNP NNP O
and CC CC O
ACEI NNP NNP O
as IN IN O
needed VBN VBN O
; : : O
   
may MD MD O
use VB VB O
TNG/Hydralazine NNP NNP O
( ( ( O
will MD MD O
hold VB VB O
BB NNP NNP O
during IN IN O
the DT DT O
acute JJ JJ O
exacerbation NN NN O
) ) ) O
- : : O
Lasix NNP NNP O
IV NNP NNP O
prn NN NN O
; : : O
   
strict JJ JJ O
I/Os NNP NNP O
[ NN NN O
admission NN NN O
wt NN NN O
180 CD CD O
# # # O
) ) ) O
- : : O
Low-sodium NNP NNP O
diet/consider NN NN O
fluid JJ JJ O
restriction NN NN O
- - - O
Repeat NNP NNP O
CXR/EKG NNP NNP O
- : : O
Azithromycin NNP NNP O
250mg CD CD O
po/Albuterol/Atrovent NN NN O
nebs NN NN O
- : : O
ECHO NNP NNP O
in IN IN O
AM/consider NNP NNP O
ETT/Cardiology NNP NNP O
: : : O
Dr NNP NNP O
Garner NNP NNP I-DOCTOR
________________________________________ NN NN O
_ NN NN O
EVELYN NNP NNP I-DOCTOR
HOLCOMB NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
   
X62950 NNP NNP O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2097-06-13 JJ JJ I-DATE
June NNP NNP I-DATE
13 CD CD O
, , , O
2097 CD CD I-DATE
Dennis NNP NNP I-DOCTOR
Cannon NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
   
Cardiovascular NNP NNP O
Division NNP NNP O
Redwood NNP NNP I-HOSPITAL
Area NNP NNP I-HOSPITAL
Hospital NNP NNP I-HOSPITAL
28 CD CD I-STREET
Tamworth NNP NNP I-STREET
Place NNP NNP I-STREET
Cass NNP NNP I-CITY
City NNP NNP I-CITY
MS NNP NNP I-STATE
25448 CD CD I-ZIP
RE:BRADY NNP NNP O
DUVALL NNP NNP I-PATIENT
RAH#425 NNP NNP O
03 CD CD I-MEDICALRECORD
15 CD CD I-MEDICALRECORD
1 CD CD I-MEDICALRECORD
Dear RB RB O
Denny NNP NNP I-DOCTOR
: : : O
Just RB RB O
a DT DT O
note NN NN O
to TO TO O
tell VB VB O
you PRP PRP O
that IN IN O
I PRP PRP O
saw VBD VBD O
Brady NNP NNP I-PATIENT
Duvall NNP NNP I-PATIENT
again RB RB O
today NN NN O
for IN IN O
his PRP$ PRP$ O
congestive JJ JJ O
heart NN NN O
failure NN NN O
. . . O
   
His PRP$ PRP$ O
clinical JJ JJ O
course NN NN O
is VBZ VBZ O
well RB RB O
known VBN VBN O
to TO TO O
you PRP PRP O
. . . O
   
He PRP PRP O
has VBZ VBZ O
had VBN VBN O
a DT DT O
slight JJ JJ O
increase NN NN O
in IN IN O
peripheral JJ JJ O
edema NN NN O
. . . O
   
This DT DT O
has VBZ VBZ O
occurred VBN VBN O
despite IN IN O
a DT DT O
medical JJ JJ O
regimen NNS NNS O
that WDT WDT O
includes VBZ VBZ O
Lasix NNP NNP O
40 CD CD O
mg NN NN O
daily JJ JJ O
, , , O
aldactone NN NN O
25 CD CD O
mg NN NN O
daily JJ JJ O
, , , O
Coumadin NNP NNP O
, , , O
atenolol NN NN O
25 CD CD O
mg NN NN O
daily JJ JJ O
, , , O
amiodarone NN NN O
200 CD CD O
mg NN NN O
daily JJ JJ O
, , , O
insulin NN NN O
, , , O
vancomycin NN NN O
that WDT WDT O
was VBD VBD O
recently RB RB O
discontinued VBN VBN O
, , , O
Zocor NNP NNP O
80 CD CD O
mg NN NN O
daily JJ JJ O
, , , O
clonopin NN NN O
, , , O
Plavix NNP NNP O
, , , O
and CC CC O
glucophage NN NN O
. . . O
   
He PRP PRP O
is VBZ VBZ O
also RB RB O
on IN IN O
captopril NN NN O
6.25 CD CD O
mg NN NN O
po NN NN O
t.i.d. NN NN O
   
From IN IN O
a DT DT O
functional JJ JJ O
point NN NN O
of IN IN O
view NN NN O
, , , O
he PRP PRP O
seems VBZ VBZ O
to TO TO O
be VB VB O
stable JJ JJ O
although IN IN O
, , , O
as IN IN O
noted VBN VBN O
, , , O
he PRP PRP O
has VBZ VBZ O
had VBN VBN O
a DT DT O
slight JJ JJ O
increase NN NN O
in IN IN O
peripheral JJ JJ O
edema NN NN O
. . . O
   
His PRP$ PRP$ O
past JJ JJ O
clinical JJ JJ O
course NN NN O
is VBZ VBZ O
well RB RB O
known VBN VBN O
to TO TO O
you PRP PRP O
. . . O
   
As IN IN O
you PRP PRP O
know VBP VBP O
, , , O
he PRP PRP O
had VBD VBD O
an DT DT O
epicardial JJ JJ O
abscess NN NN O
from IN IN O
electrode NN NN O
placement NN NN O
. . . O
   
From IN IN O
a DT DT O
clinical JJ JJ O
point NN NN O
of IN IN O
view NN NN O
, , , O
he PRP PRP O
is VBZ VBZ O
otherwise RB RB O
stable JJ JJ O
. . . O
   
Physical JJ JJ O
examination NN NN O
today NN NN O
is VBZ VBZ O
of IN IN O
note NN NN O
for IN IN O
a DT DT O
weight NN NN O
of IN IN O
193 CD CD O
pounds NNS NNS O
, , , O
blood NN NN O
pressure NN NN O
120/60 CD CD O
, , , O
with IN IN O
a DT DT O
resting VBG VBG O
pulse NN NN O
of IN IN O
   
76 CD CD O
. . . O
Neck NNP NNP O
veins NNS NNS O
are VBP VBP O
distended VBN VBN O
, , , O
with IN IN O
positive JJ JJ O
hepatojugular NN NN O
reflux NN NN O
. . . O
   
His PRP$ PRP$ O
carotid NN NN O
volume NN NN O
is VBZ VBZ O
diminished VBN VBN O
. . . O
   
His PRP$ PRP$ O
lungs NNS NNS O
are VBP VBP O
Page NNP NNP O
Two CD CD O
RE:BRADY NNP NNP O
DUVALL NNP NNP I-PATIENT
RAH#425 NNP NNP O
03 CD CD I-MEDICALRECORD
15 CD CD I-MEDICALRECORD
1 CD CD I-MEDICALRECORD
June NNP NNP I-DATE
13 CD CD O
, , , O
2097 CD CD I-DATE
generally RB RB O
clear JJ JJ O
, , , O
without IN IN O
rales NNS NNS O
or CC CC O
rhonchi NN NN O
. . . O
   
Examination NNP NNP O
of IN IN O
the DT DT O
heart NN NN O
reveals VBZ VBZ O
a DT DT O
quiet JJ JJ O
precordium NN NN O
. . . O
   
There EX EX O
is VBZ VBZ O
a DT DT O
soft JJ JJ O
S3 NNP NNP O
gallop NN NN O
, , , O
no DT DT O
murmur NN NN O
of IN IN O
mitral JJ JJ O
regurgitation NN NN O
, , , O
and CC CC O
no DT DT O
obvious JJ JJ O
murmur NN NN O
of IN IN O
tricuspid JJ JJ O
regurgitation NN NN O
. . . O
   
Abdomen NNP NNP O
is VBZ VBZ O
of IN IN O
note NN NN O
for IN IN O
a DT DT O
liver NN NN O
at IN IN O
the DT DT O
right JJ JJ O
costal NN NN O
margin NN NN O
. . . O
   
There EX EX O
is VBZ VBZ O
+ NN NN O
2 CD CD O
peripheral JJ JJ O
edema NN NN O
. . . O
   
The DT DT O
resting NN NN O
electrocardiogram NN NN O
shows VBZ VBZ O
paced VBN VBN O
rhythm NN NN O
. . . O
   
We PRP PRP O
will MD MD O
be VB VB O
increasing VBG VBG O
his PRP$ PRP$ O
Lasix NNP NNP O
to TO TO O
80 CD CD O
mg NN NN O
daily JJ JJ O
and CC CC O
following VBG VBG O
him PRP PRP O
closely RB RB O
by IN IN O
telephone NN NN O
over IN IN O
the DT DT O
next JJ JJ O
several JJ JJ O
days NNS NNS O
. . . O
   
I PRP PRP O
have VBP VBP O
made VBN VBN O
no DT DT O
other JJ JJ O
changes NNS NNS O
in IN IN O
his PRP$ PRP$ O
current JJ JJ O
medical JJ JJ O
regimen NNS NNS O
. . . O
   
Many JJ JJ O
thanks NNS NNS O
for IN IN O
letting VBG VBG O
us PRP PRP O
participate VBP VBP O
in IN IN O
his PRP$ PRP$ O
care NN NN O
. . . O
   
With IN IN O
best JJS JJS O
regards VBZ VBZ O
. . . O
   
Sincerely NNP NNP O
yours NNS NNS O
, , , O
U. NNP NNP I-DOCTOR
L. NNP NNP I-DOCTOR
Dana NNP NNP O
, , , O
Jr NNP NNP O
. . . O
, , , O
M.D. NNP NNP O
   
DD NNP NNP O
: : : O
06/13/97 CD CD I-DATE
DT NNP NNP O
: : : O
06/18/97 CD CD I-DATE
DV NNP NNP O
: : : O
06/13/97 CD CD I-DATE
/ NN NN O
elizondo NN NN I-DOCTOR
******** NN NN O
Not RB RB O
reviewed VBN VBN O
by IN IN O
Attending NNP NNP O
Physician NNP NNP O
******** NN NN O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2077-06-19 JJ JJ I-DATE
MANAMANA NNP NNP I-HOSPITAL
MEDICAL NNP NNP O
CONSULT NNP NNP O
NOTE NNP NNP O
PATIENT NNP NNP O
: : : O
Vaughn NNP NNP I-PATIENT
, , , O
Frank NNP NNP I-PATIENT
R. NN NN O
MANAMANA NNP NNP I-HOSPITAL
MR NNP NNP O
# # # O
: : : O
6767510 CD CD I-MEDICALRECORD
PCP NNP NNP O
: : : O
Henry NNP NNP I-DOCTOR
Jenkins NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
( ( ( O
503 CD CD I-PHONE
155-7742 JJ JJ I-PHONE
) ) ) O
PSYCH NNP NNP O
: : : O
Brittany NNP NNP I-DOCTOR
Prince NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
   
CONTACT NNP NNP O
: : : O
Mother NNP NNP O
, , , O
Haley NNP NNP I-PATIENT
Vaughn NNP NNP I-PATIENT
( ( ( O
158 CD CD I-PHONE
857-4114 JJ JJ I-PHONE
) ) ) O
SOURCE NNP NNP O
: : : O
Patient NNP NNP O
; : : O
   
M.D. NNP NNP O
   
Passoff NNP NNP O
; : : O
   
Previous JJ JJ O
Medical NNP NNP O
Records NNP NNP O
PRECAUTIONS NNP NNP O
: : : O
MRSA NNP NNP O
; : : O
   
VRE NNP NNP O
PRIMARY JJ JJ O
SERVICE NNP NNP O
: : : O
Psychiatry NNP NNP O
Service NNP NNP O
( ( ( O
Internal NNP NNP O
Medicine NNP NNP O
) ) ) O
CONSULT NNP NNP O
DATE NN NN O
: : : O
6/19/77 CD CD I-DATE
TIME NNP NNP O
: : : O
2:00 NN NN O
PM NNP NNP O
CC NNP NNP O
: : : O
Suicidal NNP NNP O
ideation NN NN O
REASON NNP NNP O
for IN IN O
CONSULT NNP NNP O
: : : O
Evaluation NNP NNP O
for IN IN O
history NN NN O
of IN IN O
medical JJ JJ O
problems NNS NNS O
HPI NNP NNP O
: : : O
Pt NNP NNP O
is VBZ VBZ O
a DT DT O
33 CD CD I-AGE
y.o. NN NN O
male NN NN O
with IN IN O
HTN NNP NNP O
, , , O
IDDM2 NNP NNP O
, , , O
hyperlipidemia NN NN O
, , , O
recent JJ JJ O
prolonged JJ JJ O
hospitalization NN NN O
for IN IN O
Fournier&#8217; NNP NNP O
   
s VBZ VBZ O
gangrene NN NN O
at IN IN O
MANAMANA NNP NNP I-HOSPITAL
, , , O
and CC CC O
depression NN NN O
, , , O
who WP WP O
was VBD VBD O
transferred VBN VBN O
to TO TO O
the DT DT O
MANAMANA NNP NNP I-HOSPITAL
Psychiatry NNP NNP O
by IN IN O
his PRP$ PRP$ O
MEDIQUIK NNP NNP I-HOSPITAL
psychiatrist NN NN O
, , , O
Dr NNP NNP O
. . . O
Prince NNP NNP I-DOCTOR
from IN IN O
her PRP$ PRP$ O
clinic NN NN O
today NN NN O
for IN IN O
active JJ JJ O
suicidal NN NN O
ideation NN NN O
. . . O
   
Dr NNP NNP O
. . . O
Prince NNP NNP I-DOCTOR
had VBD VBD O
arranged VBN VBN O
involuntary JJ JJ O
hospitalization NN NN O
for IN IN O
this DT DT O
pt NN NN O
with IN IN O
campus NN NN O
security NN NN O
and CC CC O
EMS NNP NNP O
, , , O
prior RB RB O
to TO TO O
his PRP$ PRP$ O
arrival NN NN O
for IN IN O
the DT DT O
appointment NN NN O
. . . O
   
However RB RB O
, , , O
per IN IN O
Mr NNP NNP O
. . . O
Vaughn NNP NNP I-PATIENT
, , , O
he PRP PRP O
arrived VBD VBD O
to TO TO O
the DT DT O
appointment NN NN O
only RB RB O
with IN IN O
the DT DT O
expectation NN NN O
of IN IN O
discussing VBG VBG O
his PRP$ PRP$ O
depression NN NN O
and CC CC O
refilling VBG VBG O
his PRP$ PRP$ O
Celexa NNP NNP O
, , , O
which WDT WDT O
he PRP PRP O
has VBZ VBZ O
been VBN VBN O
unable JJ JJ O
to TO TO O
take VB VB O
for IN IN O
the DT DT O
past NN NN O
2 CD CD O
weeks NNS NNS O
, , , O
due JJ JJ O
to TO TO O
an DT DT O
expired JJ JJ O
prescription NN NN O
. . . O
   
Dr NNP NNP O
. . . O
Prince NNP NNP I-DOCTOR
documents NNS NNS O
a DT DT O
discussion NN NN O
in IN IN O
which WDT WDT O
the DT DT O
pt NN NN O
was VBD VBD O
tearful JJ JJ O
and CC CC O
emotional JJ JJ O
, , , O
while IN IN O
describing VBG VBG O
active JJ JJ O
suicidal NN NN O
ideation NN NN O
with IN IN O
a DT DT O
plan NN NN O
to TO TO O
overdose VB VB O
on IN IN O
oxycodone NN NN O
. . . O
   
He PRP PRP O
reportedly RB RB O
had VBD VBD O
several JJ JJ O
episodes NNS NNS O
this DT DT O
past JJ JJ O
week NN NN O
, , , O
where WRB WRB O
he PRP PRP O
had VBD VBD O
more JJR JJR O
than IN IN O
a DT DT O
hundred CD CD O
oxycodone NN NN O
pills NNS NNS O
in IN IN O
his PRP$ PRP$ O
hand NN NN O
, , , O
but CC CC O
did VBD VBD O
not RB RB O
follow VB VB O
through IN IN O
on IN IN O
his PRP$ PRP$ O
plans NNS NNS O
. . . O
   
Given VBN VBN O
concern NN NN O
for IN IN O
imminent JJ JJ O
danger NN NN O
, , , O
a DT DT O
Section NN NN O
12 CD CD I-AGE
was VBD VBD O
completed VBN VBN O
, , , O
and CC CC O
pt NN NN O
was VBD VBD O
transferred VBN VBN O
to TO TO O
the DT DT O
MANAMANA NNP NNP I-HOSPITAL
ED NNP NNP O
. . . O
   
The DT DT O
pt NN NN O
does VBZ VBZ O
admit VB VB O
to TO TO O
phobias NN NN O
of IN IN O
the DT DT O
hospital NN NN O
, , , O
and CC CC O
strong JJ JJ O
desire NN NN O
to TO TO O
avoid VB VB O
admission NN NN O
. . . O
   
However RB RB O
, , , O
he PRP PRP O
states NNS NNS O
that IN IN O
his PRP$ PRP$ O
last JJ JJ O
suicidal NN NN O
ideation NN NN O
was VBD VBD O
approximately RB RB O
2 CD CD O
weeks NNS NNS O
ago RB RB O
, , , O
and CC CC O
that IN IN O
he PRP PRP O
changed VBD VBD O
his PRP$ PRP$ O
mind NN NN O
, , , O
once RB RB O
he PRP PRP O
realized VBD VBD O
his PRP$ PRP$ O
mother&#8217; NN NN O
   
s VBZ VBZ O
soon-to-be JJ JJ O
ex-husband JJ JJ O
, , , O
who WP WP O
has VBZ VBZ O
been VBN VBN O
threatening VBG VBG O
her PRP$ PRP$ O
, , , O
will MD MD O
be VB VB O
released VBN VBN O
from IN IN O
prison NN NN O
soon RB RB O
. . . O
   
Moreover NNP NNP O
, , , O
he PRP PRP O
states VBZ VBZ O
that IN IN O
he PRP PRP O
has VBZ VBZ O
been VBN VBN O
taking VBG VBG O
all DT DT O
his PRP$ PRP$ O
medications NNS NNS O
, , , O
checking VBG VBG O
his PRP$ PRP$ O
insulin NN NN O
at IN IN O
least JJS JJS O
four CD CD O
times NNS NNS O
a DT DT O
day NN NN O
for IN IN O
his PRP$ PRP$ O
sliding VBG VBG O
scale NN NN O
, , , O
and CC CC O
changing VBG VBG O
the DT DT O
dressings NNS NNS O
on IN IN O
his PRP$ PRP$ O
sacral JJ JJ O
and CC CC O
scrotal JJ JJ O
wounds NNS NNS O
, , , O
with IN IN O
intent NN NN O
to TO TO O
improving VBG VBG O
his PRP$ PRP$ O
health NN NN O
. . . O
   
The DT DT O
Medical NNP NNP O
Service NNP NNP O
was VBD VBD O
asked VBN VBN O
to TO TO O
evaluate VB VB O
the DT DT O
pt NN NN O
for IN IN O
active JJ JJ O
and CC CC O
impending VBG VBG O
medical JJ JJ O
issues NNS NNS O
prior RB RB O
to TO TO O
admission NN NN O
to TO TO O
a DT DT O
Psychiatry NNP NNP O
Service NNP NNP O
. . . O
   
PMH/PSH NNP NNP O
   
1 CD CD O
. . . O
Depression NNP NNP O
: : : O
Symptoms NNP NNP O
since IN IN O
age NN NN O
   
12 CD CD I-AGE
. . . O
2 CD CD O
. . . O
   
IDDM2 NNP NNP O
: : : O
Diagnosed NNP NNP O
at IN IN O
age NN NN O
   
18 CD CD I-AGE
. . . O
Was VBD VBD O
previously RB RB O
on IN IN O
oral JJ JJ O
hypoglycemics NNS NNS O
, , , O
but CC CC O
now RB RB O
on IN IN O
insulin NN NN O
. . . O
   
When WRB WRB O
pt NN NN O
had VBD VBD O
lost VBN VBN O
weight NN NN O
and CC CC O
down RB RB O
to TO TO O
210 CD CD O
lbs NN NN O
, , , O
he PRP PRP O
did VBD VBD O
not RB RB O
require VB VB O
insulin NN NN O
. . . O
   
Last JJ JJ O
Hgb NNP NNP O
A1c NNP NNP O
of IN IN O
11.3 CD CD O
in IN IN O
December NNP NNP I-DATE
2076 CD CD I-DATE
. . . O
   
3 CD CD O
. . . O
Microalbuminuria NNP NNP O
: : : O
Microalbumin NNP NNP O
of IN IN O
286mg/dl CD CD O
( ( ( O
12/20/76 CD CD I-DATE
) ) ) O
and CC CC O
Malb/Cre NNP NNP O
ratio NN NN O
of IN IN O
4133 CD CD O
. . . O
   
Pt NNP NNP O
was VBD VBD O
previously RB RB O
taking VBG VBG O
Lisinopril NNP NNP O
40mg CD CD O
daily JJ JJ O
and CC CC O
Losartan NNP NNP O
25mg CD CD O
daily RB RB O
, , , O
but CC CC O
is VBZ VBZ O
not RB RB O
taking VBG VBG O
an DT DT O
ACE-inhibitor NNP NNP O
or CC CC O
ARB NNP NNP O
currently RB RB O
. . . O
   
4 CD CD O
. . . O
Hyperlipidemia NNP NNP O
: : : O
Primarily NNP NNP O
hypertriglyceridemia NN NN O
. . . O
   
TG NNP NNP O
as RB RB O
high JJ JJ O
as IN IN O
3060 CD CD O
on IN IN O
6/20/76 CD CD I-DATE
in IN IN O
setting VBG VBG O
of IN IN O
poorly RB RB O
controlled VBN VBN O
DM2 NNP NNP O
. . . O
   
Last JJ JJ O
TG NNP NNP O
of IN IN O
346 CD CD O
on IN IN O
2/13/77 CD CD I-DATE
. . . O
   
Pt NNP NNP O
was VBD VBD O
previously RB RB O
on IN IN O
Fenofibrate NNP NNP O
145mg CD CD O
daily RB RB O
, , , O
but CC CC O
is VBZ VBZ O
not RB RB O
taking VBG VBG O
it PRP PRP O
currently RB RB O
. . . O
   
5 CD CD O
. . . O
HTN NNP NNP O
: : : O
On IN IN O
Toprol NNP NNP O
XL NNP NNP O
. . . O
   
6 CD CD O
. . . O
Fournier&#8217; NNP NNP O
   
s VBZ VBZ O
Gangrene NNP NNP O
: : : O
Pt NNP NNP O
presented VBN VBN O
to TO TO O
EDUCARE-PULLMAN NNP NNP I-HOSPITAL
Clinic NNP NNP O
on IN IN O
1/21/77 CD CD I-DATE
with IN IN O
buttock NN NN O
pain NN NN O
and CC CC O
folliculitis NNS NNS O
that WDT WDT O
did VBD VBD O
not RB RB O
improve VB VB O
on IN IN O
oral JJ JJ O
antibiotics NNS NNS O
. . . O
   
Subsequent NNP NNP O
scrotal JJ JJ O
pain NN NN O
, , , O
swelling VBG VBG O
, , , O
and CC CC O
found VBD VBD O
to TO TO O
have VB VB O
Fournier&#8217; NNP NNP O
   
s VBZ VBZ O
gangrene NN NN O
requiring VBG VBG O
surgical JJ JJ O
debridement NN NN O
at IN IN O
MANAMANA NNP NNP I-HOSPITAL
on IN IN O
2/01/77 CD CD I-DATE
. . . O
   
Pt NNP NNP O
had VBD VBD O
prolonged JJ JJ O
hospitalization NN NN O
with IN IN O
ICU NNP NNP O
course NN NN O
, , , O
multiple JJ JJ O
wound NN NN O
closures NNS NNS O
, , , O
diverting VBG VBG O
colostomy NN NN O
, , , O
and CC CC O
extended VBD VBD O
IV NNP NNP O
antibiotic JJ JJ O
course NN NN O
. . . O
   
Pt NNP NNP O
was VBD VBD O
discharged VBN VBN O
on IN IN O
3/12/77 CD CD I-DATE
with IN IN O
sacral NN NN O
and CC CC O
scrotal JJ JJ O
wounds NNS NNS O
improving VBG VBG O
, , , O
but CC CC O
not RB RB O
fully RB RB O
healed VBN VBN O
. . . O
   
He PRP PRP O
has VBZ VBZ O
been VBN VBN O
followed VBN VBN O
closely RB RB O
by IN IN O
MANAMANA NNP NNP I-HOSPITAL
Surgery NNP NNP O
with IN IN O
significant JJ JJ O
improvements NNS NNS O
. . . O
   
7 CD CD O
. . . O
S/p NNP NNP O
Diverting NNP NNP O
Colostomy NNP NNP O
: : : O
S/p NNP NNP O
diverting VBG VBG O
colostomy NN NN O
on IN IN O
2/6/77 CD CD I-DATE
in IN IN O
setting VBG VBG O
of IN IN O
recovery NN NN O
following VBG VBG O
Fournier&#8217; NNP NNP O
   
s VBZ VBZ O
gangrene NN NN O
. . . O
   
On IN IN O
6/9/77 CD CD I-DATE
, , , O
pt NN NN O
underwent JJ JJ O
dilatation NN NN O
of IN IN O
the DT DT O
skin NN NN O
surrounding VBG VBG O
the DT DT O
colostomy NN NN O
site NN NN O
, , , O
to TO TO O
relieve VB VB O
a DT DT O
large JJ JJ O
bowel NN NN O
obstruction NN NN O
. . . O
   
8 CD CD O
. . . O
Obesity NNP NNP O
: : : O
Currently RB RB O
weighs VBZ VBZ O
298 CD CD O
lbs NN NN O
. . . O
   
9 CD CD O
. . . O
Migraine NNP NNP O
headaches NNS NNS O
   
10 CD CD O
. . . O
S/p NNP NNP O
Cholecystectomy NNP NNP O
in IN IN O
2065 CD CD I-DATE
MEDICATIONS NNP NNP O
: : : O
( ( ( O
Confirmed NNP NNP O
with IN IN O
pt NN NN O
) ) ) O
   
1 CD CD O
. . . O
Toprol NNP NNP O
XL NNP NNP O
100mg CD CD O
PO NNP NNP O
once RB RB O
daily JJ JJ O
   
2 CD CD O
. . . O
NPH NNP NNP O
Insulin NNP NNP O
30units CD CD O
SC NNP NNP O
QAM NNP NNP O
with IN IN O
breakfast NN NN O
   
3 CD CD O
. . . O
NPH NNP NNP O
Insulin NNP NNP O
10units CD CD O
SC NNP NNP O
QPM NNP NNP O
with IN IN O
dinner NN NN O
   
4 CD CD O
. . . O
Regular NNP NNP O
Insulin NNP NNP O
Sliding NNP NNP O
Scale NNP NNP O
SC NNP NNP O
QAC NNP NNP O
+ NN NN O
QHS NNP NNP O
- : : O
For IN IN O
FS NNP NNP O
of IN IN O
130-170 JJ JJ O
, , , O
give VB VB O
2units CD CD O
- : : O
For IN IN O
FS NNP NNP O
of IN IN O
171-200 JJ JJ O
, , , O
give VB VB O
4units CD CD O
- : : O
For IN IN O
FS NNP NNP O
of IN IN O
201-250 JJ JJ O
, , , O
give VB VB O
6units CD CD O
- : : O
For IN IN O
FS NNP NNP O
greater JJR JJR O
than IN IN O
250 CD CD O
, , , O
give VB VB O
10units CD CD O
   
5 CD CD O
. . . O
Celexa NNP NNP O
60mg CD CD O
PO NNP NNP O
once RB RB O
daily JJ JJ O
( ( ( O
stopped VBD VBD O
taking VBG VBG O
2 CD CD O
weeks NNS NNS O
ago RB RB O
) ) ) O
   
6 CD CD O
. . . O
Klonopin NNP NNP O
1mg CD CD O
PO NNP NNP O
once RB RB O
daily RB RB O
PRN NNP NNP O
for IN IN O
anxiety NN NN O
( ( ( O
last JJ JJ O
dose NN NN O
was VBD VBD O
3 CD CD O
days NNS NNS O
ago RB RB O
) ) ) O
   
7 CD CD O
. . . O
MVI NNP NNP O
1tablet CD CD O
PO NNP NNP O
once RB RB O
daily JJ JJ O
   
8 CD CD O
. . . O
Zinc NNP NNP O
supplements NNS NNS O
ALLERGIES NNP NNP O
: : : O
HCTZ NNP NNP O
-& SYM SYM O
gt NN NN O
; : : O
   
hyponatremia NN NN O
Social NNP NNP O
History NN NN O
: : : O
Lives NNS NNS O
in IN IN O
Waupun NNP NNP I-CITY
, , , O
AL NNP NNP I-STATE
with IN IN O
his PRP$ PRP$ O
mother NN NN O
, , , O
Haley NNP NNP I-PATIENT
Vaughn NNP NNP I-PATIENT
Occupation NNP NNP O
: : : O
Former NNP NNP O
Motor NNP NNP I-PROFESSION
Vehicle NNP NNP I-PROFESSION
Assembling NNP NNP I-PROFESSION
Supervisor NNP NNP I-PROFESSION
. . . O
   
Currently RB RB O
Publishing NNP NNP I-PROFESSION
Manager NNP NNP I-PROFESSION
. . . O
   
Tobacco NNP NNP O
: : : O
Denies NNP NNP O
EtOH NNP NNP O
: : : O
Rare NNP NNP O
. . . O
   
1 CD CD O
drink NN NN O
a DT DT O
year NN NN O
. . . O
   
Illicits NNP NNP O
: : : O
Denies NNP NNP O
IVDU NNP NNP O
, , , O
all DT DT O
illicits NNS NNS O
, , , O
including VBG VBG O
marijuana NN NN O
. . . O
   
ROS NNP NNP O
: : : O
Please VB VB O
refer VBP VBP O
to TO TO O
HPI NNP NNP O
for IN IN O
pertinent NN NN O
positives NNS NNS O
and CC CC O
negatives NNS NNS O
. . . O
   
General NNP NNP O
: : : O
Denies NNP NNP O
fevers NNS NNS O
, , , O
chills NNS NNS O
, , , O
general JJ JJ O
weakness NN NN O
. . . O
   
Denies NNP NNP O
light-headedness JJ JJ O
. . . O
   
Skin NNP NNP O
: : : O
No DT DT O
changing VBG VBG O
moles NNS NNS O
, , , O
lumps NNS NNS O
. . . O
   
Sacral NNP NNP O
and CC CC O
scrotal JJ JJ O
wounds NNS NNS O
stable JJ JJ O
and CC CC O
improving VBG VBG O
Head NNP NNP O
: : : O
Occasional NNP NNP O
migraine NN NN O
headaches NNS NNS O
. . . O
   
Denies NNP NNP O
trauma NN NN O
Eyes NNS NNS O
: : : O
No DT DT O
visual JJ JJ O
changes NNS NNS O
or CC CC O
drainage NN NN O
Nose NN NN O
: : : O
No DT DT O
epistaxis NNS NNS O
, , , O
obstruction NN NN O
, , , O
sinusitis NNS NNS O
Mouth NN NN O
: : : O
No DT DT O
sores NNS NNS O
, , , O
no DT DT O
sore NN NN O
throat NN NN O
Resp NNP NNP O
: : : O
No DT DT O
wheezing VBG VBG O
, , , O
hemoptysis NN NN O
, , , O
shortness NN NN O
of IN IN O
breath NN NN O
CV NNP NNP O
: : : O
No DT DT O
CP NNP NNP O
, , , O
angina NN NN O
, , , O
DOE NNP NNP O
, , , O
PND NNP NNP O
, , , O
orthopnea NN NN O
, , , O
palpitations NNS NNS O
GI NNP NNP O
: : : O
Denies NNP NNP O
ABD NNP NNP O
pain NN NN O
, , , O
constipation NN NN O
, , , O
diarrhea NN NN O
. . . O
   
Colostomy NNP NNP O
site NN NN O
with IN IN O
good JJ JJ O
output NN NN O
and CC CC O
without IN IN O
bleeding VBG VBG O
GU NNP NNP O
: : : O
No DT DT O
dysuria NN NN O
, , , O
nocturia NN NN O
, , , O
hematuria NN NN O
, , , O
frequency NN NN O
, , , O
urgency NN NN O
, , , O
hesitancy NN NN O
. . . O
   
Denies NNP NNP O
urinary JJ JJ O
incontinence NN NN O
Neuro NNP NNP O
: : : O
No DT DT O
dizziness NN NN O
, , , O
involuntary JJ JJ O
movements NNS NNS O
, , , O
syncope NN NN O
, , , O
loss NN NN O
of IN IN O
coordination NN NN O
, , , O
paralysis NNS NNS O
PHYSICAL JJ JJ O
EXAM NNP NNP O
VS NNP NNP O
: : : O
T NN NN O
: : : O
97.6 CD CD O
P NN NN O
: : : O
90 CD CD O
( ( ( O
Regular NNP NNP O
) ) ) O
BP NNP NNP O
: : : O
126/72 CD CD O
RR NNP NNP O
: : : O
18 CD CD I-AGE
O2 NNP NNP O
Sat NNP NNP O
: : : O
98 CD CD O
% NN NN O
on IN IN O
R.A. NNP NNP O
   
Wt NNP NNP O
: : : O
298 CD CD O
lbs NN NN O
GEN NNP NNP O
: : : O
In IN IN O
NAD NNP NNP O
. . . O
   
Obese NN NN O
. . . O
   
Comfortable NNP NNP O
, , , O
lying VBG VBG O
flat JJ JJ O
in IN IN O
bed NN NN O
. . . O
   
HEENT NNP NNP O
: : : O
NC/AT NNP NNP O
. . . O
   
PERRL NNP NNP O
. . . O
   
EOMI NNP NNP O
. . . O
   
OP NNP NNP O
clear JJ JJ O
without IN IN O
lesions NNS NNS O
, , , O
MMM NNP NNP O
without IN IN O
erosions NNS NNS O
. . . O
   
NECK NNP NNP O
: : : O
Soft JJ JJ O
, , , O
supple NN NN O
, , , O
FROM IN IN O
, , , O
no DT DT O
thyromegaly NN NN O
. . . O
   
2 CD CD O
+ NN NN O
carotid NN NN O
pulses NNS NNS O
bilaterally RB RB O
without IN IN O
delay NN NN O
. . . O
   
No DT DT O
cervical JJ JJ O
spine NN NN O
tenderness NN NN O
. . . O
   
CHEST NN NN O
: : : O
Clear NNP NNP O
to TO TO O
auscultation NN NN O
bilaterally RB RB O
. . . O
   
No DT DT O
wheezes NNS NNS O
or CC CC O
rales NNS NNS O
. . . O
   
CV NNP NNP O
: : : O
Regular NNP NNP O
rate NN NN O
. . . O
   
Normal NNP NNP O
S1 NNP NNP O
, , , O
S2 NNP NNP O
. . . O
   
No DT DT O
m/r/g NN NN O
. . . O
   
No DT DT O
PA NNP NNP O
tap NN NN O
or CC CC O
RV NNP NNP O
heave VBP VBP O
. . . O
   
PMI NNP NNP O
along IN IN O
mid-axillary JJ JJ O
line NN NN O
. . . O
   
JVP NNP NNP O
of IN IN O
7.5 CD CD O
cm NN NN O
H2O NNP NNP O
. . . O
   
ABD NNP NNP O
: : : O
+ NN NN O
bowel NN NN O
sounds VBZ VBZ O
; : : O
   
Soft JJ JJ O
, , , O
NT NNP NNP O
, , , O
obese NN NN O
. . . O
   
No DT DT O
organomegaly RB RB O
. . . O
   
No DT DT O
rebound NN NN O
tenderness NN NN O
, , , O
no DT DT O
peritoneal NN NN O
signs NNS NNS O
, , , O
no DT DT O
fluid JJ JJ O
wave NN NN O
. . . O
   
LLQ NNP NNP O
colostomy NN NN O
site NN NN O
with IN IN O
good JJ JJ O
output NN NN O
of IN IN O
brown JJ JJ O
stool NN NN O
. . . O
   
Colostomy NNP NNP O
bag NN NN O
properly RB RB O
secured JJ JJ O
. . . O
   
BACK NNP NNP O
: : : O
No DT DT O
focal JJ JJ O
or CC CC O
paraspinal JJ JJ O
tenderness NN NN O
. . . O
   
EXT NNP NNP O
: : : O
Warm NNP NNP O
. . . O
   
No DT DT O
L.E. NNP NNP O
edema NN NN O
. . . O
   
No DT DT O
c/c NN NN O
. . . O
   
2 CD CD O
+ NN NN O
DP NNP NNP O
and CC CC O
PTs NNP NNP O
bilaterally RB RB O
. . . O
   
DERM NNP NNP O
: : : O
0.5cm CD CD O
open JJ JJ O
wound NN NN O
in IN IN O
sacram NN NN O
with IN IN O
surrounding VBG VBG O
erythema NN NN O
. . . O
   
1cm CD CD O
open JJ JJ O
wound NN NN O
at IN IN O
base NN NN O
of IN IN O
scrotum NN NN O
, , , O
close VB VB O
to TO TO O
perineum NN NN O
. . . O
   
Dressing NNP NNP O
in IN IN O
place NN NN O
. . . O
   
No DT DT O
pus NN NN O
or CC CC O
drainage NN NN O
expressed VBD VBD O
from IN IN O
both DT DT O
wounds NNS NNS O
. . . O
   
When WRB WRB O
compared VBN VBN O
to TO TO O
descriptions NNS NNS O
in IN IN O
the DT DT O
past NN NN O
, , , O
and CC CC O
per IN IN O
pt NN NN O
, , , O
both DT DT O
wounds NNS NNS O
are VBP VBP O
continuing VBG VBG O
to TO TO O
improve VB VB O
. . . O
   
NEURO NNP NNP O
: : : O
Alert NNP NNP O
and CC CC O
oriented VBD VBD O
x SYM SYM O
   
3 CD CD O
. . . O
PSYCH NNP NNP O
: : : O
Denies NNP NNP O
SI NNP NNP O
and CC CC O
HI NNP NNP O
. . . O
   
Rest NNP NNP O
of IN IN O
exam NN NN O
deferred VBN VBN O
to TO TO O
Internal NNP NNP O
Medicine NNP NNP O
Evaluation NNP NNP O
. . . O
   
EKG NNP NNP O
: : : O
Normal JJ JJ O
sinus NN NN O
rhythm NN NN O
at IN IN O
95 CD CD O
bpm NN NN O
. . . O
   
Normal NNP NNP O
axis NNS NNS O
. . . O
   
Poor NNP NNP O
R NNP NNP I-PATIENT
wave NN NN O
progression NN NN O
. . . O
   
Non-specific JJ JJ O
ST-T NNP NNP O
changes NNS NNS O
. . . O
   
No DT DT O
significant JJ JJ O
change NN NN O
from IN IN O
previous JJ JJ O
EKG NNP NNP O
on IN IN O
6/9/77 CD CD I-DATE
. . . O
   
Labs NNP NNP O
: : : O
HEMATOLOGY NNP NNP O
WBC NNP NNP O
7.8 CD CD O
( ( ( O
4.5-11.0 JJ JJ O
) ) ) O
th/cmm NN NN O
HCT NNP NNP O
38.0 CD CD O
L NNP NNP O
( ( ( O
41.0-53.0 JJ JJ O
) ) ) O
% NN NN O
HGB NNP NNP O
13.1 CD CD O
L NNP NNP O
( ( ( O
13.5-17.5 JJ JJ O
) ) ) O
gm/dl NN NN O
RBC NNP NNP O
4.63 CD CD O
( ( ( O
4.50-5.90 JJ JJ O
) ) ) O
mil/cmm NN NN O
PLT NNP NNP O
219 CD CD O
( ( ( O
150-350 NN NN O
) ) ) O
th/cumm NN NN O
MCV NNP NNP O
82 CD CD O
( ( ( O
80-100 NNP NNP O
) ) ) O
fl NN NN O
MCH NNP NNP O
28.4 CD CD O
( ( ( O
26.0-34.0 JJ JJ O
) ) ) O
pg/rbc NN NN O
MCHC NNP NNP O
34.6 CD CD O
( ( ( O
31.0-37.0 NN NN O
) ) ) O
g/dl NN NN O
RDW NNP NNP O
16.1 CD CD O
H NNP NNP O
( ( ( O
11.5-14.5 JJ JJ O
) ) ) O
% NN NN O
Poly NNP NNP O
70 CD CD O
H NNP NNP O
( ( ( O
40-70 JJ JJ O
) ) ) O
% NN NN O
Lymphs NNP NNP O
21 CD CD O
L NNP NNP O
( ( ( O
22-44 JJ JJ O
) ) ) O
% NN NN O
Monos NNP NNP O
6 CD CD O
( ( ( O
4-11 JJ JJ O
) ) ) O
% NN NN O
EOS NNP NNP O
3 CD CD O
( ( ( O
0-8 NN NN O
) ) ) O
% NN NN O
Basos NNP NNP O
0 CD CD O
( ( ( O
0-3 NN NN O
) ) ) O
% NN NN O
Absolute NNP NNP O
Neuts NNP NNP O
5.44 CD CD O
( ( ( O
1.8-7.7 NN NN O
) ) ) O
th/cmm NN NN O
Absolute NNP NNP O
Lymphs NNP NNP O
1.64 CD CD O
( ( ( O
1.0-4.8 JJ JJ O
) ) ) O
th/cmm NN NN O
Absolute NNP NNP O
Monos NNP NNP O
0.49 CD CD O
H NNP NNP O
( ( ( O
0.2-0.4 NN NN O
) ) ) O
th/cmm NN NN O
Absolute NNP NNP O
EOS NNP NNP O
0.19 CD CD O
( ( ( O
0.1-0.3 NN NN O
) ) ) O
th/cmm NN NN O
Absolute NNP NNP O
Basos NNP NNP O
0.03 CD CD O
( ( ( O
0.0-0.3 NN NN O
) ) ) O
th/cmm NN NN O
Aniso NNP NNP O
1 CD CD O
+ NN NN O
H NNP NNP O
( ( ( O
None NN NN O
) ) ) O
Hypo NNP NNP O
None NN NN O
( ( ( O
None NN NN O
) ) ) O
Macrocytes NNP NNP O
None NN NN O
( ( ( O
None NN NN O
) ) ) O
Microcytes NNP NNP O
None NN NN O
( ( ( O
None NN NN O
) ) ) O
CHEMISTRY NNP NNP O
Sodium NNP NNP O
( ( ( O
Stat NNP NNP O
Lab NNP NNP O
) ) ) O
139 CD CD O
( ( ( O
135-145 NN NN O
) ) ) O
mmol/L NN NN O
Potassium NNP NNP O
( ( ( O
Stat NNP NNP O
Lab NNP NNP O
) ) ) O
3.9 CD CD O
( ( ( O
3.4-4.8 NN NN O
) ) ) O
mmol/L NN NN O
Chloride NNP NNP O
( ( ( O
Stat NNP NNP O
Lab NNP NNP O
) ) ) O
103 CD CD O
( ( ( O
100-108 NN NN O
) ) ) O
mmol/L NN NN O
CO2 NNP NNP O
( ( ( O
Stat NNP NNP O
Lab NNP NNP O
) ) ) O
26.7 CD CD O
( ( ( O
23.0-31.9 JJ JJ O
) ) ) O
mmol/L NN NN O
BUN NNP NNP O
( ( ( O
Stat NNP NNP O
Lab NNP NNP O
) ) ) O
21 CD CD O
( ( ( O
8-25 JJ JJ O
) ) ) O
mg/dl NN NN O
Creatinine NNP NNP O
( ( ( O
Stat NNP NNP O
Lab NNP NNP O
) ) ) O
0.9 CD CD O
( ( ( O
0.6-1.5 NN NN O
) ) ) O
mg/dl NN NN O
Glucose NNP NNP O
( ( ( O
Stat NNP NNP O
Lab NNP NNP O
) ) ) O
118 CD CD O
H NNP NNP O
( ( ( O
70-110 NN NN O
) ) ) O
mg/dl NN NN O
Calcium NNP NNP O
9.6 CD CD O
( ( ( O
8.5-10.5 NNP NNP O
) ) ) O
mg/dl NN NN O
Phosphorus NNP NNP O
3.8 CD CD O
( ( ( O
2.6-4.5 NN NN O
) ) ) O
mg/dl NN NN O
Magnesium NNP NNP O
1.3 CD CD O
L NNP NNP O
( ( ( O
1.4-2.0 JJ JJ O
) ) ) O
meq/L NN NN O
Total NNP NNP O
Protein NNP NNP O
7.5 CD CD O
( ( ( O
6.0-8.3 NN NN O
) ) ) O
g/dl NN NN O
Albumin NNP NNP O
3.9 CD CD O
( ( ( O
3.3-5.0 NN NN O
) ) ) O
g/dl NN NN O
Globulin NNP NNP O
3.6 CD CD O
( ( ( O
2.6-4.1 JJ JJ O
) ) ) O
g/dl NN NN O
Direct NNP NNP O
Bilirubin NNP NNP O
0.2 CD CD O
( ( ( O
0-0.4 NN NN O
) ) ) O
mg/dl NN NN O
Total NNP NNP O
Bilirubin NNP NNP O
0.2 CD CD O
( ( ( O
0.0-1.0 NN NN O
) ) ) O
mg/dl NN NN O
Alkaline NNP NNP O
Phosphatase NNP NNP O
84 CD CD O
( ( ( O
45-115 NNP NNP O
) ) ) O
U/L NNP NNP O
Transaminase-SGPT NNP NNP O
30 CD CD O
( ( ( O
10-55 NN NN O
) ) ) O
U/L NNP NNP O
Transaminase-SGOT NNP NNP O
18 CD CD I-AGE
( ( ( O
10-40 NN NN O
) ) ) O
U/L NNP NNP O
TOXICOLOGY NNP NNP O
SCREEN NNP NNP O
: : : O
SERUM NNP NNP O
TOXICOLOGY NNP NNP O
Test NNP NNP O
Description NNP NNP O
Result NNP NNP O
Flags NNP NNP O
Ref NNP NNP O
. . . O
   
Range NNP NNP O
Units NNP NNP O
Clonazepam NNP NNP O
42 CD CD O
mcg/L NN NN O
REF NNP NNP O
. . . O
   
RANGE NNP NNP O
: : : O
10-70 JJ JJ O
TOXIC NNP NNP O
: : : O
& CC CC O
gt NN NN O
; : : O
   
80 CD CD O
Ibuprofen NNP NNP O
& CC CC O
lt NN NN O
; : : O
   
17.0 CD CD O
mg/L NN NN O
REF NNP NNP O
. . . O
   
RANGE NNP NNP O
: : : O
20-70 JJ JJ O
TOXIC NNP NNP O
: : : O
& CC CC O
gt NN NN O
; : : O
   
100 CD CD O
Tox NNP NNP O
Panel NNP NNP O
1 CD CD O
( ( ( O
ALC NNP NNP O
) ) ) O
COMPLETED NNP NNP O
: : : O
PANEL NNP NNP O
NEGATIVE NNP NNP O
( ( ( O
NOTE)Drugs NNP NNP O
included VBD VBD O
in IN IN O
PANEL NNP NNP O
1 CD CD O
( ( ( O
Detection NNP NNP O
limit NN NN O
in IN IN O
mg/L NN NN O
) ) ) O
: : : O
Ethanol NNP NNP O
( ( ( O
100 CD CD O
) ) ) O
. . . O
   
Isopropanol NNP NNP O
( ( ( O
100 CD CD O
) ) ) O
. . . O
   
Methanol NNP NNP O
( ( ( O
100 CD CD O
) ) ) O
. . . O
   
Tox NNP NNP O
Panel NNP NNP O
2 CD CD O
( ( ( O
ATS NNP NNP O
) ) ) O
COMPLETED NNP NNP O
: : : O
PANEL NNP NNP O
NEGATIVE NNP NNP O
( ( ( O
NOTE)Drugs NNP NNP O
included VBD VBD O
in IN IN O
PANEL NNP NNP O
2 CD CD O
( ( ( O
Detection NNP NNP O
limit NN NN O
in IN IN O
mg/L NN NN O
) ) ) O
: : : O
Acetaminophen NNP NNP O
( ( ( O
25 CD CD O
) ) ) O
. . . O
   
Lamotrigine NNP NNP O
( ( ( O
4 CD CD O
) ) ) O
. . . O
   
Salicylate NNP NNP O
( ( ( O
100 CD CD O
) ) ) O
. . . O
   
Tox NNP NNP O
Panel NNP NNP O
3 CD CD O
( ( ( O
BBT NNP NNP O
) ) ) O
COMPLETED NNP NNP O
: : : O
POSITIVE NNP NNP O
FINDINGS NNS NNS O
LISTED NNP NNP O
ABOVE NNP NNP O
. . . O
   
( ( ( O
NOTE)Drugs NNP NNP O
included VBD VBD O
in IN IN O
PANEL NNP NNP O
3 CD CD O
( ( ( O
Detection NNP NNP O
limit NN NN O
in IN IN O
mg/L NN NN O
) ) ) O
: : : O
Butalbital NNP NNP O
( ( ( O
10 CD CD O
) ) ) O
. . . O
   
Carbamazepine NNP NNP O
( ( ( O
2 CD CD O
) ) ) O
. . . O
   
Ibuprofen NNP NNP O
( ( ( O
17 CD CD O
) ) ) O
. . . O
   
Pentobarbital NNP NNP O
( ( ( O
6 CD CD O
) ) ) O
. . . O
   
Phenobarbital NNP NNP O
( ( ( O
11 CD CD O
) ) ) O
. . . O
   
Phenytoin NNP NNP O
( ( ( O
5 CD CD O
) ) ) O
. . . O
   
Secobarbital NNP NNP O
( ( ( O
5 CD CD O
) ) ) O
. . . O
   
Tox NNP NNP O
Panel NNP NNP O
4 CD CD O
( ( ( O
BZ NNP NNP O
) ) ) O
COMPLETED NNP NNP O
: : : O
POSITIVE NNP NNP O
FINDINGS NNS NNS O
LISTED NNP NNP O
ABOVE NNP NNP O
. . . O
   
( ( ( O
NOTE)Drugs NNP NNP O
included VBD VBD O
in IN IN O
PANEL NNP NNP O
4 CD CD O
( ( ( O
Detection NNP NNP O
limit NN NN O
in IN IN O
mcg/L NN NN O
) ) ) O
: : : O
4-OH NN NN O
Glutethimide NNP NNP O
( ( ( O
1000 CD CD O
) ) ) O
. . . O
   
Alprazolam NNP NNP O
( ( ( O
50 CD CD O
) ) ) O
. . . O
   
Chlordiazepoxide NNP NNP O
( ( ( O
200 CD CD O
) ) ) O
. . . O
   
Clonazepam NNP NNP O
( ( ( O
10 CD CD O
) ) ) O
. . . O
   
Demoxepam NNP NNP O
( ( ( O
200 CD CD O
) ) ) O
. . . O
   
Desalkylflurazepam NNP NNP O
( ( ( O
300 CD CD O
) ) ) O
. . . O
   
Diazepam NNP NNP O
( ( ( O
100 CD CD O
) ) ) O
. . . O
   
Flurazepam NNP NNP O
( ( ( O
500 CD CD O
) ) ) O
. . . O
   
Glutethimide NNP NNP O
( ( ( O
1000 CD CD O
) ) ) O
. . . O
   
Lidocaine NNP NNP O
( ( ( O
150 CD CD O
) ) ) O
. . . O
   
Lorazepam NNP NNP O
( ( ( O
150 CD CD O
) ) ) O
. . . O
   
Methaqualone NNP NNP O
( ( ( O
1000 CD CD O
) ) ) O
. . . O
   
Norchlordiazepoxide NNP NNP O
( ( ( O
200 CD CD O
) ) ) O
. . . O
   
Nordiazepam NNP NNP O
( ( ( O
100 CD CD O
) ) ) O
. . . O
   
Oxazepam NNP NNP O
( ( ( O
150 CD CD O
) ) ) O
. . . O
   
Quinidine NNP NNP O
( ( ( O
1000 CD CD O
) ) ) O
. . . O
   
Temazepam NNP NNP O
( ( ( O
250 CD CD O
) ) ) O
. . . O
   
Trazodone NNP NNP O
( ( ( O
250 CD CD O
) ) ) O
. . . O
   
Tox NNP NNP O
Panel NNP NNP O
5 CD CD O
( ( ( O
TC NNP NNP O
) ) ) O
COMPLETED NNP NNP O
: : : O
PANEL NNP NNP O
NEGATIVE NNP NNP O
( ( ( O
NOTE)Drugs NNP NNP O
included VBD VBD O
in IN IN O
PANEL NNP NNP O
5 CD CD O
( ( ( O
Detection NNP NNP O
limit NN NN O
in IN IN O
mcg/L NN NN O
) ) ) O
: : : O
Amitriptyline NNP NNP O
( ( ( O
20 CD CD O
) ) ) O
. . . O
   
Chlorpheniramine NNP NNP O
( ( ( O
40 CD CD O
) ) ) O
. . . O
   
Chlorpromazine NNP NNP O
( ( ( O
30 CD CD O
) ) ) O
. . . O
   
Clomipramine NNP NNP O
( ( ( O
20 CD CD O
) ) ) O
. . . O
   
Clozapine NNP NNP O
( ( ( O
250 CD CD O
) ) ) O
. . . O
   
Cocaethylene NNP NNP O
( ( ( O
10 CD CD O
) ) ) O
. . . O
   
Cocaine NNP NNP O
( ( ( O
10 CD CD O
) ) ) O
. . . O
   
Cyclobenzaprine NNP NNP O
( ( ( O
20 CD CD O
) ) ) O
. . . O
   
Pseudoephedrine NNP NNP O
( ( ( O
500 CD CD O
) ) ) O
. . . O
   
Desipramine NNP NNP O
( ( ( O
20 CD CD O
) ) ) O
. . . O
   
Desmethylsertraline NNP NNP O
( ( ( O
50 CD CD O
) ) ) O
. . . O
   
Dextromethorphan NNP NNP O
( ( ( O
1000 CD CD O
) ) ) O
. . . O
   
Diphenhydramine NNP NNP O
( ( ( O
20 CD CD O
) ) ) O
. . . O
   
Disopyramide IN IN O
( ( ( O
150 CD CD O
) ) ) O
. . . O
   
Doxepin NNP NNP O
( ( ( O
20 CD CD O
) ) ) O
. . . O
   
Doxylamine NNP NNP O
( ( ( O
20 CD CD O
) ) ) O
. . . O
   
Fluoxetine NNP NNP O
( ( ( O
50 CD CD O
) ) ) O
. . . O
   
Fluvoxamine NNP NNP O
( ( ( O
40 CD CD O
) ) ) O
. . . O
   
Imipramine NNP NNP O
( ( ( O
20 CD CD O
) ) ) O
. . . O
   
M-cPP NNP NNP O
( ( ( O
100 CD CD O
) ) ) O
. . . O
   
Maprotilene NNP NNP O
( ( ( O
400 CD CD O
) ) ) O
. . . O
   
Meperidine NNP NNP O
( ( ( O
200 CD CD O
) ) ) O
. . . O
   
Mesoridazine NNP NNP O
( ( ( O
500 CD CD O
) ) ) O
. . . O
   
Methadone NNP NNP O
( ( ( O
100 CD CD O
) ) ) O
. . . O
   
Norclomipramine NNP NNP O
( ( ( O
20 CD CD O
) ) ) O
. . . O
   
Nordoxepin NNP NNP O
( ( ( O
20 CD CD O
) ) ) O
. . . O
   
Norfluoxetine NNP NNP O
( ( ( O
50 CD CD O
) ) ) O
. . . O
   
Normaprotilene NNP NNP O
( ( ( O
450 CD CD O
) ) ) O
. . . O
   
Normeperidine NNP NNP O
( ( ( O
200 CD CD O
) ) ) O
. . . O
   
Norpropoxyphene NNP NNP O
( ( ( O
200 CD CD O
) ) ) O
. . . O
   
Nortriptyline NNP NNP O
( ( ( O
20 CD CD O
) ) ) O
. . . O
   
Norverapamil NNP NNP O
( ( ( O
50 CD CD O
) ) ) O
. . . O
   
Oxycodone NNP NNP O
( ( ( O
40 CD CD O
) ) ) O
. . . O
   
Paroxetine NNP NNP O
( ( ( O
50 CD CD O
) ) ) O
. . . O
   
Pentazocine NNP NNP O
( ( ( O
1000 CD CD O
) ) ) O
. . . O
   
Promazine NNP NNP O
( ( ( O
50 CD CD O
) ) ) O
. . . O
   
Propoxyphene NNP NNP O
( ( ( O
200 CD CD O
) ) ) O
. . . O
   
Propranolol NNP NNP O
( ( ( O
50 CD CD O
) ) ) O
. . . O
   
Pyrilamine NNP NNP O
( ( ( O
50 CD CD O
) ) ) O
. . . O
   
Sertraline NNP NNP O
( ( ( O
20 CD CD O
) ) ) O
. . . O
   
Thioridazine NNP NNP O
( ( ( O
100 CD CD O
) ) ) O
. . . O
   
Trifluoperazine NNP NNP O
( ( ( O
60 CD CD O
) ) ) O
. . . O
   
Trimipramine NNP NNP O
( ( ( O
50 CD CD O
) ) ) O
. . . O
   
Venlafaxine NNP NNP O
( ( ( O
50 CD CD O
) ) ) O
. . . O
   
Verapamil NNP NNP O
( ( ( O
50 CD CD O
) ) ) O
. . . O
   
URINE NNP NNP O
TOXICOLOGY NNP NNP O
Test NNP NNP O
Description NNP NNP O
Result NNP NNP O
Flags NNP NNP O
Ref NNP NNP O
. . . O
   
Range NNP NNP O
Units NNP NNP O
Ur NNP NNP O
Amphetamines NNP NNP O
NEGATIVE NNP NNP O
( ( ( O
NEG NNP NNP O
) ) ) O
Ur NNP NNP O
Methamphetamines NNP NNP O
NEGATIVE NNP NNP O
( ( ( O
NEG NNP NNP O
) ) ) O
Ur NNP NNP O
Barbiturates NNP NNP O
NEGATIVE NNP NNP O
( ( ( O
NEG NNP NNP O
) ) ) O
Ur NNP NNP O
Benzodiazepines NNP NNP O
NEGATIVE NNP NNP O
( ( ( O
NEG NNP NNP O
) ) ) O
Ur NNP NNP O
Cocaine NNP NNP O
Metab NNP NNP O
NEGATIVE NNP NNP O
( ( ( O
NEG NNP NNP O
) ) ) O
Ur NNP NNP O
Opiates NNP NNP O
NEGATIVE NNP NNP O
( ( ( O
NEG NNP NNP O
) ) ) O
Ur NNP NNP O
Phencyclidine NNP NNP O
NEGATIVE NNP NNP O
( ( ( O
NEG NNP NNP O
) ) ) O
Ur NNP NNP O
Cannabinoids NNP NNP O
NEGATIVE NNP NNP O
( ( ( O
NEG NNP NNP O
) ) ) O
Ur NNP NNP O
Tricyclics NNP NNP O
NEGATIVE NNP NNP O
( ( ( O
NEG NNP NNP O
) ) ) O
Ur NNP NNP O
Methadone NNP NNP O
NEGATIVE NNP NNP O
( ( ( O
NEG NNP NNP O
) ) ) O
Ur NNP NNP O
Acetaminophen NNP NNP O
NEGATIVE NNP NNP O
( ( ( O
NEG NNP NNP O
) ) ) O
URINALYSIS NNP NNP O
UA-Color NNP NNP O
Yellow NNP NNP O
( ( ( O
YELLOW NNP NNP O
) ) ) O
UA-Turbidity NNP NNP O
Clear NNP NNP O
( ( ( O
CLEAR NNP NNP O
) ) ) O
UA-Specific NNP NNP O
Gravity NNP NNP O
& CC CC O
gt NN NN O
; : : O
   
1.030 CD CD O
( ( ( O
1.001-1.035 NN NN O
) ) ) O
UA-pH NNP NNP O
6.0 CD CD O
( ( ( O
5.0-9.0 NNP NNP O
) ) ) O
UA-WBC NNP NNP O
Screen NNP NNP O
NEGATIVE NNP NNP O
( ( ( O
NEG NNP NNP O
) ) ) O
UA-Nitrite NNP NNP O
NEGATIVE NNP NNP O
( ( ( O
NEG NNP NNP O
) ) ) O
UA-Albumin NNP NNP O
3 CD CD O
+ NN NN O
( ( ( O
NEG NNP NNP O
) ) ) O
UA-Glucose NNP NNP O
NEGATIVE NNP NNP O
( ( ( O
NEG NNP NNP O
) ) ) O
UA-Ketones NNP NNP O
NEGATIVE NNP NNP O
( ( ( O
NEG NNP NNP O
) ) ) O
Urobilinogen NNP NNP O
NEGATIVE NNP NNP O
( ( ( O
NEG NNP NNP O
) ) ) O
Bili NNP NNP O
NEGATIVE NNP NNP O
( ( ( O
NEG NNP NNP O
) ) ) O
UA-Occult NNP NNP O
Blood NNP NNP O
1 CD CD O
+ NN NN O
( ( ( O
NEG NNP NNP O
) ) ) O
UA-SED-RBC NNP NNP O
3-5 JJ JJ O
( ( ( O
0-2 NN NN O
) ) ) O
/ NN NN O
hpf NN NN O
UA-SED-WBC NNP NNP O
0-2 NN NN O
( ( ( O
0-2 NN NN O
) ) ) O
/ NN NN O
hpf NN NN O
UA-SED-Bacteria NNP NNP O
NEGATIVE NNP NNP O
( ( ( O
NEG NNP NNP O
) ) ) O
/ NN NN O
hpf NN NN O
Hyaline NNP NNP O
Cast NNP NNP O
PEND NNP NNP O
( ( ( O
0-5 NN NN O
) ) ) O
/ NN NN O
lpf NN NN O
Squamous NNP NNP O
Cells NNS NNS O
NEGATIVE NNP NNP O
( ( ( O
NEG NNP NNP O
) ) ) O
/ NN NN O
hpf NN NN O
ASSESSMENT NNP NNP O
33 CD CD I-AGE
y.o. NN NN O
male NN NN O
with IN IN O
HTN NNP NNP O
, , , O
IDDM2 NNP NNP O
, , , O
hyperlipidemia NN NN O
, , , O
recent JJ JJ O
prolonged JJ JJ O
hospitalization NN NN O
for IN IN O
Fournier&#8217; NNP NNP O
   
s VBZ VBZ O
gangrene NN NN O
at IN IN O
MANAMANA NNP NNP I-HOSPITAL
, , , O
and CC CC O
depression NN NN O
, , , O
who WP WP O
was VBD VBD O
transferred VBN VBN O
to TO TO O
the DT DT O
MANAMANA NNP NNP I-HOSPITAL
Psychiatry NNP NNP O
by IN IN O
his PRP$ PRP$ O
MEDIQUIK NNP NNP I-HOSPITAL
psychiatrist NN NN O
, , , O
Dr NNP NNP O
. . . O
Prince NNP NNP I-DOCTOR
from IN IN O
her PRP$ PRP$ O
clinic NN NN O
today NN NN O
for IN IN O
active JJ JJ O
suicidal NN NN O
ideation NN NN O
, , , O
who WP WP O
now RB RB O
denies VBZ VBZ O
suicidal JJ JJ O
ideation NN NN O
, , , O
but CC CC O
being VBG VBG O
evaluated VBN VBN O
by IN IN O
the DT DT O
medical JJ JJ O
service NN NN O
for IN IN O
active JJ JJ O
medical JJ JJ O
issues NNS NNS O
. . . O
   
Pt NNP NNP O
does VBZ VBZ O
have VB VB O
hypertension NN NN O
, , , O
IDDM2 NNP NNP O
, , , O
hyperlipidemia NN NN O
, , , O
and CC CC O
open JJ JJ O
wounds NNS NNS O
near IN IN O
his PRP$ PRP$ O
scrotum NN NN O
and CC CC O
sacrum NN NN O
. . . O
   
All DT DT O
of IN IN O
these DT DT O
medical JJ JJ O
issues NNS NNS O
appear VBP VBP O
to TO TO O
be VB VB O
stable JJ JJ O
, , , O
although IN IN O
their PRP$ PRP$ O
management NN NN O
could MD MD O
be VB VB O
fine-tuned JJ JJ O
via IN IN O
an DT DT O
outpatient JJ JJ O
basis NN NN O
. . . O
   
Hypertension NNP NNP O
is VBZ VBZ O
being VBG VBG O
managed VBN VBN O
appropriately RB RB O
with IN IN O
a DT DT O
betablocker NN NN O
( ( ( O
HCTZ NNP NNP O
caused VBD VBD O
hyponatremia NN NN O
) ) ) O
, , , O
but CC CC O
given VBN VBN O
his PRP$ PRP$ O
history NN NN O
of IN IN O
microalbuminuria NN NN O
, , , O
he PRP PRP O
should MD MD O
also RB RB O
be VB VB O
on IN IN O
an DT DT O
ACE-I NNP NNP O
or CC CC O
ARB NNP NNP O
. . . O
   
His PRP$ PRP$ O
history NN NN O
of IN IN O
hypertriglyceridemia NN NN O
was VBD VBD O
persistent JJ JJ O
, , , O
even RB RB O
in IN IN O
the DT DT O
setting VBG VBG O
of IN IN O
insulin NN NN O
for IN IN O
DM2 NNP NNP O
and CC CC O
improved VBN VBN O
glycemic JJ JJ O
control NN NN O
. . . O
   
He PRP PRP O
would MD MD O
also RB RB O
benefit VB VB O
from IN IN O
restarting VBG VBG O
a DT DT O
fibrate NN NN O
, , , O
such JJ JJ O
as IN IN O
Lopid NNP NNP O
. . . O
   
His PRP$ PRP$ O
DM2 NNP NNP O
is VBZ VBZ O
quite RB RB O
stable JJ JJ O
, , , O
as IN IN O
pt NN NN O
reports NNS NNS O
FS NNP NNP O
of IN IN O
100 CD CD O
to TO TO O
200 CD CD O
at IN IN O
home NN NN O
with IN IN O
his PRP$ PRP$ O
current JJ JJ O
insulin NN NN O
regimen NNS NNS O
. . . O
   
The DT DT O
wounds NNS NNS O
should MD MD O
be VB VB O
evaluated VBN VBN O
by IN IN O
his PRP$ PRP$ O
Surgical NNP NNP O
Team NNP NNP O
through IN IN O
his PRP$ PRP$ O
outpatient JJ JJ O
appointments NNS NNS O
. . . O
   
His PRP$ PRP$ O
last JJ JJ O
evaluation NN NN O
by IN IN O
General NNP NNP O
Surgery NNP NNP O
just RB RB O
2 CD CD O
days NNS NNS O
ago RB RB O
showed VBD VBD O
significant JJ JJ O
improvement NN NN O
, , , O
with IN IN O
recommendations NNS NNS O
of IN IN O
BID NNP NNP O
dressing VBG VBG O
changes NNS NNS O
as IN IN O
the DT DT O
pt NN NN O
is VBZ VBZ O
currently RB RB O
doing VBG VBG O
. . . O
   
RECOMMENDATIONS NNP NNP O
: : : O
   
1 CD CD O
. . . O
Continue NNP NNP O
Toprol NNP NNP O
XL NNP NNP O
100mg CD CD O
PO NNP NNP O
once RB RB O
daily JJ JJ O
   
2 CD CD O
. . . O
Continue NNP NNP O
NPH NNP NNP O
Insulin NNP NNP O
30 CD CD O
units NNS NNS O
with IN IN O
breakfast NN NN O
and CC CC O
10 CD CD O
units NNS NNS O
with IN IN O
dinner NN NN O
. . . O
   
If IN IN O
pt NN NN O
is VBZ VBZ O
NPO NNP NNP O
, , , O
or CC CC O
refusing VBG VBG O
to TO TO O
eat VB VB O
a DT DT O
meal NN NN O
, , , O
please VB VB O
give VB VB O
only RB RB O
one-half JJ JJ O
the DT DT O
dose NN NN O
   
3 CD CD O
. . . O
Continue NNP NNP O
his PRP$ PRP$ O
regular JJ JJ O
insulin NN NN O
sliding VBG VBG O
scale NN NN O
as IN IN O
outline NN NN O
in IN IN O
the DT DT O
Medication NNP NNP O
List NN NN O
with IN IN O
QAC NNP NNP O
and CC CC O
QHS NNP NNP O
fingerstick NN NN O
checks NNS NNS O
   
4 CD CD O
. . . O
No DT DT O
concentrated JJ JJ O
sweets NNS NNS O
diet JJ JJ O
   
5 CD CD O
. . . O
Start NNP NNP O
Lisinopril NNP NNP O
10mg CD CD O
PO NNP NNP O
once RB RB O
daily JJ JJ O
   
6 CD CD O
. . . O
Start NNP NNP O
Lopid NNP NNP O
600mg CD CD O
PO NNP NNP O
BID NNP NNP O
( ( ( O
30 CD CD O
minutes NNS NNS O
before IN IN O
breakfast NN NN O
and CC CC O
dinner NN NN O
) ) ) O
   
7 CD CD O
. . . O
Consider NNP NNP O
checking NN NN O
hemoglobin NN NN O
A1c NNP NNP O
and CC CC O
fasting VBG VBG O
lipid NN NN O
profile NN NN O
with IN IN O
reflex JJ JJ O
check NN NN O
of IN IN O
LDL NNP NNP O
for IN IN O
triglyceridemia NN NN O
   
8 CD CD O
. . . O
Dry NNP NNP O
sterile JJ JJ O
dressing VBG VBG O
changes NNS NNS O
to TO TO O
his PRP$ PRP$ O
scrotal NN NN O
and CC CC O
sacral JJ JJ O
wounds NNS NNS O
TID NNP NNP O
and CC CC O
PRN NNP NNP O
if IN IN O
dressing VBG VBG O
is VBZ VBZ O
soaked VBN VBN O
   
9 CD CD O
. . . O
Will NNP NNP O
defer VB VB O
antidepressive JJ JJ O
medication NN NN O
regimen NNS NNS O
to TO TO O
Psychiatry NNP NNP O
Service NNP NNP O
Case NN NN O
and CC CC O
plan NN NN O
discussed VBN VBN O
in IN IN O
detail NN NN O
with IN IN O
Medical NNP NNP O
Consult NNP NNP O
Attending NNP NNP O
, , , O
Dr NNP NNP O
. . . O
Hector NNP NNP I-DOCTOR
Bennett NNP NNP I-DOCTOR
. . . O
   
____________________________ NN NN O
_ NN NN O
Ulysses NNP NNP I-DOCTOR
Jurado NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
   
Pager NNP NNP O
#34621 NN NN O
MANAMANA NNP NNP I-HOSPITAL
Medical NNP NNP O
SAR NNP NNP O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2082-12-02 JJ JJ I-DATE
Quindarrius NNP NNP I-PATIENT
is VBZ VBZ O
a DT DT O
72 CD CD I-AGE
y/o NN NN O
male JJ JJ O
who WP WP O
c/o VBP VBP O
chills NNS NNS O
, , , O
hot JJ JJ O
flashes NNS NNS O
, , , O
night NN NN O
sweats NNS NNS O
; : : O
   
Better NNP NNP O
with IN IN O
ASA NNP NNP O
( ( ( O
?). NN NN O
   
x SYM SYM O
3-4 JJ JJ O
days NNS NNS O
. . . O
   
Pulm NNP NNP O
- : : O
No DT DT O
cough NN NN O
. . . O
   
No DT DT O
wheeze NN NN O
. . . O
   
Stable JJ JJ O
SOB NNP NNP O
. . . O
   
Cor NNP NNP O
- : : O
No DT DT O
chest NN NN O
pain NN NN O
. . . O
   
No DT DT O
palpitations NNS NNS O
. . . O
   
No DT DT O
lighthead NN NN O
. . . O
   
No DT DT O
PND NNP NNP O
. . . O
   
No DT DT O
orthopnea NN NN O
. . . O
   
No DT DT O
claudication NN NN O
. . . O
   
No DT DT O
edema NN NN O
. . . O
   
GI NN NN O
- : : O
nothing NN NN O
new JJ JJ O
. . . O
   
gassy NN NN O
. . . O
   
No DT DT O
nausea NN NN O
. . . O
   
No DT DT O
vomitting VBG VBG O
. . . O
   
No DT DT O
dyspepsia NN NN O
. . . O
   
No DT DT O
reflux NN NN O
. . . O
   
No DT DT O
abdo NN NN O
pain NN NN O
. . . O
   
No DT DT O
diarrhea NN NN O
. . . O
   
No DT DT O
constipation NN NN O
. . . O
   
No DT DT O
melena NN NN O
. . . O
   
No DT DT O
BRBPR NNP NNP O
. . . O
   
Neuro NNP NNP O
- : : O
with IN IN O
headache NN NN O
. . . O
   
No DT DT O
vision NN NN O
change NN NN O
. . . O
   
NO DT DT O
hearing NN NN O
change NN NN O
. . . O
   
No DT DT O
numbness NN NN O
. . . O
   
No DT DT O
tingling VBG VBG O
. . . O
   
No DT DT O
loss NN NN O
of IN IN O
strength NN NN O
. . . O
   
No DT DT O
seizures NNS NNS O
. . . O
   
No DT DT O
loss NN NN O
of IN IN O
balance NN NN O
. . . O
   
FBS NNP NNP O
- : : O
high JJ JJ O
100s CD CD O
NO DT DT O
bleeding VBG VBG O
. . . O
   
Feels VBZ VBZ O
weak JJ JJ O
. . . O
   
Medications NNP NNP O
Alprazolam NNP NNP O
0.5 CD CD O
MG NNP NNP O
(0.5MG NNP NNP O
TABLET NNP NNP O
Take NNP NNP O
1 CD CD O
) ) ) O
PO NNP NNP O
BID NNP NNP O
PRN NNP NNP O
#60 NN NN O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
Clindamycin NNP NNP O
1 CD CD O
% NN NN O
GEL NNP NNP O
1 CD CD O
APPLICATION NNP NNP O
TOP NNP NNP O
BID NNP NNP O
, , , O
Apply NNP NNP O
a DT DT O
thin JJ JJ O
film NN NN O
. . . O
   
#1 NN NN O
Month NN NN O
   
( ( ( O
s VBZ VBZ O
) ) ) O
Supply NNP NNP O
Derma-smoothe/fs NNP NNP O
( ( ( O
FLUOCINOLONE NNP NNP O
0.01 CD CD O
% NN NN O
IN IN IN O
OIL NNP NNP O
) ) ) O
1 CD CD O
APPLICATION NNP NNP O
( ( ( O
0.01 CD CD O
% NN NN O
OIL NNP NNP O
) ) ) O
TOP NNP NNP O
as IN IN O
directed VBN VBN O
, , , O
apply VB VB O
qhs NN NN O
wash NN NN O
off IN IN O
qam NN NN O
#1 NN NN O
Bottle NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
Furosemide NNP NNP O
20 CD CD O
MG NNP NNP O
( ( ( O
20MG CD CD O
TABLET NNP NNP O
Take NNP NNP O
1 CD CD O
) ) ) O
PO NNP NNP O
QD NNP NNP O
#90 NN NN O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
Lisinopril NNP NNP O
10 CD CD O
MG NNP NNP O
( ( ( O
10MG CD CD O
TABLET NNP NNP O
Take NNP NNP O
1 CD CD O
) ) ) O
PO NNP NNP O
QD NNP NNP O
#90 NN NN O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
Lopressor NNP NNP O
( ( ( O
METOPROLOL NNP NNP O
TARTRATE NNP NNP O
) ) ) O
50 CD CD O
MG NNP NNP O
( ( ( O
50MG CD CD O
TABLET NNP NNP O
Take NNP NNP O
1 CD CD O
) ) ) O
PO NNP NNP O
TID NNP NNP O
#270 NN NN O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
Metformin NNP NNP O
2000 CD CD O
MG NNP NNP O
( ( ( O
500MG CD CD O
TABLET NNP NNP O
Take NNP NNP O
4 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
) ) ) O
PO NNP NNP O
2 CD CD O
tabs NNS NNS O
BID NNP NNP O
, , , O
for IN IN O
blood NN NN O
sugar NN NN O
#120 NN NN O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
Simvastatin NNP NNP O
5 CD CD O
MG NNP NNP O
( ( ( O
5MG CD CD O
TABLET NNP NNP O
Take NNP NNP O
1 CD CD O
) ) ) O
PO NNP NNP O
QHS NNP NNP O
, , , O
3D/Week CD CD O
#45 NN NN O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
Warfarin NNP NNP O
SODIUM NNP NNP O
5 CD CD O
MG NNP NNP O
( ( ( O
5MG CD CD O
TABLET NNP NNP O
Take NNP NNP O
1 CD CD O
) ) ) O
PO NNP NNP O
QPM NNP NNP O
, , , O
Take NNP NNP O
along IN IN O
w NN NN O
/ NN NN O
one CD CD O
1mg CD CD O
tab NN NN O
for IN IN O
total NN NN O
of IN IN O
7 CD CD O
mg NN NN O
QD NNP NNP O
#60 NN NN O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
Warfarin NNP NNP O
SODIUM NNP NNP O
1MG CD CD O
TABLET NNP NNP O
PO NNP NNP O
QPM NNP NNP O
, , , O
Takes VBZ VBZ O
2=one CD CD O
tab NN NN O
along IN IN O
w NN NN O
/ NN NN O
5MG CD CD O
tab NN NN O
for IN IN O
total NN NN O
of IN IN O
6 CD CD O
mg NN NN O
daily JJ JJ O
. . . O
   
#135 NN NN O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
Problems NNS NNS O
Coronary JJ JJ O
artery NN NN O
disease NN NN O
: : : O
CABG NNP NNP O
x2 NN NN O
vessels NNS NNS O
, , , O
2/78 CD CD I-DATE
. . . O
   
Aortic NNP NNP O
stenosis NNS NNS O
: : : O
AVR NNP NNP O
2/78/Dr CD CD O
Bonilla NNP NNP I-DOCTOR
Diabetes NNP NNP O
mellitus NN NN O
: : : O
Dr NNP NNP O
Ayala-Skiff NNP NNP O
Atrial NNP NNP O
fibrillation NN NN O
Spinal NNP NNP O
stenosis NN NN O
: : : O
C3-4; NNP NNP O
   
C5-6; NNP NNP O
   
C7-T1 NNP NNP O
Allergies NNP NNP O
NKA NNP NNP O
Vital NNP NNP O
Signs NNP NNP O
BP NNP NNP O
108/62 CD CD O
, , , O
P NN NN O
93 CD CD O
, , , O
Temp NNP NNP O
98.2 CD CD O
F NN NN O
, , , O
Wt NNP NNP O
200 CD CD O
lb NN NN O
O2 NNP NNP O
SAT NNP NNP O
96 CD CD O
WD,WN,NAD NNP NNP O
Head NNP NNP O
- : : O
no DT DT O
tender NN NN O
M&amp NNP NNP O
; : : O
   
T NN NN O
- - - O
lips NNS NNS O
and CC CC O
gums NNS NNS O
unremarkable JJ JJ O
. . . O
   
Moist NNP NNP O
; : : O
   
no DT DT O
erythema NN NN O
; : : O
   
no DT DT O
exudate NN NN O
; : : O
   
no DT DT O
lesions NNS NNS O
Neck RB RB O
- : : O
reduced VBN VBN O
ROM-stable JJ JJ O
. . . O
   
No DT DT O
JVD NNP NNP O
. . . O
   
No DT DT O
bruit NN NN O
. . . O
   
No DT DT O
LAN NNP NNP O
. . . O
   
No DT DT O
thyromegaly NN NN O
Cor NNP NNP O
- : : O
irreg NN NN O
rhyhm NN NN O
. . . O
   
S1S2 NNP NNP O
normal JJ JJ O
. . . O
   
No DT DT O
gallop NN NN O
. . . O
   
No DT DT O
rub NN NN O
. . . O
   
NO DT DT O
murmer NN NN O
. . . O
   
Pulm NNP NNP O
- : : O
NO DT DT O
accessory JJ JJ O
muscle NN NN O
use NN NN O
. . . O
   
Percussion NNP NNP O
- - - O
normal JJ JJ O
. . . O
   
Palpation-normal NNP NNP O
. . . O
   
Auscultation-clear JJ JJ O
. . . O
   
Abdo NNP NNP O
- : : O
normal JJ JJ O
BS NNP NNP O
; : : O
   
soft JJ JJ O
with IN IN O
no DT DT O
HSM NNP NNP O
. . . O
   
No DT DT O
mass NN NN O
. . . O
   
No DT DT O
tenderness NN NN O
Ext NNP NNP O
- - - O
no DT DT O
edema NN NN O
. . . O
   
Results11/12/2082 NNP NNP O
[ NN NN O
1 CD CD O
] NN NN O
NA NNP NNP O
136 CD CD O
[ NN NN O
2 CD CD O
] NN NN O
, , , O
K NNP NNP O
4.6 CD CD O
, , , O
BUN NNP NNP O
19 CD CD O
, , , O
CRE NNP NNP O
0.8 CD CD O
, , , O
EGFR NNP NNP O
101.0 CD CD O
[ NN NN O
3 CD CD O
] NN NN O
, , , O
GLU NNP NNP O
112 CD CD O
(H)[1] NN NN O
SPECIMEN NNP NNP O
COMMENT NNP NNP O
: : : O
Unless IN IN O
otherwise RB RB O
noted VBD VBD O
, , , O
Test NNP NNP O
performed VBD VBD O
at IN IN O
Saline NNP NNP I-HOSPITAL
Community NNP NNP I-HOSPITAL
Hospital NNP NNP I-HOSPITAL
, , , O
05 CD CD I-STREET
Pluto NNP NNP I-STREET
Street NNP NNP I-STREET
, , , O
Oconto NNP NNP I-CITY
Falls NNP NNP I-CITY
, , , O
ME PRP PRP I-STATE
25677 CD CD I-ZIP
, , , O
Christopher NNP NNP I-DOCTOR
Leslie NNP NNP I-DOCTOR
, , , O
MD NNP NNP O
, , , O
PHD NNP NNP O
, , , O
Laboratory NNP NNP O
Medical NNP NNP O
DirectorCBC NNP NNP O
SENT NNP NNP O
TO TO TO O
HRMC[2] NNP NNP O
RESULT NNP NNP O
COMMENT NNP NNP O
: : : O
RV=REPEATED NNP NNP O
AND CC CC O
VERIFIED[3] NNP NNP O
RESULT NNP NNP O
COMMENT NNP NNP O
: : : O
( ( ( O
Abnormal NNP NNP O
if IN IN O
& CC CC O
lt NN NN O
; : : O
   
60 CD CD O
mL/min/1.73m2 NN NN O
If IN IN O
patient NN NN O
is VBZ VBZ O
black JJ JJ O
multiply NN NN O
by IN IN O
1.21)11/12/2082 CD CD O
[ NN NN O
1 CD CD O
] NN NN O
ALT/SGPT NNP NNP O
26 CD CD O
, , , O
AST/SGOT NNP NNP O
19[1 CD CD O
] NN NN O
SPECIMEN NNP NNP O
COMMENT NNP NNP O
: : : O
Unless IN IN O
otherwise RB RB O
noted VBD VBD O
, , , O
Test NNP NNP O
performed VBD VBD O
at IN IN O
Saline NNP NNP I-HOSPITAL
Community NNP NNP I-HOSPITAL
Hospital NNP NNP I-HOSPITAL
, , , O
46 CD CD I-STREET
Pluto NNP NNP I-STREET
Street NNP NNP I-STREET
, , , O
Oconto NNP NNP I-CITY
Falls NNP NNP I-CITY
, , , O
ME PRP PRP I-STATE
25677 CD CD I-ZIP
, , , O
Christopher NNP NNP I-DOCTOR
Leslie NNP NNP I-DOCTOR
, , , O
MD NNP NNP O
, , , O
PHD NNP NNP O
, , , O
Laboratory NNP NNP O
Medical NNP NNP O
DirectorCBC NNP NNP O
SENT NNP NNP O
TO TO TO O
HRMC11/12/2082 NNP NNP O
[ NN NN O
1 CD CD O
] NN NN O
CK NNP NNP O
78[1 CD CD O
] NN NN O
SPECIMEN NNP NNP O
COMMENT NNP NNP O
: : : O
Unless IN IN O
otherwise RB RB O
noted VBD VBD O
, , , O
Test NNP NNP O
performed VBD VBD O
at IN IN O
Saline NNP NNP I-HOSPITAL
Community NNP NNP I-HOSPITAL
Hospital NNP NNP I-HOSPITAL
, , , O
70 CD CD I-STREET
Pluto NNP NNP I-STREET
Street NNP NNP I-STREET
, , , O
Oconto NNP NNP I-CITY
Falls NNP NNP I-CITY
, , , O
ME PRP PRP I-STATE
25677 CD CD I-ZIP
, , , O
Christopher NNP NNP I-DOCTOR
Leslie NNP NNP I-DOCTOR
, , , O
MD NNP NNP O
, , , O
PHD NNP NNP O
, , , O
Laboratory NNP NNP O
Medical NNP NNP O
DirectorCBC NNP NNP O
SENT NNP NNP O
TO TO TO O
HRMC11/12/2082 NNP NNP O
[ NN NN O
1 CD CD O
] NN NN O
CHOL NNP NNP O
133 CD CD O
( ( ( O
L NNP NNP O
) ) ) O
[ NN NN O
2 CD CD O
] NN NN O
, , , O
TRIG NNP NNP O
161 CD CD O
, , , O
HDL NNP NNP O
48 CD CD O
, , , O
LDLCAL NNP NNP O
52.8 CD CD O
, , , O
VLDL NNP NNP O
32 CD CD O
, , , O
CHOL/HDL NNP NNP O
2.8[1 CD CD O
] NN NN O
SPECIMEN NNP NNP O
COMMENT NNP NNP O
: : : O
Unless IN IN O
otherwise RB RB O
noted VBD VBD O
, , , O
Test NNP NNP O
performed VBD VBD O
at IN IN O
Saline NNP NNP I-HOSPITAL
Community NNP NNP I-HOSPITAL
Hospital NNP NNP I-HOSPITAL
, , , O
75 CD CD I-STREET
Pluto NNP NNP I-STREET
Street NNP NNP I-STREET
, , , O
Oconto NNP NNP I-CITY
Falls NNP NNP I-CITY
, , , O
ME PRP PRP I-STATE
25677 CD CD I-ZIP
, , , O
Christopher NNP NNP I-DOCTOR
Leslie NNP NNP I-DOCTOR
, , , O
MD NNP NNP O
, , , O
PHD NNP NNP O
, , , O
Laboratory NNP NNP O
Medical NNP NNP O
DirectorCBC NNP NNP O
SENT NNP NNP O
TO TO TO O
HRMC[2] NNP NNP O
RESULT NNP NNP O
COMMENT NNP NNP O
: : : O
RV=REPEATED NNP NNP O
AND CC CC O
VERIFIED11/12/2082 NNP NNP O
WBC NNP NNP O
7.43 CD CD O
, , , O
RBC NNP NNP O
4.32 CD CD O
(*#), NN NN O
HGB NNP NNP O
12.9 CD CD O
(*#), NN NN O
HCT NNP NNP O
38.1 CD CD O
(*#), NN NN O
MCV NNP NNP O
88.2 CD CD O
, , , O
MCH NNP NNP O
29.8 CD CD O
, , , O
MCHC NNP NNP O
33.8 CD CD O
, , , O
PLT NNP NNP O
208 CD CD O
(#)11/12/2082 NN NN O
RDW NNP NNP O
13.4 CD CD O
ASS NNP NNP O
; : : O
   
Anxiety NNP NNP O
? . . O
   
Anemia NNP NNP O
P NN NN O
- : : O
Take NNP NNP O
alprazolam NN NN O
BID NNP NNP O
. . . O
   
CBC,Fe/IBC NNP NNP O
, , , O
B NNP NNP O
12 CD CD O
, , , O
Folate,HgB NNP NNP O
A1C,UA NNP NNP O
. . . O
   
f/u NN NN O
1 CD CD O
mon NNP NNP O
Skiff NNP NNP I-HOSPITAL
12/03 CD CD I-DATE
. . . O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2079-04-08 JJ JJ I-DATE
OFFICE NNP NNP O
NOTE VB VB O
Perla NNP NNP I-PATIENT
Esposito NNP NNP I-PATIENT
MRN:146-55-23-5 NNP NNP O
4/08/79 CD CD I-DATE
Follow-up NNP NNP O
visit NN NN O
for IN IN O
this DT DT O
77-year-old JJ JJ O
Chilean JJ JJ I-COUNTRY
woman NN NN O
. . . O
   
She PRP PRP O
comes VBZ VBZ O
today NN NN O
bothered VBN VBN O
by IN IN O
right-sided JJ JJ O
shoulder NN NN O
pain NN NN O
. . . O
   
On IN IN O
a DT DT O
previous JJ JJ O
visit NN NN O
she PRP PRP O
had VBD VBD O
complained VBN VBN O
of IN IN O
this DT DT O
and CC CC O
I PRP PRP O
wanted VBD VBD O
to TO TO O
put VB VB O
her PRP PRP O
on IN IN O
Motrin NNP NNP O
but CC CC O
she PRP PRP O
wanted VBD VBD O
to TO TO O
try VB VB O
Tylenol NNP NNP O
. . . O
   
The DT DT O
pain NN NN O
bothers NNS NNS O
her PRP$ PRP$ O
sometimes RB RB O
at IN IN O
night NN NN O
and CC CC O
is VBZ VBZ O
throbbing VBG VBG O
. . . O
   
It PRP PRP O
bothers NNS NNS O
her PRP$ PRP$ O
when WRB WRB O
she PRP PRP O
tries VBZ VBZ O
to TO TO O
attach VB VB O
her PRP$ PRP$ O
bra NN NN O
behind IN IN O
her PRP$ PRP$ O
back RB RB O
. . . O
   
Other JJ JJ O
than IN IN O
that DT DT O
she PRP PRP O
has VBZ VBZ O
been VBN VBN O
doing VBG VBG O
fairly RB RB O
well RB RB O
. . . O
   
She PRP PRP O
has VBZ VBZ O
not RB RB O
had VBN VBN O
any DT DT O
chest NN NN O
pains NNS NNS O
. . . O
   
She PRP PRP O
has VBZ VBZ O
not RB RB O
had VBN VBN O
any DT DT O
symptoms NNS NNS O
of IN IN O
TIAs NNP NNP O
. . . O
   
She PRP PRP O
has VBZ VBZ O
a DT DT O
lot NN NN O
of IN IN O
concern NN NN O
about IN IN O
her PRP$ PRP$ O
chronic JJ JJ O
renal JJ JJ O
insufficiency NN NN O
and CC CC O
wants VBZ VBZ O
to TO TO O
discuss VB VB O
this DT DT O
. . . O
   
Medications NNP NNP O
: : : O
Lopressor NNP NNP O
. . . O
   
Hydochlorothiazide NNP NNP O
. . . O
   
Procardia NNP NNP O
XL NNP NNP O
. . . O
   
Micronase NNP NNP O
. . . O
   
Motrin NNP NNP O
. . . O
   
Aspirin NNP NNP O
. . . O
   
Allergies NNP NNP O
: : : O
Lisinopril NNP NNP O
causes NNS NNS O
hypokelemia NN NN O
. . . O
   
Family NNP NNP O
History NN NN O
: : : O
Non-contributory NNP NNP O
. . . O
   
Social NNP NNP O
History NN NN O
: : : O
She PRP PRP O
has VBZ VBZ O
a DT DT O
daughter NN NN O
, , , O
Rhodes NNP NNP I-PATIENT
, , , O
who WP WP O
has VBZ VBZ O
been VBN VBN O
very RB RB O
supportive JJ JJ O
. . . O
   
No DT DT O
cigarettes NNS NNS O
or CC CC O
alcohol NN NN O
. . . O
   
Review NNP NNP O
of IN IN O
Systems NNPS NNPS O
: : : O
She PRP PRP O
refuses VBZ VBZ O
general JJ JJ O
GYN NNP NNP O
screening VBG VBG O
. . . O
   
She PRP PRP O
had VBD VBD O
a DT DT O
hemoglobin NN NN O
A1C NNP NNP O
in IN IN O
March NNP NNP I-DATE
, , , O
which WDT WDT O
was VBD VBD O
6.4 CD CD O
. . . O
   
She PRP PRP O
had VBD VBD O
an DT DT O
ophthalmology NN NN O
exam NN NN O
in IN IN O
September NNP NNP I-DATE
. . . O
   
Physical JJ JJ O
Examination NNP NNP O
: : : O
Worried NNP NNP O
. . . O
   
Weight NNP NNP O
131 CD CD O
lb NN NN O
. . . O
   
Blood NNP NNP O
pressure NN NN O
142/60 CD CD O
. . . O
   
Pulse NNP NNP O
is VBZ VBZ O
   
72 CD CD O
. . . O
Skin NNP NNP O
exam NN NN O
unremarkable JJ JJ O
. . . O
   
HEENT NNP NNP O
: : : O
EOMI NNP NNP O
. . . O
   
No DT DT O
scleral NN NN O
icterus NN NN O
. . . O
   
No DT DT O
lymphadenopathy NN NN O
. . . O
   
No DT DT O
thyromegaly NN NN O
. . . O
   
I PRP PRP O
cannot NN NN O
hear VB VB O
any DT DT O
carotid NN NN O
bruits NNS NNS O
. . . O
   
Lungs NNS NNS O
are VBP VBP O
clear JJ JJ O
. . . O
   
No DT DT O
murmurs NNS NNS O
. . . O
   
No DT DT O
gallops NNS NNS O
. . . O
   
Benign NNP NNP O
abdomen NN NN O
. . . O
   
No DT DT O
hepatomegaly NN NN O
. . . O
   
No DT DT O
splenomegaly NN NN O
. . . O
   
No DT DT O
pedal NN NN O
edema NN NN O
. . . O
   
Examination NNP NNP O
of IN IN O
the DT DT O
right NN NN O
shoulder NN NN O
shows VBZ VBZ O
that IN IN O
she PRP PRP O
has VBZ VBZ O
tenderness NNS NNS O
on IN IN O
abduction NN NN O
beyond IN IN O
110 CD CD O
but CC CC O
her PRP$ PRP$ O
most RBS RBS O
marked VBN VBN O
tenderness NN NN O
is VBZ VBZ O
with IN IN O
her PRP$ PRP$ O
internal JJ JJ O
rotation NN NN O
and CC CC O
she PRP PRP O
is VBZ VBZ O
unable JJ JJ O
to TO TO O
do VB VB O
this DT DT O
further JJ JJ O
than IN IN O
L5 NNP NNP O
. . . O
   
Procedure NNP NNP O
: : : O
The DT DT O
right NN NN O
subdeltoid NN NN O
bursa NN NN O
was VBD VBD O
prepped VBN VBN O
with IN IN O
Betadine NNP NNP O
. . . O
   
The DT DT O
skin NN NN O
was VBD VBD O
infiltrated VBN VBN O
with IN IN O
1 CD CD O
% NN NN O
Xylocaine NNP NNP O
in IN IN O
a DT DT O
27 CD CD O
gauge NN NN O
needle NN NN O
. . . O
   
The DT DT O
subdeltoid NN NN O
bursa NN NN O
itself PRP PRP O
was VBD VBD O
entered VBN VBN O
with IN IN O
a DT DT O
21 CD CD O
gauge NN NN O
needle NN NN O
and CC CC O
a DT DT O
mixture NN NN O
of IN IN O
1cc CD CD O
of IN IN O
1 CD CD O
% NN NN O
Xylocaine NNP NNP O
and CC CC O
40mg CD CD O
of IN IN O
Depo-Medrol NNP NNP O
was VBD VBD O
injected VBN VBN O
. . . O
   
She PRP PRP O
tolerated VBD VBD O
the DT DT O
procedure NN NN O
well RB RB O
. . . O
   
Perla NNP NNP I-PATIENT
Esposito NNP NNP I-PATIENT
MRN:146-55-23-5 NNP NNP O
4/08/79 CD CD I-DATE
Page NNP NNP O
2 CD CD O
   
1 CD CD O
. . . O
Rotator NNP NNP O
Cuff NNP NNP O
Tendonitis NNP NNP O
. . . O
   
She PRP PRP O
received VBD VBD O
an DT DT O
injection NN NN O
as IN IN O
above IN IN O
. . . O
   
2 CD CD O
. . . O
CAD NNP NNP O
. . . O
   
Doing VBG VBG O
well RB RB O
without IN IN O
symptoms NNS NNS O
. . . O
   
3 CD CD O
. . . O
Hypertension NNP NNP O
. . . O
   
Good JJ JJ O
control NN NN O
. . . O
   
4 CD CD O
. . . O
Elevated NNP NNP O
Cholesterol NNP NNP O
. . . O
   
Her PRP$ PRP$ O
cholesterol NN NN O
has VBZ VBZ O
been VBN VBN O
better JJR JJR O
controlled VBN VBN O
. . . O
   
5 CD CD O
. . . O
Cerebral NNP NNP O
Vascular NNP NNP O
Disease NNP NNP O
. . . O
   
She PRP PRP O
is VBZ VBZ O
doing VBG VBG O
well RB RB O
after IN IN O
her PRP$ PRP$ O
andardirectomy NN NN O
. . . O
   
She PRP PRP O
has VBZ VBZ O
a DT DT O
mild JJ JJ O
facial JJ JJ O
droop NN NN O
otherwise RB RB O
no DT DT O
clear JJ JJ O
evidence NN NN O
of IN IN O
stroke NN NN O
. . . O
   
6 CD CD O
. . . O
Diabetes NNP NNP O
. . . O
   
She PRP PRP O
has VBZ VBZ O
excellent JJ JJ O
hemoglobin NN NN O
A1C NNP NNP O
and CC CC O
has VBZ VBZ O
had VBN VBN O
recent JJ JJ O
ophthalmology NN NN O
exam NN NN O
. . . O
   
Ulises NNP NNP I-DOCTOR
J. NN NN I-DOCTOR
Kelley NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
   
UJ NNP NNP I-DOCTOR
: : : O
kuhn NN NN I-DOCTOR
******** NN NN O
Not RB RB O
reviewed VBN VBN O
by IN IN O
Attending NNP NNP O
Physician NNP NNP O
******** NN NN O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2079-05-25 JJ JJ I-DATE
Cocke NNP NNP I-HOSPITAL
County NNP NNP I-HOSPITAL
Baptist NNP NNP I-HOSPITAL
Hospital NNP NNP I-HOSPITAL
1666 CD CD I-STREET
Keats NNP NNP I-STREET
Street NNP NNP I-STREET
GLENN NNP NNP O
, , , O
OLIVIA NNP NNP I-PATIENT
Whitewater NNP NNP I-CITY
, , , O
NC NNP NNP I-STATE
13662 CD CD I-ZIP
10776605 CD CD I-MEDICALRECORD
( ( ( O
545 CD CD O
) ) ) O
266-9272 NN NN I-PHONE
05/25/79 CD CD I-DATE
The DT DT O
patient NN NN O
returns NNS NNS O
for IN IN O
a DT DT O
follow VB VB O
up RP RP O
visit NN NN O
on IN IN O
her PRP$ PRP$ O
diabetes NNS NNS O
mellitus JJ JJ O
and CC CC O
chronic JJ JJ O
renal JJ JJ O
failure NN NN O
. . . O
   
She PRP PRP O
is VBZ VBZ O
regularly RB RB O
being VBG VBG O
followed VBN VBN O
by IN IN O
Dr NNP NNP O
. . . O
Jarvis NNP NNP I-DOCTOR
, , , O
Nephrologist NNP NNP O
at IN IN O
Salvation NNP NNP I-HOSPITAL
Army NNP NNP I-HOSPITAL
Hospital NNP NNP I-HOSPITAL
, , , O
was VBD VBD O
seen VBN VBN O
there RB RB O
about IN IN O
two CD CD O
months NNS NNS O
ago RB RB O
and CC CC O
will MD MD O
return VB VB O
there RB RB O
in IN IN O
June NNP NNP I-DATE
. . . O
   
She PRP PRP O
is VBZ VBZ O
also RB RB O
treated VBN VBN O
for IN IN O
her PRP$ PRP$ O
chronic JJ JJ O
anemia NN NN O
with IN IN O
darbopoetin NN NN O
. . . O
   
The DT DT O
patient NN NN O
recently RB RB O
has VBZ VBZ O
noticed VBN VBN O
that IN IN O
her PRP$ PRP$ O
blood NN NN O
sugars NNS NNS O
have VBP VBP O
decreased VBN VBN O
progressively RB RB O
, , , O
and CC CC O
she PRP PRP O
has VBZ VBZ O
had VBN VBN O
several JJ JJ O
episodes NNS NNS O
of IN IN O
near IN IN O
hypoglycemia NN NN O
. . . O
   
Blood NNP NNP O
sugars NNS NNS O
are VBP VBP O
often RB RB O
60 CD CD O
or CC CC O
less JJR JJR O
. . . O
   
The DT DT O
patient NN NN O
also RB RB O
complains NNS NNS O
of IN IN O
pain NN NN O
in IN IN O
her PRP$ PRP$ O
right NN NN O
middle NN NN O
finger NN NN O
and CC CC O
right JJ JJ O
shoulder NN NN O
pain NN NN O
. . . O
   
Physical JJ JJ O
examination NN NN O
reveals VBZ VBZ O
an DT DT O
elderly JJ JJ O
female JJ JJ O
in IN IN O
no DT DT O
acute JJ JJ O
distress NN NN O
. . . O
   
Blood NNP NNP O
pressure NN NN O
is VBZ VBZ O
142/60 CD CD O
, , , O
weight NN NN O
is VBZ VBZ O
176 CD CD O
pounds NNS NNS O
, , , O
and CC CC O
pulse NN NN O
is VBZ VBZ O
   
96 CD CD O
. . . O
Glucose NNP NNP O
done VBN VBN O
in IN IN O
the DT DT O
exam NN NN O
room NN NN O
today NN NN O
was VBD VBD O
110 CD CD O
. . . O
   
Chest NN NN O
is VBZ VBZ O
clear JJ JJ O
bilaterally RB RB O
. . . O
   
Heart NNP NNP O
: : : O
Regular NNP NNP O
rate NN NN O
and CC CC O
rhythm NN NN O
, , , O
positive JJ JJ O
S1 NNP NNP O
, , , O
S2 NNP NNP O
, , , O
negative JJ JJ O
S3 NNP NNP O
, , , O
S4 NNP NNP O
, , , O
and CC CC O
no DT DT O
murmur NN NN O
. . . O
   
Abdomen NNP NNP O
is VBZ VBZ O
soft JJ JJ O
, , , O
nontender NN NN O
, , , O
and CC CC O
positive JJ JJ O
bowel NN NN O
sounds VBZ VBZ O
. . . O
   
Lower JJR JJR O
extremities NNS NNS O
: : : O
No DT DT O
edema NN NN O
and CC CC O
nontender NN NN O
. . . O
   
Right RB RB O
hand NN NN O
tenderness NN NN O
in IN IN O
the DT DT O
first JJ JJ O
metacarpophalangeal NN NN O
joint NN NN O
and CC CC O
the DT DT O
overlying VBG VBG O
tendon NN NN O
and CC CC O
also RB RB O
tenderness VB VB O
diffusely RB RB O
in IN IN O
the DT DT O
right JJ JJ O
shoulder NN NN O
pain NN NN O
with IN IN O
grossly RB RB O
normal JJ JJ O
range NN NN O
of IN IN O
motion NN NN O
. . . O
   
IMPRESSION NNP NNP O
AND CC CC O
PLAN NNP NNP O
: : : O
   
1 CD CD O
. . . O
Diabetes NNP NNP O
mellitus NN NN O
. . . O
   
The DT DT O
patient NN NN O
's POS POS O
blood NN NN O
sugars NNS NNS O
have VBP VBP O
been VBN VBN O
dropping VBG VBG O
. . . O
   
The DT DT O
patient NN NN O
has VBZ VBZ O
decreased VBN VBN O
her PRP$ PRP$ O
glipizide NN NN O
already RB RB O
from IN IN O
20 CD CD O
mg NN NN O
daily JJ JJ O
to TO TO O
10 CD CD O
mg NN NN O
daily JJ JJ O
. . . O
   
I PRP PRP O
will MD MD O
further RB RB O
decrease VB VB O
it PRP PRP O
to TO TO O
5 CD CD O
mg NN NN O
daily JJ JJ O
. . . O
   
Check NNP NNP O
hemoglobin NN NN O
A1c NNP NNP O
today NN NN O
as RB RB O
well RB RB O
as IN IN O
ALT NNP NNP O
, , , O
AST NNP NNP O
, , , O
and CC CC O
creatinine NN NN O
. . . O
   
2 CD CD O
. . . O
Chronic NNP NNP O
renal JJ JJ O
failure NN NN O
. . . O
   
The DT DT O
patient NN NN O
's POS POS O
creatinine NN NN O
clearance NN NN O
is VBZ VBZ O
about IN IN O
15-17 JJ JJ O
, , , O
and CC CC O
the DT DT O
patient NN NN O
is VBZ VBZ O
approaching VBG VBG O
end-stage JJ JJ O
renal JJ JJ O
failure NN NN O
. . . O
   
She PRP PRP O
is VBZ VBZ O
being VBG VBG O
followed VBN VBN O
by IN IN O
the DT DT O
Renal NNP NNP O
Department NNP NNP O
at IN IN O
Salvation NNP NNP I-HOSPITAL
Army NNP NNP I-HOSPITAL
Hospital NNP NNP I-HOSPITAL
, , , O
and CC CC O
dialysis NN NN O
is VBZ VBZ O
being VBG VBG O
considered VBN VBN O
for IN IN O
the DT DT O
midterm NN NN O
management NN NN O
of IN IN O
the DT DT O
patient NN NN O
. . . O
   
3 CD CD O
. . . O
Tendonitis NNP NNP O
, , , O
right NN NN O
middle NN NN O
finger NN NN O
. . . O
   
After IN IN O
the DT DT O
patient NN NN O
's POS POS O
informed VBD VBD O
consent NN NN O
was VBD VBD O
obtained VBN VBN O
, , , O
the DT DT O
area NN NN O
was VBD VBD O
prepared VBN VBN O
in IN IN O
the DT DT O
usual JJ JJ O
sterile JJ JJ O
fashion NN NN O
, , , O
and CC CC O
1 CD CD O
% NN NN O
lidocaine NN NN O
along IN IN O
with IN IN O
0.2 CD CD O
cc NN NN O
of IN IN O
Depo-Medrol NNP NNP O
was VBD VBD O
injected VBN VBN O
in IN IN O
the DT DT O
area NN NN O
of IN IN O
the DT DT O
flexor NN NN O
POLLICIS NNP NNP O
longus NN NN O
tendon NN NN O
sheath NN NN O
. . . O
   
The DT DT O
patient NN NN O
tolerated VBD VBD O
the DT DT O
procedure NN NN O
well RB RB O
. . . O
   
4 CD CD O
. . . O
Anemia NNP NNP O
. . . O
   
This DT DT O
is VBZ VBZ O
obviously RB RB O
due JJ JJ O
to TO TO O
the DT DT O
patient NN NN O
's POS POS O
chronic JJ JJ O
renal JJ JJ O
disease NN NN O
. . . O
   
She PRP PRP O
has VBZ VBZ O
been VBN VBN O
receiving VBG VBG O
darbepoetin NN NN O
injections NNS NNS O
, , , O
initially RB RB O
weekly JJ JJ O
, , , O
then RB RB O
every DT DT O
other JJ JJ O
week NN NN O
, , , O
and CC CC O
now RB RB O
every DT DT O
three CD CD O
weeks NNS NNS O
. . . O
   
We PRP PRP O
will MD MD O
check VB VB O
CBC NNP NNP O
today NN NN O
. . . O
   
5 CD CD O
. . . O
Right RB RB O
shoulder NN NN O
pain NN NN O
. . . O
   
The DT DT O
patient NN NN O
cannot NN NN O
take NN NN O
nonsteroidals NNS NNS O
due JJ JJ O
to TO TO O
her PRP$ PRP$ O
renal JJ JJ O
problem NN NN O
, , , O
so IN IN O
I PRP PRP O
have VBP VBP O
given VBN VBN O
her PRP$ PRP$ O
a DT DT O
prescription NN NN O
for IN IN O
Tylenol NNP NNP O
with IN IN O
Codeine NNP NNP O
, , , O
of IN IN O
which WDT WDT O
she PRP PRP O
may MD MD O
take VB VB O
one CD CD O
or CC CC O
one-half JJ JJ O
tablet NN NN O
as IN IN O
needed VBN VBN O
to TO TO O
control VB VB O
the DT DT O
pain NN NN O
. . . O
   
6 CD CD O
. . . O
Regular NNP NNP O
healthcare NN NN O
maintenance NN NN O
. . . O
   
The DT DT O
patient NN NN O
will MD MD O
follow VB VB O
up RP RP O
with IN IN O
me PRP PRP O
in IN IN O
about IN IN O
two CD CD O
months NNS NNS O
. . . O
   
_____________________________ NN NN O
_ NN NN O
Infant NNP NNP I-DOCTOR
Brewer NNP NNP I-DOCTOR
, , , O
MD NNP NNP O
Dictated NNP NNP O
By IN IN O
: : : O
Infant NNP NNP I-DOCTOR
Brewer NNP NNP I-DOCTOR
eScription NN NN O
document:2-5091452 JJ JJ O
EMSSten NNP NNP O
Tel NNP NNP O
DD NNP NNP O
: : : O
05/25/79 CD CD I-DATE
DT NNP NNP O
: : : O
05/26/79 CD CD I-DATE
DV NNP NNP O
: : : O
05/25/79 CD CD I-DATE
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2062-06-10 NN NN I-DATE
Medical JJ JJ O
Walk NNP NNP O
In IN IN O
Unit NNP NNP O
Hartsville NNP NNP I-HOSPITAL
General NNP NNP I-HOSPITAL
Hospital NNP NNP I-HOSPITAL
21 CD CD I-STREET
Brook NNP NNP I-STREET
St NNP NNP I-STREET
Pataskala NNP NNP I-CITY
, , , O
RI NNP NNP I-STATE
33689 CD CD I-ZIP
Phone NNP NNP O
: : : O
929-462-2794 NN NN I-PHONE
Fax NNP NNP O
: : : O
648-875-5821 NN NN I-FAX
PCP NNP NNP O
: : : O
Nursing NNP NNP O
Assessment NNP NNP O
: : : O
WT NNP NNP O
: : : O
Temp NNP NNP O
: : : O
P NN NN O
: : : O
100 CD CD O
BP NNP NNP O
: : : O
190/116 CD CD O
Reason NNP NNP O
for IN IN O
visit NN NN O
: : : O
Pt NNP NNP O
just RB RB O
left VBD VBD O
the DT DT O
EW NNP NNP O
. . . O
   
Noted NNP NNP O
HTN NNP NNP O
has VBZ VBZ O
been VBN VBN O
off RP RP O
meds NNS NNS O
for IN IN O
a DT DT O
while NN NN O
. . . O
   
Was VBD VBD O
nor CC CC O
given VBN VBN O
any DT DT O
meds NNS NNS O
Lab NNP NNP O
Data NNP NNP O
: : : O
Allergies NNP NNP O
: : : O
Medication NNP NNP O
: : : O
off RP RP O
meds NNS NNS O
for IN IN O
more JJR JJR O
than IN IN O
3 CD CD O
months NNS NNS O
History NN NN O
of IN IN O
the DT DT O
Present NNP NNP O
Illness NNP NNP O
: : : O
59 CD CD I-AGE
y/o NN NN O
female JJ JJ O
here RB RB O
for IN IN O
high JJ JJ O
blood NN NN O
pressure NN NN O
. . . O
   
Pt NNP NNP O
was VBD VBD O
seen VBN VBN O
in IN IN O
EW NNP NNP O
for IN IN O
medications NNS NNS O
and CC CC O
was VBD VBD O
given VBN VBN O
Seroquel NNP NNP O
, , , O
Neurontin NNP NNP O
, , , O
and CC CC O
amytriptyline NN NN O
. . . O
   
Pt NNP NNP O
has VBZ VBZ O
been VBN VBN O
out IN IN O
of IN IN O
meds NNS NNS O
for IN IN O
more JJR JJR O
than IN IN O
3 CD CD O
months NNS NNS O
. . . O
   
Pt NNP NNP O
remembers NNS NNS O
being VBG VBG O
atenolol NN NN O
and CC CC O
HCTZ NNP NNP O
. . . O
   
Pt NNP NNP O
plans VBZ VBZ O
to TO TO O
come VB VB O
to TO TO O
the DT DT O
medical JJ JJ O
walk-in JJ JJ O
tomorrow NN NN O
with IN IN O
all DT DT O
her PRP$ PRP$ O
medications NNS NNS O
. . . O
   
Pt NNP NNP O
denies VBZ VBZ O
HA NNP NNP O
, , , O
visual JJ JJ O
problems NNS NNS O
, , , O
chest NN NN O
pain NN NN O
, , , O
problems NNS NNS O
with IN IN O
urination NN NN O
. . . O
   
Father NNP NNP O
had VBD VBD O
CAD NNP NNP O
and CC CC O
died VBD VBD O
at IN IN O
age NN NN O
   
55 CD CD I-AGE
. . . O
Mother NNP NNP O
died VBD VBD O
when WRB WRB O
she PRP PRP O
was VBD VBD O
89 CD CD I-AGE
( ( ( O
10 CD CD O
months NNS NNS O
ago RB RB O
) ) ) O
. . . O
   
Pt NNP NNP O
never RB RB O
had VBD VBD O
a DT DT O
heart NN NN O
attack NN NN O
. . . O
   
Pt NNP NNP O
never RB RB O
smoked VBD VBD O
. . . O
   
Pertinent NNP NNP O
PMH NNP NNP O
: : : O
diabetes NNS NNS O
HTN NNP NNP O
mood NN NN O
disorder NN NN O
Physical JJ JJ O
Exam NNP NNP O
: : : O
Gen NNP NNP O
: : : O
NAD NNP NNP O
Vitals NNP NNP O
: : : O
HR NNP NNP O
100 CD CD O
, , , O
BP NNP NNP O
200/130 CD CD O
on IN IN O
right NN NN O
arm NN NN O
Heart NNP NNP O
: : : O
reg NN NN O
, , , O
no DT DT O
murmur NN NN O
Lungs NNP NNP O
: : : O
CTAB NNP NNP O
Assessment/Plan NNP NNP O
: : : O
high JJ JJ O
blood NN NN O
pressure NN NN O
-- : : O
metoprolol NN NN O
50 CD CD O
po NN NN O
now RB RB O
and CC CC O
then RB RB O
bid NN NN O
-- : : O
lisinopril NN NN O
10 CD CD O
po NN NN O
now RB RB O
and CC CC O
then RB RB O
qd NN NN O
-- : : O
follow-up JJ JJ O
in IN IN O
the DT DT O
EW NNP NNP O
now RB RB O
to TO TO O
make VB VB O
sure JJ JJ O
BP NNP NNP O
is VBZ VBZ O
lower JJR JJR O
before IN IN O
discharge NN NN O
Follow-up NNP NNP O
: : : O
to TO TO O
EW NNP NNP O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2083-08-24 JJ JJ I-DATE
Fellow/NP NNP NNP O
None NN NN O
Reason NNP NNP O
for IN IN O
Visit NNP NNP O
: : : O
moderately RB RB O
to TO TO O
poorly RB RB O
differentiated VBN VBN O
adenocarcinoma NN NN O
of IN IN O
the DT DT O
esophagus NN NN O
. . . O
   
Stage NN NN O
IVB NNP NNP O
Diagnosis/Treatment NNP NNP O
Summary NNP NNP O
: : : O
Stage NN NN O
IVB NNP NNP O
( ( ( O
axillary JJ JJ O
and CC CC O
retroperitoneal NN NN O
LN NNP NNP O
and CC CC O
very RB RB O
large JJ JJ O
celiac NN NN O
axis NNS NNS O
LN NNP NNP O
mass NN NN O
) ) ) O
History NN NN O
: : : O
Patient NNP NNP O
is VBZ VBZ O
a DT DT O
72 CD CD I-AGE
year NN NN O
old JJ JJ O
man NN NN O
who WP WP O
began VBD VBD O
having VBG VBG O
dysphagia NN NN O
about IN IN O
4 CD CD O
weeks NNS NNS O
ago RB RB O
. . . O
   
On IN IN O
8/01/83 CD CD I-DATE
he PRP PRP O
was VBD VBD O
scheduled VBN VBN O
for IN IN O
a DT DT O
Colonoscopy NNP NNP O
, , , O
so IN IN O
his PRP$ PRP$ O
PCP NNP NNP O
suggested VBD VBD O
he PRP PRP O
have VBP VBP O
an DT DT O
UGI NNP NNP O
Endoscopy NNP NNP O
at IN IN O
the DT DT O
same JJ JJ O
time NN NN O
. . . O
   
The DT DT O
Colonoscopy NNP NNP O
demonstrated JJ JJ O
Diverticulosis NNP NNP O
and CC CC O
the DT DT O
UGI NNP NNP O
Endoscopy NNP NNP O
demonstrated VBD VBD O
a DT DT O
partially RB RB O
obstructing VBG VBG O
esophageal/gastric JJ JJ O
cardia NN NN O
tumor NN NN O
which WDT WDT O
was VBD VBD O
biopsied VBN VBN O
. . . O
   
Pathology NNP NNP O
revealed VBD VBD O
moderately RB RB O
to TO TO O
poorly RB RB O
differentiated VBN VBN O
adenocarcinoma NN NN O
. . . O
   
On IN IN O
8/10/83 CD CD I-DATE
an DT DT O
Abd NNP NNP O
and CC CC O
Pelvic NNP NNP O
CT NNP NNP O
were VBD VBD O
done VBN VBN O
showing VBG VBG O
: : : O
marked VBD VBD O
thickening NN NN O
of IN IN O
the DT DT O
wall NN NN O
of IN IN O
the DT DT O
distal JJ JJ O
esophagus NN NN O
(35-40cm JJ JJ O
by IN IN O
endoscopy NN NN O
- : : O
partial JJ JJ O
obstruction NN NN O
and CC CC O
circumferential JJ JJ O
) ) ) O
extending VBG VBG O
into IN IN O
the DT DT O
gastric JJ JJ O
cardia NN NN O
, , , O
consistent JJ JJ O
with IN IN O
biopsy NN NN O
proven VBN VBN O
adenocarcinoma NN NN O
. . . O
   
Also RB RB O
felt VBD VBD O
to TO TO O
be VB VB O
bleeding VBG VBG O
silently RB RB O
so RB RB O
placed VBN VBN O
on IN IN O
Fe NNP NNP O
replacement NN NN O
. . . O
   
Also RB RB O
, , , O
enlarged JJ JJ O
gastroepiploic NN NN O
, , , O
celiac NN NN O
and CC CC O
aortocaval NN NN O
lymph NN NN O
nodes NNS NNS O
consistent JJ JJ O
with IN IN O
metastatic JJ JJ O
disease NN NN O
. . . O
   
On IN IN O
8/10/83 CD CD I-DATE
a DT DT O
Chest NN NN O
CT NNP NNP O
revealed VBD VBD O
thickening NN NN O
of IN IN O
the DT DT O
lower JJR JJR O
esophagus NN NN O
extending VBG VBG O
into IN IN O
the DT DT O
chest NN NN O
esophageal NN NN O
junction NN NN O
. . . O
   
This DT DT O
is VBZ VBZ O
associated VBN VBN O
with IN IN O
lymphadenopathy NN NN O
in IN IN O
the DT DT O
( ( ( O
L NNP NNP O
) ) ) O
axilla NN NN O
, , , O
gastrohepatic JJ JJ O
ligament NN NN O
, , , O
celiac NN NN O
axis NNS NNS O
and CC CC O
retrocrural JJ JJ O
space NN NN O
. . . O
   
The DT DT O
appearance NN NN O
is VBZ VBZ O
highly RB RB O
suspicious JJ JJ O
for IN IN O
esophageal NN NN O
cancer NN NN O
and CC CC O
nodal NN NN O
spread NN NN O
. . . O
   
There EX EX O
is VBZ VBZ O
a DT DT O
3mm CD CD O
nodule NN NN O
adjacent JJ JJ O
to TO TO O
the DT DT O
( ( ( O
R NN NN O
) ) ) O
major JJ JJ O
fissure NN NN O
in IN IN O
the DT DT O
lung NN NN O
. . . O
   
PET NNP NNP O
scan VB VB O
confirmed VBD VBD O
axillary JJ JJ O
and CC CC O
abdominal JJ JJ O
involvement NN NN O
with IN IN O
cancer NN NN O
. . . O
   
The DT DT O
lung NN NN O
nodule NN NN O
was VBD VBD O
too RB RB O
small JJ JJ O
for IN IN O
PET NNP NNP O
to TO TO O
evaluate VB VB O
. . . O
   
He PRP PRP O
remains VBZ VBZ O
quite RB RB O
asymptomatic JJ JJ O
with IN IN O
no DT DT O
weight NN NN O
loss NN NN O
and CC CC O
minimal JJ JJ O
symptoms NNS NNS O
when WRB WRB O
he PRP PRP O
chews VBZ VBZ O
his PRP$ PRP$ O
food NN NN O
well RB RB O
. . . O
   
Problems/PMH NNP NNP O
: : : O
Repair NNP NNP O
of IN IN O
Zenker NNP NNP O
's POS POS O
diverticulum NN NN O
in IN IN O
2080 CD CD I-DATE
Aterial NNP NNP O
stent NN NN O
was VBD VBD O
placed VBN VBN O
in IN IN O
the DT DT O
mid JJ JJ O
LAD NNP NNP O
in IN IN O
4/80 CD CD I-DATE
Hypercholesteremia NNP NNP O
Arthritis NNP NNP O
Borderline NNP NNP O
Diabetic NNP NNP O
Heart NNP NNP O
murmur NN NN O
for IN IN O
50 CD CD O
years NNS NNS O
FH/SH NNP NNP O
: : : O
Never RB RB O
married VBN VBN O
No DT DT O
children NNS NNS O
Never RB RB O
smoked VBD VBD O
Rare NNP NNP O
ETOH NNP NNP O
- : : O
6 CD CD O
beers NNS NNS O
per IN IN O
year NN NN O
Aerospace NNP NNP I-PROFESSION
engineer NN NN I-PROFESSION
for IN IN O
40 CD CD O
years NNS NNS O
No DT DT O
family NN NN O
history NN NN O
of IN IN O
cancer NN NN O
Here RB RB O
with IN IN O
sister NN NN O
. . . O
   
Review NNP NNP O
of IN IN O
Systems NNPS NNPS O
: : : O
General NNP NNP O
: : : O
20 CD CD O
lb NN NN O
weight NN NN O
loss NN NN O
, , , O
fatigue NN NN O
, , , O
no DT DT O
fevers NNS NNS O
, , , O
no DT DT O
chills NNS NNS O
, , , O
ca MD MD O
n't RB RB O
eat VB VB O
as IN IN O
much JJ JJ O
, , , O
fills VBZ VBZ O
up RB RB O
quickly RB RB O
Respiratory NNP NNP O
: : : O
No DT DT O
cough NN NN O
, , , O
no DT DT O
SOB NNP NNP O
, , , O
no DT DT O
DOE NNP NNP O
, , , O
no DT DT O
hemoptysis NN NN O
, , , O
no DT DT O
wheezing VBG VBG O
HEENT NNP NNP O
: : : O
No DT DT O
neck NN NN O
swelling VBG VBG O
, , , O
occasional JJ JJ O
( ( ( O
R NN NN O
) ) ) O
neck NN NN O
stiffness NN NN O
, , , O
no DT DT O
hoarseness NN NN O
, , , O
no DT DT O
hearing VBG VBG O
loss NN NN O
Cardiac NNP NNP O
: : : O
No DT DT O
chest NN NN O
pain NN NN O
, , , O
no DT DT O
palpitations NNS NNS O
( ( ( O
heart NN NN O
murmur NN NN O
for IN IN O
50 CD CD O
yrs NN NN O
. . . O
) ) ) O
arrythmias NN NN O
, , , O
no DT DT O
valve NN NN O
disease NN NN O
Gastrointestinal NNP NNP O
: : : O
No DT DT O
nausea NN NN O
, , , O
no DT DT O
vomiting VBG VBG O
, , , O
no DT DT O
diarrhea NN NN O
, , , O
no DT DT O
constipation NN NN O
, , , O
no DT DT O
bleeding VBG VBG O
Neurologic NNP NNP O
: : : O
No DT DT O
seizures NNS NNS O
, , , O
no DT DT O
headache NN NN O
, , , O
no DT DT O
weakness NN NN O
, , , O
no DT DT O
numbness/tingling VBG VBG O
Lymph NNP NNP O
nodes NNS NNS O
: : : O
No DT DT O
enlarged JJ JJ O
lymph NN NN O
nodes NNS NNS O
Musculoskeletal NNP NNP O
: : : O
No DT DT O
back NN NN O
pain NN NN O
, , , O
no DT DT O
neck NN NN O
pain NN NN O
, , , O
no DT DT O
leg NN NN O
pain NN NN O
, , , O
no DT DT O
arm NN NN O
pain NN NN O
Urologic NNP NNP O
: : : O
No DT DT O
hematuria NN NN O
, , , O
no DT DT O
dysuria NN NN O
, , , O
or CC CC O
no DT DT O
obstruction NN NN O
Endocrine NNP NNP O
: : : O
No DT DT O
adrenal NN NN O
, , , O
no DT DT O
thyroid NN NN O
or CC CC O
no DT DT O
parathyroid NN NN O
disease NN NN O
Hematologic NNP NNP O
: : : O
No DT DT O
bruising VBG VBG O
, , , O
no DT DT O
clotting VBG VBG O
, , , O
no DT DT O
bleeding VBG VBG O
Medications NNP NNP O
: : : O
Atenolol NNP NNP O
50 CD CD O
mg NN NN O
QD NNP NNP O
Triamterene/HCTZ NNP NNP O
50/25 CD CD O
QD NNP NNP O
Vitamin NNP NNP O
B NNP NNP O
Complex NNP NNP O
100 CD CD O
u NN NN O
QD NNP NNP O
Folic NNP NNP O
Acid NNP NNP O
1 CD CD O
mg NN NN O
QD NNP NNP O
Iron NNP NNP O
Sulfate NNP NNP O
1 CD CD O
tab NN NN O
BID NNP NNP O
Lipitor NNP NNP O
10 CD CD O
mg NN NN O
QHS NNP NNP O
Terazosin NNP NNP O
5 CD CD O
mg NN NN O
QD NNP NNP O
Lisinopril NNP NNP O
2.5 CD CD O
mg NN NN O
QHS NNP NNP O
Ducolax NNP NNP O
2 CD CD O
tabs NNS NNS O
QD NNP NNP O
Allergies NNP NNP O
: : : O
Codeine-dizzy NNP NNP O
Physical JJ JJ O
Examination NNP NNP O
: : : O
VSS NNP NNP O
AF NNP NNP O
PS=1 NNP NNP O
Neck NNP NNP O
: : : O
no DT DT O
nodes NNS NNS O
palpable JJ JJ O
HEENT NNP NNP O
: : : O
No DT DT O
thrush NN NN O
or CC CC O
mucositis NN NN O
; : : O
   
EOMI NNP NNP O
; : : O
   
PERRL NNP NNP O
Skin NNP NNP O
: : : O
no DT DT O
rash NN NN O
Ext NNP NNP O
: : : O
without IN IN O
edema NN NN O
, , , O
clubbing VBG VBG O
Cor NNP NNP O
: : : O
S1 NNP NNP O
S2 NNP NNP O
Chest NN NN O
: : : O
clear JJ JJ O
lungs NNS NNS O
without IN IN O
wheezing VBG VBG O
or CC CC O
crackles NNS NNS O
Abdomen NNP NNP O
: : : O
soft JJ JJ O
, , , O
NT NNP NNP O
no DT DT O
HSM NNP NNP O
Nodes NNS NNS O
: : : O
neg NN NN O
cerv NN NN O
, , , O
sc NN NN O
Neuro NNP NNP O
: : : O
grossly RB RB O
non-focal JJ JJ O
Data NNP NNP O
( ( ( O
laboratory NN NN O
and CC CC O
radiographs NNS NNS O
) ) ) O
see VB VB O
above IN IN O
Assessment NNP NNP O
and CC CC O
Plan NNP NNP O
: : : O
72 CD CD I-AGE
year NN NN O
old JJ JJ O
man NN NN O
with IN IN O
Stage NN NN O
IVB NNP NNP O
metastatic JJ JJ O
esophageal NN NN O
cancer NN NN O
. . . O
   
He PRP PRP O
is VBZ VBZ O
doing VBG VBG O
quite RB RB O
well RB RB O
. . . O
   
Given VBN VBN O
the DT DT O
fairly RB RB O
asymptomatic JJ JJ O
nature NN NN O
of IN IN O
his PRP$ PRP$ O
cancer NN NN O
we PRP PRP O
have VBP VBP O
opted VBN VBN O
to TO TO O
start VB VB O
with IN IN O
radiation NN NN O
first RB RB O
, , , O
as IN IN O
his PRP$ PRP$ O
primary JJ JJ O
mass NN NN O
is VBZ VBZ O
fungating VBG VBG O
in IN IN O
nature NN NN O
and CC CC O
there EX EX O
has VBZ VBZ O
been VBN VBN O
evidence NN NN O
of IN IN O
blood NN NN O
loss NN NN O
. . . O
   
After IN IN O
radiation NN NN O
is VBZ VBZ O
completed VBN VBN O
in IN IN O
3-4 JJ JJ O
weeks NNS NNS O
, , , O
I PRP PRP O
will MD MD O
see VB VB O
him PRP PRP O
for IN IN O
consideration NN NN O
of IN IN O
chemotherapy NN NN O
but CC CC O
only RB RB O
after IN IN O
re-staging JJ JJ O
. . . O
   
If IN IN O
he PRP PRP O
remains VBZ VBZ O
asymptomatic JJ JJ O
and CC CC O
there EX EX O
has VBZ VBZ O
been VBN VBN O
little JJ JJ O
progression NN NN O
of IN IN O
disease NN NN O
, , , O
we PRP PRP O
may MD MD O
opt VB VB O
to TO TO O
observe VB VB O
him PRP PRP O
closely RB RB O
without IN IN O
treatment NN NN O
. . . O
   
If IN IN O
the DT DT O
scans NNS NNS O
show VBP VBP O
significant JJ JJ O
progression NN NN O
or CC CC O
he PRP PRP O
becomes VBZ VBZ O
symptomatic JJ JJ O
, , , O
then RB RB O
we PRP PRP O
will MD MD O
start VB VB O
systemic JJ JJ O
treatment NN NN O
soon RB RB O
afterwards RB RB O
. . . O
   
He PRP PRP O
is VBZ VBZ O
not RB RB O
a DT DT O
surgical JJ JJ O
candidate NN NN O
given VBN VBN O
his PRP$ PRP$ O
stage NN NN O
of IN IN O
disease NN NN O
and CC CC O
lack NN NN O
of IN IN O
symptoms NNS NNS O
. . . O
   
RTC NNP NNP O
in IN IN O
5 CD CD O
weeks NNS NNS O
to TO TO O
assess VB VB O
symptoms NNS NNS O
and CC CC O
to TO TO O
arrange VB VB O
restaging VBG VBG O
scans NNS NNS O
. . . O
   
____________________________________________ NN NN O
_ NN NN O
Xavier NNP NNP I-DOCTOR
Otero NNP NNP I-DOCTOR
, , , O
M.D. NN NN O
cc NN NN O
: : : O
Dr NNP NNP O
. . . O
Geno NNP NNP I-DOCTOR
Guidry NNP NNP I-DOCTOR
Dr NNP NNP O
. . . O
Gregory NNP NNP I-DOCTOR
Mcguire NNP NNP I-DOCTOR
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2094-01-29 JJ JJ I-DATE
INTERNAL NNP NNP O
MEDICINE NNP NNP O
ASSOCIATES NNP NNP O
ROSELAND NNP NNP I-HOSPITAL
COMMUNITY NNP NNP I-HOSPITAL
HOSPITAL NNP NNP I-HOSPITAL
Major NNP NNP O
Problems NNS NNS O
Diabetes NNP NNP O
mellitus JJ JJ O
Blood NNP NNP O
sugars NNS NNS O
have VBP VBP O
been VBN VBN O
good JJ JJ O
at IN IN O
home NN NN O
. . . O
   
Hemoglobin NNP NNP O
A1c's NNP NNP O
have VBP VBP O
been VBN VBN O
good JJ JJ O
. . . O
   
We PRP PRP O
are VBP VBP O
rechecking VBG VBG O
that DT DT O
again RB RB O
. . . O
   
Hypertension NNP NNP O
Blood NNP NNP O
pressure NN NN O
is VBZ VBZ O
okay JJ JJ O
today NN NN O
, , , O
140/68 CD CD O
. . . O
   
We PRP PRP O
will MD MD O
need VB VB O
to TO TO O
follow VB VB O
this DT DT O
closely RB RB O
. . . O
   
Her PRP$ PRP$ O
potassium NN NN O
has VBZ VBZ O
been VBN VBN O
up RP RP O
a DT DT O
little JJ JJ O
bit NN NN O
. . . O
   
We PRP PRP O
will MD MD O
need VB VB O
to TO TO O
change VB VB O
around IN IN O
her PRP$ PRP$ O
medications NNS NNS O
to TO TO O
see VB VB O
if IN IN O
the DT DT O
Norvasc NNP NNP O
that IN IN O
we PRP PRP O
put VBP VBP O
her PRP PRP O
on IN IN O
increased VBN VBN O
her PRP$ PRP$ O
potassium NN NN O
. . . O
   
Health NNP NNP O
maintenance NN NN O
She PRP PRP O
continues VBZ VBZ O
to TO TO O
decline VB VB O
sigmoidoscopy NN NN O
and CC CC O
mammogram NN NN O
. . . O
   
The DT DT O
patient NN NN O
's POS POS O
cyst NN NN O
at IN IN O
the DT DT O
left VBN VBN O
leg NN NN O
has VBZ VBZ O
been VBN VBN O
removed VBN VBN O
and CC CC O
is VBZ VBZ O
well RB RB O
healed VBN VBN O
at IN IN O
this DT DT O
time NN NN O
. . . O
   
Physical JJ JJ O
examination NN NN O
Blood NNP NNP O
pressure NN NN O
140/68 CD CD O
Weight NNP NNP O
166 CD CD O
pounds NNS NNS O
Neck NNP NNP O
Thyroid NNP NNP O
exam NN NN O
is VBZ VBZ O
unremarkable JJ JJ O
Nodes NNS NNS O
No DT DT O
lymphadenopathy NN NN O
Chest NN NN O
Lungs NNP NNP O
are VBP VBP O
clear JJ JJ O
with IN IN O
no DT DT O
wheezes NNS NNS O
, , , O
rales NNS NNS O
, , , O
or CC CC O
rhonchi NN NN O
Cor NNP NNP O
No DT DT O
murmurs NNS NNS O
, , , O
rubs NNS NNS O
, , , O
or CC CC O
gallops NNS NNS O
. . . O
   
Carotids NNP NNP O
with IN IN O
normal JJ JJ O
upstroke NN NN O
without IN IN O
bruits NNS NNS O
Extrem NNP NNP O
Clear NNP NNP O
Disposition NNP NNP O
Return NNP NNP O
is VBZ VBZ O
to TO TO O
see VB VB O
me PRP PRP O
later RB RB O
in IN IN O
the DT DT O
spring NN NN I-DATE
. . . O
   
Diabetes NNP NNP O
care NN NN O
is VBZ VBZ O
up-to-date JJ JJ O
. . . O
   
She PRP PRP O
has VBZ VBZ O
her PRP$ PRP$ O
eyes NNS NNS O
checked VBN VBN O
and CC CC O
feet NNS NNS O
followed VBD VBD O
closely RB RB O
. . . O
   
We PRP PRP O
will MD MD O
later RB RB O
discuss VB VB O
with IN IN O
her PRP$ PRP$ O
any DT DT O
further JJ JJ O
followup NN NN O
about IN IN O
the DT DT O
diabetes NNS NNS O
with IN IN O
Nutrition NNP NNP O
. . . O
   
Note NN NN O
transcribed VBN VBN O
by IN IN O
outside IN IN O
service NN NN O
Transcription NNP NNP O
errors NNS NNS O
may MD MD O
be VB VB O
present JJ JJ O
. . . O
   
Signed VBN VBN O
electronically RB RB O
by IN IN O
Ruba NNP NNP I-DOCTOR
Neil NNP NNP I-DOCTOR
on IN IN O
Mar NNP NNP I-DATE
8 CD CD O
, , , O
2094 CD CD I-DATE
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2109-09-10 NN NN I-DATE
Intern NNP NNP O
Levine NNP NNP I-HOSPITAL
HospitalAdmission NNP NNP O
Note VB VB O
Pt NNP NNP O
: : : O
Bryan NNP NNP O
, , , O
Archie NNP NNP I-PATIENT
MR NNP NNP O
# # # O
7246074 CD CD I-MEDICALRECORD
Admit NNP NNP O
Date NN NN O
: : : O
9/9/2109 CD CD I-DATE
Attending NNP NNP O
: : : O
Jamie NNP NNP I-DOCTOR
Uchida NNP NNP I-DOCTOR
Specialists NNP NNP O
: : : O
Residents NNS NNS O
: : : O
Nakia NNP NNP I-DOCTOR
Ingrassia NNP NNP I-DOCTOR
/ NN NN O
Xzavier NNP NNP I-DOCTOR
Lujan NNP NNP I-DOCTOR
Intern NNP NNP O
: : : O
Anthony NNP NNP I-DOCTOR
Edge NNP NNP I-DOCTOR
PCP NNP NNP O
: : : O
Source NN NN O
: : : O
patient NN NN O
, , , O
chart NN NN O
Chief NNP NNP O
Complaint NNP NNP O
: : : O
found VBD VBD O
down RB RB O
History NN NN O
of IN IN O
Present JJ JJ O
Illness NNP NNP O
: : : O
79 CD CD I-AGE
M NNP NNP O
found VBD VBD O
down RB RB O
in IN IN O
his PRP$ PRP$ O
bathroom NN NN O
after IN IN O
friend NN NN O
noticed VBD VBD O
no DT DT O
answer NN NN O
to TO TO O
phone VB VB O
call NN NN O
. . . O
   
EMS NNP NNP O
found VBD VBD O
patient NN NN O
between IN IN O
toilet NN NN O
and CC CC O
bath NN NN O
tub NN NN O
, , , O
cracked VBN VBN O
toilet NN NN O
bowl NN NN O
rim NN NN O
, , , O
hematoma NN NN O
on IN IN O
back RB RB O
of IN IN O
head NN NN O
, , , O
incontinent NN NN O
of IN IN O
urine NN NN O
and CC CC O
stool NN NN O
. . . O
   
Wednesday NNP NNP I-DATE
newspaper NN NN O
still RB RB O
on IN IN O
doorstep NN NN O
. . . O
   
Medical NNP NNP O
History NN NN O
: : : O
OA NNP NNP O
DM NNP NNP O
HTN NNP NNP O
Basal NNP NNP O
cell NN NN O
carcinoma NN NN O
Varicose NNP NNP O
veins NNS NNS O
Macular NNP NNP O
degeneration NN NN O
: : : O
functionally RB RB O
blind JJ JJ O
in IN IN O
the DT DT O
left NN NN O
eye NN NN O
from IN IN O
macular NN NN O
bleed NN NN O
1/07Followed CD CD O
by IN IN O
Dr NNP NNP O
. . . O
Xanders/Opth NNP NNP O
. . . O
   
and CC CC O
Dr NNP NNP O
. . . O
Kenny NNP NNP I-DOCTOR
. . . O
   
Peripheral NNP NNP O
neuropathy NN NN O
Cataract NNP NNP O
extraction NN NN O
: : : O
Dr NNP NNP O
. . . O
Norton NNP NNP I-DOCTOR
11/15 CD CD I-DATE
. . . O
   
Urinary NNP NNP O
incont NN NN O
Medications NNP NNP O
: : : O
Aspirin NNP NNP O
( ( ( O
ACETYLSALICYLIC NNP NNP O
ACID NNP NNP O
) ) ) O
81MG CD CD O
TABLET NNP NNP O
CHEWABLE NNP NNP O
take NN NN O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
, , , O
Mvi NNP NNP O
( ( ( O
MULTIVITAMINS NNP NNP O
) ) ) O
1 CD CD O
CAPSULE NNP NNP O
PO NNP NNP O
QD NNP NNP O
Atenolol NNP NNP O
100MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Captopril NNP NNP O
50MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
BID NNP NNP O
Hctz NNP NNP O
( ( ( O
HYDROCHLOROTHIAZIDE NNP NNP O
) ) ) O
25MG CD CD O
TABLET NNP NNP O
take NN NN O
0.5 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Metformin NNP NNP O
850MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
BID NNP NNP O
Lipitor NNP NNP O
( ( ( O
ATORVASTATIN NNP NNP O
) ) ) O
5MG CD CD O
( ( ( O
10MG CD CD O
TABLET NNP NNP O
) ) ) O
PO NNP NNP O
QD NNP NNP O
x SYM SYM O
90 CD CD O
days NNS NNS O
Allergies NNP NNP O
: : : O
NKDA NNP NNP O
Social NNP NNP O
History NN NN O
: : : O
Lives NNP NNP O
alone RB RB O
. . . O
   
Never RB RB O
married VBN VBN O
, , , O
no DT DT O
kids NNS NNS O
. . . O
   
Cousin NNP NNP O
involved VBN VBN O
in IN IN O
care NN NN O
. . . O
   
Retired NNP NNP O
. . . O
   
Quit NNP NNP O
smoking VBG VBG O
years NNS NNS O
ago RB RB O
. . . O
   
Family NNP NNP O
History NN NN O
: : : O
not RB RB O
elicited JJ JJ O
Review NNP NNP O
of IN IN O
Systems NNPS NNPS O
: : : O
ED NNP NNP O
Course NN NN O
: : : O
97 CD CD O
140 CD CD O
138/55 CD CD O
20 CD CD O
92 CD CD O
% NN NN O
2L CD CD O
1 CD CD O
L NNP NNP O
NS NNP NNP O
, , , O
lopressor NN NN O
2.5 CD CD O
+ NN NN O
5 CD CD O
+ NN NN O
5 CD CD O
iv NN NN O
, , , O
lopressor NN NN O
25 CD CD O
mg NN NN O
po NN NN O
, , , O
1 CD CD O
L NNP NNP O
NaHCO NNP NNP O
, , , O
flagyl NN NN O
500 CD CD O
iv NN NN O
, , , O
levo NN NN O
500 CD CD O
iv NN NN O
Exam NNP NNP O
: : : O
VS NNP NNP O
: : : O
98 CD CD O
130 CD CD O
117/63 CD CD O
28-32 JJ JJ O
95 CD CD O
RA NNP NNP O
Gen NNP NNP O
: : : O
agitated VBN VBN O
, , , O
yelling VBG VBG O
, , , O
NAD NNP NNP O
HEENT NNP NNP O
: : : O
5 CD CD O
cm NN NN O
bruise NN NN O
on IN IN O
occiput NN NN O
, , , O
no DT DT O
raccoon NN NN O
eyes NNS NNS O
or CC CC O
mastoid NN NN O
ecchymoses NNS NNS O
. . . O
   
Crusted NNP NNP O
mucous JJ JJ O
membranes NNS NNS O
Neck NNP NNP O
: : : O
supple NN NN O
, , , O
no DT DT O
LAD NNP NNP O
Lungs NNP NNP O
: : : O
coarse NN NN O
BS NNP NNP O
, , , O
no DT DT O
rales NNS NNS O
Back RB RB O
: : : O
nontender NN NN O
Heart NNP NNP O
: : : O
irreg NN NN O
, , , O
no DT DT O
murmur NN NN O
Abd NNP NNP O
: : : O
soft JJ JJ O
, , , O
NT NNP NNP O
, , , O
ND NNP NNP O
, , , O
hypoactive JJ JJ O
BS NNP NNP O
GU NNP NNP O
: : : O
Foley NNP NNP O
in IN IN O
place NN NN O
Rectal NNP NNP O
: : : O
Extr NNP NNP O
: : : O
no DT DT O
edema NN NN O
, , , O
crusts NNS NNS O
between IN IN O
toes NNS NNS O
, , , O
hyperkeratotic JJ JJ O
nails NNS NNS O
, , , O
dark JJ JJ O
macules NNS NNS O
on IN IN O
toes NNS NNS O
Neuro NNP NNP O
: : : O
awake NN NN O
and CC CC O
oriented VBN VBN O
, , , O
difficulty NN NN O
with IN IN O
word-finding JJ JJ O
. . . O
   
Ataxic NNP NNP O
in IN IN O
both DT DT O
UEs NNP NNP O
R NNP NNP O
>> NNP NNP O
L NNP NNP O
, , , O
unable JJ JJ O
to TO TO O
lift VB VB O
R NNP NNP O
leg NN NN O
. . . O
   
Hyporeflexic NNP NNP O
except IN IN O
R NNP NNP O
biceps NNS NNS O
, , , O
2 CD CD O
+ NN NN O
. . . O
   
Skin NNP NNP O
: : : O
Data NNP NNP O
: : : O
Chemistry NNP NNP O
: : : O
09/09/09 CD CD I-DATE
10:32 CD CD O
NA NNP NNP O
139 CD CD O
K NNP NNP O
3.8 CD CD O
CL NNP NNP O
105 CD CD O
CO2 NNP NNP O
25.0 CD CD O
BUN NNP NNP O
64(H) CD CD O
CRE NNP NNP O
2.1(H) CD CD O
GLU NNP NNP O
315(H) CD CD O
CA NNP NNP O
9.5 CD CD O
PHOS NNP NNP O
4.3 CD CD O
MG NNP NNP O
2.3(H) CD CD O
TBILI NNP NNP O
0.5 CD CD O
DBILI NNP NNP O
0.2 CD CD O
TP NNP NNP O
8.2 CD CD O
ALB NNP NNP O
3.1(L) CD CD O
GLOB NNP NNP O
5.1(H) CD CD O
AMY NNP NNP O
105(H) CD CD O
LIPS NNP NNP O
3.3 CD CD O
ALT/SGPT NNP NNP O
117(H) CD CD O
AST/SGOT NNP NNP O
98(H) CD CD O
ALKP NNP NNP O
81 CD CD O
TBILI NNP NNP O
0.5 CD CD O
DBILI NNP NNP O
0.2 CD CD O
09/10/09 CD CD I-DATE
09/09/09 CD CD I-DATE
09/09/09 CD CD I-DATE
09/09/09 CD CD I-DATE
09/09/09 CD CD I-DATE
04:52 CD CD O
12:43 CD CD O
11:49 CD CD O
11:06 CD CD O
10:32 CD CD O
CK NNP NNP O
1126(H) CD CD O
1156(H) CD CD O
CK-MB NNP NNP O
14.4(H) CD CD O
see VB VB O
detail NN NN O
CKMBRI NNP NNP O
1.2 CD CD O
TROP-I NNP NNP O
Negative NNP NNP O
TROP-T NNP NNP O
0.03 CD CD O
0.02 CD CD O
Hematology NNP NNP O
: : : O
09/09/09 CD CD I-DATE
10:25 CD CD O
WBC NNP NNP O
14.6(H) CD CD O
RBC NNP NNP O
4.87 CD CD O
HGB NNP NNP O
15.6 CD CD O
HCT NNP NNP O
45.5 CD CD O
MCV NNP NNP O
93 CD CD O
MCH NNP NNP O
31.9 CD CD O
MCHC NNP NNP O
34.2 CD CD O
PLT NNP NNP O
343 CD CD O
RDW NNP NNP O
13.0 CD CD O
% NN NN O
NEUT NNP NNP O
93(H) CD CD O
% NN NN O
LYMPH NNP NNP O
3(L) CD CD O
% NN NN O
MONO NNP NNP O
4 CD CD O
% NN NN O
EOS NNP NNP O
0 CD CD O
% NN NN O
BASO NNP NNP O
0 CD CD O
PT NNP NNP O
14.2(H) CD CD O
PTT NNP NNP O
29.4 CD CD O
Urinalysis NNP NNP O
: : : O
09/09/09 CD CD I-DATE
09/09/09 CD CD I-DATE
12:00 NN NN O
11:06 CD CD O
UA-GLUC NNP NNP O
Negative NNP NNP O
UA-KET NNP NNP O
Trace NNP NNP O
UA-SPGR NNP NNP O
> NN NN O
1.030 CD CD O
UA-BLD NNP NNP O
see VB VB O
detail NN NN O
UA-PH NNP NNP O
5.0 CD CD O
UA-ALB NNP NNP O
see VB VB O
detail NN NN O
UA-NIT NNP NNP O
Negative NNP NNP O
UA-WBC NNP NNP O
Negative NNP NNP O
MIC-SED NNP NNP O
Completed NNP NNP O
HCAST NNP NNP O
0-2 JJ JJ O
GCAST NNP NNP O
5-10 JJ JJ O
UAS-RBC NNP NNP O
20-50 JJ JJ O
UAS-WBC NNP NNP O
10-20 JJ JJ O
UAS-BACT NNP NNP O
Few JJ JJ O
UAS-SQHI NNP NNP O
Negative NNP NNP O
UAS-TUBU NNP NNP O
Few JJ JJ O
UAS-URAC NNP NNP O
Few JJ JJ O
My PRP$ PRP$ O
dipstick NN NN O
: : : O
gluc NN NN O
250 CD CD O
, , , O
no DT DT O
ketones NNS NNS O
, , , O
1.020 CD CD O
, , , O
large JJ JJ O
blood NN NN O
, , , O
pH NN NN O
5.0 CD CD O
, , , O
3 CD CD O
+ NN NN O
protein NN NN O
, , , O
no DT DT O
nitrite NN NN O
, , , O
trace VB VB O
leukocytes NNS NNS O
Urine NNP NNP O
spin NN NN O
: : : O
peach NN NN O
colored VBN VBN O
, , , O
granular JJ JJ O
casts NNS NNS O
, , , O
WBCS NNP NNP O
, , , O
rbcs NN NN O
( ( ( O
no DT DT O
dysmorphic JJ JJ O
) ) ) O
, , , O
crystals NNS NNS O
, , , O
tubular NN NN O
epithelial NN NN O
cells NNS NNS O
Imaging NNP NNP O
: : : O
CXR NNP NNP O
RLL NNP NNP O
PNA NNP NNP O
C-spine NNP NNP O
- - - O
facet NN NN O
joint NN NN O
disease NN NN O
, , , O
granuloma NN NN O
in IN IN O
R NNP NNP O
lung NN NN O
apex NN NN O
CT NNP NNP O
head NN NN O
- : : O
diffuse NN NN O
periventricular NN NN O
white JJ JJ O
matter NN NN O
attenuation NN NN O
and CC CC O
patchy JJ JJ O
areas NNS NNS O
of IN IN O
low JJ JJ O
density NN NN O
in IN IN O
the DT DT O
deep JJ JJ O
white JJ JJ O
matter NN NN O
of IN IN O
the DT DT O
centrum NN NN O
semi NN NN O
ovale NN NN O
and CC CC O
coronal JJ JJ O
radiata NN NN O
. . . O
   
There EX EX O
are VBP VBP O
bilateral JJ JJ O
vertebral NN NN O
and CC CC O
carotid NN NN O
artery NN NN O
calcifications NNS NNS O
seen VBN VBN O
. . . O
   
CT NNP NNP O
abd NN NN O
(I-/O-)- JJ JJ O
Relative NNP NNP O
iliopsoas NN NN O
fullness NN NN O
on IN IN O
the DT DT O
left NN NN O
believed VBN VBN O
on IN IN O
account NN NN O
of IN IN O
atrophy NN NN O
of IN IN O
the DT DT O
right NN NN O
sided VBD VBD O
musculature JJ JJ O
secondary JJ JJ O
to TO TO O
total JJ JJ O
hip NN NN O
arthroplasty NN NN O
on IN IN O
the DT DT O
right NN NN O
. . . O
   
Consolidation NNP NNP O
and/or NN NN O
atelectasis NN NN O
at IN IN O
the DT DT O
right JJ JJ O
base NN NN O
. . . O
   
Degenerative NNP NNP O
changes NNS NNS O
of IN IN O
the DT DT O
spine NN NN O
with IN IN O
spondylolisthesis NN NN O
of IN IN O
L4 NNP NNP O
over IN IN O
L5 NNP NNP O
EKG NNP NNP O
: : : O
Aflutter NNP NNP O
with IN IN O
variable JJ JJ O
conduction NN NN O
at IN IN O
100 CD CD O
- : : O
130 CD CD O
bpm NN NN O
Impression NNP NNP O
: : : O
79 CD CD I-AGE
M NNP NNP O
found VBD VBD O
down RB RB O
- : : O
fall NN NN O
could MD MD O
have VB VB O
been VBN VBN O
mechanical JJ JJ O
, , , O
vasovagal JJ JJ O
, , , O
vertebrobasilar JJ JJ O
disease NN NN O
, , , O
cardiac JJ JJ O
arrhythmia NN NN O
or CC CC O
valve NN NN O
disease NN NN O
, , , O
and CC CC O
remained VBD VBD O
on IN IN O
floor NN NN O
because IN IN O
of IN IN O
dementia NN NN O
+/- JJ JJ O
delerium NN NN O
, , , O
head NN NN O
injury NN NN O
from IN IN O
fall NN NN O
, , , O
stroke NN NN O
with IN IN O
weakness NN NN O
. . . O
   
He PRP PRP O
was VBD VBD O
incontinent NN NN O
of IN IN O
urine NN NN O
and CC CC O
stool NN NN O
, , , O
though IN IN O
incontinence NN NN O
may MD MD O
have VB VB O
been VBN VBN O
an DT DT O
ongoing JJ JJ O
problem NN NN O
. . . O
   
Aspiration NNP NNP O
likely JJ JJ O
, , , O
now RB RB O
with IN IN O
PNA NNP NNP O
. . . O
   
Physical JJ JJ O
exam NN NN O
concerning VBG VBG O
for IN IN O
stroke NN NN O
with IN IN O
R NNP NNP O
leg NN NN O
weakness NN NN O
, , , O
RUE NNP NNP O
flexion NN NN O
and CC CC O
dysmetria NN NN O
. . . O
   
Plan NNP NNP O
: : : O
   
1 CD CD O
. . . O
Syncope NNP NNP O
- : : O
Tele NNP NNP O
, , , O
TTE NNP NNP O
, , , O
MRI NNP NNP O
for IN IN O
stroke NN NN O
, , , O
MRA NNP NNP O
for IN IN O
VB NNP NNP O
dz NN NN O
   
2 CD CD O
. . . O
New NNP NNP O
Afib NNP NNP O
- : : O
ECHO NNP NNP O
, , , O
TSH NNP NNP O
, , , O
EKG NNP NNP O
a. NN NN O
   
Did VBD VBD O
not RB RB O
respond VB VB O
to TO TO O
metoprolol NN NN O
or CC CC O
verapamil NN NN O
, , , O
will MD MD O
load NN NN O
digoxin NN NN O
, , , O
co NN NN O
n't RB RB O
metoprolol NN NN O
po NN NN O
   
3 CD CD O
. . . O
PNA NNP NNP O
- : : O
likely JJ JJ O
aspiration NN NN O
, , , O
treat NN NN O
with IN IN O
levo NN NN O
, , , O
flagyl NN NN O
, , , O
atrovent NN NN O
inhaler NN NN O
   
4 CD CD O
. . . O
Renal NNP NNP O
failure NN NN O
- : : O
likely JJ JJ O
prerenal JJ JJ O
, , , O
though IN IN O
sediment NN NN O
exam NN NN O
c/w NN NN O
ATN NNP NNP O
. . . O
   
Rhabdomyolysis NNP NNP O
possible JJ JJ O
, , , O
though IN IN O
CK NNP NNP O
's POS POS O
only RB RB O
1000 CD CD O
. . . O
   
a. NN NN O
   
Treat NNP NNP O
with IN IN O
fluids NNS NNS O
NaHCO3 NNP NNP O
200 CD CD O
cc NN NN O
/ NN NN O
hr NN NN O
, , , O
see VB VB O
response NN NN O
in IN IN O
Cr NNP NNP O
b. NN NN O
   
U NNP NNP O
lytes NNS NNS O
, , , O
U NNP NNP O
myoglobin NN NN O
c. NN NN O
   
Renal NNP NNP O
US NNP NNP O
if IN IN O
not RB RB O
pre-renal JJ JJ O
   
5 CD CD O
. . . O
DM NNP NNP O
- : : O
RISS NNP NNP O
, , , O
hold VB VB O
metformin NN NN O
   
6 CD CD O
. . . O
Agitation NNP NNP O
- : : O
a. NN NN O
   
May NNP NNP O
improve VB VB O
with IN IN O
treatment NN NN O
of IN IN O
infection NN NN O
b. NN NN O
   
Seroquel NNP NNP O
QPM NNP NNP O
, , , O
haldol NN NN O
PRN NNP NNP O
   
7 CD CD O
. . . O
Prophylaxis NNP NNP O
a. NN NN O
   
Heparin NNP NNP O
SC NNP NNP O
5000 CD CD O
BID NNP NNP O
b. NN NN O
   
Nexium NNP NNP O
20 CD CD O
QD NNP NNP O
________________________________ NN NN O
_ NN NN O
Anthony NNP NNP I-DOCTOR
Edge NNP NNP I-DOCTOR
, , , O
MD NNP NNP O
DPhil NNP NNP O
MSc NNP NNP O
Pager NNP NNP O
74783 CD CD I-PHONE
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2076-12-11 JJ JJ I-DATE
December NNP NNP I-DATE
11 CD CD O
, , , O
2076 CD CD I-DATE
Paul NNP NNP I-DOCTOR
Arteaga NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
677 CD CD I-STREET
Mill NNP NNP I-STREET
Street NNP NNP I-STREET
Shady NNP NNP I-CITY
Cove NNP NNP I-CITY
, , , O
NY NNP NNP I-STATE
43414 CD CD I-ZIP
Re NNP NNP O
: : : O
Christine NNP NNP I-PATIENT
Olivier NNP NNP I-PATIENT
MR NNP NNP O
#652-33-21-5 NN NN O
Dear RB RB O
Dr NNP NNP O
. . . O
Arteaga NNP NNP I-DOCTOR
: : : O
Mrs NNP NNP O
. . . O
   
Olivier NNP NNP I-PATIENT
returns NNS NNS O
for IN IN O
follow-up JJ JJ O
. . . O
   
Since IN IN O
last JJ JJ O
seen VBN VBN O
, , , O
she PRP PRP O
reports NNS NNS O
return VBP VBP O
in IN IN O
a DT DT O
non-exertional JJ JJ O
left VBN VBN O
shoulder NN NN O
discomfort NN NN O
syndrome NN NN O
, , , O
occasionally RB RB O
associated VBN VBN O
with IN IN O
mild JJ JJ O
dyspnea NN NN O
. . . O
   
Of IN IN O
note NN NN O
, , , O
she PRP PRP O
underwent VBD VBD O
a DT DT O
dobutamine NN NN O
MIBI NNP NNP O
stress NN NN O
test NN NN O
last JJ JJ O
June NNP NNP I-DATE
for IN IN O
evaluating VBG VBG O
a DT DT O
similar JJ JJ O
syndrome NN NN O
, , , O
and CC CC O
at IN IN O
that DT DT O
time NN NN O
she PRP PRP O
developed VBD VBD O
her PRP$ PRP$ O
typical JJ JJ O
chest NN NN O
and CC CC O
left VBD VBD O
back RB RB O
pain NN NN O
syndrome NN NN O
in IN IN O
association NN NN O
with IN IN O
no DT DT O
diagnostic JJ JJ O
EKG NNP NNP O
changes NNS NNS O
at IN IN O
a DT DT O
peak NN NN O
heart NN NN O
rate NN NN O
of IN IN O
127 CD CD O
, , , O
peak NN NN O
blood NN NN O
pressure NN NN O
of IN IN O
160/60 CD CD O
. . . O
   
A DT DT O
simultaneously RB RB O
obtained VBN VBN O
SESTA NNP NNP O
MIBI NNP NNP O
scan VB VB O
revealed VBD VBD O
a DT DT O
global JJ JJ O
left VBD VBD O
ventricular JJ JJ O
fraction NN NN O
of IN IN O
42 CD CD O
% NN NN O
, , , O
a DT DT O
non-Q-wave JJ JJ O
myocardial NN NN O
infarction NN NN O
involving VBG VBG O
2 CD CD O
out IN IN O
of IN IN O
20 CD CD O
segments NNS NNS O
of IN IN O
the DT DT O
inferior JJ JJ O
wall NN NN O
and CC CC O
minimal JJ JJ O
peri-infarct JJ JJ O
ischemia NN NN O
. . . O
   
In IN IN O
addition NN NN O
, , , O
a DT DT O
venous JJ JJ O
duplex NN NN O
ultrasound NN NN O
study NN NN O
done VBN VBN O
to TO TO O
evaluate VB VB O
her PRP$ PRP$ O
severe NN NN O
left VBD VBD O
greater JJR JJR O
than IN IN O
right NN NN O
peripheral JJ JJ O
edema NN NN O
showed VBD VBD O
no DT DT O
evidence NN NN O
of IN IN O
DVT NNP NNP O
. . . O
   
Currently RB RB O
she PRP PRP O
remains VBZ VBZ O
on IN IN O
a DT DT O
regimen NN NN O
of IN IN O
amlodipine NN NN O
5 CD CD O
mg NN NN O
poqd NN NN O
, , , O
atenolol NN NN O
50 CD CD O
mg NN NN O
poqd NN NN O
, , , O
simvastatin NN NN O
10 CD CD O
mg NN NN O
poqd NN NN O
, , , O
lisinopril NN NN O
10 CD CD O
mg NN NN O
poqd NN NN O
, , , O
Nitropatch NNP NNP O
.4 CD CD O
mg NN NN O
q.12 NN NN O
hours NNS NNS O
, , , O
Neurontin NNP NNP O
400 CD CD O
mg NN NN O
potid NN NN O
, , , O
furosemide NN NN O
40 CD CD O
mg NN NN O
poqd NN NN O
( ( ( O
recently RB RB O
increased VBN VBN O
) ) ) O
, , , O
Lamactil NNP NNP O
150 CD CD O
mg NN NN O
pobid NN NN O
, , , O
Trusopt NNP NNP O
and CC CC O
Xalantan NNP NNP O
drops NNS NNS O
, , , O
insulin NN NN O
10 CD CD O
units NNS NNS O
of IN IN O
CZI NNP NNP O
with IN IN O
72 CD CD O
units NNS NNS O
NPH NNP NNP O
qam NN NN O
and CC CC O
74 CD CD O
units NNS NNS O
NPH NNP NNP O
qpm NN NN O
. . . O
   
Physical JJ JJ O
exam NN NN O
reveals VBZ VBZ O
an DT DT O
overweight NN NN O
woman NN NN O
in IN IN O
no DT DT O
distress NN NN O
. . . O
   
Blood NNP NNP O
pressure NN NN O
, , , O
right JJ JJ O
arm NN NN O
sitting VBG VBG O
- : : O
110/70 CD CD O
, , , O
heart NN NN O
rate NN NN O
- : : O
70 CD CD O
and CC CC O
regular JJ JJ O
, , , O
respirations NNS NNS O
- : : O
12 CD CD O
and CC CC O
unlabored JJ JJ O
, , , O
weight NN NN O
- - - O
174 CD CD O
pounds NNS NNS O
which WDT WDT O
is VBZ VBZ O
four CD CD O
pounds NNS NNS O
below IN IN O
her PRP$ PRP$ O
weight NN NN O
of IN IN O
six CD CD O
months NNS NNS O
ago RB RB O
. . . O
   
The DT DT O
neck NN NN O
is VBZ VBZ O
supple JJ JJ O
with IN IN O
JVP NNP NNP O
flat JJ JJ O
. . . O
   
Carotids NNP NNP O
are VBP VBP O
2 CD CD O
+ NN NN O
without IN IN O
significant JJ JJ O
bruits NNS NNS O
. . . O
   
Chest NN NN O
is VBZ VBZ O
clear JJ JJ O
. . . O
   
Cardiac NNP NNP O
exam NN NN O
shows VBZ VBZ O
normal JJ JJ O
S1 NNP NNP O
, , , O
physiologically RB RB O
split NN NN O
S2 NNP NNP O
, , , O
and CC CC O
a DT DT O
I/VI NNP NNP O
holosystolic JJ JJ O
murmur NN NN O
radiating VBG VBG O
from IN IN O
the DT DT O
apex NN NN O
to TO TO O
the DT DT O
axilla NN NN O
. . . O
   
No DT DT O
significant JJ JJ O
diastolic JJ JJ O
murmur NN NN O
or CC CC O
rub NN NN O
. . . O
   
The DT DT O
abdomen NN NN O
is VBZ VBZ O
benign NN NN O
. . . O
   
Extremities NNPS NNPS O
reveal VBP VBP O
marked VBN VBN O
left VBN VBN O
greater JJR JJR O
than IN IN O
right NN NN O
pedal NN NN O
edema NN NN O
. . . O
   
Peripheral NNP NNP O
pulses NNS NNS O
are VBP VBP O
diminished VBN VBN O
. . . O
   
Electrocardiogram NNP NNP O
shows VBZ VBZ O
sinus NN NN O
rhythm NN NN O
at IN IN O
a DT DT O
rate NN NN O
of IN IN O
70 CD CD O
, , , O
PR NNP NNP O
interval NN NN O
of IN IN O
.12, CD CD O
QRS NNP NNP O
of IN IN O
.06, CD CD O
QT NNP NNP O
of IN IN O
.36, CD CD O
axis NNS NNS O
of IN IN O
   
- : : O
25 CD CD O
. . . O
There EX EX O
is VBZ VBZ O
borderline NN NN O
Paul NNP NNP I-DOCTOR
Arteaga NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
   
December NNP NNP I-DATE
11 CD CD O
, , , O
2076 CD CD I-DATE
Page NNP NNP O
Two CD CD O
Re NNP NNP O
: : : O
Christine NNP NNP I-PATIENT
Olivier NNP NNP I-PATIENT
MR NNP NNP O
#652-33-21-5 NN NN O
evidence NN NN O
for IN IN O
left VBD VBD O
ventricular NN NN O
hypertrophy NN NN O
with IN IN O
secondary JJ JJ O
ST NNP NNP O
and CC CC O
T NN NN O
- - - O
wave NN NN O
changes NNS NNS O
. . . O
   
Compared VBN VBN O
with IN IN O
the DT DT O
last JJ JJ O
electrocardiogram NN NN O
, , , O
there EX EX O
has VBZ VBZ O
been VBN VBN O
no DT DT O
significant JJ JJ O
change NN NN O
. . . O
   
Presently RB RB O
, , , O
Mrs NNP NNP O
. . . O
   
Olivier NNP NNP I-PATIENT
has VBZ VBZ O
evidence NN NN O
of IN IN O
continuing VBG VBG O
chest NN NN O
and CC CC O
left VBN VBN O
shoulder NN NN O
discomfort NN NN O
which WDT WDT O
she PRP PRP O
believes VBZ VBZ O
is VBZ VBZ O
similar JJ JJ O
to TO TO O
her PRP$ PRP$ O
pre-bypass JJ JJ O
surgery NN NN O
angina NN NN O
. . . O
   
In IN IN O
this DT DT O
setting VBG VBG O
, , , O
a DT DT O
dobutamine NN NN O
stress NN NN O
test NN NN O
performed VBN VBN O
last JJ JJ O
June NNP NNP I-DATE
showed VBD VBD O
no DT DT O
evidence NN NN O
of IN IN O
provokable JJ JJ O
ischemia NN NN O
. . . O
   
I PRP PRP O
have VBP VBP O
spent VBN VBN O
some DT DT O
time NN NN O
discussing VBG VBG O
with IN IN O
Ms NNP NNP O
. . . O
Olivier NNP NNP I-PATIENT
our PRP$ PRP$ O
various JJ JJ O
therapeutic JJ JJ O
and CC CC O
diagnostic JJ JJ O
options NNS NNS O
. . . O
   
She PRP PRP O
made VBD VBD O
it PRP PRP O
quite RB RB O
clear JJ JJ O
that IN IN O
she PRP PRP O
would MD MD O
not RB RB O
consider VB VB O
repeat NN NN O
cardiac JJ JJ O
catheterization NN NN O
at IN IN O
this DT DT O
time NN NN O
, , , O
and CC CC O
furthermore RB RB O
, , , O
was VBD VBD O
very RB RB O
disinterested VBN VBN O
in IN IN O
pursuing VBG VBG O
the DT DT O
possibility NN NN O
( ( ( O
should MD MD O
she PRP PRP O
require VB VB O
it PRP PRP O
) ) ) O
of IN IN O
either DT DT O
mechanical JJ JJ O
or CC CC O
surgical JJ JJ O
re NN NN O
- - - O
vascularization NN NN O
. . . O
   
It PRP PRP O
is VBZ VBZ O
not RB RB O
entirely RB RB O
clear JJ JJ O
to TO TO O
me PRP PRP O
that IN IN O
her PRP$ PRP$ O
left JJ JJ O
shoulder NN NN O
syndrome NN NN O
is VBZ VBZ O
in IN IN O
fact NN NN O
ischemic JJ JJ O
in IN IN O
origin NN NN O
, , , O
and CC CC O
she PRP PRP O
certainly RB RB O
understands VBZ VBZ O
it PRP PRP O
may MD MD O
be VB VB O
secondary JJ JJ O
to TO TO O
musculoskeletal JJ JJ O
abnormalities NNS NNS O
. . . O
   
I PRP PRP O
have VBP VBP O
suggested VBN VBN O
that IN IN O
she PRP PRP O
discuss VBP VBP O
that IN IN O
further JJ JJ O
with IN IN O
you PRP PRP O
. . . O
   
In IN IN O
the DT DT O
meantime NN NN O
, , , O
I PRP PRP O
have VBP VBP O
asked VBN VBN O
her PRP$ PRP$ O
( ( ( O
as IN IN O
her PRP$ PRP$ O
back RB RB O
and CC CC O
chest NN NN O
discomfort NN NN O
syndrome NN NN O
appears VBZ VBZ O
to TO TO O
occur VB VB O
mostly RB RB O
at IN IN O
night NN NN O
prior RB RB O
to TO TO O
lying VBG VBG O
down RP RP O
for IN IN O
bed NN NN O
) ) ) O
to TO TO O
apply VB VB O
her PRP$ PRP$ O
Nitropatch NNP NNP O
in IN IN O
the DT DT O
evening NN NN O
and CC CC O
take VB VB O
it PRP PRP O
off RP RP O
in IN IN O
the DT DT O
morning NN NN O
. . . O
   
She PRP PRP O
will MD MD O
call VB VB O
me PRP PRP O
within IN IN O
the DT DT O
next JJ JJ O
several JJ JJ O
days NNS NNS O
to TO TO O
report VB VB O
how WRB WRB O
this DT DT O
helps VBZ VBZ O
her PRP$ PRP$ O
discomfort NN NN O
syndrome NN NN O
. . . O
   
I PRP PRP O
do VBP VBP O
not RB RB O
believe VB VB O
that IN IN O
she PRP PRP O
is VBZ VBZ O
having VBG VBG O
GERD NNP NNP O
to TO TO O
explain VB VB O
her PRP$ PRP$ O
symptoms NNS NNS O
. . . O
   
In IN IN O
light NN NN O
of IN IN O
her PRP$ PRP$ O
reluctance NN NN O
to TO TO O
undergo VB VB O
any DT DT O
further JJ JJ O
diagnostic JJ JJ O
cardiac JJ JJ O
studies NNS NNS O
, , , O
I PRP PRP O
will MD MD O
try VB VB O
to TO TO O
tailor NN NN O
her PRP$ PRP$ O
anti-ischemic JJ JJ O
medications NNS NNS O
to TO TO O
minimize VB VB O
her PRP$ PRP$ O
chest NN NN O
discomfort NN NN O
syndrome NN NN O
. . . O
   
I PRP PRP O
, , , O
of IN IN O
course NN NN O
, , , O
will MD MD O
keep VB VB O
you PRP PRP O
fully RB RB O
informed VBD VBD O
as IN IN O
to TO TO O
her PRP$ PRP$ O
progress NN NN O
, , , O
and CC CC O
I PRP PRP O
thank VBP VBP O
you PRP PRP O
for IN IN O
allowing VBG VBG O
me PRP PRP O
to TO TO O
assist VB VB O
in IN IN O
her PRP$ PRP$ O
care NN NN O
. . . O
   
Sincerely NNP NNP O
yours NNS NNS O
, , , O
Irineo NNP NNP I-DOCTOR
Tovar NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
/ NN NN O
vuong NN NN I-DOCTOR
DD NNP NNP O
: : : O
12/11/76 CD CD I-DATE
DT NNP NNP O
: : : O
01/14/77 CD CD I-DATE
DV NNP NNP O
: : : O
12/11/76 CD CD I-DATE
******** NN NN O
Not RB RB O
reviewed VBN VBN O
by IN IN O
Attending NNP NNP O
Physician NNP NNP O
******** NN NN O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2082-02-03 NN NN I-DATE
85 CD CD I-AGE
yo NN NN O
male NN NN O
for IN IN O
follow VB VB O
up RP RP O
. . . O
   
c/o NN NN O
mainly RB RB O
of IN IN O
arthritis NNS NNS O
pain NN NN O
in IN IN O
hands NNS NNS O
. . . O
   
no DT DT O
redness NN NN O
or CC CC O
swelling VBG VBG O
. . . O
   
Sleeping VBG VBG O
well RB RB O
at IN IN O
night NN NN O
with IN IN O
no DT DT O
pnd NN NN O
or CC CC O
orthopnea NN NN O
. . . O
   
sleeping VBG VBG O
in IN IN O
bed NN NN O
as IN IN O
opposed VBN VBN O
to TO TO O
couch/chair NN NN O
. . . O
   
finds VBZ VBZ O
reflux NN NN O
of IN IN O
small JJ JJ O
amount NN NN O
of IN IN O
food NN NN O
every DT DT O
three CD CD O
meals NNS NNS O
if IN IN O
he PRP PRP O
eats VBZ VBZ O
quickly RB RB O
. . . O
   
sometimes RB RB O
gets VBZ VBZ O
rushed VBN VBN O
by IN IN O
family NN NN O
members NNS NNS O
. . . O
   
no DT DT O
dysphagia NN NN O
or CC CC O
odynophagia NN NN O
. . . O
   
PROBLEMS NNS NNS O
Congestive NNP NNP O
heart NN NN O
failure NN NN O
Chronic NNP NNP O
obstructive JJ JJ O
pulmonary JJ JJ O
disease NN NN O
Hypertension NNP NNP O
Gout NNP NNP O
DJD NNP NNP O
Benign NNP NNP O
prostatic JJ JJ O
hypertrophy NN NN O
Hyperlipidemia NNP NNP O
Chronic NNP NNP O
renal JJ JJ O
dysfunction NN NN O
Peripheral NNP NNP O
vascular NN NN O
disease NN NN O
s/p NN NN O
right NN NN O
fem-tib JJ JJ O
bypass NN NN O
1/78 CD CD I-DATE
Prostatic NNP NNP O
nodule NN NN O
psa NN NN O
1.6 CD CD O
09/81 CD CD I-DATE
. . . O
   
seen VBN VBN O
by IN IN O
dr NN NN O
. . . O
hoover NN NN I-DOCTOR
in IN IN O
11/81 CD CD I-DATE
who WP WP O
recommended VBD VBD O
yearly RB RB O
follow VB VB O
up RP RP O
. . . O
   
MEDICATIONS NNP NNP O
PREDNISONE NNP NNP O
5MG CD CD O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Take NNP NNP O
as IN IN O
directed VBN VBN O
COUMADIN NNP NNP O
( ( ( O
WARFARIN NNP NNP O
SODIUM NNP NNP O
) ) ) O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QPM NNP NNP O
Take NNP NNP O
as IN IN O
directed VBN VBN O
per IN IN O
anticoag NN NN O
HYDRALAZINE NNP NNP O
HCL NNP NNP O
10MG CD CD O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QID NNP NNP O
Take NNP NNP O
as IN IN O
directed VBN VBN O
ISORDIL NNP NNP O
( ( ( O
ISOSORBIDE NNP NNP O
DINITRATE NNP NNP O
) ) ) O
20MG CD CD O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
TID NNP NNP O
Take VB VB O
as IN IN O
directed VBN VBN O
ALLOPURINOL NNP NNP O
100MG CD CD O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Take NNP NNP O
as IN IN O
directed VBN VBN O
K-DUR NNP NNP O
( ( ( O
KCL NNP NNP O
SLOW NNP NNP O
REL NNP NNP O
. . . O
) ) ) O
20MEQ CD CD O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Take NNP NNP O
as IN IN O
directed VBN VBN O
CALCIUM NNP NNP O
CARBONATE NNP NNP O
( ( ( O
500 CD CD O
MG NNP NNP O
ELEMENTAL NNP NNP O
CA NNP NNP O
) ) ) O
500MG CD CD O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Take NNP NNP O
as IN IN O
directed VBN VBN O
DIGOXIN NNP NNP O
0.125MG CD CD O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QOD NNP NNP O
Take NNP NNP O
as IN IN O
directed VBN VBN O
COLCHICINE NNP NNP O
0.6MG CD CD O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QOD NNP NNP O
Take NNP NNP O
as IN IN O
directed VBN VBN O
PRILOSEC NNP NNP O
( ( ( O
OMEPRAZOLE NNP NNP O
) ) ) O
20MG CD CD O
1 CD CD O
Capsule NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
METOPROLOL NNP NNP O
TARTRATE NNP NNP O
50MG CD CD O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
BID NNP NNP O
Take NNP NNP O
as IN IN O
directed VBN VBN O
LASIX NNP NNP O
( ( ( O
FUROSEMIDE NNP NNP O
) ) ) O
40MG CD CD O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
BID NNP NNP O
Take NNP NNP O
as IN IN O
directed VBN VBN O
CELEBREX NNP NNP O
( ( ( O
CELECOXIB NNP NNP O
) ) ) O
200MG CD CD O
1 CD CD O
Capsule NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Take NNP NNP O
as IN IN O
directed VBN VBN O
ALLERGY NNP NNP O
Penicillins NNP NNP O
Unknown JJ JJ O
exam NN NN O
: : : O
weight NN NN O
192(down CD CD O
8 CD CD O
lbs NN NN O
) ) ) O
bp NN NN O
130/70 CD CD O
pulse NN NN O
72 CD CD O
appears VBZ VBZ O
well RB RB O
lungs:slight VBN VBN O
rales NNS NNS O
at IN IN O
bases NNS NNS O
with IN IN O
diminished JJ JJ O
sounds NNS NNS O
throughout IN IN O
but CC CC O
no DT DT O
wheeze NN NN O
. . . O
   
abd NN NN O
: : : O
obese NN NN O
soft JJ JJ O
and CC CC O
nontender NN NN O
ext JJ JJ O
: : : O
no DT DT O
edema NN NN O
. . . O
   
hands NNS NNS O
: : : O
no DT DT O
redness NN NN O
or CC CC O
swelling VBG VBG O
a/p NN NN O
chf NN NN O
: : : O
stable JJ JJ O
. . . O
   
lung NN NN O
exam NN NN O
at IN IN O
baseline NN NN O
. . . O
   
follow VB VB O
present JJ JJ O
management NN NN O
. . . O
   
copd NN NN O
: : : O
stable JJ JJ O
. . . O
   
htn NN NN O
: : : O
stable JJ JJ O
. . . O
   
Gerd NNP NNP O
: : : O
tertiary JJ JJ O
contractions NNS NNS O
on IN IN O
barium NN NN O
swallow NN NN O
in IN IN O
october NNP NNP I-DATE
. . . O
   
advised VBD VBD O
to TO TO O
eat VB VB O
slowly RB RB O
, , , O
taking VBG VBG O
his PRP$ PRP$ O
time NN NN O
and CC CC O
cutting VBG VBG O
food NN NN O
in IN IN O
small JJ JJ O
pieces NNS NNS O
. . . O
   
prostatic JJ JJ O
nodule NN NN O
: : : O
seen VBN VBN O
by IN IN O
dr NN NN O
. . . O
hoover NN NN I-DOCTOR
on IN IN O
11/27/81 CD CD I-DATE
and CC CC O
found VBD VBD O
asymmetry NN NN O
with IN IN O
left VBD VBD O
> NN NN O
right NN NN O
. . . O
   
his PRP$ PRP$ O
plan NN NN O
is VBZ VBZ O
yearly JJ JJ O
exam NN NN O
. . . O
   
guaiac NN NN O
positive JJ JJ O
stool NN NN O
: : : O
Will MD MD O
be VB VB O
having VBG VBG O
colonoscopy NN NN O
in IN IN O
the DT DT O
next JJ JJ O
month NN NN O
. . . O
   
arthritis NN NN O
: : : O
asked VBD VBD O
him PRP PRP O
to TO TO O
call VB VB O
arthritis NN NN O
clinic NN NN O
: : : O
dr NN NN O
. . . O
quijada NN NN I-DOCTOR
for IN IN O
follow VB VB O
up RP RP O
. . . O
   
continue VB VB O
with IN IN O
prednisone NN NN O
. . . O
   
HEALTH NNP NNP O
MAINTENANCE NNP NNP O
Influenza NNP NNP O
10/02/2081 CD CD I-DATE
Cholesterol NNP NNP O
10/03/2081 CD CD I-DATE
217 CD CD O
DESIRABLE NNP NNP O
: : : O
less JJR JJR O
then RB RB O
200 CD CD O
Rectal NNP NNP O
exam NN NN O
10/02/2081 CD CD I-DATE
Stool NNP NNP O
Guaiac NNP NNP O
12/05/2081 CD CD I-DATE
one CD CD O
trace NN NN O
postiive JJ JJ O
out IN IN O
of IN IN O
three CD CD O
Done VBN VBN O
- - - O
positive JJ JJ O
Pneumovax NNP NNP O
11/07/75 CD CD I-DATE
Done VBN VBN O
Smoking NNP NNP O
status NN NN O
10/02/2081 CD CD I-DATE
Never RB RB O
a DT DT O
smoker NN NN O
UA-Protein NNP NNP O
08/31/2081 CD CD I-DATE
1 CD CD O
+ NN NN O
check NN NN O
tsh NN NN O
follow VB VB O
up RB RB O
in IN IN O
three CD CD O
months NNS NNS O
. . . O
   
_____________________________________________ NN NN O
_ NN NN O
David NNP NNP I-DOCTOR
S. NN NN I-DOCTOR
Hale NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2087-03-09 JJ JJ I-DATE
VIGIL NNP NNP O
, , , O
ANTHONY NNP NNP I-PATIENT
40984972 CD CD I-MEDICALRECORD
03/09/2087 CD CD I-DATE
Amir NNP NNP I-DOCTOR
Naranjo NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
   
Saint NNP NNP I-HOSPITAL
Josephs NNP NNP I-HOSPITAL
Hospital NNP NNP I-HOSPITAL
Of IN IN I-HOSPITAL
Atlanta NNP NNP I-HOSPITAL
4 CD CD I-STREET
Kelly NNP NNP I-STREET
Street NNP NNP I-STREET
Bangkok NNP NNP I-CITY
, , , O
NJ NNP NNP I-STATE
53591 CD CD I-ZIP
Dear RB RB O
Dr NNP NNP I-STREET
. . . O
Naranjo NNP NNP I-DOCTOR
: : : O
We PRP PRP O
saw VBD VBD O
Anthony NNP NNP I-PATIENT
Vigil NNP NNP I-PATIENT
in IN IN O
the DT DT O
Internal NNP NNP O
Medicine NNP NNP O
at IN IN O
the DT DT O
Dixmont NNP NNP I-HOSPITAL
State NNP NNP I-HOSPITAL
Hospital NNP NNP I-HOSPITAL
on IN IN O
03/09/2087 CD CD I-DATE
. . . O
   
He PRP PRP O
underwent JJ JJ O
orthotopic JJ JJ O
heart NN NN O
transplant NN NN O
at IN IN O
the DT DT O
Dixmont NNP NNP I-HOSPITAL
State NNP NNP I-HOSPITAL
Hospital NNP NNP I-HOSPITAL
on IN IN O
03/30/2084 CD CD I-DATE
and CC CC O
returns NNS NNS O
now RB RB O
for IN IN O
his PRP$ PRP$ O
annual JJ JJ O
evaluation NN NN O
. . . O
   
In IN IN O
the DT DT O
interval NN NN O
since IN IN O
last JJ JJ O
seen VBN VBN O
, , , O
he PRP PRP O
has VBZ VBZ O
done VBN VBN O
reasonably RB RB O
well RB RB O
. . . O
   
His PRP$ PRP$ O
last JJ JJ O
annual JJ JJ O
evaluation NN NN O
at IN IN O
Lorain NNP NNP I-HOSPITAL
Community NNP NNP I-HOSPITAL
Hospital NNP NNP I-HOSPITAL
revealed VBD VBD O
an DT DT O
ejection NN NN O
fraction NN NN O
of IN IN O
55 CD CD O
% NN NN O
by IN IN O
echocardiography NN NN O
and CC CC O
no DT DT O
coronary JJ JJ O
disease NN NN O
, , , O
although IN IN O
left VBD VBD O
anterior JJ JJ O
descending NN NN O
was VBD VBD O
tortuous JJ JJ O
. . . O
   
Filling NNP NNP O
pressures NNS NNS O
were VBD VBD O
normal JJ JJ O
, , , O
then RB RB O
with IN IN O
a DT DT O
wedge NN NN O
of IN IN O
15 CD CD O
and CC CC O
a DT DT O
right JJ JJ O
atrial JJ JJ O
pressure NN NN O
of IN IN O
9 CD CD O
while IN IN O
the DT DT O
pulmonary JJ JJ O
artery NN NN O
pressure NN NN O
was VBD VBD O
30/19 CD CD O
with IN IN O
a DT DT O
mean NN NN O
of IN IN O
   
25 CD CD O
. . . O
The DT DT O
patient NN NN O
does VBZ VBZ O
have VB VB O
a DT DT O
herniated JJ JJ O
disk NN NN O
at IN IN O
L4 NNP NNP O
and CC CC O
stenosis NN NN O
at IN IN O
L5 NNP NNP O
. . . O
   
He PRP PRP O
has VBZ VBZ O
lower JJR JJR O
extremity NN NN O
cramps NNS NNS O
, , , O
which WDT WDT O
potentially RB RB O
due JJ JJ O
to TO TO O
his PRP$ PRP$ O
spine NN NN O
disease NN NN O
have VBP VBP O
been VBN VBN O
markedly RB RB O
exacerbated VBN VBN O
by IN IN O
Pravachol NNP NNP O
. . . O
   
The DT DT O
Pravachol NNP NNP O
was VBD VBD O
therefore RB RB O
stopped VBN VBN O
, , , O
restarted VBD VBD O
, , , O
and CC CC O
stopped VBD VBD O
again RB RB O
. . . O
   
He PRP PRP O
continues VBZ VBZ O
to TO TO O
take VB VB O
insulin NN NN O
and CC CC O
his PRP$ PRP$ O
last JJ JJ O
hemoglobin NN NN O
A1c NNP NNP O
was VBD VBD O
6.6 CD CD O
. . . O
   
He PRP PRP O
has VBZ VBZ O
had VBN VBN O
two CD CD O
recent JJ JJ O
episodes NNS NNS O
of IN IN O
mild JJ JJ O
hypoglycemia NN NN O
. . . O
   
He PRP PRP O
has VBZ VBZ O
had VBN VBN O
no DT DT O
dermatologic JJ JJ O
evaluation NN NN O
. . . O
   
He PRP PRP O
denies VBZ VBZ O
angina NN NN O
, , , O
congestive JJ JJ O
heart NN NN O
failure NN NN O
, , , O
or CC CC O
arrhythmias NN NN O
. . . O
   
Physical JJ JJ O
Examination NNP NNP O
: : : O
Reveals NNP NNP O
a DT DT O
weight NN NN O
of IN IN O
183 CD CD O
pounds NNS NNS O
, , , O
blood NN NN O
pressure NN NN O
of IN IN O
121/71 CD CD O
, , , O
pulse NN NN O
of IN IN O
100 CD CD O
. . . O
   
Jugular NNP NNP O
venous JJ JJ O
pressure NN NN O
is VBZ VBZ O
8 CD CD O
cm NN NN O
of IN IN O
water NN NN O
. . . O
   
Carotid NNP NNP O
upstrokes NNS NNS O
are VBP VBP O
brisk NN NN O
without IN IN O
bruits NNS NNS O
. . . O
   
There EX EX O
are VBP VBP O
diminished JJ JJ O
breath NN NN O
sounds VBZ VBZ O
in IN IN O
the DT DT O
left NN NN O
lung NN NN O
. . . O
   
Point NNP NNP O
of IN IN O
maximum NN NN O
impulse NN NN O
is VBZ VBZ O
not RB RB O
displaced VBN VBN O
. . . O
   
First CD CD O
heart NN NN O
sound NN NN O
is VBZ VBZ O
normal JJ JJ O
, , , O
second JJ JJ O
crisp NN NN O
and CC CC O
clear JJ JJ O
. . . O
   
He PRP PRP O
has VBZ VBZ O
an DT DT O
S4 NNP NNP O
at IN IN O
the DT DT O
left VBN VBN O
sternal JJ JJ O
border NN NN O
. . . O
   
The DT DT O
abdomen NN NN O
is VBZ VBZ O
without IN IN O
hepatosplenomegaly NN NN O
. . . O
   
There EX EX O
is VBZ VBZ O
no DT DT O
peripheral JJ JJ O
edema NN NN O
. . . O
   
Peripheral NNP NNP O
pulses NNS NNS O
are VBP VBP O
diminished VBN VBN O
. . . O
   
The DT DT O
electrocardiogram NN NN O
reveals VBZ VBZ O
a DT DT O
right JJ JJ O
bundle-branch JJ JJ O
block NN NN O
pattern NN NN O
with IN IN O
an DT DT O
intrinsic JJ JJ O
rate NN NN O
of IN IN O
98 CD CD O
beats NNS NNS O
per IN IN O
minute NN NN O
. . . O
   
There EX EX O
are VBP VBP O
nonspecific JJ JJ O
T-wave NNP NNP O
changes NNS NNS O
particularly RB RB O
in IN IN O
the DT DT O
early JJ JJ O
precordium NN NN O
. . . O
   
Current NNP NNP O
Medications NNP NNP O
: : : O
Calcium NNP NNP O
with IN IN O
D NNP NNP O
1250 CD CD O
mg NN NN O
twice RB RB O
per IN IN O
day NN NN O
, , , O
Cardura NNP NNP O
4 CD CD I-STREET
mg NN NN O
, , , O
CellCept NNP NNP O
1000 CD CD O
mg NN NN O
twice RB RB O
per IN IN O
day NN NN O
, , , O
diltiazem NN NN O
CD NNP NNP O
240 CD CD O
mg NN NN O
twice RB RB O
per IN IN O
day NN NN O
, , , O
Ecotrin NNP NNP O
81 CD CD O
mg NN NN O
per IN IN O
day NN NN O
, , , O
Lantus NNP NNP O
insulin NN NN O
26 CD CD O
units NNS NNS O
at IN IN O
night NN NN O
, , , O
magnesium NN NN O
oxide NN NN O
400 CD CD O
mg NN NN O
twice RB RB O
per IN IN O
day NN NN O
, , , O
vitamin NN NN O
, , , O
cyclosporine NN NN O
100 CD CD O
mg NN NN O
twice RB RB O
per IN IN O
day NN NN O
, , , O
Neurontin NNP NNP O
100 CD CD O
mg NN NN O
twice RB RB O
per IN IN O
day NN NN O
, , , O
NovoLog NNP NNP O
insulin NN NN O
as IN IN O
needed VBN VBN O
, , , O
prednisone NN NN O
5 CD CD O
mg NN NN O
per IN IN O
day NN NN O
, , , O
vitamins NNS NNS O
C NNP NNP O
500 CD CD O
mg NN NN O
twice RB RB O
per IN IN O
day NN NN O
, , , O
and CC CC O
vitamin NN NN O
E NNP NNP O
400 CD CD O
units NNS NNS O
twice RB RB O
per IN IN O
day NN NN O
. . . O
   
Impression NNP NNP O
: : : O
The DT DT O
patient NN NN O
will MD MD O
undergo VB VB O
his PRP$ PRP$ O
annual JJ JJ O
evaluation NN NN O
over IN IN O
the DT DT O
next JJ JJ O
24 CD CD O
hours NNS NNS O
. . . O
   
This DT DT O
will MD MD O
include VB VB O
blood NN NN O
work NN NN O
, , , O
chest NN NN O
x-ray NN NN O
, , , O
echocardiogram NN NN O
, , , O
metabolic JJ JJ O
exercise NN NN O
stress NN NN O
test NN NN O
, , , O
cardiac JJ JJ O
catheterization NN NN O
, , , O
coronary JJ JJ O
angiography NN NN O
, , , O
and CC CC O
endomyocardial JJ JJ O
biopsy NN NN O
. . . O
   
We PRP PRP O
will MD MD O
see VB VB O
him PRP PRP O
after IN IN O
completion NN NN O
of IN IN O
these DT DT O
studies NNS NNS O
and CC CC O
review NN NN O
the DT DT O
results NNS NNS O
with IN IN O
him PRP PRP O
. . . O
   
We PRP PRP O
will MD MD O
transmit VB VB O
the DT DT O
results NNS NNS O
to TO TO O
you PRP PRP O
as RB RB O
well RB RB O
at IN IN O
that DT DT O
time NN NN O
. . . O
   
Sincerely NNP NNP O
, , , O
_____________________________ NN NN O
_ NN NN O
Michael NNP NNP I-DOCTOR
P NN NN I-DOCTOR
Rasmussen NNP NNP I-DOCTOR
, , , O
MD NNP NNP O
eScription NN NN O
document:0-4411667 JJ JJ O
IFFocus NNP NNP O
CC NNP NNP O
: : : O
Joshua NNP NNP I-DOCTOR
Root NNP NNP I-DOCTOR
M.D. NNP NNP O
   
Bloomfield NNP NNP I-HOSPITAL
Care NNP NNP I-HOSPITAL
Center NNP NNP I-HOSPITAL
724 CD CD I-STREET
Westwood NNP NNP I-STREET
Dr NNP NNP I-STREET
Bangkok NNP NNP I-CITY
, , , O
NJ NNP NNP I-STATE
, , , O
53591 CD CD I-ZIP
Fax NNP NNP O
: : : O
Email NNP NNP O
: : : O
CC NNP NNP O
: : : O
James NNP NNP I-DOCTOR
Ingles NNP NNP I-DOCTOR
M.D. NNP NNP O
   
Lorain NNP NNP I-HOSPITAL
Community NNP NNP I-HOSPITAL
Hospital NNP NNP I-HOSPITAL
88 CD CD I-STREET
Cote NNP NNP I-STREET
Avenue NNP NNP I-STREET
Phnom NNP NNP I-CITY
Penh NNP NNP I-CITY
, , , O
NJ NNP NNP I-STATE
, , , O
71738 CD CD I-ZIP
Fax NNP NNP O
: : : O
Email NNP NNP O
: : : O
DD NNP NNP O
: : : O
03/09/87 CD CD I-DATE
DT NNP NNP O
: : : O
03/09/87 CD CD I-DATE
DV NNP NNP O
: : : O
03/09/87 CD CD I-DATE
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2076-02-17 JJ JJ I-DATE
Internal NNP NNP O
Medicine NNP NNP O
Admission NNP NNP O
Note VB VB O
Patient NNP NNP O
Name NN NN O
: : : O
Rivers NNP NNP O
, , , O
Karsten NNP NNP I-PATIENT
MRN NNP NNP O
( ( ( O
HH NNP NNP I-HOSPITAL
) ) ) O
: : : O
32054233 CD CD I-MEDICALRECORD
Attending NNP NNP O
: : : O
Dr NNP NNP O
. . . O
Gilmore NNP NNP I-DOCTOR
CC NNP NNP O
Ulcer NNP NNP O
on IN IN O
right NN NN O
outer NN NN O
foot NN NN O
x SYM SYM O
2 CD CD O
days NNS NNS O
HPI NNP NNP O
49 CD CD I-AGE
year NN NN O
old JJ JJ O
man NN NN O
with IN IN O
longstanding JJ JJ O
diabetes NNS NNS O
and CC CC O
neuropathy NN NN O
presented VBN VBN O
to TO TO O
HH NNP NNP I-HOSPITAL
ED NNP NNP O
for IN IN O
right NN NN O
foot NN NN O
ulcer NN NN O
. . . O
   
Patient NNP NNP O
reports NNS NNS O
that IN IN O
2 CD CD O
days NNS NNS O
ago RB RB O
, , , O
when WRB WRB O
he PRP PRP O
clean VB VB O
his PRP$ PRP$ O
feet NNS NNS O
, , , O
he PRP PRP O
noticed VBD VBD O
a DT DT O
piece NN NN O
of IN IN O
skin NN NN O
detached VBN VBN O
from IN IN O
his PRP$ PRP$ O
right JJ JJ O
outer NN NN O
foot NN NN O
. . . O
   
He PRP PRP O
removed VBD VBD O
the DT DT O
skin NN NN O
and CC CC O
cleaned VBD VBD O
the DT DT O
wound NN NN O
with IN IN O
alcohol NN NN O
swab NN NN O
and CC CC O
dressed VBN VBN O
with IN IN O
bind NN NN O
aid NN NN O
. . . O
   
He PRP PRP O
did VBD VBD O
not RB RB O
note VB VB O
any DT DT O
injury NN NN O
to TO TO O
his PRP$ PRP$ O
foot NN NN O
, , , O
did VBD VBD O
not RB RB O
find VB VB O
any DT DT O
foreign JJ JJ O
object NN NN O
in IN IN O
his PRP$ PRP$ O
shoes NNS NNS O
. . . O
   
He PRP PRP O
does VBZ VBZ O
recall NN NN O
that IN IN O
5 CD CD O
days NNS NNS O
ago RB RB O
, , , O
his PRP$ PRP$ O
daughter NN NN O
broke VBD VBD O
a DT DT O
vase NN NN O
but CC CC O
he PRP PRP O
did VBD VBD O
not RB RB O
step VB VB O
on IN IN O
it PRP PRP O
. . . O
   
The DT DT O
next JJ JJ O
day NN NN O
, , , O
he PRP PRP O
noticed VBD VBD O
right NN NN O
groin NN NN O
pain NN NN O
and CC CC O
felt VBD VBD O
a DT DT O
lump NN NN O
in IN IN O
the DT DT O
area NN NN O
. . . O
   
The DT DT O
right NN NN O
foot NN NN O
became VBD VBD O
warmer NN NN O
and CC CC O
more RBR RBR O
painful JJ JJ O
. . . O
   
He PRP PRP O
however RB RB O
denies VBZ VBZ O
any DT DT O
chills NNS NNS O
, , , O
fever NN NN O
, , , O
shaking VBG VBG O
or CC CC O
diaphoresis NNS NNS O
. . . O
   
He PRP PRP O
has VBZ VBZ O
been VBN VBN O
diagnosed VBN VBN O
with IN IN O
DM NNP NNP O
for IN IN O
more JJR JJR O
than IN IN O
20 CD CD O
years NNS NNS O
, , , O
was VBD VBD O
on IN IN O
insulin NN NN O
and CC CC O
had VBD VBD O
constant JJ JJ O
high JJ JJ O
blood NN NN O
glucose NN NN O
(& NN NN O
gt NN NN O
; : : O
   
600 CD CD O
) ) ) O
most JJS JJS O
of IN IN O
the DT DT O
time NN NN O
before IN IN O
the DT DT O
gastric JJ JJ O
bypass NN NN O
surgery NN NN O
. . . O
   
He PRP PRP O
has VBZ VBZ O
neuropathy JJ JJ O
for IN IN O
more JJR JJR O
than IN IN O
10 CD CD O
years NNS NNS O
. . . O
   
He PRP PRP O
had VBD VBD O
laparoscopic JJ JJ O
Roux-en-Y NNP NNP O
on IN IN O
06/08/2074 CD CD I-DATE
. . . O
   
His PRP$ PRP$ O
weight NN NN O
lost VBD VBD O
from IN IN O
435 CD CD O
lbs NN NN O
before IN IN O
the DT DT O
Sx NNP NNP O
to TO TO O
275 CD CD O
lbs NN NN O
. . . O
   
He PRP PRP O
is VBZ VBZ O
no RB RB O
longer RB RB O
on IN IN O
insulin NN NN O
. . . O
   
Current NNP NNP O
hypoglycemic JJ JJ O
regimen NN NN O
includes VBZ VBZ O
metformin NN NN O
850 CD CD O
mg NN NN O
daily JJ JJ O
. . . O
   
Last JJ JJ O
A1C NNP NNP O
was VBD VBD O
less JJR JJR O
than IN IN O
   
7 CD CD O
. . . O
He PRP PRP O
reports NNS NNS O
dry JJ JJ O
cough NN NN O
and CC CC O
he PRP PRP O
attributes VBZ VBZ O
to TO TO O
lisinopril VB VB O
. . . O
   
In IN IN O
ED NNP NNP O
, , , O
he PRP PRP O
was VBD VBD O
given VBN VBN O
morphine NN NN O
for IN IN O
pain NN NN O
and CC CC O
vancomycin NN NN O
iv NN NN O
for IN IN O
infection NN NN O
. . . O
   
Blood NNP NNP O
culture NN NN O
sent VBD VBD O
before RB RB O
given VBN VBN O
antibiotics NNS NNS O
. . . O
   
PMH NNP NNP O
DM NNP NNP O
Obesity NNP NNP O
s/p NN NN O
Roux-en-Y NNP NNP O
Right NNP NNP O
renal JJ JJ O
cancer NN NN O
s/p NN NN O
partial JJ JJ O
nephrectomy NN NN O
HTN NNP NNP O
Diabetic NNP NNP O
neuropathy JJ JJ O
Family NNP NNP O
History NN NN O
: : : O
Renal NNP NNP O
failure NN NN O
in IN IN O
father NN NN O
Habits NNP NNP O
Denies NNP NNP O
smoking NN NN O
, , , O
ex-smoker JJ JJ O
, , , O
quit VBD VBD O
6 CD CD O
years NNS NNS O
ago RB RB O
Social NNP NNP O
ETOH NNP NNP O
Denies NNP NNP O
recreational JJ JJ O
drugs NNS NNS O
Social NNP NNP O
History NN NN O
: : : O
Occupation NNP NNP O
Floor NNP NNP I-PROFESSION
Covering NNP NNP I-PROFESSION
Installer NNP NNP I-PROFESSION
Married NNP NNP O
, , , O
lives NNS NNS O
with IN IN O
spouse NN NN O
and CC CC O
children NNS NNS O
Medications NNP NNP O
Caltrate NNP NNP O
Plus NNP NNP O
D(600MG/400IU) NNP NNP O
( ( ( O
CALCIUM NNP NNP O
600mg CD CD O
+ NN NN O
Vitamin NNP NNP O
D(400IU)) NNP NNP O
1 CD CD O
TAB NNP NNP O
PO NNP NNP O
BID NNP NNP O
Labetalol NNP NNP O
Hcl NNP NNP O
300 CD CD O
MG NNP NNP O
( ( ( O
300MG CD CD O
TABLET NNP NNP O
Take NNP NNP O
1 CD CD O
) ) ) O
PO NNP NNP O
BID NNP NNP O
x SYM SYM O
90 CD CD O
days NNS NNS O
#180 NN NN O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
Lasix NNP NNP O
( ( ( O
FUROSEMIDE NNP NNP O
) ) ) O
80 CD CD O
MG NNP NNP O
( ( ( O
80 CD CD O
MG NNP NNP O
TABLET NNP NNP O
Take NNP NNP O
1 CD CD O
) ) ) O
PO NNP NNP O
BID NNP NNP O
#1 NN NN O
Month NN NN O
   
( ( ( O
s VBZ VBZ O
) ) ) O
Supply NNP NNP O
Lisinopril NNP NNP O
20 CD CD O
MG NNP NNP O
( ( ( O
20 CD CD O
MG NNP NNP O
TABLET NNP NNP O
Take NNP NNP O
1 CD CD O
) ) ) O
PO NNP NNP O
QD NNP NNP O
#Tablet NN NN O
   
( ( ( O
s VBZ VBZ O
) ) ) O
Miconazole NNP NNP O
Nitrate NNP NNP O
2 CD CD O
% NN NN O
Powder NNP NNP O
1 CD CD O
APPLICATION NNP NNP O
( ( ( O
2 CD CD O
% NN NN O
POWDER NNP NNP O
) ) ) O
TOP JJ JJ O
TID NNP NNP O
#1 NN NN O
month NN NN O
   
( ( ( O
s VBZ VBZ O
) ) ) O
SupplyOmeprazole NNP NNP O
20 CD CD O
MG NNP NNP O
( ( ( O
20 CD CD O
MG NNP NNP O
CAPSULE NNP NNP O
DR NNP NNP O
Take NNP NNP O
1 CD CD O
) ) ) O
PO NNP NNP O
BID NNP NNP O
#60 NN NN O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
Allergies NNP NNP O
Penicillins NNP NNP O
- : : O
Rash NNP NNP O
ROS NNP NNP O
Negative NNP NNP O
except IN IN O
noted VBD VBD O
in IN IN O
HPI NNP NNP O
Physical JJ JJ O
Examination NNP NNP O
Vitals NNP NNP O
: : : O
BP NNP NNP O
142/67 CD CD O
, , , O
HR NNP NNP O
87 CD CD O
, , , O
R NN NN O
18 CD CD O
, , , O
T NN NN O
99 CD CD O
, , , O
O2 NNP NNP O
sat VBD VBD O
99 CD CD O
rm NN NN O
air NN NN O
Patient NNP NNP O
is VBZ VBZ O
in IN IN O
no DT DT O
apparent JJ JJ O
distress NN NN O
, , , O
good JJ JJ O
attention NN NN O
to TO TO O
hygiene NN NN O
and CC CC O
body NN NN O
habitus NN NN O
. . . O
   
Oriented NNP NNP O
to TO TO O
person NN NN O
, , , O
place NN NN O
and CC CC O
time NN NN O
. . . O
   
obese NN NN O
. . . O
   
Mood NNP NNP O
normal JJ JJ O
and CC CC O
appropriate JJ JJ O
to TO TO O
situation NN NN O
. . . O
   
Eyes NNS NNS O
: : : O
EOMI NNP NNP O
HEENT NNP NNP O
: : : O
NC/AT NNP NNP O
Neck NNP NNP O
: : : O
Supple.No NNP NNP O
JVD NNP NNP O
. . . O
   
Thyroid NNP NNP O
is VBZ VBZ O
palpable JJ JJ O
with IN IN O
normal JJ JJ O
size NN NN O
and CC CC O
consistency NN NN O
. . . O
   
Respiratory NNP NNP O
: : : O
Auscultation NNP NNP O
of IN IN O
lungs NNS NNS O
reveal VBP VBP O
clear JJ JJ O
lung NN NN O
fields NNS NNS O
. . . O
   
Cardiovascular NNP NNP O
: : : O
Heart NNP NNP O
auscultation NN NN O
reveals VBZ VBZ O
normal JJ JJ O
S1 NNP NNP O
and CC CC O
S2 NNP NNP O
and CC CC O
no DT DT O
murmurs NNS NNS O
. . . O
   
Abdomen NNP NNP O
: : : O
Abdomen NNP NNP O
soft JJ JJ O
, , , O
nontender NN NN O
, , , O
bowel NN NN O
sounds VBZ VBZ O
present JJ JJ O
, , , O
no DT DT O
palpable JJ JJ O
masses NNS NNS O
. . . O
   
Neurological NNP NNP O
Examination NNP NNP O
: : : O
No DT DT O
focal JJ JJ O
deficit NN NN O
. . . O
   
DTR NNP NNP O
WNL NNP NNP O
Extremity NNP NNP O
exam NN NN O
: : : O
+ NN NN O
Right RB RB O
foot NN NN O
shallow JJ JJ O
ulcer NN NN O
with IN IN O
right NN NN O
foot NN NN O
erythema NN NN O
, , , O
warm JJ JJ O
and CC CC O
tender NN NN O
. . . O
   
Right RB RB O
groin NN NN O
enlarged JJ JJ O
and CC CC O
tender NN NN O
lymph NN NN O
node NN NN O
ResultsDate/Time NNP NNP O
NA NNP NNP O
K NNP NNP O
CL NNP NNP O
CO2 NNP NNP O
02/17/2076 CD CD I-DATE
137 CD CD O
3.8 CD CD O
100 CD CD O
30 CD CD O
( ( ( O
H NNP NNP O
) ) ) O
Date/Time NNP NNP O
BUN NNP NNP O
CRE NNP NNP O
EGFR NNP NNP O
GLU NNP NNP O
02/17/2076 CD CD I-DATE
24 CD CD O
( ( ( O
H NNP NNP O
) ) ) O
1.32 CD CD O
( ( ( O
H NNP NNP O
) ) ) O
& CC CC O
gt NN NN O
; : : O
   
60 CD CD O
177 CD CD O
( ( ( O
H NNP NNP O
) ) ) O
Date/Time NNP NNP O
ANION NNP NNP O
02/17/2076 CD CD I-DATE
8 CD CD O
Date/Time NNP NNP O
CA NNP NNP O
TBILI NNP NNP O
TP NNP NNP O
ALB NNP NNP O
02/17/2076 CD CD I-DATE
9.0 CD CD O
0.6 CD CD O
6.8 CD CD O
4.0 CD CD O
Date/Time NNP NNP O
ALT/SGPT NNP NNP O
AST/SGOT NNP NNP O
ALKP NNP NNP O
TBILI NNP NNP O
02/17/2076 CD CD I-DATE
10 CD CD O
15 CD CD O
110 CD CD O
0.6 CD CD O
Date/Time NNP NNP O
UACET NNP NNP O
02/17/2076 CD CD I-DATE
NEGATIVE NNP NNP O
Date/Time NNP NNP O
WBC NNP NNP O
RBC NNP NNP O
HGB NNP NNP O
HCT NNP NNP O
02/17/2076 CD CD I-DATE
13.6 NN NN O
( ( ( O
H NNP NNP O
) ) ) O
4.30 CD CD O
( ( ( O
L NNP NNP O
) ) ) O
11.9 CD CD O
( ( ( O
L NNP NNP O
) ) ) O
35.2 CD CD O
( ( ( O
L NNP NNP O
) ) ) O
Date/Time NNP NNP O
MCV NNP NNP O
MCH NNP NNP O
MCHC NNP NNP O
PLT NNP NNP O
02/17/2076 CD CD I-DATE
82 CD CD O
27.7 CD CD O
( ( ( O
L NNP NNP O
) ) ) O
33.9 CD CD O
237 CD CD O
Date/Time NNP NNP O
RDW NNP NNP O
02/17/2076 CD CD I-DATE
13.4 CD CD O
Date/Time NNP NNP O
% NN NN O
NEUT NNP NNP O
% NN NN O
MONO NNP NNP O
% NN NN O
EOS NNP NNP O
% NN NN O
BASO NNP NNP O
02/17/2076 CD CD I-DATE
82.0 CD CD O
( ( ( O
H NNP NNP O
) ) ) O
4.1 CD CD O
1.4 CD CD O
0.3 CD CD O
Date/Time NNP NNP O
% NN NN O
LYMPH-M NNP NNP O
02/17/2076 CD CD I-DATE
12.2 NN NN O
( ( ( O
L NNP NNP O
) ) ) O
Date/Time NNP NNP O
UA-COLOR NNP NNP O
UA-APP NNP NNP O
UA-GLUC NNP NNP O
UA-BILI NNP NNP O
02/17/2076 CD CD I-DATE
YELLOW NNP NNP O
CLEAR NNP NNP O
NEGATIVE NNP NNP O
NEGATIVE NNP NNP O
Date/Time NNP NNP O
UR-SPGR NNP NNP O
UA-BLD NNP NNP O
UA-PH NNP NNP O
UA-PROT NNP NNP O
02/17/2076 CD CD I-DATE
1.019 CD CD O
NEGATIVE NNP NNP O
5.0 CD CD O
TRACE NNP NNP O
( ( ( O
H NNP NNP O
) ) ) O
Date/Time NNP NNP O
UA-UROBI NNP NNP O
UA-NIT NNP NNP O
UA-WBC NNP NNP O
02/17/2076 CD CD I-DATE
1.0 CD CD O
NEGATIVE NNP NNP O
NEGATIVE NNP NNP O
EKG NNP NNP O
: : : O
NSR NNP NNP O
at IN IN O
77 CD CD O
BPM NNP NNP O
. . . O
   
No DT DT O
st NN NN O
elevation NN NN O
CXR NNP NNP O
: : : O
No DT DT O
infiltrates NNS NNS O
Right RB RB O
foot NN NN O
x-ray NN NN O
: : : O
No DT DT O
sigh NN NN O
suggest JJ JJ O
osteomyelitis NN NN O
Assessment NNP NNP O
: : : O
49 CD CD I-AGE
year NN NN O
old JJ JJ O
male NN NN O
with IN IN O
longstanding JJ JJ O
DM NNP NNP O
and CC CC O
diabetic JJ JJ O
neuropathy NN NN O
presents VBZ VBZ O
with IN IN O
new JJ JJ O
onset NN NN O
right NN NN O
foot NN NN O
ulcer NN NN O
and CC CC O
right JJ JJ O
groin NN NN O
lymph NN NN O
node NN NN O
enlargement NN NN O
. . . O
   
WBC NNP NNP O
is VBZ VBZ O
elevated VBN VBN O
. . . O
   
He PRP PRP O
likely JJ JJ O
has VBZ VBZ O
diabetic JJ JJ O
foot NN NN O
ulcer NN NN O
and CC CC O
foot NN NN O
cellulitis NNS NNS O
. . . O
   
X-ray NNP NNP O
dose NN NN O
not RB RB O
suggest JJ JJ O
osteomyelitis NNS NNS O
. . . O
   
Plan NNP NNP O
: : : O
#1 NN NN O
) ) ) O
Diabetic NNP NNP O
foot NN NN O
ulcer NN NN O
and CC CC O
cellulitis NNS NNS O
: : : O
given VBN VBN O
his PRP$ PRP$ O
risk NN NN O
for IN IN O
polymicrobial JJ JJ O
infection NN NN O
, , , O
will MD MD O
cover VB VB O
with IN IN O
broad JJ JJ O
spectrum NN NN O
antibiotics NNS NNS O
for IN IN O
aerobes NNS NNS O
and CC CC O
anaerobes VBZ VBZ O
plus CC CC O
MRSA NNP NNP O
. . . O
   
- : : O
Vancomycin NNP NNP O
1 CD CD O
gm NN NN O
iv NN NN O
daily JJ JJ O
- : : O
Zosyn NNP NNP O
4.5 CD CD O
gm NN NN O
iv NN NN O
q6H NN NN O
- : : O
F/U NNP NNP O
blood NN NN O
culture NN NN O
- : : O
Pain NN NN O
management NN NN O
- : : O
IV NNP NNP O
NS NNP NNP O
75 CD CD O
ml/hr NN NN O
#2 NN NN O
) ) ) O
DM NNP NNP O
, , , O
well RB RB O
controlled VBN VBN O
with IN IN O
metformin NN NN O
after IN IN O
gastric JJ JJ O
bypass NN NN O
. . . O
   
- - - O
Hold NNP NNP O
metformin NN NN O
- : : O
NPH NNP NNP O
5 CD CD O
u NN NN O
SC NNP NNP O
BID NNP NNP O
- : : O
Low NNP NNP O
scale NN NN O
SS NNP NNP O
- : : O
FS NNP NNP O
qAC NN NN O
3 CD CD O
# # # O
) ) ) O
HTN NNP NNP O
, , , O
on IN IN O
lisinopril NN NN O
and CC CC O
developed JJ JJ O
dry JJ JJ O
cough NN NN O
- - - O
d/c NN NN O
lisinopril NN NN O
, , , O
start VB VB O
Cozaar NNP NNP O
50 CD CD O
mg NN NN O
daily JJ JJ O
- : : O
Continue NNP NNP O
labetalol NN NN O
300mg CD CD O
bid NN NN O
- : : O
hold VB VB O
lasix NN NN O
DVT NNP NNP O
prophylaxis NNS NNS O
Code NNP NNP O
Full NNP NNP O
Ollie NNP NNP I-DOCTOR
Kern NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2095-02-04 JJ JJ I-DATE
Patient NNP NNP O
Name NN NN O
: : : O
SHEPHERD,AARON NNP NNP I-PATIENT
W NNP NNP I-PATIENT
[ NN NN O
5613892(BMH) CD CD O
] NN NN O
Date NN NN O
of IN IN O
Visit NNP NNP O
: : : O
02/04/2095 CD CD I-DATE
, , , O
7:40 CD CD O
am VBP VBP O
Admission NNP NNP O
Note VB VB O
- : : O
Attending/PCP NNP NNP O
S NNP NNP O
- : : O
79 CD CD I-AGE
yo NN NN O
M NNP NNP O
etired VBD VBD O
Archive NNP NNP I-PROFESSION
Manager NNP NNP I-PROFESSION
with IN IN O
a DT DT O
history NN NN O
of IN IN O
recent JJ JJ O
repair NN NN O
of IN IN O
right NN NN O
inguinal JJ JJ O
hernia NN NN O
who WP WP O
presents VBZ VBZ O
to TO TO O
the DT DT O
ER NNP NNP O
with IN IN O
a DT DT O
1-week JJ JJ O
history NN NN O
of IN IN O
abdominal JJ JJ O
pain NN NN O
localizing VBG VBG O
to TO TO O
the DT DT O
right NN NN O
lower JJR JJR O
quadrant/groin NN NN O
, , , O
constipation NN NN O
, , , O
urinary JJ JJ O
incontinence NN NN O
, , , O
admitted VBN VBN O
for IN IN O
mod NN NN O
. . . O
   
/ NN NN O
severe JJ JJ O
urinary JJ JJ O
retention NN NN O
( ( ( O
2 CD CD O
liters NNS NNS O
) ) ) O
, , , O
bilateral JJ JJ O
hydronephrosis NN NN O
due JJ JJ O
to TO TO O
severe JJ JJ O
BPH NNP NNP O
, , , O
also RB RB O
ARF NNP NNP O
to TO TO O
BUN/Cr NNP NNP O
30/3.0 CD CD O
. . . O
   
PMH NNP NNP O
significant JJ JJ O
for IN IN O
: : : O
constipation NN NN O
, , , O
depression NN NN O
, , , O
psychosis NN NN O
, , , O
insomnia NN NN O
, , , O
CAD NNP NNP O
, , , O
syncope NN NN O
, , , O
HTN NNP NNP O
, , , O
DMT2 NNP NNP O
, , , O
carotid NN NN O
stenosis NN NN O
, , , O
PVD NNP NNP O
. . . O
   
Details NNS NNS O
per IN IN O
Dr NNP NNP O
. . . O
Davidson NNP NNP I-DOCTOR
. . . O
   
Problems NNS NNS O
Hydronephrosis NNP NNP O
: : : O
bila NN NN O
. . . O
   
mod/severe NN NN O
2/95 CD CD I-DATE
due JJ JJ O
to TO TO O
very RB RB O
large JJ JJ O
prostate NN NN O
Acute JJ JJ O
renal JJ JJ O
failure NN NN O
: : : O
2/95 CD CD I-DATE
30/3.0 CD CD O
Peripheral NNP NNP O
vascular NN NN O
disease NN NN O
: : : O
Ca MD MD O
+ NN NN O
+ NN NN O
celiac NN NN O
axis NNS NNS O
and CC CC O
SMA NNP NNP O
2/95 CD CD I-DATE
Coronary JJ JJ O
artery NN NN O
disease NN NN O
Depression NNP NNP O
Weight NNP NNP O
loss NN NN O
Constipation NNP NNP O
Inguinal NNP NNP O
hernia NN NN O
Glaucoma NNP NNP O
Syncope NNP NNP O
Bradycardia NNP NNP O
Benign NNP NNP O
prostatic JJ JJ O
hypertrophy NN NN O
Nocturia NNP NNP O
Psychosis NNP NNP O
Diabetes NNP NNP O
mellitus NN NN O
type NN NN O
2 CD CD O
Hyperlipidemia NNP NNP O
Last NNP NNP O
Known VBN VBN O
Medications NNP NNP O
Aspirin NNP NNP O
( ( ( O
ACETYLSALICYLIC NNP NNP O
ACID NNP NNP O
) ) ) O
325 CD CD O
MG NNP NNP O
( ( ( O
325MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Brimonidine NNP NNP O
TARTRATE NNP NNP O
1 CD CD O
DROP NNP NNP O
( ( ( O
0.2 CD CD O
% NN NN O
DROPS NNP NNP O
) ) ) O
OU NNP NNP O
BID NNP NNP O
Cilostazol NNP NNP O
100 CD CD O
MG NNP NNP O
( ( ( O
100MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
) ) ) O
PO NNP NNP O
BID NNP NNP O
Dulcolax NNP NNP O
( ( ( O
BISACODYL NNP NNP O
) ) ) O
5 CD CD O
MG NNP NNP O
( ( ( O
5MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Lasix NNP NNP O
( ( ( O
FUROSEMIDE NNP NNP O
) ) ) O
20 CD CD O
MG NNP NNP O
( ( ( O
20MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Lisinopril NNP NNP O
40 CD CD O
MG NNP NNP O
( ( ( O
40MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Metformin NNP NNP O
1000 CD CD O
MG NNP NNP O
( ( ( O
1000MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
) ) ) O
PO NNP NNP O
BID NNP NNP O
Metoprolol NNP NNP O
TARTRATE NNP NNP O
50 CD CD O
MG NNP NNP O
( ( ( O
50MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
) ) ) O
PNGT NNP NNP O
BID NNP NNP O
Mvi NNP NNP O
( ( ( O
MULTIVITAMINS NNP NNP O
) ) ) O
1 CD CD O
TAB NNP NNP O
PO NNP NNP O
QD NNP NNP O
Norvasc NNP NNP O
( ( ( O
AMLODIPINE NNP NNP O
) ) ) O
10 CD CD O
MG NNP NNP O
( ( ( O
5MG CD CD O
TABLET NNP NNP O
take NN NN O
2 CD CD O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Remeron NNP NNP O
( ( ( O
MIRTAZAPINE NNP NNP O
) ) ) O
3.75 CD CD O
MG NNP NNP O
( ( ( O
15MG CD CD O
TABLET NNP NNP O
take NN NN O
0.25 CD CD O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Zocor NNP NNP O
( ( ( O
SIMVASTATIN NNP NNP O
) ) ) O
80 CD CD O
MG NNP NNP O
( ( ( O
80MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
) ) ) O
PO NNP NNP O
QHS NNP NNP O
Zyprexa NNP NNP O
( ( ( O
OLANZAPINE NNP NNP O
) ) ) O
5 CD CD O
MG NNP NNP O
( ( ( O
5MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
) ) ) O
PO NNP NNP O
QD NNP NNP O
, , , O
Take NNP NNP O
1 CD CD O
tab NN NN O
at IN IN O
bedtime NN NN O
Allergies NNP NNP O
NKA NNP NNP O
ROS NNP NNP O
No DT DT O
back NN NN O
or CC CC O
abdominal JJ JJ O
pain NN NN O
Geriatric NNP NNP O
ROS NNP NNP O
Yes UH UH O
No DT DT O
Do VBP VBP O
n't RB RB O
know VB VB O
Memory NN NN O
Intact NNP NNP O
? . . O
   
Yes UH UH O
Judgment NNP NNP O
Intact NNP NNP O
? . . O
   
Yes UH UH O
Safety NNP NNP O
Concerns NNS NNS O
? . . O
   
no DT DT O
Nutritional NNP NNP O
Concerns NNS NNS O
( ( ( O
i.e. NN NN O
lost VBD VBD O
wt NN NN O
. . . O
   
, , , O
eats NNS NNS O
poorly RB RB O
) ) ) O
? . . O
   
no DT DT O
Continent NNP NNP O
of IN IN O
urine NN NN O
? . . O
   
no DT DT O
Ambulation NNP NNP O
: : : O
Independent JJ JJ O
Bedbound NNP NNP O
? . . O
   
no DT DT O
Falls NNP NNP O
prior RB RB O
to TO TO O
this DT DT O
hospitalization NN NN O
? . . O
   
no DT DT O
Health NNP NNP O
Maintenance NNP NNP O
Pneumonia NNP NNP O
vaccine NN NN O
received VBD VBD O
? . . O
   
2094 CD CD I-DATE
Influenza NNP NNP O
vaccine NN NN O
received VBD VBD O
in IN IN O
last JJ JJ O
year NN NN O
? . . O
   
yes UH UH O
Social NNP NNP O
Born VBN VBN O
in IN IN O
Bryan NNP NNP I-CITY
. . . O
   
Raised NNP NNP O
in IN IN O
Shirley NNP NNP I-CITY
, , , O
Il NNP NNP I-STATE
. . . O
   
Currently RB RB O
lives VBZ VBZ O
in IN IN O
Shirley NNP NNP I-CITY
. . . O
   
Married NNP NNP O
for IN IN O
53 CD CD O
years NNS NNS O
with IN IN O
6 CD CD O
children NNS NNS O
and CC CC O
7 CD CD O
grandchildren NNS NNS O
. . . O
   
Advance NNP NNP O
Care NNP NNP O
Planning NNP NNP O
HCP NNP NNP O
: : : O
Wife NN NN O
, , , O
Ernestine NNP NNP I-PATIENT
is VBZ VBZ O
primary JJ JJ O
proxy NN NN O
. . . O
   
Alternative NNP NNP O
is VBZ VBZ O
daughter NN NN O
, , , O
Teresa NNP NNP I-PATIENT
Berry NNP NNP I-PATIENT
. . . O
   
Code NNP NNP O
Status NNP NNP O
: : : O
Has VBZ VBZ O
not RB RB O
decided VBN VBN O
as IN IN O
of IN IN O
yet RB RB O
. . . O
   
O NNP NNP O
- : : O
Alert NNP NNP O
, , , O
NAD NNP NNP O
Resp NNP NNP O
. . . O
   
- - - O
Clear NNP NNP O
RRR NNP NNP O
GI NNP NNP O
- : : O
Soft JJ JJ O
, , , O
no DT DT O
masses NNS NNS O
GU NNP NNP O
- : : O
Indwelling NNP NNP O
cath NN NN O
, , , O
gross JJ JJ O
heme NN NN O
in IN IN O
urineExt JJ JJ O
- - - O
No DT DT O
edema NN NN O
Neuro NNP NNP O
- : : O
Cogent NNP NNP O
, , , O
non-focal JJ JJ O
Assessment/Plan NNP NNP O
Constipation NNP NNP O
- : : O
Add NNP NNP O
miralx NN NN O
to TO TO O
discharge VB VB O
regimen NNS NNS O
Urinary NNP NNP O
retention NN NN O
- : : O
Relieved NNP NNP O
, , , O
await NN NN O
urology NN NN O
consult NN NN O
BPH NNP NNP O
- : : O
Per IN IN O
urology NN NN O
, , , O
op NN NN O
. . . O
   
this DT DT O
admission NN NN O
vs NNS NNS O
elective JJ JJ O
ARF NNP NNP O
- : : O
due JJ JJ O
to TO TO O
obstruction NN NN O
, , , O
follow VB VB O
as IN IN O
relieved VBN VBN O
. . . O
   
Disposition NNP NNP O
- : : O
Home NNP NNP O
with IN IN O
services NNS NNS O
Discussed VBN VBN O
with IN IN O
Dr NNP NNP O
. . . O
Davidson NNP NNP I-DOCTOR
___________________________________ NN NN O
_ NN NN O
Noah NNP NNP I-DOCTOR
Joseph NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
#01220 NN NN O
for IN IN O
Dr NNP NNP O
. . . O
Judge/Lugo NNP NNP O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2093-04-24 JJ JJ I-DATE
Narrative NNP NNP O
History NN NN O
81 CD CD I-AGE
year NN NN O
old JJ JJ O
woman NN NN O
who WP WP O
presents VBZ VBZ O
for IN IN O
an DT DT O
annual JJ JJ O
exam NN NN O
with IN IN O
her PRP$ PRP$ O
daughter-in-law JJ JJ O
, , , O
Franchesca NNP NNP I-PATIENT
Justice NNP NNP I-PATIENT
. . . O
   
They PRP PRP O
would MD MD O
like VB VB O
to TO TO O
discuss VB VB O
the DT DT O
following VBG VBG O
issues NNS NNS O
: : : O
   
1 CD CD O
. . . O
Shoulder NNP NNP O
pain NN NN O
: : : O
She PRP PRP O
continues VBZ VBZ O
to TO TO O
have VB VB O
bilateral JJ JJ O
shoulder NN NN O
pain NN NN O
, , , O
but CC CC O
the DT DT O
L NNP NNP O
shoulder NN NN O
is VBZ VBZ O
worse JJR JJR O
than IN IN O
the DT DT O
right NN NN O
. . . O
   
She PRP PRP O
has VBZ VBZ O
been VBN VBN O
taking VBG VBG O
Prednisone NNP NNP O
9 CD CD O
mg NN NN O
a DT DT O
day NN NN O
for IN IN O
a DT DT O
long JJ JJ O
time NN NN O
but CC CC O
has VBZ VBZ O
not RB RB O
f/u VBN VBN O
with IN IN O
Rheum NNP NNP O
for IN IN O
about IN IN O
a DT DT O
year NN NN O
. . . O
   
She PRP PRP O
did VBD VBD O
have VB VB O
a DT DT O
cortisone NN NN O
in IN IN O
the DT DT O
L NNP NNP O
shoulder NN NN O
in IN IN O
the DT DT O
past JJ JJ O
. . . O
   
She PRP PRP O
is VBZ VBZ O
able JJ JJ O
to TO TO O
lift VB VB O
her PRP$ PRP$ O
arms NNS NNS O
over IN IN O
her PRP$ PRP$ O
head NN NN O
. . . O
   
2 CD CD O
. . . O
Depression NNP NNP O
: : : O
Her PRP$ PRP$ O
family NN NN O
feels VBZ VBZ O
that IN IN O
she PRP PRP O
is VBZ VBZ O
doing VBG VBG O
much RB RB O
better RBR RBR O
on IN IN O
the DT DT O
Effexor NNP NNP O
than IN IN O
the DT DT O
Celexa NNP NNP O
. . . O
   
The DT DT O
pt NN NN O
has VBZ VBZ O
seen VBN VBN O
Dr NNP NNP O
. . . O
Ramsey NNP NNP I-DOCTOR
in IN IN O
Psych NNP NNP O
a DT DT O
few JJ JJ O
months NNS NNS O
ago RB RB O
. . . O
   
3 CD CD O
. . . O
Dementia NNP NNP O
: : : O
Dr NNP NNP O
. . . O
Ramsey NNP NNP I-DOCTOR
recommended VBD VBD O
continuing VBG VBG O
on IN IN O
the DT DT O
Aricept NNP NNP O
. . . O
   
Overall NNP NNP O
, , , O
the DT DT O
pt NN NN O
's POS POS O
family NN NN O
feels VBZ VBZ O
that IN IN O
her PRP$ PRP$ O
memory NN NN O
is VBZ VBZ O
worsening VBG VBG O
, , , O
although IN IN O
some DT DT O
days NNS NNS O
are VBP VBP O
better JJR JJR O
than IN IN O
others NNS NNS O
. . . O
   
She PRP PRP O
has VBZ VBZ O
not RB RB O
had VBN VBN O
any DT DT O
other JJ JJ O
episodes NNS NNS O
of IN IN O
halluncination NN NN O
, , , O
as IN IN O
was VBD VBD O
described VBN VBN O
in IN IN O
an DT DT O
email NN NN O
from IN IN O
her PRP$ PRP$ O
son NN NN O
a DT DT O
couple NN NN O
weeks NNS NNS O
ago RB RB O
. . . O
   
The DT DT O
pt NN NN O
states NNS NNS O
that IN IN O
she PRP PRP O
is VBZ VBZ O
sleeping VBG VBG O
and CC CC O
eating VBG VBG O
well RB RB O
, , , O
but CC CC O
her PRP$ PRP$ O
family NN NN O
thinks VBZ VBZ O
that IN IN O
she PRP PRP O
sleeps VBZ VBZ O
too RB RB O
much JJ JJ O
. . . O
   
4 CD CD O
. . . O
Eyelid NNP NNP O
surgery NN NN O
: : : O
She PRP PRP O
is VBZ VBZ O
scheduled VBN VBN O
to TO TO O
have VB VB O
surgery NN NN O
on IN IN O
her PRP$ PRP$ O
eyelids NNS NNS O
on IN IN O
May NNP NNP I-DATE
   
25 CD CD I-DATE
. . . O
The DT DT O
drooping NN NN O
of IN IN O
the DT DT O
lids NNS NNS O
is VBZ VBZ O
so RB RB O
bad JJ JJ O
by IN IN O
the DT DT O
end NN NN O
of IN IN O
the DT DT O
day NN NN O
that IN IN O
she PRP PRP O
is VBZ VBZ O
unable JJ JJ O
to TO TO O
read VB VB O
. . . O
   
5 CD CD O
. . . O
Incontinence NNP NNP O
: : : O
She PRP PRP O
has VBZ VBZ O
now RB RB O
had VBN VBN O
3 CD CD O
collagen NN NN O
implants NNS NNS O
for IN IN O
her PRP$ PRP$ O
bladder NN NN O
. . . O
   
The DT DT O
pt NN NN O
does VBZ VBZ O
not RB RB O
think VB VB O
that IN IN O
she PRP PRP O
is VBZ VBZ O
any DT DT O
better JJR JJR O
, , , O
but CC CC O
when WRB WRB O
Dr NNP NNP O
. . . O
Xuereb NNP NNP I-DOCTOR
tested VBD VBD O
her PRP$ PRP$ O
a DT DT O
few JJ JJ O
months NNS NNS O
ago RB RB O
, , , O
she PRP PRP O
saw VBD VBD O
some DT DT O
improvement NN NN O
. . . O
   
6 CD CD O
. . . O
Diarrhea NNP NNP O
: : : O
She PRP PRP O
has VBZ VBZ O
about IN IN O
2 CD CD O
soft JJ JJ O
BM NNP NNP O
's VBZ VBZ O
a DT DT O
day NN NN O
, , , O
but CC CC O
she PRP PRP O
also RB RB O
has VBZ VBZ O
intermittent JJ JJ O
diarrhea NN NN O
. . . O
   
Her PRP$ PRP$ O
daughter-in-law NN NN O
is VBZ VBZ O
wondering VBG VBG O
if IN IN O
the DT DT O
pt NN NN O
might MD MD O
be VB VB O
lactose JJ JJ O
intolerant NN NN O
. . . O
   
She PRP PRP O
is VBZ VBZ O
not RB RB O
having VBG VBG O
any DT DT O
blood NN NN O
in IN IN O
her PRP$ PRP$ O
stool NN NN O
. . . O
   
She PRP PRP O
does VBZ VBZ O
not RB RB O
have VB VB O
any DT DT O
diarrhea NN NN O
in IN IN O
the DT DT O
middle NN NN O
of IN IN O
the DT DT O
night NN NN O
. . . O
   
She PRP PRP O
has VBZ VBZ O
never RB RB O
gotten VBN VBN O
a DT DT O
colonoscopy NN NN O
since IN IN O
the DT DT O
last JJ JJ O
attempt NN NN O
just RB RB O
prior RB RB O
to TO TO O
her PRP$ PRP$ O
hospitalization NN NN O
2 CD CD O
years NNS NNS O
ago RB RB O
. . . O
   
7 CD CD O
. . . O
DM NNP NNP O
: : : O
The DT DT O
pt NN NN O
states NNS NNS O
that IN IN O
she PRP PRP O
does VBZ VBZ O
not RB RB O
eat VB VB O
much JJ JJ O
sugar NN NN O
, , , O
but CC CC O
her PRP$ PRP$ O
daughter-in-law JJ JJ O
thinks VBZ VBZ O
that IN IN O
she PRP PRP O
probably RB RB O
does VBZ VBZ O
consume VB VB O
a DT DT O
fair JJ JJ O
number NN NN O
of IN IN O
sweets NNS NNS O
. . . O
   
8 CD CD O
. . . O
Hyperlipidemia NNP NNP O
: : : O
She PRP PRP O
has VBZ VBZ O
been VBN VBN O
on IN IN O
Zocor NNP NNP O
20 CD CD O
mg NN NN O
QD NNP NNP O
but CC CC O
is VBZ VBZ O
not RB RB O
following VBG VBG O
a DT DT O
low JJ JJ O
fat JJ JJ O
diet NN NN O
. . . O
   
9 CD CD O
. . . O
Medication NNP NNP O
compliance NN NN O
: : : O
The DT DT O
pt NN NN O
's POS POS O
family NN NN O
is VBZ VBZ O
not RB RB O
sure JJ JJ O
if IN IN O
she PRP PRP O
is VBZ VBZ O
taking VBG VBG O
her PRP$ PRP$ O
medications NNS NNS O
every DT DT O
day NN NN O
. . . O
   
They PRP PRP O
pay VBP VBP O
a DT DT O
private JJ JJ O
nurse NN NN O
to TO TO O
come VB VB O
lay VB VB O
out IN IN O
the DT DT O
meds NNS NNS O
in IN IN O
the DT DT O
am VBP VBP O
, , , O
but CC CC O
the DT DT O
pt NN NN O
is VBZ VBZ O
often RB RB O
asleep RB RB O
when WRB WRB O
she PRP PRP O
comes VBZ VBZ O
and CC CC O
will MD MD O
not RB RB O
get VB VB O
up RP RP O
to TO TO O
take VB VB O
the DT DT O
meds NNS NNS O
at IN IN O
that DT DT O
time NN NN O
. . . O
   
10 CD CD O
. . . O
Onychomycosis NNP NNP O
: : : O
The DT DT O
pt NN NN O
has VBZ VBZ O
a DT DT O
fungal JJ JJ O
infection NN NN O
in IN IN O
her PRP$ PRP$ O
great JJ JJ O
toes NNS NNS O
. . . O
   
Her PRP$ PRP$ O
daughter-in-law NN NN O
is VBZ VBZ O
wondering VBG VBG O
if IN IN O
there EX EX O
is VBZ VBZ O
anything NN NN O
topical JJ JJ O
to TO TO O
treat VB VB O
this DT DT O
with IN IN O
. . . O
   
The DT DT O
pt NN NN O
gets VBZ VBZ O
regular JJ JJ O
pedicures NNS NNS O
. . . O
   
Problems NNS NNS O
Urinary NNP NNP O
incontinence NN NN O
: : : O
s/p NN NN O
sling VBG VBG O
procedure NN NN O
in IN IN O
4/91 CD CD I-DATE
; : : O
   
s/p NN NN O
3 CD CD O
prior RB RB O
bladder NN NN O
suspension NN NN O
surgeries NNS NNS O
Hypertension NNP NNP O
Depression NNP NNP O
Elevated NNP NNP O
cholesterol NN NN O
Diarrhea NNP NNP O
Polymyalgia NNP NNP O
rheumatica NN NN O
: : : O
diagnosed VBN VBN O
in IN IN O
1/91 CD CD I-DATE
S/P NNP NNP O
rectocele NN NN O
repair NN NN O
Paroxysmal NNP NNP O
atrial NN NN O
fibrillation NN NN O
: : : O
controlled VBN VBN O
with IN IN O
medication NN NN O
Peripheral NNP NNP O
neuropathy NN NN O
: : : O
unclear JJ JJ O
etiology NN NN O
Hyperlipidemia NNP NNP O
H/O NNP NNP O
Alcohol NNP NNP O
abuse NN NN O
S/P NNP NNP O
urosepsis NN NN O
: : : O
admission NN NN O
in IN IN O
9/90 CD CD I-DATE
chronic JJ JJ O
diarrhea NN NN O
: : : O
colonoscopy NN NN O
attempted VBD VBD O
in IN IN O
9/90 CD CD I-DATE
but CC CC O
pt NN NN O
not RB RB O
able JJ JJ O
to TO TO O
tolerate VB VB O
procedure NN NN O
Dementia NNP NNP O
: : : O
Mild-moderate NNP NNP O
; : : O
   
neuropsychiatric JJ JJ O
test NN NN O
done VBN VBN O
in IN IN O
5/91 CD CD I-DATE
Diverticulitis NNP NNP O
: : : O
Hospitalized NNP NNP O
in IN IN O
7/92 CD CD I-DATE
Medications NNP NNP O
Folic NNP NNP O
ACID NNP NNP O
PO NNP NNP O
QD NNP NNP O
( ( ( O
1MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
) ) ) O
Ecotrin NNP NNP O
( ( ( O
ASPIRIN NNP NNP O
ENTERIC NNP NNP O
COATED NNP NNP O
) ) ) O
PO NNP NNP O
QD NNP NNP O
( ( ( O
325MG CD CD O
TABLET NNP NNP O
EC NNP NNP O
take VB VB O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
) ) ) O
Metoprolol NNP NNP O
TARTRATE NNP NNP O
PO NNP NNP O
TID NNP NNP O
( ( ( O
50MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
) ) ) O
Thiamine NNP NNP O
HCL NNP NNP O
PO NNP NNP O
QD NNP NNP O
( ( ( O
100MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
) ) ) O
Digoxin NNP NNP O
PO NNP NNP O
QD NNP NNP O
(0.125MG NNP NNP O
TABLET NNP NNP O
take VB VB O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
) ) ) O
Ferrous NNP NNP O
SULFATE NNP NNP O
PO NNP NNP O
QD NNP NNP O
( ( ( O
325MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
) ) ) O
Mvi NNP NNP O
( ( ( O
MULTIVITAMINS NNP NNP O
) ) ) O
1CAPSULE CD CD O
PO NNP NNP O
QD NNP NNP O
Calcium NNP NNP O
CARBONATE NNP NNP O
VIT NNP NNP O
D(1TABLET=250MG NNP NNP O
E. NN NN O
   
. . . O
   
. . . O
   
500MG CD CD O
PO NNP NNP O
TID NNP NNP O
Nitrofurantoin NNP NNP O
PO NNP NNP O
QD NNP NNP O
( ( ( O
100MG CD CD O
CAPSULE NNP NNP O
take NN NN O
1 CD CD O
Capsule NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
) ) ) O
Zocor NNP NNP O
( ( ( O
SIMVASTATIN NNP NNP O
) ) ) O
PO NNP NNP O
QHS NNP NNP O
( ( ( O
20MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
x SYM SYM O
30 CD CD O
days NNS NNS O
) ) ) O
Glyburide NNP NNP O
PO NNP NNP O
QD NNP NNP O
(2.5MG NNP NNP O
TABLET NNP NNP O
take VB VB O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
) ) ) O
Prednisone NNP NNP O
PO NNP NNP O
QAM NNP NNP O
( ( ( O
5MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
) ) ) O
Prednisone NNP NNP O
PO NNP NNP O
QAM NNP NNP O
( ( ( O
1MG CD CD O
TABLET NNP NNP O
take NN NN O
4 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
), NN NN O
total NN NN O
9 CD CD O
mg/d NN NN O
Effexor NNP NNP O
SR NNP NNP O
( ( ( O
VENLAFAXINE NNP NNP O
EXTENDED NNP NNP O
RELEASE NNP NNP O
) ) ) O
PO NNP NNP O
QD NNP NNP O
(37.5MG NNP NNP O
CAPSULE NNP NNP O
CR NNP NNP O
take VB VB O
1 CD CD O
Capsule NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
) ) ) O
Sotalol NNP NNP O
PO NNP NNP O
BID NNP NNP O
( ( ( O
80MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
) ) ) O
Aricept NNP NNP O
( ( ( O
DONEPEZIL NNP NNP O
HCL NNP NNP O
) ) ) O
10MG CD CD O
PO NNP NNP O
QHS NNP NNP O
( ( ( O
x SYM SYM O
30 CD CD O
days NNS NNS O
) ) ) O
Effexor NNP NNP O
( ( ( O
VENLAFAXINE NNP NNP O
HCL NNP NNP O
) ) ) O
PO NNP NNP O
QD NNP NNP O
(37.5MG NNP NNP O
TABLET NNP NNP O
take VB VB O
4 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
) ) ) O
Health NNP NNP O
maintenance NN NN O
Cholesterol NNP NNP O
05/24/2092 CD CD I-DATE
223 CD CD O
Stool NNP NNP O
Guaiac NNP NNP O
12/21/2091 CD CD I-DATE
Done VBN VBN O
- - - O
positive JJ JJ O
12/09/91 CD CD I-DATE
; : : O
   
12/11/91 CD CD I-DATE
; : : O
   
12/12/91.All CD CD O
slides NNS NNS O
positive JJ JJ O
. . . O
   
UA-Protein NNP NNP O
01/18/2093 CD CD I-DATE
NEGATIVE NNP NNP O
HBA1C NNP NNP O
05/25/2092 CD CD I-DATE
7.30 CD CD O
Urine NNP NNP O
Culture NNP NNP O
01/18/2093 CD CD I-DATE
see VB VB O
report NN NN O
in IN IN O
Results NNS NNS O
CATHETERIZED NNP NNP O
SPECIMEN NNP NNP O
Triglycerides NNP NNP O
08/26/2091 CD CD I-DATE
330 CD CD O
Cholesterol-LDL NNP NNP O
08/26/2091 CD CD I-DATE
148 CD CD O
Bone NNP NNP O
Density NNP NNP O
06/16/2091 CD CD I-DATE
BMD-Hip NNP NNP O
Hct NNP NNP O
( ( ( O
Hematocrit NNP NNP O
) ) ) O
12/07/2092 CD CD I-DATE
40.7 CD CD O
Cholesterol-HDL NNP NNP O
05/24/2092 CD CD I-DATE
43 CD CD O
Hgb NNP NNP O
( ( ( O
Hemoglobin NNP NNP O
) ) ) O
12/07/2092 CD CD I-DATE
13.7 CD CD O
Syphilis NNP NNP O
09/14/2090 CD CD I-DATE
FINAL NNP NNP O
Result NNP NNP O
NON-REACTIVE NNP NNP O
. . . O
   
Allergies NNP NNP O
NKDA NNP NNP O
Social NNP NNP O
History NN NN O
Lives NNS NNS O
in IN IN O
Forest NNP NNP I-HOSPITAL
Hills NNP NNP I-HOSPITAL
, , , O
an DT DT O
assisted VBN VBN O
living VBG VBG O
facility NN NN O
; : : O
   
never RB RB O
smoking NN NN O
; : : O
   
Etoh NNP NNP O
- - - O
rare JJ JJ O
- - - O
she PRP PRP O
might MD MD O
have VB VB O
one CD CD O
drink NN NN O
if IN IN O
she PRP PRP O
goes VBZ VBZ O
to TO TO O
her PRP$ PRP$ O
son NN NN O
's POS POS O
house NN NN O
for IN IN O
dinner NN NN O
; : : O
   
exercise VB VB O
- - - O
walking VBG VBG O
. . . O
   
Family NNP NNP O
History NN NN O
Family NNP NNP O
History NN NN O
: : : O
mother NN NN O
died VBD VBD O
at IN IN O
89 CD CD I-AGE
of IN IN O
"""" '' '' O
old JJ JJ O
age NN NN O
"""" '' '' O
; : : O
   
father NN NN O
died VBD VBD O
of IN IN O
unknown JJ JJ O
causes NNS NNS O
; : : O
   
no DT DT O
breast NN NN O
or CC CC O
colon NN NN O
ca NN NN O
; : : O
   
brother NN NN O
is VBZ VBZ O
s/p NN NN O
MI NNP NNP O
before IN IN O
age NN NN O
60 CD CD I-AGE
; : : O
   
+ NN NN O
DM NNP NNP O
. . . O
   
Review NNP NNP O
of IN IN O
Systems NNPS NNPS O
No DT DT O
change NN NN O
in IN IN O
weight NN NN O
, , , O
appetite NN NN O
. . . O
   
No DT DT O
dizziness NN NN O
, , , O
F/C/N/V NNP NNP O
, , , O
cough NN NN O
, , , O
SOB NNP NNP O
, , , O
CP NNP NNP O
, , , O
abd NN NN O
pain NN NN O
, , , O
constipation NN NN O
, , , O
dysuria NN NN O
, , , O
joint JJ JJ O
pain NN NN O
. . . O
   
Physical JJ JJ O
Exam NNP NNP O
BP NNP NNP O
: : : O
122/70 CD CD O
Weight NNP NNP O
: : : O
132 CD CD O
lbs NN NN O
. . . O
   
( ( ( O
down RB RB O
8 CD CD O
lbs NN NN O
) ) ) O
Height NNP NNP O
: : : O
5'2 CD CD O
"""" '' '' O
GENERAL NNP NNP O
: : : O
Elderly JJ JJ O
woman NN NN O
with IN IN O
Cushingoid NNP NNP O
facies NNS NNS O
. . . O
   
SKIN NNP NNP O
: : : O
NL NNP NNP O
turgor NN NN O
, , , O
no DT DT O
abnormal JJ JJ O
lesions NNS NNS O
. . . O
   
HEENT NNP NNP O
: : : O
NL NNP NNP O
eyes NNS NNS O
, , , O
lids NNS NNS O
drooping VBG VBG O
over IN IN O
eyes NNS NNS O
about IN IN O
1/2 CD CD O
way NN NN O
; : : O
   
NL NNP NNP O
oropharynx NN NN O
NECK NNP NNP O
: : : O
No DT DT O
thyromegally RB RB O
, , , O
no DT DT O
nodes NNS NNS O
; : : O
   
carotids NNS NNS O
2 CD CD O
+ NN NN O
bilat NN NN O
without IN IN O
bruits NNS NNS O
. . . O
   
CHEST NN NN O
: : : O
Clear JJ JJ O
lungs NNS NNS O
, , , O
NL NNP NNP O
frame NN NN O
COR NNP NNP O
: : : O
NL NNP NNP O
S1S2 NNP NNP O
, , , O
no DT DT O
murmur NN NN O
, , , O
rubs NNS NNS O
, , , O
or CC CC O
gallops NNS NNS O
. . . O
   
BACK NNP NNP O
: : : O
No DT DT O
spinal JJ JJ O
tenderness NN NN O
. . . O
   
BREASTS NNP NNP O
: : : O
Symmetrical NNP NNP O
, , , O
No DT DT O
dominant JJ JJ O
masses NNS NNS O
; : : O
   
no DT DT O
axillary JJ JJ O
masses NNS NNS O
. . . O
   
ABD NNP NNP O
: : : O
NL NNP NNP O
BS NNP NNP O
; : : O
   
soft JJ JJ O
, , , O
NO DT DT O
HSM NNP NNP O
PELVIC NNP NNP O
: : : O
deferred VBN VBN O
RECTAL NNP NNP O
: : : O
deferred VBN VBN O
EXT NNP NNP O
: : : O
No DT DT O
edema NN NN O
, , , O
clubbing VBG VBG O
, , , O
or CC CC O
cyanosis NN NN O
; : : O
   
DP NNP NNP O
pulses NNS NNS O
2 CD CD O
+ NN NN O
bilat NN NN O
NEURO NNP NNP O
: : : O
NL NNP NNP O
MS NNP NNP O
, , , O
NL NNP NNP O
gait NN NN O
Assessment NNP NNP O
and CC CC O
Plan NNP NNP O
   
1 CD CD O
. . . O
PMR NNP NNP O
: : : O
Discussed VBD VBD O
the DT DT O
importance NN NN O
of IN IN O
regular JJ JJ O
f/u NN NN O
with IN IN O
Dr NNP NNP O
. . . O
Inge NNP NNP I-DOCTOR
. . . O
   
We PRP PRP O
should MD MD O
aim VB VB O
to TO TO O
get VB VB O
the DT DT O
dose NN NN O
of IN IN O
Prednisone NNP NNP O
decreased VBD VBD O
. . . O
   
Will NNP NNP O
check VB VB O
ESR NNP NNP O
today NN NN O
. . . O
   
Franchesca NNP NNP I-PATIENT
will MD MD O
make VB VB O
sure JJ JJ O
appt NN NN O
is VBZ VBZ O
scheduled VBN VBN O
with IN IN O
Dr NNP NNP O
. . . O
Inge NNP NNP I-DOCTOR
. . . O
   
2 CD CD O
. . . O
Depression NNP NNP O
: : : O
She PRP PRP O
seems VBZ VBZ O
better JJR JJR O
. . . O
   
Continue NNP NNP O
Effexor NNP NNP O
. . . O
   
3 CD CD O
. . . O
Dementia NNP NNP O
: : : O
Will NNP NNP O
continue VB VB O
Aricept NNP NNP O
. . . O
   
Discussed NNP NNP O
keeping VBG VBG O
pt NN NN O
stimulated VBN VBN O
with IN IN O
outings NNS NNS O
, , , O
family NN NN O
visits NNS NNS O
. . . O
   
Her PRP$ PRP$ O
excessive JJ JJ O
sleeping NN NN O
is VBZ VBZ O
likely JJ JJ O
a DT DT O
combination NN NN O
of IN IN O
several JJ JJ O
factors NNS NNS O
, , , O
including VBG VBG O
her PRP$ PRP$ O
multiple JJ JJ O
medications NNS NNS O
, , , O
depression NN NN O
, , , O
and CC CC O
possibly RB RB O
the DT DT O
dementia NN NN O
. . . O
   
4 CD CD O
. . . O
Eyelid NNP NNP O
surgery NN NN O
: : : O
Pre-op NNP NNP O
exam NN NN O
today NN NN O
. . . O
   
Will NNP NNP O
order VB VB O
complete JJ JJ O
metabolic JJ JJ O
panel NN NN O
, , , O
CBC NNP NNP O
, , , O
and CC CC O
EKG NNP NNP O
. . . O
   
5 CD CD O
. . . O
Incontinence NNP NNP O
: : : O
It PRP PRP O
is VBZ VBZ O
not RB RB O
likely JJ JJ O
that IN IN O
she PRP PRP O
will MD MD O
be VB VB O
able JJ JJ O
to TO TO O
have VB VB O
any DT DT O
more JJR JJR O
procedures NNS NNS O
at IN IN O
this DT DT O
point NN NN O
. . . O
   
Some DT DT O
of IN IN O
the DT DT O
incontinence NN NN O
may MD MD O
be VB VB O
secondary JJ JJ O
to TO TO O
dementia VB VB O
rather RB RB O
than IN IN O
pure JJ JJ O
stress NN NN O
incontinence NN NN O
. . . O
   
6 CD CD O
. . . O
Diarrhea NNP NNP O
: : : O
Discussed VBD VBD O
trying VBG VBG O
a DT DT O
lactose-free JJ JJ O
diet NN NN O
for IN IN O
a DT DT O
week NN NN O
to TO TO O
determine VB VB O
if IN IN O
lactose-intolerance JJ JJ O
may MD MD O
be VB VB O
playing VBG VBG O
a DT DT O
role NN NN O
. . . O
   
Will NNP NNP O
set VBD VBD O
up RP RP O
a DT DT O
virtual JJ JJ O
colonoscopy NN NN O
since IN IN O
the DT DT O
pt NN NN O
had VBD VBD O
such JJ JJ O
a DT DT O
bad JJ JJ O
experience NN NN O
with IN IN O
the DT DT O
sedation NN NN O
for IN IN O
her PRP$ PRP$ O
colonoscopy NN NN O
2 CD CD O
years NNS NNS O
ago RB RB O
. . . O
   
7 CD CD O
. . . O
DM NNP NNP O
: : : O
Check NNP NNP O
glucose NN NN O
and CC CC O
Hgb NNP NNP O
A1C NNP NNP O
. . . O
   
8 CD CD O
. . . O
Hyperlipidemia NNP NNP O
: : : O
Check NNP NNP O
fasting VBG VBG O
lipids NNS NNS O
- : : O
she PRP PRP O
will MD MD O
get VB VB O
them PRP PRP O
drawn VBN VBN O
at IN IN O
Dameron NNP NNP I-HOSPITAL
Hospital NNP NNP I-HOSPITAL
. . . O
   
9 CD CD O
. . . O
Medication NNP NNP O
compliance NN NN O
: : : O
Discussed NNP NNP O
trying VBG VBG O
to TO TO O
get VB VB O
nurse NN NN O
to TO TO O
come VB VB O
a DT DT O
little JJ JJ O
later RB RB O
in IN IN O
the DT DT O
day NN NN O
so IN IN O
that IN IN O
pt NN NN O
could MD MD O
be VB VB O
observed VBN VBN O
while IN IN O
taking VBG VBG O
her PRP$ PRP$ O
medication NN NN O
. . . O
   
10 CD CD O
. . . O
Onychomycosis NNP NNP O
: : : O
I PRP PRP O
do VBP VBP O
not RB RB O
think VB VB O
oral JJ JJ O
medication NN NN O
would MD MD O
be VB VB O
a DT DT O
good JJ JJ O
idea NN NN O
for IN IN O
this DT DT O
patient NN NN O
because IN IN O
the DT DT O
risks NNS NNS O
of IN IN O
hepatotoxicity NN NN O
outweigh IN IN O
the DT DT O
benefits NNS NNS O
. . . O
   
Will NNP NNP O
refer VB VB O
her PRP PRP O
to TO TO O
Podiatry NNP NNP O
for IN IN O
care NN NN O
of IN IN O
the DT DT O
toenails NNS NNS O
since IN IN O
the DT DT O
pt NN NN O
has VBZ VBZ O
a DT DT O
h/o NN NN O
peripheral JJ JJ O
neuropathy NN NN O
. . . O
   
11 CD CD O
. . . O
Health NNP NNP O
maint NN NN O
: : : O
Order NNP NNP O
mammo NN NN O
to TO TO O
be VB VB O
done VBN VBN O
at IN IN O
DH NNP NNP I-HOSPITAL
; : : O
   
TSH NNP NNP O
. . . O
   
____________________________________________ NN NN O
_ NN NN O
Faith NNP NNP I-DOCTOR
G. NN NN I-DOCTOR
Ice NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
____________________________________________ NNP NNP O
_ NN NN O
Faith NNP NNP I-DOCTOR
G NNP NNP I-DOCTOR
Ice NNP NNP I-DOCTOR
, , , O
MD NNP NNP O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2076-08-10 NN NN I-DATE
BARROW NNP NNP I-HOSPITAL
MEDICAL NNP NNP I-HOSPITAL
CENTER NNP NNP I-HOSPITAL
Johnsonville NNP NNP I-HOSPITAL
Family NNP NNP I-HOSPITAL
Clinic NNP NNP I-HOSPITAL
4897 CD CD I-STREET
Governors NNP NNP I-STREET
Lane NNP NNP I-STREET
Oroville NNP NNP I-CITY
, , , O
AL NNP NNP I-STATE
89389 CD CD I-ZIP
Osborne NNP NNP O
, , , O
Mattison NNP NNP I-PATIENT
48423663 CD CD I-MEDICALRECORD
08/10/76 CD CD I-DATE
This DT DT O
patient NN NN O
is VBZ VBZ O
seen VBN VBN O
here RB RB O
in IN IN O
follow-up NN NN O
of IN IN O
the DT DT I-COUNTRY
following VBG VBG O
medical JJ JJ O
problems NNS NNS O
: : : O
PROBLEMS NNS NNS O
: : : O
   
1 CD CD O
. . . O
Coronary JJ JJ O
artery NN NN O
disease NN NN O
status NN NN O
post NN NN O
coronary JJ JJ O
artery NN NN O
bypass NN NN O
( ( ( O
saphenous JJ JJ O
vein NN NN O
) ) ) O
in IN IN O
2072 CD CD I-DATE
. . . O
   
2 CD CD O
. . . O
Pulmonary NNP NNP O
embolus NN NN O
2074 CD CD I-DATE
. . . O
   
3 CD CD O
. . . O
Idiopathic NNP NNP O
hypertension NN NN O
. . . O
   
SUBJECTIVE NNP NNP O
: : : O
He PRP PRP O
is VBZ VBZ O
entirely RB RB O
asymptomatic JJ JJ O
. . . O
   
He PRP PRP O
has VBZ VBZ O
no DT DT O
complaint NN NN O
. . . O
   
REVIEW NNP NNP O
OF IN IN O
SYSTEMS NNP NNP O
: : : O
Negative NNP NNP O
. . . O
   
There EX EX O
is VBZ VBZ O
no DT DT O
chest NN NN O
pain NN NN O
, , , O
shortness NN NN O
of IN IN O
breath NN NN O
, , , O
cough NN NN O
, , , O
peripheral JJ JJ O
edema NN NN O
, , , O
orthopnea NN NN O
or CC CC O
PND NNP NNP O
. . . O
   
All DT DT O
the DT DT I-COUNTRY
other JJ JJ O
review NN NN O
of IN IN O
systems NNS NNS O
is VBZ VBZ O
negative JJ JJ O
as IN IN O
well RB RB O
. . . O
   
MEDICATIONS NNP NNP O
: : : O
He PRP PRP O
continues VBZ VBZ O
on IN IN O
lisinopril NN NN O
10 CD CD O
mg NN NN O
q.d. NN NN O
, , , O
hydrochlorothiazide NN NN O
25 CD CD O
mg NN NN O
q.d. NN NN O
, , , O
atenolol NN NN O
50 CD CD O
mg NN NN O
q.d. NN NN O
, , , O
and CC CC O
Plavix NNP NNP O
75 CD CD O
mg NN NN O
q.d. NN NN O
   
OBJECTIVE NNP NNP O
: : : O
On IN IN O
examination NN NN O
today NN NN O
, , , O
the DT DT I-COUNTRY
patient NN NN O
appears VBZ VBZ O
well RB RB O
. . . O
   
He PRP PRP O
is VBZ VBZ O
cheerful JJ JJ O
and CC CC O
feisty JJ JJ O
. . . O
   
Blood NNP NNP O
pressure NN NN O
138/80 CD CD O
in IN IN O
the DT DT I-COUNTRY
left VBN VBN O
arm NN NN O
, , , O
sitting VBG VBG O
. . . O
   
Weight NNP NNP O
175 CD CD O
pounds NNS NNS O
. . . O
   
Apical NNP NNP O
pulse NN NN O
rate NN NN O
   
80 CD CD O
. . . O
Cardiac NNP NNP O
rhythm NN NN O
is VBZ VBZ O
regular JJ JJ O
without IN IN O
murmur NN NN O
, , , O
gallop NN NN O
, , , O
rub NN NN O
or CC CC O
click NN NN O
. . . O
   
Breath NN NN O
sounds VBZ VBZ O
are VBP VBP O
clear JJ JJ O
to TO TO O
percussion NN NN O
and CC CC O
auscultation NN NN O
. . . O
   
No DT DT O
jugular NN NN O
venous JJ JJ O
distension NN NN O
. . . O
   
No DT DT O
peripheral JJ JJ O
edema NN NN O
. . . O
   
ASSESSMENT NNP NNP O
: : : O
   
1 CD CD O
. . . O
New NNP NNP O
York NNP NNP O
Heart NNP NNP O
Association NNP NNP O
functional JJ JJ O
class-I JJ JJ O
ISHD NNP NNP O
, , , O
status NN NN O
post NN NN O
CABG NNP NNP O
. . . O
   
2 CD CD O
. . . O
Well-controlled NNP NNP O
hypertension NN NN O
. . . O
   
PLAN NNP NNP O
: : : O
   
1 CD CD O
. . . O
Current NNP NNP O
regimen NNS NNS O
. . . O
   
2 CD CD O
. . . O
Please VB VB O
note NN NN O
that IN IN O
Lipitor NNP NNP O
was VBD VBD O
added VBN VBN O
to TO TO O
his PRP$ PRP$ O
regimen NN NN O
at IN IN O
his PRP$ PRP$ O
last JJ JJ O
visit NN NN O
for IN IN O
hypercholesterolemia NN NN O
. . . O
   
Repeat NN NN O
cholesterol NN NN O
( ( ( O
which WDT WDT O
had VBD VBD O
been VBN VBN O
263 CD CD O
) ) ) O
is VBZ VBZ O
now RB RB O
103 CD CD O
. . . O
   
He PRP PRP O
will MD MD O
continue VB VB O
the DT DT I-COUNTRY
Lipitor NNP NNP O
as IN IN O
well RB RB O
. . . O
   
3 CD CD O
. . . O
He PRP PRP O
is VBZ VBZ O
to TO TO O
return VB VB O
prior RB RB O
to TO TO O
his PRP$ PRP$ O
planned JJ JJ O
winter NN NN I-DATE
sojourn NN NN O
in IN IN O
the DT DT I-COUNTRY
United NNP NNP I-COUNTRY
Kingdom NNP NNP I-COUNTRY
in IN IN O
December NNP NNP I-DATE
. . . O
   
Oscar NNP NNP I-DOCTOR
Nall NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
   
ON:fairchild NNP NNP O
; : : O
   
11-56649670.doc; JJ JJ O
   
DD:08/10/76; NNP NNP O
   
DT:08/11/76; NNP NNP O
   
DV:08/10/76 NNP NNP O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2067-05-03 JJ JJ I-DATE
Narrative NNP NNP O
History NN NN O
55 CD CD I-AGE
yo NN NN O
woman NN NN O
who WP WP O
presents VBZ VBZ O
for IN IN O
f/u NN NN O
Seen VBN VBN O
in IN IN O
Cardiac NNP NNP O
rehab NN NN O
locally RB RB O
last JJ JJ O
week NN NN O
and CC CC O
BP NNP NNP O
170/80 CD CD O
. . . O
   
They PRP PRP O
called VBD VBD O
us PRP PRP O
and CC CC O
we PRP PRP O
increased VBD VBD O
her PRP$ PRP$ O
HCTZ NNP NNP O
to TO TO O
25 CD CD O
mg NN NN O
from IN IN O
12.5 CD CD O
mg NN NN O
. . . O
   
States NNPS NNPS O
her PRP$ PRP$ O
BP NNP NNP O
's POS POS O
were VBD VBD O
fine NN NN O
there EX EX O
since IN IN O
- : : O
130-140/70-80 NN NN O
. . . O
   
Saw VBD VBD O
Dr NNP NNP O
Oakley NNP NNP I-DOCTOR
4/5/67 CD CD I-DATE
- : : O
she PRP PRP O
was VBD VBD O
happy JJ JJ O
with IN IN O
results NNS NNS O
of IN IN O
ETT NNP NNP O
at IN IN O
Clarkfield NNP NNP I-HOSPITAL
. . . O
   
To TO TO O
f/u NN NN O
7/67 CD CD I-DATE
. . . O
   
No DT DT O
CP NNP NNP O
's POS POS O
since IN IN O
last JJ JJ O
admit NN NN O
. . . O
   
Back RB RB O
to TO TO O
work VB VB O
and CC CC O
starting VBG VBG O
to TO TO O
walk VB VB O
. . . O
   
No DT DT O
wt NN NN O
loss NN NN O
and CC CC O
discouraged VBN VBN O
by IN IN O
this DT DT O
, , , O
but CC CC O
just RB RB O
starting VBG VBG O
to TO TO O
exercise VB VB O
. . . O
   
No DT DT O
smoking NN NN O
for IN IN O
3 CD CD O
months NNS NNS O
now RB RB O
! . . O
   
Still RB RB O
with IN IN O
hotflashes NNS NNS O
, , , O
wakes NNS NNS O
her PRP$ PRP$ O
up RB RB O
at IN IN O
night NN NN O
. . . O
   
Problems NNS NNS O
FH NNP NNP O
breast NN NN O
cancer NN NN O
37 CD CD I-AGE
yo NN NN O
s VBZ VBZ O
FH NNP NNP O
myocardial NN NN O
infarction NN NN O
mother NN NN O
died VBD VBD O
66 CD CD I-AGE
yo NN NN O
Hypertension NNP NNP O
Uterine NNP NNP O
fibroids NNS NNS O
u/s NN NN O
2062 CD CD I-DATE
Smoking NNP NNP O
hyperlipidemia NN NN O
CRF NNP NNP O
mild JJ JJ O
chol NN NN O
, , , O
cigs NNS NNS O
, , , O
HTN NNP NNP O
, , , O
Fhx NNP NNP O
and CC CC O
known VBN VBN O
hx NN NN O
CAD NNP NNP O
in IN IN O
pt NN NN O
. . . O
   
borderline NN NN O
diabetes NNS NNS O
mellitus NN NN O
4/63 CD CD I-DATE
125 CD CD O
, , , O
follow VBP VBP O
hgbaic NN NN O
VPB NNP NNP O
2065 CD CD I-DATE
- : : O
ETT NNP NNP O
showed VBD VBD O
freq NN NN O
PVC NNP NNP O
coronary JJ JJ O
artery NN NN O
disease NN NN O
s/p NN NN O
ant NN NN O
SEMI NNP NNP O
+ NN NN O
stent NN NN O
LAD NNP NNP O
2/67 CD CD I-DATE
, , , O
Dr NNP NNP O
Oakley NNP NNP I-DOCTOR
thyroid NN NN O
nodule NN NN O
2065 CD CD I-DATE
, , , O
hot JJ JJ O
, , , O
follow VB VB O
TSH NNP NNP O
. . . O
   
Medications NNP NNP O
NORVASC NNP NNP O
( ( ( O
AMLODIPINE NNP NNP O
) ) ) O
5MG CD CD O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
PLAVIX NNP NNP O
( ( ( O
CLOPIDOGREL NNP NNP O
) ) ) O
75 CD CD O
MG NNP NNP O
PO NNP NNP O
QD NNP NNP O
ATENOLOL NNP NNP O
50MG CD CD O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
ASA NNP NNP O
( ( ( O
ACETYLSALICYLIC NNP NNP O
ACID NNP NNP O
) ) ) O
325MG CD CD O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
ZESTRIL NNP NNP O
( ( ( O
LISINOPRIL NNP NNP O
) ) ) O
40MG CD CD O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
LIPITOR NNP NNP O
( ( ( O
ATORVASTATIN NNP NNP O
) ) ) O
10MG CD CD O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
HCTZ NNP NNP O
( ( ( O
HYDROCHLOROTHIAZIDE NNP NNP O
) ) ) O
25MG CD CD O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
NITROGLYCERIN NNP NNP O
1/150 CD CD O
( ( ( O
0.4 CD CD O
MG NNP NNP O
) ) ) O
1 CD CD O
TAB NNP NNP O
SL NNP NNP O
x1 NN NN O
PRN NNP NNP O
prn NN NN O
CP NNP NNP O
Allergies NNP NNP O
CECLOR NNP NNP O
( ( ( O
CEFACLOR NNP NNP O
) ) ) O
Rash NNP NNP O
Vital NNP NNP O
Signs NNP NNP O
BLOOD NNP NNP O
PRESSURE-SITTING NNP NNP O
150/70 CD CD O
repeat NN NN O
145/80 CD CD O
HR NNP NNP O
60 CD CD O
reg NN NN O
WT NNP NNP O
202 CD CD O
lbs NN NN O
Physical JJ JJ O
Exam NNP NNP O
Looks NNP NNP O
well RB RB O
. . . O
   
Lungs NNS NNS O
clear JJ JJ O
, , , O
CVS NNP NNP O
RRRs1s2 NNP NNP O
, , , O
Ext NNP NNP O
- - - O
no DT DT O
edema NN NN O
Assessment NNP NNP O
and CC CC O
Plan NNP NNP O
   
1 CD CD O
. . . O
H/M NNP NNP O
- : : O
Pe NNP NNP O
next JJ JJ O
appt NN NN O
in IN IN O
few JJ JJ O
months NNS NNS O
. . . O
   
Overdue NNP NNP O
for IN IN O
mammo NN NN O
- : : O
will MD MD O
need VB VB O
to TO TO O
stress VB VB O
this DT DT O
. . . O
   
2 CD CD O
. . . O
CAD NNP NNP O
- : : O
cont NN NN O
with IN IN O
cardiac JJ JJ O
rehab NN NN O
, , , O
exercise NN NN O
, , , O
Dr NNP NNP O
Oakley NNP NNP I-DOCTOR
, , , O
but CC CC O
doing VBG VBG O
well RB RB O
. . . O
   
3 CD CD O
. . . O
BP NNP NNP O
- - - O
better NN NN O
on IN IN O
increased VBN VBN O
HCTZ NNP NNP O
. . . O
   
Check NN NN O
labs NNS NNS O
next JJ JJ O
visit NN NN O
, , , O
good JJ JJ O
K NNP NNP O
recently RB RB O
and CC CC O
on IN IN O
ACEI NNP NNP O
. . . O
   
4 CD CD O
. . . O
Cigs NNP NNP O
- : : O
great JJ JJ O
! . . O
   
5 CD CD O
. . . O
Hot NNP NNP O
flashes NNS NNS O
- : : O
does VBZ VBZ O
n't RB RB O
want VB VB O
to TO TO O
try VB VB O
any DT DT O
other JJ JJ O
meds NNS NNS O
- : : O
will MD MD O
try VB VB O
to TO TO O
put VB VB O
up RP RP O
with IN IN O
it PRP PRP O
. . . O
   
6 CD CD O
. . . O
Hot NNP NNP O
thyroid NN NN O
nodule NN NN O
- : : O
recheck NN NN O
TSH NNP NNP O
next JJ JJ O
visit NN NN O
. . . O
   
7 CD CD O
. . . O
Borderline NNP NNP O
glc NN NN O
- : : O
ok JJ JJ O
hgba1c NN NN O
3/67 CD CD I-DATE
. . . O
   
8 CD CD O
. . . O
Chol NNP NNP O
- : : O
ok JJ JJ O
, , , O
fasting VBG VBG O
on IN IN O
next JJ JJ O
visit NN NN O
. . . O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2080-03-13 JJ JJ I-DATE
Ms NNP NNP O
. . . O
Louise NNP NNP I-PATIENT
Iles NNP NNP I-PATIENT
is VBZ VBZ O
a DT DT O
70 CD CD I-AGE
year NN NN O
old JJ JJ O
female JJ JJ O
patient NN NN O
of IN IN O
Dr NNP NNP O
. . . O
Xue NNP NNP I-DOCTOR
here RB RB O
today NN NN O
with IN IN O
first JJ JJ O
visit NN NN O
with IN IN O
me PRP PRP O
for IN IN O
several JJ JJ O
issues NNS NNS O
. . . O
   
Met NNP NNP O
with IN IN O
PCP NNP NNP O
in IN IN O
Feb NNP NNP I-DATE
for IN IN O
multiple JJ JJ O
issues NNS NNS O
, , , O
DM NNP NNP O
changed VBD VBD O
from IN IN O
Actos NNP NNP O
to TO TO O
Metformin NNP NNP O
, , , O
referral NN NN O
to TO TO O
Internal NNP NNP O
Medicine NNP NNP O
; : : O
   
GERD/H-pylori NNP NNP O
, , , O
( ( ( O
on IN IN O
meds NNS NNS O
, , , O
GI NNP NNP O
consult NN NN O
) ) ) O
HTN NNP NNP O
( ( ( O
changed VBN VBN O
from IN IN O
nitrates NNS NNS O
to TO TO O
Lisinopril NNP NNP O
) ) ) O
cholesterol NN NN O
, , , O
HA NNP NNP O
( ( ( O
lab NN NN O
done VBN VBN O
to TO TO O
r/o VB VB O
TA NNP NNP O
and CC CC O
PMR NNP NNP O
) ) ) O
Hepatitis NNP NNP O
She PRP PRP O
arrived VBD VBD O
20 CD CD O
minutes NNS NNS O
late RB RB O
for IN IN O
her PRP$ PRP$ O
appointment NN NN O
Today NNP NNP O
states NNS NNS O
: : : O
# # # O
1 CD CD O
HA NNP NNP O
HA NNP NNP O
are VBP VBP O
much RB RB O
better-less JJ JJ O
in IN IN O
frequency NN NN O
and CC CC O
duration NN NN O
and CC CC O
intensity NN NN O
, , , O
Left NNP NNP O
area NN NN O
occipital/temporal JJ JJ O
area NN NN O
ROS NNP NNP O
denies NNS NNS O
any DT DT O
visual JJ JJ O
problems-but NN NN O
does VBZ VBZ O
associate VB VB O
them PRP PRP O
with IN IN O
stressful JJ JJ O
times NNS NNS O
# # # O
2 CD CD O
DM NNP NNP O
Test NNP NNP O
her PRP$ PRP$ O
BG NNP NNP O
once RB RB O
a DT DT O
week-reports JJ JJ O
134 CD CD O
, , , O
today NN NN O
156-ate JJ JJ O
at IN IN O
1 CD CD O
PM NNP NNP O
rice NN NN O
Stopped NNP NNP O
Actos-now NNP NNP O
taking VBG VBG O
Metformin NNP NNP O
# # # O
3 CD CD O
HTN NNP NNP O
taking VBG VBG O
meds NNS NNS O
as IN IN O
prescribed VBN VBN O
# # # O
4 CD CD O
GERD NNP NNP O
: : : O
completed VBN VBN O
antibiotics-feeling JJ JJ O
better JJR JJR O
Medications NNP NNP O
Amoxicillin NNP NNP O
1000 CD CD O
MG NNP NNP O
( ( ( O
500 CD CD O
MG NNP NNP O
TABLET NNP NNP O
Take NNP NNP O
2 CD CD O
) ) ) O
PO NNP NNP O
BID NNP NNP O
x SYM SYM O
14 CD CD O
days NNS NNS O
#56 NN NN O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
Aspirin NNP NNP O
( ( ( O
ACETYLSALICYLIC NNP NNP O
ACID NNP NNP O
) ) ) O
81 CD CD O
MG NNP NNP O
( ( ( O
81 CD CD O
MG NNP NNP O
TABLET NNP NNP O
Take NNP NNP O
1 CD CD O
) ) ) O
PO NNP NNP O
QD NNP NNP O
x SYM SYM O
30 CD CD O
days NNS NNS O
#30 NN NN O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
Atenolol NNP NNP O
50 CD CD O
MG NNP NNP O
( ( ( O
50MG CD CD O
TABLET NNP NNP O
Take NNP NNP O
1 CD CD O
) ) ) O
PO NNP NNP O
QD NNP NNP O
x SYM SYM O
30 CD CD O
days NNS NNS O
#30 NN NN O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
Ergocalciferol NNP NNP O
50000 CD CD O
UNITS NNP NNP O
( ( ( O
50000 CD CD O
UNIT NNP NNP O
CAPSULE NNP NNP O
Take NNP NNP O
1 CD CD O
) ) ) O
PO NNP NNP O
QWEEK NNP NNP O
x SYM SYM O
42 CD CD O
days NNS NNS O
#6 NN NN O
Capsule NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
Lipitor NNP NNP O
( ( ( O
ATORVASTATIN NNP NNP O
) ) ) O
40 CD CD O
MG NNP NNP O
( ( ( O
40 CD CD O
MG NNP NNP O
TABLET NNP NNP O
Take NNP NNP O
1 CD CD O
) ) ) O
PO NNP NNP O
QHS NNP NNP O
x SYM SYM O
30 CD CD O
days NNS NNS O
#30 NN NN O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
Lisinopril NNP NNP O
5 CD CD O
MG NNP NNP O
( ( ( O
5 CD CD O
MG NNP NNP O
TABLET NNP NNP O
Take NNP NNP O
1 CD CD O
) ) ) O
PO NNP NNP O
QD NNP NNP O
x SYM SYM O
30 CD CD O
days NNS NNS O
#30 NN NN O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
Metformin NNP NNP O
500 CD CD O
MG NNP NNP O
( ( ( O
500 CD CD O
MG NNP NNP O
TABLET NNP NNP O
Take NNP NNP O
1 CD CD O
) ) ) O
PO NNP NNP O
BID NNP NNP O
x SYM SYM O
30 CD CD O
days NNS NNS O
#60 NN NN O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
Omeprazole NNP NNP O
20 CD CD O
MG NNP NNP O
( ( ( O
20 CD CD O
MG NNP NNP O
TABLET NNP NNP O
DR NNP NNP O
Take NNP NNP O
1 CD CD O
) ) ) O
PO NNP NNP O
BID NNP NNP O
x SYM SYM O
14 CD CD O
days NNS NNS O
#28 NN NN O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
Problems NNS NNS O
Diabetes NNP NNP O
mellitus NN NN O
: : : O
dx NN NN O
late JJ JJ O
2060s NN NN I-DATE
. . . O
   
No DT DT O
h/o NN NN O
macro NN NN O
or CC CC O
microvascular NN NN O
complications NNS NNS O
. . . O
   
Hypertensive NNP NNP O
disorder NN NN O
: : : O
dx NN NN O
2060s CD CD I-DATE
, , , O
was VBD VBD O
taking VBG VBG O
atenolol NN NN O
, , , O
enalapril NN NN O
and CC CC O
isosorbide NN NN O
in IN IN O
UNITED NNP NNP I-COUNTRY
KINGDOM NNP NNP I-COUNTRY
Hypercholesterolemia NNP NNP O
Obesity NNP NNP O
Osteoarthritis NNP NNP O
: : : O
L NNP NNP O
knee NN NN O
worst JJS JJS O
spot NN NN O
Gastroesophageal NNP NNP O
reflux NN NN O
disease NN NN O
: : : O
x SYM SYM O
years NNS NNS O
, , , O
never RB RB O
had VBD VBD O
EGD NNP NNP O
. . . O
   
H. NN NN O
pylori NN NN O
serology NN NN O
+ NN NN O
Helicobacter NNP NNP O
pylori NN NN O
: : : O
serology NN NN O
positive NN NN O
2068 CD CD I-DATE
and CC CC O
re-check NN NN O
2/2080 CD CD I-DATE
, , , O
no DT DT O
Ag NNP NNP O
done VBN VBN O
. . . O
   
Given VBN VBN O
triple NN NN O
therapy NN NN O
Rx NNP NNP O
by IN IN O
Internal NNP NNP O
Medicine NNP NNP O
Vitamin NNP NNP O
D NNP NNP O
deficiency NN NN O
Hepatitis NNP NNP O
B NNP NNP O
antibody NN NN O
present JJ JJ O
: : : O
Had VBD VBD O
HbsAg NNP NNP O
+ NN NN O
and CC CC O
HbsAb NNP NNP O
+ NN NN O
in IN IN O
2067 CD CD I-DATE
. . . O
   
LFTs NNP NNP O
wnl NN NN O
2067 CD CD I-DATE
and CC CC O
2080 CD CD I-DATE
. . . O
   
Allergies NNP NNP O
NKA NNP NNP O
O NNP NNP O
: : : O
Vital NNP NNP O
Signs NNP NNP O
BP NNP NNP O
160/80 CD CD O
, , , O
Wt NNP NNP O
203.8 CD CD O
lb NN NN O
Neck NNP NNP O
: : : O
no DT DT O
bruits NNS NNS O
Cardiac NNP NNP O
: : : O
HR NNP NNP O
76 CD CD O
RRR NNP NNP O
, , , O
no DT DT O
murmurs NNS NNS O
rubs NNS NNS O
or CC CC O
gallops NNS NNS O
BP NNP NNP O
both DT DT O
arms NNS NNS O
162/80 CD CD O
FINGER NNP NNP O
BLOOD NNP NNP O
GLUCOSE NNP NNP O
156 CD CD O
two CD CD O
hours NNS NNS O
PP NNP NNP O
PAIN NN NN O
LEVEL NNP NNP O
( ( ( O
0-10 NN NN O
) ) ) O
0 CD CD O
general JJ JJ O
: : : O
overweight NN NN O
female NN NN O
in IN IN O
NAD NNP NNP O
Pneumo NNP NNP O
vaccine NN NN O
: : : O
. . . O
   
5 CD CD O
ml NN NN O
given VBN VBN O
in IN IN O
right NN NN O
deltoid NN NN O
without IN IN O
difficulty NN NN O
Tdap NNP NNP O
. . . O
   
5 CD CD O
ml NN NN O
given VBN VBN O
in IN IN O
left VBD VBD O
deltoid NN NN O
without IN IN O
difficulty NN NN O
Results02/15/2080 NNP NNP O
CHOL NNP NNP O
187 CD CD O
[ NN NN O
1 CD CD O
] NN NN O
, , , O
TRIG NNP NNP O
137 CD CD O
, , , O
HDL NNP NNP O
37 CD CD O
, , , O
LDL NNP NNP O
123 CD CD O
[ NN NN O
2 CD CD O
] NN NN O
, , , O
CHOL/HDL NNP NNP O
5.1 CD CD O
[3][1] NN NN O
RESULT NNP NNP O
COMMENT NNP NNP O
: : : O
DESIRABLE NNP NNP O
: : : O
& CC CC O
lt NN NN O
; : : O
   
200[2 CD CD O
] NN NN O
RESULT NNP NNP O
COMMENT NNP NNP O
: : : O
DESIRABLE NNP NNP O
: : : O
& CC CC O
lt NN NN O
; : : O
   
130[3 CD CD O
] NN NN O
RESULT NNP NNP O
COMMENT NNP NNP O
: : : O
NORMAL JJ JJ O
RISK NNP NNP O
RATIO NN NN O
: : : O
5.0 CD CD O
OR CC CC O
LESS02/15/2080 NNP NNP O
UCREAT NNP NNP O
1.39 CD CD O
, , , O
MALB NNP NNP O
2.2 CD CD O
( ( ( O
H NNP NNP O
) ) ) O
, , , O
MALB/CRE NNP NNP O
15.802/15/2080 CD CD O
WBC NNP NNP O
4.2 CD CD O
( ( ( O
L NNP NNP O
) ) ) O
, , , O
RBC NNP NNP O
4.21 CD CD O
, , , O
HGB NNP NNP O
13.1 CD CD O
, , , O
HCT NNP NNP O
39.9 CD CD O
, , , O
MCV NNP NNP O
95 CD CD O
, , , O
MCH NNP NNP O
31.0 CD CD O
, , , O
MCHC NNP NNP O
32.7 CD CD O
, , , O
PLT NNP NNP O
22502/15/2080 CD CD O
RDW NNP NNP O
13.602/15/2080 CD CD O
METHOD NNP NNP O
Auto NNP NNP O
, , , O
% NN NN O
NEUT NNP NNP O
40 CD CD O
, , , O
% NN NN O
LYMPH NNP NNP O
52 CD CD O
( ( ( O
H NNP NNP O
) ) ) O
, , , O
% NN NN O
MONO NNP NNP O
6 CD CD O
, , , O
% NN NN O
EOS NNP NNP O
1 CD CD O
, , , O
% NN NN O
BASO NNP NNP O
102/15/2080 CD CD O
ESR NNP NNP O
21 CD CD O
(H)02/15/2080 NN NN O
HBV-CAB NNP NNP O
Positive NNP NNP O
[ NN NN O
1 CD CD O
] NN NN O
, , , O
HBV-SAB NNP NNP O
Reactive NNP NNP O
, , , O
HBV-SAG NNP NNP O
Negative[1] NNP NNP O
RESULT NNP NNP O
COMMENT NNP NNP O
: : : O
Reference NN NN O
range NN NN O
: : : O
Negative(NOTE)If NNP NNP O
clinically RB RB O
indicated VBD VBD O
, , , O
testing NN NN O
for IN IN O
Hepatitis NNP NNP O
B NNP NNP O
Core NNP NNP O
IgMAntibody NNP NNP O
, , , O
Serum NNP NNP O
, , , O
is VBZ VBZ O
necessary JJ JJ O
to TO TO O
confirm VB VB O
an DT DT O
acute JJ JJ O
or CC CC O
recentinfection.Performed VBN VBN O
by IN IN O
HMH NNP NNP I-ORGANIZATION
LABORATORIES NNP NNP I-ORGANIZATION
, , , O
382 CD CD I-STREET
Farmington NNP NNP I-STREET
Road,Mount NNP NNP O
Morris NNP NNP I-CITY
, , , O
AK NNP NNP I-STATE
34712RadiologyExam CD CD O
Number NNP NNP O
: : : O
13929520 CD CD I-MEDICALRECORD
Report NNP NNP O
Status NNP NNP O
: : : O
FinalType NNP NNP O
: : : O
Chest NN NN O
2 CD CD O
ViewsDate/Time NNP NNP O
: : : O
02/15/2080 CD CD I-DATE
09:04Exam CD CD O
Code NNP NNP O
: : : O
DNSW2Ordering NNP NNP O
Provider NNP NNP O
: : : O
Xue NNP NNP I-DOCTOR
, , , O
Laura NNP NNP I-DOCTOR
M.D.REPORT NNP NNP O
Frontal NNP NNP O
and CC CC O
lateral JJ JJ O
views NNS NNS O
of IN IN O
the DT DT O
chest NN NN O
. . . O
   
COMPARISON NNP NNP O
: : : O
None NN NN O
FINDINGS NNS NNS O
: : : O
Lines/tubes NNP NNP O
: : : O
None NN NN O
. . . O
   
Lungs NNP NNP O
: : : O
Bandlike NNP NNP O
opacity NN NN O
consistent JJ JJ O
with IN IN O
subsegmental JJ JJ O
plate NN NN O
atelectasis NN NN O
at IN IN O
the DT DT O
left VBN VBN O
lung NN NN O
base NN NN O
. . . O
   
Otherwise RB RB O
clear JJ JJ O
lungs NNS NNS O
. . . O
   
Pleura NNP NNP O
: : : O
There EX EX O
is VBZ VBZ O
no DT DT O
pleural JJ JJ O
effusion NN NN O
or CC CC O
pneumothorax NN NN O
. . . O
   
Heart NNP NNP O
and CC CC O
mediastinum NN NN O
: : : O
The DT DT O
heart NN NN O
and CC CC O
the DT DT O
mediastinum NN NN O
are VBP VBP O
normal JJ JJ O
. . . O
   
Bones NNP NNP O
: : : O
The DT DT O
thoracic NN NN O
skeleton NN NN O
is VBZ VBZ O
unremarkable JJ JJ O
. . . O
   
IMPRESSION NNP NNP O
: : : O
Bandlike NNP NNP O
opacity NN NN O
consistent JJ JJ O
with IN IN O
subsegmental JJ JJ O
plate NN NN O
atelectasis NN NN O
at IN IN O
the DT DT O
left VBN VBN O
lung NN NN O
base NN NN O
. . . O
   
Otherwise RB RB O
clear JJ JJ O
lungs NNS NNS O
. . . O
   
RADIOLOGISTS NNP NNP O
: : : O
SIGNATURES NNP NNP O
: : : O
Querry NNP NNP O
, , , O
Lucas NNP NNP I-DOCTOR
Edwin NNP NNP I-DOCTOR
MD NNP NNP O
Querry NNP NNP O
, , , O
Lucas NNP NNP I-DOCTOR
Edwin NNP NNP I-DOCTOR
MD NNP NNP O
A DT DT O
: : : O
# # # O
1 CD CD O
HA NNP NNP O
: : : O
better JJR JJR O
sounds VBZ VBZ O
more RBR RBR O
like IN IN O
stress-reviewed JJ JJ O
deep JJ JJ O
breathing NN NN O
and CC CC O
monitoring NN NN O
# # # O
2 CD CD O
DM NNP NNP O
last JJ JJ O
A1C NNP NNP O
excellent JJ JJ O
at IN IN O
5.9 CD CD O
% NN NN O
Eye NNP NNP O
: : : O
seen VBN VBN O
by IN IN O
Internal NNP NNP O
Medicine-needs NNP NNP O
repeat NN NN O
in IN IN O
1-2 JJ JJ O
months NNS NNS O
for IN IN O
inadequate JJ JJ O
image NN NN O
of IN IN O
right NN NN O
eye NN NN O
Feet NNS NNS O
: : : O
address NN NN O
next JJ JJ O
visit NN NN O
lipids NNS NNS O
: : : O
LDL NNP NNP O
123-but NN NN O
HAV NNP NNP O
+ NN NN O
discussed VBD VBD O
with IN IN O
PCP NNP NNP O
before IN IN O
beginning VBG VBG O
meds NNS NNS O
ASA NNP NNP O
81 CD CD O
mg NN NN O
daily JJ JJ O
Microalbumin NNP NNP O
: : : O
2.2-just NN NN O
began VBD VBD O
Lisinopril NNP NNP O
last JJ JJ O
month NN NN O
# # # O
3 CD CD O
HTN NNP NNP O
: : : O
above IN IN O
target NN NN O
today NN NN O
increase NN NN O
Lisinopril NNP NNP O
to TO TO O
10 CD CD O
mg NN NN O
# # # O
4 CD CD O
GERD-better NNP NNP O
after IN IN O
treatment-schedule JJ JJ O
to TO TO O
see VB VB O
GI NN NN O
# # # O
5 CD CD O
Low NNP NNP O
WBC NNP NNP O
3.4 CD CD O
in IN IN O
2/80 CD CD I-DATE
then RB RB O
up IN IN O
to TO TO O
4.2 CD CD O
in IN IN O
feb NNP NNP I-DATE
# # # O
6 CD CD O
Low NNP NNP O
Vitamin NNP NNP O
D-taking NNP NNP O
replacement NN NN O
PPD NNP NNP O
per IN IN O
patient NN NN O
+ NN NN O
in IN IN O
Mississippi-did NNP NNP O
not RB RB O
plant NN NN O
given VBN VBN O
verbal JJ JJ O
consent NN NN O
to TO TO O
administer VB VB O
Pneumo NNP NNP O
vaccine NN NN O
and CC CC O
Tdap-declined NNP NNP O
H NNP NNP O
1 CD CD O
N NNP NNP O
1 CD CD O
and CC CC O
flu NN NN O
P NN NN O
: : : O
PPD NNP NNP O
, , , O
tdap NN NN O
, , , O
H NNP NNP O
1 CD CD O
N NNP NNP O
1 CD CD O
, , , O
Pneumo NNP NNP O
vaccine NN NN O
Lisinopril NNP NNP O
10 CD CD O
mg NN NN O
po NN NN O
daily-recheck NN NN O
BMP NNP NNP O
in IN IN O
6 CD CD O
weeks NNS NNS O
screening VBG VBG O
mammogram NN NN O
and CC CC O
Bone NNP NNP O
density NN NN O
Given VBN VBN O
medication NN NN O
list NN NN O
to TO TO O
compare VB VB O
home NN NN O
bottles NNS NNS O
RTC NNP NNP O
: : : O
In IN IN O
2 CD CD O
weeks NNS NNS O
for IN IN O
BP NNP NNP O
check NN NN O
April NNP NNP I-DATE
with IN IN O
PCP NNP NNP O
and CC CC O
two CD CD O
months NNS NNS O
with IN IN O
me PRP PRP O
for IN IN O
shared VBN VBN O
care NN NN O
RCHM NNP NNP O
: : : O
PE NNP NNP O
( ( ( O
2/80 CD CD I-DATE
) ) ) O
PAP NNP NNP O
none NN NN O
in IN IN O
LMR NNP NNP O
needs VBZ VBZ O
: : : O
immunizations NNS NNS O
: : : O
pneumo NN NN O
vaccine NN NN O
and CC CC O
Tdap NNP NNP O
Visit NNP NNP O
lasted VBD VBD O
45 CD CD O
minutes NNS NNS O
& CC CC O
gt NN NN O
; : : O
   
50 CD CD O
% NN NN O
of IN IN O
time NN NN O
spent VBD VBD O
on IN IN O
medications NNS NNS O
, , , O
BG NNP NNP O
, , , O
vaccine NN NN O
and CC CC O
up RP RP O
coming VBG VBG O
appointment NN NN O
Entire JJ JJ O
visit NN NN O
done VBN VBN O
with IN IN O
professional JJ JJ O
staff NN NN O
interpreter NN NN O
. . . O
   
Medication NNP NNP O
and CC CC O
allergies NNS NNS O
reviewed VBN VBN O
and CC CC O
reconciled VBN VBN O
with IN IN O
patient NN NN O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2083-04-13 JJ JJ I-DATE
04/13/2083 CD CD I-DATE
Norma NNP NNP I-DOCTOR
Umali NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
   
Eldora NNP NNP I-HOSPITAL
Nursing NNP NNP I-HOSPITAL
Rehab NNP NNP I-HOSPITAL
Center NNP NNP I-HOSPITAL
95 CD CD I-STREET
Harris NNP NNP I-STREET
Road NNP NNP I-STREET
Long NNP NNP I-CITY
Beach NNP NNP I-CITY
, , , O
VT NNP NNP I-STATE
26289 CD CD I-ZIP
Dear RB RB O
Dr NNP NNP O
. . . O
Umali NNP NNP I-DOCTOR
: : : O
Just RB RB O
a DT DT O
quick JJ JJ O
note NN NN O
to TO TO O
let VB VB O
you PRP PRP O
know VB VB O
that IN IN O
I PRP PRP O
saw VBD VBD O
Larry NNP NNP I-PATIENT
Lockwood NNP NNP I-PATIENT
in IN IN O
followup NN NN O
today NN NN O
. . . O
   
Mr NNP NNP O
. . . O
Lockwood NNP NNP I-PATIENT
has VBZ VBZ O
been VBN VBN O
generally RB RB O
feeling NN NN O
well RB RB O
and CC CC O
has VBZ VBZ O
no DT DT O
complaints NNS NNS O
except IN IN O
ongoing JJ JJ O
left VBD VBD O
lower JJR JJR O
extremity NN NN O
edema NN NN O
in IN IN O
the DT DT O
foot NN NN O
only RB RB O
, , , O
which WDT WDT O
is VBZ VBZ O
unchanged JJ JJ O
times NNS NNS O
many JJ JJ O
years NNS NNS O
. . . O
   
He PRP PRP O
has VBZ VBZ O
otherwise RB RB O
been VBN VBN O
feeling VBG VBG O
relatively RB RB O
well RB RB O
. . . O
   
He PRP PRP O
continues VBZ VBZ O
to TO TO O
be VB VB O
followed VBN VBN O
by IN IN O
Dr NNP NNP O
. . . O
Aguilera NNP NNP I-DOCTOR
who WP WP O
prefers VBZ VBZ O
to TO TO O
take VB VB O
a DT DT O
conservative JJ JJ O
approach NN NN O
given VBN VBN O
the DT DT O
difficulty NN NN O
of IN IN O
performing VBG VBG O
a DT DT O
bone NN NN O
marrow NN NN O
biopsy NN NN O
and CC CC O
low JJ JJ O
levels NNS NNS O
of IN IN O
IgA NNP NNP O
paraprotein NN NN O
. . . O
   
Review NNP NNP O
of IN IN O
systems NNS NNS O
is VBZ VBZ O
negative JJ JJ O
except IN IN O
as IN IN O
above IN IN O
. . . O
   
Fingersticks NNP NNP O
remain VB VB O
well RB RB O
controlled VBN VBN O
in IN IN O
the DT DT O
range NN NN O
of IN IN O
80-150s. JJ JJ O
   
Interval NNP NNP O
family NN NN O
, , , O
social JJ JJ O
, , , O
and CC CC O
medical JJ JJ O
history NN NN O
are VBP VBP O
unchanged JJ JJ O
. . . O
   
Current NNP NNP O
Medications NNP NNP O
: : : O
Include NNP NNP O
lisinopril NN NN O
20 CD CD O
once RB RB O
a DT DT O
day NN NN O
, , , O
Proscar NNP NNP O
5 CD CD O
once RB RB O
a DT DT O
day NN NN O
, , , O
Flomax NNP NNP O
, , , O
aspirin NN NN O
325 CD CD O
once RB RB O
a DT DT O
day NN NN O
, , , O
atenolol NN NN O
25 CD CD O
once RB RB O
a DT DT O
day NN NN O
, , , O
trazodone NN NN O
, , , O
folate NN NN O
, , , O
MVI NNP NNP O
, , , O
saw VBD VBD O
palmetto NN NN O
, , , O
glucosamine NN NN O
, , , O
selenium NN NN O
, , , O
vitamin NN NN O
C NNP NNP O
and CC CC O
vitamin NN NN O
D NNP NNP O
, , , O
Lipitor NNP NNP O
20 CD CD O
mg NN NN O
once RB RB O
a DT DT O
day NN NN O
, , , O
and CC CC O
Plavix NNP NNP O
75 CD CD O
once RB RB O
a DT DT O
day NN NN O
. . . O
   
Physical JJ JJ O
Exam NNP NNP O
: : : O
Well-developed NNP NNP O
, , , O
obese NN NN O
in IN IN O
no DT DT O
apparent JJ JJ O
distress NN NN O
. . . O
   
BP NNP NNP O
169/83 CD CD O
and CC CC O
pulse NN NN O
   
58 CD CD O
. . . O
Neck NNP NNP O
: : : O
Supple NNP NNP O
without IN IN O
JVP NNP NNP O
or CC CC O
lymphadenopathy NN NN O
. . . O
   
Chest NN NN O
: : : O
Clear NNP NNP O
to TO TO O
auscultation NN NN O
and CC CC O
percussion NN NN O
. . . O
   
Cardiovascular NNP NNP O
exam NN NN O
: : : O
S1 NNP NNP O
and CC CC O
S2 NNP NNP O
without IN IN O
murmurs NNS NNS O
, , , O
rubs NNS NNS O
, , , O
or CC CC O
gallops NNS NNS O
. . . O
   
Extremities NNP NNP O
: : : O
No DT DT O
edema NN NN O
, , , O
warm JJ JJ O
. . . O
   
Laboratory NNP NNP O
Data NNP NNP O
: : : O
Recent JJ JJ O
BUN NNP NNP O
and CC CC O
creatinine NN NN O
18 CD CD O
and CC CC O
1.5 CD CD O
. . . O
   
Repeat NNP NNP O
labs NNS NNS O
will MD MD O
be VB VB O
done VBN VBN O
when WRB WRB O
he PRP PRP O
comes VBZ VBZ O
in IN IN O
next JJ JJ O
week NN NN O
for IN IN O
his PRP$ PRP$ O
routine NN NN O
labs NNS NNS O
at IN IN O
the DT DT O
SCH NNP NNP I-HOSPITAL
. . . O
   
Skeletal JJ JJ O
films NNS NNS O
are VBP VBP O
pending VBG VBG O
. . . O
   
Impression NNP NNP O
: : : O
Mr NNP NNP O
. . . O
Lockwood NNP NNP I-PATIENT
chronic JJ JJ O
kidney NN NN O
disease NN NN O
appears VBZ VBZ O
to TO TO O
be VB VB O
stable JJ JJ O
, , , O
as IN IN O
I PRP PRP O
have VBP VBP O
mentioned VBN VBN O
before IN IN O
, , , O
he PRP PRP O
most RBS RBS O
likely RB RB O
has VBZ VBZ O
some DT DT O
underlying VBG VBG O
diabetic JJ JJ O
and/or NN NN O
hypertensive JJ JJ O
nephropathy NN NN O
, , , O
but CC CC O
I PRP PRP O
continue VBP VBP O
to TO TO O
wonder VB VB O
whether IN IN O
the DT DT O
IgA NNP NNP O
paraprotein NN NN O
is VBZ VBZ O
playing VBG VBG O
a DT DT O
role NN NN O
in IN IN O
the DT DT O
increasing VBG VBG O
proteinuria NN NN O
and CC CC O
mild JJ JJ O
CKD NNP NNP O
. . . O
   
Chemotherapy NNP NNP O
would MD MD O
be VB VB O
indicated VBN VBN O
if IN IN O
that DT DT O
were VBD VBD O
the DT DT O
case NN NN O
. . . O
   
. . . O
   
He PRP PRP O
is VBZ VBZ O
being VBG VBG O
followed VBN VBN O
conservatively RB RB O
by IN IN O
Dr NNP NNP O
. . . O
Aguilera NNP NNP I-DOCTOR
thus RB RB O
far RB RB O
in IN IN O
the DT DT O
absence NN NN O
of IN IN O
defniitive JJ JJ O
data NNS NNS O
. . . O
   
I PRP PRP O
have VBP VBP O
ordered VBN VBN O
skull NN NN O
and CC CC O
hip NN NN O
films NNS NNS O
today NN NN O
to TO TO O
look VB VB O
for IN IN O
evidence NN NN O
of IN IN O
myeloma-related JJ JJ O
bone NN NN O
disease NN NN O
, , , O
which WDT WDT O
if IN IN O
present JJ JJ O
could MD MD O
distinguish VB VB O
more RBR RBR O
significant JJ JJ O
disease NN NN O
from IN IN O
MGUS NNP NNP O
. . . O
   
I PRP PRP O
agree VBP VBP O
with IN IN O
Dr NNP NNP O
. . . O
Altman NNP NNP I-DOCTOR
that IN IN O
in IN IN O
the DT DT O
absence NN NN O
of IN IN O
definitive JJ JJ O
data,as NN NN O
long RB RB O
as IN IN O
creatinine NN NN O
is VBZ VBZ O
improving VBG VBG O
and CC CC O
urinary JJ JJ O
protein NN NN O
levels NNS NNS O
remain VBP VBP O
stable JJ JJ O
the DT DT O
current JJ JJ O
approach NN NN O
is VBZ VBZ O
reasonable JJ JJ O
. . . O
   
However RB RB O
, , , O
we PRP PRP O
should MD MD O
have VB VB O
a DT DT O
low JJ JJ O
threshold NN NN O
for IN IN O
pushing VBG VBG O
Mr NNP NNP O
. . . O
Lockwood NNP NNP I-PATIENT
to TO TO O
having VBG VBG O
either CC CC O
a DT DT O
renal JJ JJ O
or CC CC O
more RBR RBR O
preferably RB RB O
bone NN NN O
marrow NN NN O
biopsy NN NN O
. . . O
   
In IN IN O
the DT DT O
meantime NN NN O
because IN IN O
he PRP PRP O
continues VBZ VBZ O
to TO TO O
have VB VB O
protein NN NN O
and CC CC O
albumin NN NN O
in IN IN O
his PRP$ PRP$ O
urine NN NN O
, , , O
I PRP PRP O
have VBP VBP O
initiated VBN VBN O
dual JJ JJ O
angiotensin NN NN O
blockade NN NN O
and CC CC O
have VBP VBP O
added VBN VBN O
Cozaar NNP NNP O
25 CD CD O
mg NN NN O
a DT DT O
day NN NN O
to TO TO O
his PRP$ PRP$ O
regimen NN NN O
. . . O
   
He PRP PRP O
will MD MD O
follow VB VB O
up RP RP O
with IN IN O
me PRP PRP O
in IN IN O
four CD CD O
months NNS NNS O
and CC CC O
will MD MD O
have VB VB O
labs NNS NNS O
next JJ JJ O
week NN NN O
at IN IN O
the DT DT O
SCH NNP NNP I-HOSPITAL
. . . O
   
Thank VB VB O
you PRP PRP O
for IN IN O
referring VBG VBG O
this DT DT O
patient NN NN O
. . . O
   
Sincerely NNP NNP O
, , , O
_____________________________ NN NN O
_ NN NN O
Herbert NNP NNP I-DOCTOR
Nunez NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
, , , O
M.Sc NNP NNP O
. . . O
   
eScription NN NN O
document:8-3687892 JJ JJ O
CSSten NNP NNP O
Tel NNP NNP O
CC NNP NNP O
: : : O
David NNP NNP I-DOCTOR
Aguilera NNP NNP I-DOCTOR
Southside NNP NNP I-HOSPITAL
Community NNP NNP I-HOSPITAL
Hospital NNP NNP I-HOSPITAL
8 CD CD I-STREET
Foster NNP NNP I-STREET
Court NNP NNP I-STREET
Fairview NNP NNP I-CITY
, , , O
VT NNP NNP I-STATE
85147 CD CD I-ZIP
DD NNP NNP O
: : : O
04/13/83 CD CD I-DATE
DT NNP NNP O
: : : O
04/14/83 CD CD I-DATE
DV NNP NNP O
: : : O
04/13/83 CD CD I-DATE
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2074-10-08 JJ JJ I-DATE
CARDIOLOGY NNP NNP O
COLLINGSWORTH NNP NNP I-HOSPITAL
GENERAL NNP NNP I-HOSPITAL
HOSPITAL NNP NNP I-HOSPITAL
Reason NNP NNP O
for IN IN O
visit NN NN O
: : : O
Pt NNP NNP O
is VBZ VBZ O
seen VBN VBN O
@ IN IN O
r/o NN NN O
Dr NNP NNP O
Quintana NNP NNP I-DOCTOR
in IN IN O
ER NNP NNP O
obs JJ JJ O
unit NN NN O
- : : O
in IN IN O
o/n NN NN O
with IN IN O
chest NN NN O
pain NN NN O
Interval NNP NNP O
History NN NN O
: : : O
He PRP PRP O
has VBZ VBZ O
had VBN VBN O
angioplasty NN NN O
of IN IN O
the DT DT O
circumflex JJ JJ O
vessel NN NN O
and CC CC O
angioplasty NN NN O
and CC CC O
stenting VBG VBG O
of IN IN O
a DT DT O
diagonal JJ JJ O
branch NN NN O
of IN IN O
his PRP$ PRP$ O
LAD NNP NNP O
, , , O
both DT DT O
in IN IN O
May NNP NNP I-DATE
2071 CD CD I-DATE
. . . O
   
A DT DT O
relook NN NN O
in IN IN O
February NNP NNP I-DATE
2072 CD CD I-DATE
revealed VBD VBD O
that IN IN O
the DT DT O
stent NN NN O
was VBD VBD O
patent NN NN O
. . . O
   
His PRP$ PRP$ O
sx NN NN O
with IN IN O
original JJ JJ O
stenting NN NN O
were VBD VBD O
chest NN NN O
presure NN NN O
and CC CC O
burning NN NN O
He PRP PRP O
has VBZ VBZ O
now RB RB O
come VB VB O
to TO TO O
ER NNP NNP O
with IN IN O
brief JJ JJ O
unprovoked JJ JJ O
stabs NN NN O
of IN IN O
L NNP NNP O
high JJ JJ O
lateral NN NN O
point NN NN O
pain NN NN O
w NN NN O
no DT DT O
associated VBN VBN O
sx NN NN O
occurring VBG VBG O
repeatedly RB RB O
over IN IN O
several JJ JJ O
hours NNS NNS O
w NN NN O
NO DT DT O
other JJ JJ O
relevant JJ JJ O
hx NN NN O
. . . O
   
The DT DT O
pain NN NN O
seemed VBD VBD O
to TO TO O
improve VB VB O
with IN IN O
local JJ JJ O
massage NN NN O
Family NNP NNP O
history NN NN O
: : : O
He PRP PRP O
has VBZ VBZ O
one CD CD O
sister NN NN O
living VBG VBG O
in IN IN O
St NNP NNP O
. . . O
John NNP NNP O
's POS POS O
who WP WP O
has VBZ VBZ O
diabetes NNS NNS O
. . . O
   
Both DT DT O
his PRP$ PRP$ O
parents NNS NNS O
had VBD VBD O
diabetes VBN VBN O
as RB RB O
well RB RB O
. . . O
   
They PRP PRP O
are VBP VBP O
both DT DT O
deceased VBN VBN O
Social NNP NNP O
history NN NN O
: : : O
He PRP PRP O
is VBZ VBZ O
now RB RB O
fully RB RB O
retired VBN VBN O
from IN IN O
quarrying VBG VBG I-PROFESSION
. . . O
   
He PRP PRP O
is VBZ VBZ O
married VBN VBN O
and CC CC O
lives NNS NNS O
with IN IN O
his PRP$ PRP$ O
wife NN NN O
. . . O
   
Physical JJ JJ O
examination NN NN O
: : : O
- : : O
resp NN NN O
. . . O
   
rate NN NN O
: : : O
16 CD CD O
- - - O
General NNP NNP O
: : : O
No DT DT O
acute JJ JJ O
distress NN NN O
. . . O
   
- - - O
Skin NNP NNP O
: : : O
No DT DT O
rashes NNS NNS O
, , , O
anicteric JJ JJ O
. . . O
   
- - - O
Heent NNP NNP O
: : : O
Unremarkable NNP NNP O
- - - O
Neck NNP NNP O
: : : O
Carotids NNP NNP O
2 CD CD O
+ NN NN O
without IN IN O
bruits NNS NNS O
. . . O
   
JVP NNP NNP O
no DT DT O
jugular NN NN O
venous JJ JJ O
distention NN NN O
. . . O
   
- - - O
Chest NN NN O
: : : O
Clear NNP NNP O
to TO TO O
auscultation NN NN O
and CC CC O
percussion NN NN O
. . . O
   
- - - O
Cardiac NNP NNP O
: : : O
Left NNP NNP O
ventricular NN NN O
impulse JJ JJ O
discrete NN NN O
and CC CC O
nondisplaced VBD VBD O
. . . O
   
Regular NNP NNP O
rate NN NN O
and CC CC O
rhythm NN NN O
, , , O
normal JJ JJ O
S1 NNP NNP O
and CC CC O
S2 NNP NNP O
, , , O
with IN IN O
no DT DT O
S3 NNP NNP O
or CC CC O
S4 NNP NNP O
. . . O
   
There EX EX O
was VBD VBD O
a DT DT O
2/6 CD CD O
systolic JJ JJ O
murmur NN NN O
of IN IN O
MR NNP NNP O
- - - O
Abdomen NNP NNP O
: : : O
Normal JJ JJ O
bowel NN NN O
sounds VBZ VBZ O
, , , O
soft JJ JJ O
and CC CC O
nontender NN NN O
, , , O
with IN IN O
no DT DT O
hepatosplenomegaly NN NN O
or CC CC O
masses NNS NNS O
appreciated VBN VBN O
. . . O
   
- - - O
Extremities NNP NNP O
: : : O
No DT DT O
cyanosis NN NN O
, , , O
clubbing VBG VBG O
or CC CC O
edema NN NN O
. . . O
   
2 CD CD O
+ NN NN O
femoral JJ JJ O
pulses NNS NNS O
without IN IN O
bruits NNS NNS O
. . . O
   
2 CD CD O
+ NN NN O
pedal NN NN O
pulses NNS NNS O
. . . O
   
- - - O
BP NNP NNP O
: : : O
130/75 CD CD O
EKG NNP NNP O
: : : O
NSR NNP NNP O
and CC CC O
WNL NNP NNP O
Selected NNP NNP O
recent JJ JJ O
labs NNS NNS O
: : : O
Cardiac NNP NNP O
enzymes NNS NNS O
Date NN NN O
CK NNP NNP O
CK-MB NNP NNP O
CKMBRI NNP NNP O
TROP-I NNP NNP O
TROP-T NNP NNP O
10/08/74 CD CD I-DATE
63 CD CD O
2.3 CD CD O
< NN NN O
0.01 CD CD O
10/07/74 CD CD I-DATE
NEGATIVE NNP NNP O
Assessment NNP NNP O
and CC CC O
plan NN NN O
: : : O
He PRP PRP O
has VBZ VBZ O
presented VBN VBN O
with IN IN O
very RB RB O
atypical JJ JJ O
chest NN NN O
pain NN NN O
with IN IN O
negative JJ JJ O
markers NNS NNS O
and CC CC O
unchanged JJ JJ O
ECG NNP NNP O
. . . O
   
Thjis NNP NNP O
is VBZ VBZ O
chest NN NN O
wall NN NN O
pain NN NN O
- : : O
not RB RB O
cardiac JJ JJ O
. . . O
   
It PRP PRP O
is VBZ VBZ O
clearly RB RB O
- : : O
in IN IN O
pt NN NN O
's POS POS O
view NN NN O
and CC CC O
mine NN NN O
- - - O
different JJ JJ O
from IN IN O
the DT DT O
pain NN NN O
of IN IN O
his PRP$ PRP$ O
CAD NNP NNP O
. . . O
   
He PRP PRP O
is VBZ VBZ O
OK JJ JJ O
to TO TO O
go VB VB O
home NN NN O
with IN IN O
dx NN NN O
of IN IN O
chest NN NN O
wall NN NN O
pain NN NN O
. . . O
   
OK JJ JJ O
to TO TO O
use VB VB O
Ibuprofen NNP NNP O
prn NN NN O
- : : O
should MD MD O
be VB VB O
ok JJ JJ O
in IN IN O
low JJ JJ O
dose NN NN O
on IN IN O
full JJ JJ O
stomach NN NN O
despite IN IN O
his PRP$ PRP$ O
h/o NN NN O
dyspepsia NN NN O
. . . O
   
F/u NNP NNP O
w NN NN O
Dr NNP NNP O
Cook NNP NNP I-DOCTOR
. . . O
   
Signed VBN VBN O
electronically RB RB O
by IN IN O
Bob NNP NNP I-DOCTOR
D NNP NNP I-DOCTOR
Kirkpatrick NNP NNP I-DOCTOR
MD NNP NNP O
on IN IN O
Oct NNP NNP I-DATE
8 CD CD O
, , , O
2074 CD CD I-DATE
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2074-06-05 JJ JJ I-DATE
Mills NNP NNP I-PATIENT
returns NNS NNS O
with IN IN O
Urquiza NNP NNP I-PATIENT
and CC CC O
her PRP$ PRP$ O
husband NN NN O
. . . O
   
He PRP PRP O
's VBZ VBZ O
been VBN VBN O
trying VBG VBG O
- - - O
cut VB VB O
way NN NN O
back RB RB O
on IN IN O
sodas NN NN O
, , , O
and CC CC O
chips NNS NNS O
. . . O
   
He PRP PRP O
walks VBZ VBZ O
every DT DT O
day NN NN O
- : : O
really RB RB O
no DT DT O
complaints NNS NNS O
. . . O
   
His PRP$ PRP$ O
HbA1C NNP NNP O
was VBD VBD O
up RB RB O
at IN IN O
9.2 CD CD O
. . . O
   
No DT DT O
proteinuria NN NN O
. . . O
   
No DT DT O
complaints NNS NNS O
of IN IN O
foot NN NN O
numbness NN NN O
, , , O
no DT DT O
visual JJ JJ O
sx NN NN O
. . . O
   
Lipids NNP NNP O
were VBD VBD O
fair JJ JJ O
- : : O
202 CD CD O
, , , O
HDL NNP NNP O
44 CD CD O
, , , O
Trigs NNP NNP O
461 CD CD O
. . . O
   
Cost NNP NNP O
has VBZ VBZ O
become VBN VBN O
an DT DT O
issue NN NN O
on IN IN O
meds NNS NNS O
as IN IN O
Mills NNP NNP I-PATIENT
has VBZ VBZ O
been VBN VBN O
denied VBN VBN O
state NN NN I-HEALTHPLAN
insurance NN NN I-HEALTHPLAN
for IN IN O
arcane NN NN O
reasons NNS NNS O
. . . O
   
. . . O
   
( ( ( O
his PRP$ PRP$ O
income NN NN O
is VBZ VBZ O
only RB RB O
850.00/mo) CD CD O
RoS NNP NNP O
: : : O
feels VBZ VBZ O
fine NN NN O
, , , O
ROS NNP NNP O
neg NN NN O
. . . O
   
in IN IN O
detail NN NN O
. . . O
   
Habits NNP NNP O
: : : O
no DT DT O
smoking NN NN O
or CC CC O
drinking NN NN O
. . . O
   
( ( ( O
sober NN NN O
for IN IN O
years NNS NNS O
) ) ) O
Medications NNP NNP O
Glucophage NNP NNP O
( ( ( O
METFORMIN NNP NNP O
) ) ) O
500MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
TID NNP NNP O
x SYM SYM O
90 CD CD O
days NNS NNS O
Micronase NNP NNP O
( ( ( O
GLYBURIDE NNP NNP O
) ) ) O
10 CD CD O
MG NNP NNP O
( ( ( O
5MG CD CD O
TABLET NNP NNP O
take NN NN O
2 CD CD O
) ) ) O
PO NNP NNP O
BID NNP NNP O
x SYM SYM O
90 CD CD O
days NNS NNS O
Tegretol NNP NNP O
( ( ( O
CARBAMAZEPINE NNP NNP O
) ) ) O
200MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
TID NNP NNP O
x SYM SYM O
90 CD CD O
days NNS NNS O
Monopril NNP NNP O
( ( ( O
FOSINOPRIL NNP NNP O
SODIUM NNP NNP O
) ) ) O
20MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
x SYM SYM O
90 CD CD O
days NNS NNS O
Aspirin NNP NNP O
( ( ( O
ACETYLSALICYLIC NNP NNP O
ACID NNP NNP O
) ) ) O
81MG CD CD O
TABLET NNP NNP O
CHEWABLE NNP NNP O
take NN NN O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
, , , O
Take NNP NNP O
as IN IN O
directed VBN VBN O
Lipitor NNP NNP O
( ( ( O
ATORVASTATIN NNP NNP O
) ) ) O
10MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
, , , O
Take NNP NNP O
as IN IN O
directed VBN VBN O
Hctz NNP NNP O
( ( ( O
HYDROCHLOROTHIAZIDE NNP NNP O
) ) ) O
25MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
x SYM SYM O
90 CD CD O
days NNS NNS O
, , , O
Take VB VB O
as IN IN O
directed VBN VBN O
Allergies NNPS NNPS O
NKA NNP NNP O
Vital NNP NNP O
Signs NNP NNP O
Wt NNP NNP O
202 CD CD O
lb NN NN O
Looks NNP NNP O
well RB RB O
, , , O
though RB RB O
sunburnt NN NN O
. . . O
   
BP NNP NNP O
: : : O
160/80 CD CD O
p. NN NN O
70's CD CD O
reg NN NN O
clear JJ JJ O
RRR NNP NNP O
no DT DT O
edema NN NN O
, , , O
no DT DT O
neurop NN NN O
. . . O
   
Problems NNS NNS O
Diabetes NNP NNP O
mellitus JJ JJ O
- : : O
check NN NN O
FS NNP NNP O
glucose NN NN O
today NN NN O
. . . O
   
Eventually RB RB O
we PRP PRP O
'll MD MD O
need VB VB O
to TO TO O
teach VB VB O
Mills/family NNP NNP O
how WRB WRB O
to TO TO O
do VB VB O
fingersticks NNS NNS O
, , , O
but CC CC O
we PRP PRP O
are VBP VBP O
n't RB RB O
there EX EX O
yet RB RB O
. . . O
   
working VBG VBG O
hard JJ JJ O
on IN IN O
diet NN NN O
. . . O
   
. . . O
   
. . . O
   
f/u NN NN O
1mo CD CD O
. . . O
   
He PRP PRP O
will MD MD O
need VB VB O
eye NN NN O
exam NN NN O
. . . O
   
Adding VBG VBG O
statin NN NN O
and CC CC O
Aspirin NNP NNP O
today NN NN O
. . . O
   
Hypertension NNP NNP O
- : : O
add VB VB O
HCTZ NNP NNP O
25mg CD CD O
qd NN NN O
. . . O
   
H/O NNP NNP O
Seizure NNP NNP O
disorder NN NN O
: : : O
Status NNP NNP O
post NN NN O
head NN NN O
trauma NN NN O
H/O NNP NNP O
Alcohol NNP NNP O
abuse NN NN O
- : : O
sober NN NN O
now RB RB O
. . . O
   
Health NNP NNP O
Maintenance NNP NNP O
Influenza NNP NNP O
Vaccine NNP NNP O
11/24/2072 CD CD I-DATE
Cholesterol NNP NNP O
04/03/2074 CD CD I-DATE
202 CD CD O
DESIRABLE NNP NNP O
: : : O
< NN NN O
200 CD CD O
M-alb/creat NNP NNP O
ratio NN NN O
04/03/2074 CD CD I-DATE
6.5 CD CD O
UA-Protein NNP NNP O
10/01/62 CD CD I-DATE
NEG NNP NNP O
Triglycerides NNP NNP O
04/03/2074 CD CD I-DATE
461 CD CD O
Cholesterol-LDL NNP NNP O
04/03/2074 CD CD I-DATE
-- : : O
"""" '' '' O
Calculated VBN VBN O
"""" '' '' O
LDL NNP NNP O
is VBZ VBZ O
inaccuratewhen JJ JJ O
triglycerides NNS NNS O
exceed VBP VBP O
400 CD CD O
mg/dl NN NN O
. . . O
   
Microalbumin NNP NNP O
04/03/2074 CD CD I-DATE
0.6 CD CD O
Hct NNP NNP O
( ( ( O
Hematocrit NNP NNP O
) ) ) O
04/03/2074 CD CD I-DATE
41.0 CD CD O
Cholesterol-HDL NNP NNP O
04/03/2074 CD CD I-DATE
46 CD CD O
MHCT NNP NNP O
( ( ( O
micro-Hematocrit NN NN O
) ) ) O
07/15/62 CD CD I-DATE
30 CD CD O
Hgb NNP NNP O
( ( ( O
Hemoglobin NNP NNP O
) ) ) O
04/03/2074 CD CD I-DATE
14.3 CD CD O
HbA1c NNP NNP O
04/03/2074 CD CD I-DATE
9.50 CD CD O
____________________________________________ NN NN O
_ NN NN O
Yechiel NNP NNP I-DOCTOR
Kidd NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2117-08-19 JJ JJ I-DATE
Immanuel NNP NNP I-HOSPITAL
Medical NNP NNP I-HOSPITAL
Center NNP NNP I-HOSPITAL
Emergency NNP NNP O
Department NNP NNP O
Record NNP NNP O
Patient NNP NNP O
: : : O
TRAVIS NNP NNP O
, , , O
PEGGY NNP NNP I-PATIENT
MRN NNP NNP O
: : : O
0834010 CD CD I-MEDICALRECORD
DOB NNP NNP O
: : : O
3/08/2061 CD CD I-DATE
Sex NN NN O
: : : O
F NN NN O
Registration NNP NNP O
Date/Time NNP NNP O
: : : O
8/19/2117 CD CD I-DATE
3:52:00 NN NN O
PM NNP NNP O
Provider NNP NNP O
: : : O
NICHOLAS NNP NNP I-DOCTOR
SINGH NNP NNP I-DOCTOR
Time NNP NNP O
Patient NNP NNP O
Seen VBN VBN O
17:00 CD CD O
Chief NNP NNP O
Complaint NNP NNP O
Swelling NNP NNP O
in IN IN O
the DT DT O
right NN NN O
foot NN NN O
. . . O
   
HPI NNP NNP O
56 CD CD I-AGE
yo NN NN O
f SYM SYM O
a DT DT O
known VBN VBN O
diabetic JJ JJ O
for IN IN O
past JJ JJ O
3 CD CD O
yrs NNS NNS O
has VBZ VBZ O
come VBN VBN O
with IN IN O
complaints NNS NNS O
of IN IN O
swellin NN NN O
and CC CC O
redness NN NN O
of IN IN O
the DT DT O
R NNP NNP O
foot NN NN O
for IN IN O
one CD CD O
week,she NN NN O
hit VBD VBD O
her PRP$ PRP$ O
toe NN NN O
against IN IN O
a DT DT O
beaureu NN NN O
after IN IN O
wqhich NN NN O
she PRP PRP O
developed VBD VBD O
pain NN NN O
, , , O
swelling VBG VBG O
and CC CC O
redness.There NN NN O
is VBZ VBZ O
loss NN NN O
of IN IN O
sensation.no NN NN O
h/o NN NN O
fever NN NN O
, , , O
chills NNS NNS O
and CC CC O
rigor NN NN O
. . . O
   
PMHx NNP NNP O
Diabetes,hypertension,stroke NNP NNP O
PSurHx NNP NNP O
None NN NN O
Meds NNP NNP O
diabetic JJ JJ O
medications NNS NNS O
Allergy NNP NNP O
No DT DT O
Known VBN VBN O
Drug NN NN O
Allergies NNP NNP O
Social NNP NNP O
Hx NNP NNP O
No DT DT O
Etoh/drug NNP NNP O
ROS NNP NNP O
General NNP NNP O
Negative NNP NNP O
Constitutional NNP NNP O
No DT DT O
major JJ JJ O
weight NN NN O
loss NN NN O
or CC CC O
gain NN NN O
, , , O
fatigue NN NN O
, , , O
fever NN NN O
, , , O
chills NNS NNS O
. . . O
   
Head/Eyes NNP NNP O
No DT DT O
visual JJ JJ O
changes NNS NNS O
, , , O
lesions NNS NNS O
, , , O
headaches NNS NNS O
ENT/Neck NNP NNP O
No DT DT O
hearing VBG VBG O
loss NN NN O
, , , O
tinnitus NN NN O
, , , O
vertigo NN NN O
, , , O
rhinorrhea NN NN O
, , , O
hoarseness NN NN O
, , , O
difficulty NN NN O
swallowing VBG VBG O
, , , O
oral JJ JJ O
lesions NNS NNS O
, , , O
stiffness JJ JJ O
Chest/Respiratory NNP NNP O
No DT DT O
coughing VBG VBG O
, , , O
wheezing VBG VBG O
, , , O
dyspnea NN NN O
Cardiovascular NNP NNP O
No DT DT O
chest NN NN O
pain NN NN O
, , , O
palpitations NNS NNS O
, , , O
PND NNP NNP O
, , , O
orthopnea JJ JJ O
GI/Abdominal NNP NNP O
No DT DT O
pain NN NN O
, , , O
nausea NN NN O
, , , O
vomiting VBG VBG O
, , , O
diarrhea NN NN O
, , , O
melena NN NN O
, , , O
bleeding VBG VBG O
, , , O
heartburn NN NN O
GU/Flank/CVA/Pelvic NNP NNP O
No DT DT O
menstrual JJ JJ O
irregularity NN NN O
, , , O
vaginal JJ JJ O
discharge NN NN O
, , , O
frequency NN NN O
, , , O
urgency NN NN O
, , , O
dysuria NN NN O
, , , O
bleeding VBG VBG O
Musculoskeletal/Extr/Back NNP NNP O
bilateral NN NN O
pedal NN NN O
edema,ulcer NN NN O
in IN IN O
the DT DT O
right NN NN O
foot NN NN O
. . . O
   
Skin NNP NNP O
See VB VB O
HPI NNP NNP O
Neuro NNP NNP O
Slurred NNP NNP O
speech,weakness NN NN O
in IN IN O
the DT DT O
right NN NN O
lower JJR JJR O
limb NN NN O
Psych NNP NNP O
No DT DT O
depression NN NN O
, , , O
anxiety NN NN O
, , , O
unusual JJ JJ O
stress NN NN O
Heme/Lymph/Imm NNP NNP O
No DT DT O
bruising VBG VBG O
, , , O
adenopathy JJ JJ O
, , , O
chills NNS NNS O
, , , O
sweats NNS NNS O
, , , O
fevers NNS NNS O
Endo NNP NNP O
No DT DT O
polyuria NN NN O
, , , O
polydipsia NN NN O
Physical JJ JJ O
Exam NNP NNP O
Constitutional NNP NNP O
Patient NNP NNP O
is VBZ VBZ O
a DT DT O
well RB RB O
developed VBN VBN O
, , , O
well RB RB O
nourished VBN VBN O
, , , O
healthy JJ JJ O
appearing NN NN O
, , , O
alert NN NN O
female JJ JJ O
, , , O
no DT DT O
acute JJ JJ O
distress JJ JJ O
, , , O
no DT DT O
obvious JJ JJ O
discomfort NN NN O
Head/Eyes NNP NNP O
NC/AT NNP NNP O
, , , O
pupils NNS NNS O
are VBP VBP O
equal JJ JJ O
, , , O
round NN NN O
and CC CC O
react VB VB O
normally RB RB O
to TO TO O
light VB VB O
, , , O
EOM NNP NNP O
's POS POS O
are VBP VBP O
full JJ JJ O
, , , O
no DT DT O
ocular NN NN O
discharge NN NN O
, , , O
conjunctiva NN NN O
normal JJ JJ O
ENT NNP NNP O
There EX EX O
is VBZ VBZ O
no DT DT O
nasal NN NN O
discharge NN NN O
. . . O
TM NNP NNP O
's POS POS O
clear JJ JJ O
, , , O
auditory JJ JJ O
canal NN NN O
without IN IN O
lesions NNS NNS O
, , , O
no DT DT O
intraoral JJ JJ O
lesions NNS NNS O
, , , O
good JJ JJ O
dentition NN NN O
, , , O
uvula NN NN O
midline NN NN O
, , , O
tonsils NNS NNS O
and CC CC O
pharynx NN NN O
without IN IN O
inflammation NN NN O
or CC CC O
exudates NNS NNS O
Neck NNP NNP O
Full NNP NNP O
range NN NN O
of IN IN O
motion NN NN O
, , , O
no DT DT O
stiffness NN NN O
or CC CC O
tenderness NN NN O
, , , O
thyroid NN NN O
normal JJ JJ O
size NN NN O
without IN IN O
nodularity NN NN O
. . . O
   
Carotid NNP NNP O
pulses NNS NNS O
are VBP VBP O
intact JJ JJ O
bilaterally RB RB O
without IN IN O
bruits NNS NNS O
, , , O
no DT DT O
lymphadenopathy NN NN O
, , , O
no DT DT O
masses NNS NNS O
, , , O
no DT DT O
neck NN NN O
vein NN NN O
distention NN NN O
Chest/Respiratory NNP NNP O
Clear NNP NNP O
to TO TO O
auscultation NN NN O
and CC CC O
percussion NN NN O
, , , O
no DT DT O
crackles NNS NNS O
, , , O
wheezes NNS NNS O
or CC CC O
rhonchi NN NN O
Cardiovascular NNP NNP O
Regular NNP NNP O
rate NN NN O
and CC CC O
rhythm NN NN O
, , , O
normal JJ JJ O
S1 NNP NNP O
& CC CC O
S2 NNP NNP O
, , , O
no DT DT O
murmurs NNS NNS O
, , , O
gallops NNS NNS O
or CC CC O
rubs NNS NNS O
GI/Abdomen NNP NNP O
Soft JJ JJ O
, , , O
normal JJ JJ O
bowel NN NN O
sounds VBZ VBZ O
, , , O
nontender NN NN O
, , , O
no DT DT O
intra-abdominal JJ JJ O
masses NNS NNS O
or CC CC O
hepatosplenomegaly NN NN O
Genitourinary NNP NNP O
Speculum NNP NNP O
and CC CC O
bimanual JJ JJ O
examination NN NN O
normal JJ JJ O
, , , O
no DT DT O
masses NNS NNS O
or CC CC O
tenderness JJ JJ O
Musculoskeletal NNP NNP O
No DT DT O
cyanosis NN NN O
, , , O
clubbing VBG VBG O
, , , O
or CC CC O
joint JJ JJ O
swelling VBG VBG O
Skin NNP NNP O
ulcer NN NN O
right JJ JJ O
foot,swelling NN NN O
of IN IN O
R NNP NNP O
foot,redness JJ JJ O
Neurologic NNP NNP O
Loss NN NN O
of IN IN O
sensation NN NN O
of IN IN O
b/l NN NN O
foot,slurring NN NN O
of IN IN O
speech,cn NN NN O
1to12 CD CD O
normal JJ JJ O
, , , O
power NN NN O
of IN IN O
lower JJR JJR O
limb NN NN O
muscle NN NN O
4/5 CD CD O
. . . O
   
UL NNP NNP O
POWER NNP NNP O
5/5 CD CD O
. . . O
   
Psychiatric NNP NNP O
No DT DT O
visual JJ JJ O
or CC CC O
auditory JJ JJ O
hallucination NN NN O
, , , O
not RB RB O
suicidal JJ JJ O
, , , O
not RB RB O
homicidal JJ JJ O
X-ray NNP NNP O
Interpretation NN NN O
X-ray NNP NNP O
right NN NN O
foot NN NN O
. . . O
   
Impression/Plan NNP NNP O
R NNP NNP O
Diabetic NNP NNP O
foot NN NN O
ED NNP NNP O
Attending NNP NNP O
Physician NNP NNP O
Note NN NN O
HPI NNP NNP O
56 CD CD I-AGE
year-old JJ JJ O
female JJ JJ O
reports NNS NNS O
blunt VBP VBP O
trauma NN NN O
to TO TO O
right JJ JJ O
great JJ JJ O
toe NN NN O
one CD CD O
week NN NN O
ago RB RB O
now RB RB O
with IN IN O
increasing JJ JJ O
redness NNS NNS O
and CC CC O
swelling VBG VBG O
ROS NNP NNP O
Paste NNP NNP O
and CC CC O
the DT DT O
itching VBG VBG O
sensation NN NN O
, , , O
joint JJ JJ O
pain NN NN O
, , , O
fever NN NN O
, , , O
Vitals NNP NNP O
See NNP NNP O
Nursing NNP NNP O
Notes NNPS NNPS O
PE NNP NNP O
Gen NNP NNP O
: : : O
nontoxic JJ JJ O
HEENT NNP NNP O
MMM NNP NNP O
PERRLA NNP NNP O
EOMI NNP NNP O
neck NN NN O
NT NNP NNP O
supple JJ JJ O
heart NN NN O
s1s2 NN NN O
RRR NNP NNP O
- : : O
m NN NN O
lungs NNS NNS O
CTAx2 NNP NNP O
abd NN NN O
soft JJ JJ O
NT NNP NNP O
ND NNP NNP O
ext JJ JJ O
- - - O
c/c/e NN NN O
FROM IN IN O
all DT DT O
jts NN NN O
neuro NN NN O
sens NNS NNS O
symmetric JJ JJ O
to TO TO O
LT/PP NNP NNP O
distally RB RB O
, , , O
skin NN NN O
erythema NN NN O
of IN IN O
right NN NN O
great JJ JJ O
toe NN NN O
with IN IN O
soft JJ JJ O
tissue NN NN O
swelling VBG VBG O
and CC CC O
erythema NN NN O
extending VBG VBG O
into IN IN O
the DT DT O
forefoot NN NN O
with IN IN O
edema NN NN O
Medical NNP NNP I-HOSPITAL
Decision NNP NNP O
Making VBG VBG O
ED NNP NNP O
Course NN NN O
ED NNP NNP O
IV NNP NNP O
antibiotics NNS NNS O
, , , O
check NN NN O
CBC NNP NNP O
and CC CC O
Chem-7; NNP NNP O
   
glucose NN NN O
normal JJ JJ O
; : : O
   
admit NN NN O
for IN IN O
diabetic JJ JJ O
foot NN NN O
infection/cellulitis NN NN O
Condition NNP NNP O
on IN IN O
Discharge NNP NNP O
Stable JJ JJ O
Diagnoses NNP NNP O
Right RB RB O
foot NN NN O
cellulitis NNS NNS O
Review NNP NNP O
Comments NNS NNS O
I PRP PRP O
have VBP VBP O
personally RB RB O
seen VBN VBN O
and CC CC O
examined VBD VBD O
the DT DT O
patient NN NN O
and CC CC O
confirmed VBD VBD O
the DT DT O
resident NN NN O
's POS POS O
examination NN NN O
, , , O
reviewed VBN VBN O
and CC CC O
agree VBP VBP O
with IN IN O
the DT DT O
resident NN NN O
's POS POS O
documentation NN NN O
of IN IN O
history NN NN O
, , , O
and CC CC O
discussed VBD VBD O
the DT DT O
evaluation NN NN O
, , , O
plan NN NN O
of IN IN O
care NN NN O
and CC CC O
disposition NN NN O
of IN IN O
the DT DT O
patient NN NN O
with IN IN O
the DT DT O
resident NN NN O
. . . O
   
This DT DT O
note NN NN O
has VBZ VBZ O
been VBN VBN O
electronically RB RB O
signed VBN VBN O
by IN IN O
NICHOLAS NNP NNP I-DOCTOR
SINGH NNP NNP I-DOCTOR
, , , O
MD NNP NNP O
8/25/2117 CD CD I-DATE
6:25:59 NN NN O
PM NNP NNP O
Clinical NNP NNP O
staff NN NN O
documenting VBG VBG O
in IN IN O
the DT DT O
ED NNP NNP O
note NN NN O
include VBP VBP O
: : : O
Attending/Nurse NNP NNP O
Practitioners NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
NICHOLAS NNP NNP I-DOCTOR
SINGH NNP NNP I-DOCTOR
, , , O
MD NNP NNP O
Other JJ JJ O
Providers NNP NNP O
HEATHER NNP NNP I-DOCTOR
HERNANDEZ NNP NNP I-DOCTOR
, , , O
Medical NNP NNP I-HOSPITAL
Student NNP NNP O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2089-04-04 JJ JJ I-DATE
SDU NNP NNP O
JAR NNP NNP O
Transfer NNP NNP O
Note VB VB O
Name NN NN O
: : : O
Catherine NNP NNP I-PATIENT
Kong NNP NNP I-PATIENT
MR NNP NNP O
: : : O
6746781 CD CD I-MEDICALRECORD
DOA NNP NNP O
: : : O
4/3/89 CD CD I-DATE
DOT NNP NNP O
: : : O
4/4/89 CD CD I-DATE
PCP NNP NNP O
: : : O
William NNP NNP I-DOCTOR
Sawyer NNP NNP I-DOCTOR
Attending NNP NNP O
: : : O
WARD NNP NNP O
CODE NNP NNP O
: : : O
FULL NNP NNP O
HPI NNP NNP O
: : : O
Please VB VB O
see VB VB O
admit JJ JJ O
note NN NN O
for IN IN O
details NNS NNS O
of IN IN O
history NN NN O
prior RB RB O
to TO TO O
admission NN NN O
. . . O
   
Overnight NNP NNP O
in IN IN O
the DT DT O
SDU NNP NNP O
, , , O
patient NN NN O
was VBD VBD O
given VBN VBN O
several JJ JJ O
stepwise JJ JJ O
doses NNS NNS O
of IN IN O
lasix NN NN O
. . . O
   
She PRP PRP O
put VBP VBP O
out IN IN O
about IN IN O
500cc CD CD O
to TO TO O
30 CD CD O
IV NNP NNP O
lasix NN NN O
, , , O
then RB RB O
another DT DT O
300cc CD CD O
to TO TO O
40 CD CD O
IV NNP NNP O
lasix NN NN O
. . . O
   
Patient NNP NNP O
was VBD VBD O
hypoxic JJ JJ O
on IN IN O
a DT DT O
NRB NNP NNP O
with IN IN O
sats NNS NNS O
in IN IN O
low JJ JJ O
90s NN NN O
and CC CC O
RR NNP NNP O
of IN IN O
45 CD CD O
, , , O
but CC CC O
improved VBN VBN O
when WRB WRB O
transitioned VBN VBN O
to TO TO O
high JJ JJ O
flow NN NN O
O2 NNP NNP O
with IN IN O
saturation NN NN O
in IN IN O
high JJ JJ O
90s NN NN O
and CC CC O
RR NNP NNP O
of IN IN O
   
30 CD CD O
. . . O
Bedside NNP NNP O
TTE NNP NNP O
done VBN VBN O
in IN IN O
the DT DT O
morning NN NN O
confirmed VBD VBD O
aortic JJ JJ O
valve NN NN O
leaflet NN NN O
vegetations NNS NNS O
and CC CC O
moderate JJ JJ O
AI NNP NNP O
. . . O
   
CT NNP NNP O
surgery NN NN O
was VBD VBD O
consulted VBN VBN O
, , , O
and CC CC O
given VBN VBN O
prior RB RB O
hx NN NN O
of IN IN O
angina NN NN O
and CC CC O
recent JJ JJ O
episodes NNS NNS O
of IN IN O
chest NN NN O
pain NN NN O
, , , O
they PRP PRP O
requested VBD VBD O
cardiac JJ JJ O
cath NN NN O
prior RB RB O
to TO TO O
OR CC CC O
for IN IN O
valve NN NN O
replacement NN NN O
. . . O
   
ASSESSMENT NNP NNP O
AND CC CC O
PLAN NNP NNP O
: : : O
70 CD CD I-AGE
yo NN NN O
F NN NN O
p/w NN NN O
acute JJ JJ O
CHF NNP NNP O
2/2 CD CD O
aortic JJ JJ O
insufficiency NN NN O
from IN IN O
subacute NN NN O
aortic JJ JJ O
valve NN NN O
endocarditis NN NN O
CV NNP NNP O
: : : O
Ischemia NNP NNP O
: : : O
History NN NN O
of IN IN O
stable JJ JJ O
angina NN NN O
, , , O
no DT DT O
prior RB RB O
MI NNP NNP O
. . . O
   
No DT DT O
acute JJ JJ O
ST NNP NNP O
changes NNS NNS O
, , , O
borderline NN NN O
troponin NN NN O
elevation NN NN O
, , , O
recent JJ JJ O
history NN NN O
of IN IN O
chest NN NN O
pain NN NN O
at IN IN O
rest NN NN O
. . . O
   
Cardiac NNP NNP O
cath NN NN O
today NN NN O
to TO TO O
eval NN NN O
for IN IN O
CAD NNP NNP O
Hold NNP NNP O
anticoagulation NN NN O
given VBN VBN O
likely JJ JJ O
CT NNP NNP O
surgery NN NN O
Pump NNP NNP O
: : : O
AV NNP NNP O
endocarditis NNS NNS O
by IN IN O
TTE NNP NNP O
resulting VBG VBG O
in IN IN O
moderate JJ JJ O
AI NNP NNP O
and CC CC O
significant JJ JJ O
pulmonary JJ JJ O
edema NN NN O
. . . O
   
Per IN IN O
discussion NN NN O
with IN IN O
microbiology NN NN O
lab NN NN O
at IN IN O
Community NNP NNP I-HOSPITAL
Hospital NNP NNP I-HOSPITAL
, , , O
patient NN NN O
was VBD VBD O
positive JJ JJ O
for IN IN O
Beta NNP NNP O
Strep NNP NNP O
Group NNP NNP O
B NNP NNP O
2/2 CD CD O
bottles NNS NNS O
on IN IN O
2/21/89 CD CD I-DATE
, , , O
sensitivities NNS NNS O
were VBD VBD O
not RB RB O
done VBN VBN O
. . . O
   
Continue NNP NNP O
amp/vanc/gent NN NN O
, , , O
await NN NN O
culture NN NN O
and CC CC O
sensitivity NN NN O
results NNS NNS O
Continue NNP NNP O
to TO TO O
titrate VB VB O
lasix NN NN O
to TO TO O
TBB NNP NNP O
1-2 JJ JJ O
liters NNS NNS O
per IN IN O
day NN NN O
Rhythm NNP NNP O
: : : O
Normal JJ JJ O
sinus NN NN O
rhythm NN NN O
Continue NNP NNP O
to TO TO O
monitor VB VB O
for IN IN O
any DT DT O
development NN NN O
of IN IN O
AV NNP NNP O
block NN NN O
that WDT WDT O
might MD MD O
indicate VB VB O
aortic JJ JJ O
valve NN NN O
abscess JJ JJ O
NIDDM NNP NNP O
Hold NNP NNP O
metformin NN NN O
, , , O
RISS NNP NNP O
______________________ NN NN O
_ NN NN O
Jay NNP NNP I-DOCTOR
Wallace NNP NNP I-DOCTOR
, , , O
MD NNP NNP O
, , , O
MPH NNP NNP O
pager NN NN O
92149 CD CD I-PHONE
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2092-07-28 JJ JJ I-DATE
Abdominal NNP NNP O
Pain NN NN O
80 CD CD I-AGE
yr NN NN O
old JJ JJ O
female JJ JJ O
sent NN NN O
from IN IN O
Assisted NNP NNP O
living VBG VBG O
RN NNP NNP O
for IN IN O
abdo NN NN O
pain NN NN O
that WDT WDT O
was VBD VBD O
brought VBN VBN O
to TO TO O
RN NNP NNP O
's POS POS O
attention NN NN O
yesterday NN NN O
. . . O
   
patient NN NN O
came VBD VBD O
to TO TO O
RN NNP NNP O
; : : O
   
s VBZ VBZ O
office NN NN O
7/27 CD CD I-DATE
complaining VBG VBG O
severe JJ JJ O
low JJ JJ O
abd NN NN O
pain NN NN O
"""" '' '' O
as IN IN O
in IN IN O
cramps NNS NNS O
"""" '' '' O
. . . O
   
Yesterday NN NN O
temp NN NN O
98 CD CD O
; : : O
   
1 CD CD O
BP NNP NNP O
108/64 CD CD O
. . . O
   
patient NN NN O
observed VBD VBD O
in IN IN O
pain NN NN O
with IN IN O
each DT DT O
spasm NN NN O
lasting VBG VBG O
30 CD CD O
- : : O
45 CD CD O
seconds NNS NNS O
per IN IN O
RN NNP NNP O
written VBN VBN O
report NN NN O
. . . O
   
Comes VBZ VBZ O
today NN NN O
to TO TO O
Brown NNP NNP I-HOSPITAL
Hospital NNP NNP I-HOSPITAL
for IN IN O
evaluation NN NN O
. . . O
   
Patient NNP NNP O
not RB RB O
really RB RB O
able JJ JJ O
to TO TO O
give VB VB O
me PRP PRP O
any DT DT O
hx NN NN O
. . . O
   
Her PRP$ PRP$ O
complaint NN NN O
was VBD VBD O
of IN IN O
urinary JJ JJ O
incontinence NN NN O
. . . O
   
When WRB WRB O
I PRP PRP O
asked VBD VBD O
about IN IN O
the DT DT O
abdo NN NN O
pain NN NN O
she PRP PRP O
was VBD VBD O
not RB RB O
sure JJ JJ O
of IN IN O
any DT DT O
history NN NN O
. . . O
   
Denies NNP NNP O
any DT DT O
diarrhea NN NN O
, , , O
fever NN NN O
, , , O
dysuria NN NN O
, , , O
hematuria NN NN O
, , , O
melana NN NN O
. . . O
   
Patient NNP NNP O
says VBZ VBZ O
she PRP PRP O
takes VBZ VBZ O
prune JJ JJ O
juice NN NN O
daily RB RB O
for IN IN O
bowels NNS NNS O
to TO TO O
avoid VB VB O
constipaiton NN NN O
. . . O
   
Patient NNP NNP O
denied VBD VBD O
any DT DT O
hx NN NN O
of IN IN O
diverticultis NNS NNS O
or CC CC O
prior RB RB O
similar JJ JJ O
problems NNS NNS O
. . . O
   
Asking VBG VBG O
her PRP PRP O
about IN IN O
scar NN NN O
on IN IN O
hypogastruim NN NN O
she PRP PRP O
said VBD VBD O
was VBD VBD O
a DT DT O
bladder NN NN O
operation NN NN O
. . . O
   
Pertinent NNP NNP O
PMH NNP NNP O
: : : O
Is VBZ VBZ O
diabetic JJ JJ O
on IN IN O
glyburide NN NN O
Has VBZ VBZ O
been VBN VBN O
on IN IN O
prednisone NN NN O
for IN IN O
PMR NNP NNP O
, , , O
tpaering VBG VBG O
dose NN NN O
. . . O
   
Current NNP NNP O
dose NN NN O
per IN IN O
RN NNP NNP O
sheet NN NN O
is VBZ VBZ O
total JJ JJ O
8 CD CD O
mg NN NN O
per IN IN O
day NN NN O
prednisone NN NN O
. . . O
   
Although IN IN O
mention NN NN O
of IN IN O
prior RB RB O
colonoscopy NN NN O
is VBZ VBZ O
made VBN VBN O
, , , O
I PRP PRP O
could MD MD O
not RB RB O
find VB VB O
record NN NN O
of IN IN O
results NNS NNS O
to TO TO O
see VB VB O
if IN IN O
known VBN VBN O
diverticuli VBZ VBZ O
A DT DT O
more RBR RBR O
recent JJ JJ O
colonoscopy NN NN O
attempt NN NN O
failed VBD VBD O
do VBP VBP O
to TO TO O
poor VB VB O
clean VB VB O
- : : O
out RP RP O
and CC CC O
patient NN NN O
intolerance NN NN O
Hx NNP NNP O
of IN IN O
chronic JJ JJ O
diarrhea NN NN O
Son NNP NNP O
reports NNS NNS O
worsening VBG VBG O
depression NN NN O
recently RB RB O
with IN IN O
move NN NN O
to TO TO O
the DT DT O
Forest NNP NNP I-HOSPITAL
Hills NNP NNP I-HOSPITAL
Center NNP NNP I-HOSPITAL
. . . O
   
Patient NNP NNP O
has VBZ VBZ O
appt NN NN O
with IN IN O
Dr NNP NNP O
. . . O
Regina NNP NNP I-DOCTOR
Reeves NNP NNP I-DOCTOR
of IN IN O
Geriatric NNP NNP O
Psych NNP NNP O
7/30 CD CD I-DATE
. . . O
   
Problems NNS NNS O
Urinary NNP NNP O
incontinence NN NN O
: : : O
s/p NN NN O
sling VBG VBG O
procedure NN NN O
in IN IN O
4/91 CD CD I-DATE
; : : O
   
s/p NN NN O
3 CD CD O
prior RB RB O
bladder NN NN O
suspension NN NN O
surgeries NNS NNS O
Hypertension NNP NNP O
Depression NNP NNP O
Elevated NNP NNP O
cholesterol NN NN O
Diarrhea NNP NNP O
Polymyalgia NNP NNP O
rheumatica NN NN O
: : : O
diagnosed VBN VBN O
in IN IN O
1/91 CD CD I-DATE
S/P NNP NNP O
rectocele NN NN O
repair NN NN O
Paroxysmal NNP NNP O
atrial NN NN O
fibrillation NN NN O
: : : O
controlled VBN VBN O
with IN IN O
medication NN NN O
Peripheral NNP NNP O
neuropathy NN NN O
: : : O
unclear JJ JJ O
etiology NN NN O
Hyperlipidemia NNP NNP O
H/O NNP NNP O
Alcohol NNP NNP O
abuse NN NN O
S/P NNP NNP O
urosepsis NN NN O
: : : O
admission NN NN O
in IN IN O
9/90 CD CD I-DATE
chronic JJ JJ O
diarrhea NN NN O
: : : O
colonoscopy NN NN O
attempted VBD VBD O
in IN IN O
9/90 CD CD I-DATE
but CC CC O
pt NN NN O
not RB RB O
able JJ JJ O
to TO TO O
tolerate VB VB O
procedure NN NN O
Dementia NNP NNP O
: : : O
Mild-moderate NNP NNP O
; : : O
   
neuropsychiatric JJ JJ O
test NN NN O
done VBN VBN O
in IN IN O
5/91 CD CD I-DATE
Medications NNP NNP O
Folic NNP NNP O
Acid NNP NNP O
1MG CD CD O
, , , O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Ecotrin NNP NNP O
( ( ( O
ASPIRIN NNP NNP O
Enteric NNP NNP O
Coated NNP NNP O
) ) ) O
325MG CD CD O
, , , O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Metoprolol NNP NNP O
Tartrate NNP NNP O
50MG CD CD O
, , , O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
TID NNP NNP O
SOTALOL NNP NNP O
80MG CD CD O
, , , O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
BID NNP NNP O
Thiamine NNP NNP O
Hcl NNP NNP O
100MG CD CD O
, , , O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
DIGOXIN NNP NNP O
0.125MG, CD CD O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Ferrous NNP NNP O
Sulfate NNP NNP O
325MG CD CD O
, , , O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Mvi NNP NNP O
( ( ( O
MULTIVITAMINS NNP NNP O
) ) ) O
1 CD CD O
CAPSULE NNP NNP O
PO NNP NNP O
QD NNP NNP O
Calcium NNP NNP O
Carbonate NNP NNP O
Vit NNP NNP O
D(1TABLET=250MG NNP NNP O
E. NN NN O
   
. . . O
   
. . . O
   
500 CD CD O
MG NNP NNP O
PO NNP NNP O
TID NNP NNP O
NITROFURANTOIN NNP NNP O
100MG CD CD O
, , , O
1 CD CD O
Capsule NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Aricept NNP NNP O
( ( ( O
DONEPEZIL NNP NNP O
Hcl NNP NNP O
) ) ) O
5 CD CD O
MG NNP NNP O
PO NNP NNP O
QHS NNP NNP O
x SYM SYM O
30 CD CD O
day NN NN O
   
( ( ( O
s VBZ VBZ O
) ) ) O
Zocor NNP NNP O
( ( ( O
SIMVASTATIN NNP NNP O
) ) ) O
20MG CD CD O
, , , O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QHS NNP NNP O
x SYM SYM O
30 CD CD O
day NN NN O
   
( ( ( O
s VBZ VBZ O
) ) ) O
GLYBURIDE NNP NNP O
2.5MG, CD CD O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
PREDNISONE NNP NNP O
5MG CD CD O
, , , O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QAM NNP NNP O
PREDNISONE NNP NNP O
1MG CD CD O
, , , O
3 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QAM NNP NNP O
: : : O
total JJ JJ O
8 CD CD O
mg NN NN O
/ NN NN O
Paxil NNP NNP O
( ( ( O
PAROXETINE NNP NNP O
) ) ) O
20MG CD CD O
, , , O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Vitamin NNP NNP O
B NNP NNP O
1 CD CD O
100 CD CD O
mg NN NN O
qd NN NN O
The DT DT O
above JJ JJ O
meds NNS NNS O
were VBD VBD O
same JJ JJ O
as IN IN O
on IN IN O
the DT DT O
med JJ JJ O
list NN NN O
patient NN NN O
brought VBN VBN O
from IN IN O
Forest NNP NNP I-HOSPITAL
Hills NNP NNP I-HOSPITAL
Allergies NNP NNP O
NKDA NNP NNP O
Vital NNP NNP O
signs NNS NNS O
BP NNP NNP O
144/90 CD CD O
, , , O
Temp NNP NNP O
98.9 CD CD O
NAD NNP NNP O
. . . O
   
patient NN NN O
able JJ JJ O
to TO TO O
jump VB VB O
off IN IN O
of IN IN O
table NN NN O
without IN IN O
pain NN NN O
, , , O
lively RB RB O
Lungs NNP NNP O
: : : O
clear JJ JJ O
Cor NNP NNP O
: : : O
RR NNP NNP O
72 CD CD O
Abd NNP NNP O
: : : O
soft JJ JJ O
BS NNP NNP O
normal JJ JJ O
no DT DT O
rebound NN NN O
no DT DT O
percussion NN NN O
tenderness NN NN O
, , , O
no DT DT O
guarding VBG VBG O
However RB RB O
, , , O
patient NN NN O
did VBD VBD O
wince NN NN O
in IN IN O
pain NN NN O
when WRB WRB O
I PRP PRP O
palpated VBD VBD O
LLQ NNP NNP O
. . . O
   
She PRP PRP O
denied VBD VBD O
was VBD VBD O
very RB RB O
painful JJ JJ O
though IN IN O
no DT DT O
masses NNS NNS O
, , , O
no DT DT O
h/s NN NN O
megly RB RB O
Rectal NNP NNP O
: : : O
? . . O
slight NN NN O
tender NN NN O
toward IN IN O
LLQ NNP NNP O
, , , O
no DT DT O
masses NNS NNS O
stool NN NN O
: : : O
heme NN NN O
negative JJ JJ O
Urine NNP NNP O
Dipstick NNP NNP O
: : : O
: : : O
- : : O
PH NNP NNP O
7.0 CD CD O
DS-LEUKOCYTES NNP NNP O
NEGATIVE NNP NNP O
UA-Protein NNP NNP O
TRACE NNP NNP O
DS-GLUCOSE NNP NNP O
1000 CD CD O
DS-KETONES NNP NNP O
NEGATIVE NNP NNP O
DS-BLOOD NNP NNP O
NEGATIVE NNP NNP O
Impression NNP NNP O
: : : O
Pateint NNP NNP O
appears VBZ VBZ O
well RB RB O
and CC CC O
has VBZ VBZ O
minimal JJ JJ O
physical JJ JJ O
findings NNS NNS O
( ( ( O
minimal JJ JJ O
pain NN NN O
on IN IN O
palp NN NN O
LLQ NNP NNP O
) ) ) O
but CC CC O
given VBN VBN O
that IN IN O
she PRP PRP O
is VBZ VBZ O
on IN IN O
prednisone NN NN O
which WDT WDT O
may MD MD O
mask VB VB O
symptoms NNS NNS O
, , , O
as RB RB O
well RB RB O
as IN IN O
diabetic JJ JJ O
and CC CC O
dementia NN NN O
could MD MD O
also RB RB O
obscure VB VB O
exam NN NN O
as RB RB O
well RB RB O
as IN IN O
history NN NN O
, , , O
I PRP PRP O
am VBP VBP O
concerned VBN VBN O
about IN IN O
acute JJ JJ O
diverticulitis NNS NNS O
. . . O
   
I PRP PRP O
am VBP VBP O
unable JJ JJ O
to TO TO O
find VB VB O
if IN IN O
known VBN VBN O
diverticuli NN NN O
in IN IN O
past JJ JJ O
. . . O
   
Plan NNP NNP O
: : : O
To TO TO O
get VB VB O
Abdo/Pelvic NNP NNP O
CT NNP NNP O
now RB RB O
Will MD MD O
get VB VB O
CBC NNP NNP O
with IN IN O
diff NN NN O
, , , O
chemistries NNS NNS O
including VBG VBG O
LFT NNP NNP O
's POS POS O
, , , O
amylase NN NN O
Send NNP NNP O
urine NN NN O
for IN IN O
culture NN NN O
Naima NNP NNP I-DOCTOR
Zavaleta NNP NNP I-DOCTOR
, , , O
MD NNP NNP O
. . . O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2094-12-02 JJ JJ I-DATE
CARDIOLOGY NNP NNP O
BAPTIST NNP NNP I-HOSPITAL
MEMORIAL NNP NNP I-HOSPITAL
HOSPITAL NNP NNP I-HOSPITAL
Reason NNP NNP O
for IN IN O
visit NN NN O
: : : O
coronary JJ JJ O
artery NN NN O
disease NN NN O
, , , O
hypertension NN NN O
, , , O
hyperlipidemia NN NN O
, , , O
history NN NN O
of IN IN I-DATE
syncope NN NN O
Interval NNP NNP O
History NN NN O
: : : O
Mr NNP NNP O
. . . O
Shepherd NNP NNP I-PATIENT
is VBZ VBZ O
a DT DT O
79 CD CD I-AGE
year NN NN O
old JJ JJ O
man NN NN O
with IN IN O
coronary JJ JJ O
artery NN NN O
disease NN NN O
, , , O
hypertension NN NN O
, , , O
diabetes VBZ VBZ O
mellitus NN NN O
type NN NN O
2 CD CD O
, , , O
hyperlipidemia NN NN O
, , , O
carotid NN NN O
disease NN NN O
, , , O
and CC CC O
peripheral JJ JJ O
vascular NN NN O
disease NN NN O
who WP WP O
was VBD VBD O
admitted VBN VBN O
to TO TO O
the DT DT O
medicine NN NN O
service NN NN O
in IN IN O
June NNP NNP I-DATE
, , , O
2094 CD CD I-DATE
, , , O
for IN IN O
syncope NN NN O
and CC CC O
now RB RB O
returns VBZ VBZ O
for IN IN O
cardiology NN NN O
followup NN NN O
. . . O
   
To TO TO O
summarize VB VB O
, , , O
in IN IN O
June NNP NNP I-DATE
, , , O
the DT DT O
patient NN NN O
was VBD VBD O
admitted VBN VBN O
after IN IN O
experiencing VBG VBG O
several JJ JJ O
syncopal JJ JJ O
episodes NNS NNS O
. . . O
   
They PRP PRP O
were VBD VBD O
associated VBN VBN O
with IN IN O
a DT DT O
prodrome NN NN O
of IN IN I-DATE
lightheadedness NN NN O
and CC CC O
weakness NN NN O
that WDT WDT O
sometimes RB RB O
occurred VBD VBD O
with IN IN O
positional JJ JJ O
changes NNS NNS O
and CC CC O
at IN IN O
other JJ JJ O
times NNS NNS O
at IN IN O
rest NN NN O
. . . O
   
He PRP PRP O
denied VBD VBD O
associated VBN VBN O
chest NN NN O
pain NN NN O
, , , O
palpitations NNS NNS O
, , , O
diaphoresis NNS NNS O
, , , O
vertigo NN NN O
, , , O
focal JJ JJ O
neurologic JJ JJ O
weakness NN NN O
, , , O
dysphagia NN NN O
, , , O
diplopia NN NN O
or CC CC O
blurry NN NN O
vision NN NN O
occur VB VB O
during IN IN O
the DT DT O
episodes NNS NNS O
. . . O
   
These DT DT O
spells NNS NNS O
lasted VBD VBD O
about IN IN O
4-5 CD CD O
minutes NNS NNS O
and CC CC O
there EX EX O
were VBD VBD O
no DT DT O
incontinence NN NN O
, , , O
post-ictal JJ JJ O
symptoms NNS NNS O
, , , O
or CC CC O
tonic-clonic JJ JJ O
movements NNS NNS O
. . . O
   
His PRP$ PRP$ O
workup NN NN O
included VBD VBD O
a DT DT O
surface NN NN O
echocardiogram NN NN O
that WDT WDT O
showed VBD VBD O
an DT DT O
ejection NN NN O
fraction NN NN O
of IN IN I-DATE
59 CD CD O
% NN NN O
but CC CC O
with IN IN O
inferior JJ JJ O
wall NN NN O
motion NN NN O
abnormalities NNS NNS O
. . . O
   
A DT DT O
subsequent JJ JJ O
adenosine NN NN O
MIBI NNP NNP O
showed VBD VBD O
mild JJ JJ O
inferolateral JJ JJ O
ischemia NN NN O
and CC CC O
a DT DT O
cardiac JJ JJ O
catheterization NN NN O
showed VBD VBD O
40 CD CD O
% NN NN O
ostial JJ JJ O
RCA NNP NNP O
disease NN NN O
and CC CC O
a DT DT O
75 CD CD O
% NN NN O
lesion NN NN O
in IN IN O
a DT DT O
small JJ JJ O
diameter NN NN O
distal JJ JJ O
PLV NNP NNP O
. . . O
   
The DT DT O
culprit NN NN O
lesion NN NN O
was VBD VBD O
felt VBN VBN O
to TO TO O
be VB VB O
non-intervenable JJ JJ O
and CC CC O
the DT DT O
patient NN NN O
was VBD VBD O
started VBN VBN O
on IN IN O
medical JJ JJ O
therapy NN NN O
. . . O
   
During IN IN O
his PRP$ PRP$ O
admission NN NN O
, , , O
his PRP$ PRP$ O
telemetry NN NN O
showed VBD VBD O
a DT DT O
twelve CD CD O
beat NN NN O
run NN NN O
of IN IN I-DATE
non-sustained JJ JJ O
ventricular NN NN O
tachycardia NNS NNS O
and CC CC O
so IN IN O
the DT DT O
electrophysiology NN NN O
service NN NN O
was VBD VBD O
called VBN VBN O
. . . O
   
He PRP PRP O
underwent VBD VBD O
an DT DT O
electrophysiology NN NN O
study NN NN O
which WDT WDT O
was VBD VBD O
nondiagnostic JJ JJ O
and CC CC O
a DT DT O
REVEAL NNP NNP O
monitor NN NN O
was VBD VBD O
implanted VBN VBN O
. . . O
   
Prior NNP NNP O
to TO TO O
his PRP$ PRP$ O
discharge NN NN O
, , , O
the DT DT O
patient NN NN O
exhibited JJ JJ O
features NNS NNS O
of IN IN I-DATE
depression NN NN O
with IN IN O
psychotic JJ JJ O
features NNS NNS O
and CC CC O
he PRP PRP O
was VBD VBD O
ultimately RB RB O
transferred VBN VBN O
to TO TO O
the DT DT O
in-patient JJ JJ O
psychiatry NN NN O
unit NN NN O
for IN IN O
about IN IN O
four CD CD O
weeks NNS NNS O
. . . O
   
Today NN NN O
, , , O
he PRP PRP O
presents VBZ VBZ O
with IN IN O
no DT DT O
acute JJ JJ O
complaints NNS NNS O
. . . O
   
He PRP PRP O
denies VBZ VBZ O
chest NN NN O
pain NN NN O
, , , O
dyspnea NN NN O
, , , O
or CC CC O
palpitations NNS NNS O
. . . O
   
He PRP PRP O
s VBZ VBZ O
had VBN VBN O
no DT DT O
further RB RB O
fainting VBG VBG O
spells NNS NNS O
and CC CC O
reports NNS NNS O
that IN IN O
his PRP$ PRP$ O
last JJ JJ O
REVEAL NNP NNP O
interrogation NN NN O
was VBD VBD O
unremarkable JJ JJ O
. . . O
   
His PRP$ PRP$ O
claudication NN NN O
is VBZ VBZ O
at IN IN O
his PRP$ PRP$ O
baseline NN NN O
. . . O
   
He PRP PRP O
walks VBZ VBZ O
at IN IN O
a DT DT O
mall NN NN O
for IN IN O
30 CD CD O
minutes NNS NNS O
to TO TO O
1 CD CD O
hour NN NN O
before IN IN O
he PRP PRP O
experiences VBZ VBZ O
a DT DT O
"""" '' '' O
tired JJ JJ O
"""" '' '' O
sensation NN NN O
in IN IN O
both DT DT O
legs NNS NNS O
. . . O
   
He PRP PRP O
is VBZ VBZ O
followed VBN VBN O
in IN IN O
the DT DT O
vascular NN NN O
clinic NN NN O
at IN IN O
the DT DT O
FHV NNP NNP I-HOSPITAL
medical JJ JJ O
center NN NN O
. . . O
   
Also RB RB O
of IN IN I-DATE
note NN NN O
, , , O
he PRP PRP O
underwent VBD VBD O
a DT DT O
repair NN NN O
of IN IN I-DATE
a DT DT O
right JJ JJ O
inguinal NN NN O
hernia NN NN O
in IN IN O
October NNP NNP I-DATE
of IN IN I-DATE
2094 CD CD I-DATE
by IN IN O
Dr NNP NNP O
. . . O
Small JJ JJ I-DOCTOR
without IN IN O
complications NNS NNS O
. . . O
   
Past NNP NNP O
medical JJ JJ O
history NN NN O
: : : O
Coronary JJ JJ O
artery NN NN O
disease NN NN O
* NN NN O
status NN NN O
post NN NN O
cardiac JJ JJ O
catheterization NN NN O
showing VBG VBG O
40 CD CD O
% NN NN O
ostial JJ JJ O
RCA NNP NNP O
disease NN NN O
and CC CC O
distal JJ JJ O
PLV NNP NNP O
disease NN NN O
* NN NN O
medical JJ JJ O
therapy NN NN O
, , , O
no DT DT O
intervention NN NN O
Diabetes NNP NNP O
mellitus NN NN O
, , , O
type NN NN O
2 CD CD O
Hypertension NNP NNP O
Hyperlipidemia NNP NNP O
Benign NNP NNP O
prostatic JJ JJ O
hypertrophy NN NN O
Right NNP NNP O
external JJ JJ O
carotid NN NN O
stenosis NN NN O
Peripheral NNP NNP O
vascular NN NN O
disease NN NN O
with IN IN O
claudication NN NN O
* NN NN O
followed VBN VBN O
at IN IN O
FHV NNP NNP I-HOSPITAL
vascular NN NN O
clinic JJ JJ O
Glaucoma NNP NNP O
Ventral NNP NNP O
hernia NN NN O
Allergies NNP NNP O
: : : O
No DT DT O
known VBN VBN O
allergies NNS NNS O
Medications NNP NNP O
( ( ( O
Confirmed NNP NNP O
) ) ) O
: : : O
ASA NNP NNP O
325mg CD CD O
po NN NN O
daily JJ JJ O
brimonidine NN NN O
0.2 CD CD O
% NN NN O
x SYM SYM O
1 CD CD O
drop NN NN O
ou NN NN O
bid NN NN O
Cardura NNP NNP O
4mg CD CD O
po NN NN O
daily JJ JJ O
Cymbalta NNP NNP O
60mg CD CD O
po NN NN O
daily RB RB O
Removed NNP NNP O
- : : O
Lasix NNP NNP O
20mg CD CD O
po NN NN O
daily JJ JJ O
lisinopril NN NN O
40mg CD CD O
po NN NN O
daily JJ JJ O
MiraLax NNP NNP O
17g CD CD O
PO NNP NNP O
daily JJ JJ O
Pletal NNP NNP O
100mg CD CD O
PO NNP NNP O
bid NN NN O
senna NN NN O
2tabs CD CD O
PO NNP NNP O
bedtime NN NN O
Toprol NNP NNP O
XL NNP NNP O
100mg CD CD O
po NN NN O
daily JJ JJ O
Zocor NNP NNP O
80mg CD CD O
po NN NN O
qpm NN NN O
Zyprexa NNP NNP O
3.75mg CD CD O
po NN NN O
at IN IN O
bedtime NN NN O
Family NNP NNP O
history NN NN O
: : : O
Mom NN NN O
MI NNP NNP O
at IN IN O
age NN NN O
63 CD CD I-AGE
; : : O
   
grandson NN NN O
w NN NN O
/ NN NN O
h/o NN NN O
sudden JJ JJ O
LOC NNP NNP O
at IN IN O
age NN NN O
16 CD CD I-AGE
with IN IN O
negative JJ JJ O
w/u NN NN O
by IN IN O
peds NNS NNS O
; : : O
   
otherwise RB RB O
, , , O
no DT DT O
h/o NN NN O
sudden JJ JJ O
death NN NN O
. . . O
   
Social NNP NNP O
history NN NN O
: : : O
Retired NNP NNP O
Archive NNP NNP I-PROFESSION
Manager NNP NNP I-PROFESSION
who WP WP O
lives VBZ VBZ O
with IN IN O
wife NN NN O
; : : O
   
has VBZ VBZ O
6 CD CD O
children NNS NNS O
HRB NNP NNP O
: : : O
quit VBD VBD O
smoking VBG VBG O
20 CD CD O
years NNS NNS O
ago RB RB O
40 CD CD O
pack-yr JJ JJ O
smoking NN NN O
history NN NN O
; : : O
   
no DT DT O
EtOH NNP NNP O
; : : O
   
no DT DT O
drugs NNS NNS O
Review NNP NNP O
of IN IN I-DATE
systems NNS NNS O
: : : O
General NNP NNP O
: : : O
unremarkable JJ JJ O
Skin NNP NNP O
: : : O
unremarkable JJ JJ O
HEENT NNP NNP O
: : : O
unremarkable JJ JJ O
Respiratory NNP NNP O
: : : O
unremarkable JJ JJ O
Cardiovascular NNP NNP O
: : : O
see VB VB O
above IN IN O
Gastrointestinal NNP NNP O
: : : O
unremarkable JJ JJ O
Genitourinary NNP NNP O
: : : O
nocturia NN NN O
Endocrine NNP NNP O
: : : O
unremarkable JJ JJ O
Musculoskeletal NNP NNP O
: : : O
unremarkable JJ JJ O
Neurologic NNP NNP O
: : : O
unremarkable JJ JJ O
Psychiatric NNP NNP O
: : : O
unremarkable JJ JJ O
Physical JJ JJ O
examination NN NN O
: : : O
- : : O
BMI NNP NNP O
: : : O
30.2 CD CD O
Obese NNP NNP O
, , , O
high JJ JJ O
risk NN NN O
- - - O
Pulse NNP NNP O
: : : O
56 CD CD O
regular JJ JJ O
- - - O
resp NN NN O
. . . O
   
rate NN NN O
: : : O
100 CD CD O
% NN NN O
room NN NN O
air NN NN O
- - - O
height NN NN O
: : : O
68 CD CD O
in IN IN O
. . . O
   
- - - O
weight NN NN O
: : : O
198 CD CD O
lbs NN NN O
. . . O
   
- - - O
General NNP NNP O
: : : O
pleasant NN NN O
and CC CC O
in IN IN O
no DT DT O
distress NN NN O
- : : O
Skin NNP NNP O
: : : O
unremarkable JJ JJ O
- - - O
HEENT NNP NNP O
: : : O
PERRL NNP NNP O
EOMI NNP NNP O
OP NNP NNP O
clear JJ JJ O
- - - O
Neck NNP NNP O
: : : O
bilateral JJ JJ O
carotid NN NN O
bruits NNS NNS O
; : : O
   
JVP~5 NNP NNP O
cm NN NN O
normal JJ JJ O
contours NNS NNS O
, , , O
no DT DT O
Kussmaul NNP NNP O
's POS POS O
- - - O
Chest NN NN O
: : : O
CTAB NNP NNP O
no DT DT O
dullness JJ JJ O
- - - O
Cardiac NNP NNP O
: : : O
Left NNP NNP O
ventricular NN NN O
impulse JJ JJ O
discrete NN NN O
and CC CC O
nondisplaced VBD VBD O
. . . O
   
Regular NNP NNP O
rate NN NN O
and CC CC O
rhythm NN NN O
, , , O
normal JJ JJ O
S1 NNP NNP O
and CC CC O
S2 NNP NNP O
, , , O
with IN IN O
no DT DT O
S3 NNP NNP O
or CC CC O
S4 NNP NNP O
. . . O
   
There EX EX O
were VBD VBD O
no DT DT O
murmurs NNS NNS O
, , , O
clicks NNS NNS O
or CC CC O
rubs NNS NNS O
. . . O
   
- - - O
Abdomen NNP NNP O
: : : O
soft JJ JJ O
NTND NNP NNP O
+ NN NN O
BS NNP NNP O
, , , O
ventral NN NN O
hernia NN NN O
- - - O
Extremities NNPS NNPS O
: : : O
2 CD CD O
+ NN NN O
femorals NNS NNS O
bilateral JJ JJ O
without IN IN O
bruits NNS NNS O
; : : O
   
1 CD CD O
+ NN NN O
pitting VBG VBG O
ankle NN NN O
edema NN NN O
with IN IN O
trace NN NN O
DP NNP NNP O
pulses NNS NNS O
bilaterally RB RB O
and CC CC O
no DT DT O
foot NN NN O
ulcers NNS NNS O
- - - O
BP NNP NNP O
: : : O
130/80 CD CD O
both DT DT O
arms NNS NNS O
EKG NNP NNP O
: : : O
sinus NN NN O
bradycardia NNS NNS O
at IN IN O
56 CD CD O
with IN IN O
PACs NNP NNP O
LAFB NNP NNP O
and CC CC O
IVCD NNP NNP O
with IN IN O
secondary JJ JJ O
nonspecific NN NN O
ST NNP NNP O
T NN NN O
wave NN NN O
abnormalities NNS NNS O
; : : O
   
compared VBN VBN O
with IN IN O
the DT DT O
prior JJ JJ O
tracing NN NN O
, , , O
his PRP$ PRP$ O
heart NN NN O
rate NN NN O
has VBZ VBZ O
decreased VBN VBN O
by IN IN O
30 CD CD O
Assessment NNP NNP O
and CC CC O
plan NN NN O
: : : O
79 CD CD I-AGE
year NN NN O
old JJ JJ O
man NN NN O
with IN IN O
known VBN VBN O
coronary JJ JJ O
artery NN NN O
disease NN NN O
and CC CC O
risk NN NN O
factors NNS NNS O
of IN IN I-DATE
hypertension NN NN O
, , , O
diabetes VBZ VBZ O
mellitus NN NN O
, , , O
hyperlipidemia NN NN O
, , , O
carotid NN NN O
disease NN NN O
, , , O
and CC CC O
PVD NNP NNP O
who WP WP O
has VBZ VBZ O
a DT DT O
history NN NN O
of IN IN I-DATE
syncope NN NN O
. . . O
   
He PRP PRP O
's VBZ VBZ O
had VBD VBD O
no DT DT O
recent JJ JJ O
episodes NNS NNS O
and CC CC O
is VBZ VBZ O
currently RB RB O
being VBG VBG O
monitored VBN VBN O
via IN IN O
a DT DT O
REVEAL NNP NNP O
monitor NN NN O
. . . O
   
He PRP PRP O
is VBZ VBZ O
on IN IN O
medical JJ JJ O
therapy NN NN O
for IN IN O
coronary JJ JJ O
artery NN NN O
disease NN NN O
. . . O
   
Problem NN NN O
list NN NN O
: : : O
   
1 CD CD O
. . . O
Syncope NNP NNP O
- : : O
no DT DT O
recent JJ JJ O
episodes NNS NNS O
, , , O
being VBG VBG O
monitored VBN VBN O
with IN IN O
implanted JJ JJ O
loop NN NN O
recorder NN NN O
   
2 CD CD O
. . . O
Coronary JJ JJ O
artery NN NN O
disease NN NN O
in IN IN O
RCA NNP NNP O
and CC CC O
distal JJ JJ O
PLV NNP NNP O
on IN IN O
medical JJ JJ O
therapy NN NN O
- : : O
aspirin NN NN O
325 CD CD O
- : : O
lisinopril NN NN O
40 CD CD O
- : : O
toprol NN NN O
XL NNP NNP O
100 CD CD O
- : : O
zocor NN NN O
80 CD CD O
( ( ( O
last JJ JJ O
LDL NNP NNP O
51 CD CD O
) ) ) O
   
3 CD CD O
. . . O
peripheral NN NN O
vascular NN NN O
disease NN NN O
- : : O
pletal JJ JJ O
( ( ( O
last JJ JJ O
echo NN NN O
EF NNP NNP O
normal JJ JJ O
) ) ) O
- : : O
statins NNS NNS O
- : : O
followed VBN VBN O
in IN IN O
vascular NN NN O
clinic NN NN O
at IN IN O
the DT DT O
FHV NNP NNP I-HOSPITAL
   
4 CD CD O
. . . O
mild NN NN O
lower JJR JJR O
extremity NN NN O
edema NN NN O
, , , O
no DT DT O
evidence NN NN O
of IN IN I-DATE
JVD NNP NNP O
. . . O
   
Consider NNP NNP O
lasix NN NN O
if IN IN O
worsening VBG VBG O
. . . O
   
Other JJ JJ O
problems NNS NNS O
: : : O
Diabetes NNP NNP O
mellitus NN NN O
, , , O
type NN NN O
2 CD CD O
Hypertension NNP NNP O
Hyperlipidemia NNP NNP O
BPH NNP NNP O
Glaucoma NNP NNP O
Ventral NNP NNP O
hernia NN NN O
Depression NNP NNP O
Return NNP NNP O
to TO TO O
care VB VB O
in IN IN O
6 CD CD O
months NNS NNS O
or CC CC O
sooner RBR RBR O
if IN IN O
problems NNS NNS O
arise VBP VBP O
. . . O
   
Pt NNP NNP O
seen VBN VBN O
and CC CC O
examined VBN VBN O
with IN IN O
Dr NNP NNP O
. . . O
Nuvia NNP NNP I-DOCTOR
Nadeau NNP NNP I-DOCTOR
. . . O
   
U. NNP NNP I-DOCTOR
Howard NNP NNP I-DOCTOR
Benjamin NNP NNP I-DOCTOR
, , , O
MD NNP NNP O
ATTENDING NNP NNP O
NOTE VB VB O
: : : O
I PRP PRP O
have VBP VBP O
seen VBN VBN O
and CC CC O
examined VBD VBD O
the DT DT O
patient NN NN O
, , , O
reviewed VBD VBD O
the DT DT O
history NN NN O
and CC CC O
data NNS NNS O
, , , O
and CC CC O
discussed VBD VBD O
with IN IN O
Dr NNP NNP O
. . . O
Benjamin NNP NNP I-DOCTOR
in IN IN O
detail NN NN O
. . . O
   
I PRP PRP O
agree VBP VBP O
with IN IN O
the DT DT O
findings NNS NNS O
and CC CC O
plans NNS NNS O
documented VBN VBN O
in IN IN O
his PRP$ PRP$ O
note NN NN O
. . . O
   
Nuvia NNP NNP I-DOCTOR
Nadeau NNP NNP I-DOCTOR
, , , O
MD NNP NNP O
pager NN NN O
#90859 NN NN O
cc NN NN O
: : : O
Yusuf NNP NNP I-DOCTOR
Lugo NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
   
Signed NNP NNP O
electronically RB RB O
by IN IN O
U. NNP NNP I-DOCTOR
Howard NNP NNP I-DOCTOR
Benjamin NNP NNP I-DOCTOR
, , , O
MD NNP NNP O
; : : O
   
Nuvia NNP NNP I-DOCTOR
Nadeau NNP NNP I-DOCTOR
, , , O
MD NNP NNP O
Document NNP NNP O
Status NNP NNP O
: : : O
Final NNP NNP O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2074-06-09 JJ JJ I-DATE
Reason NNP NNP O
for IN IN O
Visit NNP NNP O
This DT DT O
is VBZ VBZ O
a DT DT O
47 CD CD I-AGE
year NN NN O
old JJ JJ O
male NN NN O
referred VBD VBD O
to TO TO O
the DT DT O
diabetes NNS NNS O
management NN NN O
service NN NN O
for IN IN O
uncontrolled JJ JJ O
diabetes NNS NNS O
by IN IN O
Dr NNP NNP O
. . . O
OldhamChief NNP NNP O
Complaint NNP NNP O
This DT DT O
patient NN NN O
is VBZ VBZ O
admitted VBN VBN O
to TO TO O
the DT DT O
hospital NN NN O
for IN IN O
gastric JJ JJ O
bypassHistory NN NN O
of IN IN O
Present JJ JJ O
Illness NNP NNP O
The DT DT O
patient NN NN O
has VBZ VBZ O
a DT DT O
10 CD CD O
year NN NN O
history NN NN O
of IN IN O
Type NNP NNP O
2 CD CD O
diabetes NNS NNS O
. . . O
   
He PRP PRP O
was VBD VBD O
treated VBN VBN O
with IN IN O
metformin NN NN O
and CC CC O
insulin NN NN O
. . . O
   
Unclear NNP NNP O
when WRB WRB O
metformin NN NN O
was VBD VBD O
discontinued VBN VBN O
. . . O
   
Currently RB RB O
the DT DT O
patient NN NN O
is VBZ VBZ O
treated VBN VBN O
with IN IN O
detemir NN NN O
60 CD CD O
bid NN NN O
and CC CC O
novolog NN NN O
50 CD CD O
ac NN NN O
as IN IN O
an DT DT O
outpatient NN NN O
. . . O
   
The DT DT O
control NN NN O
has VBZ VBZ O
been VBN VBN O
poor JJ JJ O
. . . O
   
The DT DT O
patient NN NN O
tests NNS NNS O
his PRP$ PRP$ O
blood NN NN O
sugar NN NN O
several JJ JJ O
times NNS NNS O
a DT DT O
day NN NN O
with IN IN O
results NNS NNS O
ranging VBG VBG O
from IN IN O
200-300.The JJ JJ O
current JJ JJ O
diet NN NN O
is VBZ VBZ O
not RB RB O
well RB RB O
controlled VBN VBN O
. . . O
   
The DT DT O
patient NN NN O
has VBZ VBZ O
not RB RB O
been VBN VBN O
bothered VBN VBN O
by IN IN O
hypoglycemia NN NN O
. . . O
   
Diabetic NNP NNP O
complications NNS NNS O
include VBP VBP O
neuropathy JJ JJ O
with IN IN O
numbness NN NN O
in IN IN O
feet NNS NNS O
and CC CC O
nephropathy NN NN O
with IN IN O
macroalbuminuria NN NN O
. . . O
   
He PRP PRP O
had VBD VBD O
gastric JJ JJ O
bypass NN NN O
last JJ JJ O
night NN NN O
. . . O
   
He PRP PRP O
received VBD VBD O
Lantus NNP NNP O
   
30 CD CD O
. . . O
He PRP PRP O
was VBD VBD O
on IN IN O
D5W NNP NNP O
over IN IN O
night NN NN O
with IN IN O
glucose NN NN O
values NNS NNS O
over IN IN O
300 CD CD O
. . . O
. . . O
   
He PRP PRP O
currently RB RB O
is VBZ VBZ O
on IN IN O
LR NNP NNP O
iv NN NN O
drip NN NN O
. . . O
   
He PRP PRP O
has VBZ VBZ O
abdominal JJ JJ O
pain NN NN O
and CC CC O
is VBZ VBZ O
not RB RB O
yet RB RB O
eating VBG VBG O
Allergies NNP NNP O
noPast RB RB O
Medical NNP NNP O
History NN NN O
Concurrent NNP NNP O
medical JJ JJ O
problems NNS NNS O
include:htn NN NN O
, , , O
osa NN NN O
, , , O
right NN NN O
hip NN NN O
replacement NN NN O
, , , O
renal JJ JJ O
cell NN NN O
caFamily RB RB O
History NN NN O
Family NNP NNP O
history NN NN O
is VBZ VBZ O
positive JJ JJ O
for IN IN O
diabetes NN NN O
Social NNP NNP O
History NN NN O
The DT DT O
patient NN NN O
is VBZ VBZ O
employed VBN VBN O
as IN IN O
a DT DT O
floor NN NN I-PROFESSION
covering VBG VBG I-PROFESSION
installer NN NN I-PROFESSION
. . . O
   
Habits NNP NNP O
The DT DT O
patient NN NN O
is VBZ VBZ O
a DT DT O
smoker.The NN NN O
patient NN NN O
's POS POS O
alcohol NN NN O
intake NN NN O
may MD MD O
be VB VB O
excessive JJ JJ O
. . . O
   
Review NNP NNP O
of IN IN O
Systems NNPS NNPS O
ROS NNP NNP O
: : : O
quite RB RB O
nauseated VBD VBD O
now RB RB O
and CC CC O
unable JJ JJ O
to TO TO O
give VB VB O
detailsMedications NNS NNS O
lipitor NN NN O
40 CD CD O
gabapentin NN NN O
400 CD CD O
qd NN NN O
toprol NN NN O
200 CD CD O
lasix NN NN O
120 CD CD O
metolazone NN NN O
22.5 CD CD O
qod NN NN O
insulin NN NN O
as IN IN O
above IN IN O
Laboratory NNP NNP O
Data NNP NNP O
Relevant JJ JJ O
lab NN NN O
data:HgA1c NN NN O
13.7 CD CD O
( ( ( O
2/2074)K CD CD O
3.4Creatinine CD CD O
1.24Urine CD CD O
microalbumin NN NN O
screen NN NN O
positivePhysical JJ JJ O
Exam NNP NNP O
Vitals NNP NNP O
Bp NNP NNP O
140/60 CD CD O
P NN NN O
82 CD CD O
Wt.384Skin NNP NNP O
no DT DT O
acanthosis NN NN O
, , , O
Heent NNP NNP O
no DT DT O
asymmetry NN NN O
, , , O
no DT DT O
lid JJ JJ O
lagNeck NN NN O
no DT DT O
bruits NNS NNS O
heard VBD VBD O
no DT DT O
thyromegaly RB RB O
Chest NN NN O
clearCor NN NN O
S1 NNP NNP O
, , , O
S2 NNP NNP O
normal JJ JJ O
, , , O
no DT DT O
murmursAbd NN NN O
obese NN NN O
, , , O
post-opExtremities JJ JJ O
1 CD CD O
+ NN NN O
edema NN NN O
, , , O
no DT DT O
ulcers NNS NNS O
dorsalis JJ JJ O
pedis NN NN O
pulses NNS NNS O
intact JJ JJ O
, , , O
venous JJ JJ O
insufficiency NN NN O
changesNeuro NN NN O
Vibratory NNP NNP O
sense NN NN O
decreased VBD VBD O
Monofilament NNP NNP O
testing VBG VBG O
intactImpression NN NN O
My PRP$ PRP$ O
impression NN NN O
is VBZ VBZ O
that IN IN O
his PRP$ PRP$ O
diabetes NN NN O
is VBZ VBZ O
chronically RB RB O
poorly RB RB O
controlled VBN VBN O
. . . O
   
It PRP PRP O
is VBZ VBZ O
unclear JJ JJ O
if IN IN O
he PRP PRP O
is VBZ VBZ O
compliant JJ JJ O
with IN IN O
stated JJ JJ O
insulin NN NN O
doses NNS NNS O
. . . O
   
He PRP PRP O
is VBZ VBZ O
now RB RB O
post-op JJ JJ O
with IN IN O
hyperglycemia NN NN O
, , , O
having VBG VBG O
received VBN VBN O
50 CD CD O
% NN NN O
of IN IN O
his PRP$ PRP$ O
usual JJ JJ O
insulin NN NN O
dose NN NN O
last JJ JJ O
night.He NN NN O
clearly RB RB O
needs VBZ VBZ O
more JJR JJR O
insulinRecommendation NN NN O
My PRP$ PRP$ O
recommendations NNS NNS O
are:1.No VBP VBP O
need VBP VBP O
for IN IN O
D5W NNP NNP O
while IN IN O
glucose NN NN O
values NNS NNS O
remain VBP VBP O
over IN IN O
2067.Increase CD CD O
glargine NN NN O
to TO TO O
60 CD CD O
units NNS NNS O
q NN NN O
12 CD CD O
hours(give JJ JJ O
tonight NN NN O
and CC CC O
in IN IN O
am)3.Give JJ JJ O
regular JJ JJ O
30 CD CD O
units NNS NNS O
sc JJ JJ O
times NNS NNS O
one CD CD O
dose NN NN O
now4.Give JJ JJ O
new JJ JJ O
sliding VBG VBG O
scale:regular NN NN O
q NN NN O
6 CD CD O
hours NNS NNS O
BG NNP NNP O
150-200 JJ JJ O
5 CD CD O
units NNS NNS O
BG NNP NNP O
201-250 JJ JJ O
10 CD CD O
units NNS NNS O
BG NNP NNP O
251-300 JJ JJ O
15 CD CD O
units NNS NNS O
BG NNP NNP O
& CC CC O
gt NN NN O
; : : O
   
301 CD CD O
20 CD CD O
units___________________Katie NN NN O
W NNP NNP I-DOCTOR
Fitzgerald NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2081-07-17 JJ JJ I-DATE
FREDERICK NNP NNP I-PATIENT
JEFFERSON NNP NNP I-PATIENT
KRMC NNP NNP I-HOSPITAL
Unit NNP NNP O
No DT DT O
: : : O
887-09-86 JJ JJ I-MEDICALRECORD
ZUCKER NNP NNP I-HOSPITAL
HILLSIDE NNP NNP I-HOSPITAL
HOSPITAL NNP NNP I-HOSPITAL
ADULT NNP NNP O
MEDICINE NNP NNP O
Date NN NN O
: : : O
July NNP NNP I-DATE
17 CD CD O
, , , O
2081 CD CD I-DATE
Weight NNP NNP O
204 CD CD O
lb NN NN O
, , , O
up RB RB O
15 CD CD O
lb NN NN O
. . . O
   
Patient NNP NNP O
accompanied VBD VBD O
by IN IN O
wife NN NN O
who WP WP O
gives VBZ VBZ O
meds NNS NNS O
to TO TO O
patient NN NN O
. . . O
   
Patient NNP NNP O
states NNS NNS O
does VBZ VBZ O
not RB RB O
eat VB VB O
much JJ JJ O
. . . O
   
Wife NN NN O
disagrees NNS NNS O
. . . O
   
States NNS NNS O
frequent JJ JJ O
sweets NNS NNS O
in IN IN O
diet NN NN O
, , , O
cake NN NN O
, , , O
doughnuts NNS NNS O
, , , O
pie NN NN O
a DT DT O
la FW FW O
mode NN NN O
, , , O
1 CD CD O
cups NNS NNS O
of IN IN O
coffee NN NN O
- - - O
will MD MD O
have VB VB O
cookie NN NN O
with IN IN O
it PRP PRP O
. . . O
   
MEDICATIONS NNP NNP O
: : : O
Lasix NNP NNP O
40 CD CD O
mg NN NN O
1.5 CD CD O
tabs NNS NNS O
q.d. NN NN O
, , , O
calcium NN NN O
tablet NN NN O
500 CD CD O
mg NN NN O
q.d. NN NN O
, , , O
colchicine NN NN O
0.6 CD CD O
mg NN NN O
q.o.d. NN NN O
, , , O
digoxin NN NN O
0.125 CD CD O
mg NN NN O
q.o.d. NN NN O
, , , O
isosorbide NN NN O
20 CD CD O
mg NN NN O
t.i.d. NN NN O
, , , O
Hydralazine NNP NNP O
10 CD CD O
mg NN NN O
q.i.d. NN NN O
, , , O
Metoprolol NNP NNP O
50 CD CD O
mg NN NN O
b.i.d. NN NN O
, , , O
Prednisone NNP NNP O
5 CD CD O
mg NN NN O
q.d. NN NN O
, , , O
Coumadin NNP NNP O
3 CD CD O
mg NN NN O
per IN IN O
anticoag NN NN O
. . . O
   
CHF/CAD NNP NNP O
. . . O
   
Rare JJ JJ O
cough NN NN O
productive NN NN O
of IN IN O
clear JJ JJ O
sputum NN NN O
. . . O
   
Denies NNP NNP O
SOB NNP NNP O
, , , O
DOE NNP NNP O
, , , O
PND NNP NNP O
, , , O
although IN IN O
awakens NNS NNS O
2-3 JJ JJ O
x SYM SYM O
per IN IN O
night NN NN O
. . . O
   
Walks NNP NNP O
around IN IN O
, , , O
sits NNS NNS O
in IN IN O
recliner NN NN O
for IN IN O
about IN IN O
an DT DT O
hour NN NN O
, , , O
then RB RB O
back RB RB O
to TO TO O
sleep VB VB O
. . . O
   
Per IN IN O
wife NN NN O
, , , O
patient NN NN O
naps NNS NNS O
in IN IN O
chair NN NN O
during IN IN O
day NN NN O
. . . O
   
Also RB RB O
frequently RB RB O
drinks NNS NNS O
coffee NN NN O
at IN IN O
night NN NN O
. . . O
   
Patient NNP NNP O
denies NNS NNS O
CP NNP NNP O
or CC CC O
palpitations NNS NNS O
or CC CC O
difficulty NN NN O
with IN IN O
breathing VBG VBG O
. . . O
   
PHYSICAL JJ JJ O
EXAM NNP NNP O
: : : O
Weight NNP NNP O
up RP RP O
15 CD CD O
lb NN NN O
. . . O
   
BP NNP NNP O
, , , O
RA NNP NNP O
120/70 CD CD O
. . . O
   
Chest NN NN O
- : : O
Clear NNP NNP O
with IN IN O
decreased VBD VBD O
sounds VBZ VBZ O
bilateral JJ JJ O
bases NNS NNS O
, , , O
decreased VBD VBD O
breath NN NN O
sounds VBZ VBZ O
. . . O
   
Cardiac NNP NNP O
- : : O
Regular NNP NNP O
rhythm NN NN O
with IN IN O
premature JJ JJ O
beats NNS NNS O
at IN IN O
   
84 CD CD O
. . . O
No DT DT O
murmur NN NN O
. . . O
   
Extremities NNP NNP O
- : : O
No DT DT O
edema NN NN O
on IN IN O
right NN NN O
, , , O
trace VB VB O
on IN IN O
left VBD VBD O
. . . O
   
ASSESSMENT NNP NNP O
AND CC CC O
PLAN NNP NNP O
: : : O
( ( ( O
1 CD CD O
) ) ) O
CHF/CAD NNP NNP O
. . . O
   
No DT DT O
new JJ JJ O
symptoms NNS NNS O
. . . O
   
However RB RB O
, , , O
15 CD CD O
lb NN NN O
weight NN NN O
gain NN NN O
of IN IN O
concern NN NN O
. . . O
   
Consult NNP NNP O
with IN IN O
Dr NNP NNP O
. . . O
Hale NNP NNP I-DOCTOR
. . . O
   
Check NNP NNP O
chest NN NN O
x-ray NN NN O
today NN NN O
, , , O
BUN NNP NNP O
and CC CC O
creatinine NN NN O
, , , O
lytes NNS NNS O
. . . O
   
( ( ( O
2 CD CD O
) ) ) O
Obesity NNP NNP O
. . . O
   
Counselled NNP NNP O
patient NN NN O
and CC CC O
wife NN NN O
regarding VBG VBG O
d/c NN NN O
sweets NNS NNS O
in IN IN O
diet NN NN O
, , , O
need VBP VBP O
to TO TO O
focus VB VB O
on IN IN O
reducing VBG VBG O
weight NN NN O
. . . O
   
( ( ( O
3 CD CD O
) ) ) O
Wife NN NN O
mentions NNS NNS O
patient NN NN O
frequently RB RB O
forgets VBZ VBZ O
things NNS NNS O
, , , O
days NNS NNS O
of IN IN O
week NN NN O
, , , O
etc FW FW O
. . . O
   
Discussed VBN VBN O
with IN IN O
patient NN NN O
mild JJ JJ O
dementia NN NN O
. . . O
   
RTC NNP NNP O
in IN IN O
2 CD CD O
months NNS NNS O
to TO TO O
Dr NNP NNP O
. . . O
Hale NNP NNP I-DOCTOR
. . . O
   
Continue NNP NNP O
current JJ JJ O
meds NNS NNS O
. . . O
   
ADDENDUM NNP NNP O
: : : O
Patient NN NN O
at IN IN O
end NN NN O
of IN IN O
visit NN NN O
mentioned VBN VBN O
bitter JJ JJ O
taste NN NN O
, , , O
acid NN NN O
, , , O
after IN IN O
eating VBG VBG O
. . . O
   
Apparently RB RB O
never RB RB O
got VBD VBD O
prescription NN NN O
for IN IN O
ranitidine NN NN O
filled VBN VBN O
. . . O
   
Ranitidine NNP NNP O
150 CD CD O
mg NN NN O
, , , O
#60 NN NN O
, , , O
1 CD CD O
tab NN NN O
b.i.d. NN NN O
refilled JJ JJ O
x SYM SYM O
   
3 CD CD O
. . . O
Pt NNP NNP O
. . . O
   
ed NN NN O
. . . O
   
regarding VBG VBG O
decrease NN NN O
coffee NN NN O
in IN IN O
diet NN NN O
. . . O
   
Advised NNP NNP O
decaffeinated VBD VBD O
at IN IN O
h.s. NN NN O
   
Odessa NNP NNP I-DOCTOR
Kang NNP NNP I-DOCTOR
, , , O
RNC NNP NNP O
, , , O
ANP NNP NNP O
OK/quiggle/urie NNP NNP O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2108-06-26 JJ JJ I-DATE
Mr NNP NNP O
. . . O
Bryan NNP NNP I-PATIENT
returns NNS NNS O
- : : O
he PRP PRP O
saw VBD VBD O
Dr NNP NNP O
. . . O
Shoemaker NNP NNP I-DOCTOR
who WP WP O
feels VBZ VBZ O
he PRP PRP O
does VBZ VBZ O
need VB VB O
a DT DT O
revision NN NN O
. . . O
   
Mr NNP NNP O
. . . O
Bryan NNP NNP I-PATIENT
is VBZ VBZ O
thinking VBG VBG O
about IN IN O
it PRP PRP O
, , , O
but CC CC O
has VBZ VBZ O
n't RB RB O
yet RB RB O
called VBN VBN O
for IN IN O
an DT DT O
OR CC CC O
date NN NN O
. . . O
   
He PRP PRP O
has VBZ VBZ O
had VBN VBN O
a DT DT O
couple NN NN O
of IN IN O
falls NNS NNS O
, , , O
one CD CD O
right NN NN O
on IN IN O
Sheffield NNP NNP I-STREET
Road NNP NNP I-STREET
- : : O
thankfully RB RB O
nothing NN NN O
serious JJ JJ O
. . . O
   
He PRP PRP O
still RB RB O
has VBZ VBZ O
right JJ JJ O
hip NN NN O
pain NN NN O
that WDT WDT O
radiates VBZ VBZ O
to TO TO O
the DT DT O
thigh NN NN O
. . . O
   
Weight NNP NNP O
is VBZ VBZ O
back RB RB O
up RB RB O
3 CD CD O
lbs NN NN O
. . . O
   
Labs NNP NNP O
were VBD VBD O
all DT DT O
fine NN NN O
and CC CC O
HBa1C NNP NNP O
was VBD VBD O
< NN NN O
7 CD CD O
. . . O
   
ROS NNP NNP O
: : : O
occas NN NN O
. . . O
   
constipation NN NN O
, , , O
no DT DT O
CP NNP NNP O
, , , O
no DT DT O
sob NN NN O
, , , O
no DT DT O
palps NN NN O
, , , O
no DT DT O
dizziness NN NN O
. . . O
   
denies NNS NNS O
Urinary NNP NNP O
problems NNS NNS O
. . . O
   
No DT DT O
skin NN NN O
problems NNS NNS O
. . . O
   
Habits NNP NNP O
: : : O
no DT DT O
smoking NN NN O
or CC CC O
current JJ JJ O
EtOH NNP NNP O
. . . O
   
SHx NNP NNP O
: : : O
Retired NNP NNP O
. . . O
   
No DT DT O
kids NNS NNS O
. . . O
   
Lives NNS NNS O
in IN IN O
90 CD CD I-STREET
Yvonne NNP NNP I-STREET
St NNP NNP I-STREET
Very RB RB O
independent JJ JJ O
. . . O
   
Medications NNP NNP O
Aspirin NNP NNP O
( ( ( O
ACETYLSALICYLIC NNP NNP O
ACID NNP NNP O
) ) ) O
81MG CD CD O
TABLET NNP NNP O
CHEWABLE NNP NNP O
take NN NN O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
, , , O
Take NNP NNP O
as IN IN O
directed VBN VBN O
Mvi NNP NNP O
( ( ( O
MULTIVITAMINS NNP NNP O
) ) ) O
1 CD CD O
CAPSULE NNP NNP O
PO NNP NNP O
QD NNP NNP O
Atenolol NNP NNP O
100MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Captopril NNP NNP O
50MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
BID NNP NNP O
, , , O
Take NNP NNP O
as IN IN O
directed VBN VBN O
Hctz NNP NNP O
( ( ( O
HYDROCHLOROTHIAZIDE NNP NNP O
) ) ) O
25MG CD CD O
TABLET NNP NNP O
take NN NN O
0.5 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
, , , O
Take NNP NNP O
as IN IN O
directed VBN VBN O
Metformin NNP NNP O
850MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
BID NNP NNP O
Allergies NNP NNP O
NKA NNP NNP O
PE NNP NNP O
: : : O
Hobbling VBG VBG O
with IN IN O
a DT DT O
cane NN NN O
- : : O
124/70 CD CD O
p. NN NN O
78 CD CD O
reg NN NN O
rr NN NN O
16 CD CD O
clear JJ JJ O
lungs NNS NNS O
. . . O
   
RRR NNP NNP O
- : : O
m/r/g NN NN O
no DT DT O
bruits NNS NNS O
. . . O
   
blind NN NN O
in IN IN O
left VBD VBD O
eye NN NN O
decreased VBD VBD O
ROM NNP NNP O
in IN IN O
right NN NN O
hip NN NN O
to TO TO O
flexion/ext JJ JJ O
rotation NN NN O
. . . O
   
tr NN NN O
. . . O
   
edema NN NN O
. . . O
   
groin NN NN O
rash NN NN O
has VBZ VBZ O
resolved VBN VBN O
. . . O
   
a/p NN NN O
1 CD CD O
) ) ) O
Hip NNP NNP O
OA NNP NNP O
- : : O
he PRP PRP O
needs VBZ VBZ O
a DT DT O
revision NN NN O
of IN IN O
his PRP$ PRP$ O
R NN NN O
THR NNP NNP O
. . . O
   
He PRP PRP O
will MD MD O
call VB VB O
Dr NNP NNP O
. . . O
Shoemaker NNP NNP I-DOCTOR
to TO TO O
set VB VB O
an DT DT O
OR CC CC O
date NN NN O
. . . O
   
2 CD CD O
) ) ) O
htn NN NN O
- : : O
well RB RB O
controlled VBN VBN O
. . . O
   
3 CD CD O
) ) ) O
DM NNP NNP O
- : : O
fairly RB RB O
well RB RB O
controlled VBN VBN O
. . . O
   
Continue NNP NNP O
with IN IN O
metformin NN NN O
. . . O
   
On IN IN O
ACEI NNP NNP O
, , , O
ASA NNP NNP O
. . . O
   
Not RB RB O
on IN IN O
statin NN NN O
- - - O
lipids NNS NNS O
have VBP VBP O
been VBN VBN O
quite RB RB O
good JJ JJ O
. . . O
   
Followed VBN VBN O
by IN IN O
Dr NNP NNP O
. . . O
Xanders NNP NNP I-DOCTOR
for IN IN O
optho NN NN O
. . . O
   
Health NNP NNP O
maintenance NN NN O
Influenza NNP NNP O
Vaccine NNP NNP O
11/01/2107 CD CD I-DATE
FLUZONE NNP NNP O
O9824QB NNP NNP I-IDNUM
Cholesterol NNP NNP O
12/15/2105 CD CD I-DATE
168 CD CD O
DESIRABLE NNP NNP O
: : : O
< NN NN O
200 CD CD O
Rectal NNP NNP O
exam NN NN O
06/07/2107 CD CD I-DATE
Stool NNP NNP O
Guaiac NNP NNP O
06/29/2107 CD CD I-DATE
/ NN NN O
NEGATIVE/NEGATIVE NNP NNP O
Done VBN VBN O
- - - O
negative JJ JJ O
x NN NN O
's POS POS O
3 CD CD O
Pneumovax NNP NNP O
12/05/2107 CD CD I-DATE
Smoking NNP NNP O
status NN NN O
12/15/2105 CD CD I-DATE
Never RB RB O
a DT DT O
smoker NN NN O
Sigmoidoscopy NNP NNP O
12/15/2105 CD CD I-DATE
refused VBD VBD O
UA-Protein NNP NNP O
12/07/99 CD CD I-DATE
TRACE NNP NNP O
Colonoscopy NNP NNP O
06/26/2108 CD CD I-DATE
offered VBN VBN O
, , , O
patient NN NN O
refused VBD VBD O
. . . O
   
Ophthal NNP NNP O
Exam NNP NNP O
01/30/2107 CD CD I-DATE
No DT DT O
diabetic JJ JJ O
ret NN NN O
. . . O
   
+ NN NN O
mac NN NN O
. . . O
   
deg NN NN O
, , , O
blind JJ JJ O
on IN IN O
left VBD VBD O
( ( ( O
s/p NN NN O
bleed NN NN O
) ) ) O
Done VBN VBN O
elsewhere RB RB O
Followed NNP NNP O
by IN IN O
Dr NNP NNP O
. . . O
Xanders NNP NNP I-DOCTOR
of IN IN O
the DT DT O
retinal JJ JJ O
service NN NN O
for IN IN O
Mac NNP NNP O
. . . O
   
deg NN NN O
. . . O
   
HbA1c NNP NNP O
05/13/2108 CD CD I-DATE
6.70 CD CD O
Podiatry NNP NNP O
exam NN NN O
11/18/2106 CD CD I-DATE
slight JJ JJ O
neuropathy NN NN O
Triglycerides NNP NNP O
12/15/2105 CD CD I-DATE
94 CD CD O
Cholesterol-LDL NNP NNP O
12/15/2105 CD CD I-DATE
110 NN NN O
DESIRABLE NNP NNP O
: : : O
< NN NN O
130 CD CD O
Hct NNP NNP O
( ( ( O
Hematocrit NNP NNP O
) ) ) O
05/10/2108 CD CD I-DATE
37.2 CD CD O
Complete NNP NNP O
Physical JJ JJ O
Exam NNP NNP O
06/07/2107 CD CD I-DATE
Cholesterol-HDL NNP NNP O
12/15/2105 CD CD I-DATE
39 CD CD O
MHCT NNP NNP O
( ( ( O
micro-Hematocrit NN NN O
) ) ) O
12/03/99 CD CD I-DATE
33 CD CD O
Hgb NNP NNP O
( ( ( O
Hemoglobin NNP NNP O
) ) ) O
05/10/2108 CD CD I-DATE
12.9 CD CD O
____________________________________________ NN NN O
_ NN NN O
Brandon NNP NNP I-DOCTOR
Nix NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2082-04-10 JJ JJ I-DATE
Records NNPS NNPS O
not RB RB O
available JJ JJ O
Here RB RB O
for IN IN O
follow VB VB O
up RB RB O
on IN IN O
DM NNP NNP O
, , , O
and CC CC O
HTN NNP NNP O
Doing VBG VBG O
well RB RB O
, , , O
no DT DT O
new JJ JJ O
problems NNS NNS O
. . . O
   
No DT DT O
polis NN NN O
Pt NNP NNP O
did VBD VBD O
not RB RB O
bring VB VB O
BS NNP NNP O
chart NN NN O
. . . O
   
AM NNP NNP O
values NNS NNS O
: : : O
78 CD CD O
, , , O
138 CD CD O
( ( ( O
after IN IN O
breakfast NN NN O
) ) ) O
Weight NNP NNP O
: : : O
gained VBD VBD O
lbs NN NN O
Exercise NNP NNP O
: : : O
yes UH UH O
no DT DT O
Smoking NNP NNP O
: : : O
no DT DT O
Main NNP NNP O
problem NN NN O
is VBZ VBZ O
back RB RB O
and CC CC O
knee NN NN O
pains NNS NNS O
on IN IN O
and CC CC O
off IN IN O
, , , O
worse JJR JJR O
with IN IN O
bad JJ JJ O
weather NN NN O
, , , O
no DT DT O
swelling VBG VBG O
, , , O
Motrim NNP NNP O
helps VBZ VBZ O
HTN NNP NNP O
: : : O
168/78 CD CD O
at IN IN O
home NN NN O
, , , O
no DT DT O
cp NN NN O
, , , O
no DT DT O
sob NN NN O
Recurrent NNP NNP O
utis NN NN O
: : : O
no DT DT O
dysuria NN NN O
, , , O
no DT DT O
sxs NN NN O
MEDICATIONS NNP NNP O
PREMARIN NNP NNP O
( ( ( O
CONJUGATED NNP NNP O
ESTROGENS NNP NNP O
) ) ) O
2 CD CD O
GM NNP NNP O
PV NNP NNP O
QHS NNP NNP O
SIG NNP NNP O
ONE CD CD O
APPLICATOR NNP NNP O
FULL NNP NNP O
AT IN IN O
HSX NNP NNP O
1WK CD CD O
THEN RB RB O
TWICE RB RB O
PER IN IN O
WEEK NN NN O
ATIVAN NNP NNP O
( ( ( O
LORAZEPAM NNP NNP O
) ) ) O
0.5MG CD CD O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PNGT NNP NNP O
QD NNP NNP O
GLYBURIDE NNP NNP O
5MG CD CD O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
COZAAR NNP NNP O
( ( ( O
LOSARTAN NNP NNP O
) ) ) O
50MG CD CD O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
PROBLEMS NNS NNS O
Diabetes NNP NNP O
mellitus JJ JJ O
Hypertension NNP NNP O
ALLERGIES NNP NNP O
Penicillins NNP NNP O
Rash NNP NNP O
Codeine NNP NNP O
GI NNP NNP O
upset VBD VBD O
Sulfa NNP NNP O
Rash NNP NNP O
* NN NN O
lisinopril NN NN O
cough NN NN O
PE NNP NNP O
: : : O
BP NNP NNP O
: : : O
160/80 CD CD O
HR NNP NNP O
: : : O
78 CD CD O
Chest NN NN O
: : : O
clear JJ JJ O
Heart NNP NNP O
: : : O
reg NN NN O
, , , O
nl NN NN O
S1 NNP NNP O
, , , O
S2 NNP NNP O
Abd NNP NNP O
: : : O
soft JJ JJ O
, , , O
non NN NN O
tender NN NN O
Extr NNP NNP O
: : : O
no DT DT O
edema NN NN O
A-P NNP NNP O
: : : O
DM NNP NNP O
: : : O
A DT DT O
( ( ( O
A1C NNP NNP O
) ) ) O
, , , O
B NNP NNP O
( ( ( O
blood NN NN O
pressure NN NN O
) ) ) O
and CC CC O
C NNP NNP O
   
( ( ( O
cholesterol NN NN O
) ) ) O
targets NNS NNS O
emphasized VBD VBD O
. . . O
   
Diet NNP NNP O
: : : O
No DT DT O
sweets NNS NNS O
, , , O
low JJ JJ O
fat JJ JJ O
diet NN NN O
reinforced VBD VBD O
. . . O
   
Nutritionist NNP NNP O
Referral NNP NNP O
done VBN VBN O
. . . O
   
Podiatry NNP NNP O
referral NN NN O
done VBN VBN O
Opthalmology NNP NNP O
referral NN NN O
done VBN VBN O
Exercise NNP NNP O
encouraged VBD VBD O
. . . O
   
Check NNP NNP O
BS NNP NNP O
twice RB RB O
a DT DT O
day NN NN O
, , , O
write VB VB O
them PRP PRP O
down RB RB O
and CC CC O
bring VB VB O
log NN NN O
book NN NN O
all DT DT O
visits NNS NNS O
. . . O
   
Recheck NNP NNP O
A1c NNP NNP O
before IN IN O
next JJ JJ O
visit NN NN O
. . . O
   
Meds NNP NNP O
: : : O
Cont NNP NNP O
oral JJ JJ O
agent NN NN O
, , , O
same JJ JJ O
dose NN NN O
. . . O
   
ASA NNP NNP O
325 CD CD O
mg NN NN O
qd NN NN O
recommended VBD VBD O
. . . O
   
, , , O
done VBN VBN O
. . . O
   
Blood NNP NNP O
pressure:is VB VB O
high JJ JJ O
. . . O
   
Will MD MD O
double VB VB O
Cozaar NNP NNP O
dose NN NN O
to TO TO O
50 CD CD O
bid NN NN O
. . . O
   
Check NNP NNP O
chem NN NN O
7 CD CD O
LDL NNP NNP O
Cholesterol NNP NNP O
: : : O
on IN IN O
target NN NN O
. . . O
   
Cont NNP NNP O
same JJ JJ O
tx NN NN O
. . . O
   
Recheck NNP NNP O
cho NN NN O
in IN IN O
Pneumonia NNP NNP O
vac NN NN O
today NN NN O
Follow VB VB O
up RB RB O
in IN IN O
3 CD CD O
months NNS NNS O
. . . O
   
mammogram NN NN O
ordered VBD VBD O
We PRP PRP O
did VBD VBD O
not RB RB O
deal VB VB O
with IN IN O
bone NN NN O
density NN NN O
, , , O
records NNS NNS O
are VBP VBP O
not RB RB O
available JJ JJ O
and CC CC O
I PRP PRP O
do VBP VBP O
not RB RB O
remember VB VB O
what WP WP O
we PRP PRP O
did VBD VBD O
about IN IN O
it PRP PRP O
. . . O
   
Will NNP NNP O
rediscuss VB VB O
issue NN NN O
next JJ JJ O
visit NN NN O
HEALTH NNP NNP O
MAINTENANCE NNP NNP O
Complete NNP NNP O
Physical JJ JJ O
Exam NNP NNP O
05/19/2081 CD CD I-DATE
Breast NNP NNP O
Exam NNP NNP O
05/19/2081 CD CD I-DATE
Done VBN VBN O
Home NNP NNP O
glucose NN NN O
monitoring VBG VBG O
04/10/2082 CD CD I-DATE
Hypoglycemia NNP NNP O
Assessment/Counseling NNP NNP O
04/10/2082 CD CD I-DATE
M-alb/creat NNP NNP O
ratio NN NN O
04/10/2082 CD CD I-DATE
ordered VBD VBD O
Microalbumin NNP NNP O
04/10/2082 CD CD I-DATE
Microalbumin NNP NNP O
04/10/2082 CD CD I-DATE
ordered VBD VBD O
Nutrition NNP NNP O
Referral NNP NNP O
04/10/2082 CD CD I-DATE
referral NN NN O
done VBN VBN O
Ophthal NNP NNP O
Exam NNP NNP O
04/10/2082 CD CD I-DATE
referrala NN NN O
done VBN VBN O
Other JJ JJ O
Colonoscopy NNP NNP O
04/10/2082 CD CD I-DATE
offered VBN VBN O
, , , O
she PRP PRP O
will MD MD O
think VB VB O
about IN IN O
it PRP PRP O
Stool NNP NNP O
Guaiac NNP NNP O
04/10/2082 CD CD I-DATE
stool NN NN O
cards NNS NNS O
givne VBP VBP O
Other JJ JJ O
Pneumovax NNP NNP O
04/10/2082 CD CD I-DATE
Done VBN VBN O
Podiatry NNP NNP O
exam NN NN O
04/10/2082 CD CD I-DATE
referral NN NN O
done VBN VBN O
Influenza NNP NNP O
Vaccine NNP NNP O
10/24/2081 CD CD I-DATE
Cholesterol NNP NNP O
08/02/2081 CD CD I-DATE
212 CD CD O
DESIRABLE NNP NNP O
: : : O
less JJR JJR O
then RB RB O
200 CD CD O
Mammogram NNP NNP O
02/08/2081 CD CD I-DATE
BilScrMammo NNP NNP O
Pap NNP NNP O
Smear NNP NNP O
12/29/2079 CD CD I-DATE
See VB VB O
report NN NN O
in IN IN O
Results NNS NNS O
Smoking NNP NNP O
status NN NN O
01/26/2082 CD CD I-DATE
Never RB RB O
a DT DT O
smoker NN NN O
UA-Protein NNP NNP O
01/24/2082 CD CD I-DATE
Negative NNP NNP O
HBA1C NNP NNP O
08/03/2081 CD CD I-DATE
7.20 CD CD O
Domestic NNP NNP O
Violence NNP NNP O
Screening NNP NNP O
01/26/2082 CD CD I-DATE
neg NN NN O
___________________________ NN NN O
_ NN NN O
Tatyana NNP NNP I-DOCTOR
A. NN NN I-DOCTOR
Morris NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2083-01-23 JJ JJ I-DATE
Middle NNP NNP I-HOSPITAL
Tennessee NNP NNP I-HOSPITAL
Institute NNP NNP I-HOSPITAL
242 CD CD I-STREET
Crest NNP NNP I-STREET
View NNP NNP I-STREET
Terrace NNP NNP I-STREET
QIN NNP NNP O
, , , O
OWEN NNP NNP I-PATIENT
Queen NNP NNP I-CITY
Creek NNP NNP I-CITY
, , , O
ND NNP NNP I-STATE
23115 CD CD I-ZIP
88491427 CD CD I-MEDICALRECORD
( ( ( O
906 CD CD O
) ) ) O
178-3611 NN NN I-PHONE
01/23/83 CD CD I-DATE
HISTORY NN NN O
OF IN IN O
PRESENT NNP NNP O
ILLNESS NNP NNP O
: : : O
Mr NNP NNP O
. . . O
Qin NNP NNP I-PATIENT
is VBZ VBZ O
a DT DT O
patient NN NN O
of IN IN O
Dr NNP NNP O
. . . O
Potter NNP NNP I-DOCTOR
's POS POS O
, , , O
who WP WP O
is VBZ VBZ O
in IN IN O
today NN NN O
for IN IN O
urgent JJ JJ O
care NN NN O
. . . O
   
He PRP PRP O
is VBZ VBZ O
complaining VBG VBG O
of IN IN O
a DT DT O
funny JJ JJ O
sensation NN NN O
in IN IN O
his PRP$ PRP$ O
neck NN NN O
and CC CC O
occasional JJ JJ O
soreness NNS NNS O
in IN IN O
his PRP$ PRP$ O
left JJ JJ O
neck NN NN O
. . . O
   
Sometimes RB RB O
it PRP PRP O
hurts VBZ VBZ O
worse JJR JJR O
with IN IN O
breathing VBG VBG O
. . . O
   
Sometimes RB RB O
he PRP PRP O
feels VBZ VBZ O
a DT DT O
little JJ JJ O
catch NN NN O
and CC CC O
a DT DT O
fleeting JJ JJ O
moment NN NN O
of IN IN O
shortness NNS NNS O
of IN IN O
breath NN NN O
. . . O
   
Of IN IN O
note NN NN O
, , , O
he PRP PRP O
was VBD VBD O
admitted VBN VBN O
to TO TO O
the DT DT O
hospital NN NN O
last JJ JJ O
week NN NN O
for IN IN O
these DT DT O
symptoms NNS NNS O
. . . O
   
He PRP PRP O
was VBD VBD O
admitted VBN VBN O
, , , O
I PRP PRP O
think VBP VBP O
01/15-01/16 NN NN O
. . . O
   
He PRP PRP O
was VBD VBD O
ruled VBN VBN O
out IN IN O
for IN IN O
an DT DT O
MI NNP NNP O
and CC CC O
actually RB RB O
had VBD VBD O
a DT DT O
stress NN NN O
test NN NN O
, , , O
which WDT WDT O
showed VBD VBD O
no DT DT O
evidence NN NN O
of IN IN O
ischemia NN NN O
. . . O
   
Furthermore RB RB O
, , , O
he PRP PRP O
was VBD VBD O
monitored VBN VBN O
the DT DT O
entire JJ JJ O
time NN NN O
, , , O
including VBG VBG O
while IN IN O
he PRP PRP O
was VBD VBD O
having VBG VBG O
this DT DT O
symptom NN NN O
of IN IN O
a DT DT O
funny JJ JJ O
feeling NN NN O
in IN IN O
his PRP$ PRP$ O
chest NN NN O
followed VBN VBN O
by IN IN O
a DT DT O
little JJ JJ O
shortness NN NN O
of IN IN O
breath NN NN O
or CC CC O
catching VBG VBG O
his PRP$ PRP$ O
breath NN NN O
as IN IN O
he PRP PRP O
describes VBZ VBZ O
it PRP PRP O
and CC CC O
no DT DT O
arrhythmia NN NN O
was VBD VBD O
documented VBN VBN O
whatsoever RB RB O
. . . O
   
He PRP PRP O
was VBD VBD O
ultimately RB RB O
discharged VBN VBN O
from IN IN O
the DT DT O
hospital NN NN O
with IN IN O
the DT DT O
diagnosis NN NN O
of IN IN O
Costa NNP NNP O
chondritis NNS NNS O
. . . O
   
He PRP PRP O
is VBZ VBZ O
describing VBG VBG O
this DT DT O
pain NN NN O
in IN IN O
his PRP$ PRP$ O
left JJ JJ O
neck NN NN O
and CC CC O
he PRP PRP O
wonders NNS NNS O
if IN IN O
it PRP PRP O
is VBZ VBZ O
somehow RB RB O
related VBN VBN O
to TO TO O
the DT DT O
pain NN NN O
in IN IN O
his PRP$ PRP$ O
chest NN NN O
. . . O
   
He PRP PRP O
said VBD VBD O
he PRP PRP O
tried VBD VBD O
gargling VBG VBG O
with IN IN O
mouthwash NN NN O
some DT DT O
and CC CC O
that IN IN O
did VBD VBD O
seem VB VB O
to TO TO O
help VB VB O
a DT DT O
little JJ JJ O
. . . O
   
This DT DT O
neck NN NN O
or CC CC O
throat NN NN O
pain NN NN O
has VBZ VBZ O
been VBN VBN O
going VBG VBG O
on IN IN O
for IN IN O
the DT DT O
past JJ JJ O
three CD CD O
days NNS NNS O
. . . O
   
PAST NNP NNP O
MEDICAL NNP NNP O
HISTORY NN NN O
: : : O
Remarkable NNP NNP O
for IN IN O
osteoarthritis NNS NNS O
, , , O
hypertension NN NN O
and CC CC O
other JJ JJ O
noncontributory NN NN O
problems NNS NNS O
. . . O
   
MEDICATIONS NNP NNP O
: : : O
Aspirin NNP NNP O
, , , O
atenolol NN NN O
, , , O
Lipitor NNP NNP O
and CC CC O
vitamin NN NN O
E. NN NN O
ALLERGIES NNP NNP O
: : : O
None NN NN O
. . . O
   
PHYSICAL JJ JJ O
EXAMINATION NNP NNP O
: : : O
Today NN NN O
, , , O
he PRP PRP O
is VBZ VBZ O
alert NN NN O
and CC CC O
oriented VBN VBN O
. . . O
   
His PRP$ PRP$ O
weight NN NN O
is VBZ VBZ O
255.25 CD CD O
pounds NNS NNS O
, , , O
blood NN NN O
pressure NN NN O
110/80 CD CD O
, , , O
pulse NN NN O
68 CD CD O
, , , O
temperature NN NN O
97.4 CD CD O
. . . O
   
Sinuses NNP NNP O
: : : O
Non-tender NNP NNP O
. . . O
   
Nasal NNP NNP O
turbinates NNS NNS O
: : : O
Benign NNP NNP O
. . . O
   
Tympanic NNP NNP O
membranes NNS NNS O
: : : O
With IN IN O
good JJ JJ O
light NN NN O
reflex NN NN O
, , , O
landmarks NNS NNS O
well RB RB O
seen VBN VBN O
. . . O
   
Oropharynx NNP NNP O
: : : O
Without IN IN O
erythema NN NN O
, , , O
exudate NN NN O
, , , O
edema NN NN O
. . . O
   
Neck NN NN O
: : : O
Supple NNP NNP O
, , , O
without IN IN O
adenopathy JJ JJ O
. . . O
   
I PRP PRP O
am VBP VBP O
able JJ JJ O
to TO TO O
locate VB VB O
the DT DT O
spot NN NN O
that DT DT O
's VBZ VBZ O
bothering VBG VBG O
him PRP PRP O
by IN IN O
pressing VBG VBG O
on IN IN O
the DT DT O
mid JJ JJ O
outside IN IN O
of IN IN O
his PRP$ PRP$ O
left JJ JJ O
neck NN NN O
near IN IN O
where WRB WRB O
his PRP$ PRP$ O
carotid NN NN O
pulse NN NN O
is VBZ VBZ O
, , , O
but CC CC O
he PRP PRP O
does VBZ VBZ O
not RB RB O
have VB VB O
a DT DT O
lot NN NN O
of IN IN O
discomfort NN NN O
with IN IN O
this DT DT O
pressure NN NN O
and CC CC O
it PRP PRP O
does VBZ VBZ O
not RB RB O
seem VB VB O
to TO TO O
be VB VB O
quite RB RB O
what WP WP O
he PRP PRP O
is VBZ VBZ O
getting VBG VBG O
at IN IN O
. . . O
   
Carotids NNP NNP O
are VBP VBP O
2 CD CD O
+ NN NN O
bilaterally RB RB O
. . . O
   
Lungs NNP NNP O
: : : O
Clear JJ JJ O
to TO TO O
auscultation NN NN O
and CC CC O
percussion NN NN O
throughout IN IN O
. . . O
   
Heart NNP NNP O
: : : O
Regular NNP NNP O
, , , O
without IN IN O
murmur NN NN O
, , , O
rub NN NN O
or CC CC O
gallop NN NN O
. . . O
   
ASSESSMENT NNP NNP O
AND CC CC O
PLAN NNP NNP O
: : : O
I PRP PRP O
was VBD VBD O
unable JJ JJ O
to TO TO O
find VB VB O
a DT DT O
clear JJ JJ O
etiology NN NN O
for IN IN O
Mr NNP NNP O
. . . O
Quevedo NNP NNP I-PATIENT
discomfort NN NN O
, , , O
although IN IN O
I PRP PRP O
think VBP VBP O
he PRP PRP O
is VBZ VBZ O
probably RB RB O
right JJ JJ O
that IN IN O
it PRP PRP O
is VBZ VBZ O
related VBN VBN O
to TO TO O
the DT DT O
musculoskeletal JJ JJ O
chest NN NN O
pain NN NN O
that IN IN O
he PRP PRP O
is VBZ VBZ O
having VBG VBG O
. . . O
   
I PRP PRP O
did VBD VBD O
reassure VB VB O
him PRP PRP O
and CC CC O
tell VB VB O
him PRP PRP O
that IN IN O
it PRP PRP O
was VBD VBD O
okay JJ JJ O
for IN IN O
him PRP PRP O
to TO TO O
take VB VB O
ibuprofen NN NN O
for IN IN O
this DT DT O
as IN IN O
he PRP PRP O
had VBD VBD O
been VBN VBN O
directed VBN VBN O
in IN IN O
the DT DT O
hospital NN NN O
. . . O
   
He PRP PRP O
does VBZ VBZ O
have VB VB O
an DT DT O
appointment NN NN O
to TO TO O
see VB VB O
Dr NNP NNP O
. . . O
Potter NNP NNP I-DOCTOR
in IN IN O
follow-up JJ JJ O
in IN IN O
the DT DT O
next JJ JJ O
couple NN NN O
weeks NNS NNS O
and CC CC O
he PRP PRP O
will MD MD O
call VB VB O
or CC CC O
return NN NN O
if IN IN O
any DT DT O
new JJ JJ O
symptoms NNS NNS O
develop VBP VBP O
. . . O
   
_____________________________ NN NN O
_ NN NN O
Rawan NNP NNP I-DOCTOR
Pineda NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
   
Dictated NNP NNP O
By IN IN O
: : : O
Rawan NNP NNP I-DOCTOR
Pineda NNP NNP I-DOCTOR
eScription NN NN O
document:6-3221670 JJ JJ O
JSSten NNP NNP O
Tel NNP NNP O
DD NNP NNP O
: : : O
01/23/83 CD CD I-DATE
DT NNP NNP O
: : : O
01/23/83 CD CD I-DATE
DV NNP NNP O
: : : O
01/23/83 CD CD I-DATE
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2078-06-15 JJ JJ I-DATE
DISTRICT NNP NNP I-HOSPITAL
FOUR CD CD I-HOSPITAL
EMERGENCY NNP NNP O
DEPT NNP NNP O
VISIT NNP NNP O
ESPOSITO,PERLA NNP NNP I-PATIENT
146-55-23-5 JJ JJ I-MEDICALRECORD
VISIT NNP NNP O
DATE NN NN O
: : : O
06/15/78 CD CD I-DATE
PRESENTING NNP NNP O
COMPLAINT NNP NNP O
: : : O
The DT DT O
patient NN NN O
is VBZ VBZ O
a DT DT O
77 CD CD I-AGE
year NN NN O
old JJ JJ O
female JJ JJ O
with IN IN O
history NN NN O
of IN IN O
coronary JJ JJ O
artery NN NN O
disease NN NN O
who WP WP O
presents VBZ VBZ O
to TO TO O
District NNP NNP I-HOSPITAL
Four CD CD I-HOSPITAL
State NNP NNP I-HOSPITAL
Hospital NNP NNP I-HOSPITAL
emergency NN NN O
room NN NN O
department NN NN O
with IN IN O
chief JJ JJ O
complaint NN NN O
of IN IN O
numbness NN NN O
in IN IN O
her PRP$ PRP$ O
left JJ JJ O
upper JJ JJ O
extremity NN NN O
and CC CC O
left VBD VBD O
lower JJR JJR O
extremity NN NN O
after IN IN O
awakening VBG VBG O
today NN NN O
. . . O
   
She PRP PRP O
denies VBZ VBZ O
slurred VBN VBN O
speech NN NN O
, , , O
shortness NN NN O
of IN IN O
breath NN NN O
, , , O
or CC CC O
headache NN NN O
. . . O
   
HISTORY NN NN O
OF IN IN O
PRESENTING NNP NNP O
COMPLAINT NNP NNP O
: : : O
REVIEW NNP NNP O
OF IN IN O
SYSTEMS NNP NNP O
: : : O
PAST NNP NNP O
MEDICAL NNP NNP O
HISTORY NN NN O
: : : O
Positive JJ JJ O
for IN IN O
coronary JJ JJ O
artery NN NN O
bypass NN NN O
graft NN NN O
. . . O
   
MEDICATIONS NNP NNP O
: : : O
Lopressor NNP NNP O
, , , O
aspirin NN NN O
, , , O
Procardia NNP NNP O
. . . O
   
ALLERGIES NNP NNP O
: : : O
None NN NN O
. . . O
   
SOCIAL NNP NNP O
HISTORY NN NN O
AND CC CC O
FAMILY NN NN O
HISTORY NN NN O
: : : O
PHYSICAL JJ JJ O
EXAMINATION NNP NNP O
: : : O
Temperature NNP NNP O
97 CD CD O
, , , O
pulse NN NN O
64 CD CD O
, , , O
respiratory JJ JJ O
rate NN NN O
18 CD CD O
, , , O
blood NN NN O
pressure NN NN O
192/96 CD CD O
. . . O
   
HEENT NNP NNP O
: : : O
Normocephalic NNP NNP O
, , , O
atraumatic JJ JJ O
. . . O
   
Pupils NNP NNP O
equal JJ JJ O
, , , O
round NN NN O
, , , O
and CC CC O
reactive VB VB O
to TO TO O
light VB VB O
and CC CC O
accommodation NN NN O
. . . O
   
Positive NNP NNP O
for IN IN O
AV NNP NNP O
nicking VBG VBG O
. . . O
   
Extraocular NNP NNP O
movements NNS NNS O
intact VBP VBP O
. . . O
   
Neck NNP NNP O
: : : O
Supple NNP NNP O
. . . O
   
No DT DT O
jugular NN NN O
venous JJ JJ O
distension NN NN O
. . . O
   
Chest NN NN O
clear JJ JJ O
to TO TO O
auscultation NN NN O
and CC CC O
percussion NN NN O
. . . O
   
No DT DT O
rales NNS NNS O
, , , O
wheezes NNS NNS O
, , , O
or CC CC O
rhonchi NN NN O
. . . O
   
Heart NNP NNP O
: : : O
Normal JJ JJ O
S1 NNP NNP O
and CC CC O
S2 NNP NNP O
. . . O
   
No DT DT O
S3 NNP NNP O
or CC CC O
S4 NNP NNP O
or CC CC O
murmur NN NN O
. . . O
   
Abdomen NNP NNP O
: : : O
Soft JJ JJ O
, , , O
nontender NN NN O
, , , O
nondistended JJ JJ O
. . . O
   
No DT DT O
masses NNS NNS O
, , , O
rebound NN NN O
, , , O
or CC CC O
organomegaly RB RB O
. . . O
   
Extremities NNP NNP O
: : : O
Grossly NNP NNP O
within IN IN O
normal JJ JJ O
limits NNS NNS O
. . . O
   
Neurologic NNP NNP O
: : : O
She PRP PRP O
was VBD VBD O
awake JJ JJ O
and CC CC O
alert NN NN O
and CC CC O
oriented JJ JJ O
times NNS NNS O
three CD CD O
. . . O
   
Normal NNP NNP O
cerebellar NN NN O
. . . O
   
Negative NNP NNP O
Babinski NNP NNP O
. . . O
   
Muscle NNP NNP O
strength NN NN O
4/5 CD CD O
. . . O
   
LABORATORY NNP NNP O
EVALUATION NNP NNP O
: : : O
The DT DT O
patient NN NN O
had VBD VBD O
a DT DT O
head NN NN O
CT NNP NNP O
scan VB VB O
in IN IN O
the DT DT O
emergency NN NN O
room NN NN O
department NN NN O
which WDT WDT O
was VBD VBD O
noted VBN VBN O
to TO TO O
be VB VB O
negative JJ JJ O
. . . O
   
THERAPY NNP NNP O
RENDERED/COURSE NNP NNP O
IN IN IN O
ED NNP NNP O
: : : O
PROCEDURES NNP NNP O
: : : O
CONSULTATIONS NNP NNP O
( ( ( O
including VBG VBG O
PCP NNP NNP O
) ) ) O
: : : O
FINAL NNP NNP O
DIAGNOSIS NNP NNP O
: : : O
Rule NNP NNP O
out IN IN O
cerebrovascular NN NN O
accident NN NN O
. . . O
   
DISPOSITION NNP NNP O
( ( ( O
including VBG VBG O
condition NN NN O
upon IN IN O
discharge NN NN O
) ) ) O
: : : O
Admit NNP NNP O
the DT DT O
patient NN NN O
to TO TO O
medicine NN NN O
service NN NN O
for IN IN O
further JJ JJ O
workup NN NN O
and CC CC O
evaluation NN NN O
. . . O
   
__________________________________ NN NN O
_ NN NN O
DQ294/8654 NNP NNP I-IDNUM
W. NN NN I-DOCTOR
TAMAR NNP NNP I-DOCTOR
WHITEHEAD NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
   
TW31 NNP NNP I-USERNAME
D:06/15/78 NNP NNP O
T:06/16/78 NNP NNP O
Dictated NNP NNP O
by IN IN O
: : : O
W. NN NN I-DOCTOR
TAMAR NNP NNP I-DOCTOR
WHITEHEAD NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
   
TW31 NNP NNP I-USERNAME
******** NN NN O
Not RB RB O
reviewed VBN VBN O
by IN IN O
Attending NNP NNP O
Physician NNP NNP O
******** NN NN O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2061-08-26 JJ JJ I-DATE
MICU NNP NNP O
Intern NNP NNP O
Admit NNP NNP O
Note NN NN O
, , , O
Internal NNP NNP O
Medicine NNP NNP O
name NN NN O
: : : O
Goins NNP NNP O
, , , O
Jacob NNP NNP I-PATIENT
MR NNP NNP O
# # # O
: : : O
Transfer VB VB O
from IN IN O
Linden NNP NNP I-HOSPITAL
Health NNP NNP I-HOSPITAL
Care NNP NNP I-HOSPITAL
Center NNP NNP I-HOSPITAL
Date NN NN O
of IN IN O
Admission NNP NNP O
: : : O
08/25/61 CD CD I-DATE
Full NNP NNP O
code NN NN O
Contact NNP NNP O
information NN NN O
: : : O
CC/HPI NNP NNP O
: : : O
27yo CD CD O
male NN NN O
from IN IN O
Cedar NNP NNP I-CITY
Hill NNP NNP I-CITY
Lakes NNP NNP I-CITY
, , , O
Nevada NNP NNP I-STATE
w NN NN O
/ NN NN O
history NN NN O
of IN IN O
insulin-requiring JJ JJ O
DM NNP NNP O
previously RB RB O
followed VBD VBD O
at IN IN O
Cottage NNP NNP I-HOSPITAL
Sanatorium NNP NNP I-HOSPITAL
, , , O
admitted VBN VBN O
to TO TO O
Linden NNP NNP I-HOSPITAL
Health NNP NNP I-HOSPITAL
Care NNP NNP I-HOSPITAL
Center NNP NNP I-HOSPITAL
after IN IN O
becoming VBG VBG O
unresponsive JJ JJ O
during IN IN O
a DT DT O
visit NN NN O
to TO TO O
his PRP$ PRP$ O
sister NN NN O
in IN IN O
Maryland NNP NNP I-STATE
. . . O
   
By IN IN O
report NN NN O
, , , O
patient NN NN O
was VBD VBD O
sitting VBG VBG O
on IN IN O
the DT DT O
couch NN NN O
at IN IN O
his PRP$ PRP$ O
sister NN NN O
's POS POS O
house NN NN O
, , , O
slumped VBD VBD O
to TO TO O
the DT DT O
floor NN NN O
and CC CC O
had VBD VBD O
seizure NN NN O
activity NN NN O
x SYM SYM O
45seconds CD CD O
that WDT WDT O
was VBD VBD O
witnessed VBN VBN O
by IN IN O
EMS NNP NNP O
sevices NNS NNS O
. . . O
   
Accu-checks NNP NNP O
done VBN VBN O
at IN IN O
that DT DT O
time NN NN O
were VBD VBD O
> NN NN O
500 CD CD O
and CC CC O
attempts NNS NNS O
at IN IN O
intubation NN NN O
were VBD VBD O
unsuccessful JJ JJ O
. . . O
   
He PRP PRP O
was VBD VBD O
transported VBN VBN O
to TO TO O
ER NNP NNP O
, , , O
where WRB WRB O
additional JJ JJ O
attempts NNS NNS O
to TO TO O
secure VB VB O
his PRP$ PRP$ O
airway NN NN O
were VBD VBD O
also RB RB O
unsuccessful JJ JJ O
, , , O
by IN IN O
2 CD CD O
physicians NNS NNS O
. . . O
   
There EX EX O
appeared VBD VBD O
to TO TO O
be VB VB O
some DT DT O
sot NN NN O
of IN IN O
stricture NN NN O
in IN IN O
the DT DT O
upper JJ JJ O
airway NN NN O
( ( ( O
not RB RB O
obvious JJ JJ O
on IN IN O
CT NNP NNP O
scan JJ JJ O
) ) ) O
. . . O
   
However RB RB O
, , , O
pt NN NN O
had VBD VBD O
witnessed VBN VBN O
emesis NN NN O
, , , O
and CC CC O
was VBD VBD O
placed VBN VBN O
on IN IN O
100 CD CD O
% NN NN O
nonrebreather NN NN O
mask NN NN O
, , , O
with IN IN O
Versed NNP NNP O
and CC CC O
propofol NN NN O
for IN IN O
sedation NN NN O
with IN IN O
adequate JJ JJ O
O2 NNP NNP O
saturation NN NN O
. . . O
   
A DT DT O
x-ray NN NN O
confirmed VBD VBD O
dependent JJ JJ O
lung NN NN O
infiltrates NNS NNS O
consistent JJ JJ O
with IN IN O
aspiration NN NN O
pneumonia NN NN O
, , , O
and CC CC O
pt NN NN O
was VBD VBD O
started VBN VBN O
on IN IN O
Clindamycin NNP NNP O
. . . O
   
On IN IN O
arrival NN NN O
to TO TO O
the DT DT O
ER NNP NNP O
, , , O
patient NN NN O
was VBD VBD O
also RB RB O
found VBN VBN O
to TO TO O
have VB VB O
a DT DT O
blood NN NN O
pressure NN NN O
of IN IN O
248/146 CD CD O
. . . O
   
He PRP PRP O
received VBD VBD O
50mg CD CD O
dose NN NN O
of IN IN O
labetolol NN NN O
in IN IN O
the DT DT O
ER NNP NNP O
as RB RB O
well RB RB O
as IN IN O
several JJ JJ O
additional JJ JJ O
doses NNS NNS O
in IN IN O
the DT DT O
ICU NNP NNP O
. . . O
   
In IN IN O
the DT DT O
ICU NNP NNP O
, , , O
patient NN NN O
did VBD VBD O
not RB RB O
have VB VB O
any DT DT O
further RBR RBR O
witnessed VBN VBN O
seizure NN NN O
activity NN NN O
. . . O
   
A DT DT O
Head NNP NNP O
CT NNP NNP O
demonstrated VBD VBD O
no DT DT O
focal JJ JJ O
lesion NN NN O
, , , O
IC NNP NNP O
hemorrhage NN NN O
or CC CC O
other JJ JJ O
abnormality NN NN O
. . . O
   
Pt NNP NNP O
was VBD VBD O
treated VBN VBN O
with IN IN O
dilantin NN NN O
and CC CC O
IV NNP NNP O
insulin NN NN O
infusion NN NN O
. . . O
   
Serum NNP NNP O
ketones NNS NNS O
were VBD VBD O
negative JJ JJ O
. . . O
   
Additional JJ JJ O
workup NN NN O
revealed VBD VBD O
LVH NNP NNP O
by IN IN O
EKG NNP NNP O
criteria NNS NNS O
, , , O
as RB RB O
well RB RB O
as IN IN O
renal JJ JJ O
insufficiency NN NN O
Cr NNP NNP O
2.6 CD CD O
. . . O
   
Urine NNP NNP O
tox NN NN O
was VBD VBD O
positive JJ JJ O
for IN IN O
benzos NN NN O
, , , O
but CC CC O
was VBD VBD O
otherwise RB RB O
negative JJ JJ O
. . . O
   
Patient NNP NNP O
also RB RB O
developed VBD VBD O
leukoytosis NNS NNS O
( ( ( O
WBC NNP NNP O
?) NN NN O
with IN IN O
temp NN NN O
of IN IN O
102 CD CD O
degrees NNS NNS O
. . . O
   
Although IN IN O
he PRP PRP O
had VBD VBD O
minimal JJ JJ O
neck NN NN O
stiffness NN NN O
by IN IN O
neurology NN NN O
consult NN NN O
exam NN NN O
, , , O
he PRP PRP O
underwent VBD VBD O
a DT DT O
lumbar NN NN O
puncture NN NN O
that WDT WDT O
demonstrated VBD VBD O
a DT DT O
colorless NN NN O
clear JJ JJ O
fluid NN NN O
, , , O
with IN IN O
glucose NN NN O
of IN IN O
108 CD CD O
, , , O
TP NNP NNP O
   
44 CD CD O
. . . O
Grams NNP NNP O
stain VB VB O
was VBD VBD O
negative JJ JJ O
. . . O
   
Tube NNP NNP O
#4 NN NN O
contained VBD VBD O
21RBCs CD CD O
and CC CC O
7 CD CD O
WBCs NNP NNP O
with IN IN O
a DT DT O
diff NN NN O
of IN IN O
96 CD CD O
% NN NN O
PMNs NNP NNP O
and CC CC O
4 CD CD O
% NN NN O
lymphs NNS NNS O
. . . O
   
CSF NNP NNP O
cultures NNS NNS O
and CC CC O
blood NN NN O
cultures NNS NNS O
were VBD VBD O
also RB RB O
done VBN VBN O
, , , O
and CC CC O
are VBP VBP O
pending VBG VBG O
. . . O
   
During IN IN O
his PRP$ PRP$ O
hospital NN NN O
course NN NN O
, , , O
patient NN NN O
maintained VBD VBD O
adequate JJ JJ O
oxygenation NN NN O
with IN IN O
nasal NN NN O
trumpet NN NN O
in IN IN O
place NN NN O
. . . O
   
ABG NNP NNP O
on IN IN O
08/25/61 NN NN I-DATE
am VBP VBP O
was VBD VBD O
7.36/PCO2 CD CD O
45 CD CD O
/ NN NN O
PO2 NNP NNP O
366 CD CD O
, , , O
with IN IN O
bicarb NN NN O
of IN IN O
25 CD CD O
and CC CC O
100 CD CD O
% NN NN O
sats NNS NNS O
. . . O
   
His PRP$ PRP$ O
FIO2 NNP NNP O
was VBD VBD O
subsequently RB RB O
weaned VBN VBN O
. . . O
   
He PRP PRP O
remained VBD VBD O
hemodynamically RB RB O
stable JJ JJ O
with IN IN O
BP NNP NNP O
184/88 CD CD O
( ( ( O
MAP NNP NNP O
114 CD CD O
) ) ) O
HR100 NNP NNP O
, , , O
RR23 NNP NNP O
, , , O
97 CD CD O
% NN NN O
on IN IN O
cannula NN NN O
. . . O
   
Cardiac NNP NNP O
enzymes NNS NNS O
were VBD VBD O
negative JJ JJ O
. . . O
   
After IN IN O
patient NN NN O
's POS POS O
mother NN NN O
arrived VBD VBD O
from IN IN O
Georgia NNP NNP I-STATE
, , , O
she PRP PRP O
requested VBD VBD O
transfer NN NN O
to TO TO O
BMH NNP NNP I-HOSPITAL
. . . O
   
Had VBD VBD O
no DT DT O
reported VBN VBN O
history NN NN O
of IN IN O
hypertension NN NN O
or CC CC O
seizure NN NN O
disorders NNS NNS O
. . . O
   
Mother NNP NNP O
reports NNS NNS O
patient NN NN O
having VBG VBG O
occasional JJ JJ O
spells NNS NNS O
in IN IN O
the DT DT O
past JJ JJ O
, , , O
lasting JJ JJ O
5-10minutes JJ JJ O
where WRB WRB O
patient NN NN O
would MD MD O
become VB VB O
non NN NN O
communicative NN NN O
, , , O
associated VBN VBN O
with IN IN O
elevated VBD VBD O
glucose NN NN O
. . . O
   
PMH NNP NNP O
: : : O
   
1 CD CD O
. . . O
Insulin NNP NNP O
dependent JJ JJ O
DM NNP NNP O
, , , O
diagnosed JJ JJ O
age NN NN O
   
12 CD CD I-AGE
. . . O
Was VBD VBD O
followed VBN VBN O
at IN IN O
Cottage NNP NNP I-HOSPITAL
Sanatorium NNP NNP I-HOSPITAL
but CC CC O
has VBZ VBZ O
not RB RB O
had VBN VBN O
PCP NNP NNP O
or CC CC O
regular JJ JJ O
care NN NN O
for IN IN O
some DT DT O
time NN NN O
. . . O
   
Medications NNP NNP O
On IN IN O
Admission NNP NNP O
: : : O
   
1 CD CD O
. . . O
Labetolol NNP NNP O
20mg CD CD O
IV NNP NNP O
q1hr NN NN O
PRN NNP NNP O
MAP>120 NNP NNP O
   
2 CD CD O
. . . O
Ativan NNP NNP O
1-2mg JJ JJ O
IV NNP NNP O
q1h NN NN O
PRN NNP NNP O
   
3 CD CD O
. . . O
Insulin NNP NNP O
gtt NN NN O
( ( ( O
currently RB RB O
4u/hr) CD CD O
   
4 CD CD O
. . . O
Clindamycin NNP NNP O
600mg CD CD O
IV NNP NNP O
q6h NN NN O
for IN IN O
aspiration NN NN O
pneumonitis NN NN O
   
5 CD CD O
. . . O
Pepcid NNP NNP O
20mg CD CD O
IV NNP NNP O
QD NNP NNP O
   
6 CD CD O
. . . O
Dilantin NNP NNP O
100mg CD CD O
IV NNP NNP O
q8h NN NN O
   
7 CD CD O
. . . O
IV NNP NNP O
NTG NNP NNP O
5mcg/min CD CD O
during IN IN O
transfer NN NN O
Allergies NNP NNP O
: : : O
NKDA NNP NNP O
per IN IN O
OSH NNP NNP O
Soc NNP NNP O
Hx NNP NNP O
: : : O
Lives NNS NNS O
with IN IN O
Mother NNP NNP O
in IN IN O
Waycross NNP NNP I-CITY
, , , O
and CC CC O
works VBZ VBZ O
in IN IN O
a DT DT O
store NN NN O
( ( ( O
unclear JJ JJ O
type NN NN O
) ) ) O
. . . O
   
He PRP PRP O
leaves VBZ VBZ O
home NN NN O
for IN IN O
He PRP PRP O
does VBZ VBZ O
not RB RB O
smoke VB VB O
, , , O
but CC CC O
does VBZ VBZ O
have VB VB O
drinking NN NN O
binges NNS NNS O
reported VBN VBN O
by IN IN O
his PRP$ PRP$ O
mother NN NN O
when WRB WRB O
he PRP PRP O
associates VBZ VBZ O
with IN IN O
several JJ JJ O
groups NNS NNS O
of IN IN O
friends NNS NNS O
. . . O
   
Mother NNP NNP O
is VBZ VBZ O
not RB RB O
aware JJ JJ O
of IN IN O
drug NN NN O
use NN NN O
, , , O
but CC CC O
also RB RB O
cannot NN NN O
rule NN NN O
it PRP PRP O
out RP RP O
. . . O
   
FH NNP NNP O
: : : O
HTN NNP NNP O
mother NN NN O
and CC CC O
father NN NN O
Exam NNP NNP O
: : : O
VS NNP NNP O
: : : O
T NN NN O
99 CD CD O
HR NNP NNP O
92 CD CD O
BP NNP NNP O
182/80 CD CD O
RR NNP NNP O
20 CD CD O
O2sat NNP NNP O
95-98%FIO2 JJ JJ O
RA NNP NNP O
General NNP NNP O
: : : O
Responds NNP NNP O
/ NN NN O
localizes NNS NNS O
pain NN NN O
, , , O
moving VBG VBG O
all DT DT O
extremities NNS NNS O
. . . O
   
HEENT NNP NNP O
: : : O
NCAT NNP NNP O
, , , O
pupils NNS NNS O
small JJ JJ O
but CC CC O
reactive JJ JJ O
, , , O
eyes NNS NNS O
conjugate JJ JJ O
Chest NN NN O
: : : O
CTA NNP NNP O
B NNP NNP O
CVS NNP NNP O
: : : O
S1 NNP NNP O
S2 NNP NNP O
+ NN NN O
S3 NNP NNP O
, , , O
no DT DT O
murmurs NNS NNS O
. . . O
   
Abd NNP NNP O
: : : O
+ NN NN O
BS NNP NNP O
, , , O
soft JJ JJ O
, , , O
non-tender NN NN O
, , , O
non-distended JJ JJ O
. . . O
   
Subcutaneous NNP NNP O
indurated JJ JJ O
tissue NN NN O
mid NN NN O
Left NNP NNP O
upper JJ JJ O
abdomen NN NN O
, , , O
4x5cm CD CD O
. . . O
   
Extr NNP NNP O
: : : O
Normal JJ JJ O
bulk/tone NN NN O
. . . O
   
Multiple NNP NNP O
round VBP VBP O
dark JJ JJ O
lesions NNS NNS O
right JJ JJ O
arm NN NN O
; : : O
   
indurated VBN VBN O
3x4cm CD CD O
subcutaneous JJ JJ O
areas NNS NNS O
on IN IN O
bilateral NN NN O
thighs NNS NNS O
anteriorly RB RB O
. . . O
   
No DT DT O
edema NN NN O
BLE NNP NNP O
; : : O
   
2+DP. CD CD O
   
DATA NNP NNP O
( ( ( O
08/25/61 CD CD I-DATE
) ) ) O
: : : O
Unspecified NNP NNP O
pH NN NN O
7.42 CD CD O
( ( ( O
7.32-7.45 NN NN O
) ) ) O
Unspecified NNP NNP O
PCO2 NNP NNP O
35 CD CD O
( ( ( O
35-50 NN NN O
) ) ) O
mm/Hg NN NN O
Unspecified NNP NNP O
PO2 NNP NNP O
74 CD CD O
( ( ( O
40-90 JJ JJ O
) ) ) O
mm/Hg NN NN O
WBC NNP NNP O
22.6 CD CD O
H NNP NNP O
( ( ( O
4.5-11.0 JJ JJ O
) ) ) O
th/cmm NN NN O
HCT NNP NNP O
42.1 CD CD O
( ( ( O
41.0-53.0 JJ JJ O
) ) ) O
% NN NN O
HGB NNP NNP O
14.0 CD CD O
( ( ( O
13.5-17.5 NN NN O
) ) ) O
gm/dl NN NN O
RBC NNP NNP O
5.03 CD CD O
( ( ( O
4.50-5.90 JJ JJ O
) ) ) O
mil/cmm NN NN O
PLT NNP NNP O
677 CD CD O
H NNP NNP O
( ( ( O
150-350 JJ JJ O
) ) ) O
th/cumm NN NN O
MCV NNP NNP O
84 CD CD O
( ( ( O
80-100 NNP NNP O
) ) ) O
fl NN NN O
MCH NNP NNP O
27.8 CD CD O
( ( ( O
26.0-34.0 JJ JJ O
) ) ) O
pg/rbc NN NN O
MCHC NNP NNP O
33.3 CD CD O
( ( ( O
31.0-37.0 NN NN O
) ) ) O
g/dl NN NN O
RDW NNP NNP O
12.2 CD CD O
( ( ( O
11.5-14.5 NN NN O
) ) ) O
% NN NN O
PT NNP NNP O
13.4 CD CD O
H NNP NNP O
( ( ( O
11.3-13.3 JJ JJ O
) ) ) O
sec NN NN O
APTT NNP NNP O
26.1 CD CD O
( ( ( O
22.1-35.1 JJ JJ O
) ) ) O
sec NN NN O
Poly NNP NNP O
82 CD CD O
H NNP NNP O
( ( ( O
40-70 JJ JJ O
) ) ) O
% NN NN O
Lymphs NNP NNP O
10 CD CD O
L NNP NNP O
( ( ( O
22-44 JJ JJ O
) ) ) O
% NN NN O
Monos NNP NNP O
7 CD CD O
( ( ( O
4-11 JJ JJ O
) ) ) O
% NN NN O
EOS NNP NNP O
1 CD CD O
( ( ( O
0-8 NN NN O
) ) ) O
% NN NN O
Basos NNP NNP O
0 CD CD O
( ( ( O
0-3 NN NN O
) ) ) O
% NN NN O
Absolute NNP NNP O
Neuts NNP NNP O
18.54 CD CD O
H NNP NNP O
( ( ( O
1.8-7.7 JJ JJ O
) ) ) O
th/cmm NN NN O
Absolute NNP NNP O
Lymphs NNP NNP O
2.31 CD CD O
( ( ( O
1.0-4.8 JJ JJ O
) ) ) O
th/cmm NN NN O
Absolute NNP NNP O
Monos NNP NNP O
1.56 CD CD O
H NNP NNP O
( ( ( O
0.2-0.4 NN NN O
) ) ) O
th/cmm NN NN O
Absolute NNP NNP O
EOS NNP NNP O
0.12 CD CD O
( ( ( O
0.1-0.3 NN NN O
) ) ) O
th/cmm NN NN O
Absolute NNP NNP O
Basos NNP NNP O
0.07 CD CD O
( ( ( O
0.0-0.3 NN NN O
) ) ) O
th/cmm NN NN O
Aniso NNP NNP O
None NN NN O
( ( ( O
NORMAL NNP NNP O
) ) ) O
Hypo NNP NNP O
None NN NN O
( ( ( O
NORMAL NNP NNP O
) ) ) O
Macrocytes NNP NNP O
None NN NN O
Microcytes NNP NNP O
None NN NN O
Sodium NNP NNP O
( ( ( O
Stat NNP NNP O
Lab NNP NNP O
) ) ) O
145 CD CD O
( ( ( O
135-145 NN NN O
) ) ) O
mmol/L NN NN O
Potassium NNP NNP O
( ( ( O
Stat NNP NNP O
Lab NNP NNP O
) ) ) O
3.2 CD CD O
L NNP NNP O
( ( ( O
3.4-4.8 JJ JJ O
) ) ) O
mmol/L NN NN O
Chloride NNP NNP O
( ( ( O
Stat NNP NNP O
Lab NNP NNP O
) ) ) O
117 CD CD O
H NNP NNP O
( ( ( O
100-108 JJ JJ O
) ) ) O
mmol/L NN NN O
CO2 NNP NNP O
( ( ( O
Stat NNP NNP O
Lab NNP NNP O
) ) ) O
25.5 CD CD O
( ( ( O
23.0-31.9 JJ JJ O
) ) ) O
mmol/L NN NN O
BUN NNP NNP O
( ( ( O
Stat NNP NNP O
Lab NNP NNP O
) ) ) O
21 CD CD O
( ( ( O
8-25 JJ JJ O
) ) ) O
mg/dl NN NN O
Creatinine NNP NNP O
( ( ( O
Stat NNP NNP O
Lab NNP NNP O
) ) ) O
2.5 CD CD O
H NNP NNP O
( ( ( O
0.6-1.5 NN NN O
) ) ) O
mg/dl NN NN O
Glucose NNP NNP O
( ( ( O
Stat NNP NNP O
Lab NNP NNP O
) ) ) O
233 CD CD O
H NNP NNP O
( ( ( O
70-110 NN NN O
) ) ) O
mg/dl NN NN O
Calcium NNP NNP O
8.9 CD CD O
( ( ( O
8.5-10.5 NNP NNP O
) ) ) O
mg/dl NN NN O
Phosphorus NNP NNP O
1.8 CD CD O
L NNP NNP O
( ( ( O
2.6-4.5 JJ JJ O
) ) ) O
mg/dl NN NN O
Plasma NNP NNP O
Lactic NNP NNP O
Acid NNP NNP O
2.5 CD CD O
H NNP NNP O
( ( ( O
0.5-2.2 NN NN O
) ) ) O
mmol/L NN NN O
Magnesium NNP NNP O
2.1 CD CD O
H NNP NNP O
( ( ( O
1.4-2.0 JJ JJ O
) ) ) O
meq/L NN NN O
Total NNP NNP O
Protein NNP NNP O
7.0 CD CD O
( ( ( O
6.0-8.3 NN NN O
) ) ) O
g/dl NN NN O
Albumin NNP NNP O
2.7 CD CD O
L NNP NNP O
( ( ( O
3.3-5.0 JJ JJ O
) ) ) O
g/dl NN NN O
Globulin NNP NNP O
4.3 CD CD O
H NNP NNP O
( ( ( O
2.6-4.1 JJ JJ O
) ) ) O
g/dl NN NN O
Direct NNP NNP O
Bilirubin NNP NNP O
0.2 CD CD O
( ( ( O
0-0.4 NN NN O
) ) ) O
mg/dl NN NN O
Total NNP NNP O
Bilirubin NNP NNP O
1.1 CD CD O
H NNP NNP O
( ( ( O
0.0-1.0 NN NN O
) ) ) O
mg/dl NN NN O
Triglycerides NNP NNP O
118 CD CD O
( ( ( O
40-150 JJ JJ O
) ) ) O
mg/dl NN NN O
Cholesterol NNP NNP O
307 CD CD O
mg/dl NN NN O
High NNP NNP O
Density NNP NNP O
Lipoprotein NNP NNP O
85 CD CD O
( ( ( O
35-100 NN NN O
) ) ) O
mg/dl NN NN O
Alkaline NNP NNP O
Phosphatase NNP NNP O
81 CD CD O
( ( ( O
45-115 NNP NNP O
) ) ) O
U/L NNP NNP O
Transaminase-SGPT NNP NNP O
27 CD CD I-AGE
( ( ( O
10-55 NN NN O
) ) ) O
U/L NNP NNP O
Amylase NNP NNP O
222 CD CD O
H NNP NNP O
( ( ( O
3-100 NN NN O
) ) ) O
units/L NN NN O
Lipase NN NN O
1.4 CD CD O
( ( ( O
1.3-6.0 NN NN O
) ) ) O
U/dl NNP NNP O
Creatine NNP NNP O
Kinase NNP NNP O
Isoenzymes NNP NNP O
6.0 CD CD O
( ( ( O
0.0-6.9 NN NN O
) ) ) O
ng/ml NN NN O
CPK NNP NNP O
Isoenzymes NNP NNP O
Index NNP NNP O
0.1 CD CD O
( ( ( O
0.0-3.5 NN NN O
) ) ) O
% NN NN O
Troponin-T NNP NNP O
0.04 CD CD O
( ( ( O
0.00-0.09 NN NN O
) ) ) O
ng/ml NN NN O
Transaminase-SGOT NNP NNP O
81 CD CD O
H NNP NNP O
( ( ( O
10-40 JJ JJ O
) ) ) O
U/L NNP NNP O
Creatine NNP NNP O
Kinase NNP NNP O
7511 CD CD O
H NNP NNP O
( ( ( O
60-400 JJ JJ O
) ) ) O
U/L NNP NNP O
Phenytoin NNP NNP O
( ( ( O
Dilantin NNP NNP O
) ) ) O
9.1 CD CD O
( ( ( O
5.0-20.0 NNP NNP O
) ) ) O
mcg/ml NN NN O
UA-Color NNP NNP O
AMBER NNP NNP O
( ( ( O
YELLOW NNP NNP O
) ) ) O
UA-Turbidity NNP NNP O
TURBID NNP NNP O
( ( ( O
CLEAR NNP NNP O
) ) ) O
UA-Glucose NNP NNP O
3 CD CD O
+ NN NN O
( ( ( O
NEG NNP NNP O
) ) ) O
UA-Bili NNP NNP O
NEGATIVE NNP NNP O
( ( ( O
NEG NNP NNP O
) ) ) O
UA-Ketones NNP NNP O
Trace NNP NNP O
( ( ( O
NEG NNP NNP O
) ) ) O
UA-Specific NNP NNP O
Gravity NNP NNP O
1.027 CD CD O
( ( ( O
1.001-1.035 NN NN O
) ) ) O
UA-Occult NNP NNP O
Blood NNP NNP O
3 CD CD O
+ NN NN O
( ( ( O
NEG NNP NNP O
) ) ) O
UA-pH NNP NNP O
6.0 CD CD O
( ( ( O
5.0-9.0 NNP NNP O
) ) ) O
UA-Albumin NNP NNP O
3 CD CD O
+ NN NN O
( ( ( O
NEG NNP NNP O
) ) ) O
UA-Urobilinogen NNP NNP O
NEGATIVE NNP NNP O
( ( ( O
NEG NNP NNP O
) ) ) O
UA-Nitrite NNP NNP O
NEGATIVE NNP NNP O
( ( ( O
NEG NNP NNP O
) ) ) O
UA-WBC NNP NNP O
Screen NNP NNP O
Trace NNP NNP O
( ( ( O
NEG NNP NNP O
) ) ) O
UA-SED-RBC NNP NNP O
PACKED NNP NNP O
( ( ( O
0-2 NN NN O
) ) ) O
/ NN NN O
hpf NN NN O
UA-SED-WBC NNP NNP O
50-100 JJ JJ O
( ( ( O
0-2 NN NN O
) ) ) O
/ NN NN O
hpf NN NN O
UA-SED-Bacteria NNP NNP O
Moderate NNP NNP O
( ( ( O
NEG NNP NNP O
) ) ) O
/ NN NN O
hpf NN NN O
Hyaline NNP NNP O
Cast NNP NNP O
0-2 NN NN O
( ( ( O
0-5 NN NN O
) ) ) O
/ NN NN O
lpf NN NN O
Squamous NNP NNP O
Cells NNS NNS O
Many JJ JJ O
( ( ( O
NEG NNP NNP O
) ) ) O
/ NN NN O
hpf NN NN O
Uric NNP NNP O
Acid NNP NNP O
Crystals NNP NNP O
Many JJ JJ O
( ( ( O
NEG NNP NNP O
) ) ) O
/ NN NN O
hpf NN NN O
Microscopic NNP NNP O
Sediment NNP NNP O
Completed NNP NNP O
EKG NNP NNP O
: : : O
NSR NNP NNP O
, , , O
borderline NN NN O
LVH NNP NNP O
CXR NNP NNP O
: : : O
perihilar NN NN O
opacities NNS NNS O
, , , O
o/w NN NN O
clear JJ JJ O
. . . O
   
Assessment NNP NNP O
and CC CC O
Plan NNP NNP O
: : : O
27yo CD CD O
h/o NN NN O
insulin NN NN O
dependent NN NN O
DM NNP NNP O
, , , O
not RB RB O
medically RB RB O
followed VBN VBN O
, , , O
p/w NN NN O
witnessed VBN VBN O
seizure NN NN O
episode NN NN O
in IN IN O
context NN NN O
of IN IN O
severe JJ JJ O
hypertension NN NN O
. . . O
   
1 CD CD O
. . . O
Neuro NNP NNP O
- : : O
seizure NN NN O
episode NN NN O
/ NN NN O
unresponsiveness NN NN O
with IN IN O
non NN NN O
localizing VBG VBG O
neuro NN NN O
exam NN NN O
. . . O
   
Concern NNP NNP O
for IN IN O
hypertensive JJ JJ O
encephalopathy NN NN O
. . . O
   
Pt NNP NNP O
had VBD VBD O
LP NNP NNP O
at IN IN O
outside IN IN O
hospital NN NN O
which WDT WDT O
did VBD VBD O
not RB RB O
suggest VB VB O
meningitis NNS NNS O
. . . O
   
Other JJ JJ O
possibilities NNS NNS O
include VBP VBP O
infarct NN NN O
, , , O
encephalitis NNS NNS O
. . . O
   
Neurology NNP NNP O
consulted VBD VBD O
, , , O
with IN IN O
recommendations NNS NNS O
for IN IN O
: : : O
n NN NN O
EEG NNP NNP O
n NN NN O
MRI NNP NNP O
w NN NN O
/ NN NN O
susceptibility NN NN O
to TO TO O
evaluate VB VB O
for IN IN O
posterior NN NN O
leukoencephalopathy NN NN O
, , , O
MRA NNP NNP O
head/neck NN NN O
, , , O
MRV NNP NNP O
brain NN NN O
n NN NN O
Dilantin NNP NNP O
( ( ( O
continued VBD VBD O
from IN IN O
OSH NNP NNP O
) ) ) O
n NN NN O
Check NN NN O
tox NN NN O
screen NN NN O
, , , O
ammonia NN NN O
. . . O
   
Mother NNP NNP O
has VBZ VBZ O
brought VBN VBN O
in IN IN O
some DT DT O
unknown JJ JJ O
pills NNS NNS O
which WDT WDT O
we PRP PRP O
will MD MD O
try VB VB O
to TO TO O
identify VB VB O
. . . O
   
2 CD CD O
. . . O
ID NNP NNP O
- : : O
increased VBN VBN O
WBC NNP NNP O
, , , O
low JJ JJ O
grade NN NN O
temp NN NN O
s/p NN NN O
LP NNP NNP O
. . . O
   
No DT DT O
bacterial JJ JJ O
source NN NN O
for IN IN O
now RB RB O
, , , O
but CC CC O
CXR NNP NNP O
with IN IN O
opacities NNS NNS O
suspicious JJ JJ O
for IN IN O
pneumonia NN NN O
. . . O
   
Will MD MD O
start VB VB O
Vancomycin NNP NNP O
and CC CC O
cefepime NN NN O
empirically RB RB O
, , , O
and CC CC O
narrow JJ JJ O
per IN IN O
culture NN NN O
results NNS NNS O
. . . O
   
Concern NNP NNP O
for IN IN O
encephalitis NNS NNS O
, , , O
as IN IN O
HSV NNP NNP O
can MD MD O
present VB VB O
w NN NN O
/ NN NN O
HTN NNP NNP O
and CC CC O
seizures NNS NNS O
. . . O
   
Will NNP NNP O
ask VB VB O
Linden NNP NNP I-HOSPITAL
Health NNP NNP I-HOSPITAL
to TO TO O
add VB VB O
HSV NNP NNP O
PCR NNP NNP O
to TO TO O
CSF NNP NNP O
taken VBN VBN O
from IN IN O
LP NNP NNP O
prior RB RB O
to TO TO O
transfer VB VB O
. . . O
   
Start NNP NNP O
Acyclovir NNP NNP O
empirically RB RB O
in IN IN O
interim NN NN O
. . . O
   
3 CD CD O
. . . O
Resp NNP NNP O
- : : O
s/p NN NN O
multiple JJ JJ O
attempted VBD VBD O
intubations NNS NNS O
at IN IN O
OSH NNP NNP O
, , , O
currently RB RB O
breathing VBG VBG O
adequately RB RB O
on IN IN O
RA NNP NNP O
, , , O
with IN IN O
audible JJ JJ O
obstructive JJ JJ O
physiology NN NN O
. . . O
   
Given VBN VBN O
need VBP VBP O
for IN IN O
MRI NNP NNP O
, , , O
may MD MD O
have VB VB O
to TO TO O
sedate VB VB O
and CC CC O
intubate JJ JJ O
. . . O
   
Will NNP NNP O
call VB VB O
anesthesia NN NN O
. . . O
   
Continue NNP NNP O
intubated VBD VBD O
until IN IN O
MS NNP NNP O
more JJR JJR O
alert NN NN O
, , , O
for IN IN O
airway DT DT O
protection NN NN O
. . . O
   
Will MD MD O
start VB VB O
ARDSnet NNP NNP O
for IN IN O
criteria NNS NNS O
meeting VBG VBG O
low JJ JJ O
PaO2/FIO2 NNP NNP O
ratio NN NN O
and CC CC O
bilateral JJ JJ O
pulmonary JJ JJ O
infiltrates NNS NNS O
. . . O
   
4 CD CD O
. . . O
CV NNP NNP O
- : : O
severe JJ JJ O
hypertension NN NN O
w NN NN O
/ NN NN O
evidence NN NN O
of IN IN O
potential JJ JJ O
end NN NN O
organ NN NN O
damage NN NN O
( ( ( O
kidney/brain/cardiac NN NN O
) ) ) O
. . . O
   
Will NNP NNP O
control VB VB O
BP NNP NNP O
w NN NN O
/ NN NN O
Nipride NNP NNP O
drip NN NN O
, , , O
with IN IN O
addition NN NN O
of IN IN O
labetalol NN NN O
for IN IN O
HR NNP NNP O
control NN NN O
. . . O
   
Target NNP NNP O
goal NN NN O
25 CD CD O
% NN NN O
decrease NN NN O
to TO TO O
SPB~160 NNP NNP O
today NN NN O
, , , O
and CC CC O
SBP NNP NNP O
120 CD CD O
the DT DT O
following VBG VBG O
day NN NN O
. . . O
   
Check NNP NNP O
CK/TPNs NNP NNP O
. . . O
   
Continue NNP NNP O
IVF NNP NNP O
for IN IN O
potential JJ JJ O
rhabdo NN NN O
. . . O
   
5 CD CD O
. . . O
Renal NNP NNP O
- : : O
Renal NNP NNP O
failure NN NN O
w NN NN O
/ NN NN O
Cr NNP NNP O
2.6 CD CD O
, , , O
unclear JJ JJ O
baseline NN NN O
. . . O
   
Suspect NNP NNP O
acute JJ JJ O
on IN IN O
chronic JJ JJ O
component NN NN O
given VBN VBN O
DM NNP NNP O
w NN NN O
/ NN NN O
poor JJ JJ O
follow-up JJ JJ O
. . . O
   
Will NNP NNP O
check VB VB O
Urine NNP NNP O
sediment NN NN O
, , , O
lytes NNS NNS O
to TO TO O
evaluate VB VB O
. . . O
   
Reading VBG VBG O
by IN IN O
me PRP PRP O
is VBZ VBZ O
+ NN NN O
hyaline/waxy NN NN O
casts NNS NNS O
but CC CC O
no DT DT O
WBC NNP NNP O
or CC CC O
RBC NNP NNP O
casts NNS NNS O
. . . O
   
Kidney NNP NNP O
U/S NNP NNP O
pending VBG VBG O
, , , O
also RB RB O
with IN IN O
Doppler NNP NNP O
to TO TO O
evaluate VB VB O
for IN IN O
RAS NNP NNP O
. . . O
   
Also RB RB O
check NN NN O
urine NN NN O
renin/aldo NN NN O
and CC CC O
24hr CD CD O
metanephrine NN NN O
for IN IN O
pheochromocytoma NN NN O
, , , O
serum NN NN O
metanephrine NN NN O
, , , O
and CC CC O
24hr CD CD O
protein NN NN O
for IN IN O
nephritic JJ JJ O
syndrome NN NN O
in IN IN O
presence NN NN O
of IN IN O
HTN NNP NNP O
and CC CC O
hematuria NN NN O
. . . O
   
6 CD CD O
. . . O
Endo NNP NNP O
- : : O
tight JJ JJ O
glucose NN NN O
control NN NN O
; : : O
   
CZI NNP NNP O
drip NN NN O
for IN IN O
DM NNP NNP O
. . . O
   
Has VBZ VBZ O
gap NN NN O
but CC CC O
No DT DT O
ketones NNS NNS O
at IN IN O
OSH NNP NNP O
; : : O
   
did VBD VBD O
not RB RB O
arrive VB VB O
in IN IN O
DKA NNP NNP O
. . . O
   
Will MD MD O
need VB VB O
reg NN NN O
insulin NN NN O
after IN IN O
drip NN NN O
DC NNP NNP O
'd POS POS O
in IN IN O
future JJ JJ O
. . . O
   
7 CD CD O
. . . O
Access NNP NNP O
- : : O
PIV NNP NNP O
   
8 CD CD O
. . . O
Prophylaxis NNP NNP O
- : : O
nexium NN NN O
, , , O
heparin NN NN O
SQ NNP NNP O
, , , O
peridex NN NN O
, , , O
HOB NNP NNP O
   
30 CD CD O
. . . O
Infant NNP NNP I-DOCTOR
Ledford NNP NNP I-DOCTOR
#12182 NN NN O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2080-05-04 JJ JJ I-DATE
Quin NNP NNP I-PATIENT
is VBZ VBZ O
a DT DT O
69 CD CD I-AGE
y/o NN NN O
male NN NN O
with IN IN O
: : : O
Problems NNS NNS O
Coronary JJ JJ O
artery NN NN O
disease NN NN O
: : : O
CABG NNP NNP O
x2 NN NN O
vessels NNS NNS O
, , , O
2/78 CD CD I-DATE
. . . O
   
Aortic NNP NNP O
stenosis NNS NNS O
: : : O
AVR NNP NNP O
2/78/Dr CD CD O
Bonilla NNP NNP I-DOCTOR
Diabetes NNP NNP O
mellitus NN NN O
: : : O
Dr NNP NNP O
Ayala-Skiff NNP NNP O
Atrial NNP NNP O
fibrillation NN NN O
Spinal NNP NNP O
stenosis NN NN O
: : : O
C3-4; NNP NNP O
   
C5-6; NNP NNP O
   
C7-T1 NNP NNP O
Medications NNP NNP O
Asa NNP NNP O
( ( ( O
ACETYLSALICYLIC NNP NNP O
ACID NNP NNP O
) ) ) O
81MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Furosemide NNP NNP O
40 CD CD O
MG NNP NNP O
( ( ( O
40MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Metformin NNP NNP O
500MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
2 CD CD O
am VBP VBP O
, , , O
1 CD CD O
pm NN NN O
, , , O
for IN IN O
blood NN NN O
sugar NN NN O
Lopressor NNP NNP O
( ( ( O
METOPROLOL NNP NNP O
TARTRATE NNP NNP O
) ) ) O
50MG CD CD O
TABLET NNP NNP O
PO NNP NNP O
TID NNP NNP O
Lisinopril NNP NNP O
5MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Digoxin NNP NNP O
125MCG CD CD O
TABLET NNP NNP O
PO NNP NNP O
QD NNP NNP O
Simvastatin NNP NNP O
5MG CD CD O
TABLET NNP NNP O
PO NNP NNP O
QHS NNP NNP O
Viagra NNP NNP O
( ( ( O
SILDENAFIL NNP NNP O
) ) ) O
25 CD CD O
MG-50 NNP NNP O
MG NNP NNP O
( ( ( O
50MG CD CD O
TABLET NNP NNP O
) ) ) O
PO NNP NNP O
x SYM SYM O
1 CD CD O
, , , O
Take NNP NNP O
1/2-1 JJ JJ O
tab NN NN O
as IN IN O
directed VBN VBN O
. . . O
   
Metrogel NNP NNP O
0.75 CD CD O
% NN NN O
( ( ( O
METRONIDAZOLE NNP NNP O
) ) ) O
1 CD CD O
APPLICATION NNP NNP O
TOP NNP NNP O
BID NNP NNP O
Warfarin NNP NNP O
SODIUM NNP NNP O
5 CD CD O
MG NNP NNP O
( ( ( O
5MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
) ) ) O
PO NNP NNP O
QPM NNP NNP O
, , , O
Takes VBZ VBZ O
total JJ JJ O
of IN IN O
6.5 CD CD O
mg NN NN O
QD NNP NNP O
. . . O
   
Warfarin NNP NNP O
SODIUM NNP NNP O
1.5 CD CD O
MG NNP NNP O
( ( ( O
1MG CD CD O
TABLET NNP NNP O
) ) ) O
PO NNP NNP O
QPM NNP NNP O
, , , O
Takes VBZ VBZ O
1.5MG CD CD O
along IN IN O
w NN NN O
/ NN NN O
5MG CD CD O
tab NN NN O
for IN IN O
total NN NN O
of IN IN O
6.5 CD CD O
mg NN NN O
daily JJ JJ O
. . . O
   
Alprazolam NNP NNP O
0.25 CD CD O
MG NNP NNP O
(0.5MG NNP NNP O
TABLET NNP NNP O
take NN NN O
0.5 CD CD O
) ) ) O
PO NNP NNP O
QHS NNP NNP O
PRN NNP NNP O
Allergies NNP NNP O
NKA NNP NNP O
He PRP PRP O
has VBZ VBZ O
some DT DT O
chronic JJ JJ O
complaints NNS NNS O
. . . O
   
Itchy NNP NNP O
throat NN NN O
and CC CC O
runny NN NN O
nose NN NN O
. . . O
   
No DT DT O
runny NN NN O
, , , O
ithcy JJ JJ O
eyes NNS NNS O
. . . O
   
Cor NNP NNP O
- : : O
No DT DT O
SOB NNP NNP O
with IN IN O
walking VBG VBG O
but CC CC O
with IN IN O
heavy JJ JJ O
lifting NN NN O
. . . O
   
No DT DT O
palpitations NNS NNS O
. . . O
   
No DT DT O
lighthead NN NN O
. . . O
   
No DT DT O
PND NNP NNP O
. . . O
   
No DT DT O
orthopnea NN NN O
. . . O
   
No DT DT O
claudication NN NN O
. . . O
   
No DT DT O
edema NN NN O
. . . O
   
No DT DT O
nausea NN NN O
Has VBZ VBZ O
had VBN VBN O
chest NN NN O
pain NN NN O
since IN IN O
heart NN NN O
surgery NN NN O
. . . O
   
Not RB RB O
related VBN VBN O
to TO TO O
activity NN NN O
. . . O
   
Always RB RB O
present JJ JJ O
. . . O
   
Has VBZ VBZ O
MIBI NNP NNP O
schedueld NN NN O
for IN IN O
5/80 CD CD I-DATE
. . . O
   
2 CD CD O
. . . O
DM NNP NNP O
- : : O
home NN NN O
gou NN NN O
120-150 NN NN O
. . . O
   
Followed NNP NNP O
at IN IN O
Skiff NNP NNP I-HOSPITAL
. . . O
   
Endocrine NNP NNP O
: : : O
No DT DT O
polydipsia NN NN O
, , , O
polyphagia NN NN O
, , , O
weight NN NN O
change NN NN O
, , , O
sweats,heat NN NN O
intolerance.Stable JJ JJ O
nocturia NN NN O
x3 NN NN O
. . . O
   
GI NNP NNP O
- : : O
No DT DT O
nausea NN NN O
. . . O
   
No DT DT O
vomitting VBG VBG O
. . . O
   
No DT DT O
dyspepsia NN NN O
. . . O
   
No DT DT O
reflux NN NN O
. . . O
   
No DT DT O
abdo NN NN O
pain NN NN O
. . . O
   
No DT DT O
diarrhea NN NN O
. . . O
   
No DT DT O
constipation NN NN O
. . . O
   
No DT DT O
melena NN NN O
. . . O
   
No DT DT O
BRBPR NNP NNP O
. . . O
   
3 CD CD O
. . . O
With IN IN O
persistent JJ JJ O
neck NN NN O
an DT DT O
dright NN NN O
shoulder NN NN O
pain NN NN O
. . . O
   
4 CD CD O
. . . O
Anxious NNP NNP O
. . . O
   
, , , O
Verys NNP NNP O
stressed/tensed VBD VBD O
. . . O
   
With IN IN O
depression.Memory NN NN O
is VBZ VBZ O
not RB RB O
as IN IN O
good JJ JJ O
. . . O
   
Alprazolam NNP NNP O
is VBZ VBZ O
very RB RB O
helpful JJ JJ O
. . . O
   
Flowsheets NNP NNP O
BLOOD NNP NNP O
PRESSURE NN NN O
102/70 CD CD O
PULSE NNP NNP O
76 CD CD O
WEIGHT NNP NNP O
203 CD CD O
lb NN NN O
WD,WN,NAD NNP NNP O
Neck NNP NNP O
- : : O
limited JJ JJ O
lateral NN NN O
movment NN NN O
. . . O
   
No DT DT O
JVD NNP NNP O
. . . O
   
No DT DT O
bruit NN NN O
. . . O
   
No DT DT O
LAN NNP NNP O
. . . O
   
No DT DT O
thyromegaly NN NN O
Shoulder NNP NNP O
- - - O
limted JJ JJ O
ROM NNP NNP O
right JJ JJ O
shoulder NN NN O
with IN IN O
pain NN NN O
. . . O
   
Pulm NNP NNP O
- : : O
NO DT DT O
accessory JJ JJ O
muscle NN NN O
use NN NN O
. . . O
   
Percussion NNP NNP O
- - - O
normal JJ JJ O
. . . O
   
Palpation-soreness NNP NNP O
anterior NN NN O
chest NN NN O
. . . O
   
Auscultation-clear NNP NNP O
. . . O
   
Cor NNP NNP O
- : : O
reg NN NN O
rhyhm NN NN O
. . . O
   
S1S2 NNP NNP O
normal JJ JJ O
. . . O
   
No DT DT O
gallop NN NN O
. . . O
   
No DT DT O
rub NN NN O
. . . O
   
NO DT DT O
murmer NN NN O
. . . O
   
Abdo NNP NNP O
- : : O
normal JJ JJ O
BS NNP NNP O
; : : O
   
soft JJ JJ O
with IN IN O
no DT DT O
HSM NNP NNP O
. . . O
   
No DT DT O
mass NN NN O
. . . O
   
No DT DT O
tenderness NN NN O
ASS NNP NNP O
: : : O
Frozen NNP NNP O
right NN NN O
shoulder NN NN O
. . . O
   
OA-neck NNP NNP O
and CC CC O
shoulder NN NN O
Anxiety/tension/depression NNP NNP O
P NN NN O
- : : O
ROM NNP NNP O
exercsies NNS NNS O
. . . O
   
Educ NNP NNP O
re NN NN O
: : : O
neck NN NN O
and CC CC O
shoulder NN NN O
. . . O
   
Discussed NNP NNP O
adaptation NN NN O
ot JJ JJ O
age NN NN O
change NN NN O
and CC CC O
health NN NN O
problems NNS NNS O
. . . O
   
For IN IN O
now RB RB O
, , , O
take VB VB O
alprazolam NN NN O
BID NNP NNP O
PRN NNP NNP O
since IN IN O
this DT DT O
seems VBZ VBZ O
to TO TO O
be VB VB O
helpful JJ JJ O
. . . O
   
More JJR JJR O
than IN IN O
50 CD CD O
% NN NN O
of IN IN O
25 CD CD O
min NN NN O
spent VBD VBD O
discussing VBG VBG O
this DT DT O
. . . O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2078-03-26 JJ JJ I-DATE
Grace NNP NNP I-HOSPITAL
Cottage NNP NNP I-HOSPITAL
Surgery NNP NNP O
Service NNP NNP O
Consult NNP NNP O
Note NNP NNP O
Patient NNP NNP O
: : : O
Vaughn NNP NNP I-PATIENT
, , , O
Frank NNP NNP I-PATIENT
MRN NNP NNP O
: : : O
6767510 CD CD I-MEDICALRECORD
Date NN NN O
: : : O
3/26/78 CD CD I-DATE
CC NNP NNP O
: : : O
Cellulitis NNP NNP O
of IN IN O
abdominal JJ JJ O
pannus NN NN O
HPI NNP NNP O
: : : O
Mr NNP NNP O
. . . O
Vaughn NNP NNP I-PATIENT
is VBZ VBZ O
a DT DT O
33 CD CD I-AGE
yo NN NN O
diabetic JJ JJ O
male NN NN O
with IN IN O
a DT DT O
history NN NN O
of IN IN O
Fournier&#8217; NNP NNP O
   
s VBZ VBZ O
gangrene NN NN O
s/p NN NN O
multiple JJ JJ O
debridements NNS NNS O
and CC CC O
diverting VBG VBG O
colostomy NN NN O
in IN IN O
January NNP NNP I-DATE
2077 CD CD I-DATE
who WP WP O
was VBD VBD O
recently RB RB O
admitted VBN VBN O
to TO TO O
the DT DT O
LH NNP NNP I-HOSPITAL
service NN NN O
3/15-3/16/78 NN NN O
for IN IN O
cellulitis NNS NNS O
of IN IN O
his PRP$ PRP$ O
abdominal JJ JJ O
pannus NN NN O
. . . O
   
He PRP PRP O
was VBD VBD O
discharged VBN VBN O
on IN IN O
Bactrim NNP NNP O
DS NNP NNP O
one CD CD O
tab NN NN O
QD NNP NNP O
but CC CC O
returns NNS NNS O
today NN NN O
complaining NN NN O
of IN IN O
fever NN NN O
to TO TO O
101.9 CD CD O
at IN IN O
home NN NN O
with IN IN O
chills NNS NNS O
and CC CC O
nausea NN NN O
but CC CC O
no DT DT O
vomiting VBG VBG O
. . . O
   
He PRP PRP O
states VBZ VBZ O
that IN IN O
his PRP$ PRP$ O
pannus NN NN O
has VBZ VBZ O
become VBN VBN O
more JJR JJR O
tender NN NN O
to TO TO O
touch VB VB O
and CC CC O
in IN IN O
particular JJ JJ O
, , , O
there EX EX O
has VBZ VBZ O
been VBN VBN O
some DT DT O
swelling VBG VBG O
of IN IN O
the DT DT O
left NN NN O
side NN NN O
. . . O
   
He PRP PRP O
has VBZ VBZ O
also RB RB O
noted VBN VBN O
high JJ JJ O
blood NN NN O
sugars NNS NNS O
( ( ( O
300s CD CD O
) ) ) O
over IN IN O
the DT DT O
past JJ JJ O
few JJ JJ O
days NNS NNS O
. . . O
   
He PRP PRP O
denies VBZ VBZ O
dysuria NN NN O
or CC CC O
any DT DT O
change NN NN O
in IN IN O
his PRP$ PRP$ O
ostomy NN NN O
output NN NN O
. . . O
   
PMH NNP NNP O
: : : O
HTN NNP NNP O
Hypercholesterolemia NNP NNP O
DM NNP NNP O
II NNP NNP O
Fournier NNP NNP O
's POS POS O
gangrene NN NN O
s/p NN NN O
multiple JJ JJ O
debridements NNS NNS O
and CC CC O
diverting VBG VBG O
colostomy NN NN O
1/76 CD CD I-DATE
PSH NNP NNP O
: : : O
Open NNP NNP O
diverting VBG VBG O
sigmoid NN NN O
colostomy NN NN O
, , , O
irrigation NN NN O
and CC CC O
debridement NN NN O
of IN IN O
perineum NN NN O
2/6/77 CD CD I-DATE
Multiple NNP NNP O
debridements NNS NNS O
and CC CC O
EUA NNP NNP O
's POS POS O
related VBN VBN O
to TO TO O
Fournier NNP NNP O
's POS POS O
gangrene NN NN O
Medications NNP NNP O
: : : O
Insulin NNP NNP O
Glargine NNP NNP O
( ( ( O
Lantus NNP NNP O
) ) ) O
60 CD CD O
U NNP NNP O
SC NNP NNP O
QHS NNP NNP O
Simvastatin NNP NNP O
40 CD CD O
MG NNP NNP O
PO NNP NNP O
QD NNP NNP O
Metoprolol NNP NNP O
Succinate NNP NNP O
Extended NNP NNP O
Release NNP NNP O
( ( ( O
Toprol NNP NNP O
Xl NNP NNP O
) ) ) O
100 CD CD O
MG NNP NNP O
PO NNP NNP O
QD NNP NNP O
Nystatin NNP NNP O
Powder NNP NNP O
1 CD CD O
APPLICATION NNP NNP O
TOP NNP NNP O
TID NNP NNP O
Trimethoprim/sulfamethoxazole NNP NNP O
Double NNP NNP O
Strength NNP NNP O
( ( ( O
Bactrim NNP NNP O
Ds NNP NNP O
) ) ) O
1 CD CD O
TAB NNP NNP O
PO NNP NNP O
BID NNP NNP O
Oxycodone NNP NNP O
10 CD CD O
MG NNP NNP O
PO NNP NNP O
Q6H NNP NNP O
prn NN NN O
Allergies NNP NNP O
: : : O
HYDROCHLOROTHIAZIDE NNP NNP O
( ( ( O
Hyponatremia NNP NNP O
) ) ) O
IOPAMIDOL NNP NNP O
76 CD CD O
% NN NN O
( ( ( O
SOB NNP NNP O
) ) ) O
IV NNP NNP O
Contrast NN NN O
   
( ( ( O
rash NN NN O
) ) ) O
SH NNP NNP O
: : : O
Tob NNP NNP O
: : : O
denies NNS NNS O
EtOH NNP NNP O
: : : O
occasional JJ JJ O
Electroencephalographic NNP NNP I-PROFESSION
Technologist NNP NNP I-PROFESSION
, , , O
lives NNS NNS O
w NN NN O
/ NN NN O
mother NN NN O
PE NNP NNP O
: : : O
T NN NN O
95.7 CD CD O
, , , O
P NN NN O
83 CD CD O
, , , O
186/100 CD CD O
, , , O
RR NNP NNP O
18 CD CD O
, , , O
100 CD CD O
% NN NN O
on IN IN O
RA NNP NNP O
Gen NNP NNP O
: : : O
Obese NN NN O
male NN NN O
in IN IN O
NAD NNP NNP O
CV NNP NNP O
: : : O
RRR NNP NNP O
Pulm NNP NNP O
: : : O
CTAB NNP NNP O
Abd NNP NNP O
: : : O
Obese NN NN O
, , , O
large JJ JJ O
pannus NN NN O
with IN IN O
macerated JJ JJ O
skin NN NN O
in IN IN O
folds NNS NNS O
. . . O
   
Area NNP NNP O
of IN IN O
induration NN NN O
, , , O
erythema NN NN O
, , , O
and CC CC O
tenderness NN NN O
on IN IN O
left VBD VBD O
side NN NN O
, , , O
small JJ JJ O
area NN NN O
of IN IN O
fluctuance NN NN O
, , , O
pannus CC CC O
warm JJ JJ O
to TO TO O
touch VB VB O
. . . O
   
Abdomen NNP NNP O
otherwise RB RB O
soft JJ JJ O
, , , O
non-tender NN NN O
to TO TO O
palpation NN NN O
. . . O
   
Labs NNP NNP O
on IN IN O
admission NN NN O
: : : O
Test NNP NNP O
Description NNP NNP O
Result NNP NNP O
Flags NNP NNP O
Ref NNP NNP O
. . . O
   
Range NNP NNP O
Units NNP NNP O
WBC NNP NNP O
9.0 CD CD O
( ( ( O
4.5-11.0 JJ JJ O
) ) ) O
th/cmm NN NN O
HCT NNP NNP O
35.5 CD CD O
L NNP NNP O
( ( ( O
41.0-53.0 JJ JJ O
) ) ) O
% NN NN O
HGB NNP NNP O
13.3 CD CD O
L NNP NNP O
( ( ( O
13.5-17.5 JJ JJ O
) ) ) O
gm/dl NN NN O
RBC NNP NNP O
4.39 CD CD O
L NNP NNP O
( ( ( O
4.50-5.90 JJ JJ O
) ) ) O
mil/cmm NN NN O
PLT NNP NNP O
299 CD CD O
( ( ( O
150-400 NN NN O
) ) ) O
th/cumm NN NN O
MCV NNP NNP O
81 CD CD O
( ( ( O
80-100 NNP NNP O
) ) ) O
fl NN NN O
MCH NNP NNP O
30.4 CD CD O
( ( ( O
26.0-34.0 JJ JJ O
) ) ) O
pg/rbc NN NN O
MCHC NNP NNP O
37.5 CD CD O
H NNP NNP O
( ( ( O
31.0-37.0 NN NN O
) ) ) O
g/dl NN NN O
RDW NNP NNP O
14.6 CD CD O
H NNP NNP O
( ( ( O
11.5-14.5 JJ JJ O
) ) ) O
% NN NN O
Superstat NNP NNP O
PT NNP NNP O
12.2 CD CD O
( ( ( O
10.3-13.2 NN NN O
) ) ) O
sec NN NN O
Icteric NNP NNP O
Superstat NNP NNP O
PT-INR NNP NNP O
1.1 CD CD O
Icteric NNP NNP O
DIFFERENTIAL NNP NNP O
REQUEST NNP NNP O
RECEIVED NNP NNP O
Diff NNP NNP O
Method NNP NNP O
See VB VB O
Result NNP NNP O
Below NNP NNP O
Result NNP NNP O
: : : O
Automated NNP NNP O
with IN IN O
manual JJ JJ O
review NN NN O
Poly NNP NNP O
79 CD CD O
H NNP NNP O
( ( ( O
40-70 JJ JJ O
) ) ) O
% NN NN O
Lymphs NNP NNP O
16 CD CD O
L NNP NNP O
( ( ( O
22-44 JJ JJ O
) ) ) O
% NN NN O
Monos NNP NNP O
4 CD CD O
( ( ( O
4-11 JJ JJ O
) ) ) O
% NN NN O
EOS NNP NNP O
1 CD CD O
( ( ( O
0-8 NN NN O
) ) ) O
% NN NN O
Basos NNP NNP O
0 CD CD O
( ( ( O
0-3 NN NN O
) ) ) O
% NN NN O
Plasma NNP NNP O
Sodium NNP NNP O
131 CD CD O
L NNP NNP O
( ( ( O
135-145 JJ JJ O
) ) ) O
mmol/L NN NN O
Plasma NNP NNP O
Potassium NNP NNP O
3.9 CD CD O
( ( ( O
3.4-4.8 NN NN O
) ) ) O
mmol/L NN NN O
SLIGHTLY RB RB O
HEMOLYZED NNP NNP O
Plasma NNP NNP O
Chloride NNP NNP O
95 CD CD O
L NNP NNP O
( ( ( O
100-108 JJ JJ O
) ) ) O
mmol/L NN NN O
Plasma NNP NNP O
Carbon NNP NNP O
Dioxide NNP NNP O
22.0 CD CD O
L NNP NNP O
( ( ( O
23.0-31.9 JJ JJ O
) ) ) O
mmol/L NN NN O
Plasma NNP NNP O
Anion NNP NNP O
GAP NNP NNP O
14 CD CD O
( ( ( O
3-15 NN NN O
) ) ) O
mmol/L NN NN O
Plasma NNP NNP O
Urea NNP NNP O
Nitrogen NNP NNP O
9 CD CD O
( ( ( O
8-25 JJ JJ O
) ) ) O
mg/dl NN NN O
Plasma NNP NNP O
Creatinine NNP NNP O
0.74 CD CD O
( ( ( O
0.60-1.50 NN NN O
) ) ) O
mg/dl NN NN O
eGFR NN NN O
& CC CC O
gt NN NN O
; : : O
   
60 CD CD O
mL/min/1.73m2 NN NN O
Plasma NNP NNP O
Glucose NNP NNP O
236 CD CD O
H NNP NNP O
( ( ( O
70-110 NN NN O
) ) ) O
mg/dl NN NN O
Calcium NNP NNP O
9.2 CD CD O
( ( ( O
8.5-10.5 NNP NNP O
) ) ) O
mg/dl NN NN O
Phosphorus NNP NNP O
2.8 CD CD O
( ( ( O
2.6-4.5 NN NN O
) ) ) O
mg/dl NN NN O
Magnesium NNP NNP O
1.5 CD CD O
( ( ( O
1.4-2.0 NN NN O
) ) ) O
meq/L NN NN O
Total NNP NNP O
Protein NNP NNP O
6.8 CD CD O
( ( ( O
6.0-8.3 NN NN O
) ) ) O
g/dl NN NN O
Albumin NNP NNP O
3.8 CD CD O
( ( ( O
3.3-5.0 NN NN O
) ) ) O
g/dl NN NN O
Globulin NNP NNP O
3.0 CD CD O
( ( ( O
2.6-4.1 JJ JJ O
) ) ) O
g/dl NN NN O
Direct NNP NNP O
Bilirubin NNP NNP O
0.1 CD CD O
( ( ( O
0-0.4 NN NN O
) ) ) O
mg/dl NN NN O
Total NNP NNP O
Bilirubin NNP NNP O
0.5 CD CD O
( ( ( O
0.0-1.0 NN NN O
) ) ) O
mg/dl NN NN O
Alkaline NNP NNP O
Phosphatase NNP NNP O
100 CD CD O
( ( ( O
45-115 NNP NNP O
) ) ) O
U/L NNP NNP O
Transaminase-SGPT NNP NNP O
32 CD CD O
( ( ( O
10-55 NN NN O
) ) ) O
U/L NNP NNP O
Transaminase-SGOT NNP NNP O
21 CD CD O
( ( ( O
10-40 NN NN O
) ) ) O
U/L NNP NNP O
Plasma NNP NNP O
Lactic NNP NNP O
Acid NNP NNP O
2.5 CD CD O
H NNP NNP O
( ( ( O
0.5-2.2 NN NN O
) ) ) O
mmol/L NN NN O
Micro NNP NNP O
: : : O
Blood NNP NNP O
culture NN NN O
pending VBG VBG O
Urine NNP NNP O
culture NN NN O
pending VBG VBG O
Abdominal NNP NNP O
wound NN NN O
cx NN NN O
pending VBG VBG O
Studies NNPS NNPS O
: : : O
CXR NNP NNP O
: : : O
Lung NNP NNP O
fields NNS NNS O
clear JJ JJ O
, , , O
no DT DT O
evidence NN NN O
of IN IN O
pneumonia NN NN O
. . . O
   
CT NNP NNP O
abd/pelvis:There NN NN O
is VBZ VBZ O
mild JJ JJ O
inflammatory JJ JJ O
fat JJ JJ O
stranding NN NN O
, , , O
heterogeneity NN NN O
, , , O
and CC CC O
slightly RB RB O
increased VBN VBN O
vascularity NN NN O
involving VBG VBG O
the DT DT O
anterior NN NN O
abdominal JJ JJ O
wall NN NN O
, , , O
extending VBG VBG O
in IN IN O
to TO TO O
the DT DT O
scrotum NN NN O
without IN IN O
evidence NN NN O
of IN IN O
drainable JJ JJ O
fluid JJ JJ O
collection NN NN O
or CC CC O
air NN NN O
pockets NNS NNS O
. . . O
   
Mild NNP NNP O
induration NN NN O
and CC CC O
thickening NN NN O
of IN IN O
the DT DT O
overlying VBG VBG O
skin NN NN O
of IN IN O
the DT DT O
abdominal JJ JJ O
wall NN NN O
is VBZ VBZ O
also RB RB O
noted VBN VBN O
. . . O
   
Stable JJ JJ O
postsurgical JJ JJ O
scar NN NN O
in IN IN O
the DT DT O
right JJ JJ O
anterior NN NN O
abdominal JJ JJ O
wall NN NN O
. . . O
   
Surgical NNP NNP O
sutures NNS NNS O
in IN IN O
the DT DT O
anterior NN NN O
abdominal JJ JJ O
wall NN NN O
. . . O
   
There EX EX O
is VBZ VBZ O
a DT DT O
superficial JJ JJ O
soft JJ JJ O
tissue NN NN O
mass NN NN O
in IN IN O
the DT DT O
subcutaneous JJ JJ O
tissue NN NN O
of IN IN O
the DT DT O
left VBN VBN O
anterior NN NN O
abdominal JJ JJ O
wall NN NN O
, , , O
slightly RB RB O
larger JJR JJR O
on IN IN O
the DT DT O
current JJ JJ O
study NN NN O
measuring VBG VBG O
approximately RB RB O
3.3 CD CD O
cm NN NN O
. . . O
   
There EX EX O
are VBP VBP O
mild JJ JJ O
degenerative JJ JJ O
changes NNS NNS O
involving VBG VBG O
the DT DT O
thoracic NN NN O
and CC CC O
lumbar NN NN O
spine NN NN O
. . . O
   
Procedure NNP NNP O
note VB VB O
: : : O
The DT DT O
area NN NN O
of IN IN O
induration NN NN O
on IN IN O
the DT DT O
left NN NN O
side NN NN O
of IN IN O
the DT DT O
patient&#8217; NN NN O
   
s VBZ VBZ O
pannus NN NN O
was VBD VBD O
prepped VBN VBN O
with IN IN O
betadine NN NN O
. . . O
   
5cc CD CD O
of IN IN O
1 CD CD O
% NN NN O
lidocaine NN NN O
without IN IN O
epinephrine NN NN O
was VBD VBD O
infiltrated VBN VBN O
into IN IN O
the DT DT O
area NN NN O
. . . O
   
A DT DT O
2cm CD CD O
incision NN NN O
was VBD VBD O
made VBN VBN O
over IN IN O
the DT DT O
area NN NN O
of IN IN O
fluctuance NN NN O
and CC CC O
approximately RB RB O
8cc CD CD O
of IN IN O
purulent NN NN O
thick JJ JJ O
fluid NN NN O
was VBD VBD O
expressed VBN VBN O
. . . O
   
A DT DT O
culture NN NN O
of IN IN O
the DT DT O
abscess NN NN O
fluid NN NN O
was VBD VBD O
sent VBN VBN O
. . . O
   
The DT DT O
wound NN NN O
was VBD VBD O
probed VBN VBN O
gently RB RB O
to TO TO O
break VB VB O
up RP RP O
any DT DT O
loculations NNS NNS O
. . . O
   
The DT DT O
wound NN NN O
was VBD VBD O
then RB RB O
packed VBN VBN O
with IN IN O
& CC CC O
#188 NN NN O
; : : O
   
inch JJ JJ O
dry JJ JJ O
packing VBG VBG O
tape NN NN O
. . . O
   
A DT DT O
dry JJ JJ O
sterile JJ JJ O
dressing VBG VBG O
was VBD VBD O
applied VBN VBN O
. . . O
   
The DT DT O
patient NN NN O
tolerated VBD VBD O
the DT DT O
procedure NN NN O
well RB RB O
. . . O
   
Impression/Plan NNP NNP O
: : : O
33 CD CD I-AGE
year NN NN O
old JJ JJ O
diabetic JJ JJ O
male NN NN O
with IN IN O
history NN NN O
of IN IN O
Fournier&#8217; NNP NNP O
   
s VBZ VBZ O
gangrene NN NN O
s/p NN NN O
multiple JJ JJ O
debridements NNS NNS O
and CC CC O
diverting VBG VBG O
colostomy NN NN O
presents VBZ VBZ O
with IN IN O
recurrent JJ JJ O
cellulitis NNS NNS O
and CC CC O
abscess NNS NNS O
of IN IN O
the DT DT O
left VBN VBN O
side NN NN O
of IN IN O
his PRP$ PRP$ O
pannus NN NN O
. . . O
   
The DT DT O
abscess NN NN O
was VBD VBD O
drained VBN VBN O
and CC CC O
packed VBN VBN O
in IN IN O
the DT DT O
ED NNP NNP O
. . . O
   
The DT DT O
patient NN NN O
will MD MD O
be VB VB O
admitted VBN VBN O
for IN IN O
IV NNP NNP O
antibiotics NNS NNS O
and CC CC O
careful JJ JJ O
monitoring NN NN O
of IN IN O
his PRP$ PRP$ O
cellulitis NNS NNS O
. . . O
   
- : : O
Admit NNP NNP O
to TO TO O
Langmack NNP NNP I-HOSPITAL
Hospital NNP NNP I-HOSPITAL
Surgery NNP NNP O
, , , O
Senior NNP NNP O
Resident NNP NNP O
: : : O
Dr NNP NNP O
. . . O
Imani NNP NNP I-DOCTOR
Blevins NNP NNP I-DOCTOR
- : : O
BID NNP NNP O
wound NN NN O
packing VBG VBG O
- : : O
Linezolid/Cefepime/Flagyl NNP NNP O
( ( ( O
prior RB RB O
abscess NN NN O
cultures NNS NNS O
: : : O
pseudomonas NN NN O
sensitive JJ JJ O
to TO TO O
linezolid VB VB O
, , , O
klebsiella NN NN O
sensitive JJ JJ O
to TO TO O
cefepime NN NN O
) ) ) O
- : : O
Follow VB VB O
up RP RP O
wound VBD VBD O
culture NN NN O
- : : O
Serial NNP NNP O
exams NNS NNS O
with IN IN O
careful JJ JJ O
monitoring NN NN O
for IN IN O
spread NN NN O
of IN IN O
cellulitis NNS NNS O
. . . O
   
Patient NNP NNP O
discussed VBD VBD O
with IN IN O
Dr NNP NNP O
. . . O
Wesley NNP NNP I-DOCTOR
Nieves NNP NNP I-DOCTOR
, , , O
LH NNP NNP I-HOSPITAL
Surgical NNP NNP O
Senior NNP NNP O
. . . O
   
Susan NNP NNP I-DOCTOR
Noyes NNP NNP I-DOCTOR
, , , O
MD NNP NNP O
ED NNP NNP O
Surgical NNP NNP O
Senior NNP NNP O
P26381 NNP NNP O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2098-07-20 JJ JJ I-DATE
July NNP NNP I-DATE
20 CD CD O
, , , O
2098 CD CD I-DATE
Patricia NNP NNP I-DOCTOR
Islam NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
   
Redwood NNP NNP I-HOSPITAL
Area NNP NNP I-HOSPITAL
Hospital NNP NNP I-HOSPITAL
34 CD CD I-STREET
Tamworth NNP NNP I-STREET
Place/Internal NNP NNP O
Medicine NNP NNP O
Cass NNP NNP I-CITY
City NNP NNP I-CITY
, , , O
MS NNP NNP I-STATE
25448 CD CD I-ZIP
Re NNP NNP O
: : : O
Brady NNP NNP I-PATIENT
Duvall NNP NNP I-PATIENT
MR NNP NNP O
#425-03-15-1 NN NN O
Dear RB RB O
Patricia NNP NNP I-DOCTOR
: : : O
I PRP PRP O
saw VBD VBD O
Brady NNP NNP I-PATIENT
Duvall NNP NNP I-PATIENT
again RB RB O
today NN NN O
. . . O
   
He PRP PRP O
has VBZ VBZ O
been VBN VBN O
very RB RB O
stable JJ JJ O
clinically RB RB O
over IN IN O
these DT DT O
past JJ JJ O
six CD CD O
months NNS NNS O
. . . O
   
I PRP PRP O
believe VBP VBP O
this DT DT O
represents VBZ VBZ O
a DT DT O
composite NN NN O
of IN IN O
the DT DT O
following VBG VBG O
three CD CD O
major JJ JJ O
changes NNS NNS O
in IN IN O
his PRP$ PRP$ O
medical JJ JJ O
regimen NNS NNS O
. . . O
   
As IN IN O
you PRP PRP O
know VBP VBP O
, , , O
we PRP PRP O
have VBP VBP O
discontinued VBN VBN O
all DT DT O
beta NN NN O
blockers NNS NNS O
, , , O
and CC CC O
this DT DT O
has VBZ VBZ O
been VBN VBN O
associated VBN VBN O
with IN IN O
a DT DT O
symptomatic JJ JJ O
stability NN NN O
. . . O
   
He PRP PRP O
had VBD VBD O
biventricular NN NN O
pacing VBG VBG O
box NN NN O
placed VBN VBN O
, , , O
certainly RB RB O
contributing VBG VBG O
to TO TO O
his PRP$ PRP$ O
overall NN NN O
improved VBN VBN O
status NN NN O
and CC CC O
he PRP PRP O
is VBZ VBZ O
now RB RB O
taking VBG VBG O
a DT DT O
regular JJ JJ O
dose NN NN O
of IN IN O
Lasix NNP NNP O
. . . O
   
He PRP PRP O
is VBZ VBZ O
on IN IN O
80 CD CD O
mg NN NN O
alternating VBG VBG O
with IN IN O
40 CD CD O
mg NN NN O
per IN IN O
day NN NN O
. . . O
   
He PRP PRP O
does VBZ VBZ O
have VB VB O
symptoms NNS NNS O
of IN IN O
fatigue NN NN O
, , , O
but CC CC O
his PRP$ PRP$ O
overall JJ JJ O
volume NN NN O
status NN NN O
is VBZ VBZ O
quite RB RB O
reasonable JJ JJ O
. . . O
   
He PRP PRP O
is VBZ VBZ O
currently RB RB O
on IN IN O
Aldactone NNP NNP O
25 CD CD O
mg NN NN O
daily JJ JJ O
and CC CC O
Lasix NNP NNP O
80 CD CD O
mg NN NN O
per IN IN O
day NN NN O
alternating VBG VBG O
with IN IN O
40 CD CD O
mg NN NN O
per IN IN O
day NN NN O
, , , O
Captopril NNP NNP O
6.25 CD CD O
mg NN NN O
p.o. NN NN O
t.i.d. NN NN O
, , , O
Zocor NNP NNP O
, , , O
insulin NN NN O
, , , O
Glucophage NNP NNP O
, , , O
aspirin NN NN O
, , , O
and CC CC O
mexiletine NN NN O
. . . O
   
His PRP$ PRP$ O
amiodarone NN NN O
has VBZ VBZ O
been VBN VBN O
discontinued VBN VBN O
. . . O
   
He PRP PRP O
does VBZ VBZ O
have VB VB O
asymptomatic JJ JJ O
ventricular NN NN O
tachycardia NNS NNS O
, , , O
often RB RB O
paced VBN VBN O
out IN IN O
of IN IN O
this DT DT O
, , , O
but CC CC O
I PRP PRP O
am VBP VBP O
reluctant JJ JJ O
to TO TO O
recommend VB VB O
ablation NN NN O
therapy NN NN O
for IN IN O
him PRP PRP O
at IN IN O
the DT DT O
present JJ JJ O
time NN NN O
. . . O
   
He PRP PRP O
has VBZ VBZ O
not RB RB O
been VBN VBN O
shocked VBN VBN O
by IN IN O
his PRP$ PRP$ O
ICD NNP NNP O
. . . O
   
Functionally RB RB O
he PRP PRP O
seems VBZ VBZ O
quite RB RB O
stable JJ JJ O
. . . O
   
He PRP PRP O
does VBZ VBZ O
have VB VB O
mild VB VB O
fatigue NN NN O
, , , O
but CC CC O
is VBZ VBZ O
otherwise RB RB O
reasonably RB RB O
active JJ JJ O
. . . O
   
He PRP PRP O
will MD MD O
hopefully RB RB O
be VB VB O
traveling VBG VBG O
to TO TO O
Miami NNP NNP I-CITY
this DT DT O
spring NN NN I-DATE
. . . O
   
Physical JJ JJ O
examination NN NN O
today NN NN O
is VBZ VBZ O
of IN IN O
note NN NN O
for IN IN O
a DT DT O
weight NN NN O
of IN IN O
184 CD CD O
lbs NNS NNS O
. . . O
   
His PRP$ PRP$ O
blood NN NN O
pressure NN NN O
is VBZ VBZ O
118/70 CD CD O
, , , O
his PRP$ PRP$ O
resting VBG VBG O
pulse NN NN O
   
69 CD CD O
. . . O
His PRP$ PRP$ O
neck NN NN O
veins NNS NNS O
are VBP VBP O
in IN IN O
fact NN NN O
, , , O
quite RB RB O
unimpressive JJ JJ O
. . . O
   
There EX EX O
is VBZ VBZ O
minimal JJ JJ O
jugular NN NN O
distention NN NN O
, , , O
perhaps RB RB O
6-7 JJ JJ O
cm NN NN O
. . . O
   
There EX EX O
is VBZ VBZ O
no DT DT O
hepatojugular NN NN O
reflux NN NN O
. . . O
   
Re NNP NNP O
: : : O
Brady NNP NNP I-PATIENT
Duvall NNP NNP I-PATIENT
MR NNP NNP O
#425-03-15-1 NN NN O
- - - O
2 CD CD O
- : : O
07/18/98 CD CD I-DATE
Lungs NNP NNP O
were VBD VBD O
clear JJ JJ O
. . . O
   
Examination NNP NNP O
of IN IN O
his PRP$ PRP$ O
heart NN NN O
reveals VBZ VBZ O
a DT DT O
quiet JJ JJ O
precordium NN NN O
. . . O
   
S1 NNP NNP O
and CC CC O
S2 NNP NNP O
seem VBP VBP O
normal JJ JJ O
. . . O
   
No DT DT O
S3 NNP NNP O
, , , O
no DT DT O
gallop NN NN O
and CC CC O
no DT DT O
murmur NN NN O
or CC CC O
mitral JJ JJ O
regurgitation NN NN O
. . . O
   
Abdomen NNP NNP O
is VBZ VBZ O
benign NN NN O
without IN IN O
palpable JJ JJ O
liver NN NN O
or CC CC O
spleen NN NN O
and CC CC O
there EX EX O
was VBD VBD O
no DT DT O
peripheral JJ JJ O
edema NN NN O
. . . O
   
There EX EX O
are VBP VBP O
bilateral JJ JJ O
varicosities NNS NNS O
. . . O
   
His PRP$ PRP$ O
electrocardiogram NN NN O
shows VBZ VBZ O
pace NN NN O
rhythm NN NN O
. . . O
   
Mr NNP NNP O
. . . O
Brady NNP NNP I-PATIENT
Duvall NNP NNP I-PATIENT
is VBZ VBZ O
currently RB RB O
stable JJ JJ O
on IN IN O
this DT DT O
regimen NN NN O
. . . O
   
Accordingly RB RB O
, , , O
I PRP PRP O
have VBP VBP O
made VBN VBN O
no DT DT O
changes NNS NNS O
. . . O
   
I PRP PRP O
have VBP VBP O
checked VBN VBN O
appropriate JJ JJ O
electrolytes NNS NNS O
. . . O
   
Many JJ JJ O
thanks NNS NNS O
for IN IN O
letting VBG VBG O
us PRP PRP O
participate VBP VBP O
in IN IN O
his PRP$ PRP$ O
care NN NN O
. . . O
   
With IN IN O
best JJS JJS O
regards VBZ VBZ O
. . . O
   
Sincerely NNP NNP O
, , , O
U. NNP NNP I-DOCTOR
L. NNP NNP I-DOCTOR
Dana NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
/ NN NN O
paris NN NN I-DOCTOR
******** NN NN O
Not RB RB O
reviewed VBN VBN O
by IN IN O
Attending NNP NNP O
Physician NNP NNP O
******** NN NN O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2092-03-11 JJ JJ I-DATE
NAME NNP NNP O
: : : O
Hendrickson NNP NNP I-PATIENT
, , , O
Ora NNP NNP I-PATIENT
MRN NNP NNP O
: : : O
7194334 CD CD I-MEDICALRECORD
This DT DT O
patient NN NN O
is VBZ VBZ O
here RB RB O
for IN IN O
a DT DT O
follow-up JJ JJ O
. . . O
   
She PRP PRP O
was VBD VBD O
seen VBN VBN O
with IN IN O
a DT DT O
very RB RB O
complete JJ JJ O
evaluation NN NN O
by IN IN O
Ida NNP NNP I-DOCTOR
Oquinn NNP NNP I-DOCTOR
for IN IN O
her PRP$ PRP$ O
recurrent NN NN O
urinary JJ JJ O
tract NN NN O
infections NNS NNS O
. . . O
   
She PRP PRP O
submitted VBD VBD O
a DT DT O
urine JJ JJ O
sample NN NN O
initially RB RB O
that WDT WDT O
appeared VBD VBD O
fairly RB RB O
clean VB VB O
but CC CC O
then RB RB O
after IN IN O
straight JJ JJ O
cathing VBG VBG O
her PRP$ PRP$ O
urine NN NN O
Ida NNP NNP I-DOCTOR
was VBD VBD O
able JJ JJ O
to TO TO O
obtain VB VB O
cloudy NN NN O
foul NN NN O
smelling VBG VBG O
urine NN NN O
. . . O
   
A DT DT O
fair JJ JJ O
amount NN NN O
retained VBD VBD O
as IN IN O
postvoid JJ JJ O
residual JJ JJ O
. . . O
   
Ms NNP NNP O
. . . O
Hendrickson NNP NNP I-PATIENT
completed VBD VBD O
her PRP$ PRP$ O
14 CD CD I-AGE
days NNS NNS O
of IN IN O
Levaquin NNP NNP O
with IN IN O
resolution NN NN O
of IN IN O
her PRP$ PRP$ O
symptoms NNS NNS O
but CC CC O
now RB RB O
over IN IN O
the DT DT O
past JJ JJ O
few JJ JJ O
days NNS NNS O
she PRP PRP O
has VBZ VBZ O
noticed VBN VBN O
an DT DT O
odor NN NN O
and CC CC O
cloudiness NN NN O
to TO TO O
her PRP$ PRP$ O
urine NN NN O
again RB RB O
without IN IN O
fevers NNS NNS O
of IN IN O
dysuria NN NN O
or CC CC O
urinary JJ JJ O
urgency NN NN O
. . . O
   
She PRP PRP O
has VBZ VBZ O
anxiety NN NN O
associated VBN VBN O
with IN IN O
the DT DT O
possible JJ JJ O
reasons NNS NNS O
why WRB WRB O
she PRP PRP O
should MD MD O
have VB VB O
recurrent JJ JJ O
infections NNS NNS O
. . . O
   
She PRP PRP O
is VBZ VBZ O
most RBS RBS O
concerned VBN VBN O
about IN IN O
having VBG VBG O
cancer NN NN O
. . . O
   
She PRP PRP O
is VBZ VBZ O
scheduled VBN VBN O
to TO TO O
see VB VB O
Dr NNP NNP O
. . . O
Quezada NNP NNP I-DOCTOR
March NNP NNP I-DATE
24th JJ JJ I-DATE
. . . O
   
The DT DT O
patient NN NN O
reports NNS NNS O
increased VBN VBN O
anxiety NN NN O
of IN IN O
late RB RB O
as IN IN O
there EX EX O
have VBP VBP O
been VBN VBN O
issues NNS NNS O
going VBG VBG O
around IN IN O
the DT DT O
housing NN NN O
projects NNS NNS O
. . . O
   
A DT DT O
14-year-old JJ JJ O
girl NN NN O
was VBD VBD O
raped VBN VBN O
and CC CC O
one CD CD O
week NN NN O
later RB RB O
an DT DT O
individual JJ JJ O
was VBD VBD O
climbing VBG VBG O
a DT DT O
tree NN NN O
to TO TO O
try VB VB O
to TO TO O
get VB VB O
into IN IN O
her PRP$ PRP$ O
apartment NN NN O
. . . O
   
She PRP PRP O
ended VBD VBD O
up RB RB O
combating VBG VBG O
him PRP PRP O
with IN IN O
a DT DT O
broom NN NN O
and CC CC O
he PRP PRP O
ran VBD VBD O
away RB RB O
. . . O
   
She PRP PRP O
did VBD VBD O
not RB RB O
file VB VB O
a DT DT O
police NN NN O
report NN NN O
. . . O
   
As IN IN O
a DT DT O
result NN NN O
of IN IN O
this DT DT O
she PRP PRP O
has VBZ VBZ O
had VBN VBN O
more JJR JJR O
problems NNS NNS O
with IN IN O
her PRP$ PRP$ O
anxiety NN NN O
. . . O
   
She PRP PRP O
reports NNS NNS O
compliance NN NN O
with IN IN O
all DT DT O
her PRP$ PRP$ O
medications NNS NNS O
except IN IN O
that IN IN O
she PRP PRP O
ran VBD VBD O
out IN IN O
of IN IN O
her PRP$ PRP$ O
Lasix NNP NNP O
approximately RB RB O
one CD CD O
week NN NN O
ago RB RB O
. . . O
   
She PRP PRP O
had VBD VBD O
been VBN VBN O
taking VBG VBG O
20 CD CD O
mg NN NN O
one-half NN NN O
to TO TO O
one CD CD O
tablet NN NN O
sporadically RB RB O
but CC CC O
not RB RB O
on IN IN O
a DT DT O
regular JJ JJ O
basis NN NN O
. . . O
   
She PRP PRP O
denies VBZ VBZ O
any DT DT O
chest NN NN O
pressure NN NN O
or CC CC O
palpitations NNS NNS O
. . . O
   
She PRP PRP O
denies VBZ VBZ O
any DT DT O
shortness NN NN O
of IN IN O
breath NN NN O
. . . O
   
She PRP PRP O
denies VBZ VBZ O
any DT DT O
problems NNS NNS O
with IN IN O
pain NN NN O
in IN IN O
her PRP$ PRP$ O
right JJ JJ O
foot NN NN O
or CC CC O
increased VBN VBN O
swelling NN NN O
of IN IN O
her PRP$ PRP$ O
left JJ JJ O
ankle NN NN O
. . . O
   
PHYSICAL JJ JJ O
EXAM NNP NNP O
: : : O
Blood NNP NNP O
pressure NN NN O
is VBZ VBZ O
156/90 CD CD O
. . . O
   
Heart NNP NNP O
is VBZ VBZ O
regular JJ JJ O
rate NN NN O
and CC CC O
rhythm NN NN O
. . . O
   
No DT DT O
murmurs NNS NNS O
, , , O
gallops NNS NNS O
or CC CC O
rubs NNS NNS O
. . . O
   
UA NNP NNP O
reveals VBZ VBZ O
positive JJ JJ O
nitrate NN NN O
and CC CC O
2 CD CD O
+ NN NN O
leukocytes NNS NNS O
. . . O
   
Her PRP$ PRP$ O
ankle NN NN O
reveals VBZ VBZ O
trace VB VB O
edema NN NN O
on IN IN O
the DT DT O
left NN NN O
. . . O
   
Her PRP$ PRP$ O
right JJ JJ O
extremity NN NN O
is VBZ VBZ O
warm JJ JJ O
to TO TO O
palpation NN NN O
. . . O
   
ASSESSMENT NNP NNP O
AND CC CC O
PLAN NNP NNP O
: : : O
( ( ( O
1 CD CD O
) ) ) O
Hypertension NNP NNP O
. . . O
   
Blood NNP NNP O
pressure NN NN O
has VBZ VBZ O
been VBN VBN O
high JJ JJ O
over IN IN O
the DT DT O
past JJ JJ O
two CD CD O
visits NNS NNS O
. . . O
   
This DT DT O
may MD MD O
be VB VB O
due JJ JJ O
to TO TO O
the DT DT O
fact NN NN O
that IN IN O
she PRP PRP O
has VBZ VBZ O
not RB RB O
been VBN VBN O
taking VBG VBG O
her PRP$ PRP$ O
Lasix NNP NNP O
. . . O
   
I PRP PRP O
have VBP VBP O
restarted VBN VBN O
her PRP PRP O
on IN IN O
the DT DT O
Lasix NNP NNP O
20 CD CD O
mg NN NN O
to TO TO O
take VB VB O
one-half JJ JJ O
tablet NN NN O
q.d. NN NN O
on IN IN O
a DT DT O
regular JJ JJ O
basis NN NN O
. . . O
   
( ( ( O
2 CD CD O
) ) ) O
Anxiety NNP NNP O
. . . O
   
I PRP PRP O
will MD MD O
write VB VB O
a DT DT O
letter NN NN O
for IN IN O
her PRP PRP O
to TO TO O
the DT DT O
Rupert NNP NNP I-CITY
Housing NNP NNP I-ORGANIZATION
Council NNP NNP I-ORGANIZATION
to TO TO O
try VB VB O
to TO TO O
get VB VB O
her PRP$ PRP$ O
moved VBD VBD O
out IN IN O
of IN IN O
this DT DT O
current JJ JJ O
housing NN NN O
project NN NN O
to TO TO O
a DT DT O
safer JJR JJR O
environment NN NN O
. . . O
   
( ( ( O
3 CD CD O
) ) ) O
Recurrent NNP NNP O
urinary JJ JJ O
tract NN NN O
infections NNS NNS O
. . . O
   
She PRP PRP O
had VBD VBD O
a DT DT O
urine NN NN O
culture NN NN O
submitted VBD VBD O
today NN NN O
. . . O
   
She PRP PRP O
was VBD VBD O
given VBN VBN O
another DT DT O
prescription NN NN O
for IN IN O
Levaquin NNP NNP O
150 CD CD O
mg NN NN O
one CD CD O
PO NNP NNP O
q.d. NN NN O
   
She PRP PRP O
will MD MD O
stay VB VB O
on IN IN O
this DT DT O
until IN IN O
her PRP$ PRP$ O
appointment NN NN O
with IN IN O
Dr NNP NNP O
. . . O
Quezada NNP NNP I-DOCTOR
. . . O
   
I PRP PRP O
attempted VBD VBD O
to TO TO O
reassure VB VB O
her PRP PRP O
that IN IN O
it PRP PRP O
is VBZ VBZ O
unlikely JJ JJ O
that IN IN O
cancer NN NN O
is VBZ VBZ O
the DT DT O
cause NN NN O
for IN IN O
her PRP$ PRP$ O
current JJ JJ O
recurrent NN NN O
infections NNS NNS O
. . . O
   
It PRP PRP O
is VBZ VBZ O
more RBR RBR O
likely JJ JJ O
due JJ JJ O
to TO TO O
her PRP$ PRP$ O
cystocele NN NN O
. . . O
   
( ( ( O
4 CD CD O
) ) ) O
Peripheral NNP NNP O
vascular NN NN O
disease NN NN O
. . . O
   
This DT DT O
appears VBZ VBZ O
stable JJ JJ O
. . . O
   
She PRP PRP O
remains VBZ VBZ O
off IN IN O
the DT DT O
cigarettes NNS NNS O
. . . O
   
( ( ( O
5 CD CD O
) ) ) O
ASCVD NNP NNP O
. . . O
   
She PRP PRP O
remains VBZ VBZ O
without IN IN O
symptoms NNS NNS O
. . . O
   
( ( ( O
6 CD CD O
) ) ) O
GERD NNP NNP O
. . . O
   
She PRP PRP O
remains VBZ VBZ O
on IN IN O
the DT DT O
Prilosec NNP NNP O
. . . O
   
( ( ( O
7 CD CD O
) ) ) O
Hyperlipidemia NNP NNP O
. . . O
   
She PRP PRP O
remains VBZ VBZ O
on IN IN O
Lipitor NNP NNP O
. . . O
   
She PRP PRP O
should MD MD O
have VB VB O
a DT DT O
repeat NN NN O
cholesterol NN NN O
obtained VBD VBD O
with IN IN O
a DT DT O
new JJ JJ O
primary JJ JJ O
care NN NN O
physician NN NN O
in IN IN O
the DT DT O
fall NN NN O
. . . O
   
( ( ( O
8 CD CD O
) ) ) O
Borderline NNP NNP O
high JJ JJ O
sugar NN NN O
. . . O
   
The DT DT O
patient NN NN O
should MD MD O
also RB RB O
have VB VB O
this DT DT O
rechecked VBN VBN O
with IN IN O
the DT DT O
new JJ JJ O
physician NN NN O
in IN IN O
the DT DT O
fall NN NN O
. . . O
   
Mary NNP NNP I-DOCTOR
Isham NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
   
MI/ussery/echols NNP NNP O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2094-07-02 JJ JJ I-DATE
Problems NNS NNS O
coronary JJ JJ O
artery NN NN O
disease NN NN O
hypertension NN NN O
hyperlipidemia NN NN O
chronic JJ JJ O
obstructive JJ JJ O
pulmonary JJ JJ O
disease NN NN O
peripheral NN NN O
vascular NN NN O
disease NN NN O
peripheral NN NN O
edema NN NN O
: : : O
left VBN VBN O
ankle NN NN O
, , , O
doppler NN NN O
negative JJ JJ O
anxiety NN NN O
borderline NN NN O
diabetes NNS NNS O
mellitus JJ JJ O
urinary JJ JJ O
tract NN NN O
infection NN NN O
: : : O
Reoccurrent NNP NNP O
S/P NNP NNP O
cardiac JJ JJ O
bypass NN NN O
graft NN NN O
surgery NN NN O
: : : O
100 CD CD O
% NN NN O
obstr NN NN O
of IN IN O
LPC NNP NNP O
and CC CC O
mid JJ JJ O
RCA NNP NNP O
, , , O
70 CD CD O
% NN NN O
obstr NN NN O
LAD NNP NNP O
on IN IN O
cath NN NN O
11/92 CD CD I-DATE
. . . O
   
Medications NNP NNP O
Ecotrin NNP NNP O
( ( ( O
ASPIRIN NNP NNP O
ENTERIC NNP NNP O
COATED NNP NNP O
) ) ) O
325MG CD CD O
TABLET NNP NNP O
EC NNP NNP O
take VB VB O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
, , , O
Take NNP NNP O
as IN IN O
directed VBN VBN O
Ntg NNP NNP O
1/150 CD CD O
( ( ( O
NITROGLYCERIN NNP NNP O
1/150 CD CD O
( ( ( O
0.4 CD CD O
MG NNP NNP O
) ) ) O
) ) ) O
1 CD CD O
TAB NNP NNP O
SL NNP NNP O
x1 NN NN O
, , , O
USE NNP NNP O
AS NNP NNP O
DIRECTED NNP NNP O
Nystatin NNP NNP O
POWDER NNP NNP O
TOPICAL NNP NNP O
TOP NNP NNP O
BID NNP NNP O
Lipitor NNP NNP O
( ( ( O
ATORVASTATIN NNP NNP O
) ) ) O
20MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
, , , O
Take NNP NNP O
as IN IN O
directed VBN VBN O
Acetaminophen NNP NNP O
W/CODEINE NNP NNP O
30MG CD CD O
1 CD CD O
TAB NNP NNP O
PO NNP NNP O
Q4H NNP NNP O
PRN NNP NNP O
pain NN NN O
, , , O
Take NNP NNP O
as IN IN O
directed VBN VBN O
Bactroban NNP NNP O
( ( ( O
MUPIROCIN NNP NNP O
) ) ) O
TOPICAL NNP NNP O
TOP NNP NNP O
BID NNP NNP O
Plavix NNP NNP O
( ( ( O
CLOPIDOGREL NNP NNP O
) ) ) O
75 CD CD O
MG NNP NNP O
PO NNP NNP O
QD NNP NNP O
Lopressor NNP NNP O
( ( ( O
METOPROLOL NNP NNP O
TARTRATE NNP NNP O
) ) ) O
50MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
BID NNP NNP O
Nexium NNP NNP O
( ( ( O
ESOMEPRAZOLE NNP NNP O
) ) ) O
40MG CD CD O
CAPSULE NNP NNP O
EC NNP NNP O
take VB VB O
1 CD CD O
Capsule NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Avapro NNP NNP O
( ( ( O
IRBESARTAN NNP NNP O
) ) ) O
150MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Clonazepam NNP NNP O
0.5MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
BID NNP NNP O
PRN NNP NNP O
anxiety NN NN O
Procardia NNP NNP O
XL NNP NNP O
( ( ( O
NIFEDIPINE NNP NNP O
( ( ( O
SUSTAINED NNP NNP O
RELEA NNP NNP O
. . . O
   
. . . O
   
. . . O
   
60 CD CD O
MG NNP NNP O
( ( ( O
60MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Furosemide NNP NNP O
40MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
BID NNP NNP O
Kcl NNP NNP O
SUSTAINED NNP NNP O
RELEASE NNP NNP O
( ( ( O
20MEQ CD CD O
TABLET NNP NNP O
CR NNP NNP O
take VB VB O
2 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
, , , O
take NN NN O
2 CD CD O
tabs NNS NNS O
in IN IN O
am VBP VBP O
and CC CC O
2 CD CD O
tab NN NN O
in IN IN O
pm NN NN O
Follow VB VB O
up RB RB O
visit NN NN O
. . . O
   
Doing VBG VBG O
well RB RB O
, , , O
lives NNS NNS O
alone RB RB O
, , , O
independent JJ JJ O
with IN IN O
ADL NNP NNP O
's POS POS O
. . . O
   
Has VBZ VBZ O
nocturia NN NN O
X NNP NNP O
5 CD CD O
, , , O
urinates NNS NNS O
3-4 JJ JJ O
X NNP NNP O
during IN IN O
the DT DT O
day NN NN O
. . . O
   
Has VBZ VBZ O
1 CD CD O
c SYM SYM O
tea NN NN O
qd NN NN O
, , , O
no DT DT O
coffee NN NN O
or CC CC O
ETOH NNP NNP O
. . . O
   
Drinks NNS NNS O
5 CD CD O
bottles NNS NNS O
of IN IN O
water NN NN O
qd NN NN O
, , , O
16 CD CD O
oz NN NN O
cranberry NN NN O
juice NN NN O
. . . O
   
Never RB RB O
started VBD VBD O
macrobid NN NN O
. . . O
   
Denies NNP NNP O
CP NNP NNP O
, , , O
SOB NNP NNP O
, , , O
GI NNP NNP O
sx NN NN O
. . . O
   
Quit NNP NNP O
smoking VBG VBG O
11/92 CD CD I-DATE
. . . O
   
Walks NNP NNP O
30 CD CD O
min NN NN O
qd NN NN O
. . . O
   
PE NNP NNP O
: : : O
NAD NNP NNP O
P NN NN O
60 CD CD O
reg NN NN O
BP NNP NNP O
148/70 CD CD O
after IN IN O
rest NN NN O
154/70 CD CD O
Throat NNP NNP O
- : : O
neg NN NN O
Neck NN NN O
- : : O
no DT DT O
adenopathy NN NN O
or CC CC O
thyromegaly NN NN O
Lungs NNS NNS O
- : : O
Clear NNP NNP O
to TO TO O
P NN NN O
and CC CC O
a DT DT O
cor NN NN O
- - - O
reg NN NN O
S1S2 NNP NNP O
no DT DT O
m,r,g NN NN O
Breasts NNP NNP O
- : : O
no DT DT O
mass NN NN O
bilat NN NN O
Abd NNP NNP O
- : : O
soft JJ JJ O
, , , O
active JJ JJ O
BS NNP NNP O
, , , O
no DT DT O
mass NN NN O
, , , O
tenderness NN NN O
, , , O
organomegaly NN NN O
Ext NNP NNP O
- - - O
no DT DT O
edema NN NN O
IMP NNP NNP O
: : : O
   
1 CD CD O
. . . O
HT NNP NNP O
- : : O
uncontrolled JJ JJ O
. . . O
   
Will NNP NNP O
increase VB VB O
procardia NN NN O
to TO TO O
90 CD CD O
mg NN NN O
qd NN NN O
, , , O
recheck NN NN O
BP NNP NNP O
in IN IN O
1 CD CD O
month NN NN O
. . . O
   
Check NNP NNP O
K NNP NNP O
, , , O
glu NN NN O
. . . O
   
2 CD CD O
. . . O
Chronic NNP NNP O
urinary JJ JJ O
sx NN NN O
- : : O
will MD MD O
check VB VB O
u/a NN NN O
, , , O
urine JJ JJ O
culture NN NN O
, , , O
start VB VB O
macrobid NN NN O
100mg CD CD O
qd NN NN O
. . . O
   
Decrease NNP NNP O
lasix NN NN O
to TO TO O
40 CD CD O
mg NN NN O
in IN IN O
am VBP VBP O
, , , O
decrease NN NN O
KCL NNP NNP O
to TO TO O
40 CD CD O
meq NN NN O
q NN NN O
am VBP VBP O
. . . O
   
3 CD CD O
. . . O
Hx NNP NNP O
anemia NN NN O
, , , O
check NN NN O
CBC NNP NNP O
. . . O
   
4 CD CD O
. . . O
HM NNP NNP O
- : : O
schedule NN NN O
mammogram NN NN O
, , , O
pt NN NN O
declines NNS NNS O
colonscopy NN NN O
. . . O
   
RV NN NN O
7/23 CD CD I-DATE
. . . O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2094-12-09 JJ JJ I-DATE
RAH NNP NNP I-HOSPITAL
EMERGENCY NNP NNP O
DEPT NNP NNP O
VISIT NNP NNP O
DUVALL,BRADY NNP NNP I-PATIENT
C NNP NNP I-PATIENT
425-03-15-1 NN NN I-MEDICALRECORD
VISIT NNP NNP O
DATE NN NN O
: : : O
12/09/94 CD CD I-DATE
PRESENTING NNP NNP O
COMPLAINT NNP NNP O
and CC CC O
HISTORY NN NN O
OF IN IN O
PRESENTING NNP NNP O
COMPLAINT NNP NNP O
: : : O
The DT DT O
patient NN NN O
is VBZ VBZ O
a DT DT O
72-year-old JJ JJ O
gentleman NN NN O
who WP WP O
presents VBZ VBZ O
to TO TO O
the DT DT O
Emergency NNP NNP O
Department NNP NNP O
. . . O
   
He PRP PRP O
reports NNS NNS O
nightly RB RB O
fevers NNS NNS O
. . . O
   
He PRP PRP O
is VBZ VBZ O
two CD CD O
week NN NN O
status NN NN O
post NN NN O
AICD NNP NNP O
replacement NN NN O
. . . O
   
He PRP PRP O
feels VBZ VBZ O
this DT DT O
is VBZ VBZ O
a DT DT O
malaria NN NN O
exacerbation NN NN O
. . . O
   
The DT DT O
patient NN NN O
had VBD VBD O
malaria NN NN O
in IN IN O
Cambodia NNP NNP I-COUNTRY
, , , O
and CC CC O
reports NNS NNS O
he PRP PRP O
did VBD VBD O
not RB RB O
have VB VB O
treatment NN NN O
. . . O
   
His PRP$ PRP$ O
past JJ JJ O
medical JJ JJ O
history NN NN O
is VBZ VBZ O
also RB RB O
positive JJ JJ O
for IN IN O
non-insulin-dependent JJ JJ O
diabetes NNS NNS O
mellitus NN NN O
, , , O
aortic JJ JJ O
valve NN NN O
replacement NN NN O
with IN IN O
a DT DT O
porcine NN NN O
valve NN NN O
, , , O
and CC CC O
ventricular NN NN O
fibrillation NN NN O
. . . O
   
He PRP PRP O
is VBZ VBZ O
on IN IN O
Glucophage NNP NNP O
and CC CC O
aspirin NN NN O
. . . O
   
He PRP PRP O
has VBZ VBZ O
no DT DT O
known VBN VBN O
drug NN NN O
allergies NNS NNS O
. . . O
   
The DT DT O
patient NN NN O
feels VBZ VBZ O
well RB RB O
. . . O
   
He PRP PRP O
says VBZ VBZ O
that IN IN O
each DT DT O
night NN NN O
he PRP PRP O
gets VBZ VBZ O
fever NN NN O
up IN IN O
to TO TO O
101 CD CD O
degrees NNS NNS O
F. NN NN O
   
, , , O
although IN IN O
it PRP PRP O
is VBZ VBZ O
not RB RB O
that IN IN O
high JJ JJ O
each DT DT O
night NN NN O
. . . O
   
The DT DT O
patient NN NN O
's POS POS O
past JJ JJ O
medical JJ JJ O
history NN NN O
is VBZ VBZ O
also RB RB O
significant JJ JJ O
for IN IN O
CAD NNP NNP O
, , , O
with IN IN O
an DT DT O
MI NNP NNP O
in IN IN O
2092 CD CD I-DATE
and CC CC O
ventricular NN NN O
tachycardia NNS NNS O
in IN IN O
2086 CD CD I-DATE
. . . O
   
His PRP$ PRP$ O
AICD NNP NNP O
was VBD VBD O
re-done JJ JJ O
two CD CD O
weeks NNS NNS O
ago RB RB O
. . . O
   
He PRP PRP O
had VBD VBD O
a DT DT O
triple-A JJ JJ O
repair NN NN O
in IN IN O
2089 CD CD I-DATE
. . . O
   
He PRP PRP O
has VBZ VBZ O
a DT DT O
history NN NN O
of IN IN O
gout NN NN O
. . . O
   
PHYSICAL JJ JJ O
EXAMINATION NNP NNP O
: : : O
The DT DT O
patient NN NN O
is VBZ VBZ O
well-appearing JJ JJ O
now RB RB O
, , , O
with IN IN O
a DT DT O
temperature NN NN O
of IN IN O
97 CD CD O
degrees NNS NNS O
F. NN NN O
   
, , , O
a DT DT O
pulse NN NN O
of IN IN O
58 CD CD O
, , , O
a DT DT O
respiratory JJ JJ O
rate NN NN O
of IN IN O
18 CD CD O
and CC CC O
unlabored JJ JJ O
, , , O
a DT DT O
blood NN NN O
pressure NN NN O
of IN IN O
110/80 CD CD O
, , , O
and CC CC O
a DT DT O
room NN NN O
air NN NN O
saturation NN NN O
of IN IN O
96 CD CD O
% NN NN O
. . . O
   
The DT DT O
HEENT NNP NNP O
examination NN NN O
is VBZ VBZ O
negative JJ JJ O
. . . O
   
The DT DT O
lungs NNS NNS O
are VBP VBP O
clear JJ JJ O
. . . O
   
The DT DT O
heart NN NN O
has VBZ VBZ O
a DT DT O
regular JJ JJ O
rhythm NN NN O
. . . O
   
The DT DT O
abdomen NN NN O
is VBZ VBZ O
soft JJ JJ O
and CC CC O
non-tender JJ JJ O
. . . O
   
The DT DT O
patient NN NN O
appears VBZ VBZ O
quite RB RB O
well RB RB O
. . . O
   
LABORATORY NNP NNP O
EVALUATION NNP NNP O
: : : O
Blood NNP NNP O
cultures NNS NNS O
are VBP VBP O
done VBN VBN O
. . . O
   
THERAPY NNP NNP O
RENDERED/COURSE NNP NNP O
IN IN IN O
ED NNP NNP O
: : : O
The DT DT O
patient NN NN O
's POS POS O
primary JJ JJ O
care NN NN O
physician NN NN O
is VBZ VBZ O
contacted VBN VBN O
and CC CC O
will MD MD O
follow VB VB O
up RP RP O
with IN IN O
the DT DT O
patient NN NN O
. . . O
the DT DT O
patient NN NN O
's POS POS O
white JJ JJ O
blood NN NN O
cell NN NN O
count NN NN O
is VBZ VBZ O
   
6 CD CD O
. . . O
His PRP$ PRP$ O
hematocrit NN NN O
is VBZ VBZ O
   
40 CD CD O
. . . O
His PRP$ PRP$ O
potassium NN NN O
is VBZ VBZ O
4.9 CD CD O
, , , O
his PRP$ PRP$ O
BUN NNP NNP O
19 CD CD O
, , , O
and CC CC O
his PRP$ PRP$ O
creatinine NN NN O
0.9 CD CD O
. . . O
   
The DT DT O
urinalysis NN NN O
is VBZ VBZ O
negative JJ JJ O
for IN IN O
infection NN NN O
. . . O
   
He PRP PRP O
has VBZ VBZ O
no DT DT O
pulmonary JJ JJ O
infection NN NN O
evident NN NN O
. . . O
   
There EX EX O
are VBP VBP O
no DT DT O
ischemic JJ JJ O
changes NNS NNS O
on IN IN O
his PRP$ PRP$ O
EKG NNP NNP O
. . . O
   
The DT DT O
patient NN NN O
appears VBZ VBZ O
to TO TO O
be VB VB O
doing VBG VBG O
well RB RB O
after IN IN O
the DT DT O
AICD NNP NNP O
replacement NN NN O
. . . O
   
The DT DT O
AICD NNP NNP O
has VBZ VBZ O
not RB RB O
had VBN VBN O
to TO TO O
fire VB VB O
. . . O
   
FINAL NNP NNP O
DIAGNOSIS NNP NNP O
: : : O
Nightly NNP NNP O
fevers NNS NNS O
, , , O
etiology NN NN O
uncertain NN NN O
. . . O
   
DISPOSITION NNP NNP O
( ( ( O
including VBG VBG O
condition NN NN O
upon IN IN O
discharge NN NN O
) ) ) O
: : : O
The DT DT O
patient NN NN O
is VBZ VBZ O
discharged VBN VBN O
in IN IN O
good JJ JJ O
condition NN NN O
to TO TO O
careful JJ JJ O
outpatient NN NN O
followup NN NN O
. . . O
   
__________________________________ NN NN O
_ NN NN O
IL050/525 NNP NNP I-IDNUM
IKECHUKWU NNP NNP I-DOCTOR
SPEARS NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
   
IS25 NNP NNP I-USERNAME
D:12/09/94 NNP NNP O
T:12/09/94 NNP NNP O
Dictated NNP NNP O
by IN IN O
: : : O
IKECHUKWU NNP NNP I-DOCTOR
SPEARS NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
   
IS25 NNP NNP I-USERNAME
******** NN NN O
Not RB RB O
reviewed VBN VBN O
by IN IN O
Attending NNP NNP O
Physician NNP NNP O
******** NN NN O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2076-01-24 JJ JJ I-DATE
Pt NNP NNP O
is VBZ VBZ O
a DT DT O
pleasant JJ JJ O
obese NN NN O
31yo CD CD O
man NN NN O
presenting VBG VBG O
for IN IN O
f/u NN NN O
DM NNP NNP O
, , , O
HTN NNP NNP O
, , , O
lipids NNS NNS O
, , , O
insomnia NN NN O
and CC CC O
depression NN NN O
. . . O
   
Problems NNS NNS O
Diabetes NNP NNP O
mellitus NN NN O
type NN NN O
2 CD CD O
Hypertension NNP NNP O
Hyperlipidemia NNP NNP O
Elevated NNP NNP O
triglycerides NNS NNS O
Depression NNP NNP O
Obesity NNP NNP O
Back RB RB O
pain NN NN O
: : : O
DISH NNP NNP O
Medications NNP NNP O
Motrin NNP NNP O
( ( ( O
IBUPROFEN NNP NNP O
) ) ) O
800 CD CD O
MG NNP NNP O
( ( ( O
800MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
) ) ) O
PO NNP NNP O
TID NNP NNP O
PRN NNP NNP O
pain NN NN O
Metformin NNP NNP O
875 CD CD O
MG NNP NNP O
( ( ( O
875MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
) ) ) O
PO NNP NNP O
TID NNP NNP O
Lisinopril NNP NNP O
40 CD CD O
MG NNP NNP O
( ( ( O
40MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
) ) ) O
PO NNP NNP O
QD NNP NNP O
, , , O
dose NN NN O
increase NN NN O
Prozac NNP NNP O
( ( ( O
FLUOXETINE NNP NNP O
HCL NNP NNP O
) ) ) O
40 CD CD O
MG NNP NNP O
( ( ( O
20MG CD CD O
TABLET NNP NNP O
take NN NN O
2 CD CD O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Zocor NNP NNP O
( ( ( O
SIMVASTATIN NNP NNP O
) ) ) O
40 CD CD O
MG NNP NNP O
( ( ( O
40MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
) ) ) O
PO NNP NNP O
QHS NNP NNP O
, , , O
replaces VBZ VBZ O
Lipitor NNP NNP O
   
( ( ( O
insurance NN NN O
) ) ) O
Hydrochlorothiazide NNP NNP O
25 CD CD O
MG NNP NNP O
( ( ( O
25MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
) ) ) O
PO NNP NNP O
QD NNP NNP O
x SYM SYM O
30 CD CD O
days NNS NNS O
Serax NNP NNP O
( ( ( O
OXAZEPAM NNP NNP O
) ) ) O
10 CD CD O
MG NNP NNP O
( ( ( O
10MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
) ) ) O
PO NNP NNP O
QHS NNP NNP O
PRN NNP NNP O
insomnia NN NN O
x SYM SYM O
30 CD CD O
days NNS NNS O
Fioricet NNP NNP O
( ( ( O
BUTALBITAL+APAP+CAFFEINE NNP NNP O
) ) ) O
1 CD CD O
TAB NNP NNP O
( ( ( O
325-40-50 JJ JJ O
CAPSULE NNP NNP O
) ) ) O
PO NNP NNP O
Q4H NNP NNP O
PRN NNP NNP O
headache NN NN O
Last NNP NNP O
seen VBN VBN O
by IN IN O
PCP NNP NNP O
1 CD CD O
mo NN NN O
ago RB RB O
. . . O
   
At IN IN O
that DT DT O
time NN NN O
, , , O
he PRP PRP O
had VBD VBD O
been VBN VBN O
complaining VBG VBG O
of IN IN O
hypoglycemia NN NN O
w NN NN O
/ NN NN O
sugars NNS NNS O
in IN IN O
the DT DT O
70's CD CD O
causing VBG VBG O
him PRP PRP O
to TO TO O
feel VB VB O
shakey NN NN O
and CC CC O
anxious JJ JJ O
. . . O
Glyburide NNP NNP O
was VBD VBD O
stopped VBN VBN O
, , , O
Metformin NNP NNP O
dose NN NN O
was VBD VBD O
adjusted VBN VBN O
from IN IN O
1000mg CD CD O
bid NN NN O
to TO TO O
875mg CD CD O
tid NN NN O
. . . O
Today NN NN O
he PRP PRP O
states VBZ VBZ O
he PRP PRP O
has VBZ VBZ O
had VBN VBN O
no DT DT O
hypoglycemic JJ JJ O
sxs NN NN O
since IN IN O
these DT DT O
changes NNS NNS O
. . . O
He PRP PRP O
forgot VBD VBD O
his PRP$ PRP$ O
logbook NN NN O
today NN NN O
. . . O
Reports NNP NNP O
lowest JJS JJS O
sugar NN NN O
in IN IN O
the DT DT O
80's, CD CD O
highest JJS JJS O
180 CD CD O
. . . O
   
Most JJS JJS O
fastings NNS NNS O
around IN IN O
100 CD CD O
, , , O
randoms NNS NNS O
140-150's. JJ JJ O
   
He PRP PRP O
is VBZ VBZ O
still RB RB O
walking VBG VBG O
every DT DT O
day NN NN O
. . . O
   
States NNPS NNPS O
his PRP$ PRP$ O
back RB RB O
is VBZ VBZ O
"""" '' '' O
fine NN NN O
"""" '' '' O
, , , O
no RB RB O
longer RB RB O
painful JJ JJ O
, , , O
though IN IN O
sometimes RB RB O
stiff JJ JJ O
upon IN IN O
wakening NN NN O
. . . O
   
Has VBZ VBZ O
appt NN NN O
at IN IN O
Promptcare NNP NNP I-HOSPITAL
for IN IN O
eye NN NN O
exam NN NN O
later RB RB O
this DT DT O
month NN NN O
. . . O
   
Has VBZ VBZ O
gained VBN VBN O
#14 NN NN O
in IN IN O
1 CD CD O
month NN NN O
, , , O
which WDT WDT O
he PRP PRP O
blames VBZ VBZ O
on IN IN O
increased VBN VBN O
stress NN NN O
at IN IN O
home NN NN O
. . . O
   
His PRP$ PRP$ O
cat NN NN O
was VBD VBD O
injured VBN VBN O
and CC CC O
recuperating VBG VBG O
. . . O
   
His PRP$ PRP$ O
mother NN NN O
was VBD VBD O
recently RB RB O
dx NN NN O
'd MD MD O
w NN NN O
/ NN NN O
"""" '' '' O
carcinoma NN NN O
"""" '' '' O
, , , O
but CC CC O
he PRP PRP O
is VBZ VBZ O
unclear JJ JJ O
of IN IN O
type NN NN O
. . . O
   
He PRP PRP O
eats VBZ VBZ O
when WRB WRB O
he PRP PRP O
is VBZ VBZ O
stressed VBN VBN O
. . . O
   
Has VBZ VBZ O
not RB RB O
seen VBN VBN O
psych NN NN O
yet RB RB O
, , , O
but CC CC O
states NNS NNS O
they PRP PRP O
have VBP VBP O
been VBN VBN O
playing VBG VBG O
"""" '' '' O
phone NN NN O
tag NN NN O
"""" '' '' O
. . . O
   
He PRP PRP O
continues VBZ VBZ O
to TO TO O
have VB VB O
insomnia NN NN O
and CC CC O
finds VBZ VBZ O
neither DT DT O
the DT DT O
Prozac NNP NNP O
or CC CC O
Serax NNP NNP O
helpful JJ JJ O
. . . O
   
Depression NNP NNP O
is VBZ VBZ O
stable JJ JJ O
, , , O
but CC CC O
not RB RB O
any DT DT O
better JJR JJR O
. . . O
   
Would MD MD O
like VB VB O
to TO TO O
change VB VB O
from IN IN O
Prozac NNP NNP O
to TO TO O
something NN NN O
else RB RB O
. . . O
   
Plans NNS NNS O
to TO TO O
call VB VB O
psych NN NN O
today NN NN O
and CC CC O
discuss VB VB O
. . . O
   
Denies NNP NNP O
SI/HI NNP NNP O
. . . O
   
HTN NNP NNP O
managed VBD VBD O
w NN NN O
/ NN NN O
Lisinopril NNP NNP O
40mg CD CD O
and CC CC O
HCTZ NNP NNP O
25mg CD CD O
qd NN NN O
added VBD VBD O
last JJ JJ O
time NN NN O
. . . O
   
He PRP PRP O
is VBZ VBZ O
tolerating VBG VBG O
the DT DT O
med JJ JJ O
w NN NN O
/ NN NN O
no DT DT O
dizziness NN NN O
, , , O
CP NNP NNP O
, , , O
SOB NNP NNP O
, , , O
palps NN NN O
, , , O
edema NN NN O
. . . O
   
Lipids NNP NNP O
managed VBD VBD O
w NN NN O
/ NN NN O
Zocor NNP NNP O
, , , O
increased VBN VBN O
from IN IN O
20 CD CD O
to TO TO O
40mg CD CD O
qd NN NN O
last JJ JJ O
month NN NN O
. . . O
   
He PRP PRP O
denies VBZ VBZ O
myalgias NN NN O
. . . O
   
Has VBZ VBZ O
not RB RB O
made VBN VBN O
appt NN NN O
to TO TO O
see VB VB O
nutrition NN NN O
yet RB RB O
. . . O
   
He PRP PRP O
is VBZ VBZ O
a DT DT O
non-smoker JJ JJ O
. . . O
   
Recent JJ JJ O
significant JJ JJ O
labs NNS NNS O
include VBP VBP O
urine JJ JJ O
malb/creat NN NN O
4314 CD CD O
, , , O
down RB RB O
from IN IN O
6381 CD CD O
. . . O
   
A1c NNP NNP O
8.0 CD CD O
, , , O
down RB RB O
from IN IN O
10.6 NN NN O
at IN IN O
time NN NN O
of IN IN O
dx NN NN O
. . . O
   
Exam NNP NNP O
: : : O
pleasant NN NN O
obese NN NN O
31yo CD CD O
man NN NN O
NAD NNP NNP O
, , , O
in IN IN O
good JJ JJ O
spirits NNS NNS O
today NN NN O
. . . O
   
Improved NNP NNP O
eye NN NN O
contact NN NN O
, , , O
smiling VBG VBG O
Bp NNP NNP O
144/99 CD CD O
in IN IN O
triage NN NN O
, , , O
144/92 CD CD O
lg NN NN O
cuff NN NN O
rechecked VBN VBN O
by IN IN O
me PRP PRP O
HR NNP NNP O
100reg CD CD O
Wt NNP NNP O
#319 NN NN O
Random NNP NNP O
fingerstick NN NN O
114 CD CD O
Lungs NNP NNP O
: : : O
clear JJ JJ O
; : : O
   
no DT DT O
rales NNS NNS O
, , , O
ronchi NN NN O
, , , O
wheezes NNS NNS O
Cor NNP NNP O
: : : O
RRR NNP NNP O
; : : O
   
(+) NN NN O
tachy NN NN O
at IN IN O
100 CD CD O
bpm NN NN O
Extrems NNP NNP O
: : : O
no DT DT O
pedal NN NN O
edema NN NN O
bilat NN NN O
A/P NNP NNP O
: : : O
31yo CD CD O
man NN NN O
w NN NN O
/ NN NN O
multiple JJ JJ O
medical JJ JJ O
problems NNS NNS O
. . . O
   
DM NNP NNP O
control NN NN O
improving VBG VBG O
over IN IN O
time NN NN O
w NN NN O
/ NN NN O
no DT DT O
recurrence NN NN O
of IN IN O
hypoglycemia NN NN O
since IN IN O
stopping VBG VBG O
Glyburide NNP NNP O
and CC CC O
adjusting VBG VBG O
Metformin NNP NNP O
to TO TO O
875mg CD CD O
tid NN NN O
. . . O
   
No DT DT O
changes NNS NNS O
made VBN VBN O
today NN NN O
. . . O
   
Pt NNP NNP O
encouraged VBD VBD O
to TO TO O
make VB VB O
appt NN NN O
w NN NN O
/ NN NN O
nutrition NN NN O
to TO TO O
assist NN NN O
w NN NN O
/ NN NN O
DM NNP NNP O
diet NN NN O
and CC CC O
wt NN NN O
loss NN NN O
. . . O
   
Keep VBP VBP O
upcoming JJ JJ O
appt NN NN O
at IN IN O
Promptcare NNP NNP I-HOSPITAL
for IN IN O
eye NN NN O
exam NN NN O
. . . O
   
HTN NNP NNP O
uncontrolled JJ JJ O
w NN NN O
/ NN NN O
addition NN NN O
of IN IN O
HCTZ NNP NNP O
, , , O
on IN IN O
ACEI NNP NNP O
also RB RB O
for IN IN O
renal JJ JJ O
protection NN NN O
. . . O
   
Per IN IN O
PCP NNP NNP O
, , , O
add VB VB O
Atenolol NNP NNP O
25mg CD CD O
qd NN NN O
. . . O
   
Potential NNP NNP O
risks NNS NNS O
, , , O
benefits NNS NNS O
reviewed VBD VBD O
. . . O
   
For IN IN O
lipids NNS NNS O
, , , O
on IN IN O
increased VBN VBN O
Zocor NNP NNP O
x SYM SYM O
1 CD CD O
mo NN NN O
. . . O
   
Recheck NNP NNP O
LFT NNP NNP O
's POS POS O
today NN NN O
on IN IN O
increased VBN VBN O
dose NN NN O
, , , O
recheck NN NN O
lipids NNS NNS O
at IN IN O
next JJ JJ O
PCP NNP NNP O
appt NN NN O
in IN IN O
2 CD CD O
mos NN NN O
. . . O
   
Insomnia NNP NNP O
and CC CC O
depression NN NN O
stable JJ JJ O
, , , O
but CC CC O
not RB RB O
improving VBG VBG O
on IN IN O
Prozac NNP NNP O
and CC CC O
Serax NNP NNP O
. . . O
   
Pt NNP NNP O
promises VBZ VBZ O
to TO TO O
f/u NN NN O
w NN NN O
/ NN NN O
psych NN NN O
today NN NN O
by IN IN O
phone NN NN O
and CC CC O
meet NN NN O
w NN NN O
/ NN NN O
them PRP PRP O
ASAP NNP NNP O
for IN IN O
f/u NN NN O
. . . O
   
Sent NNP NNP O
to TO TO O
lab VB VB O
for IN IN O
LFT NNP NNP O
's POS POS O
, , , O
plus CC CC O
basic JJ JJ O
panel NN NN O
and CC CC O
repeat NN NN O
urine JJ JJ O
malb/creat NN NN O
; : : O
   
f/u NN NN O
as IN IN O
needed VBN VBN O
. . . O
   
PCP NNP NNP O
notified VBD VBD O
of IN IN O
today NN NN O
's POS POS O
visit NN NN O
and CC CC O
plan NN NN O
. . . O
   
____________________________________________ NN NN O
_ NN NN O
Nina NNP NNP I-DOCTOR
I PRP PRP I-DOCTOR
Morris,N.P.,M.S. NNP NNP O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2080-04-15 JJ JJ I-DATE
EDVISIT^10776605^GLENN, NNP NNP O
OLIVIA^04/15/80^URIBE, NNP NNP O
HAROLD NNP NNP I-DOCTOR
Seen VBN VBN O
by IN IN O
me PRP PRP O
along IN IN O
with IN IN O
Dr NNP NNP O
. . . O
Oglesby NNP NNP I-DOCTOR
on IN IN O
04/15/2080 CD CD I-DATE
. . . O
   
The DT DT O
history NN NN O
as IN IN O
documented VBN VBN O
by IN IN O
Dr NNP NNP O
. . . O
Oglesby NNP NNP I-DOCTOR
was VBD VBD O
reviewed VBN VBN O
by IN IN O
me PRP PRP O
with IN IN O
the DT DT O
patient NN NN O
and CC CC O
found VBD VBD O
to TO TO O
be VB VB O
accurate JJ JJ O
and CC CC O
complete JJ JJ O
. . . O
   
The DT DT O
physical JJ JJ O
exam NN NN O
was VBD VBD O
confirmed VBN VBN O
by IN IN O
my PRP$ PRP$ O
examination NN NN O
. . . O
   
Evaluation NNP NNP O
and CC CC O
management NN NN O
was VBD VBD O
also RB RB O
concurred VBN VBN O
with IN IN O
. . . O
   
HISTORY NN NN O
OF IN IN O
PRESENT NNP NNP O
ILLNESS NNP NNP O
: : : O
Briefly NNP NNP O
, , , O
this DT DT O
is VBZ VBZ O
a DT DT O
66-year-old JJ JJ O
woman NN NN O
who WP WP O
enters VBZ VBZ O
with IN IN O
recent JJ JJ O
three-month JJ JJ O
history NN NN O
of IN IN O
admission NN NN O
for IN IN O
respiratory JJ JJ O
failure NN NN O
, , , O
pneumonia NN NN O
, , , O
and CC CC O
MSSA NNP NNP O
bacteriemia NN NN O
, , , O
discharged VBN VBN O
from IN IN O
rehab NN NN O
two CD CD O
weeks NNS NNS O
ago RB RB O
, , , O
presents VBZ VBZ O
with IN IN O
two CD CD O
to TO TO O
three CD CD O
day NN NN O
history NN NN O
of IN IN O
shortness NN NN O
of IN IN O
breath NN NN O
; : : O
   
dyspnea NN NN O
on IN IN O
exertion NN NN O
; : : O
   
PND NNP NNP O
; : : O
   
orthopnea NN NN O
; : : O
   
and CC CC O
leg NN NN O
edema NN NN O
, , , O
improving VBG VBG O
, , , O
but CC CC O
complains NNS NNS O
of IN IN O
occasional JJ JJ O
chest NN NN O
tightness NNS NNS O
lasting VBG VBG O
about IN IN O
an DT DT O
hour NN NN O
, , , O
worse JJR JJR O
with IN IN O
exertion NN NN O
. . . O
   
No DT DT O
nausea NN NN O
and CC CC O
no DT DT O
vomiting VBG VBG O
. . . O
   
Nonradiating NNP NNP O
. . . O
   
Seen VBN VBN O
by IN IN O
VNA NNP NNP O
today NN NN O
, , , O
blood NN NN O
pressure NN NN O
was VBD VBD O
190/100 CD CD O
and CC CC O
sent VBD VBD O
her PRP$ PRP$ O
here RB RB O
for IN IN O
evaluation NN NN O
. . . O
   
SOCIAL NNP NNP O
HISTORY NN NN O
: : : O
Does VBZ VBZ O
not RB RB O
smoke VB VB O
and CC CC O
does VBZ VBZ O
not RB RB O
drink VB VB O
. . . O
   
PAST NNP NNP O
MEDICAL NNP NNP O
HISTORY NN NN O
: : : O
History NN NN O
of IN IN O
atrial JJ JJ O
fibrillation NN NN O
, , , O
hypertension NN NN O
, , , O
diabetes NNS NNS O
, , , O
CHF NNP NNP O
, , , O
asthma NN NN O
, , , O
and CC CC O
chronic JJ JJ O
renal JJ JJ O
insufficiency NN NN O
, , , O
the DT DT O
baseline NN NN O
creatinine NN NN O
is VBZ VBZ O
2.5 CD CD O
. . . O
   
Review NNP NNP O
of IN IN O
systems NNS NNS O
, , , O
allergies NNS NNS O
, , , O
and CC CC O
medications NNS NNS O
are VBP VBP O
as IN IN O
documented VBN VBN O
in IN IN O
the DT DT O
chart NN NN O
. . . O
   
Please VB VB O
see VB VB O
the DT DT O
notes NNS NNS O
for IN IN O
details NNS NNS O
. . . O
   
PHYSICAL JJ JJ O
EXAMINATION NNP NNP O
: : : O
Awake NNP NNP O
and CC CC O
alert NN NN O
, , , O
well-developed JJ JJ O
, , , O
well-nourished JJ JJ O
woman NN NN O
in IN IN O
mild JJ JJ O
respiratory JJ JJ O
distress NN NN O
. . . O
   
Pulse NNP NNP O
93 CD CD O
, , , O
respirations NNS NNS O
18 CD CD O
to TO TO O
20 CD CD O
, , , O
blood NN NN O
pressure NN NN O
158/83 CD CD O
, , , O
and CC CC O
O2 NNP NNP O
saturation NN NN O
100 CD CD O
% NN NN O
on IN IN O
4 CD CD O
liters NNS NNS O
nasal NN NN O
cannula NN NN O
. . . O
   
JVP NNP NNP O
at IN IN O
10 CD CD O
cm NN NN O
. . . O
   
Lung NNP NNP O
exam NN NN O
shows VBZ VBZ O
rales NNS NNS O
to TO TO O
one-third JJ JJ O
of IN IN O
the DT DT O
way NN NN O
up IN IN O
to TO TO O
the DT DT O
lung NN NN O
bases NNS NNS O
. . . O
   
Cardiovascularly RB RB O
, , , O
regular JJ JJ O
rate NN NN O
and CC CC O
rhythm NN NN O
. . . O
   
The DT DT O
rest NN NN O
of IN IN O
the DT DT O
exam NN NN O
is VBZ VBZ O
as IN IN O
documented VBN VBN O
in IN IN O
the DT DT O
chart NN NN O
other JJ JJ O
than IN IN O
pedal NN NN O
edema NN NN O
. . . O
   
LABORATORY NNP NNP O
DATA NNP NNP O
: : : O
EKG NNP NNP O
shows VBZ VBZ O
sinus NN NN O
rhythm NN NN O
and CC CC O
left VBD VBD O
anterior NN NN O
fascicular NN NN O
hemiblock NN NN O
with IN IN O
flattening VBG VBG O
at IN IN O
V2 NNP NNP O
. . . O
   
Chest NN NN O
x-ray NN NN O
shows VBZ VBZ O
pulmonary JJ JJ O
vascular NN NN O
congestion NN NN O
. . . O
   
EMERGENCY NNP NNP O
DEPARTMENT NNP NNP O
COURSE NN NN O
: : : O
As IN IN O
such JJ JJ O
, , , O
she PRP PRP O
was VBD VBD O
admitted VBN VBN O
to TO TO O
Medicine NNP NNP O
with IN IN O
a DT DT O
diagnosis NN NN O
of IN IN O
decompensated JJ JJ O
CHF NNP NNP O
, , , O
likely JJ JJ O
secondary JJ JJ O
to TO TO O
hypertension NN NN O
. . . O
   
Her PRP$ PRP$ O
blood NN NN O
pressure NN NN O
initially RB RB O
when WRB WRB O
she PRP PRP O
came VBD VBD O
in IN IN O
******** NN NN O
Not RB RB O
reviewed VBN VBN O
by IN IN O
Attending NNP NNP O
Physician NNP NNP O
******** NN NN O
DISPOSITION NNP NNP O
: : : O
She PRP PRP O
was VBD VBD O
admitted VBN VBN O
on IN IN O
04/15/2080 CD CD I-DATE
. . . O
   
_____________________________ NN NN O
_ NN NN O
URIBE NNP NNP O
, , , O
HAROLD NNP NNP I-DOCTOR
M.D. NNP NNP O
   
D NNP NNP O
: : : O
04/15/80 CD CD I-DATE
T NN NN O
: : : O
04/16/80 CD CD I-DATE
Dictated NNP NNP O
By IN IN O
: : : O
URIBE NNP NNP O
, , , O
HAROLD NNP NNP I-DOCTOR
eScription NN NN O
document:0-4339350 JJ JJ O
XJ NNP NNP I-IDNUM
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2067-03-13 JJ JJ I-DATE
History NN NN O
of IN IN O
Present JJ JJ O
Illness NNP NNP O
Pt NNP NNP O
. . . O
   
presents NNS NNS O
today NN NN O
for IN IN O
f/u NN NN O
of IN IN O
her PRP$ PRP$ O
overnight JJ JJ O
stay NN NN O
in IN IN O
the DT DT O
EDOU NNP NNP O
from IN IN O
2/20 CD CD I-DATE
to TO TO O
2/21/67 CD CD I-DATE
. . . O
   
She PRP PRP O
went VBD VBD O
by IN IN O
ambulance NN NN O
on IN IN O
2/20 CD CD I-DATE
when WRB WRB O
she PRP PRP O
noted VBD VBD O
slurred JJ JJ O
speech NN NN O
and CC CC O
an DT DT O
unsteady JJ JJ O
gait NN NN O
. . . O
   
She PRP PRP O
says VBZ VBZ O
it PRP PRP O
was VBD VBD O
like IN IN O
she PRP PRP O
was VBD VBD O
a DT DT O
drunk JJ JJ O
. . . O
   
She PRP PRP O
had VBD VBD O
n't RB RB O
been VBN VBN O
drinking NN NN O
and CC CC O
had VBD VBD O
n't RB RB O
taken VBN VBN O
or CC CC O
eaten VBN VBN O
anything NN NN O
unusual JJ JJ O
. . . O
She PRP PRP O
was VBD VBD O
very RB RB O
scared VBN VBN O
. . . O
No DT DT O
visual JJ JJ O
changes NNS NNS O
or CC CC O
other JJ JJ O
unusual JJ JJ O
sensations NNS NNS O
. . . O
She PRP PRP O
had VBD VBD O
n't RB RB O
been VBN VBN O
sick JJ JJ O
in IN IN O
any DT DT O
other JJ JJ O
way NN NN O
: : : O
no DT DT O
fevers NNS NNS O
, , , O
chills NNS NNS O
, , , O
N/V NNP NNP O
, , , O
or CC CC O
other JJ JJ O
complaints NNS NNS O
. . . O
   
She PRP PRP O
felt VBD VBD O
a DT DT O
tiny JJ JJ O
bit NN NN O
better JJR JJR O
and CC CC O
was VBD VBD O
able JJ JJ O
to TO TO O
go VB VB O
to TO TO O
the DT DT O
door NN NN O
and CC CC O
let VB VB O
the DT DT O
EMTs NNP NNP O
in IN IN O
. . . O
   
They PRP PRP O
checked VBD VBD O
her PRP$ PRP$ O
sugar NN NN O
: : : O
   
63 CD CD O
. . . O
They PRP PRP O
gave VBD VBD O
her PRP$ PRP$ O
some DT DT O
sugar NN NN O
gel NN NN O
and CC CC O
her PRP$ PRP$ O
Sx NNP NNP O
resolved VBD VBD O
. . . O
   
In IN IN O
the DT DT O
ER NNP NNP O
, , , O
her PRP$ PRP$ O
Sx NNP NNP O
did VBD VBD O
not RB RB O
reappear VB VB O
. . . O
   
Labs NNP NNP O
were VBD VBD O
notable JJ JJ O
for IN IN O
BS NNP NNP O
of IN IN O
140 CD CD O
then RB RB O
255 CD CD O
. . . O
   
( ( ( O
A1C NNP NNP O
on IN IN O
12/27/66 CD CD I-DATE
was VBD VBD O
7.8 CD CD O
. . . O
) ) ) O
Her PRP$ PRP$ O
Na NNP NNP O
+ NN NN O
was VBD VBD O
low JJ JJ O
@ IN IN O
124 CD CD O
& CC CC O
amp NN NN O
; : : O
   
126 CD CD O
, , , O
but CC CC O
this DT DT O
is VBZ VBZ O
stable JJ JJ O
for IN IN O
her PRP PRP O
. . . O
   
She PRP PRP O
had VBD VBD O
a DT DT O
normal JJ JJ O
MRI/MRA NNP NNP O
. . . O
   
Since IN IN O
then RB RB O
, , , O
she PRP PRP O
has VBZ VBZ O
felt VBN VBN O
her PRP$ PRP$ O
usual JJ JJ O
self NN NN O
. . . O
   
Medications NNP NNP O
Ambien NNP NNP O
Cr NNP NNP O
( ( ( O
ZOLPIDEM NNP NNP O
Tartrate NNP NNP O
Extended-release NNP NNP O
) ) ) O
12.5 CD CD O
MG NNP NNP O
(12.5MG NN NN O
TAB NNP NNP O
MPHASE NNP NNP O
Take NNP NNP O
1 CD CD O
) ) ) O
PO NNP NNP O
QHS NNP NNP O
#30 NN NN O
Tablet NNP NNP O
   
( ( ( O
s)Aspirin NN NN O
( ( ( O
ACETYLSALICYLIC NNP NNP O
Acid NNP NNP O
) ) ) O
81 CD CD O
MG NNP NNP O
( ( ( O
81MG CD CD O
TABLET NNP NNP O
Take NNP NNP O
1 CD CD O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Avapro NNP NNP O
( ( ( O
IRBESARTAN NNP NNP O
) ) ) O
300 CD CD O
MG NNP NNP O
( ( ( O
300MG CD CD O
TABLET NNP NNP O
Take NNP NNP O
1 CD CD O
) ) ) O
PO NNP NNP O
QD NNP NNP O
#30 NN NN O
Tablet NNP NNP O
   
( ( ( O
s)GLYBURIDE NN NN O
5 CD CD O
MG NNP NNP O
( ( ( O
5MG CD CD O
TABLET NNP NNP O
Take NNP NNP O
1 CD CD O
) ) ) O
PO NNP NNP O
BID NNP NNP O
x SYM SYM O
30 CD CD O
days NNS NNS O
#60 NN NN O
Tablet NNP NNP O
   
( ( ( O
s)Labetalol NN NN O
Hcl NNP NNP O
300 CD CD O
MG NNP NNP O
( ( ( O
300MG CD CD O
TABLET NNP NNP O
Take NNP NNP O
1 CD CD O
) ) ) O
PO NNP NNP O
BID NNP NNP O
x SYM SYM O
30 CD CD O
days NNS NNS O
#180 NN NN O
Tablet NNP NNP O
   
( ( ( O
s)Lipitor NN NN O
( ( ( O
ATORVASTATIN NNP NNP O
) ) ) O
10 CD CD O
MG NNP NNP O
( ( ( O
10MG CD CD O
TABLET NNP NNP O
Take NNP NNP O
1 CD CD O
) ) ) O
PO NNP NNP O
QHS NNP NNP O
x SYM SYM O
30 CD CD O
days NNS NNS O
#90 NN NN O
Tablet NNP NNP O
   
( ( ( O
s)METFORMIN NN NN O
850 CD CD O
MG NNP NNP O
( ( ( O
850MG CD CD O
TABLET NNP NNP O
Take NNP NNP O
1 CD CD O
) ) ) O
PO NNP NNP O
TID NNP NNP O
x SYM SYM O
30 CD CD O
days NNS NNS O
#90 NN NN O
Tablet NNP NNP O
   
( ( ( O
s)Norvasc NN NN O
( ( ( O
AMLODIPINE NNP NNP O
) ) ) O
10 CD CD O
MG NNP NNP O
( ( ( O
10MG CD CD O
TABLET NNP NNP O
Take NNP NNP O
1 CD CD O
) ) ) O
PO NNP NNP O
BID NNP NNP O
#60 NN NN O
Tablet NNP NNP O
   
( ( ( O
s)PERPHENAZINE NN NN O
4 CD CD O
MG NNP NNP O
( ( ( O
4 CD CD O
MG NNP NNP O
TABLET NNP NNP O
Take NNP NNP O
1 CD CD O
) ) ) O
PO NNP NNP O
as IN IN O
directed VBN VBN O
x SYM SYM O
30 CD CD O
days NNS NNS O
, , , O
take VB VB O
1 CD CD O
tablet NN NN O
( ( ( O
4 CD CD O
mg NN NN O
) ) ) O
QAM NNP NNP O
and CC CC O
3 CD CD O
tablets NNS NNS O
( ( ( O
12 CD CD O
mg NN NN O
) ) ) O
QHS NNP NNP O
#120 NN NN O
Tablet NNP NNP O
   
( ( ( O
s)Proair NN NN O
Hfa NNP NNP O
( ( ( O
ALBUTEROL NNP NNP O
Inhaler NNP NNP O
Hfa NNP NNP O
) ) ) O
2 CD CD O
PUFF NNP NNP O
( ( ( O
90MCG CD CD O
HFA NNP NNP O
AER NNP NNP O
AD NNP NNP O
) ) ) O
INH NNP NNP O
Q6H NNP NNP O
PRN NNP NNP O
wheezing VBG VBG O
#1 NN NN O
Inhaler NNP NNP O
   
( ( ( O
s)Seroquel NN NN O
( ( ( O
QUETIAPINE NNP NNP O
) ) ) O
50 CD CD O
MG NNP NNP O
( ( ( O
50MG CD CD O
TABLET NNP NNP O
Take NNP NNP O
1 CD CD O
) ) ) O
PO NNP NNP O
QHS NNP NNP O
x SYM SYM O
30 CD CD O
days NNS NNS O
, , , O
may MD MD O
take VB VB O
50 CD CD O
mg NN NN O
more JJR JJR O
at IN IN O
night NN NN O
as IN IN O
needed VBN VBN O
PRN NNP NNP O
persistent NN NN O
insomnia NN NN O
#45 NN NN O
Tablet NNP NNP O
   
( ( ( O
s)SIMVASTATIN NN NN O
40 CD CD O
MG NNP NNP O
( ( ( O
40MG CD CD O
TABLET NNP NNP O
Take NNP NNP O
1 CD CD O
) ) ) O
PO NNP NNP O
QHS NNP NNP O
#30 NN NN O
Tablet NNP NNP O
   
( ( ( O
s)SPIRONOLACTONE NN NN O
50 CD CD O
MG NNP NNP O
( ( ( O
50 CD CD O
MG NNP NNP O
TABLET NNP NNP O
Take NNP NNP O
1 CD CD O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Tricor NNP NNP O
( ( ( O
FENOFIBRATE NNP NNP O
( ( ( O
TRICOR NNP NNP O
) ) ) O
) ) ) O
48 CD CD O
MG NNP NNP O
PO NNP NNP O
QD NNP NNP O
#30 NN NN O
Tablet NNP NNP O
   
( ( ( O
s)Unable JJ JJ O
to TO TO O
obtain VB VB O
this DT DT O
due JJ JJ O
to TO TO O
cost.Ultravate VB VB O
0.05 CD CD O
% NN NN O
( ( ( O
HALOBETASOL NNP NNP O
Propionate NNP NNP O
0.05 CD CD O
% NN NN O
) ) ) O
1 CD CD O
APPLICATION NNP NNP O
( ( ( O
0.05 CD CD O
% NN NN O
OINT NNP NNP O
. . . O
   
( ( ( O
GM NNP NNP O
) ) ) O
) ) ) O
TOP JJ JJ O
as IN IN O
directed VBN VBN O
, , , O
APPLY NNP NNP O
TO TO TO O
AFFECTED NNP NNP O
AREAS NNS NNS O
TWICE RB RB O
DAILY NNP NNP O
X NNP NNP O
15 CD CD O
DAYS NNS NNS O
AND CC CC O
THEN RB RB O
ON IN IN O
WEEKENDS NNP NNP O
ONLY NNP NNP O
. . . O
   
#50 NN NN O
Gram NNP NNP O
   
( ( ( O
s)Urea NN NN O
35 CD CD O
% NN NN O
Lotion NNP NNP O
35 CD CD O
% NN NN O
LOTION NNP NNP O
Take VB VB O
1 CD CD O
TOP NNP NNP O
BID NNP NNP O
x SYM SYM O
30 CD CD O
days NNS NNS O
, , , O
please VB VB O
apply VBP VBP O
it PRP PRP O
at IN IN O
plantar NN NN O
aspect NN NN O
of IN IN O
both DT DT O
feet NNS NNS O
twic VBP VBP O
a DT DT O
day NN NN O
#1 NN NN O
Tube NNP NNP O
   
( ( ( O
s)Allergies NNS NNS O
LISINOPRIL NNP NNP O
- : : O
Cough NNP NNP O
, , , O
HYDROCHLOROTHIAZIDE NNP NNP O
- : : O
Hyponatremia NNP NNP O
, , , O
Review NNP NNP O
of IN IN O
Systems NNPS NNPS O
Positive NNP NNP O
and CC CC O
negative JJ JJ O
as IN IN O
listed VBN VBN O
elsewhere RB RB O
in IN IN O
this DT DT O
note.Vital JJ JJ O
Signs NNP NNP O
BLOOD NNP NNP O
PRESSURE NN NN O
120/70 CD CD O
PULSE NNP NNP O
84 CD CD O
WEIGHT NNP NNP O
224 CD CD O
lbExam NN NN O
NAD NNP NNP O
. . . O
   
Neuro NNP NNP O
: : : O
Gait NNP NNP O
, , , O
speech NN NN O
and CC CC O
strength NN NN O
are VBP VBP O
grossly RB RB O
intact.Results NNS NNS O
We PRP PRP O
reviewed VBD VBD O
her PRP$ PRP$ O
lab NN NN O
blood NN NN O
tests NNS NNS O
and CC CC O
her PRP$ PRP$ O
MRI/MRA.Problems NNP NNP O
Diabetes NNP NNP O
mellitus NN NN O
type NN NN O
2 CD CD O
I PRP PRP O
gave VBD VBD O
her PRP$ PRP$ O
another DT DT O
Rx NNP NNP O
for IN IN O
lancets.Hypertension NN NN O
Elevated NNP NNP O
triglycerides NNS NNS O
Needs NNP NNP O
generic JJ JJ O
for IN IN O
Tricor NNP NNP O
. . . O
   
Mood NNP NNP O
Disorder NNP NNP O
, , , O
NOS NNP NNP O
Hyponatremia NNP NNP O
Anemia NNP NNP O
Disposition NNP NNP O
and CC CC O
Plans NNP NNP O
Plans NNPS NNPS O
as IN IN O
above IN IN O
under IN IN O
each DT DT O
individual JJ JJ O
problem NN NN O
. . . O
   
Also RB RB O
. . . O
   
. . . O
   
. . . O
   
1 CD CD O
) ) ) O
Spell NNP NNP O
. . . O
   
DDx NNP NNP O
includes VBZ VBZ O
hypoglycemia NN NN O
vs NNS NNS O
. . . O
   
TIA NNP NNP O
. . . O
   
Still RB RB O
not RB RB O
completely RB RB O
clear JJ JJ O
which WDT WDT O
. . . O
   
That DT DT O
said VBD VBD O
, , , O
she PRP PRP O
's VBZ VBZ O
doing VBG VBG O
well RB RB O
and CC CC O
that DT DT O
is VBZ VBZ O
reassuring VBG VBG O
. . . O
She PRP PRP O
needs VBZ VBZ O
to TO TO O
check VB VB O
her PRP$ PRP$ O
sugars NNS NNS O
if IN IN O
she PRP PRP O
has VBZ VBZ O
another DT DT O
spell NN NN O
. . . O
For IN IN O
now RB RB O
, , , O
we PRP PRP O
'll MD MD O
follow VB VB O
her PRP$ PRP$ O
closely RB RB O
. . . O
   
2 CD CD O
) ) ) O
HCM NNP NNP O
: : : O
Deferred NNP NNP O
today NN NN O
. . . O
   
Follow-up NNP NNP O
: : : O
RTC NNP NNP O
as IN IN O
previously RB RB O
scheduled VBN VBN O
. . . O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2066-03-03 JJ JJ I-DATE
GRANITE NNP NNP I-HOSPITAL
COUNTY NNP NNP I-HOSPITAL
MEMORIAL NNP NNP I-HOSPITAL
Arthritis NNP NNP O
Department NNP NNP O
93 CD CD I-STREET
Weld NNP NNP I-STREET
St NNP NNP I-STREET
BIRD NNP NNP O
, , , O
TERRI NNP NNP I-PATIENT
Lisbon NNP NNP I-CITY
, , , O
SD NNP NNP I-STATE
52797 CD CD I-ZIP
80910690 CD CD I-MEDICALRECORD
3-03-66 NN NN I-DATE
ID NNP NNP O
: : : O
Mrs NNP NNP O
. . . O
   
Bird NNP NNP I-PATIENT
comes VBZ VBZ O
in IN IN O
today NN NN O
for IN IN O
a DT DT O
routine JJ JJ O
check-up JJ JJ O
. . . O
   
She PRP PRP O
is VBZ VBZ O
a DT DT O
70-year-old JJ JJ O
female JJ JJ O
with IN IN O
multiple JJ JJ O
medical JJ JJ O
problems NNS NNS O
including VBG VBG O
atrial JJ JJ O
fibrillation NN NN O
, , , O
status NN NN O
post NN NN O
renal JJ JJ O
allograft NN NN O
, , , O
status NN NN O
post NN NN O
MVR NNP NNP O
and CC CC O
AVR NNP NNP O
, , , O
on IN IN O
Coumadin NNP NNP O
now RB RB O
, , , O
history NN NN O
of IN IN O
CABG NNP NNP O
in IN IN O
the DT DT O
setting VBG VBG O
of IN IN O
her PRP$ PRP$ O
valve NN NN O
replacements NNS NNS O
, , , O
history NN NN O
of IN IN O
a DT DT O
recent JJ JJ O
aortic JJ JJ O
aneurysm NN NN O
repair NN NN O
with IN IN O
some DT DT O
mental JJ JJ O
status NN NN O
diminution NN NN O
after IN IN O
the DT DT O
surgery NN NN O
. . . O
   
MEDICATIONS NNP NNP O
: : : O
Synthroid NNP NNP O
, , , O
Hydralazine NNP NNP O
, , , O
Lopressor NNP NNP O
, , , O
prednisone NN NN O
, , , O
Coumadin NNP NNP O
, , , O
Provera NNP NNP O
, , , O
NPH NNP NNP O
insulin NN NN O
, , , O
Neurontin NNP NNP O
300mg CD CD O
t.i.d. NN NN O
, , , O
Imuran NNP NNP O
100mg CD CD O
a DT DT O
day NN NN O
, , , O
Zocor NNP NNP O
20mg CD CD O
a DT DT O
day NN NN O
, , , O
and CC CC O
Digoxin NNP NNP O
0.25 CD CD O
alternating VBG VBG O
with IN IN O
0.125mg. CD CD O
   
She PRP PRP O
is VBZ VBZ O
also RB RB O
taking VBG VBG O
Fosamax NNP NNP O
10mg CD CD O
a DT DT O
day NN NN O
and CC CC O
Premarin NNP NNP O
0.3mg CD CD O
a DT DT O
day NN NN O
. . . O
   
The DT DT O
patient NN NN O
is VBZ VBZ O
followed VBN VBN O
closely RB RB O
by IN IN O
a DT DT O
visiting VBG VBG O
nurse NN NN O
at IN IN O
home NN NN O
. . . O
   
Her PRP$ PRP$ O
blood NN NN O
pressure NN NN O
checks NNS NNS O
have VBP VBP O
all DT DT O
been VBN VBN O
120-140/70-90 JJ JJ O
and CC CC O
her PRP$ PRP$ O
blood NN NN O
sugars NNS NNS O
have VBP VBP O
been VBN VBN O
running VBG VBG O
in IN IN O
the DT DT O
morning NN NN O
between IN IN O
80 CD CD O
and CC CC O
120 CD CD O
and CC CC O
in IN IN O
the DT DT O
evening NN NN O
from IN IN O
150 CD CD O
all PDT PDT O
the DT DT O
way NN NN O
up IN IN O
to TO TO O
450 CD CD O
. . . O
   
We PRP PRP O
have VBP VBP O
made VBN VBN O
some DT DT O
adjustments NNS NNS O
recently RB RB O
in IN IN O
her PRP$ PRP$ O
NPH NNP NNP O
morning NN NN O
dose NN NN O
, , , O
and CC CC O
hope VBP VBP O
to TO TO O
see VB VB O
if IN IN O
this DT DT O
will MD MD O
make VB VB O
a DT DT O
benefit NN NN O
. . . O
   
Patient NNP NNP O
notes NNS NNS O
that IN IN O
she PRP PRP O
has VBZ VBZ O
been VBN VBN O
feeling VBG VBG O
generally RB RB O
well RB RB O
, , , O
that IN IN O
she PRP PRP O
has VBZ VBZ O
been VBN VBN O
able JJ JJ O
to TO TO O
fill VB VB O
her PRP$ PRP$ O
cassettes NNS NNS O
for IN IN O
her PRP$ PRP$ O
medicines NNS NNS O
, , , O
and CC CC O
overall JJ JJ O
manage NN NN O
her PRP$ PRP$ O
medicines NNS NNS O
without IN IN O
problems NNS NNS O
. . . O
   
She PRP PRP O
does VBZ VBZ O
note VB VB O
that IN IN O
she PRP PRP O
is VBZ VBZ O
having VBG VBG O
some DT DT O
pain NN NN O
down RP RP O
her PRP$ PRP$ O
left JJ JJ O
leg NN NN O
, , , O
which WDT WDT O
she PRP PRP O
describes VBZ VBZ O
as IN IN O
her PRP$ PRP$ O
usual JJ JJ O
sciatica NN NN O
. . . O
   
The DT DT O
patient NN NN O
has VBZ VBZ O
had VBD VBD O
this DT DT O
on IN IN O
multiple JJ JJ O
occasions NNS NNS O
, , , O
and CC CC O
it PRP PRP O
usually RB RB O
waxes NNS NNS O
and CC CC O
wanes NNS NNS O
over IN IN O
time NN NN O
. . . O
   
The DT DT O
Neurontin NNP NNP O
in IN IN O
the DT DT O
past NN NN O
has VBZ VBZ O
been VBN VBN O
very RB RB O
helpful JJ JJ O
for IN IN O
this DT DT O
. . . O
   
The DT DT O
patient NN NN O
denies VBZ VBZ O
any DT DT O
chest NN NN O
pain NN NN O
, , , O
shortness NN NN O
of IN IN O
breath NN NN O
, , , O
has VBZ VBZ O
had VBN VBN O
no DT DT O
fevers NNS NNS O
or CC CC O
weight NN NN O
loss NN NN O
recently RB RB O
, , , O
and CC CC O
has VBZ VBZ O
no DT DT O
dyspnea NN NN O
at IN IN O
nighttime NN NN O
. . . O
   
PHYSICAL JJ JJ O
EXAM NNP NNP O
: : : O
Notable NNP NNP O
for IN IN O
a DT DT O
short JJ JJ O
female JJ JJ O
in IN IN O
no DT DT O
acute JJ JJ O
distress NN NN O
, , , O
who WP WP O
walks VBZ VBZ O
with IN IN O
a DT DT O
walker NN NN O
today NN NN O
. . . O
   
Blood NNP NNP O
pressure NN NN O
: : : O
144/76 CD CD O
. . . O
   
Pulse NNP NNP O
: : : O
78 CD CD O
and CC CC O
regular JJ JJ O
. . . O
   
Her PRP$ PRP$ O
lungs NNS NNS O
bilaterally RB RB O
are VBP VBP O
clear JJ JJ O
to TO TO O
auscultation NN NN O
. . . O
   
Her PRP$ PRP$ O
heart NN NN O
is VBZ VBZ O
with IN IN O
sharp JJ JJ O
click NN NN O
during IN IN O
S1 NNP NNP O
and CC CC O
S2 NNP NNP O
. . . O
   
She PRP PRP O
has VBZ VBZ O
got VBN VBN O
a DT DT O
regular JJ JJ O
rate NN NN O
and CC CC O
rhythm NN NN O
today NN NN O
. . . O
   
Her PRP$ PRP$ O
abdomen NN NN O
is VBZ VBZ O
soft JJ JJ O
, , , O
nontender NN NN O
, , , O
with IN IN O
no DT DT O
organomegaly NN NN O
. . . O
   
She PRP PRP O
has VBZ VBZ O
got VBD VBD O
a DT DT O
well-healed JJ JJ O
abdominal JJ JJ O
scar NN NN O
. . . O
   
She PRP PRP O
has VBZ VBZ O
got VBN VBN O
no DT DT O
lower JJR JJR O
extremity NN NN O
edema NN NN O
. . . O
   
Her PRP$ PRP$ O
musculoskeletal JJ JJ O
examination NN NN O
is VBZ VBZ O
notable JJ JJ O
for IN IN O
tenderness NNS NNS O
up RB RB O
into IN IN O
the DT DT O
sciatic JJ JJ O
notch NN NN O
on IN IN O
the DT DT O
left NN NN O
side NN NN O
. . . O
   
She PRP PRP O
has VBZ VBZ O
got VBN VBN O
otherwise RB RB O
joints NNS NNS O
that WDT WDT O
move VBP VBP O
through IN IN O
a DT DT O
normal JJ JJ O
range NN NN O
of IN IN O
motion NN NN O
, , , O
no DT DT O
swelling VBG VBG O
or CC CC O
warmth NN NN O
. . . O
   
There EX EX O
is VBZ VBZ O
no DT DT O
evidence NN NN O
for IN IN O
ecchymoses NNS NNS O
or CC CC O
petechiae NN NN O
anywhere RB RB O
. . . O
   
Today NN NN O
will MD MD O
check VB VB O
a DT DT O
hemoglobin NN NN O
A1C NNP NNP O
, , , O
a DT DT O
CBC NNP NNP O
, , , O
and CC CC O
a DT DT O
chem NN NN O
7 CD CD O
for IN IN O
routine NN NN O
monitoring VBG VBG O
. . . O
   
My PRP$ PRP$ O
overall JJ JJ O
impression NN NN O
is VBZ VBZ O
that DT DT O
Ms NNP NNP O
. . . O
Bird NNP NNP I-PATIENT
is VBZ VBZ O
doing VBG VBG O
quite RB RB O
well RB RB O
. . . O
   
I PRP PRP O
will MD MD O
not RB RB O
make VB VB O
any DT DT O
changes NNS NNS O
to TO TO O
her PRP$ PRP$ O
medicines NNS NNS O
until IN IN O
I PRP PRP O
see VBP VBP O
her PRP$ PRP$ O
hemoglobin NN NN O
A1C NNP NNP O
. . . O
   
I PRP PRP O
suggested VBD VBD O
that IN IN O
I PRP PRP O
could MD MD O
give VB VB O
her PRP$ PRP$ O
an DT DT O
injection NN NN O
for IN IN O
her PRP$ PRP$ O
sciatica NN NN O
, , , O
but CC CC O
I PRP PRP O
would MD MD O
rather RB RB O
wait VB VB O
because IN IN O
of IN IN O
her PRP$ PRP$ O
anticoagulation NN NN O
, , , O
and CC CC O
to TO TO O
see VB VB O
whether IN IN O
it PRP PRP O
remits VBZ VBZ O
on IN IN O
it PRP PRP O
's VBZ VBZ O
own VBN VBN O
. . . O
   
GRANITE NNP NNP I-HOSPITAL
COUNTY NNP NNP I-HOSPITAL
MEMORIAL NNP NNP I-HOSPITAL
Arthritis NNP NNP O
Department NNP NNP O
12 CD CD I-STREET
Weld NNP NNP I-STREET
St NNP NNP I-STREET
BIRD NNP NNP O
, , , O
TERRI NNP NNP I-PATIENT
Lisbon NNP NNP I-CITY
, , , O
SD NNP NNP I-STATE
52797 CD CD I-ZIP
80910690 CD CD I-MEDICALRECORD
3-03-66 CD CD I-DATE
PAGE NNP NNP O
2 CD CD O
Lastly RB RB O
, , , O
as RB RB O
far RB RB O
as IN IN O
her PRP$ PRP$ O
ability NN NN O
to TO TO O
drive VB VB O
, , , O
this DT DT O
has VBZ VBZ O
been VBN VBN O
an DT DT O
issue NN NN O
for IN IN O
the DT DT O
last JJ JJ O
several JJ JJ O
months NNS NNS O
since IN IN O
her PRP$ PRP$ O
abdominal JJ JJ O
aortic JJ JJ O
aneurysm NN NN O
repair NN NN O
. . . O
   
She PRP PRP O
is VBZ VBZ O
clearly RB RB O
doing VBG VBG O
better JJR JJR O
from IN IN O
a DT DT O
mental JJ JJ O
status NN NN O
standpoint NN NN O
, , , O
as IN IN O
evidenced VBN VBN O
by IN IN O
her PRP$ PRP$ O
being VBG VBG O
able JJ JJ O
to TO TO O
manage VB VB O
her PRP$ PRP$ O
own JJ JJ O
medications NNS NNS O
. . . O
   
I PRP PRP O
have VBP VBP O
discussed VBN VBN O
this DT DT O
issue NN NN O
at IN IN O
length NN NN O
with IN IN O
family NN NN O
and CC CC O
her PRP$ PRP$ O
nurse NN NN O
, , , O
and CC CC O
everybody NN NN O
is VBZ VBZ O
comfortable JJ JJ O
with IN IN O
her PRP$ PRP$ O
trying VBG VBG O
to TO TO O
drive VB VB O
with IN IN O
someone NN NN O
in IN IN O
the DT DT O
car NN NN O
with IN IN O
her PRP PRP O
. . . O
   
I PRP PRP O
will MD MD O
talk VB VB O
to TO TO O
her PRP$ PRP$ O
son NN NN O
, , , O
Steven NNP NNP I-PATIENT
Bird NNP NNP I-PATIENT
, , , O
who WP WP O
lives VBZ VBZ O
downstairs NN NN O
, , , O
and CC CC O
see VB VB O
whether IN IN O
he PRP PRP O
or CC CC O
his PRP$ PRP$ O
wife NN NN O
could MD MD O
help VB VB O
with IN IN O
trying VBG VBG O
her PRP PRP O
out IN IN O
driving VBG VBG O
first JJ JJ O
in IN IN O
a DT DT O
schoolyard NN NN O
without IN IN O
any DT DT O
people NNS NNS O
there RB RB O
, , , O
and CC CC O
then RB RB O
on IN IN O
less-crowded JJ JJ O
roads NNS NNS O
, , , O
and CC CC O
then RB RB O
finally RB RB O
in IN IN O
a DT DT O
more RBR RBR O
regular JJ JJ O
situation NN NN O
. . . O
   
We PRP PRP O
will MD MD O
try VB VB O
this DT DT O
over IN IN O
time NN NN O
and CC CC O
see VB VB O
how WRB WRB O
it PRP PRP O
works VBZ VBZ O
, , , O
and CC CC O
I PRP PRP O
will MD MD O
be VB VB O
involved VBN VBN O
in IN IN O
making VBG VBG O
any DT DT O
decisions NNS NNS O
as RB RB O
far RB RB O
as IN IN O
letting VBG VBG O
her PRP$ PRP$ O
drive NN NN O
on IN IN O
her PRP$ PRP$ O
own JJ JJ O
. . . O
   
_____________________________ NN NN O
_ NN NN O
Steve NNP NNP I-DOCTOR
George NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
   
EH:UC:8398 NNP NNP I-IDNUM
DD:3-03-66 NNP NNP O
DT:3-04-66 NNP NNP O
DV:3-03-66 NNP NNP O
******** NN NN O
Not RB RB O
reviewed VBN VBN O
by IN IN O
Attending NNP NNP O
Physician NNP NNP O
******** NN NN O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2084-05-26 JJ JJ I-DATE
HCC NNP NNP I-HOSPITAL
CANCER NNP NNP O
CENTER NNP NNP O
ADMIT NNP NNP O
NOTE NNP NNP O
PATIENT NNP NNP O
: : : O
Ulyses NNP NNP I-PATIENT
Vollmer NNP NNP I-PATIENT
MRN NNP NNP O
: : : O
8740465 CD CD I-MEDICALRECORD
DOA NNP NNP O
: : : O
May NNP NNP I-DATE
26 CD CD O
, , , O
2084 CD CD I-DATE
CC NNP NNP O
: : : O
73M CD CD O
w NN NN O
/ NN NN O
metastatic JJ JJ O
esophageal NN NN O
CA NNP NNP O
presenting VBG VBG O
to TO TO O
ED NNP NNP O
after IN IN O
presyncopal NN NN O
episode NN NN O
Oncologic NNP NNP O
History NN NN O
6/83 CD CD I-DATE
Dysphagia NNP NNP O
7/83 CD CD I-DATE
EGD NNP NNP O
GE NNP NNP O
jnc NN NN O
mass NN NN O
; : : O
   
mod-poorly JJ JJ O
differentiated JJ JJ O
adenoca NN NN O
. . . O
   
CT NNP NNP O
chest NN NN O
: : : O
esoph NN NN O
wall NN NN O
thickening NN NN O
at IN IN O
35-40 JJ JJ O
cm NN NN O
extending VBG VBG O
to TO TO O
cardia VB VB O
, , , O
LAN NNP NNP O
: : : O
gastroepiploic NN NN O
, , , O
celiac NN NN O
and CC CC O
aortocaval NN NN O
, , , O
( ( ( O
L NNP NNP O
) ) ) O
axilla NN NN O
, , , O
gastrohepatic JJ JJ O
ligament NN NN O
, , , O
celiac NN NN O
axis NNS NNS O
and CC CC O
retrocrural JJ JJ O
space NN NN O
. . . O
   
Also RB RB O
3mm CD CD O
nodule NN NN O
adjacent JJ JJ O
to TO TO O
the DT DT O
( ( ( O
R NN NN O
) ) ) O
major JJ JJ O
fissure NN NN O
in IN IN O
the DT DT O
lung NN NN O
. . . O
   
PET NNP NNP O
scan VB VB O
confirmed VBD VBD O
axillary JJ JJ O
and CC CC O
abdominal JJ JJ O
involvement NN NN O
with IN IN O
cancer NN NN O
. . . O
   
8-9/83 JJ JJ I-DATE
XRT NNP NNP O
to TO TO O
esophagus VB VB O
10/83 CD CD I-DATE
Weekly NNP NNP O
taxotere NN NN O
2/17/84 CD CD I-DATE
. . . O
   
Extravasation NNP NNP O
of IN IN O
taxotere NN NN O
. . . O
   
Subsequently RB RB O
held VBD VBD O
. . . O
   
3/14/84 CD CD I-DATE
Restaging NNP NNP O
work-up JJ JJ O
revealed VBD VBD O
progressive JJ JJ O
disease NN NN O
. . . O
   
Increasing NNP NNP O
mediastinal JJ JJ O
lymphadenopathy NN NN O
stable JJ JJ O
left VBD VBD O
axillary JJ JJ O
lymphadenopathy NN NN O
. . . O
   
Interval NNP NNP O
increase NN NN O
in IN IN O
size NN NN O
in IN IN O
lingular NN NN O
and CC CC O
right JJ JJ O
upper JJ JJ O
lobe NN NN O
subpleural JJ JJ O
nodules NNS NNS O
suspicious JJ JJ O
for IN IN O
metastatic JJ JJ O
disease NN NN O
. . . O
   
New NNP NNP O
small JJ JJ O
pericardial JJ JJ O
effusion NN NN O
and CC CC O
left VBD VBD O
pleural JJ JJ O
effusion NN NN O
. . . O
   
There EX EX O
is VBZ VBZ O
partial JJ JJ O
loculation NN NN O
of IN IN O
the DT DT O
left VBN VBN O
effusion NN NN O
. . . O
   
There EX EX O
is VBZ VBZ O
significant JJ JJ O
increase NN NN O
in IN IN O
size NN NN O
in IN IN O
the DT DT O
right NN NN O
pleural JJ JJ O
effusion NN NN O
. . . O
   
3/2084 CD CD I-DATE
admitted VBN VBN O
for IN IN O
resection NN NN O
of IN IN O
brain NN NN O
met VBD VBD O
. . . O
   
WBXRT NNP NNP O
afterwards NNS NNS O
4/22/2084 CD CD I-DATE
- : : O
returns NNS NNS O
to TO TO O
clinic NN NN O
feels VBZ VBZ O
tired JJ JJ O
5/06/2084 CD CD I-DATE
- : : O
restaging NN NN O
showed VBD VBD O
worsening VBG VBG O
disease NN NN O
. . . O
   
Tired NNP NNP O
. . . O
   
Occasional NNP NNP O
CP NNP NNP O
with IN IN O
exertion NN NN O
. . . O
   
back RB RB O
pain NN NN O
5/23/2084 CD CD I-DATE
- : : O
started VBD VBD O
Irinotecan JJ JJ O
History NN NN O
of IN IN O
Present JJ JJ O
Illness NNP NNP O
: : : O
Mr NNP NNP O
. . . O
Vollmer NNP NNP I-PATIENT
is VBZ VBZ O
a DT DT O
73 CD CD I-AGE
yo NN NN O
man NN NN O
with IN IN O
stage NN NN O
IVB NNP NNP O
esophageal NN NN O
cancer NN NN O
s/p NN NN O
XRT NNP NNP O
and CC CC O
6 CD CD O
mo NN NN O
weekly JJ JJ O
taxotere NN NN O
, , , O
complicated VBN VBN O
by IN IN O
RV NNP NNP O
thrombosis NNS NNS O
( ( ( O
on IN IN O
coumadin NN NN O
) ) ) O
and CC CC O
extravasation NN NN O
of IN IN O
taxotere NN NN O
on IN IN O
2/17/84 CD CD I-DATE
. . . O
   
This DT DT O
was VBD VBD O
followed VBN VBN O
by IN IN O
brain NN NN O
resection NN NN O
and CC CC O
WBXRT NNP NNP O
. . . O
   
He PRP PRP O
started VBD VBD O
Irinotecan NNP NNP O
on IN IN O
5/23 CD CD I-DATE
. . . O
   
He PRP PRP O
woke VBD VBD O
from IN IN O
bed NN NN O
this DT DT O
am VBP VBP O
and CC CC O
fely RB RB O
dizzy NN NN O
and CC CC O
lightheaded VBN VBN O
upon IN IN O
standing NN NN O
. . . O
   
By IN IN O
the DT DT O
time NN NN O
he PRP PRP O
reached VBD VBD O
the DT DT O
kitchen NN NN O
, , , O
he PRP PRP O
fell VBD VBD O
and CC CC O
hit VBD VBD O
the DT DT O
L NNP NNP O
side NN NN O
of IN IN O
his PRP$ PRP$ O
face NN NN O
on IN IN O
the DT DT O
floor NN NN O
, , , O
sustaining VBG VBG O
a DT DT O
small JJ JJ O
cut NN NN O
at IN IN O
his PRP$ PRP$ O
nose NN NN O
. . . O
   
The DT DT O
patient NN NN O
reports NNS NNS O
that IN IN O
he PRP PRP O
did VBD VBD O
not RB RB O
lose VB VB O
consciousness NN NN O
. . . O
   
No DT DT O
vertigo NN NN O
, , , O
no DT DT O
loss NN NN O
of IN IN O
continence NN NN O
, , , O
no DT DT O
uncontrolled JJ JJ O
movements NNS NNS O
of IN IN O
the DT DT O
extremities NNS NNS O
, , , O
no DT DT O
weakness NN NN O
, , , O
no DT DT O
parasthesias NN NN O
, , , O
no DT DT O
changes NNS NNS O
in IN IN O
vision NN NN O
, , , O
no DT DT O
chest NN NN O
pain NN NN O
, , , O
no DT DT O
shortness NN NN O
of IN IN O
breath NN NN O
. . . O
   
Patient NNP NNP O
notes NNS NNS O
decreased VBD VBD O
appetite NN NN O
and CC CC O
poor JJ JJ O
PO NNP NNP O
intake NN NN O
over IN IN O
the DT DT O
past JJ JJ O
few JJ JJ O
days NNS NNS O
. . . O
   
No DT DT O
recent JJ JJ O
bouts NNS NNS O
of IN IN O
diarrhea NN NN O
or CC CC O
nausea/vomiting VBG VBG O
. . . O
   
He PRP PRP O
was VBD VBD O
brought VBN VBN O
to TO TO O
ED NNP NNP O
where WRB WRB O
he PRP PRP O
was VBD VBD O
placed VBN VBN O
on IN IN O
cardiac JJ JJ O
monitor NN NN O
. . . O
   
EKG NNP NNP O
showed VBD VBD O
NSR NNP NNP O
with IN IN O
no DT DT O
evidence NN NN O
of IN IN O
arrhythmia NN NN O
. . . O
   
Head NNP NNP O
CT NNP NNP O
showed VBD VBD O
no DT DT O
bleed NN NN O
or CC CC O
other JJ JJ O
abnormality NN NN O
. . . O
   
Labs NNP NNP O
were VBD VBD O
consistent JJ JJ O
with IN IN O
dehydration NN NN O
and CC CC O
IVF NNP NNP O
started VBD VBD O
. . . O
   
Review NNP NNP O
of IN IN O
Systems NNPS NNPS O
: : : O
General NNP NNP O
: : : O
decreased VBD VBD O
appetite NN NN O
over IN IN O
the DT DT O
past JJ JJ O
few JJ JJ O
weeks NNS NNS O
, , , O
markedly RB RB O
decreased VBD VBD O
PO NNP NNP O
intake NN NN O
over IN IN O
past JJ JJ O
several JJ JJ O
days NNS NNS O
. . . O
   
No DT DT O
fevers NNS NNS O
. . . O
   
Respiratory NNP NNP O
: : : O
no DT DT O
SOB NNP NNP O
, , , O
DOE NNP NNP O
, , , O
cough NN NN O
, , , O
hemoptysis NN NN O
HEENT NNP NNP O
: : : O
No DT DT O
neck NN NN O
swelling VBG VBG O
, , , O
no DT DT O
neck NN NN O
stiffness JJ JJ O
, , , O
no DT DT O
hoarseness NN NN O
, , , O
no DT DT O
hearing VBG VBG O
loss NN NN O
Cardiac NNP NNP O
: : : O
No DT DT O
chest NN NN O
pain NN NN O
, , , O
no DT DT O
palpitations NNS NNS O
, , , O
no DT DT O
arrythmias NN NN O
Gastrointestinal NNP NNP O
: : : O
no DT DT O
N/V/diarrhea NNP NNP O
, , , O
+ NN NN O
constipation NN NN O
, , , O
no DT DT O
bleeding VBG VBG O
Neurologic NNP NNP O
: : : O
No DT DT O
seizures NNS NNS O
, , , O
new JJ JJ O
headaches NNS NNS O
, , , O
numbness NNS NNS O
, , , O
weakness NNS NNS O
Musculoskeletal NNP NNP O
: : : O
No DT DT O
new JJ JJ O
back RB RB O
pain NN NN O
, , , O
no DT DT O
saddle NN NN O
paresthsia NN NN O
, , , O
no DT DT O
neck NN NN O
pain NN NN O
, , , O
no DT DT O
leg NN NN O
pain NN NN O
, , , O
no DT DT O
arm NN NN O
pain NN NN O
Urologic NNP NNP O
: : : O
No DT DT O
hematuria NN NN O
, , , O
no DT DT O
dysuria NN NN O
Hematologic NNP NNP O
: : : O
No DT DT O
bruising VBG VBG O
, , , O
clotting VBG VBG O
, , , O
bleeding VBG VBG O
noted VBN VBN O
Problems/PMH NNP NNP O
: : : O
Esophageal NNP NNP O
Ca NNP NNP O
as IN IN O
above IN IN O
Repair NNP NNP O
of IN IN O
Zenker NNP NNP O
's POS POS O
diverticulum NN NN O
in IN IN O
2080 CD CD I-DATE
Aterial NNP NNP O
stent NN NN O
was VBD VBD O
placed VBN VBN O
in IN IN O
the DT DT O
mid JJ JJ O
LAD NNP NNP O
in IN IN O
4/80 CD CD I-DATE
; : : O
   
+ NN NN O
stress NN NN O
thal NN NN O
5/83 CD CD I-DATE
Hypercholesteremia NNP NNP O
Arthritis NNP NNP O
Borderline NNP NNP O
Diabetic NNP NNP O
Heart NNP NNP O
murmur NN NN O
for IN IN O
50 CD CD O
years NNS NNS O
Medications NNP NNP O
Decadron NNP NNP O
2mg CD CD O
PO NNP NNP O
QD NNP NNP O
Triamterene/hctz NNP NNP O
( ( ( O
MAXZIDE NNP NNP O
TABLET NNP NNP O
) ) ) O
1 CD CD O
TAB NNP NNP O
PO NNP NNP O
QD NNP NNP O
Vitamin NNP NNP O
B NNP NNP O
COMPLEX NNP NNP O
1 CD CD O
TAB NNP NNP O
PO NNP NNP O
QD NNP NNP O
Folic NNP NNP O
ACID NNP NNP O
1 CD CD O
MG NNP NNP O
( ( ( O
1MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Iron NNP NNP O
SULFATE NNP NNP O
( ( ( O
FERROUS NNP NNP O
SULFATE NNP NNP O
) ) ) O
325 CD CD O
MG NNP NNP O
(325(65)MG NNP NNP O
TABLET NNP NNP O
take NN NN O
1 CD CD O
) ) ) O
PO NNP NNP O
BID NNP NNP O
Lipitor NNP NNP O
( ( ( O
ATORVASTATIN NNP NNP O
) ) ) O
10 CD CD O
MG NNP NNP O
( ( ( O
10MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
) ) ) O
PO NNP NNP O
QHS NNP NNP O
Dulcolax NNP NNP O
( ( ( O
BISACODYL NNP NNP O
) ) ) O
5 CD CD O
MG NNP NNP O
( ( ( O
5MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
) ) ) O
PO NNP NNP O
2 CD CD O
tabs NNS NNS O
QD NNP NNP O
Coumadin NNP NNP O
( ( ( O
WARFARIN NNP NNP O
SODIUM NNP NNP O
) ) ) O
5 CD CD O
MG NNP NNP O
( ( ( O
5MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
) ) ) O
PO NNP NNP O
QPM NNP NNP O
, , , O
take NN NN O
2 CD CD O
tablets NNS NNS O
tonight NN NN O
, , , O
then RB RB O
1 CD CD O
QD NNP NNP O
Terazosin NNP NNP O
( ( ( O
TERAZOSIN NNP NNP O
HCL NNP NNP O
) ) ) O
5 CD CD O
MG NNP NNP O
( ( ( O
5MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
) ) ) O
PO NNP NNP O
QPM NNP NNP O
Compazine NNP NNP O
( ( ( O
PROCHLORPERAZINE NNP NNP O
MALEATE NNP NNP O
) ) ) O
10 CD CD O
MG NNP NNP O
( ( ( O
10MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
) ) ) O
PO NNP NNP O
Q6H NNP NNP O
PRN NNP NNP O
nausea NN NN O
Lorazepam NNP NNP O
1 CD CD O
MG NNP NNP O
( ( ( O
1MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
) ) ) O
PO NNP NNP O
Q4H NNP NNP O
PRN NNP NNP O
nausea NN NN O
and CC CC O
sleep VB VB O
Atenolol NNP NNP O
25 CD CD O
MG NNP NNP O
( ( ( O
50MG CD CD O
TABLET NNP NNP O
take NN NN O
0.5 CD CD O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Megace NNP NNP O
( ( ( O
MEGESTROL NNP NNP O
ACETATE NNP NNP O
SUSPENSION NNP NNP O
) ) ) O
800 CD CD O
MG NNP NNP O
(40MG/ML NNP NNP O
ORAL NNP NNP O
SUSP NNP NNP O
take NN NN O
20 CD CD O
ML NNP NNP O
) ) ) O
PO NNP NNP O
QD NNP NNP O
x SYM SYM O
30 CD CD O
days NNS NNS O
Allergies NNP NNP O
Codeine NNP NNP O
- : : O
Dizzy NNP NNP O
FH/SH NNP NNP O
: : : O
Living VBG VBG O
alone RB RB O
with IN IN O
family NN NN O
close NN NN O
by IN IN O
. . . O
   
Never RB RB O
married VBN VBN O
No DT DT O
children NNS NNS O
. . . O
   
Never RB RB O
smoked VBD VBD O
Rare NNP NNP O
ETOH NNP NNP O
Aerospace NNP NNP I-PROFESSION
engineer NN NN I-PROFESSION
for IN IN O
40 CD CD O
years NNS NNS O
. . . O
   
No DT DT O
family NN NN O
history NN NN O
of IN IN O
cancer NN NN O
Vital NNP NNP O
Signs NNP NNP O
T96.1 NNP NNP O
P86 NNP NNP O
BP101/63 NNP NNP O
RR22 NNP NNP O
PulseOx94%RA NNP NNP O
No DT DT O
apparent NN NN O
distree NN NN O
, , , O
no DT DT O
lightheadedness NN NN O
upon IN IN O
sitting VBG VBG O
up RP RP O
Neck NNP NNP O
: : : O
no DT DT O
nodes NNS NNS O
palpable JJ JJ O
HEENT NNP NNP O
: : : O
No DT DT O
thrush NN NN O
or CC CC O
mucositis NN NN O
; : : O
   
EOMI NNP NNP O
; : : O
   
PERRL NNP NNP O
Skin NNP NNP O
: : : O
tan NN NN O
appearing VBG VBG O
despite IN IN O
little JJ JJ O
sun NN NN O
exposure NN NN O
Ext NNP NNP O
: : : O
without IN IN O
edema NN NN O
, , , O
clubbing VBG VBG O
Cor NNP NNP O
: : : O
S1 NNP NNP O
S2 NNP NNP O
Chest NN NN O
: : : O
clear JJ JJ O
lungs NNS NNS O
without IN IN O
wheezing VBG VBG O
or CC CC O
crackles NNS NNS O
Abdomen NNP NNP O
: : : O
soft JJ JJ O
, , , O
NT NNP NNP O
no DT DT O
HSM NNP NNP O
Nodes NNS NNS O
: : : O
neg NN NN O
cerv NN NN O
, , , O
sc NN NN O
Neuro NNP NNP O
: : : O
grossly RB RB O
non-focal JJ JJ O
ASSESSMENT NNP NNP O
AND CC CC O
PLAN NNP NNP O
: : : O
73 CD CD I-AGE
yo NN NN O
man NN NN O
with IN IN O
IVB NNP NNP O
esophageal NN NN O
adenocarcinoma NN NN O
s/p NN NN O
XRT NNP NNP O
w NN NN O
/ NN NN O
weekly JJ JJ O
taxotere NN NN O
. . . O
   
s/p NN NN O
WBXRT/resection NNP NNP O
. . . O
   
Started NNP NNP O
Irinotecan NNP NNP O
5/23 CD CD I-DATE
. . . O
   
Presyncopal NNP NNP O
episode NN NN O
in IN IN O
setting VBG VBG O
of IN IN O
dehydration NN NN O
. . . O
   
Patient NNP NNP O
's POS POS O
skin NN NN O
has VBZ VBZ O
been VBN VBN O
noted VBN VBN O
by IN IN O
his PRP$ PRP$ O
MD NNP NNP O
's POS POS O
in IN IN O
the DT DT O
past NN NN O
as IN IN O
a DT DT O
possible JJ JJ O
sign NN NN O
of IN IN O
Addisonism NNP NNP O
( ( ( O
though IN IN O
no DT DT O
evidence NN NN O
of IN IN O
disease NN NN O
involvement NN NN O
of IN IN O
adrenalsand NN NN O
labs NNS NNS O
have VBP VBP O
not RB RB O
been VBN VBN O
consistent JJ JJ O
with IN IN O
this DT DT O
in IN IN O
the DT DT O
past JJ JJ O
) ) ) O
. . . O
   
He PRP PRP O
's VBZ VBZ O
currently RB RB O
maintained VBN VBN O
with IN IN O
Decadron NNP NNP O
2mg/d. CD CD O
   
1 CD CD O
. . . O
Vigorous NNP NNP O
IVF NNP NNP O
's POS POS O
   
2 CD CD O
. . . O
Cardiac NNP NNP O
monitor NN NN O
overnight JJ JJ O
   
3 CD CD O
. . . O
Possible JJ JJ O
adrenal JJ JJ O
dysfunction NN NN O
contributed VBD VBD O
to TO TO O
this DT DT O
episode NN NN O
. . . O
   
Could MD MD O
consider VB VB O
switch NN NN O
to TO TO O
Florinef NNP NNP O
. . . O
   
4 CD CD O
. . . O
Bowel NNP NNP O
regimen NNS NNS O
for IN IN O
constipation NN NN O
which WDT WDT O
is VBZ VBZ O
causing VBG VBG O
some DT DT O
discomfort NN NN O
( ( ( O
though IN IN O
be VB VB O
wary JJ JJ O
of IN IN O
CPT-11's NNP NNP O
pro-diarrheal JJ JJ O
effects NNS NNS O
) ) ) O
. . . O
   
5 CD CD O
. . . O
Continue NNP NNP O
pain NN NN O
regimen NNS NNS O
. . . O
   
____________________________________________ NN NN O
_ NN NN O
Uriel NNP NNP I-DOCTOR
Hendricks NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
and CC CC O
Xavier NNP NNP I-DOCTOR
Otero NNP NNP I-DOCTOR
, , , O
MD NNP NNP O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2062-08-30 JJ JJ I-DATE
CCU NNP NNP O
JAR NNP NNP O
Admit NNP NNP O
Note NN NN O
Name NN NN O
: : : O
Jacob NNP NNP I-PATIENT
Goins NNP NNP I-PATIENT
MR NNP NNP O
#: NN NN O
6850327 CD CD I-MEDICALRECORD
( ( ( O
Please VB VB O
note NN NN O
that IN IN O
pt NN NN O
also RB RB O
has VBZ VBZ O
MRN NNP NNP O
4033790 CD CD I-MEDICALRECORD
) ) ) O
Date NN NN O
of IN IN O
admission NN NN O
: : : O
8/30/2062 CD CD I-DATE
Resident NNP NNP O
: : : O
Addison NNP NNP I-DOCTOR
Keefe NNP NNP I-DOCTOR
Attending NNP NNP O
: : : O
Angel NNP NNP I-DOCTOR
Vail NNP NNP I-DOCTOR
PCP NNP NNP O
: : : O
Felicia NNP NNP I-DOCTOR
Ali NNP NNP I-DOCTOR
Source NNP NNP O
: : : O
Medical NNP NNP O
Record NNP NNP O
and CC CC O
Family NNP NNP O
CC NNP NNP O
: : : O
L NNP NNP O
Arm NNP NNP O
Weakness NNP NNP O
HPI NNP NNP O
: : : O
28 CD CD I-AGE
yo NN NN O
RH NNP NNP O
M NNP NNP O
h/o NN NN O
DM1 NNP NNP O
, , , O
ESRD NNP NNP O
on IN IN O
HD NNP NNP O
, , , O
HTN NNP NNP O
, , , O
Stroke NNP NNP O
( ( ( O
thought VBD VBD O
to TO TO O
be VB VB O
due JJ JJ O
to TO TO O
thrombocytosis NNS NNS O
) ) ) O
, , , O
GTC NNP NNP O
in IN IN O
setting VBG VBG O
of IN IN O
HTN NNP NNP O
one CD CD O
year NN NN O
ago RB RB O
( ( ( O
and CC CC O
in IN IN O
June NNP NNP I-DATE
per IN IN O
family NN NN O
) ) ) O
, , , O
multiple JJ JJ O
HTN NNP NNP O
episodes NNS NNS O
on IN IN O
many JJ JJ O
anti-hypertensives JJ JJ O
, , , O
RIJ NNP NNP O
thrombosis NN NN O
, , , O
had VBD VBD O
transient NN NN O
L NNP NNP O
arm NN NN O
weakness NN NN O
at IN IN O
HD NNP NNP O
followed VBN VBN O
by IN IN O
some DT DT O
difficulty NN NN O
speaking VBG VBG O
and CC CC O
change NN NN O
in IN IN O
his PRP$ PRP$ O
mental JJ JJ O
status NN NN O
. . . O
   
He PRP PRP O
was VBD VBD O
reportedly RB RB O
in IN IN O
good JJ JJ O
health NN NN O
the DT DT O
night NN NN O
prior RB RB O
to TO TO O
admission NN NN O
and CC CC O
the DT DT O
morning NN NN O
of IN IN O
admission NN NN O
per IN IN O
his PRP$ PRP$ O
family NN NN O
, , , O
with IN IN O
no DT DT O
sick JJ JJ O
contacts NNS NNS O
and CC CC O
no DT DT O
travel NN NN O
. . . O
   
At IN IN O
HD NNP NNP O
he PRP PRP O
was VBD VBD O
hypertensive JJ JJ O
with IN IN O
SBP NNP NNP O
in IN IN O
200s CD CD O
, , , O
had VBD VBD O
transient NN NN O
L NNP NNP O
arm NN NN O
weakness NN NN O
and CC CC O
paresthesias NN NN O
which WDT WDT O
then RB RB O
resolved VBD VBD O
and CC CC O
had VBD VBD O
difficulty NN NN O
speaking VBG VBG O
and CC CC O
following VBG VBG O
commands NNS NNS O
after IN IN O
being VBG VBG O
noted VBN VBN O
by IN IN O
his PRP$ PRP$ O
nephrologist NN NN O
at IN IN O
an DT DT O
OSH NNP NNP O
to TO TO O
be VB VB O
mentating VBG VBG O
well RB RB O
with IN IN O
normal JJ JJ O
speech NN NN O
. . . O
   
No DT DT O
urinary/bowel NN NN O
incontinence NN NN O
, , , O
tonic-clonic JJ JJ O
movements NNS NNS O
or CC CC O
syncope NN NN O
was VBD VBD O
noted VBN VBN O
by IN IN O
his PRP$ PRP$ O
providers NNS NNS O
. . . O
   
He PRP PRP O
was VBD VBD O
brought VBN VBN O
to TO TO O
BMH NNP NNP I-HOSPITAL
ED NNP NNP O
because IN IN O
of IN IN O
these DT DT O
problems NNS NNS O
. . . O
   
In IN IN O
the DT DT O
ED NNP NNP O
, , , O
his PRP$ PRP$ O
initial JJ JJ O
VS NNP NNP O
were VBD VBD O
BP NNP NNP O
211/120 CD CD O
HR NNP NNP O
88 CD CD O
T NN NN O
98 CD CD O
R NN NN O
18 CD CD O
SaO2 NNP NNP O
100 CD CD O
% NN NN O
RA NNP NNP O
. . . O
   
he PRP PRP O
received VBD VBD O
a DT DT O
Head NNP NNP O
CT NNP NNP O
which WDT WDT O
showed VBD VBD O
no DT DT O
acute JJ JJ O
infarct NN NN O
or CC CC O
ICH NNP NNP O
, , , O
an DT DT O
MRI NNP NNP O
which WDT WDT O
showed VBD VBD O
no DT DT O
acute JJ JJ O
infarct NN NN O
on IN IN O
DWI NNP NNP O
, , , O
but CC CC O
he PRP PRP O
was VBD VBD O
agitated VBN VBN O
in IN IN O
the DT DT O
scanner NN NN O
and CC CC O
could MD MD O
not RB RB O
complete VB VB O
the DT DT O
study NN NN O
. . . O
   
He PRP PRP O
received VBD VBD O
5 CD CD O
mg NN NN O
hydralazine NN NN O
iv NN NN O
x SYM SYM O
2 CD CD O
and CC CC O
was VBD VBD O
started VBN VBN O
first JJ JJ O
in IN IN O
a DT DT O
TNG NNP NNP O
gtt NN NN O
and CC CC O
then RB RB O
on IN IN O
a DT DT O
nitroprusside NN NN O
gtt NN NN O
to TO TO O
100/min CD CD O
titrated VBN VBN O
to TO TO O
a DT DT O
goal NN NN O
of IN IN O
MAP NNP NNP O
120 CD CD O
. . . O
   
His PRP$ PRP$ O
BP NNP NNP O
was VBD VBD O
251/104 CD CD O
at IN IN O
2315 CD CD O
. . . O
   
and CC CC O
was VBD VBD O
His PRP$ PRP$ O
L NNP NNP O
Arm NNP NNP O
Weakness NNP NNP O
resolved VBD VBD O
, , , O
but CC CC O
he PRP PRP O
was VBD VBD O
agitated VBN VBN O
and CC CC O
he PRP PRP O
transiently RB RB O
wanted VBD VBD O
to TO TO O
leave VB VB O
AMA NNP NNP O
, , , O
and CC CC O
was VBD VBD O
admitted VBN VBN O
to TO TO O
the DT DT O
CCU NNP NNP O
for IN IN O
further JJ JJ O
management NN NN O
. . . O
   
ROS NNP NNP O
: : : O
Per IN IN O
HPI NNP NNP O
. . . O
   
Other JJ JJ O
systems NNS NNS O
negative JJ JJ O
in IN IN O
detail NN NN O
PMH NNP NNP O
: : : O
a. NN NN O
   
Thrombocytosis NNP NNP O
   
1 CD CD O
. . . O
Followed NNP NNP O
by IN IN O
Dr NNP NNP O
. . . O
Morgan NNP NNP I-DOCTOR
at IN IN O
BMH NNP NNP I-HOSPITAL
   
1 CD CD O
. . . O
- : : O
ve NN NN O
JAK2 NNP NNP O
mutation NN NN O
and CC CC O
- - - O
ve NN NN O
myeloproliferative JJ JJ O
w/u NN NN O
   
2 CD CD O
. . . O
Had NNP NNP O
high JJ JJ O
ferritin NN NN O
, , , O
low JJ JJ O
TIBC NNP NNP O
and CC CC O
high JJ JJ O
ESR NNP NNP O
levels NNS NNS O
when WRB WRB O
checked VBN VBN O
in IN IN O
the DT DT O
past NN NN O
. . . O
   
3 CD CD O
. . . O
On IN IN O
Hydrea NNP NNP O
b. NN NN O
   
ESRD NNP NNP O
due JJ JJ O
to TO TO O
DM1 NNP NNP O
and CC CC O
HTN NNP NNP O
   
1 CD CD O
. . . O
Biopsy NNP NNP O
( ( ( O
3/62 CD CD I-DATE
) ) ) O
with IN IN O
advanced VBD VBD O
diabetic JJ JJ O
glomerulopathy NN NN O
and CC CC O
secondary JJ JJ O
FSGS NNP NNP O
   
2 CD CD O
. . . O
Had NNP NNP O
R NNP NNP O
AVG NNP NNP O
( ( ( O
7/04 CD CD I-DATE
) ) ) O
, , , O
now RB RB O
on IN IN O
HD NNP NNP O
x SYM SYM O
1 CD CD O
month NN NN O
3/wk. CD CD O
   
3 CD CD O
. . . O
Being VBG VBG O
evaluated VBN VBN O
for IN IN O
transplant NN NN O
c. NN NN O
   
DM1 NNP NNP O
since IN IN O
age NN NN O
11 CD CD I-AGE
   
1 CD CD O
. . . O
HgbA1C NNP NNP O
7.6 CD CD O
% NN NN O
in IN IN O
7/62 CD CD I-DATE
   
2 CD CD O
. . . O
Repeated NNP NNP O
hypoglycemic JJ JJ O
episodes NNS NNS O
in IN IN O
the DT DT O
past JJ JJ O
   
3 CD CD O
. . . O
Hx NNP NNP O
of IN IN O
DKA NNP NNP O
d. NN NN O
   
HTN NNP NNP O
has VBZ VBZ O
had VBN VBN O
e. NN NN O
   
Hyperlipidemia NNP NNP O
f. NN NN O
   
Anemia NNP NNP O
g. NN NN O
   
GTC NNP NNP O
in IN IN O
August NNP NNP I-DATE
last JJ JJ O
year NN NN O
and CC CC O
per IN IN O
family NN NN O
report NN NN O
, , , O
in IN IN O
June NNP NNP I-DATE
of IN IN O
this DT DT O
year NN NN O
- - - O
attributed JJ JJ O
to TO TO O
HTN NNP NNP O
. . . O
   
Was VBD VBD O
briefly NN NN O
on IN IN O
dilantin NN NN O
, , , O
but CC CC O
this DT DT O
was VBD VBD O
d/c'd NN NN O
due JJ JJ O
to TO TO O
side VB VB O
effects NNS NNS O
. . . O
   
h. NN NN O
   
MRI NNP NNP O
with IN IN O
embolic JJ JJ O
foci NN NN O
in IN IN O
August NNP NNP I-DATE
2061 CD CD I-DATE
   
1 CD CD O
. . . O
w/u NN NN O
proved VBD VBD O
negative JJ JJ O
- - - O
attributed VBN VBN O
to TO TO O
thrombophilia VB VB O
Medications NNP NNP O
on IN IN O
admission NN NN O
: : : O
aspirin NN NN O
81mg CD CD O
po NN NN O
qd NN NN O
clonidine NN NN O
0.3mg CD CD O
po NN NN O
1 CD CD O
tabs NNS NNS O
po NN NN O
q NN NN O
pm NN NN O
Diovan NNP NNP O
320mg CD CD O
po NN NN O
qd NN NN O
furosemide NN NN O
20 CD CD O
mg NN NN O
po NN NN O
qd NN NN O
Humulin NNP NNP O
n NN NN O
35 CD CD O
units NNS NNS O
qam NN NN O
sc NN NN O
25 CD CD O
units NNS NNS O
qpm NN NN O
Hydrea NNP NNP O
500mg CD CD O
po NN NN O
bid NN NN O
Insulin NNP NNP O
syringes NNS NNS O
( ( ( O
u NN NN O
100 CD CD O
) ) ) O
labetalol NN NN O
hcl NN NN O
tablets NNS NNS O
600 CD CD O
mg NN NN O
po NN NN O
bid NN NN O
Lancets NNP NNP O
Lipitor NNP NNP O
40mg CD CD O
po NN NN O
qd NN NN O
lisinopril NN NN O
40mg CD CD O
po NN NN O
qd NN NN O
Nephrocaps NNP NNP O
1 CD CD O
po NN NN O
q NN NN O
d SYM SYM O
Nexium NNP NNP O
40mg CD CD O
po NN NN O
bid NN NN O
nifedipine NN NN O
xl NN NN O
90mg CD CD O
sr NN NN O
po NN NN O
qhs NN NN O
Onetouch NNP NNP O
test NN NN O
strips NNS NNS O
potassium NN NN O
chloride NN NN O
10meq CD CD O
po NN NN O
qd NN NN O
regular JJ JJ O
insulin NN NN O
25 CD CD O
units NNS NNS O
qam NN NN O
sc NN NN O
20 CD CD O
units NNS NNS O
qpm NN NN O
ALL NNP NNP O
: : : O
NKDA NNP NNP O
SH NNP NNP O
: : : O
Lives NNS NNS O
with IN IN O
: : : O
Mother NNP NNP O
. . . O
   
Used VBN VBN O
to TO TO O
work VB VB O
at IN IN O
Bebo NNP NNP I-ORGANIZATION
in IN IN O
Geologist NNP NNP I-PROFESSION
, , , O
currently RB RB O
unemployed JJ JJ O
. . . O
   
No DT DT O
EtOH NNP NNP O
, , , O
Illicits NNP NNP O
, , , O
Tobacco NNP NNP O
. . . O
   
FH NNP NNP O
: : : O
HTN NNP NNP O
in IN IN O
parents NNS NNS O
, , , O
Mother NNP NNP O
with IN IN O
Stroke NNP NNP O
, , , O
Father NNP NNP O
on IN IN O
HD NNP NNP O
, , , O
DM1 NNP NNP O
, , , O
DM2 NNP NNP O
, , , O
CKD NNP NNP O
in IN IN O
other JJ JJ O
family NN NN O
members NNS NNS O
. . . O
   
Physical JJ JJ O
Exam NNP NNP O
: : : O
V NNP NNP O
: : : O
T NN NN O
99.9 CD CD O
BP NNP NNP O
210/90 CD CD O
P NN NN O
110 CD CD O
R NN NN O
20 CD CD O
SaO2 NNP NNP O
100 CD CD O
% NN NN O
RA NNP NNP O
Gen NNP NNP O
: : : O
WDWN NNP NNP O
American NNP NNP O
male NN NN O
following VBG VBG O
commands NNS NNS O
intermittently RB RB O
. . . O
   
HEENT NNP NNP O
: : : O
NCAT NNP NNP O
, , , O
PERRL NNP NNP O
, , , O
EOMF NNP NNP O
, , , O
sclera NN NN O
anicteric NN NN O
. . . O
   
Neck NN NN O
: : : O
Supple NNP NNP O
, , , O
no DT DT O
thyromegaly NN NN O
, , , O
no DT DT O
carotid NN NN O
bruits NNS NNS O
, , , O
JVP NNP NNP O
flat JJ JJ O
Nodes NNS NNS O
: : : O
No DT DT O
cervical JJ JJ O
or CC CC O
supraclavicular JJ JJ O
LAN NNP NNP O
Cor NNP NNP O
: : : O
Tachy NNP NNP O
, , , O
RR NNP NNP O
S1 NNP NNP O
, , , O
S2 NNP NNP O
nl NN NN O
. . . O
   
No DT DT O
m/r/g NN NN O
. . . O
   
+ NN NN O
S3 NNP NNP O
, , , O
prominent JJ JJ O
PMI NNP NNP O
. . . O
   
Chest NN NN O
: : : O
CTAB NNP NNP O
anteriorly RB RB O
Abdomen NNP NNP O
: : : O
+ NN NN O
BS NNP NNP O
Soft JJ JJ O
, , , O
NT NNP NNP O
, , , O
ND NNP NNP O
. . . O
   
No DT DT O
HSM NNP NNP O
, , , O
No DT DT O
CVA NNP NNP O
tenderness NN NN O
. . . O
   
L NNP NNP O
para-umbilical JJ JJ O
bruit NN NN O
, , , O
no DT DT O
pulsatile NN NN O
mass NN NN O
. . . O
   
Ext NNP NNP O
: : : O
No DT DT O
C/C/E NNP NNP O
, , , O
warm JJ JJ O
, , , O
well-perfused JJ JJ O
, , , O
subcutaneous JJ JJ O
mass NN NN O
on IN IN O
anterior NN NN O
R NN NN O
thigh NN NN O
, , , O
R NNP NNP O
AV NNP NNP O
fistula NN NN O
with IN IN O
thrill NN NN O
. . . O
   
3 CD CD O
+ NN NN O
DP NNP NNP O
and CC CC O
PT NNP NNP O
pulses NNS NNS O
b.l. NN NN O
   
Has VBZ VBZ O
indwelling VBG VBG O
L NNP NNP O
arterial JJ JJ O
line NN NN O
. . . O
   
Skin NNP NNP O
: : : O
No DT DT O
rashes NNS NNS O
. . . O
   
Neuro NNP NNP O
: : : O
A DT DT O
, , , O
O NNP NNP O
x SYM SYM O
1 CD CD O
, , , O
PERRL NNP NNP O
, , , O
EOMF NNP NNP O
, , , O
Smile NNP NNP O
symmetric JJ JJ O
, , , O
Sensation NNP NNP O
grossly RB RB O
intact JJ JJ O
to TO TO O
light JJ JJ O
touch NN NN O
, , , O
Strength NNP NNP O
5/5 CD CD O
in IN IN O
flexion NN NN O
and CC CC O
extension NN NN O
in IN IN O
upper JJ JJ O
and CC CC O
lower JJR JJR O
extremities NNS NNS O
. . . O
   
Reflexes NNP NNP O
2 CD CD O
+ NN NN O
, , , O
toes NNS NNS O
downgoing VBG VBG O
. . . O
   
Labs NNP NNP O
and CC CC O
Studies NNPS NNPS O
: : : O
Chemistry NNP NNP O
Lytes/Renal/Glucose NNP NNP O
Sodium NNP NNP O
136 CD CD O
135-145 JJ JJ O
mmol/L NN NN O
08/29/62 CD CD I-DATE
17:13 CD CD O
Potassium NNP NNP O
3.5 CD CD O
3.4-4.8 NN NN O
mmol/L NN NN O
08/29/62 CD CD I-DATE
17:13 CD CD O
Chloride NNP NNP O
99L CD CD O
100-108 JJ JJ O
mmol/L NN NN O
08/29/62 CD CD I-DATE
17:13 CD CD O
99(L) CD CD O
08/29/62 CD CD I-DATE
17:13 CD CD O
Carbon NNP NNP O
Dioxide NNP NNP O
30.6 CD CD O
23.0-31.9 JJ JJ O
mmol/L NN NN O
08/29/62 CD CD I-DATE
17:13 CD CD O
BUN NNP NNP O
24 CD CD O
8-25 JJ JJ O
mg/dl NN NN O
08/29/62 CD CD I-DATE
17:13 CD CD O
Creatinine NNP NNP O
5.0H CD CD O
0.6-1.5 NN NN O
mg/dl NN NN O
08/29/62 CD CD I-DATE
17:13 CD CD O
5.0(H) CD CD O
08/29/62 CD CD I-DATE
17:13 CD CD O
Glucose NNP NNP O
91 CD CD O
70-110 NN NN O
mg/dl NN NN O
08/29/62 CD CD I-DATE
17:13 CD CD O
General NNP NNP O
Chemistries NNP NNP O
Bilirubin NNP NNP O
( ( ( O
To TO TO O
. . . O
   
. . . O
   
. . . O
   
0.8 CD CD O
0.0-1.0 JJ JJ O
mg/dl NN NN O
08/29/62 CD CD I-DATE
17:45 CD CD O
Bilirubin NNP NNP O
( ( ( O
Di NNP NNP O
. . . O
   
. . . O
   
. . . O
   
0.3 CD CD O
0-0.4 JJ JJ O
mg/dl NN NN O
08/29/62 CD CD I-DATE
17:45 CD CD O
Total NNP NNP O
Protein NNP NNP O
8.0 CD CD O
6.0-8.3 JJ JJ O
g/dl NN NN O
08/29/62 CD CD I-DATE
17:45 CD CD O
Albumin NNP NNP O
3.8 CD CD O
3.3-5.0 NN NN O
g/dl NN NN O
08/29/62 CD CD I-DATE
17:45 CD CD O
Globulin NNP NNP O
4.2H CD CD O
2.6-4.1 JJ JJ O
g/dl NN NN O
08/29/62 CD CD I-DATE
17:45 NN NN O
4.2(H) CD CD O
08/29/62 CD CD I-DATE
17:45 CD CD O
Liver NNP NNP O
Function NNP NNP O
Tests NNP NNP O
ALT NNP NNP O
( ( ( O
SGPT NNP NNP O
) ) ) O
11 CD CD I-AGE
10-55 JJ JJ O
U/L NNP NNP O
08/29/62 CD CD I-DATE
17:45 NN NN O
AST NNP NNP O
( ( ( O
SGOT NNP NNP O
) ) ) O
29 CD CD O
10-40 JJ JJ O
U/L NNP NNP O
08/29/62 CD CD I-DATE
17:45 NN NN O
Alk NNP NNP O
Phos NNP NNP O
76 CD CD O
45-115 JJ JJ O
U/L NNP NNP O
08/29/62 CD CD I-DATE
17:45 NN NN O
Bilirubin NNP NNP O
( ( ( O
To TO TO O
. . . O
   
. . . O
   
. . . O
   
0.8 CD CD O
0.0-1.0 JJ JJ O
mg/dl NN NN O
08/29/62 CD CD I-DATE
17:45 CD CD O
Bilirubin NNP NNP O
( ( ( O
Di NNP NNP O
. . . O
   
. . . O
   
. . . O
   
0.3 CD CD O
0-0.4 JJ JJ O
mg/dl NN NN O
08/29/62 CD CD I-DATE
17:45 CD CD O
Hematology NNP NNP O
Complete NNP NNP O
Blood NNP NNP O
Count NNP NNP O
WBC NNP NNP O
14.9H CD CD O
4.5-11.0 JJ JJ O
th/cmm NN NN O
08/29/62 CD CD I-DATE
17:12 CD CD O
14.9(H) CD CD O
08/29/62 CD CD I-DATE
17:12 CD CD O
RBC NNP NNP O
3.88L CD CD O
4.50-5.90 JJ JJ O
mil/cm NN NN O
08/29/62 CD CD I-DATE
17:12 CD CD O
3.88(L) CD CD O
08/29/62 CD CD I-DATE
17:12 CD CD O
Hgb NNP NNP O
14.3 CD CD O
13.5-17.5 JJ JJ O
gm/dl NN NN O
08/29/62 CD CD I-DATE
17:12 CD CD O
HCT NNP NNP O
41.2 CD CD O
41.0-53.0 CD CD O
% NN NN O
08/29/62 CD CD I-DATE
17:12 CD CD O
MCV NNP NNP O
106H CD CD O
80-100 JJ JJ O
fl NN NN O
08/29/62 CD CD I-DATE
17:12 CD CD O
106(H) CD CD O
08/29/62 CD CD I-DATE
17:12 CD CD O
MCH NNP NNP O
36.8H CD CD O
26.0-34.0 JJ JJ O
pg/rbc NN NN O
08/29/62 CD CD I-DATE
17:12 CD CD O
36.8(H) CD CD O
08/29/62 CD CD I-DATE
17:12 CD CD O
MCHC NNP NNP O
34.7 CD CD O
31.0-37.0 NN NN O
g/dl NN NN O
08/29/62 CD CD I-DATE
17:12 CD CD O
PLT NNP NNP O
839H CD CD O
150-350 JJ JJ O
th/cumm NN NN O
08/29/62 CD CD I-DATE
17:12 CD CD O
839(H) CD CD O
08/29/62 CD CD I-DATE
17:12 CD CD O
RDW NNP NNP O
17.1H CD CD O
11.5-14.5 NN NN O
% NN NN O
08/29/62 CD CD I-DATE
17:12 CD CD O
17.1(H) CD CD O
08/29/62 CD CD I-DATE
17:12 CD CD O
Blood NNP NNP O
Differential NNP NNP O
% NN NN O
Differential NNP NNP O
... ... ... O
   
RECEIVED NNP NNP O
08/29/62 CD CD I-DATE
17:09 CD CD O
Diff NNP NNP O
Method NNP NNP O
Auto NNP NNP O
08/29/62 CD CD I-DATE
17:13 CD CD O
Neutrophils NNP NNP O
88H CD CD O
40-70 CD CD O
% NN NN O
08/29/62 CD CD I-DATE
17:13 CD CD O
88(H) CD CD O
08/29/62 CD CD I-DATE
17:13 CD CD O
Lymphs NNP NNP O
8L CD CD O
22-44 JJ JJ O
% NN NN O
08/29/62 CD CD I-DATE
17:13 CD CD O
8(L) CD CD O
08/29/62 CD CD I-DATE
17:13 CD CD O
Monos NNP NNP O
3L CD CD O
4-11 CD CD O
% NN NN O
08/29/62 CD CD I-DATE
17:13 CD CD O
3(L) CD CD O
08/29/62 CD CD I-DATE
17:13 CD CD O
Eos NNP NNP O
1 CD CD O
0-8 NN NN O
% NN NN O
08/29/62 CD CD I-DATE
17:13 CD CD O
Basos NNP NNP O
0 CD CD O
0-3 NN NN O
% NN NN O
08/29/62 NN NN I-DATE
17:13 CD CD O
Blood NNP NNP O
Diff NNP NNP O
- : : O
Absolute NNP NNP O
Neutrophil NNP NNP O
# # # O
13.14H CD CD O
1.8-7.7 JJ JJ O
th/cmm NN NN O
08/29/62 CD CD I-DATE
17:13 CD CD O
13.14(H) CD CD O
08/29/62 CD CD I-DATE
17:13 CD CD O
Lymph NN NN O
# # # O
1.16 CD CD O
1.0-4.8 JJ JJ O
th/cmm NN NN O
08/29/62 CD CD I-DATE
17:13 CD CD O
Mono NNP NNP O
# # # O
0.45H CD CD O
0.2-0.4 CD CD O
th/cmm NN NN O
08/29/62 CD CD I-DATE
17:13 CD CD O
0.45(H) CD CD O
08/29/62 CD CD I-DATE
17:13 CD CD O
Eos NN NN O
# # # O
0.09L CD CD O
0.1-0.3 CD CD O
th/cmm NN NN O
08/29/62 CD CD I-DATE
17:13 CD CD O
0.09(L) CD CD O
08/29/62 CD CD I-DATE
17:13 CD CD O
Baso NN NN O
# # # O
0.03 CD CD O
0.0-0.3 CD CD O
th/cmm NN NN O
08/29/62 CD CD I-DATE
17:13 CD CD O
Smear NNP NNP O
Morphology NNP NNP O
Anisocytosis NNP NNP O
1+H CD CD O
None NN NN O
08/29/62 CD CD I-DATE
17:13 CD CD O
1+(H) CD CD O
08/29/62 CD CD I-DATE
17:13 CD CD O
Hypochromia NNP NNP O
None NN NN O
None NN NN O
08/29/62 CD CD I-DATE
17:13 CD CD O
Macrocytes NNP NNP O
3+H CD CD O
None NN NN O
08/29/62 CD CD I-DATE
17:13 CD CD O
3+(H) CD CD O
08/29/62 CD CD I-DATE
17:13 CD CD O
Microcytes NNP NNP O
None NN NN O
None NN NN O
08/29/62 CD CD I-DATE
17:13 CD CD O
Coagulation NNP NNP O
Routine NNP NNP O
Coagulation NNP NNP O
PT NNP NNP O
12.1 CD CD O
11.1-13.6 JJ JJ O
sec NN NN O
08/29/62 CD CD I-DATE
17:26 CD CD O
PT-INR NNP NNP O
1.0 CD CD O
08/29/62 NN NN I-DATE
17:26 CD CD O
PTT NNP NNP O
24.9 CD CD O
22.1-34.0 JJ JJ O
sec NN NN O
08/29/62 CD CD I-DATE
17:26 CD CD O
Toxicology NNP NNP O
+ NN NN O
ve NN NN O
for IN IN O
Ephedrine NNP NNP O
. . . O
   
Hypercoagulation NNP NNP O
Studies NNP NNP O
Act NNP NNP O
Prot NNP NNP O
C NNP NNP O
Re NNP NNP O
. . . O
   
. . . O
   
. . . O
   
2.5 CD CD O
> NN NN O
2.0 CD CD O
09/12/61 CD CD I-DATE
14:20 CD CD O
Protein NNP NNP O
S NNP NNP O
( ( ( O
Fu NNP NNP O
. . . O
   
. . . O
   
. . . O
   
112 CD CD O
70-140 CD CD O
% NN NN O
09/12/61 CD CD I-DATE
14:20 CD CD O
Protein NNP NNP O
C NNP NNP O
( ( ( O
Fu NNP NNP O
. . . O
   
. . . O
   
. . . O
   
160H CD CD O
70-140 CD CD O
% NN NN O
09/12/61 CD CD I-DATE
14:20 CD CD O
160(H) CD CD O
09/12/61 CD CD I-DATE
14:20 CD CD O
Homocyst NNP NNP O
   
( ( ( O
e)ine NN NN O
REFUSED NNP NNP O
0-12 NN NN O
umol/L NN NN O
09/12/61 CD CD I-DATE
06:08 CD CD O
AT3 NNP NNP O
(% NNP NNP O
NL NNP NNP O
Act NNP NNP O
. . . O
   
. . . O
   
. . . O
   
108 CD CD O
80-130 CD CD O
% NN NN O
09/12/61 CD CD I-DATE
14:20 CD CD O
Interpretatio NNP NNP O
. . . O
   
. . . O
   
. . . O
   
see VB VB O
detail NN NN O
9/14/61 CD CD I-DATE
18:31 CD CD O
Antiphospholipid NNP NNP O
Antibodies NNP NNP O
Cardiolipin NNP NNP O
A. NN NN O
   
. . . O
   
. . . O
   
4.7 CD CD O
0-15 JJ JJ O
GPL NNP NNP O
07/25/62 CD CD I-DATE
12:34 CD CD O
Cardiolipin NNP NNP O
A. NN NN O
   
. . . O
   
. . . O
   
13.0 CD CD O
0-15 JJ JJ O
MPL NNP NNP O
07/25/62 CD CD I-DATE
12:34 NN NN O
EKG NNP NNP O
Sinus NNP NNP O
Tachycardia NNP NNP O
@ IN IN O
110 CD CD O
, , , O
non-specific JJ JJ O
anterior NN NN O
ST NNP NNP O
abnormalities NNS NNS O
unchanged VBD VBD O
from IN IN O
7/13/62 CD CD I-DATE
. . . O
   
Head NNP NNP O
CT NNP NNP O
- : : O
No DT DT O
evidence NN NN O
of IN IN O
acute JJ JJ O
intra-cranial JJ JJ O
process NN NN O
MRI NNP NNP O
- : : O
No DT DT O
acute JJ JJ O
infarct NN NN O
on IN IN O
DWI NNP NNP O
, , , O
pt NN NN O
did VBD VBD O
not RB RB O
complete JJ JJ O
study NN NN O
. . . O
   
MRA NNP NNP O
Pelvis NNP NNP O
8/28/62 CD CD I-DATE
   
1 CD CD O
. . . O
Patent NNP NNP O
abdominal JJ JJ O
aorta NN NN O
and CC CC O
visceral JJ JJ O
vessels NNS NNS O
as IN IN O
above IN IN O
. . . O
   
2 CD CD O
. . . O
Patent NNP NNP O
aorto-iliac JJ JJ O
system NN NN O
   
3 CD CD O
. . . O
On IN IN O
the DT DT O
right NN NN O
: : : O
Patent NNP NNP O
arterial NN NN O
tree NN NN O
   
4 CD CD O
. . . O
On IN IN O
the DT DT O
left NN NN O
: : : O
Patent NNP NNP O
arterial NN NN O
tree NN NN O
Renal NNP NNP O
Ultrasound NNP NNP O
Doppler NNP NNP O
8/26/61 CD CD I-DATE
NO DT DT O
EVIDENCE NN NN O
OF IN IN O
HYDRONEPHROSIS NNP NNP O
. . . O
   
SLIGHTLY RB RB O
ECHOGENIC NNP NNP O
KIDNEYS NNP NNP O
. . . O
   
TRACE NNP NNP O
FREE NNP NNP O
FLUID NNP NNP O
. . . O
   
A/P NNP NNP O
: : : O
28 CD CD I-AGE
yo NN NN O
man NN NN O
with IN IN O
DM1 NNP NNP O
, , , O
ESRD-HD NNP NNP O
, , , O
HTN NNP NNP O
, , , O
Hyperlipidemia NNP NNP O
, , , O
thrombocytosis NN NN O
, , , O
here RB RB O
with IN IN O
hypertensive JJ JJ O
emergency NN NN O
. . . O
   
His PRP$ PRP$ O
BP NNP NNP O
has VBZ VBZ O
remained VBN VBN O
high JJ JJ O
, , , O
so RB RB O
will MD MD O
attempt VB VB O
to TO TO O
reduce VB VB O
by IN IN O
25 CD CD O
% NN NN O
MAP NNP NNP O
for IN IN O
a DT DT O
few JJ JJ O
hours NNS NNS O
and CC CC O
then RB RB O
start VB VB O
an DT DT O
oral JJ JJ O
agent NN NN O
. . . O
   
Nitroprusside NNP NNP O
will MD MD O
be VB VB O
used VBN VBN O
first JJ JJ O
but CC CC O
if IN IN O
he PRP PRP O
needs VBZ VBZ O
an DT DT O
extended JJ JJ O
treatment NN NN O
, , , O
will MD MD O
change VB VB O
to TO TO O
nicardipine NN NN O
( ( ( O
Bj NNP NNP O
Q NNP NNP O
Sugudoyta NNP NNP O
1165 CD CD O
Glb NNP NNP O
; : : O
   
7(9 CD CD O
Kk NNP NNP O
1):414-8) JJ JJ O
given VBN VBN O
his PRP$ PRP$ O
ESRD NNP NNP O
. . . O
   
His PRP$ PRP$ O
change NN NN O
in IN IN O
mental JJ JJ O
status NN NN O
is VBZ VBZ O
likely JJ JJ O
due JJ JJ O
to TO TO O
hypertensive JJ JJ O
encephalopathy NN NN O
, , , O
but CC CC O
it PRP PRP O
is VBZ VBZ O
hard JJ JJ O
to TO TO O
exclude VB VB O
other JJ JJ O
sources NNS NNS O
of IN IN O
end-organ JJ JJ O
involvement NN NN O
such JJ JJ O
as IN IN O
the DT DT O
heart NN NN O
( ( ( O
especially RB RB O
considering VBG VBG O
his PRP$ PRP$ O
thrombocytosis NNS NNS O
) ) ) O
given VBN VBN O
his PRP$ PRP$ O
ongoing JJ JJ O
confusion NN NN O
. . . O
   
Other JJ JJ O
sources NNS NNS O
of IN IN O
his PRP$ PRP$ O
confusion NN NN O
might MD MD O
include VB VB O
meningitis NNS NNS O
given VBN VBN O
his PRP$ PRP$ O
leukocytosis NN NN O
. . . O
   
1 CD CD O
. . . O
CV NNP NNP O
a. NN NN O
   
Pump NNP NNP O
i. NN NN O
   
Has VBZ VBZ O
an DT DT O
S3 NNP NNP O
, , , O
but CC CC O
no DT DT O
signs NNS NNS O
of IN IN O
L NNP NNP O
or CC CC O
R NNP NNP O
heart NN NN O
failure NN NN O
. . . O
   
ii NN NN O
. . . O
   
Will NNP NNP O
reduce VB VB O
afterload NN NN O
prog NN NN O
b. NN NN O
   
Rhythm NNP NNP O
i. NN NN O
   
Sinus NNP NNP O
tachycardia NNS NNS O
, , , O
will MD MD O
give VB VB O
IVFs NNP NNP O
to TO TO O
reduce VB VB O
high-reninemic JJ JJ O
natriuretic JJ JJ O
state NN NN O
. . . O
   
c. NN NN O
   
Ischemia NNP NNP O
i. NN NN O
   
No DT DT O
EKG NNP NNP O
changes NNS NNS O
consistent JJ JJ O
with IN IN O
ischemia NN NN O
, , , O
will MD MD O
cycle NN NN O
cardiac JJ JJ O
biomarkers NNS NNS O
x SYM SYM O
3 CD CD O
, , , O
give VB VB O
ASA NNP NNP O
, , , O
Lipitor NNP NNP O
. . . O
   
ii NN NN O
. . . O
   
Will NNP NNP O
reduce VB VB O
afterload NN NN O
with IN IN O
Nitroprusside NNP NNP O
, , , O
IVFs NNP NNP O
, , , O
po NN NN O
anti-hypertensives JJ JJ O
. . . O
   
2 CD CD O
. . . O
Neuro NNP NNP O
a. NN NN O
   
His PRP$ PRP$ O
mental JJ JJ O
status NN NN O
and CC CC O
leukocytosis NNS NNS O
are VBP VBP O
likely JJ JJ O
due JJ JJ O
to TO TO O
hypertensive VB VB O
encephalopathy NN NN O
but CC CC O
potentially RB RB O
concerning VBG VBG O
for IN IN O
possible JJ JJ O
meningitis NNS NNS O
. . . O
   
Will NNP NNP O
perform VB VB O
lumbar NN NN O
puncture NN NN O
, , , O
hold VB VB O
Abx NNP NNP O
since IN IN O
he PRP PRP O
has VBZ VBZ O
been VBN VBN O
in IN IN O
the DT DT O
hospital NN NN O
for IN IN O
more JJR JJR O
than IN IN O
6h CD CD O
, , , O
give VB VB O
if IN IN O
CSF NNP NNP O
studies NNS NNS O
indicate VBP VBP O
it PRP PRP O
. . . O
   
b. NN NN O
   
Neuro NNP NNP O
following VBG VBG O
. . . O
   
3 CD CD O
. . . O
HTN NNP NNP O
a. NN NN O
   
Will NNP NNP O
reduce VB VB O
MAP NNP NNP O
by IN IN O
25 CD CD O
% NN NN O
to TO TO O
~ NN NN O
100 CD CD O
, , , O
will MD MD O
start VB VB O
with IN IN O
Nitroprusside NNP NNP O
, , , O
switch NN NN O
to TO TO O
Nicardipine NNP NNP O
. . . O
   
Will NNP NNP O
re-start JJ JJ O
some DT DT O
oral JJ JJ O
agents NNS NNS O
once RB RB O
reduced VBN VBN O
. . . O
   
4 CD CD O
. . . O
DM1 NNP NNP O
a. NN NN O
   
Will NNP NNP O
start VB VB O
half-dose NN NN O
of IN IN O
Insulin NNP NNP O
NPH NNP NNP O
, , , O
cover NN NN O
with IN IN O
RISS NNP NNP O
   
5 CD CD O
. . . O
Renal NNP NNP O
a. NN NN O
   
Will NNP NNP O
need VB VB O
HD NNP NNP O
, , , O
will MD MD O
consult VB VB O
Renal NNP NNP O
. . . O
   
6 CD CD O
. . . O
Thrombocytosis NNP NNP O
a. NN NN O
   
Stable JJ JJ O
, , , O
will MD MD O
consult VB VB O
Dr NNP NNP O
. . . O
Morgan NNP NNP I-DOCTOR
's POS POS O
team NN NN O
re NN NN O
: : : O
continuing VBG VBG O
Hydroxyurea NNP NNP O
. . . O
   
7 CD CD O
. . . O
Access NNP NNP O
a. NN NN O
   
L NNP NNP O
arterial JJ JJ O
line NN NN O
, , , O
peripheral JJ JJ O
iv NN NN O
. . . O
   
8 CD CD O
. . . O
F/E/N NNP NNP O
a. NN NN O
   
IVFs NNP NNP O
, , , O
will MD MD O
start VB VB O
oral JJ JJ O
diet NN NN O
as IN IN O
mental JJ JJ O
status NN NN O
improves VBZ VBZ O
. . . O
   
9 CD CD O
. . . O
Heme NNP NNP O
a. NN NN O
   
Has VBZ VBZ O
baseline NN NN O
anemia NN NN O
, , , O
likely JJ JJ O
currently RB RB O
hemoconcentrated VBN VBN O
, , , O
will MD MD O
montor NN NN O
Hct NNP NNP O
. . . O
   
10 CD CD O
. . . O
Prophylaxis NNP NNP O
a. NN NN O
   
Senna NNP NNP O
, , , O
Colace NNP NNP O
, , , O
Nexium NNP NNP O
, , , O
Heparin NNP NNP O
. . . O
   
______________________________________________________________________ NN NN O
_ NN NN O
Name NN NN O
: : : O
Addison NNP NNP I-DOCTOR
Keefe NNP NNP I-DOCTOR
, , , O
MD NNP NNP O
PhD NNP NNP O
Pager NNP NNP O
# # # O
92783 CD CD I-PHONE
PGY-2 NNP NNP O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2097-10-31 NN NN I-DATE
INTERNAL NNP NNP O
MEDICINE NNP NNP O
ASSOCIATES NNP NNP O
ROSELAND NNP NNP I-HOSPITAL
COMMUNITY NNP NNP I-HOSPITAL
HOSPITAL NNP NNP I-HOSPITAL
Reason NNP NNP O
for IN IN O
visit NN NN O
f/u NN NN O
high JJ JJ O
blood NN NN O
sugar NN NN O
Major NNP NNP O
Problems NNS NNS O
Diabetes NNP NNP O
mellitus NN NN O
PT NNP NNP O
here RB RB O
with IN IN O
no DT DT O
complaints NNS NNS O
except IN IN O
sugar NN NN O
still RB RB O
high JJ JJ O
. . . O
   
She PRP PRP O
was VBD VBD O
seen VBN VBN O
2 CD CD O
days NNS NNS O
ago RB RB O
, , , O
for IN IN O
? . . O
UTI NNP NNP O
and CC CC O
UC NNP NNP O
was VBD VBD O
neg NN NN O
. . . O
   
SHe PRP PRP O
has VBZ VBZ O
been VBN VBN O
taking VBG VBG O
bactrim NNS NNS O
. . . O
   
She PRP PRP O
is VBZ VBZ O
up RB RB O
at IN IN O
night NN NN O
urinating VBG VBG O
freq NN NN O
, , , O
denies NNS NNS O
fever NN NN O
, , , O
GI NNP NNP O
sx NN NN O
, , , O
cough NN NN O
, , , O
rash NN NN O
, , , O
joint JJ JJ O
pain NN NN O
. . . O
   
She PRP PRP O
is VBZ VBZ O
taking VBG VBG O
her PRP$ PRP$ O
meds NNS NNS O
. . . O
   
Daughter NN NN O
in IN IN O
with IN IN O
her PRP PRP O
. . . O
   
Active JJ JJ O
Medications NNP NNP O
Bactrim NNP NNP O
DS NNP NNP O
160mg/800mg CD CD O
po NN NN O
bid NN NN O
x SYM SYM O
7 CD CD O
days NNS NNS O
Ecotrin NNP NNP O
325 CD CD O
mg NN NN O
po NN NN O
daily JJ JJ O
ferrous JJ JJ O
sulfate NN NN O
325mg CD CD O
po NN NN O
bid NN NN O
free JJ JJ O
text NN NN O
medications NNS NNS O
qid VBP VBP O
one CD CD O
touch JJ JJ O
ultra JJ JJ O
lancets NNS NNS O
furosemide NN NN O
20mg CD CD O
po NN NN O
daily JJ JJ O
glipizide NN NN O
10mg CD CD O
po NN NN O
bid NN NN O
take NN NN O
30min CD CD O
before IN IN O
a DT DT O
meal NN NN O
lisinopril NN NN O
40 CD CD O
mg NN NN O
po NN NN O
daily JJ JJ O
lovastatin NN NN O
10mg CD CD O
po NN NN O
qpm NN NN O
take NN NN O
with IN IN O
food NN NN O
metoprolol NN NN O
25mg CD CD O
, , , O
3 CD CD O
tabs NNS NNS O
po NN NN O
bid NN NN O
Norvasc NNP NNP O
10mg CD CD O
po NN NN O
daily JJ JJ O
Prandin NNP NNP O
2 CD CD O
mg NN NN O
before IN IN O
each DT DT O
meal NN NN O
vitamin NN NN O
d SYM SYM O
1000 CD CD O
units NNS NNS O
po NN NN O
daily JJ JJ O
Physical JJ JJ O
Exam NNP NNP O
Blood NNP NNP O
pressure NN NN O
147/78 CD CD O
Pulse NNP NNP O
54 CD CD O
Weight NNP NNP O
159 CD CD O
today NN NN O
, , , O
154 CD CD O
pounds NNS NNS O
Office NNP NNP O
blood NN NN O
glucose NN NN O
fingerstick NN NN O
448 CD CD O
at IN IN O
noon NN NN O
after IN IN O
breakfast NN NN O
Office NNP NNP O
O2 NNP NNP O
saturation NN NN O
100 CD CD O
% NN NN O
General NNP NNP O
appearance NN NN O
Well RB RB O
developed VBD VBD O
, , , O
well RB RB O
nourished VBN VBN O
, , , O
no DT DT O
acute JJ JJ O
distress NN NN O
. . . O
   
Skin NNP NNP O
Warm NNP NNP O
and CC CC O
dry JJ JJ O
. . . O
   
No DT DT O
rashes NNS NNS O
HEENT NNP NNP O
? . . O
jaundice NN NN O
to TO TO O
eyes NNS NNS O
Nodes NNS NNS O
no DT DT O
cervical JJ JJ O
lymphadenopathy JJ JJ O
Chest NN NN O
Lungs NNP NNP O
are VBP VBP O
clear JJ JJ O
Cor NNP NNP O
Unremarkable NNP NNP O
Abdomen NNP NNP O
Nontender NNP NNP O
without IN IN O
masses NNS NNS O
Musc NNP NNP O
skel NN NN O
no DT DT O
CVA NNP NNP O
tenderness JJ JJ O
Assessment NNP NNP O
and CC CC O
plan NN NN O
A DT DT O
elevated VBD VBD O
sugar NN NN O
? . . O
infection NN NN O
? . . O
   
source NN NN O
P NN NN O
discuss VB VB O
with IN IN O
Dr NNP NNP O
. . . O
Armstrong IN IN I-DOCTOR
to TO TO O
ER NNP NNP O
for IN IN O
complete JJ JJ O
work NN NN O
up RP RP O
. . . O
   
ER NNP NNP O
notifiec NN NN O
and CC CC O
pt NN NN O
escorted JJ JJ O
to TO TO O
ER&gt NNP NNP O
; : : O
   
Victoria NNP NNP I-DOCTOR
Keene NNP NNP I-DOCTOR
, , , O
NP NNP NNP O
Signed NNP NNP O
electronically RB RB O
by IN IN O
Victoria NNP NNP I-DOCTOR
Keene NNP NNP I-DOCTOR
, , , O
NP NNP NNP O
Document NNP NNP O
Status NNP NNP O
: : : O
Final NNP NNP O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2074-07-05 JJ JJ I-DATE
July NNP NNP I-DATE
05 CD CD O
, , , O
2074 CD CD I-DATE
Paul NNP NNP I-DOCTOR
Arteaga NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
   
Loma NNP NNP I-HOSPITAL
Linda NNP NNP I-HOSPITAL
Community NNP NNP I-HOSPITAL
Hospital NNP NNP I-HOSPITAL
89 CD CD I-STREET
Caldwell NNP NNP I-STREET
Road NNP NNP I-STREET
Shady NNP NNP I-CITY
Cove NNP NNP I-CITY
, , , O
NY NNP NNP I-STATE
63363 CD CD I-ZIP
RE NNP NNP O
: : : O
Christine NNP NNP I-PATIENT
Olivier NNP NNP I-PATIENT
MR NNP NNP O
#652-33-21-5 NN NN O
Dear RB RB O
Dr NNP NNP O
. . . O
Arteaga NNP NNP I-DOCTOR
: : : O
Mrs NNP NNP O
. . . O
   
Olivier NNP NNP I-PATIENT
presented VBD VBD O
to TO TO O
the DT DT O
office NN NN O
today NN NN O
for IN IN O
a DT DT O
second JJ JJ O
opinion NN NN O
regarding VBG VBG O
her PRP$ PRP$ O
current JJ JJ O
cardiac JJ JJ O
condition NN NN O
. . . O
   
As IN IN O
her PRP$ PRP$ O
history NN NN O
is VBZ VBZ O
well RB RB O
known VBN VBN O
to TO TO O
you PRP PRP O
, , , O
I PRP PRP O
will MD MD O
repeat VB VB O
it PRP PRP O
briefly NN NN O
for IN IN O
our PRP$ PRP$ O
records NNS NNS O
. . . O
   
Mrs NNP NNP O
. . . O
   
Olivier NNP NNP I-PATIENT
is VBZ VBZ O
a DT DT O
62-year-old JJ JJ O
woman NN NN O
with IN IN O
a DT DT O
longstanding JJ JJ O
history NN NN O
of IN IN I-DATE
coronary JJ JJ O
artery NN NN O
disease NN NN O
. . . O
   
After IN IN O
several JJ JJ O
catheterizations NNS NNS O
in IN IN O
the DT DT O
2060's CD CD I-DATE
which WDT WDT O
failed VBD VBD O
to TO TO O
document VB VB O
significant JJ JJ O
coronary JJ JJ O
artery NN NN O
disease NN NN O
( ( ( O
done VBN VBN O
for IN IN O
evaluation NN NN O
of IN IN I-DATE
chest NN NN O
pain NN NN O
) ) ) O
, , , O
angiogram NN NN O
in IN IN O
July NNP NNP I-DATE
of IN IN I-DATE
2071 CD CD I-DATE
showed VBD VBD O
moderate JJ JJ O
circumflex NN NN O
coronary JJ JJ O
artery NN NN O
disease NN NN O
for IN IN O
which WDT WDT O
she PRP PRP O
was VBD VBD O
managed VBN VBN O
medically RB RB O
. . . O
   
However RB RB O
, , , O
she PRP PRP O
suffered VBD VBD O
a DT DT O
non-Q JJ JJ O
wave NN NN O
myocardial NN NN O
infarction NN NN O
on IN IN O
February NNP NNP I-DATE
of IN IN I-DATE
2072 CD CD I-DATE
at IN IN O
which WDT WDT O
time NN NN O
she PRP PRP O
underwent JJ JJ O
cardiac JJ JJ O
catheterization NN NN O
now RB RB O
showing VBG VBG O
progressive JJ JJ O
coronary JJ JJ O
artery NN NN O
disease NN NN O
and CC CC O
therefore RB RB O
underwent JJ JJ O
a DT DT O
multi-vessel JJ JJ O
coronary JJ JJ O
bypass NN NN O
graft NN NN O
operation NN NN O
including VBG VBG O
a DT DT O
left VBD VBD O
internal JJ JJ O
mammary JJ JJ O
artery NN NN O
to TO TO O
her PRP$ PRP$ O
LAD NNP NNP O
and CC CC O
reverse VB VB O
saphenous JJ JJ O
vein NN NN O
grafts NNS NNS O
to TO TO O
her PRP$ PRP$ O
PDA NNP NNP O
, , , O
D1 NN NN O
and CC CC O
obtuse NN NN O
marginal JJ JJ O
branch NN NN O
. . . O
   
She PRP PRP O
underwent JJ JJ O
repeat NN NN O
catheterization NN NN O
in IN IN O
February NNP NNP I-DATE
of IN IN I-DATE
2073 CD CD I-DATE
at IN IN O
the DT DT O
Comfrey NNP NNP I-HOSPITAL
Clinic NNP NNP I-HOSPITAL
which WDT WDT O
showed VBD VBD O
diffuse NN NN O
native JJ JJ O
disease NN NN O
but CC CC O
apparently RB RB O
no DT DT O
significant JJ JJ O
bypass NN NN O
graft NN NN O
pathology NN NN O
. . . O
   
She PRP PRP O
underwent JJ JJ O
repeat NN NN O
cardiac JJ JJ O
catheterization NN NN O
in IN IN O
May NNP NNP I-DATE
of IN IN I-DATE
2074 CD CD I-DATE
because IN IN O
of IN IN I-DATE
a DT DT O
current JJ JJ O
angina NN NN O
and CC CC O
at IN IN O
this DT DT O
time NN NN O
she PRP PRP O
had VBD VBD O
evidence NN NN O
for IN IN O
a DT DT O
60 CD CD O
% NN NN O
proximal NN NN O
LAD NNP NNP O
stenosis NN NN O
, , , O
a DT DT O
proximal NN NN O
severe JJ JJ O
circumflex NN NN O
artery NN NN O
stenosis NN NN O
with IN IN O
no DT DT O
occlusion NN NN O
at IN IN O
the DT DT O
origin NN NN O
at IN IN O
a DT DT O
first JJ JJ O
obtuse NN NN O
marginal NN NN O
branch NN NN O
and CC CC O
a DT DT O
70 CD CD O
% NN NN O
stenosis NNS NNS O
in IN IN O
the DT DT O
mid JJ JJ O
right NN NN O
coronary JJ JJ O
artery NN NN O
. . . O
   
The DT DT O
saphenous JJ JJ O
vein NN NN O
graft NN NN O
to TO TO O
the DT DT O
diagonal JJ JJ O
branch NN NN O
was VBD VBD O
patent NN NN O
with IN IN O
a DT DT O
significant JJ JJ O
stenosis NN NN O
at IN IN O
its PRP$ PRP$ O
distal NN NN O
and CC CC O
astigmatic JJ JJ O
site NN NN O
, , , O
a DT DT O
saphenous JJ JJ O
vein NN NN O
graft NN NN O
to TO TO O
the DT DT O
second JJ JJ O
obtuse NN NN O
marginal JJ JJ O
branch NN NN O
was VBD VBD O
patent NN NN O
as IN IN O
was VBD VBD O
the DT DT O
saphenous JJ JJ O
vein NN NN O
graft NN NN O
to TO TO O
the DT DT O
posterolateral NN NN O
branch NN NN O
. . . O
   
The DT DT O
left NN NN O
intramammary JJ JJ O
artery NN NN O
to TO TO O
the DT DT O
LAD NNP NNP O
was VBD VBD O
a DT DT O
small JJ JJ O
vessel NN NN O
without IN IN O
discrete JJ JJ O
stenoses NNS NNS O
. . . O
   
Left NNP NNP O
ventriculogram NN NN O
demonstrated VBD VBD O
a DT DT O
moderate JJ JJ O
area NN NN O
of IN IN I-DATE
posterior NN NN O
basal NN NN O
akinesis NNS NNS O
with IN IN O
a DT DT O
global JJ JJ O
ejection NN NN O
fraction NN NN O
of IN IN I-DATE
60 CD CD O
% NN NN O
. . . O
   
She PRP PRP O
therefore RB RB O
was VBD VBD O
transferred VBN VBN O
to TO TO O
the DT DT O
Midwest NNP NNP I-HOSPITAL
Eire NNP NNP I-HOSPITAL
Center NNP NNP I-HOSPITAL
in IN IN O
early JJ JJ O
June NNP NNP I-DATE
where WRB WRB O
she PRP PRP O
underwent VBD VBD O
successful JJ JJ O
PTCA NNP NNP O
of IN IN I-DATE
her PRP$ PRP$ O
vein NN NN O
graft NN NN O
to TO TO O
her PRP$ PRP$ O
diagonal JJ JJ O
artery NN NN O
. . . O
   
She PRP PRP O
tolerated VBD VBD O
this DT DT O
uneventfully RB RB O
and CC CC O
was VBD VBD O
Olivier NNP NNP I-PATIENT
, , , O
Christine NNP NNP I-PATIENT
MR NNP NNP O
#652-33-21-5 NN NN O
- - - O
2 CD CD O
- : : O
July NNP NNP I-DATE
05 CD CD O
, , , O
2074 CD CD I-DATE
discharged JJ JJ O
and CC CC O
since IN IN O
then RB RB O
has VBZ VBZ O
not RB RB O
had VBN VBN O
significant JJ JJ O
exertional JJ JJ O
chest NN NN O
discomfort NN NN O
. . . O
   
Her PRP$ PRP$ O
primary JJ JJ O
complaint NN NN O
is VBZ VBZ O
one CD CD O
of IN IN I-DATE
fatigue NN NN O
and CC CC O
mild VB VB O
exertional JJ JJ O
dyspnea NN NN O
. . . O
   
She PRP PRP O
has VBZ VBZ O
undergone VBN VBN O
extensive JJ JJ O
pulmonary JJ JJ O
evaluation NN NN O
in IN IN O
the DT DT O
past NN NN O
including VBG VBG O
pulmonary JJ JJ O
function NN NN O
tests NNS NNS O
which WDT WDT O
have VBP VBP O
revealed VBN VBN O
an DT DT O
FEV1 NNP NNP O
of IN IN I-DATE
1.3 CD CD O
which WDT WDT O
is VBZ VBZ O
59 CD CD O
% NN NN O
predicted VBD VBD O
, , , O
and CC CC O
an DT DT O
FVC NNP NNP O
of IN IN I-DATE
1.5 CD CD O
which WDT WDT O
is VBZ VBZ O
also RB RB O
55 CD CD O
% NN NN O
predicted VBD VBD O
giving VBG VBG O
her PRP$ PRP$ O
a DT DT O
pattern NN NN O
consistent JJ JJ O
with IN IN O
restrictive JJ JJ O
rather RB RB O
than IN IN O
obstructive JJ JJ O
pulmonary JJ JJ O
disease NN NN O
. . . O
   
In IN IN O
addition NN NN O
, , , O
she PRP PRP O
has VBZ VBZ O
a DT DT O
history NN NN O
of IN IN I-DATE
a DT DT O
seizure NN NN O
disorder NN NN O
, , , O
diabetes NNS NNS O
, , , O
hypertension NN NN O
and CC CC O
a DT DT O
nonspecific JJ JJ O
peripheral NN NN O
neuropathy NN NN O
. . . O
   
Medications NNP NNP O
at IN IN O
present JJ JJ O
: : : O
NPH NNP NNP O
insulin NN NN O
60 CD CD O
units NNS NNS O
sub NN NN O
q NN NN O
qAM NN NN O
, , , O
CZI NNP NNP O
insulin NN NN O
30 CD CD O
units NNS NNS O
sub NN NN O
q NN NN O
qAM NN NN O
, , , O
NPH NNP NNP O
insulin NN NN O
60 CD CD O
units NNS NNS O
sub NN NN O
q NN NN O
qPM NN NN O
, , , O
enteric JJ JJ O
coated VBN VBN O
aspirin NN NN O
one CD CD O
tab NN NN O
po NN NN O
q.d. NN NN O
, , , O
atenolol NN NN O
50 CD CD O
mg NN NN O
po NN NN O
b.i.d. NN NN O
, , , O
Captopril NNP NNP O
25 CD CD I-STREET
mg NN NN O
po NN NN O
t.i.d. NN NN O
, , , O
amlodipine NN NN O
5 CD CD O
mg NN NN O
po NN NN O
q.d. NN NN O
, , , O
simvastatin NN NN O
10 CD CD O
mg NN NN O
po NN NN O
q.d. NN NN O
, , , O
nitroglycerin NN NN O
prn NN NN O
, , , O
Nitropatch NNP NNP O
.2 CD CD O
mg NN NN O
for IN IN O
twelve CD CD O
hours NNS NNS O
of IN IN I-DATE
a DT DT O
twenty-four JJ JJ O
hour NN NN O
period NN NN O
, , , O
Neurontin NNP NNP O
300 CD CD O
mg NN NN O
one CD CD O
tab NN NN O
po NN NN O
t.i.d. NN NN O
, , , O
Trusopt NNP NNP O
one CD CD O
drop NN NN O
ou NN NN O
q.d. NN NN O
, , , O
Alantin NNP NNP O
one CD CD O
drop NN NN O
ou NN NN O
q.h.s. NN NN O
and CC CC O
albuterol NN NN O
inhalers NNS NNS O
two CD CD O
puffs NNS NNS O
q.i.d. NN NN O
prn NN NN O
. . . O
   
Cigarettes NNP NNP O
- : : O
none NN NN O
at IN IN O
present JJ JJ O
. . . O
   
Physical JJ JJ O
exam NN NN O
reveals VBZ VBZ O
a DT DT O
well-nourished JJ JJ O
mildly RB RB O
overweight NN NN O
woman NN NN O
in IN IN O
no DT DT O
acute JJ JJ O
distress NN NN O
. . . O
   
Blood NNP NNP O
pressure NN NN O
right JJ JJ O
arm NN NN O
sitting VBG VBG O
140/70 CD CD O
, , , O
heart NN NN O
rate NN NN O
75 CD CD O
and CC CC O
regular JJ JJ O
, , , O
respirations NNS NNS O
12 CD CD O
and CC CC O
unlabored JJ JJ O
, , , O
weight NN NN O
172 CD CD O
pounds NNS NNS O
. . . O
   
The DT DT O
neck NN NN O
is VBZ VBZ O
supple JJ JJ O
. . . O
   
JVP NNP NNP O
flat JJ JJ O
. . . O
   
Carotids NNP NNP O
are VBP VBP O
2 CD CD O
+ NN NN O
without IN IN O
significant JJ JJ O
bruits NNS NNS O
. . . O
   
Chest NN NN O
is VBZ VBZ O
clear JJ JJ O
with IN IN O
a DT DT O
trace NN NN O
right NN NN O
basilar NN NN O
rhonchi NN NN O
. . . O
   
Cardiac NNP NNP O
exam NN NN O
shows VBZ VBZ O
a DT DT O
normal JJ JJ O
S1 NNP NNP O
, , , O
physiologically RB RB O
split NN NN O
S2 NNP NNP O
and CC CC O
a DT DT O
I-II/VI NNP NNP O
systolic JJ JJ O
ejection NN NN O
murmur NN NN O
radiating VBG VBG O
from IN IN O
the DT DT O
apex NN NN O
to TO TO O
the DT DT O
base NN NN O
, , , O
no DT DT O
significant JJ JJ O
diastolic JJ JJ O
murmur NN NN O
or CC CC O
rub NN NN O
. . . O
   
The DT DT O
abdomen NN NN O
is VBZ VBZ O
benign NN NN O
with IN IN O
bowel NN NN O
sounds VBZ VBZ O
well RB RB O
heard VBN VBN O
. . . O
   
Extremities NNP NNP O
without IN IN O
appreciable JJ JJ O
edema NN NN O
. . . O
   
Peripheral NNP NNP O
pulses NNS NNS O
are VBP VBP O
intact JJ JJ O
. . . O
   
There EX EX O
is VBZ VBZ O
1 CD CD O
+ NN NN O
bipedal NN NN O
edema NN NN O
. . . O
   
Electrocardiogram NNP NNP O
shows VBZ VBZ O
sinus NN NN O
rhythm NN NN O
at IN IN O
a DT DT O
rate NN NN O
of IN IN I-DATE
   
75 CD CD O
. . . O
PR NNP NNP O
interval NN NN O
of IN IN I-DATE
.14, CD CD O
QRS NNP NNP O
.08, CD CD O
QT NNP NNP O
.34, CD CD O
axis NNS NNS O
- : : O
20 CD CD O
degrees NNS NNS O
. . . O
   
There EX EX O
is VBZ VBZ O
evidence NN NN O
of IN IN I-DATE
a DT DT O
left VBN VBN O
atrial JJ JJ O
abnormality NN NN O
and CC CC O
poor JJ JJ O
R NNP NNP O
wave NN NN O
progression NN NN O
in IN IN O
leads VBZ VBZ O
V1 NNP NNP O
through IN IN O
V3 NNP NNP O
. . . O
   
Impression NNP NNP O
: : : O
Mrs NNP NNP O
. . . O
   
Olivier NNP NNP I-PATIENT
is VBZ VBZ O
a DT DT O
62-year-old JJ JJ O
woman NN NN O
with IN IN O
significant JJ JJ O
atherosclerosis NNS NNS O
, , , O
diabetes NN NN O
and CC CC O
now RB RB O
a DT DT O
chief JJ JJ O
complaint NN NN O
of IN IN I-DATE
modest JJ JJ O
exertional JJ JJ O
dyspnea NN NN O
and CC CC O
fatigue NN NN O
. . . O
   
She PRP PRP O
denies VBZ VBZ O
any DT DT O
active JJ JJ O
chest NN NN O
discomfort NN NN O
and CC CC O
apparently RB RB O
her PRP$ PRP$ O
recent JJ JJ O
angioplasty NN NN O
was VBD VBD O
successful JJ JJ O
at IN IN O
alleviating VBG VBG O
the DT DT O
chest NN NN O
pain NN NN O
syndrome NN NN O
. . . O
   
The DT DT O
records NNS NNS O
available JJ JJ O
to TO TO O
me PRP PRP O
indicate VBP VBP O
that IN IN O
there EX EX O
is VBZ VBZ O
no DT DT O
continued VBN VBN O
efforts NNS NNS O
to TO TO O
diminish VB VB O
her PRP$ PRP$ O
beta NN NN O
blocker NN NN O
therapy NN NN O
however RB RB O
in IN IN O
the DT DT O
past JJ JJ O
this DT DT O
had VBD VBD O
lead NN NN O
to TO TO O
an DT DT O
exacerbation NN NN O
of IN IN I-DATE
her PRP$ PRP$ O
angina NN NN O
. . . O
   
However RB RB O
, , , O
now RB RB O
that IN IN O
she PRP PRP O
is VBZ VBZ O
status JJ JJ O
post NN NN O
her PRP$ PRP$ O
PTCA NNP NNP O
it PRP PRP O
is VBZ VBZ O
possible JJ JJ O
she PRP PRP O
now RB RB O
again RB RB O
will MD MD O
tolerate VB VB O
beta NN NN O
blocker NN NN O
reduction NN NN O
and CC CC O
therefore RB RB O
, , , O
I PRP PRP O
suggested VBD VBD O
she PRP PRP O
decrease NN NN O
her PRP$ PRP$ O
atenolol NN NN O
to TO TO O
50 CD CD O
mg NN NN O
po NN NN O
q.d. NN NN O
   
She PRP PRP O
will MD MD O
have VB VB O
her PRP$ PRP$ O
blood NN NN O
pressure NN NN O
checked VBN VBN O
within IN IN O
the DT DT O
next JJ JJ O
several JJ JJ O
days NNS NNS O
and CC CC O
assuming VBG VBG O
she PRP PRP O
remains VBZ VBZ O
asymptomatic JJ JJ O
, , , O
I PRP PRP O
will MD MD O
Olivier NNP NNP I-PATIENT
, , , O
Christine NNP NNP I-PATIENT
MR NNP NNP O
#652-33-21-5 NN NN O
- - - O
3 CD CD O
- : : O
July NNP NNP I-DATE
05 CD CD O
, , , O
2074 CD CD I-DATE
also RB RB O
try VB VB O
diminishing VBG VBG O
her PRP$ PRP$ O
amlodipine NN NN O
in IN IN O
part NN NN O
because IN IN O
of IN IN I-DATE
peripheral JJ JJ O
edema NN NN O
and CC CC O
in IN IN O
part NN NN O
because IN IN O
she PRP PRP O
may MD MD O
no RB RB O
longer RB RB O
need VBP VBP O
this DT DT O
. . . O
   
Otherwise RB RB O
, , , O
I PRP PRP O
have VBP VBP O
made VBN VBN O
no DT DT O
specific JJ JJ O
alterations NNS NNS O
to TO TO O
her PRP$ PRP$ O
medical JJ JJ O
regimen NNS NNS O
except IN IN O
to TO TO O
encourage VB VB O
her PRP PRP O
to TO TO O
continue VB VB O
her PRP$ PRP$ O
aerobic NN NN O
activity NN NN O
level NN NN O
as IN IN O
best JJS JJS O
she PRP PRP O
can MD MD O
and CC CC O
watch VB VB O
her PRP$ PRP$ O
saturated JJ JJ O
fat NN NN O
and CC CC O
cholesterol NN NN O
intake NN NN O
and CC CC O
stay VB VB O
in IN IN O
close JJ JJ O
contact NN NN O
with IN IN O
you PRP PRP O
should MD MD O
her PRP$ PRP$ O
chest NN NN O
pain NN NN O
syndrome NN NN O
at IN IN O
all DT DT O
recur NN NN O
. . . O
   
I PRP PRP O
would MD MD O
be VB VB O
happy JJ JJ O
to TO TO O
assist VB VB O
in IN IN O
her PRP$ PRP$ O
management NN NN O
in IN IN O
any DT DT O
way NN NN O
you PRP PRP O
deem VBP VBP O
appropriate JJ JJ O
. . . O
   
Sincerely NNP NNP O
yours NNS NNS O
, , , O
Irineo NNP NNP I-DOCTOR
Tovar NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
   
Vereen NNP NNP I-HOSPITAL
Memorial NNP NNP I-HOSPITAL
Hospital NNP NNP I-HOSPITAL
25 CD CD I-STREET
Waverly NNP NNP I-STREET
St NNP NNP I-STREET
Colorado NNP NNP I-CITY
City NNP NNP I-CITY
, , , O
NY NNP NNP I-STATE
88736 CD CD I-ZIP
DD NNP NNP O
: : : O
07/05/74 CD CD I-DATE
DT NNP NNP O
: : : O
07/11/74 CD CD I-DATE
DV NNP NNP O
: : : O
07/05/74 CD CD I-DATE
/ NN NN O
outlaw NN NN I-DOCTOR
******** NN NN O
Approved NNP NNP O
but CC CC O
not RB RB O
reviewed VBN VBN O
by IN IN O
Attending NNP NNP O
Provider NNP NNP O
******** NN NN O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2100-02-17 JJ JJ I-DATE
February NNP NNP I-DATE
17 CD CD O
, , , O
2100 CD CD I-DATE
Lawrence NNP NNP I-DOCTOR
Townsend NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
44 CD CD I-STREET
Briggs NNP NNP I-STREET
St NNP NNP I-STREET
Re NNP NNP O
: : : O
Nancy NNP NNP I-DOCTOR
Xayarath NNP NNP I-DOCTOR
ANC NNP NNP I-HOSPITAL
Unit NNP NNP O
#: NN NN O
111-64-17 NN NN I-MEDICALRECORD
Dear RB RB O
Dr NNP NNP O
. . . O
Townsend NNP NNP I-DOCTOR
: : : O
I PRP PRP O
had VBD VBD O
the DT DT O
pleasure NN NN O
of IN IN O
seeing VBG VBG O
Nancy NNP NNP I-DOCTOR
Xayarath NNP NNP I-DOCTOR
today NN NN O
with IN IN O
regards VBZ VBZ O
to TO TO O
callus VB VB O
formation NN NN O
over IN IN O
the DT DT O
plantar NN NN O
aspect NN NN O
of IN IN O
her PRP$ PRP$ O
left JJ JJ O
foot NN NN O
. . . O
   
As IN IN O
you PRP PRP O
are VBP VBP O
aware JJ JJ O
, , , O
she PRP PRP O
is VBZ VBZ O
a DT DT O
57-year-old JJ JJ O
woman NN NN O
with IN IN O
a DT DT O
history NN NN O
of IN IN O
insulin-dependent JJ JJ O
diabetes NNS NNS O
mellitus NN NN O
and CC CC O
Charcot NNP NNP O
arthropathy NN NN O
of IN IN O
her PRP$ PRP$ O
left JJ JJ O
foot NN NN O
that WDT WDT O
has VBZ VBZ O
resulted VBN VBN O
in IN IN O
a DT DT O
rocker NN NN O
bottom NN NN O
deformity NN NN O
. . . O
   
She PRP PRP O
currently RB RB O
wears VBZ VBZ O
accommodative JJ JJ O
orthotics NNS NNS O
typical JJ JJ O
for IN IN O
somebody NN NN O
with IN IN O
her PRP$ PRP$ O
deformity NN NN O
. . . O
   
She PRP PRP O
has VBZ VBZ O
noted VBN VBN O
that IN IN O
perhaps RB RB O
over IN IN O
the DT DT O
last JJ JJ O
two CD CD O
weeks NNS NNS O
or CC CC O
so RB RB O
that IN IN O
a DT DT O
callus NN NN O
has VBZ VBZ O
formed VBN VBN O
under IN IN O
the DT DT O
plantar NN NN O
lateral NN NN O
aspect NN NN O
of IN IN O
the DT DT O
left VBN VBN O
foot NN NN O
. . . O
   
She PRP PRP O
denies VBZ VBZ O
any DT DT O
drainage NN NN O
, , , O
erythema NN NN O
, , , O
or CC CC O
increased VBD VBD O
swelling VBG VBG O
or CC CC O
warmth NN NN O
in IN IN O
the DT DT O
foot NN NN O
. . . O
   
Her PRP$ PRP$ O
orthotics NNS NNS O
were VBD VBD O
made VBN VBN O
in IN IN O
September NNP NNP I-DATE
and CC CC O
seem VBP VBP O
to TO TO O
be VB VB O
working VBG VBG O
quite RB RB O
well RB RB O
for IN IN O
her PRP PRP O
. . . O
   
She PRP PRP O
admits VBZ VBZ O
however RB RB O
that IN IN O
over IN IN O
the DT DT O
last JJ JJ O
month NN NN O
and CC CC O
half NN NN O
or CC CC O
so RB RB O
that IN IN O
she PRP PRP O
has VBZ VBZ O
been VBN VBN O
wearing VBG VBG O
boots NNS NNS O
that WDT WDT O
her PRP$ PRP$ O
current JJ JJ O
orthotics NNS NNS O
do VBP VBP O
not RB RB O
fit VB VB O
in IN IN O
. . . O
   
Apparently RB RB O
, , , O
she PRP PRP O
has VBZ VBZ O
had VBN VBN O
to TO TO O
resort VB VB O
to TO TO O
her PRP$ PRP$ O
old JJ JJ O
orthotics NNS NNS O
, , , O
which WDT WDT O
did VBD VBD O
not RB RB O
take VB VB O
her PRP$ PRP$ O
Charcot NNP NNP O
deformity NN NN O
into IN IN O
account NN NN O
. . . O
   
Her PRP$ PRP$ O
past JJ JJ O
medical JJ JJ O
history NN NN O
is VBZ VBZ O
significant JJ JJ O
for IN IN O
diabetes NN NN O
mellitus NN NN O
and CC CC O
coronary JJ JJ O
artery NN NN O
disease NN NN O
. . . O
   
Her PRP$ PRP$ O
medications NNS NNS O
include VBP VBP O
Prograf NNP NNP O
, , , O
prednisone NN NN O
, , , O
Prilosec NNP NNP O
, , , O
an DT DT O
aspirin NN NN O
a DT DT O
day NN NN O
, , , O
Imdur NNP NNP O
, , , O
calcium NN NN O
supplement NN NN O
, , , O
a DT DT O
multi NN NN O
vitamin NN NN O
, , , O
Lantus NNP NNP O
insulin NN NN O
, , , O
and CC CC O
Humalog NNP NNP O
with IN IN O
meals NNS NNS O
. . . O
   
She PRP PRP O
takes VBZ VBZ O
Imuran NNP NNP O
, , , O
Coumadin NNP NNP O
, , , O
and CC CC O
Toprol NNP NNP O
XL NNP NNP O
, , , O
as RB RB O
well RB RB O
as IN IN O
Lipitor NNP NNP O
. . . O
   
Her PRP$ PRP$ O
past JJ JJ O
surgical JJ JJ O
history NN NN O
is VBZ VBZ O
significant JJ JJ O
for IN IN O
colostomy NN NN O
in IN IN O
2094 CD CD I-DATE
, , , O
fistula NN NN O
repair NN NN O
in IN IN O
2095 CD CD I-DATE
, , , O
coronary JJ JJ O
artery NN NN O
bypass NN NN O
surgery NN NN O
times NNS NNS O
four CD CD O
in IN IN O
2096 CD CD I-DATE
, , , O
a DT DT O
kidney NN NN O
transplant NN NN O
in IN IN O
2097 CD CD I-DATE
, , , O
and CC CC O
a DT DT O
fistula NN NN O
ligation NN NN O
in IN IN O
2098 CD CD I-DATE
. . . O
   
She PRP PRP O
quit VBD VBD O
smoking VBG VBG O
ten CD CD O
years NNS NNS O
ago RB RB O
and CC CC O
has VBZ VBZ O
no DT DT O
known VBN VBN O
allergies NNS NNS O
to TO TO O
medications NNS NNS O
. . . O
   
Physical JJ JJ O
examination NN NN O
is VBZ VBZ O
centered VBN VBN O
mainly RB RB O
around IN IN O
her PRP$ PRP$ O
left JJ JJ O
foot NN NN O
. . . O
   
She PRP PRP O
has VBZ VBZ O
diminished VBN VBN O
sensation NN NN O
to TO TO O
ten-point JJ JJ O
examination NN NN O
with IN IN O
a DT DT O
Semmes-Weinstein NNP NNP O
5.05 CD CD O
monofilament NN NN O
. . . O
   
She PRP PRP O
has VBZ VBZ O
multiple JJ JJ O
toe NN NN O
amputations NNS NNS O
, , , O
all DT DT O
of IN IN O
which WDT WDT O
have VBP VBP O
healed VBN VBN O
nicely RB RB O
. . . O
   
She PRP PRP O
does VBZ VBZ O
have VB VB O
a DT DT O
palpable JJ JJ O
dorsalis NNS NNS O
pedis NN NN O
pulse NN NN O
. . . O
   
The DT DT O
skin NN NN O
is VBZ VBZ O
of IN IN O
normal JJ JJ O
turgor NN NN O
. . . O
   
She PRP PRP O
has VBZ VBZ O
no DT DT O
active JJ JJ O
plantar NN NN O
ulcers NNS NNS O
on IN IN O
Page NNP NNP O
two CD CD O
Re NNP NNP O
: : : O
Nancy NNP NNP I-DOCTOR
Xayarath NNP NNP I-DOCTOR
Date NN NN O
: : : O
February NNP NNP I-DATE
17 CD CD O
, , , O
2100 CD CD I-DATE
either CC CC O
foot NN NN O
. . . O
   
At IN IN O
the DT DT O
apex NN NN O
of IN IN O
her PRP$ PRP$ O
rocker NN NN O
bottom NN NN O
deformity NN NN O
on IN IN O
the DT DT O
left NN NN O
side NN NN O
there EX EX O
is VBZ VBZ O
a DT DT O
callus NN NN O
that IN IN O
I PRP PRP O
d SYM SYM O
brided VBN VBN O
in IN IN O
the DT DT O
office NN NN O
underlying VBG VBG O
which WDT WDT O
is VBZ VBZ O
a DT DT O
grade NN NN O
0 CD CD O
ulcer NN NN O
. . . O
   
No DT DT O
new JJ JJ O
x-rays JJ JJ O
were VBD VBD O
obtained VBN VBN O
today NN NN O
. . . O
   
Diagnosis NNP NNP O
: : : O
Grade NN NN O
0 CD CD O
ulcer NN NN O
, , , O
diabetic JJ JJ O
left VBD VBD O
foot NN NN O
. . . O
   
Plan NNP NNP O
: : : O
She PRP PRP O
has VBZ VBZ O
not RB RB O
reached VBN VBN O
the DT DT O
dermis NN NN O
on IN IN O
her PRP$ PRP$ O
left JJ JJ O
foot NN NN O
, , , O
however RB RB O
, , , O
should MD MD O
she PRP PRP O
continue VB VB O
to TO TO O
weight-bear JJ JJ O
without IN IN O
mechanical JJ JJ O
off-loading JJ JJ O
it PRP PRP O
is VBZ VBZ O
only RB RB O
a DT DT O
matter NN NN O
of IN IN O
time NN NN O
before IN IN O
this DT DT O
develops VBZ VBZ O
into IN IN O
a DT DT O
grade NN NN O
I PRP PRP O
ulcer VBP VBP O
. . . O
   
It PRP PRP O
is VBZ VBZ O
unclear JJ JJ O
to TO TO O
me PRP PRP O
whether IN IN O
the DT DT O
culprit NN NN O
is VBZ VBZ O
an DT DT O
orthotic JJ JJ O
that WDT WDT O
needs VBZ VBZ O
to TO TO O
be VB VB O
remolded VBN VBN O
or CC CC O
the DT DT O
fact NN NN O
that IN IN O
she PRP PRP O
has VBZ VBZ O
been VBN VBN O
wearing VBG VBG O
boots NNS NNS O
with IN IN O
an DT DT O
inappropriate JJ JJ O
orthotic JJ JJ O
. . . O
   
I PRP PRP O
am VBP VBP O
going VBG VBG O
to TO TO O
have VB VB O
her PRP$ PRP$ O
see VB VB O
Samantha NNP NNP I-DOCTOR
Albright NNP NNP I-DOCTOR
, , , O
our PRP$ PRP$ O
orthotist NN NN O
to TO TO O
have VB VB O
the DT DT O
insoles NNS NNS O
remolded VBN VBN O
with IN IN O
Plastizote NNP NNP O
. . . O
   
I PRP PRP O
have VBP VBP O
asked VBN VBN O
Ms NNP NNP O
. . . O
Xayarath IN IN I-DOCTOR
to TO TO O
bring VB VB O
the DT DT O
shoes NNS NNS O
that IN IN O
she PRP PRP O
typically RB RB O
wears VBZ VBZ O
as RB RB O
well RB RB O
as IN IN O
the DT DT O
boots NNS NNS O
she PRP PRP O
wears NNS NNS O
. . . O
   
We PRP PRP O
will MD MD O
follow VB VB O
this DT DT O
development NN NN O
closely RB RB O
as IN IN O
Ms NNP NNP O
. . . O
Xayarath NNP NNP I-DOCTOR
is VBZ VBZ O
perfectly RB RB O
aware JJ JJ O
of IN IN O
the DT DT O
potential JJ JJ O
downsides NNS NNS O
of IN IN O
forming VBG VBG O
an DT DT O
ulcer NN NN O
. . . O
   
She PRP PRP O
knows VBZ VBZ O
to TO TO O
contact VB VB O
me PRP PRP O
if IN IN O
she PRP PRP O
has VBZ VBZ O
any DT DT O
questions NNS NNS O
or CC CC O
concerns NNS NNS O
in IN IN O
the DT DT O
meantime NN NN O
. . . O
   
Thank VB VB O
you PRP PRP O
kindly RB RB O
for IN IN O
this DT DT O
referral NN NN O
. . . O
   
Best JJS JJS O
personal JJ JJ O
regards NNS NNS O
, , , O
Fredrich NNP NNP I-DOCTOR
L. NNP NNP I-DOCTOR
van NN NN I-DOCTOR
Butler NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
   
FLC/conley/MF NNP NNP O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2078-10-25 JJ JJ I-DATE
Chief NNP NNP O
Complaint NNP NNP O
annual JJ JJ O
exam NN NN O
History NN NN O
of IN IN O
Present JJ JJ O
Illness NNP NNP O
Last NNP NNP O
CPE NNP NNP O
2 CD CD O
yrs NNS NNS O
ago RB RB O
. . . O
   
Had VBD VBD O
severe JJ JJ O
injury NN NN O
to TO TO O
right JJ JJ O
shoulder NN NN O
and CC CC O
failed VBD VBD O
surgery NN NN O
so IN IN O
we PRP PRP O
did VBD VBD O
not RB RB O
do VB VB O
CPE NNP NNP O
last JJ JJ O
yr NN NN O
. . . O
   
Now RB RB O
pt NN NN O
fighting VBG VBG O
for IN IN O
workers NNS NNS O
comp NN NN O
and CC CC O
disability NN NN O
had VBD VBD O
has VBZ VBZ O
a DT DT O
hearing NN NN O
in IN IN O
2 CD CD O
days NNS NNS O
. . . O
   
Has VBZ VBZ O
a DT DT O
lawyer NN NN O
. . . O
   
Is VBZ VBZ O
not RB RB O
smoking VBG VBG O
any DT DT O
more JJR JJR O
. . . O
   
Has VBZ VBZ O
gained VBN VBN O
wt NN NN O
but CC CC O
feels VBZ VBZ O
she PRP PRP O
has VBZ VBZ O
"""" '' '' O
turned VBN VBN O
the DT DT O
corner NN NN O
"""" '' '' O
Reports NNP NNP O
classic JJ JJ O
orthopnea NN NN O
for IN IN O
past JJ JJ O
few JJ JJ O
days NNS NNS O
- : : O
afraid JJ JJ O
to TO TO O
go VB VB O
back RB RB O
to TO TO O
sleep VB VB O
. . . O
   
Has VBZ VBZ O
to TO TO O
sleep VB VB O
on IN IN O
3 CD CD O
pillows NNS NNS O
. . . O
   
Inhaler NNP NNP O
does VBZ VBZ O
not RB RB O
help VB VB O
. . . O
   
No DT DT O
sx NN NN O
during IN IN O
the DT DT O
day NN NN O
but CC CC O
is VBZ VBZ O
not RB RB O
as IN IN O
active JJ JJ O
. . . O
   
No DT DT O
CP NNP NNP O
, , , O
edema NN NN O
, , , O
palpitations NNS NNS O
. . . O
   
EKG NNP NNP O
done VBN VBN O
2 CD CD O
yrs NNS NNS O
ago RB RB O
showed VBD VBD O
junctional JJ JJ O
rhythm NN NN O
BS NNP NNP O
140 CD CD O
only RB RB O
occ NN NN O
near IN IN O
200 CD CD O
. . . O
   
Onw NNP NNP O
on IN IN O
24 CD CD O
units NNS NNS O
Novolog NNP NNP O
bid NN NN O
Medications NNP NNP O
Ascorbic NNP NNP O
Acid NNP NNP O
1000 CD CD O
MG NNP NNP O
PO NNP NNP O
QD NNP NNP O
Aspirin NNP NNP O
Buffered NNP NNP O
325 CD CD O
MG NNP NNP O
( ( ( O
325MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Calcium NNP NNP O
+ NN NN O
D NNP NNP O
( ( ( O
500 CD CD O
Elem NNP NNP O
. . . O
Ca MD MD O
) ) ) O
( ( ( O
CALCIUM NNP NNP O
Carbonate NNP NNP O
1250 CD CD O
Mg NNP NNP O
( ( ( O
500MG CD CD O
Elem NNP NNP O
Ca NNP NNP O
) ) ) O
/ NN NN O
Vit NNP NNP O
D NNP NNP O
200 CD CD O
Iu NNP NNP O
) ) ) O
) ) ) O
1 CD CD O
TAB NNP NNP O
(500MG-200 NNP NNP O
TABLET NNP NNP O
) ) ) O
PO NNP NNP O
BID NNP NNP O
#180 NN NN O
Carnitor NNP NNP O
( ( ( O
LEVOCARNITINE NNP NNP O
) ) ) O
1.5 CD CD O
GM NNP NNP O
( ( ( O
500MG CD CD O
TABLET NNP NNP O
) ) ) O
PO NNP NNP O
BID NNP NNP O
Coenzyme NNP NNP O
Q10 NNP NNP O
30 CD CD O
MG NNP NNP O
( ( ( O
30MG CD CD O
CAPSULE NNP NNP O
take NN NN O
1 CD CD O
) ) ) O
PO NNP NNP O
QD NNP NNP O
FUROSEMIDE NNP NNP O
20 CD CD O
MG NNP NNP O
( ( ( O
20MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
) ) ) O
PO NNP NNP O
QD NNP NNP O
#90 NN NN O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
LISINOPRIL NNP NNP O
40 CD CD I-AGE
MG NNP NNP O
( ( ( O
40MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
) ) ) O
PO NNP NNP O
BID NNP NNP O
#180 NN NN O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
Metoprolol NNP NNP O
Succinate NNP NNP O
Extended NNP NNP O
Release NNP NNP O
( ( ( O
METOPROLOL NNP NNP O
Succinate NNP NNP O
Extended NNP NNP O
Release NNP NNP O
) ) ) O
100 CD CD O
MG NNP NNP O
( ( ( O
100MG CD CD O
TAB.SR NNP NNP O
24H CD CD O
take NN NN O
1 CD CD O
) ) ) O
PO NNP NNP O
QD NNP NNP O
, , , O
non NN NN O
- - - O
childproof NN NN O
caps NNS NNS O
#90 NN NN O
TAB.SR NNP NNP O
MULTIVITAMINS NNP NNP O
1 CD CD O
TAB NNP NNP O
PO NNP NNP O
QD NNP NNP O
Novolog NNP NNP O
Mix NNP NNP O
70/30 CD CD O
( ( ( O
INSULIN NNP NNP O
Aspart NNP NNP O
70/30 CD CD O
) ) ) O
70-30 CD CD O
U/ML NNP NNP O
VIAL NNP NNP O
SC NNP NNP O
as IN IN O
directed VBN VBN O
, , , O
24 CD CD O
units NNS NNS O
bid NN NN O
#3 NN NN O
Bottle NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
SIMVASTATIN NNP NNP O
20 CD CD O
MG NNP NNP O
( ( ( O
20MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
) ) ) O
PO NNP NNP O
QHS NNP NNP O
#90 NN NN O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
Verapamil NNP NNP O
Sustained NNP NNP O
Release NNP NNP O
120 CD CD O
MG NNP NNP O
( ( ( O
120MG CD CD O
TABLET NNP NNP O
SA NNP NNP O
take NN NN O
1 CD CD O
) ) ) O
PO NNP NNP O
BID NNP NNP O
#180 NN NN O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
Allergies NNP NNP O
NKA NNP NNP O
Past NNP NNP O
Medical NNP NNP O
History NN NN O
OB:G1 NNP NNP O
P1 NNP NNP O
UCHD NNP NNP O
, , , O
no DT DT O
ARF NNP NNP O
Past NNP NNP O
Surgical NNP NNP O
History NN NN O
2 CD CD O
surgeries NNS NNS O
on IN IN O
right NN NN O
shoulder NN NN O
due JJ JJ O
to TO TO O
injury/fx JJ JJ O
Family NNP NNP O
History NN NN O
non NN NN O
contributory NN NN O
children-one JJ JJ O
son NN NN O
, , , O
Hep NNP NNP O
C NNP NNP O
no DT DT O
FH NNP NNP O
of IN IN O
colon NN NN O
cancer NN NN O
, , , O
breast NN NN O
cancer NN NN O
Social NNP NNP O
History NN NN O
smoking NN NN O
: : : O
stopped VBD VBD O
this DT DT O
yr NN NN O
EtOH NNP NNP O
: : : O
none NN NN O
drugs NNS NNS O
: : : O
none NN NN O
substance NN NN O
abuse NN NN O
: : : O
none NN NN O
OTC NNP NNP O
meds NNS NNS O
: : : O
none NN NN O
diet NN NN O
: : : O
none NN NN O
exercise NN NN O
: : : O
none NN NN O
caffeine NN NN O
: : : O
<1/d NN NN O
immunizations NNS NNS O
: : : O
needs VBZ VBZ O
flu NN NN O
shot NN NN O
work NN NN O
: : : O
former JJ JJ O
Appraiser NNP NNP I-PROFESSION
sexual JJ JJ O
: : : O
MSW NNP NNP O
, , , O
not RB RB O
sexually RB RB O
active JJ JJ O
domestic JJ JJ O
violence NN NN O
: : : O
in IN IN O
past JJ JJ O
seat NN NN O
belt NN NN O
use NN NN O
: : : O
yes UH UH O
sunscreen:yes NN NN O
living VBG VBG O
will/health NN NN O
care NN NN O
proxy NN NN O
- : : O
none NN NN O
Review NNP NNP O
of IN IN O
Systems NNP NNP O
General NNP NNP O
: : : O
wt NN NN O
up RB RB O
21 CD CD O
lbs NN NN O
, , , O
no DT DT O
fevers NNS NNS O
, , , O
chills NNS NNS O
, , , O
sweats NNS NNS O
Eye NNP NNP O
: : : O
reg NN NN O
ck NN NN O
- : : O
seen VBN VBN O
3/78 CD CD I-DATE
ENT NNP NNP O
: : : O
no DT DT O
sinus NN NN O
sx NN NN O
, , , O
reg NN NN O
dental NN NN O
exams NNS NNS O
skin NN NN O
: : : O
no DT DT O
rashes NNS NNS O
resp NN NN O
: : : O
no DT DT O
cough NN NN O
, , , O
SOB NNP NNP O
, , , O
sputum NN NN O
, , , O
hemoptysis NN NN O
CV NNP NNP O
: : : O
no DT DT O
CP NNP NNP O
, , , O
palpitations NNS NNS O
, , , O
edema NN NN O
, , , O
orthopnea NN NN O
, , , O
PND NNP NNP O
GI NNP NNP O
: : : O
no DT DT O
nausea NN NN O
, , , O
vomiting VBG VBG O
, , , O
heartburn NN NN O
, , , O
diarrhea NN NN O
, , , O
constipation NN NN O
, , , O
melena NN NN O
, , , O
hematochezia NN NN O
breast:mammogram NN NN O
done VBN VBN O
8/78 CD CD I-DATE
GU NNP NNP O
: : : O
no DT DT O
dysuria NN NN O
, , , O
hematuria NN NN O
. . . O
   
LMP NNP NNP O
: : : O
late JJ JJ O
40s NN NN I-AGE
contraception NN NN O
: : : O
NA NNP NNP O
MS NNP NNP O
: : : O
no DT DT O
arthritis NN NN O
or CC CC O
joint JJ JJ O
pain NN NN O
neuro NN NN O
: : : O
no DT DT O
dizziness NN NN O
, , , O
syncope NN NN O
; : : O
   
PN NNP NNP O
- : : O
numb NN NN O
but CC CC O
no DT DT O
pain NN NN O
MH NNP NNP O
: : : O
no DT DT O
depression NN NN O
All DT DT O
other JJ JJ O
systems NNS NNS O
were VBD VBD O
reviewed VBN VBN O
and CC CC O
are VBP VBP O
negative JJ JJ O
Vital NNP NNP O
Signs NNP NNP O
BLOOD NNP NNP O
PRESSURE NN NN O
140/80 CD CD O
PULSE NNP NNP O
81 CD CD O
HEIGHT NNP NNP O
67 CD CD O
in IN IN O
WEIGHT NNP NNP O
241 CD CD O
lb NN NN O
BMI NNP NNP O
37.8 CD CD O
Physical JJ JJ O
Exam NNP NNP O
General NNP NNP O
Appearance NNP NNP O
WD NNP NNP O
, , , O
WN NNP NNP O
obese NN NN O
WF NNP NNP O
in IN IN O
NAD NNP NNP O
, , , O
BP NNP NNP O
146/78 CD CD O
left VBD VBD O
large JJ JJ O
cuff NN NN O
by IN IN O
me PRP PRP O
Skin NNP NNP O
no DT DT O
rash NN NN O
HEENT NNP NNP O
PERRL NNP NNP O
disks NNS NNS O
sharp JJ JJ O
TMs NNP NNP O
clear JJ JJ O
, , , O
canals NNS NNS O
normal JJ JJ O
mouth NN NN O
and CC CC O
dentition NN NN O
normal JJ JJ O
neck NN NN O
: : : O
supple NN NN O
, , , O
no DT DT O
palp NN NN O
thyroid NN NN O
Chest NN NN O
clear JJ JJ O
to TO TO O
auscultation NN NN O
Breast NNP NNP O
no DT DT O
masses NNS NNS O
, , , O
nipple NN NN O
discharge NN NN O
. . . O
   
axillae NN NN O
clear JJ JJ O
Cor/Cardiac NNP NNP O
RRR NNP NNP O
, , , O
S1S2 NNP NNP O
no DT DT O
S3 NNP NNP O
no DT DT O
S4 NNP NNP O
no DT DT O
murmurs NNS NNS O
or CC CC O
gallops NNS NNS O
Abdomen NNP NNP O
soft JJ JJ O
, , , O
non NN NN O
tender NN NN O
, , , O
no DT DT O
mass NN NN O
. . . O
   
Normal JJ JJ O
liver NN NN O
, , , O
spleen NN NN O
. . . O
   
no DT DT O
rebound NN NN O
Nodes/Lymphatic NNP NNP O
no DT DT O
cervical JJ JJ O
, , , O
supraclavicular NN NN O
, , , O
axillary JJ JJ O
or CC CC O
inguinal JJ JJ O
nodes NNS NNS O
Pelvis NNP NNP O
normal JJ JJ O
external JJ JJ O
female JJ JJ O
genitalia NN NN O
no DT DT O
rash NN NN O
no DT DT O
Bartholin NNP NNP O
's POS POS O
, , , O
Skeens NNP NNP O
or CC CC O
para NN NN O
urethral JJ JJ O
tenderness NN NN O
vagina NN NN O
: : : O
normal JJ JJ O
cervix NN NN O
normal JJ JJ O
uterus NN NN O
: : : O
normal JJ JJ O
size NN NN O
, , , O
anteverted VBD VBD O
adnexae NN NN O
: : : O
non NN NN O
tender NN NN O
, , , O
no DT DT O
mass NN NN O
RV NNP NNP O
: : : O
confirms NNS NNS O
I PRP PRP O
performed VBD VBD O
pap NN NN O
smear JJ JJ O
Rectal NNP NNP O
Exam NNP NNP O
normal JJ JJ O
tone NN NN O
, , , O
no DT DT O
mass NN NN O
stool NN NN O
guaiac NN NN O
neg NN NN O
Extremity NNP NNP O
good JJ JJ O
distal NN NN O
pulses NNS NNS O
no DT DT O
edema NN NN O
Musc NNP NNP O
Skel NNP NNP O
FROM,no NNP NNP O
joint JJ JJ O
swellings NNS NNS O
Neurological NNP NNP O
oriented VBD VBD O
reflexes NNS NNS O
: : : O
KJ NNP NNP O
2 CD CD O
+ NN NN O
, , , O
AJ NNP NNP O
2 CD CD O
+ NN NN O
, , , O
symmetrical JJ JJ O
gait NN NN O
normal JJ JJ O
Psych NNP NNP O
normal JJ JJ O
affect NN NN O
Impression NNP NNP O
   
1 CD CD O
. . . O
HM NNP NNP O
: : : O
needs VBZ VBZ O
flu NN NN O
shot NN NN O
   
2 CD CD O
. . . O
DM NNP NNP O
: : : O
will MD MD O
ck VB VB O
labs NNS NNS O
likely JJ JJ O
to TO TO O
be VB VB O
out IN IN O
of IN IN O
control NN NN O
   
3 CD CD O
. . . O
wt NN NN O
gain NN NN O
   
4 CD CD O
. . . O
renal JJ JJ O
insufficiency NN NN O
- - - O
has VBZ VBZ O
not RB RB O
seen VBN VBN O
Dr NNP NNP O
. . . O
Dougherty NNP NNP I-DOCTOR
   
5 CD CD O
. . . O
right NN NN O
arm NN NN O
injury NN NN O
and CC CC O
workers NNS NNS O
comp/disability NN NN O
   
6 CD CD O
. . . O
orthopnea NN NN O
- - - O
new JJ JJ O
onset NN NN O
AF NNP NNP O
- : : O
may MD MD O
be VB VB O
underlying VBG VBG O
CAD NNP NNP O
vs NNS NNS O
cardiomyopathy NN NN O
vs NNS NNS O
due JJ JJ O
to TO TO O
BP NNP NNP O
- : : O
needs VBZ VBZ O
further JJ JJ O
eval NN NN O
. . . O
   
Lab NNP NNP O
Tests NNP NNP O
Tests NNP NNP O
ordered VBD VBD O
: : : O
EKG NNP NNP O
: : : O
AF NNP NNP O
rate NN NN O
61 CD CD O
Orders NNP NNP O
80053 CD CD O
Comprehensive NNP NNP O
Metabolic NNP NNP O
Panel NNP NNP O
85027 CD CD O
CBC NNP NNP O
( ( ( O
no DT DT O
diff NN NN O
) ) ) O
83036 CD CD O
Hemoglobin NNP NNP O
A1C NNP NNP O
81002 CD CD O
Urine NNP NNP O
Dipstick NNP NNP O
, , , O
w/o NN NN O
MIC NNP NNP O
80061 CD CD O
Lipid NNP NNP O
Panel NNP NNP O
84443 CD CD O
TSH NNP NNP O
In-Office NNP NNP O
Procedures NNP NNP O
Q0091 NNP NNP O
PAP NNP NNP O
SMEAR NNP NNP O
SCREENING NNP NNP O
82272 CD CD O
Occult NNP NNP O
Blood NNP NNP O
, , , O
Single NNP NNP O
93005 CD CD O
EKG NNP NNP O
, , , O
tracing VBG VBG O
only RB RB O
90658 CD CD O
Flu NNP NNP O
vaccine NN NN O
, , , O
split NN NN O
, , , O
3 CD CD O
yrs NN NN O
& CC CC O
> NN NN O
90471 CD CD O
IMADM NNP NNP O
PRQ NNP NNP O
ID NNP NNP O
SUBQ/IM NNP NNP O
NJXS NNP NNP O
1 CD CD O
VACC NNP NNP O
E&M NNP NNP O
Level NNP NNP O
99396 CD CD O
Preventive NNP NNP O
Visit NNP NNP O
, , , O
Established NNP NNP O
, , , O
Age NNP NNP O
40-64 NNP NNP O
Plan NNP NNP O
patient NN NN O
education NN NN O
done VBN VBN O
medications NNS NNS O
reviewed VBN VBN O
and CC CC O
reconciled JJ JJ O
patient NN NN O
will MD MD O
return:3 VB VB O
mon NNP NNP O
referral NN NN O
to TO TO O
Dr NNP NNP O
. . . O
Yarborough RB RB I-DOCTOR
for IN IN O
cardiac JJ JJ O
eval NN NN O
- - - O
new JJ JJ O
onset NN NN O
AF NNP NNP O
, , , O
mult NN NN O
CAD NNP NNP O
risk NN NN O
factors NNS NNS O
_____________________________ VBP VBP O
_ NN NN O
Billy NNP NNP I-DOCTOR
U. NNP NNP I-DOCTOR
Webber NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2083-10-06 JJ JJ I-DATE
VIGIL NNP NNP O
, , , O
ANTHONY NNP NNP I-PATIENT
40984972 CD CD I-MEDICALRECORD
10/06/2083 CD CD I-DATE
ATTENDING NNP NNP O
PHYSICIANS NNP NNP O
: : : O
Joshua NNP NNP I-DOCTOR
Root NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
   
Bloomfield NNP NNP I-HOSPITAL
Care NNP NNP I-HOSPITAL
Center NNP NNP I-HOSPITAL
, , , O
Suite NNP NNP O
8466 CD CD O
990 NN NN I-STREET
Westwood NNP NNP I-STREET
Dr NNP NNP I-STREET
Bangkok NNP NNP I-CITY
, , , O
NJ NNP NNP I-STATE
53591 CD CD I-ZIP
Amir NNP NNP I-DOCTOR
Naranjo NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
   
Boys NNP NNP I-HOSPITAL
Town NNP NNP I-HOSPITAL
National NNP NNP I-HOSPITAL
2 CD CD I-STREET
Kelly NNP NNP I-STREET
Street NNP NNP I-STREET
Bangkok NNP NNP I-CITY
, , , O
NJ NNP NNP I-STATE
53591 CD CD I-ZIP
Joshua NNP NNP I-DOCTOR
Hanna NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
   
Ashley NNP NNP I-HOSPITAL
County NNP NNP I-HOSPITAL
Medical NNP NNP I-HOSPITAL
Center NNP NNP I-HOSPITAL
61 CD CD I-STREET
Meadowview NNP NNP I-STREET
Circle NNP NNP I-STREET
Oneonta NNP NNP I-CITY
, , , O
NJ NNP NNP I-STATE
19723 CD CD I-ZIP
IDENTIFICATION NNP NNP O
: : : O
This DT DT O
65-year-old JJ JJ O
man NN NN O
with IN IN O
a DT DT O
5-year JJ JJ O
history NN NN O
of IN IN O
cardiomyopathy NN NN O
is VBZ VBZ O
is VBZ VBZ O
admitted VBN VBN O
with IN IN O
worsening VBG VBG O
heart NN NN O
failure NN NN O
and CC CC O
recent JJ JJ O
presyncope NN NN O
for IN IN O
further JJ JJ O
evaluation NN NN O
. . . O
   
He PRP PRP O
was VBD VBD O
diagnosed VBN VBN O
with IN IN O
progressive JJ JJ O
shortness NNS NNS O
of IN IN O
breath NN NN O
in IN IN O
2078 CD CD I-DATE
. . . O
   
He PRP PRP O
was VBD VBD O
treated VBN VBN O
with IN IN O
diuretics NNS NNS O
and CC CC O
other JJ JJ O
medications NNS NNS O
at IN IN O
that DT DT O
time NN NN O
. . . O
   
He PRP PRP O
did VBD VBD O
quite RB RB O
well RB RB O
until IN IN O
December NNP NNP I-DATE
of IN IN O
last JJ JJ O
year NN NN O
when WRB WRB O
he PRP PRP O
had VBD VBD O
a DT DT O
cardiac JJ JJ O
arrest NN NN O
and CC CC O
underwent JJ JJ O
ICD NNP NNP O
placement NN NN O
. . . O
   
He PRP PRP O
has VBZ VBZ O
had VBN VBN O
worsening VBG VBG O
symptoms NNS NNS O
over IN IN O
the DT DT O
last JJ JJ O
year NN NN O
with IN IN O
increasing JJ JJ O
shortness NN NN O
of IN IN O
breath NN NN O
on IN IN O
flat JJ JJ O
ground NN NN O
and CC CC O
a DT DT O
very RB RB O
severe JJ JJ O
shortness NN NN O
of IN IN O
breath NN NN O
with IN IN O
stairs NNS NNS O
. . . O
   
He PRP PRP O
has VBZ VBZ O
had VBN VBN O
some DT DT O
episodic NN NN O
nature NN NN O
to TO TO O
this DT DT O
. . . O
   
Two CD CD O
days NNS NNS O
prior RB RB O
to TO TO O
admission NN NN O
, , , O
he PRP PRP O
had VBD VBD O
relatively RB RB O
rapid JJ JJ O
onset NN NN O
of IN IN O
shortness NN NN O
of IN IN O
breath NN NN O
while IN IN O
trying VBG VBG O
to TO TO O
play VB VB O
pool NN NN O
. . . O
   
This DT DT O
recurred VBD VBD O
several JJ JJ O
times NNS NNS O
associated VBN VBN O
with IN IN O
diaphoresis NNS NNS O
. . . O
   
He PRP PRP O
had VBD VBD O
no DT DT O
palpitations NNS NNS O
at IN IN O
that DT DT O
time NN NN O
. . . O
   
He PRP PRP O
has VBZ VBZ O
no DT DT O
chest NN NN O
discomfort NN NN O
. . . O
   
His PRP$ PRP$ O
past JJ JJ O
medical JJ JJ O
history NN NN O
is VBZ VBZ O
significant JJ JJ O
for IN IN O
history NN NN O
of IN IN O
shower VB VB O
emboli NN NN O
and CC CC O
TIA NNP NNP O
in IN IN O
2081 CD CD I-DATE
. . . O
   
He PRP PRP O
has VBZ VBZ O
diabetes NNS NNS O
. . . O
   
He PRP PRP O
had VBD VBD O
spinal JJ JJ O
stenosis NN NN O
surgery NN NN O
in IN IN O
2078 CD CD I-DATE
. . . O
   
His PRP$ PRP$ O
current JJ JJ O
medical JJ JJ O
regimen NN NN O
is VBZ VBZ O
Bumex NNP NNP O
3 CD CD O
, , , O
recently RB RB O
decreased VBN VBN O
from IN IN O
12 CD CD O
due JJ JJ O
to TO TO O
worsening VBG VBG O
renal JJ JJ O
function NN NN O
. . . O
   
He PRP PRP O
is VBZ VBZ O
on IN IN O
spironolactone NN NN O
described VBD VBD O
as IN IN O
6.25 CD CD O
daily RB RB O
, , , O
digoxin NN NN O
0.125 CD CD O
, , , O
Toprol-XL NNP NNP O
12.5 CD CD O
. . . O
   
He PRP PRP O
has VBZ VBZ O
been VBN VBN O
on IN IN O
carvedilol NN NN O
, , , O
which WDT WDT O
was VBD VBD O
changed VBN VBN O
due JJ JJ O
to TO TO O
dizziness VB VB O
. . . O
   
He PRP PRP O
is VBZ VBZ O
on IN IN O
lisinopril NN NN O
1.25 CD CD O
mg NN NN O
and CC CC O
has VBZ VBZ O
had VBN VBN O
great JJ JJ O
difficulty NN NN O
tolerating VBG VBG O
any DT DT O
higher JJR JJR O
dose NN NN O
due JJ JJ O
to TO TO O
dizziness VB VB O
. . . O
   
He PRP PRP O
is VBZ VBZ O
on IN IN O
metolazone NN NN O
2.5 CD CD O
weekly NN NN O
. . . O
   
He PRP PRP O
takes VBZ VBZ O
Coumadin NNP NNP O
7.5 CD CD O
mg NN NN O
most JJS JJS O
days NNS NNS O
. . . O
   
He PRP PRP O
is VBZ VBZ O
on IN IN O
insulin NN NN O
and CC CC O
Lantus NNP NNP O
. . . O
   
He PRP PRP O
has VBZ VBZ O
no DT DT O
known VBN VBN O
drug NN NN O
allergies NNS NNS O
. . . O
   
His PRP$ PRP$ O
family NN NN O
history NN NN O
is VBZ VBZ O
essentially RB RB O
unremarkable JJ JJ O
. . . O
   
Mother NNP NNP O
unknown JJ JJ O
, , , O
father NN NN O
had VBD VBD O
onset NN NN O
of IN IN O
angina NN NN O
in IN IN O
his PRP$ PRP$ O
80s CD CD I-AGE
. . . O
   
The DT DT O
patient NN NN O
lives NNS NNS O
with IN IN O
his PRP$ PRP$ O
wife NN NN O
and CC CC O
son NN NN O
and CC CC O
is VBZ VBZ O
a DT DT O
retired VBN VBN O
Fire NNP NNP I-PROFESSION
Chief NNP NNP I-PROFESSION
. . . O
   
He PRP PRP O
had VBD VBD O
an DT DT O
80-pack-year JJ JJ O
smoking NN NN O
history NN NN O
but CC CC O
quit VBD VBD O
four CD CD O
years NNS NNS O
ago RB RB O
. . . O
   
He PRP PRP O
has VBZ VBZ O
one CD CD O
glass NN NN O
of IN IN O
alcohol NN NN O
every DT DT O
1-2 JJ JJ O
weeks NNS NNS O
. . . O
   
Review NNP NNP O
of IN IN O
systems NNS NNS O
is VBZ VBZ O
negative JJ JJ O
for IN IN O
any DT DT O
problems NNS NNS O
with IN IN O
fevers NNS NNS O
, , , O
chills NNS NNS O
, , , O
change NN NN O
in IN IN O
his PRP$ PRP$ O
bowel NN NN O
or CC CC O
bladder NN NN O
habits NNS NNS O
. . . O
   
He PRP PRP O
has VBZ VBZ O
no DT DT O
problems NNS NNS O
with IN IN O
swallowing VBG VBG O
. . . O
   
He PRP PRP O
has VBZ VBZ O
no DT DT O
problems NNS NNS O
with IN IN O
hearing NN NN O
or CC CC O
vision NN NN O
. . . O
   
Review NNP NNP O
of IN IN O
systems NNS NNS O
is VBZ VBZ O
otherwise RB RB O
negative JJ JJ O
. . . O
   
On IN IN O
physical JJ JJ O
examination NN NN O
, , , O
blood NN NN O
pressure NN NN O
is VBZ VBZ O
84/66 CD CD O
in IN IN O
the DT DT O
left VBN VBN O
arm NN NN O
and CC CC O
86/62 CD CD O
in IN IN O
the DT DT O
right JJ JJ O
arm NN NN O
. . . O
   
His PRP$ PRP$ O
chest NN NN O
is VBZ VBZ O
completely RB RB O
clear JJ JJ O
to TO TO O
auscultation NN NN O
and CC CC O
percussion NN NN O
. . . O
   
Temperature NNP NNP O
is VBZ VBZ O
35.9 CD CD O
. . . O
   
His PRP$ PRP$ O
heart NN NN O
rate NN NN O
is VBZ VBZ O
100 CD CD O
and CC CC O
a DT DT O
regular JJ JJ O
rhythm NN NN O
. . . O
   
His PRP$ PRP$ O
cardiac JJ JJ O
exam NN NN O
reveals VBZ VBZ O
left VBN VBN O
ventricular NN NN O
heave VB VB O
, , , O
which WDT WDT O
is VBZ VBZ O
visible JJ JJ O
. . . O
   
He PRP PRP O
has VBZ VBZ O
a DT DT O
palpable JJ JJ O
and CC CC O
audible JJ JJ O
third JJ JJ O
heart NN NN O
sound NN NN O
. . . O
   
The DT DT O
right NN NN O
ventricular NN NN O
impulse NN NN O
is VBZ VBZ O
present JJ JJ O
also RB RB O
. . . O
   
He PRP PRP O
has VBZ VBZ O
a DT DT O
systolic JJ JJ O
murmur NN NN O
, , , O
which WDT WDT O
is VBZ VBZ O
heard VBN VBN O
everywhere RB RB O
, , , O
not RB RB O
otherwise RB RB O
easy JJ JJ O
to TO TO O
characterize VB VB O
. . . O
   
It PRP PRP O
does VBZ VBZ O
not RB RB O
change VB VB O
with IN IN O
respiration NN NN O
. . . O
   
The DT DT O
second JJ JJ O
component NN NN O
of IN IN O
the DT DT O
second JJ JJ O
sound NN NN O
is VBZ VBZ O
slightly RB RB O
increased VBN VBN O
in IN IN O
radiation NN NN O
consistent JJ JJ O
with IN IN O
a DT DT O
PA NNP NNP O
systolic JJ JJ O
pressure NN NN O
in IN IN O
the DT DT O
range NN NN O
of IN IN O
50-60 NNP NNP O
. . . O
   
His PRP$ PRP$ O
legs NNS NNS O
are VBP VBP O
cool VB VB O
. . . O
   
Venous NNP NNP O
pattern NN NN O
is VBZ VBZ O
very RB RB O
prominent JJ JJ O
. . . O
   
His PRP$ PRP$ O
pulses NNS NNS O
are VBP VBP O
intact JJ JJ O
peripherally RB RB O
. . . O
   
He PRP PRP O
has VBZ VBZ O
no DT DT O
abdominal JJ JJ O
bruits NNS NNS O
. . . O
   
His PRP$ PRP$ O
jugular NN NN O
venous JJ JJ O
pressure NN NN O
is VBZ VBZ O
14 CD CD O
cm NN NN O
. . . O
   
He PRP PRP O
has VBZ VBZ O
no DT DT O
cervical JJ JJ O
adenopathy NN NN O
or CC CC O
thyromegaly NN NN O
. . . O
   
His PRP$ PRP$ O
liver NN NN O
percusses NNS NNS O
at IN IN O
approximately RB RB O
5 CD CD O
cm NN NN O
below IN IN O
the DT DT O
costal NN NN O
margin NN NN O
. . . O
   
He PRP PRP O
has VBZ VBZ O
some DT DT O
increased VBN VBN O
resonance NN NN O
around IN IN O
the DT DT O
umbilicus NN NN O
. . . O
   
Laterally RB RB O
, , , O
there EX EX O
is VBZ VBZ O
suggestion NN NN O
of IN IN O
some DT DT O
fluid NN NN O
in IN IN O
the DT DT O
distention NN NN O
. . . O
   
There EX EX O
is VBZ VBZ O
no DT DT O
peripheral JJ JJ O
edema NN NN O
. . . O
   
His PRP$ PRP$ O
joints NNS NNS O
are VBP VBP O
without IN IN O
obvious JJ JJ O
deformities NNS NNS O
, , , O
although IN IN O
he PRP PRP O
describes VBZ VBZ O
arthritis NN NN O
in IN IN O
his PRP$ PRP$ O
shoulder NN NN O
, , , O
neck NN NN O
, , , O
and CC CC O
back RB RB O
. . . O
   
He PRP PRP O
has VBZ VBZ O
no DT DT O
skin NN NN O
rashes NNS NNS O
or CC CC O
sores NNS NNS O
, , , O
several JJ JJ O
very RB RB O
small JJ JJ O
ecchymoses NNS NNS O
. . . O
   
His PRP$ PRP$ O
standing NN NN O
blood NN NN O
pressure NN NN O
is VBZ VBZ O
unchanged JJ JJ O
. . . O
   
He PRP PRP O
has VBZ VBZ O
atrially RB RB O
triggered VBN VBN O
ventricular NN NN O
pacing VBG VBG O
at IN IN O
   
98 CD CD O
. . . O
ASSESSMENT NNP NNP O
: : : O
   
1 CD CD O
. . . O
Etiology NNP NNP O
of IN IN O
left VBD VBD O
ventricular JJ JJ O
dysfunction NN NN O
is VBZ VBZ O
undetermined JJ JJ O
. . . O
   
We PRP PRP O
do VBP VBP O
not RB RB O
know VB VB O
information NN NN O
of IN IN O
recent JJ JJ O
catheterization NN NN O
or CC CC O
echocardiography NN NN O
. . . O
   
The DT DT O
degree NN NN O
of IN IN O
his PRP$ PRP$ O
mitral JJ JJ O
disease NN NN O
is VBZ VBZ O
not RB RB O
clear JJ JJ O
. . . O
   
He PRP PRP O
clearly RB RB O
did VBD VBD O
not RB RB O
have VB VB O
coronary JJ JJ O
artery NN NN O
disease NN NN O
on IN IN O
one CD CD O
studied VBN VBN O
initially RB RB O
. . . O
   
However RB RB O
, , , O
the DT DT O
episodicity NN NN O
is VBZ VBZ O
significant JJ JJ O
. . . O
   
2 CD CD I-STREET
. . . O
Current NNP NNP O
hemodynamic JJ JJ O
status NN NN O
shows VBZ VBZ O
marked VBD VBD O
volume NN NN O
overload NN NN O
and CC CC O
low JJ JJ O
cardiac JJ JJ O
output NN NN O
, , , O
and CC CC O
is VBZ VBZ O
cold JJ JJ O
and CC CC O
wet JJ JJ O
pattern NN NN O
. . . O
   
His PRP$ PRP$ O
history NN NN O
of IN IN O
recent JJ JJ O
diuretic JJ JJ O
use NN NN O
suggests VBZ VBZ O
that IN IN O
he PRP PRP O
may MD MD O
have VB VB O
had VBN VBN O
relatively RB RB O
rapid JJ JJ O
onset NN NN O
of IN IN O
fluid JJ JJ O
after IN IN O
his PRP$ PRP$ O
last JJ JJ O
diuretic JJ JJ O
change NN NN O
. . . O
   
However RB RB O
, , , O
the DT DT O
episode NN NN O
while IN IN O
playing VBG VBG O
pool NN NN O
also RB RB O
raises VBZ VBZ O
the DT DT O
possibility NN NN O
of IN IN O
a DT DT O
ventricular NN NN O
tachyarrhythmia NN NN O
undetected JJ JJ O
. . . O
   
It PRP PRP O
is VBZ VBZ O
also RB RB O
possible JJ JJ O
that IN IN O
this DT DT O
is VBZ VBZ O
related VBN VBN O
to TO TO O
angina NN NN O
. . . O
   
3 CD CD O
. . . O
Other JJ JJ O
related VBN VBN O
risks NNS NNS O
. . . O
   
He PRP PRP O
is VBZ VBZ O
on IN IN O
Coumadin NNP NNP O
due JJ JJ O
to TO TO O
his PRP$ PRP$ O
embolic JJ JJ O
shower NN NN O
before RB RB O
. . . O
   
It PRP PRP O
is VBZ VBZ O
possible JJ JJ O
that IN IN O
he PRP PRP O
has VBZ VBZ O
had VBN VBN O
other JJ JJ O
emboli NN NN O
, , , O
possibly RB RB O
even RB RB O
to TO TO O
coronary JJ JJ O
arteries NNS NNS O
leading VBG VBG O
to TO TO O
recent JJ JJ O
decline NN NN O
in IN IN O
function NN NN O
. . . O
   
There EX EX O
are VBP VBP O
no DT DT O
obvious JJ JJ O
contraindications NNS NNS O
to TO TO O
transplant NN NN O
. . . O
   
At IN IN O
this DT DT O
time NN NN O
, , , O
we PRP PRP O
are VBP VBP O
not RB RB O
planning VBG VBG O
to TO TO O
evaluate VB VB O
him PRP PRP O
but CC CC O
to TO TO O
treat VB VB O
the DT DT O
urgency NN NN O
of IN IN O
his PRP$ PRP$ O
heart NN NN O
failure NN NN O
decompensation NN NN O
. . . O
   
Our PRP$ PRP$ O
plan NN NN O
is VBZ VBZ O
to TO TO O
hold VB VB O
his PRP$ PRP$ O
beta-blockers JJ JJ O
and CC CC O
ACE NNP NNP O
inhibitors NNS NNS O
for IN IN O
now RB RB O
, , , O
and CC CC O
to TO TO O
begin VB VB O
him PRP PRP O
on IN IN O
an DT DT O
IV NNP NNP O
diuretic JJ JJ O
infusion NN NN O
. . . O
   
We PRP PRP O
will MD MD O
proceed VB VB O
with IN IN O
echocardiogram NN NN O
and CC CC O
catheterization NN NN O
if IN IN O
necessary JJ JJ O
to TO TO O
determine VB VB O
whether IN IN O
there EX EX O
are VBP VBP O
other JJ JJ O
conditions NNS NNS O
exacerbating VBG VBG O
his PRP$ PRP$ O
current JJ JJ O
decompensated VBN VBN O
state NN NN O
. . . O
   
_____________________________ NN NN O
_ NN NN O
Patricia NNP NNP I-DOCTOR
Cameron NNP NNP I-DOCTOR
Izzo NNP NNP I-DOCTOR
, , , O
MD NNP NNP O
Cardiac NNP NNP O
Services NNPS NNPS O
eScription NN NN O
document:2-7203595 JJ JJ O
SFFocus NNP NNP O
DD NNP NNP O
: : : O
10/07/83 CD CD I-DATE
DT NNP NNP O
: : : O
10/07/83 CD CD I-DATE
DV NNP NNP O
: : : O
10/06/83 CD CD I-DATE
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2082-08-01 JJ JJ I-DATE
OSBORNE NNP NNP O
, , , O
MATTISON NNP NNP I-PATIENT
48423663 CD CD I-MEDICALRECORD
08/01/2082 CD CD I-DATE
Willie NNP NNP I-DOCTOR
Knapp NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
   
Johnson NNP NNP I-HOSPITAL
Family NNP NNP I-HOSPITAL
Vision NNP NNP I-HOSPITAL
Care NNP NNP I-HOSPITAL
0529 CD CD I-STREET
Governors NNP NNP I-STREET
Lane NNP NNP I-STREET
Oroville NNP NNP I-CITY
, , , O
AL NNP NNP I-STATE
89389 CD CD I-ZIP
Dear RB RB O
Dr NNP NNP O
. . . O
Knapp NNP NNP I-DOCTOR
: : : O
It PRP PRP O
was VBD VBD O
our PRP$ PRP$ O
pleasure NN NN O
to TO TO O
care VB VB O
for IN IN O
Mr NNP NNP O
. . . O
Osborne NNP NNP I-PATIENT
to TO TO O
help VB VB O
with IN IN O
his PRP$ PRP$ O
decompensated JJ JJ O
heart NN NN O
failure NN NN O
. . . O
   
He PRP PRP O
was VBD VBD O
admitted VBN VBN O
on IN IN O
07/23/2082 CD CD I-DATE
, , , O
one CD CD O
month NN NN O
after IN IN O
previous JJ JJ O
admission NN NN O
for IN IN O
abdominal JJ JJ O
pain NN NN O
. . . O
   
In IN IN O
retrospect NN NN O
, , , O
that IN IN O
admission NN NN O
may MD MD O
have VB VB O
been VBN VBN O
related VBN VBN O
in IN IN O
part NN NN O
to TO TO O
GI NNP NNP O
symptoms NNS NNS O
of IN IN O
heart NN NN O
failure NN NN O
. . . O
   
He PRP PRP O
came VBD VBD O
in IN IN O
complaining NN NN O
of IN IN O
continued VBD VBD O
GI NNP NNP O
discomfort NN NN O
, , , O
orthopnea NN NN O
, , , O
lower JJR JJR O
extremity NN NN O
edema NN NN O
, , , O
and CC CC O
9 CD CD O
pounds NNS NNS O
of IN IN O
weight NN NN O
gain NN NN O
with IN IN O
increasing VBG VBG O
abdominal JJ JJ O
girth NN NN O
. . . O
   
His PRP$ PRP$ O
medications NNS NNS O
at IN IN O
the DT DT O
time NN NN O
of IN IN O
admission NN NN O
included VBD VBD O
beta-blockers JJ JJ O
and CC CC O
ACE NNP NNP O
inhibitors NNS NNS O
for IN IN O
hypertension NN NN O
, , , O
with IN IN O
no DT DT O
diuretics NNS NNS O
. . . O
   
During IN IN O
his PRP$ PRP$ O
hospitalization NN NN O
, , , O
he PRP PRP O
underwent VBD VBD O
7.5 CD CD O
kilograms NNS NNS O
of IN IN O
diuresis NNS NNS O
with IN IN O
resolution NN NN O
of IN IN O
his PRP$ PRP$ O
jugular NN NN O
venous JJ JJ O
pressure NN NN O
from IN IN O
approximately RB RB O
25 CD CD O
cm NN NN O
to TO TO O
8 CD CD O
cm NN NN O
. . . O
   
His PRP$ PRP$ O
echocardiogram NN NN O
showed VBD VBD O
an DT DT O
ejection NN NN O
fraction NN NN O
of IN IN O
approximately RB RB O
20 CD CD O
% NN NN O
with IN IN O
LV NNP NNP O
dimension NN NN O
of IN IN O
5.1 CD CD O
, , , O
enlarged JJ JJ O
right NN NN O
ventricle NN NN O
with IN IN O
mild JJ JJ O
decrease NN NN O
in IN IN O
RV NNP NNP O
function NN NN O
, , , O
but CC CC O
severe JJ JJ O
RV NNP NNP O
pressure NN NN O
overload NN NN O
with IN IN O
estimated VBN VBN O
PA NNP NNP O
pressure NN NN O
80 CD CD O
plus CC CC O
the DT DT O
right NN NN O
atrial JJ JJ O
pressure NN NN O
. . . O
   
After IN IN O
he PRP PRP O
had VBD VBD O
his PRP$ PRP$ O
diuresis NN NN O
, , , O
he PRP PRP O
underwent JJ JJ O
right JJ JJ O
heart NN NN O
catheterization NN NN O
, , , O
which WDT WDT O
revealed VBD VBD O
a DT DT O
right JJ JJ O
atrial JJ JJ O
pressure NN NN O
of IN IN O
8 CD CD O
, , , O
pulmonary JJ JJ O
capillary JJ JJ O
wedge NN NN O
pressure NN NN O
of IN IN O
18 CD CD O
, , , O
PA NNP NNP O
pressure NN NN O
of IN IN O
65/35 CD CD O
. . . O
   
He PRP PRP O
underwent VBD VBD O
a DT DT O
trial NN NN O
with IN IN O
IV NNP NNP O
nitroglycerin NN NN O
, , , O
then RB RB O
with IN IN O
sildenafil NN NN O
. . . O
   
The DT DT O
IV NNP NNP O
nitroglycerin NN NN O
decreased VBD VBD O
his PRP$ PRP$ O
BLANK NNP NNP O
pressures NNS NNS O
only RB RB O
by IN IN O
approximately RB RB O
8-10 JJ JJ O
mm NN NN O
but CC CC O
he PRP PRP O
noted VBD VBD O
a DT DT O
further JJ JJ O
improvement NN NN O
in IN IN O
his PRP$ PRP$ O
dyspnea NN NN O
. . . O
   
There EX EX O
was VBD VBD O
no DT DT O
clear JJ JJ O
improvement NN NN O
with IN IN O
the DT DT O
sildenafil NN NN O
in IN IN O
either DT DT O
his PRP$ PRP$ O
symptoms NNS NNS O
or CC CC O
hemodynamics NNS NNS O
. . . O
   
His PRP$ PRP$ O
cardiac NN NN O
output NN NN O
varied VBD VBD O
between IN IN O
3.1 CD CD O
and CC CC O
4.5 CD CD O
on IN IN O
all PDT PDT O
the DT DT O
medications NNS NNS O
. . . O
   
The DT DT O
decision NN NN O
was VBD VBD O
just RB RB O
to TO TO O
put VB VB O
him PRP PRP O
on IN IN O
oral JJ JJ O
nitroglycerin NN NN O
in IN IN O
addition NN NN O
to TO TO O
the DT DT O
other JJ JJ O
standard JJ JJ O
heart NN NN O
failure NN NN O
medications NNS NNS O
. . . O
   
He PRP PRP O
also RB RB O
underwent VBD VBD O
a DT DT O
MIBI NNP NNP O
looking VBG VBG O
for IN IN O
any DT DT O
evidence NN NN O
of IN IN O
active JJ JJ O
ischemia NN NN O
, , , O
which WDT WDT O
there EX EX O
was VBD VBD O
none NN NN O
. . . O
   
At IN IN O
the DT DT O
time NN NN O
of IN IN O
discharge NN NN O
, , , O
he PRP PRP O
is VBZ VBZ O
walking VBG VBG O
easily RB RB O
without IN IN O
postural JJ JJ O
change NN NN O
or CC CC O
symptoms NNS NNS O
. . . O
   
His PRP$ PRP$ O
medications NNS NNS O
are VBP VBP O
Isordil NNP NNP O
10 CD CD O
t.i.d. NN NN O
, , , O
Lasix NNP NNP O
40 CD CD O
mg NN NN O
p.o. NN NN O
b.i.d. NN NN O
   
He PRP PRP O
is VBZ VBZ O
on IN IN O
Toprol-XL NNP NNP O
12.5 CD CD O
daily RB RB O
. . . O
   
His PRP$ PRP$ O
lisinopril NN NN O
was VBD VBD O
decreased VBN VBN O
from IN IN O
40 CD CD O
mg NN NN O
to TO TO O
20 CD CD O
mg NN NN O
, , , O
but CC CC O
should MD MD O
he PRP PRP O
have VB VB O
any DT DT O
problems NNS NNS O
with IN IN O
hypotension NN NN O
, , , O
this DT DT O
could MD MD O
certainly RB RB O
be VB VB O
decreased VBN VBN O
further JJ JJ O
to TO TO O
10 CD CD O
or CC CC O
even RB RB O
5 CD CD O
mg NN NN O
if IN IN O
necessary JJ JJ O
to TO TO O
allow VB VB O
him PRP PRP O
comfortable JJ JJ O
ambulation NN NN O
. . . O
   
He PRP PRP O
is VBZ VBZ O
on IN IN O
Plavix NNP NNP O
75 CD CD O
mg NN NN O
daily JJ JJ O
as IN IN O
well RB RB O
and CC CC O
simvastatin NN NN O
   
40 CD CD O
. . . O
His PRP$ PRP$ O
discharge NN NN O
blood NN NN O
pressure NN NN O
is VBZ VBZ O
102/60 CD CD O
, , , O
jugular NN NN O
venous JJ JJ O
pressure NN NN O
is VBZ VBZ O
8-9 JJ JJ O
cm NN NN O
. . . O
   
His PRP$ PRP$ O
creatinine NN NN O
is VBZ VBZ O
1.3 CD CD O
with IN IN O
a DT DT O
BUN NNP NNP O
of IN IN O
44 CD CD O
, , , O
hematocrit NN NN O
40 CD CD O
, , , O
white JJ JJ O
blood NN NN O
count NN NN O
5000 CD CD O
, , , O
potassium NN NN O
3.9 CD CD O
, , , O
sodium NN NN O
139 CD CD O
. . . O
   
It PRP PRP O
has VBZ VBZ O
been VBN VBN O
my PRP$ PRP$ O
great JJ JJ O
pleasure NN NN O
to TO TO O
participate VB VB O
in IN IN O
his PRP$ PRP$ O
care NN NN O
. . . O
   
He PRP PRP O
is VBZ VBZ O
trying VBG VBG O
very RB RB O
hard JJ JJ O
to TO TO O
learn VB VB O
how WRB WRB O
to TO TO O
manage VB VB O
his PRP$ PRP$ O
disease NN NN O
at IN IN O
home NN NN O
, , , O
with IN IN O
the DT DT O
help NN NN O
of IN IN O
his PRP$ PRP$ O
family NN NN O
. . . O
   
We PRP PRP O
have VBP VBP O
emphasized VBN VBN O
not RB RB O
only RB RB O
the DT DT O
salt NN NN O
restriction NN NN O
but CC CC O
also RB RB O
a DT DT O
fluid JJ JJ O
restriction NN NN O
to TO TO O
2 CD CD O
liters NNS NNS O
a DT DT O
day NN NN O
, , , O
which WDT WDT O
includes VBZ VBZ O
all DT DT O
fluids NNS NNS O
, , , O
We PRP PRP O
would MD MD O
encourage VB VB O
him PRP PRP O
to TO TO O
resume VB VB O
his PRP$ PRP$ O
daily JJ JJ O
exercise NN NN O
such JJ JJ O
as IN IN O
walking VBG VBG O
. . . O
   
He PRP PRP O
has VBZ VBZ O
an DT DT O
appointment NN NN O
to TO TO O
see VB VB O
Dr NNP NNP O
. . . O
Anderson NNP NNP I-DOCTOR
on IN IN O
08/20/2081 CD CD I-DATE
, , , O
and CC CC O
is VBZ VBZ O
looking VBG VBG O
forward RB RB O
to TO TO O
returning VBG VBG O
to TO TO O
your PRP$ PRP$ O
care NN NN O
. . . O
   
I PRP PRP O
would MD MD O
be VB VB O
happy JJ JJ O
to TO TO O
answer VB VB O
any DT DT O
further JJ JJ O
questions NNS NNS O
about IN IN O
it PRP PRP O
. . . O
   
Sincerely NNP NNP O
, , , O
_____________________________ NN NN O
_ NN NN O
Ursula NNP NNP I-DOCTOR
Michael NNP NNP I-DOCTOR
Troyer NNP NNP I-DOCTOR
, , , O
MD NNP NNP O
eScription NN NN O
document:3-8959007 JJ JJ O
IFFocus NNP NNP O
CC NNP NNP O
: : : O
Forrest NNP NNP I-DOCTOR
T. NN NN I-DOCTOR
Anderson NNP NNP I-DOCTOR
M.D. NN NN O
23 CD CD I-STREET
Azalea NNP NNP I-STREET
Lane NNP NNP I-STREET
Cardiovascular NNP NNP O
Division NNP NNP O
Scottsville NNP NNP I-CITY
, , , O
AL NNP NNP I-STATE
99112 CD CD I-ZIP
DD NNP NNP O
: : : O
08/01/82 CD CD I-DATE
DT NNP NNP O
: : : O
08/01/82 CD CD I-DATE
DV NNP NNP O
: : : O
08/01/82 CD CD I-DATE
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2072-07-27 JJ JJ I-DATE
Narrative NNP NNP O
History NN NN O
Patient NNP NNP O
presents VBZ VBZ O
for IN IN O
an DT DT O
annual JJ JJ O
exam NN NN O
. . . O
   
Not RB RB O
seen VBN VBN O
for IN IN O
almost RB RB O
2 CD CD O
years NNS NNS O
. . . O
   
State NNP NNP O
she PRP PRP O
's VBZ VBZ O
had VBD VBD O
a DT DT O
very RB RB O
difficult JJ JJ O
time NN NN O
with IN IN O
her PRP$ PRP$ O
husband NN NN O
's POS POS O
death NN NN O
2070 CD CD I-DATE
. . . O
   
Angry NNP NNP O
and CC CC O
sad JJ JJ O
and CC CC O
guilty JJ JJ O
feelings NNS NNS O
. . . O
   
Had VBD VBD O
been VBN VBN O
staying VBG VBG O
at IN IN O
home NN NN O
a DT DT O
lot NN NN O
, , , O
missing VBG VBG O
a DT DT O
fair JJ JJ O
amount NN NN O
of IN IN O
work NN NN O
. . . O
   
Did VBD VBD O
have VB VB O
a DT DT O
lot NN NN O
of IN IN O
support NN NN O
from IN IN O
her PRP$ PRP$ O
neighbors NNS NNS O
and CC CC O
coworkers NNS NNS O
. . . O
   
Also RB RB O
does VBZ VBZ O
live VB VB O
with IN IN O
her PRP$ PRP$ O
son NN NN O
. . . O
   
Just RB RB O
seems VBZ VBZ O
to TO TO O
be VB VB O
coming VBG VBG O
out IN IN O
of IN IN O
it PRP PRP O
now RB RB O
. . . O
   
GYN NNP NNP O
- : : O
no DT DT O
vaginal JJ JJ O
bleeding NN NN O
, , , O
not RB RB O
sexually RB RB O
active JJ JJ O
. . . O
   
Exercise VB VB O
- : : O
none NN NN O
, , , O
Problems NNS NNS O
FH NNP NNP O
breast NN NN O
cancer NN NN O
: : : O
37 CD CD I-AGE
yo NN NN O
s VBZ VBZ O
- - - O
died JJ JJ O
41 CD CD I-AGE
FH NNP NNP O
myocardial NN NN O
infarction NN NN O
: : : O
mother NN NN O
died VBD VBD O
66 CD CD I-AGE
yo NN NN O
Hypertension NNP NNP O
- - - O
borderline NN NN O
today NN NN O
- : : O
check NN NN O
chem NN NN O
7 CD CD O
, , , O
refilled JJ JJ O
all DT DT O
her PRP$ PRP$ O
medications NNS NNS O
. . . O
   
Will MD MD O
start VB VB O
doing VBG VBG O
some DT DT O
exercise NN NN O
and CC CC O
trying VBG VBG O
to TO TO O
lose VB VB O
weight NN NN O
. . . O
   
Uterine NNP NNP O
fibroids NNS NNS O
: : : O
u/s NN NN O
2062 CD CD I-DATE
- : : O
not RB RB O
seen VBN VBN O
Dr NNP NNP O
Foust NNP NNP I-DOCTOR
since IN IN O
2066 CD CD I-DATE
when WRB WRB O
difficult JJ JJ O
to TO TO O
obtain VB VB O
her PRP$ PRP$ O
Pap NNP NNP O
smear NN NN O
. . . O
   
Smoking NNP NNP O
: : : O
quit VBD VBD O
2/67 CD CD I-DATE
s/p NN NN O
MI NNP NNP O
- : : O
still RB RB O
not RB RB O
smoking NN NN O
! . . O
   
borderline NN NN O
diabetes NN NN O
mellitus NN NN O
: : : O
4/63 CD CD I-DATE
125 CD CD O
, , , O
follow VBP VBP O
hgbaic JJ JJ O
- : : O
was VBD VBD O
6.5/131 CD CD O
in IN IN O
12/70 CD CD I-DATE
, , , O
gradually RB RB O
rising VBG VBG O
, , , O
recheck NN NN O
glc NN NN O
and CC CC O
a1c NN NN O
today NN NN O
VPB NNP NNP O
: : : O
2065 CD CD I-DATE
- : : O
ETT NNP NNP O
showed VBD VBD O
freq NN NN O
PVC NNP NNP O
's POS POS O
, , , O
bigeminy NN NN O
and CC CC O
couplets NNS NNS O
, , , O
nondx NN NN O
for IN IN O
ischemia NN NN O
- - - O
denies NNS NNS O
palp NN NN O
or CC CC O
dizziness NN NN O
. . . O
   
Does VBZ VBZ O
occasionally RB RB O
feel VB VB O
a DT DT O
split NN NN O
second JJ JJ O
palpitation NN NN O
. . . O
   
Takes VBZ VBZ O
a DT DT O
deep JJ JJ O
breath NN NN O
and CC CC O
it PRP PRP O
goes VBZ VBZ O
away RB RB O
. . . O
   
No DT DT O
associated VBN VBN O
symptoms NNS NNS O
. . . O
   
Perhaps RB RB O
feels VBZ VBZ O
it PRP PRP O
twice RB RB O
a DT DT O
month NN NN O
. . . O
   
Will NNP NNP O
check VB VB O
electrolytes NNS NNS O
and CC CC O
TSH NNP NNP O
. . . O
   
Coronary JJ JJ O
artery NN NN O
disease NN NN O
: : : O
s/p NN NN O
ant NN NN O
SEMI NNP NNP O
+ NN NN O
stent NN NN O
LAD NNP NNP O
2/67 CD CD I-DATE
, , , O
Dr NNP NNP O
Oakley NNP NNP I-DOCTOR
, , , O
ETT NNP NNP O
Clarkfield NNP NNP I-HOSPITAL
3/67 CD CD I-DATE
- : : O
neg NN NN O
scan VB VB O
for IN IN O
ischemia NN NN O
. . . O
   
No DT DT O
CP NNP NNP O
's POS POS O
, , , O
palp NN NN O
. . . O
   
Not RB RB O
seen VBN VBN O
cardiology NN NN O
for IN IN O
two CD CD O
to TO TO O
3 CD CD O
years NNS NNS O
. . . O
   
Will MD MD O
make VB VB O
follow-up JJ JJ O
with IN IN O
cardiology NN NN O
now RB RB O
that IN IN O
Dr NNP NNP O
Oakley NNP NNP I-DOCTOR
gone VBN VBN O
thyroid NN NN O
nodule NN NN O
: : : O
2065 CD CD I-DATE
, , , O
hot JJ JJ O
, , , O
follow VB VB O
TSH NNP NNP O
. . . O
   
TReated NNP NNP O
with IN IN O
RAI NNP NNP O
February NNP NNP I-DATE
2071 CD CD I-DATE
. . . O
   
Last NNP NNP O
TSH NNP NNP O
checked VBD VBD O
12/71 CD CD I-DATE
and CC CC O
was VBD VBD O
in IN IN O
the DT DT O
normal JJ JJ O
range NN NN O
. . . O
   
To TO TO O
see VB VB O
Dr NNP NNP O
. . . O
Dolan NNP NNP I-DOCTOR
q. NN NN O
   
year NN NN O
. . . O
   
Hyperlipidemia NNP NNP O
: : : O
CRF NNP NNP O
mild NN NN O
chol NN NN O
, , , O
cigs NNS NNS O
, , , O
HTN NNP NNP O
, , , O
Fhx NNP NNP O
and CC CC O
known VBN VBN O
hx NN NN O
CAD NNP NNP O
in IN IN O
pt NN NN O
. . . O
   
in IN IN O
January NNP NNP I-DATE
2071 CD CD I-DATE
she PRP PRP O
was VBD VBD O
written VBN VBN O
to TO TO O
increase VB VB O
her PRP$ PRP$ O
Lipitor NNP NNP O
to TO TO O
40 CD CD O
mg NN NN O
and CC CC O
then RB RB O
to TO TO O
follow-up JJ JJ O
in IN IN O
March NNP NNP I-DATE
. . . O
   
She PRP PRP O
never RB RB O
did VBD VBD O
increase VB VB O
the DT DT O
dose NN NN O
at IN IN O
that DT DT O
time NN NN O
. . . O
   
Check NNP NNP O
lfts NNS NNS O
and CC CC O
cholesterol NN NN O
fasting VBG VBG O
next JJ JJ O
week NN NN O
, , , O
and CC CC O
then RB RB O
can MD MD O
decide VB VB O
if IN IN O
we PRP PRP O
need VBP VBP O
to TO TO O
increase VB VB O
the DT DT O
Lipitor NNP NNP O
. . . O
   
Will NNP NNP O
aim NN NN O
for IN IN O
LDL NNP NNP O
less JJR JJR O
than IN IN O
100 CD CD O
Medications NNP NNP O
Asa NNP NNP O
( ( ( O
ACETYLSALICYLIC NNP NNP O
ACID NNP NNP O
) ) ) O
325MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Nitroglycerin NNP NNP O
1/150 CD CD O
( ( ( O
0.4 CD CD O
MG NNP NNP O
) ) ) O
1 CD CD O
TAB NNP NNP O
SL NNP NNP O
x1 NN NN O
PRN NNP NNP O
prn NN NN O
CP NNP NNP O
Norvasc NNP NNP O
( ( ( O
AMLODIPINE NNP NNP O
) ) ) O
5MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Triamcinolone NNP NNP O
CREAM NNP NNP O
0.5 CD CD O
% NN NN O
( ( ( O
TRIAMCINOLONE NNP NNP O
ACETONIDE NNP NNP O
0.5 CD CD O
% NN NN O
) ) ) O
TOP JJ JJ O
BID NNP NNP O
PRN NNP NNP O
Lipitor NNP NNP O
( ( ( O
ATORVASTATIN NNP NNP O
) ) ) O
20MG CD CD O
TABLET NNP NNP O
PO NNP NNP O
QD NNP NNP O
Zestril NNP NNP O
( ( ( O
LISINOPRIL NNP NNP O
) ) ) O
40MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Atenolol NNP NNP O
50MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Hctz NNP NNP O
( ( ( O
HYDROCHLOROTHIAZIDE NNP NNP O
) ) ) O
25MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Ativan NNP NNP O
( ( ( O
LORAZEPAM NNP NNP O
) ) ) O
1 CD CD O
MG NNP NNP O
( ( ( O
1MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
) ) ) O
PO NNP NNP O
qhs NN NN O
PRN NNP NNP O
, , , O
dea#pf NN NN O
0760305 CD CD I-IDNUM
Allergies NNP NNP O
CEFACLOR NNP NNP O
- : : O
Rash NNP NNP O
, , , O
Family NNP NNP O
History NN NN O
father NN NN O
- : : O
HTN NNP NNP O
, , , O
85 CD CD I-AGE
now RB RB O
mother-HTN NN NN O
, , , O
MI NNP NNP O
at IN IN O
58 CD CD I-AGE
and CC CC O
62 CD CD I-AGE
- : : O
died VBD VBD O
then RB RB O
siblings-sister NN NN O
finally RB RB O
died VBD VBD O
from IN IN O
breast NN NN O
CA NNP NNP O
after IN IN O
4 CD CD O
year NN NN O
battle NN NN O
, , , O
dx NN NN O
age NN NN O
   
37 CD CD I-AGE
. . . O
7 CD CD O
sisters NNS NNS O
- : : O
one CD CD O
with IN IN O
DM,and NNP NNP O
2 CD CD O
brothers NNS NNS O
- : : O
ok JJ JJ O
No DT DT O
change NN NN O
since IN IN O
previous JJ JJ O
annual JJ JJ O
. . . O
   
Social NNP NNP O
History NN NN O
working VBG VBG O
for IN IN O
Convergys NNP NNP I-ORGANIZATION
as IN IN O
Sculptor NNP NNP I-PROFESSION
, , , O
widowed VBN VBN O
2070 CD CD I-DATE
, , , O
one CD CD O
son NN NN O
- : : O
29 CD CD I-AGE
yo NN NN O
who WP WP O
lives VBZ VBZ O
with IN IN O
her PRP$ PRP$ O
- - - O
Specialized NNP NNP I-PROFESSION
Livestock NNP NNP I-PROFESSION
Worker NN NN I-PROFESSION
Review NNP NNP O
of IN IN O
Systems NNPS NNPS O
The DT DT O
following VBG VBG O
systems NNS NNS O
were VBD VBD O
reviewed VBN VBN O
today NN NN O
and CC CC O
were VBD VBD O
negative JJ JJ O
unless IN IN O
indicated VBD VBD O
otherwise RB RB O
in IN IN O
the DT DT O
history NN NN O
noted VBD VBD O
above IN IN O
: : : O
Constitutional NNP NNP O
, , , O
HEENT NNP NNP O
, , , O
Breast,CVS NNP NNP O
, , , O
GI NNP NNP O
, , , O
GYN NNP NNP O
, , , O
Skin NNP NNP O
, , , O
Musculoskeletal NNP NNP O
, , , O
Neuro NNP NNP O
, , , O
Psych NNP NNP O
, , , O
Respiratory NNP NNP O
, , , O
and CC CC O
Allergic NNP NNP O
Physical JJ JJ O
Exam NNP NNP O
Vital NNP NNP O
Signs NNP NNP O
BLOOD NNP NNP O
PRESSURE NN NN O
148/76 CD CD O
PULSE NNP NNP O
60 CD CD O
HEIGHT NNP NNP O
65 CD CD O
in IN IN O
WEIGHT NNP NNP O
217.5 CD CD O
lb NN NN O
BMI NNP NNP O
36.3 CD CD O
up RB RB O
3 CD CD O
lbs JJ JJ O
General NNP NNP O
: : : O
appears VBZ VBZ O
well RB RB O
HEENT NNP NNP O
: : : O
EOMI NNP NNP O
, , , O
PERRL NNP NNP O
, , , O
OP NNP NNP O
normal JJ JJ O
Skin NNP NNP O
: : : O
no DT DT O
suspicious JJ JJ O
lesions NNS NNS O
Neck NNP NNP O
: : : O
no DT DT O
thyromegaly NN NN O
, , , O
no DT DT O
bruits NNS NNS O
Nodes NNS NNS O
: : : O
no DT DT O
cervical JJ JJ O
, , , O
axillary JJ JJ O
, , , O
or CC CC O
supraclavicular JJ JJ O
lymphadenopathy JJ JJ O
Breasts NNP NNP O
- : : O
no DT DT O
nipple NN NN O
discharge NN NN O
or CC CC O
retraction NN NN O
, , , O
no DT DT O
dominant JJ JJ O
masses NNS NNS O
Chest NN NN O
: : : O
clear JJ JJ O
to TO TO O
auscultation NN NN O
, , , O
no DT DT O
rhonchi NN NN O
or CC CC O
wheeze NN NN O
COR NNP NNP O
: : : O
regular JJ JJ O
S1 NNP NNP O
, , , O
S2 NNP NNP O
, , , O
no DT DT O
murmurs NNS NNS O
, , , O
rubs NNS NNS O
or CC CC O
gallops NNS NNS O
Abd NNP NNP O
: : : O
soft JJ JJ O
, , , O
NT NNP NNP O
, , , O
no DT DT O
HSM NNP NNP O
or CC CC O
masses NNS NNS O
Musculoskeletal NNP NNP O
: : : O
no DT DT O
erythema NN NN O
, , , O
swelling VBG VBG O
, , , O
or CC CC O
tenderness NN NN O
Ext NNP NNP O
: : : O
no DT DT O
CCE NNP NNP O
, , , O
Neuro NNP NNP O
: : : O
grossly RB RB O
non-focal JJ JJ O
Health NNP NNP O
Maintenance NNP NNP O
Influenza NNP NNP O
Vaccine NNP NNP O
11/29/2067 CD CD I-DATE
Cholesterol NNP NNP O
12/16/2070 CD CD I-DATE
172 CD CD O
Mammogram NNP NNP O
03/01/64 CD CD I-DATE
see VB VB O
report NN NN O
in IN IN O
Results NNS NNS O
Pap NNP NNP O
Smear NNP NNP O
12/16/2070 CD CD I-DATE
see VB VB O
report NN NN O
in IN IN O
Results NNS NNS O
UA-Protein NNP NNP O
03/12/2066 CD CD I-DATE
NEGATIVE NNP NNP O
Colonoscopy NNP NNP O
06/04/2071 CD CD I-DATE
see VB VB O
report NN NN O
in IN IN O
Results NNS NNS O
Urine NNP NNP O
Culture NNP NNP O
03/12/2066 CD CD I-DATE
see VB VB O
report NN NN O
in IN IN O
Results NNS NNS O
Td NNP NNP O
Booster NNP NNP O
12/16/2070 CD CD I-DATE
Triglycerides NNP NNP O
12/16/2070 CD CD I-DATE
83 CD CD O
Cholesterol-LDL NNP NNP O
12/16/2070 CD CD I-DATE
108 NN NN O
Hct NNP NNP O
( ( ( O
Hematocrit NNP NNP O
) ) ) O
04/27/2072 CD CD I-DATE
40.7 CD CD O
Cholesterol-HDL NNP NNP O
12/16/2070 CD CD I-DATE
47 CD CD O
Hgb NNP NNP O
( ( ( O
Hemoglobin NNP NNP O
) ) ) O
04/27/2072 CD CD I-DATE
13.1 CD CD O
HbA1c NNP NNP O
12/16/2070 CD CD I-DATE
6.50 CD CD O
Chlamydia NNP NNP O
03/09/62 CD CD I-DATE
NEGATIVE NNP NNP O
. . . O
   
Assessment NNP NNP O
and CC CC O
Plan NNP NNP O
   
1 CD CD O
. . . O
Health NNP NNP O
Maintenance NNP NNP O
- : : O
Pap NNP NNP O
smear NN NN O
- : : O
will MD MD O
do VB VB O
every DT DT O
two CD CD O
to TO TO O
3 CD CD O
years NNS NNS O
. . . O
   
mammo NN NN O
- : : O
still RB RB O
very RB RB O
overdue JJ JJ O
- - - O
stressed JJ JJ O
needs VBZ VBZ O
to TO TO O
do VB VB O
this DT DT O
again RB RB O
and CC CC O
promises VBZ VBZ O
, , , O
colonoscopy NN NN O
fine NN NN O
2071 CD CD I-DATE
. . . O
   
To TO TO O
increase VB VB O
exercise NN NN O
. . . O
   
2 CD CD O
. . . O
Menopause NNP NNP O
- : : O
calcium NN NN O
, , , O
consider VB VB O
BD NNP NNP O
when WRB WRB O
not RB RB O
overwhelmed VBN VBN O
with IN IN O
everything NN NN O
else RB RB O
   
3 CD CD O
. . . O
Sleep NNP NNP O
, , , O
stress NN NN O
- : : O
seems VBZ VBZ O
to TO TO O
be VB VB O
doing VBG VBG O
generally RB RB O
better JJR JJR O
now RB RB O
. . . O
   
Discussed NNP NNP O
this DT DT O
for IN IN O
most JJS JJS O
of IN IN O
her PRP$ PRP$ O
45 CD CD O
minute NN NN O
appointment NN NN O
. . . O
   
Starting NNP NNP O
to TO TO O
get VB VB O
out RP RP O
now RB RB O
and CC CC O
socialize VB VB O
. . . O
   
To TO TO O
work VB VB O
quite RB RB O
regularly RB RB O
now RB RB O
. . . O
   
Not RB RB O
interested JJ JJ O
in IN IN O
further JJ JJ O
counseling NN NN O
or CC CC O
medications NNS NNS O
. . . O
   
4 CD CD O
. . . O
sinus NN NN O
congestion NN NN O
states NNS NNS O
she PRP PRP O
wakes VBZ VBZ O
up RB RB O
and CC CC O
feels VBZ VBZ O
her PRP$ PRP$ O
sinuses NNS NNS O
are VBP VBP O
clogged JJ JJ O
her PRP$ PRP$ O
eyes NNS NNS O
are VBP VBP O
puffy JJ JJ O
and CC CC O
sneezing VBG VBG O
. . . O
   
No DT DT O
help NN NN O
with IN IN O
Claritin NNP NNP O
. . . O
   
Will NNP NNP O
try VB VB O
Flonase NNP NNP O
for IN IN O
two CD CD O
to TO TO O
3 CD CD O
weeks NNS NNS O
to TO TO O
see VB VB O
if IN IN O
it PRP PRP O
helps VBZ VBZ O
. . . O
   
Rest NNP NNP O
of IN IN O
issues NNS NNS O
- - - O
see VB VB O
above IN IN O
. . . O
   
follow-up JJ JJ O
3 CD CD O
months NNS NNS O
Beverly NNP NNP I-DOCTOR
Thiel NNP NNP I-DOCTOR
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2081-01-04 JJ JJ I-DATE
INFECTIOUS NNP NNP O
DISEASE NNP NNP O
ASSOCIATES NNP NNP O
CURTIS NNP NNP I-HOSPITAL
MEDICAL NNP NNP I-HOSPITAL
CENTER NNP NNP I-HOSPITAL
Reason NNP NNP O
for IN IN O
visit NN NN O
Brucellosis NNP NNP O
History NN NN O
of IN IN O
present JJ JJ O
illness NN NN O
70y/o CD CD O
F NN NN O
who WP WP O
presented VBD VBD O
in IN IN O
late JJ JJ O
May NNP NNP I-DATE
with IN IN O
daily JJ JJ O
fever NN NN O
x SYM SYM O
2-3 JJ JJ O
months NNS NNS O
with IN IN O
low JJ JJ O
back RB RB O
pain NN NN O
x SYM SYM O
2 CD CD O
weeks NNS NNS O
, , , O
admitted VBD VBD O
May NNP NNP I-DATE
30 CD CD I-DATE
and CC CC O
found VBD VBD O
to TO TO O
have VB VB O
small JJ JJ O
gram NN NN O
negative JJ JJ O
rod NN NN O
bacteremia NN NN O
consistent JJ JJ O
with IN IN O
Brucellosis NNP NNP O
, , , O
which WDT WDT O
fits VBZ VBZ O
with IN IN O
her PRP$ PRP$ O
epidemiologic JJ JJ O
exposure NN NN O
to TO TO O
unpasteurized JJ JJ O
camels NNS NNS O
milk NN NN O
and CC CC O
her PRP$ PRP$ O
prolonged JJ JJ O
fever NN NN O
. . . O
   
There EX EX O
was VBD VBD O
initial JJ JJ O
concern NN NN O
for IN IN O
TB NNP NNP O
, , , O
but CC CC O
she PRP PRP O
ruled VBD VBD O
out IN IN O
for IN IN O
pulmonary JJ JJ O
tb NN NN O
with IN IN O
3 CD CD O
negative JJ JJ O
smears NNS NNS O
. . . O
   
PPD NNP NNP O
positive JJ JJ O
. . . O
   
She PRP PRP O
had VBD VBD O
an DT DT O
MRI NNP NNP O
of IN IN O
her PRP$ PRP$ O
spine NN NN O
that WDT WDT O
was VBD VBD O
initially RB RB O
read VBN VBN O
as IN IN O
L5/S1 NNP NNP O
diskitis/osteomyelitis NN NN O
with IN IN O
right JJ JJ O
paraspinal NN NN O
phlegmon NN NN O
. . . O
   
MSK NNP NNP O
radiologists NNS NNS O
felt VBD VBD O
that IN IN O
this DT DT O
actually RB RB O
represented VBN VBN O
degenerative JJ JJ O
change NN NN O
with IN IN O
no DT DT O
evidence NN NN O
of IN IN O
infection NN NN O
, , , O
with IN IN O
explanation NN NN O
that IN IN O
a DT DT O
large JJ JJ O
right-sided JJ JJ O
osteophyte NN NN O
is VBZ VBZ O
causing VBG VBG O
irritation NN NN O
. . . O
   
Mrs NNP NNP O
. . . O
   
Iles NNP NNP I-PATIENT
declined VBD VBD O
a DT DT O
TEE NNP NNP O
on IN IN O
during IN IN O
her PRP$ PRP$ O
admission NN NN O
. . . O
   
She PRP PRP O
was VBD VBD O
treated VBN VBN O
with IN IN O
streptomycin NN NN O
IM NNP NNP O
q NN NN O
daily JJ JJ O
x SYM SYM O
2 CD CD O
weeks,and NN NN O
concurrent NN NN O
doxycycline NN NN O
100 CD CD O
mg NN NN O
po NN NN O
bid NN NN O
plus CC CC O
rifampin NN NN O
300 CD CD O
mg NN NN O
po NN NN O
tid NN NN O
. . . O
   
She PRP PRP O
was VBD VBD O
seen VBN VBN O
in IN IN O
ID NNP NNP O
clinic NN NN O
on IN IN O
7/20 CD CD I-DATE
, , , O
9/7 CD CD I-DATE
, , , O
11/9 CD CD I-DATE
, , , O
and CC CC O
today NN NN O
( ( ( O
1/4/81 CD CD I-DATE
) ) ) O
. . . O
   
She PRP PRP O
has VBZ VBZ O
improved VBN VBN O
dramatically RB RB O
, , , O
and CC CC O
is VBZ VBZ O
able JJ JJ O
to TO TO O
walk VB VB O
independently RB RB O
without IN IN O
pain NN NN O
. . . O
   
She PRP PRP O
has VBZ VBZ O
no DT DT O
fevers NNS NNS O
, , , O
night NN NN O
sweats NNS NNS O
, , , O
weight NN NN O
loss NN NN O
, , , O
nausea NN NN O
, , , O
or CC CC O
vomiting VBG VBG O
. . . O
   
Her PRP$ PRP$ O
pain NN NN O
is VBZ VBZ O
well RB RB O
controlled VBN VBN O
minimal JJ JJ O
medications NNS NNS O
. . . O
   
Past NNP NNP O
medical JJ JJ O
history NN NN O
- : : O
DMII NNP NNP O
( ( ( O
dx NN NN O
late JJ JJ O
60s CD CD I-DATE
, , , O
last JJ JJ O
A1c NNP NNP O
= SYM SYM O
5.6 CD CD O
in IN IN O
2/80 CD CD I-DATE
) ) ) O
- : : O
HTN NNP NNP O
- : : O
Hyperlipidemia NNP NNP O
- : : O
Hep NNP NNP O
B NNP NNP O
sAb NN NN O
+ NN NN O
, , , O
sAg NN NN O
+ NN NN O
, , , O
and CC CC O
core NN NN O
Ab NNP NNP O
+ NN NN O
in IN IN O
2067 CD CD I-DATE
; : : O
   
now RB RB O
sAg NN NN O
- : : O
, , , O
sAb NN NN O
+ NN NN O
, , , O
and CC CC O
core NN NN O
Ab NNP NNP O
(+) NN NN O
in IN IN O
2/2080 CD CD I-DATE
( ( ( O
recovery NN NN O
) ) ) O
- : : O
H/o NNP NNP O
H. NN NN O
pylori NN NN O
(+) NN NN O
2068 CD CD I-DATE
and CC CC O
2080 CD CD I-DATE
s/p NN NN O
triple NN NN O
therapy NN NN O
- : : O
GERD NNP NNP O
- : : O
OA NNP NNP O
- : : O
H/o NNP NNP O
vitamin NN NN O
D NNP NNP O
deficiency NN NN O
- : : O
H/o NNP NNP O
chronic NN NN O
HAs VBZ VBZ O
( ( ( O
migraines NN NN O
vs NNS NNS O
. . . O
tension NN NN O
HAs VBZ VBZ O
) ) ) O
-+ : : O
PPD NNP NNP O
( ( ( O
in IN IN O
Mississippi NNP NNP I-STATE
in IN IN O
2067 CD CD I-DATE
) ) ) O
- : : O
H/o NNP NNP O
malaria NN NN O
Social NNP NNP O
history NN NN O
No DT DT O
tobacco NN NN O
, , , O
EtOH NNP NNP O
, , , O
illicits NNS NNS O
. . . O
   
Currently RB RB O
living VBG VBG O
with IN IN O
daughter NN NN O
in IN IN O
Grand NNP NNP I-CITY
Island NNP NNP I-CITY
. . . O
   
No DT DT O
pets NNS NNS O
. . . O
   
No DT DT O
known VBN VBN O
sick JJ JJ O
contacts NNS NNS O
. . . O
   
Changes NNS NNS O
to TO TO O
Allergies NNP NNP O
NKA NNP NNP O
: : : O
No DT DT O
Known VBN VBN O
Allergies NNP NNP O
- - - O
reaction NN NN O
: : : O
[ NN NN O
reviewed VBD VBD O
] NN NN O
Review NNP NNP O
of IN IN O
systems NNS NNS O
Denies NNP NNP O
fever NN NN O
, , , O
rigor NN NN O
, , , O
night NN NN O
sweats NNS NNS O
, , , O
headache NN NN O
, , , O
SOB NNP NNP O
, , , O
cough NN NN O
, , , O
anorexia NN NN O
, , , O
nausea NN NN O
, , , O
vomiting VBG VBG O
, , , O
diarrhea NN NN O
, , , O
abdominal JJ JJ O
pain NN NN O
, , , O
paresthesias NNS NNS O
, , , O
or CC CC O
rash NN NN O
. . . O
   
Physical JJ JJ O
Exam NNP NNP O
General NNP NNP O
appearance NN NN O
NAD NNP NNP O
Skin NNP NNP O
No DT DT O
rashes NNS NNS O
HEENT NNP NNP O
No DT DT O
palpable JJ JJ O
LN NNP NNP O
, , , O
no DT DT O
oral JJ JJ O
lesions NNS NNS O
Cor NNP NNP O
S1 NNP NNP O
S2 NNP NNP O
, , , O
no DT DT O
murmurs NNS NNS O
, , , O
no DT DT O
peripheral JJ JJ O
stigmata NN NN O
of IN IN O
endocarditis NNS NNS O
Abdomen NNP NNP O
Non NNP NNP O
tender NN NN O
, , , O
BS NNP NNP O
+ NN NN O
, , , O
No DT DT O
palpable JJ JJ O
organomegaly NN NN O
Extrem NNP NNP O
No DT DT O
clubbing VBG VBG O
, , , O
mild JJ JJ O
edema NN NN O
at IN IN O
the DT DT O
ankles NNS NNS O
Musc NNP NNP O
skel NN NN O
No DT DT O
tenderness NN NN O
on IN IN O
the DT DT O
lower JJR JJR O
back RB RB O
percussion NN NN O
. . . O
   
Normal NNP NNP O
gait NN NN O
. . . O
   
Assessment NNP NNP O
and CC CC O
plan NN NN O
70 CD CD I-AGE
yr NN NN O
F NN NN O
with IN IN O
confirmed JJ JJ O
Brucella NNP NNP O
bacteremia NN NN O
from IN IN O
May NNP NNP I-DATE
30/31 CD CD I-DATE
2080 CD CD I-DATE
and CC CC O
probable JJ JJ O
Brucella NNP NNP O
diskitis/osteomyelitis NN NN O
at IN IN O
the DT DT O
L5/S1 NNP NNP O
level NN NN O
. . . O
   
She PRP PRP O
presented VBD VBD O
with IN IN O
a DT DT O
syndrome NN NN O
of IN IN O
constitutional JJ JJ O
symptoms NNS NNS O
and CC CC O
back RB RB O
pain NN NN O
of IN IN O
3 CD CD O
months NNS NNS O
duration NN NN O
, , , O
and CC CC O
has VBZ VBZ O
improved VBN VBN O
dramatically RB RB O
after IN IN O
2 CD CD O
weeks NNS NNS O
of IN IN O
streptomycin NN NN O
IM NNP NNP O
   
( ( ( O
completed VBN VBN O
) ) ) O
, , , O
rifampin NN NN O
300 CD CD O
mg NN NN O
po NN NN O
tid NN NN O
, , , O
and CC CC O
doxycycline NN NN O
100 CD CD O
mg NN NN O
po NN NN O
bid NN NN O
. . . O
   
Her PRP$ PRP$ O
antibiotics NNS NNS O
started VBD VBD O
on IN IN O
6/4/80 CD CD I-DATE
and CC CC O
will MD MD O
be VB VB O
discontinued VBN VBN O
today NN NN O
1/4/81 CD CD I-DATE
after IN IN O
6 CD CD O
months NNS NNS O
of IN IN O
therapy NN NN O
. . . O
   
She PRP PRP O
was VBD VBD O
counseled VBN VBN O
today NN NN O
that IN IN O
she PRP PRP O
is VBZ VBZ O
to TO TO O
watch VB VB O
out RP RP O
for IN IN O
recurrence NN NN O
of IN IN O
infection NN NN O
, , , O
which WDT WDT O
may MD MD O
include VB VB O
fever NN NN O
, , , O
night NN NN O
sweats NNS NNS O
, , , O
weight NN NN O
loss NN NN O
, , , O
anorexia NN NN O
, , , O
worsening VBG VBG O
back RB RB O
pain NN NN O
, , , O
and CC CC O
fatigue NN NN O
. . . O
   
She PRP PRP O
knows VBZ VBZ O
to TO TO O
contact VB VB O
us PRP PRP O
should MD MD O
this DT DT O
occur VB VB O
. . . O
   
She PRP PRP O
was VBD VBD O
counseled VBN VBN O
to TO TO O
not RB RB O
drink VB VB O
unpasteurized JJ JJ O
camel NN NN O
milk NN NN O
. . . O
   
In IN IN O
addition NN NN O
, , , O
Mrs NNP NNP O
Iles NNP NNP I-PATIENT
is VBZ VBZ O
PPD NNP NNP O
positive JJ JJ O
: : : O
she PRP PRP O
has VBZ VBZ O
completed VBN VBN O
the DT DT O
required VBN VBN O
4 CD CD O
months NNS NNS O
of IN IN O
therapy NN NN O
for IN IN O
latent NN NN O
TB NNP NNP O
( ( ( O
she PRP PRP O
had VBD VBD O
6 CD CD O
months NNS NNS O
) ) ) O
as IN IN O
part NN NN O
of IN IN O
the DT DT O
treatment NN NN O
of IN IN O
her PRP$ PRP$ O
Brucella NNP NNP O
infection NN NN O
. . . O
   
All DT DT O
Allergies NNP NNP O
Reviewed NNP NNP O
Ms NNP NNP O
. . . O
Iles NNP NNP I-PATIENT
was VBD VBD O
seen VBN VBN O
and CC CC O
examined VBN VBN O
with IN IN O
Dr NNP NNP O
. . . O
Tillman NNP NNP I-DOCTOR
. . . O
   
Her PRP$ PRP$ O
back RB RB O
pain NN NN O
, , , O
fevers NNS NNS O
, , , O
and CC CC O
weight NN NN O
loss NN NN O
have VBP VBP O
entirely RB RB O
resolved VBN VBN O
. . . O
   
She PRP PRP O
has VBZ VBZ O
finished VBN VBN O
six CD CD O
months NNS NNS O
of IN IN O
doxy/rif NN NN O
and CC CC O
should MD MD O
stop VB VB O
these DT DT O
medications NNS NNS O
. . . O
   
We PRP PRP O
asked VBD VBD O
her PRP PRP O
to TO TO O
return VB VB O
for IN IN O
any DT DT O
new JJ JJ O
back RB RB O
pain NN NN O
, , , O
fevers NNS NNS O
, , , O
or CC CC O
weight NN NN O
loss NN NN O
. . . O
   
Todd NNP NNP I-DOCTOR
Riley NNP NNP I-DOCTOR
, , , O
MD NNP NNP O
pager NN NN O
#03268 NN NN O
cc NN NN O
: : : O
DANIELLE NNP NNP I-DOCTOR
TOMPKINS NNP NNP I-DOCTOR
, , , O
CMC NNP NNP I-HOSPITAL
Internal NNP NNP O
Medicine NNP NNP O
Signed NNP NNP O
electronically RB RB O
by IN IN O
Todd NNP NNP I-DOCTOR
Riley NNP NNP I-DOCTOR
, , , O
MD NNP NNP O
Document NNP NNP O
Status NNP NNP O
: : : O
Final NNP NNP O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2078-10-25 JJ JJ I-DATE
October NNP NNP I-DATE
25 CD CD O
, , , O
2078 CD CD I-DATE
Office NNP NNP O
Visit NNP NNP O
Re NNP NNP O
: : : O
Larry NNP NNP I-PATIENT
Lockwood NNP NNP I-PATIENT
MPC NNP NNP I-HOSPITAL
# # # O
590-33-20-3 NN NN I-MEDICALRECORD
This DT DT O
is VBZ VBZ O
a DT DT O
56 CD CD I-AGE
year NN NN O
old JJ JJ O
morbidly RB RB O
obese NN NN O
male JJ JJ O
who WP WP O
was VBD VBD O
discharged VBN VBN O
recently RB RB O
from IN IN O
the DT DT O
Marshalltown NNP NNP I-HOSPITAL
Pond NNP NNP I-HOSPITAL
Clinic NNP NNP I-HOSPITAL
who WP WP O
is VBZ VBZ O
here RB RB O
for IN IN O
follow VB VB O
up RB RB O
of IN IN O
his PRP$ PRP$ O
newly RB RB O
diagnosed VBN VBN O
diabetes NNS NNS O
mellitus NN NN O
. . . O
   
He PRP PRP O
was VBD VBD O
seen VBN VBN O
in IN IN O
the DT DT O
emergency NN NN O
room NN NN O
on IN IN O
10/21 CD CD I-DATE
with IN IN O
the DT DT O
complaint NN NN O
of IN IN O
urinary JJ JJ O
frequency NN NN O
, , , O
hesitancy NN NN O
, , , O
and CC CC O
generally RB RB O
not RB RB O
feeling NN NN O
well RB RB O
. . . O
   
Prior RB RB O
to TO TO O
that DT DT O
, , , O
he PRP PRP O
had VBD VBD O
been VBN VBN O
treated VBN VBN O
with IN IN O
antibiotics NNS NNS O
by IN IN O
his PRP$ PRP$ O
primary JJ JJ O
care NN NN O
physician NN NN O
for IN IN O
a DT DT O
urinary JJ JJ O
tract NN NN O
infection NN NN O
with IN IN O
Bactrim NNP NNP O
and CC CC O
then RB RB O
ampicillin NN NN O
but CC CC O
he PRP PRP O
did VBD VBD O
not RB RB O
get VB VB O
better JJR JJR O
. . . O
   
He PRP PRP O
went VBD VBD O
to TO TO O
the DT DT O
emergency NN NN O
room NN NN O
and CC CC O
was VBD VBD O
admitted VBN VBN O
to TO TO O
the DT DT O
hospital NN NN O
because IN IN O
his PRP$ PRP$ O
blood NN NN O
sugar NN NN O
was VBD VBD O
in IN IN O
the DT DT O
400s NN NN O
and CC CC O
he PRP PRP O
was VBD VBD O
diagnosed VBN VBN O
with IN IN O
diabetes NN NN O
at IN IN O
that DT DT O
time NN NN O
. . . O
   
He PRP PRP O
was VBD VBD O
discharged VBN VBN O
on IN IN O
10/22/78 CD CD I-DATE
on IN IN O
insulin NN NN O
NPH NNP NNP O
30 CD CD O
units NNS NNS O
in IN IN O
the DT DT O
morning NN NN O
and CC CC O
15 CD CD O
units NNS NNS O
in IN IN O
the DT DT O
PM NNP NNP O
and CC CC O
was VBD VBD O
advised VBN VBN O
to TO TO O
follow VB VB O
up RP RP O
in IN IN O
the DT DT O
outpatient NN NN O
clinic NN NN O
today NN NN O
. . . O
   
Since IN IN O
discharge NN NN O
, , , O
his PRP$ PRP$ O
blood NN NN O
sugars NNS NNS O
have VBP VBP O
been VBN VBN O
in IN IN O
the DT DT O
200s NN NN O
. . . O
   
This DT DT O
afternoon NN NN O
, , , O
it PRP PRP O
is VBZ VBZ O
242 CD CD O
2 CD CD O
hours NNS NNS O
after IN IN O
his PRP$ PRP$ O
last JJ JJ O
meal NN NN O
. . . O
   
Past NNP NNP O
Medical NNP NNP O
History NN NN O
: : : O
He PRP PRP O
has VBZ VBZ O
a DT DT O
history NN NN O
of IN IN O
benign NN NN O
prostatic JJ JJ O
hypertrophy NN NN O
. . . O
   
He PRP PRP O
sees VBZ VBZ O
a DT DT O
urologist NN NN O
and CC CC O
they PRP PRP O
are VBP VBP O
discussing VBG VBG O
a DT DT O
new JJ JJ O
procedure NN NN O
for IN IN O
the DT DT O
same JJ JJ O
. . . O
   
He PRP PRP O
cannot NN NN O
have VBP VBP O
_____ NN NN O
_ NN NN O
because IN IN O
of IN IN O
his PRP$ PRP$ O
morbid NN NN O
obesity NN NN O
, , , O
he PRP PRP O
cannot NN NN O
be VB VB O
positioned VBN VBN O
on IN IN O
the DT DT O
table NN NN O
for IN IN O
the DT DT O
same JJ JJ O
. . . O
   
He PRP PRP O
also RB RB O
gives VBZ VBZ O
a DT DT O
history NN NN O
of IN IN O
sleep NN NN O
apnea NN NN O
. . . O
   
No DT DT O
hypertension NN NN O
. . . O
   
He PRP PRP O
does VBZ VBZ O
have VB VB O
a DT DT O
history NN NN O
of IN IN O
gastric JJ JJ O
reflux NN NN O
and CC CC O
obesity NN NN O
. . . O
   
Past NNP NNP O
Surgical NNP NNP O
History NN NN O
: : : O
He PRP PRP O
has VBZ VBZ O
had VBN VBN O
bilateral JJ JJ O
hip NN NN O
surgery NN NN O
for IN IN O
slipped VBD VBD O
_____ NN NN O
_ NN NN O
as IN IN O
an DT DT O
adolescent NN NN O
. . . O
   
Review NNP NNP O
of IN IN O
Systems NNPS NNPS O
: : : O
No DT DT O
chest NN NN O
pain NN NN O
. . . O
   
Positive JJ JJ O
review NN NN O
of IN IN O
systems NNS NNS O
for IN IN O
UTI NNP NNP O
symptoms NNS NNS O
with IN IN O
increased VBN VBN O
frequency NN NN O
and CC CC O
hesitancy NN NN O
. . . O
   
Other JJ JJ O
review NN NN O
of IN IN O
systems-he NN NN O
has VBZ VBZ O
arthritis VBN VBN O
generalized VBN VBN O
with IN IN O
more JJR JJR O
pain NN NN O
in IN IN O
the DT DT O
hip NN NN O
. . . O
   
Also RB RB O
has VBZ VBZ O
acid NN NN O
reflux NN NN O
. . . O
   
Family NNP NNP O
History NN NN O
: : : O
Family NNP NNP O
history NN NN O
of IN IN O
obesity NN NN O
and CC CC O
hypertension NN NN O
but CC CC O
no DT DT O
diabetes NN NN O
or CC CC O
coronary JJ JJ O
artery NN NN O
disease NN NN O
. . . O
   
Social NNP NNP O
History NN NN O
: : : O
He PRP PRP O
is VBZ VBZ O
a DT DT O
smoker NN NN O
but CC CC O
is VBZ VBZ O
trying VBG VBG O
to TO TO O
quit VB VB O
. . . O
   
He PRP PRP O
smokes VBZ VBZ O
less JJR JJR O
than IN IN O
one CD CD O
pack NN NN O
a DT DT O
day NN NN O
. . . O
   
He PRP PRP O
is VBZ VBZ O
a DT DT O
manager NN NN I-PROFESSION
and CC CC O
is VBZ VBZ O
on IN IN O
disability NN NN O
. . . O
   
He PRP PRP O
has VBZ VBZ O
2 CD CD O
children NNS NNS O
and CC CC O
is VBZ VBZ O
separated VBN VBN O
. . . O
   
Physical JJ JJ O
Examination NNP NNP O
: : : O
He PRP PRP O
is VBZ VBZ O
morbidly RB RB O
obese NN NN O
and CC CC O
weighs VBZ VBZ O
about IN IN O
405 CD CD O
pounds NNS NNS O
. . . O
   
Blood NNP NNP O
pressure NN NN O
110/88 CD CD O
. . . O
   
Pulse NNP NNP O
   
84 CD CD O
. . . O
Skin NNP NNP O
exam-there JJ JJ O
is VBZ VBZ O
evidence NN NN O
of IN IN O
acanthosis NNS NNS O
nigricans NNS NNS O
. . . O
   
He PRP PRP O
has VBZ VBZ O
gynecomastia NN NN O
. . . O
   
Head NNP NNP O
and CC CC O
neck NN NN O
exam-atraumatic JJ JJ O
, , , O
normocephalic JJ JJ O
. . . O
   
Extraocular NNP NNP O
movements NNS NNS O
are VBP VBP O
intact JJ JJ O
. . . O
   
Pupils NNP NNP O
equal JJ JJ O
, , , O
round NN NN O
and CC CC O
reactive JJ JJ O
to TO TO O
light VB VB O
. . . O
   
Cardiovascular NNP NNP O
system NN NN O
exam-S1, JJ JJ O
S2 NNP NNP O
heard VBN VBN O
. . . O
   
No DT DT O
S3 NNP NNP O
, , , O
S4 NNP NNP O
. . . O
   
Respiratory NNP NNP O
system-clear JJ JJ O
to TO TO O
auscultation NN NN O
and CC CC O
percussion NN NN O
. . . O
   
No DT DT O
added JJ JJ O
sounds VBZ VBZ O
. . . O
   
Abdomen-obese JJ JJ O
, , , O
very RB RB O
difficult JJ JJ O
to TO TO O
examine VB VB O
for IN IN O
masses NNS NNS O
or CC CC O
hepatosplenomegaly NN NN O
. . . O
   
On IN IN O
limited JJ JJ O
exam NN NN O
, , , O
there EX EX O
are VBP VBP O
no DT DT O
masses NNS NNS O
palpable JJ JJ O
. . . O
   
CNS-cranial JJ JJ O
nerves NNS NNS O
II-XII NNP NNP O
intact JJ JJ O
. . . O
   
Examination NNP NNP O
of IN IN O
feet NNS NNS O
with IN IN O
monofilament NN NN O
is VBZ VBZ O
negative JJ JJ O
as IN IN O
he PRP PRP O
is VBZ VBZ O
not RB RB O
able JJ JJ O
to TO TO O
feel VB VB O
the DT DT O
monofilament NN NN O
in IN IN O
both DT DT O
feet NNS NNS O
. . . O
   
This DT DT O
impairment NN NN O
is VBZ VBZ O
greater NN NN O
on IN IN O
the DT DT O
right NN NN O
foot NN NN O
than IN IN O
left VBD VBD O
. . . O
   
Labs NNP NNP O
done VBN VBN O
so RB RB O
far RB RB O
: : : O
hemoglobin NN NN O
A1c NNP NNP O
of IN IN O
14 CD CD O
, , , O
glucose NN NN O
on IN IN O
10/21 CD CD I-DATE
422 CD CD O
, , , O
creatinine NN NN O
1.7 CD CD O
, , , O
BUN NNP NNP O
22 CD CD O
, , , O
sodium NN NN O
132 CD CD O
, , , O
potassium NN NN O
4.5 CD CD O
, , , O
chloride NN NN O
97 CD CD O
, , , O
liver NN NN O
function NN NN O
tests NNS NNS O
with IN IN O
ALT NNP NNP O
10 CD CD O
, , , O
AST NNP NNP O
10 CD CD O
, , , O
alkaline NN NN O
phosphatase NN NN O
126 CD CD O
, , , O
bilirubin NN NN O
0.4 CD CD O
, , , O
total JJ JJ O
protein NN NN O
8.1 CD CD O
, , , O
albumin NN NN O
3.6 CD CD O
, , , O
globulin NN NN O
4.5 CD CD O
, , , O
calcium NN NN O
9.5 CD CD O
, , , O
hemoglobin NN NN O
   
15 CD CD O
. . . O
Assessment NNP NNP O
and CC CC O
Plan NNP NNP O
: : : O
   
1 CD CD O
. . . O
New NNP NNP O
onset NN NN O
diabetes NNS NNS O
mellitus NN NN O
. . . O
   
The DT DT O
patient NN NN O
is VBZ VBZ O
morbidly RB RB O
obese NN NN O
, , , O
has VBZ VBZ O
features NNS NNS O
of IN IN O
insulin NN NN O
resistance NN NN O
. . . O
   
His PRP$ PRP$ O
blood NN NN O
sugars NNS NNS O
today NN NN O
are VBP VBP O
better JJR JJR O
since IN IN O
admission NN NN O
. . . O
   
He PRP PRP O
is VBZ VBZ O
on IN IN O
insulin NN NN O
twice RB RB O
a DT DT O
day NN NN O
. . . O
   
He PRP PRP O
checks VBZ VBZ O
his PRP$ PRP$ O
blood NN NN O
sugars VBZ VBZ O
3 CD CD O
times NNS NNS O
a DT DT O
day NN NN O
and CC CC O
since IN IN O
discharge NN NN O
, , , O
they PRP PRP O
have VBP VBP O
been VBN VBN O
around IN IN O
240 CD CD O
to TO TO O
300 CD CD O
. . . O
   
The DT DT O
patient NN NN O
is VBZ VBZ O
not RB RB O
a DT DT O
good JJ JJ O
candidate NN NN O
for IN IN O
metformin NN NN O
with IN IN O
his PRP$ PRP$ O
last JJ JJ O
creatinine NN NN O
of IN IN O
1.7 CD CD O
. . . O
   
He PRP PRP O
may MD MD O
be VB VB O
a DT DT O
candidate NN NN O
for IN IN O
Avandia NNP NNP O
. . . O
   
At IN IN O
the DT DT O
present JJ JJ O
time NN NN O
, , , O
his PRP$ PRP$ O
alkaline NN NN O
phosphatase NN NN O
is VBZ VBZ O
mildly RB RB O
elevated VBD VBD O
but CC CC O
his PRP$ PRP$ O
ALT NNP NNP O
and CC CC O
AST NNP NNP O
are VBP VBP O
normal JJ JJ O
. . . O
   
He PRP PRP O
has VBZ VBZ O
difficulty NN NN O
coming VBG VBG O
to TO TO O
the DT DT O
clinic NN NN O
and CC CC O
would MD MD O
prefer VB VB O
to TO TO O
have VB VB O
his PRP$ PRP$ O
visiting VBG VBG O
nurse NN NN O
and CC CC O
nutritionist NN NN O
communicate NN NN O
with IN IN O
the DT DT O
clinic NN NN O
physicians NNS NNS O
to TO TO O
adjust VB VB O
the DT DT O
dose NN NN O
of IN IN O
his PRP$ PRP$ O
insulin NN NN O
and CC CC O
also RB RB O
have VB VB O
his PRP$ PRP$ O
blood NN NN O
tests NNS NNS O
done VBN VBN O
locally RB RB O
rather RB RB O
than IN IN O
here RB RB O
in IN IN O
the DT DT O
clinic NN NN O
. . . O
   
We PRP PRP O
will MD MD O
increase VB VB O
his PRP$ PRP$ O
NPH NNP NNP O
to TO TO O
40 CD CD O
units NNS NNS O
in IN IN O
the DT DT O
morning NN NN O
and CC CC O
26 CD CD O
units NNS NNS O
in IN IN O
the DT DT O
PM NNP NNP O
. . . O
   
We PRP PRP O
will MD MD O
work VB VB O
with IN IN O
the DT DT O
visiting VBG VBG O
nurse NN NN O
and CC CC O
nutritionist NN NN O
to TO TO O
adjust VB VB O
the DT DT O
insulin NN NN O
dose NN NN O
and CC CC O
also RB RB O
order VB VB O
lab NN NN O
tests NNS NNS O
. . . O
   
We PRP PRP O
will MD MD O
repeat VB VB O
his PRP$ PRP$ O
hemoglobin NN NN O
A1c NNP NNP O
in IN IN O
a DT DT O
month NN NN O
and CC CC O
also RB RB O
repeat VB VB O
his PRP$ PRP$ O
creatinine NN NN O
and CC CC O
liver NN NN O
function NN NN O
tests NNS NNS O
at IN IN O
that DT DT O
time NN NN O
to TO TO O
see VB VB O
if IN IN O
he PRP PRP O
may MD MD O
be VB VB O
a DT DT O
candidate NN NN O
for IN IN O
Avandia NNP NNP O
. . . O
   
I PRP PRP O
advised VBD VBD O
the DT DT O
patient NN NN O
to TO TO O
return VB VB O
to TO TO O
the DT DT O
clinic NN NN O
in IN IN O
6 CD CD O
months NNS NNS O
and CC CC O
also RB RB O
for IN IN O
him PRP PRP O
to TO TO O
send VB VB O
the DT DT O
blood NN NN O
sugar NN NN O
results NNS NNS O
every DT DT O
week NN NN O
until IN IN O
his PRP$ PRP$ O
blood NN NN O
sugars NNS NNS O
are VBP VBP O
under IN IN O
better JJR JJR O
control NN NN O
. . . O
   
___________________________ NN NN O
_ NN NN O
Dr NNP NNP O
. . . O
Xan NNP NNP I-DOCTOR
Dunn NNP NNP I-DOCTOR
XD:ullmann NNP NNP O
DD NNP NNP O
: : : O
10.25.78/Rec=d CD CD O
11.04.78 CD CD I-DATE
DT NNP NNP O
: : : O
12.03.78 CD CD I-DATE
DV NNP NNP O
: : : O
10.25.78 CD CD I-DATE
******** NN NN O
Not RB RB O
reviewed VBN VBN O
by IN IN O
Attending NNP NNP O
Physician NNP NNP O
******** NN NN O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2069-09-17 JJ JJ I-DATE
OFFICE NNP NNP O
NOTE VB VB O
Andrew NNP NNP I-PATIENT
Conner NNP NNP I-PATIENT
MRN NNP NNP O
: : : O
9911852 CD CD I-MEDICALRECORD
September NNP NNP I-DATE
17 CD CD O
, , , O
2069 CD CD I-DATE
Problems NNS NNS O
: : : O
   
1 CD CD O
. . . O
Diabetes NNP NNP O
mellitus NN NN O
. . . O
   
He PRP PRP O
continues VBZ VBZ O
on IN IN O
Glucotrol NNP NNP O
and CC CC O
Glucophage NNP NNP O
. . . O
   
Blood NNP NNP O
sugars NNS NNS O
appear VBP VBP O
to TO TO O
be VB VB O
in IN IN O
pretty RB RB O
good JJ JJ O
range NN NN O
. . . O
   
Last JJ JJ O
A1C NNP NNP O
was VBD VBD O
respectable JJ JJ O
. . . O
   
To TO TO O
be VB VB O
repeated VBN VBN O
today NN NN O
. . . O
   
2 CD CD O
. . . O
Hyperlipidemia NNP NNP O
. . . O
   
Lipids NNP NNP O
are VBP VBP O
pending VBG VBG O
. . . O
   
3 CD CD O
. . . O
Angina NNP NNP O
. . . O
   
Previous JJ JJ O
stress NN NN O
test NN NN O
showed VBD VBD O
positive JJ JJ O
EKG NNP NNP O
changes NNS NNS O
, , , O
equivocal JJ JJ O
scan NN NN O
. . . O
   
Mild NNP NNP O
angina NN NN O
. . . O
   
Started NNP NNP O
on IN IN O
trans NNS NNS O
- : : O
derm NN NN O
nitro NN NN O
. . . O
   
Totally RB RB O
must MD MD O
quit VB VB O
all DT DT O
cigars NNS NNS O
. . . O
   
Lipids NNP NNP O
to TO TO O
be VB VB O
repeated VBN VBN O
. . . O
   
4 CD CD O
. . . O
Hypertension NNP NNP O
. . . O
   
On IN IN O
captopril NN NN O
, , , O
atenolol NN NN O
and CC CC O
trans-derm JJ JJ O
nitro NN NN O
. . . O
   
Blood NNP NNP O
pressure NN NN O
_____/ NN NN O
70 CD CD O
, , , O
pulse NN NN O
60 CD CD O
and CC CC O
regular JJ JJ O
, , , O
COR NNP NNP O
normal JJ JJ O
. . . O
   
Impression NNP NNP O
: : : O
Good JJ JJ O
control NN NN O
. . . O
   
5 CD CD O
. . . O
Weight NNP NNP O
. . . O
   
His PRP$ PRP$ O
weight NN NN O
is VBZ VBZ O
192 CD CD O
, , , O
should MD MD O
be VB VB O
175 CD CD O
. . . O
   
Discussed NNP NNP O
. . . O
   
Overall NNP NNP O
, , , O
he PRP PRP O
has VBZ VBZ O
got VBN VBN O
things NNS NNS O
he PRP PRP O
can MD MD O
do VB VB O
to TO TO O
improve VB VB O
, , , O
and CC CC O
these DT DT O
were VBD VBD O
all DT DT O
discussed VBN VBN O
in IN IN O
detail NN NN O
with IN IN O
the DT DT O
patient NN NN O
and CC CC O
his PRP$ PRP$ O
wife NN NN O
. . . O
   
Brandon NNP NNP I-DOCTOR
Walls NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
   
Dictated/Not NNP NNP O
read VB VB O
BW/yamamoto NNP NNP O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2071-02-19 NN NN I-DATE
79 CD CD I-AGE
yo NN NN O
female JJ JJ O
post NN NN O
RSH NNP NNP I-HOSPITAL
hospitalization NN NN O
for IN IN O
failure NN NN O
to TO TO O
thrive VB VB O
, , , O
nursing VBG VBG O
home NN NN O
stay NN NN O
for IN IN O
three CD CD O
months NNS NNS O
. . . O
   
home NN NN O
for IN IN O
one CD CD O
week NN NN O
. . . O
   
ruled VBD VBD O
out IN IN O
for IN IN O
MI NNP NNP O
, , , O
ct NN NN O
scan JJ JJ O
negative JJ JJ O
, , , O
diagnosed VBN VBN O
with IN IN O
depression NN NN O
. . . O
   
home NN NN O
finger NN NN O
sticks VBZ VBZ O
in IN IN O
the DT DT O
191 CD CD O
per IN IN O
vna NN NN O
. . . O
   
in IN IN O
today NN NN O
wiht NN NN O
niece NN NN O
from IN IN O
Maine NNP NNP I-STATE
. . . O
   
no DT DT O
complaints NNS NNS O
except IN IN O
for IN IN O
knee NN NN O
pain NN NN O
at IN IN O
times NNS NNS O
. . . O
   
she PRP PRP O
uses VBZ VBZ O
walker NN NN O
. . . O
   
she PRP PRP O
feels VBZ VBZ O
in IN IN O
good JJ JJ O
spirits NNS NNS O
and CC CC O
denies NNS NNS O
depression NN NN O
. . . O
   
Problems NNS NNS O
Hypertension NNP NNP O
Osteoarthritis NNP NNP O
Dizziness NNP NNP O
amputation NN NN O
: : : O
3rd CD CD O
left VBN VBN O
toe NN NN O
Depression NNP NNP O
: : : O
with IN IN O
psychotic JJ JJ O
features NNS NNS O
Lumbar NNP NNP O
disc NN NN O
disease NN NN O
: : : O
s/p NN NN O
discectomy NN NN O
Cholecystectomy NNP NNP O
: : : O
s/p NN NN O
open JJ JJ O
procedure NN NN O
H/O NNP NNP O
Atrial NNP NNP O
fibrillation NN NN O
: : : O
vs NNS NNS O
. . . O
atrial JJ JJ O
tachycardia NNS NNS O
-- : : O
s/p NN NN O
cardioversion NN NN O
2/68 CD CD I-DATE
Diabetes NNP NNP O
mellitus NN NN O
: : : O
type NN NN O
2 CD CD O
Pulmonary NNP NNP O
embolism NN NN O
: : : O
bilateral NN NN O
; : : O
   
tx NN NN O
'd MD MD O
at IN IN O
Buzan NNP NNP I-HOSPITAL
County NNP NNP I-HOSPITAL
Clinic NNP NNP I-HOSPITAL
Myocardial NNP NNP O
infarction NN NN O
: : : O
NQWMI NNP NNP O
with IN IN O
inferolateral/apical JJ JJ O
depressions NNS NNS O
5/31/69 CD CD I-DATE
- : : O
6/04/69 CD CD I-DATE
at IN IN O
Buzan NNP NNP I-HOSPITAL
County NNP NNP I-HOSPITAL
Clinic NNP NNP I-HOSPITAL
; : : O
   
no DT DT O
cath NN NN O
or CC CC O
f/u NN NN O
ETT NNP NNP O
done VBN VBN O
there RB RB O
as IN IN O
pt NN NN O
requested VBD VBD O
conservative JJ JJ O
management NN NN O
pulmonary JJ JJ O
htn NN NN O
Medications NNP NNP O
Asa NNP NNP O
( ( ( O
CHILDRENS NNP NNP O
) ) ) O
( ( ( O
ACETYLSALICYLIC NNP NNP O
Acid NNP NNP O
( ( ( O
C. NN NN O
   
. . . O
   
. . . O
   
81MG CD CD O
, , , O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Tylenol NNP NNP O
( ( ( O
ACETAMINOPHEN NNP NNP O
) ) ) O
500MG CD CD O
, , , O
2 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
TID NNP NNP O
PRN NNP NNP O
arthritis NNS NNS O
pain NN NN O
Glucophage NNP NNP O
( ( ( O
METFORMIN NNP NNP O
) ) ) O
500MG CD CD O
, , , O
2 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
BID NNP NNP O
: : : O
PLEASE NNP NNP O
MAIL NNP NNP O
TO TO TO O
PT NNP NNP O
Nexium NNP NNP O
40 CD CD O
Mg NNP NNP O
40 CD CD O
MG NNP NNP O
PO NNP NNP O
QD NNP NNP O
: : : O
PLEASE NNP NNP O
MAIL NNP NNP O
TO TO TO O
PT NNP NNP O
Colace NNP NNP O
( ( ( O
DOCUSATE NNP NNP O
Sodium NNP NNP O
) ) ) O
100MG CD CD O
, , , O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
TID NNP NNP O
PRN NNP NNP O
constip NN NN O
: : : O
please VB VB O
mail NN NN O
to TO TO O
pt VB VB O
Hydrocortisone NNP NNP O
1 CD CD O
% NN NN O
- : : O
topical JJ JJ O
CREAM NNP NNP O
TOP NNP NNP O
BID NNP NNP O
IBUPROFEN NNP NNP O
600MG CD CD O
, , , O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
Q8H NNP NNP O
PRN NNP NNP O
pain NN NN O
: : : O
to TO TO O
be VB VB O
taken VBN VBN O
with IN IN O
food NN NN O
Lasix NNP NNP O
( ( ( O
FUROSEMIDE NNP NNP O
) ) ) O
40MG CD CD O
, , , O
1.5 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
PRN NNP NNP O
AND CC CC O
prn NN NN O
Zestril NNP NNP O
( ( ( O
LISINOPRIL NNP NNP O
) ) ) O
10MG CD CD O
, , , O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
: : : O
PLEASE NNP NNP O
MAIL NNP NNP O
TO TO TO O
PT NNP NNP O
Celexa NNP NNP O
( ( ( O
CITALOPRAM NNP NNP O
) ) ) O
40MG CD CD O
, , , O
1.5 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Mvi NNP NNP O
( ( ( O
MULTIVITAMINS NNP NNP O
) ) ) O
1 CD CD O
CAPSULE NNP NNP O
PO NNP NNP O
QD NNP NNP O
ATENOLOL NNP NNP O
25MG CD CD O
, , , O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
: : : O
PLEASE NNP NNP O
MAIL NNP NNP O
TO TO TO O
PT NNP NNP O
Ritalin NNP NNP O
( ( ( O
METHYLPHENIDATE NNP NNP O
Hcl NNP NNP O
) ) ) O
5MG CD CD O
, , , O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Allergies NNP NNP O
* NN NN O
Haldol NNP NNP O
- : : O
Unknown JJ JJ O
bp:120/70 NN NN O
pulse76 NN NN O
appears VBZ VBZ O
well RB RB O
obese NN NN O
adult NN NN O
cor:RRRs1s2 NN NN O
lungs NNS NNS O
: : : O
clear JJ JJ O
abd NN NN O
: : : O
soft JJ JJ O
and CC CC O
nontender NN NN O
ext JJ JJ O
: : : O
no DT DT O
edema NN NN O
knees NNS NNS O
: : : O
thickened VBN VBN O
joints NNS NNS O
but CC CC O
no DT DT O
erythema NN NN O
or CC CC O
effusion NN NN O
a/p NN NN O
: : : O
diabetes NNS NNS O
: : : O
currently RB RB O
on IN IN O
12 CD CD O
units NNS NNS O
of IN IN O
NPH NNP NNP O
. . . O
   
previously RB RB O
on IN IN O
glucophage NN NN O
only RB RB O
. . . O
   
will MD MD O
d/c VB VB O
insulin NN NN O
. . . O
   
have VBP VBP O
vna NN NN O
see VB VB O
her PRP$ PRP$ O
twice RB RB O
a DT DT O
week NN NN O
as IN IN O
before IN IN O
for IN IN O
finger NN NN O
sticks VBZ VBZ O
. . . O
   
restart NN NN O
glucophage NN NN O
at IN IN O
two CD CD O
per IN IN O
day NN NN O
for IN IN O
a DT DT O
few JJ JJ O
days NNS NNS O
and CC CC O
if IN IN O
tolerating VBG VBG O
resume NN NN O
previous JJ JJ O
dose NN NN O
of IN IN O
2 CD CD O
tabs NNS NNS O
po NN NN O
bid NN NN O
. . . O
   
check NN NN O
hga1c NN NN O
. . . O
   
f/u NN NN O
wiht NN NN O
me PRP PRP O
next JJ JJ O
month NN NN O
in IN IN O
dr NN NN O
. . . O
Carrie NNP NNP I-DOCTOR
's POS POS O
absence NN NN O
depression NN NN O
: : : O
appears VBZ VBZ O
to TO TO O
be VB VB O
doing VBG VBG O
well RB RB O
. . . O
   
cont NN NN O
with IN IN O
celexa NN NN O
and CC CC O
ritalin NN NN O
pulm NN NN O
htn NN NN O
: : : O
cont NN NN O
with IN IN O
lasix NN NN O
. . . O
   
cad NN NN O
: : : O
stable JJ JJ O
with IN IN O
no DT DT O
angina NN NN O
or CC CC O
failure NN NN O
. . . O
   
f/u NN NN O
one CD CD O
month NN NN O
with IN IN O
me PRP PRP O
until IN IN O
dr NN NN O
. . . O
carrie NN NN I-DOCTOR
's POS POS O
return NN NN O
____________________________________________ NN NN O
_ NN NN O
Trevor NNP NNP I-DOCTOR
H. NN NN I-DOCTOR
Vaughan NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2070-08-13 JJ JJ I-DATE
Ridgewood NNP NNP I-HOSPITAL
Hospital NNP NNP I-HOSPITAL
Intern NNP NNP O
Admission NNP NNP O
Note VB VB O
CC NNP NNP O
Chest NN NN O
pain NN NN O
HPI NNP NNP O
78 CD CD I-AGE
yo NN NN O
F NN NN O
with IN IN O
PMHx NNP NNP O
sig NN NN O
for IN IN O
CHF NNP NNP O
, , , O
HTN NNP NNP O
, , , O
atrial JJ JJ O
fibrillation NN NN O
( ( ( O
cardioverted VBN VBN O
2/68 CD CD I-DATE
, , , O
now RB RB O
on IN IN O
amiodarone NN NN O
) ) ) O
, , , O
and CC CC O
DM NNP NNP O
p/w NN NN O
increased VBN VBN O
SOB NNP NNP O
and CC CC O
chest NN NN O
pain NN NN O
over IN IN O
1 CD CD O
weeks NNS NNS O
time NN NN O
. . . O
   
Symptoms NNP NNP O
not RB RB O
related VBN VBN O
to TO TO O
exertion NN NN O
and CC CC O
reports NNS NNS O
sternal JJ JJ O
area NN NN O
is VBZ VBZ O
the DT DT O
location NN NN O
of IN IN O
pain NN NN O
. . . O
   
Occurs VBZ VBZ O
at IN IN O
rest NN NN O
. . . O
   
Feels VBZ VBZ O
like IN IN O
pressure NN NN O
and CC CC O
at IN IN O
times NNS NNS O
sharp JJ JJ O
pain NN NN O
, , , O
not RB RB O
related VBN VBN O
to TO TO O
respiration NN NN O
. . . O
   
7/10 CD CD O
when WRB WRB O
maximal NN NN O
intensity NN NN O
. . . O
   
Pain NN NN O
is VBZ VBZ O
constant JJ JJ O
in IN IN O
nature NN NN O
, , , O
patient NN NN O
states NNS NNS O
lasting VBG VBG O
up RP RP O
to TO TO O
hours NNS NNS O
at IN IN O
a DT DT O
time NN NN O
. . . O
   
No DT DT O
specific JJ JJ O
provocative JJ JJ O
or CC CC O
palliative JJ JJ O
factors NNS NNS O
. . . O
   
Not RB RB O
related VBN VBN O
to TO TO O
position NN NN O
. . . O
   
Reports NNS NNS O
that IN IN O
SOB NNP NNP O
and CC CC O
chest NN NN O
pain NN NN O
are VBP VBP O
chronic JJ JJ O
problems NNS NNS O
for IN IN O
her PRP$ PRP$ O
and CC CC O
the DT DT O
reason NN NN O
she PRP PRP O
presented VBD VBD O
to TO TO O
the DT DT O
ED NNP NNP O
is VBZ VBZ O
because IN IN O
the DT DT O
symptoms NNS NNS O
have VBP VBP O
increased VBN VBN O
over IN IN O
the DT DT O
past JJ JJ O
week NN NN O
. . . O
   
No DT DT O
associated VBN VBN O
symptoms NNS NNS O
of IN IN O
N/V NNP NNP O
or CC CC O
diaphoresis NN NN O
. . . O
   
Reports NNP NNP O
occasional JJ JJ O
palpitations NNS NNS O
. . . O
   
Patient NNP NNP O
also RB RB O
feels VBZ VBZ O
pain NN NN O
in IN IN O
her PRP$ PRP$ O
back RB RB O
, , , O
shoulders NNS NNS O
, , , O
and CC CC O
arms NNS NNS O
which WDT WDT O
she PRP PRP O
attributes VBZ VBZ O
to TO TO O
her PRP$ PRP$ O
arthritis NN NN O
and CC CC O
not RB RB O
radiation NN NN O
of IN IN O
the DT DT O
pain NN NN O
. . . O
   
States NNS NNS O
that IN IN O
she PRP PRP O
sleeps VBZ VBZ O
on IN IN O
4 CD CD O
pillows NNS NNS O
and CC CC O
this DT DT O
does VBZ VBZ O
represent NN NN O
on IN IN O
acute JJ JJ O
change NN NN O
. . . O
   
Denies NNP NNP O
fever/chills VBZ VBZ O
. . . O
   
Reports NNP NNP O
constipation NN NN O
at IN IN O
baseline NN NN O
( ( ( O
BMs NNP NNP O
do VBP VBP O
not RB RB O
occur VB VB O
everyday JJ JJ O
) ) ) O
. . . O
   
Patient NNP NNP O
states NNS NNS O
she PRP PRP O
has VBZ VBZ O
frequent JJ JJ O
sinus JJ JJ O
infections NNS NNS O
. . . O
   
PMHx NNP NNP O
HTN NNP NNP O
, , , O
CHF NNP NNP O
( ( ( O
good JJ JJ O
systolic JJ JJ O
function NN NN O
though IN IN O
) ) ) O
, , , O
Afib NNP NNP O
( ( ( O
past JJ JJ O
cardioversion NN NN O
Feb NNP NNP O
. . . O
2068 CD CD I-DATE
) ) ) O
, , , O
DM NNP NNP O
Pulmonary NNP NNP O
embolism NN NN O
- : : O
bilateral NN NN O
, , , O
treated VBN VBN O
at IN IN O
Buzan NNP NNP I-HOSPITAL
County NNP NNP I-HOSPITAL
Clinic NNP NNP I-HOSPITAL
( ( ( O
CT NNP NNP O
with IN IN O
multiple JJ JJ O
filling NN NN O
defects NNS NNS O
in IN IN O
LLL NNP NNP O
, , , O
RUL NNP NNP O
, , , O
RLL NNP NNP O
c/w NN NN O
PE NNP NNP O
) ) ) O
, , , O
non-Q JJ JJ O
wave NN NN O
MI NNP NNP O
with IN IN O
inferolateral JJ JJ O
apical JJ JJ O
depressoins NNS NNS O
at IN IN O
Buzan NNP NNP I-HOSPITAL
County NNP NNP I-HOSPITAL
Clinic NNP NNP I-HOSPITAL
6/69 CD CD I-DATE
; : : O
   
RSH NNP NNP I-HOSPITAL
admission NN NN O
5/17/70 CD CD I-DATE
with IN IN O
D-dimer=1976, NNP NNP O
CT NNP NNP O
negative JJ JJ O
for IN IN O
PE NNP NNP O
and CC CC O
DVT NNP NNP O
Osteoarthritis NNP NNP O
, , , O
anxiety NN NN O
, , , O
depression NN NN O
with IN IN O
psychotic JJ JJ O
features NNS NNS O
, , , O
lumbar NN NN O
disc NN NN O
disease NN NN O
( ( ( O
s/p NN NN O
surgical JJ JJ O
repairs NNS NNS O
) ) ) O
, , , O
Echo NNP NNP O
: : : O
5/21/70 CD CD I-DATE
: : : O
The DT DT O
left VBN VBN O
ventricular JJ JJ O
systolic JJ JJ O
function NN NN O
within IN IN O
normal JJ JJ O
limits NNS NNS O
. . . O
   
There EX EX O
is VBZ VBZ O
segmental JJ JJ O
left VBN VBN O
ventricular NN NN O
dysfunction NN NN O
which WDT WDT O
involves VBZ VBZ O
the DT DT O
inferior JJ JJ O
territory NN NN O
, , , O
this DT DT O
has VBZ VBZ O
deceased VBN VBN O
sine NN NN O
12/68 CD CD I-DATE
study NN NN O
. . . O
   
The DT DT O
estimated JJ JJ O
ejection NN NN O
fraction NN NN O
is VBZ VBZ O
57 CD CD O
% NN NN O
. . . O
   
Estimated NNP NNP O
RV NNP NNP O
systolic JJ JJ O
pressure NN NN O
is VBZ VBZ O
89 CD CD O
mmHg NN NN O
. . . O
   
Right RB RB O
ventricular JJ JJ O
systolic JJ JJ O
function NN NN O
is VBZ VBZ O
within IN IN O
normal JJ JJ O
limits NNS NNS O
. . . O
   
Stress NNP NNP O
The DT DT O
ECG NNP NNP O
response NN NN O
to TO TO O
pharmacological JJ JJ O
stress NN NN O
was VBD VBD O
uninterpretable JJ JJ O
for IN IN O
ischemia NN NN O
. . . O
   
The DT DT O
myocardial NN NN O
scans NNS NNS O
are VBP VBP O
within IN IN O
normal JJ JJ O
limits NNS NNS O
and CC CC O
do VBP VBP O
not RB RB O
demonstrate VB VB O
evidence NN NN O
of IN IN O
myocardial NN NN O
ischemia NN NN O
or CC CC O
infarction NN NN O
. . . O
   
Region NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
with IN IN O
apparent JJ JJ O
reduction NN NN O
in IN IN O
tracer NN NN O
activity NN NN O
likely JJ JJ O
reflect VB VB O
soft JJ JJ O
tissue NN NN O
attenuation NN NN O
, , , O
not RB RB O
specific JJ JJ O
for IN IN O
coronary JJ JJ O
artery NN NN O
disease NN NN O
. . . O
   
LVEF=64%. NNP NNP O
   
PE NNP NNP O
protocol NN NN O
CT NNP NNP O
5/70 CD CD I-DATE
: : : O
no DT DT O
evidence NN NN O
of IN IN O
pulmonary JJ JJ O
embolism NN NN O
. . . O
   
Delayed NNP NNP O
venogram NN NN O
of IN IN O
the DT DT O
pelvis NN NN O
and CC CC O
lower JJR JJR O
extremities NNS NNS O
demonstrates VBZ VBZ O
no DT DT O
evidence NN NN O
of IN IN O
of IN IN O
DVT NNP NNP O
. . . O
   
A DT DT O
2.2 CD CD O
x SYM SYM O
1.4 CD CD O
cm NN NN O
nodule NN NN O
is VBZ VBZ O
identified VBN VBN O
on IN IN O
image NN NN O
112 CD CD O
in IN IN O
the DT DT O
right JJ JJ O
upper JJ JJ O
lobe NN NN O
. . . O
   
In IN IN O
addition NN NN O
, , , O
there EX EX O
is VBZ VBZ O
ground NN NN O
glass NN NN O
opacity NN NN O
involving VBG VBG O
the DT DT O
bilateral JJ JJ O
lungs NNS NNS O
. . . O
   
There EX EX O
is VBZ VBZ O
interstitial JJ JJ O
pulmonary JJ JJ O
edema NN NN O
and CC CC O
a DT DT O
small JJ JJ O
right JJ JJ O
pleural JJ JJ O
effusion NN NN O
. . . O
   
5/23 CD CD I-DATE
Chest NN NN O
CT NNP NNP O
: : : O
previously RB RB O
demonstrated VBN VBN O
nodule NN NN O
in IN IN O
the DT DT O
right JJ JJ O
upper JJ JJ O
lung NN NN O
measuring VBG VBG O
17 CD CD O
mm NN NN O
x SYM SYM O
11 CD CD O
mm NN NN O
has VBZ VBZ O
resolved VBN VBN O
. . . O
   
MED NNP NNP O
Amiodarone NNP NNP O
200 CD CD O
qD NN NN O
Premarin NNP NNP O
0.625 CD CD O
qD NN NN O
ASA NNP NNP O
81 CD CD O
qD NN NN O
Provera NNP NNP O
2.5 CD CD O
mg NN NN O
qD NN NN O
Atenolol NNP NNP O
25 CD CD O
qD NN NN O
Tylenol NNP NNP O
500 CD CD O
tid NN NN O
PRN NNP NNP O
Lasix NNP NNP O
40 CD CD O
bid NN NN O
Ibuprofen NNP NNP O
600 CD CD O
q8 NN NN O
PRN NNP NNP O
Glucophage NNP NNP O
500 CD CD O
bid NN NN O
Colace NNP NNP O
100 CD CD O
tid NN NN O
pRN NN NN O
Nexium NNP NNP O
40 CD CD O
qD NN NN O
Neurontin NNP NNP O
100 CD CD O
tid NN NN O
Celexa NNP NNP O
40 CD CD O
qD NN NN O
ALL NNP NNP O
Haldol NNP NNP O
- : : O
unknown JJ JJ O
reaction NN NN O
SHx NNP NNP O
Lives NNP NNP O
alone RB RB O
, , , O
upstairs RB RB O
from IN IN O
her PRP$ PRP$ O
nieces NNS NNS O
( ( ( O
Carpenter NNP NNP I-PATIENT
815-009-5048 JJ JJ I-PHONE
) ) ) O
. . . O
   
VNA NNP NNP O
visits NNS NNS O
2x/week CD CD O
organizes NNS NNS O
medications NNS NNS O
which WDT WDT O
patient NN NN O
then RB RB O
takes VBZ VBZ O
herself PRP PRP O
. . . O
   
Receives NNP NNP O
Community NNP NNP I-ORGANIZATION
Means NNP NNP I-ORGANIZATION
and CC CC O
family NN NN O
helps VBZ VBZ O
with IN IN O
shopping NN NN O
. . . O
   
Receives NNP NNP O
PT NNP NNP O
at IN IN O
home NN NN O
. . . O
   
Ambulates NNP NNP O
with IN IN O
a DT DT O
walker NN NN O
at IN IN O
baseline NN NN O
. . . O
   
Smoking NNP NNP O
: : : O
denies NNS NNS O
Alcohol NNP NNP O
: : : O
denies NNS NNS O
IVDU NNP NNP O
: : : O
none NN NN O
FHx NNP NNP O
Denies NNP NNP O
In IN IN O
ED NNP NNP O
, , , O
T=98.6, NNP NNP O
HR=90, NNP NNP O
BP=174/96, NNP NNP O
RR=18, NNP NNP O
94%RA CD CD O
96%2L; CD CD O
   
Received NNP NNP O
Lasix NNP NNP O
20 CD CD O
IV NNP NNP O
, , , O
ASA NNP NNP O
, , , O
Albuterol/Atrovent NNP NNP O
Nebs NNP NNP O
, , , O
Magnesium NNP NNP O
2g CD CD O
x1 NN NN O
, , , O
and CC CC O
Insulin NNP NNP O
6 CD CD O
units NNS NNS O
. . . O
   
PE NNP NNP O
VS NNP NNP O
Temp NNP NNP O
: : : O
97.8 CD CD O
BP NNP NNP O
: : : O
140/82 CD CD O
HR NNP NNP O
: : : O
80 CD CD O
RR NNP NNP O
: : : O
26 CD CD O
Sat:99% NNP NNP O
2L CD CD O
GEN NNP NNP O
NAD NNP NNP O
, , , O
wearing VBG VBG O
a DT DT O
hair NN NN O
piece NN NN O
HEENT NNP NNP O
PERRL NNP NNP O
, , , O
EOMI NNP NNP O
, , , O
anicteric JJ JJ O
, , , O
no DT DT O
erythema/exudates NNS NNS O
posterior NN NN O
pharynx NN NN O
NECK NNP NNP O
JVP NNP NNP O
elevated VBD VBD O
, , , O
no DT DT O
LAD NNP NNP O
CHEST NN NN O
bilateral JJ JJ O
crackles NNS NNS O
1/3 CD CD O
of IN IN O
the DT DT O
way NN NN O
up RP RP O
the DT DT O
lung NN NN O
fields NNS NNS O
, , , O
otherwise RB RB O
clear JJ JJ O
, , , O
no DT DT O
wheezes NNS NNS O
HEART NNP NNP O
RRR NNP NNP O
, , , O
no DT DT O
m/r/g NN NN O
ABD NNP NNP O
+ NN NN O
BS NNP NNP O
, , , O
soft JJ JJ O
, , , O
NTND NNP NNP O
, , , O
no DT DT O
masses NNS NNS O
EXT NNP NNP O
1 CD CD O
+ NN NN O
edema NN NN O
above IN IN O
the DT DT O
ankles NNS NNS O
, , , O
pulses NNS NNS O
equal JJ JJ O
b/l NN NN O
SKIN NNP NNP O
no DT DT O
rashes NNS NNS O
or CC CC O
lesions NNS NNS O
RECTAL NNP NNP O
Guaiac NNP NNP O
neg NN NN O
but CC CC O
minimal JJ JJ O
stool NN NN O
in IN IN O
vault NN NN O
, , , O
2mm CD CD O
erosion NN NN O
on IN IN O
buttocks NNS NNS O
NEURO NNP NNP O
AAOx3 NNP NNP O
, , , O
( ( ( O
initially RB RB O
states NNS NNS O
year NN NN O
is VBZ VBZ O
2087 CD CD I-DATE
, , , O
than IN IN O
corrects NNS NNS O
, , , O
day/month NN NN O
accurate NN NN O
No DT DT O
facial JJ JJ O
droop NN NN O
, , , O
no DT DT O
tongue NN NN O
deviation NN NN O
, , , O
uvula NN NN O
elevated VBD VBD O
midline JJ JJ O
Sensory NNP NNP O
intact JJ JJ O
Motor NNP NNP O
strength NN NN O
5/5 CD CD O
throughou NN NN O
. . . O
   
LABS NNP NNP O
WBC NNP NNP O
8.8 CD CD O
4.5-11.0 JJ JJ O
th/cmm NN NN O
HCT NNP NNP O
37.0 CD CD O
36.0-46.0 CD CD O
% NN NN O
HGB NNP NNP O
12.1 CD CD O
12.0-16.0 JJ JJ O
gm/dl NN NN O
RBC NNP NNP O
4.57 CD CD O
4.00-5.20 JJ JJ O
mil/cmm NN NN O
PLT NNP NNP O
261 CD CD O
150-350 JJ JJ O
th/cumm NN NN O
MCV NNP NNP O
81 CD CD O
80-100 JJ JJ O
fl NN NN O
MCH NNP NNP O
26.5 CD CD O
26.0-34.0 JJ JJ O
pg/rbc NN NN O
MCHC NNP NNP O
32.7 CD CD O
31.0-37.0 JJ JJ O
g/dl NN NN O
RDW NNP NNP O
15.0 CD CD O
H NNP NNP O
11.5-14.5 CD CD O
% NN NN O
Superstat NNP NNP O
PT NNP NNP O
13.6 CD CD O
H NNP NNP O
11.1-13.1 JJ JJ O
sec NN NN O
Superstat NNP NNP O
APTT NNP NNP O
23.2 CD CD O
22.1-35.1 JJ JJ O
sec NN NN O
DIFFERENTIAL NNP NNP O
REQUEST NNP NNP O
RECEIVED NNP NNP O
Diff NNP NNP O
Method NNP NNP O
Auto NNP NNP O
Poly NNP NNP O
72 CD CD O
H NNP NNP O
40-70 CD CD O
% NN NN O
Lymphs NNP NNP O
20 CD CD O
L NNP NNP O
22-44 JJ JJ O
% NN NN O
Monos NNP NNP O
4 CD CD O
4-11 JJ JJ O
% NN NN O
EOS NNP NNP O
3 CD CD O
0-8 NN NN O
% NN NN O
Basos NNP NNP O
1 CD CD O
0-3 NN NN O
% NN NN O
Absolute NNP NNP O
Neuts NNP NNP O
6.40 CD CD O
1.8-7.7 JJ JJ O
th/cmm NN NN O
Absolute NNP NNP O
Lymphs NNP NNP O
1.79 CD CD O
1.0-4.8 JJ JJ O
th/cmm NN NN O
Absolute NNP NNP O
Monos NNP NNP O
0.32 CD CD O
0.2-0.4 NN NN O
th/cmm NN NN O
Absolute NNP NNP O
EOS NNP NNP O
0.22 CD CD O
0.1-0.3 NN NN O
th/cmm NN NN O
Absolute NNP NNP O
Basos NNP NNP O
0.06 CD CD O
0.0-0.3 NN NN O
th/cmm NN NN O
Aniso NNP NNP O
None NN NN O
NORMAL NNP NNP O
Hypo NNP NNP O
2 CD CD O
+ NN NN O
NORMAL NNP NNP O
Macrocytes NNP NNP O
None NN NN O
Microcytes NNP NNP O
None NN NN O
Sodium NNP NNP O
( ( ( O
Stat NNP NNP O
Lab NNP NNP O
) ) ) O
135 CD CD O
135-145 JJ JJ O
mmol/L NN NN O
Potassium NNP NNP O
( ( ( O
Stat NNP NNP O
Lab NNP NNP O
) ) ) O
4.6 CD CD O
3.4-4.8 CD CD O
mmol/L NN NN O
Result NNP NNP O
Text NN NN O
: : : O
SLIGHTLY RB RB O
HEMOLYZED NNP NNP O
Chloride NNP NNP O
( ( ( O
Stat NNP NNP O
Lab NNP NNP O
) ) ) O
104 CD CD O
100-108 JJ JJ O
mmol/L NN NN O
CO2 NNP NNP O
( ( ( O
Stat NNP NNP O
Lab NNP NNP O
) ) ) O
21.8 CD CD O
L NNP NNP O
23.0-31.9 JJ JJ O
mmol/L NN NN O
BUN NNP NNP O
( ( ( O
Stat NNP NNP O
Lab NNP NNP O
) ) ) O
11 CD CD O
8-25 JJ JJ O
mg/dl NN NN O
Creatinine NNP NNP O
( ( ( O
Stat NNP NNP O
Lab NNP NNP O
) ) ) O
1.0 CD CD O
0.6-1.5 CD CD O
mg/dl NN NN O
Glucose NNP NNP O
( ( ( O
Stat NNP NNP O
Lab NNP NNP O
) ) ) O
296 CD CD O
H NNP NNP O
70-110 CD CD O
mg/dl NN NN O
Calcium NNP NNP O
8.9 CD CD O
8.5-10.5 JJ JJ O
mg/dl NN NN O
Phosphorus NNP NNP O
3.2 CD CD O
2.6-4.5 JJ JJ O
mg/dl NN NN O
Magnesium NNP NNP O
1.3 CD CD O
L NNP NNP O
1.4-2.0 JJ JJ O
meq/L NN NN O
Total NNP NNP O
Protein NNP NNP O
7.8 CD CD O
6.0-8.3 JJ JJ O
g/dl NN NN O
Albumin NNP NNP O
3.0 CD CD O
L NNP NNP O
3.3-5.0 JJ JJ O
g/dl NN NN O
Globulin NNP NNP O
4.8 CD CD O
H NNP NNP O
2.6-4.1 JJ JJ O
g/dl NN NN O
Direct NNP NNP O
Bilirubin NNP NNP O
< NN NN O
0.1 CD CD O
0-0.4 JJ JJ O
mg/dl NN NN O
Total NNP NNP O
Bilirubin NNP NNP O
0.5 CD CD O
0-1.0 NN NN O
mg/dl NN NN O
Alkaline NNP NNP O
Phosphatase NNP NNP O
69 CD CD O
30-100 JJ JJ O
U/L NNP NNP O
Transaminase-SGPT NNP NNP O
19 CD CD O
7-30 NN NN O
U/L NNP NNP O
Creatine NNP NNP O
Kinase NNP NNP O
Isoenz NNP NNP O
2.2 CD CD O
0.0-6.9 NN NN O
ng/ml NN NN O
CPK NNP NNP O
Isoenzymes NNP NNP O
Index NNP NNP O
0.0-3.5 NN NN O
% NN NN O
Result NNP NNP O
Text NN NN O
: : : O
CPK NNP NNP O
and/or NN NN O
CKMB NNP NNP O
too RB RB O
low JJ JJ O
to TO TO O
calculate VB VB O
Relative NNP NNP O
Index NNP NNP O
. . . O
   
Troponin-T NNP NNP O
REFUSED NNP NNP O
0.00-0.09 NN NN O
ng/ml NN NN O
Result NNP NNP O
Text NN NN O
: : : O
HEMOLYZED NNP NNP O
SPECIMEN NNP NNP O
Transaminase-SGOT NNP NNP O
60 CD CD O
H NNP NNP O
9-32 JJ JJ O
U/L NNP NNP O
Creatine NNP NNP O
Kinase NNP NNP O
62 CD CD O
40-150 JJ JJ O
U/L NNP NNP O
D-Dimer NNP NNP O
( ( ( O
ELISA NNP NNP O
) ) ) O
2257 CD CD O
H NNP NNP O
< NN NN O
500 CD CD O
ng/ml NN NN O
UA-Color NNP NNP O
Yellow NNP NNP O
YELLOW NNP NNP O
UA-Turbidity NNP NNP O
CLOUDY NNP NNP O
CLEAR NNP NNP O
UA-Glucose NNP NNP O
1 CD CD O
+ NN NN O
NEG NNP NNP O
UA-Bili NNP NNP O
NEGATIVE NNP NNP O
NEG NNP NNP O
UA-Ketones NNP NNP O
NEGATIVE NNP NNP O
NEG NNP NNP O
UA-Specific NNP NNP O
Gravity NNP NNP O
1.024 CD CD O
1.001-1.035 JJ JJ O
UA-Occult NNP NNP O
Blood NNP NNP O
Trace NNP NNP O
NEG NNP NNP O
UA-pH NNP NNP O
5.5 CD CD O
5.0-9.0 JJ JJ O
UA-Albumin NNP NNP O
3 CD CD O
+ NN NN O
NEG NNP NNP O
UA-Urobilinogen NNP NNP O
NEGATIVE NNP NNP O
NEG NNP NNP O
UA-Nitrite NNP NNP O
NEGATIVE NNP NNP O
NEG NNP NNP O
UA-WBC NNP NNP O
Screen NNP NNP O
NEGATIVE NNP NNP O
NEG NNP NNP O
UA-SED-RBC NNP NNP O
0-2 JJ JJ O
0-2 JJ JJ O
/ NN NN O
hpf NN NN O
UA-SED-WBC NNP NNP O
5-10 JJ JJ O
0-2 JJ JJ O
/ NN NN O
hpf NN NN O
UA-SED-Bacteria NNP NNP O
Few JJ JJ O
NEG NNP NNP O
/ NN NN O
hpf NN NN O
Hyaline NNP NNP O
Cast NNP NNP O
0-2 JJ JJ O
0-5 JJ JJ O
/ NN NN O
lpf NN NN O
Granular NNP NNP O
Cast NNP NNP O
0-2 NNP NNP O
NEG NNP NNP O
/ NN NN O
lpf NN NN O
Squamous NNP NNP O
Cells NNS NNS O
Moderate NNP NNP O
NEG NNP NNP O
/ NN NN O
hpf NN NN O
Amorphous NNP NNP O
Crystals NNP NNP O
Few JJ JJ O
NEG NNP NNP O
/ NN NN O
hpf NN NN O
Microscopic NNP NNP O
Sediment NNP NNP O
Completed NNP NNP O
EKG NNP NNP O
Sinus NNP NNP O
tachycardia NNS NNS O
@ IN IN O
110 CD CD O
, , , O
LBBB NNP NNP O
( ( ( O
present JJ JJ O
on IN IN O
old JJ JJ O
EKG NNP NNP O
) ) ) O
CXR NNP NNP O
Focal NNP NNP O
vascular NN NN O
redistribution NN NN O
and CC CC O
some DT DT O
interstitial JJ JJ O
opacities NNS NNS O
; : : O
   
Mild NNP NNP O
pulmonary JJ JJ O
edema NN NN O
similar JJ JJ O
to TO TO O
prior RB RB O
exam NN NN O
. . . O
   
CT NNP NNP O
PE NNP NNP O
protocol NN NN O
Assessment NNP NNP O
and CC CC O
Plan NNP NNP O
78F CD CD O
h/o NN NN O
CHF NNP NNP O
( ( ( O
diastolic JJ JJ O
dysfunction NN NN O
) ) ) O
, , , O
Afib NNP NNP O
( ( ( O
s/p NN NN O
cardioversion NN NN O
) ) ) O
, , , O
HTN NNP NNP O
, , , O
DM NNP NNP O
, , , O
past JJ JJ O
b/l NN NN O
PE NNP NNP O
presents VBZ VBZ O
with IN IN O
increased VBN VBN O
CP NNP NNP O
and CC CC O
SOB NNP NNP O
times NNS NNS O
week NN NN O
. . . O
   
Differential NNP NNP O
includes VBZ VBZ O
CHF NNP NNP O
exacerbation NN NN O
(? NNP NNP O
   
Setting NNP NNP O
of IN IN O
med VBD VBD O
noncompliance NN NN O
) ) ) O
, , , O
ACS NNP NNP O
, , , O
PE NNP NNP O
. . . O
   
1)PE CD CD O
- : : O
D-dimer NNP NNP O
is VBZ VBZ O
2257 CD CD O
; : : O
   
Heparin NNP NNP O
6000 CD CD O
unit NN NN O
bolus NN NN O
, , , O
1000 CD CD O
unit/hr NN NN O
with IN IN O
sliding VBG VBG O
scale NN NN O
; : : O
   
PE NNP NNP O
protocol NN NN O
CT NNP NNP O
; : : O
   
Continue VB VB O
to TO TO O
hold VB VB O
Metformin NNP NNP O
, , , O
received VBD VBD O
600mg CD CD O
Mucomyst NNP NNP O
in IN IN O
preparation NN NN O
for IN IN O
dye NN NN O
load NN NN O
and CC CC O
continue VB VB O
2 CD CD O
doses NNS NNS O
post NN NN O
scan JJ JJ O
; : : O
   
Preliminary NNP NNP O
CT NNP NNP O
read VBP VBP O
: : : O
no DT DT O
evidence NN NN O
of IN IN O
PE NNP NNP O
although IN IN O
limited JJ JJ O
by IN IN O
motion NN NN O
artifact NN NN O
; : : O
   
ground NN NN O
glass NN NN O
changes NNS NNS O
c/w NN NN O
with IN IN O
CHF NNP NNP O
; : : O
   
Continue NNP NNP O
Heparin NNP NNP O
as IN IN O
pt NN NN O
. . . O
   
with IN IN O
h/o NN NN O
PE NNP NNP O
and CC CC O
awaiting VBG VBG O
final JJ JJ O
CT NNP NNP O
read NN NN O
. . . O
   
2 CD CD O
) ) ) O
r/o NN NN O
MI NNP NNP O
- : : O
Enzymes NNP NNP O
negative JJ JJ O
x2 NN NN O
; : : O
   
ASA NNP NNP O
, , , O
O2 NNP NNP O
; : : O
   
B-blocker NNP NNP O
continued VBD VBD O
( ( ( O
no DT DT O
evidence NN NN O
of IN IN O
systolic JJ JJ O
dysfunction NN NN O
) ) ) O
; : : O
   
Received NNP NNP O
ACE NNP NNP O
( ( ( O
Zestril NNP NNP O
x1 NN NN O
) ) ) O
, , , O
now RB RB O
hold VB VB O
in IN IN O
setting VBG VBG O
of IN IN O
dye NN NN O
load NN NN O
3 CD CD O
) ) ) O
CHF NNP NNP O
- : : O
strict JJ JJ O
I&Os NNP NNP O
, , , O
daily JJ JJ O
weight NN NN O
, , , O
no DT DT O
salt NN NN O
diet NN NN O
; : : O
   
exam NN NN O
reveals NNS NNS O
slight JJ JJ O
fluid JJ JJ O
overload NN NN O
, , , O
after IN IN O
initial JJ JJ O
diuresis NN NN O
( ( ( O
Lasix NNP NNP O
20 CD CD O
IV NNP NNP O
x2 NN NN O
) ) ) O
will MD MD O
hold VB VB O
in IN IN O
light NN NN O
of IN IN O
CT NNP NNP O
w NN NN O
contrast NN NN O
, , , O
monitor NN NN O
fluid JJ JJ O
status NN NN O
, , , O
no DT DT O
IVF NNP NNP O
at IN IN O
this DT DT O
time NN NN O
4 CD CD O
) ) ) O
DM NNP NNP O
- - - O
hold NN NN O
Metformin NNP NNP O
, , , O
on IN IN O
Insulin NNP NNP O
SS NNP NNP O
with IN IN O
bid NN NN O
coverage NN NN O
5 CD CD O
) ) ) O
Urine NNP NNP O
- : : O
negative JJ JJ O
nitrite/WBC NN NN O
, , , O
sediment NN NN O
5-10 JJ JJ O
WBCs NNP NNP O
, , , O
few JJ JJ O
bacteria NNS NNS O
; : : O
   
Likely NNP NNP O
asymptomatic JJ JJ O
bacteruria NN NN O
in IN IN O
elderly JJ JJ O
patient NN NN O
, , , O
afebrile NN NN O
, , , O
no DT DT O
increased JJ JJ O
WBC NNP NNP O
, , , O
therefore RB RB O
no DT DT O
treatment NN NN O
at IN IN O
this DT DT O
time NN NN O
. . . O
   
Prophylaxis NNP NNP O
: : : O
-- : : O
Nexium NNP NNP O
Dispo NNP NNP O
: : : O
-- : : O
Ambulate NNP NNP O
, , , O
PT/OT NNP NNP O
Code NNP NNP O
: : : O
-- : : O
Unknown JJ JJ O
Yuri NNP NNP I-DOCTOR
Poole NNP NNP I-DOCTOR
, , , O
MD NNP NNP O
73130 CD CD I-PHONE
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2115-11-24 JJ JJ I-DATE
Neurology NNP NNP O
Resident NNP NNP O
Admit NNP NNP O
Note NN NN O
Date NN NN O
: : : O
11/23/15 CD CD I-DATE
Patient NNP NNP O
Name NN NN O
: : : O
Travis NNP NNP O
, , , O
Peggy NNP NNP I-PATIENT
MRN NNP NNP O
: : : O
0834010 CD CD I-MEDICALRECORD
PCP NNP NNP O
name NN NN O
: : : O
Richard NNP NNP I-DOCTOR
Verlin-Urbina NNP NNP I-DOCTOR
Age NNP NNP O
: : : O
54 CD CD I-AGE
Gender NNP NNP O
: : : O
Female NNP NNP O
Chief NNP NNP O
Complaint NNP NNP O
: : : O
Confusion NNP NNP O
, , , O
? . . O
Seizure NNP NNP O
HPI NNP NNP O
: : : O
This DT DT O
is VBZ VBZ O
a DT DT O
54 CD CD I-AGE
year NN NN O
old JJ JJ O
female JJ JJ O
with IN IN O
no DT DT O
known VBN VBN O
past JJ JJ O
medical JJ JJ O
history NN NN O
who WP WP O
was VBD VBD O
brought VBN VBN O
in IN IN O
via IN IN O
EMS NNP NNP O
presenting VBG VBG O
with IN IN O
confusion NN NN O
and CC CC O
right JJ JJ O
head NN NN O
deviation NN NN O
. . . O
   
According VBG VBG O
to TO TO O
mother NN NN O
, , , O
Peggy NNP NNP I-PATIENT
was VBD VBD O
"""" '' '' O
not RB RB O
acting VBG VBG O
right NN NN O
"""" '' '' O
all DT DT O
day NN NN O
. . . O
   
She PRP PRP O
appeared VBD VBD O
more JJR JJR O
confused VBN VBN O
about IN IN O
her PRP$ PRP$ O
surroundings NNS NNS O
and CC CC O
certain JJ JJ O
usual JJ JJ O
daily JJ JJ O
activities NNS NNS O
( ( ( O
such JJ JJ O
as IN IN O
using VBG VBG O
the DT DT O
remote JJ JJ O
control NN NN O
) ) ) O
. . . O
   
At IN IN O
around IN IN O
6 CD CD O
: : : O
30 CD CD O
PM NNP NNP O
, , , O
her PRP$ PRP$ O
mother NN NN O
reports NNS NNS O
that IN IN O
she PRP PRP O
appeared VBD VBD O
to TO TO O
be VB VB O
repeatedly RB RB O
bending VBG VBG O
down RB RB O
to TO TO O
pick VB VB O
up RP RP O
something NN NN O
that WDT WDT O
was VBD VBD O
n't RB RB O
there EX EX O
and CC CC O
she PRP PRP O
was VBD VBD O
not RB RB O
responding VBG VBG O
to TO TO O
voice NN NN O
. . . O
   
However RB RB O
, , , O
when WRB WRB O
EMS NNP NNP O
arrived VBD VBD O
, , , O
she PRP PRP O
was VBD VBD O
responding VBG VBG O
to TO TO O
their PRP$ PRP$ O
questions NNS NNS O
and CC CC O
appeared VBD VBD O
alert NN NN O
. . . O
   
At IN IN O
some DT DT O
point NN NN O
during IN IN O
transit NN NN O
her PRP$ PRP$ O
right JJ JJ O
head NN NN O
deviation NN NN O
began VBD VBD O
and CC CC O
her PRP$ PRP$ O
left JJ JJ O
arm NN NN O
weakness NN NN O
was VBD VBD O
noted VBN VBN O
. . . O
   
According VBG VBG O
to TO TO O
her PRP$ PRP$ O
mother NN NN O
and CC CC O
sister NN NN O
, , , O
she PRP PRP O
had VBD VBD O
not RB RB O
been VBN VBN O
complaining VBG VBG O
of IN IN O
a DT DT O
headache NN NN O
or CC CC O
dizziness NN NN O
. . . O
   
She PRP PRP O
awoke VBD VBD O
this DT DT O
morning NN NN O
with IN IN O
bilateral JJ JJ O
foot NN NN O
tingling VBG VBG O
that IN IN O
quickly RB RB O
resolved VBN VBN O
. . . O
   
Also RB RB O
no DT DT O
recent JJ JJ O
illnesses NNS NNS O
or CC CC O
falls VBZ VBZ O
. . . O
   
Time NNP NNP O
of IN IN O
onset NN NN O
: : : O
Around IN IN O
6:30 NN NN O
PM NNP NNP O
Witnessed NNP NNP O
onset NN NN O
: : : O
Yes UH UH O
Onset NNP NNP O
: : : O
acute JJ JJ O
Mode NNP NNP O
of IN IN O
arrival NN NN O
: : : O
ambulance NN NN O
Clinical NNP NNP O
Course NN NN O
: : : O
improving VBG VBG O
Pre-morbid NNP NNP O
neurological JJ JJ O
status NN NN O
: : : O
no DT DT O
disability NN NN O
Code NNP NNP O
status NN NN O
: : : O
full JJ JJ O
code NN NN O
Past NNP NNP O
Medical NNP NNP O
History NN NN O
: : : O
None NN NN O
, , , O
though IN IN O
she PRP PRP O
has VBZ VBZ O
n't RB RB O
seen VBN VBN O
a DT DT O
physician NN NN O
in IN IN O
over IN IN O
20 CD CD O
years NNS NNS O
according VBG VBG O
to TO TO O
family NN NN O
Medications NNP NNP O
: : : O
None NN NN O
Allergies NNP NNP O
: : : O
NKDA NNP NNP O
Social NNP NNP O
and CC CC O
Family NNP NNP O
History NN NN O
: : : O
Occupation NNP NNP O
: : : O
Marital NNP NNP O
status NN NN O
: : : O
Single NNP NNP O
Tobacco NNP NNP O
- : : O
Never RB RB O
EtOH NNP NNP O
- : : O
Never RB RB O
Illicit NNP NNP O
drugs NNS NNS O
: : : O
Never RB RB O
Home NNP NNP O
living VBG VBG O
situation NN NN O
: : : O
Lives NNS NNS O
with IN IN O
mother NN NN O
Family NNP NNP O
medical JJ JJ O
history NN NN O
: : : O
Mother NNP NNP O
with IN IN O
pacemaker NN NN O
, , , O
Sister NNP NNP O
with IN IN O
palpitations NNS NNS O
Examination NNP NNP O
: : : O
VS NNP NNP O
: : : O
Temp NNP NNP O
: : : O
HR NNP NNP O
: : : O
88 CD CD O
reg NN NN O
BP NNP NNP O
: : : O
171/90 CD CD O
RR NNP NNP O
: : : O
O2 NNP NNP O
Sat NNP NNP O
: : : O
94 CD CD O
% NN NN O
on IN IN O
2 CD CD O
L/min NNP NNP O
nasal NN NN O
canula NN NN O
General NNP NNP O
: : : O
Appearance NNP NNP O
: : : O
WDWN NNP NNP O
, , , O
Drowsy NNP NNP O
HEENT NNP NNP O
: : : O
NCAT NNP NNP O
, , , O
MMM NNP NNP O
, , , O
OP NNP NNP O
clear JJ JJ O
Neck NNP NNP O
: : : O
supple NN NN O
, , , O
no DT DT O
thyromegaly NN NN O
, , , O
no DT DT O
LAN NNP NNP O
, , , O
no DT DT O
bruits NNS NNS O
Chest NN NN O
: : : O
CTAB NNP NNP O
CVS NNP NNP O
: : : O
RRR NNP NNP O
, , , O
no DT DT O
m/r/g NN NN O
Abd NNP NNP O
: : : O
soft JJ JJ O
, , , O
NT NNP NNP O
, , , O
ND NNP NNP O
, , , O
+ NN NN O
BS NNP NNP O
Ext NNP NNP O
: : : O
no DT DT O
c/c/e NN NN O
, , , O
bilateral JJ JJ O
distal NN NN O
pulses NNS NNS O
strong JJ JJ O
, , , O
severe JJ JJ O
acne NN NN O
on IN IN O
left VBD VBD O
upper JJ JJ O
back RB RB O
MS NNP NNP O
: : : O
General NNP NNP O
: : : O
Drowsy NNP NNP O
, , , O
inattentive JJ JJ O
Orientation NNP NNP O
: : : O
in IN IN O
tact NN NN O
x SYM SYM O
4 CD CD O
( ( ( O
person NN NN O
, , , O
place NN NN O
, , , O
date NN NN O
, , , O
situation NN NN O
Attention NNP NNP O
: : : O
Unable NNP NNP O
to TO TO O
name VB VB O
days NNS NNS O
of IN IN O
week NN NN O
or CC CC O
spell VB VB O
world NN NN O
backwards JJ JJ O
Speech/Lang NNP NNP O
: : : O
difficult JJ JJ O
to TO TO O
assess VB VB O
since IN IN O
not RB RB O
cooperating VBG VBG O
with IN IN O
exam NN NN O
and CC CC O
drowsy NN NN O
. . . O
   
Memory NN NN O
: : : O
3/3 CD CD O
registered VBN VBN O
, , , O
0/3 CD CD O
at IN IN O
5 CD CD O
minutes NNS NNS O
Calculations NNP NNP O
: : : O
Not RB RB O
tested VBN VBN O
Neglect NNP NNP O
: : : O
Left NNP NNP O
sensory NN NN O
neglect NN NN O
Praxis NNP NNP O
: : : O
Not RB RB O
tested VBN VBN O
CN NNP NNP O
: : : O
I PRP PRP O
: : : O
Not RB RB O
tested VBN VBN O
II,III NNP NNP O
: : : O
PERRLA NNP NNP O
4 CD CD O
-> : : O
2 CD CD O
, , , O
VFFC NNP NNP O
III,IV,V NNP NNP O
: : : O
EOM NNP NNP O
full JJ JJ O
w/o NN NN O
nystagmus NN NN O
, , , O
no DT DT O
ptosis NN NN O
. . . O
   
Normal NNP NNP O
saccades/pursuits NNS NNS O
V NNP NNP O
: : : O
sensation NN NN O
intact JJ JJ O
to TO TO O
LT/PP NNP NNP O
, , , O
corneal NN NN O
reflex JJ JJ O
intact JJ JJ O
VII NNP NNP O
: : : O
face NN NN O
symmetric JJ JJ O
without IN IN O
weakness NN NN O
VIII NNP NNP O
: : : O
hears NNS NNS O
finger NN NN O
rub NN NN O
bilaterally RB RB O
IX,X NNP NNP O
: : : O
voice NN NN O
normal JJ JJ O
, , , O
palate NN NN O
elevates NNS NNS O
symmetrically RB RB O
XI NNP NNP O
: : : O
SCM/trapezii NNP NNP O
5/5 CD CD O
XII NNP NNP O
: : : O
tongue NN NN O
protrudes NNS NNS O
midline VBP VBP O
, , , O
no DT DT O
atrophy NN NN O
or CC CC O
fasciculation NN NN O
Motor NNP NNP O
: : : O
Normal JJ JJ O
bulk NN NN O
and CC CC O
tone NN NN O
; : : O
   
no DT DT O
tremor NN NN O
, , , O
rigidity NN NN O
, , , O
or CC CC O
bradykinesia NN NN O
. . . O
   
Delt NNP NNP O
Bi NNP NNP O
Tri NNP NNP O
Grip NNP NNP O
IP NNP NNP O
Quad NNP NNP O
Hamst NNP NNP O
TibAnt NNP NNP O
EHL NNP NNP O
Gastroc NNP NNP O
C5 NNP NNP O
C6 NNP NNP O
C7 NNP NNP O
C8/T1 NNP NNP O
L2 NNP NNP O
L3 NNP NNP O
L4-S1 NNP NNP O
L4 NNP NNP O
L5 NNP NNP O
S1 NNP NNP O
R NNP NNP O
5 CD CD O
5 CD CD O
5 CD CD O
5 CD CD O
5 CD CD O
5 CD CD O
5 CD CD O
5 CD CD O
5 CD CD O
5 CD CD O
L NNP NNP O
5 CD CD O
5 CD CD O
5 CD CD O
5 CD CD O
5 CD CD O
5 CD CD O
5 CD CD O
5 CD CD O
5 CD CD O
5 CD CD O
Coord NNP NNP O
: : : O
Unable NNP NNP O
to TO TO O
test VB VB O
Reflex NNP NNP O
: : : O
No DT DT O
abnormal JJ JJ O
reflexes NNS NNS O
. . . O
   
Jaw NNP NNP O
jerk NN NN O
absent NN NN O
. . . O
   
No DT DT O
Hoffman NNP NNP O
's POS POS O
. . . O
   
Bi NNP NNP O
Tri NNP NNP O
Bra NNP NNP O
Pat NNP NNP O
An DT DT O
Plantar NNP NNP O
C6 NNP NNP O
C7 NNP NNP O
C6 NNP NNP O
L4 NNP NNP O
S1 NNP NNP O
R NNP NNP O
2 CD CD O
2 CD CD O
2 CD CD O
2 CD CD O
2 CD CD O
Flexor NNP NNP O
L NNP NNP O
2 CD CD O
2 CD CD O
2 CD CD O
2 CD CD O
2 CD CD O
Flexor NNP NNP O
Sens NNP NNP O
: : : O
Left NNP NNP O
arm NN NN O
extinction NN NN O
to TO TO O
LT NNP NNP O
and CC CC O
painful JJ JJ O
stimuli NN NN O
. . . O
   
Gait NNP NNP O
: : : O
Posture NNP NNP O
, , , O
stance NN NN O
, , , O
stride NN NN O
, , , O
and CC CC O
arm-swing JJ JJ O
normal JJ JJ O
. . . O
   
Tandem NNP NNP O
gait NN NN O
intact JJ JJ O
. . . O
   
Able JJ JJ O
to TO TO O
walk VB VB O
on IN IN O
heels NNS NNS O
and CC CC O
toes NNS NNS O
. . . O
   
Romberg NNP NNP O
negative JJ JJ O
. . . O
   
NIHSS NNP NNP O
( ( ( O
stroke NN NN O
patients NNS NNS O
) ) ) O
Time NNP NNP O
of IN IN O
exam NN NN O
: : : O
1a CD CD O
: : : O
1 CD CD O
1b CD CD O
: : : O
0 CD CD O
1c CD CD O
: : : O
0 CD CD O
2 CD CD O
: : : O
0 CD CD O
3 CD CD O
: : : O
0 CD CD O
4 CD CD O
: : : O
0 CD CD O
5:4 CD CD O
6 CD CD O
: : : O
4 CD CD O
7 CD CD O
: : : O
x SYM SYM O
8 CD CD O
: : : O
0 CD CD O
9 CD CD O
: : : O
0 CD CD O
10 CD CD O
: : : O
1 CD CD O
11 CD CD O
: : : O
1 CD CD O
Laboratory NNP NNP O
Studies NNP NNP O
: : : O
Results NNS NNS O
NA NNP NNP O
134 CD CD O
, , , O
K NNP NNP O
3.8,CL CD CD O
104,CO2 NN NN O
26.2,BUN CD CD O
13,CRE CD CD O
0.6,GLU CD CD O
317 CD CD O
CA NNP NNP O
9.9,PHOS CD CD O
4.6 CD CD O
(H),MG NN NN O
1.6 CD CD O
, , , O
TBILI NNP NNP O
0.3,DBILI CD CD O
0.1,TP NN NN O
8.5 CD CD O
(H),ALB NN NN O
4.1 CD CD O
AMY NNP NNP O
37,LIPS CD CD O
2.5 CD CD O
ALT/SGPT NNP NNP O
11,AST/SGOT CD CD O
9,ALKP CD CD O
88,TBILI CD CD O
0.3,DBILI CD CD O
0.1 CD CD O
WBC NNP NNP O
10.5,HCT CD CD O
43.5,PLT CD CD O
317 CD CD O
% NN NN O
NEUT NNP NNP O
74 CD CD O
(H),%LYMPH NN NN O
19 CD CD O
(L),%MONO NN NN O
3 CD CD O
(L),%EOS NN NN O
4,%BASO CD CD O
CXR NNP NNP O
: : : O
IMPRESSION NNP NNP O
Normal NNP NNP O
portable JJ JJ O
chest NN NN O
radiograph NN NN O
. . . O
   
Head NNP NNP O
CT/CTA NNP NNP O
: : : O
Patent NNP NNP O
vessels NNS NNS O
. . . O
   
Chronic NNP NNP O
left VBD VBD O
frontal/right JJ JJ O
frontal JJ JJ O
infarcts NNS NNS O
. . . O
   
Right RB RB O
parietal JJ JJ O
/ NN NN O
frontal JJ JJ O
infarcts NNS NNS O
. . . O
   
Impression NNP NNP O
: : : O
54 CD CD I-AGE
year NN NN O
old JJ JJ O
female JJ JJ O
with IN IN O
acute JJ JJ O
right JJ JJ O
parietal/frontal JJ JJ O
infarcts NNS NNS O
. . . O
   
Plan NNP NNP O
: : : O
   
1 CD CD O
. . . O
CVR NNP NNP O
: : : O
Allow VB VB O
BP NNP NNP O
to TO TO O
autoregulate NN NN O
Heparin NNP NNP O
Started NNP NNP O
with IN IN O
goal NN NN O
PTT NNP NNP O
50-70 NNP NNP O
Stroke NNP NNP O
w/u NN NN O
including VBG VBG O
Holter NNP NNP O
and CC CC O
TTE NNP NNP O
Check NNP NNP O
cholesterol NN NN O
panel NN NN O
, , , O
homocysteine NN NN O
, , , O
lipoprotein NN NN O
a DT DT O
   
2 CD CD O
. . . O
Heme NNP NNP O
: : : O
Hypercoagulation NNP NNP O
panel NN NN O
   
3 CD CD O
. . . O
Speech/Swallow NNP NNP O
, , , O
OT NNP NNP O
, , , O
PT NNP NNP O
evaluation NN NN O
   
4 CD CD O
. . . O
Prophylaxis NNP NNP O
: : : O
Nexium NNP NNP O
, , , O
pneumoboots NNS NNS O
_______________________________ NN NN O
_ NN NN O
Hue NNP NNP I-DOCTOR
Calhoun NNP NNP I-DOCTOR
, , , O
MD NNP NNP O
#24104 NN NN O
Neurology NNP NNP O
Resident NNP NNP O
Patient NNP NNP O
is VBZ VBZ O
interested JJ JJ O
in IN IN O
hearing NN NN O
more JJR JJR O
about IN IN O
ongoing JJ JJ O
research NN NN O
protocols NNS NNS O
: : : O
Yes UH UH O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2076-09-24 JJ JJ I-DATE
Team NNP NNP O
4 CD CD O
Admit NNP NNP O
Note NN NN O
Admission NNP NNP O
Date NN NN O
: : : O
9/23/2076 CD CD I-DATE
Patient NNP NNP O
Name NN NN O
: : : O
Carrillo NNP NNP O
, , , O
Percy NNP NNP I-PATIENT
MRN NNP NNP O
# # # O
: : : O
1668727 CD CD I-MEDICALRECORD
Attending NNP NNP O
: : : O
Kidd NNP NNP O
, , , O
Yechiel NNP NNP I-DOCTOR
Historian NNP NNP O
: : : O
patient NN NN O
and CC CC O
ED NNP NNP O
report NN NN O
Reason NNP NNP O
for IN IN O
admission NN NN O
: : : O
change NN NN O
in IN IN O
MS NNP NNP O
and CC CC O
placement NN NN O
issues NNS NNS O
HPI NNP NNP O
: : : O
Patient NNP NNP O
is VBZ VBZ O
a DT DT O
63-year-old JJ JJ O
man NN NN O
with IN IN O
mental JJ JJ O
retardation NN NN O
, , , O
diabetes VBZ VBZ O
mellitus NN NN O
, , , O
hypertension NN NN O
, , , O
hyperlipidemia NN NN O
, , , O
and CC CC O
s/p NN NN O
CVA NNP NNP O
in IN IN O
2075 CD CD I-DATE
( ( ( O
subacute NN NN O
right NN NN O
medullary JJ JJ O
and CC CC O
pontine NN NN O
strokes NNS NNS O
secondary JJ JJ O
to TO TO O
extensive VB VB O
atherosclerotic JJ JJ O
disease NN NN O
of IN IN O
the DT DT O
right JJ JJ O
internal JJ JJ O
carotid NN NN O
artery NN NN O
) ) ) O
. . . O
   
He PRP PRP O
has VBZ VBZ O
been VBN VBN O
cared VBN VBN O
at IN IN O
home NN NN O
by IN IN O
his PRP$ PRP$ O
sister NN NN O
since IN IN O
his PRP$ PRP$ O
stroke NN NN O
last JJ JJ O
year NN NN O
and CC CC O
per IN IN O
his PRP$ PRP$ O
PCP&#8217; NNP NNP O
   
s VBZ VBZ O
notes NNS NNS O
earlier RBR RBR O
this DT DT O
year NN NN O
and CC CC O
per IN IN O
ED NNP NNP O
report NN NN O
his PRP$ PRP$ O
behavior NN NN O
and CC CC O
management NN NN O
has VBZ VBZ O
become VBN VBN O
steadily RB RB O
more RBR RBR O
difficult JJ JJ O
for IN IN O
his PRP$ PRP$ O
sister NN NN O
at IN IN O
home NN NN O
. . . O
   
Pt&#8217; NNP NNP O
   
s VBZ VBZ O
sister NN NN O
not RB RB O
with IN IN O
him PRP PRP O
on IN IN O
the DT DT O
floor NN NN O
however RB RB O
, , , O
per IN IN O
ED NNP NNP O
report NN NN O
pt NN NN O
supposedly RB RB O
found VBD VBD O
eating VBG VBG O
his PRP$ PRP$ O
own JJ JJ O
feces NNS NNS O
earlier RBR RBR O
and CC CC O
his PRP$ PRP$ O
sister NN NN O
expressing VBG VBG O
frustration NN NN O
and CC CC O
requesting VBG VBG O
a DT DT O
rehab NN NN O
placement NN NN O
for IN IN O
patient NN NN O
. . . O
   
Currently RB RB O
patient NN NN O
is VBZ VBZ O
alert NN NN O
an DT DT O
oriented JJ JJ O
x SYM SYM O
3 CD CD O
and CC CC O
while IN IN O
denying VBG VBG O
any DT DT O
issues NNS NNS O
or CC CC O
complaints NNS NNS O
does VBZ VBZ O
express VB VB O
understanding NN NN O
that IN IN O
he PRP PRP O
is VBZ VBZ O
admitted VBN VBN O
with IN IN O
goal NN NN O
of IN IN O
being VBG VBG O
placed VBN VBN O
at IN IN O
a DT DT O
NH NNP NNP O
or CC CC O
rehab NN NN O
place NN NN O
. . . O
   
He PRP PRP O
denies VBZ VBZ O
any DT DT O
CP NNP NNP O
, , , O
SOB NNP NNP O
, , , O
n/v NN NN O
, , , O
f/c NN NN O
, , , O
HA NNP NNP O
, , , O
change NN NN O
in IN IN O
vision NN NN O
, , , O
worsening VBG VBG O
numbness NN NN O
, , , O
tingling VBG VBG O
, , , O
or CC CC O
parasthesia NN NN O
. . . O
   
He PRP PRP O
does VBZ VBZ O
report NN NN O
decrease NN NN O
right-sided JJ JJ O
strength NN NN O
on IN IN O
his PRP$ PRP$ O
right JJ JJ O
side NN NN O
but CC CC O
reports NNS NNS O
improvement NN NN O
in IN IN O
strength NN NN O
since IN IN O
the DT DT O
CVA NNP NNP O
last JJ JJ O
year NN NN O
especially RB RB O
in IN IN O
the DT DT O
lower JJR JJR O
extremities NNS NNS O
. . . O
   
In IN IN O
ED NNP NNP O
CT NNP NNP O
of IN IN O
the DT DT O
head NN NN O
was VBD VBD O
performed VBN VBN O
and CC CC O
pt NN NN O
admitted VBN VBN O
for IN IN O
further JJ JJ O
w/u NN NN O
and CC CC O
possible JJ JJ O
placement NN NN O
. . . O
   
Past NNP NNP O
Medical NNP NNP O
History NN NN O
: : : O
HTN NNP NNP O
Hyperlipidemia NNP NNP O
seizure NN NN O
disorder NN NN O
? . . O
since IN IN O
childhood NN NN O
( ( ( O
no DT DT O
seizure NN NN O
since IN IN O
childhood NN NN O
) ) ) O
DM NNP NNP O
H/o NNP NNP O
head NN NN O
trauma NN NN O
13 CD CD O
years NNS NNS O
ago RB RB O
. . . O
   
Left NNP NNP O
subdural JJ JJ O
hematoma NN NN O
, , , O
right NN NN O
ventriculomegaly NN NN O
secondary JJ JJ O
to TO TO O
obstructive JJ JJ O
hydrocephalus NN NN O
, , , O
right NN NN O
cerebellar NN NN O
contusion NN NN O
s/p NN NN O
right JJ JJ O
suboccipital JJ JJ O
craniotomy NN NN O
mental JJ JJ O
retardation NN NN O
s/p NN NN O
CVA NNP NNP O
in IN IN O
Sep-2075 NNP NNP I-DATE
( ( ( O
subacute JJ JJ O
right JJ JJ O
medullary JJ JJ O
and CC CC O
pontine NN NN O
strokes NNS NNS O
extensive JJ JJ O
atherosclerotic JJ JJ O
disease NN NN O
of IN IN O
the DT DT O
right JJ JJ O
internal JJ JJ O
carotid NN NN O
artery NN NN O
Medications NNP NNP O
: : : O
( ( ( O
Per IN IN O
Dr NNP NNP O
. . . O
Kaufman&#8217; NNP NNP O
   
s VBZ VBZ O
note NN NN O
from IN IN O
July NNP NNP I-DATE
14 CD CD O
, , , O
2076 CD CD I-DATE
) ) ) O
Glucophage NNP NNP O
( ( ( O
METFORMIN NNP NNP O
) ) ) O
1000 CD CD O
MG NNP NNP O
( ( ( O
500MG CD CD O
TABLET NNP NNP O
take NN NN O
2 CD CD O
) ) ) O
PO NNP NNP O
BID NNP NNP O
Micronase NNP NNP O
( ( ( O
GLYBURIDE NNP NNP O
) ) ) O
5 CD CD O
MG NNP NNP O
( ( ( O
5MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
) ) ) O
PO NNP NNP O
QD NNP NNP O
x SYM SYM O
90 CD CD O
days NNS NNS O
Percocet NNP NNP O
5 CD CD O
MG/325 NNP NNP O
MG NNP NNP O
( ( ( O
OXYCODONE NNP NNP O
5 CD CD O
MG/ACETAMINOPHEN NNP NNP O
325 CD CD O
MG NNP NNP O
) ) ) O
1 CD CD O
TAB NNP NNP O
PO NNP NNP O
Q6H NNP NNP O
PRN NNP NNP O
pain NN NN O
Plavix NNP NNP O
( ( ( O
CLOPIDOGREL NNP NNP O
) ) ) O
75 CD CD O
MG NNP NNP O
( ( ( O
75MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
) ) ) O
PO NNP NNP O
QD NNP NNP O
x SYM SYM O
90 CD CD O
days NNS NNS O
Simvastatin NNP NNP O
40 CD CD O
MG NNP NNP O
( ( ( O
40MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
) ) ) O
PO NNP NNP O
QHS NNP NNP O
Tegretol NNP NNP O
( ( ( O
CARBAMAZEPINE NNP NNP O
) ) ) O
200MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
TID NNP NNP O
x SYM SYM O
30 CD CD O
days NNS NNS O
Allergies NNP NNP O
: : : O
Hydrocodone NNP NNP O
5 CD CD O
Mg NNP NNP O
+ NN NN O
Apap NNP NNP O
500mg CD CD O
- : : O
GI NNP NNP O
UPSET NNP NNP O
Family NNP NNP O
History NN NN O
: : : O
? . . O
Social NNP NNP O
History NN NN O
: : : O
legally RB RB O
blind JJ JJ O
, , , O
lives NNS NNS O
w NN NN O
/ NN NN O
sister NN NN O
Urquiza NNP NNP I-PATIENT
who WP WP O
is VBZ VBZ O
his PRP$ PRP$ O
care NN NN O
taker NN NN O
. . . O
   
Review NNP NNP O
of IN IN O
Systems NNPS NNPS O
: : : O
as IN IN O
noted VBN VBN O
above IN IN O
Physical JJ JJ O
Examination NNP NNP O
Vital NNP NNP O
Signs NNP NNP O
: : : O
T NN NN O
98.2 CD CD O
P NN NN O
77 CD CD O
BP NNP NNP O
146/74 CD CD O
RR NNP NNP O
20 CD CD O
O2 NNP NNP O
: : : O
97 CD CD O
% NN NN O
RA NNP NNP O
General NNP NNP O
: : : O
sleeping VBG VBG O
comfortably RB RB O
, , , O
NAD NNP NNP O
HEENT NNP NNP O
: : : O
PERRLA NNP NNP O
, , , O
EOMI NNP NNP O
, , , O
nystagmus NN NN O
on IN IN O
lateral NN NN O
gaze VBP VBP O
bilaterally RB RB O
, , , O
oral JJ JJ O
mucosa NN NN O
moist NN NN O
, , , O
conjunctiva NN NN O
clear JJ JJ O
Skin NNP NNP O
: : : O
no DT DT O
rash NN NN O
or CC CC O
ulcers NNS NNS O
on IN IN O
the DT DT O
trunk NN NN O
or CC CC O
extrmities NNS NNS O
Neck NNP NNP O
: : : O
supple NN NN O
with IN IN O
full JJ JJ O
ROM NNP NNP O
, , , O
no DT DT O
jvd NN NN O
Chest NN NN O
: : : O
CTA NNP NNP O
B NNP NNP O
Heart NNP NNP O
: : : O
RRR NNP NNP O
, , , O
no DT DT O
r/g/m NN NN O
Abdomen NNP NNP O
: : : O
s VBZ VBZ O
, , , O
nt NN NN O
, , , O
nd NN NN O
, , , O
+ NN NN O
BS NNP NNP O
Extremities NNP NNP O
: : : O
no DT DT O
c/c/e NN NN O
Neurological NNP NNP O
: : : O
CNII-XII NNP NNP O
grossly RB RB O
intact JJ JJ O
. . . O
   
Patient NNP NNP O
oriented VBD VBD O
to TO TO O
place VB VB O
and CC CC O
time NN NN O
and CC CC O
to TO TO O
person NN NN O
   
( ( ( O
president NN NN O
) ) ) O
with IN IN O
little JJ JJ O
help NN NN O
. . . O
   
About IN IN O
4/5 CD CD O
strength NN NN O
on IN IN O
the DT DT O
LUE NNP NNP O
, , , O
LLE NNP NNP O
, , , O
RLE NNP NNP O
. . . O
   
2-3/5 JJ JJ O
strength NN NN O
on IN IN O
the DT DT O
RUE NNP NNP O
. . . O
   
Diagnostic NNP NNP O
Studies NNPS NNPS O
: : : O
09/23/2076 CD CD I-DATE
NA NNP NNP O
139 CD CD O
, , , O
K NNP NNP O
4.0 CD CD O
, , , O
CL NNP NNP O
104 CD CD O
, , , O
CO2 NNP NNP O
26.3 CD CD O
, , , O
BUN NNP NNP O
15 CD CD O
, , , O
CRE NNP NNP O
0.9 CD CD O
, , , O
GLU NNP NNP O
199 CD CD O
( ( ( O
H NNP NNP O
) ) ) O
09/23/2076 CD CD I-DATE
WBC NNP NNP O
8.9 CD CD O
, , , O
RBC NNP NNP O
4.46 CD CD O
( ( ( O
L NNP NNP O
) ) ) O
, , , O
HGB NNP NNP O
14.4 CD CD O
, , , O
HCT NNP NNP O
38.6 CD CD O
( ( ( O
L NNP NNP O
) ) ) O
, , , O
MCV NNP NNP O
87 CD CD O
, , , O
MCH NNP NNP O
32.3 CD CD O
, , , O
MCHC NNP NNP O
37.4 CD CD O
( ( ( O
H NNP NNP O
) ) ) O
, , , O
PLT NNP NNP O
201 CD CD O
09/23/2076 CD CD I-DATE
RDW NNP NNP O
13.8 CD CD O
09/23/2076 CD CD I-DATE
PT NNP NNP O
11.8 CD CD O
, , , O
PT-INR NNP NNP O
1.0 CD CD O
, , , O
PTT NNP NNP O
24.0 CD CD O
09/23/2076 CD CD I-DATE
UA-COLOR NNP NNP O
Yellow NNP NNP O
, , , O
UA-APP NNP NNP O
Clear NNP NNP O
, , , O
UA-GLUC NNP NNP O
3 CD CD O
+ NN NN O
, , , O
UA-BILI NNP NNP O
NEGATIVE NNP NNP O
, , , O
UA-KET NNP NNP O
NEGATIVE NNP NNP O
, , , O
UA-SPGR NNP NNP O
1.020 CD CD O
, , , O
UA-BLD NNP NNP O
NEGATIVE NNP NNP O
, , , O
UA-PH NNP NNP O
6.0 CD CD O
09/23/2076 CD CD I-DATE
UA-PROT NNP NNP O
NEGATIVE NNP NNP O
, , , O
UA-UROBI NNP NNP O
NEGATIVE NNP NNP O
, , , O
UA-NIT NNP NNP O
NEGATIVE NNP NNP O
, , , O
UA-WBC NNP NNP O
NEGATIVE NNP NNP O
09/23/2076 CD CD I-DATE
TOX1 NNP NNP O
, , , O
TOX2 NNP NNP O
09/23/2076 CD CD I-DATE
UR-ACETOM NNP NNP O
NEGATIVE NNP NNP O
, , , O
UAMPH NNP NNP O
NEGATIVE NNP NNP O
, , , O
UBARB NNP NNP O
NEGATIVE NNP NNP O
, , , O
UBENZ NNP NNP O
NEGATIVE NNP NNP O
, , , O
URCOCA NNP NNP O
NEGATIVE NNP NNP O
, , , O
UMAMPH NNP NNP O
NEGATIVE NNP NNP O
, , , O
UMETHD NNP NNP O
NEGATIVE NNP NNP O
, , , O
UOPI NNP NNP O
NEGATIVE NNP NNP O
09/23/2076 CD CD I-DATE
URPCP NNP NNP O
NEGATIVE NNP NNP O
, , , O
UTHC NNP NNP O
NEGATIVE NNP NNP O
, , , O
TRC-UG NNP NNP O
POSITIVE NNP NNP O
CXR NNP NNP O
: : : O
IMPRESSION NNP NNP O
: : : O
Normal JJ JJ O
Chest NN NN O
. . . O
   
CT NNP NNP O
Head NNP NNP O
: : : O
IMPRESSION NNP NNP O
: : : O
   
1 CD CD O
. . . O
No DT DT O
acute JJ JJ O
intracranial JJ JJ O
hemorrhage NN NN O
. . . O
   
No DT DT O
focal JJ JJ O
soft JJ JJ O
tissue NN NN O
swelling VBG VBG O
. . . O
   
2 CD CD O
. . . O
Evidence NN NN O
of IN IN O
prior RB RB O
intracranial JJ JJ O
injury NN NN O
and CC CC O
surgery NN NN O
as IN IN O
described VBN VBN O
above IN IN O
, , , O
stable JJ JJ O
compared VBN VBN O
to TO TO O
prior RB RB O
study NN NN O
. . . O
   
3 CD CD O
. . . O
Stable JJ JJ O
mild JJ JJ O
opacification NN NN O
of IN IN O
the DT DT O
right NN NN O
mastoid NN NN O
air NN NN O
cells NNS NNS O
. . . O
   
Impression/Plan NNP NNP O
: : : O
63-year-old JJ JJ O
man NN NN O
with IN IN O
mental JJ JJ O
retardation NN NN O
, , , O
diabetes VBZ VBZ O
mellitus NN NN O
, , , O
hypertension NN NN O
, , , O
hyperlipidemia NN NN O
, , , O
and CC CC O
s/p NN NN O
CVA NNP NNP O
in IN IN O
2075 CD CD I-DATE
who WP WP O
has VBZ VBZ O
been VBN VBN O
taken VBN VBN O
care NN NN O
of IN IN O
by IN IN O
his PRP$ PRP$ O
sister NN NN O
. . . O
   
Steadily RB RB O
with IN IN O
worsening VBG VBG O
behavioral JJ JJ O
issues NNS NNS O
and CC CC O
more RBR RBR O
difficult JJ JJ O
to TO TO O
take VB VB O
care NN NN O
of IN IN O
by IN IN O
his PRP$ PRP$ O
sister NN NN O
. . . O
   
Head NNP NNP O
CT NNP NNP O
is VBZ VBZ O
negative JJ JJ O
for IN IN O
a DT DT O
new JJ JJ O
CVA NNP NNP O
and CC CC O
labs NNS NNS O
are VBP VBP O
grossly RB RB O
normal JJ JJ O
and CC CC O
not RB RB O
suggestive VB VB O
of IN IN O
any DT DT O
major JJ JJ O
metabolic JJ JJ O
imbalance NN NN O
. . . O
   
Patient NNP NNP O
also RB RB O
appears VBZ VBZ O
stable JJ JJ O
and CC CC O
NAD NNP NNP O
and CC CC O
fairly RB RB O
alert VB VB O
and CC CC O
oriented VBN VBN O
to TO TO O
the DT DT O
situation NN NN O
. . . O
   
He PRP PRP O
will MD MD O
likely JJ JJ O
benefit VB VB O
from IN IN O
a DT DT O
nursing VBG VBG O
home NN NN O
or CC CC O
rehab NN NN O
placement NN NN O
. . . O
   
- : : O
Continue VB VB O
with IN IN O
out IN IN O
patient NN NN O
medications NNS NNS O
- : : O
PT/OT NNP NNP O
consult NN NN O
- : : O
Social NNP NNP O
services NNS NNS O
consult NN NN O
- : : O
Regular NNP NNP O
diet JJ JJ O
- : : O
Diabetic NNP NNP O
diet NN NN O
- : : O
RISS NNP NNP O
and CC CC O
FS NNP NNP O
qid NN NN O
- : : O
Lovenox NNP NNP O
30 CD CD O
bid NN NN O
- : : O
Full NNP NNP O
Code NNP NNP O
______________ NN NN O
_ NN NN O
Tito NNP NNP I-DOCTOR
Quast NNP NNP I-DOCTOR
, , , O
MD NNP NNP O
Please VB VB O
page NN NN O
team NN NN O
4 CD CD O
with IN IN O
questions NNS NNS O
. . . O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2075-01-31 NN NN I-DATE
Narrative NNP NNP O
History NN NN O
Patient NNP NNP O
presents VBZ VBZ O
for IN IN O
an DT DT O
annual JJ JJ O
exam NN NN O
. . . O
   
Has VBZ VBZ O
been VBN VBN O
doing VBG VBG O
generally RB RB O
well RB RB O
, , , O
a DT DT O
bit NN NN O
stressed JJ JJ O
as IN IN O
another DT DT O
sister NN NN O
dx NN NN O
with IN IN O
breast NN NN O
CA NNP NNP O
last JJ JJ O
year NN NN O
. . . O
   
GYN NNP NNP O
- : : O
no DT DT O
vaginal JJ JJ O
bleeding NN NN O
, , , O
not RB RB O
sexually RB RB O
active JJ JJ O
. . . O
   
Exercise VB VB O
- : : O
none NN NN O
, , , O
Problems NNS NNS O
FH NNP NNP O
breast NN NN O
cancer NN NN O
: : : O
37 CD CD I-AGE
yo NN NN O
s VBZ VBZ O
- - - O
died JJ JJ O
41 CD CD I-AGE
, , , O
second JJ JJ O
sister NN NN O
dx JJ JJ O
age NN NN O
51 CD CD I-AGE
FH NNP NNP O
myocardial NN NN O
infarction NN NN O
: : : O
mother NN NN O
died VBD VBD O
66 CD CD I-AGE
yo NN NN O
Hypertension NNP NNP O
- : : O
high JJ JJ O
today NN NN O
- : : O
taking VBG VBG O
all DT DT O
her PRP$ PRP$ O
meds NNS NNS O
. . . O
   
Will MD MD O
start VB VB O
doing VBG VBG O
some DT DT O
exercise NN NN O
and CC CC O
trying VBG VBG O
to TO TO O
lose VB VB O
weight NN NN O
. . . O
   
Gets VBZ VBZ O
it PRP PRP O
checked VBD VBD O
at IN IN O
work NN NN O
and CC CC O
120-130/70 JJ JJ O
all PDT PDT O
the DT DT O
time NN NN O
by IN IN O
the DT DT O
nurse NN NN O
there RB RB O
. . . O
   
Was VBD VBD O
138/74 CD CD O
recently RB RB O
with IN IN O
Dr NNP NNP O
Koch NNP NNP I-DOCTOR
's POS POS O
who WP WP O
found VBD VBD O
that IN IN O
acceptable JJ JJ O
. . . O
   
Will NNP NNP O
check VB VB O
and CC CC O
chart VB VB O
it PRP PRP O
and CC CC O
if IN IN O
& CC CC O
gt NN NN O
; : : O
   
140 CD CD O
to TO TO O
rtc VB VB O
sooner RBR RBR O
Uterine NNP NNP O
fibroids NNS NNS O
: : : O
u/s NN NN O
2062 CD CD I-DATE
- : : O
not RB RB O
seen VBN VBN O
Dr NNP NNP O
Foust NNP NNP I-DOCTOR
since IN IN O
2066 CD CD I-DATE
when WRB WRB O
difficult JJ JJ O
to TO TO O
obtain VB VB O
her PRP$ PRP$ O
Pap NNP NNP O
smear NN NN O
. . . O
   
We PRP PRP O
were VBD VBD O
able JJ JJ O
to TO TO O
get VB VB O
it PRP PRP O
with IN IN O
difficulty NN NN O
in IN IN O
2070 CD CD I-DATE
Smoking NNP NNP O
: : : O
quit VBD VBD O
2/67 CD CD I-DATE
s/p NN NN O
MI NNP NNP O
- : : O
still RB RB O
not RB RB O
smoking NN NN O
! . . O
   
borderline NN NN O
diabetes NN NN O
mellitus NN NN O
: : : O
4/63 CD CD I-DATE
125 CD CD O
, , , O
follow VBP VBP O
hgbaic JJ JJ O
- : : O
was VBD VBD O
6.5/131 CD CD O
in IN IN O
12/70 CD CD I-DATE
, , , O
gradually RB RB O
rising VBG VBG O
, , , O
recheck NN NN O
glc NN NN O
and CC CC O
a1c NN NN O
today NN NN O
VPB NNP NNP O
: : : O
2065 CD CD I-DATE
- : : O
ETT NNP NNP O
showed VBD VBD O
freq NN NN O
PVC NNP NNP O
's POS POS O
, , , O
bigeminy NN NN O
and CC CC O
couplets NNS NNS O
, , , O
nondx NN NN O
for IN IN O
ischemia NN NN O
- - - O
denies NNS NNS O
palp NN NN O
or CC CC O
dizziness NN NN O
. . . O
   
Does VBZ VBZ O
occasionally RB RB O
feel VB VB O
a DT DT O
split NN NN O
second JJ JJ O
palpitation NN NN O
. . . O
   
Takes VBZ VBZ O
a DT DT O
deep JJ JJ O
breath NN NN O
and CC CC O
it PRP PRP O
goes VBZ VBZ O
away RB RB O
. . . O
   
No DT DT O
associated VBN VBN O
symptoms NNS NNS O
. . . O
   
Feels VBZ VBZ O
it PRP PRP O
rarely RB RB O
Coronary JJ JJ O
artery NN NN O
disease NN NN O
: : : O
s/p NN NN O
ant NN NN O
SEMI NNP NNP O
+ NN NN O
stent NN NN O
LAD NNP NNP O
2/67 CD CD I-DATE
, , , O
Dr NNP NNP O
Oakley NNP NNP I-DOCTOR
, , , O
ETT NNP NNP O
Clarkfield NNP NNP I-HOSPITAL
3/67 CD CD I-DATE
- : : O
neg NN NN O
scan VB VB O
for IN IN O
ischemia NN NN O
. . . O
   
No DT DT O
CP NNP NNP O
's POS POS O
, , , O
palp NN NN O
. . . O
   
Saw VBD VBD O
Dr NNP NNP O
Koch NNP NNP I-DOCTOR
1/75 CD CD I-DATE
who WP WP O
rec VBP VBP O
more RBR RBR O
aggressive JJ JJ O
cholesterol NN NN O
mgmt NN NN O
to TO TO O
LDL NNP NNP O
& CC CC O
lt NN NN O
; : : O
   
70 CD CD O
. . . O
Increased NNP NNP O
her PRP$ PRP$ O
lipitor NN NN O
to TO TO O
80 CD CD O
mg NN NN O
although IN IN O
she PRP PRP O
has VBZ VBZ O
n't RB RB O
done VBN VBN O
this DT DT O
yet RB RB O
. . . O
   
thyroid NN NN O
nodule NN NN O
: : : O
2065 CD CD I-DATE
, , , O
hot JJ JJ O
, , , O
follow VB VB O
TSH NNP NNP O
. . . O
   
TReated NNP NNP O
with IN IN O
RAI NNP NNP O
February NNP NNP I-DATE
2071 CD CD I-DATE
. . . O
   
Last NNP NNP O
TSH NNP NNP O
checked VBD VBD O
12/71 CD CD I-DATE
and CC CC O
was VBD VBD O
in IN IN O
the DT DT O
normal JJ JJ O
range NN NN O
. . . O
   
To TO TO O
see VB VB O
Dr NNP NNP O
. . . O
Dolan NNP NNP I-DOCTOR
q. NN NN O
   
year NN NN O
, , , O
although IN IN O
very RB RB O
overdue JJ JJ O
- : : O
still RB RB O
has VBZ VBZ O
n't RB RB O
gone VBN VBN O
. . . O
   
Will NNP NNP O
make VB VB O
an DT DT O
appt NN NN O
. . . O
   
Check NNP NNP O
TSH NNP NNP O
. . . O
   
Hyperlipidemia NNP NNP O
: : : O
CRF NNP NNP O
mild NN NN O
chol NN NN O
, , , O
cigs NNS NNS O
, , , O
HTN NNP NNP O
, , , O
Fhx NNP NNP O
and CC CC O
known VBN VBN O
hx NN NN O
CAD NNP NNP O
in IN IN O
pt NN NN O
. . . O
   
Will NNP NNP O
increase VB VB O
to TO TO O
80 CD CD O
mg NN NN O
of IN IN O
lipitor NN NN O
and CC CC O
then RB RB O
in IN IN O
1 CD CD O
month NN NN O
check NN NN O
lfts NNS NNS O
and CC CC O
cholesterol NN NN O
fasting VBG VBG O
at IN IN O
Moton NNP NNP I-HOSPITAL
Hospital NNP NNP I-HOSPITAL
. . . O
   
Will NNP NNP O
aim NN NN O
for IN IN O
LDL NNP NNP O
less JJR JJR O
than IN IN O
70 CD CD O
Medications NNP NNP O
Asa NNP NNP O
( ( ( O
ACETYLSALICYLIC NNP NNP O
ACID NNP NNP O
) ) ) O
325MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Nitroglycerin NNP NNP O
1/150 CD CD O
( ( ( O
0.4 CD CD O
MG NNP NNP O
) ) ) O
1 CD CD O
TAB NNP NNP O
SL NNP NNP O
x1 NN NN O
PRN NNP NNP O
prn NN NN O
CP NNP NNP O
Norvasc NNP NNP O
( ( ( O
AMLODIPINE NNP NNP O
) ) ) O
5MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Triamcinolone NNP NNP O
CREAM NNP NNP O
0.5 CD CD O
% NN NN O
( ( ( O
TRIAMCINOLONE NNP NNP O
ACETONIDE NNP NNP O
0.5 CD CD O
% NN NN O
) ) ) O
TOP JJ JJ O
BID NNP NNP O
PRN NNP NNP O
Lipitor NNP NNP O
( ( ( O
ATORVASTATIN NNP NNP O
) ) ) O
40MG CD CD O
TABLET NNP NNP O
PO NNP NNP O
QD NNP NNP O
Zestril NNP NNP O
( ( ( O
LISINOPRIL NNP NNP O
) ) ) O
40MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Atenolol NNP NNP O
50MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Hctz NNP NNP O
( ( ( O
HYDROCHLOROTHIAZIDE NNP NNP O
) ) ) O
25MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Allergies NNP NNP O
CEFACLOR NNP NNP O
- : : O
Rash NNP NNP O
, , , O
Family NNP NNP O
History NN NN O
father NN NN O
- : : O
HTN NNP NNP O
, , , O
died VBD VBD O
86 CD CD I-AGE
of IN IN O
gastric JJ JJ O
ca NN NN O
mother-HTN JJ JJ O
, , , O
MI NNP NNP O
at IN IN O
58 CD CD I-AGE
and CC CC O
62 CD CD I-AGE
- : : O
died VBD VBD O
then RB RB O
siblings-sister NN NN O
finally RB RB O
died VBD VBD O
from IN IN O
breast NN NN O
CA NNP NNP O
after IN IN O
4 CD CD O
year NN NN O
battle NN NN O
, , , O
dx NN NN O
age NN NN O
   
37 CD CD I-AGE
. . . O
2nd CD CD O
sister NN NN O
dx NN NN O
breast NN NN O
CA NNP NNP O
age NN NN O
51 CD CD I-AGE
- : : O
"""" '' '' O
aggressive JJ JJ O
- : : O
XRT NNP NNP O
and CC CC O
chemo NN NN O
. . . O
   
7 CD CD O
sisters NNS NNS O
- : : O
one CD CD O
with IN IN O
DM,and NNP NNP O
2 CD CD O
brothers NNS NNS O
- : : O
ok JJ JJ O
No DT DT O
change NN NN O
since IN IN O
previous JJ JJ O
annual JJ JJ O
. . . O
   
Social NNP NNP O
History NN NN O
working VBG VBG O
for IN IN O
Convergys NNP NNP I-ORGANIZATION
as IN IN O
Sculptor NNP NNP I-PROFESSION
, , , O
widowed VBN VBN O
2070 CD CD I-DATE
, , , O
one CD CD O
son NN NN O
- : : O
30 CD CD I-AGE
yo NN NN O
Insurance NNP NNP I-PROFESSION
Agent NNP NNP I-PROFESSION
Review NNP NNP O
of IN IN O
Systems NNPS NNPS O
The DT DT O
following VBG VBG O
systems NNS NNS O
were VBD VBD O
reviewed VBN VBN O
today NN NN O
and CC CC O
were VBD VBD O
negative JJ JJ O
unless IN IN O
indicated VBD VBD O
otherwise RB RB O
in IN IN O
the DT DT O
history NN NN O
noted VBD VBD O
above IN IN O
: : : O
Constitutional NNP NNP O
, , , O
HEENT NNP NNP O
, , , O
Breast,CVS NNP NNP O
, , , O
GI NNP NNP O
, , , O
GYN NNP NNP O
, , , O
Skin NNP NNP O
, , , O
Musculoskeletal NNP NNP O
, , , O
Neuro NNP NNP O
, , , O
Psych NNP NNP O
, , , O
Respiratory NNP NNP O
, , , O
and CC CC O
Allergic NNP NNP O
Physical JJ JJ O
Exam NNP NNP O
Vital NNP NNP O
Signs NNP NNP O
BP NNP NNP O
148/66 CD CD O
, , , O
P NN NN O
68 CD CD O
, , , O
Ht NNP NNP O
64 CD CD O
in IN IN O
, , , O
Wt NNP NNP O
233 CD CD O
lb NN NN O
- : : O
up RP RP O
9 CD CD O
lbs NN NN O
O2 NNP NNP O
SAT NNP NNP O
97 CD CD O
BMI NNP NNP O
40.1 CD CD O
General NNP NNP O
: : : O
appears VBZ VBZ O
well RB RB O
HEENT NNP NNP O
: : : O
EOMI NNP NNP O
, , , O
PERRL NNP NNP O
, , , O
OP NNP NNP O
normal JJ JJ O
Skin NNP NNP O
: : : O
no DT DT O
suspicious JJ JJ O
lesions NNS NNS O
Neck NNP NNP O
: : : O
no DT DT O
thyromegaly NN NN O
, , , O
no DT DT O
bruits NNS NNS O
Nodes NNS NNS O
: : : O
no DT DT O
cervical JJ JJ O
, , , O
axillary JJ JJ O
, , , O
or CC CC O
supraclavicular JJ JJ O
lymphadenopathy JJ JJ O
Breasts NNP NNP O
- : : O
no DT DT O
nipple NN NN O
discharge NN NN O
or CC CC O
retraction NN NN O
, , , O
no DT DT O
dominant JJ JJ O
masses NNS NNS O
Chest NN NN O
: : : O
clear JJ JJ O
to TO TO O
auscultation NN NN O
, , , O
no DT DT O
rhonchi NN NN O
or CC CC O
wheeze NN NN O
COR NNP NNP O
: : : O
regular JJ JJ O
S1 NNP NNP O
, , , O
S2 NNP NNP O
, , , O
no DT DT O
murmurs NNS NNS O
, , , O
rubs NNS NNS O
or CC CC O
gallops NNS NNS O
Abd NNP NNP O
: : : O
soft JJ JJ O
, , , O
NT NNP NNP O
, , , O
no DT DT O
HSM NNP NNP O
or CC CC O
masses NNS NNS O
Pelvic NNP NNP O
- : : O
spent NN NN O
10 CD CD O
min NN NN O
attempting VBG VBG O
to TO TO O
do VB VB O
Pap NNP NNP O
smear VB VB O
- - - O
cervix NN NN O
is VBZ VBZ O
located VBN VBN O
very RB RB O
high JJ JJ O
and CC CC O
ant NN NN O
, , , O
ca MD MD O
n't RB RB O
get VB VB O
speculum NN NN O
in IN IN O
place NN NN O
to TO TO O
get VB VB O
it PRP PRP O
tried VBD VBD O
multiple JJ JJ O
different JJ JJ O
speculums NNS NNS O
. . . O
   
Otherwise RB RB O
, , , O
no DT DT O
tenderness NN NN O
palpated JJ JJ O
, , , O
normal JJ JJ O
vulva NN NN O
and CC CC O
vagina NN NN O
. . . O
   
Musculoskeletal NNP NNP O
: : : O
no DT DT O
erythema NN NN O
, , , O
swelling VBG VBG O
, , , O
or CC CC O
tenderness NN NN O
No DT DT O
back NN NN O
tend VBP VBP O
to TO TO O
palp VB VB O
, , , O
from IN IN O
, , , O
from IN IN O
of IN IN O
the DT DT O
left VBN VBN O
hip NN NN O
joint NN NN O
Ext NNP NNP O
: : : O
no DT DT O
CCE NNP NNP O
, , , O
Neuro NNP NNP O
: : : O
grossly RB RB O
non-focal JJ JJ O
Health NNP NNP O
Maintenance NNP NNP O
Chlamydia NNP NNP O
03/09/62 CD CD I-DATE
NEGATIVE NNP NNP O
. . . O
   
Cholesterol-HDL NNP NNP O
03/05/2074 CD CD I-DATE
52 CD CD O
Cholesterol-LDL NNP NNP O
03/05/2074 CD CD I-DATE
93 CD CD O
ATP NNP NNP O
III NNP NNP O
Classification NNP NNP O
of IN IN O
LDL NNP NNP O
Cholesterol NNP NNP O
( ( ( O
mg/dl NN NN O
) ) ) O
: : : O
& CC CC O
lt NN NN O
; : : O
   
100 CD CD O
Optimal NNP NNP O
100-129 JJ JJ O
Near NNP NNP O
Optimal/Above NNP NNP O
Optimal NNP NNP O
130-159 JJ JJ O
Borderline NNP NNP O
High NNP NNP O
160-189 JJ JJ O
High NNP NNP O
= SYM SYM O
or CC CC O
& CC CC O
gt NN NN O
; : : O
   
190 CD CD O
Very RB RB O
High NNP NNP O
Cholesterol NNP NNP O
03/05/2074 CD CD I-DATE
155 CD CD O
Colonoscopy NNP NNP O
06/04/2071 CD CD I-DATE
see VB VB O
report NN NN O
in IN IN O
Results NNS NNS O
GFR NNP NNP O
   
( ( ( O
estimated VBN VBN O
) ) ) O
03/05/2074 CD CD I-DATE
77.2 CD CD O
Units NNP NNP O
: : : O
ml/min/1.73msq NN NN O
HbA1c NNP NNP O
03/05/2074 CD CD I-DATE
6.6 CD CD O
Hct NNP NNP O
( ( ( O
Hematocrit NNP NNP O
) ) ) O
04/27/2072 CD CD I-DATE
40.7 CD CD O
Hgb NNP NNP O
( ( ( O
Hemoglobin NNP NNP O
) ) ) O
04/27/2072 CD CD I-DATE
13.1 CD CD O
Influenza NNP NNP O
Vaccine NNP NNP O
11/29/2067 CD CD I-DATE
Mammogram NNP NNP O
02/10/2074 CD CD I-DATE
see VB VB O
report NN NN O
in IN IN O
Results NNS NNS O
Pap NNP NNP O
Smear NNP NNP O
12/16/2070 CD CD I-DATE
see VB VB O
report NN NN O
in IN IN O
Results NNS NNS O
Td NNP NNP O
Booster NNP NNP O
12/16/2070 CD CD I-DATE
Triglycerides NNP NNP O
03/05/2074 CD CD I-DATE
51 CD CD I-AGE
Normal NNP NNP O
: : : O
& CC CC O
lt NN NN O
; : : O
   
150 CD CD O
mg/dl NN NN O
Borderline NNP NNP O
High NNP NNP O
: : : O
150-199 NN NN O
mg/dl NN NN O
High NNP NNP O
: : : O
200-499 NN NN O
mg/dl NN NN O
Very NNP NNP O
high JJ JJ O
: : : O
& CC CC O
gt NN NN O
; : : O
   
or CC CC O
= SYM SYM O
500 CD CD O
mg/dl NN NN O
TSH NNP NNP O
03/05/2074 CD CD I-DATE
2.297 CD CD O
UA-Protein NNP NNP O
03/12/2066 CD CD I-DATE
NEGATIVE NNP NNP O
Urine NNP NNP O
Culture NNP NNP O
03/12/2066 CD CD I-DATE
see VB VB O
report NN NN O
in IN IN O
Results NNS NNS O
Assessment NNP NNP O
and CC CC O
Plan NNP NNP O
   
1 CD CD O
. . . O
Health NNP NNP O
Maintenance NNP NNP O
- : : O
Pap NNP NNP O
smear NN NN O
-- : : O
unable JJ JJ O
to TO TO O
get VB VB O
this DT DT O
time NN NN O
again RB RB O
, , , O
was VBD VBD O
able JJ JJ O
to TO TO O
do VB VB O
it PRP PRP O
2070 CD CD I-DATE
, , , O
will MD MD O
send VB VB O
back RB RB O
to TO TO O
gyn NN NN O
. . . O
   
mammo NN NN O
- : : O
to TO TO O
sched VB VB O
, , , O
colonoscopy NN NN O
fine NN NN O
2071 CD CD I-DATE
- : : O
repeat NN NN O
2081 CD CD I-DATE
. . . O
   
To TO TO O
increase VB VB O
exercise NN NN O
. . . O
   
2 CD CD O
. . . O
Menopause NNP NNP O
- : : O
calcium NN NN O
, , , O
vitamin NN NN O
d SYM SYM O
discussed VBD VBD O
- : : O
was VBD VBD O
11 CD CD I-DATE
2074 CD CD I-DATE
when WRB WRB O
not RB RB O
taking VBG VBG O
any DT DT O
supplements NNS NNS O
, , , O
repleted VBN VBN O
, , , O
then RB RB O
maintenance NN NN O
recommended VBD VBD O
, , , O
did VBD VBD O
take VB VB O
it PRP PRP O
for IN IN O
awhile RB RB O
then RB RB O
stopped VBD VBD O
months NNS NNS O
ago RB RB O
, , , O
will MD MD O
restart VB VB O
and CC CC O
will MD MD O
check VB VB O
level NN NN O
in IN IN O
a DT DT O
month.Consider NN NN O
BD NNP NNP O
when WRB WRB O
not RB RB O
overwhelmed VBN VBN O
with IN IN O
everything NN NN O
else RB RB O
   
3 CD CD O
. . . O
Sleep NNP NNP O
, , , O
stress NN NN O
- : : O
seems VBZ VBZ O
to TO TO O
be VB VB O
doing VBG VBG O
generally RB RB O
better JJR JJR O
now RB RB O
. . . O
   
4 CD CD O
sugar NN NN O
- : : O
mildly RB RB O
elevated VBD VBD O
, , , O
recheck NN NN O
A1c NNP NNP O
5 CD CD O
Lower JJR JJR O
lumbar NN NN O
pain NN NN O
- : : O
indicates VBZ VBZ O
discomfort NN NN O
in IN IN O
left VBD VBD O
lower JJR JJR O
lumbar NN NN O
area NN NN O
when WRB WRB O
getting VBG VBG O
out IN IN O
of IN IN O
a DT DT O
chair NN NN O
only RB RB O
for IN IN O
the DT DT O
last JJ JJ O
week NN NN O
. . . O
   
Seems VBZ VBZ O
consistent JJ JJ O
with IN IN O
a DT DT O
muscular JJ JJ O
strain NN NN O
, , , O
hip NN NN O
seems VBZ VBZ O
ok JJ JJ O
. . . O
   
RTC NNP NNP O
if IN IN O
symptoms NNS NNS O
worsen,change NN NN O
or CC CC O
persist NN NN O
for IN IN O
further JJ JJ O
evaluation NN NN O
. . . O
   
Rest NNP NNP O
of IN IN O
issues NNS NNS O
- - - O
see VB VB O
above IN IN O
. . . O
   
Meds NNP NNP O
refilled JJ JJ O
. . . O
   
Will MD MD O
have VB VB O
fasting VBG VBG O
labs NNS NNS O
at IN IN O
Moton NNP NNP I-HOSPITAL
Hospital NNP NNP I-HOSPITAL
in IN IN O
1 CD CD O
month NN NN O
, , , O
sched VBD VBD O
appt NN NN O
with IN IN O
Dr NNP NNP O
Dolan NNP NNP I-DOCTOR
and CC CC O
gyn NN NN O
. . . O
   
follow-up JJ JJ O
6 CD CD O
months NNS NNS O
Beverly NNP NNP I-DOCTOR
Thiel NNP NNP I-DOCTOR
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2089-06-30 JJ JJ I-DATE
CARDIOLOGY NNP NNP O
NORTHERN NNP NNP I-HOSPITAL
STATE NNP NNP I-HOSPITAL
HOSPITAL NNP NNP I-HOSPITAL
Interval NNP NNP O
History NN NN O
: : : O
Ms NNP NNP O
. . . O
Kong NNP NNP I-PATIENT
presents VBZ VBZ O
to TO TO O
follow-up JJ JJ O
her PRP$ PRP$ O
recent JJ JJ O
hospitalizations NNS NNS O
. . . O
   
Briefly NNP NNP O
, , , O
she PRP PRP O
was VBD VBD O
admitted VBN VBN O
in IN IN O
early JJ JJ O
April NNP NNP I-DATE
with IN IN O
Group NNP NNP O
B NNP NNP O
strep NN NN O
bacteremia NN NN O
and CC CC O
AoV NNP NNP O
endocarditis NNS NNS O
with IN IN O
mod NN NN O
to TO TO O
severe JJ JJ O
AI NNP NNP O
. . . O
   
The DT DT O
source NN NN O
of IN IN O
GBS NNP NNP O
bacteremia NN NN O
remains VBZ VBZ O
unclear JJ JJ O
although IN IN O
she PRP PRP O
had VBD VBD O
an DT DT O
episode NN NN O
of IN IN O
shingles NNS NNS O
a DT DT O
few JJ JJ O
weeks NNS NNS O
prior RB RB O
and CC CC O
may MD MD O
have VB VB O
caused VBN VBN O
a DT DT O
cutaneous JJ JJ O
innoculation NN NN O
. . . O
   
Pre-op NNP NNP O
angiogram NN NN O
showed VBD VBD O
no DT DT O
significant JJ JJ O
CAD NNP NNP O
. . . O
   
On IN IN O
4/5/89 CD CD I-DATE
she PRP PRP O
underwent JJ JJ O
composite JJ JJ O
aortic JJ JJ O
root NN NN O
replacement NN NN O
with IN IN O
a DT DT O
20mm CD CD O
life NN NN O
net JJ JJ O
aortic JJ JJ O
homograft NN NN O
by IN IN O
Dr NNP NNP O
. . . O
Jerome NNP NNP I-DOCTOR
. . . O
   
Due JJ JJ O
to TO TO O
heavily RB RB O
calcified VBN VBN O
RCA NNP NNP O
ostium NN NN O
, , , O
a DT DT O
button NN NN O
for IN IN O
re-implantation JJ JJ O
could MD MD O
n't RB RB O
be VB VB O
created VBN VBN O
so IN IN O
she PRP PRP O
recieved VBD VBD O
a DT DT O
single JJ JJ O
vessel NN NN O
SVG NNP NNP O
to TO TO O
prox VB VB O
RCA NNP NNP O
. . . O
   
Post NNP NNP O
op JJ JJ O
course NN NN O
was VBD VBD O
complicated VBN VBN O
by IN IN O
afib NN NN O
with IN IN O
high JJ JJ O
grade NN NN O
AV NNP NNP O
block NN NN O
for IN IN O
which WDT WDT O
she PRP PRP O
recieved VBD VBD O
a DT DT O
dual JJ JJ O
chamber NN NN O
PPM NNP NNP O
. . . O
   
She PRP PRP O
was VBD VBD O
discharged VBN VBN O
to TO TO O
rehab VB VB O
with IN IN O
a DT DT O
PICC NNP NNP O
to TO TO O
complete VB VB O
a DT DT O
course NN NN O
of IN IN O
IV NNP NNP O
PCN NNP NNP O
. . . O
   
However RB RB O
, , , O
she PRP PRP O
was VBD VBD O
re-admitted JJ JJ O
in IN IN O
early JJ JJ O
May NNP NNP I-DATE
while IN IN O
still RB RB O
at IN IN O
rehab NN NN O
with IN IN O
an DT DT O
episode NN NN O
of IN IN O
chest NN NN O
pain NN NN O
at IN IN O
rest NN NN O
. . . O
   
ECG NNP NNP O
was VBD VBD O
paced VBN VBN O
but CC CC O
biomarkers NNS NNS O
were VBD VBD O
mildly RB RB O
positive JJ JJ O
( ( ( O
troponin NN NN O
~ NN NN O
0.5 CD CD O
) ) ) O
. . . O
   
TTE NNP NNP O
showed VBD VBD O
the DT DT O
valve NN NN O
was VBD VBD O
well RB RB O
seated VBN VBN O
without IN IN O
suggestion NN NN O
of IN IN O
recurrent JJ JJ O
endocarditis NNS NNS O
. . . O
   
There EX EX O
was VBD VBD O
a DT DT O
new JJ JJ O
apical JJ JJ O
WMA NNP NNP O
. . . O
   
She PRP PRP O
underwent JJ JJ O
cath IN IN O
which WDT WDT O
showed VBD VBD O
patent NN NN O
BPG NNP NNP O
and CC CC O
no DT DT O
significant JJ JJ O
CAD NNP NNP O
. . . O
   
The DT DT O
episode NN NN O
was VBD VBD O
attributed VBN VBN O
to TO TO O
embolic JJ JJ O
phenomenon NN NN O
(? NN NN O
   
from IN IN O
afib NN NN O
, , , O
INR NNP NNP O
1.5 CD CD O
on IN IN O
admission NN NN O
) ) ) O
. . . O
   
She PRP PRP O
was VBD VBD O
discharged VBN VBN O
back RB RB O
to TO TO O
rehab NN NN O
and CC CC O
has VBZ VBZ O
done VBN VBN O
well RB RB O
since IN IN O
. . . O
   
She PRP PRP O
was VBD VBD O
seen VBN VBN O
in IN IN O
the DT DT O
ID NNP NNP O
clinic NN NN O
and CC CC O
the DT DT O
PICC NNP NNP O
line NN NN O
was VBD VBD O
pulled VBN VBN O
. . . O
   
She PRP PRP O
's VBZ VBZ O
back RB RB O
home NN NN O
from IN IN O
rehab NN NN O
now RB RB O
and CC CC O
seems VBZ VBZ O
to TO TO O
be VB VB O
fairly RB RB O
well RB RB O
. . . O
   
She PRP PRP O
gets VBZ VBZ O
fatigued VBN VBN O
easily RB RB O
and CC CC O
has VBZ VBZ O
to TO TO O
rest VB VB O
after IN IN O
walking VBG VBG O
about IN IN O
a DT DT O
100 CD CD O
yards NNS NNS O
. . . O
   
However RB RB O
, , , O
she PRP PRP O
denies VBZ VBZ O
CP NNP NNP O
, , , O
SOB NNP NNP O
, , , O
palpitations NNS NNS O
, , , O
presyncope NN NN O
or CC CC O
focal JJ JJ O
neurologic JJ JJ O
deficits NNS NNS O
. . . O
   
No DT DT O
F/C NNP NNP O
or CC CC O
weight NN NN O
loss NN NN O
. . . O
   
She PRP PRP O
has VBZ VBZ O
a DT DT O
long JJ JJ O
history NN NN O
of IN IN O
bilateral JJ JJ O
calf NN NN O
caludication NN NN O
but CC CC O
she PRP PRP O
is VBZ VBZ O
n't RB RB O
exerting VBG VBG O
herself PRP PRP O
enough RB RB O
to TO TO O
elicit NN NN O
symptoms NNS NNS O
. . . O
While IN IN O
at IN IN O
rehab NN NN O
, , , O
she PRP PRP O
was VBD VBD O
sleeping VBG VBG O
on IN IN O
4 CD CD O
pillows NNS NNS O
and CC CC O
would MD MD O
develop VB VB O
orthopnea NN NN O
if IN IN O
sleeping VBG VBG O
flat JJ JJ O
. . . O
Now RB RB O
she PRP PRP O
's VBZ VBZ O
sleeping VBG VBG O
on IN IN O
2 CD CD O
pillows NNS NNS O
for IN IN O
comfort NN NN O
and CC CC O
does VBZ VBZ O
n't RB RB O
seem VB VB O
to TO TO O
have VB VB O
anymore RB RB O
orthopnea NN NN O
. . . O
However RB RB O
, , , O
she PRP PRP O
does VBZ VBZ O
experience NN NN O
what WP WP O
sounds VBZ VBZ O
like IN IN O
PND NNP NNP O
a DT DT O
couple NN NN O
of IN IN O
times NNS NNS O
per IN IN O
week NN NN O
. . . O
She PRP PRP O
denies VBZ VBZ O
LE NNP NNP O
edema NN NN O
. . . O
She PRP PRP O
's VBZ VBZ O
tolerating VBG VBG O
all DT DT O
medications NNS NNS O
well RB RB O
. . . O
   
Home NNP NNP O
BS NNP NNP O
checks NNS NNS O
have VBP VBP O
been VBN VBN O
running VBG VBG O
90-130 CD CD O
. . . O
   
Past NNP NNP O
medical JJ JJ O
history NN NN O
: : : O
- : : O
GBS NNP NNP O
AoV NNP NNP O
endocarditis NN NN O
s/p NN NN O
aortic JJ JJ O
root NN NN O
replacement NN NN O
with IN IN O
20mm CD CD O
homograft NN NN O
- : : O
PAF/SSS NNP NNP O
s/p NN NN O
dual JJ JJ O
chamber NN NN O
PPM NNP NNP O
- : : O
PVD NNP NNP O
: : : O
-> : : O
s/p JJ JJ O
R NNP NNP O
CEA NNP NNP O
; : : O
   
CNIs NNP NNP O
( ( ( O
4/89 CD CD I-DATE
) ) ) O
mod NN NN O
50-69 CD CD O
% NN NN O
R NN NN O
ICA NNP NNP O
( ( ( O
peak NN NN O
vel NN NN O
~250cm/s), NN NN O
mild JJ JJ O
L NNP NNP O
ICA NNP NNP O
stenosis NN NN O
-> : : O
long JJ JJ O
history NN NN O
of IN IN O
bilateral JJ JJ O
calf NN NN O
claudication NN NN O
after IN IN O
10-15 JJ JJ O
mins NNS NNS O
ambulation NN NN O
; : : O
   
improved VBN VBN O
on IN IN O
pletal JJ JJ O
- : : O
patent NN NN O
foramen NNS NNS O
ovale JJ JJ O
- : : O
DM2 NNP NNP O
- : : O
breast NN NN O
CA NNP NNP O
s/p NN NN O
bilateral JJ JJ O
mastectomies NNS NNS O
; : : O
   
on IN IN O
letrozole NN NN O
- : : O
back RB RB O
surgery NN NN O
with IN IN O
rod NN NN O
placement NN NN O
at IN IN O
MSHMC NNP NNP I-HOSPITAL
2088 CD CD I-DATE
- : : O
GERD NNP NNP O
Medications NNP NNP O
( ( ( O
Confirmed NNP NNP O
) ) ) O
: : : O
Advair NNP NNP O
250/50mcg CD CD O
spray NN NN O
inh NN NN O
bid NN NN O
amiodarone NN NN O
200mg CD CD O
po NN NN O
daily JJ JJ O
aspirin NN NN O
325 CD CD O
mg NN NN O
po NN NN O
daily JJ JJ O
Combivent NNP NNP O
120/21mcg/spray CD CD O
inh NN NN O
qid NN NN O
Coumadin NNP NNP O
Femara NNP NNP O
2.5mg CD CD O
QD NNP NNP O
Lipitor NNP NNP O
20mg CD CD O
po NN NN O
daily JJ JJ O
Lopressor NNP NNP O
25mg CD CD O
po NN NN O
bid NN NN O
metformin NN NN O
hydrochloride NN NN O
500 CD CD O
mg NN NN O
po NN NN O
daily JJ JJ O
ophthalmic JJ JJ O
pilocarpine NN NN O
solution NN NN O
0.5 CD CD O
% NN NN O
QID NNP NNP O
Os NNP NNP O
cal JJ JJ O
500mg/125 CD CD O
units NNS NNS O
po NN NN O
bid NN NN O
Pletal NNP NNP O
100mg CD CD O
PO NNP NNP O
BID NNP NNP O
Prilosec NNP NNP O
40mg CD CD O
po NN NN O
BID NNP NNP O
Zantac NNP NNP O
300mg CD CD O
po NN NN O
at IN IN O
bedtime NN NN O
Allergies NNP NNP O
: : : O
No DT DT O
known VBN VBN O
drug NN NN O
allergy NN NN O
Social NNP NNP O
history NN NN O
: : : O
Retired NNP NNP O
Welder NNP NNP I-PROFESSION
, , , O
widowed VBN VBN O
, , , O
lives NNS NNS O
alone RB RB O
, , , O
2 CD CD O
children NNS NNS O
Tob NNP NNP O
- : : O
former JJ JJ O
1 CD CD O
ppd NN NN O
x SYM SYM O
30 CD CD O
yrs NNS NNS O
, , , O
quit NN NN O
2079 CD CD I-DATE
EtOH NNP NNP O
- - - O
rare JJ JJ O
Drugs NNS NNS O
- : : O
none NN NN O
Review NNP NNP O
of IN IN O
systems NNS NNS O
: : : O
otherwise RB RB O
negative JJ JJ O
in IN IN O
detail NN NN O
Physical JJ JJ O
examination NN NN O
: : : O
- : : O
BP NNP NNP O
: : : O
98/66 CD CD O
left VBN VBN O
arm NN NN O
- - - O
Pulse NNP NNP O
: : : O
70s CD CD O
regular JJ JJ O
- - - O
weight NN NN O
: : : O
123 CD CD O
lbs NN NN O
. . . O
   
- - - O
General NNP NNP O
appearance NN NN O
: : : O
well RB RB O
appearing VBG VBG O
- - - O
Skin NNP NNP O
: : : O
well RB RB O
healing VBG VBG O
mid-line JJ JJ O
sternotomy NN NN O
, , , O
pacer NN NN O
pocker NN NN O
C/D/I NNP NNP O
- : : O
Neck NNP NNP O
: : : O
carotids NNS NNS O
2 CD CD O
+ NN NN O
, , , O
soft JJ JJ O
R>L NNP NNP O
bruits NNS NNS O
, , , O
JVP<7cm NNP NNP O
- - - O
Chest NN NN O
: : : O
decreased VBN VBN O
BS NNP NNP O
at IN IN O
bases NNS NNS O
, , , O
o/w NN NN O
clear JJ JJ O
- - - O
Cardiac NNP NNP O
: : : O
RRR NNP NNP O
, , , O
I/VI NNP NNP O
early JJ JJ O
sys NN NN O
M NNP NNP O
at IN IN O
RUSB NNP NNP O
, , , O
no DT DT O
R/G NNP NNP O
- - - O
Abdomen NNP NNP O
: : : O
soft JJ JJ O
, , , O
NT NNP NNP O
, , , O
pos NNS NNS O
BS NNP NNP O
- : : O
Extremities NNP NNP O
: : : O
trace VB VB O
symmetric JJ JJ O
LE NNP NNP O
edema NN NN O
Procedures NNP NNP O
: : : O
Transthoracic NNP NNP O
echocardiogram NN NN O
STATUS NNP NNP O
POST NNP NNP O
EF NNP NNP O
56 CD CD O
% NN NN O
, , , O
well RB RB O
seated VBN VBN O
AoV NNP NNP O
bioprosthesis NN NN O
( ( ( O
peak NN NN O
12 CD CD O
, , , O
mean NN NN O
6 CD CD O
) ) ) O
, , , O
apical JJ JJ O
WMA NNP NNP O
, , , O
normal JJ JJ O
RV NNP NNP O
fxn NN NN O
, , , O
L->R NNP NNP O
shunting VBG VBG O
by IN IN O
Doppler NNP NNP O
c/w NN NN O
PFO NNP NNP O
EKG NNP NNP O
: : : O
A-V NNP NNP O
sequentially RB RB O
paced VBN VBN O
at IN IN O
70 CD CD O
Impression NNP NNP O
: : : O
Overall NNP NNP O
, , , O
Ms NNP NNP O
. . . O
Kong NNP NNP I-PATIENT
seems VBZ VBZ O
to TO TO O
be VB VB O
recovering VBG VBG O
quite RB RB O
well RB RB O
after IN IN O
a DT DT O
difficult JJ JJ O
couple NN NN O
of IN IN O
months NNS NNS O
. . . O
   
Her PRP$ PRP$ O
exercise NN NN O
tolerance NN NN O
is VBZ VBZ O
fairly RB RB O
poor JJ JJ O
, , , O
likely JJ JJ O
reflecting NN NN O
deconditioning VBG VBG O
. . . O
   
To TO TO O
that DT DT O
end NN NN O
, , , O
I PRP PRP O
've VBP VBP O
referred VBN VBN O
her PRP PRP O
to TO TO O
the DT DT O
cardiac NN NN O
rehab NN NN O
program NN NN O
at IN IN O
Glenbeigh NNP NNP I-HOSPITAL
Hospital NNP NNP I-HOSPITAL
( ( ( O
closer JJR JJR O
to TO TO O
home NN NN O
) ) ) O
. . . O
   
She PRP PRP O
has VBZ VBZ O
occasional JJ JJ O
episodes NNS NNS O
of IN IN O
possible JJ JJ O
PND NNP NNP O
but CC CC O
no DT DT O
other JJ JJ O
evidence NN NN O
of IN IN O
volume NN NN O
overload NN NN O
on IN IN O
exam NN NN O
. . . O
   
If IN IN O
her PRP$ PRP$ O
symptoms NNS NNS O
persist NN NN O
, , , O
I PRP PRP O
've VBP VBP O
asked VBN VBN O
her PRP PRP O
to TO TO O
notify VB VB O
me PRP PRP O
and CC CC O
we PRP PRP O
'll MD MD O
try VB VB O
a DT DT O
low JJ JJ O
dose NN NN O
of IN IN O
lasix NN NN O
. . . O
In IN IN O
terms NNS NNS O
of IN IN O
rhythm NN NN O
issues NNS NNS O
, , , O
she PRP PRP O
is VBZ VBZ O
now RB RB O
completely RB RB O
paced VBN VBN O
. . . O
She PRP PRP O
probably RB RB O
does VBZ VBZ O
n't RB RB O
need VB VB O
amio NN NN O
anymore RB RB O
so IN IN O
we PRP PRP O
'll MD MD O
stop VB VB O
it PRP PRP O
today NN NN O
. . . O
In IN IN O
terms NNS NNS O
of IN IN O
coumadin NN NN O
, , , O
it PRP PRP O
's VBZ VBZ O
probably RB RB O
reasonable JJ JJ O
to TO TO O
continue VB VB O
for IN IN O
3 CD CD O
months NNS NNS O
following VBG VBG O
valve NN NN O
replacement NN NN O
. . . O
She PRP PRP O
's VBZ VBZ O
due JJ JJ O
to TO TO O
see VB VB O
Dr NNP NNP O
. . . O
Jerome NNP NNP I-DOCTOR
next JJ JJ O
month NN NN O
; : : O
   
we PRP PRP O
'll MD MD O
defer VB VB O
to TO TO O
him PRP PRP O
in IN IN O
terms NNS NNS O
of IN IN O
the DT DT O
duration NN NN O
of IN IN O
post-op JJ JJ O
anti-coagulation NN NN O
from IN IN O
a DT DT O
bioprosthetic JJ JJ O
valve NN NN O
perspective NN NN O
. . . O
   
With IN IN O
regard NN NN O
to TO TO O
Afib NNP NNP O
, , , O
she PRP PRP O
had VBD VBD O
post-op JJ JJ O
Afib NNP NNP O
but CC CC O
now RB RB O
she PRP PRP O
's VBZ VBZ O
atrially RB RB O
paced VBN VBN O
. . . O
If IN IN O
future JJ JJ O
PPM NNP NNP O
interogations NNS NNS O
do VBP VBP O
n't RB RB O
reveal VB VB O
underlying VBG VBG O
Afib NNP NNP O
, , , O
she PRP PRP O
may MD MD O
not RB RB O
need VB VB O
coumadin NN NN O
in IN IN O
the DT DT O
long JJ JJ O
run NN NN O
. . . O
She PRP PRP O
'll MD MD O
return VB VB O
to TO TO O
clinic NN NN O
in IN IN O
6 CD CD O
months NNS NNS O
or CC CC O
sooner RBR RBR O
prn NN NN O
. . . O
   
Seen VBN VBN O
with IN IN O
Dr NNP NNP O
. . . O
Richard NNP NNP I-DOCTOR
Oden NNP NNP I-DOCTOR
. . . O
   
Changes NNS NNS O
to TO TO O
Medications NNP NNP O
this DT DT O
visit NN NN O
Pletal NNP NNP O
100mg CD CD O
PO NNP NNP O
BID NNP NNP O
Start NNP NNP O
: : : O
06/30/2089 CD CD I-DATE
ophthalmic JJ JJ O
pilocarpine NN NN O
solution NN NN O
0.5 CD CD O
% NN NN O
QID NNP NNP O
Start NNP NNP O
: : : O
06/30/2089 CD CD I-DATE
Zantac NNP NNP O
300mg CD CD O
po NN NN O
at IN IN O
bedtime NN NN O
Start NNP NNP O
: : : O
06/30/2089 CD CD I-DATE
Prilosec NNP NNP O
40mg CD CD O
po NN NN O
BID NNP NNP O
Start NNP NNP O
: : : O
06/30/2089 CD CD I-DATE
Femara NNP NNP O
2.5mg CD CD O
QD NNP NNP O
Start NNP NNP O
: : : O
06/30/2089 CD CD I-DATE
metformin NN NN O
hydrochloride NN NN O
500 CD CD O
mg NN NN O
po NN NN O
daily JJ JJ O
Start NNP NNP O
: : : O
06/30/2089 CD CD I-DATE
Lipitor NNP NNP O
20mg CD CD O
po NN NN O
daily JJ JJ O
Start NNP NNP O
: : : O
06/30/2089 CD CD I-DATE
aspirin NN NN O
325 CD CD O
mg NN NN O
po NN NN O
daily JJ JJ O
Start NNP NNP O
: : : O
06/30/2089 CD CD I-DATE
Combivent NNP NNP O
120/21mcg/spray CD CD O
inh NN NN O
qid NN NN O
Start NNP NNP O
: : : O
06/30/2089 CD CD I-DATE
Os NNP NNP O
cal JJ JJ O
500mg/125 CD CD O
units NNS NNS O
po NN NN O
bid NN NN O
Start NNP NNP O
: : : O
06/30/2089 CD CD I-DATE
Lopressor NNP NNP O
25mg CD CD O
po NN NN O
bid NN NN O
Start NNP NNP O
: : : O
06/30/2089 CD CD I-DATE
amiodarone NN NN O
200mg CD CD O
po NN NN O
daily JJ JJ O
Start NNP NNP O
: : : O
06/30/2089 CD CD I-DATE
End NN NN O
: : : O
7/3/2089 CD CD I-DATE
- - - O
Inactivated NNP NNP O
Coumadin NNP NNP O
Start NNP NNP O
: : : O
06/30/2089 CD CD I-DATE
Advair NNP NNP O
250/50mcg CD CD O
spray NN NN O
inh NN NN O
bid NN NN O
Start NNP NNP O
: : : O
06/30/2089 CD CD I-DATE
Frank NNP NNP I-DOCTOR
Oden NNP NNP I-DOCTOR
, , , O
MD NNP NNP O
cc NN NN O
: : : O
Jason NNP NNP I-DOCTOR
Santana NNP NNP I-DOCTOR
, , , O
MD NNP NNP O
Signed NNP NNP O
electronically RB RB O
by IN IN O
Frank NNP NNP I-DOCTOR
Oden NNP NNP I-DOCTOR
, , , O
MD NNP NNP O
Document NNP NNP O
Status NNP NNP O
: : : O
Final NNP NNP O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2066-02-07 NN NN I-DATE
KCM NNP NNP I-HOSPITAL
EMERGENCY NNP NNP O
DEPT NNP NNP O
VISIT NNP NNP O
RIVERS,KARSTEN NNP NNP I-PATIENT
957-18-08-4 NNP NNP I-MEDICALRECORD
VISIT NNP NNP O
DATE NN NN O
: : : O
02/07/66 CD CD I-DATE
The DT DT O
patient NN NN O
was VBD VBD O
seen VBN VBN O
and CC CC O
examined VBN VBN O
by IN IN O
me PRP PRP O
. . . O
   
HISTORY NN NN O
OF IN IN O
PRESENTING NNP NNP O
COMPLAINT NNP NNP O
: : : O
This DT DT O
is VBZ VBZ O
a DT DT O
39-year-old JJ JJ O
man NN NN O
with IN IN O
a DT DT O
history NN NN O
of IN IN O
hypertension NN NN O
and CC CC O
diabetes NNS NNS O
, , , O
whose WP$ WP$ O
social JJ JJ O
history NN NN O
is VBZ VBZ O
unremarkable JJ JJ O
, , , O
who WP WP O
has VBZ VBZ O
a DT DT O
negative JJ JJ O
review NN NN O
of IN IN O
systems NNS NNS O
, , , O
and CC CC O
who WP WP O
has VBZ VBZ O
no DT DT O
history NN NN O
of IN IN O
any DT DT O
surgical JJ JJ O
procedures NNS NNS O
. . . O
   
He PRP PRP O
presents VBZ VBZ O
with IN IN O
a DT DT O
burn NN NN O
on IN IN O
the DT DT O
right JJ JJ O
side NN NN O
of IN IN O
the DT DT O
neck NN NN O
. . . O
   
He PRP PRP O
presents VBZ VBZ O
to TO TO O
the DT DT O
emergency NN NN O
department NN NN O
with IN IN O
a DT DT O
minor JJ JJ O
amount NN NN O
of IN IN O
redness NN NN O
on IN IN O
the DT DT O
right JJ JJ O
side NN NN O
of IN IN O
the DT DT O
neck NN NN O
and CC CC O
minor JJ JJ O
soft JJ JJ O
tissue NN NN O
swelling VBG VBG O
. . . O
   
The DT DT O
trachea NN NN O
is VBZ VBZ O
midline NN NN O
. . . O
   
The DT DT O
uvula NN NN O
is VBZ VBZ O
midline NN NN O
. . . O
   
There EX EX O
is VBZ VBZ O
no DT DT O
airway NN NN O
compromise NN NN O
. . . O
   
There EX EX O
are VBP VBP O
no DT DT O
airway NN NN O
complaints NNS NNS O
. . . O
   
PHYSICAL JJ JJ O
EXAMINATION NNP NNP O
: : : O
No DT DT O
voice NN NN O
change NN NN O
. . . O
   
The DT DT O
airway NN NN O
is VBZ VBZ O
patent NN NN O
and CC CC O
intact JJ JJ O
. . . O
   
The DT DT O
lungs NNS NNS O
are VBP VBP O
clear JJ JJ O
, , , O
with IN IN O
no DT DT O
wheezes NNS NNS O
. . . O
   
The DT DT O
examination NN NN O
shows VBZ VBZ O
a DT DT O
first-degree JJ JJ O
burn NN NN O
of IN IN O
the DT DT O
right JJ JJ O
side NN NN O
of IN IN O
the DT DT O
neck NN NN O
, , , O
with IN IN O
no DT DT O
blistering VBG VBG O
and CC CC O
no DT DT O
breakage NN NN O
of IN IN O
the DT DT O
skin NN NN O
. . . O
   
THERAPY NNP NNP O
RENDERED/COURSE NNP NNP O
IN IN IN O
ED NNP NNP O
: : : O
The DT DT O
patient NN NN O
received VBD VBD O
a DT DT O
tetanus NN NN O
shot NN NN O
and CC CC O
was VBD VBD O
seen VBN VBN O
by IN IN O
the DT DT O
Burn NNP NNP O
Service NNP NNP O
. . . O
   
He PRP PRP O
was VBD VBD O
dressed VBN VBN O
with IN IN O
Bacitracin NNP NNP O
and CC CC O
discharged JJ JJ O
home NN NN O
. . . O
   
He PRP PRP O
was VBD VBD O
to TO TO O
follow VB VB O
up RP RP O
in IN IN O
48 CD CD O
hours NNS NNS O
just RB RB O
for IN IN O
a DT DT O
recheck NN NN O
. . . O
   
The DT DT O
Burn NNP NNP O
Service NNP NNP O
essentially RB RB O
signed VBD VBD O
off RP RP O
on IN IN O
him PRP PRP O
, , , O
with IN IN O
no DT DT O
need NN NN O
for IN IN O
follow-up JJ JJ O
, , , O
but CC CC O
given VBN VBN O
this DT DT O
was VBD VBD O
his PRP$ PRP$ O
neck NN NN O
and CC CC O
only RB RB O
first-degree JJ JJ O
, , , O
I PRP PRP O
asked VBD VBD O
him PRP PRP O
to TO TO O
return VB VB O
here RB RB O
for IN IN O
follow-up JJ JJ O
. . . O
   
FINAL NNP NNP O
DIAGNOSIS NNP NNP O
: : : O
First-degree NNP NNP O
burn NN NN O
of IN IN O
the DT DT O
right JJ JJ O
side NN NN O
of IN IN O
the DT DT O
neck NN NN O
. . . O
   
DISPOSITION NNP NNP O
( ( ( O
including VBG VBG O
condition NN NN O
upon IN IN O
discharge NN NN O
) ) ) O
: : : O
He PRP PRP O
is VBZ VBZ O
discharged VBN VBN O
with IN IN O
Bacitracin NNP NNP O
ointment NN NN O
and CC CC O
analgesics NNS NNS O
, , , O
and CC CC O
is VBZ VBZ O
to TO TO O
follow VB VB O
up RP RP O
in IN IN O
48 CD CD O
hours NNS NNS O
. . . O
   
The DT DT O
patient NN NN O
's POS POS O
condition NN NN O
on IN IN O
discharge NN NN O
is VBZ VBZ O
stable JJ JJ O
. . . O
   
__________________________________ NN NN O
_ NN NN O
RO904/06747 NNP NNP I-IDNUM
XAVIER NNP NNP I-DOCTOR
ODONNELL NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
   
XO71 NNP NNP I-USERNAME
D:02/07/66 NNP NNP O
T:02/07/66 NNP NNP O
Dictated NNP NNP O
by IN IN O
: : : O
XAVIER NNP NNP I-DOCTOR
ODONNELL NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
   
XO71 NNP NNP I-USERNAME
******** NN NN O
Not RB RB O
reviewed VBN VBN O
by IN IN O
Attending NNP NNP O
Physician NNP NNP O
******** NN NN O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2077-11-10 JJ JJ I-DATE
Reason NNP NNP O
for IN IN O
Visit NNP NNP O
follow VB VB O
up RP RP O
First CD CD O
visit NN NN O
in IN IN O
over IN IN O
5 CD CD O
months NNS NNS O
. . . O
   
Had VBD VBD O
injury NN NN O
at IN IN O
work NN NN O
, , , O
fell VBD VBD O
and CC CC O
rx NN NN O
right JJ JJ O
shoulder NN NN O
- : : O
had VBD VBD O
surgery NN NN O
and CC CC O
now RB RB O
will MD MD O
have VB VB O
to TO TO O
have VB VB O
shoulder NN NN O
replacement NN NN O
by IN IN O
Dr NNP NNP O
. . . O
Denny NNP NNP I-DOCTOR
. . . O
   
Went VBD VBD O
through IN IN O
rehab NN NN O
and CC CC O
has VBZ VBZ O
been VBN VBN O
living VBG VBG O
with IN IN O
her PRP$ PRP$ O
son NN NN O
in IN IN O
Washington NNP NNP I-STATE
- : : O
her PRP$ PRP$ O
apartment NN NN O
is VBZ VBZ O
being VBG VBG O
fixed VBN VBN O
up RP RP O
but CC CC O
likely JJ JJ O
she PRP PRP O
will MD MD O
move VB VB O
because IN IN O
of IN IN O
issues NNS NNS O
with IN IN O
elevator NN NN O
- - - O
lookiing VBG VBG O
for IN IN O
elderly JJ JJ O
housing NN NN O
. . . O
   
No DT DT O
pain NN NN O
issues NNS NNS O
, , , O
still RB RB O
has VBZ VBZ O
constipation NN NN O
- - - O
takes VBZ VBZ O
senna NN NN O
and CC CC O
colace NN NN O
bid NN NN O
. . . O
   
Is VBZ VBZ O
concerned VBN VBN O
about IN IN O
addictive JJ JJ O
personality NN NN O
- - - O
off RP RP O
narcotics NNS NNS O
but CC CC O
is VBZ VBZ O
attending VBG VBG O
NA NNP NNP O
meetings NNS NNS O
and CC CC O
wants VBZ VBZ O
to TO TO O
get VB VB O
of IN IN O
amitriptyline NN NN O
and CC CC O
trazodone-would JJ JJ O
like IN IN O
to TO TO O
try VB VB O
neurontin NN NN O
. . . O
   
BS NNP NNP O
are VBP VBP O
good JJ JJ O
- - - O
on IN IN O
18 CD CD O
units NNS NNS O
insulin NN NN O
bid NN NN O
and CC CC O
has VBZ VBZ O
been VBN VBN O
trying VBG VBG O
to TO TO O
lose VB VB O
wt NN NN O
- : : O
1 CD CD O
+ NN NN O
/ NN NN O
week NN NN O
. . . O
   
Will MD MD O
have VB VB O
EMG NNP NNP O
on IN IN O
11/26 CD CD I-DATE
because IN IN O
of IN IN O
numbness JJ JJ O
right JJ JJ O
hand NN NN O
and CC CC O
concern NN NN O
about IN IN O
brachial NN NN O
nerve NN NN O
. . . O
   
Will MD MD O
also RB RB O
have VB VB O
CT NNP NNP O
. . . O
   
She PRP PRP O
has VBZ VBZ O
tingling VBG VBG O
left VBN VBN O
medial JJ JJ O
fingers NNS NNS O
- - - O
advised JJ JJ O
EMG NNP NNP O
of IN IN O
that DT DT O
hand NN NN O
too RB RB O
. . . O
   
Needs NNP NNP O
BMD NNP NNP O
- : : O
needs VBZ VBZ O
to TO TO O
get VB VB O
clearance NN NN O
from IN IN O
workers NNS NNS O
comp VBP VBP O
. . . O
   
Generally RB RB O
doing VBG VBG O
well RB RB O
. . . O
   
Using VBG VBG O
Chantix NNP NNP O
. . . O
   
Reviewed NNP NNP O
meds NNS NNS O
. . . O
   
Needs NNP NNP O
new JJ JJ O
rx NN NN O
. . . O
   
BS NNP NNP O
117-121 JJ JJ O
, , , O
no DT DT O
hypoglycemai NN NN O
Medications NNP NNP O
Text NN NN O
verapamil NN NN O
120 CD CD O
mg NN NN O
bid NN NN O
novolog NN NN O
70/30 CD CD O
18units CD CD O
bid NN NN O
amitriptylin NN NN O
50/25 CD CD O
- : : O
will MD MD O
stop VB VB O
lisinopril NN NN O
10mg CD CD O
qd--BPs JJ JJ O
have VBP VBP O
been VBN VBN O
high JJ JJ O
MVI NNP NNP O
ASA NNP NNP O
325 CD CD O
mg NN NN O
qd NN NN O
simvastain NN NN O
20mg CD CD O
qd NN NN O
vit NN NN O
c SYM SYM O
1000mg CD CD O
qd NN NN O
metoprolol NN NN O
100mg CD CD O
qd NN NN O
lasix NN NN O
20mg CD CD O
- : : O
no RB RB O
longer RB RB O
taking VBG VBG O
chantix NN NN O
Allergies NNP NNP O
NKA NNP NNP O
Past NNP NNP O
Medical NNP NNP O
History NN NN O
OB:G1 NNP NNP O
P1 NNP NNP O
UCHD NNP NNP O
, , , O
no DT DT O
ARF NNP NNP O
Family NNP NNP O
History NN NN O
non NN NN O
contributory NN NN O
children-one JJ JJ O
son NN NN O
, , , O
Hep NNP NNP O
C NNP NNP O
no DT DT O
FH NNP NNP O
of IN IN O
colon NN NN O
cancer NN NN O
, , , O
breast NN NN O
cancer NN NN O
Social NNP NNP O
History NN NN O
smoking NN NN O
: : : O
up IN IN O
to TO TO O
1.5 CD CD O
ppd NN NN O
on IN IN O
weekends NNS NNS O
EtOH NNP NNP O
: : : O
rare JJ JJ O
drugs NNS NNS O
: : : O
MJ--thinking NNP NNP O
about IN IN O
stopping VBG VBG O
because IN IN O
it PRP PRP O
causes VBZ VBZ O
increase NN NN O
in IN IN O
appetite NN NN O
substance NN NN O
abuse NN NN O
: : : O
none NN NN O
OTC NNP NNP O
meds NNS NNS O
: : : O
none NN NN O
diet NN NN O
: : : O
optifast NN NN O
exercise NN NN O
: : : O
walk VBP VBP O
caffeine NN NN O
: : : O
NA NNP NNP O
immunizations NNS NNS O
: : : O
needs VBZ VBZ O
flu NN NN O
shot NN NN O
work NN NN O
: : : O
Appraiser-currently NNP NNP O
unemployed VBD VBD O
sexual JJ JJ O
: : : O
MSW NNP NNP O
, , , O
not RB RB O
sexually RB RB O
active JJ JJ O
domestic JJ JJ O
violence NN NN O
: : : O
in IN IN O
past JJ JJ O
seat NN NN O
belt NN NN O
use NN NN O
: : : O
yes UH UH O
sunscreen:yes NN NN O
living VBG VBG O
will/health NN NN O
care NN NN O
proxy NN NN O
- : : O
none NN NN O
Review NNP NNP O
of IN IN O
Systems NNP NNP O
General NNP NNP O
: : : O
wt NN NN O
lost VBD VBD O
11.5 CD CD O
lbs NN NN O
since IN IN O
May NNP NNP I-DATE
Eye NNP NNP O
: : : O
reg NN NN O
ck-done NN NN O
this DT DT O
yr NN NN O
ENT NNP NNP O
: : : O
no DT DT O
sinus NN NN O
sx NN NN O
, , , O
skin NN NN O
: : : O
no DT DT O
rashes NNS NNS O
esp NN NN O
: : : O
no DT DT O
cough NN NN O
, , , O
SOB NNP NNP O
, , , O
sputum NN NN O
, , , O
hemoptysis NN NN O
CV NNP NNP O
: : : O
no DT DT O
CP NNP NNP O
, , , O
palpitations NNS NNS O
, , , O
edema NN NN O
, , , O
orthopnea NN NN O
, , , O
PND NNP NNP O
GI NNP NNP O
: : : O
no DT DT O
nausea NN NN O
, , , O
vomiting VBG VBG O
, , , O
heartburn NN NN O
, , , O
diarrhea NN NN O
, , , O
constipation NN NN O
, , , O
melena NN NN O
, , , O
hematochezia NN NN O
breast NN NN O
: : : O
mammogram NN NN O
-- : : O
needs VBZ VBZ O
GU NNP NNP O
: : : O
no DT DT O
dysuria NN NN O
, , , O
hematuria NN NN O
. . . O
   
LMP NNP NNP O
: : : O
late JJ JJ O
40s NN NN I-AGE
contraception NN NN O
: : : O
NA NNP NNP O
MS NNP NNP O
: : : O
no DT DT O
arthritis NN NN O
or CC CC O
joint JJ JJ O
pain NN NN O
neuro NN NN O
: : : O
no DT DT O
dizziness NN NN O
, , , O
syncope NN NN O
MH NNP NNP O
: : : O
no DT DT O
depression NN NN O
All DT DT O
other JJ JJ O
systems NNS NNS O
were VBD VBD O
reviewed VBN VBN O
and CC CC O
are VBP VBP O
negative JJ JJ O
Vital NNP NNP O
Signs NNP NNP O
BLOOD NNP NNP O
PRESSURE NN NN O
146/76 CD CD O
PULSE NNP NNP O
78 CD CD O
WEIGHT NNP NNP O
210 CD CD O
lb NN NN O
Physical JJ JJ O
Exam NNP NNP O
looks VBZ VBZ O
well RB RB O
. . . O
   
does VBZ VBZ O
not RB RB O
smell NN NN O
of IN IN O
smoke NN NN O
wt NN NN O
dec NN NN O
11.5 CD CD O
lbs NN NN O
BP NNP NNP O
138/80 CD CD O
left VBD VBD O
arm NN NN O
large JJ JJ O
cuff NN NN O
by IN IN O
me PRP PRP O
lungs NNS NNS O
clear JJ JJ O
heart NN NN O
S1S2 NNP NNP O
no DT DT O
murmur NN NN O
no DT DT O
edema NN NN O
Assessment NNP NNP O
   
1 CD CD O
. . . O
HBP NNP NNP O
- : : O
cont NN NN O
current JJ JJ O
meds NNS NNS O
- : : O
doing VBG VBG O
well RB RB O
   
2 CD CD O
. . . O
smoking NN NN O
- : : O
onChantix NN NN O
   
3 CD CD O
. . . O
right NN NN O
shoulder NN NN O
fx NN NN O
   
4 CD CD O
. . . O
HPV NNP NNP O
- : : O
?? NN NN O
   
5 CD CD O
. . . O
DM-HBA1C NNP NNP O
6.1 CD CD O
- : : O
doing VBG VBG O
well RB RB O
   
6 CD CD O
. . . O
HM NNP NNP O
: : : O
needseye NN NN O
ck NN NN O
, , , O
mammogra NN NN O
   
7 CD CD O
. . . O
CRF-creat NNP NNP O
stable JJ JJ O
   
8 CD CD O
. . . O
? . . O
   
CTS NNP NNP O
   
9 CD CD O
. . . O
PN NNP NNP O
- : : O
will MD MD O
stop VB VB O
amitriptyline NN NN O
and CC CC O
start VB VB O
on IN IN O
gabapentin NN NN O
100mg CD CD O
bid NN NN O
- : : O
-> SYM SYM O
300mg CD CD O
bid NN NN O
Orders NNP NNP O
E&M NNP NNP O
Level NNP NNP O
99214 CD CD O
Level NNP NNP O
4 CD CD O
, , , O
Outpatient NNP NNP O
Visit NNP NNP O
, , , O
Established NNP NNP O
Patient NNP NNP O
In-Office NNP NNP O
Procedures NNP NNP O
90471 CD CD O
IMADM NNP NNP O
PRQ NNP NNP O
ID NNP NNP O
SUBQ/IM NNP NNP O
NJXS NNP NNP O
1 CD CD O
VACC NNP NNP O
90658 CD CD O
Flu NNP NNP O
vaccine NN NN O
, , , O
split NN NN O
, , , O
3 CD CD O
yrs NN NN O
& CC CC O
> NN NN O
Diagnosis NNP NNP O
V04.81 NNP NNP O
Need NNP NNP O
for IN IN O
prophylactic JJ JJ O
vaccination NN NN O
and CC CC O
inoculation NN NN O
against IN IN O
influenza NN NN O
250.60 CD CD O
Diabetes NNP NNP O
mellitus NN NN O
with IN IN O
neurological JJ JJ O
manifestations NNS NNS O
, , , O
type NN NN O
II NNP NNP O
or CC CC O
unspecified JJ JJ O
type NN NN O
, , , O
not RB RB O
stated VBN VBN O
as IN IN O
uncontrolled JJ JJ O
250.00 CD CD O
Diabetes NNP NNP O
mellitus NN NN O
without IN IN O
mention NN NN O
of IN IN O
complication NN NN O
, , , O
type NN NN O
II NNP NNP O
or CC CC O
unspecified JJ JJ O
type NN NN O
, , , O
not RB RB O
stated VBN VBN O
as IN IN O
uncontrolled JJ JJ O
401.9 CD CD O
Unspecified NNP NNP O
essential JJ JJ O
hypertension NN NN O
Plan NNP NNP O
   
1 CD CD O
. . . O
Medications NNP NNP O
reviewed VBD VBD O
and CC CC O
reconciled VBD VBD O
   
2 CD CD O
. . . O
needs NNS NNS O
left VBD VBD O
EMG NNP NNP O
   
3 CD CD O
. . . O
RTO NNP NNP O
1 CD CD O
mon NNP NNP O
   
4 CD CD O
. . . O
new JJ JJ O
rx NN NN O
written VBN VBN O
   
5 CD CD O
. . . O
bowel NN NN O
regimen NN NN O
discussed VBD VBD O
. . . O
   
__________________________________ NN NN O
_ NN NN O
Billy NNP NNP I-DOCTOR
U. NNP NNP I-DOCTOR
Webber NNP NNP I-DOCTOR
, , , O
MD NNP NNP O
, , , O
FACP NNP NNP O
, , , O
AAHIVS NNP NNP O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2099-08-10 JJ JJ I-DATE
Follow-up NNP NNP O
Visit NNP NNP O
- : : O
Diabetes NNP NNP O
Medications NNP NNP O
: : : O
Humalog NNP NNP O
0-2/4-8/6-8 NN NN O
111-64-17 JJ JJ I-MEDICALRECORD
Lantus NNP NNP O
15 CD CD O
U NNP NNP O
hs NN NN O
Xayarath NN NN O
, , , O
Nancy NNP NNP I-PATIENT
Prograf NNP NNP O
3/2 CD CD O
mg NN NN O
bid NN NN O
CellCept NNP NNP O
500 CD CD O
mg NN NN O
bid NN NN O
Prednisone NNP NNP O
2.5 CD CD O
mg NN NN O
qd NN NN O
starting VBG VBG O
last JJ JJ O
week NN NN O
Nexium NNP NNP O
20 CD CD O
mg NN NN O
qd NN NN O
Lipitor NNP NNP O
20 CD CD O
mg NN NN O
qd NN NN O
Toprol NNP NNP O
XL NNP NNP O
25 CD CD O
mg NN NN O
qPM NN NN O
Coumadin NNP NNP O
4 CD CD O
mg NN NN O
qd NN NN O
( ( ( O
for IN IN O
SVC NNP NNP O
stent NN NN O
) ) ) O
ASA NNP NNP O
325 CD CD O
mg NN NN O
qd NN NN O
Caltrate NNP NNP O
with IN IN O
D NNP NNP O
1200-1500 JJ JJ O
mg NN NN O
per IN IN O
day NN NN O
in IN IN O
divided JJ JJ O
doses NNS NNS O
Fosamax NNP NNP O
70 CD CD O
mg NN NN O
qw NN NN O
Calcium NNP NNP O
with IN IN O
D NNP NNP O
500 CD CD O
mg NN NN O
qd NN NN O
should MD MD O
be VB VB O
bid-tid JJ JJ O
Centrum NNP NNP O
QD NNP NNP O
Reason NNP NNP O
for IN IN O
Visit NNP NNP O
: : : O
Diabetes NNP NNP O
f/u NN NN O
. . . O
   
Still RB RB O
not RB RB O
hooked VBD VBD O
up RP RP O
with IN IN O
Anti_Coag NNP NNP O
. . . O
   
Had VBD VBD O
stress NN NN O
test NN NN O
"recently:""blockages""." NN NN O
   
Having VBG VBG O
another DT DT O
done VBN VBN O
at IN IN O
Brighton NNP NNP I-HOSPITAL
. . . O
   
BG NNP NNP O
's POS POS O
everywhere RB RB O
. . . O
   
Had VBD VBD O
2 CD CD O
reactions NNS NNS O
one CD CD O
in IN IN O
am VBP VBP O
and CC CC O
one CD CD O
in IN IN O
pm NN NN O
. . . O
   
Diet NNP NNP O
: : : O
B NNP NNP O
: : : O
toast NN NN O
, , , O
cheese NN NN O
, , , O
fruit NN NN O
L NNP NNP O
: : : O
soup NN NN O
and CC CC O
sandwich NN NN O
S VBZ VBZ O
: : : O
"""" '' '' O
regular JJ JJ O
meal NN NN O
"""" '' '' O
Activity/Exercise NNP NNP O
: : : O
Monitoring NNP NNP O
: : : O
Breakfast NNP NNP O
Lunch NNP NNP O
Supper NNP NNP O
hs NN NN O
Pertinent NNP NNP O
Labs NNP NNP O
: : : O
07/28/2099 CD CD I-DATE
BUN NNP NNP O
18 CD CD O
, , , O
CRE NNP NNP O
1.1 CD CD O
07/28/2099 CD CD I-DATE
HGBA1C NNP NNP O
10.00 CD CD O
( ( ( O
H NNP NNP O
) ) ) O
05/11/2099 CD CD I-DATE
HGBA1C NNP NNP O
9.30 CD CD O
( ( ( O
H NNP NNP O
) ) ) O
Physical JJ JJ O
Exam NNP NNP O
: : : O
-- : : O
Assessment NNP NNP O
and CC CC O
Plan NNP NNP O
: : : O
Diabetes NNP NNP O
. . . O
   
Widely NNP NNP O
varying VBG VBG O
BGs NNP NNP O
that WDT WDT O
would MD MD O
be VB VB O
best JJS JJS O
explained VBN VBN O
by IN IN O
more JJR JJR O
data NNS NNS O
and CC CC O
would MD MD O
benefit VB VB O
by IN IN O
better JJR JJR O
understanding NN NN O
of IN IN O
carbs NNS NNS O
and CC CC O
influence NN NN O
on IN IN O
sugar NN NN O
. . . O
   
Discussed NNP NNP O
"""" '' '' O
1500 CD CD O
"""" '' '' O
rule NN NN O
. . . O
   
She PRP PRP O
has VBZ VBZ O
correction NN NN O
factor NN NN O
of IN IN O
50-60 JJ JJ O
and CC CC O
insulin NN NN O
to TO TO O
carb VB VB O
ratioj NN NN O
of IN IN O
1/20 CD CD O
based VBN VBN O
on IN IN O
current JJ JJ O
total JJ JJ O
daily JJ JJ O
doses NNS NNS O
. . . O
   
Could MD MD O
try VB VB O
to TO TO O
address VB VB O
Humalog NNP NNP O
doses NNS NNS O
using VBG VBG O
this DT DT O
. . . O
   
Try VB VB O
to TO TO O
keep VB VB O
record NN NN O
of IN IN O
food NN NN O
, , , O
bg NN NN O
and CC CC O
insulin NN NN O
. . . O
   
Needs NNP NNP O
Anti-Coag NNP NNP O
appt NN NN O
which WDT WDT O
will MD MD O
be VB VB O
arranged VBN VBN O
today NN NN O
. . . O
   
Follow-up:Dr NNP NNP O
. . . O
   
Townsend NNP NNP I-DOCTOR
Sept NNP NNP I-DATE
. . . O
   
_________________________________________ NN NN O
_ NN NN O
Pamela NNP NNP I-DOCTOR
Ybarra NNP NNP I-DOCTOR
, , , O
RN NNP NNP O
, , , O
NP NNP NNP O
, , , O
CDE NNP NNP O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2078-07-15 JJ JJ I-DATE
Reason NNP NNP O
for IN IN O
Visit NNP NNP O
Owen NNP NNP I-PATIENT
is VBZ VBZ O
61 CD CD I-AGE
y/o NN NN O
male JJ JJ O
c/o NN NN O
difficulty NN NN O
loosing VBG VBG O
weight NN NN O
. . . O
   
Tries NNP NNP O
to TO TO O
watch VB VB O
diet NN NN O
. . . O
   
Walks NNP NNP O
QOD NNP NNP O
. . . O
   
2 CD CD O
- : : O
Occ NNP NNP O
soreness NN NN O
in IN IN O
ears NNS NNS O
. . . O
   
No DT DT O
change NN NN O
hearing NN NN O
. . . O
   
No DT DT O
dc NN NN O
. . . O
   
3 CD CD O
- : : O
Occ NNP NNP O
soreness NN NN O
left VBD VBD O
knee NN NN O
. . . O
   
Had VBD VBD O
major JJ JJ O
trauma NN NN O
and CC CC I-PROFESSION
surgery NN NN O
in IN IN O
past JJ JJ O
. . . O
   
Other JJ JJ O
joints NNS NNS O
are VBP VBP O
fine NN NN O
. . . O
   
PMH NNP NNP O
: : : O
OA,HTN,Prior NNP NNP O
skin NN NN O
ulcer NN NN O
, , , O
partially RB RB O
severed VBN VBN O
LLE NNP NNP O
, , , O
appendectomy NN NN O
, , , O
cholecystectomy,irridectomy NN NN O
, , , O
past JJ JJ O
smoker NN NN O
. . . O
   
Medications NNP NNP O
ATENOLOL NNP NNP O
25MG CD CD O
PO NNP NNP O
QD NNP NNP O
VITAMIN NNP NNP O
E NNP NNP O
PO NNP NNP O
QD NNP NNP O
ASA NNP NNP O
PO NNP NNP O
AMPICILLIN NNP NNP O
PO NNP NNP O
Allergies NNP NNP O
NKDA NNP NNP O
NONE NN NN O
Family NNP NNP O
History NN NN O
CVA,HTN NNP NNP O
. . . O
   
Social NNP NNP O
History NN NN O
LIves NNS NNS O
with IN IN O
mother NN NN O
. . . O
   
Conference NNP NNP I-PROFESSION
and CC CC I-PROFESSION
Event NN NN I-PROFESSION
Planner NNP NNP I-PROFESSION
. . . O
   
Habits NNP NNP O
No DT DT O
cigs NN NN O
. . . O
   
Occ NNP NNP O
ETOH NNP NNP O
. . . O
   
Review NNP NNP O
of IN IN O
Systems NNPS NNPS O
GEN-sleep NNP NNP O
is VBZ VBZ O
fine NN NN O
. . . O
   
No DT DT O
depression NN NN O
. . . O
   
No DT DT O
complaints NNS NNS O
related VBN VBN O
to TO TO O
HENT NNP NNP O
. . . O
   
Eye NNP NNP O
exam NN NN O
8/77 CD CD I-DATE
. . . O
   
NO DT DT O
complaints NNS NNS O
related VBN VBN O
to TO TO O
neck NN NN O
. . . O
   
Occ NNP NNP O
wheeze NN NN O
otherwise RB RB O
no DT DT O
pulm NN NN O
symptoms NNS NNS O
. . . O
   
No DT DT O
CVS NNP NNP O
, , , O
GI NNP NNP O
, , , O
GU NNP NNP O
, , , O
or CC CC O
CNS NNP NNP O
Physical JJ JJ O
Exam NNP NNP O
BP NNP NNP O
146/90 CD CD O
' POS POS O
WT-244; NNP NNP O
   
P-84; NNP NNP O
   
NAD,WD,WN NNP NNP O
. . . O
   
HEENT-no NNP NNP O
tenderness NN NN O
; : : O
   
sclera NN NN O
and CC CC I-PROFESSION
conj NN NN O
unremarkable JJ JJ O
, , , O
EOMI,PERLA NNP NNP O
, , , O
fundi-discs JJ JJ O
sharp JJ JJ O
; : : O
   
canals NNS NNS O
clear JJ JJ O
with IN IN O
normal JJ JJ O
TMs NNP NNP O
and CC CC I-PROFESSION
landmarks NNS NNS O
. . . O
   
no DT DT O
lesions NNS NNS O
, , , O
exudate NN NN O
, , , O
erythema NN NN O
of IN IN O
M&T NNP NNP O
. . . O
   
Neck NN NN O
- : : O
supple NN NN O
with IN IN O
no DT DT O
lymphadenopathy NN NN O
, , , O
thyromegaly NN NN O
, , , O
bruit NN NN O
, , , O
JVD NNP NNP O
, , , O
Chest-clear JJ JJ O
A&P NNP NNP O
; : : O
   
Cor NNP NNP O
- : : O
reg NN NN O
rhythm NN NN O
, , , O
S1S2 NNP NNP O
normal JJ JJ O
with IN IN O
no DT DT O
murmer NN NN O
or CC CC O
gallop NN NN O
; : : O
   
Abdo NNP NNP O
- : : O
normal JJ JJ O
BS,soft NNP NNP O
with IN IN O
no DT DT O
mass,HSM NN NN O
or CC CC O
tenderness NN NN O
. . . O
   
DRE_ NNP NNP O
normal JJ JJ O
sized VBD VBD O
prostate NN NN O
with IN IN O
no DT DT O
nodules NNS NNS O
. . . O
   
Ext NNP NNP O
- - - O
hyperpig NN NN O
LLE NNP NNP O
; : : O
   
+ NN NN O
edema NN NN O
LLE NNP NNP O
; : : O
   
No DT DT O
crepitus NN NN O
, , , O
or CC CC O
DROM NNP NNP O
. . . O
   
DP NNP NNP O
+ NN NN O
1 CD CD O
bilat NN NN O
. . . O
   
Assessment NNP NNP O
Borderline NNP NNP O
BP NNP NNP O
but CC CC O
very RB RB O
excited VBN VBN O
. . . O
   
Knee NNP NNP O
pain NN NN O
due JJ JJ O
to TO TO O
prior RB RB O
trauma NN NN O
. . . O
   
Chr NNP NNP O
derm NN NN O
changes NNS NNS O
LLE NNP NNP O
. . . O
   
Overweight NNP NNP O
. . . O
   
Disposition NNP NNP O
and CC CC I-PROFESSION
Plans NNP NNP O
Diet NNP NNP O
educ NN NN O
. . . O
   
FOBT NNP NNP O
. . . O
   
PSA NNP NNP O
. . . O
   
Cont NNP NNP O
meds NNS NNS O
. . . O
   
RTC NNP NNP O
6 CD CD O
mon NNP NNP O
or CC CC O
PRN NNP NNP O
. . . O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2097-12-04 JJ JJ I-DATE
SECTIONS NNP NNP O
OF IN IN O
THIS DT DT O
NOTE NN NN O
WERE VBD VBD O
CREATED NNP NNP O
WITH IN IN O
A DT DT O
' POS POS O
COPY NNP NNP O
AND CC CC O
PASTE NNP NNP O
' POS POS O
ACTION NNP NNP O
. . . O
   
THESE DT DT O
SECTIONS NNP NNP O
MAY NNP NNP O
NOT RB RB O
HAVE NNP NNP O
COPIED NNP NNP O
COMPLETELY RB RB O
. . . O
   
PLEASE NNP NNP O
USE NNP NNP O
CAUTION NNP NNP O
WHEN WRB WRB O
RENDERING NNP NNP O
CLINICAL NNP NNP O
JUDGMENT NNP NNP O
BASED NNP NNP O
ON IN IN O
THE DT DT O
INFORMATION NNP NNP O
IN IN IN O
THIS DT DT O
NOTE NN NN O
. . . O
   
Internal NNP NNP O
Medicine NNP NNP O
Medical NNP NNP O
Student NNP NNP O
Admission NNP NNP O
Note VB VB O
PATIENT NNP NNP O
: : : O
Rojas NNP NNP I-PATIENT
, , , O
Alaina NNP NNP I-PATIENT
MRN NNP NNP O
: : : O
7269058 CD CD I-MEDICALRECORD
ADMIT NNP NNP O
DATE NN NN O
: : : O
12/04/2097 CD CD I-DATE
PCP NNP NNP O
: : : O
Dr NNP NNP O
. . . O
Ruba NNP NNP I-DOCTOR
Neil NNP NNP I-DOCTOR
, , , O
Dr NNP NNP O
. . . O
William NNP NNP I-DOCTOR
Aquino NNP NNP I-DOCTOR
   
( ( ( O
onc NN NN O
) ) ) O
CONTACT NNP NNP O
: : : O
Claire NNP NNP I-PATIENT
Ortega NNP NNP I-PATIENT
( ( ( O
daughter NN NN O
, , , O
660-750-9168 JJ JJ I-PHONE
) ) ) O
CODE NNP NNP O
STATUS NNP NNP O
: : : O
Full NNP NNP O
SOURCE NNP NNP O
: : : O
Previous JJ JJ O
notes NNS NNS O
CHIEF NNP NNP O
COMPLAINT NNP NNP O
: : : O
Mechanical NNP NNP O
Fall NN NN O
HISTORY NN NN O
OF IN IN O
PRESENT NNP NNP O
ILLNESS NNP NNP O
: : : O
( ( ( O
Patient NNP NNP O
was VBD VBD O
taken VBN VBN O
to TO TO O
surgery NN NN O
immediately RB RB O
upon IN IN O
arriving VBG VBG O
to TO TO O
floor NN NN O
) ) ) O
Per IN IN O
PCP NNP NNP O
: : : O
Ms NNP NNP O
. . . O
Rojas NNP NNP I-PATIENT
is VBZ VBZ O
a DT DT O
87-year-old JJ JJ O
woman NN NN O
with IN IN O
a DT DT O
PMH NNP NNP O
of IN IN O
metastatic JJ JJ O
pancreatic JJ JJ O
cancer NN NN O
recently RB RB O
diagnosed VBD VBD O
s/p NN NN O
1 CD CD O
dose NN NN O
of IN IN O
gemcitabine NN NN O
( ( ( O
on IN IN O
11/14 CD CD I-DATE
) ) ) O
, , , O
DM NNP NNP O
, , , O
HTN NNP NNP O
, , , O
and CC CC O
CRI NNP NNP O
who WP WP O
presents VBZ VBZ O
s/p NN NN O
mechanical JJ JJ O
fall NN NN O
at IN IN O
home NN NN O
resulting VBG VBG O
in IN IN O
a DT DT O
right JJ JJ O
hip NN NN O
fracture NN NN O
. . . O
   
Patient NNP NNP O
was VBD VBD O
in IN IN O
USOH NNP NNP O
until IN IN O
the DT DT O
day NN NN O
of IN IN O
admission NN NN O
when WRB WRB O
she PRP PRP O
got VBD VBD O
up RB RB O
out IN IN O
of IN IN O
a DT DT O
chair NN NN O
to TO TO O
reach VB VB O
for IN IN O
her PRP$ PRP$ O
glasses NNS NNS O
, , , O
and CC CC O
then RB RB O
went VBD VBD O
to TO TO O
sit VB VB O
back RB RB O
down RB RB O
and CC CC O
missed VBD VBD O
the DT DT O
chair NN NN O
and CC CC O
fell VBD VBD O
to TO TO O
the DT DT O
ground NN NN O
. . . O
   
Per IN IN O
the DT DT O
PCP NNP NNP O
, , , O
the DT DT O
patient NN NN O
had VBD VBD O
no DT DT O
presyncopal NN NN O
symptoms NNS NNS O
and CC CC O
did VBD VBD O
not RB RB O
lose VB VB O
consciousness NN NN O
. . . O
   
ED NNP NNP O
COURSE NN NN O
: : : O
T NN NN O
97.8 CD CD O
P NN NN O
56 CD CD O
BP NNP NNP O
: : : O
156/59 CD CD O
RR NNP NNP O
: : : O
20 CD CD O
97 CD CD O
% NN NN O
RA NNP NNP O
Foreshortened NNP NNP O
RLExt NNP NNP O
Needs NNP NNP O
basal NN NN O
insulin NN NN O
PMH/PSH NNP NNP O
: : : O
( ( ( O
1 CD CD O
) ) ) O
Pancreatic NNP NNP O
cancer NN NN O
a. NN NN O
   
10/30/2097 CD CD I-DATE
, , , O
patient NN NN O
presented VBN VBN O
to TO TO O
PCP NNP NNP O
with IN IN O
dark JJ JJ O
urine NN NN O
and CC CC O
progressively RB RB O
increasing VBG VBG O
FBSGs NNP NNP O
( ( ( O
h/o NN NN O
DM NNP NNP O
) ) ) O
. . . O
   
She PRP PRP O
was VBD VBD O
admitted VBN VBN O
for IN IN O
evaluation NN NN O
of IN IN O
hyperglycemia NN NN O
and CC CC O
was VBD VBD O
noted VBN VBN O
to TO TO O
be VB VB O
jaundiced VBN VBN O
with IN IN O
elevated JJ JJ O
LFTs NNP NNP O
. . . O
   
RUQ NNP NNP O
U/S NNP NNP O
showed VBD VBD O
CBD NNP NNP O
dilatation NN NN O
with IN IN O
hypoechoic JJ JJ O
mass NN NN O
near IN IN O
head NN NN O
of IN IN O
pancreas NNS NNS O
measuring VBG VBG O
4.1x5x5.5cm CD CD O
b. NN NN O
   
11/03/2097 CD CD I-DATE
, , , O
ERCP NNP NNP O
showed VBD VBD O
3cm CD CD O
distal NN NN O
bile NN NN O
duct NN NN O
stricture NN NN O
that WDT WDT O
was VBD VBD O
stented VBN VBN O
. . . O
   
LFTs NNP NNP O
trended VBD VBD O
down RB RB O
s/p JJ JJ O
biliary JJ JJ O
stenting VBG VBG O
. . . O
   
Biopsy NNP NNP O
obtained VBN VBN O
under IN IN O
EUS NNP NNP O
guidance NN NN O
showed VBD VBD O
pancreatic JJ JJ O
adenocarcinoma NN NN O
. . . O
   
CT NNP NNP O
scan VB VB O
revealed VBD VBD O
pulmonary JJ JJ O
nodules NNS NNS O
, , , O
likely JJ JJ O
metastatic JJ JJ O
disease NN NN O
c. NN NN O
   
11/14/2097 CD CD I-DATE
, , , O
treated VBN VBN O
with IN IN O
1st CD CD O
dose NN NN O
of IN IN O
25 CD CD O
% NN NN O
dose NN NN O
gemcitabine NN NN O
( ( ( O
given VBN VBN O
CKD NNP NNP O
) ) ) O
, , , O
course NN NN O
s/p NN NN O
chemotx NN NN O
c/b NN NN O
fatigue NN NN O
, , , O
rash NN NN O
, , , O
worsening VBG VBG O
renal JJ JJ O
function NN NN O
and CC CC O
anemia NN NN O
. . . O
   
This DT DT O
resolved VBD VBD O
with IN IN O
fluids NNS NNS O
, , , O
blood NN NN O
tx NN NN O
, , , O
and CC CC O
discontinuation NN NN O
of IN IN O
most JJS JJS O
of IN IN O
her PRP$ PRP$ O
BP NNP NNP O
medications NNS NNS O
. . . O
   
She PRP PRP O
was VBD VBD O
scheduled VBN VBN O
for IN IN O
her PRP$ PRP$ O
second JJ JJ O
dose NN NN O
of IN IN O
gemcitabine NN NN O
on IN IN O
12/05 CD CD I-DATE
( ( ( O
2 CD CD O
) ) ) O
Diabetes NNP NNP O
mellitus NN NN O
a. NN NN O
   
Last JJ JJ O
HgbA1c NNP NNP O
= SYM SYM O
7.2 CD CD O
( ( ( O
10/08/2097 CD CD I-DATE
) ) ) O
b. NN NN O
   
Was VBD VBD O
maintained VBN VBN O
on IN IN O
Glucophage NNP NNP O
, , , O
but CC CC O
this DT DT O
was VBD VBD O
discontinued VBN VBN O
2/2 CD CD O
worsening VBG VBG O
renal JJ JJ O
function NN NN O
c. NN NN O
   
Recently RB RB O
placed VBD VBD O
on IN IN O
insulin NN NN O
with IN IN O
BS&#8217; NNP NNP O
   
s VBZ VBZ O
to TO TO O
be VB VB O
kept VBN VBN O
around IN IN O
200 CD CD O
given VBN VBN O
CA NNP NNP O
dx NN NN O
HTN NNP NNP O
( ( ( O
TTE NNP NNP O
on IN IN O
11/11 CD CD I-DATE
showed VBD VBD O
EF=69%, NNP NNP O
no DT DT O
LVH NNP NNP O
) ) ) O
Chronic NNP NNP O
renal JJ JJ O
failure NN NN O
& CC CC O
#8211 NN NN O
; : : O
   
baseline NN NN O
creatinine NN NN O
1.8-2.2 JJ JJ O
h/o NN NN O
BCC NNP NNP O
h/o NN NN O
TIA NNP NNP O
MEDICATIONS NNP NNP O
ON IN IN O
ADMISSION NNP NNP O
: : : O
Vitamin NNP NNP O
d SYM SYM O
1000 CD CD O
units NNS NNS O
po NN NN O
daily JJ JJ O
Novolin NNP NNP O
R NNP NNP O
innolet NN NN O
2-6 JJ JJ O
units NNS NNS O
sc NN NN O
bid NN NN O
prn NN NN O
per IN IN O
sliding VBG VBG O
scale NN NN O
Novolin NNP NNP O
N NNP NNP O
innolet NN NN O
22 CD CD O
units NNS NNS O
sc NN NN O
qam NN NN O
ferrous JJ JJ O
sulfate NN NN O
325mg CD CD O
po NN NN O
daily JJ JJ O
metoprolol NN NN O
25mg CD CD O
po NN NN O
bid NN NN O
2 CD CD O
tabs NNS NNS O
furosemide NN NN O
10mg CD CD O
po NN NN O
daily JJ JJ O
Ecotrin NNP NNP O
325 CD CD O
mg NN NN O
po NN NN O
daily JJ JJ O
Home NNP NNP O
physical JJ JJ O
therapy NN NN O
for IN IN O
strengthening VBG VBG O
and CC CC O
ROM NNP NNP O
generally RB RB O
. . . O
   
Additionally RB RB O
L NNP NNP O
shoulder VB VB O
ROM NNP NNP O
and CC CC O
strengthening VBG VBG O
for IN IN O
frozen VBN VBN O
shoulder NN NN O
. . . O
   
ALLERGIES NNP NNP O
: : : O
NKDA NNP NNP O
SOCIAL NNP NNP O
HISTORY NN NN O
: : : O
Continues NNP NNP O
to TO TO O
get VB VB O
out IN IN O
to TO TO O
the DT DT O
American NNP NNP I-ORGANIZATION
Senior NNP NNP I-ORGANIZATION
Center NNP NNP I-ORGANIZATION
, , , O
except IN IN O
on IN IN O
one CD CD O
day NN NN O
. . . O
   
Living VBG VBG O
independently RB RB O
with IN IN O
supportive JJ JJ O
family NN NN O
. . . O
   
Three CD CD O
daughters NNS NNS O
and CC CC O
2 CD CD O
sons NNS NNS O
are VBP VBP O
very RB RB O
involved VBN VBN O
with IN IN O
her PRP PRP O
. . . O
   
FAMILY NN NN O
HISTORY NN NN O
: : : O
She PRP PRP O
was VBD VBD O
born VBN VBN O
in IN IN O
Arroyo NNP NNP I-CITY
Grande NNP NNP I-CITY
. . . O
   
She PRP PRP O
had VBD VBD O
five CD CD O
children NNS NNS O
; : : O
   
four CD CD O
of IN IN O
them PRP PRP O
are VBP VBP O
alive JJ JJ O
, , , O
all DT DT O
living VBG VBG O
in IN IN O
the DT DT O
area NN NN O
. . . O
   
Husband NNP NNP O
died VBD VBD O
in IN IN O
2080 CD CD I-DATE
. . . O
   
Mother NNP NNP O
had VBD VBD O
Parkinson NNP NNP O
's POS POS O
disease NN NN O
. . . O
   
Sister NNP NNP O
had VBD VBD O
breast NN NN O
cancer NN NN O
at IN IN O
the DT DT O
age NN NN O
of IN IN O
   
72 CD CD I-AGE
. . . O
PHYSICAL JJ JJ O
EXAM NNP NNP O
: : : O
( ( ( O
Exam NNP NNP O
was VBD VBD O
deferred VBN VBN O
because IN IN O
patient NN NN O
was VBD VBD O
taken VBN VBN O
immediately RB RB O
to TO TO O
OR CC CC O
) ) ) O
VITALS NNP NNP O
( ( ( O
on IN IN O
arrival NN NN O
to TO TO O
floor NN NN O
) ) ) O
: : : O
TEMP NNP NNP O
: : : O
100.3 CD CD O
HR NNP NNP O
: : : O
62 CD CD O
BP NNP NNP O
: : : O
171/59 CD CD O
RR NNP NNP O
: : : O
18 CD CD O
O2SAT NNP NNP O
: : : O
98 CD CD O
% NN NN O
on IN IN O
RA NNP NNP O
LABORATORY NNP NNP O
DATA NNP NNP O
: : : O
Chemistries NNS NNS O
12/04/97 CD CD I-DATE
12/01/97 CD CD I-DATE
00:08 CD CD O
20:12 CD CD O
NA NNP NNP O
130(L) CD CD O
138 CD CD O
K NNP NNP O
4.3 CD CD O
4.8 CD CD O
CL NNP NNP O
98(L) CD CD O
104 CD CD O
CO2 NNP NNP O
19.1(L) CD CD O
22.8(L) CD CD O
BUN NNP NNP O
60(H) CD CD O
58(H) CD CD O
CRE NNP NNP O
2.1(H) CD CD O
2.2(H) CD CD O
GLU NNP NNP O
381(H) CD CD O
362(H) CD CD O
General NNP NNP O
Chemistries NNP NNP O
Calcium NNP NNP O
8.6 CD CD O
( ( ( O
8.5-10.5 NNP NNP O
) ) ) O
mg/dl NN NN O
Phosphorus NNP NNP O
3.3 CD CD O
( ( ( O
2.6-4.5 NN NN O
) ) ) O
mg/dl NN NN O
Magnesium NNP NNP O
1.6 CD CD O
( ( ( O
1.4-2.0 NN NN O
) ) ) O
meq/L NN NN O
Liver NNP NNP O
Function NNP NNP O
Tests NNP NNP O
Total NNP NNP O
Protein NNP NNP O
7.1 CD CD O
( ( ( O
6.0-8.3 NN NN O
) ) ) O
g/dl NN NN O
Albumin NNP NNP O
3.6 CD CD O
( ( ( O
3.3-5.0 NN NN O
) ) ) O
g/dl NN NN O
Globulin NNP NNP O
3.5 CD CD O
( ( ( O
2.6-4.1 JJ JJ O
) ) ) O
g/dl NN NN O
Total NNP NNP O
Bilirubin NNP NNP O
0.8 CD CD O
( ( ( O
0.0-1.0 NN NN O
) ) ) O
mg/dl NN NN O
Alkaline NNP NNP O
Phosphatase NNP NNP O
84 CD CD O
( ( ( O
30-100 NN NN O
) ) ) O
U/L NNP NNP O
Transaminase-SGPT NNP NNP O
15 CD CD O
( ( ( O
7-30 NN NN O
) ) ) O
U/L NNP NNP O
Transaminase-SGOT NNP NNP O
19 CD CD O
( ( ( O
9-32 NN NN O
) ) ) O
U/L NNP NNP O
CBC NNP NNP O
: : : O
WBC NNP NNP O
10.8 CD CD O
( ( ( O
4.5-11.0 JJ JJ O
) ) ) O
th/cmm NN NN O
HCT NNP NNP O
27.3 CD CD O
L NNP NNP O
( ( ( O
36.0-46.0 JJ JJ O
) ) ) O
% NN NN O
HGB NNP NNP O
9.5 CD CD O
L NNP NNP O
( ( ( O
12.0-16.0 JJ JJ O
) ) ) O
gm/dl NN NN O
RBC NNP NNP O
3.07 CD CD O
L NNP NNP O
( ( ( O
4.00-5.20 JJ JJ O
) ) ) O
mil/cmm NN NN O
PLT NNP NNP O
351 CD CD O
H NNP NNP O
( ( ( O
150-350 JJ JJ O
) ) ) O
th/cumm NN NN O
MCV NNP NNP O
89 CD CD O
( ( ( O
80-100 NNP NNP O
) ) ) O
fl NN NN O
MCH NNP NNP O
31.0 CD CD O
( ( ( O
26.0-34.0 JJ JJ O
) ) ) O
pg/rbc NN NN O
MCHC NNP NNP O
34.8 CD CD O
( ( ( O
31.0-37.0 NN NN O
) ) ) O
g/dl NN NN O
RDW NNP NNP O
16.0 CD CD O
H NNP NNP O
( ( ( O
11.5-14.5 JJ JJ O
) ) ) O
% NN NN O
DIFFERENTIAL NNP NNP O
REQUEST NNP NNP O
RECEIVED NNP NNP O
Diff NNP NNP O
Method NNP NNP O
Auto NNP NNP O
Poly NNP NNP O
82 CD CD O
H NNP NNP O
( ( ( O
40-70 JJ JJ O
) ) ) O
% NN NN O
Lymphs NNP NNP O
10 CD CD O
L NNP NNP O
( ( ( O
22-44 JJ JJ O
) ) ) O
% NN NN O
Monos NNP NNP O
6 CD CD O
( ( ( O
4-11 JJ JJ O
) ) ) O
% NN NN O
EOS NNP NNP O
1 CD CD O
( ( ( O
0-8 NN NN O
) ) ) O
% NN NN O
Basos NNP NNP O
1 CD CD O
( ( ( O
0-3 NN NN O
) ) ) O
% NN NN O
Absolute NNP NNP O
Neuts NNP NNP O
8.92 CD CD O
H NNP NNP O
( ( ( O
1.8-7.7 JJ JJ O
) ) ) O
th/cmm NN NN O
Absolute NNP NNP O
Lymphs NNP NNP O
1.00 CD CD O
( ( ( O
1.0-4.8 JJ JJ O
) ) ) O
th/cmm NN NN O
Absolute NNP NNP O
Monos NNP NNP O
0.63 CD CD O
H NNP NNP O
( ( ( O
0.2-0.4 NN NN O
) ) ) O
th/cmm NN NN O
Absolute NNP NNP O
EOS NNP NNP O
0.14 CD CD O
( ( ( O
0.1-0.3 NN NN O
) ) ) O
th/cmm NN NN O
Absolute NNP NNP O
Basos NNP NNP O
0.07 CD CD O
( ( ( O
0.0-0.3 NN NN O
) ) ) O
th/cmm NN NN O
Aniso NNP NNP O
1 CD CD O
+ NN NN O
H NNP NNP O
( ( ( O
None NN NN O
) ) ) O
Hypo NNP NNP O
None NN NN O
( ( ( O
None NN NN O
) ) ) O
Macrocytes NNP NNP O
None NN NN O
( ( ( O
None NN NN O
) ) ) O
Microcytes NNP NNP O
None NN NN O
( ( ( O
None NN NN O
) ) ) O
Coagulation NNP NNP O
Studies NNPS NNPS O
Superstat NNP NNP O
PT NNP NNP O
12.9 CD CD O
( ( ( O
10.3-13.2 NN NN O
) ) ) O
sec NN NN O
Superstat NNP NNP O
PT-INR NNP NNP O
1.1 CD CD O
Superstat NNP NNP O
APTT NNP NNP O
20.6 CD CD O
L NNP NNP O
( ( ( O
22.1-34.0 JJ JJ O
) ) ) O
sec NN NN O
STUDIES NNP NNP O
: : : O
Plain NNP NNP O
Films NNP NNP O
: : : O
FINDINGS NNS NNS O
: : : O
Right RB RB O
hip NN NN O
: : : O
There EX EX O
is VBZ VBZ O
a DT DT O
transverse NN NN O
transcervical JJ JJ O
fracture NN NN O
through IN IN O
the DT DT O
sphenoid NN NN O
. . . O
   
There EX EX O
is VBZ VBZ O
lateral JJ JJ O
superior JJ JJ O
displacement NN NN O
of IN IN O
the DT DT O
distal JJ JJ O
segment NN NN O
. . . O
   
There EX EX O
is VBZ VBZ O
no DT DT O
evidence NN NN O
of IN IN O
dislocation NN NN O
. . . O
   
Pelvis NNP NNP O
: : : O
There EX EX O
is VBZ VBZ O
diffuse NN NN O
osteopenia NN NN O
involving VBG VBG O
the DT DT O
pelvis NN NN O
. . . O
   
Again RB RB O
noted VBD VBD O
is VBZ VBZ O
a DT DT O
transcervical JJ JJ O
fracture NN NN O
to TO TO O
the DT DT O
right NN NN O
femur NN NN O
. . . O
   
There EX EX O
is VBZ VBZ O
superior JJ JJ O
lateral NN NN O
displacement NN NN O
of IN IN O
the DT DT O
distal JJ JJ O
fracture NN NN O
segment NN NN O
. . . O
   
The DT DT O
sacrum NN NN O
is VBZ VBZ O
not RB RB O
well RB RB O
seen VBN VBN O
secondary JJ JJ O
to TO TO O
overlying VBG VBG O
bowel NN NN O
gas NN NN O
. . . O
   
Minimal NNP NNP O
degenerative JJ JJ O
changes NNS NNS O
of IN IN O
the DT DT O
lumbar NN NN O
spine NN NN O
are VBP VBP O
noted VBN VBN O
. . . O
   
Shoulder NNP NNP O
: : : O
There EX EX O
is VBZ VBZ O
no DT DT O
evidence NN NN O
of IN IN O
left VBD VBD O
shoulder NN NN O
dislocation NN NN O
or CC CC O
acute JJ JJ O
fracture NN NN O
. . . O
   
The DT DT O
visualized JJ JJ O
lung NN NN O
fields NNS NNS O
and CC CC O
ribs NNS NNS O
are VBP VBP O
intact JJ JJ O
. . . O
   
There EX EX O
is VBZ VBZ O
minimal JJ JJ O
degenerative JJ JJ O
change NN NN O
involving VBG VBG O
the DT DT O
left NN NN O
a.c. NN NN O
joint NN NN O
. . . O
   
Chest NN NN O
: : : O
Comparison NNP NNP O
to TO TO O
10/31/97 CD CD I-DATE
. . . O
   
Multiple NNP NNP O
pulmonary JJ JJ O
nodules NNS NNS O
are VBP VBP O
noted VBN VBN O
. . . O
   
There EX EX O
is VBZ VBZ O
no DT DT O
evidence NN NN O
of IN IN O
focal JJ JJ O
consolidation NN NN O
or CC CC O
pulmonary JJ JJ O
edema NN NN O
. . . O
   
No DT DT O
large JJ JJ O
pleural JJ JJ O
effusion NN NN O
or CC CC O
appreciable JJ JJ O
pneumothorax NN NN O
is VBZ VBZ O
identified VBN VBN O
. . . O
   
The DT DT O
cardiomediastinal JJ JJ O
silhouette NN NN O
is VBZ VBZ O
stable JJ JJ O
. . . O
   
Degenerative NNP NNP O
changes NNS NNS O
of IN IN O
the DT DT O
thoracic NN NN O
spine NN NN O
are VBP VBP O
noted VBN VBN O
. . . O
   
IMPRESSION NNP NNP O
: : : O
Right RB RB O
transcervical JJ JJ O
femoral JJ JJ O
fracture NN NN O
. . . O
   
No DT DT O
evidence NN NN O
of IN IN O
dislocation NN NN O
. . . O
   
No DT DT O
evidence NN NN O
of IN IN O
shoulder NN NN O
dislocation NN NN O
. . . O
   
Multiple NNP NNP O
pulmonary JJ JJ O
nodules NNS NNS O
consistent JJ JJ O
with IN IN O
metastatic JJ JJ O
disease NN NN O
. . . O
   
FINDINGS NNS NNS O
: : : O
Previously RB RB O
noted VBD VBD O
minimally RB RB O
displaced VBN VBN O
right NN NN O
hip NN NN O
fracture NN NN O
. . . O
   
Osteoarthrosis NNP NNP O
of IN IN O
the DT DT O
knee NN NN O
. . . O
   
Soft JJ JJ O
tissues NNS NNS O
swelling VBG VBG O
along IN IN O
the DT DT O
medial JJ JJ O
aspect NN NN O
of IN IN O
the DT DT O
knee NN NN O
is VBZ VBZ O
noted VBN VBN O
. . . O
   
There EX EX O
are VBP VBP O
vascular JJ JJ O
calcifications NNS NNS O
. . . O
   
Generalized NNP NNP O
osteopenia NN NN O
. . . O
   
IMPRESSION NNP NNP O
: : : O
Right RB RB O
hip NN NN O
fracture NN NN O
as IN IN O
previously RB RB O
described VBD VBD O
. . . O
   
Osteoarthrosis NNP NNP O
of IN IN O
the DT DT O
knee NN NN O
. . . O
   
EKG NNP NNP O
: : : O
Sinus NNP NNP O
bradycardia NNS NNS O
. . . O
   
ASSESSMENT NNP NNP O
& CC CC O
amp NN NN O
; : : O
   
PLAN NNP NNP O
: : : O
87yo CD CD O
F NN NN O
with IN IN O
h/o NN NN O
metastatic JJ JJ O
pancreatic JJ JJ O
CA NNP NNP O
s/p NN NN O
1 CD CD O
dose NN NN O
of IN IN O
gemcitabine NN NN O
and CC CC O
biliary JJ JJ O
stenting NN NN O
, , , O
CKD NNP NNP O
, , , O
DM NNP NNP O
, , , O
and CC CC O
HTN NNP NNP O
who WP WP O
p/w VBP VBP O
right JJ JJ O
hip NN NN O
fracture NN NN O
s/p NN NN O
mechanical JJ JJ O
fall NN NN O
at IN IN O
home NN NN O
. . . O
   
The DT DT O
plan NN NN O
of IN IN O
care NN NN O
by IN IN O
issue NN NN O
is VBZ VBZ O
as IN IN O
follows VBZ VBZ O
: : : O
( ( ( O
1 CD CD O
) ) ) O
Right RB RB O
hip NN NN O
fracture NN NN O
: : : O
Patient NNP NNP O
will MD MD O
require VB VB O
post-operative JJ JJ O
anti-coagulation JJ JJ O
. . . O
   
Patient NNP NNP O
is VBZ VBZ O
undergoing VBG VBG O
high-risk JJ JJ O
procedure NN NN O
and CC CC O
is VBZ VBZ O
also RB RB O
at IN IN O
increased VBN VBN O
risk NN NN O
for IN IN O
VTE NNP NNP O
given VBN VBN O
cancer NN NN O
dx NN NN O
. . . O
   
According VBG VBG O
to TO TO O
guidelines NNS NNS O
from IN IN O
ACCP NNP NNP O
: : : O
#UFH NN NN O
5000 CD CD O
Units NNP NNP O
SC NNP NNP O
TID NNP NNP O
[ NN NN O
or CC CC O
LMWH NNP NNP O
& CC CC O
gt NN NN O
; : : O
   
3400 CD CD O
Units NNP NNP O
SC NNP NNP O
QD NNP NNP O
( ( ( O
her PRP$ PRP$ O
CrCl NNP NNP O
& CC CC O
lt NN NN O
; : : O
   
30 CD CD O
, , , O
therefore RB RB O
renally RB RB O
dosed JJ JJ O
= SYM SYM O
LMWH NNP NNP O
30mg CD CD O
SC NNP NNP O
QD NNP NNP O
) ) ) O
] NN NN O
to TO TO O
be VB VB O
started VBN VBN O
either CC CC O
in IN IN O
PACU NNP NNP O
or CC CC O
on IN IN O
the DT DT O
floor NN NN O
. . . O
   
#Compression NN NN O
stockings NNS NNS O
#Pneumo-boots JJ JJ O
#Plan NN NN O
to TO TO O
continue VB VB O
VTE NNP NNP O
prophylaxis NNS NNS O
for IN IN O
4-6 JJ JJ O
weeks NNS NNS O
post-op JJ JJ O
#Encourage NN NN O
ambulation NN NN O
as RB RB O
soon RB RB O
as IN IN O
tolerated JJ JJ O
( ( ( O
per IN IN O
ortho NN NN O
, , , O
pt NN NN O
might MD MD O
be VB VB O
ambulatory JJ JJ O
as RB RB O
soon RB RB O
as IN IN O
tomorrow NN NN O
) ) ) O
( ( ( O
2 CD CD O
) ) ) O
DM NNP NNP O
Patient NNP NNP O
recently RB RB O
started VBD VBD O
on IN IN O
insulin NN NN O
at IN IN O
home NN NN O
. . . O
   
Will NNP NNP O
continue VB VB O
half NN NN O
dose NN NN O
of IN IN O
home NN NN O
insulin NN NN O
with IN IN O
IVF NNP NNP O
with IN IN O
glucose NN NN O
. . . O
   
#RISS, NN NN O
until IN IN O
tolerating VBG VBG O
POs NNP NNP O
, , , O
then RB RB O
restart VB VB O
normal JJ JJ O
insulin NN NN O
. . . O
   
( ( ( O
3 CD CD O
) ) ) O
Dispo NNP NNP O
Plan NNP NNP O
to TO TO O
D/C NNP NNP O
when WRB WRB O
clinically RB RB O
stable JJ JJ O
post-op JJ JJ O
. . . O
   
Per IN IN O
PCP NNP NNP O
, , , O
patient NN NN O
would MD MD O
like VB VB O
to TO TO O
return VB VB O
directly RB RB O
home NN NN O
after IN IN O
surgery NN NN O
without IN IN O
rehab NN NN O
( ( ( O
home NN NN O
rehab NN NN O
) ) ) O
. . . O
   
Family NNP NNP O
notes NNS NNS O
that IN IN O
patient NN NN O
currently RB RB O
lives VBZ VBZ O
at IN IN O
daughter&#8217; NN NN O
   
s VBZ VBZ O
home NN NN O
where WRB WRB O
there EX EX O
are VBP VBP O
many JJ JJ O
steps NNS NNS O
which WDT WDT O
would MD MD O
make VB VB O
home NN NN O
rehab NN NN O
difficult JJ JJ O
. . . O
   
#Consider NN NN O
rehab NN NN O
placement NN NN O
, , , O
follow-up JJ JJ O
attending NN NN O
recs NN NN O
, , , O
discuss VB VB O
with IN IN O
family NN NN O
in IN IN O
AM NNP NNP O
______________________________________ NNP NNP O
_ NN NN O
Brandon NNP NNP I-DOCTOR
Hale NNP NNP I-DOCTOR
EFS NNP NNP I-HOSPITAL
III NNP NNP O
, , , O
Internal NNP NNP O
Medicine NNP NNP O
Pager NNP NNP O
#28913 NN NN O
ADDENDUM NNP NNP O
: : : O
Case NN NN O
and CC CC O
plan NN NN O
discussed VBN VBN O
and CC CC O
incorporated VBN VBN O
into IN IN O
this DT DT O
excellent JJ JJ O
EFSIII NNP NNP O
Note VB VB O
. . . O
   
______________________________ NN NN O
_ NN NN O
Fred NNP NNP I-DOCTOR
Allen NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
   
Medicine NNP NNP O
PGY1 NNP NNP O
Pager NNP NNP O
#80817 NN NN O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2084-03-05 NN NN I-DATE
77 CD CD I-AGE
yo NN NN O
F NN NN O
one CD CD O
hour NN NN O
late JJ JJ O
for IN IN O
appt NN NN O
. . . O
   
She PRP PRP O
is VBZ VBZ O
planning VBG VBG O
parathyroid NN NN O
surgery NN NN O
. . . O
   
She PRP PRP O
is VBZ VBZ O
supposed VBN VBN O
to TO TO O
be VB VB O
taking VBG VBG O
ca NNS NNS O
and CC CC O
vit NN NN O
. . . O
   
D NNP NNP O
supplements NNS NNS O
. . . O
   
She PRP PRP O
took VBD VBD O
the DT DT O
vit NN NN O
. . . O
   
D NNP NNP O
for IN IN O
a DT DT O
few JJ JJ O
days NNS NNS O
, , , O
but CC CC O
that DT DT O
is VBZ VBZ O
all DT DT O
. . . O
   
She PRP PRP O
has VBZ VBZ O
fatigue NN NN O
and CC CC O
leg NN NN O
cramps NNS NNS O
attrib NN NN O
. . . O
   
to TO TO O
hyperparathyroidism NN NN O
. . . O
   
Medications NNP NNP O
Premarin NNP NNP O
( ( ( O
CONJUGATED NNP NNP O
Estrogens NNP NNP O
) ) ) O
2 CD CD O
GM NNP NNP O
PV NNP NNP O
QHS NNP NNP O
: : : O
SIG NNP NNP O
ONE CD CD O
APPLICATOR NNP NNP O
FULL NNP NNP O
AT IN IN O
HSX NNP NNP O
1WK CD CD O
THEN RB RB O
TWICE RB RB O
PER IN IN O
WEEK NN NN O
Ativan NNP NNP O
( ( ( O
LORAZEPAM NNP NNP O
) ) ) O
0.5MG, CD CD O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PNGT NNP NNP O
QD NNP NNP O
Hydralazine NNP NNP O
Hcl NNP NNP O
25MG CD CD O
, , , O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
BID NNP NNP O
GLYBURIDE NNP NNP O
5MG CD CD O
, , , O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
ATENOLOL NNP NNP O
50MG CD CD O
, , , O
0.5 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Aspirin NNP NNP O
( ( ( O
CHILDRENS NNP NNP O
) ) ) O
( ( ( O
ACETYLSALICYLIC NNP NNP O
Aci NNP NNP O
. . . O
   
. . . O
   
. . . O
   
81MG CD CD O
, , , O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Stopped NNP NNP O
cozaar NN NN O
b/o NN NN O
noncoverage NN NN O
, , , O
stopped VBD VBD O
nifedipine NN NN O
b/c NN NN O
did VBD VBD O
not RB RB O
agree VB VB O
w NN NN O
/ NN NN O
her PRP PRP O
. . . O
   
Allergies NNP NNP O
Codeine NNP NNP O
- : : O
GI NNP NNP O
upset VBD VBD O
Sulfa NNP NNP O
- : : O
Rash NNP NNP O
* NN NN O
lisinopril NN NN O
- : : O
cough NN NN O
Penicillins NNS NNS O
- : : O
Rash NNP NNP O
* NN NN O
hctz NN NN O
- : : O
cramps NNS NNS O
Problems NNS NNS O
Diabetes NNP NNP O
mellitus JJ JJ O
- - - O
does VBZ VBZ O
not RB RB O
do VB VB O
home NN NN O
glucometry NN NN O
b/c NN NN O
thinks VBZ VBZ O
she PRP PRP O
knows VBZ VBZ O
what WP WP O
her PRP$ PRP$ O
sugar NN NN O
is VBZ VBZ O
w/o JJ JJ O
testing NN NN O
it PRP PRP O
. . . O
   
Recent JJ JJ O
HBA1C<7%, NNP NNP O
LDL NNP NNP O
124 CD CD O
. . . O
   
Hypertension NNP NNP O
- : : O
no DT DT O
CP NNP NNP O
, , , O
SOB NNP NNP O
, , , O
HA NNP NNP O
, , , O
edema NN NN O
, , , O
dizziness NN NN O
. . . O
   
Renal NNP NNP O
cancer NN NN O
: : : O
incidentally RB RB O
discovered VBN VBN O
, , , O
s/p NN NN O
nephrectomy NN NN O
Dyspepsia NNP NNP O
/ NN NN O
H NNP NNP O
Pylori NNP NNP O
: : : O
unable JJ JJ O
to TO TO O
tolerate VB VB O
bismuth NN NN O
, , , O
TCN NNP NNP O
, , , O
metronidazole NN NN O
or CC CC O
clarithromycin NN NN O
and CC CC O
metronidazole NN NN O
. . . O
   
No DT DT O
sx NN NN O
at IN IN O
this DT DT O
time NN NN O
. . . O
   
Thyroid NNP NNP O
nodules NNS NNS O
: : : O
biopsy NN NN O
benign NN NN O
Plantar NNP NNP O
Fasciitis NNP NNP O
Osteoporosis NNP NNP O
: : : O
bone NN NN O
density NN NN O
9/11/2082 CD CD I-DATE
Colonic NNP NNP O
polyps NN NN O
: : : O
tubular NN NN O
adenoma NN NN O
. . . O
   
g SYM SYM O
+ NN NN O
stool NN NN O
5/83 CD CD I-DATE
. . . O
   
Refusing NNP NNP O
f/u NN NN O
colo NN NN O
. . . O
   
Diverticulosis NNP NNP O
H/O NNP NNP O
Vitamin NNP NNP O
D NNP NNP O
deficiency NN NN O
SH NNP NNP O
- : : O
mostly RB RB O
worried VBN VBN O
about IN IN O
husband NN NN O
's POS POS O
health NN NN O
problems NNS NNS O
. . . O
   
PE NNP NNP O
- : : O
appears VBZ VBZ O
well RB RB O
BP NNP NNP O
170/100 CD CD O
HR NNP NNP O
66 CD CD O
Lungs NNP NNP O
clear JJ JJ O
Cor NNP NNP O
reg NN NN O
w/o NN NN O
MRG NNP NNP O
No DT DT O
edema NN NN O
IMP NNP NNP O
HyperPTH NNP NNP O
- : : O
for IN IN O
surgery NN NN O
, , , O
but CC CC O
we PRP PRP O
need VBP VBP O
to TO TO O
control VB VB O
her PRP$ PRP$ O
BP NNP NNP O
first JJ JJ O
. . . O
   
She PRP PRP O
needs VBZ VBZ O
to TO TO O
take VB VB O
the DT DT O
supplements NNS NNS O
rec VBP VBP O
. . . O
   
by IN IN O
Dr NNP NNP O
Lawson NNP NNP I-DOCTOR
. . . O
   
HTN NNP NNP O
not RB RB O
controlled VBD VBD O
, , , O
not RB RB O
adherent NN NN O
to TO TO O
rx VB VB O
, , , O
various JJ JJ O
barriers NNS NNS O
. . . O
   
DM NNP NNP O
pr NN NN O
. . . O
   
controlled VBN VBN O
, , , O
though RB RB O
does VBZ VBZ O
not RB RB O
check VB VB O
glycemia NN NN O
. . . O
   
Needs NNP NNP O
LDL<100 NNP NNP O
Anxiety NNP NNP O
Hx NNP NNP O
colon NN NN O
polyps NN NN O
, , , O
f/u NN NN O
is VBZ VBZ O
recommended VBN VBN O
. . . O
   
Hx NNP NNP O
renal JJ JJ O
ca NN NN O
, , , O
rec NN NN O
. . . O
   
f/u NN NN O
. . . O
   
H. NN NN O
pylori NN NN O
, , , O
not RB RB O
treated VBN VBN O
, , , O
no DT DT O
current JJ JJ O
sx NN NN O
. . . O
   
PLAN NNP NNP O
: : : O
Given VBN VBN O
rec NN NN O
. . . O
   
for IN IN O
Caltrate NNP NNP O
600+D CD CD O
to TO TO O
take VB VB O
bid NN NN O
. . . O
   
Rx NNP NNP O
Benicar NNP NNP O
, , , O
ARB NNP NNP O
covered VBN VBN O
by IN IN O
free JJ JJ O
care NN NN O
. . . O
   
Lipitor NNP NNP O
rx NN NN O
. . . O
   
She PRP PRP O
agrees VBZ VBZ O
to TO TO O
resume VB VB O
furosemide NN NN O
, , , O
if IN IN O
can MD MD O
skip VB VB O
it PRP PRP O
on IN IN O
days NNS NNS O
she PRP PRP O
goes VBZ VBZ O
out IN IN O
, , , O
rx NN NN O
to TO TO O
RHC NNP NNP O
. . . O
   
F/U NNP NNP O
1-2 JJ JJ O
mo NN NN O
, , , O
BP NNP NNP O
, , , O
breast NN NN O
check NN NN O
, , , O
order NN NN O
abd/pelvic JJ JJ O
CT NNP NNP O
surveillance NN NN O
s/p NN NN O
renal JJ JJ O
ca NN NN O
, , , O
f/u NN NN O
labs NNS NNS O
. . . O
   
She PRP PRP O
declines VBZ VBZ O
colo NN NN O
, , , O
despite IN IN O
stated JJ JJ O
risk NN NN O
of IN IN O
colon NN NN O
ca NN NN O
w NN NN O
/ NN NN O
polyps NN NN O
, , , O
but CC CC O
might MD MD O
consider VB VB O
it PRP PRP O
later RB RB O
. . . O
   
She PRP PRP O
is VBZ VBZ O
advised VBN VBN O
to TO TO O
stop VB VB O
the DT DT O
asa NN NN O
10 CD CD O
days NNS NNS O
prior RB RB O
to TO TO O
any DT DT O
surgery NN NN O
. . . O
   
____________________________________________ NN NN O
_ NN NN O
Patricia NNP NNP I-DOCTOR
Lund NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
cc:Dr NN NN O
Lawson NNP NNP I-DOCTOR
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2062-05-30 JJ JJ I-DATE
Internal NNP NNP O
Medicine NNP NNP O
BARTON NNP NNP I-HOSPITAL
MEMORIAL NNP NNP I-HOSPITAL
HOSPITAL NNP NNP I-HOSPITAL
History NN NN O
of IN IN O
present JJ JJ O
illness NN NN O
This DT DT O
was VBD VBD O
a DT DT O
followup NN NN O
visit NN NN O
for IN IN O
this DT DT O
28-year-old JJ JJ O
black JJ JJ O
man NN NN O
with IN IN O
the DT DT O
medical JJ JJ O
problems NNS NNS O
of IN IN O
type NN NN O
1 CD CD O
diabetes NNS NNS O
mellitus NN NN O
, , , O
hypertension NN NN O
, , , O
thrombocytosis NN NN O
, , , O
and CC CC O
chronic JJ JJ O
renal JJ JJ O
insufficiency NN NN O
. . . O
   
The DT DT O
patient NN NN O
states NNS NNS O
that IN IN O
since IN IN O
I PRP PRP O
last JJ JJ O
saw VBD VBD O
him PRP PRP O
, , , O
he PRP PRP O
is VBZ VBZ O
being VBG VBG O
evaluated VBN VBN O
further JJ JJ O
for IN IN O
renal JJ JJ O
transplant NN NN O
. . . O
   
In IN IN O
addition NN NN O
, , , O
attempts NNS NNS O
were VBD VBD O
made VBN VBN O
to TO TO O
place VB VB O
an DT DT O
AV NNP NNP O
fistula NN NN O
for IN IN O
dialysis NNS NNS O
in IN IN O
his PRP$ PRP$ O
right JJ JJ O
arm NN NN O
and CC CC O
this DT DT O
did VBD VBD O
not RB RB O
work VB VB O
out RP RP O
. . . O
   
Given VBN VBN O
that IN IN O
this DT DT O
one CD CD O
did VBD VBD O
not RB RB O
work VB VB O
out RP RP O
, , , O
a DT DT O
decision NN NN O
was VBD VBD O
made VBN VBN O
to TO TO O
wait VB VB O
to TO TO O
see VB VB O
if IN IN O
there EX EX O
was VBD VBD O
a DT DT O
transplant JJ JJ O
candidate NN NN O
for IN IN O
him PRP PRP O
to TO TO O
get VB VB O
a DT DT O
renal JJ JJ O
transplant NN NN O
rather RB RB O
than IN IN O
put VB VB O
all DT DT O
of IN IN O
the DT DT O
pieces NNS NNS O
in IN IN O
place NN NN O
for IN IN O
hemodialysis NN NN O
if IN IN O
in IN IN O
fact NN NN O
he PRP PRP O
would MD MD O
need VB VB O
it PRP PRP O
. . . O
   
Most JJS JJS O
recently RB RB O
, , , O
the DT DT O
patient NN NN O
's POS POS O
creatinine NN NN O
was VBD VBD O
6.4 CD CD O
and CC CC O
his PRP$ PRP$ O
BUN NNP NNP O
was VBD VBD O
46 CD CD O
two CD CD O
weeks NNS NNS O
ago RB RB O
. . . O
   
Major NNP NNP O
Problems NNS NNS O
Diabetes NNP NNP O
mellitus NN NN O
Type NNP NNP O
1 CD CD O
diabetes NNS NNS O
mellitus NN NN O
. . . O
   
The DT DT O
patient NN NN O
's POS POS O
diabetes NN NN O
is VBZ VBZ O
currently RB RB O
well RB RB O
controlled VBN VBN O
on IN IN O
his PRP$ PRP$ O
current JJ JJ O
regimen NNS NNS O
of IN IN O
NPH NNP NNP O
and CC CC O
Regular NNP NNP O
Insulin NNP NNP O
. . . O
   
Most JJS JJS O
recently RB RB O
, , , O
his PRP$ PRP$ O
hemoglobin NN NN O
A1c NNP NNP O
was VBD VBD O
6.6 CD CD O
on IN IN O
02/27/2062 CD CD I-DATE
. . . O
   
The DT DT O
patient NN NN O
states NNS NNS O
that IN IN O
all DT DT O
of IN IN O
his PRP$ PRP$ O
fingersticks NNS NNS O
at IN IN O
home NN NN O
have VBP VBP O
been VBN VBN O
consistently RB RB O
between IN IN O
70 CD CD O
and CC CC O
110 CD CD O
. . . O
   
Chronic NNP NNP O
renal JJ JJ O
insufficiency NN NN O
The DT DT O
patient NN NN O
is VBZ VBZ O
being VBG VBG O
evaluated VBN VBN O
for IN IN O
renal JJ JJ O
transplant NN NN O
and CC CC O
possible JJ JJ O
candidate NN NN O
that IN IN O
his PRP$ PRP$ O
family NN NN O
members NNS NNS O
and CC CC O
friends NNS NNS O
will MD MD O
be VB VB O
tested VBN VBN O
to TO TO O
see VB VB O
whether IN IN O
there EX EX O
are VBP VBP O
a DT DT O
match NN NN O
shortly RB RB O
. . . O
   
Hypertension NNP NNP O
The DT DT O
patient NN NN O
is VBZ VBZ O
on IN IN O
a DT DT O
tremendous JJ JJ O
amount NN NN O
of IN IN O
medication NN NN O
to TO TO O
treat VB VB O
his PRP$ PRP$ O
hypertension NN NN O
. . . O
   
Currently RB RB O
, , , O
he PRP PRP O
is VBZ VBZ O
on IN IN O
labetalol NN NN O
600 CD CD O
mg NN NN O
PO NNP NNP O
BID NNP NNP O
, , , O
furosemide NN NN O
20 CD CD O
mg NN NN O
PO NNP NNP O
QD NNP NNP O
, , , O
clonidine NN NN O
0.3 CD CD O
mg NN NN O
PO NNP NNP O
QHS NNP NNP O
, , , O
lisinopril NN NN O
40 CD CD O
mg NN NN O
PO NNP NNP O
QD NNP NNP O
, , , O
and CC CC O
nifedipine NN NN O
XL NNP NNP O
90 CD CD O
mg NN NN O
PO NNP NNP O
QHS NNP NNP O
. . . O
   
BHypertension NNP NNP O
is VBZ VBZ O
currently RB RB O
well RB RB O
controlled VBN VBN O
on IN IN O
this DT DT O
regimen NN NN O
. . . O
   
Erectile NNP NNP O
dysfunction NN NN O
The DT DT O
patient NN NN O
was VBD VBD O
experiencing VBG VBG O
erectile JJ JJ O
dysfunction NN NN O
largely RB RB O
on IN IN O
Toprol NNP NNP O
. . . O
   
For IN IN O
this DT DT O
reason NN NN O
, , , O
the DT DT O
Toprol NNP NNP O
was VBD VBD O
discontinued VBN VBN O
and CC CC O
the DT DT O
patient NN NN O
is VBZ VBZ O
having VBG VBG O
less JJR JJR O
of IN IN O
a DT DT O
problem NN NN O
with IN IN O
this DT DT O
issue NN NN O
currently RB RB O
. . . O
   
Anemia NNP NNP O
The DT DT O
patient NN NN O
's POS POS O
anemia NN NN O
is VBZ VBZ O
due JJ JJ O
to TO TO O
multiple JJ JJ O
different JJ JJ O
factors NNS NNS O
. . . O
   
He PRP PRP O
has VBZ VBZ O
recently RB RB O
been VBN VBN O
started VBN VBN O
on IN IN O
erythropoietin NN NN O
, , , O
which WDT WDT O
he PRP PRP O
is VBZ VBZ O
getting VBG VBG O
via IN IN O
injection NN NN O
in IN IN O
the DT DT O
Internal NNP NNP O
Medicine NNP NNP O
three CD CD O
times NNS NNS O
a DT DT O
week NN NN O
. . . O
   
Most JJS JJS O
recently RB RB O
, , , O
his PRP$ PRP$ O
hematocrit NN NN O
was VBD VBD O
29.4 CD CD O
% NN NN O
two CD CD O
weeks NNS NNS O
ago RB RB O
. . . O
   
Thrombocytosis NNP NNP O
The DT DT O
patient NN NN O
is VBZ VBZ O
on IN IN O
Hydria NNP NNP O
500 CD CD O
mg NN NN O
PO NNP NNP O
QD NNP NNP O
for IN IN O
this DT DT O
problem NN NN O
and CC CC O
he PRP PRP O
is VBZ VBZ O
being VBG VBG O
followed VBN VBN O
by IN IN O
Hematology NNP NNP O
. . . O
   
Hyperlipidemia NNP NNP O
The DT DT O
patient NN NN O
's POS POS O
hyperlipidemia NN NN O
is VBZ VBZ O
new JJ JJ O
. . . O
   
Most JJS JJS O
recently RB RB O
, , , O
his PRP$ PRP$ O
lipids NNS NNS O
were VBD VBD O
done VBN VBN O
on IN IN O
02/27/2062 CD CD I-DATE
and CC CC O
at IN IN O
that DT DT O
time NN NN O
his PRP$ PRP$ O
total JJ JJ O
cholesterol NN NN O
was VBD VBD O
294 CD CD O
and CC CC O
his PRP$ PRP$ O
LDL NNP NNP O
was VBD VBD O
209 CD CD O
. . . O
   
This DT DT O
is VBZ VBZ O
a DT DT O
new JJ JJ O
problem NN NN O
for IN IN O
the DT DT O
patient NN NN O
, , , O
given VBN VBN O
that IN IN O
his PRP$ PRP$ O
lipids NNS NNS O
were VBD VBD O
fairly RB RB O
normal JJ JJ O
six CD CD O
months NNS NNS O
ago RB RB O
. . . O
   
Given VBN VBN O
this DT DT O
, , , O
the DT DT O
patient NN NN O
was VBD VBD O
started VBN VBN O
on IN IN O
Lipitor NNP NNP O
20 CD CD O
mg NN NN O
PO NNP NNP O
QD NNP NNP O
for IN IN O
hyperlipidemia NN NN O
. . . O
   
We PRP PRP O
will MD MD O
repeat VB VB O
his PRP$ PRP$ O
lipid JJ JJ O
panel NN NN O
at IN IN O
the DT DT O
time NN NN O
of IN IN O
his PRP$ PRP$ O
next JJ JJ O
visit NN NN O
in IN IN O
eight CD CD O
weeks NNS NNS O
. . . O
   
Active JJ JJ O
Medications NNP NNP O
aspirin NN NN O
81mg CD CD O
po NN NN O
qd NN NN O
clonidine NN NN O
0.3mg CD CD O
po NN NN O
1 CD CD O
tabs NNS NNS O
po NN NN O
q NN NN O
pm NN NN O
furosemide NN NN O
20 CD CD O
mg NN NN O
po NN NN O
qd NN NN O
Humulin NNP NNP O
n NN NN O
40 CD CD O
units NNS NNS O
qam NN NN O
sc NN NN O
36 CD CD O
units NNS NNS O
qpm NN NN O
take NN NN O
30-60min NN NN O
before IN IN O
a DT DT O
meal NN NN O
or CC CC O
hs NN NN O
Hydrea NNP NNP O
500mg CD CD O
po NN NN O
bid NN NN O
Insulin NNP NNP O
syringes NNS NNS O
( ( ( O
u NN NN O
100 CD CD O
) ) ) O
labetalol NN NN O
HCl NNP NNP O
tablets NNS NNS O
600 CD CD O
mg NN NN O
po NN NN O
bid NN NN O
Lancets NNP NNP O
Lipitor NNP NNP O
20mg CD CD O
po NN NN O
qd NN NN O
lisinopril NN NN O
40mg CD CD O
po NN NN O
qd NN NN O
Nexium NNP NNP O
40mg CD CD O
po NN NN O
bid NN NN O
take NN NN O
1h CD CD O
before IN IN O
meal NN NN O
nifedipine NN NN O
xl NN NN O
90mg CD CD O
sr NN NN O
po NN NN O
qhs NN NN O
do VBP VBP O
not RB RB O
cut/crush/chew VB VB O
Onetouch RB RB O
test NN NN O
strips NNS NNS O
potassium NN NN O
chloride NN NN O
10meq CD CD O
po NN NN O
qd NN NN O
regular JJ JJ O
insulin NN NN O
25 CD CD O
units NNS NNS O
qam NN NN O
sc NN NN O
20 CD CD O
units NNS NNS O
qpm NN NN O
give JJ JJ O
30-60min NN NN O
before IN IN O
a DT DT O
meal NN NN O
Change NNP NNP O
in IN IN O
therapies NNS NNS O
and CC CC O
Renewals NNP NNP O
Hydrea NNP NNP O
500mg CD CD O
po NN NN O
bid NN NN O
QTY:60 NNP NNP O
Refills:5 NNP NNP O
Start NNP NNP O
: : : O
10/16/2061 CD CD I-DATE
Toprol NNP NNP O
xl NN NN O
100 CD CD O
mg NN NN O
po NN NN O
bid NN NN O
QTY:30 NNP NNP O
Refills:5 NNP NNP O
Start NNP NNP O
: : : O
10/16/2061 CD CD I-DATE
End NN NN O
: : : O
5/30/2062 CD CD I-DATE
- - - O
Inactivated NNP NNP O
furosemide NN NN O
20 CD CD O
mg NN NN O
po NN NN O
qd NN NN O
QTY:30 NNP NNP O
Refills:5 NNP NNP O
Start NNP NNP O
: : : O
10/16/2061 CD CD I-DATE
labetalol NN NN O
HCl NNP NNP O
tablets NNS NNS O
600 CD CD O
mg NN NN O
po NN NN O
bid NN NN O
QTY:60 NNP NNP O
Refills:5 NNP NNP O
Start NNP NNP O
: : : O
05/30/2062 CD CD I-DATE
Lipitor NNP NNP O
20mg CD CD O
po NN NN O
qd NN NN O
QTY:30 NNP NNP O
Refills:5 NNP NNP O
Start NNP NNP O
: : : O
05/30/2062 CD CD I-DATE
Physical JJ JJ O
examination NN NN O
Blood NNP NNP O
pressure NN NN O
120/88 CD CD O
Weight NNP NNP O
215 CD CD O
pounds NNS NNS O
General NNP NNP O
appearance NN NN O
This DT DT O
was VBD VBD O
a DT DT O
well-developed JJ JJ O
, , , O
well-nourished JJ JJ O
black JJ JJ O
man NN NN O
, , , O
in IN IN O
no DT DT O
distress NN NN O
Chest NN NN O
Lungs NNP NNP O
were VBD VBD O
clear JJ JJ O
throughout IN IN O
to TO TO O
AandP NNP NNP O
Cor NNP NNP O
Regular NNP NNP O
rate NN NN O
and CC CC O
rhythm NN NN O
with IN IN O
no DT DT O
murmurs NNS NNS O
, , , O
rubs NNS NNS O
, , , O
or CC CC O
gallops NNS NNS O
Selected VBN VBN O
recent JJ JJ O
labs NNS NNS O
Fingerstick NNP NNP O
blood NN NN O
sugar NN NN O
   
75 CD CD O
. . . O
Disposition NNP NNP O
The DT DT O
patient NN NN O
will MD MD O
follow VB VB O
up RP RP O
with IN IN O
me PRP PRP O
again RB RB O
in IN IN O
six CD CD O
to TO TO O
eight CD CD O
weeks NNS NNS O
. . . O
   
Note NN NN O
transcribed VBN VBN O
by IN IN O
outside IN IN O
service NN NN O
Transcription NNP NNP O
errors NNS NNS O
may MD MD O
be VB VB O
present JJ JJ O
. . . O
   
Signed VBN VBN O
electronically RB RB O
by IN IN O
Ali NNP NNP O
, , , O
Felicia NNP NNP I-DOCTOR
on IN IN O
Jun NNP NNP I-DATE
6 CD CD O
, , , O
2062 CD CD I-DATE
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2067-04-14 NNP NNP I-DATE
Colonial NNP NNP I-HOSPITAL
Haven NNP NNP I-HOSPITAL
Intern NNP NNP O
Admission NNP NNP O
Note VB VB O
PATIENT NNP NNP O
: : : O
Pamela NNP NNP I-PATIENT
Ostrander NNP NNP I-PATIENT
MRN NNP NNP O
: : : O
1612187 CD CD I-MEDICALRECORD
ADMIT NNP NNP O
DATE NN NN O
: : : O
4/13/67 CD CD I-DATE
PCP NNP NNP O
: : : O
Gregory NNP NNP I-DOCTOR
Rosas NNP NNP I-DOCTOR
, , , O
MD NNP NNP O
ATTENDING NNP NNP O
PHYSICIAN NNP NNP O
: : : O
Gregory NNP NNP I-DOCTOR
Rosas NNP NNP I-DOCTOR
, , , O
MD NNP NNP O
CHIEF NNP NNP O
COMPLAINT NNP NNP O
Hyponatremia NNP NNP O
HISTORY NN NN O
OF IN IN O
THE DT DT O
PRESENT NNP NNP O
ILLNESS NNP NNP O
Ms NNP NNP O
. . . O
Ostrander NNP NNP I-PATIENT
is VBZ VBZ O
a DT DT O
64 CD CD I-AGE
yo NN NN O
woman NN NN O
with IN IN O
a DT DT O
hx NN NN O
of IN IN O
schizophrenia NN NN O
, , , O
DM2 NNP NNP O
, , , O
HTN NNP NNP O
, , , O
HL NNP NNP O
presenting VBG VBG O
with IN IN O
confusion NN NN O
and CC CC O
hyponatremia NN NN O
. . . O
   
Patient NNP NNP O
states NNS NNS O
over IN IN O
the DT DT O
past JJ JJ O
2 CD CD O
days NNS NNS O
she PRP PRP O
has VBZ VBZ O
felt VBN VBN O
confused VBN VBN O
and CC CC O
weak JJ JJ O
, , , O
citing VBG VBG O
that IN IN O
when WRB WRB O
someone NN NN O
would MD MD O
call VB VB O
she PRP PRP O
was VBD VBD O
unable JJ JJ O
to TO TO O
speak VB VB O
. . . O
   
She PRP PRP O
also RB RB O
has VBZ VBZ O
felt VBN VBN O
unsteady JJ JJ O
on IN IN O
her PRP$ PRP$ O
feet NNS NNS O
and CC CC O
fell VBD VBD O
twice RB RB O
yesterday NN NN O
when WRB WRB O
out IN IN O
walking VBG VBG O
, , , O
hitting VBG VBG O
her PRP$ PRP$ O
face NN NN O
and CC CC O
arm NN NN O
. . . O
   
She PRP PRP O
reports VBZ VBZ O
dizziness JJ JJ O
prior RB RB O
to TO TO O
fall VB VB O
but CC CC O
denies NNS NNS O
chest NN NN O
pain NN NN O
, , , O
palpitations NNS NNS O
or CC CC O
SOB NNP NNP O
. . . O
   
There EX EX O
was VBD VBD O
no DT DT O
loss NN NN O
of IN IN O
consciousness NN NN O
and CC CC O
she PRP PRP O
was VBD VBD O
able JJ JJ O
to TO TO O
get VB VB O
up/ambulate NN NN O
after IN IN O
fall NN NN O
. . . O
   
Of IN IN O
note NN NN O
, , , O
she PRP PRP O
has VBZ VBZ O
switched VBN VBN O
from IN IN O
drinking VBG VBG O
7 CD CD O
cans NNS NNS O
of IN IN O
diet NN NN O
coke NN NN O
per IN IN O
day NN NN O
to TO TO O
7 CD CD O
cans NNS NNS O
of IN IN O
regular JJ JJ O
coke NN NN O
because IN IN O
the DT DT O
facility NN NN O
where WRB WRB O
she PRP PRP O
lives VBZ VBZ O
ran VBD VBD O
out IN IN O
of IN IN O
diet NN NN O
coke NN NN O
. . . O
   
She PRP PRP O
is VBZ VBZ O
also RB RB O
restricting VBG VBG O
her PRP$ PRP$ O
caloric JJ JJ O
intake NN NN O
and CC CC O
her PRP$ PRP$ O
meals NNS NNS O
consist NN NN O
of IN IN O
a DT DT O
croissant NN NN O
at IN IN O
breakfast NN NN O
, , , O
cottage NN NN O
cheese NN NN O
at IN IN O
lunch NN NN O
and CC CC O
an DT DT O
avocado NN NN O
for IN IN O
dinner NN NN O
, , , O
in IN IN O
attempt NN NN O
to TO TO O
lose VB VB O
weight NN NN O
. . . O
   
She PRP PRP O
has VBZ VBZ O
not RB RB O
had VBN VBN O
any DT DT O
recent JJ JJ O
medication NN NN O
changes NNS NNS O
. . . O
   
She PRP PRP O
denies VBZ VBZ O
recent JJ JJ O
fever NN NN O
, , , O
chills NNS NNS O
, , , O
CP NNP NNP O
, , , O
headache NN NN O
, , , O
abdominal JJ JJ O
pain NN NN O
, , , O
diarrhea NN NN O
, , , O
dysuria NN NN O
. . . O
   
She PRP PRP O
does VBZ VBZ O
report NN NN O
significant JJ JJ O
thirst NN NN O
and CC CC O
frequent JJ JJ O
urination NN NN O
. . . O
   
She PRP PRP O
also RB RB O
reports NNS NNS O
SOB NNP NNP O
with IN IN O
exertion NN NN O
, , , O
particularly RB RB O
walking VBG VBG O
up RP RP O
stairs NNS NNS O
. . . O
   
In IN IN O
the DT DT O
ED NNP NNP O
initial JJ JJ O
VS NNP NNP O
were VBD VBD O
T NN NN O
99.2 CD CD O
HR NNP NNP O
98 CD CD O
BP NNP NNP O
173/93 CD CD O
RR NNP NNP O
   
22 CD CD O
. . . O
Labs NNP NNP O
were VBD VBD O
significant JJ JJ O
for IN IN O
a DT DT O
Na NNP NNP O
118 CD CD O
, , , O
K NNP NNP O
3.5 CD CD O
, , , O
Cl NNP NNP O
82 CD CD O
, , , O
CO2 NNP NNP O
17.5 CD CD O
, , , O
AG NNP NNP O
19 CD CD O
, , , O
WBC NNP NNP O
15 CD CD O
, , , O
Hct NNP NNP O
   
32 CD CD O
. . . O
CXR NNP NNP O
was VBD VBD O
clear JJ JJ O
. . . O
   
She PRP PRP O
was VBD VBD O
given VBN VBN O
a DT DT O
total NN NN O
of IN IN O
1L CD CD O
NS NNP NNP O
and CC CC O
free JJ JJ O
water NN NN O
restricted VBD VBD O
. . . O
   
She PRP PRP O
was VBD VBD O
admitted VBN VBN O
to TO TO O
medicine VB VB O
for IN IN O
further JJ JJ O
evaluation NN NN O
. . . O
   
REVIEW NNP NNP O
OF IN IN O
SYSTEMS NNP NNP O
Negative NNP NNP O
in IN IN O
detail NN NN O
except IN IN O
as IN IN O
in IN IN O
HPI NNP NNP O
. . . O
   
PAST NNP NNP O
MEDICAL NNP NNP O
HISTORY NN NN O
Insomnia NNP NNP O
Mild NNP NNP O
sleep VB VB O
apnea NN NN O
Schizophrenia NNP NNP O
Mood NNP NNP O
D/O NNP NNP O
Diabetes NNP NNP O
type NN NN O
2 CD CD O
& CC CC O
#8211 NN NN O
; : : O
   
last JJ JJ O
HgbA1c NNP NNP O
12/66 CD CD I-DATE
, , , O
7.8 CD CD O
HTN NNP NNP O
Hyperlipidemia NNP NNP O
& CC CC O
#8211 NN NN O
; : : O
   
TG NNP NNP O
121 CD CD O
, , , O
total JJ JJ O
chol NN NN O
147 CD CD O
9/66 CD CD I-DATE
Chronic NNP NNP O
hyponatremia NN NN O
& CC CC O
#8211 NN NN O
; : : O
   
high JJ JJ O
120s CD CD O
, , , O
low JJ JJ O
130s NN NN O
Anemia NNP NNP O
& CC CC O
#8211 NN NN O
; : : O
   
iron NN NN O
deficiet NN NN O
6/65 CD CD I-DATE
Colonoscopy NNP NNP O
2063 CD CD I-DATE
& CC CC O
#8211 NN NN O
; : : O
   
tubular JJ JJ O
adenoma NN NN O
FAMILY NN NN O
HISTORY NN NN O
Maternal NNP NNP O
& CC CC O
#8211 NN NN O
; : : O
   
healthy JJ JJ O
Paternal NNP NNP O
& CC CC O
#8211 NN NN O
; : : O
   
MI NNP NNP O
SOCIAL NNP NNP O
HISTORY NN NN O
General NNP NNP O
& CC CC O
#8211 NN NN O
; : : O
   
Lives NNP NNP O
alone RB RB O
in IN IN O
senior JJ JJ O
housing NN NN O
. . . O
   
Divorced NNP NNP O
. . . O
   
No DT DT O
children NNS NNS O
. . . O
   
Going VBG VBG O
to TO TO O
Peru NNP NNP I-COUNTRY
next JJ JJ O
week NN NN O
to TO TO O
visit VB VB O
brother NN NN O
who WP WP O
is VBZ VBZ O
having VBG VBG O
a DT DT O
child NN NN O
. . . O
   
Tobacco NNP NNP O
& CC CC O
#8211 NN NN O
; : : O
   
Never RB RB O
smoker NN NN O
. . . O
   
Alcohol NNP NNP O
& CC CC O
#8211 NN NN O
; : : O
   
Once RB RB O
every DT DT O
2 CD CD O
years NNS NNS O
. . . O
   
Illicit NNP NNP O
drugs NNS NNS O
& CC CC O
#8211 NN NN O
; : : O
   
None NN NN O
. . . O
   
ALLERGIES/ADVERSE NNP NNP O
REACTIONS NNP NNP O
LISINOPRIL NNP NNP O
- : : O
Cough NNP NNP O
, , , O
HYDROCHLOROTHIAZIDE NNP NNP O
- : : O
Hyponatremia NNP NNP O
MEDICATIONS NNP NNP O
ON IN IN O
ADMISSION NNP NNP O
Ambien NNP NNP O
CR NNP NNP O
12.5 CD CD O
qhs NN NN O
Seroquel NNP NNP O
50mg CD CD O
- : : O
100mg CD CD O
qhs NN NN O
Alburterol NNP NNP O
PRN NNP NNP O
Trilafon NNP NNP O
8mg CD CD O
BID NNP NNP O
Aspirin NNP NNP O
81mg CD CD O
daily JJ JJ O
Avapro NNP NNP O
300mg CD CD O
daily JJ JJ O
Glyburide NNP NNP O
5mg CD CD O
BID NNP NNP O
Labetalol NNP NNP O
300mg CD CD O
BID NNP NNP O
Metformin NNP NNP O
850mg CD CD O
TID NNP NNP O
Norvasc NNP NNP O
10mg CD CD O
BID NNP NNP O
Simvastatin NNP NNP O
40mg CD CD O
qhs NN NN O
Spironolactone NNP NNP O
50mg CD CD O
daily JJ JJ O
Tricor NNP NNP O
48mg CD CD O
daily RB RB O
& CC CC O
#8211 NN NN O
; : : O
   
not RB RB O
taking VBG VBG O
PHYSICAL JJ JJ O
EXAMINATION NNP NNP O
VITALS NNP NNP O
: : : O
T NN NN O
97.9 CD CD O
HR NNP NNP O
106 CD CD O
BP NNP NNP O
180/90 CD CD O
RR NNP NNP O
20 CD CD O
O2 NNP NNP O
sat VBD VBD O
97 CD CD O
% NN NN O
RA NNP NNP O
General NNP NNP O
& CC CC O
#8211 NN NN O
; : : O
   
obese JJ JJ O
female JJ JJ O
in IN IN O
no DT DT O
acute JJ JJ O
distress JJ JJ O
HEENT NNP NNP O
& CC CC O
#8211 NN NN O
; : : O
   
normocephalic JJ JJ O
, , , O
atraumatic JJ JJ O
; : : O
   
PERRL NNP NNP O
, , , O
EOMI NNP NNP O
; : : O
   
sclerae NN NN O
anicteric JJ JJ O
, , , O
dry JJ JJ O
mucous JJ JJ O
membranes NNS NNS O
, , , O
cracked VBN VBN O
lips NNS NNS O
Neck NNP NNP O
- : : O
no DT DT O
lymphadenopathy NN NN O
, , , O
JVP NNP NNP O
flat JJ JJ O
Pulmonary NNP NNP O
& CC CC O
#8211 NN NN O
; : : O
   
clear JJ JJ O
to TO TO O
auscultation NN NN O
bilaterally RB RB O
, , , O
no DT DT O
crackles NNS NNS O
or CC CC O
wheezes NNS NNS O
Cardiac NNP NNP O
& CC CC O
#8211 NN NN O
; : : O
   
regular JJ JJ O
rate NN NN O
and CC CC O
rhythm NN NN O
; : : O
   
S1 NNP NNP O
and CC CC O
S2 NNP NNP O
normal JJ JJ O
; : : O
   
no DT DT O
murmurs NNS NNS O
, , , O
rubs NNS NNS O
or CC CC O
gallops NNS NNS O
; : : O
   
2+pulses CD CD O
in IN IN O
the DT DT O
extremities NNS NNS O
bilaterally RB RB O
Abdomen NNP NNP O
& CC CC O
#8211 NN NN O
; : : O
   
obese NN NN O
, , , O
soft JJ JJ O
, , , O
non-distended JJ JJ O
; : : O
   
non-tender NN NN O
; : : O
   
normal JJ JJ O
bowel NN NN O
sounds VBZ VBZ O
Extremity NNP NNP O
& CC CC O
#8211 NN NN O
; : : O
   
warm JJ JJ O
and CC CC O
well-perfused JJ JJ O
; : : O
   
no DT DT O
edema NN NN O
Neurology NNP NNP O
& CC CC O
#8211 NN NN O
; : : O
   
CN NNP NNP O
II-XII NNP NNP O
grossly RB RB O
intact JJ JJ O
, , , O
good JJ JJ O
strength NN NN O
bilaterally RB RB O
, , , O
normal JJ JJ O
sensation NN NN O
bilaterally RB RB O
Mental NNP NNP O
status NN NN O
& CC CC O
#8211 NN NN O
; : : O
   
alert VB VB O
and CC CC O
oriented VBN VBN O
x SYM SYM O
3 CD CD O
; : : O
   
1/3 CD CD O
recall NN NN O
LABORATORIES NNP NNP O
04/13/2067 CD CD I-DATE
NA NNP NNP O
127 CD CD O
( ( ( O
L NNP NNP O
) ) ) O
, , , O
K NNP NNP O
3.0 CD CD O
( ( ( O
L NNP NNP O
) ) ) O
, , , O
CL NNP NNP O
92 CD CD O
( ( ( O
L NNP NNP O
) ) ) O
, , , O
CO2 NNP NNP O
19.2 CD CD O
( ( ( O
L NNP NNP O
) ) ) O
, , , O
BUN NNP NNP O
4 CD CD O
( ( ( O
L NNP NNP O
) ) ) O
, , , O
CRE NNP NNP O
0.90 CD CD O
, , , O
EGFR NNP NNP O
& CC CC O
gt NN NN O
; : : O
   
60 CD CD O
, , , O
GLU NNP NNP O
204 CD CD O
(H)04/13/2067 NN NN O
NA NNP NNP O
118 CD CD O
( ( ( O
L NNP NNP O
) ) ) O
, , , O
K NNP NNP O
3.5 CD CD O
, , , O
CL NNP NNP O
82 CD CD O
( ( ( O
L NNP NNP O
) ) ) O
, , , O
CO2 NNP NNP O
17.5 CD CD O
( ( ( O
L NNP NNP O
) ) ) O
, , , O
BUN NNP NNP O
2 CD CD O
( ( ( O
L NNP NNP O
) ) ) O
, , , O
CRE NNP NNP O
0.76 CD CD O
, , , O
EGFR NNP NNP O
& CC CC O
gt NN NN O
; : : O
   
60 CD CD O
, , , O
GLU NNP NNP O
207 CD CD O
(H)04/13/2067 NN NN O
ANION NNP NNP O
16 CD CD O
(H)04/13/2067 NN NN O
ANION NNP NNP O
19 CD CD O
(H)04/13/2067 NN NN O
CA NNP NNP O
9.6 CD CD O
, , , O
PHOS NNP NNP O
2.4 CD CD O
( ( ( O
L NNP NNP O
) ) ) O
, , , O
MG NNP NNP O
1.5 CD CD O
, , , O
URIC NNP NNP O
3.204/13/2067 CD CD O
CA NNP NNP O
9.204/13/2067 CD CD O
OSM NNP NNP O
241 CD CD O
(L)04/13/2067 NN NN O
TEMP NNP NNP O
37.0 CD CD O
, , , O
FIO2 NNP NNP O
UNSPEC NNP NNP O
. . . O
   
, , , O
vPO2 NN NN O
66 CD CD O
( ( ( O
H NNP NNP O
) ) ) O
, , , O
vPCO2 NN NN O
35 CD CD O
( ( ( O
L NNP NNP O
) ) ) O
, , , O
vPH NN NN O
7.43 CD CD O
( ( ( O
H NNP NNP O
) ) ) O
, , , O
UBASEX NNP NNP O
NEG NNP NNP O
04/13/2067 CD CD I-DATE
CK-MB NNP NNP O
15.8 CD CD O
( ( ( O
H NNP NNP O
) ) ) O
, , , O
TROP-T NNP NNP O
& CC CC O
lt NN NN O
; : : O
   
0.0104/13/2067 CD CD O
UNA NNP NNP O
21 CD CD O
, , , O
UOSM NNP NNP O
6204/13/2067 CD CD O
UCREAT NNP NNP O
0.0604/13/2067 CD CD O
WBC NNP NNP O
14.3 CD CD O
( ( ( O
H NNP NNP O
) ) ) O
, , , O
RBC NNP NNP O
4.45 CD CD O
, , , O
HGB NNP NNP O
11.6 CD CD O
( ( ( O
L NNP NNP O
) ) ) O
, , , O
HCT NNP NNP O
34.2 CD CD O
( ( ( O
L NNP NNP O
) ) ) O
, , , O
MCV NNP NNP O
77 CD CD O
( ( ( O
L NNP NNP O
) ) ) O
, , , O
MCH NNP NNP O
26.1 CD CD O
, , , O
MCHC NNP NNP O
34.0 CD CD O
, , , O
PLT NNP NNP O
520 CD CD O
(H)04/13/2067 NN NN O
WBC NNP NNP O
14.9 CD CD O
( ( ( O
H NNP NNP O
) ) ) O
, , , O
RBC NNP NNP O
4.23 CD CD O
, , , O
HGB NNP NNP O
11.1 CD CD O
( ( ( O
L NNP NNP O
) ) ) O
, , , O
HCT NNP NNP O
32.1 CD CD O
( ( ( O
L NNP NNP O
) ) ) O
, , , O
MCV NNP NNP O
76 CD CD O
( ( ( O
L NNP NNP O
) ) ) O
, , , O
MCH NNP NNP O
26.3 CD CD O
, , , O
MCHC NNP NNP O
34.7 CD CD O
, , , O
PLT NNP NNP O
467 CD CD O
(H)04/13/2067 NN NN O
RDW NNP NNP O
13.904/13/2067 CD CD O
RDW NNP NNP O
13.804/13/2067 CD CD O
METHOD NNP NNP O
Auto NNP NNP O
, , , O
% NN NN O
NEUT NNP NNP O
78 CD CD O
( ( ( O
H NNP NNP O
) ) ) O
, , , O
% NN NN O
LYMPH NNP NNP O
14 CD CD O
( ( ( O
L NNP NNP O
) ) ) O
, , , O
% NN NN O
MONO NNP NNP O
7 CD CD O
, , , O
% NN NN O
EOS NNP NNP O
1 CD CD O
, , , O
% NN NN O
BASO NNP NNP O
004/13/2067 CD CD O
ANEUT NNP NNP O
11.53 CD CD O
( ( ( O
H NNP NNP O
) ) ) O
, , , O
ALYMP NNP NNP O
2.08 CD CD O
, , , O
AMONS NNP NNP O
1.10 CD CD O
, , , O
AEOSN NNP NNP O
0.19 CD CD O
, , , O
ABASOP NNP NNP O
0.0304/13/2067 CD CD O
ANISO NNP NNP O
None NN NN O
, , , O
HYPO NNP NNP O
None NN NN O
, , , O
MACRO NNP NNP O
None NN NN O
, , , O
MICRO NNP NNP O
1 CD CD O
+ NN NN O
(H)04/13/2067 NN NN O
UA-COLOR NNP NNP O
COLORLESS NNP NNP O
, , , O
UA-APP NNP NNP O
Clear NNP NNP O
, , , O
UA-GLUC NNP NNP O
Negative NNP NNP O
, , , O
UA-BILI NNP NNP O
Negative NNP NNP O
, , , O
UA-KET NNP NNP O
Negative NNP NNP O
, , , O
UR-SPGR NNP NNP O
1.005 CD CD O
, , , O
UA-BLD NNP NNP O
Trace NNP NNP O
, , , O
UA-PH NNP NNP O
6.004/13/2067 CD CD O
UA-COLOR NNP NNP O
Yellow NNP NNP O
, , , O
UA-APP NNP NNP O
Clear NNP NNP O
, , , O
UA-GLUC NNP NNP O
2 CD CD O
+ NN NN O
, , , O
UA-BILI NNP NNP O
Negative NNP NNP O
, , , O
UA-KET NNP NNP O
Negative NNP NNP O
, , , O
UR-SPGR NNP NNP O
& CC CC O
lt NN NN O
; : : O
   
1.005 CD CD O
, , , O
UA-BLD NNP NNP O
1 CD CD O
+ NN NN O
, , , O
UA-PH NNP NNP O
6.004/13/2067 CD CD O
UA-PROT NNP NNP O
Negative NNP NNP O
, , , O
UA-UROBI NNP NNP O
Negative NNP NNP O
, , , O
UA-NIT NNP NNP O
Negative NNP NNP O
, , , O
UA-WBC NNP NNP O
Negative04/13/2067 NNP NNP O
UA-PROT NNP NNP O
Negative NNP NNP O
, , , O
UA-UROBI NNP NNP O
Negative NNP NNP O
, , , O
UA-NIT NNP NNP O
Negative NNP NNP O
, , , O
UA-WBC NNP NNP O
Negative04/13/2067 NNP NNP O
MIC-SED NNP NNP O
Completed NNP NNP O
, , , O
UAS-RBC NNP NNP O
0-2 NN NN O
, , , O
UAS-WBC NNP NNP O
None NN NN O
, , , O
UAS-BACT NNP NNP O
Few JJ JJ O
, , , O
UAS-MUC NNP NNP O
PRESENT04/13/2067 NNP NNP O
UAS-RBC NNP NNP O
0-2 NN NN O
, , , O
UAS-WBC NNP NNP O
None04/13/2067 NNP NNP O
UA-CAPH NNP NNP O
PRESENT NNP NNP O
MICROBIOLOGY NNP NNP O
None NN NN O
RADIOLOGICAL NNP NNP O
STUDIES NNP NNP O
CXR NNP NNP O
- : : O
No DT DT O
evidence NN NN O
of IN IN O
pneumonia NN NN O
or CC CC O
pulmonary JJ JJ O
edema NN NN O
. . . O
   
EKG NNP NNP O
& CC CC O
#8211 NN NN O
; : : O
   
Sinus NNP NNP O
tachycardia NNS NNS O
. . . O
   
Rate NNP NNP O
106 CD CD O
. . . O
   
Q NNP NNP O
waves NNS NNS O
in IN IN O
II NNP NNP O
, , , O
III NNP NNP O
, , , O
aVF NN NN O
, , , O
V3 NNP NNP O
. . . O
   
Slightly RB RB O
changed VBN VBN O
from IN IN O
prior RB RB O
. . . O
   
ASSESSMENT NNP NNP O
AND CC CC O
PLAN NNP NNP O
Ms NNP NNP O
. . . O
Ostrander NNP NNP I-PATIENT
is VBZ VBZ O
a DT DT O
64 CD CD I-AGE
yo NN NN O
Peruvian NNP NNP I-COUNTRY
woman NN NN O
with IN IN O
schizophrenia NN NN O
, , , O
HTN NNP NNP O
, , , O
DM2 NNP NNP O
, , , O
HL NNP NNP O
presenting VBG VBG O
with IN IN O
confusion NN NN O
and CC CC O
found VBD VBD O
to TO TO O
have VB VB O
significant JJ JJ O
metabolic JJ JJ O
disarray NN NN O
including VBG VBG O
hyponatremia NN NN O
, , , O
hypokalemia NN NN O
, , , O
hypochloremia NN NN O
and CC CC O
an DT DT O
anion NN NN O
gap NN NN O
. . . O
   
She PRP PRP O
also RB RB O
has VBZ VBZ O
a DT DT O
mild JJ JJ O
leukocytosis NN NN O
, , , O
anemia NN NN O
& CC CC O
#8211 NN NN O
; : : O
   
at IN IN O
baseline NN NN O
, , , O
and CC CC O
thrombocytosis NNS NNS O
. . . O
   
##: NN NN O
Hyponatremia NNP NNP O
& CC CC O
#8211 NN NN O
; : : O
   
Calculated NNP NNP O
serum NN NN O
osmolality NN NN O
is VBZ VBZ O
248 CD CD O
mOsm/L NN NN O
( ( ( O
measured VBN VBN O
241 CD CD O
) ) ) O
suggesting VBG VBG O
a DT DT O
hypotonic JJ JJ O
hyponatremia NN NN O
. . . O
   
Clinically NNP NNP O
she PRP PRP O
appears VBZ VBZ O
euvolemic JJ JJ O
, , , O
despite IN IN O
having VBG VBG O
a DT DT O
dry JJ JJ O
mouth NN NN O
which WDT WDT O
may MD MD O
be VB VB O
from IN IN O
patient&#8217; NN NN O
   
s VBZ VBZ O
antipsychotics NNS NNS O
. . . O
   
A DT DT O
Uosm NNP NNP O
of IN IN O
62 CD CD O
is VBZ VBZ O
most RBS RBS O
suggestive JJ JJ O
of IN IN O
primary JJ JJ O
polydipsia NN NN O
vs NNS NNS O
. . . O
low JJ JJ O
solute NN NN O
. . . O
   
Patient NNP NNP O
is VBZ VBZ O
drinking VBG VBG O
2L CD CD O
coke/day NN NN O
and CC CC O
complaining VBG VBG O
of IN IN O
excessive JJ JJ O
thirst NN NN O
, , , O
per IN IN O
PCP/psych NNP NNP O
notes NNS NNS O
she PRP PRP O
is VBZ VBZ O
told VBN VBN O
to TO TO O
limit VB VB O
fluids NNS NNS O
to TO TO O
1L CD CD O
. . . O
   
Interestingly NNP NNP O
this DT DT O
may MD MD O
have VB VB O
been VBN VBN O
precipitated VBN VBN O
by IN IN O
switching VBG VBG O
from IN IN O
diet JJ JJ O
coke NN NN O
to TO TO O
coke NN NN O
as IN IN O
diet JJ JJ O
coke NN NN O
contains VBZ VBZ O
30mg CD CD O
Na NNP NNP O
and CC CC O
0gm CD CD O
carbs NNS NNS O
while IN IN O
regular JJ JJ O
coke NN NN O
contains VBZ VBZ O
45mg CD CD O
Na NNP NNP O
and CC CC O
39gm CD CD O
carbohydrates NNS NNS O
. . . O
   
Increased NNP NNP O
carbohydrates NNS NNS O
with IN IN O
little JJ JJ O
sodium NN NN O
, , , O
protein NN NN O
or CC CC O
potassium NN NN O
load NN NN O
( ( ( O
such JJ JJ O
as IN IN O
in IN IN O
beer NN NN O
potomania NN NN O
) ) ) O
can MD MD O
inhibit VB VB O
protein NN NN O
breakdown NN NN O
and CC CC O
urea NN NN O
excretion NN NN O
, , , O
therefore RB RB O
decreasing VBG VBG O
daily RB RB O
solute NN NN O
excretion NN NN O
to TO TO O
& CC CC O
lt NN NN O
; : : O
   
250mOsm CD CD O
, , , O
which WDT WDT O
can MD MD O
result VB VB O
in IN IN O
hypoNa NN NN O
if IN IN O
fluid JJ JJ O
intake NN NN O
is VBZ VBZ O
increased VBN VBN O
. . . O
   
Correct NNP NNP O
at IN IN O
a DT DT O
rate NN NN O
of IN IN O
& CC CC O
lt NN NN O
; : : O
   
0.5mEq/L/h CD CD O
since IN IN O
she PRP PRP O
is VBZ VBZ O
no RB RB O
longer RB RB O
symptomatic JJ JJ O
Q6H NNP NNP O
lytes NNS NNS O
to TO TO O
ensure VB VB O
correct JJ JJ O
rate NN NN O
of IN IN O
correction NN NN O
& CC CC O
#8211 NN NN O
; : : O
   
prevent VB VB O
osmotic JJ JJ O
demyelination NN NN O
Fluid NNP NNP O
restrict NN NN O
to TO TO O
1L CD CD O
fluid/day NN NN O
Since IN IN O
she PRP PRP O
is VBZ VBZ O
euvolemic JJ JJ O
, , , O
no DT DT O
indication NN NN O
for IN IN O
NS NNP NNP O
repletion NN NN O
Patient NNP NNP O
refused VBD VBD O
nutrition NN NN O
consult NN NN O
to TO TO O
discuss VB VB O
dietary JJ JJ O
choices NNS NNS O
& CC CC O
#8211 NN NN O
; : : O
   
clearly RB RB O
she PRP PRP O
is VBZ VBZ O
making VBG VBG O
poor JJ JJ O
dietary JJ JJ O
choices NNS NNS O
and CC CC O
her PRP$ PRP$ O
caloric JJ JJ O
intake NN NN O
is VBZ VBZ O
~ NN NN O
800-1000 CD CD O
kcal/day NN NN O
currently RB RB O
from IN IN O
food NN NN O
(+~ NN NN O
1000kcal CD CD O
from IN IN O
soda NN NN O
) ) ) O
##: NN NN O
Protected NNP NNP O
fall NN NN O
& CC CC O
#8211 NN NN O
; : : O
   
History NN NN O
is VBZ VBZ O
suggestive JJ JJ O
of IN IN O
fall NN NN O
in IN IN O
setting VBG VBG O
of IN IN O
electrolyte NN NN O
distribution NN NN O
and CC CC O
consequential JJ JJ O
lightheadedness NN NN O
. . . O
   
Does VBZ VBZ O
not RB RB O
seem VB VB O
cardiac NN NN O
in IN IN O
origin NN NN O
, , , O
however RB RB O
Q NNP NNP O
waves NNS NNS O
in IN IN O
inferior JJ JJ O
leads VBZ VBZ O
appear IN IN O
to TO TO O
have VB VB O
progressed VBN VBN O
from IN IN O
last JJ JJ O
EKG NNP NNP O
on IN IN O
2/20/67 CD CD I-DATE
. . . O
   
Protected NNP NNP O
fall NN NN O
argues VBZ VBZ O
against IN IN O
acute JJ JJ O
arrhythmic JJ JJ O
event NN NN O
. . . O
   
Check NN NN O
orthostatics NNS NNS O
Will NNP NNP O
check NN NN O
cardiac NN NN O
enzymes NNS NNS O
as IN IN O
EKG NNP NNP O
is VBZ VBZ O
suggestive JJ JJ O
of IN IN O
progressive JJ JJ O
Q NNP NNP O
waves NNS NNS O
in IN IN O
inferior JJ JJ O
leads VBZ VBZ O
. . . O
   
Monitor NNP NNP O
on IN IN O
telemetry NN NN O
. . . O
   
Physical JJ JJ O
therapy NN NN O
consult NN NN O
. . . O
   
##: NN NN O
Anemia NNP NNP O
& CC CC O
#8211 NN NN O
; : : O
   
Hct NNP NNP O
at IN IN O
baseline NN NN O
, , , O
however RB RB O
was VBD VBD O
iron NN NN O
deficit NN NN O
in IN IN O
6/65 CD CD I-DATE
and CC CC O
had VBD VBD O
a DT DT O
tubular NN NN O
adenoma NN NN O
resection NN NN O
on IN IN O
colo NN NN O
. . . O
   
Will NNP NNP O
repeat VB VB O
iron NN NN O
studies NNS NNS O
to TO TO O
ensure VB VB O
iron NN NN O
replete NN NN O
. . . O
   
Fe NNP NNP O
, , , O
TIBC NNP NNP O
, , , O
ferritin NN NN O
Consider NNP NNP O
repeat NN NN O
outpt NN NN O
colonoscopy NN NN O
to TO TO O
r/o VB VB O
GI NNP NNP O
malignancy/lesion NN NN O
contributing VBG VBG O
to TO TO O
anemia VB VB O
##: NN NN O
Elevated NNP NNP O
anion NN NN O
gap NN NN O
. . . O
   
Delta-delta NNP NNP O
is VBZ VBZ O
8/6=1.3 CD CD O
= SYM SYM O
Pure NNP NNP O
metabolic JJ JJ O
acidosis NN NN O
. . . O
   
Osmolar NNP NNP O
gap NN NN O
is VBZ VBZ O
& CC CC O
lt NN NN O
; : : O
   
10 CD CD O
so RB RB O
ingestion NN NN O
is VBZ VBZ O
less RBR RBR O
likely JJ JJ O
. . . O
   
There EX EX O
are VBP VBP O
no DT DT O
ketones NNS NNS O
in IN IN O
the DT DT O
UA NNP NNP O
and CC CC O
there EX EX O
is VBZ VBZ O
no DT DT O
evidence NN NN O
of IN IN O
renal JJ JJ O
failure NN NN O
. . . O
   
pH NN NN O
is VBZ VBZ O
not RB RB O
suggestive JJ JJ O
of IN IN O
an DT DT O
acidosis NN NN O
. . . O
   
AG NNP NNP O
is VBZ VBZ O
likely JJ JJ O
from IN IN O
severe JJ JJ O
metabolic JJ JJ O
disarray NN NN O
( ( ( O
decreased VBN VBN O
anions NNS NNS O
and CC CC O
cations NNS NNS O
) ) ) O
. . . O
   
Check NNP NNP O
lactate JJ JJ O
Repeat NNP NNP O
AG NNP NNP O
##: NN NN O
Leukocytosis NNP NNP O
- : : O
no DT DT O
evidence NN NN O
of IN IN O
infection NN NN O
, , , O
although IN IN O
infection NN NN O
could MD MD O
contribute VB VB O
to TO TO O
confusion NN NN O
. . . O
   
UA NNP NNP O
and CC CC O
CXR NNP NNP O
were VBD VBD O
negative JJ JJ O
. . . O
   
If IN IN O
persistent JJ JJ O
or CC CC O
febrile NN NN O
will MD MD O
obtain VB VB O
cultures NNS NNS O
. . . O
   
Repeat NNP NNP O
CBC NNP NNP O
##: NN NN O
Diabetes NNP NNP O
& CC CC O
#8211 NN NN O
; : : O
   
continue VB VB O
metformin NN NN O
, , , O
glyburide NN NN O
Finger NNP NNP O
sticks VBZ VBZ O
AC NNP NNP O
with IN IN O
RISS NNP NNP O
##: NN NN O
Schizophrenia NNP NNP O
& CC CC O
#8211 NN NN O
; : : O
   
continue VB VB O
trilafon NN NN O
##: NN NN O
Insomnia NNP NNP O
& CC CC O
#8211 NN NN O
; : : O
   
continue VB VB O
seroquel NN NN O
, , , O
ambient NN NN O
##: NN NN O
Hypertension NNP NNP O
& CC CC O
#8211 NN NN O
; : : O
   
continue VB VB O
avapro NN NN O
, , , O
labetalol NN NN O
, , , O
norvasc NN NN O
, , , O
spironolactone NN NN O
, , , O
aspirin NN NN O
##: NN NN O
Hyperlipidemia NNP NNP O
& CC CC O
#8211 NN NN O
; : : O
   
continue VB VB O
simvastatin NN NN O
FEN NNP NNP O
: : : O
1L CD CD O
fluid JJ JJ O
restriction NN NN O
, , , O
no DT DT O
caffeine NN NN O
. . . O
   
Aggressively RB RB O
replete JJ JJ O
K NNP NNP O
, , , O
phos NN NN O
and CC CC O
recheck NN NN O
lytes NNS NNS O
Q6H NNP NNP O
. . . O
   
PROPHYLAXIS NNP NNP O
GI NNP NNP O
: : : O
not RB RB O
indicated VBD VBD O
DVT NNP NNP O
: : : O
Ambulatory NNP NNP O
BOWEL NNP NNP O
: : : O
Colace NNP NNP O
, , , O
Senna NNP NNP O
prn NN NN O
CODE NNP NNP O
: : : O
Full NNP NNP O
code NN NN O
_________________________________ NN NN O
_ NN NN O
Alina NNP NNP I-DOCTOR
Mccoy NNP NNP I-DOCTOR
, , , O
MD NNP NNP O
PGY-1, NNP NNP O
Pager NNP NNP O
#65261 NN NN O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2066-01-20 JJ JJ I-DATE
GRANITE NNP NNP I-HOSPITAL
COUNTY NNP NNP I-HOSPITAL
MEMORIAL NNP NNP I-HOSPITAL
Arthritis NNP NNP O
Department NNP NNP O
17 CD CD I-STREET
Weld NNP NNP I-STREET
St NNP NNP I-STREET
Bird NNP NNP I-PATIENT
, , , O
Terri NNP NNP I-PATIENT
Lisbon NNP NNP I-CITY
, , , O
SD NNP NNP I-STATE
52797 CD CD I-ZIP
80910690 CD CD I-MEDICALRECORD
659-5187 JJ JJ I-PHONE
1-20-66 JJ JJ I-DATE
Ms NNP NNP O
. . . O
Bird NNP NNP I-PATIENT
comes VBZ VBZ O
in IN IN O
today NN NN O
to TO TO O
follow VB VB O
up RP RP O
on IN IN O
her PRP$ PRP$ O
weight NN NN O
and CC CC O
blood NN NN O
sugar NN NN O
control NN NN O
, , , O
as RB RB O
well RB RB O
as IN IN O
to TO TO O
discuss VB VB O
her PRP$ PRP$ O
overall JJ JJ O
mental JJ JJ O
status NN NN O
and CC CC O
its PRP$ PRP$ O
effects NNS NNS O
on IN IN O
her PRP$ PRP$ O
living VBG VBG O
situation NN NN O
. . . O
   
PMH NNP NNP O
: : : O
Her PRP$ PRP$ O
past JJ JJ O
medical JJ JJ O
history NN NN O
includes VBZ VBZ O
atrial JJ JJ O
fibrillation NN NN O
, , , O
status NN NN O
post NN NN O
renal JJ JJ O
allograft NN NN O
, , , O
status NN NN O
post NN NN O
aortic JJ JJ O
and CC CC O
mitral JJ JJ O
valve NN NN O
replacements NNS NNS O
with IN IN O
a DT DT O
mechanical JJ JJ O
valve NN NN O
, , , O
on IN IN O
chronic JJ JJ O
Coumadin NNP NNP O
, , , O
a DT DT O
recent JJ JJ O
aortic JJ JJ O
aneurysm NN NN O
repair NN NN O
and CC CC O
complications NNS NNS O
around IN IN O
that DT DT O
, , , O
including VBG VBG O
a DT DT O
cellulitis NN NN O
which WDT WDT O
has VBZ VBZ O
been VBN VBN O
treated VBN VBN O
, , , O
and CC CC O
now RB RB O
waxing VBG VBG O
and CC CC O
waning VBG VBG O
mental JJ JJ O
status NN NN O
. . . O
   
She PRP PRP O
also RB RB O
is VBZ VBZ O
insulin-dependent JJ JJ O
diabetic JJ JJ O
. . . O
   
MEDICATIONS NNP NNP O
: : : O
Her PRP$ PRP$ O
medications NNS NNS O
currently RB RB O
include VBP VBP O
: : : O
   
1 CD CD O
. . . O
Neurontin NNP NNP O
300 CD CD O
t.i.d. NN NN O
   
2 CD CD O
. . . O
Insulin NNP NNP O
NPH NNP NNP O
20 CD CD O
units NNS NNS O
in IN IN O
the DT DT O
morning NN NN O
, , , O
10 CD CD O
in IN IN O
the DT DT O
evening NN NN O
. . . O
   
3 CD CD O
. . . O
Fosamax NNP NNP O
each DT DT O
day NN NN O
. . . O
   
4 CD CD O
. . . O
Premarin NNP NNP O
and CC CC O
Provera NNP NNP O
. . . O
   
5 CD CD O
. . . O
Tums NNP NNP O
Extra-Strength NNP NNP O
. . . O
   
6 CD CD O
. . . O
digoxin NN NN O
0.25 CD CD O
and CC CC O
0125 CD CD O
. . . O
   
7 CD CD O
. . . O
Mevacor NNP NNP O
40 CD CD O
a DT DT O
day NN NN O
. . . O
   
8 CD CD O
. . . O
Coumadin NNP NNP O
1mg CD CD O
each DT DT O
day NN NN O
, , , O
except IN IN O
Sunday NNP NNP I-DATE
2mg CD CD O
. . . O
   
9 CD CD O
. . . O
Imuran NNP NNP O
100mg CD CD O
a DT DT O
day NN NN O
. . . O
   
10 CD CD O
. . . O
prednisone NN NN O
20mg CD CD O
every DT DT O
other JJ JJ O
day NN NN O
. . . O
   
REVIEW NNP NNP O
OF IN IN O
SYSTEMS NNP NNP O
: : : O
The DT DT O
patient NN NN O
notes NNS NNS O
that IN IN O
she PRP PRP O
has VBZ VBZ O
been VBN VBN O
feeling NN NN O
well RB RB O
and CC CC O
more RBR RBR O
active JJ JJ O
. . . O
   
She PRP PRP O
is VBZ VBZ O
able JJ JJ O
to TO TO O
walk VB VB O
around IN IN O
her PRP$ PRP$ O
house NN NN O
without IN IN O
her PRP$ PRP$ O
walker NN NN O
. . . O
   
She PRP PRP O
does VBZ VBZ O
use NN NN O
the DT DT O
walker NN NN O
outside IN IN O
of IN IN O
the DT DT O
house NN NN O
for IN IN O
safety NN NN O
and CC CC O
precaution NN NN O
. . . O
   
She PRP PRP O
is VBZ VBZ O
independent JJ JJ O
in IN IN O
bathing NN NN O
and CC CC O
washing VBG VBG O
, , , O
as RB RB O
well RB RB O
as IN IN O
cooking NN NN O
and CC CC O
preparing VBG VBG O
meals NNS NNS O
. . . O
   
She PRP PRP O
, , , O
however RB RB O
, , , O
is VBZ VBZ O
requiring VBG VBG O
a DT DT O
lot NN NN O
of IN IN O
assistance NN NN O
with IN IN O
managing VBG VBG O
her PRP$ PRP$ O
medications NNS NNS O
. . . O
   
She PRP PRP O
has VBZ VBZ O
her PRP$ PRP$ O
daughter-in-law JJ JJ O
downstairs NNS NNS O
help VB VB O
her PRP PRP O
with IN IN O
this DT DT O
. . . O
   
She PRP PRP O
has VBZ VBZ O
not RB RB O
been VBN VBN O
out IN IN O
of IN IN O
the DT DT O
house NN NN O
much JJ JJ O
in IN IN O
the DT DT O
last JJ JJ O
several JJ JJ O
months NNS NNS O
, , , O
and CC CC O
, , , O
while IN IN O
she PRP PRP O
wants VBZ VBZ O
to TO TO O
drive VB VB O
, , , O
no-one NN NN O
has VBZ VBZ O
allowed VBN VBN O
her PRP PRP O
to TO TO O
get VB VB O
behind IN IN O
the DT DT O
wheel NN NN O
. . . O
   
The DT DT O
patient NN NN O
otherwise RB RB O
feels VBZ VBZ O
well RB RB O
with IN IN O
no DT DT O
chest NN NN O
pain NN NN O
, , , O
no DT DT O
shortness NN NN O
of IN IN O
breath NN NN O
, , , O
no DT DT O
change NN NN O
in IN IN O
her PRP$ PRP$ O
bowel NN NN O
or CC CC O
bladder NN NN O
. . . O
   
HABITS NNP NNP O
: : : O
She PRP PRP O
has VBZ VBZ O
had VBN VBN O
a DT DT O
weight NN NN O
which WDT WDT O
has VBZ VBZ O
been VBN VBN O
stable JJ JJ O
, , , O
and CC CC O
her PRP$ PRP$ O
appetite NN NN O
has VBZ VBZ O
been VBN VBN O
good JJ JJ O
. . . O
   
PHYSICAL JJ JJ O
EXAMINATION NNP NNP O
: : : O
Notable NNP NNP O
for IN IN O
a DT DT O
well-appearing JJ JJ O
female JJ JJ O
who WP WP O
walks VBZ VBZ O
with IN IN O
a DT DT O
walker NN NN O
, , , O
slowly RB RB O
, , , O
but CC CC O
in IN IN O
no DT DT O
acute JJ JJ O
distress NN NN O
. . . O
   
Her PRP$ PRP$ O
weight NN NN O
is VBZ VBZ O
104 CD CD O
lbs NN NN O
. . . O
   
Her PRP$ PRP$ O
blood NN NN O
pressure NN NN O
today NN NN O
is VBZ VBZ O
130/72 CD CD O
. . . O
   
Her PRP$ PRP$ O
pulse NN NN O
is VBZ VBZ O
80 CD CD O
and CC CC O
regular JJ JJ O
today NN NN O
. . . O
   
She PRP PRP O
has VBZ VBZ O
no DT DT O
peripheral NN NN O
edema NN NN O
, , , O
and CC CC O
she PRP PRP O
is VBZ VBZ O
comfortable JJ JJ O
sitting VBG VBG O
in IN IN O
a DT DT O
chair NN NN O
. . . O
   
IMPRESSION NNP NNP O
: : : O
My PRP$ PRP$ O
overall JJ JJ O
impression NN NN O
is VBZ VBZ O
that DT DT O
Ms NNP NNP O
. . . O
Bird NNP NNP I-PATIENT
is VBZ VBZ O
stable JJ JJ O
with IN IN O
her PRP$ PRP$ O
current JJ JJ O
regimen NNS NNS O
and CC CC O
medications NNS NNS O
. . . O
   
We PRP PRP O
have VBP VBP O
been VBN VBN O
manipulating VBG VBG O
her PRP$ PRP$ O
GRANITE NNP NNP I-HOSPITAL
COUNTY NNP NNP I-HOSPITAL
MEMORIAL NNP NNP I-HOSPITAL
Arthritis NNP NNP O
Department NNP NNP O
32 CD CD I-STREET
Weld NNP NNP I-STREET
St NNP NNP I-STREET
Bird NNP NNP I-PATIENT
, , , O
Terri NNP NNP I-PATIENT
Lisbon NNP NNP I-CITY
, , , O
SD NNP NNP I-STATE
52797 CD CD I-ZIP
80910690 CD CD I-MEDICALRECORD
659-5187 CD CD I-PHONE
1-20-66 JJ JJ I-DATE
Page NNP NNP O
2 CD CD O
Coumadin NNP NNP O
to TO TO O
keep VB VB O
her PRP$ PRP$ O
INR NNP NNP O
between IN IN O
2 CD CD O
and CC CC O
3.5 CD CD O
and CC CC O
, , , O
most RBS RBS O
recently RB RB O
, , , O
it PRP PRP O
was VBD VBD O
2.5 CD CD O
, , , O
earlier RBR RBR O
this DT DT O
week NN NN O
. . . O
   
She PRP PRP O
will MD MD O
continue VB VB O
on IN IN O
her PRP$ PRP$ O
current JJ JJ O
medications NNS NNS O
, , , O
as IN IN O
noted VBN VBN O
above IN IN O
. . . O
   
The DT DT O
bulk NN NN O
of IN IN O
the DT DT O
discussion NN NN O
was VBD VBD O
regarding VBG VBG O
her PRP$ PRP$ O
home NN NN O
situation NN NN O
and CC CC O
her PRP$ PRP$ O
mental JJ JJ O
status NN NN O
. . . O
   
She PRP PRP O
has VBZ VBZ O
clearly RB RB O
improved VBN VBN O
her PRP$ PRP$ O
mental JJ JJ O
status NN NN O
gradually RB RB O
over IN IN O
the DT DT O
last JJ JJ O
several JJ JJ O
months NNS NNS O
. . . O
   
She PRP PRP O
is VBZ VBZ O
anxious JJ JJ O
to TO TO O
drive VB VB O
. . . O
   
However RB RB O
, , , O
everyone NN NN O
in IN IN O
the DT DT O
family NN NN O
who WP WP O
is VBZ VBZ O
with IN IN O
her PRP$ PRP$ O
at IN IN O
the DT DT O
visit NN NN O
and CC CC O
her PRP$ PRP$ O
visiting VBG VBG O
nurse NN NN O
agree VBP VBP O
that IN IN O
she PRP PRP O
is VBZ VBZ O
not RB RB O
mentally RB RB O
sound VB VB O
enough JJ JJ O
to TO TO O
be VB VB O
behind IN IN O
a DT DT O
wheel NN NN O
. . . O
   
I PRP PRP O
explained VBD VBD O
this DT DT O
in IN IN O
no DT DT O
uncertain JJ JJ O
terms NNS NNS O
, , , O
and CC CC O
also RB RB O
set VBD VBD O
a DT DT O
milestone NN NN O
in IN IN O
management NN NN O
of IN IN O
her PRP$ PRP$ O
own JJ JJ O
medications NNS NNS O
. . . O
   
Hence RB RB O
, , , O
our PRP$ PRP$ O
three CD CD O
goals NNS NNS O
that IN IN O
we PRP PRP O
set VBD VBD O
today NN NN O
were VBD VBD O
: : : O
   
1 CD CD O
. . . O
Management NNP NNP O
of IN IN O
the DT DT O
patient NN NN O
's POS POS O
own JJ JJ O
medications NNS NNS O
, , , O
which WDT WDT O
she PRP PRP O
was VBD VBD O
doing VBG VBG O
six CD CD O
months NNS NNS O
ago RB RB O
. . . O
   
2 CD CD O
. . . O
To TO TO O
get VB VB O
out IN IN O
of IN IN O
the DT DT O
house NN NN O
at IN IN O
least JJS JJS O
once RB RB O
a DT DT O
week NN NN O
, , , O
using VBG VBG O
either CC CC O
community NN NN O
transportation NN NN O
or CC CC O
a DT DT O
family NN NN O
member NN NN O
. . . O
   
3 CD CD O
. . . O
To TO TO O
be VB VB O
doing VBG VBG O
the DT DT O
family NN NN O
's POS POS O
laundry NNS NNS O
each DT DT O
week NN NN O
. . . O
   
While IN IN O
the DT DT O
patient NN NN O
was VBD VBD O
not RB RB O
happy JJ JJ O
about IN IN O
being VBG VBG O
told VBN VBN O
that IN IN O
she PRP PRP O
could MD MD O
not RB RB O
drive VB VB O
, , , O
she PRP PRP O
understood VBD VBD O
the DT DT O
reasons NNS NNS O
and CC CC O
was VBD VBD O
satisfied VBN VBN O
with IN IN O
the DT DT O
goals NNS NNS O
that IN IN O
we PRP PRP O
set VBD VBD O
. . . O
   
Hence RB RB O
, , , O
I PRP PRP O
will MD MD O
see VB VB O
her PRP$ PRP$ O
back RB RB O
in IN IN O
about IN IN O
six CD CD O
weeks NNS NNS O
and CC CC O
see VB VB O
how WRB WRB O
she PRP PRP O
is VBZ VBZ O
doing VBG VBG O
with IN IN O
these DT DT O
goals NNS NNS O
. . . O
   
As RB RB O
well RB RB O
, , , O
we PRP PRP O
will MD MD O
continue VB VB O
to TO TO O
have VB VB O
the DT DT O
visiting VBG VBG O
nurse NN NN O
see VB VB O
her PRP$ PRP$ O
every DT DT O
other JJ JJ O
week NN NN O
to TO TO O
monitor VB VB O
her PRP$ PRP$ O
blood NN NN O
sugar NN NN O
and CC CC O
Coumadin NNP NNP O
. . . O
   
_____________________________ NN NN O
_ NN NN O
Steve NNP NNP I-DOCTOR
George NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
ft:ZO:1640 NN NN I-IDNUM
DD:1-20-66 NNP NNP O
DT:1-21-66 NNP NNP O
DV:1-20-66 NNP NNP O
******** NN NN O
Not RB RB O
reviewed VBN VBN O
by IN IN O
Attending NNP NNP O
Physician NNP NNP O
******** NN NN O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2094-01-25 JJ JJ I-DATE
Problems NNS NNS O
coronary JJ JJ O
artery NN NN O
disease NN NN O
hypertension NN NN O
hyperlipidemia NN NN O
chronic JJ JJ O
obstructive JJ JJ O
pulmonary JJ JJ O
disease NN NN O
peripheral NN NN O
vascular NN NN O
disease NN NN O
peripheral NN NN O
edema NN NN O
: : : O
left VBN VBN O
ankle NN NN O
, , , O
doppler NN NN O
negative JJ JJ O
anxiety NN NN O
borderline NN NN O
diabetes NNS NNS O
mellitus JJ JJ O
urinary JJ JJ O
tract NN NN O
infection NN NN O
: : : O
Reoccurrent NNP NNP O
S/P NNP NNP O
cardiac JJ JJ O
bypass NN NN O
graft NN NN O
surgery NN NN O
: : : O
100 CD CD O
% NN NN O
obstr NN NN O
of IN IN O
LPC NNP NNP O
and CC CC O
mid JJ JJ O
RCA NNP NNP O
, , , O
70 CD CD O
% NN NN O
obstr NN NN O
LAD NNP NNP O
on IN IN O
cath NN NN O
11/92 CD CD I-DATE
. . . O
   
Medications NNP NNP O
Ecotrin NNP NNP O
( ( ( O
ASPIRIN NNP NNP O
Enteric NNP NNP O
Coated NNP NNP O
) ) ) O
325MG CD CD O
, , , O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
: : : O
Take VB VB O
as IN IN O
directed VBN VBN O
Ntg NNP NNP O
1/150 CD CD O
( ( ( O
NITROGLYCERIN NNP NNP O
1/150 CD CD O
( ( ( O
0.4 CD CD O
Mg NNP NNP O
) ) ) O
) ) ) O
1 CD CD O
TAB NNP NNP O
SL NNP NNP O
x1 NN NN O
: : : O
USE NNP NNP O
AS NNP NNP O
DIRECTED NNP NNP O
Nystatin NNP NNP O
Powder NNP NNP O
TOPICAL NNP NNP O
TOP NNP NNP O
BID NNP NNP O
Cozaar NNP NNP O
( ( ( O
LOSARTAN NNP NNP O
) ) ) O
50MG CD CD O
, , , O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
Q12H NNP NNP O
: : : O
Take VB VB O
as IN IN O
directed VBN VBN O
Lipitor NNP NNP O
( ( ( O
ATORVASTATIN NNP NNP O
) ) ) O
20MG CD CD O
, , , O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
: : : O
Take VB VB O
as IN IN O
directed VBN VBN O
Procardia NNP NNP O
Xl NNP NNP O
( ( ( O
NIFEDIPINE NNP NNP O
( ( ( O
SUSTAINED NNP NNP O
Relea NNP NNP O
. . . O
   
. . . O
   
. . . O
   
60 CD CD O
MG NNP NNP O
PO NNP NNP O
BID NNP NNP O
FUROSEMIDE NNP NNP O
40MG CD CD O
, , , O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
BID NNP NNP O
Lopressor NNP NNP O
( ( ( O
METOPROLOL NNP NNP O
Tartrate NNP NNP O
) ) ) O
50MG CD CD O
, , , O
0.5 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
BID NNP NNP O
Nexium NNP NNP O
( ( ( O
ESOMEPRAZOLE NNP NNP O
) ) ) O
20MG CD CD O
, , , O
1 CD CD O
Capsule NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Macrobid NNP NNP O
( ( ( O
NITROFURANTOIN NNP NNP O
Sr NNP NNP O
) ) ) O
100MG CD CD O
, , , O
1 CD CD O
Capsule NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Acetaminophen NNP NNP O
W/codeine NNP NNP O
30mg CD CD O
1 CD CD O
TAB NNP NNP O
PO NNP NNP O
Q4H NNP NNP O
PRN NNP NNP O
pain NN NN O
: : : O
Take VB VB O
as IN IN O
directed VBN VBN O
CLONAZEPAM NNP NNP O
0.5MG, CD CD O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
BID NNP NNP O
CLARITHROMYCIN NNP NNP O
500MG CD CD O
, , , O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
BID NNP NNP O
x SYM SYM O
10 CD CD O
day NN NN O
   
( ( ( O
s VBZ VBZ O
) ) ) O
Pt NNP NNP O
developed VBD VBD O
infection NN NN O
in IN IN O
a DT DT O
bunion NN NN O
approx NN NN O
2 CD CD O
weeks NNS NNS O
ago RB RB O
, , , O
seen VBN VBN O
here RB RB O
2 CD CD O
days NNS NNS O
ago RB RB O
, , , O
placed VBN VBN O
on IN IN O
biaxin NN NN O
( ( ( O
allergic IN IN O
to TO TO O
penicillin NN NN O
) ) ) O
. . . O
   
Pt NNP NNP O
notes NNS NNS O
no DT DT O
improvement NN NN O
in IN IN O
pain NN NN O
in IN IN O
foot NN NN O
and CC CC O
cannot NN NN O
lie NN NN O
on IN IN O
bed NN NN O
at IN IN O
night NN NN O
due JJ JJ O
to TO TO O
worsening VBG VBG O
pain NN NN O
, , , O
needs VBZ VBZ O
to TO TO O
sleep VB VB O
in IN IN O
chair NN NN O
with IN IN O
foot NN NN O
down RB RB O
. . . O
   
Hx NNP NNP O
CAD NNP NNP O
, , , O
PVD NNP NNP O
, , , O
glucose NN NN O
intolerance NN NN O
. . . O
   
PE NNP NNP O
: : : O
NAD NNP NNP O
right NN NN O
foot NN NN O
- : : O
distal JJ JJ O
one CD CD O
third JJ JJ O
of IN IN O
foot NN NN O
is VBZ VBZ O
swollen VBN VBN O
, , , O
erythematous JJ JJ O
with IN IN O
digital JJ JJ O
tinea NN NN O
all DT DT O
toes NNS NNS O
. . . O
   
The DT DT O
bunion NN NN O
area NN NN O
is VBZ VBZ O
swollen VBN VBN O
, , , O
erythematous JJ JJ O
, , , O
tender NN NN O
, , , O
with IN IN O
central JJ JJ O
ulceration NN NN O
draining VBG VBG O
yellow JJ JJ O
pus NN NN O
( ( ( O
small JJ JJ O
amt NN NN O
) ) ) O
IMP NNP NNP O
: : : O
Cellulitis NNP NNP O
RLE NNP NNP O
with IN IN O
ulcer NN NN O
over IN IN O
bunion NN NN O
in IN IN O
pt NN NN O
with IN IN O
PVD NNP NNP O
, , , O
possibly RB RB O
diabetes NNS NNS O
. . . O
   
Foot NN NN O
has VBZ VBZ O
worsened VBN VBN O
on IN IN O
oral JJ JJ O
antibiotics NNS NNS O
. . . O
   
Sx NNP NNP O
with IN IN O
elevation NN NN O
worrisome NN NN O
for IN IN O
arterial JJ JJ O
insuff NN NN O
. . . O
   
Pt NNP NNP O
sent VBD VBD O
to TO TO O
EW NNP NNP O
for IN IN O
eval NN NN O
, , , O
admission NN NN O
for IN IN O
IV NNP NNP O
antibiotics NNS NNS O
. . . O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2078-01-30 NN NN I-DATE
We PRP PRP O
are VBP VBP O
consulted VBN VBN O
by IN IN O
Dr NNP NNP O
. . . O
Bonilla NNP NNP I-DOCTOR
for IN IN O
assistance NN NN O
with IN IN O
glycemic JJ JJ O
management NN NN O
. . . O
   
Mr NNP NNP O
. . . O
Ervin NNP NNP I-PATIENT
is VBZ VBZ O
a DT DT O
67 CD CD I-AGE
y/o NN NN O
gentleman NN NN O
who WP WP O
is VBZ VBZ O
presently RB RB O
POD NNP NNP O
# # # O
1 CD CD O
after IN IN O
AVR NNP NNP O
and CC CC O
2V CD CD O
CABG NNP NNP O
. . . O
   
He PRP PRP O
had VBD VBD O
known VBN VBN O
calcific JJ JJ O
AS NNP NNP O
and CC CC O
presented VBN VBN O
with IN IN O
increasing VBG VBG O
fatigue NN NN O
and CC CC O
dyspnea NN NN O
on IN IN O
exertion NN NN O
. . . O
   
He PRP PRP O
was VBD VBD O
subsequently RB RB O
found VBN VBN O
to TO TO O
have VB VB O
worsening NN NN O
AS NNP NNP O
and CC CC O
CAD NNP NNP O
, , , O
including VBG VBG O
LM NNP NNP O
disease NN NN O
. . . O
   
His PRP$ PRP$ O
peri-operative JJ JJ O
course NN NN O
has VBZ VBZ O
been VBN VBN O
notable JJ JJ O
for IN IN O
hyperglycemia NN NN O
with IN IN O
maximum NN NN O
BG NNP NNP O
252 CD CD O
. . . O
   
He PRP PRP O
was VBD VBD O
started VBN VBN O
on IN IN O
an DT DT O
insulin NN NN O
infusion NN NN O
according VBG VBG O
to TO TO O
the DT DT O
Portland NNP NNP O
Protocol NNP NNP O
and CC CC O
remains VBZ VBZ O
on IN IN O
0.5-2 JJ JJ O
units/hour NN NN O
since IN IN O
midnight NN NN O
with IN IN O
BS NNP NNP O
117-134-163-151-125-137-98-99 JJ JJ O
. . . O
   
Mr NNP NNP O
. . . O
Ervin NNP NNP I-PATIENT
recalls VBZ VBZ O
having VBG VBG O
been VBN VBN O
diagnosed VBN VBN O
with IN IN O
DM NNP NNP O
at IN IN O
the DT DT O
age NN NN O
of IN IN O
19 CD CD I-AGE
as IN IN O
part NN NN O
of IN IN O
a DT DT O
military JJ JJ O
physical JJ JJ O
. . . O
   
He PRP PRP O
was VBD VBD O
overweight NN NN O
and CC CC O
was VBD VBD O
placed VBN VBN O
on IN IN O
dietary JJ JJ O
therapy NN NN O
. . . O
   
Per IN IN O
his PRP$ PRP$ O
own JJ JJ O
report NN NN O
his PRP$ PRP$ O
DM NNP NNP O
was VBD VBD O
diet JJ JJ O
controlled VBN VBN O
and CC CC O
"""" '' '' O
seemed VBD VBD O
to TO TO O
disappear VB VB O
"""" '' '' O
several JJ JJ O
years NNS NNS O
after IN IN O
initial JJ JJ O
diagnosis NN NN O
. . . O
   
Approximately RB RB O
4 CD CD O
years NNS NNS O
ago RB RB O
he PRP PRP O
experienced VBD VBD O
blurry NN NN O
vision NN NN O
and CC CC O
was VBD VBD O
again RB RB O
noted VBN VBN O
to TO TO O
have VB VB O
elevated VBN VBN O
BGs NNP NNP O
( ( ( O
he PRP PRP O
is VBZ VBZ O
uncertain JJ JJ O
of IN IN O
the DT DT O
magnitude NN NN O
of IN IN O
the DT DT O
BG NNP NNP O
elevation NN NN O
) ) ) O
. . . O
   
He PRP PRP O
resumed VBD VBD O
dietary JJ JJ O
therapy NN NN O
and CC CC O
has VBZ VBZ O
achieved VBN VBN O
good JJ JJ O
control NN NN O
with IN IN O
a DT DT O
pre-op JJ JJ O
A1c NNP NNP O
of IN IN O
6.2 CD CD O
. . . O
   
He PRP PRP O
is VBZ VBZ O
followed VBN VBN O
at IN IN O
the DT DT O
Skiff NNP NNP I-HOSPITAL
. . . O
   
He PRP PRP O
has VBZ VBZ O
never RB RB O
been VBN VBN O
on IN IN O
insulin NN NN O
or CC CC O
OHAs NNP NNP O
and CC CC O
denies NNS NNS O
knowledge NN NN O
of IN IN O
diabetic JJ JJ O
complications NNS NNS O
. . . O
   
He PRP PRP O
checks VBZ VBZ O
BS NNP NNP O
at IN IN O
home NN NN O
sporadically RB RB O
which WDT WDT O
are VBP VBP O
usually RB RB O
in IN IN O
the DT DT O
low-mid JJ JJ O
100s NN NN O
. . . O
   
He PRP PRP O
says VBZ VBZ O
when WRB WRB O
he PRP PRP O
experiences VBZ VBZ O
hyperglycemic JJ JJ O
symptoms NNS NNS O
( ( ( O
i.e. NN NN O
occasional JJ JJ O
nocturia NN NN O
) ) ) O
he PRP PRP O
walks VBZ VBZ O
to TO TO O
bring VB VB O
down RP RP O
his PRP$ PRP$ O
blood NN NN O
sugar NN NN O
. . . O
   
In IN IN O
general JJ JJ O
he PRP PRP O
is VBZ VBZ O
active JJ JJ O
, , , O
walking VBG VBG O
several JJ JJ O
miles/day NN NN O
. . . O
   
Past NNP NNP O
Medical NNP NNP O
History NN NN O
: : : O
HTN NNP NNP O
, , , O
AS NNP NNP O
, , , O
DM2 NNP NNP O
as IN IN O
above IN IN O
Current NNP NNP O
Medications NNP NNP O
: : : O
Insulin NNP NNP O
, , , O
K/Mg NNP NNP O
, , , O
ASA NNP NNP O
, , , O
Toradol NNP NNP O
, , , O
Zofran NNP NNP O
, , , O
Vanco NNP NNP O
, , , O
Carafate NNP NNP O
Social NNP NNP O
History NN NN O
: : : O
remote JJ JJ O
tobacco NN NN O
, , , O
ETOH NNP NNP O
Famiy NNP NNP O
History NN NN O
: : : O
Son NNP NNP O
with IN IN O
DM1 NNP NNP O
, , , O
Grandmother NNP NNP O
with IN IN O
DM NNP NNP O
ROS NNP NNP O
: : : O
Denies NNS NNS O
HA NNP NNP O
or CC CC O
changes NNS NNS O
in IN IN O
vision NN NN O
. . . O
   
+ NN NN O
SOB NNP NNP O
PTA NNP NNP O
. . . O
   
No DT DT O
abdominal JJ JJ O
pain NN NN O
or CC CC O
changes NNS NNS O
in IN IN O
bowels NNS NNS O
. . . O
   
No DT DT O
dysuria NN NN O
, , , O
occasional JJ JJ O
nocturia NN NN O
. . . O
   
No DT DT O
recent JJ JJ O
lower JJR JJR O
extremity NN NN O
swelling NN NN O
. . . O
   
Remainder NNP NNP O
of IN IN O
review NN NN O
of IN IN O
systems NNS NNS O
is VBZ VBZ O
negative JJ JJ O
or CC CC O
as IN IN O
per IN IN O
HPI NNP NNP O
. . . O
   
Physical JJ JJ O
Exam NNP NNP O
: : : O
Vitals NNP NNP O
: : : O
98.2 CD CD O
70 CD CD O
120/68 CD CD O
Gen NNP NNP O
: : : O
pleasant NN NN O
, , , O
heavy JJ JJ O
set VBN VBN O
( ( ( O
but CC CC O
muscular JJ JJ O
) ) ) O
gentleman NN NN O
in IN IN O
NAD NNP NNP O
HEENT NNP NNP O
: : : O
NC/AT NNP NNP O
EOMI NNP NNP O
Neck NNP NNP O
: : : O
supple JJ JJ O
central JJ JJ O
venous JJ JJ O
line NN NN O
in IN IN O
place NN NN O
CV NNP NNP O
: : : O
distant JJ JJ O
HS NNP NNP O
Chest NN NN O
: : : O
wound NN NN O
intact JJ JJ O
Lungs NNP NNP O
: : : O
Clear JJ JJ O
anteriorly RB RB O
Abd NNP NNP O
: : : O
S/NT NNP NNP O
Extremities NNP NNP O
: : : O
no DT DT O
edema NN NN O
, , , O
well RB RB O
perfused VBN VBN O
Neuro NNP NNP O
: : : O
A&Ox3 NNP NNP O
Skin NNP NNP O
: : : O
intact JJ JJ O
Labs NNP NNP O
: : : O
pre-op NN NN O
A1c NNP NNP O
6.2 CD CD O
. . . O
   
Prior NNP NNP O
A1c NNP NNP O
7.2 CD CD O
in IN IN O
4/73 CD CD I-DATE
A/P NNP NNP O
Mr NNP NNP O
. . . O
Ervin NNP NNP I-PATIENT
has VBZ VBZ O
DM2 NNP NNP O
which WDT WDT O
was VBD VBD O
adequately RB RB O
controlled VBN VBN O
pre-operatively JJ JJ O
with IN IN O
diet NN NN O
and CC CC O
exercise NN NN O
. . . O
   
He PRP PRP O
is VBZ VBZ O
presently RB RB O
requiring VBG VBG O
insulin NN NN O
in IN IN O
the DT DT O
setting VBG VBG O
of IN IN O
the DT DT O
stress NN NN O
of IN IN O
surgery NN NN O
. . . O
   
Meticulous NNP NNP O
BG NNP NNP O
control NN NN O
is VBZ VBZ O
important JJ JJ O
in IN IN O
the DT DT O
post-operative JJ JJ O
period NN NN O
. . . O
   
The DT DT O
goal NN NN O
is VBZ VBZ O
to TO TO O
maintain VB VB O
BS<175. NNP NNP O
   
He PRP PRP O
should MD MD O
remain VB VB O
on IN IN O
the DT DT O
Portland NNP NNP O
Protocol NNP NNP O
until IN IN O
at IN IN O
least JJS JJS O
POD NNP NNP O
#3 NN NN O
. . . O
   
At IN IN O
that DT DT O
point NN NN O
only RB RB O
if IN IN O
he PRP PRP O
is VBZ VBZ O
fully RB RB O
stabilized VBN VBN O
and CC CC O
eating VBG VBG O
well RB RB O
can MD MD O
he PRP PRP O
be VB VB O
transitioned VBN VBN O
on IN IN O
to TO TO O
an DT DT O
alternative JJ JJ O
regimen NNS NNS O
. . . O
   
He PRP PRP O
may MD MD O
transiently RB RB O
require VB VB O
subcutaneous JJ JJ O
insulin NN NN O
but CC CC O
will MD MD O
ideally RB RB O
be VB VB O
able JJ JJ O
to TO TO O
resume VB VB O
dietary JJ JJ O
control NN NN O
of IN IN O
DM NNP NNP O
. . . O
   
Thank VB VB O
you PRP PRP O
for IN IN O
allowing VBG VBG O
us PRP PRP O
to TO TO O
participate VB VB O
in IN IN O
the DT DT O
care NN NN O
of IN IN O
this DT DT O
patient NN NN O
. . . O
   
Our PRP$ PRP$ O
team NN NN O
will MD MD O
follow VB VB O
with IN IN O
you PRP PRP O
. . . O
   
____________________________________________ NN NN O
_ NN NN O
Paige NNP NNP I-DOCTOR
Quadirah NNP NNP I-DOCTOR
Hooper NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2079-10-13 JJ JJ I-DATE
Quindarrius NNP NNP I-PATIENT
is VBZ VBZ O
a DT DT O
69 CD CD I-AGE
y/o NN NN O
male NN NN O
with IN IN O
: : : O
Problems NNS NNS O
Coronary JJ JJ O
artery NN NN O
disease NN NN O
: : : O
CABG NNP NNP O
x2 NN NN O
vessels NNS NNS O
, , , O
2/78 CD CD I-DATE
. . . O
   
Aortic NNP NNP O
stenosis NNS NNS O
: : : O
AVR NNP NNP O
2/78/Dr CD CD O
Bonilla NNP NNP I-DOCTOR
Diabetes NNP NNP O
mellitus NN NN O
: : : O
Dr NNP NNP O
Ayala-Skiff NNP NNP O
Atrial NNP NNP O
fibrillation NN NN O
Spinal NNP NNP O
stenosis NN NN O
: : : O
C3-4; NNP NNP O
   
C5-6; NNP NNP O
   
C7-T1 NNP NNP O
Medications NNP NNP O
Asa NNP NNP O
( ( ( O
ACETYLSALICYLIC NNP NNP O
ACID NNP NNP O
) ) ) O
81MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Furosemide NNP NNP O
40 CD CD O
MG NNP NNP O
( ( ( O
40MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Metformin NNP NNP O
500MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
2 CD CD O
am VBP VBP O
, , , O
1 CD CD O
pm NN NN O
, , , O
for IN IN O
blood NN NN O
sugar NN NN O
Lopressor NNP NNP O
( ( ( O
METOPROLOL NNP NNP O
TARTRATE NNP NNP O
) ) ) O
50MG CD CD O
TABLET NNP NNP O
PO NNP NNP O
TID NNP NNP O
Lisinopril NNP NNP O
5MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Digoxin NNP NNP O
125MCG CD CD O
TABLET NNP NNP O
PO NNP NNP O
QD NNP NNP O
Simvastatin NNP NNP O
5MG CD CD O
TABLET NNP NNP O
PO NNP NNP O
QHS NNP NNP O
Viagra NNP NNP O
( ( ( O
SILDENAFIL NNP NNP O
) ) ) O
25 CD CD O
MG-50 NNP NNP O
MG NNP NNP O
( ( ( O
50MG CD CD O
TABLET NNP NNP O
) ) ) O
PO NNP NNP O
x SYM SYM O
1 CD CD O
, , , O
Take NNP NNP O
1/2-1 JJ JJ O
tab NN NN O
as IN IN O
directed VBN VBN O
. . . O
   
Metrogel NNP NNP O
0.75 CD CD O
% NN NN O
( ( ( O
METRONIDAZOLE NNP NNP O
) ) ) O
1 CD CD O
APPLICATION NNP NNP O
TOP NNP NNP O
BID NNP NNP O
Warfarin NNP NNP O
SODIUM NNP NNP O
5 CD CD O
MG NNP NNP O
( ( ( O
5MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
) ) ) O
PO NNP NNP O
QPM NNP NNP O
, , , O
Takes VBZ VBZ O
total JJ JJ O
of IN IN O
5.5 CD CD O
mg NN NN O
QD NNP NNP O
. . . O
   
Warfarin NNP NNP O
SODIUM NNP NNP O
0.5 CD CD O
MG NNP NNP O
( ( ( O
1MG CD CD O
TABLET NNP NNP O
take NN NN O
0.5 CD CD O
) ) ) O
PO NNP NNP O
QPM NNP NNP O
, , , O
Takes VBZ VBZ O
total JJ JJ O
of IN IN O
5.5 CD CD O
mg NN NN O
QD NNP NNP O
. . . O
   
Alprazolam NNP NNP O
0.25 CD CD O
MG NNP NNP O
(0.5MG NNP NNP O
TABLET NNP NNP O
take NN NN O
0.5 CD CD O
) ) ) O
PO NNP NNP O
QHS NNP NNP O
PRN NNP NNP O
Allergies NNP NNP O
NKA NNP NNP O
Evaluation NNP NNP O
of IN IN O
treatment NN NN O
of IN IN O
: : : O
1.Reverted CD CD O
to TO TO O
afib VB VB O
over IN IN O
spring NN NN I-DATE
. . . O
   
Cor NNP NNP O
- : : O
No DT DT O
chest NN NN O
pain NN NN O
. . . O
   
Occ NNP NNP O
DOE NNP NNP O
. . . O
   
No DT DT O
palpitations NNS NNS O
. . . O
   
No DT DT O
lighthead NN NN O
. . . O
   
No DT DT O
PND NNP NNP O
. . . O
   
No DT DT O
orthopnea NN NN O
. . . O
   
No DT DT O
claudication NN NN O
. . . O
   
No DT DT O
edema NN NN O
. . . O
   
2 CD CD O
. . . O
DM NNP NNP O
well RB RB O
controlled VBD VBD O
. . . O
   
HgB NNP NNP O
A1C=6.7 NNP NNP O
9/79 CD CD I-DATE
. . . O
   
Eye NNP NNP O
exam NN NN O
4/79 CD CD I-DATE
. . . O
   
Endocrine NNP NNP O
: : : O
No DT DT O
polydipsia NN NN O
, , , O
polyuria NN NN O
, , , O
polyphagia NN NN O
, , , O
weight NN NN O
change NN NN O
, , , O
sweats,heat NN NN O
intolerance NN NN O
. . . O
   
LDL=44. NNP NNP O
   
3 CD CD O
. . . O
Last JJ JJ O
visit NN NN O
given VBN VBN O
Metrogel NNP NNP O
for IN IN O
rosacea NN NN O
. . . O
   
No DT DT O
change NN NN O
. . . O
   
Needs NNP NNP O
derm VB VB O
eval NN NN O
and CC CC O
treatmetn NN NN O
of IN IN O
probable JJ JJ O
actinic JJ JJ O
keratoses NNS NNS O
. . . O
   
4 CD CD O
. . . O
C/O NNP NNP O
occ JJ JJ O
hoarse NN NN O
. . . O
   
No DT DT O
sore NN NN O
throat NN NN O
. . . O
   
Occ NNP NNP O
dry JJ JJ O
. . . O
   
Worse JJR JJR O
after IN IN O
arguing VBG VBG O
. . . O
   
NO DT DT O
reflux NN NN O
. . . O
   
Oc NNP NNP O
dyspepsia NN NN O
. . . O
   
No DT DT O
ETOH NNP NNP O
or CC CC O
cigs NN NN O
. . . O
   
5 CD CD O
. . . O
GU NNP NNP O
- : : O
no DT DT O
dysuria NN NN O
; : : O
   
no DT DT O
hematuria NN NN O
. . . O
   
No DT DT O
dc NN NN O
. . . O
   
nocturia NN NN O
x SYM SYM O
2 CD CD O
; : : O
   
NO DT DT O
frequency NN NN O
. . . O
   
NO DT DT O
Hx NNP NNP O
STD NNP NNP O
. . . O
   
Vital NNP NNP O
Signs NNP NNP O
BP NNP NNP O
102/74 CD CD O
, , , O
P NN NN O
76 CD CD O
, , , O
RR NNP NNP O
14 CD CD O
WD,WN,NAD NNP NNP O
Skin NNP NNP O
facial JJ JJ O
erythema NN NN O
. . . O
   
Telangiectasia NNP NNP O
. . . O
   
With IN IN O
scaley NN NN O
areas NNS NNS O
. . . O
   
M&T NNP NNP O
- : : O
lips NNS NNS O
and CC CC O
gums NNS NNS O
unremarkable JJ JJ O
. . . O
   
Moist NNP NNP O
; : : O
   
no DT DT O
erythema NN NN O
; : : O
   
no DT DT O
exudate NN NN O
; : : O
   
no DT DT O
lesions NNS NNS O
Neck RB RB O
- : : O
supple NN NN O
. . . O
   
No DT DT O
JVD NNP NNP O
. . . O
   
No DT DT O
bruit NN NN O
. . . O
   
No DT DT O
LAN NNP NNP O
. . . O
   
No DT DT O
thyromegaly NN NN O
Pulm NNP NNP O
- : : O
NO DT DT O
accessory JJ JJ O
muscle NN NN O
use NN NN O
. . . O
   
Percussion NNP NNP O
- - - O
normal JJ JJ O
. . . O
   
Palpation-normal NNP NNP O
. . . O
   
Auscultation-clear JJ JJ O
. . . O
   
Cor NNP NNP O
- : : O
irreg NN NN O
rhyhm NN NN O
. . . O
   
S1S2 NNP NNP O
normal JJ JJ O
. . . O
   
No DT DT O
gallop NN NN O
. . . O
   
No DT DT O
rub NN NN O
. . . O
   
NO DT DT O
murmer NN NN O
. . . O
   
Abdo NNP NNP O
- : : O
normal JJ JJ O
BS NNP NNP O
; : : O
   
soft JJ JJ O
with IN IN O
no DT DT O
HSM NNP NNP O
. . . O
   
No DT DT O
mass NN NN O
. . . O
   
No DT DT O
tenderness NN NN O
DRE-sphincter NNP NNP O
normal JJ JJ O
. . . O
   
No DT DT O
lesions NNS NNS O
. . . O
   
Prostate NNP NNP O
- : : O
small JJ JJ O
, , , O
firm NN NN O
, , , O
smooth JJ JJ O
, , , O
no DT DT O
nodules NNS NNS O
. . . O
   
Stool NNP NNP O
brown-heme JJ JJ O
neg NN NN O
. . . O
   
Ext NNP NNP O
- - - O
no DT DT O
edema NN NN O
. . . O
   
PT-+2 NNP NNP O
ASS NNP NNP O
: : : O
R/O NNP NNP O
actionicn NN NN O
keratoses NNS NNS O
DM-well NNP NNP O
controlled VBD VBD O
Asymp NNP NNP O
card NN NN O
Normal NNP NNP O
prostate NN NN O
exam NN NN O
. . . O
   
P NN NN O
- : : O
Cont NNP NNP O
meds NNS NNS O
FLu NNP NNP O
vaccine NN NN O
given VBN VBN O
by IN IN O
mne NN NN O
Appt NNP NNP O
for IN IN O
screening VBG VBG O
colonosocopy NN NN O
. . . O
   
crat,glu,K NN NN O
, , , O
INR NNP NNP O
. . . O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2076-08-30 JJ JJ I-DATE
EDVISIT^24490460^VAUGHN, NNP NNP O
FRANK^08/30/76^JABLONSKI, NNP NNP O
SHIRLEY NNP NNP I-DOCTOR
The DT DT O
patient NN NN O
was VBD VBD O
interviewed VBN VBN O
and CC CC O
examined VBN VBN O
by IN IN O
myself PRP PRP O
, , , O
Dr NNP NNP O
. . . O
Jablonski NNP NNP I-DOCTOR
, , , O
as RB RB O
well RB RB O
as IN IN O
the DT DT O
resident NN NN O
, , , O
Dr NNP NNP O
. . . O
Ortiz NNP NNP I-DOCTOR
for IN IN O
visit NN NN O
on IN IN O
08/30/2076 CD CD I-DATE
. . . O
   
Please VB VB O
see VB VB O
note NN NN O
for IN IN O
details NNS NNS O
reviewed VBN VBN O
in IN IN O
full JJ JJ O
. . . O
   
HISTORY NN NN O
OF IN IN O
PRESENT NNP NNP O
ILLNESS NNP NNP O
: : : O
This DT DT O
is VBZ VBZ O
an DT DT O
obese NN NN O
32-year-old JJ JJ O
gentleman NN NN O
with IN IN O
history NN NN O
of IN IN O
high JJ JJ O
cholesterol NN NN O
, , , O
hypertension NN NN O
, , , O
and CC CC O
diabetes NNS NNS O
who WP WP O
comes VBZ VBZ O
in IN IN O
after IN IN O
trying VBG VBG O
to TO TO O
increase VB VB O
his PRP$ PRP$ O
exercise NN NN O
over IN IN O
the DT DT O
last JJ JJ O
couple NN NN O
of IN IN O
weeks NNS NNS O
with IN IN O
shortness NN NN O
of IN IN O
breath NN NN O
and CC CC O
fatigue NN NN O
and CC CC O
difficulty NN NN O
breathing VBG VBG O
since IN IN O
his PRP$ PRP$ O
walking VBG VBG O
yesterday NN NN O
. . . O
   
He PRP PRP O
went VBD VBD O
to TO TO O
bed NN NN O
and CC CC O
woke VBD VBD O
up RB RB O
today NN NN O
with IN IN O
continued VBD VBD O
symptoms NNS NNS O
. . . O
   
FAMILY NN NN O
HISTORY NN NN O
: : : O
Besides IN IN O
his PRP$ PRP$ O
past JJ JJ O
medical JJ JJ O
history NN NN O
, , , O
he PRP PRP O
has VBZ VBZ O
a DT DT O
significant JJ JJ O
CAD NNP NNP O
in IN IN O
his PRP$ PRP$ O
grandfather NN NN O
with IN IN O
CHF NNP NNP O
. . . O
   
His PRP$ PRP$ O
father NN NN O
died VBD VBD O
at IN IN O
early JJ JJ O
age NN NN O
of IN IN O
19 CD CD I-AGE
of IN IN O
a DT DT O
traumatic JJ JJ O
accident NN NN O
. . . O
   
SOCIAL NNP NNP O
HISTORY NN NN O
: : : O
She PRP PRP O
does VBZ VBZ O
not RB RB O
drink VB VB O
and CC CC O
does VBZ VBZ O
not RB RB O
smoke VB VB O
. . . O
   
PAST NNP NNP O
SURGICAL NNP NNP O
HISTORY NN NN O
: : : O
He PRP PRP O
himself PRP PRP O
has VBZ VBZ O
had VBN VBN O
no DT DT O
surgeries NNS NNS O
except IN IN O
a DT DT O
cholecystectomy NN NN O
. . . O
   
REVIEW NNP NNP O
OF IN IN O
SYSTEMS NNP NNP O
: : : O
Shortness NNP NNP O
of IN IN O
breath NN NN O
, , , O
no DT DT O
chest NN NN O
pain NN NN O
, , , O
no DT DT O
lightheadedness NN NN O
, , , O
no DT DT O
leg NN NN O
swelling VBG VBG O
, , , O
no DT DT O
palpitations NNS NNS O
, , , O
and CC CC O
came VBD VBD O
in IN IN O
acutely RB RB O
diaphoretic JJ JJ O
with IN IN O
shortness NN NN O
of IN IN O
breath NN NN O
. . . O
   
MEDICATIONS NNP NNP O
: : : O
Lantus NNP NNP O
, , , O
glipizide NN NN O
, , , O
Zocor NNP NNP O
, , , O
atenolol NN NN O
, , , O
and CC CC O
was VBD VBD O
recently RB RB O
started VBN VBN O
insulin NN NN O
as IN IN O
above IN IN O
a DT DT O
week NN NN O
ago RB RB O
. . . O
   
ALLERGIES NNP NNP O
: : : O
No DT DT O
known VBN VBN O
drug NN NN O
allergies NNS NNS O
. . . O
   
PHYSICAL JJ JJ O
EXAMINATION NNP NNP O
: : : O
Mildly RB RB O
obese NN NN O
gentleman NN NN O
with IN IN O
a DT DT O
pulse NN NN O
of IN IN O
100 CD CD O
, , , O
respiratory JJ JJ O
rate NN NN O
28 CD CD O
, , , O
O2 NNP NNP O
saturation NN NN O
97 CD CD O
on IN IN O
4 CD CD O
L NNP NNP O
, , , O
blood NN NN O
pressure NN NN O
132/69 CD CD O
, , , O
and CC CC O
temperature NN NN O
98.1 CD CD O
. . . O
   
HEENT NNP NNP O
is VBZ VBZ O
anicteric JJ JJ O
. . . O
   
Neck NN NN O
is VBZ VBZ O
supple JJ JJ O
. . . O
   
Heart NNP NNP O
is VBZ VBZ O
regular JJ JJ O
rate NN NN O
and CC CC O
rhythm NN NN O
although IN IN O
distant JJ JJ O
heart NN NN O
sounds VBZ VBZ O
. . . O
   
He PRP PRP O
is VBZ VBZ O
tachypneic NN NN O
but CC CC O
no DT DT O
obvious JJ JJ O
wheezes NNS NNS O
. . . O
   
He PRP PRP O
has VBZ VBZ O
soft JJ JJ O
abdomen NN NN O
. . . O
   
Extremities NNP NNP O
showed VBD VBD O
no DT DT O
cyanosis NN NN O
, , , O
clubbing VBG VBG O
, , , O
or CC CC O
edema NN NN O
, , , O
no DT DT O
calf NN NN O
tenderness NN NN O
. . . O
   
Neurologic NNP NNP O
: : : O
Oriented NNP NNP O
x3 NN NN O
. . . O
   
No DT DT O
obvious JJ JJ O
cranial JJ JJ O
, , , O
motor NN NN O
, , , O
or CC CC O
sensory JJ JJ O
deficits NNS NNS O
. . . O
   
Differential NNP NNP O
can MD MD O
be VB VB O
acute JJ JJ O
coronary JJ JJ O
syndrome NN NN O
versus CC CC O
PE NNP NNP O
. . . O
   
His PRP$ PRP$ O
weight NN NN O
is VBZ VBZ O
330 CD CD O
pounds NNS NNS O
, , , O
went VBD VBD O
ahead RB RB O
and CC CC O
got VBD VBD O
a DT DT O
d-dimer JJ JJ O
, , , O
which WDT WDT O
was VBD VBD O
negative JJ JJ O
. . . O
   
We PRP PRP O
went VBD VBD O
ahead RB RB O
and CC CC O
got VBD VBD O
an DT DT O
EKG NNP NNP O
, , , O
which WDT WDT O
is VBZ VBZ O
normal JJ JJ O
. . . O
   
Normal JJ JJ O
chest NN NN O
x-ray NN NN O
. . . O
   
Normal NNP NNP O
CKs NNP NNP O
, , , O
troponins NNS NNS O
, , , O
and CC CC O
SMA-7. NNP NNP O
   
His PRP$ PRP$ O
magnesium NN NN O
is VBZ VBZ O
slightly RB RB O
therapeutic JJ JJ O
at IN IN O
1.7 CD CD O
, , , O
which WDT WDT O
was VBD VBD O
repleted VBN VBN O
. . . O
   
His PRP$ PRP$ O
hematocrit NN NN O
and CC CC O
white JJ JJ O
count NN NN O
were VBD VBD O
normal JJ JJ O
. . . O
   
DIAGNOSIS NNP NNP O
: : : O
Shortness NNP NNP O
of IN IN O
breath NN NN O
, , , O
concern NN NN O
for IN IN O
ischemic JJ JJ O
equivalent NN NN O
. . . O
   
DISPOSITION NNP NNP O
: : : O
Admitted NNP NNP O
to TO TO O
the DT DT O
Medicine NNP NNP O
Service NNP NNP O
in IN IN O
stable JJ JJ O
condition NN NN O
. . . O
   
_____________________________ NN NN O
_ NN NN O
JABLONSKI NNP NNP O
, , , O
SHIRLEY NNP NNP I-DOCTOR
M.D. NNP NNP O
   
D NNP NNP O
: : : O
08/30/76 CD CD I-DATE
T NN NN O
: : : O
08/30/76 CD CD I-DATE
Dictated NNP NNP O
By IN IN O
: : : O
JABLONSKI NNP NNP O
, , , O
SHIRLEY NNP NNP I-DOCTOR
eScription NN NN O
document:2-3735520 JJ JJ O
BFFocus NNP NNP O
******** NN NN O
Not RB RB O
reviewed VBN VBN O
by IN IN O
Attending NNP NNP O
Physician NNP NNP O
******** NN NN O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2095-03-27 JJ JJ I-DATE
Wt NNP NNP O
198 CD CD O
146/84 NN NN O
72 CD CD I-AGE
yo NN NN O
male JJ JJ O
with IN IN O
few JJ JJ O
months NNS NNS O
of IN IN O
cardiac JJ JJ O
problems NNS NNS O
, , , O
including VBG VBG O
need VBP VBP O
for IN IN O
ablation NN NN O
of IN IN O
arrhythmia NN NN O
focus NN NN O
, , , O
done VBN VBN O
1/95 CD CD I-DATE
. . . O
   
Has VBZ VBZ O
hx NN NN O
CAD NNP NNP O
with IN IN O
MI NNP NNP O
2062 CD CD I-DATE
and CC CC O
2086 CD CD I-DATE
, , , O
with IN IN O
echo NN NN O
1/95 CD CD I-DATE
showing VBG VBG O
40-45 CD CD O
% NN NN O
EF NNP NNP O
with IN IN O
posterior NN NN O
and CC CC O
apical JJ JJ O
hypokinesis NN NN O
. . . O
   
No DT DT O
CHF NNP NNP O
sx NN NN O
, , , O
tho NN NN O
has VBZ VBZ O
moderate JJ JJ O
fluid JJ JJ O
retention NN NN O
at IN IN O
times NNS NNS O
. . . O
   
Takes VBZ VBZ O
lasix NN NN O
40mg CD CD O
PRN NNP NNP O
( ( ( O
about IN IN O
1-2 JJ JJ O
times NNS NNS O
per IN IN O
wk NN NN O
, , , O
when WRB WRB O
edematous JJ JJ O
, , , O
tho NN NN O
even RB RB O
with IN IN O
periph NN NN O
edema NN NN O
, , , O
no DT DT O
signif NN NN O
SOB/CHF NNP NNP O
sx NN NN O
. . . O
   
). NN NN O
   
For IN IN O
past JJ JJ O
6 CD CD O
wks NN NN O
has VBZ VBZ O
been VBN VBN O
on IN IN O
atenolol NN NN O
25 CD CD O
qd NN NN O
( ( ( O
has VBZ VBZ O
not RB RB O
been VBN VBN O
able JJ JJ O
to TO TO O
tolerate VB VB O
amiodarone NN NN O
, , , O
lisinopril NN NN O
in IN IN O
past JJ JJ O
) ) ) O
, , , O
but CC CC O
has VBZ VBZ O
felt VBN VBN O
very RB RB O
malaised VBN VBN O
, , , O
weak JJ JJ O
, , , O
lacking VBG VBG O
in IN IN O
energy NN NN O
, , , O
"""" '' '' O
weak JJ JJ O
"""" '' '' O
in IN IN O
the DT DT O
legs NNS NNS O
. . . O
   
Feels VBZ VBZ O
his PRP$ PRP$ O
appetite NN NN O
was VBD VBD O
also RB RB O
affected VBN VBN O
and CC CC O
he PRP PRP O
lost VBD VBD O
8 CD CD O
pounds NNS NNS O
. . . O
   
He PRP PRP O
got VBD VBD O
fed VBN VBN O
up RP RP O
and CC CC O
2 CD CD O
days NNS NNS O
ago RB RB O
on IN IN O
his PRP$ PRP$ O
own JJ JJ O
, , , O
he PRP PRP O
stopped VBD VBD O
the DT DT O
atenolol NN NN O
and CC CC O
since IN IN O
then RB RB O
has VBZ VBZ O
felt VBN VBN O
nearly RB RB O
back RB RB O
to TO TO O
usual JJ JJ O
self NN NN O
. . . O
   
HE PRP PRP O
says VBZ VBZ O
that IN IN O
he PRP PRP O
will MD MD O
not RB RB O
go VB VB O
back RB RB O
on IN IN O
atenolol NN NN O
. . . O
   
At IN IN O
last JJ JJ O
visit NN NN O
, , , O
was VBD VBD O
encouraged VBN VBN O
by IN IN O
Dr NNP NNP O
Corona NNP NNP I-DOCTOR
to TO TO O
try VB VB O
to TO TO O
continue VB VB O
with IN IN O
atenolol NN NN O
. . . O
   
DM NNP NNP O
on IN IN O
glucophage NN NN O
1500mg CD CD O
qd NN NN O
( ( ( O
500 CD CD O
AM NNP NNP O
, , , O
1000PM CD CD O
) ) ) O
, , , O
without IN IN O
signif JJ JJ O
poly NN NN O
sx NN NN O
, , , O
with IN IN O
recent JJ JJ O
fingerstick NN NN O
of IN IN O
180 CD CD O
in IN IN O
AM NNP NNP O
and CC CC O
220 CD CD O
in IN IN O
PM NNP NNP O
. . . O
   
EXAM NNP NNP O
: : : O
Lungs NNS NNS O
are VBP VBP O
clear JJ JJ O
. . . O
   
Extrem NNP NNP O
3 CD CD O
+ NN NN O
edema NN NN O
. . . O
   
IMP NNP NNP O
: : : O
Side NNP NNP O
effects NNS NNS O
from IN IN O
atenolol NN NN O
. . . O
   
AICD/ventricular NNP NNP O
arrhythmia NN NN O
, , , O
controlled VBN VBN O
recently RB RB O
. . . O
   
Fluid NNP NNP O
retention NN NN O
. . . O
   
PRN NNP NNP O
lasix NN NN O
not RB RB O
ideal JJ JJ O
. . . O
   
DM NNP NNP O
not RB RB O
as RB RB O
well RB RB O
controlled VBN VBN O
as IN IN O
desirable JJ JJ O
. . . O
   
LDL NNP NNP O
138 CD CD O
, , , O
should MD MD O
be VB VB O
lower JJR JJR O
, , , O
tho NN NN O
he PRP PRP O
is VBZ VBZ O
so RB RB O
intolerant NN NN O
of IN IN O
meds NNS NNS O
. . . O
   
PLAN NNP NNP O
: : : O
Will NNP NNP O
discuss VB VB O
with IN IN O
Dr NNP NNP O
Corona NNP NNP I-DOCTOR
about IN IN O
unwillingness NNS NNS O
to TO TO O
take VB VB O
beta NN NN O
blocker NN NN O
and CC CC O
if IN IN O
any DT DT O
other JJ JJ O
agent NN NN O
indicated VBD VBD O
. . . O
   
BP NNP NNP O
not RB RB O
ideally RB RB O
controlled VBN VBN O
. . . O
   
Encouraged NNP NNP O
regular JJ JJ O
lasix NN NN O
use NN NN O
of IN IN O
20mg CD CD O
twice RB RB O
per IN IN O
wk NN NN O
, , , O
salt NN NN O
restriction NN NN O
Consider NNP NNP O
lipitor NN NN O
for IN IN O
LDL NNP NNP O
138 CD CD O
, , , O
but CC CC O
next JJ JJ O
visit NN NN O
. . . O
   
Increase VB VB O
metformin NN NN O
to TO TO O
1000 CD CD O
BID NNP NNP O
. . . O
   
Pneumovax NNP NNP O
today NN NN O
. . . O
   
Patricia NNP NNP I-DOCTOR
Islam NNP NNP I-DOCTOR
MD NNP NNP O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2080-11-30 JJ JJ I-DATE
Reason NNP NNP O
for IN IN O
Visit NNP NNP O
Owen NNP NNP I-PATIENT
is VBZ VBZ O
a DT DT O
63 CD CD I-AGE
y/o NN NN O
male JJ JJ O
here RB RB O
for IN IN O
evaluation NN NN O
of IN IN O
treatment NN NN O
. . . O
   
Doin NNP NNP O
relatively RB RB O
well RB RB O
. . . O
   
Problems NNS NNS O
OA NNP NNP O
LLE-PARTIALLY NNP NNP O
SEVERED-MULT NNP NNP O
. . . O
   
SURGERIES NNP NNP O
IRRIDECTOMY NNP NNP O
SKIN NNP NNP O
ULCER-DR NNP NNP O
Esposito NNP NNP I-DOCTOR
PAST NNP NNP O
SMOKER NNP NNP O
HTN NNP NNP O
Medications NNP NNP O
ASA NNP NNP O
PO NNP NNP O
Vitamin NNP NNP O
E NNP NNP O
PO NNP NNP O
QD NNP NNP O
: : : O
400 CD CD O
IU NNP NNP O
ATENOLOL NNP NNP O
25 CD CD O
MG NNP NNP O
PO NNP NNP O
QD NNP NNP O
Lipitor NNP NNP O
( ( ( O
ATORVASTATIN NNP NNP O
) ) ) O
10MG CD CD O
, , , O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Allergies NNP NNP O
NKDA NNP NNP O
- : : O
NONE NN NN O
Narrative NNP NNP O
History NN NN O
Takes VBZ VBZ O
meds JJ JJ O
. . . O
   
No DT DT O
SEs NNP NNP O
. . . O
   
Denies NNP NNP O
vision NN NN O
change NN NN O
, , , O
headache NN NN O
, , , O
chest NN NN O
pain NN NN O
, , , O
SOB NNP NNP O
, , , O
light JJ JJ O
head NN NN O
, , , O
palptations NNS NNS O
. . . O
   
Denies NNP NNP O
loss NN NN O
of IN IN O
balance NN NN O
, , , O
strength NN NN O
or CC CC O
sensation NN NN O
. . . O
   
Pulm NNP NNP O
- : : O
no DT DT O
cough NN NN O
. . . O
   
Occ NNP NNP O
wheeze NN NN O
. . . O
   
No DT DT O
SOB NNP NNP O
. . . O
   
GI NNP NNP O
- : : O
no DT DT O
nausea NN NN O
, , , O
vomitting VBG VBG O
, , , O
dyspepsia NN NN O
, , , O
reflux NN NN O
, , , O
abdo NN NN O
pain NN NN O
, , , O
diarrhea NN NN O
, , , O
constipation NN NN O
, , , O
melena NN NN O
, , , O
BRBPR NNP NNP O
. . . O
   
GU NNP NNP O
- : : O
asymp NN NN O
Locomotor NNP NNP O
- : : O
pain NN NN O
left VBD VBD O
knee/leg NN NN O
. . . O
   
Sees VBZ VBZ O
Dr NNP NNP O
Esposito NNP NNP I-DOCTOR
for IN IN O
chr NN NN O
ulcer NN NN O
. . . O
   
Has VBZ VBZ O
surgical JJ JJ O
boot NN NN O
on IN IN O
now RB RB O
. . . O
   
Exercise NNP NNP O
- : : O
no DT DT O
Diet-no NNP NNP O
Cigs-no NNP NNP O
ETOH-no NNP NNP O
Exam NNP NNP O
BP=132/76 NNP NNP O
, , , O
P NN NN O
= SYM SYM O
68 CD CD O
, , , O
Wt NNP NNP O
= SYM SYM O
261 CD CD O
; : : O
   
NAD,WD NNP NNP O
, , , O
WN NNP NNP O
Head NNP NNP O
- : : O
no DT DT O
tenderness NN NN O
M&T NNP NNP O
- : : O
moist NN NN O
; : : O
   
no DT DT O
erythema NN NN O
; : : O
   
no DT DT O
exudate NN NN O
; : : O
   
no DT DT O
lesions NNS NNS O
Neck RB RB O
- : : O
supple NN NN O
with IN IN O
no DT DT O
JVD NNP NNP O
, , , O
bruit NN NN O
, , , O
LAN NNP NNP O
or CC CC O
thyromegaly NN NN O
. . . O
   
Chest NN NN O
- : : O
clear JJ JJ O
A&P NNP NNP O
Cor NNP NNP O
- : : O
reg NN NN O
rhythm,S1S2 NN NN O
normal JJ JJ O
with IN IN O
no DT DT O
murmer NN NN O
, , , O
gallop NN NN O
or CC CC O
rub NN NN O
Abdo NNP NNP O
- : : O
obese NN NN O
; : : O
   
normal JJ JJ O
BS NNP NNP O
; : : O
   
soft JJ JJ O
with IN IN O
no DT DT O
HSM,mass NNP NNP O
or CC CC O
tenderness NN NN O
. . . O
   
DRE NNP NNP O
- : : O
normal JJ JJ O
sphincter NN NN O
. . . O
   
Prostate NNP NNP O
small JJ JJ O
with IN IN O
no DT DT O
nodules NNS NNS O
. . . O
   
Brown NNP NNP O
stool NN NN O
. . . O
   
Ext NNP NNP O
- - - O
Surg NNP NNP O
boot NN NN O
LLE NNP NNP O
. . . O
   
RLE-no NNP NNP O
edema NN NN O
. . . O
   
Assessment NNP NNP O
Normotensive NNP NNP O
. . . O
   
Increased VBN VBN O
weight NN NN O
. . . O
   
Did VBD VBD O
have VB VB O
elevated VBN VBN O
glucose NN NN O
last JJ JJ O
visit NN NN O
. . . O
   
Disposition NNP NNP O
and CC CC O
Plans NNP NNP O
CBC,glu,PSA NNP NNP O
. . . O
   
Decrease NNP NNP O
weight NN NN O
- : : O
increase NN NN O
exercise NN NN O
and CC CC O
eat VB VB O
less JJR JJR O
. . . O
   
Cont NNP NNP O
meds NNS NNS O
. . . O
   
RTC NNP NNP O
6 CD CD O
mon NNP NNP O
or CC CC O
PRN NNP NNP O
. . . O
   
_____________________________ NN NN O
_ NN NN O
William NNP NNP I-DOCTOR
Seth NNP NNP I-DOCTOR
Potter NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2083-12-15 JJ JJ I-DATE
f/u NN NN O
visit NN NN O
for IN IN O
multiple JJ JJ O
chronic JJ JJ O
medical JJ JJ O
probs NN NN O
Problems NNS NNS O
Congestive NNP NNP O
heart NN NN O
failure NN NN O
Chronic NNP NNP O
obstructive JJ JJ O
pulmonary JJ JJ O
disease NN NN O
Hypertension NNP NNP O
Gout NNP NNP O
DJD NNP NNP O
Benign NNP NNP O
prostatic JJ JJ O
hypertrophy NN NN O
Hyperlipidemia NNP NNP O
Chronic NNP NNP O
renal JJ JJ O
dysfunction NN NN O
Peripheral NNP NNP O
vascular NN NN O
disease NN NN O
: : : O
s/p NN NN O
right NN NN O
fem-tib JJ JJ O
bypass NN NN O
1/78 CD CD I-DATE
Prostatic NNP NNP O
nodule NN NN O
: : : O
psa NN NN O
1.6 CD CD O
09/81 CD CD I-DATE
. . . O
   
seen VBN VBN O
by IN IN O
dr NN NN O
. . . O
hoover NN NN I-DOCTOR
in IN IN O
11/81 CD CD I-DATE
who WP WP O
recommended VBD VBD O
yearly RB RB O
follow VB VB O
up RP RP O
. . . O
   
Coronary JJ JJ O
artery NN NN O
disease NN NN O
: : : O
ett NN NN O
exam NN NN O
: : : O
2080The CD CD O
ECG NNP NNP O
response NN NN O
to TO TO O
pharmacological JJ JJ O
stress NN NN O
was VBD VBD O
uninterpretable JJ JJ O
for IN IN O
ischemia NN NN O
. . . O
   
The DT DT O
myocardial NN NN O
perfusion NN NN O
images NNS NNS O
reveal VBP VBP O
no DT DT O
evidence NN NN O
of IN IN O
ischemia NN NN O
. . . O
   
The DT DT O
images NNS NNS O
are VBP VBP O
suggestive JJ JJ O
of IN IN O
possible JJ JJ O
prior RB RB O
inferior NN NN O
infarction NN NN O
although IN IN O
soft JJ JJ O
tissue NN NN O
attenuation NN NN O
prevents NNS NNS O
a DT DT O
definitive JJ JJ O
evaluation NN NN O
of IN IN O
this DT DT O
territory NN NN O
. . . O
   
sigmoid NN NN O
colorectal JJ JJ O
cancer NN NN O
: : : O
s/p NN NN O
sigmoid NN NN O
colectomy NN NN O
and CC CC O
sigmoidoscopy NN NN O
04/82 CD CD I-DATE
rs3PE NN NN O
Diabetes NNP NNP O
mellitus NN NN O
Medications NNP NNP O
Calcium NNP NNP O
Carbonate NNP NNP O
( ( ( O
500 CD CD O
Mg NNP NNP O
Elemental NNP NNP O
Ca NNP NNP O
) ) ) O
500MG CD CD O
, , , O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
: : : O
Take VB VB O
as IN IN O
directed VBN VBN O
Prilosec NNP NNP O
( ( ( O
OMEPRAZOLE NNP NNP O
) ) ) O
20MG CD CD O
, , , O
1 CD CD O
Capsule NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Celebrex NNP NNP O
( ( ( O
CELECOXIB NNP NNP O
) ) ) O
200MG CD CD O
, , , O
1 CD CD O
Capsule NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
: : : O
Take VB VB O
as IN IN O
directed VBN VBN O
COLCHICINE NNP NNP O
0.6MG, CD CD O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QOD NNP NNP O
: : : O
Take VB VB O
as IN IN O
directed VBN VBN O
Lopid NNP NNP O
( ( ( O
GEMFIBROZIL NNP NNP O
) ) ) O
600MG CD CD O
, , , O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
BID NNP NNP O
DIGOXIN NNP NNP O
0.125MG, CD CD O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QOD NNP NNP O
: : : O
Take VB VB O
as IN IN O
directed VBN VBN O
PREDNISONE NNP NNP O
5MG CD CD O
, , , O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Coumadin NNP NNP O
( ( ( O
WARFARIN NNP NNP O
Sodium NNP NNP O
) ) ) O
3MG CD CD O
, , , O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QPM NNP NNP O
: : : O
Take VB VB O
as IN IN O
directed VBN VBN O
per IN IN O
anticoag NN NN O
Isordil NNP NNP O
( ( ( O
ISOSORBIDE NNP NNP O
Dinitrate NNP NNP O
) ) ) O
20MG CD CD O
, , , O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
TID NNP NNP O
: : : O
Take VB VB O
as IN IN O
directed VBN VBN O
Kenalog NNP NNP O
0.1 CD CD O
% NN NN O
( ( ( O
TRIAMCINOLONE NNP NNP O
Acetonide NNP NNP O
0.1 CD CD O
% NN NN O
) ) ) O
0.1 CD CD O
% NN NN O
, , , O
1 CD CD O
application NN NN O
TOP NNP NNP O
BID NNP NNP O
ALLOPURINOL NNP NNP O
100MG CD CD O
, , , O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
: : : O
Take VB VB O
as IN IN O
directed VBN VBN O
Hydralazine NNP NNP O
Hcl NNP NNP O
10MG CD CD O
, , , O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QID NNP NNP O
x SYM SYM O
60 CD CD O
day NN NN O
   
( ( ( O
s VBZ VBZ O
) ) ) O
: : : O
Take VB VB O
as IN IN O
directed VBN VBN O
Lasix NNP NNP O
( ( ( O
FUROSEMIDE NNP NNP O
) ) ) O
40MG CD CD O
, , , O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Metoprolol NNP NNP O
Tartrate NNP NNP O
50MG CD CD O
, , , O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
BID NNP NNP O
GLYBURIDE NNP NNP O
1.25MG, CD CD O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
CAD NNP NNP O
/ NN NN O
HTN NNP NNP O
no DT DT O
cp NN NN O
, , , O
sob NN NN O
or CC CC O
palpitations NNS NNS O
no DT DT O
doe NN NN O
or CC CC O
nocturnal JJ JJ O
sx NN NN O
knows VBZ VBZ O
not RB RB O
to TO TO O
shovel NN NN O
snow NN NN O
overdue JJ JJ O
for IN IN O
bp NN NN O
med VBN VBN O
which WDT WDT O
he PRP PRP O
will MD MD O
take VB VB O
when WRB WRB O
he PRP PRP O
gets VBZ VBZ O
home NN NN O
DM NNP NNP O
brings VBZ VBZ O
in IN IN O
home NN NN O
record NN NN O
fbs NN NN O
range NN NN O
: : : O
116,115,107 CD CD O
, , , O
117 CD CD O
, , , O
98 CD CD O
, , , O
99 CD CD O
, , , O
136 CD CD O
4PM CD CD O
bs NN NN O
151 CD CD O
, , , O
146 CD CD O
, , , O
155 CD CD O
, , , O
144 CD CD O
, , , O
145 CD CD O
, , , O
114 CD CD O
, , , O
211(ate CD CD O
candy NN NN O
) ) ) O
per IN IN O
son NN NN O
pt NN NN O
still RB RB O
on IN IN O
half NN NN O
tab NN NN O
glucotrol NN NN O
until IN IN O
bottle NN NN O
finished VBD VBD O
then RB RB O
will MD MD O
change VB VB O
to TO TO O
glyburide VB VB O
pt NN NN O
feels VBZ VBZ O
he PRP PRP O
is VBZ VBZ O
eating VBG VBG O
less JJR JJR O
now RB RB O
no DT DT O
hypo NN NN O
sx NN NN O
prostate NN NN O
nodule NN NN O
no DT DT O
gu NN NN O
sx NN NN O
pvd NN NN O
denies NNS NNS O
leg NN NN O
pains NNS NNS O
had VBD VBD O
nodules NNS NNS O
L NNP NNP O
arm NN NN O
excised VBD VBD O
concerned VBN VBN O
re NN NN O
lump NN NN O
around IN IN O
navel NN NN O
occ NN NN O
tender NN NN O
denies NNS NNS O
pain NN NN O
no DT DT O
increase NN NN O
in IN IN O
size NN NN O
O NNP NNP O
: : : O
Vital NNP NNP O
signs NNS NNS O
BP NNP NNP O
160/80 CD CD O
Right NNP NNP O
Arm NNP NNP O
, , , O
P NN NN O
72 CD CD O
Regular NNP NNP O
, , , O
Wt NNP NNP O
183 CD CD O
lb NN NN O
chest NN NN O
clear JJ JJ O
decreased VBD VBD O
sounds VBZ VBZ O
at IN IN O
base NN NN O
cor NN NN O
rr NN NN O
at IN IN O
72 CD CD O
no DT DT O
m/g NN NN O
abdo NN NN O
sm NN NN O
ventral NN NN O
hernia NN NN O
above IN IN O
umbilicus JJ JJ O
reducible JJ JJ O
nontender NN NN O
Labs NNP NNP O
Psa NNP NNP O
3 CD CD O
freepsa NN NN O
0.97 CD CD O
pct NN NN O
free JJ JJ O
32.3 CD CD O
hgbA1c NN NN O
6.4 CD CD O
( ( ( O
127 CD CD O
) ) ) O
path NN NN O
report NN NN O
= SYM SYM O
palisading VBG VBG O
granulomatous JJ JJ O
tissue NN NN O
reaction NN NN O
A DT DT O
: : : O
htn NN NN O
borderline NN NN O
? . . O
re NN NN O
to TO TO O
med VB VB O
overdue JJ JJ O
cad NN NN O
stable JJ JJ O
pvd NN NN O
stable JJ JJ O
dM NN NN O
at IN IN O
goal NN NN O
to TO TO O
change VB VB O
to TO TO O
glyburide VB VB O
soon RB RB O
monitor NN NN O
bs NN NN O
on IN IN O
new JJ JJ O
meds NNS NNS O
psa NN NN O
f/u NN NN O
Dr NNP NNP O
Hoover NNP NNP I-DOCTOR
sm NN NN O
abdo NN NN O
hernia NN NN O
pt NN NN O
ed NN NN O
re NN NN O
prob NN NN O
monitor NN NN O
L NNP NNP O
arm NN NN O
nodules NNS NNS O
unclear JJ JJ O
path NN NN O
dx NN NN O
rtc NN NN O
as IN IN O
sched VBN VBN O
to TO TO O
Dr NNP NNP O
Hale NNP NNP I-DOCTOR
to TO TO O
me PRP PRP O
April NNP NNP I-DATE
call NN NN O
earlier RBR RBR O
prn NN NN O
____________________________________________ NN NN O
_ NN NN O
Ottilie NNP NNP I-DOCTOR
Kang,RNC,ANP NNP NNP O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2074-12-05 JJ JJ I-DATE
December NNP NNP I-DATE
05 CD CD O
, , , O
2074 CD CD I-DATE
Paul NNP NNP I-DOCTOR
Arteaga NNP NNP I-DOCTOR
, , , O
M.D. NN NN O
228 CD CD I-STREET
Caldwell NNP NNP I-STREET
Road NNP NNP I-STREET
Colorado NNP NNP I-CITY
City NNP NNP I-CITY
, , , O
NY NNP NNP I-STATE
43414 CD CD I-ZIP
RE NNP NNP O
: : : O
Christine NNP NNP I-PATIENT
Olivier NNP NNP I-PATIENT
MR NNP NNP O
#652-33-21-5 NN NN O
Dear RB RB O
Dr NNP NNP O
. . . O
Arteaga NNP NNP I-DOCTOR
: : : O
Mrs NNP NNP O
. . . O
   
Olivier NNP NNP I-PATIENT
returns NNS NNS O
for IN IN O
routine JJ JJ O
follow-up JJ JJ O
. . . O
   
Currently RB RB O
, , , O
she PRP PRP O
complains NNS NNS O
of IN IN O
mild JJ JJ O
exertional JJ JJ O
fatigue NN NN O
and CC CC O
rare VB VB O
exertional JJ JJ O
chest NN NN O
discomfort NN NN O
. . . O
   
In IN IN O
addition NN NN O
, , , O
she PRP PRP O
states NNS NNS O
that IN IN O
she PRP PRP O
has VBZ VBZ O
no DT DT O
energy NN NN O
and CC CC O
worries NNS NNS O
that IN IN O
her PRP$ PRP$ O
coronary JJ JJ O
artery NN NN O
pathology NN NN O
has VBZ VBZ O
returned VBN VBN O
. . . O
   
She PRP PRP O
reports NNS NNS O
occasionally RB RB O
taking VBG VBG O
sublingual JJ JJ O
nitroglycerin NN NN O
for IN IN O
chest NN NN O
discomfort NN NN O
but CC CC O
this DT DT O
is VBZ VBZ O
on IN IN O
an DT DT O
infrequent JJ JJ O
basis NN NN O
. . . O
   
She PRP PRP O
remains VBZ VBZ O
on IN IN O
a DT DT O
plethora NN NN O
of IN IN O
medications NNS NNS O
including VBG VBG O
NPH NNP NNP O
insulin NN NN O
64 CD CD O
units NNS NNS O
sub NN NN O
q NN NN O
qAM NN NN O
along IN IN O
with IN IN O
34 CD CD O
units NNS NNS O
CZI NNP NNP O
sub NN NN O
q NN NN O
qAM NN NN O
and CC CC O
68 CD CD O
units NNS NNS O
NPH NNP NNP O
sub NN NN O
q NN NN O
qPM NN NN O
, , , O
enteric JJ JJ O
coated VBN VBN O
aspirin NN NN O
one CD CD O
tab NN NN O
po NN NN O
q.d. NN NN O
, , , O
Captopril NNP NNP O
25 CD CD O
mg NN NN O
po NN NN O
t.i.d. NN NN O
, , , O
Lasix NNP NNP O
40 CD CD O
mg NN NN O
po NN NN O
b.i.d. NN NN O
, , , O
simvastatin NN NN O
10 CD CD O
mg NN NN O
po NN NN O
q.d. NN NN O
, , , O
amlodipine NN NN O
5 CD CD O
mg NN NN O
po NN NN O
q.d. NN NN O
, , , O
Neurontin NNP NNP O
900 CD CD O
mg NN NN O
po NN NN O
t.i.d. NN NN O
, , , O
atenolol NN NN O
50 CD CD O
mg NN NN O
po NN NN O
q.d. NN NN O
, , , O
estrogen NN NN O
0.05 CD CD O
topically RB RB O
q NN NN O
three CD CD O
days NNS NNS O
and CC CC O
a DT DT O
nitropatch NN NN O
.2 CD CD O
mg NN NN O
per IN IN O
twenty-four NN NN O
hours NNS NNS O
which WDT WDT O
she PRP PRP O
wears NNS NNS O
for IN IN O
twelve CD CD O
over IN IN O
twenty-four JJ JJ O
hour NN NN O
period NN NN O
. . . O
   
Physical JJ JJ O
exam NN NN O
reveals VBZ VBZ O
a DT DT O
well-nourished JJ JJ O
woman NN NN O
in IN IN O
no DT DT O
acute JJ JJ O
distress NN NN O
. . . O
   
Blood NNP NNP O
pressure NN NN O
right JJ JJ O
arm NN NN O
sitting VBG VBG O
140/80 CD CD O
, , , O
heart NN NN O
rate NN NN O
85 CD CD O
and CC CC O
regular JJ JJ O
, , , O
respirations NNS NNS O
12 CD CD O
and CC CC O
unlabored JJ JJ O
, , , O
weight NN NN O
174 CD CD O
pounds NNS NNS O
. . . O
   
The DT DT O
neck NN NN O
is VBZ VBZ O
supple JJ JJ O
. . . O
   
JVP NNP NNP O
flat JJ JJ O
. . . O
   
Carotids NNP NNP O
are VBP VBP O
2 CD CD O
+ NN NN O
without IN IN O
significant JJ JJ O
bruits NNS NNS O
. . . O
   
Chest NN NN O
is VBZ VBZ O
completely RB RB O
clear JJ JJ O
. . . O
   
Cardiac NNP NNP O
exam NN NN O
shows VBZ VBZ O
a DT DT O
normal JJ JJ O
S1 NNP NNP O
, , , O
physiologically RB RB O
split NN NN O
S2 NNP NNP O
and CC CC O
a DT DT O
I-II/VI NNP NNP O
systolic JJ JJ O
ejection NN NN O
murmur NN NN O
radiating VBG VBG O
from IN IN O
the DT DT O
apex NN NN O
to TO TO O
the DT DT O
base NN NN O
, , , O
no DT DT O
significant JJ JJ O
diastolic JJ JJ O
murmur NN NN O
or CC CC O
rub NN NN O
. . . O
   
The DT DT O
abdomen NN NN O
is VBZ VBZ O
benign NN NN O
. . . O
   
Extremities NNP NNP O
without IN IN O
appreciable JJ JJ O
edema NN NN O
. . . O
   
Peripheral NNP NNP O
pulses NNS NNS O
are VBP VBP O
intact JJ JJ O
. . . O
   
Electrocardiogram NNP NNP O
shows VBZ VBZ O
sinus NN NN O
rhythm NN NN O
at IN IN O
a DT DT O
rate NN NN O
of IN IN O
   
85 CD CD O
. . . O
PR NNP NNP O
interval NN NN O
of IN IN O
.14, CD CD O
QRS NNP NNP O
.08, CD CD O
QT NNP NNP O
.32, CD CD O
axis NNS NNS O
- : : O
20 CD CD O
degrees NNS NNS O
. . . O
   
There EX EX O
are VBP VBP O
mild JJ JJ O
diffuse NN NN O
nonspecific NN NN O
ST-T NNP NNP O
wave NN NN O
changes NNS NNS O
as RB RB O
well RB RB O
as IN IN O
evidence NN NN O
for IN IN O
left VBD VBD O
ventricular NN NN O
hypertrophy NN NN O
. . . O
   
Compared VBN VBN O
to TO TO O
her PRP$ PRP$ O
last JJ JJ O
electrocardiogram NN NN O
, , , O
her PRP$ PRP$ O
heart NN NN O
rate NN NN O
is VBZ VBZ O
slower JJR JJR O
and CC CC O
her PRP$ PRP$ O
ST-T NNP NNP O
wave NN NN O
changes NNS NNS O
are VBP VBP O
less RBR RBR O
prominent JJ JJ O
. . . O
   
Olivier NNP NNP I-PATIENT
, , , O
Christine NNP NNP I-PATIENT
MR NNP NNP O
#652-33-21-5 NN NN O
- - - O
2 CD CD O
- : : O
December NNP NNP I-DATE
05 CD CD O
, , , O
2074 CD CD I-DATE
Impression NNP NNP O
: : : O
Mrs NNP NNP O
. . . O
   
Olivier NNP NNP I-PATIENT
has VBZ VBZ O
currently RB RB O
recovered VBN VBN O
from IN IN O
her PRP$ PRP$ O
multi-lesion JJ JJ O
PTCA NNP NNP O
and CC CC O
stent NN NN O
placement NN NN O
therapy NN NN O
. . . O
   
Currently RB RB O
it PRP PRP O
is VBZ VBZ O
not RB RB O
clear JJ JJ O
to TO TO O
me PRP PRP O
that IN IN O
her PRP$ PRP$ O
symptoms NNS NNS O
are VBP VBP O
secondary JJ JJ O
to TO TO O
recurrent VB VB O
ischemia NN NN O
, , , O
however RB RB O
I PRP PRP O
will MD MD O
have VB VB O
her PRP$ PRP$ O
undergo NN NN O
an DT DT O
exercise NN NN O
tolerance NN NN O
test NN NN O
( ( ( O
adenosine NN NN O
MIBI NNP NNP O
) ) ) O
to TO TO O
help VB VB O
to TO TO O
further VB VB O
evaluate VB VB O
this DT DT O
. . . O
   
In IN IN O
addition NN NN O
, , , O
I PRP PRP O
will MD MD O
obtain VB VB O
routine JJ JJ O
blood NN NN O
studies NNS NNS O
including VBG VBG O
an DT DT O
glycosylated JJ JJ O
hemoglobin NN NN O
. . . O
   
It PRP PRP O
is VBZ VBZ O
certainly RB RB O
possible JJ JJ O
that IN IN O
her PRP$ PRP$ O
fatigue NN NN O
and CC CC O
generalized JJ JJ O
sense NN NN O
of IN IN O
lack NN NN O
of IN IN O
energy NN NN O
is VBZ VBZ O
from IN IN O
a DT DT O
non-cardiac JJ JJ O
cause NN NN O
. . . O
   
Pending NNP NNP O
review NN NN O
of IN IN O
these DT DT O
lab NN NN O
studies NNS NNS O
however RB RB O
, , , O
I PRP PRP O
have VBP VBP O
not RB RB O
altered VBN VBN O
her PRP$ PRP$ O
present JJ JJ O
regimen NNS NNS O
. . . O
   
She PRP PRP O
will MD MD O
contact VB VB O
you PRP PRP O
or CC CC O
myself PRP PRP O
should MD MD O
her PRP$ PRP$ O
chest NN NN O
pain NN NN O
syndrome NN NN O
at IN IN O
all DT DT O
progress NN NN O
in IN IN O
terms NNS NNS O
of IN IN O
severity NN NN O
or CC CC O
duration NN NN O
. . . O
   
Thank VB VB O
you PRP PRP O
very RB RB O
much RB RB O
for IN IN O
allowing VBG VBG O
me PRP PRP O
to TO TO O
assist VB VB O
in IN IN O
her PRP$ PRP$ O
care NN NN O
. . . O
   
Sincerely NNP NNP O
yours NNS NNS O
, , , O
Irineo NNP NNP I-DOCTOR
Tovar NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
   
Vereen NNP NNP I-HOSPITAL
Memorial NNP NNP I-HOSPITAL
Hospital NNP NNP I-HOSPITAL
47 CD CD I-STREET
Waverly NNP NNP I-STREET
St NNP NNP I-STREET
Colorado NNP NNP I-CITY
City NNP NNP I-CITY
, , , O
NY NNP NNP I-STATE
88736 CD CD I-ZIP
DD NNP NNP O
: : : O
12/05/74 CD CD I-DATE
DT NNP NNP O
: : : O
12/08/74 CD CD I-DATE
DV NNP NNP O
: : : O
12/05/74 CD CD I-DATE
/ NN NN O
outlaw NN NN I-DOCTOR
******** NN NN O
Approved NNP NNP O
but CC CC O
not RB RB O
reviewed VBN VBN O
by IN IN O
Attending NNP NNP O
Provider NNP NNP O
******** NN NN O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2073-10-26 JJ JJ I-DATE
RIVERS NNP NNP O
, , , O
KARSTEN NNP NNP I-PATIENT
95718084 CD CD I-MEDICALRECORD
10/26/2073 NN NN I-DATE
To TO TO O
Whom WP WP O
It PRP PRP O
May NNP NNP O
Concern NNP NNP O
: : : O
I PRP PRP O
had VBD VBD O
the DT DT O
pleasure NN NN O
of IN IN O
seeing VBG VBG O
Mr NNP NNP O
. . . O
Karsten NNP NNP I-PATIENT
Rivers NNP NNP I-PATIENT
in IN IN O
the DT DT O
Cardiovascular NNP NNP O
Clinic NNP NNP O
at IN IN O
the DT DT O
Kimball NNP NNP I-HOSPITAL
County NNP NNP I-HOSPITAL
Manor NNP NNP I-HOSPITAL
for IN IN O
initial JJ JJ O
evaluation NN NN O
and CC CC O
management NN NN O
. . . O
   
As IN IN O
you PRP PRP O
may MD MD O
know VB VB O
, , , O
he PRP PRP O
is VBZ VBZ O
a DT DT O
47-year-old JJ JJ O
gentleman NN NN O
with IN IN O
a DT DT O
history NN NN O
of IN IN O
poorly RB RB O
controlled VBN VBN O
hypertension NN NN O
, , , O
poorly RB RB O
controlled VBN VBN O
insulin-dependent JJ JJ O
diabetes NNS NNS O
mellitus NN NN O
, , , O
former JJ JJ O
tobacco NN NN O
use NN NN O
, , , O
morbid NN NN O
obesity NN NN O
, , , O
no DT DT O
family NN NN O
history NN NN O
of IN IN O
early JJ JJ O
coronary JJ JJ O
disease NN NN O
and CC CC O
no DT DT O
known VBN VBN O
coronary JJ JJ O
disease NN NN O
. . . O
   
He PRP PRP O
was VBD VBD O
presented VBN VBN O
to TO TO O
the DT DT O
Cardiovascular NNP NNP O
Clinic NNP NNP O
today NN NN O
for IN IN O
preoperative JJ JJ O
evaluation NN NN O
prior RB RB O
to TO TO O
an DT DT O
orthopedic JJ JJ O
surgery NN NN O
scheduled VBN VBN O
for IN IN O
later RB RB O
on IN IN O
this DT DT O
week NN NN O
by IN IN O
Dr NNP NNP O
. . . O
Phillip NNP NNP I-DOCTOR
Isaac NNP NNP I-DOCTOR
Crosby NNP NNP I-DOCTOR
, , , O
at IN IN O
the DT DT O
Lamoni NNP NNP I-HOSPITAL
Nursing NNP NNP I-HOSPITAL
Rehabilitation NNP NNP I-HOSPITAL
Center NNP NNP I-HOSPITAL
. . . O
   
This DT DT O
gentleman NN NN O
has VBZ VBZ O
a DT DT O
torn VBN VBN O
ligament NN NN O
in IN IN O
his PRP$ PRP$ O
right JJ JJ O
hip NN NN O
and CC CC O
is VBZ VBZ O
scheduled VBN VBN O
for IN IN O
laparoscopic NN NN O
repair NN NN O
at IN IN O
the DT DT O
Lamoni NNP NNP I-HOSPITAL
Nursing NNP NNP I-HOSPITAL
Rehabilitation NNP NNP I-HOSPITAL
. . . O
   
Mr NNP NNP O
. . . O
Rivers NNP NNP I-PATIENT
, , , O
as IN IN O
mentioned VBN VBN O
, , , O
denies NNS NNS O
any DT DT O
history NN NN O
of IN IN O
known VBN VBN O
coronary JJ JJ O
artery NN NN O
disease NN NN O
. . . O
   
He PRP PRP O
has VBZ VBZ O
had VBN VBN O
a DT DT O
prior RB RB O
stress NN NN O
test NN NN O
greater JJR JJR O
than IN IN O
15 CD CD O
years NNS NNS O
ago RB RB O
, , , O
but CC CC O
none NN NN O
recently RB RB O
. . . O
   
He PRP PRP O
denies VBZ VBZ O
any DT DT O
recent JJ JJ O
catheterization NN NN O
or CC CC O
echocardiogram NN NN O
. . . O
   
He PRP PRP O
works VBZ VBZ O
currently RB RB O
as IN IN O
a DT DT O
floor NN NN I-PROFESSION
coverer NN NN I-PROFESSION
in IN IN O
Shelton NNP NNP I-CITY
and CC CC O
has VBZ VBZ O
done VBN VBN O
so IN IN O
for IN IN O
20 CD CD O
years NNS NNS O
. . . O
   
He PRP PRP O
is VBZ VBZ O
able JJ JJ O
to TO TO O
ambulate VB VB O
approximately RB RB O
two CD CD O
flights NNS NNS O
of IN IN O
steps NNS NNS O
, , , O
but CC CC O
at IN IN O
the DT DT O
top NN NN O
of IN IN O
the DT DT O
steps NNS NNS O
develops VBZ VBZ O
slight JJ JJ O
dyspnea NN NN O
on IN IN O
exertion NN NN O
, , , O
unclear JJ JJ O
whether IN IN O
or CC CC O
not RB RB O
this DT DT O
is VBZ VBZ O
related VBN VBN O
to TO TO O
a DT DT O
cardiac JJ JJ O
etiology NN NN O
or CC CC O
secondary JJ JJ O
to TO TO O
his PRP$ PRP$ O
morbid NN NN O
obesity NN NN O
with IN IN O
his PRP$ PRP$ O
weight NN NN O
over IN IN O
400 CD CD O
pounds NNS NNS O
. . . O
   
He PRP PRP O
denies VBZ VBZ O
any DT DT O
heart NN NN O
failure NN NN O
symptoms NNS NNS O
, , , O
orthopnea NN NN O
, , , O
PND NNP NNP O
, , , O
lower JJR JJR O
extremity NN NN O
edema NN NN O
or CC CC O
nocturia NN NN O
though IN IN O
he PRP PRP O
has VBZ VBZ O
been VBN VBN O
maintained VBN VBN O
on IN IN O
Lasix NNP NNP O
diuresis NNS NNS O
in IN IN O
the DT DT O
past JJ JJ O
though IN IN O
none NN NN O
currently RB RB O
. . . O
   
Additionally RB RB O
, , , O
he PRP PRP O
has VBZ VBZ O
poorly RB RB O
controlled VBN VBN O
diabetes NN NN O
for IN IN O
which WDT WDT O
he PRP PRP O
is VBZ VBZ O
being VBG VBG O
followed VBN VBN O
in IN IN O
the DT DT O
Diabetes NNP NNP O
Clinic NNP NNP O
here RB RB O
at IN IN O
the DT DT O
KCM NNP NNP I-HOSPITAL
as RB RB O
well RB RB O
as IN IN O
poorly RB RB O
controlled VBN VBN O
hypertension NN NN O
for IN IN O
which WDT WDT O
he PRP PRP O
is VBZ VBZ O
on IN IN O
multiple JJ JJ O
agents NNS NNS O
. . . O
   
He PRP PRP O
denies VBZ VBZ O
any DT DT O
history NN NN O
of IN IN O
exertional JJ JJ O
chest NN NN O
discomfort NN NN O
and CC CC O
as IN IN O
mentioned VBN VBN O
, , , O
he PRP PRP O
is VBZ VBZ O
still RB RB O
quite RB RB O
active JJ JJ O
despite IN IN O
his PRP$ PRP$ O
BLANK NNP NNP O
as IN IN O
an DT DT O
Interior NNP NNP I-ORGANIZATION
Designs NNS NNS I-ORGANIZATION
floor NN NN I-PROFESSION
coverer NN NN I-PROFESSION
. . . O
   
Review NNP NNP O
of IN IN O
systems NNS NNS O
is VBZ VBZ O
otherwise RB RB O
unremarkable JJ JJ O
. . . O
   
Past NNP NNP O
medical JJ JJ O
history NN NN O
is VBZ VBZ O
remarkable JJ JJ O
for IN IN O
hypertension NN NN O
, , , O
hypercholesterolemia NN NN O
, , , O
insulin NN NN O
dependent NN NN O
diabetes NNS NNS O
mellitus NN NN O
and CC CC O
morbid NN NN O
obesity NN NN O
. . . O
   
Medications NNP NNP O
include VBP VBP O
Toprol-XL NNP NNP O
125 CD CD O
mg NN NN O
p.o. NN NN O
daily JJ JJ O
, , , O
aspirin NN NN O
81 CD CD O
mg NN NN O
p.o. NN NN O
daily JJ JJ O
, , , O
Lipitor NNP NNP O
20 CD CD O
mg NN NN O
p.o. NN NN O
daily JJ JJ O
, , , O
Neurontin NNP NNP O
400 CD CD O
mg NN NN O
p.o. NN NN O
daily JJ JJ O
, , , O
insulin NN NN O
, , , O
Aldactone NNP NNP O
25 CD CD O
mg NN NN O
p.o. NN NN O
daily JJ JJ O
, , , O
Avapro NNP NNP O
300 CD CD O
mg NN NN O
p.o. NN NN O
daily JJ JJ O
and CC CC O
minoxidil NN NN O
10 CD CD O
mg NN NN O
p.o. NN NN O
daily JJ JJ O
. . . O
   
He PRP PRP O
is VBZ VBZ O
allergic JJ JJ O
to TO TO O
penicillin NN NN O
for IN IN O
which WDT WDT O
he PRP PRP O
develops VBZ VBZ O
a DT DT O
rash NN NN O
. . . O
   
His PRP$ PRP$ O
social JJ JJ O
history NN NN O
is VBZ VBZ O
remarkable JJ JJ O
for IN IN O
former JJ JJ O
tobacco NN NN O
use NN NN O
for IN IN O
many JJ JJ O
years NNS NNS O
, , , O
though IN IN O
he PRP PRP O
quit VBD VBD O
more JJR JJR O
than IN IN O
three CD CD O
years NNS NNS O
ago RB RB O
. . . O
   
He PRP PRP O
has VBZ VBZ O
no DT DT O
extensive JJ JJ O
alcohol NN NN O
or CC CC O
illicit JJ JJ O
drug NN NN O
use NN NN O
history NN NN O
. . . O
   
He PRP PRP O
lives VBZ VBZ O
locally RB RB O
with IN IN O
his PRP$ PRP$ O
wife NN NN O
and CC CC O
five CD CD O
children NNS NNS O
and CC CC O
as IN IN O
mentioned VBN VBN O
is VBZ VBZ O
a DT DT O
floor NN NN I-PROFESSION
coverer NN NN I-PROFESSION
in IN IN O
ID NNP NNP I-ORGANIZATION
working VBG VBG O
at IN IN O
Provo NNP NNP I-CITY
. . . O
   
He PRP PRP O
is VBZ VBZ O
followed VBN VBN O
by IN IN O
Dr NNP NNP O
. . . O
Gilmore NNP NNP I-DOCTOR
at IN IN O
the DT DT O
Helena NNP NNP I-HOSPITAL
Hospital NNP NNP I-HOSPITAL
for IN IN O
primary JJ JJ O
care NN NN O
. . . O
   
On IN IN O
examination NN NN O
, , , O
he PRP PRP O
is VBZ VBZ O
afebrile RB RB O
, , , O
heart NN NN O
rate NN NN O
is VBZ VBZ O
98 CD CD O
and CC CC O
regular JJ JJ O
, , , O
blood NN NN O
pressure NN NN O
148/78 CD CD O
and CC CC O
respiratory NN NN O
rate NN NN O
is VBZ VBZ O
16 CD CD O
breaths NNS NNS O
per IN IN O
minute NN NN O
in IN IN O
no DT DT O
acute JJ JJ O
distress NN NN O
. . . O
   
He PRP PRP O
is VBZ VBZ O
a DT DT O
well-appearing JJ JJ O
gentleman NN NN O
in IN IN O
stated JJ JJ O
age NN NN O
with IN IN O
morbid NN NN O
obesity NN NN O
. . . O
   
His PRP$ PRP$ O
jugular NN NN O
venous JJ JJ O
pressure NN NN O
is VBZ VBZ O
difficult JJ JJ O
to TO TO O
estimate VB VB O
given VBN VBN O
his PRP$ PRP$ O
habitus NN NN O
. . . O
   
He PRP PRP O
is VBZ VBZ O
clear JJ JJ O
to TO TO O
auscultation NN NN O
bilaterally RB RB O
. . . O
   
He PRP PRP O
has VBZ VBZ O
a DT DT O
regular JJ JJ O
rate NN NN O
and CC CC O
rhythm NN NN O
with IN IN O
a DT DT O
normal JJ JJ O
S1 NNP NNP O
, , , O
S2 NNP NNP O
and CC CC O
no DT DT O
murmur NN NN O
, , , O
rub NN NN O
or CC CC O
gallop NN NN O
. . . O
   
His PRP$ PRP$ O
abdomen NN NN O
is VBZ VBZ O
obese NN NN O
, , , O
nontender NN NN O
with IN IN O
positive JJ JJ O
bowel NN NN O
sounds VBZ VBZ O
and CC CC O
no DT DT O
hepatomegalies NNS NNS O
appreciated VBD VBD O
. . . O
   
His PRP$ PRP$ O
extremities NNS NNS O
are VBP VBP O
warm JJ JJ O
and CC CC O
well RB RB O
perfused VBN VBN O
with IN IN O
trace NN NN O
edema NN NN O
at IN IN O
the DT DT O
ankles NNS NNS O
. . . O
   
He PRP PRP O
has VBZ VBZ O
good JJ JJ O
distal JJ JJ O
pulsations NNS NNS O
. . . O
   
His PRP$ PRP$ O
carotids NNS NNS O
are VBP VBP O
2 CD CD O
+ NN NN O
bilaterally RB RB O
without IN IN O
bruit NN NN O
. . . O
   
Laboratory NNP NNP O
values NNS NNS O
are VBP VBP O
not RB RB O
available JJ JJ O
today NN NN O
. . . O
   
ECG NNP NNP O
reveals VBZ VBZ O
normal JJ JJ O
sinus NN NN O
rhythm NN NN O
with IN IN O
a DT DT O
heart NN NN O
rate NN NN O
of IN IN O
   
99 CD CD O
. . . O
He PRP PRP O
has VBZ VBZ O
left VBN VBN O
anterior NN NN O
fascicular NN NN O
hemiblock NN NN O
with IN IN O
normal JJ JJ O
R NNP NNP O
wave NN NN O
progression NN NN O
through IN IN O
his PRP$ PRP$ O
precordium NN NN O
. . . O
   
No DT DT O
evidence NN NN O
for IN IN O
LVH NNP NNP O
or CC CC O
prior RB RB O
infarction NN NN O
. . . O
   
He PRP PRP O
does VBZ VBZ O
have VB VB O
low JJ JJ O
voltage NN NN O
in IN IN O
his PRP$ PRP$ O
limb NN NN O
leads VBZ VBZ O
, , , O
consistent JJ JJ O
with IN IN O
his PRP$ PRP$ O
morbid NN NN O
obesity NN NN O
. . . O
   
Impression NNP NNP O
: : : O
Mr NNP NNP O
. . . O
Rivers NNP NNP I-PATIENT
is VBZ VBZ O
a DT DT O
very RB RB O
pleasant JJ JJ O
47-year-old JJ JJ O
gentleman NN NN O
with IN IN O
multiple JJ JJ O
cardiac JJ JJ O
risk NN NN O
factors NNS NNS O
, , , O
notably RB RB O
insulin-dependent JJ JJ O
diabetes NNS NNS O
mellitus NN NN O
as RB RB O
well RB RB O
as IN IN O
poorly RB RB O
controlled VBN VBN O
hypertension NN NN O
with IN IN O
no DT DT O
known VBN VBN O
coronary JJ JJ O
artery NN NN O
disease NN NN O
now RB RB O
presenting VBG VBG O
for IN IN O
cardiovascular JJ JJ O
clearance NN NN O
prior RB RB O
to TO TO O
elective VB VB O
hip NN NN O
repair NN NN O
scheduled VBN VBN O
for IN IN O
three CD CD O
days NNS NNS O
from IN IN O
now RB RB O
. . . O
   
This DT DT O
gentleman NN NN O
has VBZ VBZ O
no DT DT O
known VBN VBN O
coronary JJ JJ O
disease NN NN O
and CC CC O
has VBZ VBZ O
a DT DT O
reasonable JJ JJ O
exercise NN NN O
capacity NN NN O
, , , O
which WDT WDT O
I PRP PRP O
estimate VBP VBP O
to TO TO O
be VB VB O
3 CD CD O
to TO TO O
5 CD CD O
METS NNP NNP O
. . . O
   
Most JJS JJS O
recently RB RB O
, , , O
given VBN VBN O
his PRP$ PRP$ O
hip NN NN O
and CC CC O
orthopedic JJ JJ O
issues NNS NNS O
, , , O
he PRP PRP O
has VBZ VBZ O
been VBN VBN O
unable JJ JJ O
to TO TO O
ambulate VB VB O
even RB RB O
to TO TO O
three CD CD O
METS NNP NNP O
. . . O
   
However RB RB O
, , , O
prior RB RB O
to TO TO O
his PRP$ PRP$ O
orthopedic JJ JJ O
injury NN NN O
several JJ JJ O
months NNS NNS O
ago RB RB O
, , , O
he PRP PRP O
was VBD VBD O
able JJ JJ O
to TO TO O
ambulate VB VB O
up RP RP O
two CD CD O
flights NNS NNS O
of IN IN O
steps NNS NNS O
with IN IN O
only RB RB O
minimal NN NN O
dyspnea NN NN O
upon IN IN O
reaching VBG VBG O
the DT DT O
top JJ JJ O
step NN NN O
and CC CC O
without IN IN O
any DT DT O
exertional JJ JJ O
chest NN NN O
discomfort NN NN O
. . . O
   
However RB RB O
, , , O
given VBN VBN O
his PRP$ PRP$ O
multiple JJ JJ O
risk NN NN O
factors NNS NNS O
, , , O
notably RB RB O
his PRP$ PRP$ O
poorly RB RB O
controlled VBN VBN O
diabetes NNS NNS O
and CC CC O
poorly RB RB O
controlled VBN VBN O
hypertension NN NN O
as RB RB O
well RB RB O
as IN IN O
former JJ JJ O
tobacco NN NN O
use NN NN O
, , , O
he PRP PRP O
certainly RB RB O
is VBZ VBZ O
at IN IN O
very RB RB O
high JJ JJ O
risk NN NN O
for IN IN O
obstructive JJ JJ O
coronary JJ JJ O
disease NN NN O
. . . O
   
As IN IN O
such JJ JJ O
, , , O
I PRP PRP O
recommended VBD VBD O
we PRP PRP O
obtain VBP VBP O
a DT DT O
Persantine NNP NNP O
PET NNP NNP O
stress NN NN O
test NN NN O
for IN IN O
tomorrow NN NN O
morning NN NN O
. . . O
   
If IN IN O
this DT DT O
test NN NN O
is VBZ VBZ O
normal JJ JJ O
without IN IN O
any DT DT O
high JJ JJ O
risk NN NN O
features NNS NNS O
or CC CC O
without IN IN O
any DT DT O
evidence NN NN O
for IN IN O
obstructive JJ JJ O
coronary JJ JJ O
disease NN NN O
, , , O
it PRP PRP O
would MD MD O
be VB VB O
reasonable JJ JJ O
for IN IN O
him PRP PRP O
to TO TO O
proceed VB VB O
with IN IN O
surgery NN NN O
later RB RB O
on IN IN O
this DT DT O
week NN NN O
. . . O
   
This DT DT O
test NN NN O
will MD MD O
also RB RB O
suffice VB VB O
for IN IN O
his PRP$ PRP$ O
upcoming JJ JJ O
gastric JJ JJ O
laparoscopic NN NN O
bypass NN NN O
surgery NN NN O
, , , O
which WDT WDT O
is VBZ VBZ O
scheduled VBN VBN O
for IN IN O
01/2074 CD CD I-DATE
. . . O
   
With IN IN O
regards VBZ VBZ O
to TO TO O
his PRP$ PRP$ O
medication NN NN O
, , , O
his PRP$ PRP$ O
blood NN NN O
pressure NN NN O
still RB RB O
is VBZ VBZ O
not RB RB O
at IN IN O
goal NN NN O
below IN IN O
130 CD CD O
. . . O
   
As IN IN O
such JJ JJ O
, , , O
I PRP PRP O
have VBP VBP O
increased VBN VBN O
his PRP$ PRP$ O
Toprol-XL NNP NNP O
from IN IN O
125 CD CD O
mg NN NN O
to TO TO O
200 CD CD O
mg NN NN O
p.o. NN NN O
daily JJ JJ O
. . . O
   
This DT DT O
medication NN NN O
should MD MD O
be VB VB O
continued VBN VBN O
through IN IN O
all DT DT O
surgery NN NN O
. . . O
   
Additionally RB RB O
, , , O
if IN IN O
this DT DT O
is VBZ VBZ O
not RB RB O
sufficient JJ JJ O
in IN IN O
bringing VBG VBG O
his PRP$ PRP$ O
blood NN NN O
pressure NN NN O
down RB RB O
below IN IN O
130 CD CD O
, , , O
I PRP PRP O
would MD MD O
recommend VB VB O
the DT DT O
addition NN NN O
of IN IN O
a DT DT O
diuretic JJ JJ O
to TO TO O
his PRP$ PRP$ O
regimen NN NN O
either CC CC O
Lasix NNP NNP O
20 CD CD O
mg NN NN O
p.o. NN NN O
daily JJ JJ O
or CC CC O
hydrochlorothiazide NN NN O
25 CD CD O
mg NN NN O
p.o. NN NN O
daily JJ JJ O
. . . O
   
Additionally RB RB O
, , , O
it PRP PRP O
will MD MD O
be VB VB O
essential JJ JJ O
that IN IN O
his PRP$ PRP$ O
diabetes NN NN O
be VB VB O
taken VBN VBN O
better JJR JJR O
control NN NN O
of IN IN O
and CC CC O
he PRP PRP O
is VBZ VBZ O
now RB RB O
working VBG VBG O
closely RB RB O
with IN IN O
the DT DT O
diabetes NN NN O
center NN NN O
here RB RB O
at IN IN O
the DT DT O
KCM NNP NNP I-HOSPITAL
to TO TO O
do VB VB O
so RB RB O
. . . O
   
His PRP$ PRP$ O
last JJ JJ O
A1c NNP NNP O
was VBD VBD O
approximately RB RB O
13 CD CD O
and CC CC O
this DT DT O
is VBZ VBZ O
certainly RB RB O
way NN NN O
out IN IN O
of IN IN O
range NN NN O
for IN IN O
someone NN NN O
of IN IN O
his PRP$ PRP$ O
young JJ JJ O
age NN NN O
. . . O
   
I PRP PRP O
am VBP VBP O
hopeful JJ JJ O
with IN IN O
continued VBD VBD O
medical JJ JJ O
therapy NN NN O
this DT DT O
gentleman NN NN O
can MD MD O
continue VB VB O
to TO TO O
improve VB VB O
his PRP$ PRP$ O
life NN NN O
and CC CC O
undergo NN NN O
orthopedic JJ JJ O
surgery NN NN O
as RB RB O
well RB RB O
as IN IN O
gastric JJ JJ O
bypass NN NN O
surgery NN NN O
with IN IN O
significant JJ JJ O
improvement NN NN O
to TO TO O
his PRP$ PRP$ O
quality NN NN O
of IN IN O
life NN NN O
and CC CC O
future JJ JJ O
cardiac JJ JJ O
risk NN NN O
. . . O
   
With IN IN O
regards VBZ VBZ O
to TO TO O
his PRP$ PRP$ O
hypertension NN NN O
, , , O
he PRP PRP O
is VBZ VBZ O
on IN IN O
multiple JJ JJ O
agents NNS NNS O
including VBG VBG O
Toprol-XL NNP NNP O
, , , O
Aldactone NNP NNP O
, , , O
Avapro NNP NNP O
and CC CC O
minoxidil NN NN O
. . . O
   
Given VBN VBN O
the DT DT O
multitude NN NN O
of IN IN O
agents NNS NNS O
, , , O
it PRP PRP O
would MD MD O
be VB VB O
reasonable JJ JJ O
to TO TO O
screen VB VB O
this DT DT O
gentleman NN NN O
for IN IN O
secondary JJ JJ O
causes NNS NNS O
of IN IN O
hypertension NN NN O
including VBG VBG O
hyperthyroidism NN NN O
as RB RB O
well RB RB O
as IN IN O
hyperaldosteronism NN NN O
, , , O
but CC CC O
notably RB RB O
he PRP PRP O
has VBZ VBZ O
currently RB RB O
started VBN VBN O
the DT DT O
Aldactone NNP NNP O
and CC CC O
this DT DT O
would MD MD O
be VB VB O
difficult JJ JJ O
to TO TO O
do VB VB O
while IN IN O
on IN IN O
the DT DT O
medication NN NN O
. . . O
   
We PRP PRP O
could MD MD O
consider VB VB O
in IN IN O
the DT DT O
future NN NN O
, , , O
if IN IN O
his PRP$ PRP$ O
blood NN NN O
pressure NN NN O
is VBZ VBZ O
not RB RB O
well RB RB O
controlled VBN VBN O
either CC CC O
washing VBG VBG O
out IN IN O
the DT DT O
Aldactone NNP NNP O
and CC CC O
then RB RB O
followed VBN VBN O
by IN IN O
renin NN NN O
and CC CC O
aldosterone NN NN O
testing NN NN O
versus CC CC O
BLANK NNP NNP O
sampling VBG VBG O
in IN IN O
the DT DT O
future NN NN O
if IN IN O
deemed VBN VBN O
necessary JJ JJ O
. . . O
   
Additionally RB RB O
, , , O
if IN IN O
he PRP PRP O
is VBZ VBZ O
found VBN VBN O
to TO TO O
have VB VB O
coronary JJ JJ O
artery NN NN O
disease NN NN O
, , , O
one CD CD O
other JJ JJ O
option NN NN O
despite IN IN O
his PRP$ PRP$ O
lack NN NN O
of IN IN O
claudication NN NN O
would MD MD O
be VB VB O
evaluation NN NN O
of IN IN O
renal JJ JJ O
artery NN NN O
stenosis NN NN O
. . . O
   
As IN IN O
mentioned VBN VBN O
, , , O
I PRP PRP O
will MD MD O
obtain VB VB O
the DT DT O
stress NN NN O
imaging VBG VBG O
tomorrow NN NN O
morning NN NN O
and CC CC O
then RB RB O
we PRP PRP O
will MD MD O
be VB VB O
able JJ JJ O
to TO TO O
have VB VB O
a DT DT O
better JJR JJR O
assessment NN NN O
of IN IN O
whether IN IN O
or CC CC O
not RB RB O
it PRP PRP O
would MD MD O
be VB VB O
reasonable JJ JJ O
to TO TO O
proceed VB VB O
with IN IN O
surgery NN NN O
in IN IN O
the DT DT O
near JJ JJ O
future NN NN O
. . . O
   
I PRP PRP O
will MD MD O
follow VB VB O
back RB RB O
with IN IN O
him PRP PRP O
in IN IN O
approximately RB RB O
several JJ JJ O
months NNS NNS O
' POS POS O
time NN NN O
for IN IN O
followup NN NN O
of IN IN O
his PRP$ PRP$ O
general JJ JJ O
cardiovascular NN NN O
care NN NN O
. . . O
   
Please VB VB O
do VBP VBP O
not RB RB O
hesitate VB VB O
to TO TO O
contact VB VB O
me PRP PRP O
if IN IN O
there EX EX O
is VBZ VBZ O
anything NN NN O
I PRP PRP O
can MD MD O
do VB VB O
to TO TO O
contribute VB VB O
to TO TO O
his PRP$ PRP$ O
ongoing JJ JJ O
medical JJ JJ O
care NN NN O
in IN IN O
the DT DT O
interim NN NN O
. . . O
   
He PRP PRP O
has VBZ VBZ O
been VBN VBN O
provided VBN VBN O
both DT DT O
my PRP$ PRP$ O
e-mail JJ JJ O
and CC CC O
pager NN NN O
number NN NN O
to TO TO O
contact VB VB O
me PRP PRP O
if IN IN O
there EX EX O
is VBZ VBZ O
anything NN NN O
I PRP PRP O
can MD MD O
do VB VB O
to TO TO O
assist VB VB O
in IN IN O
his PRP$ PRP$ O
care NN NN O
going VBG VBG O
forward RB RB O
. . . O
   
Thank VB VB O
you PRP PRP O
. . . O
   
Sincerely NNP NNP O
, , , O
_____________________________ NN NN O
_ NN NN O
Kenneth NNP NNP I-DOCTOR
Sweet NNP NNP I-DOCTOR
, , , O
MD NNP NNP O
eScription NN NN O
document:9-9031123 JJ JJ O
IFFocus NNP NNP O
CC NNP NNP O
: : : O
Gabriel NNP NNP I-DOCTOR
Michael NNP NNP I-DOCTOR
MD NNP NNP O
67 CD CD I-STREET
COMANCHE NNP NNP I-STREET
STREET NNP NNP I-STREET
SHELTON NNP NNP I-CITY
, , , O
NH NNP NNP I-STATE
, , , O
23574 CD CD I-ZIP
Fax NNP NNP O
: : : O
Email NNP NNP O
: : : O
gmichael@KCM.ORG NN NN I-EMAIL
CC NNP NNP O
: : : O
Phillip NNP NNP I-DOCTOR
Isaac NNP NNP I-DOCTOR
Crosby NNP NNP I-DOCTOR
M.D. NNP NNP O
   
Lamoni NNP NNP I-HOSPITAL
Nursing NNP NNP I-HOSPITAL
Rehabilitation NNP NNP I-HOSPITAL
Center NNP NNP I-HOSPITAL
725 CD CD I-STREET
Dan NNP NNP I-STREET
Chan NNP NNP I-STREET
Shelton NNP NNP I-CITY
, , , O
NH NNP NNP I-STATE
, , , O
64187 CD CD I-ZIP
Fax NNP NNP O
: : : O
Email NNP NNP O
: : : O
DD NNP NNP O
: : : O
10/26/73 CD CD I-DATE
DT NNP NNP O
: : : O
10/27/73 CD CD I-DATE
DV NNP NNP O
: : : O
10/26/73 CD CD I-DATE
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2083-12-30 JJ JJ I-DATE
Lantus NNP NNP O
and CC CC O
Novolog NNP NNP O
Insulin NNP NNP O
Guidelines NNP NNP O
   
1 CD CD O
. . . O
Check NNP NNP O
blood NN NN O
sugars NNS NNS O
before IN IN O
meals NNS NNS O
and CC CC O
at IN IN O
bedtime NN NN O
. . . O
   
In IN IN O
addition NN NN O
, , , O
some DT DT O
meals NNS NNS O
you PRP PRP O
may MD MD O
want VB VB O
to TO TO O
check VB VB O
your PRP$ PRP$ O
blood NN NN O
sugar NN NN O
( ( ( O
blood NN NN O
glucose NN NN O
or CC CC O
BG NNP NNP O
) ) ) O
1 CD CD O
hour NN NN O
after IN IN O
taking VBG VBG O
your PRP$ PRP$ O
Novolog NNP NNP O
. . . O
   
If IN IN O
it PRP PRP O
is VBZ VBZ O
over IN IN O
150 CD CD O
you PRP PRP O
may MD MD O
need VB VB O
to TO TO O
take VB VB O
more JJR JJR O
Novolog NNP NNP O
with IN IN O
meals NNS NNS O
or CC CC O
decrease VB VB O
your PRP$ PRP$ O
carbohydrate NN NN O
intake NN NN O
. . . O
   
You PRP PRP O
do VBP VBP O
not RB RB O
have VB VB O
to TO TO O
do VB VB O
this DT DT O
at IN IN O
every DT DT O
meal NN NN O
and CC CC O
you PRP PRP O
can MD MD O
alternate VB VB O
meals NNS NNS O
and/or NN NN O
days NNS NNS O
. . . O
   
For IN IN O
example NN NN O
: : : O
Sat NNP NNP I-DATE
check NN NN O
before RB RB O
and CC CC O
after IN IN O
breakfast NN NN O
; : : O
   
Friday NNP NNP I-DATE
- : : O
lunch NN NN O
; : : O
   
Thursday NNP NNP I-DATE
- : : O
supper,etc NN NN O
. . . O
   
2 CD CD O
. . . O
Be VB VB O
careful JJ JJ O
of IN IN O
the DT DT O
amount NN NN O
of IN IN O
carbohydrates NNS NNS O
( ( ( O
breads NNS NNS O
, , , O
pasta NN NN O
, , , O
cereal NN NN O
, , , O
fruit NN NN O
, , , O
etc FW FW O
) ) ) O
you PRP PRP O
eat VBP VBP O
at IN IN O
each DT DT O
meal NN NN O
and CC CC O
between IN IN O
meals NNS NNS O
. . . O
   
Try VB VB O
to TO TO O
average VB VB O
about IN IN O
60 CD CD O
gms NN NN O
. . . O
   
per IN IN O
meal NN NN O
and CC CC O
15 CD CD O
gms NN NN O
. . . O
   
for IN IN O
snacks NNS NNS O
. . . O
   
3 CD CD O
. . . O
The DT DT O
goal NN NN O
for IN IN O
your PRP$ PRP$ O
blood NN NN O
sugars NNS NNS O
when WRB WRB O
you PRP PRP O
get VBP VBP O
up RB RB O
in IN IN O
the DT DT O
morning NN NN O
and CC CC O
before IN IN O
meals NNS NNS O
is VBZ VBZ O
80-110 JJ JJ O
, , , O
1 CD CD O
hour NN NN O
after IN IN O
taking VBG VBG O
Novolog NNP NNP O
( ( ( O
at IN IN O
the DT DT O
start NN NN O
of IN IN O
the DT DT O
meal NN NN O
) ) ) O
it PRP PRP O
is VBZ VBZ O
less JJR JJR O
than IN IN O
140 CD CD O
, , , O
and CC CC O
at IN IN O
bedtime NN NN O
100 CD CD O
to TO TO O
140 CD CD O
. . . O
   
4 CD CD O
. . . O
Your PRP$ PRP$ O
insulin NN NN O
may MD MD O
need VB VB O
adjusting VBG VBG O
several JJ JJ O
times NNS NNS O
before IN IN O
those DT DT O
goals NNS NNS O
can MD MD O
be VB VB O
met VBN VBN O
. . . O
   
When WRB WRB O
exercising VBG VBG O
you PRP PRP O
may MD MD O
need VB VB O
more JJR JJR O
carbs NNS NNS O
or CC CC O
less JJR JJR O
Novolog NNP NNP O
with IN IN O
meals NNS NNS O
. . . O
   
Long-acting NNP NNP O
insulin NN NN O
: : : O
Lantus NNP NNP O
( ( ( O
insulin NN NN O
glargine NN NN O
) ) ) O
Take NNP NNP O
_ NN NN O
14 CD CD O
_ NN NN O
units NNS NNS O
at IN IN O
bedtime NN NN O
. . . O
   
Do VBP VBP O
not RB RB O
mix VB VB O
with IN IN O
any DT DT O
other JJ JJ O
insulin NN NN O
. . . O
   
Lantus NNP NNP O
starts VBZ VBZ O
to TO TO O
work VB VB O
in IN IN O
about IN IN O
1 CD CD O
hr NN NN O
and CC CC O
lasts VBZ VBZ O
about IN IN O
24 CD CD O
hours NNS NNS O
. . . O
   
It PRP PRP O
has VBZ VBZ O
no DT DT O
peak NN NN O
. . . O
   
If IN IN O
your PRP$ PRP$ O
fasting VBG VBG O
blood NN NN O
sugar NN NN O
for IN IN O
two CD CD O
or CC CC O
more JJR JJR O
mornings NNS NNS O
is VBZ VBZ O
more JJR JJR O
than IN IN O
120 CD CD O
, , , O
increase NN NN O
your PRP$ PRP$ O
Lantus NNP NNP O
by IN IN O
2 CD CD O
units NNS NNS O
at IN IN O
the DT DT O
next JJ JJ O
dose NN NN O
. . . O
   
If IN IN O
it PRP PRP O
is VBZ VBZ O
more JJR JJR O
than IN IN O
140 CD CD O
for IN IN O
two CD CD O
mornings NNS NNS O
then RB RB O
increase NN NN O
by IN IN O
4 CD CD O
units NNS NNS O
at IN IN O
the DT DT O
next JJ JJ O
dose NN NN O
. . . O
   
If IN IN O
your PRP$ PRP$ O
fasting VBG VBG O
blood NN NN O
sugar NN NN O
is VBZ VBZ O
less JJR JJR O
than IN IN O
70 CD CD O
then RB RB O
decrease NN NN O
your PRP$ PRP$ O
next JJ JJ O
dose NN NN O
of IN IN O
Lantus NNP NNP O
by IN IN O
2 CD CD O
to TO TO O
4 CD CD O
units NNS NNS O
. . . O
   
Short-acting NNP NNP O
insulin NN NN O
: : : O
Novolog NNP NNP O
Take NNP NNP O
16 CD CD O
units NNS NNS O
of IN IN O
novolog NN NN O
with IN IN O
breakfast NN NN O
, , , O
6 CD CD O
units NNS NNS O
with IN IN O
lunch NN NN O
, , , O
and CC CC O
10 CD CD O
units NNS NNS O
with IN IN O
supper NN NN O
( ( ( O
called VBN VBN O
"""" '' '' O
standing NN NN O
dose NN NN O
"""" '' '' O
) ) ) O
within IN IN O
15 CD CD O
minutes NNS NNS O
of IN IN O
starting VBG VBG O
eat NN NN O
your PRP$ PRP$ O
meals NNS NNS O
. . . O
   
Do VBP VBP O
not RB RB O
take VB VB O
standing NN NN O
dose NN NN O
if IN IN O
not RB RB O
eating VBG VBG O
. . . O
   
Novolog NNP NNP O
starts VBZ VBZ O
to TO TO O
work VB VB O
in IN IN O
15 CD CD O
minutes NNS NNS O
and CC CC O
lasts VBZ VBZ O
about IN IN O
2 CD CD O
hours NNS NNS O
. . . O
   
It PRP PRP O
peaks VBZ VBZ O
in IN IN O
about IN IN O
1 CD CD O
hour NN NN O
. . . O
   
You PRP PRP O
need VBP VBP O
to TO TO O
eat VB VB O
enough JJ JJ O
carbs NNS NNS O
to TO TO O
cover VB VB O
this DT DT O
insulin NN NN O
or CC CC O
you PRP PRP O
will MD MD O
have VB VB O
a DT DT O
low JJ JJ O
blood NN NN O
sugar NN NN O
. . . O
   
If IN IN O
blood NN NN O
sugar NN NN O
is VBZ VBZ O
< NN NN O
80 CD CD O
take VB VB O
your PRP$ PRP$ O
standing NN NN O
dose NN NN O
or CC CC O
sliding VBG VBG O
scale NN NN O
. . . O
   
If IN IN O
< NN NN O
60 CD CD O
do VBP VBP O
not RB RB O
take VB VB O
standing NN NN O
dose NN NN O
. . . O
   
Take VB VB O
Novolog NNP NNP O
sliding VBG VBG O
scale NN NN O
   
( ( ( O
below IN IN O
) ) ) O
in IN IN O
addition NN NN O
to TO TO O
standing NN NN O
dose NN NN O
Novolog NNP NNP O
at IN IN O
mealtime NN NN O
If IN IN O
Blood NNP NNP O
sugar NN NN O
is VBZ VBZ O
125 CD CD O
- : : O
150 CD CD O
take VB VB O
2 CD CD O
units NNS NNS O
more JJR JJR O
150 CD CD O
- : : O
200 CD CD O
take VB VB O
3 CD CD O
units NNS NNS O
more JJR JJR O
201 CD CD O
- : : O
250 CD CD O
take VB VB O
4 CD CD O
units NNS NNS O
more JJR JJR O
251 CD CD O
- : : O
300 CD CD O
take VB VB O
6 CD CD O
units NNS NNS O
more JJR JJR O
301 CD CD O
- : : O
350 CD CD O
take VB VB O
8 CD CD O
units NNS NNS O
more JJR JJR O
> NN NN O
351 CD CD O
take NN NN O
10 CD CD O
units NNS NNS O
more JJR JJR O
and CC CC O
call NN NN O
MD NNP NNP O
if IN IN O
blood NN NN O
sugar NN NN O
has VBZ VBZ O
not RB RB O
decreased VBN VBN O
or CC CC O
has VBZ VBZ O
increased VBN VBN O
after IN IN O
2 CD CD O
hours NNS NNS O
. . . O
   
Bedtime NNP NNP O
High NNP NNP O
Blood NNP NNP O
Sugar NNP NNP O
: : : O
If IN IN O
your PRP$ PRP$ O
blood NN NN O
sugar NN NN O
at IN IN O
bedtime NN NN O
is VBZ VBZ O
greater JJR JJR O
than IN IN O
200 CD CD O
take VB VB O
Novolog NNP NNP O
by IN IN O
the DT DT O
sliding VBG VBG O
scale NN NN O
below IN IN O
in IN IN O
addition NN NN O
to TO TO O
Lantus NNP NNP O
. . . O
   
Do VBP VBP O
not RB RB O
mix VB VB O
the DT DT O
two CD CD O
insulins NNS NNS O
. . . O
   
Do VBP VBP O
not RB RB O
take VB VB O
standing NN NN O
dose NN NN O
insulin NN NN O
at IN IN O
bedtime NN NN O
. . . O
   
Have VBP VBP O
your PRP$ PRP$ O
blood NN NN O
sugar NN NN O
checked VBD VBD O
1 CD CD O
to TO TO O
2 CD CD O
hours NNS NNS O
after IN IN O
taking VBG VBG O
novolog NN NN O
at IN IN O
bedtime NN NN O
to TO TO O
make VB VB O
sure JJ JJ O
you PRP PRP O
have VBP VBP O
n't RB RB O
gone VBN VBN O
too RB RB O
low JJ JJ O
. . . O
   
If IN IN O
you PRP PRP O
are VBP VBP O
below IN IN O
80 CD CD O
then RB RB O
have VBP VBP O
a DT DT O
snack NN NN O
and CC CC O
juice NN NN O
to TO TO O
hold VB VB O
you PRP PRP O
over IN IN O
until IN IN O
morning NN NN O
. . . O
   
If IN IN O
bedtime NN NN O
blood NN NN O
sugar NN NN O
is VBZ VBZ O
201 CD CD O
- : : O
250 CD CD O
take VB VB O
2 CD CD O
units NNS NNS O
251 CD CD O
- : : O
300 CD CD O
take VB VB O
3 CD CD O
units NNS NNS O
301 CD CD O
- : : O
350 CD CD O
take VB VB O
4 CD CD O
units NNS NNS O
Please VB VB O
follow VB VB O
up RP RP O
with IN IN O
your PRP$ PRP$ O
endocrinologist NN NN O
or CC CC O
primary JJ JJ O
care NN NN O
practitioner NN NN O
in IN IN O
1-2 JJ JJ O
weeks NNS NNS O
. . . O
   
Bring NNP NNP O
this DT DT O
paper NN NN O
and CC CC O
your PRP$ PRP$ O
blood NN NN O
sugar NN NN O
results NNS NNS O
from IN IN O
the DT DT O
time NN NN O
you PRP PRP O
were VBD VBD O
discharged VBN VBN O
. . . O
   
For IN IN O
urgent JJ JJ O
problems NNS NNS O
or CC CC O
questions NNS NNS O
about IN IN O
your PRP$ PRP$ O
blood NN NN O
sugar NN NN O
or CC CC O
insulin NN NN O
call NN NN O
387-8267 NN NN I-PHONE
and CC CC O
ask VB VB O
for IN IN O
the DT DT O
page NN NN O
operator NN NN O
. . . O
   
Have VBP VBP O
beeper NN NN O
#68537 NN NN O
paged JJ JJ O
( ( ( O
the DT DT O
diabetes NNS NNS O
specialist NN NN O
on-call JJ JJ O
will MD MD O
call VB VB O
you PRP PRP O
back RB RB O
if IN IN O
you PRP PRP O
leave VBP VBP O
a DT DT O
message NN NN O
) ) ) O
. . . O
   
You PRP PRP O
may MD MD O
also RB RB O
try VB VB O
my PRP$ PRP$ O
pager NN NN O
anytime NN NN O
( ( ( O
30568 CD CD I-PHONE
) ) ) O
but CC CC O
I PRP PRP O
am VBP VBP O
not RB RB O
always RB RB O
available JJ JJ O
. . . O
   
Olive NNP NNP I-DOCTOR
Tripp NNP NNP I-DOCTOR
, , , O
ACNP NNP NNP O
, , , O
CDE NNP NNP O
Dixmont NNP NNP I-HOSPITAL
State NNP NNP I-HOSPITAL
Hospital NNP NNP I-HOSPITAL
Diabetes NNP NNP O
Management NNP NNP O
Service NNP NNP O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2071-05-18 JJ JJ I-DATE
OFFICE NNP NNP O
NOTE NNP NNP O
Conner NNP NNP O
, , , O
Andrew NNP NNP I-PATIENT
MR NNP NNP O
#9911852 NN NN O
May NNP NNP I-DATE
18 CD CD O
, , , O
2071 CD CD I-DATE
Andy NNP NNP I-PATIENT
comes VBZ VBZ O
in IN IN O
for IN IN O
followup NN NN O
of IN IN O
hospitalization NN NN O
on IN IN O
May NNP NNP I-DATE
6 CD CD I-DATE
, , , O
for IN IN O
coronary JJ JJ O
artery NN NN O
disease NN NN O
and CC CC O
he PRP PRP O
had VBD VBD O
increasing VBG VBG O
angina NN NN O
pectoris NN NN O
leading VBG VBG O
to TO TO O
catheterization NN NN O
. . . O
   
He PRP PRP O
underwent JJ JJ O
angioplasty NN NN O
of IN IN O
the DT DT O
circumflex NN NN O
vessels NNS NNS O
and CC CC O
then RB RB O
angioplasty NN NN O
and CC CC O
stenting VBG VBG O
of IN IN O
the DT DT O
first JJ JJ O
diagonal JJ JJ O
branch NN NN O
to TO TO O
the DT DT O
LAD NNP NNP O
. . . O
   
The DT DT O
latter JJ JJ O
one CD CD O
was VBD VBD O
done VBN VBN O
in IN IN O
the DT DT O
second JJ JJ O
setting NN NN O
and CC CC O
part NN NN O
of IN IN O
the DT DT O
study NN NN O
where WRB WRB O
the DT DT O
___ NN NN O
_ NN NN O
the DT DT O
stent NN NN O
versus CC CC O
a DT DT O
plain JJ JJ O
stent NN NN O
. . . O
   
This DT DT O
was VBD VBD O
done VBN VBN O
by IN IN O
Dr NNP NNP O
. . . O
Winn NNP NNP I-DOCTOR
, , , O
and CC CC O
Dr NNP NNP O
. . . O
Cook NNP NNP I-DOCTOR
. . . O
   
Since IN IN O
then RB RB O
he PRP PRP O
has VBZ VBZ O
been VBN VBN O
tired JJ JJ O
, , , O
otherwise RB RB O
felt VBD VBD O
well RB RB O
. . . O
   
He PRP PRP O
had VBD VBD O
reasonable JJ JJ O
lipids NNS NNS O
but CC CC O
low JJ JJ O
HDL NNP NNP O
syndrome NN NN O
. . . O
   
His PRP$ PRP$ O
blood NN NN O
sugars NNS NNS O
have VBP VBP O
been VBN VBN O
controlled VBN VBN O
recently RB RB O
with IN IN O
A1C's NNP NNP O
in IN IN O
the DT DT O
6 CD CD I-DATE
range NN NN O
. . . O
   
He PRP PRP O
is VBZ VBZ O
overweight NN NN O
and CC CC O
does VBZ VBZ O
not RB RB O
do VB VB O
any DT DT O
regular JJ JJ O
exercise NN NN O
program NN NN O
. . . O
   
He PRP PRP O
is VBZ VBZ O
on IN IN O
for IN IN O
arthritis NNS NNS O
. . . O
   
His PRP$ PRP$ O
current JJ JJ O
medications NNS NNS O
consist VBP VBP O
of IN IN O
aspirin NN NN O
325 CD CD O
mg NN NN O
per IN IN O
day NN NN O
, , , O
Plavix NNP NNP O
75 CD CD O
mg NN NN O
per IN IN O
day NN NN O
, , , O
Glucatrol NNP NNP O
10 CD CD O
mg NN NN O
twice RB RB O
daily JJ JJ O
and CC CC O
Glucophage NNP NNP O
500 CD CD O
mg NN NN O
twice RB RB O
daily RB RB O
, , , O
Atenolol NNP NNP O
25 CD CD O
mg NN NN O
daily JJ JJ O
, , , O
Nexium NNP NNP O
20 CD CD O
mg NN NN O
per IN IN O
day NN NN O
, , , O
Flomax NNP NNP O
.4 CD CD O
and CC CC O
Zestril NNP NNP O
. . . O
   
He PRP PRP O
feels VBZ VBZ O
well RB RB O
. . . O
   
He PRP PRP O
is VBZ VBZ O
a DT DT O
little JJ JJ O
fatigued NN NN O
. . . O
   
No DT DT O
obvious JJ JJ O
angina NN NN O
. . . O
   
His PRP$ PRP$ O
blood NN NN O
pressure NN NN O
is VBZ VBZ O
running VBG VBG O
110/70 CD CD O
, , , O
his PRP$ PRP$ O
pulse NN NN O
is VBZ VBZ O
running VBG VBG O
60 CD CD O
and CC CC O
regular JJ JJ O
. . . O
   
JVP NNP NNP O
is VBZ VBZ O
normal JJ JJ O
. . . O
   
Carotids NNP NNP O
are VBP VBP O
normal JJ JJ O
. . . O
   
The DT DT O
lungs NNS NNS O
are VBP VBP O
clear JJ JJ O
. . . O
   
Coronary JJ JJ O
: : : O
S3 NNP NNP O
. . . O
   
IMPRESSION NNP NNP O
: : : O
Doing VBG VBG O
well RB RB O
. . . O
   
I PRP PRP O
think VBP VBP O
he PRP PRP O
should MD MD O
probably RB RB O
be VB VB O
on IN IN O
Lipitor NNP NNP O
even RB RB O
though IN IN O
he PRP PRP O
is VBZ VBZ O
on IN IN O
low JJ JJ O
lipids NNS NNS O
and CC CC O
I PRP PRP O
also RB RB O
think VBP VBP O
that IN IN O
he PRP PRP O
would MD MD O
benefit VB VB O
from IN IN O
cardiac JJ JJ O
rehabilitation NN NN O
. . . O
   
He PRP PRP O
will MD MD O
also RB RB O
pay VB VB O
close VB VB O
attention NN NN O
to TO TO O
diabetes NNS NNS O
and CC CC O
he PRP PRP O
is VBZ VBZ O
prepared VBN VBN O
to TO TO O
move VB VB O
on IN IN O
with IN IN O
insulin NN NN O
. . . O
   
Brandon NNP NNP I-DOCTOR
Walls NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
   
Dictated/Not NNP NNP O
Read NNP NNP O
BW/yen NNP NNP O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2080-07-03 JJ JJ I-DATE
History NN NN O
of IN IN O
Present JJ JJ O
Illness NNP NNP O
POD NNP NNP O
# # # O
3 CD CD O
Procedure NNP NNP O
femoral-femoral JJ JJ O
bypass NN NN O
graft NN NN O
Surgeon NNP NNP O
U. NNP NNP I-DOCTOR
Needham NNP NNP I-DOCTOR
Narrative NNP NNP O
History NN NN O
This DT DT O
gentleman NN NN O
has VBZ VBZ O
type NN NN O
2 CD CD O
DM NNP NNP O
diagnosed VBD VBD O
in IN IN O
2078 CD CD I-DATE
. . . O
   
At IN IN O
that DT DT O
time NN NN O
he PRP PRP O
was VBD VBD O
seen VBN VBN O
at IN IN O
the DT DT O
ED NNP NNP O
with IN IN O
urinary JJ JJ O
frequency NN NN O
and CC CC O
was VBD VBD O
not RB RB O
feeling NN NN O
well RB RB O
. . . O
   
He PRP PRP O
was VBD VBD O
admitted VBN VBN O
to TO TO O
the DT DT O
hospital NN NN O
for IN IN O
BG NNP NNP O
's POS POS O
of IN IN O
400's. CD CD O
   
He PRP PRP O
was VBD VBD O
discharged VBN VBN O
on IN IN O
NPH NNP NNP O
insulin NN NN O
30 CD CD O
units NNS NNS O
q NN NN O
am VBP VBP O
and CC CC O
15 CD CD O
units NNS NNS O
q NN NN O
pm NN NN O
. . . O
   
He PRP PRP O
has VBZ VBZ O
followed VBN VBN O
up RP RP O
with IN IN O
Dr NNP NNP O
. . . O
Xan NNP NNP I-DOCTOR
Dunn NNP NNP I-DOCTOR
from IN IN O
our PRP$ PRP$ O
Diabetes NNP NNP O
department NN NN O
. . . O
   
His PRP$ PRP$ O
latest JJS JJS O
home NN NN O
DM NNP NNP O
regimen NNS NNS O
consists NNS NNS O
of IN IN O
NPH NNP NNP O
insulin NN NN O
25 CD CD O
units NNS NNS O
q NN NN O
am VBP VBP O
and CC CC O
10 CD CD O
units NNS NNS O
q NN NN O
hs NN NN O
. . . O
   
His PRP$ PRP$ O
home NN NN O
BG NNP NNP O
's POS POS O
are VBP VBP O
usually RB RB O
130 CD CD O
or CC CC O
less JJR JJR O
. . . O
   
He PRP PRP O
has VBZ VBZ O
hypoglycemia NN NN O
unawareness JJ JJ O
. . . O
   
He PRP PRP O
has VBZ VBZ O
PVD NNP NNP O
s/p NN NN O
fem-fem JJ JJ O
bypass NN NN O
graft NN NN O
6/30/80 CD CD I-DATE
, , , O
ulcer NN NN O
on IN IN O
R NNP NNP O
big JJ JJ O
toe NN NN O
, , , O
(+) NNP NNP O
peripheral JJ JJ O
neuropathy NN NN O
. . . O
   
Past NNP NNP O
Medical NNP NNP O
History NN NN O
Morbidly RB RB O
obese NN NN O
, , , O
+ NN NN O
sleep VB VB O
apnea NN NN O
, , , O
+ NN NN O
BPH NNP NNP O
, , , O
h/o NN NN O
gastric JJ JJ O
reflux NN NN O
, , , O
h/o NN NN O
pseudotumor NN NN O
cerebri NN NN O
, , , O
s/p NN NN O
hip NN NN O
surgery NN NN O
Family NNP NNP O
History NN NN O
no DT DT O
diabetes NN NN O
Social NNP NNP O
History NN NN O
Smoking NNP NNP O
(+) NN NN O
Medications NNP NNP O
Text NN NN O
Meds NNP NNP O
now RB RB O
: : : O
NPH NNP NNP O
insulin NN NN O
25 CD CD O
units NNS NNS O
q NN NN O
am VBP VBP O
and CC CC O
10 CD CD O
units NNS NNS O
q NN NN O
hs NN NN O
regular JJ JJ O
insulin NN NN O
SS NNP NNP O
201-250--4 JJ JJ O
units NNS NNS O
simvastatin NN NN O
, , , O
lasix NN NN O
, , , O
levaquin NN NN O
, , , O
clindamycin NN NN O
, , , O
lisinopril NN NN O
, , , O
ECASA NNP NNP O
, , , O
lopressor NN NN O
, , , O
pepcid NN NN O
Physical JJ JJ O
Exam NNP NNP O
BP NNP NNP O
140/73 CD CD O
PR NNP NNP O
72/min CD CD O
T NN NN O
98.7 CD CD O
General NNP NNP O
Appearance NNP NNP O
morbidly RB RB O
obese NN NN O
HEENT NNP NNP O
anicteric JJ JJ O
sclerae NN NN O
Neck NNP NNP O
trachea NN NN O
midline NN NN O
Chest NN NN O
CTA NNP NNP O
Cor/Cardiac NNP NNP O
RRR NNP NNP O
Abdomen NNP NNP O
Soft JJ JJ O
, , , O
obese NN NN O
Extremity NNP NNP O
dressing VBG VBG O
intact JJ JJ O
on IN IN O
ulcer NN NN O
, , , O
R NNP NNP O
big JJ JJ O
toe NN NN O
Neurological NNP NNP O
alert NN NN O
, , , O
oriented VBN VBN O
Skin NNP NNP O
(+) NNP NNP O
acanthosis NN NN O
nigracans NNS NNS O
Laboratory NNP NNP O
Data NNP NNP O
A1c NNP NNP O
6.1 CD CD O
in IN IN O
03/80 CD CD I-DATE
FS NNP NNP O
's POS POS O
7/02 CD CD I-DATE
65 CD CD O
( ( ( O
treated VBN VBN O
with IN IN O
OJ)--110 NNP NNP O
91 CD CD O
238 NN NN O
165 CD CD O
7/03 CD CD I-DATE
101 CD CD O
119 CD CD O
s. NN NN O
   
creatinine NN NN O
1.4 CD CD O
LFT NNP NNP O
wnl NN NN O
WBC NNP NNP O
13.7 CD CD O
Assessment NNP NNP O
Type NNP NNP O
2 CD CD O
DM NNP NNP O
complicated VBN VBN O
by IN IN O
PVD NNP NNP O
and CC CC O
neuropathy NN NN O
. . . O
   
He PRP PRP O
was VBD VBD O
not RB RB O
eating VBG VBG O
well RB RB O
7/01-7/02 NN NN O
but CC CC O
says VBZ VBZ O
his PRP$ PRP$ O
appetite NN NN O
has VBZ VBZ O
now RB RB O
recovered VBN VBN O
. . . O
   
Recommendation NNP NNP O
   
1 CD CD O
. . . O
Continue NNP NNP O
NPH NNP NNP O
insulin NN NN O
25 CD CD O
units NNS NNS O
q NN NN O
am VBP VBP O
and CC CC O
10 CD CD O
units NNS NNS O
q NN NN O
hs NN NN O
. . . O
   
2 CD CD O
. . . O
Suggest NNP NNP O
to TO TO O
change VB VB O
regular JJ JJ O
insulin NN NN O
sliding VBG VBG O
scale NN NN O
to TO TO O
humalog NN NN O
as IN IN O
this DT DT O
is VBZ VBZ O
more JJR JJR O
physiologic JJ JJ O
( ( ( O
acts NNS NNS O
faster RBR RBR O
and CC CC O
clears NNS NNS O
faster RBR RBR O
as RB RB O
well RB RB O
) ) ) O
. . . O
   
Give VB VB O
only RB RB O
half NN NN O
doses NNS NNS O
of IN IN O
this DT DT O
at IN IN O
hs NN NN O
since IN IN O
he PRP PRP O
will MD MD O
not RB RB O
be VB VB O
eating VBG VBG O
then RB RB O
. . . O
   
3 CD CD O
. . . O
Please VB VB O
get VB VB O
a DT DT O
Hemoglobin NNP NNP O
A1c NNP NNP O
. . . O
   
This DT DT O
will MD MD O
help VB VB O
us PRP PRP O
assess JJ JJ O
blood NN NN O
glucose NN NN O
control NN NN O
for IN IN O
the DT DT O
past JJ JJ O
2-3 JJ JJ O
months NNS NNS O
and CC CC O
can MD MD O
help VB VB O
in IN IN O
discharge NN NN O
planning NN NN O
. . . O
   
4 CD CD O
. . . O
He PRP PRP O
should MD MD O
folow-up JJ JJ O
with IN IN O
Dr NNP NNP O
. . . O
Dunn NNP NNP I-DOCTOR
from IN IN O
Diabetes NNP NNP O
. . . O
   
Thank VB VB O
you PRP PRP O
. . . O
   
U. NNP NNP I-DOCTOR
Natalyn NNP NNP I-DOCTOR
Gold NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
, , , O
M.P.H. NNP NNP O
b26494 NN NN O
( ( ( O
beeper NN NN O
for IN IN O
weekend NN NN O
: : : O
65860 CD CD I-PHONE
) ) ) O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2116-08-26 JJ JJ I-DATE
Physical JJ JJ O
exam NN NN O
: : : O
CC NNP NNP O
: : : O
HPI NNP NNP O
: : : O
55 CD CD I-AGE
y/o NN NN O
caucasian NN NN O
female NN NN O
with IN IN O
hx NN NN O
as IN IN O
bellow NN NN O
here RB RB O
for IN IN O
follow VB VB O
up RP RP O
. . . O
   
Denies NNP NNP O
weight NN NN O
loss NN NN O
or CC CC O
gain NN NN O
, , , O
change NN NN O
in IN IN O
appetite NN NN O
, , , O
problems NNS NNS O
sleeping VBG VBG O
, , , O
night NN NN O
sweats NNS NNS O
, , , O
fevers NNS NNS O
, , , O
headaches NNS NNS O
, , , O
visual JJ JJ O
changes NNS NNS O
, , , O
dysphagia NN NN O
, , , O
shortness NN NN O
of IN IN O
breath NN NN O
, , , O
orthopnea NN NN O
, , , O
PND NNP NNP O
, , , O
cough NN NN O
, , , O
chest NN NN O
pain NN NN O
, , , O
lower JJR JJR O
extremity NN NN O
edema NN NN O
, , , O
abdominal JJ JJ O
pain NN NN O
, , , O
nausea NN NN O
, , , O
vomiting VBG VBG O
, , , O
diarrhea NN NN O
, , , O
constipation NN NN O
, , , O
blood NN NN O
in IN IN O
stool NN NN O
, , , O
black JJ JJ O
stool NN NN O
, , , O
dysuria NN NN O
, , , O
nocturia NN NN O
, , , O
urinary JJ JJ O
or CC CC O
fecal JJ JJ O
incontinence NN NN O
, , , O
rashes NNS NNS O
, , , O
change NN NN O
in IN IN O
moles NNS NNS O
, , , O
joint JJ JJ O
pain NN NN O
, , , O
or CC CC O
depressed VBD VBD O
mood NN NN O
. . . O
   
no DT DT O
vaginal NN NN O
discharge NN NN O
, , , O
no DT DT O
pelvic JJ JJ O
pain NN NN O
, , , O
no DT DT O
dyspareunia NN NN O
. . . O
   
Problems NNS NNS O
Proteinuria NNP NNP O
Depression NNP NNP O
Osteoarthritis NNP NNP O
Noncompliance NNP NNP O
s/p NN NN O
left VBD VBD O
leg NN NN O
surgery NN NN O
2097 CD CD I-DATE
Diabetes NNP NNP O
mellitus NN NN O
type NN NN O
2 CD CD O
Cerebrovascular NNP NNP O
disease NN NN O
: : : O
Multiple JJ JJ O
strokes NNS NNS O
on IN IN O
MRI NNP NNP O
Cerebrovascular NNP NNP O
accident NN NN O
: : : O
11/15 CD CD I-DATE
Hypertension NNP NNP O
Hyperlipidemia NNP NNP O
knowlege NN NN O
deficits NNS NNS O
multiinfarct NN NN O
dementia NN NN O
? . . O
   
sedentary JJ JJ O
lifestyle NN NN O
poor JJ JJ O
dentition NN NN O
: : : O
multiple JJ JJ O
cavities NNS NNS O
Medications NNP NNP O
Fragmin NNP NNP O
( ( ( O
DALTEPARIN NNP NNP O
SODIUM NNP NNP O
) ) ) O
8500 CD CD O
UNITS NNP NNP O
SC NNP NNP O
Q12H NNP NNP O
, , , O
Anticoagulation NNP NNP O
as IN IN O
per IN IN O
Neurology NNP NNP O
- : : O
Thomas NNP NNP I-DOCTOR
Javier NNP NNP I-DOCTOR
MD NNP NNP O
. . . O
   
Stop NNP NNP O
on IN IN O
12/17 CD CD I-DATE
, , , O
12/18,12/19 CD CD O
, , , O
12/20 CD CD I-DATE
for IN IN O
breast NN NN O
biopsy NN NN O
on IN IN O
12/20 CD CD I-DATE
. . . O
   
Lipitor NNP NNP O
( ( ( O
ATORVASTATIN NNP NNP O
) ) ) O
20 CD CD O
MG NNP NNP O
( ( ( O
20MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
) ) ) O
PO NNP NNP O
QHS NNP NNP O
, , , O
For IN IN O
high JJ JJ O
cholesterol NN NN O
. . . O
   
One CD CD O
pill NN NN O
every DT DT O
night NN NN O
. . . O
   
Glucotrol NN NN O
( ( ( O
GLIPIZIDE NNP NNP O
) ) ) O
5 CD CD O
MG NNP NNP O
( ( ( O
5MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
) ) ) O
PO NNP NNP O
BID NNP NNP O
, , , O
For IN IN O
diabetes NN NN O
. . . O
   
One CD CD O
pill NN NN O
twice RB RB O
per IN IN O
day NN NN O
. . . O
   
Fluoxetine NNP NNP O
HCL NNP NNP O
20 CD CD O
MG NNP NNP O
( ( ( O
20MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
) ) ) O
PO NNP NNP O
QD NNP NNP O
, , , O
Take NNP NNP O
one CD CD O
pill NN NN O
per IN IN O
day NN NN O
. . . O
   
Metformin NNP NNP O
500 CD CD O
MG NNP NNP O
( ( ( O
500MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
) ) ) O
PO NNP NNP O
BID NNP NNP O
Ciprofloxacin NNP NNP O
500 CD CD O
MG NNP NNP O
( ( ( O
500MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
) ) ) O
PO NNP NNP O
Q12H NNP NNP O
Lisinopril NNP NNP O
20 CD CD O
MG NNP NNP O
( ( ( O
20MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
) ) ) O
PO NNP NNP O
QD NNP NNP O
, , , O
For IN IN O
blood NN NN O
pressure NN NN O
. . . O
   
Allergies NNP NNP O
NKA NNP NNP O
FAMILY NNP NNP O
HX NNP NNP O
: : : O
No DT DT O
changes NNS NNS O
. . . O
   
SOCIAL NNP NNP O
HX NNP NNP O
: : : O
No DT DT O
tobacco NN NN O
, , , O
alcohol NN NN O
, , , O
or CC CC O
drug NN NN O
use NN NN O
. . . O
   
Denies NNP NNP O
domestic JJ JJ O
violence NN NN O
. . . O
   
Uses NNP NNP O
seat NN NN O
belts NNS NNS O
. . . O
   
PE NNP NNP O
: : : O
Vital NNP NNP O
Signs NNP NNP O
BP NNP NNP O
: : : O
118/74 CD CD O
P-72 NNP NNP O
GEN NNP NNP O
: : : O
NAD NNP NNP O
HEENT NNP NNP O
: : : O
PERRL NNP NNP O
, , , O
no DT DT O
icterus NN NN O
or CC CC O
scleral JJ JJ O
injection NN NN O
OP NNP NNP O
: : : O
clear JJ JJ O
, , , O
no DT DT O
erythema NN NN O
or CC CC O
exudate NN NN O
. . . O
   
poor JJ JJ O
dentition NN NN O
but CC CC O
no DT DT O
abscess NN NN O
noted VBD VBD O
. . . O
   
Lungs NNP NNP O
: : : O
CTA NNP NNP O
bilaterally RB RB O
LNs NNP NNP O
: : : O
no DT DT O
cervical JJ JJ O
lymphadenopathy NN NN O
. . . O
   
Heart NNP NNP O
: : : O
RRR NNP NNP O
, , , O
no DT DT O
MRG NNP NNP O
. . . O
   
radial NN NN O
, , , O
, , , O
DP NNP NNP O
pulses NNS NNS O
2 CD CD O
+ NN NN O
. . . O
   
No DT DT O
carotid NN NN O
, , , O
abdominal JJ JJ O
bruits NNS NNS O
. . . O
   
Abdomen NNP NNP O
: : : O
soft JJ JJ O
, , , O
non-tender NN NN O
, , , O
non-distended JJ JJ O
, , , O
BS NNP NNP O
present JJ JJ O
Extremities NNP NNP O
: : : O
No DT DT O
C/C/E NNP NNP O
Skin NNP NNP O
: : : O
no DT DT O
rashes NNS NNS O
, , , O
no DT DT O
irregular JJ JJ O
moles NNS NNS O
Neuro NNP NNP O
: : : O
EOMI NNP NNP O
, , , O
CN NNP NNP O
II-XII NNP NNP O
intact JJ JJ O
, , , O
nonfocal JJ JJ O
. . . O
   
Labs NNP NNP O
: : : O
None NN NN O
. . . O
   
Impression NNP NNP O
and CC CC O
Plan NNP NNP O
: : : O
1 CD CD O
) ) ) O
Uncontrolled NNP NNP O
DM NNP NNP O
: : : O
Control NNP NNP O
improved VBN VBN O
over IN IN O
last JJ JJ O
1 CD CD O
month NN NN O
. . . O
   
However RB RB O
BG NNP NNP O
still RB RB O
markedly RB RB O
elevated VBD VBD O
. . . O
   
Given VBN VBN O
her PRP$ PRP$ O
h/o NN NN O
noncompliance NN NN O
I PRP PRP O
think VBP VBP O
this DT DT O
is VBZ VBZ O
a DT DT O
big JJ JJ O
step NN NN O
. . . O
   
Check NNP NNP O
HBA1c NNP NNP O
. . . O
   
2 CD CD O
) ) ) O
Proteinuria NNP NNP O
: : : O
recheck NN NN O
this DT DT O
. . . O
   
3 CD CD O
) ) ) O
Depression NNP NNP O
: : : O
Improved NNP NNP O
. . . O
   
Cont NNP NNP O
. . . O
   
fluoxetine NN NN O
for IN IN O
now RB RB O
. . . O
   
referral NN NN O
to TO TO O
MH NNP NNP O
again RB RB O
today NN NN O
. . . O
   
4 CD CD O
) ) ) O
HTN NNP NNP O
: : : O
Optimally RB RB O
controlled VBN VBN O
. . . O
   
5 CD CD O
) ) ) O
CVD NNP NNP O
: : : O
S/p NNP NNP O
CVA NNP NNP O
: : : O
Stable JJ JJ O
. . . O
   
Pt NNP NNP O
. . . O
   
very RB RB O
poor JJ JJ O
historian NN NN O
. . . O
   
Unclear NNP NNP O
how WRB WRB O
long RB RB O
ago RB RB O
she PRP PRP O
stopped VBD VBD O
fragmin NN NN O
. . . O
   
ASA NNP NNP O
qd NN NN O
for IN IN O
now RB RB O
. . . O
   
follow VB VB O
up RB RB O
with IN IN O
neurology NN NN O
as IN IN O
scheduled VBN VBN O
on IN IN O
9/02/16 CD CD I-DATE
. . . O
   
6 CD CD O
) ) ) O
Hep NNP NNP O
B NNP NNP O
vaccine NN NN O
today NN NN O
first JJ JJ O
dose NN NN O
. . . O
   
7 CD CD O
) ) ) O
OA NNP NNP O
: : : O
Stable JJ JJ O
. . . O
   
Tylenol NNP NNP O
prn NN NN O
. . . O
   
8 CD CD O
) ) ) O
HM NNP NNP O
: : : O
Complete JJ JJ O
annual JJ JJ O
PE NNP NNP O
when WRB WRB O
above IN IN O
issues NNS NNS O
stable JJ JJ O
. . . O
   
____________________________________________ NN NN O
_ NN NN O
Richard NNP NNP I-DOCTOR
A. NN NN I-DOCTOR
Verlin-Urbina NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2070-05-15 NN NN I-DATE
78 CD CD I-AGE
y NN NN O
o NN NN O
female JJ JJ O
pt NN NN O
dr NN NN O
olivas NN NN I-DOCTOR
at IN IN O
home NN NN O
. . . O
   
special JJ JJ O
visit NN NN O
to TO TO O
prepare VB VB O
meds NNS NNS O
for IN IN O
the DT DT O
week NN NN O
end NN NN O
. . . O
   
unfortunately RB RB O
pt NN NN O
does VBZ VBZ O
not RB RB O
know VB VB O
why WRB WRB O
she PRP PRP O
does VBZ VBZ O
not RB RB O
yet RB RB O
have VB VB O
new JJ JJ O
meds NNS NNS O
. . . O
   
expects NNS NNS O
family NN NN O
to TO TO O
deliver VB VB O
them PRP PRP O
to TO TO O
her PRP$ PRP$ O
later RB RB O
today NN NN O
. . . O
   
Has VBZ VBZ O
not RB RB O
taken VBN VBN O
meds NNS NNS O
today NN NN O
and CC CC O
does VBZ VBZ O
not RB RB O
have VB VB O
lasix NN NN O
, , , O
neurontin NN NN O
, , , O
protonix NN NN O
. . . O
   
very RB RB O
anxious JJ JJ O
, , , O
worried VBN VBN O
about IN IN O
having VBG VBG O
to TO TO O
be VB VB O
placed VBN VBN O
in IN IN O
nursing VBG VBG O
home NN NN O
because IN IN O
cannot NN NN O
do VBP VBP O
own VBN VBN O
med JJ JJ O
preparation NN NN O
, , , O
test NN NN O
fingersticks NNS NNS O
. . . O
   
says VBZ VBZ O
she PRP PRP O
is VBZ VBZ O
having VBG VBG O
some DT DT O
sob NN NN O
at IN IN O
rest NN NN O
but CC CC O
no DT DT O
doe NN NN O
, , , O
orthop NN NN O
, , , O
pnd NN NN O
, , , O
cp NN NN O
. . . O
   
ankle NN NN O
swelling NN NN O
is VBZ VBZ O
also RB RB O
a DT DT O
little RB RB O
more JJR JJR O
. . . O
   
Allergies NNPS NNPS O
* NN NN O
Haldol NNP NNP O
- : : O
Unknown JJ JJ O
Medications NNP NNP O
Asa NNP NNP O
( ( ( O
CHILDRENS NNP NNP O
) ) ) O
( ( ( O
ACETYLSALICYLIC NNP NNP O
Acid NNP NNP O
( ( ( O
C. NN NN O
   
. . . O
   
. . . O
   
81MG CD CD O
, , , O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Mvi NNP NNP O
( ( ( O
MULTIVITAMINS NNP NNP O
) ) ) O
1 CD CD O
CAPSULE NNP NNP O
PO NNP NNP O
QD NNP NNP O
Pericolace NNP NNP O
( ( ( O
DOCUSATE NNP NNP O
W/casanthranol NNP NNP O
) ) ) O
1 CD CD O
CAPSULE NNP NNP O
PO NNP NNP O
QD NNP NNP O
AMIODARONE NNP NNP O
200MG CD CD O
, , , O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Lasix NNP NNP O
( ( ( O
FUROSEMIDE NNP NNP O
) ) ) O
40MG CD CD O
, , , O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
BID NNP NNP O
Premarin NNP NNP O
( ( ( O
CONJUGATED NNP NNP O
Estrogens NNP NNP O
) ) ) O
0.625MG, CD CD O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Provera NNP NNP O
( ( ( O
MEDROXYPROGESTERONE NNP NNP O
) ) ) O
2.5MG, CD CD O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Celexa NNP NNP O
( ( ( O
CITALOPRAM NNP NNP O
) ) ) O
40MG CD CD O
, , , O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
ATENOLOL NNP NNP O
25MG CD CD O
, , , O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Tylenol NNP NNP O
( ( ( O
ACETAMINOPHEN NNP NNP O
) ) ) O
500MG CD CD O
, , , O
2 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
TID NNP NNP O
PRN NNP NNP O
arthritis NNS NNS O
pain NN NN O
Advil NNP NNP O
( ( ( O
IBUPROFEN NNP NNP O
) ) ) O
200MG CD CD O
, , , O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
BID NNP NNP O
PRN NNP NNP O
pain NN NN O
not RB RB O
relieved VBN VBN O
by IN IN O
tylenol NN NN O
Protonix NNP NNP O
( ( ( O
PANTOPRAZOLE NNP NNP O
) ) ) O
40MG CD CD O
, , , O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
PRN NNP NNP O
. . . O
   
Glucophage NNP NNP O
( ( ( O
METFORMIN NNP NNP O
) ) ) O
500MG CD CD O
, , , O
2 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
BID NNP NNP O
Neurontin NNP NNP O
( ( ( O
GABAPENTIN NNP NNP O
) ) ) O
100MG CD CD O
, , , O
2 CD CD O
Capsule NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
TID NNP NNP O
Problems NNS NNS O
Hypertension NNP NNP O
Osteoarthritis NNP NNP O
Dizziness NNP NNP O
amputation NN NN O
: : : O
3rd CD CD O
left VBN VBN O
toe NN NN O
Depression NNP NNP O
: : : O
with IN IN O
psychotic JJ JJ O
features NNS NNS O
Lumbar NNP NNP O
disc NN NN O
disease NN NN O
: : : O
s/p NN NN O
discectomy NN NN O
Cholecystectomy NNP NNP O
: : : O
s/p NN NN O
open JJ JJ O
procedure NN NN O
H/O NNP NNP O
Atrial NNP NNP O
fibrillation NN NN O
: : : O
vs NNS NNS O
. . . O
atrial JJ JJ O
tachycardia NNS NNS O
-- : : O
s/p NN NN O
cardioversion NN NN O
2/68 CD CD I-DATE
Diabetes NNP NNP O
mellitus NN NN O
: : : O
type NN NN O
2 CD CD O
Pulmonary NNP NNP O
embolism NN NN O
: : : O
bilateral NN NN O
; : : O
   
tx NN NN O
'd MD MD O
at IN IN O
Buzan NNP NNP I-HOSPITAL
Chiropractic NNP NNP I-HOSPITAL
Clinic NNP NNP I-HOSPITAL
Myocardial NNP NNP O
infarction NN NN O
: : : O
NQWMI NNP NNP O
with IN IN O
inferolateral/apical JJ JJ O
depressions NNS NNS O
5/31/69 CD CD I-DATE
- : : O
6/04/69 CD CD I-DATE
at IN IN O
Buzan NNP NNP I-HOSPITAL
County NNP NNP I-HOSPITAL
Clinic NNP NNP I-HOSPITAL
; : : O
   
no DT DT O
cath NN NN O
or CC CC O
f/u NN NN O
ETT NNP NNP O
done VBN VBN O
there RB RB O
as IN IN O
pt NN NN O
requested VBD VBD O
conservative JJ JJ O
management NN NN O
O NNP NNP O
: : : O
bp NN NN O
144/82 CD CD O
r LS LS O
sitting VBG VBG O
. . . O
   
hr NN NN O
68 CD CD O
reg NN NN O
rr NN NN O
   
20 CD CD O
. . . O
chest NN NN O
clear JJ JJ O
, , , O
cor NN NN O
no DT DT O
MRG NNP NNP O
, , , O
ext JJ JJ O
1-2 JJ JJ O
+ NN NN O
edema NN NN O
, , , O
callus NN NN O
on IN IN O
heal NN NN O
improved VBN VBN O
, , , O
no DT DT O
open JJ JJ O
areas NNS NNS O
, , , O
infection NN NN O
. . . O
   
A/P NNP NNP O
: : : O
call NN NN O
to TO TO O
castro VB VB I-PATIENT
, , , O
message NN NN O
left VBD VBD O
with IN IN O
daughter NN NN O
re NN NN O
need VBP VBP O
to TO TO O
get VB VB O
lasix NN NN O
and CC CC O
add VB VB O
to TO TO O
med VB VB O
boxes NNS NNS O
asap NN NN O
, , , O
no DT DT O
message NN NN O
machine NN NN O
working VBG VBG O
and CC CC O
no DT DT O
answer NN NN O
with IN IN O
alaniz NN NN I-PATIENT
's POS POS O
number NN NN O
. . . O
   
will MD MD O
return VB VB O
4 CD CD O
days NNS NNS O
to TO TO O
check VB VB O
on IN IN O
situation NN NN O
with IN IN O
meds NNS NNS O
. . . O
   
castro NN NN I-PATIENT
will MD MD O
check VB VB O
on IN IN O
patient NN NN O
daily RB RB O
over IN IN O
that DT DT O
time NN NN O
. . . O
   
____________________________________________ NN NN O
_ NN NN O
Kay NNP NNP I-DOCTOR
K. NN NN I-DOCTOR
Edge,RNC,ANP NNP NNP O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2115-12-14 NN NN I-DATE
Physical JJ JJ O
exam NN NN O
: : : O
CC NNP NNP O
: : : O
HPI NNP NNP O
: : : O
Accompanied NNP NNP O
by IN IN O
sister NN NN O
in IN IN O
law NN NN O
Amelia NNP NNP I-PATIENT
Travis NNP NNP I-PATIENT
220-523-4413 JJ JJ I-PHONE
   
( ( ( O
h NN NN O
) ) ) O
; : : O
   
199-683-8353 JJ JJ I-PHONE
   
( ( ( O
cell NN NN O
) ) ) O
. . . O
   
54 CD CD I-AGE
y/o NN NN O
female JJ JJ O
with IN IN O
uncontrolled JJ JJ O
DM NNP NNP O
, , , O
HTN NNP NNP O
, , , O
hyperlipidemia NN NN O
, , , O
left VBD VBD O
breast NN NN O
suspicious JJ JJ O
masses NNS NNS O
, , , O
CVD NNP NNP O
, , , O
and CC CC O
recent JJ JJ O
hospitalization NN NN O
for IN IN O
CVA NNP NNP O
, , , O
here RB RB O
for IN IN O
follow VB VB O
up RB RB O
and CC CC O
adjustment NN NN O
of IN IN O
her PRP$ PRP$ O
meds NNS NNS O
. . . O
   
She PRP PRP O
does VBZ VBZ O
not RB RB O
bring VB VB O
in IN IN O
her PRP$ PRP$ O
glucometer NN NN O
or CC CC O
log NN NN O
book NN NN O
. . . O
   
She PRP PRP O
does VBZ VBZ O
bring VB VB O
in IN IN O
some DT DT O
of IN IN O
her PRP$ PRP$ O
meds NNS NNS O
. . . O
   
Denies NNS NNS O
change VBP VBP O
in IN IN O
appetite NN NN O
, , , O
problems NNS NNS O
sleeping VBG VBG O
, , , O
night NN NN O
sweats NNS NNS O
, , , O
fevers NNS NNS O
, , , O
headaches NNS NNS O
, , , O
visual JJ JJ O
changes NNS NNS O
, , , O
dysphagia NN NN O
, , , O
shortness NN NN O
of IN IN O
breath NN NN O
, , , O
orthopnea NN NN O
, , , O
PND NNP NNP O
, , , O
cough NN NN O
, , , O
chest NN NN O
pain NN NN O
, , , O
lower JJR JJR O
extremity NN NN O
edema NN NN O
, , , O
abdominal JJ JJ O
pain NN NN O
, , , O
nausea NN NN O
, , , O
vomiting VBG VBG O
, , , O
diarrhea NN NN O
, , , O
constipation NN NN O
, , , O
blood NN NN O
in IN IN O
stool NN NN O
, , , O
black JJ JJ O
stool NN NN O
, , , O
dysuria NN NN O
, , , O
nocturia NN NN O
, , , O
urinary JJ JJ O
or CC CC O
fecal JJ JJ O
incontinence NN NN O
, , , O
rashes NNS NNS O
, , , O
joint JJ JJ O
pain NN NN O
, , , O
or CC CC O
depressed VBD VBD O
mood NN NN O
. . . O
   
no DT DT O
vaginal NN NN O
discharge NN NN O
, , , O
no DT DT O
pelvic JJ JJ O
pain NN NN O
. . . O
   
Problems NNS NNS O
s/p NN NN O
left VBD VBD O
leg NN NN O
surgery NN NN O
2097 CD CD I-DATE
Diabetes NNP NNP O
mellitus NN NN O
type NN NN O
2 CD CD O
Cerebrovascular NNP NNP O
disease NN NN O
: : : O
Multiple JJ JJ O
strokes NNS NNS O
on IN IN O
MRI NNP NNP O
Cerebrovascular NNP NNP O
accident NN NN O
: : : O
11/15 CD CD I-DATE
Hypertension NNP NNP O
Hyperlipidemia NNP NNP O
knowlege NN NN O
deficits NNS NNS O
multiinfarct NN NN O
dementia NN NN O
? . . O
   
sedentary JJ JJ O
lifestyle NN NN O
poor JJ JJ O
dentition NN NN O
: : : O
multiple JJ JJ O
cavities NNS NNS O
Medications NNP NNP O
Fragmin NNP NNP O
( ( ( O
DALTEPARIN NNP NNP O
SODIUM NNP NNP O
) ) ) O
8500 CD CD O
UNITS NNP NNP O
SC NNP NNP O
Q12H NNP NNP O
, , , O
Anticoagulation NNP NNP O
as IN IN O
per IN IN O
Neurology NNP NNP O
- : : O
Thomas NNP NNP I-DOCTOR
Javier NNP NNP I-DOCTOR
MD NNP NNP O
. . . O
   
Stop NNP NNP O
on IN IN O
12/17 CD CD I-DATE
, , , O
12/18,12/19 CD CD O
, , , O
12/20 CD CD I-DATE
for IN IN O
breast NN NN O
biopsy NN NN O
on IN IN O
12/20 CD CD I-DATE
. . . O
   
Metformin NNP NNP O
500 CD CD O
mg NN NN O
po NN NN O
BID NNP NNP O
Lopressor NNP NNP O
50 CD CD O
mg NN NN O
po NN NN O
BID NNP NNP O
Allergies NNP NNP O
NKA NNP NNP O
SOCIAL NNP NNP O
HX NNP NNP O
: : : O
No DT DT O
tobacco NN NN O
, , , O
alcohol NN NN O
, , , O
or CC CC O
drug NN NN O
use NN NN O
. . . O
   
Denies NNP NNP O
domestic JJ JJ O
violence NN NN O
. . . O
   
Uses NNP NNP O
seat NN NN O
belts NNS NNS O
. . . O
   
Living VBG VBG O
with IN IN O
sister NN NN O
in IN IN O
law NN NN O
Amelia NNP NNP I-PATIENT
Travis NNP NNP I-PATIENT
and CC CC O
mother NN NN O
. . . O
   
PE NNP NNP O
: : : O
BP NNP NNP O
: : : O
142/84 CD CD O
P-72 NNP NNP O
GEN NNP NNP O
: : : O
Pleasant NNP NNP O
female NN NN O
in IN IN O
NAD NNP NNP O
. . . O
   
HEENT NNP NNP O
: : : O
PERRL NNP NNP O
, , , O
no DT DT O
icterus NN NN O
or CC CC O
scleral JJ JJ O
injection NN NN O
OP NNP NNP O
: : : O
clear JJ JJ O
, , , O
no DT DT O
erythema NN NN O
or CC CC O
exudate NN NN O
Neck NNP NNP O
: : : O
supple NN NN O
, , , O
no DT DT O
lymph NN NN O
nodes NNS NNS O
, , , O
no DT DT O
thyromegaly NN NN O
, , , O
no DT DT O
thyroid NN NN O
nodules NNS NNS O
, , , O
no DT DT O
masses NNS NNS O
Lungs NNP NNP O
: : : O
CTA NNP NNP O
bilaterally RB RB O
LNs NNP NNP O
: : : O
no DT DT O
cervical JJ JJ O
lymphadenopathy NN NN O
. . . O
   
Heart NNP NNP O
: : : O
RRR NNP NNP O
, , , O
no DT DT O
MRG NNP NNP O
. . . O
   
Abdomen NNP NNP O
: : : O
soft JJ JJ O
, , , O
non-tender NN NN O
, , , O
non-distended JJ JJ O
, , , O
BS NNP NNP O
present JJ JJ O
, , , O
no DT DT O
HSM NNP NNP O
, , , O
no DT DT O
Masses NNP NNP O
Extremities NNP NNP O
: : : O
No DT DT O
C/C/E NNP NNP O
Skin NNP NNP O
: : : O
no DT DT O
rashes NNS NNS O
, , , O
no DT DT O
irregular JJ JJ O
moles NNS NNS O
Neuro NNP NNP O
: : : O
EOMI NNP NNP O
, , , O
visual JJ JJ O
fields NNS NNS O
intact JJ JJ O
, , , O
CN NNP NNP O
II-XII NNP NNP O
intact JJ JJ O
, , , O
UE NNP NNP O
and CC CC O
LE NNP NNP O
reflexes NNS NNS O
2 CD CD O
+ NN NN O
and CC CC O
symmetrical JJ JJ O
. . . O
   
Nonfocal NNP NNP O
. . . O
   
Labs NNPS NNPS O
: : : O
None NN NN O
. . . O
   
Impression NNP NNP O
and CC CC O
Plan NNP NNP O
: : : O
1 CD CD O
) ) ) O
Uncontrolled NNP NNP O
DM NNP NNP O
: : : O
Add NNP NNP O
Glipizide NNP NNP O
5 CD CD O
mg NN NN O
po NN NN O
BID NNP NNP O
. . . O
   
Cont NNP NNP O
. . . O
   
Metformin NNP NNP O
500 CD CD O
mg NN NN O
po NN NN O
BID NNP NNP O
. . . O
   
Check NNP NNP O
microalbumin NN NN O
. . . O
   
Re-emphasized NNP NNP O
importance NN NN O
of IN IN O
bringing VBG VBG O
in IN IN O
glucometer NN NN O
and CC CC O
BG NNP NNP O
log VBP VBP O
book NN NN O
along IN IN O
with IN IN O
all DT DT O
meds NNS NNS O
to TO TO O
each DT DT O
and CC CC O
every DT DT O
visit NN NN O
. . . O
   
Check NNP NNP O
on IN IN O
referrals NNS NNS O
to TO TO O
ophthalmologist VB VB O
, , , O
podiatry NN NN O
, , , O
diabetic JJ JJ O
teaching NN NN O
nurse NN NN O
, , , O
nutrition NN NN O
. . . O
   
2 CD CD O
) ) ) O
HTN NNP NNP O
: : : O
Add NNP NNP O
Lisinopril NNP NNP O
5 CD CD O
mg NN NN O
po NN NN O
qd NN NN O
. . . O
   
3 CD CD O
) ) ) O
CVD NNP NNP O
s/p NN NN O
CVA NNP NNP O
: : : O
Stable JJ JJ O
. . . O
   
Cont NNP NNP O
. . . O
   
Fragmin NNP NNP O
8500 CD CD O
units NNS NNS O
SQ NNP NNP O
BID NNP NNP O
as IN IN O
per IN IN O
neurology NN NN O
. . . O
   
Follow VB VB O
up RB RB O
with IN IN O
neurology NN NN O
. . . O
   
4 CD CD O
) ) ) O
Hyperlipidemia NNP NNP O
: : : O
Add NNP NNP O
lipitor NN NN O
20 CD CD O
mg NN NN O
po NN NN O
qhs NN NN O
. . . O
   
5 CD CD O
) ) ) O
Left NNP NNP O
breast NN NN O
masses NNS NNS O
: : : O
Biopsy NNP NNP O
on IN IN O
12/20/15 CD CD I-DATE
. . . O
   
She PRP PRP O
is VBZ VBZ O
to TO TO O
stop VB VB O
Fragmin NNP NNP O
on IN IN O
12/17/15 CD CD I-DATE
for IN IN O
this DT DT O
. . . O
   
6)Poor CD CD O
dentition NN NN O
: : : O
Referral NNP NNP O
to TO TO O
dentistry NN NN O
. . . O
   
7 CD CD O
) ) ) O
HM NNP NNP O
: : : O
Health NN NN O
Maintenance NNP NNP O
Cholesterol NNP NNP O
11/25/2115 CD CD I-DATE
207 CD CD O
DESIRABLE NNP NNP O
: : : O
< NN NN O
200 CD CD O
M-alb/creat NNP NNP O
ratio NN NN O
12/14/2115 CD CD I-DATE
47.8 CD CD O
Mammogram NNP NNP O
11/27/2115 CD CD I-DATE
BilDigDxMamoAll NNP NNP O
Pap NNP NNP O
Smear NNP NNP O
10/05/2115 CD CD I-DATE
2000 CD CD O
Smoking NNP NNP O
status NN NN O
10/05/2115 CD CD I-DATE
as IN IN O
teen-once NN NN O
UA-Protein NNP NNP O
11/25/2115 CD CD I-DATE
NEGATIVE NNP NNP O
HBA1C NNP NNP O
12/14/2115 CD CD I-DATE
11.80 CD CD O
Urine NNP NNP O
Culture NNP NNP O
11/25/2115 CD CD I-DATE
see VB VB O
report NN NN O
in IN IN O
Results NNS NNS O
Triglycerides NNP NNP O
11/25/2115 CD CD I-DATE
131 CD CD O
Cholesterol-LDL NNP NNP O
11/25/2115 CD CD I-DATE
121 NN NN O
DESIRABLE NNP NNP O
: : : O
< NN NN O
130 CD CD O
Microalbumin NNP NNP O
12/14/2115 CD CD I-DATE
6.5 CD CD O
Bone NNP NNP O
Density NNP NNP O
11/30/2115 CD CD I-DATE
BMD-Hip NNP NNP O
Hct NNP NNP O
( ( ( O
Hematocrit NNP NNP O
) ) ) O
11/27/2115 CD CD I-DATE
37.3 CD CD O
Domestic NNP NNP O
Violence NNP NNP O
Screening NNP NNP O
10/05/2115 CD CD I-DATE
denies NNS NNS O
Complete NNP NNP O
Physical JJ JJ O
Exam NNP NNP O
10/05/2115 CD CD I-DATE
Unremarkable NNP NNP O
Cholesterol-HDL NNP NNP O
11/25/2115 CD CD I-DATE
60 CD CD O
Hgb NNP NNP O
( ( ( O
Hemoglobin NNP NNP O
) ) ) O
11/27/2115 CD CD I-DATE
12.9 CD CD O
RTC NNP NNP O
6 CD CD O
weeks NNS NNS O
____________________________________________ NN NN O
_ NN NN O
Richard NNP NNP I-DOCTOR
A. NN NN I-DOCTOR
Verlin-Urbina NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2081-03-30 NN NN I-DATE
Asked NNP NNP O
by IN IN O
Dr NNP NNP O
Dunn NNP NNP I-DOCTOR
and CC CC O
Dr NNP NNP O
. . . O
Needham NNP NNP I-DOCTOR
to TO TO O
comment VB VB O
on IN IN O
DM NNP NNP O
management NN NN O
in IN IN O
this DT DT O
58 CD CD I-AGE
y/o NN NN O
man NN NN O
admited VBN VBN O
for IN IN O
amputation NN NN O
site NN NN O
debridement NN NN O
. . . O
   
He PRP PRP O
had VBD VBD O
fem-pop NN NN O
in IN IN O
2080 CD CD I-DATE
, , , O
and CC CC O
a DT DT O
R NNP NNP O
toe NN NN O
amp NN NN O
in IN IN O
9/80 CD CD I-DATE
. . . O
   
Howevere NNP NNP O
the DT DT O
site NN NN O
never RB RB O
healed VBD VBD O
, , , O
despite IN IN O
lack NN NN O
of IN IN O
clear JJ JJ O
infection NN NN O
. . . O
   
He PRP PRP O
is VBZ VBZ O
readmited VBN VBN O
on IN IN O
3/28 CD CD I-DATE
for IN IN O
debridement NN NN O
. . . O
   
Narrative NNP NNP O
History NN NN O
Type NNP NNP O
2 CD CD O
DM NNP NNP O
diagnosed VBD VBD O
in IN IN O
2078 CD CD I-DATE
- : : O
presented VBN VBN O
with IN IN O
urinary JJ JJ O
frequency NN NN O
and CC CC O
was VBD VBD O
not RB RB O
feeling NN NN O
well RB RB O
. . . O
   
He PRP PRP O
was VBD VBD O
admitted VBN VBN O
to TO TO O
the DT DT O
hospital NN NN O
for IN IN O
BG NNP NNP O
's POS POS O
of IN IN O
400's CD CD O
and CC CC O
discharged VBN VBN O
on IN IN O
NPH NNP NNP O
insulin NN NN O
30 CD CD O
units NNS NNS O
q NN NN O
am VBP VBP O
and CC CC O
15 CD CD O
units NNS NNS O
q NN NN O
pm NN NN O
. . . O
   
He PRP PRP O
has VBZ VBZ O
followed VBN VBN O
up RP RP O
with IN IN O
Dr NNP NNP O
. . . O
Dunn NNP NNP I-DOCTOR
from IN IN O
our PRP$ PRP$ O
Diabetes NNP NNP O
department NN NN O
. . . O
   
He PRP PRP O
has VBZ VBZ O
not RB RB O
seen VBN VBN O
her PRP$ PRP$ O
since IN IN O
3/80 CD CD I-DATE
but CC CC O
has VBZ VBZ O
kept VBN VBN O
up RP RP O
with IN IN O
her PRP PRP O
by IN IN O
phone NN NN O
. . . O
   
His PRP$ PRP$ O
home NN NN O
DM NNP NNP O
regimen NNS NNS O
consists NNS NNS O
of IN IN O
NPH NNP NNP O
insulin NN NN O
25 CD CD O
units NNS NNS O
q NN NN O
am VBP VBP O
and CC CC O
10 CD CD O
units NNS NNS O
q NN NN O
hs NN NN O
. . . O
   
Last JJ JJ O
A1c NNP NNP O
was VBD VBD O
6.1 CD CD O
3/80 CD CD I-DATE
and CC CC O
his PRP$ PRP$ O
BG NNP NNP O
's POS POS O
run NN NN O
~ NN NN O
100 CD CD O
. . . O
   
He PRP PRP O
has VBZ VBZ O
hypoglycemia NN NN O
unawareness JJ JJ O
. . . O
   
He PRP PRP O
has VBZ VBZ O
PVD NNP NNP O
s/p NN NN O
fem-fem JJ JJ O
bypass NN NN O
graft NN NN O
6/30/80 CD CD I-DATE
, , , O
ulcer NN NN O
on IN IN O
R NNP NNP O
big JJ JJ O
toe NN NN O
, , , O
(+) NNP NNP O
peripheral JJ JJ O
neuropathy NN NN O
. . . O
   
Past NNP NNP O
Medical NNP NNP O
History NN NN O
Morbidly RB RB O
obese NN NN O
, , , O
+ NN NN O
sleep VB VB O
apnea NN NN O
, , , O
+ NN NN O
BPH NNP NNP O
, , , O
h/o NN NN O
gastric JJ JJ O
reflux NN NN O
, , , O
h/o NN NN O
pseudotumor NN NN O
cerebri NN NN O
, , , O
s/p NN NN O
hip NN NN O
surgery NN NN O
Family NNP NNP O
History NN NN O
no DT DT O
diabetes NN NN O
Social NNP NNP O
History NN NN O
Smoking NNP NNP O
(+) NN NN O
Medications NNP NNP O
Text NN NN O
Meds NNP NNP O
now RB RB O
: : : O
NPH NNP NNP O
insulin NN NN O
25 CD CD O
units NNS NNS O
q NN NN O
am VBP VBP O
and CC CC O
10 CD CD O
units NNS NNS O
q NN NN O
hs NN NN O
regular JJ JJ O
insulin NN NN O
SS NNP NNP O
if IN IN O
BG NNP NNP O
> NN NN O
125 CD CD O
simvastatin NN NN O
lasix NN NN O
lisinopril NN NN O
ECASA NNP NNP O
esomeprazole NN NN O
atenolol NN NN O
SC NNP NNP O
heparin NN NN O
Folate NNP NNP O
Ancef NNP NNP O
1 CD CD O
gm NN NN O
Q8H NNP NNP O
Physical JJ JJ O
Exam NNP NNP O
BP NNP NNP O
140/73 CD CD O
Pulse NNP NNP O
48 CD CD O
reg NN NN O
T NN NN O
98.7 CD CD O
General NNP NNP O
Appearance NNP NNP O
morbidly RB RB O
obese NN NN O
pleasant NN NN O
and CC CC O
talkative JJ JJ O
HEENT NNP NNP O
anicteric JJ JJ O
sclerae NN NN O
Neck NNP NNP O
trachea NN NN O
midline NN NN O
Chest NN NN O
CTA NNP NNP O
Cor/Cardiac NNP NNP O
RRR NNP NNP O
Abdomen NNP NNP O
Soft JJ JJ O
, , , O
obese NN NN O
Extremity NNP NNP O
dressing VBG VBG O
intact JJ JJ O
on IN IN O
ulcer NN NN O
, , , O
R NNP NNP O
foot NN NN O
Neurological NNP NNP O
alert NN NN O
, , , O
oriented VBN VBN O
Skin NNP NNP O
(+) NNP NNP O
acanthosis NN NN O
nigracans NNS NNS O
Laboratory NNP NNP O
Data NNP NNP O
A1c NNP NNP O
6.1 CD CD O
in IN IN O
3/80 CD CD I-DATE
FS NNP NNP O
's POS POS O
49 CD CD O
on IN IN O
admission NN NN O
( ( ( O
no DT DT O
sx NN NN O
) ) ) O
104 CD CD O
94 CD CD O
132 CD CD O
65 CD CD O
92 CD CD O
95 CD CD O
LFT NNP NNP O
wnl NN NN O
Creat NNP NNP O
1.3 CD CD O
Assessment NNP NNP O
Type NNP NNP O
2 CD CD O
DM NNP NNP O
complicated VBN VBN O
by IN IN O
PVD NNP NNP O
and CC CC O
neuropathy NN NN O
. . . O
   
Well RB RB O
controlled VBN VBN O
on IN IN O
his PRP$ PRP$ O
home NN NN O
regimen NN NN O
. . . O
   
Recommendation NNP NNP O
   
1 CD CD O
. . . O
Continue NNP NNP O
NPH NNP NNP O
insulin NN NN O
25 CD CD O
units NNS NNS O
q NN NN O
am VBP VBP O
and CC CC O
10 CD CD O
units NNS NNS O
q NN NN O
hs NN NN O
. . . O
   
2 CD CD O
. . . O
Suggest NNP NNP O
to TO TO O
change VB VB O
regular JJ JJ O
insulin NN NN O
sliding VBG VBG O
scale NN NN O
to TO TO O
humalog NN NN O
as IN IN O
this DT DT O
is VBZ VBZ O
more JJR JJR O
physiologic JJ JJ O
( ( ( O
acts NNS NNS O
faster RBR RBR O
and CC CC O
clears NNS NNS O
faster RBR RBR O
as RB RB O
well RB RB O
) ) ) O
. . . O
   
Give VB VB O
only RB RB O
half NN NN O
doses NNS NNS O
of IN IN O
this DT DT O
at IN IN O
hs NN NN O
since IN IN O
he PRP PRP O
will MD MD O
not RB RB O
be VB VB O
eating VBG VBG O
then RB RB O
. . . O
   
3 CD CD O
. . . O
Please VB VB O
get VB VB O
a DT DT O
Hemoglobin NNP NNP O
A1c NNP NNP O
. . . O
   
This DT DT O
will MD MD O
help VB VB O
us PRP PRP O
assess JJ JJ O
blood NN NN O
glucose NN NN O
control NN NN O
for IN IN O
the DT DT O
past JJ JJ O
2-3 JJ JJ O
months NNS NNS O
and CC CC O
can MD MD O
help VB VB O
in IN IN O
discharge NN NN O
planning NN NN O
. . . O
   
4 CD CD O
. . . O
He PRP PRP O
should MD MD O
folow-up JJ JJ O
with IN IN O
Dr NNP NNP O
. . . O
Dunn NNP NNP I-DOCTOR
from IN IN O
Diabetes NNP NNP O
. . . O
   
Thank VB VB O
you PRP PRP O
. . . O
   
Barbara NNP NNP I-DOCTOR
Ely NNP NNP I-DOCTOR
MD NNP NNP O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2073-12-14 JJ JJ I-DATE
CARDIOLOGY NNP NNP O
COLLINGSWORTH NNP NNP I-HOSPITAL
GENERAL NNP NNP I-HOSPITAL
HOSPITAL NNP NNP I-HOSPITAL
Current NNP NNP O
Medications NNP NNP O
: : : O
Changes NNS NNS O
to TO TO O
Medications NNP NNP O
this DT DT O
visit NN NN O
Ecotrin NNP NNP O
325 CD CD O
mg NN NN O
po NN NN O
qd NN NN O
QTY:90 NNP NNP O
Refills:3 NNP NNP O
Start NNP NNP O
: : : O
12/14/2073 CD CD I-DATE
Plavix NNP NNP O
75mg CD CD O
po NN NN O
qd NN NN O
QTY:90 NNP NNP O
Refills:3 NNP NNP O
Start NNP NNP O
: : : O
12/14/2073 CD CD I-DATE
Glucotrol NNP NNP O
tablets NNS NNS O
20 CD CD O
mg NN NN O
BID NNP NNP O
QTY:180 NNP NNP O
Refills:3 NNP NNP O
Start NNP NNP O
: : : O
12/14/2073 CD CD I-DATE
Glucophage NNP NNP O
1000 CD CD O
mg NN NN O
po NN NN O
bid NN NN O
QTY:180 NNP NNP O
Refills:3 NNP NNP O
Start NNP NNP O
: : : O
12/14/2073 CD CD I-DATE
take VB VB O
with IN IN O
meals NNS NNS O
Actos NNP NNP O
15mg CD CD O
po NN NN O
qd NN NN O
QTY:90 NNP NNP O
Refills:3 NNP NNP O
Start NNP NNP O
: : : O
12/14/2073 CD CD I-DATE
atenolol NN NN O
50mg CD CD O
po NN NN O
qd NN NN O
QTY:90 NNP NNP O
Refills:3 NNP NNP O
Start NNP NNP O
: : : O
12/14/2073 CD CD I-DATE
Protonix NNP NNP O
40 CD CD O
mg NN NN O
po NN NN O
qd NN NN O
QTY:90 NNP NNP O
Refills:3 NNP NNP O
Start NNP NNP O
: : : O
12/14/2073 CD CD I-DATE
do VBP VBP O
not RB RB O
cut/crush/chew VB VB O
lisinopril NN NN O
20 CD CD O
mg NN NN O
po NN NN O
qd NN NN O
QTY:90 NNP NNP O
Refills:3 NNP NNP O
Start NNP NNP O
: : : O
12/14/2073 CD CD I-DATE
lorazepam NN NN O
0.5mg CD CD O
po NN NN O
QHS NNP NNP O
QTY:90 NNP NNP O
Refills:3 NNP NNP O
Start NNP NNP O
: : : O
12/14/2073 CD CD I-DATE
Signed VBN VBN O
electronically RB RB O
by IN IN O
Xavier NNP NNP I-DOCTOR
V NNP NNP I-DOCTOR
Cook NNP NNP I-DOCTOR
MD NNP NNP O
on IN IN O
Dec NNP NNP I-DATE
20 CD CD O
, , , O
2073 CD CD I-DATE
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2095-07-25 JJ JJ I-DATE
BMH NNP NNP I-HOSPITAL
Senior NNP NNP O
Health NNP NNP O
Return NNP NNP O
Visit NNP NNP O
CC NNP NNP O
: : : O
79 CD CD I-AGE
yo NN NN O
man NN NN O
hx NN NN O
depression NN NN O
, , , O
psychosis NN NN O
, , , O
insomnia NN NN O
, , , O
CAD NNP NNP O
, , , O
syncope NN NN O
, , , O
HTN NNP NNP O
, , , O
DMT2 NNP NNP O
, , , O
carotid NN NN O
stenosis NN NN O
, , , O
PVD NNP NNP O
, , , O
recent JJ JJ O
right JJ JJ O
inguinal NN NN O
hernia NN NN O
repair NN NN O
c/b NN NN O
hydrocele NN NN O
, , , O
recent JJ JJ O
TURP NNP NNP O
for IN IN O
Bladder NNP NNP O
outlet NN NN O
obs NN NN O
presents VBZ VBZ O
for IN IN O
f/u NN NN O
of IN IN O
these DT DT O
and CC CC O
other JJ JJ O
chronic JJ JJ O
health NN NN O
problems NNS NNS O
HPI NNP NNP O
: : : O
Briefly NNP NNP O
, , , O
patient NN NN O
to TO TO O
BMH NNP NNP I-HOSPITAL
with IN IN O
syncope NN NN O
in IN IN O
spring NN NN I-DATE
2094 CD CD I-DATE
. . . O
   
Work VBP VBP O
up RB RB O
unremarkable JJ JJ O
including VBG VBG O
cerebrovascular NN NN O
imaging VBG VBG O
, , , O
cardiac JJ JJ O
cath NN NN O
, , , O
EP NNP NNP O
study NN NN O
, , , O
loop NN NN O
recorder NN NN O
. . . O
   
Noted NNP NNP O
to TO TO O
have VB VB O
stable JJ JJ O
CAD NNP NNP O
and CC CC O
is VBZ VBZ O
on IN IN O
regimen NNS NNS O
for IN IN O
that DT DT O
including VBG VBG O
ACEI NNP NNP O
, , , O
BB NNP NNP O
, , , O
ASA NNP NNP O
, , , O
Statin NNP NNP O
. . . O
   
In IN IN O
hospital NN NN O
, , , O
was VBD VBD O
noted VBN VBN O
that IN IN O
pt NN NN O
had VBD VBD O
had VBN VBN O
40 CD CD O
lb NN NN O
weight NN NN O
loss NN NN O
over IN IN O
previous JJ JJ O
months NNS NNS O
. . . O
   
Chronically RB RB O
elevated VBD VBD O
PSA NNP NNP O
noted VBD VBD O
. . . O
   
Bone NNP NNP O
scan NN NN O
performed VBN VBN O
was VBD VBD O
unremarkable JJ JJ O
. . . O
   
Right RB RB O
inguinal JJ JJ O
hernia NN NN O
noted VBD VBD O
, , , O
was VBD VBD O
repaired VBN VBN O
in IN IN O
October NNP NNP I-DATE
. . . O
   
Pt NNP NNP O
noted VBD VBD O
to TO TO O
be VB VB O
depressed VBN VBN O
and CC CC O
psychotic JJ JJ O
, , , O
requiring VBG VBG O
inpt NN NN O
hospitalization NN NN O
on IN IN O
Psych NNP NNP O
floor NN NN O
. . . O
   
Depn NNP NNP O
successfully RB RB O
treated VBN VBN O
and CC CC O
psychosis NNS NNS O
improved VBN VBN O
as RB RB O
well RB RB O
. . . O
   
Has VBZ VBZ O
been VBN VBN O
followed VBN VBN O
by IN IN O
Dr NNP NNP O
. . . O
Nobles NNP NNP I-DOCTOR
s/p NN NN O
d/c NN NN O
. . . O
   
Presented VBN VBN O
to TO TO O
BMH NNP NNP I-HOSPITAL
in IN IN O
early JJ JJ O
Feb NNP NNP I-DATE
with IN IN O
abdominal JJ JJ O
pain NN NN O
, , , O
found VBD VBD O
to TO TO O
have VB VB O
bladder NN NN O
outlet NN NN O
obs NN NN O
from IN IN O
enlarged JJ JJ O
prostate NN NN O
leading VBG VBG O
to TO TO O
b/l VB VB O
hydronephrosis NN NN O
. . . O
   
Repeatedly RB RB O
failed VBD VBD O
voiding VBG VBG O
trials NNS NNS O
s/p NN NN O
d/c NN NN O
despite IN IN O
maximal NN NN O
medical JJ JJ O
therapy NN NN O
. . . O
   
Therefore RB RB O
, , , O
had VBD VBD O
an DT DT O
uncomplicated JJ JJ O
TURP NNP NNP O
. . . O
   
Since IN IN O
TURP NNP NNP O
, , , O
pt NN NN O
had VBD VBD O
successful JJ JJ O
voiding VBG VBG O
trial NN NN O
. . . O
   
Had VBD VBD O
been VBN VBN O
asked VBN VBN O
to TO TO O
continue VB VB O
his PRP$ PRP$ O
proscar NN NN O
and CC CC O
2 CD CD O
flomax NN NN O
qd NN NN O
for IN IN O
another DT DT O
month NN NN O
, , , O
then RB RB O
stop VB VB O
proscar NN NN O
and CC CC O
continue VB VB O
with IN IN O
just RB RB O
one CD CD O
flomax NN NN O
qd NN NN O
after IN IN O
this DT DT O
period NN NN O
of IN IN O
time NN NN O
. . . O
   
Still RB RB O
taking VBG VBG O
both DT DT O
, , , O
however RB RB O
, , , O
at IN IN O
this DT DT O
time NN NN O
. . . O
   
Seen VBN VBN O
by IN IN O
cardiology NN NN O
. . . O
   
Felt NNP NNP O
stable JJ JJ O
from IN IN O
CV NNP NNP O
perspective NN NN O
. . . O
   
Recommended NNP NNP O
lower JJR JJR O
ext NN NN O
ABIs/PVRs NNP NNP O
which WDT WDT O
pt NN NN O
declined VBD VBD O
at IN IN O
time NN NN O
. . . O
   
Recommended NNP NNP O
restarting VBG VBG O
ASA NNP NNP O
s/p NN NN O
TURP NNP NNP O
. . . O
   
Mood NNP NNP O
stable JJ JJ O
. . . O
   
Has VBZ VBZ O
been VBN VBN O
only RB RB O
taking VBG VBG O
3.75mg CD CD O
Zyprexa NNP NNP O
qd NN NN O
, , , O
not RB RB O
been VBN VBN O
taking VBG VBG O
7.5mg CD CD O
as IN IN O
prescribed VBN VBN O
. . . O
   
Has VBZ VBZ O
been VBN VBN O
having VBG VBG O
some DT DT O
weight NN NN O
loss NN NN O
per IN IN O
hx NN NN O
-- : : O
however RB RB O
, , , O
not RB RB O
so RB RB O
upon IN IN O
checking NN NN O
of IN IN O
weights NNS NNS O
in IN IN O
LMR NNP NNP O
. . . O
   
Notes NNP NNP O
that IN IN O
he PRP PRP O
feels VBZ VBZ O
weaker JJR JJR O
than IN IN O
usual JJ JJ O
"--""" NN NN O
weak JJ JJ O
as IN IN O
a DT DT O
kitten NN NN O
. . . O
"""" '' '' O
Feels VBZ VBZ O
coincides NNS NNS O
with IN IN O
when WRB WRB O
he PRP PRP O
was VBD VBD O
hospitalized VBN VBN O
and CC CC O
meds NNS NNS O
then RB RB O
started VBD VBD O
. . . O
   
Also RB RB O
notes VBZ VBZ O
watery JJ JJ O
eyes NNS NNS O
x SYM SYM O
few JJ JJ O
months NNS NNS O
. . . O
   
WOnders NNP NNP O
whether IN IN O
this DT DT O
can MD MD O
be VB VB O
due JJ JJ O
to TO TO O
FLomax NNP NNP O
PMH NNP NNP O
: : : O
   
1 CD CD O
. . . O
NIDDM NNP NNP O
. . . O
   
Had NNP NNP O
had VBD VBD O
DM NNP NNP O
for IN IN O
& CC CC O
gt NN NN O
; : : O
   
15 CD CD O
yrs NN NN O
   
2 CD CD O
. . . O
HTN NNP NNP O
x SYM SYM O
yrs NN NN O
   
3 CD CD O
. . . O
Hyperlipidemia NNP NNP O
   
4 CD CD O
. . . O
BPH NNP NNP O
   
5 CD CD O
. . . O
Diverticulosis NNP NNP O
( ( ( O
noted VBD VBD O
on IN IN O
abd NN NN O
CT NNP NNP O
) ) ) O
   
6 CD CD O
. . . O
Basal NNP NNP O
cell NN NN O
carcinoma NN NN O
excisions NNS NNS O
on IN IN O
chest NN NN O
: : : O
followed VBN VBN O
by IN IN O
dermatologist NN NN O
   
7 CD CD O
. . . O
Carotids NNP NNP O
Stenosis NNP NNP O
   
8 CD CD O
. . . O
Claudication NNP NNP O
: : : O
walks VBZ VBZ O
a DT DT O
couple NN NN O
blocks NNS NNS O
before IN IN O
begins VBZ VBZ O
feeling NN NN O
cramps NNS NNS O
in IN IN O
leg NN NN O
   
9 CD CD O
. . . O
Glaucoma NNP NNP O
   
10 CD CD O
. . . O
Inguinal NNP NNP O
Hernia NNP NNP O
: : : O
9/93 CD CD I-DATE
pending VBG VBG O
surgery NN NN O
   
11 CD CD O
. . . O
? . . O
Ventral NNP NNP O
hernia NN NN O
12 CD CD O
: : : O
Depression NNP NNP O
13 CD CD O
: : : O
Psychosis NNP NNP O
14 CD CD O
: : : O
Insomnia NNP NNP O
Medications NNP NNP O
Aspirin NNP NNP O
( ( ( O
ACETYLSALICYLIC NNP NNP O
ACID NNP NNP O
) ) ) O
325 CD CD O
MG NNP NNP O
( ( ( O
325MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
) ) ) O
PO NNP NNP O
QD NNP NNP O
, , , O
on IN IN O
hold NN NN O
for IN IN O
hematuria NN NN O
3/02/2095 CD CD I-DATE
Brimonidine NNP NNP O
TARTRATE NNP NNP O
1 CD CD O
DROP NNP NNP O
( ( ( O
0.2 CD CD O
% NN NN O
DROPS NNP NNP O
) ) ) O
OU NNP NNP O
QAM NNP NNP O
Cilostazol NNP NNP O
100 CD CD O
MG NNP NNP O
( ( ( O
100MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
) ) ) O
PO NNP NNP O
BID NNP NNP O
, , , O
3/022095 CD CD I-DATE
on IN IN O
hold NN NN O
for IN IN O
hematuria NN NN O
#90 NN NN O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
Dulcolax NNP NNP O
( ( ( O
BISACODYL NNP NNP O
) ) ) O
5 CD CD O
MG NNP NNP O
( ( ( O
5MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Flomax NNP NNP O
( ( ( O
TAMSULOSIN NNP NNP O
) ) ) O
0.8 CD CD O
MG NNP NNP O
(0.4MG NN NN O
CAP.SR NNP NNP O
24H CD CD O
take NN NN O
2 CD CD O
) ) ) O
PO NNP NNP O
QPM NNP NNP O
x SYM SYM O
30 CD CD O
days NNS NNS O
#60 NN NN O
CAP.SR NNP NNP O
Glipizide NNP NNP O
2.5 CD CD O
MG NNP NNP O
( ( ( O
5MG CD CD O
TABLET NNP NNP O
take NN NN O
0.5 CD CD O
) ) ) O
PO NNP NNP O
bid NN NN O
, , , O
before IN IN O
BK NNP NNP O
and CC CC O
dinner NN NN O
Metoprolol NNP NNP O
TARTRATE NNP NNP O
12.5 CD CD O
MG NNP NNP O
( ( ( O
25MG CD CD O
TABLET NNP NNP O
take NN NN O
0.5 CD CD O
) ) ) O
PNGT NNP NNP O
BID NNP NNP O
x SYM SYM O
90 CD CD O
days NNS NNS O
#90 NN NN O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
Mvi NNP NNP O
( ( ( O
MULTIVITAMINS NNP NNP O
) ) ) O
1 CD CD O
TAB NNP NNP O
PO NNP NNP O
QD NNP NNP O
#1 NN NN O
Bottle NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
Norvasc NNP NNP O
( ( ( O
AMLODIPINE NNP NNP O
) ) ) O
10 CD CD O
MG NNP NNP O
( ( ( O
5MG CD CD O
TABLET NNP NNP O
take NN NN O
2 CD CD O
) ) ) O
PO NNP NNP O
QD NNP NNP O
#90 NN NN O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
Proscar NNP NNP O
( ( ( O
FINASTERIDE NNP NNP O
( ( ( O
BPH NNP NNP O
) ) ) O
) ) ) O
5 CD CD O
MG NNP NNP O
( ( ( O
5MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
) ) ) O
PO NNP NNP O
QD NNP NNP O
x SYM SYM O
30 CD CD O
days NNS NNS O
#30 NN NN O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
Psyllium NNP NNP O
PACKET NNP NNP O
take NN NN O
1 CD CD O
PO NNP NNP O
QD NNP NNP O
PRN NNP NNP O
Remeron NNP NNP O
( ( ( O
MIRTAZAPINE NNP NNP O
) ) ) O
15 CD CD O
MG NNP NNP O
( ( ( O
30MG CD CD O
TABLET NNP NNP O
take NN NN O
0.5 CD CD O
) ) ) O
PO NNP NNP O
QPM NNP NNP O
#90 NN NN O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
Sennosides NNP NNP O
1 CD CD O
TAB NNP NNP O
PO NNP NNP O
QD NNP NNP O
Zocor NNP NNP O
( ( ( O
SIMVASTATIN NNP NNP O
) ) ) O
80 CD CD O
MG NNP NNP O
( ( ( O
80MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
) ) ) O
PO NNP NNP O
QHS NNP NNP O
#90 NN NN O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
Zyprexa NNP NNP O
( ( ( O
OLANZAPINE NNP NNP O
) ) ) O
7.5 CD CD O
MG NNP NNP O
( ( ( O
5MG CD CD O
TABLET NNP NNP O
take NN NN O
1.5 CD CD O
) ) ) O
PO NNP NNP O
QD NNP NNP O
, , , O
Take NNP NNP O
1 CD CD O
tab NN NN O
at IN IN O
bedtime NN NN O
#90 NN NN O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
Allergies NNPS NNPS O
: : : O
NKDA NNP NNP O
Health NNP NNP O
Maintenance NNP NNP O
: : : O
   
1 CD CD O
. . . O
Pneumovax NNP NNP O
: : : O
Has VBZ VBZ O
had VBN VBN O
in IN IN O
past JJ JJ O
   
2 CD CD O
. . . O
Influenza NNP NNP O
Vaccine NNP NNP O
: : : O
Gets VBZ VBZ O
flu NN NN O
vaccine NN NN O
each DT DT O
year NN NN O
- - - O
got RP RP O
this DT DT O
year NN NN O
through IN IN O
FHV NNP NNP I-HOSPITAL
   
3 CD CD O
. . . O
Colonoscopy NNP NNP O
: : : O
Done VBN VBN O
in IN IN O
2094 CD CD I-DATE
showing VBG VBG O
only RB RB O
mild NN NN O
sigmoid NN NN O
tics NNS NNS O
   
4 CD CD O
. . . O
Pap NNP NNP O
test NN NN O
: : : O
n/a NN NN O
   
5 CD CD O
. . . O
Mammograms NNP NNP O
: : : O
n/a NN NN O
   
6 CD CD O
. . . O
Dex NNP NNP O
screening VBG VBG O
: : : O
never RB RB O
   
7 CD CD O
. . . O
Dental NNP NNP O
: : : O
Sees VBZ VBZ O
dentist NN NN O
Dr NNP NNP O
. . . O
Uecker NNP NNP I-DOCTOR
every DT DT O
few JJ JJ O
years NNS NNS O
   
8 CD CD O
. . . O
Opthalmologic NNP NNP O
: : : O
Sees VBZ VBZ O
yearly RB RB O
through IN IN O
FHV NNP NNP I-HOSPITAL
Functional NNP NNP O
Status NNP NNP O
: : : O
   
1 CD CD O
. . . O
ADLs NNP NNP O
: : : O
independent JJ JJ O
   
2 CD CD O
. . . O
IADLs NNP NNP O
: : : O
independent JJ JJ O
   
3 CD CD O
. . . O
Mobility NNP NNP O
: : : O
independent JJ JJ O
HCP NNP NNP O
: : : O
Wife NN NN O
, , , O
Ernestine NNP NNP I-PATIENT
is VBZ VBZ O
primary JJ JJ O
proxy NN NN O
. . . O
   
Alternative NNP NNP O
is VBZ VBZ O
daughter NN NN O
, , , O
Teresa NNP NNP I-PATIENT
Berry NNP NNP I-PATIENT
. . . O
   
PE NNP NNP O
: : : O
BP NNP NNP O
112/58 CD CD O
, , , O
P NN NN O
60 CD CD O
, , , O
RR NNP NNP O
16 CD CD O
, , , O
Temp NNP NNP O
96.9 CD CD O
F NN NN O
, , , O
Ht NNP NNP O
70 CD CD O
in IN IN O
, , , O
Wt NNP NNP O
208 CD CD O
lb NN NN O
BMI NNP NNP O
29.9 CD CD O
Gen NNP NNP O
: : : O
NAD NNP NNP O
, , , O
Ox3 NNP NNP O
, , , O
Alert NNP NNP O
, , , O
pleasant JJ JJ O
, , , O
normal JJ JJ O
affect NN NN O
, , , O
normal JJ JJ O
thought NN NN O
process NN NN O
and CC CC O
content NN NN O
, , , O
denies NNS NNS O
AH NNP NNP O
, , , O
VH NNP NNP O
, , , O
SI NNP NNP O
. . . O
   
HEENT NNP NNP O
: : : O
PERRL NNP NNP O
, , , O
JVP NNP NNP O
8cm CD CD O
Chest NN NN O
: : : O
CTA NNP NNP O
b/l NN NN O
Heart NNP NNP O
: : : O
RRR NNP NNP O
, , , O
normal JJ JJ O
s1 NN NN O
an DT DT O
s2 NN NN O
Abd NNP NNP O
: : : O
obese NN NN O
, , , O
distended VBD VBD O
, , , O
soft JJ JJ O
, , , O
no DT DT O
organomegaly NN NN O
Ext NNP NNP O
: : : O
No DT DT O
edema NN NN O
b/l NN NN O
, , , O
distal JJ JJ O
legs NNS NNS O
hairless NN NN O
, , , O
1 CD CD O
+ NN NN O
DP NNP NNP O
pulses NNS NNS O
b/l NN NN O
, , , O
venous JJ JJ O
stasis NN NN O
changes NNS NNS O
, , , O
no DT DT O
ulcers NNS NNS O
Skin NNP NNP O
: : : O
no DT DT O
rashes NNS NNS O
, , , O
no DT DT O
lesions NNS NNS O
Neuro NNP NNP O
: : : O
CN NNP NNP O
2-12 JJ JJ O
intact JJ JJ O
. . . O
   
Gait NNP NNP O
WNL NNP NNP O
Impression/Plan NNP NNP O
by IN IN O
issue NN NN O
: : : O
   
1 CD CD O
. . . O
Urinary NNP NNP O
retention NN NN O
: : : O
s/p NN NN O
successful JJ JJ O
TURP NNP NNP O
. . . O
   
on IN IN O
Flomax/Proscar NNP NNP O
. . . O
   
Likely NNP NNP O
does VBZ VBZ O
not RB RB O
need VB VB O
Proscar NNP NNP O
at IN IN O
this DT DT O
time NN NN O
per IN IN O
3/27 CD CD I-DATE
urology NN NN O
note NN NN O
. . . O
   
Will NNP NNP O
d/c NN NN O
. . . O
   
? . . O
need VBP VBP O
for IN IN O
FLomax NNP NNP O
s/p NN NN O
TURP NNP NNP O
given VBN VBN O
findings NNS NNS O
of IN IN O
weakness/runny JJ JJ O
eyes NNS NNS O
. . . O
   
WIll NNP NNP O
set VBD VBD O
up RP RP O
with IN IN O
Dr NNP NNP O
. . . O
Eastman NNP NNP I-DOCTOR
for IN IN O
f/u NN NN O
. . . O
   
2 CD CD O
. . . O
Depression NNP NNP O
: : : O
Appears VBZ VBZ O
fairly RB RB O
euthymic JJ JJ O
. . . O
   
Getting VBG VBG O
f/u NN NN O
thru NN NN O
Dr NNP NNP O
. . . O
Nobles NNP NNP I-DOCTOR
and CC CC O
FHV NNP NNP I-HOSPITAL
. . . O
   
Continue NNP NNP O
Remeron NNP NNP O
. . . O
   
PRN NNP NNP O
f/u NN NN O
with IN IN O
me PRP PRP O
if IN IN O
symptoms NNS NNS O
worsen NN NN O
-- : : O
have VBP VBP O
explained VBN VBN O
this DT DT O
to TO TO O
pt NN NN O
who WP WP O
agrees VBZ VBZ O
with IN IN O
plan NN NN O
. . . O
   
3 CD CD O
. . . O
Psychosis NNP NNP O
: : : O
No DT DT O
evidence NN NN O
currenlty NN NN O
. . . O
   
On IN IN O
Zyprexa NNP NNP O
, , , O
had VBD VBD O
been VBN VBN O
taking VBG VBG O
half NN NN O
of IN IN O
prescribed VBN VBN O
dose NN NN O
. . . O
   
Dose NNP NNP O
not RB RB O
want VBP VBP O
further RB RB O
increase VB VB O
at IN IN O
this DT DT O
time NN NN O
. . . O
   
Ok NN NN O
as IN IN O
w/o NN NN O
delusions/psychosis NN NN O
. . . O
   
4 CD CD O
. . . O
Weakness NNP NNP O
: : : O
Given VBN VBN O
low JJ JJ O
BP NNP NNP O
today NN NN O
, , , O
? . . O
relationship NN NN O
to TO TO O
low JJ JJ O
BP NNP NNP O
vs NNS NNS O
. . . O
polypharmacy NN NN O
. . . O
   
TSH/CBC NNP NNP O
today NN NN O
. . . O
   
D/c NNP NNP O
proscar NN NN O
. . . O
   
Hope NNP NNP O
to TO TO O
D/c NNP NNP O
FLomax NNP NNP O
in IN IN O
near JJ JJ O
future NN NN O
. . . O
   
5 CD CD O
. . . O
Runny NNP NNP O
eyes NNS NNS O
: : : O
? . . O
relation NN NN O
to TO TO O
FLomax NNP NNP O
. . . O
   
Hope VBP VBP O
to TO TO O
be VB VB O
able JJ JJ O
to TO TO O
stop VB VB O
s/p NN NN O
urology NN NN O
visit NN NN O
. . . O
   
No DT DT O
evidence NN NN O
bacterial JJ JJ O
conjunctivitis NNS NNS O
at IN IN O
this DT DT O
time NN NN O
. . . O
   
Ophthalmology NNP NNP O
visit NN NN O
. . . O
   
6 CD CD O
. . . O
Syncope NNP NNP O
: : : O
No DT DT O
further JJ JJ O
episodes NNS NNS O
. . . O
   
Getting VBG VBG O
f/u NN NN O
with IN IN O
cards NNS NNS O
for IN IN O
REVEAL NNP NNP O
interrogation NN NN O
. . . O
   
7 CD CD O
. . . O
Constipation NNP NNP O
: : : O
Resolved NNP NNP O
. . . O
   
Now RB RB O
with IN IN O
daily JJ JJ O
BMs NNP NNP O
. . . O
   
Have VBP VBP O
encouraged VBN VBN O
continued VBN VBN O
adherence NN NN O
to TO TO O
laxatives NNS NNS O
. . . O
   
NTD NNP NNP O
   
8 CD CD O
. . . O
Hernia NNP NNP O
: : : O
Repaired NNP NNP O
. . . O
   
No DT DT O
evidence NN NN O
of IN IN O
recurrence NN NN O
   
9 CD CD O
. . . O
CAD NNP NNP O
: : : O
No DT DT O
CP NNP NNP O
. . . O
   
continue VB VB O
ASA NNP NNP O
, , , O
BB NNP NNP O
, , , O
ACEI NNP NNP O
. . . O
   
CP NNP NNP O
free JJ JJ O
. . . O
   
NTD NNP NNP O
for IN IN O
now RB RB O
   
10 CD CD O
. . . O
PVD NNP NNP O
: : : O
stable JJ JJ O
symptoms NNS NNS O
. . . O
   
On IN IN O
full JJ JJ O
dose NN NN O
ASA NNP NNP O
. . . O
   
Pt NNP NNP O
not RB RB O
wanting VBG VBG O
further JJ JJ O
studies NNS NNS O
to TO TO O
characterize VB VB O
degree NN NN O
of IN IN O
disease NN NN O
at IN IN O
this DT DT O
time NN NN O
. . . O
   
11 CD CD O
. . . O
Hyperlipidemia NNP NNP O
: : : O
Previous JJ JJ O
fasting VBG VBG O
lipid NN NN O
panel NN NN O
with IN IN O
LDL NNP NNP O
   
51 CD CD O
. . . O
Old NNP NNP O
data NNS NNS O
-- : : O
will MD MD O
resend VB VB O
today NN NN O
. . . O
   
Sending NNP NNP O
LFTs NNP NNP O
as RB RB O
well RB RB O
. . . O
   
12 CD CD O
. . . O
DM NNP NNP O
: : : O
Recent JJ JJ O
A1c NNP NNP O
of IN IN O
6.7 CD CD O
. . . O
   
A1c NNP NNP O
today NN NN O
. . . O
   
13 CD CD O
. . . O
HTN NNP NNP O
: : : O
BP NNP NNP O
today NN NN O
WNL NNP NNP O
. . . O
   
No DT DT O
changes NNS NNS O
in IN IN O
medication NN NN O
today NN NN O
. . . O
   
14 CD CD O
. . . O
Hx NNP NNP O
elevated VBD VBD O
PSA NNP NNP O
: : : O
Hx NNP NNP O
of IN IN O
PSA NNP NNP O
~ NN NN O
9.5 CD CD O
. . . O
   
Has VBZ VBZ O
gotten VBN VBN O
biopsy NN NN O
at IN IN O
FHV NNP NNP I-HOSPITAL
, , , O
WNL NNP NNP O
. . . O
   
Bone NNP NNP O
scan JJ JJ O
WNL NNP NNP O
. . . O
   
Now RB RB O
s/p NN NN O
TURP NNP NNP O
. . . O
   
PSA NNP NNP O
today NN NN O
   
15 CD CD O
. . . O
Health NNP NNP O
maintenance NN NN O
: : : O
Pneumovax NNP NNP O
gotten VBN VBN O
thru NN NN O
FHV NNP NNP I-HOSPITAL
. . . O
   
Has VBZ VBZ O
had VBN VBN O
colo NN NN O
. . . O
   
16 CD CD O
. . . O
RTC NNP NNP O
in IN IN O
4 CD CD O
months NNS NNS O
, , , O
sooner RBR RBR O
PRN NNP NNP O
; : : O
   
will MD MD O
fax NN NN O
labs NNS NNS O
to TO TO O
Dr NNP NNP O
. . . O
Potts NNP NNP I-DOCTOR
at IN IN O
Florence NNP NNP I-HOSPITAL
Heights NNP NNP I-HOSPITAL
Village NNP NNP I-HOSPITAL
, , , O
phone NN NN O
668-508-1062 NN NN I-PHONE
; : : O
   
fasx JJ JJ O
534-184-9285 JJ JJ I-FAX
Yusuf NNP NNP I-DOCTOR
Lugo NNP NNP I-DOCTOR
, , , O
MD NNP NNP O
, , , O
42390 CD CD I-PHONE
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2095-01-31 NN NN I-DATE
TEAM NNP NNP O
2 CD CD O
ADMISSION NNP NNP O
NOTE NNP NNP O
Name NN NN O
: : : O
Victoria NNP NNP I-PATIENT
Justice NNP NNP I-PATIENT
MR NNP NNP O
#: NN NN O
3744922 CD CD I-MEDICALRECORD
Date NN NN O
of IN IN O
admission NN NN O
: : : O
1/30/2094 CD CD I-DATE
Attending NNP NNP O
: : : O
Dr NNP NNP O
. . . O
Ledford NNP NNP I-DOCTOR
PCP NNP NNP O
: : : O
Dr NNP NNP O
. . . O
Faith NNP NNP I-DOCTOR
Ice NNP NNP I-DOCTOR
History NN NN O
compiled VBD VBD O
from IN IN O
patient NN NN O
's POS POS O
record NN NN O
and CC CC O
son NN NN O
CC NNP NNP O
: : : O
altered VBN VBN O
mental JJ JJ O
status NN NN O
HPI NNP NNP O
: : : O
83yo CD CD O
female NN NN O
with IN IN O
a DT DT O
h/o NN NN O
dementia NN NN O
, , , O
HTN NNP NNP O
, , , O
DM NNP NNP O
, , , O
Afib NNP NNP O
, , , O
PMR NNP NNP O
, , , O
and CC CC O
chronic JJ JJ O
diarrhea NN NN O
sent VBD VBD O
from IN IN O
her PRP$ PRP$ O
assisted JJ JJ O
living NN NN O
facility NN NN O
for IN IN O
altered VBN VBN O
mental JJ JJ O
status NN NN O
and CC CC O
suspected VBD VBD O
UTI NNP NNP O
. . . O
   
Per IN IN O
the DT DT O
patient NN NN O
's POS POS O
son NN NN O
, , , O
the DT DT O
staff NN NN O
at IN IN O
her PRP$ PRP$ O
facility NN NN O
has VBZ VBZ O
noted VBN VBN O
the DT DT O
patient NN NN O
to TO TO O
be VB VB O
more JJR JJR O
confused VBN VBN O
over IN IN O
the DT DT O
last JJ JJ O
3 CD CD O
days NNS NNS O
. . . O
   
She PRP PRP O
has VBZ VBZ O
had VBN VBN O
more JJR JJR O
frequent JJ JJ O
episodes NNS NNS O
of IN IN O
fecal JJ JJ O
incontinence NN NN O
with IN IN O
soiling VBG VBG O
of IN IN O
her PRP$ PRP$ O
bed NN NN O
and CC CC O
carpet NN NN O
. . . O
   
Some DT DT O
blood NN NN O
was VBD VBD O
also RB RB O
noted VBN VBN O
in IN IN O
her PRP$ PRP$ O
toilet NN NN O
. . . O
   
Her PRP$ PRP$ O
son NN NN O
also RB RB O
reports NNS NNS O
that IN IN O
she PRP PRP O
has VBZ VBZ O
been VBN VBN O
less JJR JJR O
awake JJ JJ O
than IN IN O
usual JJ JJ O
and CC CC O
has VBZ VBZ O
had VBN VBN O
some DT DT O
congestion NN NN O
and CC CC O
coughing VBG VBG O
. . . O
   
She PRP PRP O
has VBZ VBZ O
had VBN VBN O
no DT DT O
fevers NNS NNS O
, , , O
chills NNS NNS O
, , , O
chest NN NN O
pain NN NN O
, , , O
sob NN NN O
, , , O
nausea NN NN O
, , , O
vomiting VBG VBG O
, , , O
or CC CC O
urinary JJ JJ O
symptoms NNS NNS O
. . . O
   
A DT DT O
urinalysis NN NN O
was VBD VBD O
reportedly RB RB O
positive JJ JJ O
at IN IN O
her PRP$ PRP$ O
assisted VBN VBN O
living VBG VBG O
facility NN NN O
and CC CC O
the DT DT O
patient NN NN O
was VBD VBD O
sent VBN VBN O
to TO TO O
the DT DT O
emergency NN NN O
department NN NN O
for IN IN O
further JJ JJ O
evaluation NN NN O
. . . O
   
At IN IN O
baseline NN NN O
, , , O
the DT DT O
patient NN NN O
is VBZ VBZ O
generally RB RB O
quite RB RB O
confused JJ JJ O
. . . O
   
She PRP PRP O
knows VBZ VBZ O
her PRP$ PRP$ O
name NN NN O
and CC CC O
often RB RB O
location NN NN O
but CC CC O
not RB RB O
the DT DT O
date/year NN NN O
and CC CC O
talks NNS NNS O
frequently RB RB O
of IN IN O
her PRP$ PRP$ O
late JJ JJ O
husband NN NN O
and CC CC O
parents NNS NNS O
whom WP WP O
she PRP PRP O
believes VBZ VBZ O
are VBP VBP O
still RB RB O
alive JJ JJ O
. . . O
   
Her PRP$ PRP$ O
assisted JJ JJ O
living NN NN O
facility NN NN O
has VBZ VBZ O
recently RB RB O
suggested VBN VBN O
that IN IN O
she PRP PRP O
be VB VB O
transferred VBN VBN O
to TO TO O
their PRP$ PRP$ O
higher JJR JJR O
level NN NN O
of IN IN O
care NN NN O
program NN NN O
. . . O
   
ED NNP NNP O
: : : O
T NN NN O
98.1 CD CD O
, , , O
P NN NN O
110 CD CD O
, , , O
R NN NN O
20 CD CD O
, , , O
BP NNP NNP O
130/56 CD CD O
, , , O
SaO2 NNP NNP O
98 CD CD O
% NN NN O
RA NNP NNP O
. . . O
   
She PRP PRP O
has VBZ VBZ O
dry JJ JJ O
MM NNP NNP O
. . . O
   
Lungs NNP NNP O
clear JJ JJ O
. . . O
   
Heart NNP NNP O
irregular NN NN O
. . . O
   
AAOx1 NNP NNP O
and CC CC O
otherwise RB RB O
nonfocal JJ JJ O
neuro NN NN O
exam NN NN O
. . . O
   
Her PRP$ PRP$ O
initial JJ JJ O
labs NNS NNS O
were VBD VBD O
notable JJ JJ O
for IN IN O
a DT DT O
Hct NNP NNP O
of IN IN O
44.6 CD CD O
which WDT WDT O
was VBD VBD O
34.5 CD CD O
on IN IN O
repeat NN NN O
. . . O
   
Rectal NNP NNP O
exam NN NN O
brown JJ JJ O
stool NN NN O
guaiac NN NN O
positive JJ JJ O
. . . O
   
CXR NNP NNP O
showed VBD VBD O
no DT DT O
sign NN NN O
of IN IN O
pneumonia NN NN O
. . . O
   
Urinalysis NNP NNP O
was VBD VBD O
negative JJ JJ O
for IN IN O
any DT DT O
signs NNS NNS O
of IN IN O
infection NN NN O
. . . O
   
Blood NNP NNP O
cultures NNS NNS O
were VBD VBD O
sent VBN VBN O
. . . O
   
The DT DT O
patient NN NN O
was VBD VBD O
treated VBN VBN O
with IN IN O
levofloxacin NN NN O
500mg CD CD O
po NN NN O
and CC CC O
3LNS CD CD O
, , , O
as RB RB O
well RB RB O
as IN IN O
many JJ JJ O
of IN IN O
her PRP$ PRP$ O
home NN NN O
meds NNS NNS O
, , , O
including VBG VBG O
Lopressor NNP NNP O
, , , O
Sotalol NNP NNP O
, , , O
prednisone NN NN O
, , , O
iron NN NN O
, , , O
thiamine NN NN O
, , , O
folic JJ JJ O
acid NN NN O
, , , O
mvi NN NN O
, , , O
calcium NN NN O
, , , O
glyburide NN NN O
, , , O
and CC CC O
effexor NN NN O
. . . O
   
Aspirin NNP NNP O
was VBD VBD O
held VBN VBN O
. . . O
   
She PRP PRP O
was VBD VBD O
transfused VBN VBN O
one CD CD O
unit NN NN O
of IN IN O
PRBCs NNP NNP O
and CC CC O
admitted VBN VBN O
to TO TO O
medicine VB VB O
for IN IN O
further JJ JJ O
evaluation NN NN O
. . . O
   
PMH NNP NNP O
: : : O
   
1 CD CD O
. . . O
Dementia NNP NNP O
   
2 CD CD O
. . . O
Paroxysmal NNP NNP O
atrial JJ JJ O
fibrillation NN NN O
   
3 CD CD O
. . . O
Hypertension NNP NNP O
   
4 CD CD O
. . . O
Diabetes NNP NNP O
   
5 CD CD O
. . . O
Hyperlipidemia NNP NNP O
   
6 CD CD O
. . . O
Depression NNP NNP O
   
7 CD CD O
. . . O
Polymyalgia NNP NNP O
rheumatica NN NN O
- : : O
dx NN NN O
1/91 CD CD I-DATE
. . . O
   
on IN IN O
steroids NNS NNS O
. . . O
   
8 CD CD O
. . . O
Chronic NNP NNP O
diarrhea NN NN O
- - - O
evaluated VBN VBN O
by IN IN O
GI NNP NNP O
in IN IN O
10/94 CD CD I-DATE
felt VBD VBD O
likely JJ JJ O
IBS NNP NNP O
and CC CC O
fecal JJ JJ O
incontinence NN NN O
   
9 CD CD O
. . . O
H/o NNP NNP O
Urosepsis NNP NNP O
- : : O
9/90 CD CD I-DATE
   
10 CD CD O
. . . O
H/o NNP NNP O
Diverticulitis NNP NNP O
- : : O
7/92 CD CD I-DATE
   
11 CD CD O
. . . O
Urinary NNP NNP O
incontinence NN NN O
: : : O
s/p NN NN O
sling VBG VBG O
procedure NN NN O
in IN IN O
4/91 CD CD I-DATE
; : : O
   
s/p NN NN O
3 CD CD O
prior RB RB O
bladder NN NN O
suspension NN NN O
sx NN NN O
   
12 CD CD O
. . . O
S/P NNP NNP O
rectocele NN NN O
repair NN NN O
   
13 CD CD O
. . . O
Peripheral NNP NNP O
neuropathy NN NN O
: : : O
unclear JJ JJ O
etiology NN NN O
   
14 CD CD O
. . . O
H/o NNP NNP O
Alcohol NNP NNP O
abuse NN NN O
Medications NNP NNP O
on IN IN O
admission NN NN O
( ( ( O
from IN IN O
ALF NNP NNP O
) ) ) O
: : : O
   
1 CD CD O
. . . O
aricept VBD VBD O
10mg CD CD O
po NN NN O
qd NN NN O
   
2 CD CD O
. . . O
digoxin NN NN O
0.125mg CD CD O
po NN NN O
qd NN NN O
   
3 CD CD O
. . . O
folic JJ JJ O
acid NN NN O
1mg CD CD O
po NN NN O
qd NN NN O
   
4 CD CD O
. . . O
nitrofurantoin NN NN O
100mg CD CD O
po NN NN O
qd NN NN O
   
5 CD CD O
. . . O
zocor NN NN O
80mg CD CD O
po NN NN O
qd NN NN O
   
6 CD CD O
. . . O
glyburide NN NN O
10mg CD CD O
po NN NN O
qd NN NN O
   
7 CD CD O
. . . O
prednisone NN NN O
5mg CD CD O
po NN NN O
qd NN NN O
   
8 CD CD O
. . . O
calcium NN NN O
600/D CD CD O
tid NN NN O
   
9 CD CD O
. . . O
thiamine NN NN O
100mg CD CD O
po NN NN O
qd NN NN O
   
10 CD CD O
. . . O
ferrous JJ JJ O
sulfate NN NN O
one CD CD O
tab NN NN O
po NN NN O
qd NN NN O
   
11 CD CD O
. . . O
MVI NNP NNP O
   
12 CD CD O
. . . O
asa NN NN O
325mg CD CD O
po NN NN O
qd NN NN O
   
13 CD CD O
. . . O
sotalol NN NN O
80mg CD CD O
po NN NN O
bid NN NN O
   
14 CD CD O
. . . O
effexor NN NN O
37.5 CD CD O
2 CD CD O
tabs NN NN O
po NN NN O
bid NN NN O
   
15 CD CD O
. . . O
lopressor NN NN O
50mg CD CD O
po NN NN O
tid NN NN O
ALL NNP NNP O
: : : O
Demerol NNP NNP O
SH NNP NNP O
: : : O
Lives NNS NNS O
in IN IN O
assisted VBN VBN O
living VBG VBG O
( ( ( O
Forest NNP NNP I-HOSPITAL
Hils NNP NNP I-HOSPITAL
) ) ) O
. . . O
   
Two CD CD O
sons NNS NNS O
involved VBN VBN O
. . . O
   
Never RB RB O
smoked VBD VBD O
. . . O
   
? . . O
h/o NN NN O
etoh NN NN O
abuse NN NN O
. . . O
   
FH NNP NNP O
: : : O
Family NNP NNP O
History NN NN O
: : : O
mother NN NN O
died VBD VBD O
at IN IN O
89 CD CD I-AGE
of IN IN O
"""" '' '' O
old JJ JJ O
age NN NN O
"""" '' '' O
; : : O
   
father NN NN O
died VBD VBD O
of IN IN O
unknown JJ JJ O
causes NNS NNS O
; : : O
   
no DT DT O
breast NN NN O
or CC CC O
colon NN NN O
ca NN NN O
; : : O
   
brother NN NN O
is VBZ VBZ O
s/p NN NN O
MI NNP NNP O
before IN IN O
age NN NN O
60 CD CD I-AGE
; : : O
   
+ NN NN O
DM NNP NNP O
. . . O
   
Physical JJ JJ O
Exam NNP NNP O
: : : O
V NNP NNP O
: : : O
T97.6, NNP NNP O
P NN NN O
73 CD CD O
, , , O
R NN NN O
18 CD CD O
, , , O
BP NNP NNP O
99/64 CD CD O
, , , O
97 CD CD O
% NN NN O
RA NNP NNP O
Gen NNP NNP O
: : : O
very RB RB O
pleasant JJ JJ O
but CC CC O
confused VBN VBN O
elderly JJ JJ O
female JJ JJ O
lying VBG VBG O
in IN IN O
bed NN NN O
comfortable JJ JJ O
HEENT NNP NNP O
: : : O
PERRL NNP NNP O
, , , O
EOMI NNP NNP O
, , , O
sclera NN NN O
anicteric JJ JJ O
, , , O
MMM NNP NNP O
Neck NNP NNP O
: : : O
Supple NNP NNP O
, , , O
no DT DT O
thyromegaly NN NN O
, , , O
no DT DT O
carotid NN NN O
bruits NNS NNS O
, , , O
JVP NNP NNP O
7cm CD CD O
Nodes NNS NNS O
: : : O
No DT DT O
cervical JJ JJ O
or CC CC O
supraclavicular JJ JJ O
LAN NNP NNP O
Cor NNP NNP O
: : : O
irregular NN NN O
, , , O
no DT DT O
murmur NN NN O
appreciated VBD VBD O
Chest NN NN O
: : : O
CTAB NNP NNP O
Abdomen NNP NNP O
: : : O
S/NT/ND NNP NNP O
, , , O
+ NN NN O
BS NNP NNP O
. . . O
   
No DT DT O
HSM NNP NNP O
, , , O
No DT DT O
CVA NNP NNP O
tenderness NN NN O
Ext NNP NNP O
: : : O
No DT DT O
C/C/E NNP NNP O
. . . O
   
Peripheral NNP NNP O
pulses NNS NNS O
intact JJ JJ O
. . . O
   
Skin NNP NNP O
: : : O
No DT DT O
rashes NNS NNS O
. . . O
   
Neuro NNP NNP O
: : : O
Able JJ JJ O
to TO TO O
tell VB VB O
me PRP PRP O
her PRP$ PRP$ O
name NN NN O
but CC CC O
not RB RB O
her PRP$ PRP$ O
date NN NN O
of IN IN O
birth NN NN O
or CC CC O
the DT DT O
current JJ JJ O
date NN NN O
. . . O
   
Knows VBZ VBZ O
she PRP PRP O
is VBZ VBZ O
in IN IN O
the DT DT O
hospital NN NN O
but CC CC O
not RB RB O
which WDT WDT O
one CD CD O
. . . O
   
Pleasantly RB RB O
involved VBN VBN O
in IN IN O
her PRP$ PRP$ O
own JJ JJ O
conversation NN NN O
. . . O
   
Says VBZ VBZ O
she PRP PRP O
lives VBZ VBZ O
in IN IN O
Arkansas NNP NNP I-STATE
with IN IN O
her PRP$ PRP$ O
late JJ JJ O
husband NN NN O
, , , O
a DT DT O
mechanic JJ JJ I-PROFESSION
. . . O
   
CNII-XII NNP NNP O
intact JJ JJ O
. . . O
   
Muscle NNP NNP O
strength NN NN O
5/5 CD CD O
and CC CC O
sensation NN NN O
intact JJ JJ O
throughout IN IN O
. . . O
   
DTRs NNP NNP O
2 CD CD O
+ NN NN O
. . . O
   
Babinski NNP NNP O
downgoing VBG VBG O
bilat NN NN O
. . . O
   
No DT DT O
asterixis NNS NNS O
. . . O
   
Labs NNP NNP O
and CC CC O
Studies NNPS NNPS O
: : : O
Test NNP NNP O
Name NN NN O
BMA NNP NNP I-HOSPITAL
BMA NNP NNP I-HOSPITAL
01/30/95 CD CD I-DATE
01/29/95 CD CD I-DATE
07:36 CD CD O
16:58 CD CD O
NA NNP NNP O
135 CD CD O
137 CD CD O
K NNP NNP O
3.7 CD CD O
3.5 CD CD O
CL NNP NNP O
107 CD CD O
103 CD CD O
CO2 NNP NNP O
24.3 CD CD O
26.8 CD CD O
BUN NNP NNP O
18 CD CD O
27(H) CD CD O
CRE NNP NNP O
0.8 CD CD O
0.9 CD CD O
GLU NNP NNP O
257(H) CD CD O
111(H) CD CD O
01/30/95 CD CD I-DATE
01/29/95 CD CD I-DATE
07:39 CD CD O
17:27 CD CD O
WBC NNP NNP O
9.4 CD CD O
10.8 CD CD O
RBC NNP NNP O
3.81(L) CD CD O
5.02 CD CD O
HGB NNP NNP O
11.7(L) CD CD O
15.4 CD CD O
HCT NNP NNP O
34.5(L) CD CD O
44.6 CD CD O
MCV NNP NNP O
90 CD CD O
89 CD CD I-AGE
MCH NNP NNP O
30.7 CD CD O
30.8 CD CD O
MCHC NNP NNP O
33.9 CD CD O
34.7 CD CD O
PLT NNP NNP O
419(H) CD CD O
491(H) CD CD O
RDW NNP NNP O
12.8 CD CD O
12.9 CD CD O
DIFFR NNP NNP O
Received NNP NNP O
Received NNP NNP O
METHOD NNP NNP O
Auto NNP NNP O
Auto NNP NNP O
% NN NN O
NEUT NNP NNP O
68 CD CD O
71(H) CD CD O
% NN NN O
LYMPH NNP NNP O
21(L) CD CD O
21(L) CD CD O
% NN NN O
MONO NNP NNP O
8 CD CD O
5 CD CD O
% NN NN O
EOS NNP NNP O
3 CD CD O
3 CD CD O
% NN NN O
BASO NNP NNP O
0 CD CD O
0 CD CD O
01/29/95 CD CD I-DATE
21:30 NN NN O
UA-GLUC NNP NNP O
Negative NNP NNP O
UA-KET NNP NNP O
1 CD CD O
+ NN NN O
UA-SPGR NNP NNP O
1.020 CD CD O
UA-BLD NNP NNP O
2 CD CD O
+ NN NN O
UA-PH NNP NNP O
5.0 CD CD O
UA-PROT NNP NNP O
Trace NNP NNP O
UA-NIT NNP NNP O
Negative NNP NNP O
UA-WBC NNP NNP O
Trace NNP NNP O
HCAST NNP NNP O
0-2 JJ JJ O
UAS-RBC NNP NNP O
20-50 JJ JJ O
UAS-WBC NNP NNP O
5-10 JJ JJ O
UAS-BACT NNP NNP O
Few JJ JJ O
UAS-SQHI NNP NNP O
Few JJ JJ O
Dig NNP NNP O
level NN NN O
0.3 CD CD O
Blood NNP NNP O
cx NN NN O
1/29/95 CD CD I-DATE
x2 NN NN O
NGTD NNP NNP O
urine NN NN O
cx NN NN O
1/29/95 CD CD I-DATE
NG NNP NNP O
CXR NNP NNP O
1/29/95 CD CD I-DATE
: : : O
minimal NN NN O
left VBD VBD O
basilar JJ JJ O
subsegmental JJ JJ O
atelectasis NN NN O
EKG NNP NNP O
: : : O
aflutter NN NN O
with IN IN O
variable JJ JJ O
block NN NN O
, , , O
no DT DT O
ischemic JJ JJ O
changes NNS NNS O
A/P NNP NNP O
: : : O
83 CD CD I-AGE
yo NN NN O
female JJ JJ O
with IN IN O
dementia NN NN O
, , , O
HTN NNP NNP O
, , , O
DM NNP NNP O
, , , O
AF NNP NNP O
, , , O
and CC CC O
PMR NNP NNP O
with IN IN O
worsening VBG VBG O
mental JJ JJ O
status NN NN O
over IN IN O
several JJ JJ O
days NNS NNS O
. . . O
   
Per IN IN O
report NN NN O
, , , O
her PRP$ PRP$ O
urinalysis NN NN O
was VBD VBD O
positive JJ JJ O
at IN IN O
her PRP$ PRP$ O
living VBG VBG O
facility NN NN O
, , , O
however RB RB O
there EX EX O
is VBZ VBZ O
no DT DT O
evidence NN NN O
of IN IN O
urinary JJ JJ O
or CC CC O
other JJ JJ O
infection NN NN O
now RB RB O
( ( ( O
now RB RB O
WBC NNP NNP O
or CC CC O
fever NN NN O
; : : O
   
CXR NNP NNP O
neg NN NN O
, , , O
Ucx/Blcx NNP NNP O
NG NNP NNP O
) ) ) O
. . . O
   
Suspect NNP NNP O
her PRP$ PRP$ O
altered JJ JJ O
mental JJ JJ O
status NN NN O
is VBZ VBZ O
secondary JJ JJ O
to TO TO O
progressive VB VB O
dementia NN NN O
and CC CC O
dehydration NN NN O
. . . O
   
The DT DT O
patient NN NN O
was VBD VBD O
also RB RB O
noted VBN VBN O
to TO TO O
have VB VB O
blood NN NN O
in IN IN O
her PRP$ PRP$ O
stool NN NN O
at IN IN O
home NN NN O
and CC CC O
a DT DT O
10 CD CD O
point NN NN O
Hct NNP NNP O
drop NN NN O
in IN IN O
the DT DT O
emergency NN NN O
department NN NN O
. . . O
   
While IN IN O
the DT DT O
patient NN NN O
did VBD VBD O
get VB VB O
3L CD CD O
of IN IN O
fluid NN NN O
in IN IN O
between IN IN O
which WDT WDT O
could MD MD O
cause VB VB O
dilutional JJ JJ O
anemia NN NN O
, , , O
given VBN VBN O
the DT DT O
patient NN NN O
's POS POS O
history NN NN O
of IN IN O
blood NN NN O
in IN IN O
stool NN NN O
and CC CC O
guaiac JJ JJ O
positivity NN NN O
, , , O
will MD MD O
work-up JJ JJ O
possible JJ JJ O
GI NNP NNP O
bleed NN NN O
. . . O
   
1 CD CD O
. . . O
Decreased NNP NNP O
Hct NNP NNP O
- : : O
GIB NNP NNP O
v. NN NN O
   
dilutional NN NN O
. . . O
   
Does VBZ VBZ O
have VB VB O
h/o VBN VBN O
diverticulitis NNS NNS O
. . . O
   
a. NN NN O
   
Serial NNP NNP O
Hcts NNP NNP O
q8 NN NN O
b. NN NN O
   
2 CD CD O
large JJ JJ O
bore NN NN O
IVs NNP NNP O
at IN IN O
all DT DT O
times NNS NNS O
c. NN NN O
   
Consider NNP NNP O
GI NNP NNP O
consult NN NN O
if IN IN O
Hct NNP NNP O
continues VBZ VBZ O
to TO TO O
drop VB VB O
for IN IN O
possible JJ JJ O
EGD/colonoscopy NNP NNP O
( ( ( O
although IN IN O
pt NN NN O
has VBZ VBZ O
had VBN VBN O
multiple JJ JJ O
unsuccessful JJ JJ O
colonoscopy NN NN O
attempts NNS NNS O
in IN IN O
past JJ JJ O
) ) ) O
d. NN NN O
   
Nexium NNP NNP O
40mg CD CD O
po NN NN O
qd NN NN O
   
2 CD CD O
. . . O
AMS NNP NNP O
- : : O
likely JJ JJ O
progressive JJ JJ O
dementia NN NN O
in IN IN O
setting VBG VBG O
of IN IN O
dehydration NN NN O
. . . O
   
a. NN NN O
   
F/u NNP NNP O
urine NN NN O
and CC CC O
blood NN NN O
cultures NNS NNS O
b. NN NN O
   
Hold NNP NNP O
antibiotics NNS NNS O
as IN IN O
no DT DT O
clear JJ JJ O
source NN NN O
of IN IN O
infection NN NN O
c. NN NN O
   
Check NNP NNP O
TSH NNP NNP O
, , , O
B12 NNP NNP O
, , , O
folate NN NN O
, , , O
LFTs NNP NNP O
, , , O
lytes NNS NNS O
d. NN NN O
   
Hydrated NNP NNP O
in IN IN O
ED NNP NNP O
e. NN NN O
   
Check NNP NNP O
head NN NN O
CT NNP NNP O
f. NN NN O
   
Attempt NNP NNP O
to TO TO O
wean VB VB O
effexor NN NN O
; : : O
   
consult NN NN O
geri-psych JJ JJ O
per IN IN O
attending VBG VBG O
   
3 CD CD O
. . . O
Rhythm NNP NNP O
- : : O
has VBZ VBZ O
h/o NN NN O
afib NN NN O
and CC CC O
SVT NNP NNP O
, , , O
now RB RB O
in IN IN O
aflutter NN NN O
with IN IN O
variable JJ JJ O
block NN NN O
. . . O
   
HR NNP NNP O
goes VBZ VBZ O
up RB RB O
with IN IN O
activity NN NN O
and CC CC O
when WRB WRB O
due JJ JJ O
for IN IN O
meds NNS NNS O
. . . O
   
a. NN NN O
   
Cont NNP NNP O
lopressor NN NN O
, , , O
sotalol NN NN O
, , , O
digoxin NN NN O
b. NN NN O
   
Hold NNP NNP O
aspirin NN NN O
for IN IN O
possible JJ JJ O
GIB NNP NNP O
c. NN NN O
   
Telemetry NNP NNP O
monitoring VBG VBG O
   
4 CD CD O
. . . O
Hyperlipidemia NNP NNP O
- : : O
statin NN NN O
recently RB RB O
increased VBD VBD O
a. NN NN O
   
Check NNP NNP O
fasting VBG VBG O
lipids NNS NNS O
b. NN NN O
   
LFTs NNP NNP O
   
5 CD CD O
. . . O
Diabetes NNP NNP O
- : : O
glyburide NN NN O
recently RB RB O
increased VBD VBD O
. . . O
   
Will NNP NNP O
hold VB VB O
for IN IN O
now RB RB O
in IN IN O
case NN NN O
needs VBZ VBZ O
to TO TO O
be VB VB O
NPO NNP NNP O
. . . O
   
a. NN NN O
   
RISS NNP NNP O
coverage NN NN O
b. NN NN O
   
Check NNP NNP O
HbA1c NNP NNP O
   
6 CD CD O
. . . O
PMR NNP NNP O
- : : O
Cont NNP NNP O
Prednisone NNP NNP O
5mg CD CD O
po NN NN O
qd NN NN O
; : : O
   
would MD MD O
like VB VB O
to TO TO O
try VB VB O
to TO TO O
taper VB VB O
if IN IN O
possible JJ JJ O
   
7 CD CD O
. . . O
FEN NNP NNP O
- : : O
appears VBZ VBZ O
euvolemic JJ JJ O
now RB RB O
. . . O
   
Diabetic NNP NNP O
diet NN NN O
. . . O
   
8 CD CD O
. . . O
Prophy NNP NNP O
- : : O
no DT DT O
fragmin/heparin NN NN O
. . . O
   
Pneumoboots NNP NNP O
. . . O
   
Nexium NNP NNP O
. . . O
   
9 CD CD O
. . . O
Dispo NNP NNP O
- : : O
consult NN NN O
physical JJ JJ O
therapy NN NN O
   
10 CD CD O
. . . O
Code NNP NNP O
- : : O
FULL NNP NNP O
CODE NNP NNP O
, , , O
discussion NN NN O
with IN IN O
son NN NN O
________________________________________________________________ NN NN O
_ NN NN O
Emmerson NNP NNP I-DOCTOR
F. NN NN I-DOCTOR
Carpenter NNP NNP I-DOCTOR
, , , O
MD NNP NNP O
Pager NNP NNP O
40987 CD CD I-PHONE
PGY-1 NNP NNP O
Medicine NNP NNP O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2084-06-12 JJ JJ I-DATE
VIGIL NNP NNP O
, , , O
ANTHONY NNP NNP I-PATIENT
40984972 CD CD I-MEDICALRECORD
06/12/2084 CD CD I-DATE
Joshua NNP NNP I-DOCTOR
A. NN NN I-DOCTOR
Root NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
   
Nutfield NNP NNP I-HOSPITAL
Surgicenter NNP NNP I-HOSPITAL
980 CD CD I-STREET
Westwood NNP NNP I-STREET
Dr NNP NNP I-STREET
, , , O
Suite NNP NNP O
8466 CD CD O
Bangkok NNP NNP I-CITY
, , , O
NJ NNP NNP I-STATE
53591 CD CD I-ZIP
Dear RB RB O
Dr NNP NNP I-STREET
. . . O
Root NNP NNP I-DOCTOR
: : : O
We PRP PRP O
had VBD VBD O
the DT DT O
pleasure NN NN O
of IN IN O
seeing VBG VBG O
this DT DT O
patient NN NN O
today NN NN O
in IN IN O
followup NN NN O
of IN IN O
his PRP$ PRP$ O
transplant NN NN O
of IN IN O
03/25/2084 CD CD I-DATE
. . . O
   
He PRP PRP O
is VBZ VBZ O
doing VBG VBG O
quite RB RB O
well RB RB O
. . . O
   
There EX EX O
are VBP VBP O
no DT DT O
exertional JJ JJ O
complaints NNS NNS O
of IN IN O
dyspnea NN NN O
or CC CC O
chest NN NN O
discomfort NN NN O
. . . O
   
He PRP PRP O
is VBZ VBZ O
taking VBG VBG O
his PRP$ PRP$ O
medications NNS NNS O
without IN IN O
problems NNS NNS O
and CC CC O
denies NNS NNS O
fever RB RB O
, , , O
cough NN NN O
, , , O
rash NN NN O
or CC CC O
diarrhea NN NN O
. . . O
   
He PRP PRP O
tells VBZ VBZ O
me PRP PRP O
his PRP$ PRP$ O
blood NN NN O
pressures NNS NNS O
at IN IN O
home NN NN O
are VBP VBP O
as RB RB O
high JJ JJ O
as IN IN O
140-160 JJ JJ O
in IN IN O
the DT DT O
morning NN NN O
systolic JJ JJ O
dropping NN NN O
to TO TO O
the DT DT O
130 CD CD O
systolic JJ JJ O
in IN IN O
the DT DT O
evenings NNS NNS O
. . . O
   
His PRP$ PRP$ O
current JJ JJ O
medications NNS NNS O
are VBP VBP O
unchanged JJ JJ O
and CC CC O
include VBP VBP O
Neoral NNP NNP O
125 CD CD O
mg NN NN O
b.i.d. NN NN O
, , , O
prednisone NN NN O
15 CD CD O
mg NN NN O
daily JJ JJ O
, , , O
CellCept NNP NNP O
1 CD CD O
g SYM SYM O
b.i.d. NN NN O
, , , O
aspirin NN NN O
325 CD CD O
mg NN NN O
daily JJ JJ O
, , , O
Bactrim NNP NNP O
double JJ JJ O
strength NN NN O
one CD CD O
tablet NN NN O
every DT DT O
other JJ JJ O
day NN NN O
, , , O
calcium NN NN O
and CC CC O
vitamin NN NN O
D NNP NNP O
one CD CD O
tablet NN NN O
b.i.d. NN NN O
, , , O
diltiazem NN NN O
CD NNP NNP O
240 CD CD O
mg NN NN O
q. NN NN O
   
a.m. NN NN O
and CC CC O
120 CD CD O
q. NN NN O
   
p.m. NN NN O
, , , O
Lantus NNP NNP O
Insulin NNP NNP O
20 CD CD O
units NNS NNS O
at IN IN O
bedtime NN NN O
, , , O
magnesium NN NN O
gluconate NN NN O
500 CD CD O
mg NN NN O
b.i.d. NN NN O
, , , O
multivitamin NN NN O
daily RB RB O
, , , O
Neurontin NNP NNP O
100 CD CD O
mg NN NN O
t.i.d. NN NN O
, , , O
NovoLog NNP NNP O
insulin NN NN O
p.r.n. NN NN O
, , , O
nystatin NN NN O
elixir NN NN O
5 CD CD O
mL NN NN O
q.i.d. NN NN O
, , , O
omeprazole NN NN O
40 CD CD O
mg NN NN O
daily JJ JJ O
, , , O
Valcyte NNP NNP O
450 CD CD O
mg NN NN O
daily JJ JJ O
, , , O
vitamin NN NN O
C NNP NNP O
500 CD CD O
mg NN NN O
b.i.d. NN NN O
, , , O
and CC CC O
vitamin NN NN O
E NNP NNP O
400 CD CD O
mg NN NN O
b.i.d. NN NN O
   
On IN IN O
exam NN NN O
, , , O
he PRP PRP O
looks VBZ VBZ O
great JJ JJ O
. . . O
   
His PRP$ PRP$ O
blood NN NN O
pressure NN NN O
is VBZ VBZ O
166/98 CD CD O
initially RB RB O
, , , O
148/82 CD CD O
on IN IN O
repeat NN NN O
. . . O
   
His PRP$ PRP$ O
heart NN NN O
rate NN NN O
is VBZ VBZ O
110 CD CD O
. . . O
   
He PRP PRP O
weighs VBZ VBZ O
163 CD CD O
pounds NNS NNS O
. . . O
   
His PRP$ PRP$ O
head NN NN O
and CC CC O
neck NN NN O
examination NN NN O
is VBZ VBZ O
unremarkable JJ JJ O
. . . O
   
His PRP$ PRP$ O
venous JJ JJ O
pressures NNS NNS O
are VBP VBP O
less JJR JJR O
than IN IN O
7 CD CD O
cm NN NN O
of IN IN O
water NN NN O
. . . O
   
The DT DT O
lungs NNS NNS O
are VBP VBP O
clear JJ JJ O
. . . O
   
The DT DT O
cardiac JJ JJ O
exam NN NN O
reveals VBZ VBZ O
a DT DT O
tachycardic JJ JJ O
rhythm NN NN O
with IN IN O
no DT DT O
rub NN NN O
, , , O
murmur NN NN O
or CC CC O
gallop NN NN O
. . . O
   
The DT DT O
abdomen NN NN O
is VBZ VBZ O
unremarkable JJ JJ O
. . . O
   
His PRP$ PRP$ O
numerous JJ JJ O
surgical JJ JJ O
wounds NNS NNS O
are VBP VBP O
well RB RB O
healed VBN VBN O
. . . O
   
His PRP$ PRP$ O
extremities NNS NNS O
are VBP VBP O
warm JJ JJ O
without IN IN O
edema NN NN O
. . . O
   
Electrocardiography NNP NNP O
is VBZ VBZ O
notable JJ JJ O
for IN IN O
sinus JJ JJ O
tachycardia NNS NNS O
at IN IN O
108 CD CD O
beats NNS NNS O
per IN IN O
minute NN NN O
, , , O
some DT DT O
nonspecific JJ JJ O
ST NNP NNP O
changes NNS NNS O
. . . O
   
He PRP PRP O
underwent JJ JJ O
right JJ JJ O
heart NN NN O
catheterization NN NN O
and CC CC O
biopsy NN NN O
today NN NN O
. . . O
   
His PRP$ PRP$ O
right JJ JJ O
atrial JJ JJ O
pressure NN NN O
was VBD VBD O
   
5 CD CD O
. . . O
His PRP$ PRP$ O
wedge NN NN O
pressure NN NN O
was VBD VBD O
   
17 CD CD O
. . . O
His PRP$ PRP$ O
PA NNP NNP O
pressures NNS NNS O
were VBD VBD O
40/20 CD CD O
with IN IN O
a DT DT O
mean NN NN O
of IN IN O
   
30 CD CD O
. . . O
The DT DT O
biopsy NN NN O
results NNS NNS O
are VBP VBP O
pending VBG VBG O
at IN IN O
the DT DT O
time NN NN O
of IN IN O
this DT DT O
dictation NN NN O
. . . O
   
In IN IN O
summary NN NN O
, , , O
the DT DT O
patient NN NN O
is VBZ VBZ O
doing VBG VBG O
well RB RB O
now RB RB O
six CD CD O
weeks NNS NNS O
after IN IN O
cardiac JJ JJ O
transplantation NN NN O
. . . O
   
We PRP PRP O
will MD MD O
be VB VB O
making VBG VBG O
changes NNS NNS O
to TO TO O
his PRP$ PRP$ O
immunosuppressive JJ JJ O
regimen NNS NNS O
as IN IN O
dictated VBN VBN O
by IN IN O
the DT DT O
results NNS NNS O
of IN IN O
his PRP$ PRP$ O
blood NN NN O
work NN NN O
and CC CC O
biopsy NN NN O
. . . O
   
It PRP PRP O
is VBZ VBZ O
very RB RB O
gratifying VBG VBG O
to TO TO O
see VB VB O
how WRB WRB O
well RB RB O
he PRP PRP O
is VBZ VBZ O
doing VBG VBG O
. . . O
   
We PRP PRP O
will MD MD O
be VB VB O
sure JJ JJ O
to TO TO O
update VB VB O
you PRP PRP O
on IN IN O
a DT DT O
regular JJ JJ O
basis NN NN O
. . . O
   
Sincerely NNP NNP O
, , , O
_____________________________ NN NN O
_ NN NN O
Glenn NNP NNP I-DOCTOR
V NNP NNP I-DOCTOR
Baxter NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
eScription NN NN O
document:2-6397786 JJ JJ O
SFFocus NNP NNP O
CC NNP NNP O
: : : O
Amir NNP NNP I-DOCTOR
Naranjo NNP NNP I-DOCTOR
M.D. NNP NNP O
   
Boys NNP NNP I-HOSPITAL
Town NNP NNP I-HOSPITAL
National NNP NNP I-HOSPITAL
Research NNP NNP I-HOSPITAL
Hospital NNP NNP I-HOSPITAL
3 CD CD I-STREET
Kelly NNP NNP I-STREET
Street NNP NNP I-STREET
Bangkok NNP NNP I-CITY
, , , O
NJ NNP NNP I-STATE
53591 CD CD I-ZIP
DD NNP NNP O
: : : O
06/12/84 CD CD I-DATE
DT NNP NNP O
: : : O
06/12/84 CD CD I-DATE
DV NNP NNP O
: : : O
06/12/84 CD CD I-DATE
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2071-04-11 JJ JJ I-DATE
Burn NNP NNP O
Surgery NNP NNP O
Admission NNP NNP O
H&P NNP NNP O
Date/Time NNP NNP O
: : : O
4/11/71 CD CD I-DATE
, , , O
9am CD CD O
**************************************************** NN NN O
Name NN NN O
: : : O
Rivers NNP NNP O
, , , O
Karsten NNP NNP I-PATIENT
MRN NNP NNP O
# # # O
95718084 CD CD I-MEDICALRECORD
Resident NNP NNP O
: : : O
Gillis NNP NNP I-DOCTOR
Attending NNP NNP O
: : : O
Michael NNP NNP I-DOCTOR
**************************************************** NN NN O
CC NNP NNP O
: : : O
burn VB VB O
to TO TO O
R NNP NNP O
foot NN NN O
HPI NNP NNP O
: : : O
44yo CD CD O
diabetic JJ JJ O
M NNP NNP O
with IN IN O
peripheral JJ JJ O
neuropathy NN NN O
, , , O
fell VBD VBD O
asleep RB RB O
in IN IN O
front NN NN O
of IN IN O
space NN NN O
heater NN NN O
approximately RB RB O
3 CD CD O
weeks NNS NNS O
ago RB RB O
and CC CC O
noted VBD VBD O
swelling/blisters NNS NNS O
at IN IN O
tips NNS NNS O
of IN IN O
R NNP NNP O
1st-3rd JJ JJ O
toes NNS NNS O
upon IN IN O
waking VBG VBG O
. . . O
   
His PRP$ PRP$ O
wounds NNS NNS O
have VBP VBP O
been VBN VBN O
managed VBN VBN O
until IN IN O
this DT DT O
time NN NN O
by IN IN O
his PRP$ PRP$ O
podiatrist NN NN O
and CC CC O
his PRP$ PRP$ O
mother NN NN O
( ( ( O
a DT DT O
former JJ JJ O
doctor NN NN I-PROFESSION
) ) ) O
has VBZ VBZ O
been VBN VBN O
doing VBG VBG O
dressing VBG VBG O
changes NNS NNS O
at IN IN O
home NN NN O
- : : O
initially RB RB O
with IN IN O
silvadene NN NN O
but CC CC O
over IN IN O
the DT DT O
past JJ JJ O
several JJ JJ O
days NNS NNS O
with IN IN O
? . . O
betadine NN NN O
as IN IN O
directed VBN VBN O
by IN IN O
his PRP$ PRP$ O
podiatrist NN NN O
. . . O
   
The DT DT O
pt NN NN O
is VBZ VBZ O
a DT DT O
floor NN NN I-PROFESSION
covering VBG VBG I-PROFESSION
installer NN NN I-PROFESSION
, , , O
and CC CC O
has VBZ VBZ O
been VBN VBN O
bearing VBG VBG O
weight NN NN O
on IN IN O
the DT DT O
R NNP NNP O
foot NN NN O
since IN IN O
his PRP$ PRP$ O
injury NN NN O
and CC CC O
admits NNS NNS O
that IN IN O
he PRP PRP O
has VBZ VBZ O
not RB RB O
been VBN VBN O
compliant JJ JJ O
wearing VBG VBG O
a DT DT O
heel NN NN O
boot NN NN O
. . . O
   
He PRP PRP O
has VBZ VBZ O
not RB RB O
had VBN VBN O
fever/chills NNS NNS O
, , , O
nausea/emesis NNS NNS O
and CC CC O
in IN IN O
general JJ JJ O
feels VBZ VBZ O
well RB RB O
. . . O
   
He PRP PRP O
has VBZ VBZ O
not RB RB O
had VBN VBN O
pain NN NN O
in IN IN O
the DT DT O
foot NN NN O
, , , O
but CC CC O
does VBZ VBZ O
have VB VB O
a DT DT O
significant JJ JJ O
neuropathy NN NN O
. . . O
   
His PRP$ PRP$ O
podiatrist NN NN O
recommended VBD VBD O
that IN IN O
he PRP PRP O
be VB VB O
evaluated VBN VBN O
by IN IN O
plastic/burn NN NN O
surgery NN NN O
and CC CC O
he PRP PRP O
presents VBZ VBZ O
to TO TO O
burn VB VB O
clinic NN NN O
for IN IN O
further JJ JJ O
evaluation NN NN O
. . . O
   
-- : : O
PMHx NNP NNP O
: : : O
NIDDM NNP NNP O
HTN NNP NNP O
dyslipidemia NN NN O
PSHx NNP NNP O
: : : O
R NN NN O
shoulder NN NN O
L NNP NNP O
hip NN NN O
umbilical JJ JJ O
hernia NN NN O
Meds NNP NNP O
: : : O
toprol NN NN O
xl NN NN O
100 CD CD O
qd NN NN O
glucophage NN NN O
1000 CD CD O
bid NN NN O
neurontin NN NN O
400 CD CD O
bid NN NN O
minoxidil NN NN O
10 CD CD O
qd NN NN O
lipitor NN NN O
20 CD CD O
qd NN NN O
lasix NN NN O
20 CD CD O
qd NN NN O
avalide NN NN O
300/12.5 CD CD O
qd NN NN O
ASA NNP NNP O
81 CD CD O
qd NN NN O
cipro NN NN O
500 CD CD O
bid NN NN O
All DT DT O
: : : O
Augmentin NNP NNP O
- - - O
rash NN NN O
SHx NNP NNP O
: : : O
smoker NN NN O
-- : : O
PE NNP NNP O
: : : O
General NNP NNP O
: : : O
AOx3 NNP NNP O
, , , O
NAD NNP NNP O
Chest NN NN O
: : : O
CTA NNP NNP O
B NNP NNP O
Heart NNP NNP O
: : : O
RRR NNP NNP O
Abdomen NNP NNP O
: : : O
obese NN NN O
, , , O
NT/ND NNP NNP O
Extremities NNP NNP O
: : : O
wwp NN NN O
, , , O
+ NN NN O
3rd CD CD O
degree NN NN O
burns NNS NNS O
with IN IN O
areas NNS NNS O
of IN IN O
grey JJ JJ O
eschar NN NN O
at IN IN O
tips NNS NNS O
of IN IN O
1st-3rd JJ JJ O
toes NNS NNS O
on IN IN O
R NNP NNP O
extending VBG VBG O
to TO TO O
plantar VB VB O
surfaces VBZ VBZ O
; : : O
   
some DT DT O
areas NNS NNS O
of IN IN O
pink JJ JJ O
granulating VBG VBG O
tissue NN NN O
. . . O
   
+ NN NN O
surrounding VBG VBG O
erythema NN NN O
- - - O
does VBZ VBZ O
not RB RB O
extend VB VB O
beyond IN IN O
toes NNS NNS O
onto IN IN O
foot NN NN O
, , , O
most RBS RBS O
significant JJ JJ O
on IN IN O
3rd CD CD O
toe NN NN O
. . . O
   
+ NN NN O
wound NN NN O
on IN IN O
lat NN NN O
surface NN NN O
of IN IN O
4th CD CD O
toe NN NN O
( ( ( O
site NN NN O
of IN IN O
recent JJ JJ O
corn NN NN O
removal NN NN O
per IN IN O
pt NN NN O
) ) ) O
- : : O
clean VB VB O
with IN IN O
no DT DT O
erythema/drainage NN NN O
Pulses NNP NNP O
: : : O
dp/pt NN NN O
2 CD CD O
+ NN NN O
bilaterally RB RB O
-- : : O
Labs NNP NNP O
: : : O
pending VBG VBG O
EKG NNP NNP O
: : : O
pending VBG VBG O
-- : : O
Imaging NNP NNP O
: : : O
CXR NNP NNP O
: : : O
pending VBG VBG O
-- : : O
Assessment NNP NNP O
: : : O
44yo CD CD O
M NNP NNP O
with IN IN O
3rd CD CD O
degree NN NN O
burn NN NN O
to TO TO O
R NNP NNP O
1st/2nd/3rd CD CD O
toes NNS NNS O
and CC CC O
superimposed VBD VBD O
cellulitis NNS NNS O
. . . O
   
-- : : O
Plan NNP NNP O
: : : O
Admit NNP NNP O
to TO TO O
Michael/burn NNP NNP O
service NN NN O
triple JJ JJ O
abx NN NN O
, , , O
leg NN NN O
elevation NN NN O
at IN IN O
all DT DT O
times NNS NNS O
, , , O
NWB NNP NNP O
RLE NNP NNP O
dressing VBG VBG O
changes NNS NNS O
with IN IN O
silvadine/gauze NN NN O
bid NN NN O
OR CC CC O
for IN IN O
debridement/possible JJ JJ O
grafting NN NN O
when WRB WRB O
celluliltis NN NN O
improves VBZ VBZ O
; : : O
   
f/u NN NN O
labs NNS NNS O
, , , O
UA NNP NNP O
, , , O
CXR NNP NNP O
, , , O
EKG NNP NNP O
-- : : O
D/W NNP NNP O
Dr NNP NNP O
. . . O
Michael NNP NNP I-DOCTOR
, , , O
who WP WP O
agrees VBZ VBZ O
with IN IN O
assessment NN NN O
and CC CC O
plan NN NN O
. . . O
   
-- : : O
Julia NNP NNP I-DOCTOR
Gillis NNP NNP I-DOCTOR
MD NNP NNP O
50741 CD CD I-PHONE
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2099-01-06 JJ JJ I-DATE
Chief NNP NNP O
Complaint NNP NNP O
annual JJ JJ O
, , , O
menopausal NN NN O
vaginal JJ JJ O
atrophy NN NN O
Last JJ JJ O
Pap NNP NNP O
: : : O
2096 CD CD I-DATE
Last NNP NNP O
Mammogram NNP NNP O
: : : O
9/98 CD CD I-DATE
WNL NNP NNP O
LMP NNP NNP O
: : : O
2096 CD CD I-DATE
Last NNP NNP O
Bone NNP NNP O
Density NNP NNP O
: : : O
6/98 CD CD I-DATE
- : : O
t-1.80 JJ JJ O
Contraception NNP NNP O
: : : O
Abstinence NNP NNP O
unable JJ JJ O
to TO TO O
have VB VB O
intercourse NN NN O
Past JJ JJ O
History NN NN O
--- : : O
Menstrual NNP NNP O
History NN NN O
--- : : O
menopausal NN NN O
, , , O
no DT DT O
PMB NNP NNP O
Abnormal NNP NNP O
Paps NNP NNP O
: : : O
s/p NN NN O
CKC NNP NNP O
2060s CD CD I-DATE
STD NNP NNP O
's POS POS O
: : : O
None NN NN O
Problems NNS NNS O
Diabetes NNP NNP O
mellitus JJ JJ O
CAD NNP NNP O
s/p NN NN O
quadruple NN NN O
bypass NN NN O
2096 CD CD I-DATE
s/p NN NN O
E.coli NNP NNP O
sepsis NN NN O
2096 CD CD I-DATE
ARDS NNP NNP O
/ NN NN O
Seizures NNP NNP O
requiring VBG VBG O
extended VBN VBN O
MICU NNP NNP O
stay NN NN O
, , , O
colostomy NN NN O
SVC NNP NNP O
thromobosis NN NN O
2096 CD CD I-DATE
s/p NN NN O
sternal JJ JJ O
oseomyelitis NN NN O
w NN NN O
/ NN NN O
graft NN NN O
2096 CD CD I-DATE
s/p NN NN O
cold-knife NN NN O
cone NN NN O
in IN IN O
2060s CD CD I-DATE
s/p NN NN O
partial JJ JJ O
thyroidectomy NN NN O
Medication NNP NNP O
list NN NN O
: : : O
: : : O
MVI NNP NNP O
, , , O
CA+D NNP NNP O
, , , O
fossamax NN NN O
, , , O
prograf NN NN O
, , , O
cellcept NN NN O
, , , O
prednisone NN NN O
, , , O
nexxium NN NN O
, , , O
ASA NNP NNP O
, , , O
lipitor NN NN O
, , , O
Toprol NNP NNP O
XL NNP NNP O
, , , O
coumadin NN NN O
, , , O
insulin NN NN O
Physical JJ JJ O
Exam NNP NNP O
General NNP NNP O
Appearance NNP NNP O
: : : O
NL NNP NNP O
Habitus NNP NNP O
Neck NNP NNP O
: : : O
Normal NNP NNP O
Thyroid NNP NNP O
: : : O
Normal JJ JJ O
Resp NNP NNP O
. . . O
   
Effort NNP NNP O
: : : O
Normal JJ JJ O
Ausc NNP NNP O
. . . O
   
Lungs NNP NNP O
: : : O
Normal JJ JJ O
Ausc NNP NNP O
. . . O
   
Heart NNP NNP O
: : : O
Abnormal NNP NNP O
2/6 CD CD O
SEM NNP NNP O
Abdomen NNP NNP O
: : : O
Abnormal NNP NNP O
colostomy NN NN O
, , , O
benign NN NN O
Liver/Spleen NNP NNP O
: : : O
Normal NNP NNP O
Neck NNP NNP O
: : : O
Normal NNP NNP O
Axilla NNP NNP O
: : : O
Normal NNP NNP O
+ NN NN O
costochondritis NNS NNS O
Mood NNP NNP O
and CC CC O
Affect NNP NNP O
: : : O
Normal JJ JJ O
Breasts NNP NNP O
: : : O
Normal JJ JJ O
Ext NNP NNP O
. . . O
   
Genitalia NNP NNP O
: : : O
Normal JJ JJ O
Ureth NNP NNP O
Meatus NNP NNP O
: : : O
Normal NNP NNP O
Bladder NNP NNP O
: : : O
Normal JJ JJ O
Vagina/pelv NNP NNP O
. . . O
   
supp NN NN O
: : : O
Abnormal NNP NNP O
atrophic JJ JJ O
, , , O
very RB RB O
painful JJ JJ O
, , , O
pt NN NN O
could MD MD O
n't RB RB O
tolerate VB VB O
exam NN NN O
Assessment NNP NNP O
and CC CC O
Plan NNP NNP O
56 CD CD I-AGE
y.o. NN NN O
w NN NN O
/ NN NN O
mult NN NN O
medical JJ JJ O
problems NNS NNS O
presenting VBG VBG O
for IN IN O
vaginal JJ JJ O
atrophy NN NN O
. . . O
   
HCM NNP NNP O
: : : O
due JJ JJ O
for IN IN O
pap NN NN O
but CC CC O
unable JJ JJ O
to TO TO O
tolerate VB VB O
exam NN NN O
d/t NN NN O
pain NN NN O
. . . O
   
Will NNP NNP O
re-try JJ JJ O
2 CD CD O
mos NN NN O
after IN IN O
using VBG VBG O
vagifem NN NN O
. . . O
   
Mammo NNP NNP O
, , , O
BMD NNP NNP O
up-to-date JJ JJ O
. . . O
   
Atrophy NNP NNP O
: : : O
vagifem NN NN O
BIW NNP NNP O
RTC NNP NNP O
2 CD CD O
mos NN NN O
Agree NNP NNP O
with IN IN O
Vagifem NNP NNP O
treatment NN NN O
for IN IN O
atrophic JJ JJ O
vaginitis NNS NNS O
. . . O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2077-08-04 JJ JJ I-DATE
EDVISIT^42817774^AARON, NNP NNP O
JEAN^08/04/77^VALENTIN, NNP NNP O
IDA NNP NNP I-DOCTOR
CHIEF NNP NNP O
COMPLAINT NNP NNP O
: : : O
Status NNP NNP O
post NN NN O
fall NN NN O
, , , O
right JJ JJ O
shoulder NN NN O
pain NN NN O
. . . O
   
I PRP PRP O
saw VBD VBD O
the DT DT O
patient NN NN O
with IN IN O
Dr NNP NNP O
. . . O
Andrew NNP NNP I-DOCTOR
Newhouse NNP NNP I-DOCTOR
. . . O
   
Please VB VB O
see VB VB O
his PRP$ PRP$ O
note NN NN O
for IN IN O
further JJ JJ O
details NNS NNS O
. . . O
   
I PRP PRP O
confirm VBP VBP O
that IN IN O
I PRP PRP O
have VBP VBP O
interviewed VBN VBN O
and CC CC O
examined VBD VBD O
the DT DT O
patient NN NN O
, , , O
reviewed VBD VBD O
the DT DT O
resident NN NN O
's POS POS O
documentation NN NN O
, , , O
and CC CC O
discussed VBD VBD O
the DT DT O
evaluation NN NN O
, , , O
plan NN NN O
of IN IN O
care NN NN O
, , , O
and CC CC O
disposition NN NN O
with IN IN O
the DT DT O
patient NN NN O
. . . O
   
HISTORY NN NN O
OF IN IN O
PRESENT NNP NNP O
ILLNESS NNP NNP O
: : : O
The DT DT O
patient NN NN O
is VBZ VBZ O
a DT DT O
63-year-old JJ JJ O
female JJ JJ O
who WP WP O
presents VBZ VBZ O
after IN IN O
mechanical JJ JJ O
trip NN NN O
and CC CC O
follow VB VB O
at IN IN O
work NN NN O
today NN NN O
and CC CC O
hit VBD VBD O
her PRP$ PRP$ O
forehead NN NN O
. . . O
   
No DT DT O
loss NN NN O
of IN IN O
consciousness NN NN O
, , , O
no DT DT O
headache NN NN O
, , , O
no DT DT O
visual JJ JJ O
changes NNS NNS O
, , , O
no DT DT O
upper JJ JJ O
or CC CC O
lower JJR JJR O
extremities NNS NNS O
, , , O
paresthesias NNS NNS O
or CC CC O
weakness NNS NNS O
. . . O
   
She PRP PRP O
fell VBD VBD O
onto IN IN O
her PRP$ PRP$ O
right JJ JJ O
shoulder NN NN O
, , , O
is VBZ VBZ O
complaining VBG VBG O
about IN IN O
pain NN NN O
at IN IN O
that DT DT O
area NN NN O
. . . O
   
No DT DT O
focal JJ JJ O
weakness NN NN O
, , , O
no DT DT O
neck NN NN O
pain NN NN O
, , , O
no DT DT O
back RB RB O
pain NN NN O
, , , O
no DT DT O
chest NN NN O
pain NN NN O
, , , O
shortness NN NN O
of IN IN O
breath NN NN O
, , , O
no DT DT O
belly RB RB O
pain NN NN O
. . . O
   
PAST NNP NNP O
MEDICAL NNP NNP O
HISTORY NN NN O
: : : O
Hypertension NNP NNP O
, , , O
diabetes NN NN O
, , , O
hypercholesterolemia NN NN O
, , , O
neuropathy NN NN O
, , , O
and CC CC O
diverticulitis NNS NNS O
. . . O
   
MEDICATIONS NNP NNP O
: : : O
Currently RB RB O
on IN IN O
Novolog NNP NNP O
, , , O
verapamil NN NN O
, , , O
lisinopril NN NN O
, , , O
amitriptyline NN NN O
, , , O
and CC CC O
aspirin NN NN O
. . . O
   
ALLERGIES NNP NNP O
: : : O
No DT DT O
known VBN VBN O
allergies NNS NNS O
SOCIAL NNP NNP O
HISTORY NN NN O
: : : O
One CD CD O
pack NN NN O
per IN IN O
day NN NN O
smoker NN NN O
and CC CC O
does VBZ VBZ O
not RB RB O
drink VB VB O
. . . O
   
She PRP PRP O
denies VBZ VBZ O
IV NNP NNP O
drug NN NN O
use NN NN O
. . . O
   
She PRP PRP O
lives VBZ VBZ O
alone RB RB O
. . . O
   
FAMILY NN NN O
HISTORY NN NN O
: : : O
Noncontributory NNP NNP O
. . . O
   
REVIEW NNP NNP O
OF IN IN O
SYSTEMS NNP NNP O
: : : O
As IN IN O
per IN IN O
resident NN NN O
's POS POS O
note NN NN O
and CC CC O
my PRP$ PRP$ O
HPI NNP NNP O
. . . O
   
PHYSICAL JJ JJ O
EXAMINATION NNP NNP O
: : : O
She PRP PRP O
is VBZ VBZ O
awake JJ JJ O
, , , O
alert NN NN O
, , , O
and CC CC O
nontoxic NN NN O
but CC CC O
does VBZ VBZ O
appear VB VB O
uncomfortable JJ JJ O
. . . O
   
Afebrile NNP NNP O
, , , O
vital JJ JJ O
signs NNS NNS O
are VBP VBP O
notable JJ JJ O
for IN IN O
a DT DT O
blood NN NN O
pressure NN NN O
of IN IN O
185/79 CD CD O
, , , O
O2 NNP NNP O
saturation NN NN O
99 CD CD O
% NN NN O
on IN IN O
room NN NN O
air NN NN O
, , , O
respiratory JJ JJ O
rate NN NN O
18 CD CD O
, , , O
and CC CC O
pulse NN NN O
   
89 CD CD O
. . . O
HEENT NNP NNP O
exam NN NN O
: : : O
Normocephalic NNP NNP O
and CC CC O
atraumatic JJ JJ O
. . . O
   
No DT DT O
facial JJ JJ O
tenderness NN NN O
. . . O
   
No DT DT O
cervical JJ JJ O
spine NN NN O
tenderness NN NN O
in IN IN O
the DT DT O
midline NN NN O
. . . O
   
Lungs NNP NNP O
: : : O
Clear JJ JJ O
anteriorly RB RB O
. . . O
   
No DT DT O
TLS NNP NNP O
spine NN NN O
tenderness NN NN O
in IN IN O
the DT DT O
midline NN NN O
. . . O
   
Heart NNP NNP O
: : : O
Regular NNP NNP O
rate NN NN O
and CC CC O
rhythm NN NN O
. . . O
   
Abdomen NNP NNP O
: : : O
Soft JJ JJ O
, , , O
nontender NN NN O
, , , O
and CC CC O
nondistended VBD VBD O
. . . O
   
Her PRP$ PRP$ O
right JJ JJ O
shoulder NN NN O
that WDT WDT O
is VBZ VBZ O
held VBN VBN O
by IN IN O
her PRP$ PRP$ O
side NN NN O
, , , O
she PRP PRP O
has VBZ VBZ O
exquisite JJ JJ O
tenderness NN NN O
, , , O
unable JJ JJ O
to TO TO O
really RB RB O
move VB VB O
it PRP PRP O
. . . O
   
She PRP PRP O
has VBZ VBZ O
intact JJ JJ O
axillary JJ JJ O
nerve NN NN O
sensation NN NN O
, , , O
full JJ JJ O
strength NN NN O
in IN IN O
her PRP$ PRP$ O
hand NN NN O
and CC CC O
fingers NNS NNS O
. . . O
   
Alert NNP NNP O
and CC CC O
oriented VBD VBD O
x3 NN NN O
. . . O
   
Normal NNP NNP O
mood NN NN O
and CC CC O
affect NN NN O
. . . O
   
EMERGENCY NNP NNP O
DEPARTMENT NNP NNP O
COURSE NN NN O
: : : O
The DT DT O
patient NN NN O
thought VBD VBD O
she PRP PRP O
hit VBD VBD O
her PRP$ PRP$ O
forehead NN NN O
does VBZ VBZ O
not RB RB O
have VB VB O
signs NNS NNS O
or CC CC O
symptoms NNS NNS O
suggestive JJ JJ O
of IN IN O
intracerebral JJ JJ O
injuries NNS NNS O
. . . O
   
I PRP PRP O
do VBP VBP O
not RB RB O
feel VB VB O
she PRP PRP O
needs VBZ VBZ O
imaging VBG VBG O
though IN IN O
she PRP PRP O
has VBZ VBZ O
pain NN NN O
in IN IN O
her PRP$ PRP$ O
shoulder NN NN O
. . . O
   
She PRP PRP O
is VBZ VBZ O
awake JJ JJ O
and CC CC O
alert NN NN O
and CC CC O
answers NNS NNS O
questions NNS NNS O
appropriately RB RB O
. . . O
   
She PRP PRP O
has VBZ VBZ O
no DT DT O
cervical JJ JJ O
spine NN NN O
tenderness NN NN O
in IN IN O
the DT DT O
midline NN NN O
. . . O
   
She PRP PRP O
did VBD VBD O
have VB VB O
plain JJ JJ O
films NNS NNS O
of IN IN O
her PRP$ PRP$ O
right JJ JJ O
shoulder NN NN O
that IN IN O
show NN NN O
comminuted VBD VBD O
fracture NN NN O
of IN IN O
the DT DT O
right NN NN O
humerus NN NN O
involving VBG VBG O
the DT DT O
surgical JJ JJ O
neck NN NN O
, , , O
greater JJR JJR O
tuberosity NN NN O
, , , O
anatomic JJ JJ O
neck NN NN O
with IN IN O
medial JJ JJ O
displacement NN NN O
distal JJ JJ O
fragment NN NN O
. . . O
   
She PRP PRP O
also RB RB O
had VBD VBD O
a DT DT O
chest NN NN O
x-ray NN NN O
that WDT WDT O
showed VBD VBD O
some DT DT O
mild JJ JJ O
pulmonary JJ JJ O
vascular NN NN O
congestion NN NN O
. . . O
   
The DT DT O
patient NN NN O
had VBD VBD O
preoperative JJ JJ O
screening NN NN O
labs NNS NNS O
that WDT WDT O
included VBD VBD O
sodium NN NN O
138 CD CD O
, , , O
K NNP NNP O
4.2 CD CD O
, , , O
chloride NN NN O
101 CD CD O
, , , O
bicarbonate NN NN O
25 CD CD O
, , , O
BUN NNP NNP O
20 CD CD O
, , , O
creatinine NN NN O
1.4 CD CD O
, , , O
glucose NN NN O
395 CD CD O
and CC CC O
calcium NN NN O
   
10 CD CD O
. . . O
White NNP NNP O
count NN NN O
of IN IN O
27 CD CD O
, , , O
hematocrit NN NN O
41 CD CD O
, , , O
and CC CC O
platelet NN NN O
count NN NN O
286,000 CD CD O
. . . O
   
Coags NNP NNP O
within IN IN O
normal JJ JJ O
limits NNS NNS O
. . . O
   
The DT DT O
patient NN NN O
will MD MD O
be VB VB O
admitted VBN VBN O
to TO TO O
the DT DT O
Orthopedics NNP NNP O
Surgery NNP NNP O
. . . O
   
We PRP PRP O
will MD MD O
check VB VB O
UA NNP NNP O
given VBN VBN O
her PRP$ PRP$ O
white JJ JJ O
count NN NN O
. . . O
   
Of IN IN O
note NN NN O
, , , O
she PRP PRP O
did VBD VBD O
have VB VB O
her PRP$ PRP$ O
differential JJ JJ O
still RB RB O
pending VBG VBG O
. . . O
   
DIAGNOSIS NNP NNP O
: : : O
Right RB RB O
shoulder NN NN O
fracture NN NN O
status NN NN O
post NN NN O
mechanical JJ JJ O
fall NN NN O
. . . O
   
DISPOSITION NNP NNP O
: : : O
Admitted NNP NNP O
to TO TO O
Ortho NNP NNP O
. . . O
   
CONDITION NNP NNP O
: : : O
Stable JJ JJ O
. . . O
   
She PRP PRP O
will MD MD O
also RB RB O
be VB VB O
treated VBN VBN O
for IN IN O
hyperglycemia NN NN O
, , , O
which WDT WDT O
is VBZ VBZ O
also RB RB O
another DT DT O
diagnosis NN NN O
. . . O
   
_____________________________ NN NN O
_ NN NN O
VALENTIN NNP NNP O
, , , O
IDA NNP NNP I-DOCTOR
MD NNP NNP O
D NNP NNP O
: : : O
08/04/77 CD CD I-DATE
T NN NN O
: : : O
08/04/77 CD CD I-DATE
Dictated NNP NNP O
By IN IN O
: : : O
VALENTIN NNP NNP O
, , , O
IDA NNP NNP I-DOCTOR
eScription NN NN O
document:2-7000249 JJ JJ O
BFFocus NNP NNP O
******** NN NN O
Not RB RB O
reviewed VBN VBN O
by IN IN O
Attending NNP NNP O
Physician NNP NNP O
******** NN NN O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2111-01-05 JJ JJ I-DATE
UROLOGY NNP NNP O
Consult NNP NNP O
Patient NNP NNP O
: : : O
Bryan NNP NNP O
, , , O
Archie NNP NNP I-PATIENT
MRN NNP NNP O
: : : O
7246074 CD CD I-MEDICALRECORD
Date NN NN O
: : : O
1/5/11 CD CD I-DATE
CC NNP NNP O
: : : O
hematuria NN NN O
HPI NNP NNP O
: : : O
81yo CD CD O
M NNP NNP O
with IN IN O
chronic JJ JJ O
incontinence NN NN O
who WP WP O
last JJ JJ O
night NN NN O
noted VBD VBD O
small JJ JJ O
amount NN NN O
of IN IN O
blood NN NN O
in IN IN O
diaper NN NN O
. . . O
   
This DT DT O
AM NNP NNP O
caregiver RB RB O
changed VBD VBD O
diaper NN NN O
and CC CC O
noted VBD VBD O
large JJ JJ O
amount NN NN O
of IN IN O
clots NNS NNS O
and CC CC O
brought VBN VBN O
patient NN NN O
to TO TO O
hospital NN NN O
. . . O
   
Patient NNP NNP O
complains NNS NNS O
of IN IN O
crotch NN NN O
pain NN NN O
and CC CC O
waking VBG VBG O
up RP RP O
with IN IN O
suprapubic NN NN O
pain NN NN O
during IN IN O
night NN NN O
. . . O
   
Denies NNP NNP O
fever RB RB O
, , , O
chills NNS NNS O
, , , O
nausea NN NN O
, , , O
vomiting VBG VBG O
, , , O
diarrhea NN NN O
. . . O
   
Does VBZ VBZ O
not RB RB O
believe VB VB O
he PRP PRP O
has VBZ VBZ O
blood NN NN O
in IN IN O
stool NN NN O
or CC CC O
melena NN NN O
. . . O
   
Has VBZ VBZ O
never RB RB O
had VBN VBN O
bloody JJ JJ O
urine NN NN O
before IN IN O
, , , O
though IN IN O
it PRP PRP O
is VBZ VBZ O
not RB RB O
clear JJ JJ O
that IN IN O
patient NN NN O
s VBZ VBZ O
given VBN VBN O
history NN NN O
is VBZ VBZ O
accurate JJ JJ O
. . . O
   
PMH/PSH NNP NNP O
: : : O
type NN NN O
2 CD CD O
diabetes NNS NNS O
, , , O
sacral JJ JJ O
decub NN NN O
ulcer NN NN O
, , , O
R NN NN O
hip NN NN O
arthroplasty NN NN O
, , , O
htn NN NN O
, , , O
OA NNP NNP O
, , , O
afib NN NN O
MEDS NNP NNP O
: : : O
coumadin NN NN O
, , , O
novolin NN NN O
sliding VBG VBG O
scale NN NN O
, , , O
aspirin NN NN O
325mg CD CD O
daily RB RB O
, , , O
digoxin NN NN O
0.125mg CD CD O
daily RB RB O
, , , O
folic JJ JJ O
acid NN NN O
1mg CD CD O
daily RB RB O
, , , O
NPH NNP NNP O
6Units CD CD O
SC NNP NNP O
QPM NNP NNP O
, , , O
lipitor NN NN O
40mg CD CD O
daily RB RB O
, , , O
prilosec NN NN O
20mg CD CD O
daily RB RB O
, , , O
miralax NN NN O
17g CD CD O
BID NNP NNP O
, , , O
Toprol NNP NNP O
XL NNP NNP O
150mg CD CD O
BID NNP NNP O
, , , O
Tylenol NNP NNP O
, , , O
Senna NNP NNP O
, , , O
Dulcolax NNP NNP O
supp NN NN O
prn NN NN O
, , , O
MOM NN NN O
prn NN NN O
, , , O
Reglan NNP NNP O
5mg CD CD O
QID NNP NNP O
prn NN NN O
N/V NNP NNP O
, , , O
Scot-tussin NNP NNP O
s/f NN NN O
original JJ JJ O
10ml CD CD O
Q6H NNP NNP O
prn NN NN O
cough NN NN O
, , , O
NPH NNP NNP O
34 CD CD O
Units NNP NNP O
SC NNP NNP O
QAM NNP NNP O
ALLERGIES NNP NNP O
: : : O
NKDA NNP NNP O
FMH/SH NNP NNP O
: : : O
quit VBD VBD O
smoking VBG VBG O
2059 CD CD I-DATE
, , , O
no DT DT O
etoh NN NN O
. . . O
   
Lives NNP NNP O
in IN IN O
nursing VBG VBG O
home NN NN O
. . . O
   
PE NNP NNP O
: : : O
T NN NN O
= SYM SYM O
101.6 CD CD O
BP NNP NNP O
= SYM SYM O
207/94 CD CD O
P NN NN O
= SYM SYM O
114 CD CD O
RR NNP NNP O
= SYM SYM O
20 CD CD O
SaO2 NNP NNP O
= SYM SYM O
99 CD CD O
% NN NN O
RA NNP NNP O
Gen=NAD NNP NNP O
. . . O
   
CV=RRR NNP NNP O
Lungs=CTAB NNP NNP O
Abd=soft NNP NNP O
, , , O
mildly RB RB O
distended VBN VBN O
, , , O
mildly RB RB O
tender NN NN O
in IN IN O
suprapubic NN NN O
area NN NN O
. . . O
   
GU NNP NNP O
= SYM SYM O
large JJ JJ O
clots NNS NNS O
from IN IN O
foley NN NN O
catheter NN NN O
with IN IN O
grossly RB RB O
bloody JJ JJ O
urine NN NN O
RELEVANT JJ JJ O
LAB/IMAGING NNP NNP O
STUDIES NNP NNP O
: : : O
CBC NNP NNP O
: : : O
17.9>33.8<462 CD CD O
differential NN NN O
92/4/4/0 CD CD O
Coags NNP NNP O
: : : O
INR NNP NNP O
4.9 CD CD O
, , , O
PTT NNP NNP O
44.1 CD CD O
UA NNP NNP O
: : : O
nitrite NN NN O
+, NN NN O
3 CD CD O
+ NN NN O
alb NN NN O
, , , O
packed VBN VBN O
RBC NNP NNP O
, , , O
3-5 JJ JJ O
WBC NNP NNP O
, , , O
few JJ JJ O
bacteria NNS NNS O
, , , O
squamous JJ JJ O
cell NN NN O
neg NN NN O
Chemistry NNP NNP O
: : : O
Na NNP NNP O
140 CD CD O
, , , O
K NNP NNP O
5.2 CD CD O
, , , O
Cl NNP NNP O
108 CD CD O
, , , O
CO2 NNP NNP O
18.2 CD CD O
, , , O
BUN NNP NNP O
41 CD CD O
, , , O
Cr NNP NNP O
2.1 CD CD O
, , , O
Glu NNP NNP O
97 CD CD O
, , , O
Ca NNP NNP O
9.1 CD CD O
, , , O
Mg NNP NNP O
1.5 CD CD O
, , , O
Phos NNP NNP O
2.8 CD CD O
LFTs NNP NNP O
: : : O
total JJ JJ O
protein NN NN O
8.6 CD CD O
, , , O
alb NN NN O
3.6 CD CD O
, , , O
DB NNP NNP O
0 CD CD O
, , , O
TB NNP NNP O
0.2 CD CD O
, , , O
AP NNP NNP O
157 CD CD O
, , , O
SGPT NNP NNP O
16 CD CD O
, , , O
SGOT NNP NNP O
22 CD CD O
, , , O
amylase NN NN O
99 CD CD O
, , , O
lipase NN NN O
4.3 CD CD O
CXR NNP NNP O
ordered VBD VBD O
EKG NNP NNP O
: : : O
pending VBG VBG O
Renal NNP NNP O
US NNP NNP O
: : : O
Bilateral NNP NNP O
moderate JJ JJ O
pelvicaliectasis NN NN O
, , , O
new JJ JJ O
from IN IN O
prior RB RB O
CT NNP NNP O
from IN IN O
2109 CD CD I-DATE
. . . O
   
Echogenic NNP NNP O
materials NNS NNS O
in IN IN O
bladder NN NN O
, , , O
presumably RB RB O
blood NN NN O
. . . O
   
No DT DT O
mass NN NN O
or CC CC O
stones NNS NNS O
seen VBN VBN O
. . . O
   
PROCEDURES NNP NNP O
: : : O
Whistle NNP NNP O
tip NN NN O
foley NN NN O
placed VBN VBN O
and CC CC O
bladder NN NN O
was VBD VBD O
hand NN NN O
irrigated VBN VBN O
with IN IN O
3L CD CD O
NS NNP NNP O
with IN IN O
large JJ JJ O
amount NN NN O
of IN IN O
clot NN NN O
removed VBD VBD O
. . . O
   
Placed NNP NNP O
on IN IN O
Murphy NNP NNP O
drip NN NN O
with IN IN O
lightening NN NN O
of IN IN O
urine NN NN O
over IN IN O
1 CD CD O
hour NN NN O
. . . O
   
ASSESSMENT/RECOMMENDATIONS NNP NNP O
: : : O
81yo CD CD O
M NNP NNP O
with IN IN O
gross JJ JJ O
hematuria NN NN O
with IN IN O
clot NN NN O
, , , O
fever NN NN O
, , , O
and CC CC O
elevated VBD VBD O
WBC NNP NNP O
. . . O
   
Renal NNP NNP O
US NNP NNP O
obtained VBD VBD O
rather RB RB O
than IN IN O
CT NNP NNP O
scan JJ JJ O
b/c NN NN O
of IN IN O
elevated VBD VBD O
creatinine NN NN O
in IN IN O
diabetic JJ JJ O
patient NN NN O
. . . O
   
- : : O
Admit NNP NNP O
to TO TO O
Urology NNP NNP O
service NN NN O
. . . O
   
Patient NNP NNP O
needs VBZ VBZ O
to TO TO O
be VB VB O
on IN IN O
cardiac JJ JJ O
monitor NN NN O
. . . O
   
- : : O
IV NNP NNP O
fluids NNS NNS O
: : : O
D5 NNP NNP O
NS NNP NNP O
at IN IN O
100cc/hr. CD CD O
   
- : : O
Please VB VB O
obtain VB VB O
CXR NNP NNP O
and CC CC O
EKG NNP NNP O
. . . O
   
- : : O
NPO NNP NNP O
after IN IN O
midnight NN NN O
- - - O
hold NN NN O
coumadin NN NN O
. . . O
   
Patient NNP NNP O
receiving VBG VBG O
FFP NNP NNP O
to TO TO O
reverse VB VB O
anticoagulation NN NN O
. . . O
   
- : : O
Will NNP NNP O
continue VB VB O
Levaquin NNP NNP O
( ( ( O
renal JJ JJ O
dosing VBG VBG O
) ) ) O
- : : O
Please VB VB O
send VB VB O
blood NN NN O
cultures NNS NNS O
and CC CC O
urine JJ JJ O
culture NN NN O
. . . O
   
- : : O
Will NNP NNP O
recheck NN NN O
chem NN NN O
. . . O
   
7 CD CD O
, , , O
CBC NNP NNP O
, , , O
coags NNS NNS O
in IN IN O
morning NN NN O
. . . O
   
____________________________________________ NN NN O
_ NN NN O
Evelyn NNP NNP I-DOCTOR
Xuan NNP NNP I-DOCTOR
, , , O
MD NNP NNP O
HRC NNP NNP I-HOSPITAL
Urology NNP NNP O
59931 CD CD I-PHONE
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2075-10-05 JJ JJ I-DATE
MEC NNP NNP I-HOSPITAL
EMERGENCY NNP NNP O
DEPT NNP NNP O
VISIT NNP NNP O
OLIVIER,CHRISTINE NNP NNP I-PATIENT
652-33-21-5 NNP NNP I-MEDICALRECORD
VISIT NNP NNP O
DATE NN NN O
: : : O
10/05/75 CD CD I-DATE
PRESENTING NNP NNP O
COMPLAINT NNP NNP O
: : : O
Chest NN NN O
pain NN NN O
. . . O
   
HISTORY NN NN O
OF IN IN O
PRESENTING NNP NNP O
COMPLAINT NNP NNP O
: : : O
The DT DT O
resident NN NN O
's POS POS O
note NN NN O
was VBD VBD O
reviewed VBN VBN O
, , , O
and CC CC O
the DT DT O
patient NN NN O
seen VBN VBN O
and CC CC O
examined VBN VBN O
on IN IN O
arrival NN NN O
. . . O
   
This DT DT O
is VBZ VBZ O
a DT DT O
65-year-old JJ JJ O
female JJ JJ O
status NN NN O
post NN NN O
multiple JJ JJ O
angioplasties NNS NNS O
and CC CC O
stent JJ JJ O
placement NN NN O
. . . O
   
She PRP PRP O
had VBD VBD O
recurrence NN NN O
of IN IN O
her PRP$ PRP$ O
typical JJ JJ O
angina NN NN O
at IN IN O
home NN NN O
, , , O
took VBD VBD O
three CD CD O
nitroglycerin NN NN O
with IN IN O
minimal JJ JJ O
relief NN NN O
, , , O
and CC CC O
activated VBD VBD O
the DT DT O
911 CD CD O
system NN NN O
. . . O
   
Her PRP$ PRP$ O
pre-hospital JJ JJ O
electrocardiogram NN NN O
shows VBZ VBZ O
a DT DT O
small JJ JJ O
amount NN NN O
of IN IN O
ST NNP NNP O
depression NN NN O
, , , O
perhaps RB RB O
1 CD CD O
mm NN NN O
, , , O
and CC CC O
flattening VBG VBG O
V3-V6. NNP NNP O
   
This DT DT O
is VBZ VBZ O
comparable JJ JJ O
to TO TO O
a DT DT O
previous JJ JJ O
electrocardiogram NN NN O
in IN IN O
October NNP NNP I-DATE
, , , O
which WDT WDT O
may MD MD O
have VB VB O
been VBN VBN O
her PRP$ PRP$ O
most RBS RBS O
recent JJ JJ O
presentation NN NN O
with IN IN O
ischemia NN NN O
. . . O
   
She PRP PRP O
was VBD VBD O
given VBN VBN O
aspirin NN NN O
and CC CC O
nitroglycerin NN NN O
, , , O
and CC CC O
continued VBD VBD O
to TO TO O
have VB VB O
pain NN NN O
in IN IN O
the DT DT O
Emergency NNP NNP O
Department NNP NNP O
. . . O
   
The DT DT O
total JJ JJ O
duration NN NN O
of IN IN O
pain NN NN O
was VBD VBD O
approximately RB RB O
two CD CD O
hours NNS NNS O
. . . O
   
PHYSICAL JJ JJ O
EXAMINATION NNP NNP O
: : : O
Her PRP$ PRP$ O
vital JJ JJ O
signs NNS NNS O
remained VBD VBD O
stable JJ JJ O
. . . O
   
LABORATORY NNP NNP O
EVALUATION NNP NNP O
: : : O
Her PRP$ PRP$ O
initial JJ JJ O
enzymes NNS NNS O
were VBD VBD O
flat JJ JJ O
. . . O
   
THERAPY NNP NNP O
RENDERED/COURSE NNP NNP O
IN IN IN O
ED NNP NNP O
: : : O
She PRP PRP O
is VBZ VBZ O
being VBG VBG O
taken VBN VBN O
to TO TO O
the DT DT O
Cardiac NNP NNP O
Catheterization NNP NNP O
Laboratory NNP NNP O
for IN IN O
an DT DT O
urgent JJ JJ O
study NN NN O
to TO TO O
rule VB VB O
out IN IN O
acute JJ JJ O
coronary JJ JJ O
syndrome NN NN O
. . . O
   
FINAL NNP NNP O
DIAGNOSIS NNP NNP O
: : : O
Rule NNP NNP O
out IN IN O
unstable JJ JJ O
angina NN NN O
. . . O
   
DISPOSITION NNP NNP O
( ( ( O
including VBG VBG O
condition NN NN O
upon IN IN O
discharge NN NN O
) ) ) O
: : : O
The DT DT O
patient NN NN O
is VBZ VBZ O
taken VBN VBN O
to TO TO O
the DT DT O
Cardiac NNP NNP O
Catheterization NNP NNP O
Laboratory NNP NNP O
. . . O
   
The DT DT O
condition NN NN O
at IN IN O
the DT DT O
time NN NN O
of IN IN O
this DT DT O
dictation NN NN O
is VBZ VBZ O
favorable JJ JJ O
. . . O
   
__________________________________ NN NN O
_ NN NN O
FK981/1979 NNP NNP I-IDNUM
RONNIE NNP NNP I-DOCTOR
PALMER NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
   
RP400 NNP NNP I-USERNAME
D:10/05/75 NNP NNP O
T:10/05/75 NNP NNP O
Dictated NNP NNP O
by IN IN O
: : : O
RONNIE NNP NNP I-DOCTOR
PALMER NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
   
RP400 NNP NNP I-USERNAME
******** NN NN O
Not RB RB O
reviewed VBN VBN O
by IN IN O
Attending NNP NNP O
Physician NNP NNP O
******** NN NN O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2083-01-12 NN NN I-DATE
86 CD CD I-AGE
yo NN NN O
male NN NN O
for IN IN O
follow VB VB O
up RP RP O
. . . O
   
his PRP$ PRP$ O
main JJ JJ O
complaint NN NN O
is VBZ VBZ O
of IN IN O
ongoing JJ JJ O
left VBD VBD O
shoulder NN NN O
discomfort NN NN O
especially RB RB O
when WRB WRB O
raising VBG VBG O
arm NN NN O
over IN IN O
his PRP$ PRP$ O
head NN NN O
. . . O
   
some DT DT O
discomfort NN NN O
at IN IN O
night NN NN O
when WRB WRB O
he PRP PRP O
sleeps VBZ VBZ O
on IN IN O
it PRP PRP O
. . . O
   
also RB RB O
c/o NN NN O
intermittent JJ JJ O
regurgitation NN NN O
of IN IN O
food NN NN O
contents NNS NNS O
after IN IN O
meals NNS NNS O
. . . O
   
no DT DT O
dysphagia NN NN O
or CC CC O
odynophagia NN NN O
. . . O
   
ros NN NN O
; : : O
   
negative JJ JJ O
for IN IN O
chest NN NN O
pain NN NN O
, , , O
pressure NN NN O
, , , O
dyspnea NN NN O
, , , O
edema NN NN O
or CC CC O
cold JJ JJ O
symptoms NNS NNS O
. . . O
   
Problems NNS NNS O
Congestive NNP NNP O
heart NN NN O
failure NN NN O
Chronic NNP NNP O
obstructive JJ JJ O
pulmonary JJ JJ O
disease NN NN O
Hypertension NNP NNP O
Gout NNP NNP O
DJD NNP NNP O
Benign NNP NNP O
prostatic JJ JJ O
hypertrophy NN NN O
Hyperlipidemia NNP NNP O
Chronic NNP NNP O
renal JJ JJ O
dysfunction NN NN O
Peripheral NNP NNP O
vascular NN NN O
disease NN NN O
: : : O
s/p NN NN O
right NN NN O
fem-tib JJ JJ O
bypass NN NN O
1/78 CD CD I-DATE
Prostatic NNP NNP O
nodule NN NN O
: : : O
psa NN NN O
1.6 CD CD O
09/81 CD CD I-DATE
. . . O
   
seen VBN VBN O
by IN IN O
dr NN NN O
. . . O
hoover NN NN I-DOCTOR
in IN IN O
11/81 CD CD I-DATE
who WP WP O
recommended VBD VBD O
yearly RB RB O
follow VB VB O
up RP RP O
. . . O
   
Coronary JJ JJ O
artery NN NN O
disease NN NN O
: : : O
ett NN NN O
exam NN NN O
: : : O
2080The CD CD O
ECG NNP NNP O
response NN NN O
to TO TO O
pharmacological JJ JJ O
stress NN NN O
was VBD VBD O
uninterpretable JJ JJ O
for IN IN O
ischemia NN NN O
. . . O
   
The DT DT O
myocardial NN NN O
perfusion NN NN O
images NNS NNS O
reveal VBP VBP O
no DT DT O
evidence NN NN O
of IN IN O
ischemia NN NN O
. . . O
   
The DT DT O
images NNS NNS O
are VBP VBP O
suggestive JJ JJ O
of IN IN O
possible JJ JJ O
prior RB RB O
inferior NN NN O
infarction NN NN O
although IN IN O
soft JJ JJ O
tissue NN NN O
attenuation NN NN O
prevents NNS NNS O
a DT DT O
definitive JJ JJ O
evaluation NN NN O
of IN IN O
this DT DT O
territory NN NN O
. . . O
   
sigmoid NN NN O
colorectal JJ JJ O
cancer NN NN O
: : : O
s/p NN NN O
sigmoid NN NN O
colectomy NN NN O
and CC CC O
sigmoidoscopy NN NN O
04/82 CD CD I-DATE
rs3PE NN NN O
Medications NNP NNP O
Calcium NNP NNP O
Carbonate NNP NNP O
( ( ( O
500 CD CD O
Mg NNP NNP O
Elemental NNP NNP O
Ca NNP NNP O
) ) ) O
500MG CD CD O
, , , O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
: : : O
Take VB VB O
as IN IN O
directed VBN VBN O
Prilosec NNP NNP O
( ( ( O
OMEPRAZOLE NNP NNP O
) ) ) O
20MG CD CD O
, , , O
1 CD CD O
Capsule NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Lasix NNP NNP O
( ( ( O
FUROSEMIDE NNP NNP O
) ) ) O
40MG CD CD O
, , , O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
BID NNP NNP O
: : : O
Take VB VB O
as IN IN O
directed VBN VBN O
Celebrex NNP NNP O
( ( ( O
CELECOXIB NNP NNP O
) ) ) O
200MG CD CD O
, , , O
1 CD CD O
Capsule NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
: : : O
Take VB VB O
as IN IN O
directed VBN VBN O
PREDNISONE NNP NNP O
5MG CD CD O
, , , O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Hydralazine NNP NNP O
Hcl NNP NNP O
10MG CD CD O
, , , O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QID NNP NNP O
x SYM SYM O
60 CD CD O
day NN NN O
   
( ( ( O
s VBZ VBZ O
) ) ) O
: : : O
Take VB VB O
as IN IN O
directed VBN VBN O
Isordil NNP NNP O
( ( ( O
ISOSORBIDE NNP NNP O
Dinitrate NNP NNP O
) ) ) O
20MG CD CD O
, , , O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
TID NNP NNP O
: : : O
Take VB VB O
as IN IN O
directed VBN VBN O
Coumadin NNP NNP O
( ( ( O
WARFARIN NNP NNP O
Sodium NNP NNP O
) ) ) O
3MG CD CD O
, , , O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QPM NNP NNP O
: : : O
Take VB VB O
as IN IN O
directed VBN VBN O
per IN IN O
anticoag NN NN O
COLCHICINE NNP NNP O
0.6MG, CD CD O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QOD NNP NNP O
: : : O
Take VB VB O
as IN IN O
directed VBN VBN O
Metoprolol NNP NNP O
Tartrate NNP NNP O
50MG CD CD O
, , , O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
BID NNP NNP O
: : : O
Take VB VB O
as IN IN O
directed VBN VBN O
ALLOPURINOL NNP NNP O
100MG CD CD O
, , , O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
: : : O
Take VB VB O
as IN IN O
directed VBN VBN O
DIGOXIN NNP NNP O
0.125MG, CD CD O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QOD NNP NNP O
: : : O
Take VB VB O
as IN IN O
directed VBN VBN O
Allergies NNPS NNPS O
Penicillins NNP NNP O
- : : O
Unknown JJ JJ O
exam NN NN O
weight NN NN O
188(down CD CD O
6lbs CD CD O
) ) ) O
120/70 CD CD O
76 CD CD O
appears VBZ VBZ O
well RB RB O
left VBN VBN O
shoulder NN NN O
: : : O
able JJ JJ O
to TO TO O
abduct VB VB O
up IN IN O
to TO TO O
110 CD CD O
degrees NNS NNS O
before IN IN O
discomfort NN NN O
. . . O
   
no DT DT O
subacromial NN NN O
or CC CC O
anterior NN NN O
biceps NNS NNS O
tendon NN NN O
tenderness NN NN O
. . . O
   
cor NN NN O
; : : O
   
RRRs1s2 NNP NNP O
lungs NNS NNS O
: : : O
clear JJ JJ O
ext NN NN O
: : : O
no DT DT O
edema NN NN O
a/p NN NN O
gerd NN NN O
: : : O
no DT DT O
dysphagia NN NN O
but CC CC O
i NNP NNP O
notice VBP VBP O
he PRP PRP O
has VBZ VBZ O
lost VBN VBN O
six CD CD O
lbs NN NN O
since IN IN O
last JJ JJ O
visit NN NN O
. . . O
   
will MD MD O
send VB VB O
him PRP PRP O
for IN IN O
ugi NN NN O
series NN NN O
to TO TO O
investigate VB VB O
further JJ JJ O
. . . O
   
continue VB VB O
with IN IN O
prilosec NN NN O
left VBN VBN O
shoulder NN NN O
tendinitis NNS NNS O
: : : O
continue VB VB O
with IN IN O
celebrex NN NN O
. . . O
   
he PRP PRP O
is VBZ VBZ O
followed VBN VBN O
by IN IN O
rheumatology NN NN O
. . . O
   
b12 NN NN O
deficiency NN NN O
: : : O
lvl NN NN O
222 CD CD O
. . . O
   
b12 NN NN O
1000mcg CD CD O
im NN NN O
to TO TO O
left VBD VBD O
deltoid NN NN O
. . . O
   
follow VB VB O
up RB RB O
in IN IN O
six CD CD O
weeks NNS NNS O
. . . O
   
hypertriglyceridemia NN NN O
: : : O
chol NN NN O
210 CD CD O
but CC CC O
trig NN NN O
of IN IN O
497 CD CD O
and CC CC O
hdl NN NN O
32 CD CD O
: : : O
begin VB VB O
lopid NN NN O
600 CD CD O
mg NN NN O
po NN NN O
bid NN NN O
. . . O
   
cad NN NN O
: : : O
stable JJ JJ O
with IN IN O
no DT DT O
angina NN NN O
or CC CC O
failure NN NN O
. . . O
   
htn NN NN O
; : : O
   
stable JJ JJ O
. . . O
   
Health NN NN O
maintenance NN NN O
Influenza NNP NNP O
Vaccine NNP NNP O
10/06/2082 CD CD I-DATE
Cholesterol NNP NNP O
10/15/2082 CD CD I-DATE
210 CD CD O
DESIRABLE NNP NNP O
: : : O
less JJR JJR O
then RB RB O
200 CD CD O
Rectal NNP NNP O
exam NN NN O
10/02/2081 CD CD I-DATE
Stool NNP NNP O
Guaiac NNP NNP O
12/05/2081 CD CD I-DATE
one CD CD O
trace NN NN O
postiive JJ JJ O
out IN IN O
of IN IN O
three CD CD O
Done VBN VBN O
- - - O
positive JJ JJ O
Pneumovax NNP NNP O
11/07/75 CD CD I-DATE
Smoking NNP NNP O
status NN NN O
10/02/2081 CD CD I-DATE
Never RB RB O
a DT DT O
smoker NN NN O
UA-Protein NNP NNP O
08/31/2081 CD CD I-DATE
1 CD CD O
+ NN NN O
____________________________________________ NN NN O
_ NN NN O
David NNP NNP I-DOCTOR
S. NN NN I-DOCTOR
Hale NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2079-12-01 JJ JJ I-DATE
Patient NNP NNP O
Name NN NN O
: : : O
QIN,OWEN NNP NNP I-PATIENT
[ NN NN O
MRN NNP NNP O
: : : O
88491427LBH CD CD O
] NN NN O
Date NN NN O
of IN IN O
Visit NNP NNP O
: : : O
12/01/79 CD CD I-DATE
Reason NNP NNP O
for IN IN O
Visit NNP NNP O
Owen NNP NNP I-PATIENT
is VBZ VBZ O
a DT DT O
62 CD CD I-AGE
y/o NN NN O
male JJ JJ O
here RB RB O
for IN IN O
evl NN NN O
of IN IN O
Rx NNP NNP O
. . . O
   
Problems NNS NNS O
OA NNP NNP O
LLE-PARTIALLY NNP NNP O
SEVERED-MULT NNP NNP O
. . . O
   
SURGERIES NNP NNP O
IRRIDECTOMY NNP NNP O
SKIN NNP NNP O
ULCER-DR NNP NNP O
ESPOSITO NNP NNP I-DOCTOR
PAST NNP NNP O
SMOKER NNP NNP O
HTN NNP NNP O
Medications NNP NNP O
ASA NNP NNP O
PO NNP NNP O
VITAMIN NNP NNP O
E NNP NNP O
PO NNP NNP O
QD NNP NNP O
ATENOLOL NNP NNP O
25MG CD CD O
PO NNP NNP O
QD NNP NNP O
LIPITOR NNP NNP O
( ( ( O
ATORVASTATIN NNP NNP O
) ) ) O
10MG CD CD O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
Allergies NNP NNP O
NKDA NNP NNP O
NONE NN NN O
Narrative NNP NNP O
History NN NN O
Takes VBZ VBZ O
meds JJ JJ O
. . . O
   
No DT DT O
SEs NNP NNP O
. . . O
   
Denies NNP NNP O
vision NN NN O
change NN NN O
, , , O
headache NN NN O
, , , O
chest NN NN O
pain NN NN O
, , , O
SOB NNP NNP O
, , , O
light JJ JJ O
head NN NN O
, , , O
palptations NNS NNS O
. . . O
   
Denies NNP NNP O
loss NN NN O
of IN IN O
balance NN NN O
, , , O
strength NN NN O
or CC CC O
sensation NN NN O
. . . O
   
Gets VBZ VBZ O
new JJ JJ O
Unna NNP NNP O
boot NN NN O
q NN NN O
week NN NN O
. . . O
   
Ulcer NNP NNP O
slowly RB RB O
getting VBG VBG O
better JJR JJR O
. . . O
   
No DT DT O
GI NNP NNP O
symptoms NNS NNS O
. . . O
   
No DT DT O
GU NNP NNP O
symptoms NNS NNS O
except IN IN O
nocturia NN NN O
x3-4. NN NN O
   
Vision NNP NNP O
is VBZ VBZ O
fine NN NN O
. . . O
   
Exercise-no NNP NNP O
Diet NNP NNP O
- : : O
eats VBZ VBZ O
too RB RB O
much JJ JJ O
Cigs-no NNP NNP O
ETOH-no NNP NNP O
Exam NNP NNP O
BP NNP NNP O
= SYM SYM O
126/78 CD CD O
, , , O
P NN NN O
= SYM SYM O
76 CD CD O
, , , O
Wt NNP NNP O
= SYM SYM O
252 CD CD O
; : : O
   
NAD,WD NNP NNP O
, , , O
WN NNP NNP O
Head NNP NNP O
- : : O
no DT DT O
tenderness NN NN O
Neck NN NN O
- : : O
supple NN NN O
with IN IN O
no DT DT O
JVD NNP NNP O
, , , O
bruit NN NN O
, , , O
LAN NNP NNP O
or CC CC O
thyromegaly NN NN O
. . . O
   
Chest NN NN O
- : : O
clear JJ JJ O
A&P NNP NNP O
Cor NNP NNP O
- : : O
reg NN NN O
rhythm,S1S2 NN NN O
normal JJ JJ O
with IN IN O
no DT DT O
murmer NN NN O
, , , O
gallop NN NN O
or CC CC O
rub NN NN O
Abdo NNP NNP O
- : : O
obese NN NN O
; : : O
   
normal JJ JJ O
BS NNP NNP O
; : : O
   
soft JJ JJ O
with IN IN O
no DT DT O
HSM NNP NNP O
, , , O
mass NN NN O
or CC CC O
tenderness NN NN O
. . . O
   
DRE NNP NNP O
- : : O
normal JJ JJ O
sphincter NN NN O
. . . O
   
Prostate NNP NNP O
smooth JJ JJ O
with IN IN O
no DT DT O
nodules NNS NNS O
and CC CC O
normal JJ JJ O
consistency NN NN O
. . . O
   
Ext NNP NNP O
- - - O
no DT DT O
edema NN NN O
. . . O
   
Pulses NNP NNP O
intact JJ JJ O
and CC CC O
symmetric JJ JJ O
right NN NN O
. . . O
   
Unna NNP NNP O
boot NN NN O
left VBD VBD O
. . . O
   
Assessment NNP NNP O
Doing VBG VBG O
well RB RB O
. . . O
   
Disposition NNP NNP O
and CC CC O
Plans NNP NNP O
Cont NNP NNP O
meds NNS NNS O
. . . O
   
BMP,PSA NNP NNP O
, , , O
FOBT NNP NNP O
. . . O
   
FLu NNP NNP O
vaccine NN NN O
. . . O
   
F/U NNP NNP O
Dr NNP NNP O
Esposito NNP NNP I-DOCTOR
. . . O
   
RTC NNP NNP O
6 CD CD O
mon NNP NNP O
or CC CC O
PRN NNP NNP O
. . . O
   
_____________________________ NN NN O
_ NN NN O
William NNP NNP I-DOCTOR
Seth NNP NNP I-DOCTOR
Potter NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
   
-DOCSTART- -X- -X- O
   
OFFICE NNP NNP O
NOTE VB VB O
Esposito NNP NNP O
, , , O
Perla NNP NNP I-PATIENT
MR NNP NNP O
#146-55-23-5 NN NN O
01/18/82 CD CD I-DATE
Telephone NNP NNP O
: : : O
349-3828 JJ JJ I-PHONE
80-year-old JJ JJ O
Chilean JJ JJ I-COUNTRY
woman NN NN O
who WP WP O
has VBZ VBZ O
not RB RB O
been VBN VBN O
back RB RB O
in IN IN O
over IN IN O
a DT DT O
year NN NN O
with IN IN O
chief JJ JJ O
complaint NN NN O
of IN IN O
red JJ JJ O
eye NN NN O
. . . O
   
Has VBZ VBZ O
had VBD VBD O
a DT DT O
recent JJ JJ O
URI NNP NNP O
. . . O
   
Cough NNP NNP O
. . . O
   
Woke NNP NNP O
up RP RP O
this DT DT O
am VBP VBP O
with IN IN O
red JJ JJ O
right NN NN O
eye NN NN O
and CC CC O
MEDICATIONS NNP NNP O
: : : O
Procardia NNP NNP O
XL NNP NNP O
. . . O
   
Lopressor NNP NNP O
. . . O
   
Micronase NNP NNP O
. . . O
   
Aspirin NNP NNP O
. . . O
   
ALLERGIES NNP NNP O
: : : O
LISINOPRIL NNP NNP O
causes NNS NNS O
hyperkalemia NN NN O
. . . O
   
FAMILY NN NN O
HISTORY NN NN O
: : : O
No DT DT O
interval NN NN O
change NN NN O
. . . O
   
SOCIAL NNP NNP O
HISTORY NN NN O
: : : O
Supportive JJ JJ O
family NN NN O
. . . O
   
Retired NNP NNP O
. . . O
   
No DT DT O
cigarettes NNS NNS O
. . . O
   
No DT DT O
excess NN NN O
of IN IN O
alcohol NN NN O
. . . O
   
REVIEW NNP NNP O
OF IN IN O
SYSTEMS NNP NNP O
: : : O
No DT DT O
chest NN NN O
pains NNS NNS O
. . . O
   
No DT DT O
unusual JJ JJ O
nocturia NN NN O
. . . O
   
Her PRP$ PRP$ O
last JJ JJ O
A1C NNP NNP O
was VBD VBD O
6.1 CD CD O
. . . O
   
She PRP PRP O
has VBZ VBZ O
a DT DT O
history NN NN O
of IN IN O
a DT DT O
chronically RB RB O
elevated VBN VBN O
creatinine NN NN O
. . . O
   
Her PRP$ PRP$ O
last JJ JJ O
one CD CD O
was VBD VBD O
2.1 CD CD O
last JJ JJ O
January NNP NNP I-DATE
. . . O
   
The DT DT O
rest NN NN O
of IN IN O
the DT DT O
ROS NNP NNP O
is VBZ VBZ O
negative JJ JJ O
. . . O
   
On IN IN O
physical JJ JJ O
examination NN NN O
she PRP PRP O
looks VBZ VBZ O
well RB RB O
. . . O
   
================ SYM SYM O
Vital NNP NNP O
signs NNS NNS O
================ VBP VBP O
Blood NNP NNP O
Pressure NN NN O
: : : O
142/62 CD CD O
156/60 CD CD O
( ( ( O
by IN IN O
myself PRP PRP O
) ) ) O
Weight NNP NNP O
: : : O
141.5 CD CD O
Pulse NNP NNP O
68 CD CD O
Skin NNP NNP O
: : : O
Unremarkable NNP NNP O
. . . O
   
HEENT NNP NNP O
: : : O
EOMI NNP NNP O
. . . O
   
Right RB RB O
pupil NN NN O
reactive JJ JJ O
. . . O
   
S/p NNP NNP O
irridectomy NN NN O
on IN IN O
the DT DT O
left NN NN O
. . . O
   
NO DT DT O
retinopathy NN NN O
visualized JJ JJ O
although IN IN O
exam NN NN O
is VBZ VBZ O
limited VBN VBN O
. . . O
   
The DT DT O
right NN NN O
conjunctiva NN NN O
is VBZ VBZ O
injected VBN VBN O
with IN IN O
minimal JJ JJ O
discharge NN NN O
. . . O
   
Benign NNP NNP O
pharynx NN NN O
. . . O
   
No DT DT O
lymphadenopathy NN NN O
. . . O
   
No DT DT O
thyromegaly NN NN O
. . . O
   
Soft JJ JJ O
left VBD VBD O
carotid NN NN O
bruit NN NN O
vs NNS NNS O
. . . O
transmitted VBD VBD O
murmur NN NN O
. . . O
   
? . . O
Mild NNP NNP O
facial JJ JJ O
droop NN NN O
. . . O
   
Her PRP$ PRP$ O
lungs NNS NNS O
are VBP VBP O
clear JJ JJ O
. . . O
   
Brief NNP NNP O
II\VI NNP NNP O
systolic JJ JJ O
ejection NN NN O
murmur NN NN O
along IN IN O
the DT DT O
left VBN VBN O
sternal JJ JJ O
border NN NN O
radiating VBG VBG O
into IN IN O
the DT DT O
right JJ JJ O
sternal JJ JJ O
border NN NN O
. . . O
   
Benign NNP NNP O
abdomen NN NN O
. . . O
   
No DT DT O
hepatomegaly NN NN O
. . . O
   
No DT DT O
splenomegaly NN NN O
. . . O
   
No DT DT O
pedal NN NN O
edema NN NN O
. . . O
   
#1 NN NN O
) ) ) O
Conjunctivitis NNP NNP O
. . . O
   
Probably RB RB O
viral JJ JJ O
but CC CC O
she PRP PRP O
had VBD VBD O
more JJR JJR O
discharge NN NN O
this DT DT O
morning NN NN O
. . . O
   
Rx NNP NNP O
with IN IN O
Ilotycin NNP NNP O
. . . O
   
#2 NN NN O
) ) ) O
History NN NN O
of IN IN O
coronary JJ JJ O
disease NN NN O
. . . O
   
No DT DT O
symptoms NNS NNS O
. . . O
   
#3 NN NN O
) ) ) O
Hypertension NNP NNP O
. . . O
   
She PRP PRP O
seems VBZ VBZ O
a DT DT O
little JJ JJ O
vague NN NN O
about IN IN O
her PRP$ PRP$ O
meds NNS NNS O
. . . O
   
She PRP PRP O
has VBZ VBZ O
not RB RB O
been VBN VBN O
back RB RB O
in IN IN O
more JJR JJR O
than IN IN O
a DT DT O
year NN NN O
and CC CC O
still RB RB O
has VBZ VBZ O
meds NNS NNS O
left VBN VBN O
. . . O
   
I PRP PRP O
will MD MD O
see VB VB O
her PRP$ PRP$ O
back RB RB O
shortly RB RB O
to TO TO O
recheck VB VB O
. . . O
   
#4 NN NN O
) ) ) O
Diabetes NNP NNP O
. . . O
   
We PRP PRP O
'll MD MD O
check VB VB O
an DT DT O
A1C NNP NNP O
. . . O
   
#5 NN NN O
) ) ) O
Chronic NNP NNP O
renal JJ JJ O
insufficiency NN NN O
. . . O
   
We PRP PRP O
'll MD MD O
check VB VB O
a DT DT O
creatinine NN NN O
. . . O
   
The DT DT O
last JJ JJ O
value NN NN O
was VBD VBD O
2.1 CD CD O
. . . O
   
#6 NN NN O
) ) ) O
General NNP NNP O
. . . O
   
Obtain NNP NNP O
a DT DT O
mammogram NN NN O
. . . O
   
Ulises NNP NNP I-DOCTOR
J. NN NN I-DOCTOR
Kelley NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2065-10-20 JJ JJ I-DATE
GRANITE NNP NNP I-HOSPITAL
EMERGENCY NNP NNP O
DEPT NNP NNP O
VISIT NNP NNP O
BIRD,TERRI NNP NNP I-PATIENT
809-10-69-0 NNP NNP I-MEDICALRECORD
VISIT NNP NNP O
DATE NN NN O
: : : O
10/20/65 CD CD I-DATE
PRESENTING NNP NNP O
COMPLAINT NNP NNP O
: : : O
HISTORY NN NN O
OF IN IN O
PRESENTING NNP NNP O
COMPLAINT NNP NNP O
: : : O
The DT DT O
patient NN NN O
is VBZ VBZ O
a DT DT O
70 CD CD I-AGE
year NN NN O
old JJ JJ O
female JJ JJ O
with IN IN O
long JJ JJ O
past JJ JJ O
medical JJ JJ O
history NN NN O
of IN IN O
medical JJ JJ O
problems NNS NNS O
, , , O
including VBG VBG O
abdominal JJ JJ O
aortic JJ JJ O
aneurysm NN NN O
repair NN NN O
, , , O
chronic JJ JJ O
pneumonia NN NN O
, , , O
chronic JJ JJ O
wound NN NN O
infection NN NN O
, , , O
history NN NN O
of IN IN O
chronic JJ JJ O
urinary JJ JJ O
tract NN NN O
infections NNS NNS O
, , , O
change NN NN O
in IN IN O
mental JJ JJ O
status NN NN O
, , , O
peripheral JJ JJ O
vascular NN NN O
disease NN NN O
, , , O
hypertension NN NN O
, , , O
and CC CC O
coronary JJ JJ O
artery NN NN O
disease NN NN O
. . . O
   
The DT DT O
patient NN NN O
was VBD VBD O
in IN IN O
her PRP$ PRP$ O
usual JJ JJ O
state NN NN O
of IN IN O
poor JJ JJ O
health NN NN O
when WRB WRB O
she PRP PRP O
was VBD VBD O
noticed VBN VBN O
by IN IN O
caregivers NNS NNS O
to TO TO O
be VB VB O
confused VBN VBN O
and CC CC O
lethargic JJ JJ O
. . . O
   
The DT DT O
patient NN NN O
was VBD VBD O
transferred VBN VBN O
to TO TO O
the DT DT O
emergency NN NN O
room NN NN O
department NN NN O
. . . O
   
REVIEW NNP NNP O
OF IN IN O
SYSTEMS NNP NNP O
: : : O
PAST NNP NNP O
MEDICAL NNP NNP O
HISTORY NN NN O
: : : O
MEDICATIONS NNP NNP O
: : : O
Unknown JJ JJ O
medications NNS NNS O
at IN IN O
this DT DT O
time NN NN O
. . . O
   
ALLERGIES NNP NNP O
: : : O
Sulfa NNP NNP O
and CC CC O
penicillin NN NN O
. . . O
   
Aspirin NNP NNP O
and CC CC O
all DT DT O
cephalosporins NNS NNS O
. . . O
   
SOCIAL NNP NNP O
HISTORY NN NN O
AND CC CC O
FAMILY NN NN O
HISTORY NN NN O
: : : O
PHYSICAL JJ JJ O
EXAMINATION NNP NNP O
: : : O
Temperature NNP NNP O
101.6 CD CD O
degrees NNS NNS O
, , , O
pulse NN NN O
90 CD CD O
, , , O
respiratory JJ JJ O
rate NN NN O
18 CD CD O
, , , O
blood NN NN O
pressure NN NN O
114/60 CD CD O
, , , O
room NN NN O
air NN NN O
saturation NN NN O
91 CD CD O
% NN NN O
. . . O
   
HEENT NNP NNP O
: : : O
Normocephalic NNP NNP O
, , , O
atraumatic JJ JJ O
. . . O
   
Pupils NNP NNP O
equal JJ JJ O
, , , O
round NN NN O
, , , O
and CC CC O
reactive VB VB O
to TO TO O
light VB VB O
and CC CC O
accommodation NN NN O
. . . O
   
Neck NNP NNP O
supple NN NN O
and CC CC O
nontender NN NN O
. . . O
   
Chest NN NN O
: : : O
Bibasilar NNP NNP O
crackles NNS NNS O
. . . O
   
Left NNP NNP O
sided VBD VBD O
rhonchi NN NN O
. . . O
   
Abdomen NNP NNP O
: : : O
Obvious JJ JJ O
infected JJ JJ O
wound NN NN O
. . . O
   
Minimally RB RB O
tender NN NN O
. . . O
   
Extremities NNP NNP O
: : : O
Negative NNP NNP O
. . . O
   
Neurologic NNP NNP O
: : : O
Symmetric NNP NNP O
. . . O
   
Alert NNP NNP O
and CC CC O
oriented JJ JJ O
times NNS NNS O
two CD CD O
. . . O
   
Reflexes NNP NNP O
normal JJ JJ O
, , , O
strength NN NN O
normal JJ JJ O
. . . O
   
LABORATORY NNP NNP O
EVALUATION NNP NNP O
: : : O
WBC NNP NNP O
   
28 CD CD O
. . . O
THERAPY NNP NNP O
RENDERED/COURSE NNP NNP O
IN IN IN O
ED NNP NNP O
: : : O
The DT DT O
patient NN NN O
was VBD VBD O
given VBN VBN O
IV NNP NNP O
antibiotics NNS NNS O
and CC CC O
will MD MD O
be VB VB O
admitted VBN VBN O
to TO TO O
the DT DT O
medical JJ JJ O
service NN NN O
for IN IN O
workup NN NN O
. . . O
   
PROCEDURES NNP NNP O
: : : O
CONSULTATIONS NNP NNP O
( ( ( O
including VBG VBG O
PCP NNP NNP O
) ) ) O
: : : O
FINAL NNP NNP O
DIAGNOSIS NNP NNP O
: : : O
Urosepsis NNP NNP O
. . . O
   
DISPOSITION NNP NNP O
( ( ( O
including VBG VBG O
condition NN NN O
upon IN IN O
discharge NN NN O
) ) ) O
: : : O
She PRP PRP O
was VBD VBD O
admitted VBN VBN O
in IN IN O
poor JJ JJ O
condition NN NN O
. . . O
   
__________________________________ NN NN O
_ NN NN O
ZD548/6212 NNP NNP I-IDNUM
D:10/21/65 NNP NNP O
T:10/21/65 NNP NNP O
Dictated NNP NNP O
by IN IN O
: : : O
RUBEN NNP NNP I-DOCTOR
ZACARIAS NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
   
RZ1 NNP NNP I-USERNAME
******** NN NN O
Not RB RB O
reviewed VBN VBN O
by IN IN O
Attending NNP NNP O
Physician NNP NNP O
******** NN NN O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2095-10-23 JJ JJ I-DATE
RAH NNP NNP I-HOSPITAL
EMERGENCY NNP NNP O
DEPT NNP NNP O
VISIT NNP NNP O
DUVALL,BRADY NNP NNP I-PATIENT
C NNP NNP I-PATIENT
425-03-15-1 NN NN I-MEDICALRECORD
VISIT NNP NNP O
DATE NN NN O
: : : O
10/23/95 CD CD I-DATE
HISTORY NN NN O
OF IN IN O
PRESENTING NNP NNP O
COMPLAINT NNP NNP O
: : : O
The DT DT O
patient NN NN O
is VBZ VBZ O
an DT DT O
unfortunate JJ JJ O
73 CD CD I-AGE
year NN NN O
old JJ JJ O
man NN NN O
who WP WP O
has VBZ VBZ O
had VBN VBN O
two CD CD O
myocardial JJ JJ O
infarctions NNS NNS O
in IN IN O
the DT DT O
past NN NN O
, , , O
including VBG VBG O
an DT DT O
IMI NNP NNP O
, , , O
and CC CC O
ventricular NN NN O
tachycardia NNS NNS O
and CC CC O
ventricular NN NN O
fibrillation NN NN O
who WP WP O
has VBZ VBZ O
an DT DT O
AICD NNP NNP O
in IN IN O
who WP WP O
presents VBZ VBZ O
today NN NN O
with IN IN O
his PRP$ PRP$ O
AICD NNP NNP O
firing VBG VBG O
multiple JJ JJ O
times NNS NNS O
. . . O
   
The DT DT O
patient NN NN O
's POS POS O
AICD NNP NNP O
actually RB RB O
fired VBD VBD O
multiple JJ JJ O
times NNS NNS O
while IN IN O
he PRP PRP O
was VBD VBD O
in IN IN O
the DT DT O
Emergency NNP NNP O
Department NNP NNP O
. . . O
   
REVIEW NNP NNP O
OF IN IN O
SYSTEMS NNP NNP O
: : : O
The DT DT O
patient NN NN O
has VBZ VBZ O
no DT DT O
chest NN NN O
pain NN NN O
, , , O
syncope NN NN O
, , , O
or CC CC O
shortness NN NN O
of IN IN O
breath NN NN O
. . . O
   
He PRP PRP O
presents VBZ VBZ O
in IN IN O
ventricular NN NN O
tachycardia NNS NNS O
with IN IN O
his PRP$ PRP$ O
AICD NNP NNP O
firing VBG VBG O
. . . O
   
PAST NNP NNP O
MEDICAL NNP NNP O
HISTORY NN NN O
: : : O
The DT DT O
patient NN NN O
has VBZ VBZ O
a DT DT O
significant JJ JJ O
coronary JJ JJ O
artery NN NN O
disease NN NN O
history NN NN O
and CC CC O
recently RB RB O
had VBD VBD O
his PRP$ PRP$ O
pacer NN NN O
placed VBN VBN O
, , , O
approximately RB RB O
a DT DT O
month NN NN O
ago RB RB O
. . . O
   
He PRP PRP O
has VBZ VBZ O
had VBN VBN O
two CD CD O
myocardial JJ JJ O
infarctions NNS NNS O
. . . O
   
He PRP PRP O
has VBZ VBZ O
diabetes NNS NNS O
. . . O
   
MEDICATIONS NNP NNP O
: : : O
Glyburide NNP NNP O
and CC CC O
metformin NN NN O
. . . O
   
ALLERGIES NNP NNP O
: : : O
Atenolol NNP NNP O
. . . O
   
PHYSICAL JJ JJ O
EXAMINATION NNP NNP O
: : : O
VITAL NNP NNP O
SIGNS NNP NNP O
: : : O
Vital NNP NNP O
signs NNS NNS O
remained VBD VBD O
stable JJ JJ O
, , , O
including VBG VBG O
blood NN NN O
pressure NN NN O
. . . O
   
HEENT NNP NNP O
: : : O
Normal JJ JJ O
. . . O
   
LUNGS NNP NNP O
: : : O
Clear NNP NNP O
. . . O
   
CARDIOVASCULAR NNP NNP O
: : : O
Tachycardic NNP NNP O
with IN IN O
a DT DT O
paced JJ JJ O
rhythm NN NN O
. . . O
   
ABDOMEN NNP NNP O
: : : O
Soft JJ JJ O
, , , O
non-tender NN NN O
. . . O
   
LUNGS NNP NNP O
: : : O
Clear JJ JJ O
bilaterally RB RB O
. . . O
   
LABORATORY NNP NNP O
EVALUATION NNP NNP O
: : : O
The DT DT O
patient NN NN O
's POS POS O
EKG NNP NNP O
shows VBZ VBZ O
ventricular NN NN O
tachycardia NNS NNS O
and CC CC O
some DT DT O
ST NNP NNP O
elevations NNS NNS O
in IN IN O
the DT DT O
inferior JJ JJ O
leads VBZ VBZ O
. . . O
   
Chest NN NN O
x-ray NN NN O
was VBD VBD O
clear JJ JJ O
. . . O
   
Electrolytes NNP NNP O
were VBD VBD O
sent VBN VBN O
to TO TO O
check VB VB O
his PRP$ PRP$ O
potassium NN NN O
. . . O
   
THERAPY NNP NNP O
RENDERED/COURSE NNP NNP O
IN IN IN O
ED NNP NNP O
: : : O
The DT DT O
patient NN NN O
was VBD VBD O
loaded VBN VBN O
on IN IN O
lidocaine NN NN O
and CC CC O
paced VBN VBN O
on IN IN O
a DT DT O
lidocaine NN NN O
drip NN NN O
. . . O
   
He PRP PRP O
also RB RB O
received VBD VBD O
Lasix NNP NNP O
and CC CC O
metoprolol NN NN O
. . . O
   
He PRP PRP O
also RB RB O
received VBD VBD O
2 CD CD O
mg NN NN O
of IN IN O
Ativan NNP NNP O
for IN IN O
sedation NN NN O
. . . O
   
He PRP PRP O
had VBD VBD O
no DT DT O
chest NN NN O
pain NN NN O
while IN IN O
he PRP PRP O
was VBD VBD O
in IN IN O
the DT DT O
Emergency NNP NNP O
Department NNP NNP O
; : : O
   
his PRP$ PRP$ O
only RB RB O
pain NN NN O
was VBD VBD O
from IN IN O
the DT DT O
pacer NN NN O
firing VBG VBG O
. . . O
   
CONSULTATIONS NNP NNP O
( ( ( O
including VBG VBG O
PCP NNP NNP O
) ) ) O
: : : O
The DT DT O
patient NN NN O
was VBD VBD O
seen VBN VBN O
by IN IN O
Internal NNP NNP O
Medicine NNP NNP O
and CC CC O
also RB RB O
by IN IN O
the DT DT O
Internal NNP NNP O
Medicine NNP NNP O
fellow NN NN O
. . . O
   
FINAL NNP NNP O
DIAGNOSIS NNP NNP O
: : : O
History NN NN O
of IN IN O
coronary JJ JJ O
artery NN NN O
disease NN NN O
, , , O
now RB RB O
with IN IN O
ventricular NN NN O
tachycardia NNS NNS O
and CC CC O
ST NNP NNP O
elevations NNS NNS O
on IN IN O
EKG NNP NNP O
with IN IN O
pacer NN NN O
firing VBG VBG O
. . . O
   
DISPOSITION NNP NNP O
( ( ( O
including VBG VBG O
condition NN NN O
upon IN IN O
discharge NN NN O
) ) ) O
: : : O
The DT DT O
patient NN NN O
was VBD VBD O
urgently RB RB O
rushed VBN VBN O
to TO TO O
the DT DT O
Cath NNP NNP O
Lab NNP NNP O
. . . O
   
He PRP PRP O
is VBZ VBZ O
currently RB RB O
in IN IN O
stable JJ JJ O
condition NN NN O
. . . O
   
__________________________________ NN NN O
_ NN NN O
OT109/6637 NNP NNP I-IDNUM
FRANK NNP NNP I-DOCTOR
EMMONS NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
   
FE01 NNP NNP I-USERNAME
D:10/23/95 NNP NNP O
T:10/23/95 NNP NNP O
Dictated NNP NNP O
by IN IN O
: : : O
FRANK NNP NNP I-DOCTOR
EMMONS NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
   
FE01 NNP NNP I-USERNAME
******** NN NN O
Not RB RB O
reviewed VBN VBN O
by IN IN O
Attending NNP NNP O
Physician NNP NNP O
******** NN NN O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2077-02-28 JJ JJ I-DATE
ENDOCRINE/DIABETES NNP NNP O
STAFF NNP NNP O
CONSULTATION NNP NNP O
Patient NNP NNP O
: : : O
VAUGHN NNP NNP O
, , , O
FRANK NNP NNP I-PATIENT
MANAMANA NNP NNP I-HOSPITAL
MRN NNP NNP O
: : : O
6767510 CD CD I-MEDICALRECORD
Requesting NNP NNP O
MD NNP NNP O
: : : O
Dr NNP NNP O
. . . O
Quale NNP NNP I-DOCTOR
Service NNP NNP O
: : : O
SICU NNP NNP O
CC/ID NNP NNP O
: : : O
Asked VBD VBD O
to TO TO O
see VB VB O
this DT DT O
33 CD CD I-AGE
y/o NN NN O
M NNP NNP O
admitted VBD VBD O
with IN IN I-PROFESSION
Fourier NNP NNP O
's POS POS O
gangrene NN NN O
, , , O
s/p NN NN O
multiple JJ JJ O
surgical JJ JJ O
procedures NNS NNS O
, , , O
for IN IN O
DM NNP NNP O
management NN NN O
HPI/ROS NNP NNP O
: : : O
Pt NNP NNP O
is VBZ VBZ O
a DT DT O
33 CD CD I-AGE
y/o NN NN O
with IN IN I-PROFESSION
DM-2 NNP NNP O
who WP WP O
was VBD VBD O
in IN IN O
his PRP$ PRP$ O
USH NNP NNP O
until IN IN O
about IN IN O
2 CD CD O
weeks NNS NNS O
PTA NNP NNP O
, , , O
when WRB WRB O
he PRP PRP O
developed VBD VBD O
buttock NN NN O
pain NN NN O
. . . O
   
He PRP PRP O
had VBD VBD O
some DT DT O
purulent NN NN O
D/C NNP NNP O
from IN IN O
rectum NN NN O
and CC CC O
worsening VBG VBG O
of IN IN I-PROFESSION
glucose NN NN O
control NN NN O
. . . O
   
He PRP PRP O
was VBD VBD O
seen VBN VBN O
in IN IN O
EDUCARE-PULLMAN NNP NNP I-HOSPITAL
Urgent NNP NNP O
Care NNP NNP O
on IN IN O
1/21/77 CD CD I-DATE
at IN IN O
which WDT WDT O
time NN NN O
a DT DT O
small JJ JJ O
erythematous JJ JJ O
and CC CC O
tender NN NN O
cyst NN NN O
was VBD VBD O
noted VBN VBN O
between IN IN O
his PRP$ PRP$ O
buttocks NNS NNS O
. . . O
   
He PRP PRP O
was VBD VBD O
prescribed VBN VBN O
sitz JJ JJ O
baths NNS NNS O
and CC CC O
Keflex NNP NNP O
for IN IN O
pilonidol NN NN O
cyst NN NN O
vs NNS NNS O
. . . O
ruptured VBD VBD O
boil NN NN O
. . . O
   
He PRP PRP O
was VBD VBD O
seen VBN VBN O
again RB RB O
in IN IN O
EDUCARE-PULLMAN NNP NNP I-HOSPITAL
on IN IN O
1/29/77 CD CD I-DATE
at IN IN O
which WDT WDT O
time NN NN O
he PRP PRP O
reported VBD VBD O
resolution NN NN O
of IN IN I-PROFESSION
his PRP$ PRP$ O
buttock NN NN O
pain NN NN O
. . . O
   
He PRP PRP O
denied VBD VBD O
fevers NNS NNS O
or CC CC O
neurologic JJ JJ O
symptoms NNS NNS O
. . . O
   
Exam NNP NNP O
was VBD VBD O
notable JJ JJ O
for IN IN O
only RB RB O
a DT DT O
tiny JJ JJ O
pustule NN NN O
in IN IN O
the DT DT O
upper JJ JJ O
gluteal NN NN O
cleft NN NN O
, , , O
minimally RB RB O
erythematous JJ JJ O
, , , O
non-tender JJ JJ O
, , , O
without IN IN O
drainage NN NN O
. . . O
   
On IN IN O
the DT DT O
morning NN NN O
of IN IN I-PROFESSION
2/01/77 CD CD I-DATE
he PRP PRP O
developed JJ JJ O
worsening VBG VBG O
of IN IN I-PROFESSION
his PRP$ PRP$ O
shortness NN NN O
of IN IN I-PROFESSION
breath NN NN O
, , , O
followed VBN VBN O
by IN IN O
the DT DT O
development NN NN O
of IN IN I-PROFESSION
left VBD VBD O
jaw NN NN O
pain NN NN O
, , , O
and CC CC O
cold JJ JJ O
sweats NNS NNS O
, , , O
so IN IN O
he PRP PRP O
presented VBD VBD O
to TO TO O
the DT DT O
MANAMANA NNP NNP I-HOSPITAL
ED NNP NNP O
. . . O
   
On IN IN O
presentation NN NN O
, , , O
he PRP PRP O
also RB RB O
admitted VBD VBD O
to TO TO O
three CD CD O
days NNS NNS O
of IN IN I-PROFESSION
scrotal NN NN O
and CC CC O
perineal NN NN O
pain NN NN O
and CC CC O
swelling VBG VBG O
. . . O
   
In IN IN O
the DT DT O
ED NNP NNP O
he PRP PRP O
was VBD VBD O
tachycardic JJ JJ O
to TO TO O
113 CD CD O
, , , O
normotensive JJ JJ O
, , , O
initially RB RB O
low-grade JJ JJ O
fever NN NN O
, , , O
but CC CC O
later RB RB O
spiked VBN VBN O
to TO TO O
102.9 CD CD O
. . . O
   
On IN IN O
examination NN NN O
, , , O
there EX EX O
was VBD VBD O
severe JJ JJ O
bilateral JJ JJ O
testicular NN NN O
swelling VBG VBG O
and CC CC O
pain NN NN O
, , , O
with IN IN I-PROFESSION
a DT DT O
fluctuant JJ JJ O
mass NN NN O
between IN IN O
the DT DT O
rectum NN NN O
and CC CC O
scrotum NN NN O
. . . O
   
His PRP$ PRP$ O
WBC NNP NNP O
was VBD VBD O
18,000 CD CD O
with IN IN I-PROFESSION
91 CD CD O
% NN NN O
PMNs NNP NNP O
. . . O
   
An DT DT O
abdominal JJ JJ O
CT NNP NNP O
revealed VBD VBD O
extensive JJ JJ O
subcutaneous JJ JJ O
edema NN NN O
in IN IN O
the DT DT O
perineum NN NN O
, , , O
with IN IN I-PROFESSION
multiple JJ JJ O
foci NN NN O
of IN IN I-PROFESSION
air NN NN O
consistent JJ JJ O
with IN IN I-PROFESSION
a DT DT O
necrotizing VBG VBG O
infection NN NN O
; : : O
   
and CC CC O
extensive JJ JJ O
fluid NN NN O
in IN IN O
the DT DT O
scrotum NN NN O
, , , O
consistent JJ JJ O
with IN IN I-PROFESSION
Fournier NNP NNP O
's POS POS O
gangrene NN NN O
. . . O
   
The DT DT O
patient NN NN O
was VBD VBD O
treated VBN VBN O
with IN IN I-PROFESSION
IV NNP NNP O
Abx NNP NNP O
and CC CC O
was VBD VBD O
taken VBN VBN O
urgently RB RB O
to TO TO O
the DT DT O
OR CC CC O
, , , O
where WRB WRB O
he PRP PRP O
underwent VBD VBD O
extensive JJ JJ O
debridement NN NN O
at IN IN O
which WDT WDT O
time NN NN O
substantial JJ JJ O
necrosis NN NN O
and CC CC O
pus NN NN O
were VBD VBD O
discovered VBN VBN O
. . . O
   
He PRP PRP O
was VBD VBD O
admitted VBN VBN O
to TO TO O
the DT DT O
SICU NNP NNP O
and CC CC O
has VBZ VBZ O
since IN IN O
undergone JJ JJ O
multiple JJ JJ O
debridements NNS NNS O
, , , O
last JJ JJ O
on IN IN O
2/20/77 CD CD I-DATE
. . . O
   
In IN IN O
terms NNS NNS O
of IN IN I-PROFESSION
his PRP$ PRP$ O
DM NNP NNP O
, , , O
he PRP PRP O
has VBZ VBZ O
type NN NN O
2 CD CD O
diagnosed VBN VBN O
in IN IN O
October NNP NNP I-DATE
2075 CD CD I-DATE
. . . O
   
At IN IN O
the DT DT O
time NN NN O
he PRP PRP O
was VBD VBD O
feeling VBG VBG O
"""" '' '' O
lousy JJ JJ O
, , , O
"""" '' '' O
tired JJ JJ O
, , , O
nauseated JJ JJ O
, , , O
and CC CC O
increased VBD VBD O
urinary JJ JJ O
frequency NN NN O
: : : O
went VBD VBD O
to TO TO O
Payson NNP NNP I-HOSPITAL
Hospital NNP NNP I-HOSPITAL
and CC CC O
FS NNP NNP O
was VBD VBD O
376 CD CD O
. . . O
   
Pt NNP NNP O
was VBD VBD O
admitted VBN VBN O
overnight JJ JJ O
and CC CC O
given VBN VBN O
insulin NN NN O
; : : O
   
started VBD VBD O
on IN IN O
Metformin NNP NNP O
500 CD CD O
bid NN NN O
, , , O
eventually RB RB O
insulin NN NN O
was VBD VBD O
added VBN VBN O
. . . O
   
He PRP PRP O
was VBD VBD O
being VBG VBG O
followed VBN VBN O
by IN IN O
Dr NNP NNP O
. . . O
Talley NNP NNP I-DOCTOR
at IN IN O
the DT DT O
Promptcare NNP NNP I-HOSPITAL
but CC CC O
stopped VBD VBD O
going VBG VBG O
there RB RB O
. . . O
   
Most JJS JJS O
recently RB RB O
treated VBN VBN O
with IN IN I-PROFESSION
Lantus NNP NNP O
50 CD CD O
units NNS NNS O
at IN IN O
bedtime NN NN O
plus CC CC O
maximal NN NN O
doses NNS NNS O
of IN IN I-PROFESSION
Glipizide NNP NNP O
10 CD CD O
bid NN NN O
and CC CC O
Metformin NNP NNP O
1000 CD CD O
bid NN NN O
, , , O
with IN IN I-PROFESSION
uncontrolled JJ JJ O
HbA1c NNP NNP O
( ( ( O
see VB VB O
below IN IN O
) ) ) O
. . . O
   
He PRP PRP O
has VBZ VBZ O
microalbuminuria NN NN O
. . . O
   
He PRP PRP O
is VBZ VBZ O
unable JJ JJ O
to TO TO O
give VB VB O
me PRP PRP O
a DT DT O
full JJ JJ O
history NN NN O
. . . O
   
In IN IN O
the DT DT O
SICU NNP NNP O
he PRP PRP O
has VBZ VBZ O
been VBN VBN O
treated VBN VBN O
with IN IN I-PROFESSION
an DT DT O
insulin NN NN O
drip NN NN O
, , , O
which WDT WDT O
oscillates VBZ VBZ O
between IN IN O
4-11 JJ JJ O
U/hr NNP NNP O
. . . O
   
He PRP PRP O
is VBZ VBZ O
being VBG VBG O
fed VBN VBN O
with IN IN I-PROFESSION
Glucerna NNP NNP O
continuous JJ JJ O
TF NNP NNP O
at IN IN O
120 CD CD O
cc/hr NN NN O
, , , O
and CC CC O
has VBZ VBZ O
been VBN VBN O
started VBN VBN O
on IN IN O
NPH NNP NNP O
50 CD CD O
U NNP NNP O
q12h NN NN O
. . . O
   
PMH NNP NNP O
: : : O
   
1 CD CD O
. . . O
DM-2 NNP NNP O
   
2 CD CD O
. . . O
HTN NNP NNP O
   
3 CD CD O
. . . O
Mixed NNP NNP O
dyslipidemia NN NN O
   
4 CD CD O
. . . O
Depression NNP NNP O
   
5 CD CD O
. . . O
Obesity NNP NNP O
   
6 CD CD O
. . . O
Back RB RB O
pain NN NN O
   
7 CD CD O
. . . O
Fourier NNP NNP O
's POS POS O
gangrene NN NN O
as IN IN O
above IN IN O
   
8 CD CD O
. . . O
Hyponatremia NNP NNP O
on IN IN O
HCTZ NNP NNP O
ALL NNP NNP O
: : : O
NKDA NNP NNP O
MEDS NNP NNP O
PTA NNP NNP O
: : : O
   
1 CD CD O
. . . O
ASA NNP NNP O
81 CD CD O
daily JJ JJ O
   
2 CD CD O
. . . O
Atenolol NNP NNP O
100 CD CD O
qam NN NN O
, , , O
50 CD CD O
qpm NN NN O
   
3 CD CD O
. . . O
Celexa NNP NNP O
60 CD CD O
daily JJ JJ O
   
4 CD CD O
. . . O
Fenofibrate NNP NNP O
145 CD CD O
daily JJ JJ O
   
5 CD CD O
. . . O
Glipizide NNP NNP O
10 CD CD O
bid NN NN O
   
6 CD CD O
. . . O
Klonopin NNP NNP O
1 CD CD O
prn NN NN O
   
7 CD CD O
. . . O
Lantus NNP NNP O
insulin NN NN O
50 CD CD O
units NNS NNS O
bedtime NN NN O
   
8 CD CD O
. . . O
Lipitor NNP NNP O
80 CD CD O
daily JJ JJ O
   
9 CD CD O
. . . O
Lisinopril NNP NNP O
40 CD CD O
daily JJ JJ O
   
10 CD CD O
. . . O
Losartan NNP NNP O
25 CD CD O
daily JJ JJ O
   
11 CD CD O
. . . O
Metformin NNP NNP O
1000 CD CD O
bid NN NN O
Current NNP NNP O
MEDS NNP NNP O
: : : O
   
1 CD CD O
. . . O
Insulin NNP NNP O
gtt NN NN O
4-11 JJ JJ O
U/hr NNP NNP O
   
2 CD CD O
. . . O
Lopressor NNP NNP O
75 CD CD O
qid NN NN O
   
3 CD CD O
. . . O
Seroquel NNP NNP O
25 CD CD O
bid NN NN O
   
4 CD CD O
. . . O
Nexium NNP NNP O
40 CD CD O
daily JJ JJ O
   
5 CD CD O
. . . O
Celexa NNP NNP O
60 CD CD O
daily JJ JJ O
   
6 CD CD O
. . . O
Vancomycin NNP NNP O
2g CD CD O
IV NNP NNP O
q12h NN NN O
   
7 CD CD O
. . . O
Cefepime NNP NNP O
2g CD CD O
IV NNP NNP O
q12h NN NN O
   
8 CD CD O
. . . O
Ativan NNP NNP O
0.5 CD CD O
IV NNP NNP O
q12h NN NN O
   
9 CD CD O
. . . O
Dilaudid NNP NNP O
0.25 CD CD O
IV NNP NNP O
q4h NN NN O
   
10 CD CD O
. . . O
Levofloxacin NNP NNP O
750 CD CD O
mg NN NN O
IV NNP NNP O
daily JJ JJ O
   
11 CD CD O
. . . O
Lovenox NNP NNP O
30 CD CD O
mg NN NN O
bid NN NN O
   
12 CD CD O
. . . O
NPH NNP NNP O
50 CD CD O
units NNS NNS O
q12h NN NN O
   
13 CD CD O
. . . O
Iron NNP NNP O
sulfate NN NN O
300 CD CD O
tid NN NN O
HAB NNP NNP O
: : : O
Tobacco NNP NNP O
: : : O
denies NNS NNS O
EtOH NNP NNP O
: : : O
occasional JJ JJ O
RD NNP NNP O
: : : O
denies NNS NNS O
SH NNP NNP O
: : : O
Works NNP NNP O
as IN IN O
a DT DT O
Teacher NN NN I-PROFESSION
of IN IN I-PROFESSION
Persons NNP NNP I-PROFESSION
with IN IN I-PROFESSION
Disabilities NNS NNS I-PROFESSION
. . . O
   
FH NNP NNP O
: : : O
Father NNP NNP O
had VBD VBD O
an DT DT O
MI NNP NNP O
in IN IN O
his PRP$ PRP$ O
40's. CD CD O
   
PE NNP NNP O
: : : O
VS NNP NNP O
: : : O
T NN NN O
100.2 CD CD O
P NN NN O
95 CD CD O
BP NNP NNP O
127/75 CD CD O
RR NNP NNP O
18 CD CD O
O2 NNP NNP O
99 CD CD O
% NN NN O
2L CD CD O
NC NNP NNP O
Wt NNP NNP O
341 CD CD O
lbs NN NN O
PTA NNP NNP O
Gen NNP NNP O
: : : O
Alert NNP NNP O
, , , O
calm VB VB O
, , , O
comfortable JJ JJ O
, , , O
NAD NNP NNP O
; : : O
   
decreased VBD VBD O
phonation NN NN O
but CC CC O
understands NNS NNS O
and CC CC O
follows VBZ VBZ O
commands NNS NNS O
HEENT NNP NNP O
: : : O
NC/AT NNP NNP O
, , , O
EOMI NNP NNP O
, , , O
PERRL NNP NNP O
, , , O
OP NNP NNP O
clear JJ JJ O
, , , O
dry JJ JJ O
MM NNP NNP O
, , , O
Anicteric NNP NNP O
Neck NNP NNP O
: : : O
Supple NNP NNP O
, , , O
LAD NNP NNP O
, , , O
carotids NNS NNS O
2 CD CD O
+ NN NN O
w/o NN NN O
bruits NNS NNS O
Lungs NNP NNP O
: : : O
CTA NNP NNP O
B NNP NNP O
( ( ( O
anterior NN NN O
exam NN NN O
) ) ) O
CV NNP NNP O
: : : O
RRR NNP NNP O
Nl NNP NNP O
S1 NNP NNP O
S2 NNP NNP O
M/G/R NNP NNP O
Abdomen NNP NNP O
: : : O
NABS NNP NNP O
soft JJ JJ O
ND NNP NNP O
Ostomy NNP NNP O
pink VB VB O
with IN IN I-PROFESSION
light JJ JJ O
brown JJ JJ O
stool NN NN O
Ext NNP NNP O
: : : O
c/c/e NN NN O
DP NNP NNP O
2 CD CD O
+ NN NN O
B NNP NNP O
Warm NNP NNP O
and CC CC O
well RB RB O
perfused VBN VBN O
Neuro NNP NNP O
: : : O
MS NNP NNP O
: : : O
A&Ox3 NNP NNP O
Moves NNP NNP O
all DT DT O
4 CD CD O
Data NNS NNS O
02/28/2077 CD CD I-DATE
NA NNP NNP O
143 CD CD O
, , , O
K NNP NNP O
4.0 CD CD O
, , , O
CL NNP NNP O
110 CD CD O
( ( ( O
H NNP NNP O
) ) ) O
, , , O
CO2 NNP NNP O
23.0 CD CD O
, , , O
BUN NNP NNP O
28 CD CD O
( ( ( O
H NNP NNP O
) ) ) O
, , , O
CRE NNP NNP O
0.8 CD CD O
, , , O
GLU NNP NNP O
101 CD CD O
02/28/2077 CD CD I-DATE
CA NNP NNP O
9.3 CD CD O
, , , O
PHOS NNP NNP O
3.3 CD CD O
, , , O
MG NNP NNP O
1.6 CD CD O
02/27/2077 CD CD I-DATE
IC NNP NNP O
1.21 CD CD O
02/28/2077 NN NN I-DATE
WBC NNP NNP O
10.5 CD CD O
, , , O
RBC NNP NNP O
3.11 CD CD O
( ( ( O
L NNP NNP O
) ) ) O
, , , O
HGB NNP NNP O
8.8 CD CD O
( ( ( O
L NNP NNP O
) ) ) O
, , , O
HCT NNP NNP O
26.1 CD CD O
( ( ( O
L NNP NNP O
) ) ) O
, , , O
MCV NNP NNP O
84 CD CD O
, , , O
MCH NNP NNP O
28.4 CD CD O
, , , O
MCHC NNP NNP O
33.8 CD CD O
, , , O
PLT NNP NNP O
351 CD CD O
( ( ( O
H NNP NNP O
) ) ) O
, , , O
RDW NNP NNP O
17.6 CD CD O
( ( ( O
H NNP NNP O
) ) ) O
02/26/2077 CD CD I-DATE
ALT/SGPT NNP NNP O
26 CD CD O
, , , O
AST/SGOT NNP NNP O
20 CD CD O
, , , O
ALKP NNP NNP O
75 CD CD O
, , , O
TBILI NNP NNP O
0.3 CD CD O
, , , O
DBILI NNP NNP O
0.1 CD CD O
02/13/2077 CD CD I-DATE
CHOL NNP NNP O
124 CD CD O
, , , O
TRIG NNP NNP O
346 CD CD O
( ( ( O
H NNP NNP O
) ) ) O
02/07/2077 CD CD I-DATE
CHOL NNP NNP O
106 CD CD O
, , , O
TRIG NNP NNP O
226 CD CD O
( ( ( O
H NNP NNP O
) ) ) O
02/04/2077 CD CD I-DATE
CHOL NNP NNP O
141 CD CD O
, , , O
TRIG NNP NNP O
478 CD CD O
( ( ( O
H NNP NNP O
) ) ) O
, , , O
HDL NNP NNP O
13 CD CD O
( ( ( O
L NNP NNP O
) ) ) O
, , , O
LDL NNP NNP O
--, CD CD O
CHOL/HDL NNP NNP O
10.8 CD CD O
02/10/2077 CD CD I-DATE
CORT NNP NNP O
30.4 CD CD O
02/10/2077 CD CD I-DATE
CORT NNP NNP O
13.6 CD CD O
12/20/2076 CD CD I-DATE
MALB NNP NNP O
286 CD CD O
(*), NN NN O
MALB/CRE NNP NNP O
4132.9 CD CD O
(*) NN NN O
12/20/2076 CD CD I-DATE
HGBA1C NNP NNP O
11.3 CD CD O
(*) NN NN O
08/30/2076 CD CD I-DATE
HGBA1C NNP NNP O
10.0 CD CD O
(*) NN NN O
06/20/2076 CD CD I-DATE
HGBA1C NNP NNP O
11.4 CD CD O
(*) NN NN O
03/26/2076 CD CD I-DATE
HGBA1C NNP NNP O
8.4 CD CD O
(*) NN NN O
12/20/2075 CD CD I-DATE
HGBA1C NNP NNP O
8.0 CD CD O
(*) NN NN O
11/14/2075 CD CD I-DATE
HGBA1C NNP NNP O
10.6 CD CD O
(*) NN NN O
Impression NNP NNP O
: : : O
33 CD CD I-AGE
y/o NN NN O
M NNP NNP O
with IN IN I-PROFESSION
DM-2 NNP NNP O
requiring VBG VBG O
insulin NN NN O
, , , O
uncontrolled JJ JJ O
PTA NNP NNP O
, , , O
here RB RB O
recovering VBG VBG O
from IN IN O
Fournier NNP NNP O
's POS POS O
gangrene NN NN O
, , , O
still RB RB O
in IN IN O
ICU NNP NNP O
with IN IN I-PROFESSION
multiple JJ JJ O
IV NNP NNP O
Abx NNP NNP O
and CC CC O
being VBG VBG O
fed VBN VBN O
with IN IN I-PROFESSION
TF NNP NNP O
, , , O
requiring VBG VBG O
high JJ JJ O
doses NNS NNS O
of IN IN I-PROFESSION
insulin NN NN O
both DT DT O
IV NNP NNP O
and CC CC O
SQ NNP NNP O
. . . O
Pt NNP NNP O
's POS POS O
insulin NN NN O
requirement NN NN O
is VBZ VBZ O
very RB RB O
large JJ JJ O
due JJ JJ O
to TO TO O
1 CD CD O
) ) ) O
marked VBD VBD O
insulin NN NN O
resistance NN NN O
secondary JJ JJ O
to TO TO O
obesity NN NN O
, , , O
2 CD CD O
) ) ) O
ongoing JJ JJ O
infection NN NN O
and CC CC O
critical JJ JJ O
illness NN NN O
, , , O
and CC CC O
3 CD CD O
) ) ) O
enteral JJ JJ O
TF NNP NNP O
. . . O
   
Would MD MD O
maintain VB VB O
on IN IN O
insulin NN NN O
drip NN NN O
while IN IN O
titrating VBG VBG O
NPH NNP NNP O
doses NNS NNS O
upwards NNS NNS O
by IN IN O
10 CD CD O
U NNP NNP O
q12h NN NN O
each DT DT O
dose NN NN O
as RB RB O
long RB RB O
as IN IN O
czi NN NN O
drip NN NN O
is VBZ VBZ O
needed VBN VBN O
. . . O
   
Considering VBG VBG O
his PRP$ PRP$ O
current JJ JJ O
requirement NN NN O
of IN IN I-PROFESSION
at IN IN O
least JJS JJS O
120 CD CD O
U NNP NNP O
IV/24h NNP NNP O
on IN IN O
top NN NN O
of IN IN I-PROFESSION
his PRP$ PRP$ O
SQ NNP NNP O
doses NNS NNS O
, , , O
he PRP PRP O
will MD MD O
probably RB RB O
need VB VB O
close VB VB O
to TO TO O
100 CD CD O
U NNP NNP O
q12h NN NN O
. . . O
   
Could MD MD O
safely RB RB O
increase VB VB O
his PRP$ PRP$ O
NPH NNP NNP O
to TO TO O
80 CD CD O
U NNP NNP O
q12h NN NN O
right RB RB O
now RB RB O
. . . O
   
Would MD MD O
make VB VB O
sure JJ JJ O
that IN IN O
in IN IN O
the DT DT O
Instructions NNP NNP O
to TO TO O
this DT DT O
order NN NN O
it PRP PRP O
's VBZ VBZ O
written VBN VBN O
to TO TO O
hold VB VB O
NPH NNP NNP O
if IN IN O
TF NNP NNP O
stop NN NN O
for IN IN O
any DT DT O
reason NN NN O
, , , O
and CC CC O
start VB VB O
D10W NNP NNP O
@ IN IN O
50 CD CD O
cc/hr NN NN O
for IN IN O
12h CD CD O
after IN IN O
the DT DT O
last JJ JJ O
NPH NNP NNP O
dose NN NN O
if IN IN O
that DT DT O
happens VBZ VBZ O
. . . O
   
Recommend NNP NNP O
: : : O
   
1 CD CD O
. . . O
Increase VB VB O
NPH NNP NNP O
to TO TO O
80 CD CD O
U NNP NNP O
q12h NN NN O
   
2 CD CD O
. . . O
Titrate NNP NNP O
NPH NNP NNP O
doses NNS NNS O
upwards NNS NNS O
by IN IN O
10 CD CD O
U NNP NNP O
q12h NN NN O
each DT DT O
dose NN NN O
as RB RB O
long RB RB O
as IN IN O
czi NN NN O
drip NN NN O
is VBZ VBZ O
needed VBN VBN O
   
3 CD CD O
. . . O
Please VB VB O
make VB VB O
sure JJ JJ O
that IN IN O
in IN IN O
the DT DT O
Instructions NNP NNP O
to TO TO O
the DT DT O
NPH NNP NNP O
order NN NN O
it PRP PRP O
's VBZ VBZ O
written VBN VBN O
to TO TO O
hold VB VB O
NPH NNP NNP O
if IN IN O
TF NNP NNP O
stop NN NN O
for IN IN O
any DT DT O
reason NN NN O
, , , O
and CC CC O
start VB VB O
D10W NNP NNP O
@ IN IN O
50 CD CD O
cc/hr NN NN O
for IN IN O
12h CD CD O
after IN IN O
the DT DT O
last JJ JJ O
NPH NNP NNP O
dose NN NN O
( ( ( O
especially RB RB O
if IN IN O
pt NN NN O
transfers NNS NNS O
to TO TO O
floor NN NN O
) ) ) O
   
4 CD CD O
. . . O
Would MD MD O
consider VB VB O
reintroducing VBG VBG O
ACEi NNP NNP O
for IN IN O
kidney NN NN O
protection NN NN O
into IN IN O
his PRP$ PRP$ O
BP NNP NNP O
regimen NNS NNS O
( ( ( O
e.g. NN NN O
   
Lisinopril NNP NNP O
10 CD CD O
mg NN NN O
daily JJ JJ O
) ) ) O
   
5 CD CD O
. . . O
Pt NNP NNP O
will MD MD O
likely RB RB O
need VB VB O
fibrate NN NN O
for IN IN O
hypertriglyceridemia NN NN O
as IN IN O
he PRP PRP O
improves VBZ VBZ O
Thank VB VB O
you PRP PRP O
for IN IN O
interesting JJ JJ O
consult NN NN O
Dr NNP NNP O
. . . O
Tan NNP NNP I-DOCTOR
will MD MD O
follow VB VB O
Uriel NNP NNP I-DOCTOR
J. NN NN I-DOCTOR
Pierson NNP NNP I-DOCTOR
, , , O
MD NNP NNP O
, , , O
PhD NNP NNP O
Pager NNP NNP O
# # # O
77198 CD CD I-PHONE
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2079-01-06 JJ JJ I-DATE
EDVISIT^52402461^Ervin, NNP NNP O
Quindarrius^01/06/79^MEDINA, NNP NNP O
LUTHER NNP NNP I-DOCTOR
Seen VBN VBN O
on IN IN O
01/06/2079 CD CD I-DATE
with IN IN O
Dr NNP NNP O
. . . O
Delaney NNP NNP I-DOCTOR
. . . O
   
I PRP PRP O
confirmed VBD VBD O
that IN IN O
I PRP PRP O
have VBP VBP O
interviewed VBN VBN O
and CC CC O
examined VBD VBD O
the DT DT O
patient NN NN O
, , , O
reviewed VBD VBD O
the DT DT O
resident NN NN O
's POS POS O
documentation NN NN O
on IN IN O
the DT DT O
patient NN NN O
's POS POS O
chart NN NN O
, , , O
and CC CC O
discussed VBD VBD O
the DT DT O
evaluation NN NN O
, , , O
plan NN NN O
of IN IN O
care NN NN O
, , , O
and CC CC O
disposition NN NN O
with IN IN O
the DT DT O
patient NN NN O
. . . O
Please VB VB O
see VB VB O
the DT DT O
resident NN NN O
's POS POS O
note NN NN O
for IN IN O
details NNS NNS O
. . . O
   
HISTORY NN NN O
OF IN IN O
PRESENT NNP NNP O
ILLNESS NNP NNP O
: : : O
Briefly NNP NNP O
, , , O
this DT DT O
is VBZ VBZ O
a DT DT O
68-year-old JJ JJ O
gentleman NN NN O
who WP WP O
presents VBZ VBZ O
from IN IN O
rehab NN NN O
with IN IN O
1 CD CD O
week NN NN O
of IN IN O
diaphoresis NNS NNS O
and CC CC O
2 CD CD O
days NNS NNS O
of IN IN O
shortness NN NN O
of IN IN O
breath NN NN O
and CC CC O
nonproductive JJ JJ O
cough NN NN O
. . . O
   
He PRP PRP O
has VBZ VBZ O
a DT DT O
history NN NN O
of IN IN O
diabetes NN NN O
, , , O
hypertension NN NN O
, , , O
spinal JJ JJ O
stenosis NN NN O
, , , O
atrial JJ JJ O
fibrillation NN NN O
, , , O
CHF NNP NNP O
, , , O
CABG NNP NNP O
, , , O
and CC CC O
aortic JJ JJ O
valve NN NN O
replacement NN NN O
. . . O
   
PHYSICAL JJ JJ O
EXAMINATION NNP NNP O
: : : O
He PRP PRP O
is VBZ VBZ O
profoundly RB RB O
diaphoretic JJ JJ O
and CC CC O
is VBZ VBZ O
in IN IN O
mild JJ JJ O
respiratory JJ JJ O
distress NN NN O
. . . O
   
Pulse NNP NNP O
82 CD CD O
, , , O
respirations NNS NNS O
20 CD CD O
, , , O
blood NN NN O
pressure NN NN O
145/95 CD CD O
, , , O
pulse NN NN O
oximetry NN NN O
98 CD CD O
% NN NN O
on IN IN O
room NN NN O
air NN NN O
, , , O
and CC CC O
his PRP$ PRP$ O
temperature NN NN O
is VBZ VBZ O
95.9 CD CD O
. . . O
   
He PRP PRP O
has VBZ VBZ O
crackles NNS NNS O
and CC CC O
bronchial JJ JJ O
breath NN NN O
sounds VBZ VBZ O
in IN IN O
his PRP$ PRP$ O
right NN NN O
middle NN NN O
and CC CC O
upper JJ JJ O
lung NN NN O
fields NNS NNS O
. . . O
   
He PRP PRP O
has VBZ VBZ O
a DT DT O
regular JJ JJ O
rate NN NN O
and CC CC O
rhythm NN NN O
with IN IN O
a DT DT O
2/6 CD CD O
systolic JJ JJ O
murmur NN NN O
. . . O
   
LABORATORY NNP NNP O
DATA NNP NNP O
: : : O
His PRP$ PRP$ O
chest NN NN O
x-ray NN NN O
shows VBZ VBZ O
right JJ JJ O
upper JJ JJ O
lobe NN NN O
infiltrate NN NN O
. . . O
   
Sodium NNP NNP O
is VBZ VBZ O
135 CD CD O
. . . O
   
His PRP$ PRP$ O
white JJ JJ O
count NN NN O
is VBZ VBZ O
9.8 CD CD O
with IN IN O
left VBD VBD O
shift NN NN O
. . . O
   
CLINICAL NNP NNP O
IMPRESSION NNP NNP O
: : : O
Pneumonia NNP NNP O
. . . O
   
******** NN NN O
Not RB RB O
reviewed VBN VBN O
by IN IN O
Attending NNP NNP O
Physician NNP NNP O
******** NN NN O
PLAN NNP NNP O
: : : O
Admission NNP NNP O
for IN IN O
IV NNP NNP O
antibiotics NNS NNS O
. . . O
   
_____________________________ NN NN O
_ NN NN O
MEDINA NNP NNP O
, , , O
LUTHER NNP NNP I-DOCTOR
M.D. NNP NNP O
   
D NNP NNP O
: : : O
01/07/79 CD CD I-DATE
T NN NN O
: : : O
01/07/79 CD CD I-DATE
Dictated NNP NNP O
By IN IN O
: : : O
MEDINA NNP NNP O
, , , O
LUTHER NNP NNP I-DOCTOR
eScription NN NN O
document:9-5046707 JJ JJ O
BFFocus NNP NNP O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2097-11-02 JJ JJ I-DATE
EDOBS^14477347^BENNETT, NNP NNP O
NANCY^11/02/97^OAKLEY, NNP NNP O
ALBERT NNP NNP I-DOCTOR
This DT DT O
is VBZ VBZ O
a DT DT O
shared JJ JJ O
visit NN NN O
with IN IN O
resident NN NN O
, , , O
Dr NNP NNP O
. . . O
Cantrell NNP NNP I-DOCTOR
. . . O
   
HISTORY NN NN O
OF IN IN O
PRESENT NNP NNP O
ILLNESS NNP NNP O
: : : O
Briefly NNP NNP O
, , , O
this DT DT O
is VBZ VBZ O
a DT DT O
79-year-old JJ JJ O
female JJ JJ O
with IN IN O
a DT DT O
past JJ JJ O
history NN NN O
of IN IN O
insulin-dependent JJ JJ O
diabetes NNS NNS O
, , , O
bronchitis NNS NNS O
, , , O
congestive JJ JJ O
heart NN NN O
failure NN NN O
with IN IN O
an DT DT O
ejection NN NN O
fraction NN NN O
of IN IN O
65 CD CD O
% NN NN O
, , , O
COPD NNP NNP O
, , , O
and CC CC O
polyarteritis NNS NNS O
presenting VBG VBG O
here RB RB O
with IN IN O
some DT DT O
generalized JJ JJ O
weakness NN NN O
since IN IN O
yesterday NN NN O
. . . O
   
She PRP PRP O
has VBZ VBZ O
no DT DT O
focal JJ JJ O
deficits NNS NNS O
. . . O
   
She PRP PRP O
had VBD VBD O
no DT DT O
fall NN NN O
, , , O
no DT DT O
fevers NNS NNS O
, , , O
no DT DT O
chest NN NN O
pain NN NN O
, , , O
no DT DT O
shortness NN NN O
of IN IN O
breath NN NN O
, , , O
no DT DT O
abdominal JJ JJ O
pain NN NN O
, , , O
no DT DT O
nausea NN NN O
, , , O
no DT DT O
vomiting VBG VBG O
, , , O
and CC CC O
no DT DT O
diarrhea NN NN O
. . . O
   
She PRP PRP O
is VBZ VBZ O
able JJ JJ O
to TO TO O
ambulate VB VB O
with IN IN O
a DT DT O
walker NN NN O
. . . O
   
She PRP PRP O
denies VBZ VBZ O
headache NN NN O
. . . O
   
She PRP PRP O
was VBD VBD O
feeling VBG VBG O
well RB RB O
until IN IN O
yesterday NN NN O
. . . O
   
She PRP PRP O
had VBD VBD O
no DT DT O
recent JJ JJ O
medication NN NN O
changes NNS NNS O
. . . O
   
She PRP PRP O
has VBZ VBZ O
chronic JJ JJ O
lower JJR JJR O
extremity NN NN O
edema NN NN O
, , , O
left VBD VBD O
greater JJR JJR O
than IN IN O
right NN NN O
. . . O
   
She PRP PRP O
has VBZ VBZ O
stable JJ JJ O
2-pillow JJ JJ O
orthopnea NN NN O
. . . O
   
She PRP PRP O
is VBZ VBZ O
followed VBN VBN O
by IN IN O
Dr NNP NNP O
. . . O
Whitman NNP NNP I-DOCTOR
of IN IN O
Cardiology NNP NNP O
. . . O
   
She PRP PRP O
takes VBZ VBZ O
Lasix NNP NNP O
80 CD CD O
mg NN NN O
twice RB RB O
daily JJ JJ O
among IN IN O
other JJ JJ O
medications NNS NNS O
and CC CC O
the DT DT O
status NN NN O
was VBD VBD O
stable JJ JJ O
. . . O
   
She PRP PRP O
had VBD VBD O
a DT DT O
normal JJ JJ O
cardiac JJ JJ O
stress NN NN O
test NN NN O
approximately RB RB O
4 CD CD O
months NNS NNS O
ago RB RB O
. . . O
   
PHYSICAL JJ JJ O
EXAMINATION NNP NNP O
: : : O
She PRP PRP O
presents VBZ VBZ O
with IN IN O
a DT DT O
heart NN NN O
rate NN NN O
of IN IN O
84 CD CD O
, , , O
respiratory JJ JJ O
rate NN NN O
of IN IN O
16 CD CD O
, , , O
blood NN NN O
pressure NN NN O
initially RB RB O
of IN IN O
220/90 CD CD O
, , , O
systolic JJ JJ O
pressure NN NN O
decreased VBD VBD O
to TO TO O
175 CD CD O
without IN IN O
treatment NN NN O
shortly RB RB O
after IN IN O
arrival NN NN O
, , , O
and CC CC O
oxygen NN NN O
saturation NN NN O
of IN IN O
99 CD CD O
% NN NN O
on IN IN O
room NN NN O
air NN NN O
with IN IN O
temperature NN NN O
of IN IN O
98.5 CD CD O
. . . O
   
She PRP PRP O
is VBZ VBZ O
awake JJ JJ O
and CC CC O
alert VB VB O
. . . O
   
She PRP PRP O
is VBZ VBZ O
in IN IN O
no DT DT O
acute JJ JJ O
distress NN NN O
. . . O
   
She PRP PRP O
has VBZ VBZ O
moist JJ JJ O
mucous JJ JJ O
membranes NNS NNS O
. . . O
   
Her PRP$ PRP$ O
neck NN NN O
is VBZ VBZ O
supple JJ JJ O
with IN IN O
full JJ JJ O
range NN NN O
of IN IN O
motion NN NN O
. . . O
   
She PRP PRP O
has VBZ VBZ O
mild JJ JJ O
left-sided JJ JJ O
facial JJ JJ O
droop NN NN O
, , , O
which WDT WDT O
she PRP PRP O
states VBZ VBZ O
is VBZ VBZ O
old JJ JJ O
. . . O
   
She PRP PRP O
has VBZ VBZ O
clear JJ JJ O
and CC CC O
equal JJ JJ O
breath NN NN O
sounds VBZ VBZ O
bilaterally RB RB O
and CC CC O
no DT DT O
respiratory JJ JJ O
distress NN NN O
. . . O
   
Heart NNP NNP O
is VBZ VBZ O
regular JJ JJ O
without IN IN O
murmurs NNS NNS O
. . . O
   
She PRP PRP O
has VBZ VBZ O
soft JJ JJ O
, , , O
nontender NN NN O
belly RB RB O
. . . O
   
She PRP PRP O
has VBZ VBZ O
asymmetric JJ JJ O
lower JJR JJR O
extremity NN NN O
edema NN NN O
with IN IN O
2-3 JJ JJ O
+ NN NN O
pitting VBG VBG O
edema NN NN O
to TO TO O
the DT DT O
left NN NN O
and CC CC O
1 CD CD O
+ NN NN O
pitting VBG VBG O
edema NN NN O
to TO TO O
the DT DT O
right NN NN O
, , , O
which WDT WDT O
she PRP PRP O
states VBZ VBZ O
is VBZ VBZ O
chronic JJ JJ O
and CC CC O
unchanged JJ JJ O
from IN IN O
baseline NN NN O
. . . O
   
She PRP PRP O
has VBZ VBZ O
5/5 CD CD O
strength NN NN O
throughout IN IN O
. . . O
   
She PRP PRP O
has VBZ VBZ O
no DT DT O
pronator NN NN O
drift NN NN O
. . . O
   
She PRP PRP O
is VBZ VBZ O
able JJ JJ O
to TO TO O
ambulate VB VB O
with IN IN O
a DT DT O
walker NN NN O
. . . O
   
LABORATORY NNP NNP O
DATA NNP NNP O
: : : O
Basic NNP NNP O
laboratory NN NN O
testing NN NN O
shows VBZ VBZ O
an DT DT O
unremarkable JJ JJ O
CBC NNP NNP O
and CC CC O
Chem-7. NNP NNP O
   
A DT DT O
set NN NN O
of IN IN O
cardiac JJ JJ O
marker NN NN O
shows VBZ VBZ O
a DT DT O
troponin NN NN O
of IN IN O
0.06 CD CD O
, , , O
which WDT WDT O
is VBZ VBZ O
decreased VBN VBN O
from IN IN O
her PRP$ PRP$ O
most RBS RBS O
recent JJ JJ O
baseline NN NN O
, , , O
which WDT WDT O
has VBZ VBZ O
been VBN VBN O
elevated VBN VBN O
over IN IN O
the DT DT O
past JJ JJ O
several JJ JJ O
months NNS NNS O
. . . O
   
Her PRP$ PRP$ O
BNP NNP NNP O
was VBD VBD O
112 CD CD O
. . . O
   
Her PRP$ PRP$ O
urinalysis NN NN O
was VBD VBD O
unremarkable JJ JJ O
. . . O
   
Her PRP$ PRP$ O
EKG NNP NNP O
was VBD VBD O
a DT DT O
paced JJ JJ O
rhythm NN NN O
. . . O
   
Chest NN NN O
x-ray NN NN O
was VBD VBD O
unremarkable JJ JJ O
. . . O
   
EMERGENCY NNP NNP O
DEPARTMENT NNP NNP O
COURSE NN NN O
: : : O
The DT DT O
patient NN NN O
was VBD VBD O
discussed VBN VBN O
with IN IN O
Dr NNP NNP O
. . . O
Whitman NNP NNP I-DOCTOR
who WP WP O
recommended VBD VBD O
the DT DT O
patient NN NN O
be VB VB O
admitted VBN VBN O
to TO TO O
the DT DT O
Observation NNP NNP O
Unit NNP NNP O
for IN IN O
another DT DT O
set NN NN O
of IN IN O
cardiac JJ JJ O
markers NNS NNS O
to TO TO O
___ NNP NNP O
_ NN NN O
troponin NN NN O
as RB RB O
well RB RB O
as IN IN O
observation NN NN O
. . . O
   
He PRP PRP O
will MD MD O
see VB VB O
the DT DT O
patient NN NN O
in IN IN O
the DT DT O
morning NN NN O
. . . O
   
If IN IN O
the DT DT O
patient NN NN O
's POS POS O
___ NN NN O
_ NN NN O
set VBN VBN O
of IN IN O
cardiac JJ JJ O
markers NNS NNS O
are VBP VBP O
not RB RB O
increasing VBG VBG O
and CC CC O
she PRP PRP O
feels VBZ VBZ O
well RB RB O
enough RB RB O
to TO TO O
go VB VB O
home NN NN O
, , , O
she PRP PRP O
will MD MD O
likely RB RB O
be VB VB O
discharged VBN VBN O
after IN IN O
Dr NNP NNP O
. . . O
Whitman NNP NNP I-DOCTOR
sees VBZ VBZ O
her PRP$ PRP$ O
and CC CC O
makes VBZ VBZ O
any DT DT O
medication NN NN O
adjustments NNS NNS O
that WDT WDT O
are VBP VBP O
necessary JJ JJ O
. . . O
   
PRIMARY JJ JJ O
DIAGNOSIS NNP NNP O
: : : O
Hypertension NNP NNP O
. . . O
   
SECONDARY JJ JJ O
DIAGNOSIS NNP NNP O
: : : O
Generalized NNP NNP O
weakness NN NN O
. . . O
   
DISPOSITION NNP NNP O
: : : O
Observation NNP NNP O
Unit NNP NNP O
. . . O
   
_____________________________ NN NN O
_ NN NN O
OAKLEY NNP NNP O
, , , O
ALBERT NNP NNP I-DOCTOR
M.D. NNP NNP O
   
D NNP NNP O
: : : O
11/02/97 CD CD I-DATE
T NN NN O
: : : O
11/02/97 CD CD I-DATE
Dictated NNP NNP O
By IN IN O
: : : O
OAKLEY NNP NNP O
, , , O
ALBERT NNP NNP I-DOCTOR
eScription NN NN O
document:1-98167165 JJ JJ O
BFFocus NNP NNP O
******** NN NN O
Not RB RB O
reviewed VBN VBN O
by IN IN O
Attending NNP NNP O
Physician NNP NNP O
******** NN NN O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2112-01-17 NN NN I-DATE
CC NNP NNP O
: : : O
Follow-up NNP NNP O
labs/MRI NN NN O
HPI NNP NNP O
: : : O
49 CD CD I-AGE
y.o. NN NN O
female JJ JJ O
with IN IN O
h/o NN NN O
diabetes NN NN O
who WP WP O
had VBD VBD O
meds NNS NNS O
resumed VBN VBN O
on IN IN O
last JJ JJ O
visit NN NN O
. . . O
   
She PRP PRP O
is VBZ VBZ O
unable JJ JJ O
to TO TO O
check VB VB O
her PRP$ PRP$ O
blood NN NN O
sugar NN NN O
due JJ JJ O
to TO TO O
unable JJ JJ O
to TO TO O
afford VB VB O
strips NNS NNS O
and CC CC O
insurance NN NN O
will MD MD O
not RB RB O
pay VB VB O
for IN IN O
them PRP PRP O
. . . O
   
She PRP PRP O
was VBD VBD O
started VBN VBN O
on IN IN O
pravachol NN NN O
for IN IN O
hyperlipidemia NN NN O
and CC CC O
lisinopril NN NN O
for IN IN O
microalbuminuira NN NN O
on IN IN O
last JJ JJ O
visit NN NN O
without IN IN O
side NN NN O
effect NN NN O
to TO TO O
meds NNS NNS O
. . . O
   
She PRP PRP O
had VBD VBD O
an DT DT O
MRI NNP NNP O
of IN IN O
hips NNS NNS O
which WDT WDT O
shows VBZ VBZ O
mild NN NN O
DJD NNP NNP O
and CC CC O
arterial JJ JJ O
noninvasives NNS NNS O
showing VBG VBG O
mild JJ JJ O
disease NN NN O
on IN IN O
the DT DT O
right NN NN O
and CC CC O
moderate JJ JJ O
on IN IN O
the DT DT O
left NN NN O
. . . O
   
Mammogram NNP NNP O
was VBD VBD O
negative JJ JJ O
. . . O
   
She PRP PRP O
continues VBZ VBZ O
to TO TO O
smoke NN NN O
but CC CC O
is VBZ VBZ O
done VBN VBN O
to TO TO O
one CD CD O
pack/day NN NN O
from IN IN O
two CD CD O
pack/day NN NN O
. . . O
   
She PRP PRP O
denies VBZ VBZ O
any DT DT O
chest NN NN O
pain NN NN O
, , , O
shortness NN NN O
of IN IN O
breath NN NN O
or CC CC O
palpitations NNS NNS O
. . . O
   
She PRP PRP O
has VBZ VBZ O
difficulty NN NN O
walking VBG VBG O
long JJ JJ O
distances NNS NNS O
due JJ JJ O
to TO TO O
claudication NN NN O
. . . O
   
Problems NNS NNS O
Peripheral NNP NNP O
vascular NN NN O
disease NN NN O
Diabetes NNP NNP O
mellitus NN NN O
type NN NN O
2 CD CD O
Hyperlipidemia NNP NNP O
Claudication NNP NNP O
Medications NNP NNP O
Claritin NNP NNP O
( ( ( O
LORATADINE NNP NNP O
) ) ) O
10 CD CD O
MG NNP NNP O
( ( ( O
10MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
) ) ) O
PO NNP NNP O
QD NNP NNP O
x SYM SYM O
30 CD CD O
days NNS NNS O
Glipizide NNP NNP O
Xl NNP NNP O
( ( ( O
GLIPIZIDE NNP NNP O
Xl NNP NNP O
) ) ) O
10 CD CD O
MG NNP NNP O
( ( ( O
10MG CD CD O
TAB NNP NNP O
OSM NNP NNP O
24 CD CD O
take NN NN O
1 CD CD O
) ) ) O
PO NNP NNP O
QD NNP NNP O
x SYM SYM O
30 CD CD O
days NNS NNS O
IBUPROFEN NNP NNP O
800 CD CD O
MG NNP NNP O
( ( ( O
800MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
) ) ) O
PO NNP NNP O
TID NNP NNP O
PRN NNP NNP O
pain NN NN O
x SYM SYM O
30 CD CD O
days NNS NNS O
, , , O
Take VB VB O
with IN IN O
food NN NN O
or CC CC O
milk NN NN O
. . . O
   
LISINOPRIL NNP NNP O
2.5 CD CD O
MG NNP NNP O
(2.5MG NNP NNP O
TABLET NNP NNP O
take NN NN O
1 CD CD O
) ) ) O
PO NNP NNP O
QD NNP NNP O
x SYM SYM O
30 CD CD O
days NNS NNS O
METFORMIN NNP NNP O
500 CD CD O
MG NNP NNP O
( ( ( O
500MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
) ) ) O
PO NNP NNP O
BID NNP NNP O
x SYM SYM O
30 CD CD O
days NNS NNS O
Pravastatin NNP NNP O
( ( ( O
PRAVASTATIN NNP NNP O
) ) ) O
10 CD CD O
MG NNP NNP O
( ( ( O
10MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
) ) ) O
PO NNP NNP O
QHS NNP NNP O
x SYM SYM O
30 CD CD O
days NNS NNS O
Tylenol NNP NNP O
#3 NN NN O
( ( ( O
ACETAMINOPHEN NNP NNP O
W/codeine NNP NNP O
30mg CD CD O
) ) ) O
1 CD CD O
TAB NNP NNP O
PO NNP NNP O
Q6H NNP NNP O
x SYM SYM O
21 CD CD O
days NNS NNS O
, , , O
Do VBP VBP O
not RB RB O
drive VB VB O
, , , O
drink NN NN O
alcohol NN NN O
with IN IN O
this DT DT O
medication NN NN O
. . . O
   
Allergies NNP NNP O
NKA NNP NNP O
Family/social NNP NNP O
History NN NN O
Coronary JJ JJ O
Artery NNP NNP O
Disease NNP NNP O
Relative NNP NNP O
: : : O
Brother NNP NNP O
; : : O
   
Comments NNS NNS O
: : : O
H/o NNP NNP O
4V CD CD O
CABG NNP NNP O
Bone NNP NNP O
Cancer NNP NNP O
Relative NNP NNP O
: : : O
Father NNP NNP O
; : : O
   
Age NNP NNP O
of IN IN O
Onset NNP NNP O
: : : O
53 CD CD I-AGE
; : : O
   
Living VBG VBG O
: : : O
No DT DT O
Uterine NNP NNP O
Cancer NNP NNP O
Relative NNP NNP O
: : : O
Mother NNP NNP O
; : : O
   
Age NNP NNP O
of IN IN O
Onset NNP NNP O
: : : O
46 CD CD I-AGE
; : : O
   
Living VBG VBG O
: : : O
No DT DT O
Diabetes NNP NNP O
Mellitus NNP NNP O
Type NNP NNP O
2 CD CD O
Relative NNP NNP O
: : : O
Brother NNP NNP O
; : : O
   
Relative NNP NNP O
: : : O
Sister NNP NNP O
; : : O
   
Relative NNP NNP O
: : : O
Grandfather NNP NNP O
, , , O
maternal JJ JJ O
; : : O
   
Health NNP NNP O
Maint NNP NNP O
Smoking NNP NNP O
status NN NN O
01/17/2112 CD CD I-DATE
Current JJ JJ O
smoker NN NN O
Last JJ JJ O
Counsel NNP NNP O
date NN NN O
: : : O
01/17/2112 CD CD I-DATE
, , , O
No DT DT O
Of IN IN O
Cigarettes NNP NNP O
Smoked NNP NNP O
per IN IN O
Day NNP NNP O
: : : O
10-19 JJ JJ O
CIG/DAY NNP NNP O
( ( ( O
1/2-1 JJ JJ O
ppd NN NN O
) ) ) O
, , , O
Readiness NNP NNP O
to TO TO O
Change NNP NNP O
: : : O
Ready JJ JJ O
to TO TO O
quit VB VB O
now RB RB O
Mammogram NNP NNP O
01/11/2112 CD CD I-DATE
see VB VB O
report NN NN O
in IN IN O
Results NNS NNS O
Pap NNP NNP O
Smear NNP NNP O
09/28/99 CD CD I-DATE
see VB VB O
report NN NN O
in IN IN O
Results NNS NNS O
Pneumovax NNP NNP O
12/26/2111 CD CD I-DATE
Flowsheets NNP NNP O
BLOOD NNP NNP O
PRESSURE NN NN O
110/72 CD CD O
PULSE NNP NNP O
78 CD CD O
WEIGHT NNP NNP O
207 CD CD O
lb NN NN O
AGE NNP NNP O
49y7.7m CD CD I-AGE
EXAM NNP NNP O
: : : O
Deferred NNP NNP O
. . . O
   
A/P NNP NNP O
: : : O
   
1 CD CD O
. . . O
PVD NNP NNP O
. . . O
   
Start NNP NNP O
walking VBG VBG O
program NN NN O
, , , O
d/c NN NN O
tobacco NN NN O
, , , O
cholesterol NN NN O
, , , O
diabetes NNS NNS O
and CC CC O
hypertension NN NN O
control NN NN O
. . . O
   
Start NNP NNP O
Pletal NNP NNP O
. . . O
   
Will NNP NNP O
also RB RB O
evaluate NN NN O
for IN IN O
CAD NNP NNP O
given VBN VBN O
multiple JJ JJ O
risk NN NN O
factors NNS NNS O
. . . O
   
Check NNP NNP O
EKG NNP NNP O
and CC CC O
schedule NN NN O
nonexercise NN NN O
stress NN NN O
test NN NN O
. . . O
   
2 CD CD O
. . . O
Diabetes NNP NNP O
. . . O
   
Continue NNP NNP O
current JJ JJ O
meds NNS NNS O
and CC CC O
check NN NN O
labs NNS NNS O
at IN IN O
f/u NN NN O
visit NN NN O
in IN IN O
2 CD CD O
months NNS NNS O
. . . O
   
Referral NNP NNP O
for IN IN O
eye NN NN O
exam NN NN O
. . . O
   
3 CD CD O
. . . O
Hyperlipidemia NNP NNP O
. . . O
   
Continue NNP NNP O
on IN IN O
Pravachol NNP NNP O
and CC CC O
check NN NN O
last JJ JJ O
at IN IN O
next JJ JJ O
visit NN NN O
. . . O
   
4 CD CD O
. . . O
Tobacco NNP NNP O
use NN NN O
. . . O
   
Pt NNP NNP O
advised VBD VBD O
to TO TO O
d/c VB VB O
tobacco NN NN O
. . . O
   
She PRP PRP O
wants VBZ VBZ O
to TO TO O
try VB VB O
on IN IN O
her PRP$ PRP$ O
own JJ JJ O
and CC CC O
if IN IN O
no DT DT O
success NN NN O
will MD MD O
consider VB VB O
supplemental JJ JJ O
therapies NNS NNS O
. . . O
   
____________________________________________ NN NN O
_ NN NN O
Grace NNP NNP I-DOCTOR
C. NN NN I-DOCTOR
Valerie-Yun NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2095-01-31 NN NN I-DATE
EDVISIT^65219816^HALL, NNP NNP O
NICK^01/31/95^PENN, NNP NNP O
GINO NNP NNP I-DOCTOR
The DT DT O
patient NN NN O
was VBD VBD O
seen VBN VBN O
and CC CC O
examined VBN VBN O
in IN IN O
the DT DT O
Emergency NNP NNP O
Department NNP NNP O
on IN IN O
01/31/2095 CD CD I-DATE
. . . O
   
The DT DT O
patient NN NN O
was VBD VBD O
seen VBN VBN O
by IN IN O
Dr NNP NNP O
. . . O
Ibarra NNP NNP I-DOCTOR
. . . O
   
I PRP PRP O
have VBP VBP O
discussed VBN VBN O
the DT DT O
management NN NN O
with IN IN O
her PRP PRP O
. . . O
   
I PRP PRP O
have VBP VBP O
also RB RB O
seen VBN VBN O
the DT DT O
patient NN NN O
personally RB RB O
and CC CC O
reviewed VBD VBD O
the DT DT O
ED NNP NNP O
record NN NN O
. . . O
   
This DT DT O
is VBZ VBZ O
an DT DT O
addendum NN NN O
to TO TO O
the DT DT O
record NN NN O
. . . O
   
I PRP PRP O
have VBP VBP O
also RB RB O
reviewed VBN VBN O
the DT DT O
old JJ JJ O
medical JJ JJ O
record NN NN O
and CC CC O
discussed VBD VBD O
the DT DT O
management NN NN O
with IN IN O
Dr NNP NNP O
. . . O
Gil NNP NNP I-DOCTOR
, , , O
who WP WP O
will MD MD O
be VB VB O
speaking VBG VBG O
with IN IN O
Dr NNP NNP O
. . . O
Gomez NNP NNP I-DOCTOR
about IN IN O
accepting VBG VBG O
this DT DT O
patient NN NN O
to TO TO O
the DT DT O
Cardiology NNP NNP O
Service NNP NNP O
. . . O
   
HISTORY NN NN O
OF IN IN O
PRESENT NNP NNP O
ILLNESS NNP NNP O
: : : O
This DT DT O
is VBZ VBZ O
a DT DT O
54-year-old JJ JJ O
gentleman NN NN O
who WP WP O
has VBZ VBZ O
a DT DT O
history NN NN O
of IN IN O
stent JJ JJ O
placements NNS NNS O
as IN IN O
he PRP PRP O
had VBD VBD O
a DT DT O
cardiac JJ JJ O
arrest NN NN O
status NN NN O
post NN NN O
lobectomy NN NN O
for IN IN O
squamous JJ JJ O
cell NN NN O
carcinoma NN NN O
. . . O
   
This DT DT O
occurred VBD VBD O
in IN IN O
02/2094 CD CD I-DATE
, , , O
where WRB WRB O
the DT DT O
patient NN NN O
was VBD VBD O
taken VBN VBN O
to TO TO O
the DT DT O
Cath NNP NNP O
Lab NNP NNP O
after IN IN O
His PRP$ PRP$ O
postoperative JJ JJ O
rest NN NN O
. . . O
   
Stents NNP NNP O
were VBD VBD O
placed VBN VBN O
and CC CC O
the DT DT O
patient NN NN O
says VBZ VBZ O
he PRP PRP O
has VBZ VBZ O
been VBN VBN O
doing VBG VBG O
well RB RB O
. . . O
   
In IN IN O
the DT DT O
meantime NN NN O
, , , O
he PRP PRP O
has VBZ VBZ O
had VBN VBN O
no DT DT O
chest NN NN O
pain NN NN O
or CC CC O
shortness NN NN O
of IN IN O
breath NN NN O
until IN IN O
one CD CD O
week NN NN O
prior RB RB O
, , , O
he PRP PRP O
was VBD VBD O
on IN IN O
a DT DT O
treadmill NN NN O
and CC CC O
felt VBD VBD O
unwell NN NN O
with IN IN O
shortness NN NN O
of IN IN O
breath NN NN O
and CC CC O
chest NN NN O
discomfort NN NN O
. . . O
   
He PRP PRP O
stopped VBD VBD O
and CC CC O
felt VBD VBD O
better JJR JJR O
. . . O
   
Last JJ JJ O
night NN NN O
, , , O
he PRP PRP O
was VBD VBD O
in IN IN O
bed NN NN O
watching VBG VBG O
TV NN NN O
, , , O
he PRP PRP O
felt VBD VBD O
some DT DT O
chest NN NN O
discomfort NN NN O
and CC CC O
took VBD VBD O
nitroglycerin NN NN O
with IN IN O
relief NN NN O
of IN IN O
pain NN NN O
, , , O
and CC CC O
this DT DT O
morning NN NN O
he PRP PRP O
was VBD VBD O
walking VBG VBG O
and CC CC O
walked VBD VBD O
about IN IN O
100 CD CD O
yards NNS NNS O
, , , O
felt VBD VBD O
short JJ JJ O
of IN IN O
breath NN NN O
and CC CC O
chest NN NN O
pain NN NN O
at IN IN O
rest NN NN O
and CC CC O
took VBD VBD O
nitroglycerin NN NN O
with IN IN O
relieve NN NN O
and CC CC O
now RB RB O
has VBZ VBZ O
no DT DT O
chest NN NN O
pain NN NN O
or CC CC O
shortness NN NN O
of IN IN O
breath NN NN O
at IN IN O
this DT DT O
time NN NN O
. . . O
   
His PRP$ PRP$ O
chest NN NN O
pain NN NN O
he PRP PRP O
describes VBZ VBZ O
it PRP PRP O
as IN IN O
pressure NN NN O
with IN IN O
exertion NN NN O
and CC CC O
he PRP PRP O
feels VBZ VBZ O
well RB RB O
now RB RB O
. . . O
   
No DT DT O
fevers NNS NNS O
, , , O
chills NNS NNS O
, , , O
or CC CC O
cough NN NN O
. . . O
   
REVIEW NNP NNP O
OF IN IN O
SYSTEMS NNP NNP O
: : : O
As IN IN O
indicated VBN VBN O
and CC CC O
otherwise RB RB O
negative JJ JJ O
. . . O
   
PAST NNP NNP O
MEDICAL NNP NNP O
HISTORY NN NN O
: : : O
As IN IN O
indicated VBN VBN O
and CC CC O
also RB RB O
includes VBZ VBZ O
hypertension NN NN O
and CC CC O
increased VBD VBD O
cholesterol NN NN O
. . . O
   
SOCIAL NNP NNP O
HISTORY NN NN O
: : : O
He PRP PRP O
is VBZ VBZ O
a DT DT O
nonsmoker NN NN O
. . . O
   
PHYSICAL JJ JJ O
EXAMINATION NNP NNP O
: : : O
The DT DT O
patient NN NN O
is VBZ VBZ O
pleasant JJ JJ O
, , , O
well RB RB O
appearing VBG VBG O
, , , O
and CC CC O
in IN IN O
no DT DT O
acute JJ JJ O
distress NN NN O
. . . O
   
Normocephalic NNP NNP O
and CC CC O
atraumatic JJ JJ O
. . . O
   
Chest NN NN O
is VBZ VBZ O
clear JJ JJ O
. . . O
   
Heart NNP NNP O
is VBZ VBZ O
regular JJ JJ O
. . . O
   
Abdomen NNP NNP O
is VBZ VBZ O
soft JJ JJ O
and CC CC O
nontender NN NN O
. . . O
   
Extremities NNS NNS O
are VBP VBP O
nontender NN NN O
. . . O
   
Rectal NNP NNP O
exam NN NN O
is VBZ VBZ O
heme-negative JJ JJ O
. . . O
   
ASSESSMENT NNP NNP O
AND CC CC O
PLAN NNP NNP O
: : : O
This DT DT O
is VBZ VBZ O
a DT DT O
gentleman NN NN O
with IN IN O
a DT DT O
history NN NN O
of IN IN O
coronary JJ JJ O
artery NN NN O
disease NN NN O
and CC CC O
cardiac JJ JJ O
arrest NN NN O
, , , O
who WP WP O
has VBZ VBZ O
a DT DT O
very RB RB O
typical JJ JJ O
symptoms NNS NNS O
concerning VBG VBG O
for IN IN O
coronary JJ JJ O
artery NN NN O
disease NN NN O
and CC CC O
angina NN NN O
including VBG VBG O
components NNS NNS O
at IN IN O
rest NN NN O
. . . O
   
We PRP PRP O
have VBP VBP O
started VBN VBN O
heparin NN NN O
on IN IN O
the DT DT O
patient NN NN O
medicated VBD VBD O
with IN IN O
cardiologist NN NN O
for IN IN O
the DT DT O
possibility NN NN O
of IN IN O
early JJ JJ O
catheterization NN NN O
. . . O
   
Laboratory NNP NNP O
was VBD VBD O
pending VBG VBG O
at IN IN O
the DT DT O
time NN NN O
of IN IN O
this DT DT O
dictation NN NN O
. . . O
   
DISPOSITION NNP NNP O
: : : O
The DT DT O
patient NN NN O
will MD MD O
be VB VB O
admitted VBN VBN O
to TO TO O
Cardiology NNP NNP O
in IN IN O
fair JJ JJ O
condition NN NN O
. . . O
   
_____________________________ NN NN O
_ NN NN O
PENN NNP NNP O
, , , O
GINO NNP NNP I-DOCTOR
M.D. NNP NNP O
   
D NNP NNP O
: : : O
01/31/95 CD CD I-DATE
T NN NN O
: : : O
01/31/95 CD CD I-DATE
Dictated NNP NNP O
By IN IN O
: : : O
PENN NNP NNP O
, , , O
GINO NNP NNP I-DOCTOR
eScription NN NN O
document:2-5902888 JJ JJ O
BFFocus NNP NNP O
******** NN NN O
Not RB RB O
reviewed VBN VBN O
by IN IN O
Attending NNP NNP O
Physician NNP NNP O
******** NN NN O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2086-11-07 NN NN I-DATE
November NNP NNP I-DATE
07 CD CD O
, , , O
2086 CD CD I-DATE
Usha NNP NNP I-DOCTOR
Gibbons NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
   
Cooley NNP NNP I-HOSPITAL
Internal NNP NNP O
Medicine NNP NNP O
Associates NNPS NNPS O
Cooley NNP NNP I-HOSPITAL
Dickinson NNP NNP I-HOSPITAL
Hospital NNP NNP I-HOSPITAL
99 CD CD I-STREET
Greenfield NNP NNP I-STREET
Drive NNP NNP I-STREET
Schuyler NNP NNP I-CITY
, , , O
FL NNP NNP I-STATE
76969 CD CD I-ZIP
Re NNP NNP O
: : : O
Benitez NNP NNP I-PATIENT
, , , O
Wonda NNP NNP I-PATIENT
MRN NNP NNP O
: : : O
89276954 CD CD I-MEDICALRECORD
Dear RB RB O
Usha NNP NNP I-DOCTOR
: : : O
I PRP PRP O
just RB RB O
had VBD VBD O
the DT DT O
pleasure NN NN O
of IN IN O
seeing VBG VBG O
Ms NNP NNP O
. . . O
Benitez NNP NNP I-PATIENT
for IN IN O
a DT DT O
follow VB VB O
up RP RP O
cardiovascular JJ JJ O
examination NN NN O
. . . O
   
She PRP PRP O
has VBZ VBZ O
been VBN VBN O
reasonably RB RB O
stable JJ JJ O
since IN IN O
I PRP PRP O
saw VBD VBD O
her PRP$ PRP$ O
last JJ JJ O
in IN IN O
July NNP NNP I-DATE
. . . O
   
She PRP PRP O
has VBZ VBZ O
had VBN VBN O
several JJ JJ O
episodes NNS NNS O
of IN IN O
chest NN NN O
discomfort NN NN O
characterized VBN VBN O
as IN IN O
a DT DT O
tightness NN NN O
which WDT WDT O
has VBZ VBZ O
been VBN VBN O
quite RB RB O
transient NN NN O
. . . O
   
The DT DT O
frequency NN NN O
has VBZ VBZ O
been VBN VBN O
less JJR JJR O
than IN IN O
one CD CD O
time NN NN O
per IN IN O
month NN NN O
. . . O
   
The DT DT O
last JJ JJ O
occurred VBD VBD O
yesterday NN NN O
while IN IN O
she PRP PRP O
was VBD VBD O
walking VBG VBG O
in IN IN O
a DT DT O
shopping NN NN O
mall NN NN O
. . . O
   
She PRP PRP O
continued VBD VBD O
to TO TO O
walk VB VB O
and CC CC O
her PRP$ PRP$ O
symptom NN NN O
resolved VBD VBD O
. . . O
   
She PRP PRP O
has VBZ VBZ O
not RB RB O
had VBN VBN O
any DT DT O
associated VBN VBN O
shortness NN NN O
of IN IN O
breath NN NN O
or CC CC O
diaphoresis NNS NNS O
. . . O
   
She PRP PRP O
has VBZ VBZ O
had VBN VBN O
no DT DT O
symptoms NNS NNS O
of IN IN O
cardiovascular JJ JJ O
ischemia NN NN O
, , , O
denying VBG VBG O
transient JJ JJ O
hemiparesis NN NN O
, , , O
hemiparesthesia NN NN O
, , , O
or CC CC O
amaurosis NN NN O
fugax NN NN O
. . . O
   
She PRP PRP O
denies VBZ VBZ O
claudication NN NN O
but CC CC O
does VBZ VBZ O
admit VB VB O
to TO TO O
back RB RB O
pain NN NN O
, , , O
bilateral JJ JJ O
hip NN NN O
pain NN NN O
with IN IN O
walking VBG VBG O
. . . O
   
She PRP PRP O
still RB RB O
notes VBZ VBZ O
paresthesias NN NN O
of IN IN O
both DT DT O
feet NNS NNS O
. . . O
   
She PRP PRP O
continues VBZ VBZ O
to TO TO O
be VB VB O
bothered VBN VBN O
by IN IN O
tinnitus NN NN O
as RB RB O
well RB RB O
as IN IN O
headaches NNS NNS O
. . . O
   
Her PRP$ PRP$ O
current JJ JJ O
medical JJ JJ O
regimen NN NN O
includes VBZ VBZ O
losartan NN NN O
75 CD CD O
mg NN NN O
p.o. NN NN O
b.i.d. NN NN O
, , , O
nifedipine NN NN O
XL NNP NNP O
60 CD CD O
mg NN NN O
p.o. NN NN O
q.d. NN NN O
, , , O
aspirin NN NN O
325 CD CD O
mg NN NN O
p.o. NN NN O
q.d. NN NN O
, , , O
atorvastatin NN NN O
40 CD CD O
mg NN NN O
p.o. NN NN O
q.d. NN NN O
, , , O
metoprolol NN NN O
12.5 CD CD O
mg NN NN O
p.o. NN NN O
b.i.d. NN NN O
, , , O
Synthroid NNP NNP O
? . . O
5 CD CD O
mcg NN NN O
five CD CD O
days NNS NNS O
per IN IN O
week NN NN O
and CC CC O
10.5 CD CD O
mcg NN NN O
two CD CD O
days NNS NNS O
per IN IN O
week NN NN O
, , , O
furosemide NN NN O
20 CD CD I-STREET
mg NN NN O
p.o. NN NN O
q.d. NN NN O
p.r.n. NN NN O
, , , O
quinine NN NN O
sulfate NN NN O
324 CD CD O
mg NN NN O
p.o. NN NN O
h.s. NN NN O
( ( ( O
for IN IN O
cramping VBG VBG O
) ) ) O
, , , O
nitroglycerin NN NN O
p.r.n. NN NN O
, , , O
Zoloft NNP NNP O
15 CD CD O
mg NN NN O
p.o. NN NN O
h.s. NN NN O
, , , O
lorazepam NN NN O
15 CD CD O
mg NN NN O
p.o. NN NN O
q.h.s. NN NN O
, , , O
magnesium NN NN O
oxide NN NN O
250 CD CD O
mg NN NN O
p.o. NN NN O
q.d. NN NN O
and CC CC O
Ranitidine NNP NNP O
150 CD CD O
mg NN NN O
p.o. NN NN O
p.r.n. NN NN O
   
On IN IN O
examination NN NN O
she PRP PRP O
appears VBZ VBZ O
well RB RB O
. . . O
   
Weight NNP NNP O
is VBZ VBZ O
142 CD CD O
pounds NNS NNS O
. . . O
   
Blood NNP NNP O
pressure NN NN O
is VBZ VBZ O
140/60 CD CD O
. . . O
   
Heart NNP NNP O
rate NN NN O
is VBZ VBZ O
50 CD CD O
and CC CC O
regular JJ JJ O
. . . O
   
Neck NN NN O
veins NNS NNS O
are VBP VBP O
6 CD CD O
cm NN NN O
above IN IN O
the DT DT O
mid JJ JJ O
right NN NN O
atrium NN NN O
. . . O
   
There EX EX O
are VBP VBP O
bilateral JJ JJ O
carotid NN NN O
bruits NNS NNS O
. . . O
   
Lungs NNS NNS O
are VBP VBP O
resonant JJ JJ O
to TO TO O
percussion NN NN O
and CC CC O
clear JJ JJ O
to TO TO O
auscultation NN NN O
. . . O
   
On IN IN O
cardiac JJ JJ O
exam NN NN O
the DT DT O
PMI NNP NNP O
is VBZ VBZ O
in IN IN O
the DT DT O
fifth JJ JJ O
intercostal NN NN O
space NN NN O
at IN IN O
the DT DT O
midclavicular NN NN O
line NN NN O
. . . O
   
There EX EX O
is VBZ VBZ O
a DT DT O
1 CD CD O
+ NN NN O
left VBD VBD O
ventricular JJ JJ O
lift NN NN O
. . . O
   
The DT DT O
first JJ JJ O
heart NN NN O
sound NN NN O
is VBZ VBZ O
normal JJ JJ O
. . . O
   
The DT DT O
second JJ JJ O
Benitez NNP NNP I-PATIENT
, , , O
Wonda NNP NNP I-PATIENT
MRN NNP NNP O
: : : O
89276954 CD CD I-MEDICALRECORD
November NNP NNP I-DATE
07 CD CD O
, , , O
2086 CD CD I-DATE
- : : O
2 CD CD O
- : : O
is VBZ VBZ O
split NN NN O
physiologically RB RB O
. . . O
   
There EX EX O
is VBZ VBZ O
a DT DT O
grade NN NN O
2/6 CD CD O
mid JJ JJ O
systolic JJ JJ O
murmur NN NN O
at IN IN O
the DT DT O
apex NN NN O
and CC CC O
a DT DT O
grade NN NN O
2/6 CD CD O
systolic JJ JJ O
ejection NN NN O
murmur NN NN O
along IN IN O
the DT DT O
left VBN VBN O
sternal JJ JJ O
border NN NN O
. . . O
   
There EX EX O
is VBZ VBZ O
a DT DT O
fourth JJ JJ O
heart NN NN O
sound NN NN O
at IN IN O
the DT DT O
apex NN NN O
. . . O
   
Abdominal NNP NNP O
examination NN NN O
reveals VBZ VBZ O
no DT DT O
masses NNS NNS O
, , , O
no DT DT O
hepatosplenomegaly NN NN O
. . . O
   
Extremities NNS NNS O
are VBP VBP O
notable JJ JJ O
for IN IN O
2 CD CD O
+ NN NN O
bilateral JJ JJ O
femoral JJ JJ O
pulses NNS NNS O
, , , O
palpable JJ JJ O
bilateral NN NN O
tibial JJ JJ O
artery NN NN O
bypass NN NN O
graft NN NN O
pulses NNS NNS O
, , , O
absent JJ JJ O
bilateral NN NN O
popliteal NN NN O
pulses NNS NNS O
, , , O
1 CD CD O
+ NN NN O
right JJ JJ O
dorsalis NNS NNS O
pedis NN NN O
, , , O
absent JJ JJ O
right JJ JJ O
posterior NN NN O
tibial NN NN O
and CC CC O
absent NN NN O
left VBD VBD O
pedal JJ JJ O
pulses NNS NNS O
. . . O
   
Her PRP$ PRP$ O
electrocardiogram NN NN O
shows VBZ VBZ O
sinus NN NN O
bradycardia NNS NNS O
with IN IN O
first JJ JJ O
degree NN NN O
AV NNP NNP O
block NN NN O
and CC CC O
findings NNS NNS O
suggestive JJ JJ O
of IN IN O
a DT DT O
prior RB RB O
anterolateral NN NN O
myocardial NN NN O
infarction NN NN O
. . . O
   
There EX EX O
has VBZ VBZ O
been VBN VBN O
no DT DT O
diagnostic JJ JJ O
change NN NN O
since IN IN O
July NNP NNP I-DATE
18 CD CD O
, , , O
2086 CD CD I-DATE
. . . O
   
Carotid NNP NNP O
duplex JJ JJ O
ultrasound NN NN O
examination NN NN O
performed VBN VBN O
on IN IN O
October NNP NNP I-DATE
31 CD CD O
, , , O
2086 CD CD I-DATE
showed VBD VBD O
a DT DT O
55 CD CD O
% NN NN O
stenosis NN NN O
of IN IN O
the DT DT O
right JJ JJ O
internal JJ JJ O
carotid NN NN O
artery NN NN O
and CC CC O
a DT DT O
50 CD CD O
% NN NN O
stenosis NN NN O
of IN IN O
the DT DT O
left VBN VBN O
internal JJ JJ O
carotid NN NN O
artery NN NN O
. . . O
   
The DT DT O
velocity NN NN O
of IN IN O
the DT DT O
right JJ JJ O
internal JJ JJ O
carotid NN NN O
artery NN NN O
and CC CC O
the DT DT O
subsequent JJ JJ O
calculation NN NN O
of IN IN O
stenosis NNS NNS O
was VBD VBD O
less JJR JJR O
than IN IN O
it PRP PRP O
had VBD VBD O
been VBN VBN O
in IN IN O
February NNP NNP I-DATE
2086 CD CD I-DATE
. . . O
   
Graft NNP NNP O
scans NNS NNS O
obtained VBN VBN O
on IN IN O
October NNP NNP I-DATE
31 CD CD O
, , , O
2086 CD CD I-DATE
demonstrated VBD VBD O
patent NN NN O
left VBD VBD O
femoral-anterior JJ JJ O
tibial JJ JJ O
artery NN NN O
bypass NN NN O
graft NN NN O
with IN IN O
increased VBN VBN O
velocities NNS NNS O
consistent JJ JJ O
with IN IN O
a DT DT O
greater JJR JJR O
than IN IN O
75 CD CD O
% NN NN O
stenosis NN NN O
at IN IN O
the DT DT O
mid JJ JJ O
thigh NN NN O
level NN NN O
and CC CC O
this DT DT O
was VBD VBD O
increased VBN VBN O
from IN IN O
a DT DT O
study NN NN O
of IN IN O
August NNP NNP I-DATE
06 CD CD O
, , , O
2086 CD CD I-DATE
. . . O
   
The DT DT O
right JJ JJ O
femoral-dorsalis JJ JJ O
pedis NN NN O
arterial JJ JJ O
bypass NN NN O
graft NN NN O
was VBD VBD O
patent NN NN O
with IN IN O
no DT DT O
evidence NN NN O
of IN IN O
significant JJ JJ O
stenoses NNS NNS O
. . . O
   
In IN IN O
summary NN NN O
, , , O
her PRP$ PRP$ O
problems NNS NNS O
relevant JJ JJ O
to TO TO O
this DT DT O
visit NN NN O
include VBP VBP O
: : : O
   
1 CD CD O
. . . O
Coronary JJ JJ O
artery NN NN O
disease NN NN O
. . . O
   
Status NNP NNP O
post NN NN O
coronary JJ JJ O
artery NN NN O
bypass NN NN O
surgery NN NN O
. . . O
   
LIMA NNP NNP O
to TO TO O
the DT DT O
LAD NNP NNP O
and CC CC O
SVGs NNP NNP O
to TO TO O
the DT DT O
diagonal NN NN O
and CC CC O
posterolateral NN NN O
left VBD VBD O
ventricular JJ JJ O
branch NN NN O
. . . O
   
She PRP PRP O
has VBZ VBZ O
occasional JJ JJ O
and CC CC O
very RB RB O
transient JJ JJ O
episodes NNS NNS O
of IN IN O
angina NN NN O
. . . O
   
I PRP PRP O
have VBP VBP O
suggested VBN VBN O
continuing VBG VBG O
her PRP$ PRP$ O
current JJ JJ O
medical JJ JJ O
regimen NNS NNS O
. . . O
   
As IN IN O
noted VBN VBN O
previously RB RB O
, , , O
I PRP PRP O
prefer VBP VBP O
to TO TO O
manage VB VB O
her PRP$ PRP$ O
medically RB RB O
unless IN IN O
her PRP$ PRP$ O
symptoms NNS NNS O
worsen NN NN O
. . . O
   
2 CD CD O
. . . O
Carotid NNP NNP O
artery NN NN O
disease NN NN O
. . . O
   
She PRP PRP O
is VBZ VBZ O
asymptomatic JJ JJ O
. . . O
   
I PRP PRP O
recommend VBP VBP O
periodic JJ JJ O
surveillance NN NN O
with IN IN O
carotid NN NN O
ultrasound NN NN O
. . . O
   
3 CD CD O
. . . O
Peripheral NNP NNP O
arterial JJ JJ O
disease NN NN O
. . . O
   
Both DT DT O
grafts NNS NNS O
are VBP VBP O
patent NN NN O
but CC CC O
the DT DT O
left VBN VBN O
femoral-anterior JJ JJ O
bypass NN NN O
graft NN NN O
appears VBZ VBZ O
by IN IN O
ultrasound NN NN O
to TO TO O
have VB VB O
a DT DT O
significant JJ JJ O
stenosis NN NN O
. . . O
   
I PRP PRP O
have VBP VBP O
asked VBN VBN O
her PRP PRP O
to TO TO O
discuss VB VB O
this DT DT O
finding NN NN O
with IN IN O
you PRP PRP O
further RB RB O
. . . O
   
Benitez NNP NNP I-PATIENT
, , , O
Wonda NNP NNP I-PATIENT
MRN NNP NNP O
: : : O
89276954 CD CD I-MEDICALRECORD
November NNP NNP I-DATE
07 CD CD O
, , , O
2086 CD CD I-DATE
- : : O
3 CD CD O
- : : O
   
4 CD CD O
. . . O
Hypercholesterolemia NNP NNP O
. . . O
   
A DT DT O
lipid NN NN O
profile NN NN O
will MD MD O
be VB VB O
checked VBN VBN O
today NN NN O
. . . O
   
5 CD CD O
. . . O
Systolic NNP NNP O
murmur NN NN O
and CC CC O
query NN NN O
antibiotic JJ JJ O
prophylaxis NNS NNS O
for IN IN O
dental JJ JJ O
procedures NNS NNS O
. . . O
   
I PRP PRP O
am VBP VBP O
evaluating VBG VBG O
her PRP$ PRP$ O
murmurs NNS NNS O
, , , O
which WDT WDT O
were VBD VBD O
presumably RB RB O
aortic JJ JJ O
sclerosis NN NN O
and CC CC O
mitral JJ JJ O
regurgitation NN NN O
, , , O
with IN IN O
an DT DT O
echocardiogram NN NN O
. . . O
   
Sincerely NNP NNP O
, , , O
Thomas NNP NNP I-DOCTOR
Waller NNP NNP I-DOCTOR
, , , O
M.D. NN NN O
cc NN NN O
: : : O
Terry NNP NNP I-DOCTOR
W. NN NN I-DOCTOR
Neel NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
   
Vascular NNP NNP O
Surgery NNP NNP O
Cooley NNP NNP I-HOSPITAL
Dickinson NNP NNP I-HOSPITAL
Hospital NNP NNP I-HOSPITAL
20 CD CD I-STREET
Greenfield NNP NNP I-STREET
Drive NNP NNP I-STREET
Schuyler NNP NNP I-CITY
, , , O
FL NNP NNP I-STATE
76969 CD CD I-ZIP
TW/sanchez NNP NNP O
******** NN NN O
Not RB RB O
reviewed VBN VBN O
by IN IN O
Attending NNP NNP O
Physician NNP NNP O
******** NN NN O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2075-10-17 JJ JJ I-DATE
Novolog NNP NNP O
3/4-5/5/6 JJ JJ O
683-51-28 JJ JJ I-MEDICALRECORD
Lantus NNP NNP O
20-21 JJ JJ O
at IN IN O
hs NN NN O
Xuan NNP NNP O
, , , O
Wendy NNP NNP I-PATIENT
Neoral NNP NNP O
100/100 CD CD O
mg NN NN O
bid NN NN O
CellCept NNP NNP O
1000 CD CD O
mg NN NN O
bid NN NN O
Lopressor NNP NNP O
12.5 CD CD O
mg NN NN O
bid NN NN O
Lipitor NNP NNP O
10 CD CD O
mg NN NN O
qd NN NN O
Neurontin NNP NNP O
600/600/1200 CD CD O
mg NN NN O
tid NN NN O
Tums NNP NNP O
200 CD CD O
mg NN NN O
ii NN NN O
bid NN NN O
Prilosec NNP NNP O
20 CD CD O
mg NN NN O
bid NN NN O
MVI NNP NNP O
i NNP NNP O
bid NN NN O
ASA NNP NNP O
325 CD CD O
mg NN NN O
qd NN NN O
Quinine NNP NNP O
Sulfate NNP NNP O
260 CD CD O
mg NN NN O
at IN IN O
hs NN NN O
Bilberry NNP NNP O
to TO TO O
help VB VB O
with IN IN O
night NN NN O
vision NN NN O
- - - O
from IN IN O
acupuncturist NN NN O
Flax NNP NNP O
Seed NNP NNP O
Oil NNP NNP O
ii NN NN O
qd NN NN O
October NNP NNP I-DATE
17 CD CD O
, , , O
2075 CD CD I-DATE
Interim NNP NNP O
History NN NN O
: : : O
Comes VBZ VBZ O
to TO TO O
review VB VB O
her PRP$ PRP$ O
medical JJ JJ O
problems NNS NNS O
. . . O
   
Has VBZ VBZ O
been VBN VBN O
feeling VBG VBG O
well RB RB O
. . . O
   
Home NNP NNP O
Blood NNP NNP O
Tests NNP NNP O
: : : O
Records NNS NNS O
downloaded VBN VBN O
from IN IN O
meter NN NN O
with IN IN O
little JJ JJ O
detail NN NN O
and CC CC O
somewhat RB RB O
scattered JJ JJ O
BS NNP NNP O
. . . O
   
B NNP NNP O
57-448 NNP NNP O
L NNP NNP O
71-222 CD CD O
S NNP NNP O
101-254 JJ JJ O
HS NNP NNP O
163-399 NN NN O
No DT DT O
food NN NN O
records NNS NNS O
. . . O
   
No DT DT O
severe JJ JJ O
hypoglycemia NN NN O
. . . O
   
Has VBZ VBZ O
had VBD VBD O
a DT DT O
couple NN NN O
of IN IN O
nocturnal JJ JJ O
reactions NNS NNS O
. . . O
   
There EX EX O
are VBP VBP O
not RB RB O
enough RB RB O
data NNS NNS O
points NNS NNS O
to TO TO O
determine VB VB O
whether IN IN O
the DT DT O
Lantus NNP NNP O
dose NN NN O
is VBZ VBZ O
appropriate JJ JJ O
. . . O
   
Retinopathy NNP NNP O
: : : O
Saw VBD VBD O
Dr NNP NNP O
. . . O
Aragon NNP NNP I-DOCTOR
over IN IN O
the DT DT O
spring NN NN I-DATE
. . . O
   
Has VBZ VBZ O
had VBN VBN O
extensive JJ JJ O
laser NN NN O
in IN IN O
the DT DT O
past NN NN O
, , , O
and CC CC O
had VBD VBD O
some DT DT O
last JJ JJ O
year NN NN O
OS NNP NNP O
after IN IN O
her PRP$ PRP$ O
surgery NN NN O
. . . O
   
Nephropathy NNP NNP O
: : : O
Her PRP$ PRP$ O
creatinine NN NN O
was VBD VBD O
stable JJ JJ O
at IN IN O
1.3 CD CD O
in IN IN O
July NNP NNP I-DATE
Neuropathy NNP NNP O
: : : O
Feet NNS NNS O
are VBP VBP O
not RB RB O
bothering VBG VBG O
her PRP PRP O
. . . O
   
Sometimes RB RB O
has VBZ VBZ O
a DT DT O
peculiar JJ JJ O
diffuse NN NN O
tingling VBG VBG O
sensation NN NN O
precipitated VBN VBN O
by IN IN O
motion NN NN O
. . . O
   
Cardiac NNP NNP O
: : : O
No DT DT O
chest NN NN O
pain NN NN O
. . . O
   
No DT DT O
unusual JJ JJ O
dyspnea NN NN O
on IN IN O
exertion NN NN O
. . . O
   
Has VBZ VBZ O
been VBN VBN O
able JJ JJ O
to TO TO O
exercise VB VB O
in IN IN O
the DT DT O
gym NN NN O
twice RB RB O
a DT DT O
week NN NN O
, , , O
walking VBG VBG O
steadily RB RB O
at IN IN O
a DT DT O
pretty RB RB O
fast RB RB O
pace NN NN O
for IN IN O
an DT DT O
hour NN NN O
. . . O
   
Vascular NNP NNP O
: : : O
No DT DT O
claudication NN NN O
Past JJ JJ O
Medical NNP NNP O
History NN NN O
: : : O
Medications NNP NNP O
: : : O
no DT DT O
significant JJ JJ O
changes NNS NNS O
Immunizations NNP NNP O
. . . O
   
Has VBZ VBZ O
not RB RB O
had VBN VBN O
flu NN NN O
shot NN NN O
yet RB RB O
this DT DT O
year NN NN O
. . . O
   
Had VBD VBD O
the DT DT O
second JJ JJ O
of IN IN O
hepatitis NN NN O
A DT DT O
series NN NN O
in IN IN O
L NNP NNP O
deltoid VB VB O
today NN NN O
. . . O
   
Review NNP NNP O
of IN IN O
Systems NNPS NNPS O
: : : O
above IN IN O
Breast NNP NNP O
: : : O
Saw VBD VBD O
Dr NNP NNP O
. . . O
Bruce NNP NNP I-DOCTOR
a DT DT O
few JJ JJ O
weeks NNS NNS O
ago RB RB O
. . . O
   
Ultrasound NNP NNP O
showed VBD VBD O
what WP WP O
is VBZ VBZ O
being VBG VBG O
interpreted VBN VBN O
as IN IN O
a DT DT O
stable JJ JJ O
slightly RB RB O
enlarge NN NN O
intramammary JJ JJ O
lymph NN NN O
node NN NN O
. . . O
   
She PRP PRP O
find VBP VBP O
the DT DT O
lower JJR JJR O
part NN NN O
of IN IN O
the DT DT O
sternotomy NN NN O
scar NN NN O
to TO TO O
be VB VB O
very RB RB O
uncomfortable JJ JJ O
in IN IN O
most JJS JJS O
bras NNS NNS O
and CC CC O
wants VBZ VBZ O
to TO TO O
consider VB VB O
whether IN IN O
it PRP PRP O
can MD MD O
be VB VB O
improved VBN VBN O
. . . O
   
Gyn NNP NNP O
: : : O
Overdue NNP NNP O
to TO TO O
see VB VB O
Yareli NNP NNP I-DOCTOR
Kilgore NNP NNP I-DOCTOR
; : : O
   
she PRP PRP O
will MD MD O
make VB VB O
the DT DT O
appointment NN NN O
. . . O
   
Skin NNP NNP O
: : : O
Has VBZ VBZ O
noted VBN VBN O
some DT DT O
crusting VBG VBG O
lesions NNS NNS O
on IN IN O
her PRP$ PRP$ O
scalp NN NN O
. . . O
   
Physical JJ JJ O
Exam NNP NNP O
: : : O
Looks NNP NNP O
well RB RB O
. . . O
   
In IN IN O
very RB RB O
good JJ JJ O
spirits NNS NNS O
. . . O
   
Jake NNP NNP I-PATIENT
is VBZ VBZ O
with IN IN O
her PRP PRP O
. . . O
   
BP NNP NNP O
: : : O
134/80 CD CD O
P NN NN O
: : : O
72 CD CD O
Seated NNP NNP O
BP NNP NNP O
: : : O
116/76 CD CD O
P NN NN O
: : : O
76 CD CD O
Standing NNP NNP O
Wt NNP NNP O
: : : O
168 CD CD O
without IN IN O
shoes NNS NNS O
, , , O
stable JJ JJ O
HEENT NNP NNP O
: : : O
Anicteric NNP NNP O
. . . O
   
Carotids NNP NNP O
: : : O
Normal JJ JJ O
pulses NNS NNS O
, , , O
without IN IN O
bruits NNS NNS O
Chest NN NN O
: : : O
Clear NNP NNP O
to TO TO O
percussion NN NN O
and CC CC O
auscultation NN NN O
There EX EX O
is VBZ VBZ O
a DT DT O
small JJ JJ O
keloid NN NN O
at IN IN O
the DT DT O
inferior JJ JJ O
portion NN NN O
of IN IN O
the DT DT O
median JJ JJ O
sternotomy NN NN O
scar NN NN O
Heart NNP NNP O
: : : O
Normal JJ JJ O
S1 NNP NNP O
; : : O
   
physiologic JJ JJ O
S2 NNP NNP O
. . . O
   
No DT DT O
gallops NNS NNS O
. . . O
   
2/6 CD CD O
systolic JJ JJ O
ejection NN NN O
murmur NN NN O
Abdomen NNP NNP O
: : : O
No DT DT O
hepatosplenomegaly NN NN O
. . . O
   
No DT DT O
masses NNS NNS O
. . . O
   
No DT DT O
tenderness NN NN O
. . . O
   
No DT DT O
palpable JJ JJ O
AAA NNP NNP O
. . . O
   
Extremities NNP NNP O
: : : O
No DT DT O
edema NN NN O
. . . O
   
DP NNP NNP O
1 CD CD O
+ NN NN O
,=. NN NN O
   
PT NNP NNP O
1 CD CD O
+ NN NN O
,=. NN NN O
   
No DT DT O
open JJ JJ O
areas NNS NNS O
of IN IN O
feet NNS NNS O
. . . O
   
Has VBZ VBZ O
several JJ JJ O
toe NN NN O
deformities NNS NNS O
, , , O
dystrophic JJ JJ O
nails NNS NNS O
and CC CC O
probable JJ JJ O
onychomycosis NN NN O
. . . O
   
Skin NNP NNP O
: : : O
Crusting NNP NNP O
lesion NN NN O
on IN IN O
scalp NN NN O
Impressions NNP NNP O
and CC CC O
Plan NNP NNP O
: : : O
Hard NNP NNP O
to TO TO O
assess VB VB O
control NN NN O
. . . O
   
She PRP PRP O
is VBZ VBZ O
reluctant JJ JJ O
to TO TO O
keep VB VB O
hand NN NN O
records NNS NNS O
. . . O
   
Will NNP NNP O
try VB VB O
to TO TO O
add VB VB O
an DT DT O
ACE NNP NNP O
inhibitor NN NN O
again RB RB O
. . . O
   
Start NNP NNP O
captopril NN NN O
6.25 CD CD O
mg NN NN O
bid NN NN O
and CC CC O
increase VB VB O
the DT DT O
12.5 CD CD O
mg NN NN O
bid NN NN O
if IN IN O
tolerated JJ JJ O
. . . O
   
Check NNP NNP O
BP NNP NNP O
at IN IN O
home NN NN O
. . . O
   
She PRP PRP O
would MD MD O
like VB VB O
to TO TO O
consider VB VB O
treatment NN NN O
for IN IN O
onychomycosis NNS NNS O
. . . O
   
Would MD MD O
suggest VB VB O
that DT DT O
Dr NNP NNP O
. . . O
Xie NNP NNP I-DOCTOR
send VB VB O
a DT DT O
paring NN NN O
for IN IN O
fungal JJ JJ O
culture NN NN O
before IN IN O
we PRP PRP O
consider VBP VBP O
it PRP PRP O
. . . O
   
Also RB RB O
, , , O
LFTs NNP NNP O
were VBD VBD O
slightly RB RB O
abnormal JJ JJ O
in IN IN O
July NNP NNP I-DATE
and CC CC O
will MD MD O
need VB VB O
to TO TO O
be VB VB O
repeated VBN VBN O
. . . O
   
Finally RB RB O
, , , O
would MD MD O
have VB VB O
to TO TO O
check VB VB O
medication NN NN O
incompatibilities NNS NNS O
before IN IN O
proceeding VBG VBG O
. . . O
   
Refer VBP VBP O
to TO TO O
Dr NNP NNP O
. . . O
xia NN NN I-DOCTOR
for IN IN O
consideration NN NN O
of IN IN O
modification NN NN O
of IN IN O
her PRP$ PRP$ O
sternotomy NN NN O
scar NN NN O
. . . O
   
Warned NNP NNP O
her PRP PRP O
that IN IN O
he PRP PRP O
may MD MD O
not RB RB O
feel VB VB O
that IN IN O
it PRP PRP O
is VBZ VBZ O
a DT DT O
good JJ JJ O
idea NN NN O
either CC CC O
on IN IN O
pure JJ JJ O
surgical JJ JJ O
grounds NNS NNS O
on IN IN O
because IN IN O
of IN IN O
her PRP$ PRP$ O
immunosuppression NN NN O
, , , O
but CC CC O
it PRP PRP O
is VBZ VBZ O
worth JJ JJ O
asking VBG VBG O
his PRP$ PRP$ O
opinion NN NN O
. . . O
   
Refer NNP NNP O
to TO TO O
Dr NNP NNP O
. . . O
Keeler NNP NNP I-DOCTOR
for IN IN O
evaluation NN NN O
of IN IN O
scalp NN NN O
lesions NNS NNS O
. . . O
   
Flu NNP NNP O
shot NN NN O
R NN NN O
deltoid NN NN O
with IN IN O
usual JJ JJ O
preamble JJ JJ O
. . . O
   
Aventis NNP NNP O
Fluzone NNP NNP O
Lot NN NN O
L5317YR NNP NNP I-BIOID
. . . O
   
Exp NNP NNP O
. . . O
7/10/76 CD CD I-DATE
. . . O
   
A1c NNP NNP O
, , , O
SGOT NNP NNP O
, , , O
SGPT NNP NNP O
, , , O
alkaline NN NN O
phosphatase NN NN O
, , , O
Bili NNP NNP O
T/D NNP NNP O
, , , O
Electrolytes NNP NNP O
, , , O
BUN/Creatinine NNP NNP O
Electrolytes NNP NNP O
, , , O
BUN/Creatinine NNP NNP O
again RB RB O
in IN IN O
1 CD CD O
month NN NN O
if IN IN O
she PRP PRP O
is VBZ VBZ O
taking VBG VBG O
captopril NN NN O
at IN IN O
that DT DT O
time NN NN O
. . . O
   
Appointments NNP NNP O
: : : O
cc NN NN O
: : : O
Xavier NNP NNP I-DOCTOR
Dotson NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
   
Yael NNP NNP I-DOCTOR
Keeler NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
   
Ysidro NNP NNP I-DOCTOR
Xia NNP NNP I-DOCTOR
. . . O
   
M.D. NNP NNP O
   
Transplant NNP NNP O
Associates NNPS NNPS O
Yacob NNP NNP I-DOCTOR
T. NN NN I-DOCTOR
Kane NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
, , , O
Ph.D NNP NNP O
. . . O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2092-08-16 JJ JJ I-DATE
Eye NNP NNP I-HOSPITAL
Specialties NNP NNP I-HOSPITAL
Intern NNP NNP O
Admission NNP NNP O
H NNP NNP I-PATIENT
& CC CC O
P NN NN O
Patient NNP NNP O
Name NN NN O
: : : O
Wood NN NN O
, , , O
Cade NNP NNP I-PATIENT
MR NNP NNP O
# # # O
6691247 CD CD I-MEDICALRECORD
Location NNP NNP O
: : : O
BIG99 NNP NNP O
PCP NNP NNP O
: : : O
Dr NNP NNP O
. . . O
Otto NNP NNP I-DOCTOR
Suzanne NNP NNP I-DOCTOR
Date NN NN O
of IN IN O
Admission NNP NNP O
: : : O
8/15/92 CD CD I-DATE
ID/CC NNP NNP O
: : : O
59 CD CD I-AGE
y.o. NN NN O
male NN NN O
with IN IN O
SOB NNP NNP O
during IN IN O
a DT DT O
CT NNP NNP O
on IN IN O
the DT DT O
day NN NN O
of IN IN O
admission NN NN O
HPI NNP NNP O
: : : O
Pt NNP NNP O
. . . O
   
is VBZ VBZ O
a DT DT O
59 CD CD I-AGE
y.o. NN NN O
male NN NN O
with IN IN O
DLBCL NNP NNP O
dx NN NN O
'ed VBZ VBZ O
with IN IN O
stage NN NN O
4 CD CD O
DLBCL NNP NNP O
in IN IN O
11/07 CD CD I-DATE
, , , O
S/P NNP NNP O
CHOP-R NNP NNP O
( ( ( O
finished VBD VBD O
3/08 CD CD I-DATE
) ) ) O
, , , O
HTN NNP NNP O
, , , O
GERD NNP NNP O
, , , O
and CC CC O
anemia NN NN O
who WP WP O
p/w VBP VBP O
acute JJ JJ O
onset NN NN O
of IN IN O
SOB NNP NNP O
while IN IN O
lying VBG VBG O
down RB RB O
during IN IN O
a DT DT O
f/u NN NN O
staging VBG VBG O
non-contrast JJ JJ O
CT NNP NNP O
on IN IN O
the DT DT O
day NN NN O
of IN IN O
admission NN NN O
. . . O
   
Pt NNP NNP O
. . . O
   
notes NNS NNS O
a DT DT O
5lbs CD CD O
weight NN NN O
gain NN NN O
over IN IN O
the DT DT O
past JJ JJ O
week NN NN O
. . . O
   
He PRP PRP O
also RB RB O
reports VBZ VBZ O
a DT DT O
1-2 JJ JJ O
week NN NN O
h/o NN NN O
increasing VBG VBG O
DOE NNP NNP O
when WRB WRB O
he PRP PRP O
performs VBZ VBZ O
his PRP$ PRP$ O
household NN NN O
chores NNS NNS O
or CC CC O
working VBG VBG O
in IN IN O
his PRP$ PRP$ O
backyard NN NN O
. . . O
   
At IN IN O
his PRP$ PRP$ O
baseline NN NN O
, , , O
can MD MD O
can MD MD O
walk VB VB O
of IN IN O
a DT DT O
mile NN NN O
w/o NN NN O
dyspnea NN NN O
or CC CC O
CP NNP NNP O
. . . O
   
4 CD CD O
days NNS NNS O
PTA NNP NNP O
, , , O
he PRP PRP O
had VBD VBD O
to TO TO O
take VB VB O
it PRP PRP O
easy JJ JJ O
during IN IN O
a DT DT O
picnic NN NN O
as IN IN O
he PRP PRP O
would MD MD O
easily RB RB O
develop VB VB O
DOE NNP NNP O
with IN IN O
minimal JJ JJ O
exertion NN NN O
. . . O
   
2days CD CD O
PTA NNP NNP O
, , , O
pt NN NN O
. . . O
   
experienced VBD VBD O
coughing VBG VBG O
bouts NNS NNS O
when WRB WRB O
he PRP PRP O
tried VBD VBD O
to TO TO O
lie VB VB O
down RB RB O
for IN IN O
sleep NN NN O
. . . O
   
The DT DT O
patient NN NN O
acutely RB RB O
developed VBD VBD O
SOB NNP NNP O
after IN IN O
lying VBG VBG O
down RP RP O
for IN IN O
a DT DT O
few JJ JJ O
minutes NNS NNS O
during IN IN O
his PRP$ PRP$ O
CT NNP NNP O
. . . O
   
He PRP PRP O
felt VBD VBD O
1/10 CD CD O
CP NNP NNP O
during IN IN O
this DT DT O
episode NN NN O
located VBN VBN O
in IN IN O
the DT DT O
R NNP NNP O
middle JJ JJ O
sub-sternum JJ JJ O
. . . O
   
The DT DT O
pain NN NN O
lasted VBD VBD O
for IN IN O
approximately RB RB O
10 CD CD O
min NN NN O
, , , O
dull JJ JJ O
in IN IN O
quality NN NN O
, , , O
did VBD VBD O
not RB RB O
radiate VB VB O
, , , O
did VBD VBD O
not RB RB O
change VB VB O
with IN IN O
position NN NN O
, , , O
relieved VBD VBD O
after IN IN O
given VBN VBN O
NTG NNP NNP O
in IN IN O
the DT DT O
ED NNP NNP O
. . . O
   
He PRP PRP O
experienced VBD VBD O
a DT DT O
similar JJ JJ O
CP NNP NNP O
during IN IN O
an DT DT O
administration NN NN O
of IN IN O
his PRP$ PRP$ O
chemo NN NN O
several JJ JJ O
months NNS NNS O
PTA NNP NNP O
. . . O
   
This DT DT O
CP NNP NNP O
was VBD VBD O
determined VBN VBN O
not RB RB O
be VB VB O
be VB VB O
cardiogenic JJ JJ O
. . . O
   
+ NN NN O
diaphoresis NNS NNS O
, , , O
- : : O
N/V NNP NNP O
, , , O
- : : O
lightheadedness NN NN O
, , , O
- : : O
palpitations NNS NNS O
. . . O
   
He PRP PRP O
reports NNS NNS O
eating VBG VBG O
a DT DT O
lot NN NN O
of IN IN O
salty NN NN O
foods NNS NNS O
. . . O
   
- : : O
recent JJ JJ O
URI/sick NNP NNP O
contacts NNS NNS O
. . . O
   
Onc NNP NNP O
Hx NNP NNP O
- : : O
59yo CD CD O
man NN NN O
with IN IN O
h/o NN NN O
1y CD CD O
microcytic JJ JJ O
anemia NN NN O
( ( ( O
low JJ JJ O
Fe NNP NNP O
, , , O
low JJ JJ O
ferritin NN NN O
) ) ) O
Found NNP NNP O
to TO TO O
have VB VB O
ascending VBG VBG O
colon NN NN O
adenomatous JJ JJ O
polyp NN NN O
persistent JJ JJ O
despite IN IN O
several JJ JJ O
colonoscopic JJ JJ O
resections NNS NNS O
. . . O
   
Also RB RB O
noted VBD VBD O
anorexia NN NN O
, , , O
fatigue NN NN O
, , , O
bloody JJ JJ O
stools NNS NNS O
. . . O
   
11/8/91 CD CD I-DATE
admitted VBN VBN O
to TO TO O
SMI NNP NNP I-HOSPITAL
with IN IN O
sudden JJ JJ O
RLQ NNP NNP O
pain NN NN O
. . . O
   
Ab NNP NNP O
CT NNP NNP O
notable JJ JJ O
for IN IN O
large JJ JJ O
mass NN NN O
arising VBG VBG O
out IN IN O
of IN IN O
the DT DT O
small JJ JJ O
bowel NN NN O
with IN IN O
liver NN NN O
lesions NNS NNS O
. . . O
   
11/11/91 CD CD I-DATE
liver NN NN O
bx NN NN O
: : : O
DLBCL NNP NNP O
. . . O
   
11/16/91 CD CD I-DATE
seen VBN VBN O
in IN IN O
clinic NN NN O
. . . O
   
Discussed NNP NNP O
diagnosis NN NN O
. . . O
   
Arranged NNP NNP O
staging VBG VBG O
. . . O
   
Anemic NNP NNP O
. . . O
   
11/28/91 CD CD I-DATE
BM NNP NNP O
bx NN NN O
-> SYM SYM O
negative JJ JJ O
for IN IN O
BM NNP NNP O
involvement NN NN O
, , , O
PAC NNP NNP O
placement NN NN O
11/30/91 CD CD I-DATE
cycle NN NN O
#1 NN NN O
CHOP-R NNP NNP O
. . . O
   
Mild NNP NNP O
transfusion NN NN O
reaction NN NN O
with IN IN O
PRBC NNP NNP O
12/02/91 CD CD I-DATE
PRBC NNP NNP O
successfully RB RB O
given VBN VBN O
. . . O
   
Neulasta NNP NNP O
. . . O
   
12/7/91 CD CD I-DATE
In IN IN O
f/u NN NN O
, , , O
noted VBD VBD O
to TO TO O
be VB VB O
neutropenic JJ JJ O
despite IN IN O
Neulasta NNP NNP O
and CC CC O
with IN IN O
oral JJ JJ O
candidiasis NNS NNS O
. . . O
   
Tx NNP NNP O
diflucan NN NN O
, , , O
prophylactic JJ JJ O
Levoquin NNP NNP O
. . . O
   
Anemic NNP NNP O
-> : : O
2U CD CD O
PRBC NNP NNP O
. . . O
   
12/21/91 CD CD I-DATE
cycle NN NN O
#2 NN NN O
CHOP-R NNP NNP O
, , , O
c/b NN NN O
episode NN NN O
non-cardiac JJ JJ O
chest NN NN O
pain NN NN O
completed VBN VBN O
CHOP/R NNP NNP O
x SYM SYM O
6 CD CD O
cycles NNS NNS O
in IN IN O
3/08 CD CD I-DATE
ED NNP NNP O
course NN NN O
: : : O
VS NNP NNP O
: : : O
HR=78 NNP NNP O
BP=178/108 NNP NNP O
Tc-96.6 NNP NNP O
RR=28 NNP NNP O
SaO2=96% NNP NNP O
RA NNP NNP O
Given NNP NNP O
ASA NNP NNP O
325 CD CD O
mg NN NN O
, , , O
NTG NNP NNP O
X1 NNP NNP O
, , , O
Lasix NNP NNP O
20mg CD CD O
IV NNP NNP O
X1 NNP NNP O
, , , O
500 CD CD O
ccNS NN NN O
. . . O
   
PMHx NNP NNP O
: : : O
   
1 CD CD O
. . . O
Stage NN NN O
IV NNP NNP O
DLBCL NNP NNP O
11/07 CD CD I-DATE
. . . O
   
Likely NNP NNP O
intestinal JJ JJ O
origin NN NN O
Involvement NNP NNP O
of IN IN O
liver NN NN O
; : : O
   
no DT DT O
bone NN NN O
marrow NN NN O
or CC CC O
thoracic NN NN O
involvement NN NN O
. . . O
   
S/p NNP NNP O
6 CD CD O
cycles NNS NNS O
CHOP-R NNP NNP O
chemotherapy NN NN O
. . . O
   
Last JJ JJ O
cycle NN NN O
3/14/92 CD CD I-DATE
. . . O
   
Repeat NNP NNP O
CT NNP NNP O
1/27/92 CD CD I-DATE
showed VBD VBD O
RLQ NNP NNP O
mass NN NN O
reduced VBN VBN O
in IN IN O
size NN NN O
to TO TO O
9x5 CD CD O
cm NN NN O
. . . O
   
CT NNP NNP O
4/04/92 CD CD I-DATE
showed VBD VBD O
considerable JJ JJ O
inflammatory JJ JJ O
reaction NN NN O
in IN IN O
the DT DT O
right NN NN O
lower JJR JJR O
quadrant JJ JJ O
engulfing VBG VBG O
loops NNS NNS O
of IN IN O
small JJ JJ O
bowel NN NN O
c/w NN NN O
a DT DT O
focal JJ JJ O
small JJ JJ O
bowel NN NN O
perforation NN NN O
. . . O
   
2 CD CD O
. . . O
Microcytic NNP NNP O
anemia NN NN O
diagnosed VBD VBD O
3/07 CD CD I-DATE
. . . O
   
3 CD CD O
. . . O
Diverticulosis NNP NNP O
   
4 CD CD O
. . . O
Colonic NNP NNP O
polyps NN NN O
- : : O
tubulovillous JJ JJ O
adenoma NN NN O
resected VBD VBD O
10/87 CD CD I-DATE
. . . O
   
Repeat NNP NNP O
excisions NNS NNS O
06 CD CD I-DATE
, , , O
12/06 CD CD I-DATE
. . . O
   
Cecal NNP NNP O
polyp NN NN O
- : : O
tubular NN NN O
adenoma NN NN O
resected VBD VBD O
3/07 CD CD I-DATE
. . . O
   
Last JJ JJ O
colonoscopy NN NN O
10/07 CD CD I-DATE
with IN IN O
resection NN NN O
of IN IN O
10x3 CD CD O
mm NN NN O
polyp NN NN O
in IN IN O
ascending VBG VBG O
colon NN NN O
. . . O
   
5 CD CD O
. . . O
GERD NNP NNP O
- : : O
endoscopy NN NN O
3/07 CD CD I-DATE
revealed VBD VBD O
3 CD CD O
linear JJ JJ O
esophageal NN NN O
ulcerations NNS NNS O
from IN IN O
30cm CD CD O
to TO TO O
40 CD CD O
cm NN NN O
with IN IN O
no DT DT O
evidence NN NN O
of IN IN O
gastric JJ JJ O
or CC CC O
duodenal JJ JJ O
ulceration NN NN O
. . . O
   
6 CD CD O
. . . O
HTN NNP NNP O
   
7 CD CD O
. . . O
Hyperlipidemia-Lipitor NNP NNP O
d/c'ed NN NN O
prior RB RB O
to TO TO O
chemotherapy NN NN O
regimen NNS NNS O
. . . O
   
Allergies NNP NNP O
: : : O
Demerol NN NN O
- - - O
syncope NN NN O
Fluconazole NNP NNP O
- : : O
GI NNP NNP O
upset NN NN O
Medications NNP NNP O
at IN IN O
home NN NN O
: : : O
Omeprazole NNP NNP O
- : : O
20mg CD CD O
QHS NNP NNP O
Lisinopril NNP NNP O
40 CD CD O
mg NN NN O
PO NNP NNP O
QD NNP NNP O
Lopressor NNP NNP O
50 CD CD O
mg NN NN O
PO NNP NNP O
BID NNP NNP O
PSHx NNP NNP O
: : : O
6/14/92 CD CD I-DATE
Resection NNP NNP O
of IN IN O
the DT DT O
terminal NN NN O
ileum NN NN O
and CC CC O
ascending VBG VBG O
colon NN NN O
for IN IN O
partial JJ JJ O
obstruction NN NN O
at IN IN O
the DT DT O
terminal NN NN O
ileum NN NN O
. . . O
   
Pathology NNP NNP O
showed VBD VBD O
small JJ JJ O
intestine NN NN O
with IN IN O
abscess JJ JJ O
formation NN NN O
, , , O
foreign JJ JJ O
body NN NN O
giant NN NN O
cell NN NN O
reaction NN NN O
, , , O
marked VBD VBD O
transmural JJ JJ O
fibrosis NNS NNS O
with IN IN O
foamy NN NN O
histiocytes NNS NNS O
and CC CC O
acute JJ JJ O
and CC CC O
organized JJ JJ O
serositis NNS NNS O
consistent JJ JJ O
with IN IN O
perforated JJ JJ O
viscus NN NN O
. . . O
   
There EX EX O
was VBD VBD O
also RB RB O
tubular JJ JJ O
adenoma NN NN O
measuring VBG VBG O
0.4 CD CD O
cm NN NN O
in IN IN O
the DT DT O
ascending VBG VBG O
colon NN NN O
- : : O
completely RB RB O
excised VBN VBN O
. . . O
   
, , , O
no DT DT O
evidence NN NN O
of IN IN O
malignancy NN NN O
. . . O
   
SHx NNP NNP O
: : : O
Pt NNP NNP O
. . . O
   
is VBZ VBZ O
single JJ JJ O
, , , O
lives NNS NNS O
by IN IN O
himself PRP PRP O
. . . O
   
He PRP PRP O
formerly RB RB O
worked VBD VBD O
in IN IN O
goods NNS NNS I-PROFESSION
production NN NN I-PROFESSION
but CC CC O
was VBD VBD O
laid VBN VBN O
off RP RP O
1 CD CD O
yr NN NN O
. . . O
   
PTA NNP NNP O
. . . O
   
He PRP PRP O
has VBZ VBZ O
a DT DT O
supportive JJ JJ O
network NN NN O
of IN IN O
family NN NN O
and CC CC O
friends NNS NNS O
. . . O
   
He PRP PRP O
does VBZ VBZ O
not RB RB O
smoke NN NN O
, , , O
has VBZ VBZ O
1 CD CD O
alcoholic JJ JJ O
beverage NN NN O
every DT DT O
few JJ JJ O
months NNS NNS O
, , , O
and CC CC O
denies NNS NNS O
illicit JJ JJ O
drug NN NN O
use NN NN O
. . . O
   
FHx NNP NNP O
: : : O
Father NNP NNP O
- - - O
DM NNP NNP O
, , , O
Alzheimer NNP NNP O
's POS POS O
Mother NNP NNP O
- : : O
DM NNP NNP O
, , , O
HTN NNP NNP O
ROS NNP NNP O
: : : O
No DT DT O
F/C/NS NNP NNP O
. . . O
   
+ NN NN O
5lbs CD CD O
weight NN NN O
gain NN NN O
in IN IN O
2 CD CD O
weeks NNS NNS O
. . . O
   
No DT DT O
hemoptysis/wheezing/sore NN NN O
throat/rash NN NN O
. . . O
   
No DT DT O
N/V/D/hematochezia/melena NNP NNP O
. . . O
   
No DT DT O
delta NN NN O
MS/LOC NNP NNP O
. . . O
   
No DT DT O
slurring NN NN O
of IN IN O
speech NN NN O
, , , O
unilateral JJ JJ O
weakness NN NN O
. . . O
   
No DT DT O
dysuria NN NN O
. . . O
   
- : : O
polyuria/polydypsia NN NN O
, , , O
heat/cold JJ JJ O
intolerance NN NN O
. . . O
   
Exam NNP NNP O
: : : O
VS NNP NNP O
: : : O
HR=65 NNP NNP O
BP=157/98 NNP NNP O
RR=20 NNP NNP O
SaO2=95% NNP NNP O
RA NNP NNP O
General NNP NNP O
: : : O
NAD NNP NNP O
HEENT NNP NNP O
: : : O
NC/AT NNP NNP O
, , , O
PERRL NNP NNP O
, , , O
. . . O
   
EOMI NNP NNP O
, , , O
Neck NNP NNP O
: : : O
Supple NNP NNP O
, , , O
full JJ JJ O
ROM NNP NNP O
, , , O
no DT DT O
LAD NNP NNP O
, , , O
no DT DT O
thyromegaly NN NN O
, , , O
Chest NN NN O
: : : O
CTA&P NNP NNP O
bilaterally RB RB O
, , , O
no DT DT O
wheezes NNS NNS O
, , , O
crackles NNS NNS O
, , , O
or CC CC O
ronchi NN NN O
CVS NNP NNP O
: : : O
RRR NNP NNP O
nl NN NN O
S1 NNP NNP O
S2 NNP NNP O
, , , O
no DT DT O
m/r/g NN NN O
, , , O
JVP NNP NNP O
= SYM SYM O
7 CD CD O
, , , O
2 CD CD O
+ NN NN O
brisk NN NN O
carotids NNS NNS O
w/o NN NN O
bruits NNS NNS O
Abd NNP NNP O
: : : O
soft JJ JJ O
, , , O
NT/ND NNP NNP O
, , , O
nl NN NN O
BS NNP NNP O
, , , O
no DT DT O
HSM NNP NNP O
Extr NNP NNP O
: : : O
WWP NNP NNP O
, , , O
no DT DT O
c/c/e NN NN O
2 CD CD O
+ NN NN O
DP/PT NNP NNP O
bilaterally RB RB O
Neuro NNP NNP O
: : : O
A+OX3, NNP NNP O
MS NNP NNP O
nl NN NN O
, , , O
CN NNP NNP O
II NNP NNP O
through IN IN O
XII NNP NNP O
intact JJ JJ O
, , , O
Motor NNP NNP O
5/5 CD CD O
UE NNP NNP O
and CC CC O
LE NNP NNP O
, , , O
Sensory NNP NNP O
intact JJ JJ O
. . . O
   
DTR NNP NNP O
's POS POS O
2 CD CD O
+ NN NN O
and CC CC O
symmetric JJ JJ O
in IN IN O
bilat NN NN O
LE NNP NNP O
and CC CC O
UE NNP NNP O
. . . O
   
Toes NNP NNP O
down RB RB O
bilaterally RB RB O
. . . O
   
F NN NN O
to TO TO O
N NNP NNP O
nl NN NN O
, , , O
RAM NNP NNP O
nl NN NN O
. . . O
   
Skin NNP NNP O
: : : O
- : : O
rash NN NN O
DATA NNP NNP O
: : : O
08/15/92 CD CD I-DATE
12:19 CD CD O
NA NNP NNP O
138 CD CD O
K NNP NNP O
3.8 CD CD O
CL NNP NNP O
108 CD CD O
CO2 NNP NNP O
25.6 CD CD O
BUN NNP NNP O
16 CD CD O
CRE NNP NNP O
1.0 CD CD O
GLU NNP NNP O
104 CD CD O
08/15/92 CD CD I-DATE
08/15/92 CD CD I-DATE
22:40 CD CD O
13:09 CD CD O
CK NNP NNP O
40(L) CD CD O
CK-MB NNP NNP O
1.9 CD CD O
Negative NNP NNP O
CKMBRI NNP NNP O
see VB VB O
detail NN NN O
TROP-I NNP NNP O
Negative NNP NNP O
TROP-T NNP NNP O
< NN NN O
0.01 CD CD O
Lab NNP NNP O
Results NNS NNS O
for IN IN O
: : : O
WOOD NN NN O
, , , O
CADE NNP NNP I-PATIENT
H NNP NNP I-PATIENT
Test NNP NNP O
Name NN NN O
SMI NNP NNP I-HOSPITAL
08/15/92 CD CD I-DATE
12:13 CD CD O
WBC NNP NNP O
8.5 CD CD O
RBC NNP NNP O
4.11(L) CD CD O
HGB NNP NNP O
12.4(L) CD CD O
HCT NNP NNP O
34.8(L) CD CD O
MCV NNP NNP O
85 CD CD O
MCH NNP NNP O
30.1 CD CD O
MCHC NNP NNP O
35.5 CD CD O
PLT NNP NNP O
185 CD CD O
RDW NNP NNP O
14.3 CD CD O
DIFFR NNP NNP O
Received NNP NNP O
METHOD NNP NNP O
see VB VB O
detail NN NN O
% NN NN O
NEUT NNP NNP O
88(H) CD CD O
% NN NN O
LYMPH NNP NNP O
6(L) CD CD O
% NN NN O
MONO NNP NNP O
4 CD CD O
% NN NN O
EOS NNP NNP O
2 CD CD O
% NN NN O
BASO NNP NNP O
0 CD CD O
CXR NNP NNP O
: : : O
New NNP NNP O
mild NN NN O
interstitial JJ JJ O
pulmonary JJ JJ O
edema NN NN O
. . . O
   
EKG NNP NNP O
: : : O
Nl NNP NNP O
sinus NN NN O
rhythm NN NN O
, , , O
L NNP NNP O
axis NNS NNS O
deviation NN NN O
, , , O
nl NN NN O
intervals NNS NNS O
, , , O
T NN NN O
wave NN NN O
inversions NNS NNS O
I PRP PRP O
, , , O
aVL NN NN O
, , , O
T NN NN O
wave NN NN O
flattening VBG VBG O
V3-V6, NNP NNP O
old JJ JJ O
inferior JJ JJ O
infarct NN NN O
. . . O
   
Echo NNP NNP O
11/07 CD CD I-DATE
- : : O
There EX EX O
is VBZ VBZ O
symmetric JJ JJ O
left VBN VBN O
ventricular NN NN O
hypertrophy NN NN O
. . . O
   
There EX EX O
are VBP VBP O
no DT DT O
obvious JJ JJ O
segmental JJ JJ O
wall NN NN O
motion NN NN O
abnormalities NNS NNS O
. . . O
   
Theestimated NNP NNP O
ejection NN NN O
fraction NN NN O
is VBZ VBZ O
73 CD CD O
%. NN NN O
   
__________________________________________ NN NN O
_ NN NN O
Impression NNP NNP O
: : : O
Pt NNP NNP O
. . . O
   
is VBZ VBZ O
a DT DT O
59 CD CD I-AGE
y.o. NN NN O
male NN NN O
with IN IN O
DLBCL NNP NNP O
dx NN NN O
'ed VBZ VBZ O
11/07 CD CD I-DATE
s/p NN NN O
CHOP-R NNP NNP O
, , , O
HTN NNP NNP O
, , , O
hyperlipidemia NN NN O
, , , O
GERD NNP NNP O
, , , O
and CC CC O
anemia NN NN O
who WP WP O
p/w VBP VBP O
acute JJ JJ O
onset NN NN O
SOB NNP NNP O
in IN IN O
the DT DT O
setting VBG VBG O
of IN IN O
a DT DT O
BP NNP NNP O
= SYM SYM O
178/108 CD CD O
likely JJ JJ O
2/2 CD CD O
flash VBP VBP O
pulmonary JJ JJ O
edema NN NN O
. . . O
   
Plan NNP NNP O
: : : O
CHF NNP NNP O
- - - O
pt.'s NN NN O
PE NNP NNP O
resolved VBD VBD O
s/p NN NN O
20 CD CD O
mg NN NN O
IV NNP NNP O
lasix NN NN O
, , , O
administration NN NN O
of IN IN O
lopressor NN NN O
, , , O
and CC CC O
NTG NNP NNP O
. . . O
   
He PRP PRP O
showed VBD VBD O
no DT DT O
signs NNS NNS O
of IN IN O
volume NN NN O
overload NN NN O
during IN IN O
the DT DT O
physical JJ JJ O
exam NN NN O
. . . O
   
Chest NN NN O
CT NNP NNP O
showed VBD VBD O
no DT DT O
acute JJ JJ O
hemorrhage NN NN O
, , , O
PTX NNP NNP O
, , , O
or CC CC O
lymphangitic JJ JJ O
spread NN NN O
( ( ( O
preliminary JJ JJ O
read NN NN O
) ) ) O
. . . O
   
Follow-up NNP NNP O
official NN NN O
CT NNP NNP O
read NN NN O
. . . O
   
No DT DT O
contrast NN NN O
was VBD VBD O
given VBN VBN O
, , , O
therefore RB RB O
, , , O
acute JJ JJ O
SOB NNP NNP O
could MD MD O
not RB RB O
be VB VB O
secondary JJ JJ O
to TO TO O
contrast NN NN O
allergy NN NN O
. . . O
   
This DT DT O
pt.'s NN NN O
salty NN NN O
diet NN NN O
and CC CC O
uncontrolled JJ JJ O
HTN NNP NNP O
most RBS RBS O
likely JJ JJ O
led VBN VBN O
to TO TO O
the DT DT O
acute JJ JJ O
decompensation NN NN O
. . . O
   
No DT DT O
evidence NN NN O
of IN IN O
infection NN NN O
. . . O
   
Pt NNP NNP O
. . . O
   
will MD MD O
receive VB VB O
an DT DT O
Echo NNP NNP O
to TO TO O
evaluate VB VB O
for IN IN O
possible JJ JJ O
worsening VBG VBG O
LVEF NNP NNP O
s/p NN NN O
antrhacycline NN NN O
chemo NN NN O
vs NNS NNS O
. . . O
diastolic JJ JJ O
dysfunction NN NN O
with IN IN O
LV NNP NNP O
hypertrophy NN NN O
. . . O
   
F/U NNP NNP O
BNP NNP NNP O
. . . O
   
Will NNP NNP O
re-dose JJ JJ O
lasix NN NN O
only RB RB O
if IN IN O
necessitated VBN VBN O
by IN IN O
clinical JJ JJ O
signs NNS NNS O
of IN IN O
volume NN NN O
overload NN NN O
. . . O
   
Angina NNP NNP O
- : : O
This DT DT O
pt NN NN O
. . . O
   
has VBZ VBZ O
EKG NNP NNP O
changes NNS NNS O
and CC CC O
pain NN NN O
that WDT WDT O
is VBZ VBZ O
possibly RB RB O
cardiogenic JJ JJ O
in IN IN O
origin NN NN O
. . . O
   
Will NNP NNP O
obtain VB VB O
serial JJ JJ O
enzymes NNS NNS O
to TO TO O
r/o VB VB O
MI NNP NNP O
. . . O
   
Begin NNP NNP O
ASA NNP NNP O
, , , O
increase NN NN O
lopressor NN NN O
to TO TO O
50 CD CD O
TID NNP NNP O
, , , O
captopril NN NN O
instead RB RB O
of IN IN O
lisinopril NN NN O
for IN IN O
easier JJR JJR O
titration NN NN O
of IN IN O
BPs NNP NNP O
, , , O
2LO2 CD CD O
via IN IN O
nasal NN NN O
canula NN NN O
. . . O
   
Consider NNP NNP O
stress NN NN O
test NN NN O
before IN IN O
d/c NN NN O
. . . O
   
Prophylaxis NNP NNP O
- - - O
fragmin NN NN O
5000 CD CD O
SC NNP NNP O
QD NNP NNP O
. . . O
   
SOB NNP NNP O
resolved VBD VBD O
after IN IN O
lasix NN NN O
+ NN NN O
lopressor NN NN O
. . . O
   
Unlikely NNP NNP O
PE NNP NNP O
in IN IN O
this DT DT O
setting VBG VBG O
but CC CC O
pt NN NN O
. . . O
   
is VBZ VBZ O
hypercoagulable JJ JJ O
given VBN VBN O
malignancy NN NN O
. . . O
   
Low NNP NNP O
threshold NN NN O
for IN IN O
CT NNP NNP O
PE NNP NNP O
protocol NN NN O
. . . O
   
GERD-Omeprazole NNP NNP O
. . . O
   
Onc NNP NNP O
- : : O
Will NNP NNP O
check NN NN O
uric JJ JJ O
acid NN NN O
and CC CC O
LDH NNP NNP O
to TO TO O
eval NN NN O
. . . O
   
for IN IN O
possible JJ JJ O
TLS NNP NNP O
. . . O
   
Unlikely NNP NNP O
given VBN VBN O
normal JJ JJ O
electrolytes NNS NNS O
and CC CC O
good JJ JJ O
renal JJ JJ O
function NN NN O
. . . O
   
CT NNP NNP O
shows VBZ VBZ O
no DT DT O
lymphangitic JJ JJ O
spread NN NN O
but CC CC O
must MD MD O
f/u VB VB O
official JJ JJ O
read NN NN O
in IN IN O
the DT DT O
AM NNP NNP O
. . . O
   
________________________________ NN NN O
_ NN NN O
Henderson NNP NNP I-DOCTOR
Xin NNP NNP I-DOCTOR
, , , O
MD NNP NNP O
Team NNP NNP O
3 CD CD O
Intern NNP NNP O
Department NNP NNP O
of IN IN O
Internal NNP NNP O
Medicine NNP NNP O
Saint NNP NNP I-HOSPITAL
Marys NNP NNP I-HOSPITAL
Infirmary NNP NNP I-HOSPITAL
Pager NNP NNP O
#44348 NN NN O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2072-06-12 JJ JJ I-DATE
Internal NNP NNP O
Medicine NNP NNP O
Admit NNP NNP O
Note NN NN O
06/12/72 CD CD I-DATE
Patient NNP NNP O
Name NN NN O
: : : O
Xavier NNP NNP I-PATIENT
Rutledge NNP NNP I-PATIENT
( ( ( O
KEKELA NNP NNP I-HOSPITAL
53954143 CD CD I-MEDICALRECORD
) ) ) O
Renal NNP NNP O
TPx NNP NNP O
Details NNS NNS O
: : : O
Cadaveric NNP NNP O
RTX NNP NNP O
2060 CD CD I-DATE
w NN NN O
/ NN NN O
CAN MD MD O
and CC CC O
baseline NN NN O
Cr NNP NNP O
2.5 CD CD O
Renal NNP NNP O
Dx NNP NNP O
: : : O
ESRD NNP NNP O
of IN IN O
unclear JJ JJ O
cause NN NN O
Current NNP NNP O
Immsp NNP NNP O
: : : O
CsA NNP NNP O
and CC CC O
Prednisone NNP NNP O
Reason NNP NNP O
for IN IN O
Admit NNP NNP O
: : : O
Fever NNP NNP O
, , , O
diarrhea NN NN O
and CC CC O
probable JJ JJ O
UTI NNP NNP O
Background NNP NNP O
: : : O
63M CD CD O
with IN IN O
known VBN VBN O
CRRTx NNP NNP O
since IN IN O
2060 CD CD I-DATE
with IN IN O
known VBN VBN O
CKD NNP NNP O
and CC CC O
baseline NN NN O
Cr NNP NNP O
2.5 CD CD O
with IN IN O
urethral JJ JJ O
stricture NN NN O
and CC CC O
in-dwelling JJ JJ O
Foley NNP NNP O
catheter NN NN O
who WP WP O
presented VBD VBD O
to TO TO O
ED NNP NNP O
with IN IN O
h/o NN NN O
multiple JJ JJ O
episodes NNS NNS O
of IN IN O
diarrhea NN NN O
last JJ JJ O
night NN NN O
, , , O
cloudy NN NN O
urine NN NN O
and CC CC O
severe JJ JJ O
weakness NN NN O
. . . O
   
He PRP PRP O
was VBD VBD O
on IN IN O
Ampicillin NNP NNP O
for IN IN O
a DT DT O
recent JJ JJ O
UTI NNP NNP O
. . . O
   
He PRP PRP O
denies VBZ VBZ O
any DT DT O
fevers NNS NNS O
this DT DT O
past JJ JJ O
weekend NN NN O
, , , O
however RB RB O
he PRP PRP O
was VBD VBD O
febrile JJ JJ O
today NN NN O
at IN IN O
102 CD CD O
F. NN NN O
He PRP PRP O
has VBZ VBZ O
chronic JJ JJ O
lower JJR JJR O
extremity NN NN O
edema NN NN O
for IN IN O
which WDT WDT O
he PRP PRP O
is VBZ VBZ O
on IN IN O
high JJ JJ O
dose NN NN O
lasix NN NN O
with IN IN O
minimal JJ JJ O
response NN NN O
. . . O
   
In IN IN O
ED NNP NNP O
patient NN NN O
was VBD VBD O
hypoglycemic JJ JJ O
with IN IN O
FSBS NNP NNP O
   
46 CD CD O
. . . O
He PRP PRP O
was VBD VBD O
givin NN NN O
1amp CD CD O
D50 NNP NNP O
and CC CC O
a DT DT O
liter NN NN O
of IN IN O
NS NNP NNP O
IV NNP NNP O
. . . O
   
Medical NNP NNP O
Hx NNP NNP O
: : : O
   
1 CD CD O
. . . O
ESRD NNP NNP O
s/p NN NN O
CRRTx NNP NNP O
2060 CD CD I-DATE
- : : O
Prior NNP NNP O
to TO TO O
TPx NNP NNP O
was VBD VBD O
on IN IN O
HD NNP NNP O
via IN IN O
RUE NNP NNP O
AVF NNP NNP O
, , , O
presumed VBD VBD O
ESRD NNP NNP O
d/t NN NN O
HTN NNP NNP O
- - - O
CRRTx NNP NNP O
2060 CD CD I-DATE
requiring VBG VBG O
re-implantation NN NN O
of IN IN O
the DT DT O
ureter NN NN O
two CD CD O
times NNS NNS O
- : : O
Renal NNP NNP O
Bx NNP NNP O
( ( ( O
2065 CD CD I-DATE
) ) ) O
: : : O
cyclosporine NN NN O
toxicity NN NN O
, , , O
nephrolithiasis NN NN O
, , , O
TIF NNP NNP O
- - - O
Baseline NNP NNP O
Cr NNP NNP O
2.4 CD CD O
- : : O
2.8 CD CD O
, , , O
Renal NNP NNP O
Bx NNP NNP O
2065 CD CD I-DATE
: : : O
   
2 CD CD O
. . . O
Urethral NNP NNP O
stricture NN NN O
requiring VBG VBG O
repeated VBN VBN O
catherisation NN NN O
and CC CC O
c/b NN NN O
UTI NNP NNP O
's POS POS O
, , , O
foley NN NN O
in IN IN O
place NN NN O
. . . O
   
Plan NNP NNP O
for IN IN O
suprapubic NN NN O
catheter NN NN O
placement NN NN O
by IN IN O
Dr NNP NNP O
. . . O
Acevedo NNP NNP I-DOCTOR
. . . O
   
- - - O
Multiple NNP NNP O
UTI NNP NNP O
's POS POS O
w NN NN O
/ NN NN O
h/o NN NN O
Candida NNP NNP O
( ( ( O
Apr NNP NNP I-DATE
2072 CD CD I-DATE
) ) ) O
, , , O
Klebsiella NNP NNP O
( ( ( O
September NNP NNP I-DATE
2071 CD CD I-DATE
) ) ) O
, , , O
Proteus NNP NNP O
   
3 CD CD O
. . . O
Type NNP NNP O
2 CD CD O
DM NNP NNP O
- : : O
Diagnosed NNP NNP O
following VBG VBG O
TPx NNP NNP O
and CC CC O
steroids NNS NNS O
- : : O
On IN IN O
insulin NN NN O
   
4 CD CD O
. . . O
CMV NNP NNP O
retinitis NN NN O
post-transplant JJ JJ O
   
5 CD CD O
. . . O
Aortic NNP NNP O
stenosis NNS NNS O
- - - O
Echo NNP NNP O
2071 CD CD I-DATE
: : : O
AVA NNP NNP O
1.3 CD CD O
cm NN NN O
and CC CC O
peak NN NN O
gradient NN NN O
28 CD CD O
mmHg NN NN O
   
6 CD CD O
. . . O
Recurrent NNP NNP O
LE NNP NNP O
DVT NNP NNP O
's POS POS O
- - - O
on IN IN O
Coumadin NNP NNP O
   
7 CD CD O
. . . O
HTN NNP NNP O
   
8 CD CD O
. . . O
Torn NNP NNP O
right RB RB O
rotator NN NN O
cuff NN NN O
   
9 CD CD O
. . . O
Gout NNP NNP O
   
10 CD CD O
. . . O
BPH NNP NNP O
   
11 CD CD O
. . . O
Hypercholesterolemia NNP NNP O
   
12 CD CD O
. . . O
s/p NN NN O
left VBD VBD O
5th CD CD O
toe NN NN O
amputation NN NN O
   
13 CD CD O
. . . O
h/o NN NN O
C. NN NN O
dif NN NN O
colitis NN NN O
   
14 CD CD O
. . . O
s/p NN NN O
ccy NN NN O
and CC CC O
appy JJ JJ O
   
15 CD CD O
. . . O
G6PD NNP NNP O
deficiency NN NN O
Medications NNP NNP O
: : : O
Neoral NNP NNP O
100mg CD CD O
bid NN NN O
po NN NN O
Prednisone NNP NNP O
5/10mg CD CD O
qd NN NN O
po NN NN O
Lopressor NNP NNP O
50mg CD CD O
bid NN NN O
po NN NN O
Lasix NNP NNP O
80 CD CD O
mg NN NN O
bid NN NN O
po NN NN O
Iron NNP NNP O
Sulfate NNP NNP O
325mg CD CD O
bid NN NN O
po NN NN O
Calcium NNP NNP O
Carbonate NNP NNP O
500 CD CD O
mg NN NN O
tid NN NN O
po NN NN O
Flomax NNP NNP O
0.8mg CD CD O
qhs NN NN O
po NN NN O
Proscar NNP NNP O
5 CD CD O
mg NN NN O
qd NN NN O
po NN NN O
Coumadin NNP NNP O
1 CD CD O
mg NN NN O
qd NN NN O
po NN NN O
Procrit NNP NNP O
10,000 CD CD O
U NNP NNP O
q NN NN O
week NN NN O
( ( ( O
Wed NNP NNP O
) ) ) O
NPH NNP NNP O
22 CD CD O
units NNS NNS O
qam NN NN O
and CC CC O
10 CD CD O
U NNP NNP O
qpm NN NN O
, , , O
Insulin NNP NNP O
sliding VBG VBG O
scale NN NN O
qAC+HS NN NN O
Immodium NNP NNP O
q4-6hrs JJ JJ O
prn NN NN O
loose JJ JJ O
stools NNS NNS O
Ampicillin NNP NNP O
500mg CD CD O
qid NN NN O
Allergies NNP NNP O
: : : O
Codeine NNP NNP O
-> SYM SYM O
Nausea NNP NNP O
, , , O
Potassium NNP NNP O
-> SYM SYM O
Nausea NNP NNP O
and CC CC O
Rash NNP NNP O
, , , O
Quinine NNP NNP O
Social NNP NNP O
History NN NN O
: : : O
Lives NNS NNS O
with IN IN O
wife NN NN O
, , , O
retired VBD VBD O
. . . O
   
Denies NNP NNP O
tobacoo NN NN O
( ( ( O
quit VBD VBD O
30 CD CD O
yrs NN NN O
ago RB RB O
) ) ) O
, , , O
ETOH9(quit NNP NNP O
30 CD CD O
yrs NNS NNS O
ago RB RB O
) ) ) O
, , , O
and CC CC O
ilicit JJ JJ O
drug NN NN O
use NN NN O
Family NNP NNP O
History NN NN O
: : : O
unremarkable JJ JJ O
On IN IN O
examination NN NN O
: : : O
General NNP NNP O
: : : O
Lying NNP NNP O
on IN IN O
bed NN NN O
in IN IN O
no DT DT O
distress NN NN O
Vitals NNP NNP O
: : : O
T99.8 NNP NNP O
F NN NN O
; : : O
   
BP NNP NNP O
97/44 CD CD O
mmHg NN NN O
; : : O
   
HR NNP NNP O
77/min; CD CD O
   
R NN NN O
20 CD CD O
HEENT NNP NNP O
: : : O
(+) NN NN O
orbital JJ JJ O
edema NN NN O
b/l NN NN O
, , , O
(+) NNP NNP O
facial JJ JJ O
flushing NN NN O
CVS NNP NNP O
: : : O
S1 NNP NNP O
and CC CC O
S2 NNP NNP O
, , , O
no DT DT O
S3/Rub, NNP NNP O
clinical JJ JJ O
ESM NNP NNP O
loudes NNS NNS O
over IN IN O
aortic JJ JJ O
areaResp NN NN O
: : : O
slight JJ JJ O
expiratory NN NN O
wheeze NN NN O
RLLB NNP NNP O
, , , O
no DT DT O
rhonchi NN NN O
or CC CC O
rales NNS NNS O
. . . O
   
Abd NNP NNP O
: : : O
Soft JJ JJ O
, , , O
non NN NN O
tender NN NN O
, , , O
no DT DT O
masses NNS NNS O
, , , O
NABS NNP NNP O
. . . O
   
Left NNP NNP O
sided VBD VBD O
palpable JJ JJ O
graft NN NN O
with IN IN O
no DT DT O
tenderness NN NN O
. . . O
   
Cloudy NNP NNP O
urine NN NN O
in IN IN O
Foley NNP NNP O
Legs NNS NNS O
: : : O
3 CD CD O
+ NN NN O
edema NN NN O
bilaterally RB RB O
RUE NNP NNP O
: : : O
AVF NNP NNP O
with IN IN O
thrill NN NN O
and CC CC O
bruit NN NN O
Neuro NNP NNP O
: : : O
A DT DT O
& CC CC O
O NNP NNP O
x SYM SYM O
3 CD CD O
Results NNS NNS O
Date/Time NNP NNP O
PT NNP NNP O
PT-INR NNP NNP O
PTT NNP NNP O
06/12/2072 CD CD I-DATE
28.3 CD CD O
(*#) NN NN O
2.7 CD CD O
(*) NN NN O
46.6 CD CD O
(*#) NN NN O
Date/Time NNP NNP O
NA NNP NNP O
K NNP NNP O
CL NNP NNP O
CO2 NNP NNP O
06/12/2072 CD CD I-DATE
138 CD CD O
3.6 CD CD O
110 CD CD O
(*) NN NN O
20 CD CD O
Date/Time NNP NNP O
BUN NNP NNP O
CRE NNP NNP O
EGFR NNP NNP O
GLU NNP NNP O
06/12/2072 CD CD I-DATE
89 CD CD O
(*) NN NN O
3.1 CD CD O
(*) NN NN O
22 CD CD O
[ NN NN O
11 CD CD O
] NN NN O
48 CD CD O
Date/Time NNP NNP O
ANION NNP NNP O
06/12/2072 CD CD I-DATE
8 CD CD O
Date/Time NNP NNP O
CA NNP NNP O
PHOS NNP NNP O
MG NNP NNP O
TBILI NNP NNP O
06/12/2072 CD CD I-DATE
8.5 CD CD O
(*) NN NN O
4.1 CD CD O
1.7 CD CD O
(*) NN NN O
0.7 CD CD O
Date/Time NNP NNP O
TP NNP NNP O
ALB NNP NNP O
GLOB NNP NNP O
LDH NNP NNP O
06/12/2072 CD CD I-DATE
5.3 CD CD O
(*) NN NN O
2.7 CD CD O
(*) NN NN O
2.6 CD CD O
284 CD CD O
Date/Time NNP NNP O
AMY NNP NNP O
LIPS NNP NNP O
06/12/2072 CD CD I-DATE
25 CD CD O
4 CD CD O
[ NN NN O
21 CD CD O
] NN NN O
Date/Time NNP NNP O
bPO2 NN NN O
bPCO2 NN NN O
bPH NN NN O
UBASEX NNP NNP O
06/12/2072 CD CD I-DATE
[ NN NN O
22 CD CD O
] NN NN O
39 CD CD O
(*) NN NN O
38 CD CD O
(#) NN NN O
7.32 CD CD O
(*#) NN NN O
- : : O
6 CD CD O
Date/Time NNP NNP O
O2 NNP NNP O
Sat NNP NNP O
K-PL NNP NNP O
CO2-PL NNP NNP O
HGBBG NNP NNP O
06/12/2072 CD CD I-DATE
[ NN NN O
23 CD CD O
] NN NN O
74.2 CD CD O
(*) NN NN O
3.5 CD CD O
20 CD CD O
(*) NN NN O
10.3 CD CD O
Date/Time NNP NNP O
HCT-BG NNP NNP O
06/12/2072 CD CD I-DATE
[ NN NN O
24 CD CD O
] NN NN O
30 CD CD O
(*) NN NN O
Date/Time NNP NNP O
ALT/SGPT NNP NNP O
AST/SGOT NNP NNP O
ALKP NNP NNP O
TBILI NNP NNP O
06/12/2072 CD CD I-DATE
96 CD CD O
(*#) NN NN O
157 CD CD O
(*#) NN NN O
178 CD CD O
(*#) NN NN O
0.7 CD CD O
Date/Time NNP NNP O
LDH NNP NNP O
06/12/2072 CD CD I-DATE
284 CD CD O
(*) NN NN O
Date/Time NNP NNP O
UK NNP NNP O
06/12/2072 CD CD I-DATE
13 CD CD O
Date/Time NNP NNP O
UTIME NNP NNP O
06/12/2072 CD CD I-DATE
RANDOM NNP NNP O
Date/Time NNP NNP O
UTIME NNP NNP O
U/UNA NNP NNP O
U/UCL NNP NNP O
U/UOSM NNP NNP O
06/12/2072 CD CD I-DATE
RANDOM NNP NNP O
70 CD CD O
77 CD CD O
PEND NNP NNP O
Date/Time NNP NNP O
MHGB NNP NNP O
COHGB NNP NNP O
06/12/2072 CD CD I-DATE
[ NN NN O
30 CD CD O
] NN NN O
0.3 CD CD O
0.5 CD CD O
Date/Time NNP NNP O
UA-COLOR NNP NNP O
UA-GLUC NNP NNP O
UA-BILI NNP NNP O
UA-KET NNP NNP O
06/12/2072 CD CD I-DATE
YELLOW NNP NNP O
[ NN NN O
31 CD CD O
] NN NN O
NEG NNP NNP O
NEG NNP NNP O
NEG NNP NNP O
Date/Time NNP NNP O
UA-SPGR NNP NNP O
UA-BLD NNP NNP O
UA-PH NNP NNP O
UA-PROT NNP NNP O
06/12/2072 CD CD I-DATE
1.014 NN NN O
3 CD CD O
+ NN NN O
5.0 CD CD O
2 CD CD O
+ NN NN O
Date/Time NNP NNP O
UA-UROBI NNP NNP O
UA-NIT NNP NNP O
UA-WBC NNP NNP O
MIC-SED NNP NNP O
06/12/2072 CD CD I-DATE
NEG NNP NNP O
NEG NNP NNP O
3 CD CD O
+ NN NN O
NEG NNP NNP O
Date/Time NNP NNP O
OCAST NNP NNP O
HCAST NNP NNP O
UAS-RBC NNP NNP O
UAS-WBC NNP NNP O
06/12/2072 CD CD I-DATE
NEG NNP NNP O
0 CD CD O
233 CD CD O
(*) NN NN O
316 CD CD O
Date/Time NNP NNP O
UAS-BACT NNP NNP O
UAS-SQHI NNP NNP O
UAS-CRYS NNP NNP O
06/12/2072 CD CD I-DATE
TR NNP NNP O
3 CD CD O
+ NN NN O
NEG NNP NNP O
Date/Time NNP NNP O
UA-EPIS NNP NNP O
06/12/2072 CD CD I-DATE
NEG NNP NNP O
Date/Time NNP NNP O
WBC NNP NNP O
RBC NNP NNP O
HGB NNP NNP O
HCT NNP NNP O
06/12/2072 CD CD I-DATE
13.61 CD CD O
(*) NN NN O
3.86 CD CD O
(*) NN NN O
10.7 CD CD O
(*) NN NN O
32.3 CD CD O
06/12/2072 CD CD I-DATE
13.65 CD CD O
(*#) NN NN O
3.76 CD CD O
(*) NN NN O
10.4 CD CD O
(*) NN NN O
32.2 CD CD O
Date/Time NNP NNP O
MCV NNP NNP O
MCH NNP NNP O
MCHC NNP NNP O
PLT NNP NNP O
06/12/2072 CD CD I-DATE
83.7 CD CD O
27.8 CD CD O
33.2 CD CD O
157 CD CD O
06/12/2072 CD CD I-DATE
85.7 CD CD O
27.5 CD CD O
32.1 CD CD O
151 CD CD O
Date/Time NNP NNP O
RDW NNP NNP O
06/12/2072 CD CD I-DATE
17.5 CD CD O
(*) NN NN O
06/12/2072 CD CD I-DATE
17.3 CD CD O
(*) NN NN O
Date/Time NNP NNP O
% NN NN O
POLY-A NNP NNP O
% NN NN O
LYMPH-A NNP NNP O
% NN NN O
MONO-A NNP NNP O
% NN NN O
EOS-A NNP NNP O
06/12/2072 CD CD I-DATE
88.8 CD CD O
(*) NN NN O
4.4 CD CD O
(*) NN NN O
6.0 CD CD O
0.5 CD CD O
Date/Time NNP NNP O
% NN NN O
BASO-A NNP NNP O
% NN NN O
POLY-M NNP NNP O
% NN NN O
BAND-M NNP NNP O
% NN NN O
LYMPH-M NNP NNP O
06/12/2072 CD CD I-DATE
0.3 NN NN O
89 CD CD O
(*) NN NN O
2 CD CD O
1 CD CD O
(*) NN NN O
06/12/2072 CD CD I-DATE
92 CD CD O
(*) NN NN O
1 CD CD O
1 CD CD O
(*) NN NN O
Date/Time NNP NNP O
% NN NN O
ATYPS NNP NNP O
% NN NN O
MONO-M NNP NNP O
% NN NN O
EOS-M NNP NNP O
% NN NN O
BASO-M NNP NNP O
06/12/2072 CD CD I-DATE
0 CD CD O
8 CD CD O
0 CD CD O
0 CD CD O
06/12/2072 CD CD I-DATE
0 CD CD O
6 CD CD O
0 CD CD O
0 CD CD O
Date/Time NNP NNP O
ANEUT-A NNP NNP O
ALYMP-A NNP NNP O
AMONO-A NNP NNP O
AEOS-A NNP NNP O
06/12/2072 CD CD I-DATE
12.09 CD CD O
(*) NN NN O
.6 CD CD O
(*) NN NN O
0.82 CD CD O
(*) NN NN O
0.06 CD CD O
Date/Time NNP NNP O
ABASO-A NNP NNP O
06/12/2072 CD CD I-DATE
0.04 CD CD O
Date/Time NNP NNP O
ANISO NNP NNP O
POIK NNP NNP O
POLYCH NNP NNP O
HYPO NNP NNP O
06/12/2072 CD CD I-DATE
+ NN NN O
1 CD CD O
+ NN NN O
1 CD CD O
+ NN NN O
+ NN NN O
06/12/2072 CD CD I-DATE
1 CD CD O
+ NN NN O
Date/Time NNP NNP O
MACRO NNP NNP O
MICRO NNP NNP O
OVALS NNP NNP O
TEARDR NNP NNP O
06/12/2072 CD CD I-DATE
1 CD CD O
+ NN NN O
+ NN NN O
1 CD CD O
+ NN NN O
06/12/2072 CD CD I-DATE
1 CD CD O
+ NN NN O
1 CD CD O
+ NN NN O
Date/Time NNP NNP O
PLT-EST NNP NNP O
06/12/2072 CD CD I-DATE
NL NNP NNP O
06/12/2072 CD CD I-DATE
NL NNP NNP O
Date/Time NNP NNP O
ESR NNP NNP O
06/12/2072 CD CD I-DATE
PEND NNP NNP O
06/12/2072 CD CD I-DATE
20 CD CD O
(*)[ NN NN O
32 CD CD O
] NN NN O
Radiology NNP NNP O
: : : O
06/12/2072 CD CD I-DATE
12:16 CD CD O
KEKELA NNP NNP I-HOSPITAL
Radiology NNP NNP O
Report NNP NNP O
Status NNP NNP O
: : : O
Final NNP NNP O
Type NNP NNP O
: : : O
Chest NN NN O
PA NNP NNP O
& CC CC O
Lateral NNP NNP O
HISTORY NN NN O
: : : O
Fever NNP NNP O
. . . O
   
Chest NN NN O
: : : O
Frontal NNP NNP O
and CC CC O
lateral JJ JJ O
views NNS NNS O
of IN IN O
the DT DT O
chest NN NN O
are VBP VBP O
compared VBN VBN O
to TO TO O
prior RB RB O
exam NN NN O
dated VBD VBD O
5/31/2072 CD CD I-DATE
and CC CC O
show VB VB O
mild JJ JJ O
enlargement NN NN O
of IN IN O
the DT DT O
cardiac JJ JJ O
silhouette NN NN O
and CC CC O
an DT DT O
atherosclerotic JJ JJ O
aorta NN NN O
. . . O
   
There EX EX O
are VBP VBP O
small JJ JJ O
bilateral JJ JJ O
posterior NN NN O
pleural NN NN O
effusions NNS NNS O
. . . O
   
Adjacent NNP NNP O
parenchymal NN NN O
opacity NN NN O
may MD MD O
reflect VB VB O
atelectasis NN NN O
or CC CC O
early JJ JJ O
pneumonia NN NN O
in IN IN O
theappropriate NN NN O
clinical JJ JJ O
setting VBG VBG O
. . . O
   
Mild NNP NNP O
diffuse NN NN O
elevation NN NN O
of IN IN O
the DT DT O
interstitium NN NN O
appears VBZ VBZ O
chronic JJ JJ O
. . . O
   
Right RB RB O
upper JJ JJ O
lobe NN NN O
granuloma NN NN O
. . . O
   
IMPRESSION NNP NNP O
: : : O
Mild NNP NNP O
cardiomegaly NN NN O
with IN IN O
small JJ JJ O
bilateral JJ JJ O
posterior NN NN O
pleural NN NN O
effusions NNS NNS O
. . . O
   
Adjacent NNP NNP O
parenchymal JJ JJ O
opacity NN NN O
could MD MD O
reflect VB VB O
subsegmental JJ JJ O
atelectasis NN NN O
or CC CC O
early JJ JJ O
pneumonia NN NN O
in IN IN O
the DT DT O
appropriate JJ JJ O
clinical JJ JJ O
setting VBG VBG O
. . . O
   
These DT DT O
findings NNS NNS O
were VBD VBD O
communicated VBN VBN O
by IN IN O
me PRP PRP O
to TO TO O
Dr NNP NNP O
. . . O
Ximena NNP NNP I-DOCTOR
Webber NNP NNP I-DOCTOR
at IN IN O
2:25 CD CD O
p.m NN NN O
A/P NNP NNP O
: : : O
63M CD CD O
with IN IN O
known VBN VBN O
CRRTx NNP NNP O
since IN IN O
2060 CD CD I-DATE
with IN IN O
known VBN VBN O
CKD NNP NNP O
and CC CC O
baseline NN NN O
Cr NNP NNP O
2.5 CD CD O
with IN IN O
urethral JJ JJ O
stricture NN NN O
and CC CC O
in-dwelling JJ JJ O
Foley NNP NNP O
. . . O
   
Pt NNP NNP O
. . . O
   
now RB RB O
with IN IN O
fevers NNS NNS O
, , , O
UTI NNP NNP O
, , , O
and CC CC O
diarrhea NN NN O
. . . O
   
He PRP PRP O
will MD MD O
be VB VB O
admitted VBN VBN O
to TO TO O
George NNP NNP I-DOCTOR
Rutledge NNP NNP I-PATIENT
, , , O
M.D. NNP NNP O
on IN IN O
the DT DT O
Internal NNP NNP O
Medicine NNP NNP O
. . . O
   
1 CD CD O
. . . O
Renal NNP NNP O
- : : O
CRRTx NNP NNP O
with IN IN O
creatinine NN NN O
elevated VBD VBD O
3.1 CD CD O
( ( ( O
2.5 CD CD O
) ) ) O
, , , O
? . . O
pyelonephritis NNS NNS O
- - - O
Urine NNP NNP O
cultures NNS NNS O
sent VBD VBD O
in IN IN O
the DT DT O
ED NNP NNP O
. . . O
   
- - - O
Would MD MD O
hold VB VB O
further JJ JJ O
iv JJ JJ O
fluids NNS NNS O
. . . O
   
- : : O
Continue NNP NNP O
current JJ JJ O
Lasix NNP NNP O
dose NN NN O
- : : O
Strict NNP NNP O
I/O NNP NNP O
- : : O
Check NNP NNP O
Urine NNP NNP O
Protein/Creat NNP NNP O
Ratio NN NN O
   
2 CD CD O
. . . O
Urologic NNP NNP O
- : : O
urethral JJ JJ O
stricture NN NN O
and CC CC O
in-dwelling JJ JJ O
foley NN NN O
cath NN NN O
with IN IN O
fever NN NN O
and CC CC O
high JJ JJ O
urinary JJ JJ O
WBC NNP NNP O
. . . O
   
- - - O
Given NNP NNP O
iv NN NN O
Levofloxacin/Ceftaz NNP NNP O
in IN IN O
the DT DT O
ED NNP NNP O
. . . O
   
- : : O
Need VBP VBP O
to TO TO O
change VB VB O
Foley NNP NNP O
cathether NN NN O
. . . O
   
- : : O
Dr NNP NNP O
Acevedo NNP NNP I-DOCTOR
to TO TO O
review VB VB O
for IN IN O
suprapubic NN NN O
catheter NN NN O
placement NN NN O
. . . O
   
3 CD CD O
. . . O
Immunosuppresion NNP NNP O
- : : O
Continue NNP NNP O
CsA NNP NNP O
and CC CC O
Prednisone NNP NNP O
- : : O
Check NNP NNP O
CsA NNP NNP O
level NN NN O
in IN IN O
the DT DT O
am VBP VBP O
. . . O
   
4 CD CD O
. . . O
Pulm NNP NNP O
- : : O
   
5 CD CD O
. . . O
Endo NNP NNP O
- : : O
hypoglycemic JJ JJ O
in IN IN O
ED NNP NNP O
, , , O
will MD MD O
monitor VB VB O
closely RB RB O
with IN IN O
q NN NN O
AC NNP NNP O
+ NN NN O
HS NNP NNP O
accuchecks NNS NNS O
. . . O
   
6 CD CD O
. . . O
GI NNP NNP O
- : : O
diarrhea NN NN O
- : : O
Will NNP NNP O
send VB VB O
stool NN NN O
for IN IN O
C-diff NNP NNP O
- - - O
Will NNP NNP O
check NN NN O
CMV NNP NNP O
viral NN NN O
load NN NN O
   
7 CD CD O
. . . O
Fluid NNP NNP O
Status NNP NNP O
- : : O
volume NN NN O
overloaded JJ JJ O
- - - O
Adequate NNP NNP O
on IN IN O
oral JJ JJ O
lasix NN NN O
____________________________________________ NN NN O
_ NN NN O
Arlene NNP NNP I-DOCTOR
T. NN NN I-DOCTOR
Whitaker,PA-C NNP NNP O
Internal NNP NNP O
Medicine NNP NNP O
beeper NN NN O
#11830 NN NN O
Patient NNP NNP O
seen VBN VBN O
and CC CC O
examined VBN VBN O
with IN IN O
renal JJ JJ O
fellow NN NN O
. . . O
   
I PRP PRP O
agree VBP VBP O
with IN IN O
the DT DT O
review NN NN O
of IN IN O
patient NN NN O
problems NNS NNS O
, , , O
history NN NN O
, , , O
medication NN NN O
, , , O
physical JJ JJ O
examination NN NN O
, , , O
assessment NN NN O
and CC CC O
plan NN NN O
as IN IN O
detailed VBN VBN O
in IN IN O
the DT DT O
fellow NN NN O
note NN NN O
above IN IN O
. . . O
   
Followup NNP NNP O
clinic JJ JJ O
visit NN NN O
arranged VBD VBD O
with IN IN O
patient NN NN O
. . . O
   
Case NN NN O
was VBD VBD O
discussed VBN VBN O
with IN IN O
patient NN NN O
, , , O
renal JJ JJ O
transplant NN NN O
nurse NN NN O
, , , O
and CC CC O
pharmacist NN NN O
. . . O
   
George NNP NNP I-DOCTOR
T. NN NN I-DOCTOR
Rutledge NNP NNP I-PATIENT
, , , O
M.D. NNP NNP O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2105-08-27 JJ JJ I-DATE
SICU NNP NNP O
visit NN NN O
( ( ( O
Hamilton NNP NNP I-DOCTOR
04239 CD CD I-PHONE
) ) ) O
8/26/05 CD CD I-DATE
11 CD CD O
45 CD CD O
pm NN NN O
74 CD CD I-AGE
yo NN NN O
male NN NN O
with IN IN O
a DT DT O
history NN NN O
of IN IN O
CAD NNP NNP O
, , , O
PVD NNP NNP O
s/p NN NN O
right NN NN O
femoral JJ JJ O
to TO TO O
above VB VB O
knee NN NN O
popliteal NN NN O
bypass NN NN O
with IN IN O
PTFE NNP NNP O
( ( ( O
5/00 CD CD I-DATE
) ) ) O
and CC CC O
recent JJ JJ O
admission NN NN O
for IN IN O
RLE NNP NNP O
angioplasty NN NN O
X NNP NNP O
22 CD CD O
who WP WP O
presents VBZ VBZ O
with IN IN O
R NNP NNP O
foot NN NN O
rest NN NN O
pain NN NN O
and CC CC O
discoloration NN NN O
and CC CC O
underwent JJ JJ O
fem NN NN O
pop NN NN O
bypass NN NN O
graft NN NN O
. . . O
   
The DT DT O
case NN NN O
was VBD VBD O
complicated VBN VBN O
by IN IN O
large JJ JJ O
blood NN NN O
loss NN NN O
anemia NN NN O
and CC CC O
hypotension NN NN O
. . . O
   
In IN IN O
the DT DT O
PACU NNP NNP O
the DT DT O
patient NN NN O
continued VBD VBD O
to TO TO O
be VB VB O
hypotensive JJ JJ O
and CC CC O
have VBP VBP O
low JJ JJ O
uop NN NN O
. . . O
   
We PRP PRP O
placed VBD VBD O
a DT DT O
central JJ JJ O
line NN NN O
( ( ( O
starting VBG VBG O
CVP NNP NNP O
was VBD VBD O
0 CD CD O
) ) ) O
and CC CC O
continued VBD VBD O
resuscitation NN NN O
. . . O
   
The DT DT O
patient NN NN O
developed VBN VBN O
ST NNP NNP O
changes NNS NNS O
and CC CC O
also RB RB O
had VBD VBD O
acute JJ JJ O
on IN IN O
chronic JJ JJ O
renal JJ JJ O
failure NN NN O
( ( ( O
RIFLE NNP NNP O
F NN NN O
) ) ) O
. . . O
   
WE PRP PRP O
transfused VBD VBD O
and CC CC O
transferred VBD VBD O
him PRP PRP O
to TO TO O
the DT DT O
ICU NNP NNP O
. . . O
   
We PRP PRP O
discussed VBD VBD O
this DT DT O
at IN IN O
length NN NN O
with IN IN O
the DT DT O
surgical JJ JJ O
service NN NN O
as RB RB O
well RB RB O
as IN IN O
cardiology NN NN O
. . . O
   
I PRP PRP O
examined VBD VBD O
the DT DT O
patient NN NN O
reviewed VBD VBD O
the DT DT O
chart NN NN O
and CC CC O
discussed VBD VBD O
the DT DT O
case NN NN O
. . . O
   
I PRP PRP O
agree VBP VBP O
with IN IN O
history NN NN O
and CC CC O
exam NN NN O
as IN IN O
outlined VBN VBN O
in IN IN O
residents NNS NNS O
note VBP VBP O
Issues NNS NNS O
: : : O
Cardiac NNP NNP O
ischemia NN NN O
: : : O
Ischemia NNP NNP O
was VBD VBD O
mostly RB RB O
due JJ JJ O
to TO TO O
hypotension NN NN O
and CC CC O
low JJ JJ O
HGB NNP NNP O
as RB RB O
well RB RB O
as IN IN O
tachycardia NNS NNS O
. . . O
   
Will NNP NNP O
give VB VB O
aspirin NN NN O
and CC CC O
lower JJR JJR O
HR NNP NNP O
to TO TO O
70's CD CD O
with IN IN O
Beta NNP NNP O
blockers NNS NNS O
. . . O
   
Contue NNP NNP O
statin NN NN O
. . . O
   
Willt NNP NNP O
ransfuse NN NN O
to TO TO O
HGB NNP NNP O
around IN IN O
10 CD CD O
and CC CC O
continue VB VB O
to TO TO O
check VB VB O
troponins NNS NNS O
Decreased NNP NNP O
myocardial NN NN O
function NN NN O
: : : O
he PRP PRP O
has VBZ VBZ O
low JJ JJ O
central JJ JJ O
venous JJ JJ O
saturation NN NN O
and CC CC O
increased VBN VBN O
lactate NN NN O
. . . O
   
Will NNP NNP O
give VB VB O
fluids NNS NNS O
and CC CC O
transfuse VB VB O
the DT DT O
patient NN NN O
. . . O
   
Will NNP NNP O
get VB VB O
echo NN NN O
in IN IN O
am VBP VBP O
. . . O
   
If IN IN O
his PRP$ PRP$ O
central JJ JJ O
venous JJ JJ O
sat NN NN O
and CC CC O
lactate NN NN O
does VBZ VBZ O
not RB RB O
signficantly RB RB O
improve VB VB O
with IN IN O
these DT DT O
measures NNS NNS O
would MD MD O
stay VB VB O
away RB RB O
from IN IN O
inotropes NNS NNS O
for IN IN O
now RB RB O
given VBN VBN O
his PRP$ PRP$ O
rate NN NN O
related VBN VBN O
ischemia NN NN O
Acute JJ JJ O
blood-loss JJ JJ O
naemia NN NN O
: : : O
will MD MD O
transfuse VB VB O
to TO TO O
Metabolic NNP NNP O
acidosis NN NN O
: : : O
the DT DT O
patetin NN NN O
has VBZ VBZ O
signifcant JJ JJ O
metabolic JJ JJ O
acidosis NN NN O
. . . O
   
We PRP PRP O
will MD MD O
for IN IN O
now RB RB O
give VB VB O
volume NN NN O
. . . O
   
Acute JJ JJ O
renal JJ JJ O
failure NN NN O
: : : O
He PRP PRP O
has VBZ VBZ O
significantly RB RB O
decreaed VBN VBN O
uop NN NN O
. . . O
   
We PRP PRP O
are VBP VBP O
sending VBG VBG O
urine JJ JJ O
lytes NNS NNS O
and CC CC O
casts NNS NNS O
. . . O
   
Will NNP NNP O
increase VB VB O
filling VBG VBG O
pressures NNS NNS O
. . . O
   
For IN IN O
now RB RB O
would MD MD O
not RB RB O
use VB VB O
furosemide NN NN O
given VBN VBN O
low JJ JJ O
central JJ JJ O
filling NN NN O
pressures NNS NNS O
. . . O
   
V. NN NN I-DOCTOR
Hamilton NNP NNP I-DOCTOR
cc NN NN O
122 CD CD O
min NN NN O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2085-12-07 NN NN I-DATE
ZASTROW NNP NNP O
, , , O
IRENE NNP NNP I-PATIENT
42521583 CD CD I-MEDICALRECORD
12/07/2085 CD CD I-DATE
DATE NN NN O
OF IN IN O
ADMISSION NNP NNP O
: : : O
12/06/2085 CD CD I-DATE
. . . O
   
This DT DT O
66-year-old JJ JJ O
woman NN NN O
phoned VBD VBD O
my PRP$ PRP$ O
office NN NN O
complaining VBG VBG O
of IN IN O
exertional JJ JJ O
chest NN NN O
discomfort NN NN O
. . . O
   
We PRP PRP O
instructed VBD VBD O
her PRP PRP O
to TO TO O
presented VBN VBN O
to TO TO O
the DT DT O
Emergency NNP NNP O
Department NNP NNP O
at IN IN O
Davis NNP NNP I-HOSPITAL
Monthan NNP NNP I-HOSPITAL
Hospital NNP NNP I-HOSPITAL
. . . O
   
She PRP PRP O
had VBD VBD O
experienced VBN VBN O
multiple JJ JJ O
episodes NNS NNS O
of IN IN O
chest NN NN O
pressure NN NN O
with IN IN O
exertion NN NN O
lasting JJ JJ O
5-10 JJ JJ O
minutes NNS NNS O
and CC CC O
radiating VBG VBG O
to TO TO O
her PRP$ PRP$ O
left JJ JJ O
axilla NN NN O
. . . O
   
On IN IN O
10/30/2085 CD CD I-DATE
, , , O
she PRP PRP O
suffered VBD VBD O
non-ST JJ JJ O
segment NN NN O
elevation NN NN O
myocardial NN NN O
infarction NN NN O
in IN IN O
Pennsylvania NNP NNP I-STATE
and CC CC O
was VBD VBD O
managed VBN VBN O
with IN IN O
percutaneous JJ JJ O
coronary JJ JJ O
intervention NN NN O
. . . O
   
Chest NN NN O
discomfort NN NN O
recurred JJ JJ O
and CC CC O
on IN IN O
11/03/2085 CD CD I-DATE
, , , O
she PRP PRP O
was VBD VBD O
recatheterized VBN VBN O
at IN IN O
Davis NNP NNP I-HOSPITAL
Monthan NNP NNP I-HOSPITAL
Hospital NNP NNP I-HOSPITAL
where WRB WRB O
her PRP$ PRP$ O
mid JJ JJ O
LAD NNP NNP O
stent NN NN O
was VBD VBD O
expanded VBN VBN O
. . . O
   
She PRP PRP O
has VBZ VBZ O
had VBN VBN O
worsening VBG VBG O
substernal JJ JJ O
chest NN NN O
discomfort NN NN O
over IN IN O
the DT DT O
past JJ JJ O
two CD CD O
to TO TO O
three CD CD O
days NNS NNS O
. . . O
   
Her PRP$ PRP$ O
discomfort NN NN O
is VBZ VBZ O
relieved VBN VBN O
with IN IN O
nitroglycerin NN NN O
. . . O
   
Overnight NNP NNP O
, , , O
she PRP PRP O
had VBD VBD O
on IN IN O
and CC CC O
off IN IN O
chest NN NN O
discomfort NN NN O
with IN IN O
anterior NN NN O
T-wave NNP NNP O
lability NN NN O
. . . O
   
She PRP PRP O
was VBD VBD O
placed VBN VBN O
on IN IN O
intravenous JJ JJ O
heparin NN NN O
and CC CC O
intravenous JJ JJ O
nitroglycerin NN NN O
. . . O
   
She PRP PRP O
suffered VBD VBD O
pulmonary JJ JJ O
embolism NN NN O
in IN IN O
2074 CD CD I-DATE
. . . O
   
That DT DT O
is VBZ VBZ O
when WRB WRB O
I PRP PRP O
first RB RB O
met VBD VBD O
her PRP PRP O
. . . O
   
She PRP PRP O
has VBZ VBZ O
gastroesophageal JJ JJ O
reflux NN NN O
disease NN NN O
. . . O
   
She PRP PRP O
is VBZ VBZ O
married VBN VBN O
; : : O
   
her PRP$ PRP$ O
husband NN NN O
works VBZ VBZ O
at IN IN O
24 CD CD I-ORGANIZATION
Hour NNP NNP I-ORGANIZATION
Fitness NNP NNP I-ORGANIZATION
as IN IN O
a DT DT O
personal JJ JJ I-PROFESSION
trainer NN NN I-PROFESSION
in IN IN O
the DT DT O
weight NN NN I-ORGANIZATION
room NN NN I-ORGANIZATION
. . . O
   
She PRP PRP O
does VBZ VBZ O
not RB RB O
smoke VB VB O
cigarettes NNS NNS O
. . . O
   
She PRP PRP O
has VBZ VBZ O
four CD CD O
children NNS NNS O
. . . O
   
Home NNP NNP O
medications NNS NNS O
include VBP VBP O
aspirin NN NN O
325 CD CD O
mg NN NN O
daily JJ JJ O
, , , O
atenolol NN NN O
25 CD CD O
mg NN NN O
daily JJ JJ O
, , , O
Lipitor NNP NNP O
80 CD CD O
mg NN NN O
daily JJ JJ O
, , , O
Plavix NNP NNP O
75 CD CD O
mg NN NN O
daily JJ JJ O
, , , O
insulin NN NN O
, , , O
and CC CC O
sublingual JJ JJ O
nitroglycerin NN NN O
as IN IN O
needed VBN VBN O
. . . O
   
The DT DT O
review NN NN O
of IN IN O
systems NNS NNS O
is VBZ VBZ O
negative JJ JJ O
other JJ JJ O
than IN IN O
the DT DT O
above JJ JJ O
. . . O
   
On IN IN O
physical JJ JJ O
examination NN NN O
, , , O
she PRP PRP O
appears VBZ VBZ O
well RB RB O
. . . O
   
Afebrile NNP NNP O
, , , O
blood NN NN O
pressure NN NN O
126/82 CD CD O
mmHg NN NN O
, , , O
heart NN NN O
rate NN NN O
72 CD CD O
and CC CC O
regular JJ JJ O
, , , O
and CC CC O
respiratory JJ JJ O
rate NN NN O
13 CD CD O
per IN IN O
minute NN NN O
. . . O
   
HEENT NNP NNP O
is VBZ VBZ O
normal JJ JJ O
. . . O
   
The DT DT O
neck NN NN O
veins NNS NNS O
are VBP VBP O
not RB RB O
distended VBN VBN O
. . . O
   
The DT DT O
chest NN NN O
is VBZ VBZ O
clear JJ JJ O
. . . O
   
On IN IN O
cardiac JJ JJ O
examination NN NN O
, , , O
she PRP PRP O
has VBZ VBZ O
a DT DT O
regular JJ JJ O
rhythm NN NN O
with IN IN O
a DT DT O
normal JJ JJ O
S1 NNP NNP O
, , , O
single JJ JJ O
S2 NNP NNP O
, , , O
and CC CC O
no DT DT O
murmur NN NN O
, , , O
rub NN NN O
, , , O
or CC CC O
gallop NN NN O
. . . O
   
Abdomen NNP NNP O
has VBZ VBZ O
no DT DT O
masses NNS NNS O
or CC CC O
hepatomegaly NN NN O
. . . O
   
The DT DT O
legs NNS NNS O
have VBP VBP O
no DT DT O
clubbing VBG VBG O
or CC CC O
cyanosis NNS NNS O
, , , O
but CC CC O
there EX EX O
is VBZ VBZ O
right JJ JJ O
leg NN NN O
greater JJR JJR O
than IN IN O
left VBD VBD O
leg NN NN O
edema NN NN O
. . . O
   
The DT DT O
skin NN NN O
has VBZ VBZ O
no DT DT O
rash NN NN O
. . . O
   
My PRP$ PRP$ O
assessment NN NN O
is VBZ VBZ O
that IN IN O
Irene NNP NNP I-PATIENT
Zastrow NNP NNP I-PATIENT
has VBZ VBZ O
"""" '' '' O
small JJ JJ O
vessel NN NN O
"""" '' '' O
coronary JJ JJ O
artery NN NN O
disease NN NN O
in IN IN O
addition NN NN O
to TO TO O
epicardial JJ JJ O
coronary JJ JJ O
artery NN NN O
disease NN NN O
. . . O
   
We PRP PRP O
will MD MD O
intensify VB VB O
her PRP$ PRP$ O
medical JJ JJ O
regimen NNS NNS O
by IN IN O
prescribing VBG VBG O
higher JJR JJR O
doses NNS NNS O
of IN IN O
beta NN NN O
blockade NN NN O
and CC CC O
by IN IN O
initiating VBG VBG O
a DT DT O
long-acting JJ JJ O
nitrate NN NN O
. . . O
   
We PRP PRP O
will MD MD O
also RB RB O
repeat VB VB O
the DT DT O
chest NN NN O
CT NNP NNP O
scan VB VB O
to TO TO O
make VB VB O
sure JJ JJ O
she PRP PRP O
has VBZ VBZ O
not RB RB O
suffered VBN VBN O
from IN IN O
recurrent JJ JJ O
pulmonary JJ JJ O
embolism NN NN O
. . . O
   
I PRP PRP O
discussed VBD VBD O
this DT DT O
plan NN NN O
with IN IN O
her PRP$ PRP$ O
, , , O
her PRP$ PRP$ O
husband NN NN O
, , , O
and CC CC O
the DT DT O
medical JJ JJ O
house NN NN O
staff NN NN O
. . . O
   
_____________________________ NN NN O
_ NN NN O
Victor NNP NNP I-DOCTOR
Z. NNP NNP I-DOCTOR
Qazi NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
eScription NN NN O
document:5-9929422 JJ JJ O
IFFocus NNP NNP O
DD NNP NNP O
: : : O
12/07/85 CD CD I-DATE
DT NNP NNP O
: : : O
12/07/85 CD CD I-DATE
DV NNP NNP O
: : : O
12/07/85 CD CD I-DATE
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2082-07-04 JJ JJ I-DATE
Beaumont NNP NNP I-HOSPITAL
Hospital NNP NNP I-HOSPITAL
Physician NNP NNP O
Group NNP NNP O
229 CD CD I-STREET
Crowley NNP NNP I-STREET
Avenue NNP NNP I-STREET
Rhodes NNP NNP O
, , , O
Yajaira NNP NNP I-PATIENT
Rutland NNP NNP I-CITY
, , , O
FL NNP NNP I-STATE
94265 CD CD I-ZIP
97627182 CD CD I-MEDICALRECORD
( ( ( O
153 CD CD O
) ) ) O
636-7011 NN NN I-PHONE
07/04/82 CD CD I-DATE
( ( ( O
584 CD CD O
) ) ) O
728-8734 CD CD I-PHONE
SUBJECTIVE NNP NNP O
: : : O
The DT DT O
patient NN NN O
returns NNS NNS O
. . . O
   
She PRP PRP O
has VBZ VBZ O
had VBN VBN O
three CD CD O
operations NNS NNS O
on IN IN O
her PRP$ PRP$ O
back RB RB O
, , , O
finally RB RB O
ending VBG VBG O
with IN IN O
a DT DT O
fusion NN NN O
of IN IN O
L2-L3 NNP NNP O
and CC CC O
a DT DT O
laminectomy NN NN O
in IN IN O
that DT DT O
area NN NN O
for IN IN O
recurrent JJ JJ O
disk NN NN O
disease NN NN O
at IN IN O
L2-L3. NNP NNP O
   
She PRP PRP O
still RB RB O
is VBZ VBZ O
having VBG VBG O
severe JJ JJ O
pain NN NN O
going VBG VBG O
down RP RP O
her PRP$ PRP$ O
right NN NN O
leg NN NN O
and CC CC O
anterior NN NN O
knee NN NN O
which WDT WDT O
is VBZ VBZ O
unchanged JJ JJ O
or CC CC O
perhaps RB RB O
somewhat RB RB O
better JJR JJR O
. . . O
   
She PRP PRP O
sees VBZ VBZ O
Dr NNP NNP O
. . . O
Herring NNP NNP I-DOCTOR
with IN IN O
regularity NN NN O
. . . O
   
She PRP PRP O
has VBZ VBZ O
seen VBN VBN O
Dr NNP NNP O
. . . O
Oscar NNP NNP I-DOCTOR
Riggs NNP NNP I-DOCTOR
. . . O
   
She PRP PRP O
has VBZ VBZ O
nothing NN NN O
wrong JJ JJ O
with IN IN O
her PRP$ PRP$ O
hips NNS NNS O
and CC CC O
she PRP PRP O
has VBZ VBZ O
had VBN VBN O
multiple JJ JJ O
CT NNP NNP O
scans NNS NNS O
showing VBG VBG O
the DT DT O
numerous JJ JJ O
operations NNS NNS O
and CC CC O
fusion NN NN O
. . . O
   
MEDICATIONS NNP NNP O
: : : O
   
1 CD CD O
. . . O
Lipitor NNP NNP O
20 CD CD O
mg NN NN O
q.d. NN NN O
   
2 CD CD O
. . . O
Glynase NNP NNP O
1.5 CD CD O
mg NN NN O
b.i.d. NN NN O
   
3 CD CD O
. . . O
Trandate NNP NNP O
100 CD CD O
mg NN NN O
q.d. NN NN O
   
4 CD CD O
. . . O
Tegretol NNP NNP O
300 CD CD O
mg NN NN O
in IN IN O
a.m. NN NN O
, , , O
200 CD CD O
mg NN NN O
in IN IN O
the DT DT O
p.m. NN NN O
   
5 CD CD O
. . . O
Premarin NNP NNP O
0.625 CD CD O
mg NN NN O
30 CD CD O
days NNS NNS O
a DT DT O
month NN NN O
. . . O
   
6 CD CD O
. . . O
Provera NNP NNP O
5 CD CD O
mg NN NN O
12 CD CD O
days NNS NNS O
a DT DT O
month NN NN O
. . . O
   
7 CD CD O
. . . O
Enteric-coated NNP NNP O
aspirin NN NN O
81 CD CD O
mg NN NN O
q.d. NN NN O
   
8 CD CD O
. . . O
Calcium NNP NNP O
1200 CD CD O
mg NN NN O
q.d. NN NN O
   
She PRP PRP O
is VBZ VBZ O
in IN IN O
physiotherapy NN NN O
presently RB RB O
. . . O
   
She PRP PRP O
is VBZ VBZ O
not RB RB O
smoking VBG VBG O
nor CC CC O
drinking VBG VBG O
. . . O
   
She PRP PRP O
has VBZ VBZ O
been VBN VBN O
eating VBG VBG O
and CC CC O
has VBZ VBZ O
gained VBN VBN O
considerable JJ JJ O
weight NN NN O
. . . O
   
She PRP PRP O
has VBZ VBZ O
no DT DT O
cardiopulmonary NN NN O
, , , O
GI NNP NNP O
or CC CC O
GU NNP NNP O
complaints NNS NNS O
. . . O
   
She PRP PRP O
is VBZ VBZ O
to TO TO O
see VB VB O
Dr NNP NNP O
. . . O
Bruce NNP NNP I-DOCTOR
Godfrey NNP NNP I-DOCTOR
's POS POS O
replacement NN NN O
in IN IN O
August NNP NNP I-DATE
and CC CC O
to TO TO O
get VB VB O
a DT DT O
mammogram NN NN O
at IN IN O
that DT DT O
time NN NN O
. . . O
   
Hopefully RB RB O
, , , O
she PRP PRP O
will MD MD O
be VB VB O
able JJ JJ O
to TO TO O
lie VB VB O
on IN IN O
the DT DT O
table NN NN O
when WRB WRB O
that DT DT O
occurs VBZ VBZ O
. . . O
   
She PRP PRP O
is VBZ VBZ O
now RB RB O
able JJ JJ O
to TO TO O
drive VB VB O
a DT DT O
car NN NN O
, , , O
but CC CC O
walks VBZ VBZ O
with IN IN O
a DT DT O
cane NN NN O
and CC CC O
cannot NN NN O
lie NN NN O
down RB RB O
with IN IN O
any DT DT O
degree NN NN O
of IN IN O
ease NN NN O
. . . O
   
PHYSICAL JJ JJ O
EXAMINATION NNP NNP O
: : : O
She PRP PRP O
weighs VBZ VBZ O
192 CD CD O
lbs NN NN O
stripped VBD VBD O
and CC CC O
her PRP$ PRP$ O
blood NN NN O
pressure NN NN O
is VBZ VBZ O
160/90 CD CD O
in IN IN O
the DT DT O
left VBN VBN O
arm NN NN O
standing NN NN O
, , , O
pulse NN NN O
is VBZ VBZ O
72 CD CD O
and CC CC O
regular JJ JJ O
. . . O
   
She PRP PRP O
appears VBZ VBZ O
as IN IN O
a DT DT O
well RB RB O
developed VBN VBN O
, , , O
overweight NN NN O
white JJ JJ O
female JJ JJ O
in IN IN O
pain NN NN O
, , , O
having VBG VBG O
to TO TO O
hold VB VB O
on IN IN O
while IN IN O
standing NN NN O
, , , O
easily RB RB O
weeping VBG VBG O
, , , O
but CC CC O
pleasant JJ JJ O
. . . O
   
There EX EX O
is VBZ VBZ O
no DT DT O
icterus NN NN O
, , , O
cyanosis NN NN O
or CC CC O
edema NN NN O
. . . O
   
The DT DT O
eyes NNS NNS O
reveal VBP VBP O
2 CD CD O
+ NN NN O
arcus NN NN O
. . . O
   
Pupils NNP NNP O
are VBP VBP O
round NN NN O
, , , O
reactive JJ JJ O
and CC CC O
equal JJ JJ O
. . . O
   
Nose NN NN O
and CC CC O
throat NN NN O
examination NN NN O
is VBZ VBZ O
unremarkable JJ JJ O
. . . O
   
Neck NN NN O
veins NNS NNS O
are VBP VBP O
flat JJ JJ O
. . . O
   
Carotids NNP NNP O
are VBP VBP O
2 CD CD O
+ NN NN O
and CC CC O
equal JJ JJ O
and CC CC O
without IN IN O
bruit NN NN O
. . . O
   
Thyroid NNP NNP O
small JJ JJ O
and CC CC O
smooth JJ JJ O
. . . O
   
Lungs NNS NNS O
are VBP VBP O
clear JJ JJ O
to TO TO O
P&A NNP NNP O
. . . O
   
The DT DT O
heart NN NN O
is VBZ VBZ O
not RB RB O
enlarged VBN VBN O
. . . O
   
There EX EX O
is VBZ VBZ O
a DT DT O
regular JJ JJ O
sinus NN NN O
rhythm NN NN O
and CC CC O
no DT DT O
significant JJ JJ O
murmurs NNS NNS O
. . . O
   
S1 NNP NNP O
and CC CC O
S2 NNP NNP O
are VBP VBP O
normal JJ JJ O
. . . O
   
Liver NNP NNP O
and CC CC O
spleen NN NN O
cannot NN NN O
be VB VB O
felt VBN VBN O
. . . O
   
She PRP PRP O
has VBZ VBZ O
good JJ JJ O
peripheral JJ JJ O
pulses NNS NNS O
. . . O
   
IMPRESSION NNP NNP O
: : : O
   
1 CD CD O
. . . O
Diabetes NNP NNP O
mellitus NN NN O
type NN NN O
   
2 CD CD O
. . . O
She PRP PRP O
has VBZ VBZ O
had VBN VBN O
an DT DT O
eye NN NN O
exam NN NN O
at IN IN O
Mitchel NNP NNP I-HOSPITAL
Memorial NNP NNP I-HOSPITAL
Hospital NNP NNP I-HOSPITAL
this DT DT O
past JJ JJ O
year NN NN O
, , , O
but CC CC O
her PRP$ PRP$ O
diabetes NN NN O
is VBZ VBZ O
poorly RB RB O
controlled VBN VBN O
as IN IN O
her PRP$ PRP$ O
blood NN NN O
sugars NNS NNS O
have VBP VBP O
been VBN VBN O
in IN IN O
the DT DT O
150-200 JJ JJ O
range NN NN O
. . . O
   
I PRP PRP O
have VBP VBP O
told VBN VBN O
her PRP PRP O
to TO TO O
increase VB VB O
her PRP$ PRP$ O
Glynase NN NN O
to TO TO O
3 CD CD O
mg NN NN O
twice RB RB O
a DT DT O
day NN NN O
until IN IN O
she PRP PRP O
is VBZ VBZ O
able JJ JJ O
to TO TO O
diet VB VB O
. . . O
   
2 CD CD O
. . . O
L2-L3 NNP NNP O
disk NN NN O
with IN IN O
fusion NN NN O
. . . O
   
3 CD CD O
. . . O
Mild NNP NNP O
hypertension NN NN O
, , , O
on IN IN O
no DT DT O
medication NN NN O
. . . O
   
Will MD MD O
not RB RB O
start VB VB O
any DT DT O
until IN IN O
she PRP PRP O
loses VBZ VBZ O
weight NN NN O
. . . O
   
_____________________________ NN NN O
_ NN NN O
Brett NNP NNP I-DOCTOR
F. NN NN I-DOCTOR
Rutherford NNP NNP I-DOCTOR
, , , O
M.D. NN NN O
   
CC NNP NNP O
: : : O
eScription NN NN O
document:0-532059 JJ JJ O
DD NNP NNP O
: : : O
07/04/82 CD CD I-DATE
DT NNP NNP O
: : : O
07/05/82 CD CD I-DATE
DV NNP NNP O
: : : O
07/04/82 CD CD I-DATE
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2064-06-16 JJ JJ I-DATE
EDUCARE-FARGO NNP NNP I-HOSPITAL
INPATIENT NNP NNP O
DIALYSIS NNP NNP O
FELLOW NNP NNP O
NOTE VB VB O
Outpatient NNP NNP O
Nephrologist NNP NNP O
: : : O
unknown JJ JJ O
Outpatient NNP NNP O
Dialysis NNP NNP O
Unit NNP NNP O
: : : O
CMH NNP NNP I-HOSPITAL
Dialysis NNP NNP O
access NN NN O
: : : O
L NNP NNP O
AVG NNP NNP O
Reason NNP NNP O
for IN IN O
admission NN NN O
: : : O
N/V NNP NNP O
, , , O
abdo NN NN O
pain NN NN O
HPI NNP NNP O
: : : O
Pt NNP NNP O
is VBZ VBZ O
Spanish-speaking NNP NNP O
only RB RB O
- : : O
Hx NNP NNP O
from IN IN O
patient NN NN O
and CC CC O
chart NN NN O
. . . O
   
44M CD CD O
ESRD NNP NNP O
on IN IN O
HD NNP NNP O
presumed VBD VBD O
2/2 CD CD O
Type NNP NNP O
1 CD CD O
DM NNP NNP O
with IN IN O
nausea/vomiting NN NN O
since IN IN O
Wednesday NNP NNP I-DATE
( ( ( O
2d CD CD O
ago RB RB O
) ) ) O
. . . O
   
No DT DT O
CP/SOB NNP NNP O
, , , O
no DT DT O
sick JJ JJ O
contacts NNS NNS O
( ( ( O
lives NNS NNS O
with IN IN O
mother NN NN O
) ) ) O
. . . O
   
Has VBZ VBZ O
felt VBN VBN O
"""" '' '' O
warm JJ JJ O
"""" '' '' O
, , , O
but CC CC O
did VBD VBD O
not RB RB O
take VB VB O
temperature NN NN O
at IN IN O
home NN NN O
. . . O
   
Last RB RB O
ate NN NN O
at IN IN O
breakfast NN NN O
Thursday NNP NNP I-DATE
morning NN NN O
   
( ( ( O
yesterday NN NN O
) ) ) O
. . . O
   
No DT DT O
abdo NN NN O
pain NN NN O
, , , O
no DT DT O
diarrhea NN NN O
. . . O
   
Came VBD VBD O
to TO TO O
ED NNP NNP O
last JJ JJ O
night NN NN O
, , , O
afebrile IN IN O
- - - O
given VBN VBN O
morphine NN NN O
2mg CD CD O
IV NNP NNP O
x SYM SYM O
1 CD CD O
for IN IN O
2/10 CD CD O
abdo NN NN O
pain NN NN O
and CC CC O
now RB RB O
says VBZ VBZ O
pain NN NN O
++ NNP NNP O
improved VBD VBD O
. . . O
   
Also RB RB O
noted VBD VBD O
to TO TO O
be VB VB O
hypertensive JJ JJ O
( ( ( O
190/100 CD CD O
) ) ) O
and CC CC O
Rx NNP NNP O
with IN IN O
his PRP$ PRP$ O
usual JJ JJ O
po NN NN O
meds NNS NNS O
in IN IN O
addition NN NN O
to TO TO O
hydralazine NN NN O
10mg CD CD O
IV NNP NNP O
x SYM SYM O
   
1 CD CD O
. . . O
He PRP PRP O
was VBD VBD O
also RB RB O
received VBN VBN O
Kayexalate NNP NNP O
30g CD CD O
x SYM SYM O
1 CD CD O
in IN IN O
the DT DT O
ED NNP NNP O
for IN IN O
K NNP NNP O
6.0 CD CD O
. . . O
   
Chronic NNP NNP O
dysuria NN NN O
- : : O
still RB RB O
makes VBZ VBZ O
significant JJ JJ O
urine NN NN O
. . . O
   
Has VBZ VBZ O
been VBN VBN O
compliant JJ JJ O
with IN IN O
dialysis NN NN O
sessions NNS NNS O
, , , O
last JJ JJ O
dialysis NN NN O
Tuesday NNP NNP I-DATE
. . . O
   
ROS NNP NNP O
otherwise RB RB O
negative JJ JJ O
. . . O
   
Past NNP NNP O
Medical NNP NNP O
History NN NN O
: : : O
ESRD NNP NNP O
on IN IN O
HD NNP NNP O
x SYM SYM O
2yrs CD CD O
- : : O
L NNP NNP O
AVG NNP NNP O
placed VBD VBD O
2 CD CD O
yrs NNS NNS O
ago RB RB O
, , , O
previously RB RB O
dialyzed JJ JJ O
via IN IN O
tunneled VBD VBD O
catheter NN NN O
Type NNP NNP O
1 CD CD O
DM NNP NNP O
since IN IN O
age NN NN O
25 CD CD I-AGE
- : : O
+ NN NN O
legally RB RB O
blind JJ JJ O
, , , O
PVD NNP NNP O
, , , O
nephropathy JJ JJ O
bilateral NN NN O
TMA NNP NNP O
- : : O
healing VBG VBG O
ulcer NN NN O
on IN IN O
R NNP NNP O
Allergies NNP NNP O
: : : O
NKDA NNP NNP O
Medications NNP NNP O
( ( ( O
as IN IN O
per IN IN O
his PRP$ PRP$ O
clinic JJ JJ O
visit NN NN O
06/11/64 CD CD I-DATE
- : : O
needs VBZ VBZ O
to TO TO O
be VB VB O
clarified VBN VBN O
) ) ) O
: : : O
PhosLo NNP NNP O
667 CD CD O
mg NN NN O
b.i.d. NN NN O
, , , O
omeprazole NN NN O
20 CD CD O
mg NN NN O
daily JJ JJ O
, , , O
Zelnorm NNP NNP O
6 CD CD O
mg NN NN O
b.i.d. NN NN O
, , , O
metoclopramide NN NN O
10 CD CD O
mg NN NN O
t.i.d. NN NN O
, , , O
Lopid NNP NNP O
600 CD CD O
mg NN NN O
daily JJ JJ O
, , , O
lisinopril NN NN O
20 CD CD O
mg NN NN O
MWFS NNP NNP O
, , , O
lactulose VB VB O
two CD CD O
teaspoonfuls NNS NNS O
b.i.d. NN NN O
, , , O
Humulin NNP NNP O
70/35 CD CD O
units NNS NNS O
daily RB RB O
, , , O
and CC CC O
enalapril NN NN O
10 CD CD O
mg NN NN O
on IN IN O
Thursdays NNP NNP I-DATE
and CC CC O
Sundays NNS NNS I-DATE
, , , O
losartan NN NN O
50 CD CD O
mg NN NN O
, , , O
citalopram NN NN O
40 CD CD O
mg NN NN O
and CC CC O
atropine NN NN O
eye NN NN O
drops NNS NNS O
in IN IN O
the DT DT O
left NN NN O
eye NN NN O
t.i.d. NN NN O
   
He PRP PRP O
also RB RB O
uses VBZ VBZ O
prednisolone NN NN O
eyedrops NNS NNS O
daily RB RB O
. . . O
   
Social NNP NNP O
History NN NN O
: : : O
No DT DT O
cigarette NN NN O
or CC CC O
illicit JJ JJ O
drug NN NN O
use NN NN O
. . . O
   
Previous JJ JJ O
heavy JJ JJ O
EtOH NNP NNP O
use NN NN O
, , , O
though RB RB O
none NN NN O
now RB RB O
. . . O
   
Lives NNP NNP O
with IN IN O
his PRP$ PRP$ O
mother NN NN O
who WP WP O
is VBZ VBZ O
also RB RB O
diabetic JJ JJ O
and CC CC O
also RB RB O
blind JJ JJ O
. . . O
   
Visiting VBG VBG O
nurses NNS NNS O
are VBP VBP O
coming VBG VBG O
to TO TO O
the DT DT O
home NN NN O
according VBG VBG O
to TO TO O
the DT DT O
patient NN NN O
twice RB RB O
per IN IN O
week NN NN O
and CC CC O
there EX EX O
is VBZ VBZ O
also RB RB O
a DT DT O
health NN NN O
care NN NN O
worker NN NN O
who WP WP O
comes VBZ VBZ O
to TO TO O
help VB VB O
with IN IN O
bathing VBG VBG O
three CD CD O
times NNS NNS O
per IN IN O
week NN NN O
. . . O
   
Originally RB RB O
from IN IN O
Panama NNP NNP I-COUNTRY
, , , O
grew VBD VBD O
up RB RB O
in IN IN O
Peru NNP NNP I-COUNTRY
, , , O
and CC CC O
came VBD VBD O
to TO TO O
the DT DT O
US NNP NNP I-COUNTRY
at IN IN O
age NN NN O
   
11 CD CD I-AGE
. . . O
Former NNP NNP O
Editor NNP NNP I-PROFESSION
. . . O
   
PHYSICAL JJ JJ O
EXAM NNP NNP O
Temp NNP NNP O
: : : O
96 CD CD O
BP NNP NNP O
: : : O
130/71 CD CD O
HR NNP NNP O
: : : O
92 CD CD O
97%RA CD CD O
Gen NNP NNP O
: : : O
Chronically-unwell NNP NNP O
appearing VBG VBG O
man NN NN O
, , , O
but CC CC O
in IN IN O
NAD NNP NNP O
. . . O
   
HEENT NNP NNP O
: : : O
sclerae NN NN O
non-icteric JJ JJ O
, , , O
O&P NNP NNP O
clear JJ JJ O
and CC CC O
moist NN NN O
, , , O
missing VBG VBG O
teeth NNS NNS O
Neck NNP NNP O
: : : O
supple NN NN O
, , , O
no DT DT O
LAD NNP NNP O
, , , O
no DT DT O
JVD NNP NNP O
, , , O
no DT DT O
thyromegaly NN NN O
, , , O
no DT DT O
carotid NN NN O
bruits NNS NNS O
Lungs NNP NNP O
: : : O
CTA NNP NNP O
b/l NN NN O
Cor NNP NNP O
: : : O
regular JJ JJ O
, , , O
s1s2 NN NN O
, , , O
no DT DT O
m/c/r/g NN NN O
Abd NNP NNP O
: : : O
soft JJ JJ O
, , , O
NTND NNP NNP O
, , , O
no DT DT O
HSM NNP NNP O
, , , O
no DT DT O
abdominal JJ JJ O
bruits NNS NNS O
Ext NNP NNP O
: : : O
no DT DT O
edema NN NN O
in IN IN O
LE NNP NNP O
b/l NN NN O
, , , O
bilateral JJ JJ O
TMA NNP NNP O
Skin NNP NNP O
: : : O
warm JJ JJ O
, , , O
smooth JJ JJ O
, , , O
no DT DT O
rashes NNS NNS O
Back RB RB O
: : : O
no DT DT O
CVAT NNP NNP O
Vascular NNP NNP O
access NN NN O
: : : O
site NN NN O
clean VB VB O
and CC CC O
without IN IN O
inflammation NN NN O
, , , O
systolic JJ JJ O
and CC CC O
diastolic JJ JJ O
bruit NN NN O
present JJ JJ O
LABS NNP NNP O
: : : O
Date/Time NNP NNP O
NA NNP NNP O
K NNP NNP O
CL NNP NNP O
CO2 NNP NNP O
06/16/2064 CD CD I-DATE
137 NN NN O
6.0 CD CD O
(*) NN NN O
104 CD CD O
23 CD CD O
Date/Time NNP NNP O
BUN NNP NNP O
CRE NNP NNP O
EGFR NNP NNP O
GLU NNP NNP O
06/16/2064 CD CD I-DATE
58 CD CD O
(*#) NN NN O
7.1 CD CD O
(*) NN NN O
9 CD CD O
[ NN NN O
1 CD CD O
] NN NN O
108 CD CD O
Date/Time NNP NNP O
ANION NNP NNP O
06/16/2064 CD CD I-DATE
10 CD CD O
Date/Time NNP NNP O
CA NNP NNP O
TBILI NNP NNP O
TP NNP NNP O
ALB NNP NNP O
06/16/2064 CD CD I-DATE
10.5 CD CD O
0.5 CD CD O
8.3 CD CD O
(*) NN NN O
4.4 CD CD O
Date/Time NNP NNP O
GLOB NNP NNP O
06/16/2064 CD CD I-DATE
3.9 CD CD O
Date/Time NNP NNP O
ALT/SGPT NNP NNP O
AST/SGOT NNP NNP O
ALKP NNP NNP O
TBILI NNP NNP O
06/16/2064 CD CD I-DATE
32 CD CD O
21 CD CD O
155 CD CD O
(*) NN NN O
0.5 CD CD O
Date/Time NNP NNP O
CK NNP NNP O
CK-MB NNP NNP O
TROP-I NNP NNP O
06/16/2064 CD CD I-DATE
137 NN NN O
2.9 CD CD O
< NN NN O
assay NN NN O
Date/Time NNP NNP O
WBC NNP NNP O
HGB NNP NNP O
HCT NNP NNP O
MCV NNP NNP O
06/16/2064 CD CD I-DATE
6.21 CD CD O
14.7 CD CD O
43.3 CD CD O
93.3 CD CD O
(#) NN NN O
Date/Time NNP NNP O
PLT NNP NNP O
06/16/2064 CD CD I-DATE
226 CD CD O
Date/Time NNP NNP O
PT NNP NNP O
PT-INR NNP NNP O
PTT NNP NNP O
06/16/2064 CD CD I-DATE
13.9 CD CD O
1.1 CD CD O
32.2 CD CD O
Date/Time NNP NNP O
UA-GLUC NNP NNP O
UA-KET NNP NNP O
UA-SPGR NNP NNP O
UA-BLD NNP NNP O
06/16/2064 CD CD I-DATE
TR NNP NNP O
NEG NNP NNP O
1.016 CD CD O
1 CD CD O
+ NN NN O
Date/Time NNP NNP O
UA-PH NNP NNP O
UA-PROT NNP NNP O
UA-NIT NNP NNP O
UA-WBC NNP NNP O
06/16/2064 CD CD I-DATE
8.0 CD CD O
3 CD CD O
+ NN NN O
NEG NNP NNP O
NEG NNP NNP O
ECG NNP NNP O
: : : O
NSR NNP NNP O
, , , O
nil NN NN O
acute JJ JJ O
, , , O
unchanged JJ JJ O
from IN IN O
previous JJ JJ O
05/05/64 CD CD I-DATE
ASSESSMENT NNP NNP O
AND CC CC O
PLAN NNP NNP O
: : : O
44M CD CD O
with IN IN O
ESRD NNP NNP O
on IN IN O
HD NNP NNP O
presents VBZ VBZ O
with IN IN O
N/V NNP NNP O
. . . O
   
His PRP$ PRP$ O
symptoms NNS NNS O
appear VBP VBP O
to TO TO O
be VB VB O
resolving VBG VBG O
and CC CC O
this DT DT O
may MD MD O
represent VB VB O
a DT DT O
viral JJ JJ O
gastroenteritis NN NN O
, , , O
as IN IN O
his PRP$ PRP$ O
cardiac JJ JJ O
enzymes NNS NNS O
are VBP VBP O
negative JJ JJ O
and CC CC O
sugars NNS NNS O
have VBP VBP O
been VBN VBN O
well-controlled JJ JJ O
since IN IN O
presentation NN NN O
to TO TO O
ED NNP NNP O
. . . O
   
He PRP PRP O
may MD MD O
have VB VB O
an DT DT O
element NN NN O
of IN IN O
diabetic JJ JJ O
gastroparesis NNS NNS O
given VBN VBN O
his PRP$ PRP$ O
medication NN NN O
list NN NN O
. . . O
   
We PRP PRP O
will MD MD O
add VB VB O
amylase NN NN O
and CC CC O
lipase NN NN O
to TO TO O
his PRP$ PRP$ O
bloodwork NN NN O
to TO TO O
r/o VB VB O
pancreatitis NNS NNS O
. . . O
   
Consider NNP NNP O
AXR NNP NNP O
to TO TO O
r/o VB VB O
constipation NN NN O
( ( ( O
normally RB RB O
on IN IN O
lactulose NN NN O
) ) ) O
. . . O
   
Plan NNP NNP O
: : : O
   
1 CD CD O
. . . O
HD NNP NNP O
today NN NN O
as IN IN O
per IN IN O
usual JJ JJ O
schedule NN NN O
and CC CC O
prescription NN NN O
. . . O
   
Hold VB VB O
Epo NNP NNP O
given VBN VBN O
Hct NNP NNP O
elevated VBD VBD O
. . . O
   
2 CD CD O
. . . O
Will NNP NNP O
draw VB VB O
blood NN NN O
Cx NNP NNP O
x SYM SYM O
2 CD CD O
, , , O
iron NN NN O
studies NNS NNS O
, , , O
25OH CD CD O
Vitamin NNP NNP O
D NNP NNP O
, , , O
PTH NNP NNP O
in IN IN O
HD NNP NNP O
. . . O
   
3 CD CD O
. . . O
Start NNP NNP O
Nephrocaps NNP NNP O
. . . O
   
4 CD CD O
. . . O
CAD NNP NNP O
risk NN NN O
: : : O
Start NNP NNP O
ASA NNP NNP O
81mg CD CD O
qd NN NN O
. . . O
   
5 CD CD O
. . . O
Polypharmacy NNP NNP O
: : : O
On IN IN O
multiple JJ JJ O
antihypertensives NNS NNS O
at IN IN O
different JJ JJ O
doses NNS NNS O
. . . O
   
Would MD MD O
d/c VB VB O
enalapril NN NN O
and CC CC O
losartan NN NN O
. . . O
   
Use NN NN O
only RB RB O
lisinopril NN NN O
daily JJ JJ O
( ( ( O
titrate NN NN O
up RB RB O
as IN IN O
needed VBN VBN O
) ) ) O
, , , O
but CC CC O
ask VB VB O
patient NN NN O
to TO TO O
take VB VB O
meds NNS NNS O
after IN IN O
dialysis NN NN O
on IN IN O
dialysis NN NN O
days NNS NNS O
. . . O
   
6 CD CD O
. . . O
Social NNP NNP O
work NN NN O
to TO TO O
see VB VB O
( ( ( O
already RB RB O
informed VBN VBN O
) ) ) O
. . . O
   
Nicole NNP NNP I-DOCTOR
Ostrowski NNP NNP I-DOCTOR
Renal NNP NNP O
Fellow NNP NNP O
56986 CD CD I-PHONE
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2064-09-10 NN NN I-DATE
Patient NNP NNP O
Name NN NN O
: : : O
ISENBERG,MICHAEL NNP NNP I-PATIENT
[ NN NN O
MRN NNP NNP O
: : : O
3674193HCC CD CD O
] NN NN O
Date NN NN O
of IN IN O
Visit NNP NNP O
: : : O
9/10/2064 CD CD I-DATE
Vascular NNP NNP O
Surgery NNP NNP O
Consult NNP NNP O
Note VB VB O
: : : O
I PRP PRP O
am VBP VBP O
asked VBN VBN O
to TO TO O
examine VB VB O
Mr NNP NNP O
. . . O
Isenberg NNP NNP I-PATIENT
and CC CC O
comment NN NN O
on IN IN O
recent JJ JJ O
CT NNP NNP O
findings NNS NNS O
of IN IN O
a DT DT O
intraluminal JJ JJ O
defect NN NN O
in IN IN O
the DT DT O
right JJ JJ O
subclavian JJ JJ O
artery NN NN O
. . . O
   
PMH NNP NNP O
/ NN NN O
PSH NNP NNP O
: : : O
   
1 CD CD O
. . . O
CAD NNP NNP O
- : : O
S/p NNP NNP O
2-V JJ JJ O
CABG NNP NNP O
off IN IN O
pump NN NN O
in IN IN O
4/64 CD CD I-DATE
   
2 CD CD O
. . . O
CHF NNP NNP O
- : : O
EF NNP NNP O
38 CD CD O
% NN NN O
, , , O
mild JJ JJ O
MR NNP NNP O
, , , O
diffusely RB RB O
hypokinetic JJ JJ O
LV NNP NNP O
w NN NN O
/ NN NN O
apical JJ JJ O
aneurysm NN NN O
, , , O
RVSP NNP NNP O
46mmHg CD CD O
, , , O
upper JJ JJ O
segment NN NN O
septal JJ JJ O
hypertrophy NN NN O
w/o NN NN O
evidence NN NN O
of IN IN O
obstruction NN NN O
on IN IN O
TTE NNP NNP O
on IN IN O
3/24/64 CD CD I-DATE
   
3 CD CD O
. . . O
HTN NNP NNP O
   
4 CD CD O
. . . O
Hyperlipidemia NNP NNP O
   
5 CD CD O
. . . O
DMII NNP NNP O
   
6 CD CD O
. . . O
CRI NNP NNP O
- : : O
Baseline NNP NNP O
Pcr NNP NNP O
is VBZ VBZ O
between IN IN O
1.6-1.8 JJ JJ O
Medications NNP NNP O
: : : O
Plavix NNP NNP O
75 CD CD O
mg NN NN O
qd NN NN O
Aspirin NNP NNP O
325 CD CD O
mg NN NN O
qd NN NN O
Lipitor NNP NNP O
80 CD CD O
mg NN NN O
qd NN NN O
Lisinopril NNP NNP O
2.5 CD CD O
mg NN NN O
qd NN NN O
Atenolol NNP NNP O
25 CD CD O
mg NN NN O
qd NN NN O
Fluoxetine NNP NNP O
10 CD CD O
mg NN NN O
qd NN NN O
Allergies NNP NNP O
: : : O
NKDA NNP NNP O
Mr NNP NNP O
Isenberg NNP NNP I-PATIENT
is VBZ VBZ O
a DT DT O
82 CD CD I-AGE
yo NN NN O
gentleman NN NN O
one CD CD O
week NN NN O
out IN IN O
from IN IN O
attempted VBD VBD O
placement NN NN O
of IN IN O
right NN NN O
subclavian JJ JJ O
pacemaker NN NN O
- - - O
complicated VBN VBN O
by IN IN O
brief JJ JJ O
arterial JJ JJ O
puncture NN NN O
, , , O
prompt VB VB O
removal NN NN O
of IN IN O
the DT DT O
arterial JJ JJ O
catheter NN NN O
and CC CC O
successful JJ JJ O
compression NN NN O
. . . O
   
Duplex NNP NNP O
ultrasonography NN NN O
after IN IN O
compression NN NN O
showed VBD VBD O
no DT DT O
evidence NN NN O
of IN IN O
a DT DT O
pseudoaneurysm NN NN O
. . . O
   
A DT DT O
CTA NNP NNP O
done VBN VBN O
yesterday NN NN O
to TO TO O
evaluate VB VB O
his PRP$ PRP$ O
thyroid NN NN O
was VBD VBD O
read VBN VBN O
as IN IN O
: : : O
"""" '' '' O
Hematoma NNP NNP O
around IN IN O
right NN NN O
subclavian JJ JJ O
artery NN NN O
. . . O
Narrowing NNP NNP O
of IN IN O
the DT DT O
artery NN NN O
. . . O
Apparent NNP NNP O
filling VBG VBG O
defect NN NN O
, , , O
most RBS RBS O
likely JJ JJ O
artifactual NN NN O
. . . O
If IN IN O
thrombus NN NN O
is VBZ VBZ O
of IN IN O
clinical JJ JJ O
concern NN NN O
, , , O
upper JJ JJ O
extremity NN NN O
ultrasound NN NN O
may MD MD O
be VB VB O
obtained VBN VBN O
. . . O
"""" '' '' O
On IN IN O
physical JJ JJ O
examination NN NN O
, , , O
he PRP PRP O
has VBZ VBZ O
mild JJ JJ O
non NN NN O
expansile NN NN O
hematoma NN NN O
of IN IN O
the DT DT O
right NN NN O
chest NN NN O
wall NN NN O
. . . O
   
His PRP$ PRP$ O
right JJ JJ O
hand NN NN O
is VBZ VBZ O
warm JJ JJ O
and CC CC O
well RB RB O
perfused VBD VBD O
, , , O
with IN IN O
1 CD CD O
+ NN NN O
radial JJ JJ O
and CC CC O
brachial JJ JJ O
pulses NNS NNS O
. . . O
   
There EX EX O
are VBP VBP O
no DT DT O
thrills NNS NNS O
or CC CC O
bruits NNS NNS O
. . . O
   
My PRP$ PRP$ O
review NN NN O
of IN IN O
arterial JJ JJ O
components NNS NNS O
of IN IN O
the DT DT O
CT NNP NNP O
show NN NN O
the DT DT O
following VBG VBG O
: : : O
1 CD CD O
) ) ) O
. . . O
   
Hematoma NNP NNP O
- : : O
to TO TO O
be VB VB O
expected VBN VBN O
2 CD CD O
) ) ) O
. . . O
   
Diffuse NNP NNP O
arterial JJ JJ O
calcifications NNS NNS O
- : : O
obscures RP RP O
the DT DT O
ability NN NN O
to TO TO O
read VB VB O
what WP WP O
is VBZ VBZ O
or CC CC O
is VBZ VBZ O
not RB RB O
in IN IN O
the DT DT O
lumen NNS NNS O
. . . O
   
3 CD CD O
) ) ) O
. . . O
   
Venous NNP NNP O
contrast NN NN O
bolus NN NN O
delivered VBN VBN O
on IN IN O
the DT DT O
right NN NN O
side NN NN O
- : : O
obscures RP RP O
our PRP$ PRP$ O
ability NN NN O
to TO TO O
discern VB VB O
the DT DT O
anatomy NN NN O
in IN IN O
the DT DT O
area NN NN O
of IN IN O
the DT DT O
subclavian JJ JJ O
artery NN NN O
. . . O
   
4 CD CD O
) ) ) O
. . . O
   
Contrast NN NN O
bolus NN NN O
inadequate JJ JJ O
to TO TO O
comment VB VB O
on IN IN O
arterial JJ JJ O
anatomy NN NN O
. . . O
   
Based VBN VBN O
on IN IN O
his PRP$ PRP$ O
clinical JJ JJ O
exam NN NN O
, , , O
and CC CC O
the DT DT O
fact NN NN O
that IN IN O
he PRP PRP O
is VBZ VBZ O
on IN IN O
an DT DT O
anticoagulant NN NN O
, , , O
a DT DT O
follow VB VB O
up RP RP O
subclavian JJ JJ O
artery NN NN O
ultrasound JJ JJ O
examination NN NN O
is VBZ VBZ O
in IN IN O
order NN NN O
. . . O
   
This DT DT O
test NN NN O
should MD MD O
be VB VB O
geared VBN VBN O
towards IN IN O
determining VBG VBG O
whether IN IN O
there EX EX O
is VBZ VBZ O
any DT DT O
evidence NN NN O
of IN IN O
a DT DT O
pseudoaneurysm NN NN O
. . . O
   
If IN IN O
there EX EX O
is VBZ VBZ O
an DT DT O
intraarterial JJ JJ O
filling VBG VBG O
defect NN NN O
, , , O
I PRP PRP O
would MD MD O
not RB RB O
pursue VB VB O
it PRP PRP O
. . . O
   
He PRP PRP O
is VBZ VBZ O
anticoagulated VBN VBN O
and CC CC O
his PRP$ PRP$ O
arm NN NN O
is VBZ VBZ O
viable JJ JJ O
. . . O
   
There EX EX O
are VBP VBP O
no DT DT O
stigmata NN NN O
of IN IN O
atheroemboli NN NN O
. . . O
   
Uriel NNP NNP I-DOCTOR
A. NN NN I-DOCTOR
Xavier NNP NNP I-DOCTOR
, , , O
MD NNP NNP O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2071-11-20 JJ JJ I-DATE
Patient NNP NNP O
Name NN NN O
: : : O
LILLY NNP NNP O
, , , O
LARRY NNP NNP I-PATIENT
; : : O
   
MRN NNP NNP O
: : : O
2155941 CD CD I-MEDICALRECORD
Dictated NNP NNP O
on IN IN O
: : : O
11/20/2071 CD CD I-DATE
by IN IN O
ANDRE-ISRAEL NNP NNP I-DOCTOR
SANTIAGO NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
   
DIAGNOSIS NNP NNP O
: : : O
Bilateral NNP NNP O
, , , O
right NN NN O
greater JJR JJR O
than IN IN O
left VBD VBD O
, , , O
carpal JJ JJ O
tunnel NN NN O
syndrome NN NN O
. . . O
   
HISTORY NN NN O
: : : O
This DT DT O
is VBZ VBZ O
a DT DT O
first JJ JJ O
office NN NN O
visit NN NN O
for IN IN O
this DT DT O
77-year-old, JJ JJ O
right-hand-dominant JJ JJ O
, , , O
founder NN NN O
of IN IN O
Bed NN NN I-ORGANIZATION
Bath NNP NNP I-ORGANIZATION
and CC CC I-ORGANIZATION
Beyond IN IN I-ORGANIZATION
, , , O
who WP WP O
comes VBZ VBZ O
for IN IN O
evaluation NN NN O
of IN IN O
right RB RB O
greater JJR JJR O
than IN IN O
left VBD VBD O
hand NN NN O
and CC CC I-ORGANIZATION
wrist NN NN O
pain NN NN O
. . . O
   
The DT DT O
patient NN NN O
reports NNS NNS O
having VBG VBG O
a DT DT O
longstanding JJ JJ O
history NN NN O
of IN IN O
greater JJR JJR O
than IN IN O
four CD CD O
months NNS NNS O
of IN IN O
worsening VBG VBG O
pain NN NN O
, , , O
paresthesias NN NN O
, , , O
and CC CC I-ORGANIZATION
"""" '' '' O
numbness NN NN O
"""" '' '' O
on IN IN O
the DT DT O
right NN NN O
worse JJR JJR O
than IN IN O
left VBD VBD O
hand NN NN O
. . . O
   
This DT DT O
is VBZ VBZ O
worse JJR JJR O
at IN IN O
night NN NN O
and CC CC I-ORGANIZATION
does VBZ VBZ O
occasionally RB RB O
wake NN NN O
him PRP PRP O
up RP RP O
from IN IN O
sleep NN NN O
. . . O
   
Also RB RB O
bothers NNS NNS O
him PRP PRP O
during IN IN O
prolonged JJ JJ O
activity NN NN O
. . . O
   
He PRP PRP O
also RB RB O
reports NNS NNS O
recently RB RB O
over IN IN O
the DT DT O
past JJ JJ O
few JJ JJ O
months NNS NNS O
noting VBG VBG O
difficulty NN NN O
with IN IN O
the DT DT O
key JJ JJ O
pinch NN NN O
, , , O
grasp VB VB O
, , , O
and CC CC I-ORGANIZATION
fine NN NN O
motor NN NN O
function NN NN O
. . . O
   
Previous JJ JJ O
evaluation NN NN O
consisted VBD VBD O
of IN IN O
cervical JJ JJ O
spine NN NN O
MRI NNP NNP O
as RB RB O
well RB RB O
as IN IN O
EMG NNP NNP O
nerve NN NN O
conduction NN NN O
studies NNS NNS O
demonstrating VBG VBG O
findings NNS NNS O
significant JJ JJ O
for IN IN O
severe JJ JJ O
compression NN NN O
neuropathy NN NN O
of IN IN O
the DT DT O
median NN NN O
nerve NN NN O
at IN IN O
the DT DT O
level NN NN O
of IN IN O
wrist NN NN O
. . . O
   
He PRP PRP O
now RB RB O
comes VBZ VBZ O
for IN IN O
evaluation NN NN O
for IN IN O
potential JJ JJ O
carpal NN NN O
tunnel NN NN O
surgery NN NN O
release NN NN O
. . . O
   
PAST NNP NNP O
MEDICAL NNP NNP O
HISTORY NN NN O
: : : O
Glucose NNP NNP O
intolerance NN NN O
, , , O
history NN NN O
of IN IN O
previous JJ JJ O
CVA NNP NNP O
, , , O
status NN NN O
post NN NN O
CABG NNP NNP O
, , , O
hypertension NN NN O
, , , O
GER NNP NNP O
. . . O
   
MEDICATIONS NNP NNP O
: : : O
Lopressor NNP NNP O
, , , O
Zocor NNP NNP O
, , , O
Ecotrin NNP NNP O
, , , O
Effexor NNP NNP O
, , , O
and CC CC I-ORGANIZATION
Nexium NNP NNP O
. . . O
   
ALLERGIES NNP NNP O
: : : O
None NN NN O
. . . O
   
PHYSICAL JJ JJ O
EXAMINATION NNP NNP O
: : : O
On IN IN O
examination NN NN O
today NN NN O
, , , O
he PRP PRP O
is VBZ VBZ O
very RB RB O
pleasant JJ JJ O
, , , O
well RB RB O
appearing VBG VBG O
in IN IN O
no DT DT O
apparent JJ JJ O
distress NN NN O
. . . O
   
Examination NNP NNP O
of IN IN O
the DT DT O
right JJ JJ O
hand NN NN O
demonstrates VBZ VBZ O
marked VBD VBD O
thenar NN NN O
atrophy NN NN O
. . . O
   
There EX EX O
is VBZ VBZ O
no DT DT O
active JJ JJ O
abductor NN NN O
pollicis NN NN O
brevis NN NN O
and CC CC I-ORGANIZATION
very RB RB O
weak JJ JJ O
opponens NNS NNS O
. . . O
   
He PRP PRP O
has VBZ VBZ O
a DT DT O
positive JJ JJ O
Tinel NNP NNP O
's POS POS O
, , , O
positive JJ JJ O
Phalen NNP NNP O
's POS POS O
, , , O
and CC CC I-ORGANIZATION
positive JJ JJ O
median NN NN O
nerve NN NN O
compression NN NN O
test NN NN O
at IN IN O
the DT DT O
wrist NN NN O
. . . O
   
His PRP$ PRP$ O
interossei NN NN O
and CC CC I-ORGANIZATION
extensors NNS NNS O
are VBP VBP O
full JJ JJ O
. . . O
   
Sensation NNP NNP O
is VBZ VBZ O
intact JJ JJ O
throughout IN IN O
. . . O
   
EMG NNP NNP O
studies NNS NNS O
from IN IN O
11/09/2071 CD CD I-DATE
, , , O
performed VBN VBN O
here RB RB O
at IN IN O
Folsom NNP NNP I-HOSPITAL
Convalescent NNP NNP I-HOSPITAL
Hospital NNP NNP I-HOSPITAL
, , , O
significant JJ JJ O
for IN IN O
right RB RB O
worse JJR JJR O
than IN IN O
left VBD VBD O
median JJ JJ O
nerve NN NN O
compression NN NN O
neuropathy NN NN O
at IN IN O
the DT DT O
wrists NNS NNS O
. . . O
   
IMPRESSION NNP NNP O
: : : O
The DT DT O
patient NN NN O
is VBZ VBZ O
seen VBN VBN O
and CC CC I-ORGANIZATION
examined VBN VBN O
with IN IN O
Dr NNP NNP O
. . . O
Santiago NNP NNP I-DOCTOR
. . . O
   
At IN IN O
this DT DT O
time NN NN O
, , , O
we PRP PRP O
feel VBP VBP O
that IN IN O
Larry NNP NNP I-PATIENT
has VBZ VBZ O
indeed RB RB O
a DT DT O
significant JJ JJ O
, , , O
right NN NN O
worse JJR JJR O
than IN IN O
left VBD VBD O
, , , O
bilateral JJ JJ O
carpal NN NN O
tunnel NN NN O
syndrome NN NN O
. . . O
   
Given VBN VBN O
the DT DT O
amount NN NN O
of IN IN O
weakness NN NN O
and CC CC I-ORGANIZATION
thenar NN NN O
wasting NN NN O
, , , O
he PRP PRP O
has VBZ VBZ O
difficulty NN NN O
with IN IN O
abductor NN NN O
pollicis NN NN O
, , , O
we PRP PRP O
have VBP VBP O
recommended VBN VBN O
proceeding VBG VBG O
with IN IN O
both DT DT O
carpal JJ JJ O
tunnel NN NN O
release NN NN O
as RB RB O
well RB RB O
as IN IN O
possible JJ JJ O
FTS NNP NNP O
of IN IN O
ring NN NN O
finger NN NN O
to TO TO O
thumb VB VB O
tendon NN NN O
transfer NN NN O
. . . O
   
We PRP PRP O
discussed VBD VBD O
with IN IN O
Larry NNP NNP I-PATIENT
the DT DT O
risks NNS NNS O
and CC CC I-ORGANIZATION
benefits NNS NNS O
of IN IN O
this DT DT O
procedure NN NN O
and CC CC I-ORGANIZATION
he PRP PRP O
is VBZ VBZ O
in IN IN O
agreement NN NN O
of IN IN O
the DT DT O
plan NN NN O
. . . O
   
We PRP PRP O
will MD MD O
try VB VB O
to TO TO O
schedule VB VB O
him PRP PRP O
to TO TO O
proceed VB VB O
with IN IN O
surgery NN NN O
at IN IN O
some DT DT O
point NN NN O
in IN IN O
the DT DT O
near JJ JJ O
future NN NN O
. . . O
   
We PRP PRP O
filled VBD VBD O
out IN IN O
both DT DT O
history NN NN O
and CC CC I-ORGANIZATION
physical JJ JJ O
, , , O
as RB RB O
well RB RB O
as IN IN O
a DT DT O
surgical JJ JJ O
consent NN NN O
form NN NN O
today NN NN O
in IN IN O
the DT DT O
office NN NN O
. . . O
   
_________________________ NN NN O
_ NN NN O
Andre-Israel NNP NNP I-DOCTOR
Santiago NNP NNP I-DOCTOR
, , , O
M.D. NN NN O
   
CC NNP NNP O
: : : O
Stephen NNP NNP I-DOCTOR
Mccullough NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
   
Folsom NNP NNP I-HOSPITAL
Convalescent NNP NNP I-HOSPITAL
Dictated NNP NNP O
by IN IN O
: : : O
____ NN NN O
_ NN NN O
DD:11/20/2071 NNP NNP O
DT:11/22/2071 NNP NNP O
CH:18306 NNP NNP I-IDNUM
: : : O
0077 CD CD O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2132-09-28 JJ JJ I-DATE
962-85-18 JJ JJ I-MEDICALRECORD
Jain NNP NNP O
, , , O
Oliver NNP NNP I-PATIENT
September NNP NNP I-DATE
28 CD CD O
, , , O
2132 CD CD I-DATE
Endocrine/Diabetes NNP NNP O
Present NNP NNP O
Illness NNP NNP O
: : : O
Asked VBD VBD O
to TO TO O
see VB VB O
this DT DT O
66 CD CD I-AGE
year NN NN O
old JJ JJ O
man NN NN O
who WP WP O
was VBD VBD O
transferred VBN VBN O
to TO TO O
LEPROSARIUM NNP NNP I-HOSPITAL
for IN IN O
care NN NN O
of IN IN O
an DT DT O
ischemic JJ JJ O
R NN NN O
foot NN NN O
. . . O
   
He PRP PRP O
has VBZ VBZ O
had VBD VBD O
a DT DT O
series NN NN O
of IN IN O
illness NN NN O
over IN IN O
the DT DT O
spring NN NN I-DATE
, , , O
beginning VBG VBG O
with IN IN O
a DT DT O
hospitalization NN NN O
for IN IN O
pneumonia NN NN O
in IN IN O
June NNP NNP I-DATE
. . . O
   
He PRP PRP O
later RB RB O
developed VBD VBD O
what WP WP O
was VBD VBD O
thought VBN VBN O
to TO TO O
be VB VB O
a DT DT O
splenic JJ JJ O
subcapsular NN NN O
hematoma NN NN O
( ( ( O
on IN IN O
Coumadin NNP NNP O
for IN IN O
chronic JJ JJ O
atrial JJ JJ O
fibrillation NN NN O
) ) ) O
and CC CC O
then RB RB O
subsequently RB RB O
developed VBN VBN O
LUQ NNP NNP O
pain NN NN O
and CC CC O
was VBD VBD O
found VBN VBN O
to TO TO O
have VB VB O
a DT DT O
splenic JJ JJ O
abscess NN NN O
that WDT WDT O
was VBD VBD O
drained VBN VBN O
. . . O
   
In IN IN O
the DT DT O
course NN NN O
of IN IN O
this DT DT O
illness NN NN O
, , , O
he PRP PRP O
also RB RB O
developed VBD VBD O
an DT DT O
ischemic JJ JJ O
R NN NN O
foot NN NN O
and CC CC O
was VBD VBD O
found VBN VBN O
( ( ( O
at IN IN O
what WP WP O
stage NN NN O
? . . O
) ) ) O
to TO TO O
have VB VB O
a DT DT O
popliteal NN NN O
aneurysm NN NN O
. . . O
   
At IN IN O
the DT DT O
time NN NN O
of IN IN O
his PRP$ PRP$ O
admission NN NN O
, , , O
he PRP PRP O
was VBD VBD O
found VBN VBN O
to TO TO O
have VB VB O
diabetes NNS NNS O
. . . O
   
He PRP PRP O
has VBZ VBZ O
been VBN VBN O
treated VBN VBN O
with IN IN O
Lantus NNP NNP O
insulin NN NN O
, , , O
most RBS RBS O
recently RB RB O
15 CD CD O
Units NNP NNP O
at IN IN O
bedtime NN NN O
, , , O
on IN IN O
which WDT WDT O
regimen NNS NNS O
he PRP PRP O
has VBZ VBZ O
had VBN VBN O
consistent JJ JJ O
overnight JJ JJ O
drops NNS NNS O
, , , O
often RB RB O
to TO TO O
hypoglycemic JJ JJ O
levels NNS NNS O
. . . O
   
He PRP PRP O
reports NNS NNS O
that IN IN O
he PRP PRP O
weighed VBD VBD O
about IN IN O
200 CD CD O
pounds NNS NNS O
before IN IN O
this DT DT O
illness NN NN O
but CC CC O
has VBZ VBZ O
lost VBN VBN O
about IN IN O
50 CD CD O
pounds NNS NNS O
. . . O
   
Retinopathy NNP NNP O
: : : O
He PRP PRP O
has VBZ VBZ O
had VBN VBN O
an DT DT O
eye NN NN O
exam NN NN O
in IN IN O
the DT DT O
recent JJ JJ O
past JJ JJ O
but CC CC O
I PRP PRP O
do VBP VBP O
not RB RB O
know VB VB O
any DT DT O
details NNS NNS O
. . . O
   
Nephropathy NNP NNP O
: : : O
BUN/Cr NNP NNP O
8/0.77 CD CD O
Neuropathy NNP NNP O
: : : O
Do VBP VBP O
not RB RB O
get VB VB O
a DT DT O
history NN NN O
of IN IN O
peripheral JJ JJ O
neuropathy NN NN O
Cardiac NNP NNP O
: : : O
Aware JJ JJ O
of IN IN O
having VBG VBG O
atrial JJ JJ O
fibrillation NN NN O
for IN IN O
about IN IN O
4 CD CD O
years NNS NNS O
. . . O
   
Not RB RB O
aware JJ JJ O
of IN IN O
any DT DT O
history NN NN O
of IN IN O
coronary JJ JJ O
artery NN NN O
disease NN NN O
. . . O
   
Vascular NNP NNP O
: : : O
? . . O
claudication NN NN O
preceding VBG VBG O
this DT DT O
spring&#8217; NN NN O
   
s VBZ VBZ O
illness NN NN O
. . . O
   
Past NNP NNP O
Medical NNP NNP O
History NN NN O
: : : O
Surgery NNP NNP O
: : : O
R NN NN O
elbow NN NN O
surgery NN NN O
Umbilical NNP NNP O
hernia NN NN O
repair NN NN O
Medical NNP NNP O
: : : O
Hypertension NNP NNP O
Hyperlipidemia NNP NNP O
Chronic NNP NNP O
atrial JJ JJ O
fibrillation NN NN O
Allergies NNP NNP O
: : : O
No DT DT O
known VBN VBN O
drug NN NN O
allergies NNS NNS O
. . . O
   
Smoking NNP NNP O
History NN NN O
: : : O
None NN NN O
. . . O
   
Alcohol NNP NNP O
History NN NN O
: : : O
Occasional NNP NNP O
6-pack NN NN O
for IN IN O
a DT DT O
football NN NN O
game NN NN O
Family NNP NNP O
History NN NN O
: : : O
Father NNP NNP O
: : : O
Also RB RB O
developed VBN VBN O
, , , O
or CC CC O
was VBD VBD O
found VBN VBN O
to TO TO O
have VB VB O
, , , O
diabetes NNS NNS O
in IN IN O
the DT DT O
context NN NN O
of IN IN O
another DT DT O
illness NN NN O
within IN IN O
the DT DT O
last JJ JJ O
decade NN NN O
and CC CC O
now RB RB O
takes VBZ VBZ O
insulin NN NN O
in IN IN O
his PRP$ PRP$ O
80&#8217; CD CD O
   
s. NN NN O
   
Social NNP NNP O
History NN NN O
: : : O
Lives NNS NNS O
with IN IN O
his PRP$ PRP$ O
wife NN NN O
. . . O
   
Review NNP NNP O
of IN IN O
Systems NNPS NNPS O
: : : O
above IN IN O
Review NNP NNP O
of IN IN O
systems NNS NNS O
is VBZ VBZ O
otherwise RB RB O
negative JJ JJ O
. . . O
   
Physical JJ JJ O
Exam NNP NNP O
: : : O
Pleasant NNP NNP O
man NN NN O
in IN IN O
no DT DT O
distress NN NN O
, , , O
flat JJ JJ O
p NN NN O
angio NN NN O
. . . O
   
BP NNP NNP O
: : : O
120-140/60-80 NN NN O
P NN NN O
: : : O
60&#8217; CD CD O
   
s-70&#8217; JJ JJ O
   
s VBZ VBZ O
, , , O
irregularly RB RB O
irregular JJ JJ O
Wt NNP NNP O
: : : O
about IN IN O
150 CD CD O
by IN IN O
history NN NN O
Ht NNP NNP O
: : : O
about IN IN O
5&#8217; CD CD O
   
9.5&#8221; CD CD O
   
HEENT NNP NNP O
: : : O
Anicteric NNP NNP O
. . . O
   
Full NNP NNP O
EOM NNP NNP O
's POS POS O
. . . O
   
Fundi NNP NNP O
: : : O
Not RB RB O
examined VBD VBD O
Carotids NNP NNP O
: : : O
Normal JJ JJ O
pulses NNS NNS O
, , , O
without IN IN O
bruits NNS NNS O
Chest NN NN O
: : : O
Clear NNP NNP O
to TO TO O
auscultation NN NN O
anteriorly RB RB O
Heart NNP NNP O
: : : O
Normal JJ JJ O
S1 NNP NNP O
; : : O
   
physiologic JJ JJ O
S2 NNP NNP O
. . . O
   
No DT DT O
gallops NNS NNS O
. . . O
   
No DT DT O
murmurs NNS NNS O
Abdomen NNP NNP O
: : : O
No DT DT O
hepatosplenomegaly NN NN O
. . . O
   
No DT DT O
masses NNS NNS O
. . . O
   
Mild NNP NNP O
LUQ NNP NNP O
tenderness NN NN O
. . . O
   
Upper NNP NNP O
abdominal JJ JJ O
scar NN NN O
is VBZ VBZ O
well RB RB O
healed VBN VBN O
. . . O
   
Extremities NNP NNP O
: : : O
R NN NN O
forefoot NN NN O
appears VBZ VBZ O
gangrenous JJ JJ O
. . . O
   
L NNP NNP O
foot NN NN O
is VBZ VBZ O
not RB RB O
ischemic JJ JJ O
but CC CC O
no DT DT O
pedal NN NN O
pulses NNS NNS O
are VBP VBP O
palpable JJ JJ O
. . . O
   
Impressions NNP NNP O
and CC CC O
Plan NNP NNP O
: : : O
66 CD CD I-AGE
year NN NN O
old JJ JJ O
man NN NN O
with IN IN O
gangrenous JJ JJ O
R NNP NNP O
foot NN NN O
and CC CC O
evidence NN NN O
for IN IN O
PVD NNP NNP O
on IN IN O
L NNP NNP O
as RB RB O
well RB RB O
. . . O
   
Diabetes NNP NNP O
, , , O
type NN NN O
2 CD CD O
, , , O
of IN IN O
uncertain JJ JJ O
duration NN NN O
. . . O
   
A1c NNP NNP O
is VBZ VBZ O
being VBG VBG O
checked VBN VBN O
. . . O
   
D/C NNP NNP O
Lantus NNP NNP O
. . . O
   
Start NNP NNP O
NPH NNP NNP O
10 CD CD O
Units NNP NNP O
qAM NN NN O
. . . O
   
After IN IN O
he PRP PRP O
is VBZ VBZ O
through IN IN O
with IN IN O
surgical JJ JJ O
procedure NN NN O
, , , O
it PRP PRP O
is VBZ VBZ O
unlikely JJ JJ O
that IN IN O
he PRP PRP O
will MD MD O
need VB VB O
insulin NN NN O
. . . O
   
Thanks NNS NNS O
. . . O
   
Oren NNP NNP I-DOCTOR
S. NN NN I-DOCTOR
Ip NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
, , , O
Ph.D NNP NNP O
. . . O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2069-10-07 NN NN I-DATE
ZOLLMAN NNP NNP I-HOSPITAL
EMERGENCY NNP NNP O
DEPT NNP NNP O
VISIT NNP NNP O
MASSEY,RAMONA NNP NNP I-PATIENT
446-90-33-6 NNP NNP I-MEDICALRECORD
VISIT NNP NNP O
DATE NN NN O
: : : O
10/07/69 CD CD I-DATE
TIME NNP NNP O
OF IN IN O
DICTATION NNP NNP O
: : : O
1 CD CD O
p.m. NN NN O
   
PRESENTING NNP NNP O
COMPLAINT NNP NNP O
and CC CC O
HISTORY NN NN O
OF IN IN O
PRESENTING NNP NNP O
COMPLAINT NNP NNP O
: : : O
This DT DT O
patient NN NN O
is VBZ VBZ O
a DT DT O
63-year-old JJ JJ O
female JJ JJ O
who WP WP O
presents VBZ VBZ O
to TO TO O
the DT DT O
Zollman NNP NNP I-HOSPITAL
Community NNP NNP I-HOSPITAL
Clinic NNP NNP I-HOSPITAL
Emergency NNP NNP O
Department NNP NNP O
from IN IN O
home NN NN O
after IN IN O
the DT DT O
patient NN NN O
was VBD VBD O
found VBN VBN O
down RB RB O
by IN IN O
her PRP$ PRP$ O
daughter NN NN O
inside IN IN O
her PRP$ PRP$ O
home NN NN O
for IN IN O
an DT DT O
unspecified JJ JJ O
amount NN NN O
of IN IN O
time NN NN O
. . . O
   
The DT DT O
paramedics NNS NNS O
and CC CC O
police NN NN O
were VBD VBD O
called VBN VBN O
the DT DT O
scene NN NN O
. . . O
   
The DT DT O
police NN NN O
were VBD VBD O
able JJ JJ O
to TO TO O
force VB VB O
open JJ JJ O
the DT DT O
door NN NN O
of IN IN O
the DT DT O
home NN NN O
. . . O
   
The DT DT O
patient NN NN O
was VBD VBD O
found VBN VBN O
unconscious JJ JJ O
on IN IN O
the DT DT O
floor NN NN O
, , , O
having VBG VBG O
a DT DT O
generalized JJ JJ O
tonic NN NN O
clonic JJ JJ O
seizure NN NN O
. . . O
   
The DT DT O
patient NN NN O
was VBD VBD O
intubated VBN VBN O
and CC CC O
given VBN VBN O
4 CD CD O
mg NN NN O
of IN IN O
Ativan NNP NNP O
prior RB RB O
to TO TO O
arrival NN NN O
in IN IN O
the DT DT O
Emergency NNP NNP O
Department NNP NNP O
with IN IN O
the DT DT O
paramedics NNS NNS O
. . . O
   
On IN IN O
arrival NN NN O
in IN IN O
the DT DT O
Emergency NNP NNP O
Department NNP NNP O
, , , O
the DT DT O
patient NN NN O
was VBD VBD O
noted VBN VBN O
to TO TO O
be VB VB O
comatose NN NN O
, , , O
intubated VBN VBN O
, , , O
and CC CC O
clearly RB RB O
in IN IN O
acute JJ JJ O
distress NNS NNS O
. . . O
   
The DT DT O
patient NN NN O
has VBZ VBZ O
a DT DT O
history NN NN O
of IN IN O
diabetes NN NN O
mellitus NN NN O
. . . O
   
She PRP PRP O
has VBZ VBZ O
had VBN VBN O
a DT DT O
seizure NN NN O
in IN IN O
the DT DT O
past NN NN O
, , , O
apparently RB RB O
secondary JJ JJ O
to TO TO O
hypoglycemia VB VB O
. . . O
   
She PRP PRP O
also RB RB O
has VBZ VBZ O
a DT DT O
history NN NN O
of IN IN O
high JJ JJ O
blood NN NN O
pressure NN NN O
. . . O
   
She PRP PRP O
is VBZ VBZ O
on IN IN O
diltiazem NN NN O
, , , O
lisinopril NN NN O
, , , O
and CC CC O
medications NNS NNS O
for IN IN O
hypercholesterolemia NN NN O
. . . O
   
PHYSICAL JJ JJ O
EXAMINATION NNP NNP O
: : : O
Her PRP$ PRP$ O
temperature NN NN O
is VBZ VBZ O
100.6 CD CD O
degrees NNS NNS O
F. NN NN O
   
, , , O
her PRP$ PRP$ O
pulse NN NN O
150 CD CD O
, , , O
her PRP$ PRP$ O
respiratory NN NN O
rate NN NN O
12 CD CD O
, , , O
her PRP$ PRP$ O
blood NN NN O
pressure NN NN O
on IN IN O
arrival NN NN O
205/90 CD CD O
, , , O
and CC CC O
her PRP$ PRP$ O
O2 NNP NNP O
saturation NN NN O
is VBZ VBZ O
98 CD CD O
% NN NN O
. . . O
   
On IN IN O
physical JJ JJ O
examination NN NN O
, , , O
the DT DT O
HEENT NNP NNP O
examination NN NN O
reveals VBZ VBZ O
a DT DT O
normocephalic JJ JJ O
head NN NN O
with IN IN O
no DT DT O
evidence NN NN O
of IN IN O
trauma NN NN O
on IN IN O
examination NN NN O
. . . O
   
The DT DT O
pupils NNS NNS O
are VBP VBP O
equal JJ JJ O
and CC CC O
round NN NN O
, , , O
weakly RB RB O
reactive JJ JJ O
to TO TO O
light VB VB O
. . . O
   
The DT DT O
pupils NNS NNS O
are VBP VBP O
2 CD CD O
mm NN NN O
. . . O
   
The DT DT O
fundi NN NN O
cannot NN NN O
be VB VB O
visualized VBN VBN O
. . . O
   
The DT DT O
neck NN NN O
is VBZ VBZ O
supple JJ JJ O
. . . O
   
There EX EX O
are VBP VBP O
no DT DT O
step-offs JJ JJ O
noted JJ JJ O
. . . O
   
The DT DT O
chest NN NN O
is VBZ VBZ O
clear JJ JJ O
to TO TO O
auscultation NN NN O
bilaterally RB RB O
. . . O
   
The DT DT O
heart NN NN O
has VBZ VBZ O
normal JJ JJ O
S1 NNP NNP O
and CC CC O
S2 NNP NNP O
, , , O
no DT DT O
S3 NNP NNP O
or CC CC O
S4 NNP NNP O
, , , O
and CC CC O
no DT DT O
murmur NN NN O
. . . O
   
The DT DT O
abdomen NN NN O
is VBZ VBZ O
protuberant JJ JJ O
, , , O
but CC CC O
soft JJ JJ O
and CC CC O
non-tender JJ JJ O
, , , O
without IN IN O
guarding VBG VBG O
, , , O
rebound NN NN O
, , , O
masses NNS NNS O
, , , O
or CC CC O
organomegaly RB RB O
. . . O
   
The DT DT O
extremities NNS NNS O
are VBP VBP O
grossly RB RB O
within IN IN O
normal JJ JJ O
limits NNS NNS O
. . . O
   
Grossly RB RB O
, , , O
there EX EX O
is VBZ VBZ O
no DT DT O
posturing VBG VBG O
; : : O
   
there EX EX O
are VBP VBP O
no DT DT O
Babinskis NNP NNP O
; : : O
   
the DT DT O
reflexes NNS NNS O
are VBP VBP O
about IN IN O
1 CD CD O
+ NN NN O
bilaterally RB RB O
. . . O
   
LABORATORY NNP NNP O
EVALUATION NNP NNP O
: : : O
The DT DT O
head NN NN O
CT NNP NNP O
is VBZ VBZ O
noted VBN VBN O
to TO TO O
be VB VB O
negative JJ JJ O
. . . O
   
The DT DT O
EKG NNP NNP O
reveals VBZ VBZ O
ST NNP NNP O
elevations NNS NNS O
in IN IN O
III NNP NNP O
and CC CC O
possibly RB RB O
aVF VB VB O
. . . O
   
The DT DT O
heart NN NN O
rate NN NN O
is VBZ VBZ O
approximately RB RB O
130 CD CD O
. . . O
   
The DT DT O
chest NN NN O
x-ray NN NN O
shows VBZ VBZ O
proper JJ JJ O
tube NN NN O
placement NN NN O
. . . O
   
The DT DT O
troponin NN NN O
I PRP PRP O
is VBZ VBZ O
2.2 CD CD O
, , , O
and CC CC O
is VBZ VBZ O
in IN IN O
the DT DT O
process NN NN O
of IN IN O
being VBG VBG O
repeated VBN VBN O
. . . O
   
The DT DT O
glucose NN NN O
is VBZ VBZ O
174 CD CD O
, , , O
the DT DT O
BUN NNP NNP O
57 CD CD O
, , , O
the DT DT O
creatinine NN NN O
5.8 CD CD O
, , , O
the DT DT O
sodium NN NN O
137 CD CD O
, , , O
the DT DT O
potassium NN NN O
5.3 CD CD O
, , , O
the DT DT O
chloride NN NN O
101 CD CD O
, , , O
the DT DT O
CO2 NNP NNP O
   
18 CD CD O
. . . O
The DT DT O
CK NNP NNP O
is VBZ VBZ O
noted VBN VBN O
to TO TO O
be VB VB O
920 CD CD O
, , , O
and CC CC O
the DT DT O
CK-MB NNP NNP O
is VBZ VBZ O
2.6 CD CD O
% NN NN O
. . . O
   
The DT DT O
toxicology NN NN O
screen NN NN O
is VBZ VBZ O
negative JJ JJ O
. . . O
   
The DT DT O
troponin NN NN O
I PRP PRP O
again RB RB O
is VBZ VBZ O
2.2 CD CD O
. . . O
   
The DT DT O
urine JJ JJ O
toxicology NN NN O
is VBZ VBZ O
also RB RB O
noted VBN VBN O
to TO TO O
be VB VB O
negative JJ JJ O
. . . O
   
The DT DT O
white JJ JJ O
count NN NN O
is VBZ VBZ O
14 CD CD O
, , , O
the DT DT O
hemoglobin NN NN O
11 CD CD O
, , , O
the DT DT O
hematocrit NN NN O
36 CD CD O
, , , O
and CC CC O
the DT DT O
platelet NN NN O
count NN NN O
350 CD CD O
. . . O
   
The DT DT O
urinalysis NN NN O
shows VBZ VBZ O
3 CD CD O
+ NN NN O
blood NN NN O
. . . O
   
There EX EX O
are VBP VBP O
only RB RB O
1-3 JJ JJ O
WBCs NNP NNP O
in IN IN O
the DT DT O
urine NN NN O
. . . O
   
THERAPY NNP NNP O
RENDERED/COURSE NNP NNP O
IN IN IN O
ED NNP NNP O
: : : O
The DT DT O
plan NN NN O
is VBZ VBZ O
to TO TO O
admit VB VB O
the DT DT O
patient NN NN O
to TO TO O
the DT DT O
Intensive NNP NNP O
Care NNP NNP O
Unit NNP NNP O
for IN IN O
further JJ JJ O
work-up JJ JJ O
and CC CC O
evaluation NN NN O
. . . O
   
An DT DT O
LP NNP NNP O
will MD MD O
be VB VB O
done VBN VBN O
in IN IN O
the DT DT O
Emergency NNP NNP O
Department NNP NNP O
, , , O
and CC CC O
following VBG VBG O
the DT DT O
LP NNP NNP O
, , , O
the DT DT O
patient NN NN O
will MD MD O
be VB VB O
sent VBN VBN O
to TO TO O
the DT DT O
Medical NNP NNP O
Intensive NNP NNP O
Care NNP NNP O
Unit NNP NNP O
. . . O
   
FINAL NNP NNP O
DIAGNOSIS NNP NNP O
: : : O
The DT DT O
diagnostic JJ JJ O
impression NN NN O
in IN IN O
the DT DT O
Emergency NNP NNP O
Department NNP NNP O
is VBZ VBZ O
seizure NN NN O
and CC CC O
coma NN NN O
of IN IN O
undetermined JJ JJ O
etiology NN NN O
. . . O
   
DISPOSITION NNP NNP O
( ( ( O
including VBG VBG O
condition NN NN O
on IN IN O
discharge NN NN O
) ) ) O
: : : O
The DT DT O
patient NN NN O
will MD MD O
be VB VB O
admitted VBN VBN O
to TO TO O
the DT DT O
Medical NNP NNP O
Intensive NNP NNP O
Care NNP NNP O
Unit NNP NNP O
following VBG VBG O
her PRP$ PRP$ O
lumbar NN NN O
puncture NN NN O
. . . O
   
__________________________________ NN NN O
_ NN NN O
HB768/1408 NNP NNP I-IDNUM
H. NN NN I-DOCTOR
SHAWN NNP NNP I-DOCTOR
HOWELL NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
   
SH37 NNP NNP I-USERNAME
D:10/07/69 NNP NNP O
T:10/07/69 NNP NNP O
Dictated NNP NNP O
by IN IN O
: : : O
H. NN NN I-DOCTOR
SHAWN NNP NNP I-DOCTOR
HOWELL NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
   
SH37 NNP NNP I-USERNAME
******** NN NN O
Not RB RB O
reviewed VBN VBN O
by IN IN O
Attending NNP NNP O
Physician NNP NNP O
******** NN NN O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2097-03-04 JJ JJ I-DATE
CARDIOLOGY NNP NNP O
ELIZABETHTOWN NNP NNP I-HOSPITAL
STATE NNP NNP I-HOSPITAL
HOSPITAL NNP NNP I-HOSPITAL
RE NNP NNP O
: : : O
I PRP PRP O
had VBD VBD O
the DT DT O
pleasure NN NN O
of IN IN O
seeing VBG VBG O
Verna NNP NNP I-PATIENT
Cantu NNP NNP I-PATIENT
in IN IN O
consultation NN NN O
today NN NN O
for IN IN O
management NN NN O
of IN IN O
coronary JJ JJ O
artery NN NN O
disease NN NN O
and CC CC O
aortic JJ JJ O
stenosis NNS NNS O
. . . O
   
Dear RB RB O
Dr NNP NNP O
. . . O
Levon NNP NNP I-DOCTOR
Nichols NNP NNP I-DOCTOR
, , , O
She PRP PRP O
is VBZ VBZ O
a DT DT O
very RB RB O
pleasant JJ JJ O
60 CD CD I-AGE
year NN NN O
old JJ JJ O
female JJ JJ O
with IN IN O
cardiovascular JJ JJ O
risk NN NN O
factors NNS NNS O
of IN IN O
non-insulin JJ JJ O
dependent NN NN O
diabetes NNS NNS O
mellitus NN NN O
, , , O
hypertension NN NN O
, , , O
peripheral JJ JJ O
arterial NN NN O
disease NN NN O
, , , O
and CC CC O
prior RB RB O
tobacco NN NN O
abuse NN NN O
. . . O
   
She PRP PRP O
has VBZ VBZ O
no DT DT O
prior JJ JJ O
history NN NN O
of IN IN O
myocardial NN NN O
infarction NN NN O
, , , O
arrhythmia NN NN O
, , , O
or CC CC O
congestive JJ JJ O
heart NN NN O
failure NN NN O
. . . O
   
About IN IN O
15 CD CD O
years NNS NNS O
ago RB RB O
she PRP PRP O
underwent VBD VBD O
an DT DT O
ETT NNP NNP O
for IN IN O
evaluation NN NN O
of IN IN O
exertional JJ JJ O
lightheadedness NNS NNS O
which WDT WDT O
by IN IN O
her PRP$ PRP$ O
reports NNS NNS O
was VBD VBD O
unremarkable JJ JJ O
. . . O
   
She PRP PRP O
has VBZ VBZ O
an DT DT O
extensive JJ JJ O
vascular NN NN O
history NN NN O
s/p NN NN O
right JJ JJ O
popliteal NN NN O
PTA/Stent NNP NNP O
and CC CC O
left VBD VBD O
common JJ JJ O
femoral JJ JJ O
endarterectomy NN NN O
for IN IN O
which WDT WDT O
she PRP PRP O
has VBZ VBZ O
been VBN VBN O
receiving VBG VBG O
regular JJ JJ O
care NN NN O
from IN IN O
Dr NNP NNP O
. . . O
Nichols NNP NNP I-DOCTOR
. . . O
   
She PRP PRP O
has VBZ VBZ O
a DT DT O
history NN NN O
of IN IN O
mixed JJ JJ O
connective JJ JJ O
tissue NN NN O
disease NN NN O
with IN IN O
Raynaud NNP NNP O
's POS POS O
for IN IN O
which WDT WDT O
she PRP PRP O
has VBZ VBZ O
been VBN VBN O
followed VBN VBN O
by IN IN O
Dr NNP NNP O
. . . O
Lucille NNP NNP I-DOCTOR
Jackson NNP NNP I-DOCTOR
. . . O
   
She PRP PRP O
reports NNS NNS O
that IN IN O
for IN IN O
the DT DT O
past JJ JJ O
year NN NN O
she PRP PRP O
has VBZ VBZ O
had VBN VBN O
dyspnea NN NN O
on IN IN O
exertion NN NN O
which WDT WDT O
typically RB RB O
manifests VBZ VBZ O
itself PRP PRP O
when WRB WRB O
she PRP PRP O
is VBZ VBZ O
trying VBG VBG O
to TO TO O
climb VB VB O
the DT DT O
2.5 CD CD O
flights NNS NNS O
of IN IN O
stairs NNS NNS O
that IN IN O
she PRP PRP O
has VBZ VBZ O
at IN IN O
home NN NN O
. . . O
   
She PRP PRP O
feels VBZ VBZ O
shortness JJ JJ O
of IN IN O
breath NN NN O
requiring VBG VBG O
her PRP PRP O
to TO TO O
stop VB VB O
when WRB WRB O
she PRP PRP O
gets VBZ VBZ O
to TO TO O
the DT DT O
top JJ JJ O
. . . O
   
She PRP PRP O
denies VBZ VBZ O
exertional JJ JJ O
chest NN NN O
pain NN NN O
or CC CC O
lightheadedness NN NN O
. . . O
   
She PRP PRP O
denies VBZ VBZ O
orthopnea NN NN O
, , , O
paroxysmal NN NN O
nocturnal NN NN O
dyspnea NN NN O
, , , O
or CC CC O
edema NN NN O
. . . O
   
She PRP PRP O
denies VBZ VBZ O
lightheadedness JJ JJ O
, , , O
dizziness NN NN O
, , , O
palpitations NNS NNS O
, , , O
or CC CC O
syncope NN NN O
. . . O
   
Currently RB RB O
she PRP PRP O
reports NNS NNS O
no DT DT O
symptoms NNS NNS O
of IN IN O
claudication NN NN O
. . . O
   
No DT DT O
regular JJ JJ O
exercise NN NN O
. . . O
   
A DT DT O
couple NN NN O
of IN IN O
times NNS NNS O
a DT DT O
day NN NN O
. . . O
   
Bowls NNP NNP O
on IN IN O
Sunday NNP NNP I-DATE
night NN NN O
with IN IN O
no DT DT O
shortness NN NN O
of IN IN O
breath NN NN O
. . . O
   
She PRP PRP O
has VBZ VBZ O
also RB RB O
been VBN VBN O
noted VBN VBN O
to TO TO O
have VB VB O
a DT DT O
systolic JJ JJ O
murmur NN NN O
on IN IN O
previous JJ JJ O
exams NNS NNS O
. . . O
   
An DT DT O
echocardiogram NN NN O
in IN IN O
2094 CD CD I-DATE
revealed VBD VBD O
aortic JJ JJ O
valve NN NN O
leaflet NN NN O
thickening NN NN O
but CC CC O
did VBD VBD O
not RB RB O
report VB VB O
significant JJ JJ O
aortic JJ JJ O
stenosis NN NN O
, , , O
though IN IN O
this DT DT O
was VBD VBD O
a DT DT O
technically RB RB O
difficult JJ JJ O
study NN NN O
by IN IN O
report NN NN O
. . . O
   
For IN IN O
evaluation NN NN O
of IN IN O
these DT DT O
symptoms NNS NNS O
she PRP PRP O
underwent VBD VBD O
an DT DT O
ETT-MIBI NNP NNP O
which WDT WDT O
was VBD VBD O
notable JJ JJ O
for IN IN O
poor JJ JJ O
exercise NN NN O
capacity NN NN O
, , , O
drop NN NN O
in IN IN O
blood NN NN O
pressure NN NN O
, , , O
exercise NN NN O
induced VBD VBD O
LBBB NNP NNP O
, , , O
and CC CC O
perfusion NN NN O
abnormality NN NN O
suggesting VBG VBG O
distal JJ JJ O
LAD NNP NNP O
territory NN NN O
ischemia NN NN O
. . . O
   
Past NNP NNP O
medical JJ JJ O
history NN NN O
: : : O
   
1 CD CD O
. . . O
Diabetes NNP NNP O
Mellitus NNP NNP O
: : : O
On IN IN O
oral JJ JJ O
medications NNS NNS O
for IN IN O
7 CD CD O
years NNS NNS O
+ NN NN O
Retinopathy NNP NNP O
both DT DT O
eyes NNS NNS O
~ NN NN O
7 CD CD O
yrs NNS NNS O
ago RB RB O
, , , O
no DT DT O
nephropathy NN NN O
. . . O
   
+ NN NN O
neuropathy NN NN O
   
2 CD CD O
. . . O
Hypertension NNP NNP O
controlled VBD VBD O
on IN IN O
medication NN NN O
~ NN NN O
5yrs CD CD O
, , , O
requiring VBG VBG O
frequent JJ JJ O
adjustments NNS NNS O
of IN IN O
meds NNS NNS O
, , , O
140/70 CD CD O
   
3 CD CD O
. . . O
Peripheral NNP NNP O
arterial JJ JJ O
disease NN NN O
. . . O
   
Status NNP NNP O
post NN NN O
left VBD VBD O
common JJ JJ O
femoral JJ JJ O
endarterectomy NN NN O
by IN IN O
Dr NNP NNP O
. . . O
Vanover NNP NNP I-DOCTOR
11/26/95 CD CD I-DATE
. . . O
   
4 CD CD O
. . . O
Carotid NNP NNP O
artery NN NN O
disease NN NN O
. . . O
   
Mild NNP NNP O
bilateral JJ JJ O
internal JJ JJ O
carotid NN NN O
artery NN NN O
stenoses NNS NNS O
duplex JJ JJ O
ultrasound NN NN O
6/96 CD CD I-DATE
. . . O
   
5 CD CD O
. . . O
Mixed NNP NNP O
connective JJ JJ O
tissue NN NN O
disease NN NN O
with IN IN O
Raynaud NNP NNP O
's POS POS O
. . . O
   
Followed NNP NNP O
by IN IN O
Dr NNP NNP O
. . . O
Lucille NNP NNP I-DOCTOR
Jackson NNP NNP I-DOCTOR
. . . O
   
In IN IN O
2094 CD CD I-DATE
was VBD VBD O
having VBG VBG O
leg NN NN O
pains NNS NNS O
. . . O
   
6 CD CD O
. . . O
Melanoma NNP NNP O
involving VBG VBG O
right NN NN O
thigh NN NN O
. . . O
   
s/p NN NN O
surgical JJ JJ O
resection NN NN O
20 CD CD O
years NNS NNS O
ago RB RB O
   
7 CD CD O
. . . O
Arthritis NNP NNP O
primarily RB RB O
of IN IN O
hands NNS NNS O
Prior NNP NNP O
surgeries VBZ VBZ O
: : : O
tonsillectomy NN NN O
, , , O
melanoma NN NN O
resection NN NN O
. . . O
   
Supplements NNP NNP O
: : : O
Calcium NNP NNP O
with IN IN O
Vit NNP NNP O
. . . O
   
D. NN NN O
Changes NNS NNS O
to TO TO O
Allergies NNP NNP O
NKA NNP NNP O
: : : O
No DT DT O
Known VBN VBN O
Allergies NNP NNP O
- - - O
reaction NN NN O
: : : O
[ NN NN O
reviewed NNS NNS O
] NN NN O
Family NNP NNP O
history NN NN O
: : : O
Mother NNP NNP O
had VBD VBD O
rheumatic JJ JJ O
heart NN NN O
disease NN NN O
, , , O
had VBD VBD O
3 CD CD O
valve NN NN O
surgeries NNS NNS O
. . . O
   
Died VBD VBD O
at IN IN O
the DT DT O
age NN NN O
of IN IN O
49 CD CD I-AGE
from IN IN O
complications NNS NNS O
of IN IN O
a DT DT O
urinary JJ JJ O
infection NN NN O
in IN IN O
the DT DT O
setting VBG VBG O
of IN IN O
stroke NN NN O
. . . O
   
Father NNP NNP O
had VBD VBD O
cirrhosis NNS NNS O
and CC CC O
died VBD VBD O
at IN IN O
the DT DT O
age NN NN O
of IN IN O
51 CD CD I-AGE
, , , O
alcoholic JJ JJ O
. . . O
   
Sister NNP NNP O
: : : O
alive JJ JJ O
and CC CC O
well RB RB O
. . . O
   
There EX EX O
is VBZ VBZ O
no DT DT O
family NN NN O
history NN NN O
of IN IN O
premature JJ JJ O
coronary JJ JJ O
artery NN NN O
disease NN NN O
, , , O
cardiomyopathy NN NN O
, , , O
or CC CC O
arrhythmia NN NN O
. . . O
   
Social NNP NNP O
history NN NN O
: : : O
Works NNP NNP O
as IN IN O
Broadcast NNP NNP I-PROFESSION
Technician NNP NNP I-PROFESSION
NPR NNP NNP I-ORGANIZATION
for IN IN O
10 CD CD O
years NNS NNS O
. . . O
   
Tobacco NNP NNP O
: : : O
quit VBD VBD O
20 CD CD O
years NNS NNS O
ago RB RB O
. . . O
   
1 CD CD O
ppd NN NN O
for IN IN O
25 CD CD O
years NNS NNS O
. . . O
   
EtoH NNP NNP O
: : : O
none NN NN O
Lives NNS NNS O
with IN IN O
husband NN NN O
and CC CC O
son NN NN O
. . . O
   
Review NNP NNP O
of IN IN O
systems NNS NNS O
: : : O
No DT DT O
bright JJ JJ O
red JJ JJ O
blood NN NN O
per IN IN O
rectum NN NN O
or CC CC O
melena NN NN O
. . . O
   
No DT DT O
transient NN NN O
ischemic JJ JJ O
attack NN NN O
, , , O
or CC CC O
stroke NN NN O
. . . O
   
She PRP PRP O
reports VBZ VBZ O
some DT DT O
left VBN VBN O
forearm JJ JJ O
muscle NN NN O
tightness NN NN O
with IN IN O
usual JJ JJ O
activities NNS NNS O
. . . O
   
Relieved NNP NNP O
with IN IN O
rest NN NN O
for IN IN O
the DT DT O
past JJ JJ O
one CD CD O
year NN NN O
. . . O
   
Physical JJ JJ O
examination NN NN O
: : : O
- : : O
BMI NNP NNP O
: : : O
28.3 CD CD O
Overweight NNP NNP O
, , , O
moderate JJ JJ O
risk NN NN O
- - - O
Pulse NNP NNP O
: : : O
91 CD CD O
reg NN NN O
- : : O
resp NN NN O
. . . O
   
rate NN NN O
: : : O
18 CD CD O
- - - O
height NN NN O
: : : O
58 CD CD O
in IN IN O
. . . O
   
- - - O
weight NN NN O
: : : O
135 CD CD O
lbs NN NN O
. . . O
   
- - - O
General NNP NNP O
appearance NN NN O
: : : O
overweight NN NN O
, , , O
pleasant NN NN O
, , , O
in IN IN O
no DT DT O
distress NN NN O
- : : O
Skin NNP NNP O
: : : O
No DT DT O
rashes NNS NNS O
. . . O
   
No DT DT O
jaundice NN NN O
. . . O
   
- - - O
HEENT NNP NNP O
: : : O
Conjunctivae NNP NNP O
clear JJ JJ O
, , , O
oropharynx JJ JJ O
benign NN NN O
. . . O
   
Upper NNP NNP O
and CC CC O
lower JJR JJR O
dentures NNS NNS O
- - - O
Neck NNP NNP O
: : : O
Neck NN NN O
is VBZ VBZ O
supple JJ JJ O
. . . O
   
Bilateral NNP NNP O
carotid NN NN O
upstrokes NNS NNS O
are VBP VBP O
diminished VBN VBN O
in IN IN O
volume NN NN O
and CC CC O
delayed VBD VBD O
in IN IN O
timing NN NN O
with IN IN O
radiation NN NN O
of IN IN O
aortic JJ JJ O
murmur NN NN O
. . . O
   
JVP NNP NNP O
is VBZ VBZ O
normal JJ JJ O
and CC CC O
estimated VBN VBN O
at IN IN O
7 CD CD O
cm NN NN O
H20 NNP NNP O
with IN IN O
no DT DT O
hepatojugular NN NN O
reflux NN NN O
. . . O
   
There EX EX O
is VBZ VBZ O
no DT DT O
cervical JJ JJ O
adenopathy NN NN O
or CC CC O
thyromegaly NN NN O
. . . O
   
- - - O
Chest NN NN O
: : : O
Mild NNP NNP O
bibasilar NN NN O
rales NNS NNS O
at IN IN O
the DT DT O
bases NNS NNS O
. . . O
   
No DT DT O
rhonchi NN NN O
or CC CC O
wheezes NNS NNS O
. . . O
   
- - - O
Cardiac NNP NNP O
: : : O
Regular NNP NNP O
, , , O
soft JJ JJ O
S1 NNP NNP O
, , , O
There EX EX O
is VBZ VBZ O
a DT DT O
III/VI NNP NNP O
late JJ JJ O
peaking NN NN O
crescendo-decrescendo NN NN O
murmur NN NN O
at IN IN O
the DT DT O
base NN NN O
which WDT WDT O
radiates VBZ VBZ O
to TO TO O
the DT DT O
carotids NNS NNS O
and CC CC O
throughout IN IN O
the DT DT O
pre-cordium NN NN O
and CC CC O
left VBD VBD O
thorax NN NN O
. . . O
   
P2 NNP NNP O
is VBZ VBZ O
preserved VBN VBN O
and CC CC O
heard VBN VBN O
towards IN IN O
the DT DT O
apex NN NN O
. . . O
   
No DT DT O
RV NNP NNP O
heave VB VB O
. . . O
   
PMI NNP NNP O
does VBZ VBZ O
not RB RB O
feel VB VB O
displaced VBN VBN O
. . . O
   
- - - O
Abdomen NNP NNP O
: : : O
Soft JJ JJ O
, , , O
non-tender NN NN O
, , , O
non-distended JJ JJ O
with IN IN O
normal JJ JJ O
bowel NN NN O
sounds VBZ VBZ O
. . . O
   
abdominal JJ JJ O
bruit NN NN O
over IN IN O
epigastric JJ JJ O
area NN NN O
. . . O
   
No DT DT O
hepatosplenomegaly NN NN O
. . . O
   
- - - O
Extremities NNP NNP O
: : : O
No DT DT O
cyanosis NN NN O
, , , O
clubbing VBG VBG O
or CC CC O
edema NN NN O
. . . O
   
2 CD CD O
+ NN NN O
femoral JJ JJ O
pulses NNS NNS O
with IN IN O
a DT DT O
left NN NN O
bruit NN NN O
. . . O
   
2 CD CD O
+ NN NN O
pedal NN NN O
pulses NNS NNS O
. . . O
   
High NNP NNP O
pitched VBD VBD O
bruits NNS NNS O
appreciated VBD VBD O
while IN IN O
measuring VBG VBG O
brachial JJ JJ O
blood NN NN O
pressure NN NN O
in IN IN O
both DT DT O
arms NNS NNS O
. . . O
   
- - - O
Neuro NNP NNP O
: : : O
Alert NNP NNP O
and CC CC O
oriented VBD VBD O
x SYM SYM O
   
3 CD CD O
. . . O
Normal NNP NNP O
gait NN NN O
- - - O
BP NNP NNP O
: : : O
162/60 CD CD O
RA NNP NNP O
144/66 CD CD O
LA NNP NNP O
EKG NNP NNP O
: : : O
Normal JJ JJ O
sinus NN NN O
rhythm NN NN O
at IN IN O
91 CD CD O
bpm NN NN O
. . . O
   
Left NNP NNP O
anterior NN NN O
fascicular NN NN O
block NN NN O
. . . O
   
Compared VBN VBN O
with IN IN O
prior RB RB O
from IN IN O
11/95 CD CD I-DATE
there EX EX O
has VBZ VBZ O
been VBN VBN O
no DT DT O
significant JJ JJ O
change NN NN O
. . . O
   
Selected NNP NNP O
recent JJ JJ O
labs NNS NNS O
: : : O
Metabolic NNP NNP O
Date NN NN O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2095-06-03 JJ JJ I-DATE
Urology NNP NNP O
Consult NNP NNP O
Note VB VB O
Patient NNP NNP O
Name NN NN O
: : : O
Yee NNP NNP O
, , , O
Michael NNP NNP I-PATIENT
PH NNP NNP I-HOSPITAL
# # # O
: : : O
12693819 CD CD I-MEDICALRECORD
Date/Time NNP NNP O
: : : O
6/03/95 CD CD I-DATE
Attending NNP NNP O
: : : O
Ferreira NNP NNP I-DOCTOR
CC NNP NNP O
: : : O
Obstructive NNP NNP O
Uropathy NNP NNP O
HPI NNP NNP O
: : : O
77yM CD CD O
well RB RB O
known VBN VBN O
to TO TO O
Dr NNP NNP O
Ferreira/Wright NNP NNP O
practice NN NN O
. . . O
   
Muscular NNP NNP O
Dystrophy NNP NNP O
, , , O
CRI NNP NNP O
. . . O
   
Stents NNP NNP O
initially RB RB O
placed VBD VBD O
Nov NNP NNP I-DATE
2093 CD CD I-DATE
for IN IN O
elevated VBD VBD O
Cr NNP NNP O
and CC CC O
CT NNP NNP O
with IN IN O
hydro NN NN O
( ( ( O
bsl NN NN O
Cr NNP NNP O
was VBD VBD O
1.5-1.7 JJ JJ O
) ) ) O
; : : O
   
unknown JJ JJ O
etiology NN NN O
. . . O
   
Last RB RB O
changed JJ JJ O
Dec NNP NNP I-DATE
2094 CD CD I-DATE
. . . O
   
Continues NNP NNP O
to TO TO O
present VB VB O
with IN IN O
UTI NNP NNP O
's POS POS O
intermittently RB RB O
normally RB RB O
treated VBN VBN O
in IN IN O
ED NNP NNP O
. . . O
   
This DT DT O
admission NN NN O
presents VBZ VBZ O
with IN IN O
renal JJ JJ O
failure/hyperkalemia NN NN O
( ( ( O
Crt NNP NNP O
up IN IN O
to TO TO O
8 CD CD O
, , , O
K NNP NNP O
8 CD CD O
) ) ) O
, , , O
urinary JJ JJ O
tract NN NN O
infection NN NN O
and CC CC O
mental JJ JJ O
status NN NN O
changes NNS NNS O
. . . O
   
PMH NNP NNP O
: : : O
Muscular NNP NNP O
Dystrophy NNP NNP O
, , , O
CRI NNP NNP O
with IN IN O
baseline NN NN O
of IN IN O
1.5 CD CD O
, , , O
hyperkalemia NN NN O
secondary JJ JJ O
to TO TO O
hyperaldosteronemia NN NN O
( ( ( O
type NN NN O
III NNP NNP O
RTA NNP NNP O
) ) ) O
CAD NNP NNP O
s/p NN NN O
CABG NNP NNP O
, , , O
seizure NN NN O
disorder NN NN O
, , , O
fungal JJ JJ O
UTI NNP NNP O
, , , O
PVD NNP NNP O
, , , O
GERD NNP NNP O
, , , O
COPD NNP NNP O
(2.5L NN NN O
home NN NN O
O2 NNP NNP O
) ) ) O
, , , O
IDDM NNP NNP O
PSH NNP NNP O
: : : O
CABG NNP NNP O
; : : O
   
cystoscopy NN NN O
, , , O
B NNP NNP O
RPG NNP NNP O
, , , O
B NNP NNP O
ureteral JJ JJ O
stent NN NN O
placement NN NN O
11/93 CD CD I-DATE
; : : O
   
cystoscopy NN NN O
, , , O
B NNP NNP O
ureteral JJ JJ O
stent NN NN O
change NN NN O
2/94 CD CD I-DATE
and CC CC O
then RB RB O
again RB RB O
12/94 CD CD I-DATE
. . . O
   
MED NNP NNP O
: : : O
See VB VB O
admission NN NN O
list NN NN O
ALL NNP NNP O
: : : O
EmycinPE NNP NNP O
: : : O
AFVSS NNP NNP O
NAD NNP NNP O
, , , O
delirious JJ JJ O
S/NT/ND NNP NNP O
Foley NNP NNP O
intact JJ JJ O
with IN IN O
clear JJ JJ O
urine NN NN O
, , , O
soiling VBG VBG O
of IN IN O
bed NN NN O
, , , O
deferred VBN VBN O
DRE NNP NNP O
LABS NNP NNP O
: : : O
BUN/Crt NNP NNP O
: : : O
209/8.5&#224; CD CD O
   
7.8 CD CD O
, , , O
K NNP NNP O
8&#224; CD CD O
   
4.3 CD CD O
, , , O
14.6&#224; CD CD O
   
11/31/313MICRO: CD CD O
UA NNP NNP O
positive JJ JJ O
for IN IN O
infection NN NN O
; : : O
   
Ucx NNP NNP O
and CC CC O
Blood NNP NNP O
Cx NNP NNP O
pending VBG VBG O
RADS NNP NNP O
: : : O
RUS NNP NNP O
3/29 CD CD I-DATE
: : : O
Left NNP NNP O
kidney NN NN O
not RB RB O
visualized JJ JJ O
. . . O
   
The DT DT O
right NN NN O
kidney NN NN O
is VBZ VBZ O
without IN IN O
evidence NN NN O
of IN IN O
hydronephrosis NNS NNS O
. . . O
   
There EX EX O
is VBZ VBZ O
an DT DT O
echogenicity NN NN O
in IN IN O
the DT DT O
right JJ JJ O
renal NN NN O
cortex NN NN O
compatible JJ JJ O
with IN IN O
chronic JJ JJ O
renal JJ JJ O
medical JJ JJ O
disease NN NN O
. . . O
   
Last JJ JJ O
CT NNP NNP O
was VBD VBD O
in IN IN O
12/94 CD CD I-DATE
and CC CC O
showed VBD VBD O
bilateral JJ JJ O
stability NN NN O
of IN IN O
stents NNS NNS O
, , , O
no DT DT O
obvious JJ JJ O
processUnderlying VBG VBG O
obstruction NN NN O
. . . O
   
A/P NNP NNP O
: : : O
77M CD CD O
w NN NN O
/ NN NN O
multiple JJ JJ O
medical JJ JJ O
problems NNS NNS O
including VBG VBG O
muscular JJ JJ O
dystrophy NN NN O
and CC CC O
B NNP NNP O
ureteral JJ JJ O
obstruction NN NN O
managed VBN VBN O
with IN IN O
chronic JJ JJ O
indwelling VBG VBG O
stents NNS NNS O
, , , O
the DT DT O
etiology NN NN O
which WDT WDT O
is VBZ VBZ O
unclear JJ JJ O
, , , O
now RB RB O
admitted VBN VBN O
w NN NN O
/ NN NN O
ARF NNP NNP O
, , , O
hyperkalemia NN NN O
and CC CC O
a DT DT O
presumed JJ JJ O
UTI NNP NNP O
. . . O
   
His PRP$ PRP$ O
ureteral JJ JJ O
stents NNS NNS O
were VBD VBD O
last JJ JJ O
changed VBD VBD O
12/94 CD CD I-DATE
, , , O
but CC CC O
he PRP PRP O
has VBZ VBZ O
never RB RB O
obtained VBN VBN O
a DT DT O
diagnosis NN NN O
for IN IN O
his PRP$ PRP$ O
B NNP NNP O
ureteral JJ JJ O
obstruction NN NN O
; : : O
   
in IN IN O
12/94 CD CD I-DATE
, , , O
left VBD VBD O
RPG NNP NNP O
showed VBD VBD O
hydroureter NN NN O
to TO TO O
UVJ NNP NNP O
and CC CC O
on IN IN O
the DT DT O
right NN NN O
a DT DT O
distal JJ JJ O
ureteral JJ JJ O
stricture NN NN O
was VBD VBD O
noted VBN VBN O
at IN IN O
the DT DT O
UVJ NNP NNP O
. . . O
   
Difficult JJ JJ O
management NN NN O
issue NN NN O
since IN IN O
fails NNS NNS O
to TO TO O
follow-up JJ JJ O
and CC CC O
is VBZ VBZ O
normally RB RB O
cared VBN VBN O
for IN IN O
during IN IN O
acute JJ JJ O
episode NN NN O
admissions NNS NNS O
. . . O
   
We PRP PRP O
recommend VBP VBP O
: : : O
F/U NNP NNP O
UCx NNP NNP O
and CC CC O
continue VB VB O
empiric JJ JJ O
treatment NN NN O
; : : O
   
managed VBN VBN O
by IN IN O
ID NNP NNP O
in IN IN O
the DT DT O
past JJ JJ O
and CC CC O
their PRP$ PRP$ O
services NNS NNS O
may MD MD O
be VB VB O
helpful JJ JJ O
if IN IN O
he PRP PRP O
doesn&#8217; VBZ VBZ O
   
t NN NN O
respond NN NN O
at IN IN O
present JJ JJ O
. . . O
   
Continue NNP NNP O
hydration NN NN O
and CC CC O
treatment NN NN O
for IN IN O
hyperkalemia/ARF NN NN O
; : : O
   
may MD MD O
benefit VB VB O
from IN IN O
renal JJ JJ O
consult NN NN O
given VBN VBN O
h/o NN NN O
RTA NNP NNP O
F/U NNP NNP O
RUS NNP NNP O
to TO TO O
assess VB VB O
for IN IN O
recurrent JJ JJ O
hydronephrosis NN NN O
. . . O
   
Left NNP NNP O
kidney NN NN O
not RB RB O
well RB RB O
visualized VBN VBN O
at IN IN O
last JJ JJ O
US NNP NNP O
. . . O
   
Depending VBG VBG O
on IN IN O
the DT DT O
results NNS NNS O
of IN IN O
this DT DT O
study NN NN O
, , , O
consider VB VB O
ureteral JJ JJ O
stent NN NN O
change NN NN O
vs NNS NNS O
. . . O
staged VBD VBD O
removal NN NN O
. . . O
   
Needs VBZ VBZ O
to TO TO O
be VB VB O
medically RB RB O
optimized JJ JJ O
prior RB RB O
to TO TO O
undergoing VBG VBG O
anaesthesia NN NN O
. . . O
   
D/w NNP NNP O
Dr NNP NNP O
. . . O
Ferreira NNP NNP I-DOCTOR
, , , O
who WP WP O
agrees VBZ VBZ O
with IN IN O
above IN IN O
plan NN NN O
. . . O
   
Leo NNP NNP I-DOCTOR
Villalobos NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
   
PGY-4 NNP NNP O
Urology NNP NNP O
Consult NNP NNP O
Resident NNP NNP O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2095-06-09 NN NN I-DATE
62 CD CD I-AGE
yo NN NN O
wf NN NN O
presenting VBG VBG O
to TO TO O
my PRP$ PRP$ O
office NN NN O
for IN IN O
for IN IN O
FU NNP NNP O
post NN NN O
admission NN NN O
to TO TO O
UGM NNP NNP I-HOSPITAL
for IN IN O
rapid JJ JJ O
AF NNP NNP O
PMHx NNP NNP O
: : : O
htn NN NN O
found VBD VBD O
DM NNP NNP O
2 CD CD O
, , , O
HLP NNP NNP O
hypothyroidism NN NN O
ALL NNP NNP O
PNC NNP NNP O
rash NN NN O
FHx NNP NNP O
CAD NNP NNP O
M NNP NNP O
Ca NNP NNP O
no DT DT O
Endo NNP NNP O
M NNP NNP O
with IN IN O
DM NNP NNP O
SHx NNP NNP O
tobacco NN NN O
neg NN NN O
ETOH NNP NNP O
neg NN NN O
drugs NNS NNS O
neg JJ JJ O
work NN NN O
detective JJ JJ I-PROFESSION
marital JJ JJ O
div NN NN O
1 CD CD O
c SYM SYM O
dom NN NN O
violence NN NN O
neg NN NN O
belts NNS NNS O
no DT DT O
/ NN NN O
advised VBD VBD O
to TO TO O
use VB VB O
seatbelts NNS NNS O
. . . O
   
ROS NNP NNP O
chest NN NN O
pain NN NN O
neg NN NN O
palpitation NN NN O
neg NN NN O
syncope NN NN O
neg NN NN O
dyspnea NN NN O
neg NN NN O
wheezing VBG VBG O
neg NN NN O
cough NN NN O
neg NN NN O
coryza NN NN O
neg NN NN O
nocturia NN NN O
0 CD CD O
menses NNS NNS O
hysterectomy NN NN O
2064 CD CD I-DATE
for IN IN O
endometriosis NN NN O
. . . O
   
diet NN NN O
just RB RB O
joined VBD VBD O
WW NNP NNP I-ORGANIZATION
1200 CD CD O
cal JJ JJ O
ADA NNP NNP O
NAS NNP NNP O
METS NNP NNP O
3 CD CD O
cholesterol NN NN O
PEx NNP NNP O
BP NNP NNP O
160/86 CD CD O
HR NNP NNP O
72 CD CD O
RR NNP NNP O
16 CD CD O
wt NN NN O
236 CD CD O
lbs NN NN O
NEURO NNP NNP O
mental JJ JJ O
status NN NN O
nl NN NN O
DTR NNP NNP O
nl NN NN O
gait NN NN O
nl NN NN O
motor NN NN O
nl NN NN O
sensory NN NN O
nl NN NN O
NECK NNP NNP O
jvd NN NN O
no DT DT O
carotids/bruits NNS NNS O
no DT DT O
nodes NNS NNS O
neg NN NN O
thyroid NN NN O
wnl NN NN O
CHEST NN NN O
wheezes NNS NNS O
no DT DT O
COR NNP NNP O
sounds VBZ VBZ O
S1 NNP NNP O
S2 NNP NNP O
reg NN NN O
ABDOMEN NNP NNP O
soft JJ JJ O
NT NNP NNP O
masses NNS NNS O
no DT DT O
obese NN NN O
no DT DT O
bruits NNS NNS O
EXTREMITIES NNP NNP O
edema NN NN O
no DT DT O
DTR NNP NNP O
normal JJ JJ O
. . . O
   
A+P NNP NNP O
AF NNP NNP O
with IN IN O
RHR NNP NNP O
, , , O
new JJ JJ O
onset NN NN O
; : : O
   
sp JJ JJ O
ECV NNP NNP O
in IN IN O
NSR NNP NNP O
now RB RB O
; : : O
   
P NN NN O
: : : O
same JJ JJ O
meds NNS NNS O
HTN NNP NNP O
BP NNP NNP O
high JJ JJ O
at IN IN O
office NN NN O
, , , O
P NN NN O
: : : O
increase NN NN O
lisinopril NN NN O
20 CD CD O
mg/d NN NN O
. . . O
   
Type NNP NNP O
2 CD CD O
dm NN NN O
on IN IN O
diet NN NN O
and CC CC O
glyburide NN NN O
; : : O
   
poor JJ JJ O
compl NN NN O
with IN IN O
HBGM NNP NNP O
. . . O
   
on IN IN O
WW NNP NNP I-ORGANIZATION
diet NN NN O
1200 CD CD O
cal JJ JJ O
ada NN NN O
nas NN NN O
; : : O
   
P NN NN O
: : : O
continue VB VB O
diet NN NN O
, , , O
glyburide NN NN O
, , , O
check NN NN O
BS NNP NNP O
bid NN NN O
HLP NNP NNP O
on IN IN O
statin,and NN NN O
diet NN NN O
; : : O
   
P NN NN O
: : : O
continue VB VB O
same JJ JJ O
. . . O
   
Hypothyroidism NNP NNP O
clinically RB RB O
euthyr NN NN O
; : : O
   
last JJ JJ O
TSH NNP NNP O
ok JJ JJ O
; : : O
   
P NN NN O
; : : O
   
continue VB VB O
levothyroxine NN NN O
. . . O
   
LVH NNP NNP O
P NN NN O
: : : O
control NN NN O
BP NNP NNP O
. . . O
   
All DT DT O
PNC NNP NNP O
. . . O
   
Medications NNP NNP O
Asa NNP NNP O
( ( ( O
CHILDREN NNP NNP O
81MG CD CD O
TABLET NNP NNP O
Take NNP NNP O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
QD NNP NNP O
, , , O
Take NNP NNP O
as IN IN O
directed VBN VBN O
Dyazide NNP NNP O
50/25 CD CD O
( ( ( O
Take NNP NNP O
1 CD CD O
) ) ) O
PO NNP NNP O
QD NNP NNP O
, , , O
50/25 CD CD O
#90 NN NN O
Capsule NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
Flonase NNP NNP O
( ( ( O
FLUTICASONE NNP NNP O
NASAL NNP NNP O
SPRAY NNP NNP O
) ) ) O
1-2 JJ JJ O
SPRAY NNP NNP O
NAS NNP NNP O
QD NNP NNP O
x SYM SYM O
14 CD CD O
days NNS NNS O
#1 NN NN O
Bottle NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
Glyburide NNP NNP O
5MG CD CD O
TABLET NNP NNP O
Take NNP NNP O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
BID NNP NNP O
15 CD CD O
minutes NNS NNS O
prior RB RB O
to TO TO O
breakfast NN NN O
and CC CC O
supper NN NN O
#60 NN NN O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
Levothyroxine NNP NNP O
SODIUM NNP NNP O
112MCG CD CD O
TABLET NNP NNP O
PO NNP NNP O
QD NNP NNP O
, , , O
Take NNP NNP O
as IN IN O
directed VBN VBN O
#90 NN NN O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
Lisinopril NNP NNP O
10 CD CD O
MG NNP NNP O
( ( ( O
10MG CD CD O
TABLET NNP NNP O
Take NNP NNP O
1 CD CD O
) ) ) O
PO NNP NNP O
QD NNP NNP O
, , , O
Take NNP NNP O
as IN IN O
directed VBN VBN O
#30 NN NN O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
Simvastatin NNP NNP O
40 CD CD O
MG NNP NNP O
( ( ( O
40MG CD CD O
TABLET NNP NNP O
Take NNP NNP O
1 CD CD O
) ) ) O
PO NNP NNP O
QPM NNP NNP O
#90 NN NN O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
Toprol NNP NNP O
XL NNP NNP O
( ( ( O
METOPROLOL NNP NNP O
SUCCINATE NNP NNP O
EXTENDED NNP NNP O
RELEASE NNP NNP O
) ) ) O
100MG CD CD O
TABLET NNP NNP O
CR NNP NNP O
24HR CD CD O
Take NNP NNP O
1.5 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
PO NNP NNP O
QD NNP NNP O
, , , O
Please VB VB O
keep VB VB O
appt NN NN O
for IN IN O
further JJ JJ O
refills NNS NNS O
#135 NN NN O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
Warfarin NNP NNP O
SODIUM NNP NNP O
4 CD CD O
MG NNP NNP O
( ( ( O
1MG CD CD O
TABLET NNP NNP O
Take NNP NNP O
4 CD CD O
) ) ) O
PO NNP NNP O
QPM NNP NNP O
, , , O
Take NNP NNP O
as IN IN O
directed VBN VBN O
per IN IN O
AMA NNP NNP I-HOSPITAL
clinic NN NN O
X. NNP NNP I-DOCTOR
Hayes NNP NNP I-DOCTOR
, , , O
M.D NNP NNP O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2086-04-18 JJ JJ I-DATE
ZASTROW NNP NNP O
, , , O
IRENE NNP NNP I-PATIENT
42521583 CD CD I-MEDICALRECORD
04/18/2086 CD CD I-DATE
Iva NNP NNP I-DOCTOR
Hall NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
   
Internal NNP NNP O
Medicine NNP NNP O
Davis NNP NNP I-HOSPITAL
Monthan NNP NNP I-HOSPITAL
Hospital NNP NNP I-HOSPITAL
39 CD CD I-STREET
Gleneagle NNP NNP I-STREET
Drive NNP NNP I-STREET
Naples NNP NNP I-CITY
, , , O
OK JJ JJ I-STATE
73257 CD CD I-ZIP
Dear RB RB O
Iva NNP NNP I-DOCTOR
: : : O
Irene NNP NNP I-PATIENT
Zastrow NNP NNP I-PATIENT
, , , O
66 CD CD I-AGE
years NNS NNS O
old JJ JJ O
, , , O
returned VBD VBD O
for IN IN O
followup NN NN O
of IN IN O
coronary JJ JJ O
artery NN NN O
disease NN NN O
and CC CC O
non-ST JJ JJ O
segment NN NN O
elevation NN NN O
myocardial NN NN O
infarction NN NN O
that IN IN O
she PRP PRP O
suffered VBD VBD O
in IN IN O
Pennsylvania NNP NNP I-STATE
on IN IN O
10/29/2085 CD CD I-DATE
. . . O
   
At IN IN O
that DT DT O
time NN NN O
, , , O
she PRP PRP O
had VBD VBD O
a DT DT O
drug-eluting JJ JJ O
stent NN NN O
placed VBN VBN O
in IN IN O
her PRP$ PRP$ O
left JJ JJ O
anterior NN NN O
descending VBG VBG O
coronary JJ JJ O
artery NN NN O
. . . O
   
On IN IN O
11/03/2085 CD CD I-DATE
, , , O
she PRP PRP O
had VBD VBD O
repeat NN NN O
percutaneous JJ JJ O
coronary JJ JJ O
intervention NN NN O
because IN IN O
of IN IN O
persistent JJ JJ O
chest NN NN O
pain NN NN O
and CC CC O
required VBD VBD O
an DT DT O
additional JJ JJ O
inflation NN NN O
and CC CC O
reexpansion NN NN O
of IN IN O
the DT DT O
drug-eluting JJ JJ O
stent NN NN O
. . . O
   
On IN IN O
12/07/2085 CD CD I-DATE
, , , O
she PRP PRP O
had VBD VBD O
repeated VBN VBN O
cardiac JJ JJ O
catheterization NN NN O
because IN IN O
of IN IN O
chest NN NN O
pain NN NN O
but CC CC O
no DT DT O
additional JJ JJ O
percutaneous JJ JJ O
coronary JJ JJ O
intervention NN NN O
was VBD VBD O
required VBN VBN O
. . . O
   
She PRP PRP O
feels VBZ VBZ O
that IN IN O
she PRP PRP O
is VBZ VBZ O
having VBG VBG O
less JJR JJR O
chest NN NN O
discomfort NN NN O
as IN IN O
we PRP PRP O
have VBP VBP O
"""" '' '' O
ramped VBN VBN O
up RB RB O
"""" '' '' O
her PRP$ PRP$ O
cardiac JJ JJ O
medications NNS NNS O
. . . O
   
She PRP PRP O
has VBZ VBZ O
no DT DT O
shortness NN NN O
of IN IN O
breath NN NN O
. . . O
   
She PRP PRP O
does VBZ VBZ O
get VB VB O
occasional JJ JJ O
abdominal JJ JJ O
pulsations NNS NNS O
. . . O
   
She PRP PRP O
does VBZ VBZ O
get VB VB O
epigastric JJ JJ O
discomfort NN NN O
. . . O
   
Current NNP NNP O
medications NNS NNS O
include VBP VBP O
ranolazine NN NN O
1000 CD CD O
mg NN NN O
twice RB RB O
daily RB RB O
, , , O
aspirin NN NN O
325 CD CD O
mg NN NN O
once RB RB O
daily RB RB O
, , , O
Plavix NNP NNP O
75 CD CD O
mg NN NN O
once RB RB O
daily RB RB O
, , , O
isosorbide NN NN O
mononitrate NN NN O
30 CD CD O
mg NN NN O
once RB RB O
daily RB RB O
, , , O
Lipitor NNP NNP O
20 CD CD O
mg NN NN O
daily JJ JJ O
, , , O
and CC CC O
insulin NN NN O
. . . O
   
The DT DT O
review NN NN O
of IN IN O
systems NNS NNS O
is VBZ VBZ O
negative JJ JJ O
other JJ JJ O
than IN IN O
the DT DT O
above JJ JJ O
. . . O
   
On IN IN O
physical JJ JJ O
examination NN NN O
, , , O
she PRP PRP O
appears VBZ VBZ O
well RB RB O
. . . O
   
Weight NNP NNP O
165 CD CD O
pounds NNS NNS O
, , , O
blood NN NN O
pressure NN NN O
109/73 CD CD O
mmHg NN NN O
, , , O
heart NN NN O
rate NN NN O
77 CD CD O
and CC CC O
regular JJ JJ O
, , , O
respiratory JJ JJ O
rate NN NN O
   
14 CD CD O
. . . O
HEENT NNP NNP O
: : : O
Normal NNP NNP O
. . . O
   
The DT DT O
neck NN NN O
veins NNS NNS O
are VBP VBP O
not RB RB O
distended VBN VBN O
. . . O
   
The DT DT O
chest NN NN O
is VBZ VBZ O
clear JJ JJ O
. . . O
   
On IN IN O
cardiac JJ JJ O
examination NN NN O
, , , O
she PRP PRP O
has VBZ VBZ O
a DT DT O
regular JJ JJ O
rhythm NN NN O
with IN IN O
a DT DT O
normal JJ JJ O
S1 NNP NNP O
, , , O
single JJ JJ O
S2 NNP NNP O
, , , O
and CC CC O
no DT DT O
murmur NN NN O
, , , O
rub NN NN O
, , , O
or CC CC O
gallop NN NN O
. . . O
   
Abdomen NNP NNP O
has VBZ VBZ O
no DT DT O
masses NNS NNS O
or CC CC O
hepatomegaly NN NN O
. . . O
   
The DT DT O
legs NNS NNS O
have VBP VBP O
no DT DT O
clubbing VBG VBG O
, , , O
cyanosis NNS NNS O
, , , O
or CC CC O
edema NN NN O
. . . O
   
The DT DT O
skin NN NN O
has VBZ VBZ O
no DT DT O
rash NN NN O
. . . O
   
Irene NNP NNP I-PATIENT
Zastrow NNP NNP I-PATIENT
is VBZ VBZ O
improving VBG VBG O
from IN IN O
the DT DT O
clinical JJ JJ O
cardiovascular NN NN O
view NN NN O
point NN NN O
. . . O
   
I PRP PRP O
will MD MD O
obtain VB VB O
an DT DT O
exercise NN NN O
treadmill NN NN O
test NN NN O
using VBG VBG O
the DT DT O
standard JJ JJ O
Bruce NNP NNP O
protocol NN NN O
to TO TO O
obtain VB VB O
additional JJ JJ O
objective NN NN O
data NNS NNS O
. . . O
   
Although IN IN O
theoretically RB RB O
she PRP PRP O
should MD MD O
not RB RB O
have VB VB O
acid NN NN O
secretion NN NN O
due JJ JJ O
to TO TO O
pernicious JJ JJ O
anemia NN NN O
, , , O
I PRP PRP O
do VBP VBP O
suspect VB VB O
she PRP PRP O
has VBZ VBZ O
acid NN NN O
reflux NN NN O
, , , O
and CC CC O
I PRP PRP O
am VBP VBP O
reinstituting VBG VBG O
today NN NN O
Prilosec NNP NNP O
20 CD CD O
mg NN NN O
twice RB RB O
daily JJ JJ O
. . . O
   
I PRP PRP O
am VBP VBP O
prescribing VBG VBG O
physical JJ JJ O
therapy NN NN O
for IN IN O
her PRP$ PRP$ O
"""" '' '' O
stiff NN NN O
neck NN NN O
. . . O
"""" '' '' O
I PRP PRP O
am VBP VBP O
ordering VBG VBG O
an DT DT O
abdominal JJ JJ O
ultrasound NN NN O
to TO TO O
exclude VB VB O
abdominal JJ JJ O
aortic JJ JJ O
aneurysm NN NN O
due JJ JJ O
to TO TO O
her PRP$ PRP$ O
complaint NN NN O
of IN IN O
episodic JJ JJ O
abdominal NN NN O
severe JJ JJ O
pulsations NNS NNS O
. . . O
   
I PRP PRP O
reassured VBD VBD O
her PRP$ PRP$ O
and CC CC O
told VBD VBD O
her PRP$ PRP$ O
she PRP PRP O
is VBZ VBZ O
clinically RB RB O
improving VBG VBG O
. . . O
   
I PRP PRP O
will MD MD O
plan VB VB O
to TO TO O
see VB VB O
her PRP$ PRP$ O
again RB RB O
in IN IN O
about IN IN O
four CD CD O
months NNS NNS O
. . . O
   
Best JJS JJS O
personal JJ JJ O
regards NNS NNS O
. . . O
   
Sincerely NNP NNP O
yours NNS NNS O
, , , O
_____________________________ NN NN O
_ NN NN O
Victor NNP NNP I-DOCTOR
Z. NNP NNP I-DOCTOR
Qazi NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
eScription NN NN O
document:2-2223674 JJ JJ O
IFFocus NNP NNP O
DD NNP NNP O
: : : O
04/18/86 CD CD I-DATE
DT NNP NNP O
: : : O
04/18/86 CD CD I-DATE
DV NNP NNP O
: : : O
04/18/86 CD CD I-DATE
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2086-11-04 JJ JJ I-DATE
CARDIOLOGY NNP NNP O
WETZEL NNP NNP I-HOSPITAL
COUNTY NNP NNP I-HOSPITAL
HOSPITAL NNP NNP I-HOSPITAL
Reason NNP NNP O
for IN IN O
visit NN NN O
: : : O
Mr NNP NNP O
Qazi NNP NNP I-PATIENT
returns NNS NNS O
for IN IN O
followup NN NN O
of IN IN O
his PRP$ PRP$ O
coronary JJ JJ O
disease NN NN O
. . . O
   
Interval NNP NNP O
History NN NN O
: : : O
He PRP PRP O
has VBZ VBZ O
no DT DT O
symptoms NN NN O
of IN IN O
chest NN NN O
pain NN NN O
or CC CC O
pressure NN NN O
, , , O
no DT DT O
palpitations NNS NNS O
dyspnea NN NN O
or CC CC O
orthopnea.He NN NN O
specifically RB RB O
denies VBZ VBZ O
predictable JJ JJ O
exertional JJ JJ O
chest NN NN O
pressure NN NN O
. . . O
   
Thinks VBZ VBZ O
he PRP PRP O
may MD MD O
have VB VB O
tried VBN VBN O
one CD CD O
TNG NNP NNP O
inthe NN NN O
course NN NN O
of IN IN O
the DT DT O
last JJ JJ O
year NN NN O
He PRP PRP O
hasbeen JJ JJ O
active JJ JJ O
physically RB RB O
and CC CC O
does VBZ VBZ O
a DT DT O
considerable JJ JJ O
amount NN NN O
of IN IN O
scuba NN NN O
diving VBG VBG O
in IN IN O
addition NN NN O
to TO TO O
his PRP$ PRP$ O
duties NNS NNS O
at IN IN O
Mason NNP NNP I-ORGANIZATION
House NNP NNP I-ORGANIZATION
. . . O
   
He PRP PRP O
seems VBZ VBZ O
to TO TO O
be VB VB O
putting VBG VBG O
on IN IN O
some DT DT O
weight NN NN O
. . . O
   
He PRP PRP O
's VBZ VBZ O
D/Ced NNP NNP O
his PRP$ PRP$ O
HCTZ NNP NNP O
because IN IN O
of IN IN O
light JJ JJ O
headedene NN NN O
Past NNP NNP O
medical JJ JJ O
history NN NN O
: : : O
   
1 CD CD O
. . . O
CAD NNP NNP O
: : : O
- : : O
Cath NNP NNP O
1/73 CD CD I-DATE
: : : O
80 CD CD O
% NN NN O
prox NN NN O
RCA NNP NNP O
stenosis NN NN O
w NN NN O
/ NN NN O
thrombus NN NN O
, , , O
mod NN NN O
D1 NNP NNP O
stenosis NN NN O
, , , O
clear JJ JJ O
Lcx NNP NNP O
. . . O
   
LV NNP NNP O
gram NN NN O
EF NNP NNP O
69 CD CD O
% NN NN O
, , , O
normal JJ JJ O
motion NN NN O
. . . O
   
- : : O
Cath NNP NNP O
9/81 CD CD I-DATE
: : : O
Critical JJ JJ O
proximal NN NN O
ramus NN NN O
lesion NN NN O
. . . O
   
RCA NNP NNP O
with IN IN O
proximal NN NN O
40 CD CD O
% NN NN O
lesion NN NN O
, , , O
patent NN NN O
RCA NNP NNP O
stent NN NN O
. . . O
   
Patent NNP NNP O
left VBD VBD O
main JJ JJ O
, , , O
apical JJ JJ O
LAD NNP NNP O
with IN IN O
99 CD CD O
% NN NN O
lesion NN NN O
with IN IN O
L-L NNP NNP O
collaterals NNS NNS O
. . . O
   
Cfx NNP NNP O
35 CD CD O
% NN NN O
mid JJ JJ O
lesion NN NN O
. . . O
   
Normal NNP NNP O
LVEDP NNP NNP O
, , , O
no DT DT O
AS NNP NNP O
. . . O
   
LVf NNP NNP O
50-55 NNP NNP O
% NN NN O
. . . O
   
- : : O
Also RB RB O
with IN IN O
h/o NN NN O
RCA NNP NNP O
stent NN NN O
, , , O
unclear JJ JJ O
where WRB WRB O
procedure NN NN O
was VBD VBD O
done VBN VBN O
and CC CC O
patient NN NN O
unable JJ JJ O
to TO TO O
recall VB VB O
details NNS NNS O
. . . O
   
He PRP PRP O
was VBD VBD O
transferred VBN VBN O
in IN IN O
January NNP NNP I-DATE
2083 CD CD I-DATE
to TO TO O
the DT DT O
WCH NNP NNP I-HOSPITAL
after IN IN O
presenting VBG VBG O
to TO TO O
the DT DT O
Florida NNP NNP I-HOSPITAL
Hospital NNP NNP I-HOSPITAL
Orlando NNP NNP I-HOSPITAL
with IN IN O
a DT DT O
non NN NN O
ST NNP NNP O
segment NN NN O
elevation NN NN O
MI NNP NNP O
in IN IN O
the DT DT O
anterolateral JJ JJ O
zone NN NN O
. . . O
   
He PRP PRP O
underwent JJ JJ O
angioplasty NN NN O
and CC CC O
stenting VBG VBG O
of IN IN O
his PRP$ PRP$ O
proximal NN NN O
LAD NNP NNP O
using VBG VBG O
a DT DT O
2.5 CD CD O
x SYM SYM O
13 CD CD O
mm NN NN O
Cypher NNP NNP O
drug NN NN O
eluting VBG VBG O
stent NN NN O
. . . O
   
2 CD CD O
. . . O
HTN NNP NNP O
   
3 CD CD O
. . . O
Hyperlipidemia NNP NNP O
Family NNP NNP O
history NN NN O
: : : O
Mother NNP NNP O
: : : O
deceased VBD VBD O
in IN IN O
60's CD CD I-AGE
with IN IN O
leukemia NN NN O
Father NNP NNP O
: : : O
extensive JJ JJ O
CAD NNP NNP O
, , , O
with IN IN O
first JJ JJ O
MI NNP NNP O
in IN IN O
50's. CD CD O
   
Had NNP NNP O
MI NNP NNP O
x7 NN NN O
, , , O
died VBD VBD O
in IN IN O
70s CD CD I-AGE
. . . O
   
Social NNP NNP O
history NN NN O
: : : O
He PRP PRP O
runs VBZ VBZ O
Mason NNP NNP I-ORGANIZATION
House,a NNP NNP O
halfway NN NN O
home NN NN O
. . . O
   
He PRP PRP O
has VBZ VBZ O
h/o NN NN O
drug/ETOH NN NN O
abuse NN NN O
but CC CC O
clean VB VB O
and CC CC O
sober VB VB O
x SYM SYM O
25 CD CD O
years NNS NNS O
. . . O
   
He PRP PRP O
is VBZ VBZ O
not RB RB O
married VBN VBN O
, , , O
no DT DT O
children NNS NNS O
. . . O
   
Tobacco NNP NNP O
: : : O
+ NN NN O
for IN IN O
40 CD CD O
years NNS NNS O
2-4ppd. JJ JJ O
   
Review NNP NNP O
of IN IN O
systems NNS NNS O
: : : O
There EX EX O
are VBP VBP O
no DT DT O
new JJ JJ O
findings NNS NNS O
except IN IN O
as IN IN O
above IN IN O
. . . O
   
All DT DT O
the DT DT O
following VBG VBG O
a DT DT O
normal JJ JJ O
or CC CC O
negative JJ JJ O
: : : O
General NNP NNP O
: : : O
Unexpected NNP NNP O
weight NN NN O
gain NN NN O
or CC CC O
weight NN NN O
loss NN NN O
, , , O
night NN NN O
sweats NNS NNS O
fever NN NN O
or CC CC O
chills NNS NNS O
. . . O
   
Head NNP NNP O
and CC CC O
neck NN NN O
: : : O
Headaches NNP NNP O
, , , O
dizzy NN NN O
spells NNS NNS O
hoarseness VBP VBP O
. . . O
   
Respiratory NNP NNP O
: : : O
Cough NNP NNP O
wheezing NN NN O
, , , O
sputum NN NN O
production NN NN O
, , , O
hemoptysis NN NN O
. . . O
   
Cardiovascular NNP NNP O
: : : O
See VB VB O
history NN NN O
above IN IN O
. . . O
   
Gastrointestinal NNP NNP O
: : : O
Frequent NNP NNP O
heartburn NN NN O
or CC CC O
indigestion NN NN O
, , , O
difficulty NN NN O
swallowing VBG VBG O
, , , O
nausea NN NN O
vomiting VBG VBG O
jaundice NN NN O
, , , O
unusual JJ JJ O
constipation NN NN O
or CC CC O
diarrhea NN NN O
, , , O
black JJ JJ O
or CC CC O
bloody JJ JJ O
stools NNS NNS O
. . . O
   
Urinary NNP NNP O
: : : O
Frequent NNP NNP O
urination NN NN O
at IN IN O
night NN NN O
, , , O
urinary JJ JJ O
infections NNS NNS O
, , , O
kidney NN NN O
stones NNS NNS O
, , , O
blood NN NN O
in IN IN O
the DT DT O
urine NN NN O
. . . O
   
Neurologic NNP NNP O
: : : O
Transient NNP NNP O
paralysis NN NN O
, , , O
seizures NNS NNS O
, , , O
loss NN NN O
of IN IN O
vision NN NN O
in IN IN O
one CD CD O
eye NN NN O
, , , O
numbness NN NN O
or CC CC O
tingling VBG VBG O
in IN IN O
the DT DT O
feet NNS NNS O
. . . O
   
Hematologic NNP NNP O
: : : O
Easy NNP NNP O
bruising NN NN O
, , , O
recurrent JJ JJ O
infections NNS NNS O
. . . O
   
Skin NNP NNP O
: : : O
New NNP NNP O
rashes NNS NNS O
or CC CC O
eruptions NNS NNS O
, , , O
poor JJ JJ O
healing NN NN O
of IN IN O
foot NN NN O
sores NNS NNS O
, , , O
moles NNS NNS O
changing VBG VBG O
in IN IN O
size NN NN O
or CC CC O
color NN NN O
. . . O
   
Endocrine NNP NNP O
: : : O
Polyuria NNP NNP O
, , , O
polydipsia NN NN O
, , , O
heat NN NN O
or CC CC O
cold JJ JJ O
intolerance NN NN O
. . . O
   
Musculoskeletal NNP NNP O
: : : O
Low NNP NNP O
back RB RB O
pain NN NN O
, , , O
joint JJ JJ O
pains NNS NNS O
, , , O
joint JJ JJ O
swelling VBG VBG O
. . . O
   
Physical JJ JJ O
examination NN NN O
: : : O
- : : O
temp NN NN O
: : : O
afebrile IN IN O
- - - O
Pulse NNP NNP O
: : : O
60 CD CD O
- : : O
resp NN NN O
. . . O
   
rate NN NN O
: : : O
14 CD CD O
- - - O
weight NN NN O
: : : O
190 CD CD O
lbs NN NN O
. . . O
   
- - - O
General NNP NNP O
: : : O
No DT DT O
acute JJ JJ O
distress NN NN O
. . . O
   
Overweight NNP NNP O
- - - O
Skin NNP NNP O
: : : O
No DT DT O
rashes NNS NNS O
, , , O
anicteric JJ JJ O
. . . O
   
- - - O
HEENT NNP NNP O
: : : O
Unremarkable NNP NNP O
- - - O
Neck NNP NNP O
: : : O
Carotids NNP NNP O
2 CD CD O
+ NN NN O
without IN IN O
bruits NNS NNS O
. . . O
   
JVP NNP NNP O
no DT DT O
jugular NN NN O
venous JJ JJ O
distention NN NN O
. . . O
   
- - - O
Chest NN NN O
: : : O
Clear NNP NNP O
to TO TO O
auscultation NN NN O
and CC CC O
percussion NN NN O
. . . O
   
- - - O
Cardiac NNP NNP O
: : : O
Left NNP NNP O
ventricular NN NN O
impulse JJ JJ O
discrete NN NN O
and CC CC O
nondisplaced VBD VBD O
. . . O
   
Regular NNP NNP O
rate NN NN O
and CC CC O
rhythm NN NN O
, , , O
normal JJ JJ O
S1 NNP NNP O
and CC CC O
S2 NNP NNP O
, , , O
with IN IN O
no DT DT O
S3 NNP NNP O
or CC CC O
S4 NNP NNP O
. . . O
   
There EX EX O
were VBD VBD O
no DT DT O
murmurs NNS NNS O
, , , O
clicks NNS NNS O
or CC CC O
rubs NNS NNS O
. . . O
   
- - - O
Abdomen NNP NNP O
: : : O
Obese.Normal NNP NNP O
bowel NN NN O
sounds VBZ VBZ O
, , , O
soft JJ JJ O
and CC CC O
nontender NN NN O
, , , O
with IN IN O
no DT DT O
hepatosplenomegaly NN NN O
or CC CC O
masses NNS NNS O
appreciated VBN VBN O
. . . O
   
- - - O
Extremities NNP NNP O
: : : O
No DT DT O
edema NN NN O
. . . O
   
2 CD CD O
+ NN NN O
PT NNP NNP O
bilateral JJ JJ O
- - - O
BP NNP NNP O
: : : O
140/80 CD CD O
EKG NNP NNP O
: : : O
Normal JJ JJ O
sinus NN NN O
rhythm NN NN O
. . . O
   
There EX EX O
is VBZ VBZ O
incomplete JJ JJ O
right NN NN O
bundle NN NN O
branch NN NN O
block NN NN O
. . . O
   
There EX EX O
are VBP VBP O
very RB RB O
small JJ JJ O
Q-waves NNP NNP O
in IN IN O
leads VBZ VBZ O
V2 NNP NNP O
V3 NNP NNP O
V4 NNP NNP O
and CC CC O
V5 NNP NNP O
The DT DT O
tracing NN NN O
is VBZ VBZ O
unchanged JJ JJ O
Selected NNP NNP O
recent JJ JJ O
labs NNS NNS O
: : : O
He PRP PRP O
has VBZ VBZ O
not RB RB O
had VBN VBN O
any DT DT O
recent JJ JJ O
laboratory NN NN O
studies.Lab NN NN O
requisition NN NN O
provided VBN VBN O
Impression NNP NNP O
: : : O
Assessment NNP NNP O
and CC CC O
plan NN NN O
: : : O
He PRP PRP O
is VBZ VBZ O
doing VBG VBG O
quite RB RB O
well RB RB O
at IN IN O
this DT DT O
point NN NN O
and CC CC O
has VBZ VBZ O
no DT DT O
symptoms NNS NNS O
he PRP PRP O
will MD MD O
remain VB VB O
on IN IN O
his PRP$ PRP$ O
present JJ JJ O
medications NNS NNS O
and CC CC O
I PRP PRP O
will MD MD O
see VB VB O
him PRP PRP O
again RB RB O
in IN IN O
another DT DT O
year NN NN O
Medication NNP NNP O
List NN NN O
   
( ( ( O
confirmed VBN VBN O
) ) ) O
CONFIRMED NNP NNP O
- - - O
bupropion NN NN O
extended VBD VBD O
release NN NN O
150mg CD CD O
po NN NN O
qam NN NN O
- : : O
Ecotrin NNP NNP O
325 CD CD O
mg NN NN O
po NN NN O
daily JJ JJ O
- : : O
nitroglycerin NN NN O
0.4 CD CD O
mg NN NN O
sl NN NN O
every DT DT O
5 CD CD O
minutes NNS NNS O
PRN NNP NNP O
chest NN NN O
pain NN NN O
- : : O
Plavix NNP NNP O
75mg CD CD O
po NN NN O
daily JJ JJ O
- : : O
simvastatin NN NN O
80mg CD CD O
po NN NN O
qpm NN NN O
- : : O
Toprol NNP NNP O
XL NNP NNP O
50 CD CD O
mg NN NN O
mg NN NN O
po NN NN O
bid NN NN O
- : : O
Tricor NNP NNP O
48mg CD CD O
po NN NN O
daily JJ JJ O
------------------------------------------------------------ : : O
STOPPED NNP NNP O
- : : O
hydrochlorothiazide NN NN O
25mg CD CD O
1 CD CD O
po NN NN O
daily JJ JJ O
Quinten NNP NNP I-DOCTOR
B. NN NN I-DOCTOR
Prado NNP NNP I-DOCTOR
, , , O
MD NNP NNP O
pager NN NN O
#82910 NN NN O
Signed NNP NNP O
electronically RB RB O
by IN IN O
Quinten NNP NNP I-DOCTOR
B. NN NN I-DOCTOR
Prado NNP NNP I-DOCTOR
, , , O
MD NNP NNP O
Document NNP NNP O
Status NNP NNP O
: : : O
Final NNP NNP O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2070-10-24 JJ JJ I-DATE
EDVISIT^53954143^Rutledge, NNP NNP O
Xavier^10/24/70^OCASIO, NNP NNP O
WANDA NNP NNP I-DOCTOR
This DT DT O
patient NN NN O
was VBD VBD O
seen VBN VBN O
by IN IN O
myself PRP PRP O
and CC CC O
Dr NNP NNP O
. . . O
Pappas NNP NNP I-DOCTOR
on IN IN O
10/24/2070 CD CD I-DATE
. . . O
   
I PRP PRP O
confirm VBP VBP O
that IN IN O
I PRP PRP O
interviewed VBD VBD O
and CC CC O
examined VBD VBD O
the DT DT O
patient NN NN O
, , , O
reviewed VBD VBD O
the DT DT O
resident NN NN O
's POS POS O
documentation NN NN O
and CC CC O
discussed VBN VBN O
plan NN NN O
of IN IN O
care NN NN O
with IN IN O
the DT DT O
patient NN NN O
. . . O
   
HISTORY NN NN O
OF IN IN O
PRESENT NNP NNP O
ILLNESS NNP NNP O
: : : O
This DT DT O
is VBZ VBZ O
a DT DT O
61-year-old JJ JJ O
gentleman NN NN O
with IN IN O
a DT DT O
history NN NN O
of IN IN O
cadaveric JJ JJ O
renal NN NN O
transplant NN NN O
11 CD CD O
years NNS NNS O
ago RB RB O
with IN IN O
a DT DT O
history NN NN O
of IN IN O
DVT NNP NNP O
, , , O
on IN IN O
Coumadin NNP NNP O
, , , O
diabetes NN NN O
, , , O
chronic JJ JJ O
right NN NN O
lower JJR JJR O
extremity NN NN O
edema NN NN O
, , , O
who WP WP O
comes VBZ VBZ O
in IN IN O
with IN IN O
dysuria NN NN O
and CC CC O
chills NNS NNS O
. . . O
   
He PRP PRP O
had VBD VBD O
no DT DT O
urinary JJ JJ O
output NN NN O
since IN IN O
last JJ JJ O
night NN NN O
. . . O
   
He PRP PRP O
says VBZ VBZ O
his PRP$ PRP$ O
fevers NNS NNS O
started VBD VBD O
this DT DT O
morning NN NN O
above IN IN O
101 CD CD O
. . . O
   
He PRP PRP O
went VBD VBD O
to TO TO O
his PRP$ PRP$ O
PCP NNP NNP O
who WP WP O
sent VBD VBD O
him PRP PRP O
here RB RB O
. . . O
   
He PRP PRP O
denies VBZ VBZ O
any DT DT O
nausea NN NN O
or CC CC O
vomiting VBG VBG O
. . . O
   
He PRP PRP O
has VBZ VBZ O
mild JJ JJ O
lower JJR JJR O
suprapubic NN NN O
abdominal JJ JJ O
pain NN NN O
and CC CC O
some DT DT O
mild JJ JJ O
flank NN NN O
pain NN NN O
. . . O
   
He PRP PRP O
has VBZ VBZ O
had VBN VBN O
some DT DT O
urinary JJ JJ O
frequency NN NN O
. . . O
   
PAST NNP NNP O
MEDICAL NNP NNP O
HISTORY NN NN O
: : : O
Hypertension NNP NNP O
, , , O
diabetes NN NN O
, , , O
gout NN NN O
, , , O
hypercholesterolemia NN NN O
, , , O
end-stage JJ JJ O
renal NN NN O
disease NN NN O
, , , O
status NN NN O
post NN NN O
transplant NN NN O
, , , O
anemia NN NN O
, , , O
BPH NNP NNP O
, , , O
and CC CC O
DVT NNP NNP O
. . . O
   
MEDICATIONS NNP NNP O
: : : O
Please VB VB O
refer VBP VBP O
to TO TO O
the DT DT O
EDUCARE-FARGO NNP NNP I-HOSPITAL
list NN NN O
in IN IN O
the DT DT O
chart NN NN O
. . . O
   
ALLERGIES NNP NNP O
: : : O
He PRP PRP O
has VBZ VBZ O
allergies NNS NNS O
to TO TO O
codeine VB VB O
. . . O
   
SOCIAL NNP NNP O
HISTORY NN NN O
: : : O
He PRP PRP O
is VBZ VBZ O
not RB RB O
a DT DT O
smoker NN NN O
, , , O
drinker NN NN O
, , , O
or CC CC O
drug NN NN O
user NN NN O
. . . O
   
REVIEW NNP NNP O
OF IN IN O
SYSTEMS NNP NNP O
: : : O
As IN IN O
noted VBN VBN O
in IN IN O
the DT DT O
HPI NNP NNP O
, , , O
otherwise RB RB O
negative JJ JJ O
. . . O
   
PHYSICAL JJ JJ O
EXAMINATION NNP NNP O
: : : O
He PRP PRP O
is VBZ VBZ O
an DT DT O
ill-appearing JJ JJ O
gentleman NN NN O
with IN IN O
rigors NNS NNS O
. . . O
   
Vital NNP NNP O
signs NNS NNS O
are VBP VBP O
as IN IN O
noted VBN VBN O
. . . O
   
Head NNP NNP O
, , , O
eyes NNS NNS O
, , , O
ears NNS NNS O
, , , O
nose NN NN O
, , , O
and CC CC O
throat NN NN O
are VBP VBP O
unremarkable JJ JJ O
. . . O
   
Neck NN NN O
is VBZ VBZ O
supple JJ JJ O
. . . O
   
He PRP PRP O
does VBZ VBZ O
have VB VB O
dry VB VB O
mucous JJ JJ O
membranes NNS NNS O
. . . O
   
Chest NN NN O
is VBZ VBZ O
clear JJ JJ O
to TO TO O
auscultation NN NN O
. . . O
   
Heart NNP NNP O
is VBZ VBZ O
slightly RB RB O
tachycardic JJ JJ O
. . . O
   
Abdomen NNP NNP O
has VBZ VBZ O
some DT DT O
suprapubic NN NN O
fullness NN NN O
and CC CC O
tenderness NN NN O
but CC CC O
otherwise RB RB O
is VBZ VBZ O
benign NN NN O
. . . O
   
His PRP$ PRP$ O
rectal JJ JJ O
exam NN NN O
is VBZ VBZ O
heme-positive JJ JJ O
. . . O
   
There EX EX O
is VBZ VBZ O
no DT DT O
prostate NN NN O
tenderness NNS NNS O
. . . O
   
His PRP$ PRP$ O
skin NN NN O
is VBZ VBZ O
warm JJ JJ O
and CC CC O
flushed VBN VBN O
. . . O
   
He PRP PRP O
has VBZ VBZ O
got VBN VBN O
toe NN NN O
amputations NNS NNS O
. . . O
   
Extremities NNS NNS O
are VBP VBP O
otherwise RB RB O
unremarkable JJ JJ O
. . . O
   
Neuro NNP NNP O
exam NN NN O
is VBZ VBZ O
nonfocal JJ JJ O
. . . O
   
LABORATORY NNP NNP O
DATA NNP NNP O
: : : O
He PRP PRP O
has VBZ VBZ O
got VBN VBN O
a DT DT O
white JJ JJ O
count NN NN O
of IN IN O
14 CD CD O
, , , O
hematocrit NN NN O
of IN IN O
35 CD CD O
, , , O
and CC CC O
platelet NN NN O
count NN NN O
139,000 CD CD O
. . . O
   
SMA-7 NNP NNP O
shows VBZ VBZ O
bicarbonate NN NN O
of IN IN O
15 CD CD O
with IN IN O
an DT DT O
anion NN NN O
gap NN NN O
of IN IN O
15 CD CD O
, , , O
and CC CC O
a DT DT O
creatinine NN NN O
of IN IN O
4.7 CD CD O
which WDT WDT O
is VBZ VBZ O
up RB RB O
from IN IN O
his PRP$ PRP$ O
baseline NN NN O
. . . O
   
LFTs NNP NNP O
are VBP VBP O
otherwise RB RB O
unremarkable JJ JJ O
. . . O
   
A DT DT O
chest NN NN O
x-ray NN NN O
was VBD VBD O
unremarkable JJ JJ O
. . . O
   
EMERGENCY NNP NNP O
DEPARTMENT NNP NNP O
COURSE NN NN O
: : : O
He PRP PRP O
did VBD VBD O
get VB VB O
a DT DT O
Foley NNP NNP O
catheter NN NN O
with IN IN O
******** NN NN O
Not RB RB O
reviewed VBN VBN O
by IN IN O
Attending NNP NNP O
Physician NNP NNP O
******** NN NN O
obstruction NN NN O
. . . O
   
He PRP PRP O
was VBD VBD O
given VBN VBN O
levofloxacin NN NN O
and CC CC O
vancomycin NN NN O
. . . O
   
He PRP PRP O
was VBD VBD O
also RB RB O
given VBN VBN O
Tylenol NNP NNP O
. . . O
   
He PRP PRP O
got VBD VBD O
some DT DT O
IV NNP NNP O
fluids NNS NNS O
. . . O
   
He PRP PRP O
had VBD VBD O
an DT DT O
INR NNP NNP O
of IN IN O
2.6 CD CD O
which WDT WDT O
was VBD VBD O
about IN IN O
baseline NN NN O
. . . O
   
The DT DT O
plan NN NN O
was VBD VBD O
to TO TO O
admit VB VB O
him PRP PRP O
to TO TO O
the DT DT O
hospital NN NN O
. . . O
   
Transplant NNP NNP O
was VBD VBD O
subsequently RB RB O
called VBN VBN O
. . . O
   
DIAGNOSIS NNP NNP O
: : : O
Pyelonephritis NNP NNP O
. . . O
   
_____________________________ NN NN O
_ NN NN O
OCASIO NNP NNP O
, , , O
WANDA NNP NNP I-DOCTOR
M.D. NNP NNP O
   
D NNP NNP O
: : : O
10/26/70 CD CD I-DATE
T NN NN O
: : : O
10/26/70 CD CD I-DATE
Dictated NNP NNP O
By IN IN O
: : : O
OCASIO NNP NNP O
, , , O
WANDA NNP NNP I-DOCTOR
eScription NN NN O
document:5-6955464 JJ JJ O
BFFocus NNP NNP O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2096-09-05 JJ JJ I-DATE
Stonybrook NNP NNP I-HOSPITAL
Team NNP NNP O
2 CD CD O
Admission NNP NNP O
Note NNP NNP O
PATIENT NNP NNP O
: : : O
Dalley NNP NNP O
, , , O
Wade NNP NNP I-PATIENT
MRN NNP NNP O
: : : O
5694653 CD CD I-MEDICALRECORD
ADMIT NNP NNP O
DATE NN NN O
: : : O
09/05/96 CD CD I-DATE
PCP NNP NNP O
: : : O
Dr NNP NNP O
. . . O
Xavier NNP NNP I-DOCTOR
CONTACT NNP NNP O
: : : O
Dr NNP NNP O
. . . O
Xavier NNP NNP I-DOCTOR
CC NNP NNP O
: : : O
Diarrhea NNP NNP O
and CC CC O
cough NN NN O
HPI NNP NNP O
: : : O
This DT DT O
is VBZ VBZ O
a DT DT O
61 CD CD I-AGE
y.o NN NN O
male JJ JJ O
w NN NN O
/ NN NN O
h.o NN NN O
of IN IN O
aspiration NN NN O
PNA NNP NNP O
( ( ( O
says VBZ VBZ O
he PRP PRP O
has VBZ VBZ O
had VBN VBN O
many JJ JJ O
bouts NNS NNS O
over IN IN O
past JJ JJ O
2 CD CD O
yrs NNS NNS O
and CC CC O
though IN IN O
due JJ JJ O
to TO TO O
dyskienisa VB VB O
and CC CC O
all DT DT O
studies NNS NNS O
in IN IN O
past JJ JJ O
negative JJ JJ O
) ) ) O
, , , O
PE NNP NNP O
, , , O
Promyel NNP NNP O
. . . O
   
Leukemia NNP NNP O
in IN IN O
remission NN NN O
since IN IN O
2090 CD CD I-DATE
, , , O
TIA NNP NNP O
( ( ( O
on IN IN O
coumadin NN NN O
7.5mg), CD CD O
dyskinesia NN NN O
, , , O
DM2 NNP NNP O
who WP WP O
presents VBZ VBZ O
with IN IN O
non NN NN O
productive JJ JJ O
cough NN NN O
x2 NN NN O
days NNS NNS O
w NN NN O
/ NN NN O
diarrhea NN NN O
and CC CC O
mild JJ JJ O
nausea NN NN O
. . . O
   
Diarrhea NNP NNP O
began VBD VBD O
at IN IN O
1:00am CD CD O
night NN NN O
before IN IN O
he PRP PRP O
was VBD VBD O
seen VBN VBN O
by IN IN O
PCP NNP NNP O
. . . O
   
Had VBD VBD O
hamburger NN NN O
and CC CC O
hot JJ JJ O
dog NN NN O
the DT DT O
night NN NN O
before IN IN O
. . . O
   
No DT DT O
history NN NN O
of IN IN O
C. NN NN O
Diff NNP NNP O
in IN IN O
past JJ JJ O
, , , O
was VBD VBD O
not RB RB O
on IN IN O
abx NN NN O
at IN IN O
the DT DT O
time NN NN O
, , , O
and CC CC O
only RB RB O
sick JJ JJ O
contact NN NN O
was VBD VBD O
wife NN NN O
who WP WP O
had VBD VBD O
bronchitis NNS NNS O
that WDT WDT O
began VBD VBD O
2 CD CD O
days NNS NNS O
prior RB RB O
but CC CC O
she PRP PRP O
did VBD VBD O
not RB RB O
have VB VB O
any DT DT O
GI NNP NNP O
symptoms NNS NNS O
. . . O
   
He PRP PRP O
was VBD VBD O
seen VBN VBN O
by IN IN O
PCP NNP NNP O
dr NN NN O
. . . O
xavier NN NN I-DOCTOR
the DT DT O
next JJ JJ O
day NN NN O
who WP WP O
though IN IN O
he PRP PRP O
had VBD VBD O
a DT DT O
PNA NNP NNP O
and CC CC O
felt VBD VBD O
GI NNP NNP O
symptoms NNS NNS O
were VBD VBD O
food NN NN O
or CC CC O
PNA NNP NNP O
related VBD VBD O
. . . O
   
He PRP PRP O
was VBD VBD O
started VBN VBN O
on IN IN O
augmentin NN NN O
875/125 CD CD O
which WDT WDT O
did VBD VBD O
not RB RB O
help VB VB O
him PRP PRP O
. . . O
   
The DT DT O
diarrhea NN NN O
worsened VBD VBD O
but CC CC O
denied VBD VBD O
BRPR NNP NNP O
, , , O
melena NN NN O
, , , O
Hematoschezia NNP NNP O
. . . O
   
Colonsocopy NNP NNP O
in IN IN O
past JJ JJ O
only RB RB O
significant JJ JJ O
for IN IN O
diverticulosis NN NN O
. . . O
   
He PRP PRP O
took VBD VBD O
his PRP$ PRP$ O
temp NN NN O
at IN IN O
home NN NN O
and CC CC O
was VBD VBD O
102.8 CD CD O
and CC CC O
had VBD VBD O
episode NN NN O
of IN IN O
chills NNS NNS O
but CC CC O
no DT DT O
CP NNP NNP O
, , , O
SOB NNP NNP O
, , , O
Ab NNP NNP O
Pain NN NN O
, , , O
or CC CC O
other JJ JJ O
symptoms NNS NNS O
. . . O
   
No DT DT O
recent JJ JJ O
travel NN NN O
, , , O
sputum NN NN O
was VBD VBD O
clear JJ JJ O
and CC CC O
minimal JJ JJ O
, , , O
and CC CC O
no DT DT O
hemoptysis NN NN O
. . . O
   
No DT DT O
recent JJ JJ O
hospitalizations NNS NNS O
. . . O
   
Was VBD VBD O
advised VBN VBN O
to TO TO O
come VB VB O
to TO TO O
ED NNP NNP O
by IN IN O
PCP NNP NNP O
. . . O
   
ED NNP NNP O
COURSE NN NN O
: : : O
In IN IN O
the DT DT O
ED NNP NNP O
his PRP$ PRP$ O
Vs NNP NNP O
were VBD VBD O
98.8 CD CD O
, , , O
88-109 JJ JJ O
, , , O
112-145/63-77 JJ JJ O
, , , O
22-24 JJ JJ O
, , , O
93 CD CD O
% NN NN O
on IN IN O
2L CD CD O
and CC CC O
94 CD CD O
% NN NN O
on IN IN O
2L CD CD O
. . . O
   
He PRP PRP O
as IN IN O
given VBN VBN O
fluids NNS NNS O
, , , O
Levofloxacin NNP NNP O
750mg CD CD O
x1 NN NN O
, , , O
Mg NNP NNP O
and CC CC O
K NNP NNP O
was VBD VBD O
repleted VBN VBN O
as IN IN O
it PRP PRP O
was VBD VBD O
1.5 CD CD O
and CC CC O
3.3 CD CD O
respectively RB RB O
. . . O
   
CXR NNP NNP O
showed VBD VBD O
LLL NNP NNP O
PNA NNP NNP O
. . . O
   
Bcx NNP NNP O
sent VBD VBD O
. . . O
   
OTHER JJ JJ O
ROS NNP NNP O
: : : O
Negative NNP NNP O
except IN IN O
per IN IN O
history NN NN O
MEDICAL NNP NNP O
HISTORY NN NN O
Promyelocytic NNP NNP O
Leukemia NNP NNP O
in IN IN O
remission NN NN O
for IN IN O
since IN IN O
08/2090 CD CD I-DATE
Dyskinesia NNP NNP O
likely JJ JJ O
2/2 CD CD O
to TO TO O
perphenazine VB VB O
exposure NN NN O
during IN IN O
last JJ JJ O
chemo NN NN O
HTN NNP NNP O
now RB RB O
resolved VBD VBD O
PE NNP NNP O
in IN IN O
3/93 CD CD I-DATE
s/p NN NN O
thyroid NN NN O
nodule NN NN O
removal NN NN O
and CC CC O
was VBD VBD O
on IN IN O
6mo CD CD O
course NN NN O
of IN IN O
coumadin NN NN O
TIA NNP NNP O
at IN IN O
PCH NNP NNP I-HOSPITAL
in IN IN O
7/93 CD CD I-DATE
and CC CC O
on IN IN O
coumadin NN NN O
since IN IN O
. . . O
   
Past JJ JJ O
coag NN NN O
work-up JJ JJ O
negative JJ JJ O
PNA NNP NNP O
- : : O
h/o NN NN O
of IN IN O
aspiration NN NN O
pneumonia NN NN O
DM2 NNP NNP O
s/p NN NN O
subtotal JJ JJ O
thyroidectomy NN NN O
( ( ( O
no DT DT O
cancer NN NN O
) ) ) O
on IN IN O
levo NN NN O
for IN IN O
hypthroid NN NN O
Spondylosis NNP NNP O
DM2 NNP NNP O
Colonoscopy NNP NNP O
in IN IN O
2094 CD CD I-DATE
showed VBD VBD O
divertiuclosis NN NN O
but CC CC O
no DT DT O
polyps NN NN O
Echo NNP NNP O
in IN IN O
2093 CD CD I-DATE
was VBD VBD O
nml NN NN O
w NN NN O
/ NN NN O
EF NNP NNP O
of IN IN O
60 CD CD O
% NN NN O
Barium NNP NNP O
swallow NN NN O
in IN IN O
2093 CD CD I-DATE
normal JJ JJ O
FAMILY NN NN O
HISTORY NN NN O
Mother NNP NNP O
died VBD VBD O
of IN IN O
breast NN NN O
Ca NNP NNP O
at IN IN O
76 CD CD I-AGE
and CC CC O
father NN NN O
of IN IN O
MI NNP NNP O
at IN IN O
67 CD CD I-AGE
2 CD CD O
daughters NNS NNS O
are VBP VBP O
healthy JJ JJ O
SOCIAL NNP NNP O
HISTORY NN NN O
1ppd CD CD O
for IN IN O
15yrs CD CD O
and CC CC O
stopped VBD VBD O
15yrs CD CD O
ago RB RB O
Rare NNP NNP O
EtOH NNP NNP O
Works NNP NNP O
at IN IN O
dupont NN NN I-ORGANIZATION
ALLERGIES NNP NNP O
: : : O
Perphenazine NNP NNP O
, , , O
caused VBD VBD O
dyskinesia NN NN O
MEDICATIONS NNP NNP O
ON IN IN O
ADMISSION NNP NNP O
   
1 CD CD O
. . . O
Acetylsalicylic NNP NNP O
Acid NNP NNP O
( ( ( O
Aspirin NNP NNP O
) ) ) O
PO NNP NNP O
QD NNP NNP O
81MG CD CD O
form NN NN O
: : : O
TABLET NNP NNP O
CHEWABLE NNP NNP O
take VB VB O
: : : O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
   
2 CD CD O
. . . O
Albuterol NNP NNP O
Inhaler NNP NNP O
Hfa NNP NNP O
( ( ( O
Proair NNP NNP O
Hfa NNP NNP O
) ) ) O
2 CD CD O
PUFF NNP NNP O
INH NNP NNP O
QID NNP NNP O
prn NN NN O
wheeze/cough NN NN O
   
3 CD CD O
. . . O
Tessalon NNP NNP O
Perles NNP NNP O
( ( ( O
Benzonatate NNP NNP O
) ) ) O
PO NNP NNP O
TID NNP NNP O
prn NN NN O
cough NN NN O
100MG CD CD O
form NN NN O
: : : O
CAPSULE NNP NNP O
LF NNP NNP O
take VB VB O
: : : O
1 CD CD O
Capsule NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
   
4 CD CD O
. . . O
Clozapine NNP NNP O
125 CD CD O
MG NNP NNP O
PO NNP NNP O
QD NNP NNP O
   
5 CD CD O
. . . O
Levothyroxine NNP NNP O
Sodium NNP NNP O
125 CD CD O
MCG NNP NNP O
PO NNP NNP O
QD NNP NNP O
   
6 CD CD O
. . . O
Metformin NNP NNP O
850 CD CD O
MG NNP NNP O
PO NNP NNP O
TID NNP NNP O
with IN IN O
meals NNS NNS O
   
7 CD CD O
. . . O
Multivitamins NNP NNP O
1 CD CD O
CAPSULE NNP NNP O
PO NNP NNP O
QD NNP NNP O
   
8 CD CD O
. . . O
Prilosec NNP NNP O
( ( ( O
Omeprazole NNP NNP O
) ) ) O
PO NNP NNP O
BID NNP NNP O
20MG CD CD O
form NN NN O
: : : O
CAPSULE NNP NNP O
CR NNP NNP O
take VB VB O
: : : O
1 CD CD O
Capsule NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
   
9 CD CD O
. . . O
Reserpine NNP NNP O
1.5 CD CD O
MG NNP NNP O
PO NNP NNP O
QD NNP NNP O
   
10 CD CD O
. . . O
Simvastatin NNP NNP O
20 CD CD O
MG NNP NNP O
PO NNP NNP O
QHS NNP NNP O
   
11 CD CD O
. . . O
Sitagliptin NNP NNP O
( ( ( O
Januvia NNP NNP O
) ) ) O
100 CD CD O
MG NNP NNP O
PO NNP NNP O
QD NNP NNP O
   
12 CD CD O
. . . O
Venlafaxine NNP NNP O
Extended NNP NNP O
Release NNP NNP O
( ( ( O
Effexor NNP NNP O
Xr NNP NNP O
) ) ) O
150 CD CD O
MG NNP NNP O
PO NNP NNP O
QD NNP NNP O
   
13 CD CD O
. . . O
Warfarin NNP NNP O
Sodium NNP NNP O
7.5 CD CD O
MG NNP NNP O
PO NNP NNP O
QPM NNP NNP O
adjusted VBD VBD O
to TO TO O
maintain VB VB O
INR NNP NNP O
2-3 JJ JJ O
. . . O
   
PHYSICAL JJ JJ O
EXAM NNP NNP O
VITALS NNP NNP O
: : : O
99.1 CD CD O
, , , O
89 CD CD O
, , , O
121/71 CD CD O
, , , O
20 CD CD O
, , , O
96 CD CD O
% NN NN O
on IN IN O
4L CD CD O
Gen NNP NNP O
: : : O
NAD NNP NNP O
, , , O
A&amp NNP NNP O
; : : O
   
Ox3 NNP NNP O
HEENT NNP NNP O
: : : O
oral JJ JJ O
mucosa NN NN O
clear JJ JJ O
, , , O
no DT DT O
lymphadenopathy NN NN O
, , , O
PERLA NNP NNP O
, , , O
EOMI NNP NNP O
Neck NNP NNP O
: : : O
no DT DT O
JVP NNP NNP O
, , , O
no DT DT O
nodules NNS NNS O
, , , O
no DT DT O
tenderness NN NN O
Chest NN NN O
: : : O
Rhonci NNP NNP O
most JJS JJS O
pronounced VBN VBN O
on IN IN O
left VBD VBD O
and CC CC O
e-a JJ JJ O
changes NNS NNS O
on IN IN O
LL NNP NNP O
base NN NN O
CVS NNP NNP O
: : : O
RRR NNP NNP O
, , , O
no DT DT O
MRG NNP NNP O
Ab NNP NNP O
: : : O
soft JJ JJ O
, , , O
NT NNP NNP O
, , , O
ND NNP NNP O
, , , O
No DT DT O
rebound NN NN O
, , , O
no DT DT O
HSM NNP NNP O
Labs NNP NNP O
CBC NNP NNP O
: : : O
8.6/38.5/198 CD CD O
Electrolytes NNP NNP O
: : : O
Na NNP NNP O
137 CD CD O
, , , O
K NNP NNP O
3.3 CD CD O
, , , O
Cl NNP NNP O
103 CD CD O
, , , O
CO2 NNP NNP O
24,5 CD CD O
, , , O
BUN/Cr NNP NNP O
12/1.30 CD CD O
Ca NNP NNP O
9.4 CD CD O
, , , O
Mg NNP NNP O
1.3 CD CD O
, , , O
Phos NNP NNP O
2.5 CD CD O
INR NNP NNP O
3.5 CD CD O
, , , O
UA NNP NNP O
-, : : O
Bcx NNP NNP O
in IN IN O
past JJ JJ O
negative JJ JJ O
Radiology NNP NNP O
CXR NNP NNP O
: : : O
LLL NNP NNP O
PNA NNP NNP O
ASSESSMENT NNP NNP O
& CC CC O
amp NN NN O
; : : O
   
PLAN NNP NNP O
: : : O
This DT DT O
is VBZ VBZ O
a DT DT O
61 CD CD I-AGE
y.o NN NN O
male JJ JJ O
w NN NN O
/ NN NN O
h.o NN NN O
of IN IN O
aspiration NN NN O
PNA NNP NNP O
, , , O
PE NNP NNP O
, , , O
Promyel NNP NNP O
. . . O
   
Leukemia NNP NNP O
in IN IN O
remission NN NN O
since IN IN O
2090 CD CD I-DATE
, , , O
TIA NNP NNP O
( ( ( O
on IN IN O
coumadin NN NN O
7.5mg), CD CD O
dyskinesia NN NN O
, , , O
DM2 NNP NNP O
who WP WP O
presents VBZ VBZ O
with IN IN O
non NN NN O
productive JJ JJ O
cough NN NN O
x2 NN NN O
days NNS NNS O
w NN NN O
/ NN NN O
diarrhea NN NN O
and CC CC O
mild JJ JJ O
nausea NN NN O
. . . O
   
The DT DT O
diarrhea NN NN O
seems VBZ VBZ O
to TO TO O
have VB VB O
been VBN VBN O
present JJ JJ O
before IN IN O
the DT DT O
abx NN NN O
and CC CC O
like IN IN O
worsened VBN VBN O
by IN IN O
it PRP PRP O
. . . O
   
Considering VBG VBG O
its PRP$ PRP$ O
sudden JJ JJ O
nature NN NN O
after IN IN O
meal NN NN O
likely JJ JJ O
a DT DT O
gastroenteritis NN NN O
and CC CC O
it PRP PRP O
is VBZ VBZ O
now RB RB O
worsened VBN VBN O
with IN IN O
augmenting VBG VBG O
. . . O
   
His PRP$ PRP$ O
PNA NNP NNP O
is VBZ VBZ O
either CC CC O
2/2 CD CD O
to TO TO O
aspiration NN NN O
or CC CC O
CAP NNP NNP O
. . . O
   
ISSUE NNP NNP O
#1 NN NN O
: : : O
PNA NNP NNP O
- : : O
will MD MD O
tx VB VB O
with IN IN O
levo NN NN O
750mg CD CD O
po NN NN O
x5-7 JJ JJ O
days NNS NNS O
. . . O
   
Remains NNP NNP O
afebrile NN NN O
and CC CC O
BP NNP NNP O
stable JJ JJ O
- : : O
BCX NNP NNP O
, , , O
UCx NNP NNP O
, , , O
Urine NNP NNP O
Legionella NNP NNP O
ISSUE NNP NNP O
#2 NN NN O
: : : O
Combination NNP NNP O
of IN IN O
gastroenteritis NNS NNS O
and CC CC O
worsened VBN VBN O
by IN IN O
augmentin NN NN O
- : : O
Stop NNP NNP O
augmentin NN NN O
- : : O
Send NNP NNP O
C. NN NN O
Diff NNP NNP O
and CC CC O
dydrate NN NN O
ISSUE NNP NNP O
#3 NN NN O
: : : O
Cr NNP NNP O
increase NN NN O
- : : O
likely JJ JJ O
pre-renal JJ JJ O
and CC CC O
will MD MD O
give VB VB O
fluids NNS NNS O
. . . O
   
If IN IN O
does VBZ VBZ O
not RB RB O
resolve VB VB O
will MD MD O
send VB VB O
urine NN NN O
studies NNS NNS O
ISSUE NNP NNP O
#4 NN NN O
: : : O
DM2 NNP NNP O
- : : O
will MD MD O
hold VB VB O
metformin NN NN O
and CC CC O
juanivia NN NN O
and CC CC O
start VB VB O
sliding VBG VBG O
scale NN NN O
while IN IN O
he PRP PRP O
is VBZ VBZ O
in IN IN O
the DT DT O
hospital NN NN O
ISSUE NNP NNP O
#5 NN NN O
: : : O
h/o NN NN O
of IN IN O
TIA NNP NNP O
and CC CC O
supratherapeutic JJ JJ O
INR NNP NNP O
- : : O
will MD MD O
hold VB VB O
coumadin NN NN O
today NN NN O
and CC CC O
recheck NN NN O
INR NNP NNP O
tommarow NN NN O
and CC CC O
adjust NN NN O
accordingly RB RB O
Otherwise RB RB O
for IN IN O
all DT DT O
other JJ JJ O
PMHx NNP NNP O
issues NNS NNS O
will MD MD O
maintain VB VB O
on IN IN O
home NN NN O
medications NNS NNS O
as IN IN O
they PRP PRP O
are VBP VBP O
not RB RB O
active JJ JJ O
issues NNS NNS O
at IN IN O
this DT DT O
point NN NN O
FEN NNP NNP O
: : : O
Regular NNP NNP O
diabetic JJ JJ O
diet NN NN O
. . . O
   
Fluids NNP NNP O
of IN IN O
NS NNP NNP O
at IN IN O
125cc/hr CD CD O
PROPHYLAXIS NNP NNP O
GI NNP NNP O
: : : O
Colace NNP NNP O
, , , O
senna NN NN O
. . . O
   
Continue NNP NNP O
PPI NNP NNP O
DVT NNP NNP O
: : : O
Already RB RB O
on IN IN O
coumadin NN NN O
CODE NNP NNP O
: : : O
Full NNP NNP O
_________________________________ NN NN O
_ NN NN O
Jonnie NNP NNP I-DOCTOR
Vue NNP NNP I-DOCTOR
, , , O
Pager NNP NNP O
36407 CD CD I-PHONE
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2093-07-10 NN NN I-DATE
Kaur NNP NNP I-DOCTOR
, , , O
Xan NNP NNP I-DOCTOR
G NNP NNP I-DOCTOR
Internal NNP NNP O
Medicine NNP NNP O
, , , O
Buite NNP NNP O
N NNP NNP O
Victor NNP NNP I-HOSPITAL
Cullen NNP NNP I-HOSPITAL
State NNP NNP I-HOSPITAL
Hospital NNP NNP I-HOSPITAL
, , , O
4th JJ JJ O
Hloor NNP NNP O
, , , O
Aoom NNP NNP O
498 CD CD O
Cortland NNP NNP I-CITY
, , , O
IL NNP NNP I-STATE
, , , O
75166-9513 NN NN I-ZIP
RE NNP NNP O
: : : O
CADE NNP NNP I-PATIENT
WOOD NN NN I-PATIENT
07/10/2093 CD CD I-DATE
Admission NNP NNP O
Note VB VB O
BIGELOW NNP NNP O
U NNP NNP O
INTERN NNP NNP O
ADMISSION NNP NNP O
NOTE NNP NNP O
PATIENT NNP NNP O
: : : O
WOOD NN NN I-PATIENT
, , , O
CADE NNP NNP I-PATIENT
MRN NNP NNP O
: : : O
6691247 CD CD I-MEDICALRECORD
ATTENDING NNP NNP O
: : : O
WEISS NNP NNP I-DOCTOR
PCP NNP NNP O
: : : O
OTTO NNP NNP O
, , , O
SUZANNE NNP NNP I-DOCTOR
CODE NNP NNP O
: : : O
FULL NNP NNP O
CC NNP NNP O
: : : O
Testicular NNP NNP O
pain NN NN O
HPI NNP NNP O
: : : O
60 CD CD I-AGE
yo NN NN O
male NN NN O
with IN IN O
a DT DT O
5 CD CD O
day NN NN O
history NN NN O
of IN IN O
sharp JJ JJ O
testicular NN NN O
pain NN NN O
, , , O
increased VBN VBN O
frequency NN NN O
that WDT WDT O
would MD MD O
awake VB VB O
him PRP PRP O
5-6 JJ JJ O
times NNS NNS O
a DT DT O
night NN NN O
, , , O
and CC CC O
burning NN NN O
on IN IN O
urination NN NN O
. . . O
   
Pt NNP NNP O
states NNS NNS O
that IN IN O
the DT DT O
pain NN NN O
would MD MD O
come VB VB O
and CC CC O
go VB VB O
, , , O
and CC CC O
was VBD VBD O
a DT DT O
10/10 CD CD O
. . . O
   
Pt NNP NNP O
began VBD VBD O
getting VBG VBG O
up RP RP O
so RB RB O
many JJ JJ O
times NNS NNS O
at IN IN O
night NN NN O
that IN IN O
he PRP PRP O
decreased VBD VBD O
his PRP$ PRP$ O
PO NNP NNP O
intake NN NN O
to TO TO O
decrease VB VB O
his PRP$ PRP$ O
urination NN NN O
. . . O
   
The DT DT O
pain NN NN O
continued VBD VBD O
to TO TO O
get VB VB O
worse JJR JJR O
and CC CC O
he PRP PRP O
went VBD VBD O
to TO TO O
his PRP$ PRP$ O
PCP NNP NNP O
who WP WP O
sent VBD VBD O
him PRP PRP O
to TO TO O
the DT DT O
EW NNP NNP O
EW NNP NNP O
course NN NN O
: : : O
in IN IN O
the DT DT O
EW NNP NNP O
pt NN NN O
was VBD VBD O
found VBN VBN O
to TO TO O
have VB VB O
a DT DT O
CRE NNP NNP O
of IN IN O
3 CD CD O
, , , O
which WDT WDT O
is VBZ VBZ O
elevated VBN VBN O
from IN IN O
his PRP$ PRP$ O
baseline NN NN O
of IN IN O
1.6 CD CD O
. . . O
   
Pt NNP NNP O
was VBD VBD O
cathed VBN VBN O
and CC CC O
immediately RB RB O
put VB VB O
out IN IN O
300ccs CD CD O
of IN IN O
dark JJ JJ O
yellow JJ JJ O
fluid JJ JJ O
. . . O
   
A DT DT O
UA NNP NNP O
was VBD VBD O
found VBN VBN O
to TO TO O
be VB VB O
positive JJ JJ O
and CC CC O
the DT DT O
pt NN NN O
was VBD VBD O
started VBN VBN O
on IN IN O
Levo NNP NNP O
. . . O
   
On IN IN O
presentation NN NN O
the DT DT O
pt NN NN O
denied VBD VBD O
any DT DT O
blood NN NN O
, , , O
d/c NN NN O
, , , O
penile JJ JJ O
pain NN NN O
, , , O
n/v NN NN O
/ NN NN O
, , , O
f/c NN NN O
or CC CC O
dizziness NN NN O
, , , O
trouble NN NN O
starting VBG VBG O
or CC CC O
stopping VBG VBG O
stream NN NN O
. . . O
   
Pt NNP NNP O
was VBD VBD O
stooling VBG VBG O
normally RB RB O
, , , O
and CC CC O
has VBZ VBZ O
not RB RB O
had VBN VBN O
any DT DT O
sexual JJ JJ O
contacts NNS NNS O
in IN IN O
the DT DT O
last JJ JJ O
10 CD CD O
years NNS NNS O
. . . O
   
ROS NNP NNP O
: : : O
Per IN IN O
HPI NNP NNP O
: : : O
No DT DT O
F/C/NS NNP NNP O
. . . O
   
No DT DT O
CP/Palps NNP NNP O
. . . O
   
No DT DT O
Orthopnea/PND/LE NNP NNP O
edema/Claudication NN NN O
. . . O
   
No DT DT O
SOB/cough/hemoptysis/wheezing/sore NNP NNP O
throat/rash NN NN O
. . . O
   
No DT DT O
hematochezia/melena NN NN O
. . . O
   
No DT DT O
delta NN NN O
MS/LOC NNP NNP O
. . . O
   
No DT DT O
slurring NN NN O
of IN IN O
speech NN NN O
, , , O
unilateral JJ JJ O
weakness NN NN O
. . . O
   
No DT DT O
exposures/ingestions/recent NN NN O
travel NN NN O
. . . O
   
PMH NNP NNP O
: : : O
Hypertension NNP NNP O
Hyperlipidemia NNP NNP O
Colonic NNP NNP O
Poilyp NNP NNP O
/ NN NN O
tubular NN NN O
adenoma NN NN O
( ( ( O
repeat NN NN O
colonoscopy NN NN O
Q3 NN NN O
years NNS NNS O
) ) ) O
LGI NNP NNP O
bleed VBD VBD O
Diverticulitis NNP NNP O
Lymphoma NNP NNP O
B NNP NNP O
cell NN NN O
treated VBD VBD O
w NN NN O
CHOP(2091) NNP NNP O
CHF NNP NNP O
Neuropathy NNP NNP O
( ( ( O
likely JJ JJ O
due JJ JJ O
to TO TO O
vincristine NN NN O
Echo NNP NNP O
8/08 CD CD I-DATE
EF NNP NNP O
46 CD CD O
% NN NN O
Hypo NNP NNP O
kinetic JJ JJ O
LV NNP NNP O
esp NN NN O
. . . O
   
inf/posterior NN NN O
Medications NNP NNP O
on IN IN O
admission NN NN O
( ( ( O
confirmed VBN VBN O
with IN IN O
patient NN NN O
) ) ) O
: : : O
Zestril NNP NNP O
40MG CD CD O
PO NNP NNP O
qd NN NN O
lopressor NN NN O
50MG CD CD O
bid NN NN O
lasix NN NN O
20MG CD CD O
qd NN NN O
Omeprozole NNP NNP O
20mg CD CD O
qd NN NN O
HCTZ NNP NNP O
12.5MG CD CD O
qd NN NN O
. . . O
   
PYRIDOXINE NNP NNP O
HCL NNP NNP O
50MG CD CD O
PO NNP NNP O
qd NN NN O
. . . O
   
Proventil NNP NNP O
MDI NNP NNP O
2PUFFS CD CD O
q4 NN NN O
prn NN NN O
. . . O
   
NIASPAN NNP NNP O
500MG CD CD O
1-2 JJ JJ O
QHS NNP NNP O
. . . O
   
CETAPHIL NNP NNP O
topically RB RB O
prn NN NN O
CLOBETASOL NNP NNP O
PROPIONATE NNP NNP O
0.05 CD CD O
% NN NN O
cream NN NN O
topically RB RB O
bid NN NN O
prn NN NN O
. . . O
   
aspirin NN NN O
81MG CD CD O
qd NN NN O
. . . O
   
ALL NNP NNP O
: : : O
Demerol NNP NNP O
SH NNP NNP O
: : : O
1 CD CD O
pack NN NN O
year NN NN O
history NN NN O
, , , O
- : : O
ETOH NNP NNP O
, , , O
- : : O
Drugs NNS NNS O
FH NNP NNP O
: : : O
Pt NNP NNP O
. . . O
   
Lives NNP NNP O
alone RB RB O
, , , O
no DT DT O
kids NNS NNS O
not RB RB O
married VBN VBN O
Physical JJ JJ O
Exam NNP NNP O
: : : O
V NNP NNP O
: : : O
98.1 CD CD O
, , , O
HR NNP NNP O
75 CD CD O
, , , O
rr NN NN O
18 CD CD O
O2 NNP NNP O
97 CD CD O
% NN NN O
RA NNP NNP O
Gen NNP NNP O
: : : O
AAO NNP NNP O
x3 NN NN O
nad NN NN O
, , , O
obese NN NN O
well RB RB O
appearing VBG VBG O
gentleman NN NN O
HEENT NNP NNP O
: : : O
PERRL NNP NNP O
, , , O
EOMI NNP NNP O
, , , O
sclera NN NN O
anicteric NN NN O
. . . O
   
Neck NN NN O
: : : O
Supple NNP NNP O
, , , O
no DT DT O
thyromegaly NN NN O
, , , O
no DT DT O
carotid NN NN O
bruits NNS NNS O
, , , O
JVP NNP NNP O
Nodes NNS NNS O
: : : O
No DT DT O
cervical JJ JJ O
or CC CC O
supraclavicular JJ JJ O
LAN NNP NNP O
Cor NNP NNP O
: : : O
( ( ( O
difficult JJ JJ O
exam NN NN O
, , , O
pt NN NN O
obease NN NN O
) ) ) O
RRR NNP NNP O
S1 NNP NNP O
, , , O
S2 NNP NNP O
nl NN NN O
. . . O
   
No DT DT O
m/r/g NN NN O
. . . O
   
No DT DT O
S3 NNP NNP O
, , , O
S4 NNP NNP O
Chest NN NN O
: : : O
CTAB NNP NNP O
Abdomen NNP NNP O
: : : O
+ NN NN O
BS NNP NNP O
Soft JJ JJ O
, , , O
ND NNP NNP O
. . . O
   
No DT DT O
HSM NNP NNP O
, , , O
slight JJ JJ O
tenderness NNS NNS O
in IN IN O
super JJ JJ O
pubic NN NN O
region NN NN O
. . . O
   
Midline NNP NNP O
ABD NNP NNP O
scar NN NN O
from IN IN O
SP NNP NNP O
to TO TO O
diaphragm NN NN O
. . . O
   
+ NN NN O
CVA NNP NNP O
tenderness NN NN O
. . . O
   
Genital NNP NNP O
: : : O
Normal JJ JJ O
genital NN NN O
with IN IN O
some DT DT O
tenderness NN NN O
in IN IN O
the DT DT O
epydidimis NN NN O
of IN IN O
the DT DT O
right JJ JJ O
teste NN NN O
. . . O
   
No DT DT O
erthema NN NN O
. . . O
   
Ext NNP NNP O
: : : O
No DT DT O
C/C/E NNP NNP O
. . . O
   
Diminished NNP NNP O
light JJ JJ O
touch NN NN O
sensation NN NN O
on IN IN O
hands NNS NNS O
and CC CC O
feet NNS NNS O
. . . O
   
Varicosities NNS NNS O
on IN IN O
L NNP NNP O
leg NN NN O
, , , O
painful JJ JJ O
to TO TO O
touch VB VB O
. . . O
   
Skin NNP NNP O
: : : O
No DT DT O
rashes NNS NNS O
. . . O
   
Neuro NNP NNP O
: : : O
non-focal JJ JJ O
Labs NNP NNP O
and CC CC O
Studies NNPS NNPS O
: : : O
U/S NNP NNP O
: : : O
IMPRESSION NNP NNP O
: : : O
   
1 CD CD O
. . . O
Normal NNP NNP O
pulsed VBD VBD O
and CC CC O
color NN NN O
Doppler NNP NNP O
flow NN NN O
within IN IN O
both DT DT O
testes NNS NNS O
, , , O
Without IN IN O
evidence NN NN O
for IN IN O
torsion NN NN O
. . . O
   
2 CD CD O
. . . O
Bilateral NNP NNP O
hydroceles NNS NNS O
and CC CC O
a DT DT O
right JJ JJ O
varicocele NN NN O
. . . O
   
3 CD CD O
. . . O
Bilateral NNP NNP O
renal JJ JJ O
cysts NNS NNS O
Test NNP NNP O
Name NN NN O
SMI NNP NNP I-HOSPITAL
07/09/93 CD CD I-DATE
10:21 NN NN O
WBC NNP NNP O
15.5(H) CD CD O
RBC NNP NNP O
4.34(L) CD CD O
HGB NNP NNP O
13.4(L) CD CD O
HCT NNP NNP O
37.0(L) CD CD O
MCV NNP NNP O
85 CD CD O
MCH NNP NNP O
30.9 CD CD O
MCHC NNP NNP O
36.2 CD CD O
PLT NNP NNP O
216 CD CD O
RDW NNP NNP O
14.4 CD CD O
NA NNP NNP O
138 CD CD O
K NNP NNP O
3.8 CD CD O
CL NNP NNP O
109(H) CD CD O
CO2 NNP NNP O
25.1 CD CD O
BUN NNP NNP O
40(H) CD CD O
CRE NNP NNP O
3.0(H) CD CD O
GLU NNP NNP O
136(H) CD CD O
07/09/93 CD CD I-DATE
13:25 CD CD O
UA-GLUC NNP NNP O
Negative NNP NNP O
UA-KET NNP NNP O
Negative NNP NNP O
UA-SPGR NNP NNP O
1.010 CD CD O
UA-BLD NNP NNP O
Negative NNP NNP O
UA-PH NNP NNP O
5.0 CD CD O
UA-ALB NNP NNP O
Negative NNP NNP O
UA-NIT NNP NNP O
Positive NNP NNP O
UA-WBC NNP NNP O
Trace NNP NNP O
A/P NNP NNP O
: : : O
1.ARF: CD CD O
Possible JJ JJ O
Post-obstructive NNP NNP O
. . . O
   
Will NNP NNP O
hold VB VB O
ACE NNP NNP O
, , , O
hctz NN NN O
and CC CC O
lasix NN NN O
. . . O
   
Due NNP NNP O
to TO TO O
possibility NN NN O
of IN IN O
being VBG VBG O
pre-renal JJ JJ O
. . . O
   
Will MD MD O
get VB VB O
a DT DT O
UA NNP NNP O
, , , O
Urine NNP NNP O
sodium NN NN O
and CC CC O
CRE NNP NNP O
and CC CC O
will MD MD O
treat VB VB O
with IN IN O
levofloxicin NN NN O
adjusted VBN VBN O
for IN IN O
renal JJ JJ O
clearance NN NN O
at IN IN O
250mg CD CD O
po NN NN O
qd NN NN O
. . . O
   
Will NNP NNP O
send VB VB O
urine NN NN O
for IN IN O
Culture NNP NNP O
and CC CC O
sensitivities NNS NNS O
. . . O
   
Will NNP NNP O
get VB VB O
urine JJ JJ O
sediment NN NN O
and CC CC O
osmols NNS NNS O
. . . O
   
Will MD MD O
not RB RB O
order VB VB O
PSA NNP NNP O
due JJ JJ O
to TO TO O
instrumentation NN NN O
. . . O
   
Must MD MD O
consider VB VB O
reoccurrence NN NN O
of IN IN O
lymphoma NN NN O
, , , O
new JJ JJ O
malignancy NN NN O
secondary JJ JJ O
to TO TO O
cancer VB VB O
chemo NN NN O
? . . O
   
Will NNP NNP O
consult VB VB O
renal NN NN O
in IN IN O
the DT DT O
AM NNP NNP O
, , , O
and CC CC O
consider VB VB O
getting VBG VBG O
UPEP NNP NNP O
, , , O
BJ NNP NNP O
protein NN NN O
, , , O
ANA NNP NNP O
. . . O
   
Part NN NN O
of IN IN O
ARF NNP NNP O
may MD MD O
be VB VB O
secondary JJ JJ O
to TO TO O
fluid JJ JJ O
restriction NN NN O
by IN IN O
the DT DT O
Pt NNP NNP O
. . . O
   
Will NNP NNP O
give VB VB O
NS NNP NNP O
at IN IN O
a DT DT O
rate NN NN O
of IN IN O
150cc CD CD O
an DT DT O
hour NN NN O
x SYM SYM O
1L CD CD O
. . . O
   
Pt NNP NNP O
with IN IN O
know VBP VBP O
CHF NNP NNP O
will MD MD O
watch VB VB O
fluid NN NN O
. . . O
   
2 CD CD O
. . . O
UTI NNP NNP O
: : : O
pt NN NN O
on IN IN O
Levo NNP NNP O
pending VBG VBG O
culture NN NN O
and CC CC O
sensitivities NNS NNS O
. . . O
   
3 CD CD O
. . . O
Varocele NNP NNP O
: : : O
Will NNP NNP O
consult VB VB O
urology NN NN O
in IN IN O
the DT DT O
Am NNP NNP O
. . . O
   
Pt NNP NNP O
is VBZ VBZ O
currently RB RB O
without IN IN O
pain NN NN O
. . . O
   
4.HTN: CD CD O
Hold VB VB O
all DT DT O
meds NNS NNS O
but CC CC O
lopressor NN NN O
. . . O
   
Will NNP NNP O
watch VB VB O
BP NNP NNP O
. . . O
   
5 CD CD O
. . . O
Prophylaxis NNP NNP O
: : : O
Pt NNP NNP O
ambulatory NN NN O
. . . O
   
Will NNP NNP O
resume VB VB O
GI NNP NNP O
prophylaxis NNS NNS O
. . . O
   
______________________________________________________________________ NN NN O
_ NN NN O
Name NN NN O
: : : O
Xan NNP NNP I-DOCTOR
Kaur NNP NNP I-DOCTOR
M.D. NNP NNP O
   
Pager NNP NNP O
#29827 NN NN O
PGY-1 NNP NNP O
Signed NNP NNP O
electronically RB RB O
by IN IN O
Kaur NNP NNP I-DOCTOR
, , , O
Xan NNP NNP I-DOCTOR
G NNP NNP I-DOCTOR
on IN IN O
Jul NNP NNP I-DATE
10 CD CD O
, , , O
2093 CD CD I-DATE
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2078-06-14 JJ JJ I-DATE
Medicine NNP NNP O
Consult NNP NNP O
Note VB VB O
PATIENT NNP NNP O
: : : O
Carlson NNP NNP I-PATIENT
, , , O
Rebecca NNP NNP I-PATIENT
MRN NNP NNP O
: : : O
9500004 CD CD I-MEDICALRECORD
CONSULT NNP NNP O
DATE NN NN O
: : : O
6/14/78 CD CD I-DATE
ATTENDING NNP NNP O
: : : O
Ila NNP NNP I-DOCTOR
Araujo NNP NNP I-DOCTOR
Code NNP NNP O
status NN NN O
: : : O
presumed VBD VBD O
full JJ JJ O
Source NNP NNP O
: : : O
patient NN NN O
and CC CC O
chart NN NN O
CC NNP NNP O
: : : O
preop NN NN O
risk NN NN O
stratification NN NN O
HPI NNP NNP O
: : : O
Ms NNP NNP O
Carlson NNP NNP I-PATIENT
is VBZ VBZ O
a DT DT O
88F CD CD O
with IN IN O
hx NN NN O
multiple JJ JJ O
falls NNS NNS O
fractures NNS NNS O
including VBG VBG O
hip NN NN O
fx NN NN O
2077 CD CD I-DATE
s/p NN NN O
ORIF NNP NNP O
, , , O
C2 NNP NNP O
dens NNS NNS O
fx NN NN O
, , , O
pubic NN NN O
rami NN NN O
fx NN NN O
, , , O
past JJ JJ O
periop NN NN O
DVT NNP NNP O
( ( ( O
age NN NN O
40s CD CD I-AGE
) ) ) O
, , , O
also RB RB O
HTN NNP NNP O
, , , O
diet-controlled JJ JJ O
DM NNP NNP O
, , , O
dx NN NN O
NMS NNP NNP O
in IN IN O
setting VBG VBG O
of IN IN O
postop NN NN O
haldol NN NN O
in IN IN O
2077 CD CD I-DATE
, , , O
p/w NN NN O
another DT DT O
fall NN NN O
this DT DT O
AM NNP NNP O
at IN IN O
her PRP$ PRP$ O
SNF NNP NNP O
. . . O
   
She PRP PRP O
was VBD VBD O
in IN IN O
the DT DT O
kitchen NN NN O
washing VBG VBG O
dishes NNS NNS O
, , , O
when WRB WRB O
she PRP PRP O
fell VBD VBD O
. . . O
   
She PRP PRP O
is VBZ VBZ O
not RB RB O
able JJ JJ O
to TO TO O
tell VB VB O
me PRP PRP O
exactly RB RB O
what WP WP O
happened VBD VBD O
, , , O
but CC CC O
denies NNS NNS O
that WDT WDT O
CP NNP NNP O
, , , O
SOB NNP NNP O
, , , O
or CC CC O
dizziness/lightheadedness NN NN O
played VBD VBD O
a DT DT O
role NN NN O
. . . O
   
Pt NNP NNP O
is VBZ VBZ O
currently RB RB O
s/p VBN VBN O
morphine NN NN O
, , , O
and CC CC O
per IN IN O
her PRP$ PRP$ O
daughter NN NN O
is VBZ VBZ O
more RBR RBR O
confused JJ JJ O
and CC CC O
sleepy JJ JJ O
than IN IN O
usual JJ JJ O
. . . O
   
But CC CC O
even RB RB O
at IN IN O
a DT DT O
baseline NN NN O
, , , O
daughter NN NN O
states NNS NNS O
that IN IN O
pt NN NN O
has VBZ VBZ O
poor JJ JJ O
short-term JJ JJ O
memory.ROS NN NN O
& CC CC O
#8211 NN NN O
; : : O
   
pt NN NN O
denies NNS NNS O
CP NNP NNP O
, , , O
SOB NNP NNP O
, , , O
DOE NNP NNP O
. . . O
   
Family NNP NNP O
has VBZ VBZ O
not RB RB O
heard VBN VBN O
her PRP$ PRP$ O
complain NN NN O
of IN IN O
these DT DT O
. . . O
   
CARDIOLOGY NNP NNP O
STUDIES:TTE NNP NNP O
11/77 CD CD I-DATE
: : : O
EF NNP NNP O
78 CD CD O
% NN NN O
no DT DT O
WMA NNP NNP O
. . . O
   
Mod NNP NNP O
to TO TO O
severe VB VB O
TRPMH NNP NNP O
: : : O
NMS NNP NNP O
vs NNS NNS O
serotonin NN NN O
syndrome NN NN O
in IN IN O
setting VBG VBG O
of IN IN O
last JJ JJ O
hospitalization NN NN O
for IN IN O
last JJ JJ O
hip NN NN O
surgery NN NN O
Mild NNP NNP O
dementia NN NN O
Hx NNP NNP O
falls VBZ VBZ O
s/p JJ JJ O
hysterectomy NN NN O
HTNDM NNP NNP O
h/o NN NN O
DVT NNP NNP O
age NN NN O
~ NN NN O
40s CD CD I-AGE
with IN IN O
subsequent JJ JJ O
chronic JJ JJ O
LLE NNP NNP O
venous JJ JJ O
stasis NN NN O
Dyslipidemia NNP NNP O
Hypothyroidism NNP NNP O
c2 NN NN O
dens NNS NNS O
type NN NN O
III NNP NNP O
fracture NN NN O
11/77R CD CD O
superior/inferior NN NN O
pubic NN NN O
rami NN NN O
fractures NNS NNS O
11/77left CD CD O
hemiarthroplasty NN NN O
- : : O
7/77 CD CD I-DATE
ALLERGIES NNP NNP O
: : : O
HCTZ NNP NNP O
, , , O
& CC CC O
#8216 NN NN O
; : : O
   
antipsychotic JJ JJ O
drug&#8217; NN NN O
   
causing VBG VBG O
fever NN NN O
, , , O
rigidity NN NN O
, , , O
dystonia NN NN O
at IN IN O
last JJ JJ O
hospitalization NN NN O
MEDICATIONS NNP NNP O
ON IN IN O
ADMISSION NNP NNP O
Atenolol NNP NNP O
75Atorvastatin CD CD O
10ASA CD CD O
81Detrol CD CD O
LA NNP NNP O
2Levothyroxine CD CD O
25 CD CD O
mcgSenna NN NN O
2 CD CD O
tabs NNS NNS O
dailyColace NN NN O
100 CD CD O
tidNamenda NN NN O
5 CD CD O
bidBID NN NN O
fingersticksNorvasc NN NN O
5Lisinopril CD CD O
10Buspar CD CD O
5 CD CD O
mg NN NN O
bidBoost/ensure NN NN O
supplements NNS NNS O
tidFerrous JJ JJ O
sulfate NN NN O
325 CD CD O
mg NN NN O
bidKlonopin NN NN O
0.25 CD CD O
mg NN NN O
bidMagnexium NN NN O
oxide NN NN O
800 CD CD O
tidTylenol NN NN O
prnCa+D NN NN O
250/125 CD CD O
daily1000mg NN NN O
illegible JJ JJ O
med JJ JJ O
po NN NN O
qAMCURRENT NN NN O
MEDICATIONSMorphine NNP NNP O
2mg CD CD O
IV NNP NNP O
x SYM SYM O
2NS CD CD O
@75cc/hrFAMILY NN NN O
HISTORY NN NN O
: : : O
deferredSOCIAL NN NN O
HISTORY NN NN O
: : : O
lived VBD VBD O
alone RB RB O
, , , O
until IN IN O
started VBD VBD O
having VBG VBG O
more JJR JJR O
frequent JJ JJ O
falls VBZ VBZ O
last JJ JJ O
year NN NN O
, , , O
has VBZ VBZ O
most RBS RBS O
recently RB RB O
been VBN VBN O
living VBG VBG O
in IN IN O
Parkview NNP NNP I-HOSPITAL
Haven NNP NNP I-HOSPITAL
. . . O
   
Has VBZ VBZ O
daughter NN NN O
and CC CC O
son NN NN O
who WP WP O
are VBP VBP O
involved VBN VBN O
in IN IN O
her PRP$ PRP$ O
care NN NN O
. . . O
   
They PRP PRP O
had VBD VBD O
been VBN VBN O
planning VBG VBG O
to TO TO O
have VB VB O
her PRP$ PRP$ O
come VB VB O
back RB RB O
home NN NN O
with IN IN O
24h CD CD O
care NN NN O
, , , O
when WRB WRB O
this DT DT O
latest JJS JJS O
fall NN NN O
occurs VBZ VBZ O
. . . O
   
Pt NNP NNP O
usually RB RB O
walks VBZ VBZ O
with IN IN O
her PRP$ PRP$ O
walker.PHYSICAL NN NN O
EXAMVITALS NNP NNP O
: : : O
T NN NN O
97.6 CD CD O
HR NNP NNP O
68-80 JJ JJ O
BP NNP NNP O
137-179/60-75 JJ JJ O
RR NNP NNP O
14-24 JJ JJ O
O2Sat NNP NNP O
: : : O
96-100 CD CD O
% NN NN O
RAGEN NNP NNP O
NAD NNP NNP O
, , , O
sleepy JJ JJ O
but CC CC O
arousableHEENT NN NN O
MMM NNP NNP O
, , , O
no DT DT O
scleral NN NN O
icterus NN NN O
, , , O
no DT DT O
pale JJ JJ O
conjunctivaNECK NN NN O
supple NN NN O
, , , O
no DT DT O
thyromegaly NN NN O
, , , O
no DT DT O
cervical JJ JJ O
LANHeart NNP NNP O
: : : O
irregularly RB RB O
irregular JJ JJ O
, , , O
tachy NN NN O
, , , O
no DT DT O
murmurs NNS NNS O
noted VBD VBD O
, , , O
no DT DT O
JVDLUNG NNP NNP O
: : : O
clear JJ JJ O
anteriorly RB RB O
; : : O
   
no DT DT O
increased JJ JJ O
work NN NN O
of IN IN O
breathingABD NN NN O
: : : O
Soft JJ JJ O
, , , O
NT NNP NNP O
, , , O
ND NNP NNP O
, , , O
+ NN NN O
BS NNP NNP O
. . . O
   
No DT DT O
masses NNS NNS O
, , , O
rebound/guarding.EXT NN NN O
: : : O
wwp NN NN O
bilat NN NN O
, , , O
left VBD VBD O
leg NN NN O
with IN IN O
chronic JJ JJ O
venous JJ JJ O
stasis NNS NNS O
and CC CC O
2 CD CD O
+ NN NN O
pitting VBG VBG O
edema NN NN O
that IN IN O
daughter NN NN O
says VBZ VBZ O
is VBZ VBZ O
chronicNEURO JJ JJ O
: : : O
alert NN NN O
to TO TO O
hospital NN NN O
, , , O
family NN NN O
members NNS NNS O
, , , O
responds VBZ VBZ O
to TO TO O
questions NNS NNS O
; : : O
   
when WRB WRB O
asked VBD VBD O
where WRB WRB O
she PRP PRP O
lives VBZ VBZ O
, , , O
she PRP PRP O
gave VBD VBD O
her PRP$ PRP$ O
home NN NN O
address NN NN O
although IN IN O
she&#8217; NN NN O
   
s VBZ VBZ O
been VBN VBN O
living VBG VBG O
at IN IN O
parkview NN NN I-HOSPITAL
haven NN NN I-HOSPITAL
most RBS RBS O
recently.LABS JJ JJ O
Sodium NNP NNP O
138 CD CD O
135-145 JJ JJ O
mmol/L NN NN O
06/14/78 CD CD I-DATE
10:32 CD CD O
146(H) CD CD O
11/18/77 CD CD I-DATE
04:50 CD CD O
Potassium NNP NNP O
3.7 CD CD O
3.4-4.8 NN NN O
mmol/L NN NN O
06/14/78 CD CD I-DATE
10:32 CD CD O
3.3(L) CD CD O
11/17/77 CD CD I-DATE
16:42 CD CD O
Chloride NNP NNP O
102 CD CD O
100-108 JJ JJ O
mmol/L NN NN O
06/14/78 CD CD I-DATE
10:32 CD CD O
109(H) CD CD O
11/18/77 CD CD I-DATE
04:50 CD CD O
Carbon NNP NNP O
Dioxide NNP NNP O
24.7 CD CD O
23.0-31.9 JJ JJ O
mmol/L NN NN O
06/14/78 CD CD I-DATE
10:32 CD CD O
33.7(H) CD CD O
07/13/77 CD CD I-DATE
21:57 CD CD O
BUN NNP NNP O
23 CD CD O
8-25 JJ JJ O
mg/dl NN NN O
06/14/78 CD CD I-DATE
10:32 CD CD O
26(H) CD CD O
11/17/77 CD CD I-DATE
00:56 CD CD O
Creatinine NNP NNP O
0.81 CD CD O
0.60-1.50 NN NN O
mg/dl NN NN O
06/14/78 CD CD I-DATE
10:32 CD CD O
GFR NNP NNP O
   
( ( ( O
estimated VBN VBN O
) ) ) O
& CC CC O
gt NN NN O
; : : O
   
60 CD CD O
mL/min/1.73m2 NN NN O
06/14/78 CD CD I-DATE
10:32 CD CD O
Glucose NNP NNP O
142H CD CD O
70-110 NN NN O
mg/dl NN NN O
06/14/78 CD CD I-DATE
10:32 CD CD O
142(H) CD CD O
06/14/78 CD CD I-DATE
10:32 CD CD O
Anion NNP NNP O
Gap NNP NNP O
11 CD CD O
3-15 NN NN O
mmol/L NN NN O
06/14/78 CD CD I-DATE
10:32 CD CD O
16(H) CD CD O
11/16/77 CD CD I-DATE
15:01 CD CD O
Calcium NNP NNP O
9.2 CD CD O
8.5-10.5 JJ JJ O
mg/dl NN NN O
06/14/78 CD CD I-DATE
10:32 CD CD O
8.3(L) CD CD O
11/16/77 CD CD I-DATE
14:57 CD CD O
Phosphorus NNP NNP O
2.2L CD CD O
2.6-4.5 JJ JJ O
mg/dl NN NN O
06/14/78 CD CD I-DATE
10:32 CD CD O
2.2(L) CD CD O
06/14/78 CD CD I-DATE
10:32 CD CD O
Magnesium NNP NNP O
1.7 CD CD O
1.4-2.0 NN NN O
meq/L NN NN O
06/14/78 CD CD I-DATE
10:32 CD CD O
1.3(L) CD CD O
11/13/77 CD CD I-DATE
22:00 CD CD O
Cardiac NNP NNP O
Tests NNP NNP O
CK NNP NNP O
58 CD CD O
40-150 JJ JJ O
U/L NNP NNP O
06/14/78 CD CD I-DATE
10:32 CD CD O
198(H) CD CD O
11/19/77 CD CD I-DATE
05:36 CD CD O
CK-MB NNP NNP O
NEGATIVE NNP NNP O
NEG NNP NNP O
06/14/78 CD CD I-DATE
10:56 NN NN O
7.6(H) CD CD O
11/16/77 CD CD I-DATE
20:15 CD CD O
Troponin-I NNP NNP O
NEGATIVE NNP NNP O
NEG NNP NNP O
06/14/78 CD CD I-DATE
10:56 CD CD O
WBC NNP NNP O
8.9 CD CD O
4.5-11.0 JJ JJ O
th/cmm NN NN O
06/14/78 CD CD I-DATE
10:17 CD CD O
14.1(H) CD CD O
11/21/77 CD CD I-DATE
11:38 CD CD O
HCT NNP NNP O
30.6L CD CD O
36.0-46.0 CD CD O
% NN NN O
06/14/78 CD CD I-DATE
10:17 CD CD O
30.6(L) CD CD O
06/14/78 CD CD I-DATE
10:17 CD CD O
PLT NNP NNP O
246 CD CD O
150-400 JJ JJ O
th/cumm NN NN O
06/14/78 CD CD I-DATE
10:17 CD CD O
438(H) CD CD O
11/22/77 CD CD I-DATE
12:09 CD CD O
PT-INR NNP NNP O
1.0 CD CD O
06/14/78 NN NN I-DATE
10:32Urinalysis CD CD O
6/14/78 CD CD I-DATE
: : : O
2 CD CD O
+ NN NN O
ketone NN NN O
, , , O
2 CD CD O
+ NN NN O
bld NN NN O
, , , O
nitrite NN NN O
pos NN NN O
, , , O
0-2 JJ JJ O
WBC NNP NNP O
, , , O
0-2 JJ JJ O
RBC NNP NNP O
. . . O
   
& CC CC O
#8226 NN NN O
; : : O
   
Radiology NNP NNP O
: : : O
6/14/78 CD CD I-DATE
: : : O
Cspine NNP NNP O
CT NNP NNP O
: : : O
No DT DT O
acute JJ JJ O
displaced JJ JJ O
fracture NN NN O
. . . O
   
Deformity NNP NNP O
of IN IN O
the DT DT O
odontoid NN NN O
process NN NN O
, , , O
consistent JJ JJ O
with IN IN O
old JJ JJ O
odontoid NN NN O
process NN NN O
fracture NN NN O
. . . O
   
Multilevel NNP NNP O
degenerative JJ JJ O
changes NNS NNS O
as IN IN O
described VBN VBN O
above IN IN O
. . . O
   
Indeterminate NNP NNP O
5 CD CD O
mm NN NN O
nodule NN NN O
noted VBD VBD O
in IN IN O
the DT DT O
right NN NN O
lung NN NN O
apex NN NN O
, , , O
stable JJ JJ O
from IN IN O
the DT DT O
prior JJ JJ O
study NN NN O
dated VBD VBD O
11/13/2077.6/14/78 CD CD O
: : : O
CT NNP NNP O
head NN NN O
No DT DT O
acute JJ JJ O
intracranial JJ JJ O
abnormality NN NN O
identified VBN VBN O
. . . O
   
Nonspecific NNP NNP O
white JJ JJ O
matter NN NN O
changes NNS NNS O
, , , O
most RBS RBS O
likely JJ JJ O
representing VBG VBG O
chronic JJ JJ O
small JJ JJ O
vessel NN NN O
change NN NN O
in IN IN O
this DT DT O
age NN NN O
group.6/14/78: NN NN O
Cspine NNP NNP O
XR NNP NNP O
: : : O
No DT DT O
evidence NN NN O
of IN IN O
displaced VBN VBN O
fracture NN NN O
or CC CC O
malalignment.6/14/78: NN NN O
LS NNP NNP O
spine NN NN O
XR NNP NNP O
: : : O
No DT DT O
displaced JJ JJ O
lumbar NN NN O
spine NN NN O
fracture.6/14/78: NN NN O
ankle NN NN O
XR NNP NNP O
: : : O
   
1 CD CD O
. . . O
Posterior NNP NNP O
talus NN NN O
fracture NN NN O
. . . O
   
2 CD CD O
. . . O
Possible JJ JJ O
fractures NNS NNS O
of IN IN O
the DT DT O
posterior NN NN O
malleolus NN NN O
, , , O
distal JJ JJ O
fibula NN NN O
. . . O
   
3 CD CD O
. . . O
Subtalar NNP NNP O
subluxation NN NN O
. . . O
   
4 CD CD O
. . . O
Given NNP NNP O
the DT DT O
severe JJ JJ O
osteopenia NN NN O
, , , O
suggest VBP VBP O
CT NNP NNP O
scan VB VB O
for IN IN O
more RBR RBR O
definitive JJ JJ O
evaluation.6/14/78: NN NN O
CXR NNP NNP O
: : : O
No DT DT O
evidence NN NN O
of IN IN O
traumatic JJ JJ O
injury NN NN O
in IN IN O
the DT DT O
chest6/14/78: NN NN O
hip/pelvis NN NN O
XR NNP NNP O
: : : O
   
1 CD CD O
. . . O
Acute JJ JJ O
, , , O
comminuted JJ JJ O
right NN NN O
intertrochanteric JJ JJ O
hip NN NN O
fracture NN NN O
. . . O
   
2 CD CD O
. . . O
Left NNP NNP O
hip NN NN O
hardware NN NN O
, , , O
appears VBZ VBZ O
intact JJ JJ O
. . . O
   
3 CD CD O
. . . O
Healed NNP NNP O
pubic NN NN O
ramus NN NN O
fractures.6/14/78: NN NN O
ankle NN NN O
CT NNP NNP O
: : : O
No DT DT O
evidence NN NN O
of IN IN O
talar NN NN O
fracture NN NN O
or CC CC O
any DT DT O
other JJ JJ O
acute JJ JJ O
displaced JJ JJ O
fracture NN NN O
. . . O
   
There EX EX O
is VBZ VBZ O
patchy NN NN O
osteopenia NN NN O
. . . O
   
& CC CC O
#8226 NN NN O
; : : O
   
EKG NNP NNP O
: : : O
6/14/78 CD CD I-DATE
at IN IN O
10:25AM: CD CD O
sinus NN NN O
~@ NN NN O
71 CD CD O
, , , O
left VBD VBD O
axis NNS NNS O
, , , O
no DT DT O
ST NNP NNP O
changes.6/14/78 NN NN O
at IN IN O
4:14PM: CD CD O
AF NNP NNP O
with IN IN O
RVR NNP NNP O
~ NN NN O
141 CD CD O
still RB RB O
no DT DT O
ischemic JJ JJ O
ST NNP NNP O
changes.ASSESSMENT NN NN O
& CC CC O
amp NN NN O
; : : O
   
PLAN88F NNP NNP O
with IN IN O
dementia NN NN O
, , , O
HTN NNP NNP O
, , , O
hx NN NN O
multiple JJ JJ O
falls NNS NNS O
, , , O
s/p NN NN O
hip NN NN O
fx NN NN O
2077 CD CD I-DATE
, , , O
hx NN NN O
likely JJ JJ O
NMS NNP NNP O
in IN IN O
setting VBG VBG O
of IN IN O
haldol NN NN O
, , , O
p/w NN NN O
another DT DT O
fall NN NN O
, , , O
likely JJ JJ O
mechanical JJ JJ O
, , , O
and CC CC O
hip NN NN O
fx NN NN O
. . . O
   
We PRP PRP O
are VBP VBP O
asked VBN VBN O
to TO TO O
consult VB VB O
for IN IN O
periop NN NN O
risk NN NN O
eval NN NN O
prior RB RB O
to TO TO O
ORIF.1. NNP NNP O
   
Periop NNP NNP O
cardiac JJ JJ O
risk NN NN O
: : : O
Pt&#8217; NNP NNP O
   
s VBZ VBZ O
RCRI NNP NNP O
is VBZ VBZ O
zero CD CD O
, , , O
and CC CC O
has VBZ VBZ O
no DT DT O
Hx NNP NNP O
CAD NNP NNP O
. . . O
   
Now RB RB O
, , , O
as IN IN O
she PRP PRP O
as IN IN O
in IN IN O
RVR NNP NNP O
to TO TO O
140s NN NN O
, , , O
she PRP PRP O
has VBZ VBZ O
no DT DT O
ST NNP NNP O
depressions NNS NNS O
. . . O
   
Pt NNP NNP O
does VBZ VBZ O
not RB RB O
need VB VB O
periop NN NN O
beta NN NN O
blockade NN NN O
from IN IN O
a DT DT O
risk NN NN O
perspective NN NN O
, , , O
but CC CC O
should MD MD O
continue VB VB O
on IN IN O
home NN NN O
beta NN NN O
blockade NN NN O
given VBN VBN O
her PRP$ PRP$ O
HTN NNP NNP O
and CC CC O
now RB RB O
new JJ JJ O
AF.2. NNP NNP O
   
new JJ JJ O
AF NNP NNP O
: : : O
pt NN NN O
is VBZ VBZ O
now RB RB O
in IN IN O
new JJ JJ O
AF/RVR NNP NNP O
, , , O
asymptomatic JJ JJ O
, , , O
after IN IN O
missing VBG VBG O
her PRP$ PRP$ O
AM NNP NNP O
atenolol NN NN O
. . . O
   
She PRP PRP O
is VBZ VBZ O
getting VBG VBG O
5mg CD CD O
IV NNP NNP O
lopressor NN NN O
plus CC CC O
25 CD CD O
mg NN NN O
po NN NN O
lopressor NN NN O
in IN IN O
the DT DT O
ED NNP NNP O
, , , O
hopefully RB RB O
this DT DT O
will MD MD O
provide VB VB O
some DT DT O
rate NN NN O
control NN NN O
. . . O
   
She PRP PRP O
should MD MD O
continue VB VB O
on IN IN O
BB NNP NNP O
. . . O
   
- : : O
try NN NN O
37.5 CD CD O
mg NN NN O
lopressor NN NN O
q8h NN NN O
; : : O
   
hold VB VB O
for IN IN O
HR NNP NNP O
& CC CC O
lt NN NN O
; : : O
   
60 CD CD O
, , , O
SBP NNP NNP O
& CC CC O
lt NN NN O
; : : O
   
100 CD CD O
- : : O
it PRP PRP O
is VBZ VBZ O
possible JJ JJ O
that IN IN O
arrhythmia NN NN O
may MD MD O
precipitate NN NN O
falls VBZ VBZ O
. . . O
   
She PRP PRP O
may MD MD O
benefit VB VB O
from IN IN O
a DT DT O
holter NN NN O
monitor NN NN O
as IN IN O
an DT DT O
outpatient NN NN O
, , , O
to TO TO O
see VB VB O
whether IN IN O
she PRP PRP O
is VBZ VBZ O
frequently RB RB O
in IN IN O
AF NNP NNP O
, , , O
or CC CC O
whether IN IN O
this DT DT O
was VBD VBD O
precipitated VBN VBN O
by IN IN O
illness NN NN O
and CC CC O
missing VBG VBG O
BB NNP NNP O
( ( ( O
more RBR RBR O
likely JJ JJ O
) ) ) O
. . . O
   
- - - O
keep VB VB O
pt NN NN O
on IN IN O
tele NN NN O
while IN IN O
in IN IN O
house3 NN NN O
. . . O
   
Hx NNP NNP O
NMS/serotonin NNP NNP O
syndrome NN NN O
: : : O
pt NN NN O
carries VBZ VBZ O
a DT DT O
dx NN NN O
of IN IN O
NMS NNP NNP O
from IN IN O
prior RB RB O
med VBD VBD O
use NN NN O
the DT DT O
last JJ JJ O
time NN NN O
she PRP PRP O
was VBD VBD O
hospitalized VBN VBN O
for IN IN O
hip NN NN O
surgery NN NN O
( ( ( O
see VB VB O
CAS NNP NNP O
notes NNS NNS O
11/16/77 CD CD I-DATE
) ) ) O
. . . O
   
However RB RB O
, , , O
pt NN NN O
is VBZ VBZ O
elderly JJ JJ O
and CC CC O
with IN IN O
hx NN NN O
of IN IN O
dementia NN NN O
, , , O
is VBZ VBZ O
at IN IN O
risk NN NN O
for IN IN O
postop NN NN O
dementia NN NN O
. . . O
   
Given VBN VBN O
this DT DT O
, , , O
avoid NN NN O
anti-dopaminergic JJ JJ O
meds NNS NNS O
like IN IN O
haldol NN NN O
, , , O
seroquel NN NN O
, , , O
zydis/zyprexa NN NN O
, , , O
reglan NN NN O
. . . O
   
This DT DT O
pt NN NN O
tolerates NNS NNS O
small JJ JJ O
doses NNS NNS O
of IN IN O
benzo NN NN O
as IN IN O
a DT DT O
home NN NN O
med NN NN O
, , , O
therefore RB RB O
pt NN NN O
can MD MD O
try VB VB O
: : : O
- : : O
home NN NN O
klonopin NN NN O
0.25mg CD CD O
po NN NN O
bid NN NN O
standing NN NN O
- : : O
ativan NN NN O
0.5 CD CD O
mg NN NN O
q6h NN NN O
prn NN NN O
agitation NN NN O
- : : O
monitor NN NN O
for IN IN O
signs NNS NNS O
of IN IN O
NMS NNP NNP O
: : : O
mental JJ JJ O
status NN NN O
changes NNS NNS O
with IN IN O
muscle NN NN O
rigidity NN NN O
, , , O
fever NN NN O
, , , O
autonomic JJ JJ O
instability NN NN O
. . . O
   
Check NNP NNP O
CK NNP NNP O
if IN IN O
this DT DT O
happens VBZ VBZ O
and CC CC O
page NN NN O
med VBD VBD O
consult NN NN O
06885 CD CD I-PHONE
if IN IN O
any DT DT O
concerns.Thank NN NN O
you PRP PRP O
for IN IN O
this DT DT O
consult NN NN O
. . . O
   
We PRP PRP O
will MD MD O
follow VB VB O
with IN IN O
you.__________________________________Peggy NN NN O
Ellis NNP NNP I-DOCTOR
, , , O
PGY-2 NNP NNP O
Pager NNP NNP O
#75412 NN NN O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2085-11-01 JJ JJ I-DATE
November NNP NNP I-DATE
01 CD CD O
, , , O
2085 CD CD I-DATE
Usha NNP NNP I-DOCTOR
Gibbons NNP NNP I-DOCTOR
, , , O
MD NNP NNP O
Cooley NNP NNP I-HOSPITAL
Internal NNP NNP O
Medicine NNP NNP O
Associates NNPS NNPS O
Cooley NNP NNP I-HOSPITAL
Dickinson NNP NNP I-HOSPITAL
Hospital NNP NNP I-HOSPITAL
49 CD CD I-STREET
Greenfield NNP NNP I-STREET
Drive NNP NNP I-STREET
Schuyler NNP NNP I-CITY
, , , O
FL NNP NNP I-STATE
76969 CD CD I-ZIP
RE NNP NNP O
: : : O
BENITEZ NNP NNP O
, , , O
Wonda NNP NNP I-PATIENT
MRN NNP NNP O
: : : O
892-76-95-4 JJ JJ I-MEDICALRECORD
Dear RB RB O
Usha NNP NNP I-DOCTOR
: : : O
I PRP PRP O
had VBD VBD O
the DT DT O
pleasure NN NN O
of IN IN O
seeing VBG VBG O
one CD CD O
of IN IN O
your PRP$ PRP$ O
patients NNS NNS O
, , , O
Ms NNP NNP O
. . . O
Benitez NNP NNP I-PATIENT
, , , O
in IN IN O
my PRP$ PRP$ O
Cardiovascular NNP NNP O
Clinic NNP NNP O
today NN NN O
for IN IN O
follow-up JJ JJ O
status NN NN O
post NN NN O
coronary JJ JJ O
artery NN NN O
bypass NN NN O
surgery NN NN O
. . . O
   
As IN IN O
you PRP PRP O
know VBP VBP O
, , , O
Ms NNP NNP O
. . . O
Benitez NNP NNP I-PATIENT
has VBZ VBZ O
been VBN VBN O
having VBG VBG O
a DT DT O
terrible JJ JJ O
past JJ JJ O
month NN NN O
with IN IN O
increasing VBG VBG O
episodes NNS NNS O
of IN IN O
substernal JJ JJ O
chest NN NN O
discomfort NN NN O
. . . O
   
One CD CD O
episode NN NN O
occurred VBD VBD O
during IN IN O
Ramadan NNP NNP I-DATE
when WRB WRB O
she PRP PRP O
was VBD VBD O
fasting VBG VBG O
and CC CC O
another DT DT O
occurred VBD VBD O
while IN IN O
she PRP PRP O
was VBD VBD O
in IN IN O
a DT DT O
restaurant NN NN O
. . . O
   
Both DT DT O
of IN IN O
these DT DT O
episodes NNS NNS O
were VBD VBD O
relieved VBN VBN O
with IN IN O
sublingual JJ JJ O
nitroglycerine NN NN O
. . . O
   
I PRP PRP O
am VBP VBP O
concerned VBN VBN O
about IN IN O
her PRP$ PRP$ O
discomfort NN NN O
because IN IN O
of IN IN O
an DT DT O
earlier JJR JJR O
Persantine NNP NNP O
MIBI NNP NNP O
study NN NN O
showing VBG VBG O
anteroapical JJ JJ O
redistribution NN NN O
on IN IN O
her PRP$ PRP$ O
test NN NN O
and CC CC O
the DT DT O
fact NN NN O
that IN IN O
it PRP PRP O
was VBD VBD O
relieved VBN VBN O
by IN IN O
nitroglycerine NN NN O
. . . O
   
Currently RB RB O
she PRP PRP O
denies VBZ VBZ O
any DT DT O
PND NNP NNP O
, , , O
orthopnea NN NN O
or CC CC O
chest NN NN O
discomfort NN NN O
. . . O
   
She PRP PRP O
continues VBZ VBZ O
to TO TO O
have VB VB O
back RB RB O
and CC CC O
bilateral JJ JJ O
hip NN NN O
pain NN NN O
and CC CC O
has VBZ VBZ O
been VBN VBN O
taking VBG VBG O
corticosteroid NN NN O
shots NNS NNS O
for IN IN O
that DT DT O
. . . O
   
On IN IN O
physical JJ JJ O
examination NN NN O
, , , O
she PRP PRP O
is VBZ VBZ O
an DT DT O
anxious JJ JJ O
, , , O
concerned VBN VBN O
, , , O
elderly JJ JJ O
woman NN NN O
. . . O
   
Blood NNP NNP O
pressure NN NN O
is VBZ VBZ O
160/70 CD CD O
in IN IN O
the DT DT O
left VBN VBN O
arm NN NN O
. . . O
   
Jugular NNP NNP O
venous JJ JJ O
pulse NN NN O
is VBZ VBZ O
not RB RB O
observed VBN VBN O
. . . O
   
She PRP PRP O
has VBZ VBZ O
bilateral JJ JJ O
carotid NN NN O
bruits NNS NNS O
. . . O
   
Chest NN NN O
exam NN NN O
is VBZ VBZ O
clear JJ JJ O
. . . O
   
Cardiac NNP NNP O
exam NN NN O
shows VBZ VBZ O
an DT DT O
S4 NNP NNP O
gallop NN NN O
, , , O
a DT DT O
normal JJ JJ O
S1 NNP NNP O
, , , O
a DT DT O
physiologically RB RB O
split NN NN O
S2 NNP NNP O
and CC CC O
a DT DT O
2/6 CD CD O
systolic JJ JJ O
murmur NN NN O
at IN IN O
the DT DT O
left VBN VBN O
sternal JJ JJ O
border NN NN O
. . . O
   
Abdominal NNP NNP O
exam NN NN O
is VBZ VBZ O
benign NN NN O
. . . O
   
Peripheral NNP NNP O
exam NN NN O
shows VBZ VBZ O
trace NN NN O
pedal NN NN O
edema NN NN O
. . . O
   
EKG NNP NNP O
shows VBZ VBZ O
sinus NN NN O
bradycardia NNS NNS O
at IN IN O
a DT DT O
rate NN NN O
of IN IN O
50 CD CD O
beats NNS NNS O
per IN IN O
minute NN NN O
. . . O
   
There EX EX O
are VBP VBP O
Q NNP NNP O
waves NNS NNS O
in IN IN O
V1 NNP NNP O
through IN IN O
V4 NNP NNP O
, , , O
consistent JJ JJ O
with IN IN O
an DT DT O
old JJ JJ O
anterolateral NN NN O
MI NNP NNP O
. . . O
   
The DT DT O
tracing NN NN O
was VBD VBD O
otherwise RB RB O
unchanged JJ JJ O
compared VBN VBN O
with IN IN O
previous JJ JJ O
tracings NNS NNS O
. . . O
   
RE NNP NNP O
: : : O
BENITEZ NNP NNP O
, , , O
Wonda NNP NNP I-PATIENT
MRN NNP NNP O
: : : O
892-76-95-4 JJ JJ I-MEDICALRECORD
- - - O
2 CD CD O
- : : O
November NNP NNP I-DATE
01 CD CD O
, , , O
2085 CD CD I-DATE
IMPRESSION NNP NNP O
: : : O
I PRP PRP O
think VBP VBP O
we PRP PRP O
should MD MD O
schedule VB VB O
Ms NNP NNP O
. . . O
Benitez NNP NNP I-PATIENT
for IN IN O
a DT DT O
Persantine NNP NNP O
thallium NN NN O
test NN NN O
as RB RB O
soon RB RB O
as IN IN O
possible JJ JJ O
. . . O
   
If IN IN O
she PRP PRP O
can MD MD O
exercise VB VB O
on IN IN O
this DT DT O
test NN NN O
, , , O
that WDT WDT O
would MD MD O
be VB VB O
even RB RB O
better JJR JJR O
. . . O
   
When WRB WRB O
the DT DT O
results NNS NNS O
are VBP VBP O
back RB RB O
, , , O
I PRP PRP O
will MD MD O
get VB VB O
back RB RB O
you PRP PRP O
regarding VBG VBG O
further JJ JJ O
recommendations NNS NNS O
. . . O
   
My PRP$ PRP$ O
hope NN NN O
is VBZ VBZ O
that IN IN O
we PRP PRP O
will MD MD O
not RB RB O
have VB VB O
to TO TO O
revascularize VB VB O
her PRP$ PRP$ O
again RB RB O
. . . O
   
If IN IN O
we PRP PRP O
do VBP VBP O
, , , O
I PRP PRP O
am VBP VBP O
hoping VBG VBG O
to TO TO O
do VB VB O
so RB RB O
with IN IN O
potential JJ JJ O
angioplasty NN NN O
and CC CC O
stenting VBG VBG O
. . . O
   
In IN IN O
the DT DT O
meantime NN NN O
, , , O
I PRP PRP O
have VBP VBP O
switched VBN VBN O
her PRP PRP O
from IN IN O
Zocor NNP NNP O
40 CD CD O
mg NN NN O
to TO TO O
Lipitor NNP NNP O
40 CD CD O
mg NN NN O
a DT DT O
day NN NN O
in IN IN O
the DT DT O
hopes NNS NNS O
of IN IN O
targeting VBG VBG O
her PRP$ PRP$ O
LDL NNP NNP O
cholesterol NN NN O
to TO TO O
the DT DT O
new JJ JJ O
guidelines NNS NNS O
of IN IN O
100 CD CD O
. . . O
   
Her PRP$ PRP$ O
previous JJ JJ O
LDL NNP NNP O
cholesterol NN NN O
was VBD VBD O
111 CD CD O
. . . O
   
I PRP PRP O
also RB RB O
suggested VBD VBD O
to TO TO O
her PRP PRP O
in IN IN O
the DT DT O
meantime NN NN O
to TO TO O
cut VB VB O
down RB RB O
on IN IN O
her PRP$ PRP$ O
physical JJ JJ O
activities NNS NNS O
until IN IN O
we PRP PRP O
know VBP VBP O
the DT DT O
results NNS NNS O
of IN IN O
the DT DT O
thallium NN NN O
test NN NN O
and CC CC O
also RB RB O
to TO TO O
forgo VB VB O
one CD CD O
episode NN NN O
of IN IN O
her PRP$ PRP$ O
steroid NN NN O
injection NN NN O
for IN IN O
her PRP$ PRP$ O
back RB RB O
. . . O
   
Please VB VB O
let VB VB O
me PRP PRP O
know VB VB O
if IN IN O
you PRP PRP O
have VBP VBP O
any DT DT O
further JJ JJ O
questions NNS NNS O
or CC CC O
concerns NNS NNS O
regarding VBG VBG O
this DT DT O
patient NN NN O
. . . O
   
Again RB RB O
, , , O
thank VB VB O
you PRP PRP O
for IN IN O
referring VBG VBG O
her PRP PRP O
to TO TO O
our PRP$ PRP$ O
clinic NN NN O
. . . O
   
With IN IN O
warm JJ JJ O
regards VBZ VBZ O
, , , O
Gordon NNP NNP I-DOCTOR
Q. NN NN I-DOCTOR
Iniguez NNP NNP I-DOCTOR
, , , O
MD NNP NNP O
GI/JZ NNP NNP O
******** NN NN O
Not RB RB O
reviewed VBN VBN O
by IN IN O
Attending NNP NNP O
Physician NNP NNP O
******** NN NN O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2136-12-05 JJ JJ I-DATE
HIGHLAND NNP NNP I-HOSPITAL
HOSITAL NNP NNP I-HOSPITAL
VISIT NNP NNP O
PT NNP NNP O
: : : O
Ellen NNP NNP I-PATIENT
Law NNP NNP I-PATIENT
date NN NN O
of IN IN O
visit NN NN O
: : : O
12/05/36 CD CD I-DATE
CC NNP NNP O
: : : O
fu NN NN O
cards NNS NNS O
, , , O
htn NN NN O
, , , O
hyperlipidemia NN NN O
, , , O
DM NNP NNP O
HPI NNP NNP O
: : : O
Since IN IN O
our PRP$ PRP$ O
last JJ JJ O
visit NN NN O
, , , O
saw VBD VBD O
Cardiology NNP NNP O
re NN NN O
her PRP$ PRP$ O
neck NN NN O
and CC CC O
jaw NN NN O
pain NN NN O
w NN NN O
exertion NN NN O
, , , O
Dr NNP NNP O
. . . O
Uphoff NNP NNP I-DOCTOR
who WP WP O
feels VBZ VBZ O
that IN IN O
she PRP PRP O
has VBZ VBZ O
stable JJ JJ O
angina NN NN O
. . . O
   
he PRP PRP O
recommended VBD VBD O
that IN IN O
she PRP PRP O
optimize NN NN O
her PRP$ PRP$ O
medical JJ JJ O
management NN NN O
by IN IN O
increasing VBG VBG O
her PRP$ PRP$ O
BB NNP NNP O
and CC CC O
CCB NNP NNP O
. . . O
   
At IN IN O
this DT DT O
point NN NN O
, , , O
she PRP PRP O
has VBZ VBZ O
increased VBN VBN O
her PRP$ PRP$ O
BB NNP NNP O
to TO TO O
2 CD CD O
pills NNS NNS O
2x CD CD O
per IN IN O
day NN NN O
. . . O
   
she PRP PRP O
feels VBZ VBZ O
ok JJ JJ O
on IN IN O
this DT DT O
. . . O
   
no DT DT O
lightheadedness NN NN O
or CC CC O
dizziness NN NN O
. . . O
   
She PRP PRP O
is VBZ VBZ O
also RB RB O
going VBG VBG O
to TO TO O
start VB VB O
nitrates NNS NNS O
as RB RB O
soon RB RB O
as IN IN O
they PRP PRP O
arrive--imdur NN NN O
30mg CD CD O
qd NN NN O
. . . O
   
still RB RB O
having VBG VBG O
intermittenly RB RB O
jaw NN NN O
discomfort NN NN O
walking VBG VBG O
up RP RP O
stairs NNS NNS O
. . . O
   
no DT DT O
chest NN NN O
pressure NN NN O
or CC CC O
jaw NN NN O
discomfort NN NN O
at IN IN O
rest NN NN O
. . . O
   
she PRP PRP O
has VBZ VBZ O
not RB RB O
gained VBN VBN O
any DT DT O
wt NN NN O
. . . O
   
however RB RB O
, , , O
has VBZ VBZ O
not RB RB O
been VBN VBN O
able JJ JJ O
to TO TO O
increase VB VB O
her PRP$ PRP$ O
lantus NN NN O
bc NN NN O
she PRP PRP O
was VBD VBD O
not RB RB O
sent VBN VBN O
the DT DT O
correct JJ JJ O
amount NN NN O
and CC CC O
would MD MD O
run VB VB O
out IN IN O
if IN IN O
she PRP PRP O
increaesd VBZ VBZ O
to TO TO O
previously RB RB O
recommended VBD VBD O
dose NN NN O
. . . O
   
also RB RB O
started VBD VBD O
pravastain NN NN O
since IN IN O
our PRP$ PRP$ O
last JJ JJ O
visit NN NN O
. . . O
   
has VBZ VBZ O
not RB RB O
noticed VBN VBN O
any DT DT O
muscle NN NN O
aches NNS NNS O
or CC CC O
generalized JJ JJ O
weakness NN NN O
. . . O
   
has VBZ VBZ O
only RB RB O
been VBN VBN O
on IN IN O
this DT DT O
for IN IN O
2 CD CD O
weeks NNS NNS O
though IN IN O
. . . O
   
no DT DT O
hypoglycemia NN NN O
; : : O
   
good JJ JJ O
energy NN NN O
; : : O
   
feeling NN NN O
well RB RB O
overall JJ JJ O
. . . O
   
describes VBZ VBZ O
feeling NN NN O
pressure NN NN O
, , , O
fullness NN NN O
in IN IN O
left VBN VBN O
ear NN NN O
; : : O
   
slight JJ JJ O
decrease NN NN O
in IN IN O
hearing NN NN O
. . . O
   
Problems NNS NNS O
Diabetes NNP NNP O
mellitus JJ JJ O
Malignant NNP NNP O
tumor NN NN O
of IN IN O
urinary JJ JJ O
bladder NN NN O
: : : O
stage NN NN O
1 CD CD O
, , , O
now RB RB O
s/p NN NN O
bcg NN NN O
treatment NN NN O
, , , O
followed VBN VBN O
by IN IN O
urology NN NN O
Hypertensive NNP NNP O
disorder NN NN O
Obesity NNP NNP O
Retinal NNP NNP O
detachment NN NN O
: : : O
s/p NN NN O
repair NN NN O
Dr NNP NNP O
. . . O
Cleveland NNP NNP I-DOCTOR
Medications NNP NNP O
Aspirin NNP NNP O
( ( ( O
ACETYLSALICYLIC NNP NNP O
ACID NNP NNP O
) ) ) O
81 CD CD O
MG NNP NNP O
( ( ( O
81MG CD CD O
TABLET NNP NNP O
Take NNP NNP O
1 CD CD O
) ) ) O
PO NNP NNP O
QD NNP NNP O
#90 NN NN O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
Cozaar NNP NNP O
( ( ( O
LOSARTAN NNP NNP O
) ) ) O
50 CD CD O
MG NNP NNP O
( ( ( O
50MG CD CD O
TABLET NNP NNP O
Take NNP NNP O
1 CD CD O
) ) ) O
PO NNP NNP O
BID NNP NNP O
, , , O
Member NNP NNP O
ID NNP NNP O
# # # O
55080437876 CD CD I-IDNUM
#180 NN NN O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
Hydrochlorothiazide NNP NNP O
25 CD CD O
MG NNP NNP O
( ( ( O
25MG CD CD O
TABLET NNP NNP O
Take NNP NNP O
1 CD CD O
) ) ) O
PO NNP NNP O
QD NNP NNP O
, , , O
Member NNP NNP O
ID NNP NNP O
# # # O
033388269 CD CD I-IDNUM
#90 NN NN O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
Imdur NNP NNP O
ER NNP NNP O
( ( ( O
ISOSORBIDE NNP NNP O
MONONITRATE NNP NNP O
( ( ( O
SR NNP NNP O
) ) ) O
) ) ) O
30 CD CD O
MG NNP NNP O
( ( ( O
30 CD CD O
MG NNP NNP O
TAB.SR NNP NNP O
24H CD CD O
Take NNP NNP O
1 CD CD O
) ) ) O
PO NNP NNP O
QD NNP NNP O
#90 NN NN O
TAB.SR NNP NNP O
Lantus NNP NNP O
( ( ( O
INSULIN NNP NNP O
GLARGINE NNP NNP O
) ) ) O
100 CD CD O
U/ML NNP NNP O
VIAL NNP NNP O
ML NNP NNP O
SC NNP NNP O
AS NNP NNP O
DIRECTED NNP NNP O
, , , O
65U CD CD O
before IN IN O
breakfast NN NN O
and CC CC O
10 CD CD O
units NNS NNS O
at IN IN O
night NN NN O
Member NNP NNP O
ID NNP NNP O
# # # O
033388269 CD CD I-IDNUM
#3 NN NN O
Month NN NN O
   
( ( ( O
s VBZ VBZ O
) ) ) O
Supply NNP NNP O
Metformin NNP NNP O
1000 CD CD O
MG NNP NNP O
( ( ( O
1000MG CD CD O
TABLET NNP NNP O
Take NNP NNP O
1 CD CD O
) ) ) O
PO NNP NNP O
BID NNP NNP O
#180 NN NN O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
Metoprolol NNP NNP O
TARTRATE NNP NNP O
50 CD CD O
MG NNP NNP O
( ( ( O
50MG CD CD O
TABLET NNP NNP O
Take NNP NNP O
1 CD CD O
) ) ) O
PO NNP NNP O
QD NNP NNP O
AS NNP NNP O
DIRECTED NNP NNP O
, , , O
2 CD CD O
PO NNP NNP O
QAM NNP NNP O
AND CC CC O
1 CD CD O
PO NNP NNP O
QPM NNP NNP O
#180 NN NN O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
Norvasc NNP NNP O
( ( ( O
AMLODIPINE NNP NNP O
) ) ) O
5 CD CD O
MG NNP NNP O
( ( ( O
5 CD CD O
MG NNP NNP O
TABLET NNP NNP O
Take NNP NNP O
1 CD CD O
) ) ) O
PO NNP NNP O
QD NNP NNP O
x SYM SYM O
90 CD CD O
days NNS NNS O
#90 NN NN O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
Novolog NNP NNP O
flexpens NNS NNS O
SC NNP NNP O
AC NNP NNP O
AS NNP NNP O
DIRECTED NNP NNP O
, , , O
10U CD CD O
before IN IN O
breakfast NN NN O
, , , O
10U CD CD O
before IN IN O
lunch NN NN O
, , , O
20U CD CD O
before IN IN O
dinner NN NN O
#15 NN NN O
prefilled JJ JJ O
pens NNS NNS O
One CD CD O
touch JJ JJ O
ultra NN NN O
test NN NN O
strips NNS NNS O
1 CD CD O
SC NNP NNP O
BID NNP NNP O
#3 NN NN O
Month NN NN O
   
( ( ( O
s VBZ VBZ O
) ) ) O
Supply NNP NNP O
Pravastatin NNP NNP O
20 CD CD O
MG NNP NNP O
( ( ( O
20MG CD CD O
TABLET NNP NNP O
Take NNP NNP O
1 CD CD O
) ) ) O
PO NNP NNP O
QHS NNP NNP O
#90 NN NN O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
Solostar NNP NNP O
prefilled VBD VBD O
disposable JJ JJ O
lantus NN NN O
insulin NN NN O
pen NN NN O
65 CD CD O
UNITS NNP NNP O
SC NNP NNP O
qd NN NN O
, , , O
Member NNP NNP O
ID NNP NNP O
# # # O
033388269 CD CD I-IDNUM
#3 NN NN O
Month NN NN O
   
( ( ( O
s VBZ VBZ O
) ) ) O
Supply NNP NNP O
Zostavax NNP NNP O
( ( ( O
ZOSTER NNP NNP O
VACCINE NNP NNP O
LIVE NNP NNP O
( ( ( O
PF NNP NNP O
) ) ) O
) ) ) O
1 CD CD O
VIAL NNP NNP O
SC NNP NNP O
X1 NNP NNP O
x SYM SYM O
365 CD CD O
days NNS NNS O
, , , O
   
1 CD CD O
. . . O
Reconstitute NNP NNP O
and CC CC O
inject NN NN O
1 CD CD O
vial NN NN O
. . . O
   
Sub-cutaneous JJ JJ O
upper JJ JJ O
arm NN NN O
. . . O
   
2 CD CD O
. . . O
Please VB VB O
document NN NN O
vaccine NN NN O
administration NN NN O
in IN IN O
the DT DT O
LMR NNP NNP O
immunization NN NN O
module NN NN O
( ( ( O
or CC CC O
notify VB VB O
the DT DT O
practice NN NN O
in IN IN O
writing VBG VBG O
if IN IN O
no DT DT O
LMR NNP NNP O
access NN NN O
) ) ) O
. . . O
   
#1 NN NN O
vial NN NN O
Allergies NNP NNP O
AZITHROMYCIN NNP NNP O
- : : O
Unknown JJ JJ O
Ace NNP NNP O
Inhibitor NNP NNP O
- : : O
cough NN NN O
, , , O
TOB NNP NNP O
: : : O
quit NN NN O
2120 CD CD I-DATE
; : : O
   
smoked VBD VBD O
2ppd CD CD O
x SYM SYM O
15 CD CD O
yrs NN NN O
ETOH NNP NNP O
: : : O
none NN NN O
IVDU/illict NNP NNP O
drugs NNS NNS O
: : : O
none NN NN O
SH NNP NNP O
: : : O
originally RB RB O
from IN IN O
Mt NNP NNP I-STATE
. . . O
Married NNP NNP O
for IN IN O
39 CD CD O
years NNS NNS O
to TO TO O
Friedman NNP NNP I-PATIENT
, , , O
describes VBZ VBZ O
marriage NN NN O
as IN IN O
good JJ JJ O
, , , O
safe JJ JJ O
. . . O
   
Has VBZ VBZ O
2 CD CD O
children NNS NNS O
and CC CC O
8 CD CD O
grandchildren NNS NNS O
. . . O
   
Has VBZ VBZ O
2 CD CD O
daugthers NNS NNS O
, , , O
1 CD CD O
lives NNS NNS O
in IN IN O
hartsville NN NN I-CITY
and CC CC O
1 CD CD O
in IN IN O
nuku NN NN O
'alofa NNP NNP O
. . . O
   
no DT DT O
pets NNS NNS O
. . . O
   
fulltime NN NN O
author NN NN I-PROFESSION
. . . O
   
husband NN NN O
has VBZ VBZ O
h/p NN NN O
prostate NN NN O
CA NNP NNP O
. . . O
   
FH NNP NNP O
: : : O
( ( ( O
no DT DT O
known VBN VBN O
) ) ) O
h/o NN NN O
sudden JJ JJ O
death NN NN O
, , , O
hyperlipidemia NN NN O
+ NN NN O
Dm NNP NNP O
in IN IN O
father NN NN O
( ( ( O
dxd NN NN O
in IN IN O
his PRP$ PRP$ O
60-70 JJ JJ O
) ) ) O
+ NN NN O
mgm NN NN O
w NN NN O
stroke NN NN O
( ( ( O
+ NN NN O
CHF NNP NNP O
in IN IN O
ther NN NN O
mother NN NN O
+ NN NN O
mUncles NNS NNS O
x SYM SYM O
2 CD CD O
with IN IN O
MIs NNP NNP O
(~ NN NN O
60's_ CD CD O
( ( ( O
no DT DT O
known VBN VBN O
) ) ) O
h/o NN NN O
endometrial NN NN O
, , , O
ovarian JJ JJ O
, , , O
thyroid NN NN O
, , , O
melanoma NN NN O
, , , O
breast NN NN O
, , , O
prostate NN NN O
+ NN NN O
colon NN NN O
cancer NN NN O
in IN IN O
her PRP$ PRP$ O
mother NN NN O
, , , O
dx NN NN O
'd MD MD O
55-60yo JJ JJ O
( ( ( O
no DT DT O
known VBN VBN O
) ) ) O
h/o NN NN O
osteoporosis/premature NN NN O
bone NN NN O
loss NN NN O
( ( ( O
no DT DT O
known VBN VBN O
) ) ) O
h/o NN NN O
colon NN NN O
polyp NN NN O
, , , O
dysplasic JJ JJ O
nevi NN NN O
( ( ( O
no DT DT O
known VBN VBN O
) ) ) O
h/o NN NN O
pe NN NN O
, , , O
DVT NNP NNP O
, , , O
miscarriages NNS NNS O
, , , O
bleeding VBG VBG O
disorders NNS NNS O
(+) NN NN O
h/o NN NN O
glaucoma NN NN O
in IN IN O
mUncle NN NN O
( ( ( O
no DT DT O
known VBN VBN O
) ) ) O
h/o NN NN O
depression NN NN O
, , , O
suicide NN NN O
, , , O
schizophrenia NN NN O
+ NN NN O
dementia NN NN O
in IN IN O
her PRP$ PRP$ O
mother NN NN O
+ NN NN O
alcoholis NNS NNS O
in IN IN O
2 CD CD O
muncles NNS NNS O
+ NN NN O
bipolar JJ JJ O
do VBP VBP O
in IN IN O
grandson NN NN O
VS NNP NNP O
: : : O
130/66 CD CD O
76 CD CD O
97.1 CD CD O
98%RA CD CD O
250 CD CD O
lbs NN NN O
57.25 CD CD O
general JJ JJ O
: : : O
well RB RB O
- - - O
appearing VBG VBG O
F NN NN O
in IN IN O
NAD NNP NNP O
HEENT NNP NNP O
: : : O
anicteric JJ JJ O
, , , O
PERRL NNP NNP O
, , , O
EOMI NNP NNP O
, , , O
mmm NN NN O
; : : O
   
difficult JJ JJ O
to TO TO O
assess VB VB O
JVP NNP NNP O
, , , O
L NNP NNP O
TM NNP NNP O
w NN NN O
nearly RB RB O
obstructing VBG VBG O
cerumen NNS NNS O
; : : O
   
R NNP NNP O
w NN NN O
nl NN NN O
TM NNP NNP O
and CC CC O
light JJ JJ O
reflex JJ JJ O
. . . O
   
PULM NNP NNP O
: : : O
CTAB NNP NNP O
w NN NN O
good JJ JJ O
air NN NN O
movement NN NN O
. . . O
   
no DT DT O
wheezes NNS NNS O
, , , O
rhonchi NN NN O
, , , O
or CC CC O
crackles NNS NNS O
COR NNP NNP O
: : : O
rrr NN NN O
, , , O
nls1s1 NN NN O
, , , O
no DT DT O
m/r/g NN NN O
EXT NNP NNP O
: : : O
wwp NN NN O
, , , O
no DT DT O
edema NN NN O
A/P NNP NNP O
: : : O
61 CD CD I-AGE
yo NN NN O
F NN NN O
with IN IN O
PMH NNP NNP O
of IN IN O
HTN NNP NNP O
, , , O
hyperlipidemia NN NN O
, , , O
DM NNP NNP O
, , , O
obesity NN NN O
, , , O
bladder NN NN O
cancer NN NN O
presenting VBG VBG O
for IN IN O
fu NN NN O
of IN IN O
multiple JJ JJ O
medical JJ JJ O
issues NNS NNS O
. . . O
   
1 CD CD O
) ) ) O
DM NNP NNP O
: : : O
Dx NNP NNP O
'd NNP NNP O
~ NN NN O
2129 CD CD I-DATE
, , , O
c/b NN NN O
diabetic JJ JJ O
retinopathy NN NN O
s/p NN NN O
laser NN NN O
tx NN NN O
and CC CC O
likely JJ JJ O
neuropathy NN NN O
. . . O
   
Most JJS JJS O
recent JJ JJ O
10/36 CD CD I-DATE
HgbA1c NNP NNP O
: : : O
7.0 CD CD O
% NN NN O
, , , O
very RB RB O
near JJ JJ O
goal NN NN O
of IN IN O
& CC CC O
lt NN NN O
; : : O
   
7.0 CD CD O
% NN NN O
and CC CC O
improving VBG VBG O
compared VBN VBN O
to TO TO O
7.8 CD CD O
% NN NN O
since IN IN O
increase NN NN O
in IN IN O
lantus NN NN O
dose NN NN O
. . . O
   
Did VBD VBD O
not RB RB O
bring VB VB O
FS NNP NNP O
log NN NN O
today NN NN O
but CC CC O
continues VBZ VBZ O
to TO TO O
report VB VB O
that IN IN O
her PRP$ PRP$ O
fasting VBG VBG O
glucose NN NN O
in IN IN O
AM NNP NNP O
still RB RB O
often RB RB O
above IN IN O
goal NN NN O
and CC CC O
that IN IN O
her PRP$ PRP$ O
largest JJS JJS O
meal NN NN O
and CC CC O
need VBP VBP O
for IN IN O
novolg NN NN O
is VBZ VBZ O
at IN IN O
dinner NN NN O
. . . O
   
Previously RB RB O
recommended VBD VBD O
starting VBG VBG O
BID NNP NNP O
dosing VBG VBG O
of IN IN O
lantus NN NN O
and CC CC O
adding VBG VBG O
10 CD CD O
units NNS NNS O
in IN IN O
PM NNP NNP O
, , , O
but CC CC O
not RB RB O
able JJ JJ O
to TO TO O
obtain VB VB O
yet RB RB O
from IN IN O
pfizer NN NN I-ORGANIZATION
; : : O
   
discussed VBN VBN O
that IN IN O
for IN IN O
some DT DT O
individuals NNS NNS O
it PRP PRP O
dose VBD VBD O
not RB RB O
last JJ JJ O
for IN IN O
24 CD CD O
hours NNS NNS O
adn NN NN O
that IN IN O
they PRP PRP O
get VBP VBP O
better JJR JJR O
glucose NN NN O
control NN NN O
w NN NN O
BID NNP NNP O
dosing VBG VBG O
. . . O
   
Discussed VBD VBD O
that IN IN O
she PRP PRP O
will MD MD O
likely RB RB O
need VB VB O
to TO TO O
decrease VB VB O
her PRP$ PRP$ O
PM NNP NNP O
dose NN NN O
of IN IN O
novolog NN NN O
---- SYM SYM O
recheck NN NN O
hgba1c NN NN O
~ NN NN O
1/2137 CD CD I-DATE
---- : : O
continue VB VB O
metformin NN NN O
1000mg CD CD O
BID NNP NNP O
, , , O
lantus NN NN O
65units CD CD O
qam NN NN O
and CC CC O
novolog NN NN O
70/30 CD CD O
but CC CC O
also RB RB O
adding VBG VBG O
10 CD CD O
units NNS NNS O
of IN IN O
lantus NN NN O
in IN IN O
PM NNP NNP O
---- SYM SYM O
continue VB VB O
glucose NN NN O
monitoring NN NN O
for IN IN O
likely JJ JJ O
need VBP VBP O
for IN IN O
further JJ JJ O
adjustments NNS NNS O
to TO TO O
regimen NNS NNS O
---- : : O
7/36 CD CD I-DATE
urine NN NN O
microalbumin/crt NN NN O
: : : O
35.9 CD CD O
above IN IN O
goal NN NN O
of IN IN O
& CC CC O
lt NN NN O
; : : O
   
30 CD CD O
; : : O
   
have VBP VBP O
made VBN VBN O
changes NNS NNS O
to TO TO O
BP NNP NNP O
regimen NNS NNS O
and CC CC O
BP NNP NNP O
now RB RB O
within IN IN O
goal NN NN O
; : : O
   
will MD MD O
recheck VB VB O
u NN NN O
microalb/crt NN NN O
in IN IN O
1/2137 CD CD I-DATE
---- : : O
OPTHO NNP NNP O
: : : O
followd NN NN O
by IN IN O
dr NN NN O
arias NN NN I-DOCTOR
; : : O
   
reports NNS NNS O
uptodate JJ JJ O
---- : : O
PODIOTRY NNP NNP O
: : : O
pt NN NN O
w NN NN O
likely JJ JJ O
diabetic JJ JJ O
neuropathy NN NN O
and CC CC O
e/o NN NN O
oncychomycosis NN NN O
; : : O
   
referrred VBN VBN O
to TO TO O
podiotry VB VB O
for IN IN O
further JJ JJ O
care NN NN O
and CC CC O
monitoring VBG VBG O
at IN IN O
previous JJ JJ O
visit NN NN O
---- NN NN O
BP NNP NNP O
: : : O
within IN IN O
goal NN NN O
on IN IN O
HCTZ NNP NNP O
, , , O
Cozzar NNP NNP O
, , , O
metoprolol NN NN O
and CC CC O
norvasc NN NN O
---- : : O
2136 CD CD I-DATE
LDL NNP NNP O
: : : O
114 CD CD O
above IN IN O
goal NN NN O
of IN IN O
& CC CC O
lt NN NN O
; : : O
   
100 CD CD O
, , , O
not RB RB O
on IN IN O
statin NN NN O
; : : O
   
started VBD VBD O
simvastatin NN NN O
which WDT WDT O
was VBD VBD O
dc NN NN O
'd MD MD O
2/2 CD CD O
myalgias NNS NNS O
and CC CC O
generalized JJ JJ O
weakness NN NN O
( ( ( O
nl NN NN O
LFTS NNP NNP O
and CC CC O
CK NNP NNP O
) ) ) O
; : : O
   
pt NN NN O
has VBZ VBZ O
started VBN VBN O
pravastain NN NN O
and CC CC O
appears VBZ VBZ O
to TO TO O
be VB VB O
doing VBG VBG O
well RB RB O
on IN IN O
this DT DT O
---- : : O
9/36 CD CD I-DATE
Gabriella NNP NNP I-DOCTOR
Yockey NNP NNP I-DOCTOR
---- SYM SYM O
discussed VBN VBN O
nutrition NN NN O
referral NN NN O
; : : O
   
pt NN NN O
declined VBD VBD O
but CC CC O
plans NNS NNS O
on IN IN O
joining VBG VBG O
south RB RB I-ORGANIZATION
beach NN NN I-ORGANIZATION
diet JJ JJ I-ORGANIZATION
---- : : O
discussed VBN VBN O
importance NN NN O
of IN IN O
wt NN NN O
loss NN NN O
; : : O
   
pt NN NN O
to TO TO O
try VB VB O
south RB RB I-ORGANIZATION
beach NN NN I-ORGANIZATION
diet NN NN I-ORGANIZATION
; : : O
   
---- SYM SYM O
PNEUMOVAX NNP NNP O
: : : O
2136 CD CD I-DATE
---- SYM SYM O
Flu NNP NNP O
shot/H1N1: NN NN O
flu NN NN O
shot NN NN O
uptodate JJ JJ O
; : : O
   
receiving VBG VBG O
h1n1 NN NN O
today NN NN O
2 CD CD O
) ) ) O
HTN NNP NNP O
: : : O
Dx NNP NNP O
'd NNP NNP O
in IN IN O
~ NN NN O
2129 CD CD I-DATE
. . . O
   
BP NNP NNP O
very RB RB O
near IN IN O
goal NN NN O
today NN NN O
on IN IN O
current JJ JJ O
regimen NNS NNS O
of IN IN O
HCTZ NNP NNP O
25mg CD CD O
qd NN NN O
, , , O
cozaar NN NN O
50mg CD CD O
BId NNP NNP O
, , , O
metoprolol NN NN O
100mg CD CD O
BID NNP NNP O
and CC CC O
norvasc NN NN O
5 CD CD O
mg NN NN O
qd NN NN O
which WDT WDT O
appears VBZ VBZ O
to TO TO O
be VB VB O
well-tolerated JJ JJ O
. . . O
   
Will MD MD O
not RB RB O
make VB VB O
any DT DT O
additional JJ JJ O
changes NNS NNS O
since IN IN O
pt NN NN O
is VBZ VBZ O
planning VBG VBG O
on IN IN O
adding VBG VBG O
imdur NN NN O
30mg CD CD O
as RB RB O
soon RB RB O
as IN IN O
she PRP PRP O
received VBD VBD O
it PRP PRP O
from IN IN O
Pfizer NNP NNP I-ORGANIZATION
. . . O
   
10/2136 CD CD I-DATE
chem NN NN O
7 CD CD O
, , , O
renal JJ JJ O
fxn NN NN O
, , , O
ca MD MD O
wnl NN NN O
. . . O
   
----- SYM SYM O
encouraged VBD VBD O
low JJ JJ O
na NN NN O
diet NN NN I-ORGANIZATION
, , , O
wt NN NN O
loss NN NN O
---- SYM SYM O
continue VB VB O
HCTZ NNP NNP O
25mg CD CD O
qd NN NN O
, , , O
cozaar NN NN O
50mg CD CD O
BId NNP NNP O
, , , O
and CC CC O
metoprolol NN NN O
100mg CD CD O
BID NNP NNP O
, , , O
and CC CC O
norvasc NN NN O
5 CD CD O
mg NN NN O
qd NN NN O
---- SYM SYM O
reviewed VBD VBD O
si/sxs NN NN O
for IN IN O
which WDT WDT O
she PRP PRP O
should MD MD O
seek VB VB O
immediate JJ JJ O
medical JJ JJ O
attention NN NN O
3 CD CD O
) ) ) O
dyslipidemia NN NN O
: : : O
7/36 CD CD I-DATE
LDL NNP NNP O
114 CD CD O
above IN IN O
goal NN NN O
of IN IN O
& CC CC O
lt NN NN O
; : : O
   
100 CD CD O
given VBN VBN O
DM NNP NNP O
and CC CC O
likely JJ JJ O
CAD NNP NNP O
. . . O
   
Pt NNP NNP O
w NN NN O
brief JJ JJ O
2 CD CD O
week NN NN O
trial NN NN O
of IN IN O
simvastatin NN NN O
self-dc'd JJ JJ O
2/2 CD CD O
myalgias NN NN O
and CC CC O
generalized JJ JJ O
weakness NN NN O
but CC CC O
nl NN NN O
LFTS/CK/GFR NNP NNP O
. . . O
   
Pt NNP NNP O
now RB RB O
on IN IN O
pravastatin NN NN O
x SYM SYM O
2 CD CD O
weeks NNS NNS O
and CC CC O
appears VBZ VBZ O
to TO TO O
be VB VB O
well-tolerated JJ JJ O
thus RB RB O
far RB RB O
. . . O
   
Again RB RB O
reviewed VBD VBD O
possible JJ JJ O
side NN NN O
effects NNS NNS O
and CC CC O
she PRP PRP O
knows VBZ VBZ O
to TO TO O
call VB VB O
w NN NN O
any DT DT O
concerns NNS NNS O
or CC CC O
questions NNS NNS O
---- : : O
continue VB VB O
pravastatin NN NN O
20mg CD CD O
qhs NN NN O
; : : O
   
reivwed VBN VBN O
possible JJ JJ O
side NN NN O
effects NNS NNS O
and CC CC O
instructed VBN VBN O
to TO TO O
call VB VB O
w NN NN O
concerns NNS NNS O
---- : : O
pt NN NN O
instructed VBN VBN O
that IN IN O
she PRP PRP O
will MD MD O
need VB VB O
repeat NN NN O
lipids NNS NNS O
and CC CC O
LFTS NNP NNP O
in IN IN O
~ NN NN O
6-8 JJ JJ O
weeks NNS NNS O
after IN IN O
starting VBG VBG O
pravasatin NN NN O
; : : O
   
will MD MD O
check VB VB O
at IN IN O
next JJ JJ O
visit NN NN O
---- SYM SYM O
recommended VBD VBD O
low JJ JJ O
cholesterol NN NN O
diet NN NN I-ORGANIZATION
4 CD CD O
) ) ) O
Likely NNP NNP O
stable JJ JJ O
angina/CAD NN NN O
; : : O
   
now RB RB O
s/p NN NN O
Cardiology NNP NNP O
, , , O
consult NN NN O
w NN NN O
Dr NNP NNP O
. . . O
Uphoff NNP NNP I-DOCTOR
who WP WP O
feels VBZ VBZ O
that IN IN O
clinical JJ JJ O
presentation NN NN O
c/w NN NN O
stable JJ JJ O
angina/CAD NN NN O
and CC CC O
has VBZ VBZ O
recommended VBN VBN O
trial NN NN O
of IN IN O
optimizing VBG VBG O
medical JJ JJ O
management NN NN O
w NN NN O
nitrates NNS NNS O
and CC CC O
BB/CCB NNP NNP O
for IN IN O
now RB RB O
. . . O
   
Reviewed NNP NNP O
consult NN NN O
recs NN NN O
with IN IN O
patient NN NN O
. . . O
   
however RB RB O
, , , O
if IN IN O
this DT DT O
does VBZ VBZ O
not RB RB O
work VB VB O
, , , O
will MD MD O
consider VB VB O
possible JJ JJ O
cath/stress NN NN O
test NN NN O
. . . O
   
pt NN NN O
appears VBZ VBZ O
to TO TO O
be VB VB O
tolerating VBG VBG O
increase NN NN O
in IN IN O
BB NNP NNP O
and CC CC O
has VBZ VBZ O
not RB RB O
yet RB RB O
started VBD VBD O
imdur NN NN O
. . . O
   
recent JJ JJ O
LDL NNP NNP O
above IN IN O
goal NN NN O
but CC CC O
just RB RB O
restarted VBD VBD O
statin NN NN O
so RB RB O
will MD MD O
need VB VB O
fu NN NN O
measurement NN NN O
in IN IN O
~ NN NN O
4 CD CD O
weeks NNS NNS O
. . . O
   
---- : : O
continue VB VB O
asa NN NN O
81 CD CD O
mg NN NN O
qd NN NN O
; : : O
   
increased VBN VBN O
metoprolol NN NN O
100mg CD CD O
BID NNP NNP O
, , , O
ARB NNP NNP O
, , , O
and CC CC O
pravastatin NN NN O
20mg CD CD O
qhs NN NN O
---- : : O
fu NN NN O
appt NN NN O
w NN NN O
dr NN NN O
uphoff NN NN I-DOCTOR
in IN IN O
~ NN NN O
1 CD CD O
week NN NN O
---- : : O
pt NN NN O
to TO TO O
add VB VB O
imdur NN NN O
30mg CD CD O
as RB RB O
soon RB RB O
as IN IN O
arrives NNS NNS O
from IN IN O
pharmacy NN NN O
5 CD CD O
) ) ) O
Left NNP NNP O
ear NN NN O
impaction NN NN O
: : : O
Left NNP NNP O
TM NNP NNP O
w NN NN O
nearly RB RB O
completely RB RB O
obstructing JJ JJ O
cerumen NNS NNS O
. . . O
   
Irrigated NNP NNP O
ear NN NN O
w NN NN O
full JJ JJ O
removal NN NN O
and CC CC O
visualizatino NN NN O
of IN IN O
nl NN NN O
TM NNP NNP O
post NN NN O
irrigation NN NN O
. . . O
   
Pt NNP NNP O
confirms VBZ VBZ O
complete JJ JJ O
resolution NN NN O
of IN IN O
sxs NN NN O
w NN NN O
return NN NN O
of IN IN O
nl NN NN O
hearing NN NN O
. . . O
   
pt NN NN O
felt VBD VBD O
well RB RB O
post VBN VBN O
irrigation NN NN O
w NN NN O
no DT DT O
dizziness NN NN O
. . . O
   
disucsed VBD VBD O
possible JJ JJ O
dizziness NNS NNS O
and CC CC O
she PRP PRP O
will MD MD O
sit VB VB O
in IN IN O
waiting VBG VBG O
room NN NN O
for IN IN O
a DT DT O
while NN NN O
and CC CC O
make VB VB O
sure JJ JJ O
that IN IN O
she PRP PRP O
does VBZ VBZ O
not RB RB O
experience VB VB O
. . . O
   
6 CD CD O
) ) ) O
HCM NNP NNP O
: : : O
---- SYM SYM O
recevied VBN VBN O
flu NN NN O
shot NN NN O
---- : : O
will MD MD O
give VB VB O
h1n1 NN NN O
today NN NN O
--- : : O
will MD MD O
give VB VB O
tdap NN NN O
today NN NN O
To TO TO O
DO NNP NNP O
; : : O
   
---- SYM SYM O
fu NN NN O
on IN IN O
mammogram NN NN O
--- : : O
continue VB VB O
to TO TO O
discuss VB VB O
colonscopy NN NN O
Pt NNP NNP O
to TO TO O
RTc NNP NNP O
in IN IN O
~ NN NN O
1 CD CD O
mos NN NN O
or CC CC O
sooner NN NN O
if IN IN O
needed VBN VBN O
. . . O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2084-10-14 JJ JJ I-DATE
IORIO NNP NNP O
, , , O
Olivia NNP NNP I-PATIENT
( ( ( O
9290228 CD CD I-MEDICALRECORD
) ) ) O
OFFICE NNP NNP O
VISIT NNP NNP O
: : : O
10/14/84 CD CD I-DATE
This DT DT O
28-year-old JJ JJ O
young JJ JJ O
woman NN NN O
, , , O
status NN NN O
post NN NN O
two CD CD O
failed VBD VBD O
renal JJ JJ O
transplants NNS NNS O
, , , O
re-presents JJ JJ O
for IN IN O
evaluation NN NN O
. . . O
   
She PRP PRP O
is VBZ VBZ O
less RBR RBR O
depressed JJ JJ O
, , , O
more JJR JJR O
upbeat NN NN O
. . . O
   
Now RB RB O
a DT DT O
year NN NN O
since IN IN O
her PRP$ PRP$ O
father NN NN O
's POS POS O
death NN NN O
(? NN NN O
   
drug NN NN O
overdose NN NN O
) ) ) O
. . . O
   
She PRP PRP O
is VBZ VBZ O
on IN IN O
tapering VBG VBG O
prednisone NN NN O
after IN IN O
her PRP$ PRP$ O
severe JJ JJ O
rejection NN NN O
for IN IN O
noncompliance NN NN O
. . . O
   
She PRP PRP O
has VBZ VBZ O
multiple JJ JJ O
access NN NN O
problems NNS NNS O
, , , O
history NN NN O
of IN IN O
seizures NNS NNS O
, , , O
and CC CC O
severe JJ JJ O
hyperparathyroidism NN NN O
. . . O
   
Medications NNP NNP O
: : : O
Her PRP$ PRP$ O
meds NNS NNS O
include VBP VBP O
Prednisone NNP NNP O
2 CD CD O
mg NN NN O
in IN IN O
the DT DT O
a.m. NN NN O
, , , O
Nephrocaps NNP NNP O
, , , O
Prilosec NNP NNP O
20 CD CD O
q.d. NN NN O
, , , O
Midodrine NNP NNP O
5 CD CD O
mg NN NN O
only RB RB O
before IN IN O
dialysis NN NN O
, , , O
Diltanin NNP NNP O
400 CD CD O
mg NN NN O
b.i.d. NN NN O
, , , O
Tegretol NNP NNP O
250 CD CD O
b.i.d. NN NN O
, , , O
Renagel NNP NNP O
4 CD CD O
caps NNS NNS O
at IN IN O
breafast NN NN O
, , , O
lunch NN NN O
, , , O
dinner NN NN O
, , , O
3 CD CD O
capsules NNS NNS O
with IN IN O
snacks NNS NNS O
plus CC CC O
2 CD CD O
tablespoons NNS NNS O
Alternagel NNP NNP O
, , , O
Doxepin NNP NNP O
50 CD CD O
q.h.s. NN NN O
, , , O
Coumadin NNP NNP O
5 CD CD O
mg NN NN O
, , , O
Xanax NNP NNP O
4-5 JJ JJ O
tablets NNS NNS O
of IN IN O
0.5 CD CD O
q.d. NN NN O
, , , O
Celexa NNP NNP O
   
20 CD CD O
. . . O
Allergies NNP NNP O
: : : O
She PRP PRP O
has VBZ VBZ O
allergies NNS NNS O
to TO TO O
Cipro NNP NNP O
, , , O
Demerol NNP NNP O
, , , O
penicillin NN NN O
, , , O
and CC CC O
gets VBZ VBZ O
red JJ JJ O
man NN NN O
syndrome NN NN O
from IN IN O
Vanco NNP NNP O
if IN IN O
given VBN VBN O
rapidly RB RB O
. . . O
   
She PRP PRP O
has VBZ VBZ O
seasonal JJ JJ O
allergies NNS NNS O
and CC CC O
takes VBZ VBZ O
Zyrtec NNP NNP O
10 CD CD O
mg NN NN O
, , , O
Flonase NNP NNP O
2 CD CD O
sprays NNS NNS O
each DT DT O
nostril NN NN O
, , , O
Albuterol NNP NNP O
2 CD CD O
puffs NNS NNS O
4x CD CD O
a DT DT O
day NN NN O
as IN IN O
needed VBN VBN O
, , , O
and CC CC O
Advair NNP NNP O
2 CD CD O
puffs NNS NNS O
as IN IN O
needed VBN VBN O
. . . O
   
Social NNP NNP O
History NN NN O
: : : O
She PRP PRP O
is VBZ VBZ O
taking VBG VBG O
1 CD CD O
course NN NN O
at IN IN O
computer NN NN O
school NN NN O
. . . O
   
Physical JJ JJ O
Examination NNP NNP O
: : : O
Her PRP$ PRP$ O
blood NN NN O
pressure NN NN O
was VBD VBD O
170/90 CD CD O
- : : O
this DT DT O
is VBZ VBZ O
much RB RB O
higher JJR JJR O
for IN IN O
her PRP PRP O
. . . O
   
She PRP PRP O
has VBZ VBZ O
conjunctival NN NN O
injection NN NN O
, , , O
which WDT WDT O
is VBZ VBZ O
her PRP$ PRP$ O
acute JJ JJ O
red JJ JJ O
eye NN NN O
of IN IN O
uremia NN NN O
. . . O
   
Neck NN NN O
is VBZ VBZ O
supple JJ JJ O
. . . O
   
Carotid NNP NNP O
upstroke NN NN O
is VBZ VBZ O
normal JJ JJ O
. . . O
   
Thyroid NNP NNP O
is VBZ VBZ O
not RB RB O
enlarged VBN VBN O
. . . O
   
Chest NN NN O
is VBZ VBZ O
clear JJ JJ O
. . . O
   
She PRP PRP O
is VBZ VBZ O
chronically RB RB O
ill JJ JJ O
appearing VBG VBG O
. . . O
   
She PRP PRP O
has VBZ VBZ O
an DT DT O
S4 NNP NNP O
, , , O
no DT DT O
S3 NNP NNP O
. . . O
   
Abdomen NNP NNP O
is VBZ VBZ O
soft JJ JJ O
, , , O
nontender NN NN O
. . . O
   
Bowel NNP NNP O
sounds VBZ VBZ O
are VBP VBP O
normal JJ JJ O
. . . O
   
She PRP PRP O
has VBZ VBZ O
a DT DT O
graft NN NN O
in IN IN O
her PRP$ PRP$ O
leg NN NN O
. . . O
   
She PRP PRP O
as IN IN O
1 CD CD O
+ NN NN O
to TO TO O
2 CD CD O
+ NN NN O
edema NN NN O
. . . O
   
She PRP PRP O
has VBZ VBZ O
been VBN VBN O
gaining VBG VBG O
4 CD CD O
kg NN NN O
in IN IN O
the DT DT O
interdialytic JJ JJ O
period NN NN O
. . . O
   
Impression NNP NNP O
: : : O
Blood NNP NNP O
pressure NN NN O
is VBZ VBZ O
up RB RB O
. . . O
   
Hold VB VB O
the DT DT O
Midodrine NNP NNP O
, , , O
readjust NN NN O
her PRP$ PRP$ O
dry JJ JJ O
weight NN NN O
. . . O
   
She PRP PRP O
claims VBZ VBZ O
it PRP PRP O
is VBZ VBZ O
45 CD CD O
kg NN NN O
, , , O
I PRP PRP O
think VBP VBP O
it PRP PRP O
may MD MD O
be VB VB O
lower JJR JJR O
. . . O
   
May NNP NNP O
need VB VB O
antihypertensives NNS NNS O
if IN IN O
blood NN NN O
pressure NN NN O
remains NNS NNS O
elevated VBD VBD O
. . . O
   
Reinforced NNP NNP O
the DT DT O
need NN NN O
for IN IN O
calcium/phosphorus NN NN O
management NN NN O
. . . O
   
She PRP PRP O
will MD MD O
be VB VB O
seeing VBG VBG O
Dr NNP NNP O
. . . O
Ebert NNP NNP I-DOCTOR
. . . O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2095-03-12 NN NN I-DATE
3/12/2095 CD CD I-DATE
Youssef NNP NNP I-DOCTOR
Null NNP NNP I-DOCTOR
Ludlow NNP NNP I-HOSPITAL
Medical NNP NNP I-HOSPITAL
Center NNP NNP I-HOSPITAL
87 CD CD I-STREET
Manatee NNP NNP I-STREET
Street NNP NNP I-STREET
Post NNP NNP I-CITY
, , , O
IN IN IN I-STATE
86454 CD CD I-ZIP
Dear RB RB O
Dr NNP NNP O
. . . O
Null NNP NNP I-DOCTOR
, , , O
I PRP PRP O
had VBD VBD O
the DT DT I-LOCATION-OTHER
pleasure NN NN O
of IN IN O
seeing VBG VBG O
Nick NNP NNP I-PATIENT
Hall NNP NNP I-PATIENT
in IN IN O
WSH NNP NNP I-HOSPITAL
cardiology NN NN O
clinic NN NN O
today NN NN O
in IN IN O
follow-up JJ JJ O
for IN IN O
his PRP$ PRP$ O
known VBN VBN O
coronary JJ JJ O
artery NN NN O
disease NN NN O
and CC CC O
recent JJ JJ O
admission NN NN O
to TO TO O
Wytheville NNP NNP I-HOSPITAL
South NNP NNP I-HOSPITAL
with IN IN O
a DT DT O
non-ST JJ JJ O
elevation NN NN O
myocardial NN NN O
infarction NN NN O
. . . O
   
As IN IN O
I PRP PRP O
'm VBP VBP O
sure JJ JJ O
you PRP PRP O
recall VBP VBP O
, , , O
he PRP PRP O
is VBZ VBZ O
a DT DT O
lovely JJ JJ O
54 CD CD I-AGE
year NN NN O
old JJ JJ O
gentleman NN NN O
whose WP$ WP$ O
history NN NN O
of IN IN O
Hodgkins NNP NNP O
disease NN NN O
status-post JJ JJ O
mantle JJ JJ O
radiation NN NN O
in IN IN O
the DT DT I-LOCATION-OTHER
early JJ JJ O
70's, CD CD O
squamous JJ JJ O
cell NN NN O
lung NN NN O
cancer NN NN O
status NN NN O
post NN NN O
left VBD VBD O
upper JJ JJ O
lobectomy NN NN O
1/94 CD CD I-DATE
, , , O
and CC CC O
coronary JJ JJ O
artery NN NN O
disease NN NN O
, , , O
status NN NN O
post-PCI NN NN O
to TO TO O
the DT DT I-LOCATION-OTHER
LAD NNP NNP O
and CC CC O
RCA NNP NNP O
in IN IN O
' POS POS O
90 CD CD O
and CC CC O
' POS POS O
87 CD CD I-STREET
, , , O
respectively RB RB O
, , , O
and CC CC O
perioperative JJ JJ O
VT/VF NNP NNP O
arrest NN NN O
at IN IN O
the DT DT I-LOCATION-OTHER
time NN NN O
of IN IN O
his PRP$ PRP$ O
LUL NNP NNP O
resection NN NN O
1/94 CD CD I-DATE
. . . O
   
At IN IN O
that DT DT O
time NN NN O
, , , O
emergent NN NN O
catheterization NN NN O
revealed VBD VBD O
massive JJ JJ O
volume NN NN O
of IN IN O
thrombus NN NN O
extending VBG VBG O
throughout IN IN O
his PRP$ PRP$ O
RCA NNP NNP O
, , , O
managed VBN VBN O
with IN IN O
extensive JJ JJ O
suction NN NN O
catheter NN NN O
use NN NN O
and CC CC O
POBA NNP NNP O
, , , O
with IN IN O
a DT DT O
good JJ JJ O
angiographic JJ JJ O
result NN NN O
. . . O
   
No DT DT O
stents NNS NNS O
were VBD VBD O
placed VBN VBN O
given VBN VBN O
the DT DT I-LOCATION-OTHER
thrombus NN NN O
burden NN NN O
. . . O
   
Remarkably RB RB O
, , , O
subsequent JJ JJ O
echocardiogram NN NN O
revealed VBD VBD O
normal JJ JJ O
LV NNP NNP O
systolic JJ JJ O
function NN NN O
, , , O
with IN IN O
basal NN NN O
inferoposterior NN NN O
HK NNP NNP O
noted VBD VBD O
. . . O
   
His PRP$ PRP$ O
peak NN NN O
TnI NNP NNP O
was VBD VBD O
33.6 CD CD O
, , , O
his PRP$ PRP$ O
peak NN NN O
CK NNP NNP O
was VBD VBD O
1710 CD CD O
, , , O
and CC CC O
his PRP$ PRP$ O
peak NN NN O
MB NNP NNP O
was VBD VBD O
87.2 CD CD O
. . . O
   
He PRP PRP O
had VBD VBD O
a DT DT O
relatively RB RB O
unremarkable JJ JJ O
course NN NN O
post-catheterization NN NN O
; : : O
   
plavix NN NN O
initiation NN NN O
was VBD VBD O
delayed VBN VBN O
until IN IN O
his PRP$ PRP$ O
chest NN NN O
tube NN NN O
was VBD VBD O
removed VBN VBN O
, , , O
after IN IN O
which WDT WDT O
it PRP PRP O
was VBD VBD O
started VBN VBN O
without IN IN O
incident NN NN O
. . . O
   
He PRP PRP O
was VBD VBD O
discharged VBN VBN O
2/11/94 CD CD I-DATE
, , , O
and CC CC O
had VBD VBD O
done VBN VBN O
well RB RB O
until IN IN O
1/31/2095 CD CD I-DATE
, , , O
when WRB WRB O
he PRP PRP O
presented VBD VBD O
to TO TO O
WSH NNP NNP I-HOSPITAL
with IN IN O
unstable JJ JJ O
angina NN NN O
, , , O
having VBG VBG O
noted VBN VBN O
new JJ JJ O
sudden JJ JJ O
onset NN NN O
angina NN NN O
and CC CC O
dyspnea NN NN O
while IN IN O
making VBG VBG O
his PRP$ PRP$ O
daily JJ JJ O
walk NN NN O
. . . O
   
He PRP PRP O
had VBD VBD O
a DT DT O
positive JJ JJ O
troponin NN NN O
, , , O
and CC CC O
was VBD VBD O
taken VBN VBN O
urgently RB RB O
to TO TO O
cardiac VB VB O
catheterization NN NN O
, , , O
which WDT WDT O
revealed VBD VBD O
a DT DT O
proximal NN NN O
LAD NNP NNP O
lesion NN NN O
( ( ( O
felt VBD VBD O
to TO TO O
be VB VB O
the DT DT I-LOCATION-OTHER
culprit NN NN O
) ) ) O
and CC CC O
ostial JJ JJ O
RCA NNP NNP O
lesion NN NN O
, , , O
both DT DT O
of IN IN O
which WDT WDT O
were VBD VBD O
stented VBN VBN O
with IN IN O
CYPHER NNP NNP O
stents NNS NNS O
. . . O
   
At IN IN O
that DT DT O
time NN NN O
the DT DT I-LOCATION-OTHER
decision NN NN O
was VBD VBD O
made VBN VBN O
to TO TO O
increase VB VB O
his PRP$ PRP$ O
plavix NN NN O
from IN IN O
75 CD CD O
to TO TO O
150 CD CD O
as IN IN O
an DT DT O
attempt NN NN O
to TO TO O
maximize VB VB O
his PRP$ PRP$ O
medical JJ JJ O
management NN NN O
, , , O
given VBN VBN O
his PRP$ PRP$ O
history NN NN O
and CC CC O
disease NN NN O
burden NN NN O
. . . O
   
Since IN IN O
that DT DT O
admission NN NN O
, , , O
he PRP PRP O
has VBZ VBZ O
done VBN VBN O
exceedingly RB RB O
well RB RB O
, , , O
and CC CC O
presents VBZ VBZ O
today NN NN O
without IN IN O
complaints NNS NNS O
. . . O
   
He PRP PRP O
continues VBZ VBZ O
to TO TO O
walk VB VB O
2 CD CD O
miles NNS NNS O
~ NN NN O
4 CD CD O
times/week NN NN O
without IN IN O
exertional JJ JJ O
symptoms NNS NNS O
. . . O
   
He PRP PRP O
specifically RB RB O
denies VBZ VBZ O
chest NN NN O
pain NN NN O
, , , O
dyspnea NN NN O
, , , O
orthopnea NN NN O
, , , O
PND NNP NNP O
, , , O
or CC CC O
lower JJR JJR O
extremity NN NN O
edema NN NN O
. . . O
   
He PRP PRP O
has VBZ VBZ O
had VBN VBN O
no DT DT O
palpitations NNS NNS O
, , , O
dizziness/presyncope NN NN O
, , , O
or CC CC O
claudication NN NN O
. . . O
   
He PRP PRP O
has VBZ VBZ O
significantly RB RB O
modified VBN VBN O
his PRP$ PRP$ O
diet NN NN O
to TO TO O
eliminate VB VB O
dairy NN NN O
and CC CC O
hydrogenated JJ JJ O
products/snacks NNS NNS O
, , , O
with IN IN O
a DT DT O
5 CD CD O
# # # O
weight NN NN O
loss NN NN O
, , , O
and CC CC O
is VBZ VBZ O
motivated VBN VBN O
to TO TO O
further VB VB O
reduce VB VB O
his PRP$ PRP$ O
weight NN NN O
. . . O
   
He PRP PRP O
states VBZ VBZ O
that IN IN O
he PRP PRP O
feels VBZ VBZ O
"""" '' '' O
great JJ JJ O
"""" '' '' O
and CC CC O
isdoing VBG VBG O
quite RB RB O
well RB RB O
. . . O
   
He PRP PRP O
does VBZ VBZ O
not RB RB O
that IN IN O
occasionally RB RB O
at IN IN O
this DT DT O
work NN NN O
, , , O
when WRB WRB O
he PRP PRP O
is VBZ VBZ O
frustrated/upset VBN VBN O
, , , O
he PRP PRP O
will MD MD O
take VB VB O
his PRP$ PRP$ O
pressure NN NN O
and CC CC O
find VB VB O
his PRP$ PRP$ O
systolic JJ JJ O
to TO TO O
be VB VB O
~ NN NN O
150 CD CD O
, , , O
but CC CC O
this DT DT O
comes VBZ VBZ O
down RB RB O
within IN IN O
minutes NNS NNS O
if IN IN O
he PRP PRP O
relaxes VBZ VBZ O
, , , O
and CC CC O
his PRP$ PRP$ O
pressures NNS NNS O
are VBP VBP O
great JJ JJ O
at IN IN O
home NN NN O
. . . O
   
He PRP PRP O
has VBZ VBZ O
had VBN VBN O
no DT DT O
GI NN NN O
symptoms NNS NNS O
on IN IN O
the DT DT I-LOCATION-OTHER
aggressive JJ JJ O
antiplatelet NN NN O
regimen NNS NNS O
, , , O
despite IN IN O
not RB RB O
being VBG VBG O
on IN IN O
a DT DT O
PPI NNP NNP O
. . . O
   
Regarding VBG VBG O
his PRP$ PRP$ O
squamous JJ JJ O
cell NN NN O
lung NN NN O
cancer NN NN O
, , , O
it PRP PRP O
is VBZ VBZ O
my PRP$ PRP$ O
understanding NN NN O
that IN IN O
he PRP PRP O
had VBD VBD O
no DT DT O
evidence NN NN O
of IN IN O
metastatic JJ JJ O
disease NN NN O
and CC CC O
that IN IN O
margins NNS NNS O
were VBD VBD O
negative JJ JJ O
; : : O
   
he PRP PRP O
is VBZ VBZ O
not RB RB O
currently RB RB O
planned VBN VBN O
for IN IN O
any DT DT O
adjuvant NN NN O
therapy NN NN O
, , , O
but CC CC O
will MD MD O
be VB VB O
closely RB RB O
followed VBN VBN O
. . . O
   
His PRP$ PRP$ O
most RBS RBS O
recent JJ JJ O
imaging NN NN O
was VBD VBD O
11/94 CD CD I-DATE
, , , O
which WDT WDT O
was VBD VBD O
negative JJ JJ O
for IN IN O
evidence NN NN O
of IN IN O
metastasis NNS NNS O
by IN IN O
repor NN NN O
. . . O
   
Regarding VBG VBG O
his PRP$ PRP$ O
remote JJ JJ O
history NN NN O
of IN IN O
Hodgkins NNP NNP O
, , , O
he PRP PRP O
is VBZ VBZ O
followed VBN VBN O
at IN IN O
RFPC NNP NNP I-HOSPITAL
on IN IN O
an DT DT O
annual JJ JJ O
basis NN NN O
. . . O
   
His PRP$ PRP$ O
past JJ JJ O
medical JJ JJ O
history NN NN O
includes VBZ VBZ O
: : : O
CAD NNP NNP O
s/p NN NN O
IMI NNP NNP O
' POS POS O
88 CD CD O
( ( ( O
totally RB RB O
occluded VBD VBD O
RCA NNP NNP O
with IN IN O
good JJ JJ O
collaterals NNS NNS O
, , , O
revascularized VBN VBN O
with IN IN O
3 CD CD O
stents NNS NNS O
to TO TO O
the DT DT I-LOCATION-OTHER
RCA NNP NNP O
) ) ) O
, , , O
MI NNP NNP O
' POS POS O
90 CD CD O
( ( ( O
LAD NNP NNP O
stent NN NN O
) ) ) O
, , , O
inferior JJ JJ O
STEMI NNP NNP O
2/94 CD CD I-DATE
as IN IN O
above IN IN O
s/p NN NN O
POBA NNP NNP O
VF NNP NNP O
arrest NN NN O
in IN IN O
setting VBG VBG O
of IN IN O
STEMI NNP NNP O
Hodgkin NNP NNP O
's POS POS O
' POS POS O
81 CD CD O
- : : O
splenectomy NN NN O
, , , O
XRT NNP NNP O
LUL NNP NNP O
squamous JJ JJ O
cell NN NN O
cancer NN NN O
s/p NN NN O
L NNP NNP O
upper JJ JJ O
lobectomy NN NN O
2/94 CD CD I-DATE
hyperlipidemia NN NN O
( ( ( O
low JJ JJ O
HDL NNP NNP O
and CC CC O
high JJ JJ O
LDL NNP NNP O
- : : O
tried VBD VBD O
niaspan NN NN O
in IN IN O
the DT DT I-LOCATION-OTHER
past JJ JJ O
without IN IN O
much JJ JJ O
benefit NN NN O
) ) ) O
hypothyroid NN NN O
basal NN NN O
cell NN NN O
skin NN NN O
CA NNP NNP O
nephrolithiasis NN NN O
His PRP$ PRP$ O
medications NNS NNS O
include VBP VBP O
: : : O
Lipitor NNP NNP O
80 CD CD O
mg NN NN O
Plavix NNP NNP O
150 CD CD O
mg NN NN O
ASA NNP NNP O
325 CD CD O
mg NN NN O
po NN NN O
QD NNP NNP O
Toprol NNP NNP O
200 CD CD O
mg NN NN O
po NN NN O
BID NNP NNP O
Levoxyl NNP NNP O
Omega-3-fatty NNP NNP O
acids NNS NNS O
Multivitamin NNP NNP O
He PRP PRP O
has VBZ VBZ O
a DT DT O
history NN NN O
of IN IN O
intolerance NN NN O
   
( ( ( O
dizziness NN NN O
) ) ) O
with IN IN O
lisinopril NN NN O
. . . O
   
His PRP$ PRP$ O
family NN NN O
history NN NN O
is VBZ VBZ O
notable JJ JJ O
for IN IN O
hyperlipidemia NN NN O
and CC CC O
hypertension NN NN O
, , , O
but CC CC O
negative JJ JJ O
for IN IN O
CAD NNP NNP O
. . . O
   
He PRP PRP O
works VBZ VBZ O
in IN IN O
consulting VBG VBG I-PROFESSION
, , , O
and CC CC O
travels VBZ VBZ O
around IN IN O
the DT DT I-LOCATION-OTHER
midwest NN NN I-LOCATION-OTHER
as IN IN O
part NN NN O
of IN IN O
his PRP$ PRP$ O
job NN NN O
. . . O
   
He PRP PRP O
also RB RB O
works VBZ VBZ O
a DT DT O
few JJ JJ O
days NNS NNS O
a DT DT O
week NN NN O
at IN IN O
the DT DT I-LOCATION-OTHER
local JJ JJ O
supermarket NN NN I-ORGANIZATION
cashiering NN NN I-PROFESSION
, , , O
and CC CC O
works VBZ VBZ O
as IN IN O
a DT DT O
museum NN NN I-PROFESSION
docent NN NN I-PROFESSION
a DT DT O
few JJ JJ O
times NNS NNS O
a DT DT O
week NN NN O
. . . O
   
He PRP PRP O
is VBZ VBZ O
married VBN VBN O
, , , O
and CC CC O
lives NNS NNS O
in IN IN O
Lincoln NNP NNP I-CITY
City NNP NNP I-CITY
. . . O
   
He PRP PRP O
and CC CC O
his PRP$ PRP$ O
wife NN NN O
have VBP VBP O
4 CD CD O
children NNS NNS O
, , , O
ages NNS NNS O
15 CD CD I-AGE
/ NN NN O
17 CD CD I-AGE
/ NN NN O
20 CD CD I-AGE
/ NN NN O
24 CD CD I-AGE
; : : O
   
they PRP PRP O
have VBP VBP O
no DT DT O
pets NNS NNS O
. . . O
   
He PRP PRP O
has VBZ VBZ O
never RB RB O
smoked VBN VBN O
cigarettes NNS NNS O
. . . O
   
He PRP PRP O
drinks NNS NNS O
1 CD CD O
glass NN NN O
of IN IN O
wine NN NN O
a DT DT O
night NN NN O
. . . O
   
On IN IN O
physical JJ JJ O
exam NN NN O
today NN NN O
, , , O
he PRP PRP O
has VBZ VBZ O
a DT DT O
heart NN NN O
rate NN NN O
of IN IN O
75 CD CD O
and CC CC O
a DT DT O
blood NN NN O
pressure NN NN O
of IN IN O
129/81 CD CD O
, , , O
with IN IN O
a DT DT O
weight NN NN O
of IN IN O
220 CD CD O
# # # O
. . . O
   
He PRP PRP O
is VBZ VBZ O
a DT DT O
well RB RB O
developed VBN VBN O
well RB RB O
nourished VBN VBN O
gentleman NN NN O
in IN IN O
no DT DT O
apparent JJ JJ O
distress NN NN O
. . . O
   
His PRP$ PRP$ O
JVP NNP NNP O
is VBZ VBZ O
~ NN NN O
7-8 JJ JJ O
cm NN NN O
; : : O
   
he PRP PRP O
has VBZ VBZ O
no DT DT O
carotid NN NN O
bruits NNS NNS O
. . . O
   
His PRP$ PRP$ O
lungs NNS NNS O
are VBP VBP O
clear JJ JJ O
to TO TO O
auscultation NN NN O
bilaterally RB RB O
. . . O
   
He PRP PRP O
has VBZ VBZ O
a DT DT O
regular JJ JJ O
rate NN NN O
and CC CC O
rhythm NN NN O
with IN IN O
a DT DT O
normal JJ JJ O
S1 NNP NNP O
and CC CC O
a DT DT O
physiologically RB RB O
split NN NN O
S2 NNP NNP O
, , , O
and CC CC O
no DT DT O
murmurs NNS NNS O
, , , O
rubs NNS NNS O
, , , O
or CC CC O
gallups NNS NNS O
. . . O
   
His PRP$ PRP$ O
abdomen NN NN O
is VBZ VBZ O
benign NN NN O
. . . O
   
He PRP PRP O
is VBZ VBZ O
warm JJ JJ O
and CC CC O
well RB RB O
perfused VBN VBN O
peripherally RB RB O
without IN IN O
significant JJ JJ O
edema NN NN O
, , , O
and CC CC O
with IN IN O
2 CD CD O
+ NN NN O
PT NNP NNP O
pulses NNS NNS O
bilaterally RB RB O
. . . O
   
His PRP$ PRP$ O
EKG NNP NNP O
in IN IN O
clinic NN NN O
today NN NN O
is VBZ VBZ O
NSR NNP NNP O
at IN IN O
75 CD CD O
with IN IN O
possible JJ JJ O
left VBD VBD O
atrial JJ JJ O
abnormality NN NN O
, , , O
a DT DT O
nonspeciifc NN NN O
IVCD NNP NNP O
, , , O
and CC CC O
inferior JJ JJ O
Q NNP NNP O
waves NNS NNS O
in IN IN O
III/F NNP NNP O
, , , O
consistent JJ JJ O
with IN IN O
an DT DT O
inferior JJ JJ O
MI NNP NNP O
. . . O
   
In IN IN O
summary NN NN O
, , , O
this DT DT O
is VBZ VBZ O
a DT DT O
54 CD CD I-AGE
year NN NN O
old JJ JJ O
man NN NN O
who WP WP O
had VBD VBD O
a DT DT O
VF NNP NNP O
arrest NN NN O
in IN IN O
the DT DT I-LOCATION-OTHER
setting VBG VBG O
of IN IN O
perioperative JJ JJ O
inferior JJ JJ O
STEMI NNP NNP O
, , , O
status NN NN O
post NN NN O
extensive JJ JJ O
angiojet NN NN O
and CC CC O
POBA NNP NNP O
of IN IN O
acute JJ JJ O
in-stent JJ JJ O
thrombosis NN NN O
of IN IN O
presumed JJ JJ O
bare JJ JJ O
metal NN NN O
stents NNS NNS O
in IN IN O
his PRP$ PRP$ O
RCA NNP NNP O
, , , O
who WP WP O
represented VBD VBD O
1 CD CD O
year NN NN O
later RB RB O
( ( ( O
1/95 CD CD I-DATE
) ) ) O
with IN IN O
NSTEMI NNP NNP O
now RB RB O
s/p NN NN O
PCI NNP NNP O
to TO TO O
his PRP$ PRP$ O
RCA NNP NNP O
and CC CC O
LAD NNP NNP O
. . . O
   
He PRP PRP O
is VBZ VBZ O
now RB RB O
asymptomatic JJ JJ O
status NN NN O
post NN NN O
this DT DT O
intervention NN NN O
Given VBN VBN O
his PRP$ PRP$ O
history NN NN O
, , , O
we PRP PRP O
agree VBP VBP O
with IN IN O
antiplatelet NN NN O
therapy NN NN O
, , , O
with IN IN O
a DT DT O
plan NN NN O
for IN IN O
lifelong JJ JJ O
plavix NN NN O
and CC CC O
aspirin NN NN O
. . . O
   
Should MD MD O
he PRP PRP O
require VB VB O
future JJ JJ O
invasive JJ JJ O
diagnostic JJ JJ O
procedures NNS NNS O
, , , O
it PRP PRP O
would MD MD O
be VB VB O
reasonable JJ JJ O
to TO TO O
decrease VB VB O
doses NNS NNS O
to TO TO O
75 CD CD O
plavix/81 NN NN O
ASA NNP NNP O
, , , O
but CC CC O
we PRP PRP O
would MD MD O
not RB RB O
favor VB VB O
DC NNP NNP O
of IN IN O
either DT DT O
of IN IN O
these DT DT O
medications NNS NNS O
altogether RB RB O
. . . O
   
His PRP$ PRP$ O
blood NN NN O
pressure NN NN O
and CC CC O
heart NN NN O
rate NN NN O
are VBP VBP O
well RB RB O
controlled VBN VBN O
on IN IN O
his PRP$ PRP$ O
current JJ JJ O
regimen NNS NNS O
, , , O
as IN IN O
demonstrated VBN VBN O
by IN IN O
his PRP$ PRP$ O
home NN NN O
records NNS NNS O
. . . O
   
His PRP$ PRP$ O
LDL NNP NNP O
is VBZ VBZ O
near IN IN O
goal NN NN O
, , , O
with IN IN O
a DT DT O
low JJ JJ O
HDL NNP NNP O
that WDT WDT O
was VBD VBD O
unaffected JJ JJ O
by IN IN O
high-dose JJ JJ O
niaspan NN NN O
in IN IN O
the DT DT I-LOCATION-OTHER
past NN NN O
. . . O
   
I PRP PRP O
share VBP VBP O
his PRP$ PRP$ O
hope VBP VBP O
that IN IN O
with IN IN O
further JJ JJ O
diet/weight NN NN O
loss NN NN O
and CC CC O
exercise NN NN O
, , , O
these DT DT O
will MD MD O
both DT DT O
improve VB VB O
to TO TO O
goal NN NN O
. . . O
   
As IN IN O
I PRP PRP O
have VBP VBP O
discussed VBN VBN O
with IN IN O
he PRP PRP O
and CC CC O
his PRP$ PRP$ O
wife NN NN O
, , , O
given VBN VBN O
his PRP$ PRP$ O
history NN NN O
of IN IN O
Hodgkin NNP NNP O
's POS POS O
, , , O
as RB RB O
well RB RB O
as IN IN O
his PRP$ PRP$ O
known VBN VBN O
CAD NNP NNP O
, , , O
he PRP PRP O
is VBZ VBZ O
clearly RB RB O
at IN IN O
risk NN NN O
for IN IN O
future JJ JJ O
events NNS NNS O
, , , O
including VBG VBG O
the DT DT I-LOCATION-OTHER
possibility NN NN O
of IN IN O
bypass NN NN O
surgery NN NN O
in IN IN O
the DT DT I-LOCATION-OTHER
future NN NN O
. . . O
   
We PRP PRP O
will MD MD O
be VB VB O
guided VBN VBN O
by IN IN O
his PRP$ PRP$ O
symptoms NNS NNS O
, , , O
and CC CC O
he PRP PRP O
knows VBZ VBZ O
to TO TO O
call VB VB O
me PRP PRP O
if IN IN O
he PRP PRP O
has VBZ VBZ O
any DT DT O
problems/symptoms NNS NNS O
. . . O
   
It PRP PRP O
was VBD VBD O
a DT DT O
pleasure NN NN O
to TO TO O
see VB VB O
Mr NNP NNP O
. . . O
Hall NNP NNP I-PATIENT
in IN IN O
cardiology NN NN O
clinic NN NN O
today NN NN O
. . . O
   
I PRP PRP O
will MD MD O
plan VB VB O
to TO TO O
see VB VB O
him PRP PRP O
in IN IN O
follow-up JJ JJ O
in IN IN O
6 CD CD O
months NNS NNS O
time NN NN O
, , , O
but CC CC O
he PRP PRP O
knows VBZ VBZ O
to TO TO O
call VB VB O
sooner RBR RBR O
should MD MD O
he PRP PRP O
have VB VB O
any DT DT O
problems NNS NNS O
or CC CC O
concerns NNS NNS O
. . . O
   
Regards NNP NNP O
, , , O
____________________________________________ NN NN O
_ NN NN O
Florence NNP NNP I-DOCTOR
Heather NNP NNP I-DOCTOR
Gil NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
, , , O
Ph.D NNP NNP O
. . . O
   
CC NNP NNP O
: : : O
Dr NNP NNP O
. . . O
Nick NNP NNP I-PATIENT
Golden NNP NNP I-DOCTOR
Thoracic NNP NNP O
Surgery NNP NNP O
Wytheville NNP NNP I-HOSPITAL
South NNP NNP I-HOSPITAL
Hospital NNP NNP I-HOSPITAL
Dr NNP NNP O
. . . O
Paul NNP NNP I-DOCTOR
Reilly NNP NNP I-DOCTOR
Riverside NNP NNP I-HOSPITAL
Family NNP NNP I-HOSPITAL
Practice NNP NNP I-HOSPITAL
Center NNP NNP I-HOSPITAL
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2112-09-30 JJ JJ I-DATE
SECTIONS NNP NNP O
OF IN IN O
THIS DT DT O
NOTE NN NN O
WERE VBD VBD O
CREATED NNP NNP O
WITH IN IN O
A DT DT O
' POS POS O
COPY NNP NNP O
AND CC CC O
PASTE NNP NNP O
' POS POS O
ACTION NNP NNP O
. . . O
   
THESE DT DT O
SECTIONS NNP NNP O
MAY NNP NNP O
NOT RB RB O
HAVE NNP NNP O
COPIED NNP NNP O
COMPLETELY RB RB O
. . . O
   
PLEASE NNP NNP O
USE NNP NNP O
CAUTION NNP NNP O
WHEN WRB WRB O
RENDERING NNP NNP O
CLINICAL NNP NNP O
JUDGMENT NNP NNP O
BASED NNP NNP O
ON IN IN O
THE DT DT O
INFORMATION NNP NNP O
IN IN IN O
THIS DT DT O
NOTE NN NN O
. . . O
   
Vascular NNP NNP O
surgery NN NN O
consult NN NN O
note NN NN O
Date NN NN O
: : : O
09/30/2112 CD CD I-DATE
Time NNP NNP O
: : : O
10pm CD CD O
Patient:Adair NNP NNP O
, , , O
Helen NNP NNP I-PATIENT
MR NNP NNP O
# # # O
: : : O
6842267 CD CD I-MEDICALRECORD
CC NNP NNP O
: : : O
Right RB RB O
foot NN NN O
infection NN NN O
HPI NNP NNP O
: : : O
50 CD CD I-AGE
y/o NN NN O
F NN NN O
diabetic JJ JJ O
female JJ JJ O
who WP WP O
noticed VBD VBD O
redness NN NN O
of IN IN O
the DT DT O
right NN NN O
4th CD CD O
and CC CC O
5th CD CD O
toes NNS NNS O
about IN IN O
a DT DT O
week NN NN O
ago.She NN NN O
was VBD VBD O
seen VBN VBN O
and CC CC O
given VBN VBN O
cipro.Her NN NN O
infection NN NN O
progressed.She RB RB O
now RB RB O
presents VBZ VBZ O
with IN IN O
worsening VBG VBG O
infection NN NN O
, , , O
pain NN NN O
, , , O
but CC CC O
no DT DT O
fever.Of NN NN O
note NN NN O
, , , O
ROS NNP NNP O
is VBZ VBZ O
positive JJ JJ O
for IN IN O
symptoms NNS NNS O
of IN IN O
claudication NN NN O
. . . O
   
PMH/PSH NNP NNP O
: : : O
Diabetes NNP NNP O
mellitus NN NN O
type NN NN O
2 CD CD O
Hyperlipidemia NNP NNP O
Claudication NNP NNP O
Peripheral NNP NNP O
vascular NN NN O
disease NN NN O
MEDS NNP NNP O
: : : O
Cilostazol NNP NNP O
( ( ( O
CILOSTAZOL NNP NNP O
) ) ) O
100 CD CD O
MG NNP NNP O
( ( ( O
100MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
) ) ) O
PO NNP NNP O
BID NNP NNP O
Glipizide NNP NNP O
Xl NNP NNP O
( ( ( O
GLIPIZIDE NNP NNP O
Xl NNP NNP O
) ) ) O
10 CD CD O
MG NNP NNP O
( ( ( O
10MG CD CD O
TAB NNP NNP O
OSM NNP NNP O
24 CD CD O
take NN NN O
1 CD CD O
) ) ) O
PO NNP NNP O
QD NNP NNP O
LISINOPRIL NNP NNP O
2.5 CD CD O
MG NNP NNP O
(2.5MG NNP NNP O
TABLET NNP NNP O
take NN NN O
1 CD CD O
) ) ) O
PO NNP NNP O
QD NNP NNP O
METFORMIN NNP NNP O
500 CD CD O
MG NNP NNP O
( ( ( O
500MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
) ) ) O
PO NNP NNP O
BID NNP NNP O
x SYM SYM O
30 CD CD O
days NNS NNS O
Pravastatin NNP NNP O
( ( ( O
PRAVASTATIN NNP NNP O
) ) ) O
10 CD CD O
MG NNP NNP O
( ( ( O
10MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
) ) ) O
PO NNP NNP O
QHS NNP NNP O
x SYM SYM O
30 CD CD O
days NNS NNS O
Tramadol NNP NNP O
( ( ( O
TRAMADOL NNP NNP O
) ) ) O
50 CD CD I-AGE
MG NNP NNP O
( ( ( O
50MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
) ) ) O
PO NNP NNP O
Q6H NNP NNP O
PRN NNP NNP O
x SYM SYM O
30 CD CD O
days NNS NNS O
ALLERGY NNP NNP O
: : : O
nkda NN NN O
EXAM NNP NNP O
: : : O
Temp NNP NNP O
= SYM SYM O
98 CD CD O
HR NNP NNP O
= SYM SYM O
104 CD CD O
BP NNP NNP O
= SYM SYM O
129/80 CD CD O
RR NNP NNP O
= SYM SYM O
16 CD CD O
Sat NNP NNP O
= SYM SYM O
97%RA CD CD O
NAD NNP NNP O
, , , O
AAOx3 NNP NNP O
Ext NNP NNP O
Right RB RB O
5th CD CD O
toe NN NN O
appears VBZ VBZ O
necrotic JJ JJ O
, , , O
4th JJ JJ O
toe NN NN O
ulcerated JJ JJ O
laterally RB RB O
where WRB WRB O
the DT DT O
4th JJ JJ O
and CC CC O
5th CD CD O
toe NN NN O
rub NN NN O
together RB RB O
R NNP NNP O
forefoot NN NN O
is VBZ VBZ O
erythematous JJ JJ O
and CC CC O
warm JJ JJ O
, , , O
+ NN NN O
edema NN NN O
. . . O
   
Pulse NNP NNP O
Fem NNP NNP O
DP NNP NNP O
PT NNP NNP O
Right RB RB O
1 CD CD O
+ NN NN O
D NNP NNP O
- : : O
Left NNP NNP O
1 CD CD O
+ NN NN O
D NNP NNP O
- : : O
LABS NNP NNP O
: : : O
Chemistry NNP NNP O
Detail NNP NNP O
for IN IN O
ADAIR NNP NNP O
, , , O
HELEN NNP NNP I-PATIENT
V NNP NNP I-PATIENT
NVHBLOOD NNP NNP O
30-Sep-2112 NN NN I-DATE
20:54Accession# CD CD O
2693D15325 CD CD I-MEDICALRECORD
Test NNP NNP O
Description NNP NNP O
Result NNP NNP O
Flags NNP NNP O
Ref NNP NNP O
. . . O
   
Range NNP NNP O
Units NNP NNP O
Plasma NNP NNP O
Sodium NNP NNP O
134 CD CD O
L NNP NNP O
( ( ( O
135-145 JJ JJ O
) ) ) O
mmol/L NN NN O
Plasma NNP NNP O
Potassium NNP NNP O
3.7 CD CD O
( ( ( O
3.4-4.8 NN NN O
) ) ) O
mmol/L NN NN O
Plasma NNP NNP O
Chloride NNP NNP O
101 CD CD O
( ( ( O
100-108 NN NN O
) ) ) O
mmol/L NN NN O
Plasma NNP NNP O
Carbon NNP NNP O
Dioxide NNP NNP O
26.5 CD CD O
( ( ( O
23.0-31.9 JJ JJ O
) ) ) O
mmol/L NN NN O
Plasma NNP NNP O
Urea NNP NNP O
Nitrogen NNP NNP O
19 CD CD O
( ( ( O
8-25 JJ JJ O
) ) ) O
mg/dl NN NN O
Plasma NNP NNP O
Creatinine NNP NNP O
1.2 CD CD O
( ( ( O
0.6-1.5 NN NN O
) ) ) O
mg/dl NN NN O
Plasma NNP NNP O
Glucose NNP NNP O
155 CD CD O
H NNP NNP O
( ( ( O
70-110 NN NN O
) ) ) O
mg/dl NN NN O
WBC NNP NNP O
12.7 CD CD O
H NNP NNP O
( ( ( O
4.5-11.0 JJ JJ O
) ) ) O
th/cmm NN NN O
HCT NNP NNP O
34.5 CD CD O
L NNP NNP O
( ( ( O
36.0-46.0 JJ JJ O
) ) ) O
% NN NN O
HGB NNP NNP O
12.0 CD CD O
( ( ( O
12.0-16.0 NN NN O
) ) ) O
gm/dl NN NN O
RBC NNP NNP O
4.03 CD CD O
( ( ( O
4.00-5.20 NN NN O
) ) ) O
mil/cmm NN NN O
PLT NNP NNP O
350 CD CD O
( ( ( O
150-350 NN NN O
) ) ) O
th/cumm NN NN O
Superstat NNP NNP O
PT NNP NNP O
12.9 CD CD O
( ( ( O
10.3-13.2 NN NN O
) ) ) O
sec NN NN O
Superstat NNP NNP O
PT-INR NNP NNP O
1.1 CD CD O
Superstat NNP NNP O
APTT NNP NNP O
28.8 CD CD O
( ( ( O
22.1-34.0 JJ JJ O
) ) ) O
sec NN NN O
MRA NNP NNP O
: : : O
recently RB RB O
performed VBN VBN O
but CC CC O
not RB RB O
read.By VB VB O
my PRP$ PRP$ O
read NN NN O
, , , O
looks VBZ VBZ O
as IN IN O
though IN IN O
iliacs NNS NNS O
and CC CC O
CFAs NNP NNP O
are VBP VBP O
OK JJ JJ O
, , , O
but CC CC O
there EX EX O
is VBZ VBZ O
left VBN VBN O
and CC CC O
right JJ JJ O
SFA NNP NNP O
lesions.The NN NN O
popliteal NN NN O
artery NN NN O
reconstitutes NNS NNS O
bilaterally.Distally RB RB O
, , , O
one CD CD O
vessel NN NN O
run NN NN O
off RP RP O
( ( ( O
DP NNP NNP O
) ) ) O
. . . O
   
Please VB VB O
A/P NNP NNP O
: : : O
Diabetic NNP NNP O
foot NN NN O
infection.PVD NN NN O
. . . O
   
* NN NN O
Agree NNP NNP O
with IN IN O
admit NN NN O
to TO TO O
medicine VB VB O
for IN IN O
IV NNP NNP O
antibiotics NNS NNS O
* NN NN O
Vascular NNP NNP O
surgery NN NN O
service NN NN O
/ NN NN O
Dr NNP NNP O
. . . O
Salgado&#8217; NNP NNP O
   
s VBZ VBZ O
service NN NN O
will MD MD O
follow VB VB O
with IN IN O
you PRP PRP O
* NN NN O
She PRP PRP O
is VBZ VBZ O
likely JJ JJ O
a DT DT O
candidate NN NN O
for IN IN O
revascularization.Will NN NN O
review NN NN O
MRA NNP NNP O
and CC CC O
provide VB VB O
further JJ JJ O
recommendations NNS NNS O
* NN NN O
Further NNP NNP O
recommendations NNS NNS O
for IN IN O
toe NN NN O
in IN IN O
the DT DT O
AM NNP NNP O
. . . O
   
* NN NN O
Will NNP NNP O
follow VB VB O
with IN IN O
you PRP PRP O
, , , O
please VB VB O
call NN NN O
Vascular NNP NNP O
Millen NNP NNP I-CITY
service NN NN O
with IN IN O
questions NNS NNS O
. . . O
   
* NN NN O
Discussed NNP NNP O
with IN IN O
Dr NNP NNP O
. . . O
Kennedy NNP NNP I-DOCTOR
___________________________________________________ NNP NNP O
_ NN NN O
Vance NNP NNP I-DOCTOR
U. NNP NNP I-DOCTOR
Arias NNP NNP I-DOCTOR
, , , O
MD NNP NNP O
, , , O
Resident NNP NNP O
in IN IN O
Surgery NNP NNP O
, , , O
Pager NNP NNP O
51363 CD CD I-PHONE
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2088-12-21 JJ JJ I-DATE
POLK NNP NNP I-HOSPITAL
GENERAL NNP NNP I-HOSPITAL
HOSPITAL NNP NNP I-HOSPITAL
Internal NNP NNP O
Medicine NNP NNP O
42 CD CD I-STREET
Lisbon NNP NNP I-STREET
Lane NNP NNP I-STREET
Holden NNP NNP O
, , , O
Matias NNP NNP I-PATIENT
Palacios NNP NNP I-CITY
, , , O
NE NNP NNP I-STATE
73819 CD CD I-ZIP
97198841 CD CD I-MEDICALRECORD
12-21-88 JJ JJ I-DATE
Patient NNP NNP O
is VBZ VBZ O
a DT DT O
34-year-old JJ JJ O
man NN NN O
who WP WP O
comes VBZ VBZ O
in IN IN O
for IN IN O
follow VB VB O
up RB RB O
on IN IN O
his PRP$ PRP$ O
newly RB RB O
diagnosed VBN VBN O
type NN NN O
II NNP NNP O
diabetes NNS NNS O
. . . O
   
He PRP PRP O
has VBZ VBZ O
been VBN VBN O
very RB RB O
compliant JJ JJ O
with IN IN O
his PRP$ PRP$ O
medication NN NN O
regimen NNS NNS O
which WDT WDT O
consists VBZ VBZ O
of IN IN O
metformin NN NN O
850mg CD CD O
PO NNP NNP O
t.i.d. NN NN O
and CC CC O
NPH NNP NNP O
insulin NN NN O
subQ NN NN O
q.AM NN NN O
. . . O
   
He PRP PRP O
has VBZ VBZ O
had VBN VBN O
2 CD CD O
episodes NNS NNS O
of IN IN O
sweating VBG VBG O
, , , O
but CC CC O
he PRP PRP O
did VBD VBD O
not RB RB O
check VB VB O
his PRP$ PRP$ O
blood NN NN O
sugar NN NN O
at IN IN O
the DT DT O
time NN NN O
. . . O
   
He PRP PRP O
has VBZ VBZ O
not RB RB O
had VBN VBN O
any DT DT O
frank NN NN O
palpitations NNS NNS O
or CC CC O
lightheadedness NN NN O
. . . O
   
He PRP PRP O
did VBD VBD O
have VB VB O
1 CD CD O
episode NN NN O
where WRB WRB O
he PRP PRP O
had VBD VBD O
the DT DT O
sensation NN NN O
of IN IN O
several JJ JJ O
extra JJ JJ O
heart NN NN O
beats NNS NNS O
. . . O
   
This DT DT O
was VBD VBD O
not RB RB O
accompanied VBN VBN O
by IN IN O
other JJ JJ O
symptoms NNS NNS O
including VBG VBG O
no DT DT O
chest NN NN O
pain NN NN O
. . . O
   
He PRP PRP O
has VBZ VBZ O
never RB RB O
had VBN VBN O
a DT DT O
fingerstick JJ JJ O
blood NN NN O
glucose NN NN O
below IN IN O
the DT DT O
mid JJ JJ O
150's. CD CD O
   
I PRP PRP O
am VBP VBP O
looking VBG VBG O
through IN IN O
his PRP$ PRP$ O
log NN NN O
and CC CC O
see VB VB O
that IN IN O
his PRP$ PRP$ O
AM NNP NNP O
prebreakfast JJ JJ O
glucoses NNS NNS O
have VBP VBP O
been VBN VBN O
between IN IN O
178-306 JJ JJ O
and CC CC O
before IN IN O
dinner NN NN O
they PRP PRP O
have VBP VBP O
been VBN VBN O
between IN IN O
157-296 JJ JJ O
. . . O
   
He PRP PRP O
has VBZ VBZ O
already RB RB O
met VBN VBN O
several JJ JJ O
times NNS NNS O
with IN IN O
Makenzie NNP NNP I-DOCTOR
Kim NNP NNP I-DOCTOR
for IN IN O
diabetes NN NN O
education NN NN O
and CC CC O
for IN IN O
tailoring VBG VBG O
of IN IN O
his PRP$ PRP$ O
therapy NN NN O
and CC CC O
has VBZ VBZ O
met VBN VBN O
with IN IN O
a DT DT O
nutritionist NN NN O
to TO TO O
review VB VB O
the DT DT O
concepts NNS NNS O
of IN IN O
a DT DT O
diabetic JJ JJ O
diet NN NN O
. . . O
   
On IN IN O
physical JJ JJ O
exam NN NN O
, , , O
he PRP PRP O
is VBZ VBZ O
in IN IN O
no DT DT O
distress NN NN O
, , , O
his PRP$ PRP$ O
weight NN NN O
is VBZ VBZ O
231 CD CD O
, , , O
his PRP$ PRP$ O
blood NN NN O
pressure NN NN O
is VBZ VBZ O
132/78 CD CD O
in IN IN O
the DT DT O
right JJ JJ O
arm NN NN O
sitting VBG VBG O
. . . O
   
IMPRESSION NNP NNP O
AND CC CC O
PLAN NNP NNP O
: : : O
He PRP PRP O
still RB RB O
has VBZ VBZ O
high JJ JJ O
sugars NNS NNS O
. . . O
   
I PRP PRP O
will MD MD O
increase VB VB O
his PRP$ PRP$ O
insulin NN NN O
regimen NNS NNS O
. . . O
   
He PRP PRP O
is VBZ VBZ O
amenable JJ JJ O
to TO TO O
adding VBG VBG O
a DT DT O
second JJ JJ O
injection NN NN O
and CC CC O
so IN IN O
his PRP$ PRP$ O
new JJ JJ O
regimen NNS NNS O
will MD MD O
be VB VB O
NPH NNP NNP O
insulin NN NN O
15 CD CD O
units NNS NNS O
before IN IN O
breakfast NN NN O
and CC CC O
15 CD CD O
units NNS NNS O
before RB RB O
bedtime NN NN O
. . . O
   
And CC CC O
he PRP PRP O
continues VBZ VBZ O
to TO TO O
take VB VB O
metformin NN NN O
850mg CD CD O
PO NNP NNP O
t.i.d. NN NN O
and CC CC O
I PRP PRP O
have VBP VBP O
given VBN VBN O
him PRP PRP O
a DT DT O
prescription NN NN O
for IN IN O
this DT DT O
, , , O
#90 NN NN O
, , , O
refills VBZ VBZ O
3 CD CD O
, , , O
as RB RB O
well RB RB O
as IN IN O
syringes NNS NNS O
and CC CC O
needles NNS NNS O
, , , O
#60 NN NN O
, , , O
refills VBZ VBZ O
   
3 CD CD O
. . . O
He PRP PRP O
is VBZ VBZ O
to TO TO O
follow VB VB O
up RP RP O
with IN IN O
me PRP PRP O
in IN IN O
several JJ JJ O
months NNS NNS O
and CC CC O
sooner RBR RBR O
if IN IN O
he PRP PRP O
has VBZ VBZ O
new JJ JJ O
problems NNS NNS O
or CC CC O
concerns NNS NNS O
. . . O
   
I PRP PRP O
have VBP VBP O
advised VBN VBN O
him PRP PRP O
about IN IN O
increasing VBG VBG O
his PRP$ PRP$ O
level NN NN O
of IN IN O
activity NN NN O
and CC CC O
about IN IN O
maintaining VBG VBG O
his PRP$ PRP$ O
diet NN NN O
and CC CC O
I PRP PRP O
have VBP VBP O
also RB RB O
asked VBN VBN O
him PRP PRP O
to TO TO O
contact VB VB O
me PRP PRP O
if IN IN O
he PRP PRP O
should MD MD O
have VB VB O
any DT DT O
symptoms NNS NNS O
of IN IN O
hypoglycemia NN NN O
and CC CC O
to TO TO O
obtain VB VB O
his PRP$ PRP$ O
fingerstick JJ JJ O
glucose NN NN O
reading NN NN O
at IN IN O
that DT DT O
time NN NN O
as RB RB O
well RB RB O
. . . O
   
________________________ NN NN O
_ NN NN O
Xaiden NNP NNP I-DOCTOR
Roberson NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
   
PZ:WX:4138 NNP NNP O
DD:12-21-88 NNP NNP O
DT:12-23-88 NNP NNP O
DV:12-21-88 NNP NNP O
******** NN NN O
Approved NNP NNP O
but CC CC O
not RB RB O
reviewed VBN VBN O
by IN IN O
Provider NNP NNP O
******** NN NN O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2081-02-13 JJ JJ I-DATE
PACU NNP NNP O
Overnight NNP NNP O
Admission NNP NNP O
H&amp NNP NNP O
; : : O
   
P NN NN O
Patient NNP NNP O
Name NN NN O
: : : O
Ray NNP NNP O
, , , O
Patricia NNP NNP I-PATIENT
L NNP NNP I-PATIENT
MR NNP NNP O
# # # O
: : : O
8744185 CD CD I-MEDICALRECORD
Date NN NN O
: : : O
2/13 CD CD I-DATE
Time NNP NNP O
: : : O
6 CD CD O
pm NN NN O
Diagnosis NNP NNP O
: : : O
left VBD VBD O
knee NN NN O
prosthesis NN NN O
infection NN NN O
, , , O
s/p NN NN O
left VBD VBD O
knee NN NN O
prosthesis NNS NNS O
removal NN NN O
and CC CC O
antibiotic JJ JJ O
spacer NN NN O
insert NN NN O
Admitting NNP NNP O
Service NNP NNP O
: : : O
History NN NN O
of IN IN O
Present JJ JJ O
Illness NNP NNP O
: : : O
72 CD CD I-AGE
yo NN NN O
F NN NN O
hx NN NN O
AS NNP NNP O
x/p NN NN O
AVR NNP NNP O
, , , O
MR NNP NNP O
, , , O
MI NNP NNP O
, , , O
HTN NNP NNP O
, , , O
DM NNP NNP O
, , , O
HLD NNP NNP O
, , , O
interstitial JJ JJ O
lung NN NN O
disese NN NN O
, , , O
and CC CC O
PE NNP NNP O
. . . O
   
She PRP PRP O
had VBD VBD O
TKR NNP NNP O
7 CD CD O
yr NN NN O
ago RB RB O
, , , O
and CC CC O
now RB RB O
ESR NNP NNP O
and CC CC O
CRP NNP NNP O
elevated VBD VBD O
with IN IN O
severe JJ JJ O
knee NN NN O
pain NN NN O
, , , O
? . . O
   
infection NN NN O
in IN IN O
left VBD VBD O
knee NN NN O
. . . O
   
She PRP PRP O
has VBZ VBZ O
been VBN VBN O
afebrile JJ JJ O
. . . O
   
She PRP PRP O
had VBD VBD O
left VBN VBN O
knee NN NN O
prosthesis NNS NNS O
removal NN NN O
and CC CC O
antibiotic JJ JJ O
spacer NN NN O
insert NN NN O
2/13 CD CD I-DATE
. . . O
   
Intraoperative NNP NNP O
Course NN NN O
: : : O
Airway NNP NNP O
: : : O
easy JJ JJ O
mask NN NN O
, , , O
gd1 NN NN O
view NN NN O
I/O NNP NNP O
: : : O
EBL NNP NNP O
200 CD CD O
ML NNP NNP O
, , , O
UO NNP NNP O
900 CD CD O
ml NN NN O
, , , O
LR NNP NNP O
2000 CD CD O
ml NN NN O
Access NNP NNP O
: : : O
PIV NNP NNP O
Abnormal NNP NNP O
issues NNS NNS O
: : : O
no DT DT O
Antibiotics NNP NNP O
: : : O
vancomycin NN NN O
1 CD CD O
gm NN NN O
10 CD CD O
AM NNP NNP O
Pain NN NN O
control NN NN O
: : : O
( ( ( O
1 CD CD O
) ) ) O
Aortic NNP NNP O
stenosis NNS NNS O
- : : O
s/p NN NN O
redo-AVR NN NN O
in IN IN O
4/80 CD CD I-DATE
. . . O
   
Rocky NNP NNP O
postoperative JJ JJ O
course NN NN O
notable JJ JJ O
for IN IN O
respiratory JJ JJ O
failure NN NN O
requiring VBG VBG O
prolonged JJ JJ O
ventilator NN NN O
support NN NN O
and CC CC O
sepsis NNS NNS O
. . . O
   
( ( ( O
2 CD CD O
) ) ) O
Mitral NNP NNP O
regurgitation NN NN O
- : : O
moderate JJ JJ O
to TO TO O
severe JJ JJ O
MR NNP NNP O
by IN IN O
echo NN NN O
in IN IN O
5/80 CD CD I-DATE
though IN IN O
more RBR RBR O
recent JJ JJ O
echo NN NN O
( ( ( O
2/11/81 CD CD I-DATE
) ) ) O
from IN IN O
Wheeling VBG VBG I-HOSPITAL
Clinic NNP NNP I-HOSPITAL
showed VBD VBD O
mild JJ JJ O
MR NNP NNP O
( ( ( O
3 CD CD O
) ) ) O
s/p NN NN O
MI NNP NNP O
in IN IN O
4/80 CD CD I-DATE
. . . O
   
Admitted NNP NNP O
for IN IN O
chest NN NN O
pain NN NN O
at IN IN O
Wheeling NNP NNP I-HOSPITAL
Clinic NNP NNP I-HOSPITAL
on IN IN O
2/9/81 CD CD I-DATE
. . . O
   
Pharmacologic NNP NNP O
stress NN NN O
test NN NN O
there EX EX O
showed VBD VBD O
normal JJ JJ O
perfusion NN NN O
without IN IN O
any DT DT O
fixed JJ JJ O
or CC CC O
reversible JJ JJ O
perfusion NN NN O
abnormalities NNS NNS O
. . . O
   
Followed NNP NNP O
by IN IN O
Dr NNP NNP O
. . . O
Vernon NNP NNP I-DOCTOR
. . . O
   
Past JJ JJ O
Medical/Surgical NNP NNP O
History NN NN O
: : : O
AS IN IN O
: : : O
s/p NN NN O
AVR NNP NNP O
2078 CD CD I-DATE
; : : O
   
revision NN NN O
2080 CD CD I-DATE
; : : O
   
Rocky NNP NNP O
postoperative JJ JJ O
course NN NN O
notable JJ JJ O
for IN IN O
respiratory JJ JJ O
failure NN NN O
requiring VBG VBG O
prolonged JJ JJ O
ventilator NN NN O
support NN NN O
and CC CC O
sepsis NNS NNS O
. . . O
   
MR NNP NNP O
: : : O
mod NN NN O
to TO TO O
severe JJ JJ O
by IN IN O
echo NN NN O
in IN IN O
5/80 CD CD I-DATE
though IN IN O
more RBR RBR O
recent JJ JJ O
echo NN NN O
( ( ( O
2/11/81 CD CD I-DATE
) ) ) O
from IN IN O
Wheeling VBG VBG I-HOSPITAL
Clinic NNP NNP I-HOSPITAL
showed VBD VBD O
mild JJ JJ O
MR NNP NNP O
PE NNP NNP O
4/2080 CD CD I-DATE
on IN IN O
coumadin NN NN O
s/p NN NN O
MI NNP NNP O
in IN IN O
4/80 CD CD I-DATE
. . . O
   
Admitted NNP NNP O
for IN IN O
chest NN NN O
pain NN NN O
at IN IN O
Wheeling NNP NNP I-HOSPITAL
Clinic NNP NNP I-HOSPITAL
on IN IN O
2/9/81 CD CD I-DATE
. . . O
   
Pharmacologic NNP NNP O
stress NN NN O
test NN NN O
there EX EX O
showed VBD VBD O
normal JJ JJ O
perfusion NN NN O
without IN IN O
any DT DT O
fixed JJ JJ O
or CC CC O
reversible JJ JJ O
perfusion NN NN O
abnormalities NNS NNS O
. . . O
   
Followed NNP NNP O
by IN IN O
Dr NNP NNP O
. . . O
Vernon NNP NNP I-DOCTOR
. . . O
   
interstitial JJ JJ O
lung NN NN O
disease NN NN O
: : : O
FVC NNP NNP O
35-49 CD CD O
% NN NN O
, , , O
followed VBN VBN O
by IN IN O
Dr NNP NNP O
. . . O
Ohara NNP NNP I-DOCTOR
at IN IN O
Wheeling NNP NNP I-HOSPITAL
Clinic NNP NNP I-HOSPITAL
HTN/HL NNP NNP O
DM NNP NNP O
, , , O
diet NN NN O
controlled VBN VBN O
anxiety NN NN O
hx NN NN O
of IN IN O
renal JJ JJ O
failure NN NN O
urinary JJ JJ O
incontinence NN NN O
, , , O
s/p NN NN O
bladder NN NN O
suspension NN NN O
TKA NNP NNP O
2074 CD CD I-DATE
R NNP NNP O
cubital JJ JJ O
tunnel NN NN O
release NN NN O
2073 CD CD I-DATE
cataract NN NN O
surgery NN NN O
Home NNP NNP O
Medications NNP NNP O
: : : O
ASA NNP NNP O
, , , O
Furosemide NNP NNP O
, , , O
Gabapentin NNP NNP O
, , , O
K-Dru NNP NNP O
, , , O
Toprol NNP NNP O
, , , O
Zocor NNP NNP O
, , , O
Iron NNP NNP O
, , , O
Percocet NNP NNP O
, , , O
Stool NNP NNP O
softener NN NN O
, , , O
B12 NNP NNP O
, , , O
D NNP NNP O
Allergies NNP NNP O
: : : O
PCN NNP NNP O
, , , O
Cephalexin NNP NNP O
, , , O
Quinolones NNP NNP O
, , , O
Clindamycin NNP NNP O
, , , O
Sulfa NNP NNP O
Anesthetic NNP NNP O
History NN NN O
: : : O
no DT DT O
GA NNP NNP O
issues NNS NNS O
Social NNP NNP O
History NN NN O
: : : O
Tob NNP NNP O
: : : O
2 CD CD O
pack/y NN NN O
since IN IN O
30 CD CD I-AGE
yo NN NN O
Etoh NNP NNP O
: : : O
denies NNS NNS O
Illicits NNP NNP O
: : : O
denies NNS NNS O
Review NNP NNP O
of IN IN O
Systems NNPS NNPS O
: : : O
see VB VB O
HPI NNP NNP O
Exam NNP NNP O
: : : O
VS NNP NNP O
: : : O
HR NNP NNP O
84 CD CD O
, , , O
158/56 CD CD O
, , , O
93 CD CD O
% NN NN O
NC NNP NNP O
O2 NNP NNP O
General NNP NNP O
: : : O
responsive JJ JJ O
HEENT NNP NNP O
: : : O
EOMI NNP NNP O
, , , O
PERRL NNP NNP O
Chest NN NN O
: : : O
CTA NNP NNP O
CVS NNP NNP O
: : : O
II/VI NNP NNP O
systolic JJ JJ O
murmur NN NN O
Abd NNP NNP O
: : : O
not RB RB O
tender NN NN O
Extremities NNP NNP O
: : : O
well RB RB O
perfused VBN VBN O
. . . O
   
Neuro NNP NNP O
: : : O
A&amp NNP NNP O
; : : O
   
O NNP NNP O
x SYM SYM O
3 CD CD O
, , , O
no DT DT O
focal JJ JJ O
signs NNS NNS O
DATA NNP NNP O
Post NNP NNP O
op NN NN O
labs NNS NNS O
: : : O
Results02/13/2081 NNP NNP O
NA NNP NNP O
138 CD CD O
, , , O
K NNP NNP O
5.2 CD CD O
( ( ( O
H NNP NNP O
) ) ) O
[ NN NN O
1 CD CD O
] NN NN O
, , , O
CL NNP NNP O
104 CD CD O
, , , O
CO2 NNP NNP O
28.5 CD CD O
, , , O
BUN NNP NNP O
13 CD CD O
, , , O
CRE NNP NNP O
1.12 CD CD O
, , , O
EGFR NNP NNP O
51 CD CD O
[ NN NN O
2 CD CD O
] NN NN O
, , , O
GLU NNP NNP O
124 CD CD O
(H)[1] NN NN O
RESULT NNP NNP O
COMMENT NNP NNP O
: : : O
HEMOLYZED NNP NNP O
SPECIMEN02/13/2081 NNP NNP O
GLU NNP NNP O
112 CD CD O
(H)02/12/2081 NN NN O
NA NNP NNP O
136 CD CD O
, , , O
K NNP NNP O
3.4 CD CD O
, , , O
CL NNP NNP O
97 CD CD O
( ( ( O
L NNP NNP I-PATIENT
) ) ) O
, , , O
CO2 NNP NNP O
30.7 CD CD O
, , , O
BUN NNP NNP O
16 CD CD O
, , , O
CRE NNP NNP O
1.16 CD CD O
, , , O
EGFR NNP NNP O
49 CD CD O
[ NN NN O
1 CD CD O
] NN NN O
, , , O
GLU NNP NNP O
104 CD CD O
02/13/2081 CD CD I-DATE
CA NNP NNP O
8.5 CD CD O
, , , O
MG NNP NNP O
1.502/12/2081 CD CD O
MG NNP NNP O
1.702/13/2081 CD CD O
TEMP NNP NNP O
36.5 CD CD O
, , , O
FIO2 NNP NNP O
0.32 CD CD O
, , , O
aPO2 NN NN O
163 CD CD O
( ( ( O
H NNP NNP O
) ) ) O
, , , O
aPCO2 NN NN O
36 CD CD O
, , , O
aPH NN NN O
7.49 CD CD O
( ( ( O
H NNP NNP O
) ) ) O
, , , O
UBASEX NNP NNP O
3.7 CD CD O
, , , O
HGB NNP NNP O
BG NNP NNP O
10.9 CD CD O
(L)02/13/2081 NN NN O
WBC NNP NNP O
9.5 CD CD O
, , , O
RBC NNP NNP O
NOT RB RB O
DONE VBN VBN O
, , , O
HGB NNP NNP O
Unable NNP NNP O
to TO TO O
calculate VB VB O
RBC NNP NNP O
parameters NNS NNS O
, , , O
MHCT NNP NNP O
performed VBD VBD O
. . . O
   
, , , O
HCT NNP NNP O
MANUAL NNP NNP O
METHOD NNP NNP O
, , , O
MHCT NNP NNP O
30.0 CD CD O
( ( ( O
L NNP NNP I-PATIENT
) ) ) O
, , , O
MCV NNP NNP O
NOT RB RB O
DONE VBN VBN O
, , , O
MCH NNP NNP O
NOT RB RB O
DONE VBN VBN O
, , , O
MCHC NNP NNP O
NOT RB RB O
DONE02/12/2081 NNP NNP O
WBC NNP NNP O
7.0 CD CD O
, , , O
RBC NNP NNP O
3.92 CD CD O
( ( ( O
L NNP NNP I-PATIENT
) ) ) O
, , , O
HGB NNP NNP O
10.6 CD CD O
( ( ( O
L NNP NNP I-PATIENT
) ) ) O
, , , O
HCT NNP NNP O
32.1 CD CD O
( ( ( O
L NNP NNP I-PATIENT
) ) ) O
, , , O
MCV NNP NNP O
82 CD CD O
, , , O
MCH NNP NNP O
27.1 CD CD O
, , , O
MCHC NNP NNP O
33.102/13/2081 CD CD O
PLT NNP NNP O
364 CD CD O
, , , O
RDW NNP NNP O
NOT RB RB O
DONE02/12/2081 NNP NNP O
PLT NNP NNP O
377 CD CD O
, , , O
RDW NNP NNP O
15.3 CD CD O
(H)02/12/2081 NN NN O
PT NNP NNP O
14.3 CD CD O
( ( ( O
H NNP NNP O
) ) ) O
, , , O
PT-INR NNP NNP O
1.2 CD CD O
, , , O
PTT NNP NNP O
27.802/13/2081 CD CD O
UA-COLOR NNP NNP O
Yellow NNP NNP O
, , , O
UA-APP NNP NNP O
Clear NNP NNP O
, , , O
UA-GLUC NNP NNP O
Negative NNP NNP O
, , , O
UA-BILI NNP NNP O
Negative NNP NNP O
, , , O
UA-KET NNP NNP O
Negative NNP NNP O
, , , O
UR-SPGR NNP NNP O
1.006 CD CD O
, , , O
UA-BLD NNP NNP O
Negative NNP NNP O
, , , O
UA-PH NNP NNP O
6.502/13/2081 CD CD O
UA-PROT NNP NNP O
Negative NNP NNP O
, , , O
UA-UROBI NNP NNP O
Negative NNP NNP O
, , , O
UA-NIT NNP NNP O
Negative NNP NNP O
, , , O
UA-WBC NNP NNP O
NegativeCardiologyType NNP NNP O
: : : O
ECHODate NNP NNP O
: : : O
05/09/2080Left CD CD O
Ventricle NNP NNP O
: : : O
Overall RB RB O
left VBN VBN O
ventricular NN NN O
function NN NN O
is VBZ VBZ O
normal JJ JJ O
. . . O
   
The DT DT O
estimated JJ JJ O
ejection NN NN O
fraction NN NN O
is VBZ VBZ O
55-60 JJ JJ O
% NN NN O
. . . O
   
There EX EX O
are VBP VBP O
no DT DT O
regional JJ JJ O
wall NN NN O
motion NN NN O
abnormalities NNS NNS O
. . . O
   
The DT DT O
aortic JJ JJ O
valve NN NN O
appears VBZ VBZ O
to TO TO O
be VB VB O
a DT DT O
well RB RB O
seated VBN VBN O
bioprosthetic JJ JJ O
valve NN NN O
with IN IN O
normal JJ JJ O
function NN NN O
( ( ( O
21 CD CD O
mm NN NN O
Perimount NNP NNP O
ThermaFix NNP NNP O
by IN IN O
clinical JJ JJ O
record NN NN O
) ) ) O
. . . O
   
The DT DT O
peak NN NN O
antegrade NN NN O
aortic JJ JJ O
valve NN NN O
velocity NN NN O
is VBZ VBZ O
3.25 CD CD O
m/s NN NN O
. . . O
   
The DT DT O
peak NN NN O
instantaneous JJ JJ O
aortic JJ JJ O
valve NN NN O
gradient NN NN O
is VBZ VBZ O
42.1 CD CD O
mmHg NN NN O
. . . O
   
The DT DT O
mean NN NN O
aortic JJ JJ O
valve NN NN O
gradient NN NN O
is VBZ VBZ O
23.0 CD CD O
mmHg NN NN O
. . . O
   
There EX EX O
is VBZ VBZ O
trivial JJ JJ O
aortic JJ JJ O
insufficiency NN NN O
. . . O
   
Mitral NNP NNP O
Valve NNP NNP O
: : : O
The DT DT O
mitral JJ JJ O
valve NN NN O
is VBZ VBZ O
mildly RB RB O
diffusely RB RB O
thickened VBN VBN O
. . . O
   
There EX EX O
is VBZ VBZ O
moderate JJ JJ O
to TO TO O
severe VB VB O
mitral JJ JJ O
regurgitation NN NN O
with IN IN O
a DT DT O
central JJ JJ O
jet.Type NN NN O
: : : O
Chest NN NN O
2 CD CD O
ViewsDate/Time NNP NNP O
: : : O
02/12/2081 CD CD I-DATE
21:02 CD CD O
Lungs NNP NNP O
: : : O
The DT DT O
lung NN NN O
volumes NNS NNS O
are VBP VBP O
low JJ JJ O
and CC CC O
decrease NN NN O
sensitivity NN NN O
and CC CC O
specificity NN NN O
for IN IN O
pathology NN NN O
. . . O
   
There EX EX O
is VBZ VBZ O
prominence NN NN O
of IN IN O
the DT DT O
interstitium NN NN O
, , , O
which WDT WDT O
could MD MD O
represent VB VB O
very RB RB O
mild JJ JJ O
interstitial JJ JJ O
edema NN NN O
. . . O
   
There EX EX O
is VBZ VBZ O
no DT DT O
focal JJ JJ O
air NN NN O
space NN NN O
opacity NN NN O
to TO TO O
suggest VB VB O
pneumonia NN NN O
. . . O
   
Pleura NNP NNP O
: : : O
There EX EX O
is VBZ VBZ O
no DT DT O
pleural JJ JJ O
effusion NN NN O
or CC CC O
pneumothorax NN NN O
. . . O
   
Heart NNP NNP O
and CC CC O
mediastinum NN NN O
: : : O
The DT DT O
cardiac JJ JJ O
silhouette NN NN O
is VBZ VBZ O
within IN IN O
normal JJ JJ O
limits NNS NNS O
in IN IN O
size NN NN O
. . . O
   
Aortic NNP NNP O
valve NN NN O
prosthesis NN NN O
is VBZ VBZ O
noted VBN VBN O
. . . O
   
Bones NNP NNP O
: : : O
There EX EX O
are VBP VBP O
mild JJ JJ O
degenerative JJ JJ O
changes NNS NNS O
of IN IN O
the DT DT O
bony NN NN O
thorax NN NN O
. . . O
   
Contrast NN NN O
is VBZ VBZ O
noted VBN VBN O
in IN IN O
the DT DT O
bowel NN NN O
from IN IN O
prior RB RB O
procedure NN NN O
. . . O
   
IMPRESSION NNP NNP O
: : : O
Possible JJ JJ O
very RB RB O
mild JJ JJ O
interstitial JJ JJ O
edema NN NN O
. . . O
   
No DT DT O
evidence NN NN O
of IN IN O
focal JJ JJ O
pneumonia NN NN O
. . . O
   
Assessment NNP NNP O
and CC CC O
Plan NNP NNP O
: : : O
72 CD CD I-AGE
yo NN NN O
F NN NN O
hx NN NN O
AS NNP NNP O
x/p NN NN O
AVR NNP NNP O
, , , O
MR NNP NNP O
, , , O
MI NNP NNP O
, , , O
HTN NNP NNP O
, , , O
DM NNP NNP O
, , , O
HLD NNP NNP O
, , , O
interstitial JJ JJ O
lung NN NN O
disese NN NN O
, , , O
and CC CC O
PE NNP NNP O
. . . O
   
,? NN NN O
   
infection NN NN O
in IN IN O
left VBD VBD O
knee NN NN O
. . . O
   
s/p NN NN O
left VBD VBD O
knee NN NN O
prosthesis NNS NNS O
removal NN NN O
and CC CC O
antibiotic JJ JJ O
spacer NN NN O
insert NN NN O
Neuro NNP NNP O
: : : O
pain NN NN O
controlled VBN VBN O
with IN IN O
morphine NN NN O
PCA NNP NNP O
CV NNP NNP O
: : : O
did VBD VBD O
not RB RB O
receive VB VB O
Toprol NNP NNP O
today NN NN O
. . . O
   
monitor NN NN O
BP NNP NNP O
. . . O
   
give VB VB O
lopressor NN NN O
IV NNP NNP O
prn NN NN O
for IN IN O
BP NNP NNP O
tonight NN NN O
. . . O
   
resume NN NN O
Toprol NNP NNP O
tomorrow NN NN O
. . . O
   
Resp NNP NNP O
: : : O
ILD NNP NNP O
, , , O
continue VB VB O
neb NN NN O
treatment NN NN O
prn NN NN O
. . . O
   
keep VB VB O
SpO2 NNP NNP O
& CC CC O
gt NN NN O
; : : O
   
92 CD CD O
% NN NN O
Renal NNP NNP O
: : : O
monitor NN NN O
UO NNP NNP O
. . . O
   
target NN NN O
& CC CC O
gt NN NN O
; : : O
   
0.5 CD CD O
/ NN NN O
kg/hr NN NN O
. . . O
   
she PRP PRP O
had VBD VBD O
wbc NN NN O
in IN IN O
OSH NNP NNP O
UA NNP NNP O
. . . O
   
send VB VB O
UA NNP NNP O
now RB RB O
. . . O
   
GI NNP NNP O
: : : O
advance NN NN O
diest NN NN O
as IN IN O
tolerated VBN VBN O
. . . O
   
ID NNP NNP O
: : : O
monitor NN NN O
WBC NNP NNP O
, , , O
continue VB VB O
Vanco NNP NNP O
Endo NNP NNP O
: : : O
monitor NN NN O
bld NN NN O
sugar NN NN O
in IN IN O
AM NNP NNP O
labs NNS NNS O
. . . O
   
Heme NNP NNP O
: : : O
monitor NN NN O
drain NN NN O
from IN IN O
left VBD VBD O
knee NN NN O
. . . O
   
f/u NN NN O
CBC NNP NNP O
. . . O
   
keep VB VB O
Hgb&gt NNP NNP O
; : : O
   
9 CD CD O
. . . O
resume NN NN O
coumadin NN NN O
tonight NN NN O
. . . O
   
FEN/IVF NNP NNP O
: : : O
D5NS NNP NNP O
20 CD CD O
K NNP NNP O
100 CD CD O
cc/hr NN NN O
Psych NNP NNP O
: : : O
NC NNP NNP O
Activity NN NN O
: : : O
bed NN NN O
rest NN NN O
. . . O
   
Access NNP NNP O
: : : O
PIV NNP NNP O
aline NN NN O
Prophphylaxis NNP NNP O
: : : O
boots NNS NNS O
, , , O
TEDS NNP NNP O
, , , O
prilosec NN NN O
. . . O
   
Code NNP NNP O
Status NNP NNP O
: : : O
Full NNP NNP O
________________________________ NN NN O
_ NN NN O
Iman NNP NNP I-DOCTOR
Lutz NNP NNP I-DOCTOR
, , , O
MD NNP NNP O
MS NNP NNP O
Resident NNP NNP O
, , , O
PACU NNP NNP O
LEPROSARIUM NNP NNP I-HOSPITAL
Pager NNP NNP O
#97681 NN NN O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2094-08-12 JJ JJ I-DATE
Patient NNP NNP O
Name NN NN O
: : : O
HOLDEN,MATIAS NNP NNP I-PATIENT
[ NN NN O
MRN NNP NNP O
: : : O
97198841PGH CD CD O
] NN NN O
Date NN NN O
of IN IN O
Visit NNP NNP O
: : : O
08/12/94 CD CD I-DATE
Reason NNP NNP O
for IN IN O
Visit NNP NNP O
Return NNP NNP O
visit NN NN O
for IN IN O
this DT DT O
39m CD CD O
with IN IN O
hx NN NN O
poorly RB RB O
controlled VBN VBN O
DM NNP NNP O
who WP WP O
comes VBZ VBZ O
for IN IN O
further JJ JJ O
mgmt NN NN O
of IN IN O
DM NNP NNP O
, , , O
HCV NNP NNP O
. . . O
   
History NN NN O
of IN IN O
Present JJ JJ O
Illness NNP NNP O
Decided NNP NNP O
to TO TO O
change VB VB O
his PRP$ PRP$ O
lantus NN NN O
to TO TO O
bid NN NN O
( ( ( O
30 CD CD O
u NN NN O
bid NN NN O
) ) ) O
and CC CC O
found VBD VBD O
great JJ JJ O
response NN NN O
- - - O
-> NN NN O
bs NN NN O
now RB RB O
90-120 JJ JJ O
range NN NN O
mostly RB RB O
, , , O
all DT DT O
under IN IN O
200 CD CD O
. . . O
   
troubled VBN VBN O
by IN IN O
his PRP$ PRP$ O
hcv NN NN O
infxn NN NN O
, , , O
has VBZ VBZ O
been VBN VBN O
ruminating VBG VBG O
on IN IN O
how WRB WRB O
he PRP PRP O
got VBD VBD O
it PRP PRP O
. . . O
   
had VBD VBD O
2 CD CD O
episodes NNS NNS O
needle NN NN O
sticks NNS NNS O
at IN IN O
a DT DT O
past JJ JJ O
job NN NN O
2 CD CD O
+ NN NN O
yrs NNS NNS O
ago RB RB O
, , , O
wonders NNS NNS O
if IN IN O
could MD MD O
have VB VB O
gotten VBN VBN O
then RB RB O
. . . O
   
never RB RB O
used VBN VBN O
iv NN NN O
drugs NNS NNS O
, , , O
never RB RB O
had VBD VBD O
partner NN NN O
who WP WP O
used VBD VBD O
iv JJ JJ O
drugs NNS NNS O
. . . O
   
reviewed VBD VBD O
methods NNS NNS O
of IN IN O
transmission NN NN O
, , , O
low JJ JJ O
risk NN NN O
of IN IN O
sexual JJ JJ O
transmission NN NN O
, , , O
etc FW FW O
. . . O
   
Problems NNS NNS O
DM NNP NNP O
H/O NNP NNP O
NEPHROLITHIASIS NNP NNP O
ANKLE NNP NNP O
FRACTURE NNP NNP O
H/O NNP NNP O
DRUG NN NN O
ABUSE NNP NNP O
TOBACCO NNP NNP O
WORK NN NN O
# # # O
310-7911 NN NN I-PHONE
EXT NNP NNP O
5 CD CD I-PHONE
ROSACEA NNP NNP O
Elevated NNP NNP O
lipids NNS NNS O
Microalbuminuria NNP NNP O
? . . O
migraine NN NN O
FHX NNP NNP O
: : : O
M/F/Sis/Bro NNP NNP O
DM NNP NNP O
, , , O
F NN NN O
s/p NN NN O
LE NNP NNP O
amputation NN NN O
; : : O
   
Sis NNP NNP O
migraines NNS NNS O
; : : O
   
no DT DT O
CAD/CVA NNP NNP O
, , , O
no DT DT O
htn NN NN O
, , , O
no DT DT O
prostate/colon NN NN O
CA NNP NNP O
New NNP NNP O
Phone NNP NNP O
3/11/94 CD CD I-DATE
: : : O
124-607-0785 NN NN I-PHONE
, , , O
work NN NN O
485-914-7948 JJ JJ I-PHONE
Allergies NNPS NNPS O
NKA NNP NNP O
Medications NNP NNP O
ECASA NNP NNP O
( ( ( O
ASPIRIN NNP NNP O
ENTERIC NNP NNP O
COATED NNP NNP O
) ) ) O
( ( ( O
81MG CD CD O
TABLET NNP NNP O
EC NNP NNP O
take VB VB O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
) ) ) O
PO NNP NNP O
QD NNP NNP O
* NN NN O
GLUCOSE NNP NNP O
TEST NNP NNP O
STRIPS NNP NNP O
TOPICAL NNP NNP O
( ( ( O
take VB VB O
) ) ) O
TOP JJ JJ O
DAILY JJ JJ O
USE NNP NNP O
INSULIN NNP NNP O
SYRINGES NNP NNP O
FOR IN IN O
DAILY NNP NNP O
( ( ( O
take VB VB O
) ) ) O
TP NNP NNP O
bid NN NN O
and CC CC O
prn NN NN O
* NN NN O
LANCETS NNP NNP O
Topical NNP NNP O
( ( ( O
take VB VB O
) ) ) O
TOP JJ JJ O
daily JJ JJ O
use NN NN O
LANTUS NNP NNP O
( ( ( O
INSULIN NNP NNP O
GLARGINE NNP NNP O
) ) ) O
30 CD CD O
UNITS NNP NNP O
SC NNP NNP O
BID NNP NNP O
LISINOPRIL NNP NNP O
10 CD CD O
MG NNP NNP O
PO NNP NNP O
QD NNP NNP O
METFORMIN NNP NNP O
850 CD CD O
MG NNP NNP O
PO NNP NNP O
TID NNP NNP O
PRAVASTATIN NNP NNP O
( ( ( O
40MG CD CD O
TABLET NNP NNP O
take NN NN O
1 CD CD O
Tablet NNP NNP O
   
( ( ( O
s VBZ VBZ O
) ) ) O
) ) ) O
PO NNP NNP O
QHS NNP NNP O
on IN IN O
20 CD CD O
at IN IN O
time NN NN O
of IN IN O
visit NN NN O
Social NNP NNP O
History NN NN O
Lives NNS NNS O
with IN IN O
GF NNP NNP O
and CC CC O
her PRP$ PRP$ O
children NNS NNS O
. . . O
   
Is VBZ VBZ O
no RB RB O
longer RB RB O
involved VBN VBN O
with IN IN O
ex-wife JJ JJ O
, , , O
who WP WP O
is VBZ VBZ O
mother NN NN O
of IN IN O
his PRP$ PRP$ O
children NNS NNS O
. . . O
   
From IN IN O
Portugal NNP NNP I-COUNTRY
originally RB RB O
; : : O
   
lived VBD VBD O
in IN IN O
OR CC CC I-STATE
for IN IN O
18 CD CD O
yrs NN NN O
, , , O
in IN IN O
palacios NN NN I-CITY
since IN IN O
2080 CD CD I-DATE
, , , O
plans NNS NNS O
to TO TO O
stay VB VB O
. . . O
   
Recently RB RB O
visited VBN VBN O
father/family RB RB O
in IN IN O
Portugal NNP NNP I-COUNTRY
. . . O
   
Has VBZ VBZ O
dtr NN NN O
9 CD CD I-AGE
, , , O
son NN NN O
11 CD CD I-AGE
in IN IN O
Portugal NNP NNP I-COUNTRY
. . . O
   
Works NNP NNP O
as IN IN O
aveterinary JJ JJ O
assisstant NN NN I-PROFESSION
, , , O
oversees NNS NNS O
19 CD CD O
clients NNS NNS O
, , , O
really RB RB O
likes VBZ VBZ O
it PRP PRP O
. . . O
   
Feels VBZ VBZ O
he PRP PRP O
understands VBZ VBZ O
what WP WP O
they PRP PRP O
are VBP VBP O
going VBG VBG O
thru NN NN O
from IN IN O
his PRP$ PRP$ O
own JJ JJ O
prior RB RB O
experience NN NN O
. . . O
   
Not RB RB O
happy JJ JJ O
with IN IN O
his PRP$ PRP$ O
ins NNS NNS O
plan NN NN O
d/t NN NN O
hi NN NN O
copays NNS NNS O
& CC CC O
poor JJ JJ O
rx NN NN O
coverage NN NN O
, , , O
but CC CC O
his PRP$ PRP$ O
employer NN NN O
only RB RB O
offers VBZ VBZ O
one CD CD O
plan NN NN O
. . . O
   
No DT DT O
etoh NN NN O
, , , O
no DT DT O
drug NN NN O
use NN NN O
currently RB RB O
. . . O
   
No DT DT O
hx NN NN O
ivdu NN NN O
. . . O
   
Has VBZ VBZ O
Rx NNP NNP O
coverage NN NN O
, , , O
but CC CC O
copays NNS NNS O
have VBP VBP O
all DT DT O
been VBN VBN O
increasing VBG VBG O
. . . O
   
Vital NNP NNP O
Signs NNP NNP O
Blood NNP NNP O
Pressure NN NN O
: : : O
105/68 CD CD O
Left NNP NNP O
Arm NNP NNP O
Pulse NNP NNP O
: : : O
68 CD CD O
Regular NNP NNP O
Weight NNP NNP O
: : : O
220 CD CD O
Pounds NNP NNP O
Physical JJ JJ O
Exam NNP NNP O
Gen NNP NNP O
: : : O
well RB RB O
appearing NN NN O
, , , O
NAD NNP NNP O
, , , O
good JJ JJ O
spirits NNS NNS O
. . . O
   
Impression NNP NNP O
39m CD CD O
with IN IN O
poorly RB RB O
controlled VBN VBN O
DM NNP NNP O
, , , O
albuminuria NN NN O
who WP WP O
comes VBZ VBZ O
for IN IN O
further JJ JJ O
mgmt NN NN O
dm NN NN O
and CC CC O
with IN IN O
recently RB RB O
dx NN NN O
'd MD MD O
hcv NN NN O
. . . O
   
Over IN IN O
1/2 CD CD O
this DT DT O
25 CD CD O
minute NN NN O
visit NN NN O
was VBD VBD O
spent VBN VBN O
discussing VBG VBG O
modes NNS NNS O
of IN IN O
transmission NN NN O
of IN IN O
hcv NN NN O
and CC CC O
counseling VBG VBG O
regarding VBG VBG O
likely JJ JJ O
etiology/plans NNS NNS O
for IN IN O
bs NN NN O
, , , O
as RB RB O
well RB RB O
as IN IN O
disc NN NN O
of IN IN O
DM NNP NNP O
mgmt NN NN O
. . . O
   
Plan NNP NNP O
DM NNP NNP O
: : : O
a1c NN NN O
had VBD VBD O
come VBN VBN O
down RB RB O
from IN IN O
11.8-->9.9, JJ JJ O
but CC CC O
up IN IN O
to TO TO O
10.4 CD CD O
last JJ JJ O
check NN NN O
. . . O
   
now RB RB O
bs NN NN O
much JJ JJ O
better RBR RBR O
on IN IN O
total JJ JJ O
lantus NN NN O
60u CD CD O
daily RB RB O
, , , O
split NN NN O
bid NN NN O
. . . O
   
cont NN NN O
current JJ JJ O
regimen NNS NNS O
, , , O
recheck NN NN O
a1c NN NN O
next JJ JJ O
visit NN NN O
. . . O
   
gave VBD VBD O
# # # O
for IN IN O
pt NN NN O
to TO TO O
r/s VB VB O
f/u NN NN O
with IN IN O
optho NN NN O
, , , O
last JJ JJ O
visit NN NN O
spring NN NN I-DATE
2093 CD CD I-DATE
. . . O
   
cont NN NN O
metformin NN NN O
. . . O
   
had VBD VBD O
abnl NN NN O
findings NNS NNS O
w/photos VBP VBP O
taken VBN VBN O
on IN IN O
dil NN NN O
exam NN NN O
; : : O
   
was VBD VBD O
to TO TO O
have VB VB O
f/u NN NN O
2/94 CD CD I-DATE
but CC CC O
did VBD VBD O
n't RB RB O
happen VB VB O
. . . O
   
malb NN NN O
elevated VBD VBD O
97 CD CD O
in IN IN O
9/93 CD CD I-DATE
; : : O
   
on IN IN O
acei NN NN O
. . . O
   
taking VBG VBG O
asa NN NN O
qd NN NN O
. . . O
   
had VBD VBD O
pneumovax NN NN O
2090 CD CD I-DATE
. . . O
   
foot NN NN O
exam NN NN O
nl NN NN O
12/93 CD CD I-DATE
. . . O
   
Albuminuria NNP NNP O
: : : O
cont NN NN O
acei NN NN O
. . . O
   
last JJ JJ O
97 CD CD O
9/93 CD CD I-DATE
. . . O
   
cr NN NN O
stable JJ JJ O
1.2 CD CD O
12/93 CD CD I-DATE
. . . O
   
follow VB VB O
cr NN NN O
on IN IN O
metformin NN NN O
. . . O
   
HCV NNP NNP O
: : : O
hiv NN NN O
was VBD VBD O
neg NN NN O
. . . O
   
hbv NN NN O
immune NN NN O
. . . O
   
hav NN NN O
immune NN NN O
. . . O
   
he PRP PRP O
had VBD VBD O
a DT DT O
needle NN NN O
stick NN NN O
around IN IN O
june NNP NNP I-DATE
2092 CD CD I-DATE
at IN IN O
work NN NN O
, , , O
was VBD VBD O
n't RB RB O
tested VBN VBN O
at IN IN O
that DT DT O
time NN NN O
for IN IN O
hcv/hiv NN NN O
, , , O
but CC CC O
had VBD VBD O
f/u NN NN O
test NN NN O
( ( ( O
for IN IN O
hiv NN NN O
only RB RB O
apparently RB RB O
) ) ) O
w/dr NN NN O
. . . O
   
roberson NN NN I-DOCTOR
, , , O
neg NN NN O
at IN IN O
that DT DT O
time NN NN O
. . . O
   
discussed VBN VBN O
that IN IN O
hcv NN NN O
may MD MD O
well RB RB O
have VB VB O
been VBN VBN O
from IN IN O
needle NN NN O
stick NN NN O
. . . O
   
ruq NN NN O
u/s NN NN O
was VBD VBD O
nl NN NN O
, , , O
hcv NN NN O
genotype NN NN O
1a CD CD O
. . . O
   
lfts NNS NNS O
have VBP VBP O
been VBN VBN O
consistently RB RB O
nl NN NN O
, , , O
last JJ JJ O
6/94 CD CD I-DATE
. . . O
   
was VBD VBD O
to TO TO O
have VB VB O
liver NN NN O
bx NN NN O
w/dr NN NN O
. . . O
   
kruse NN NN I-DOCTOR
in IN IN O
april NNP NNP I-DATE
, , , O
but CC CC O
never RB RB O
occurred VBD VBD O
. . . O
   
i NNP NNP O
will MD MD O
contact VB VB O
dr NN NN O
. . . O
kruse NN NN I-DOCTOR
to TO TO O
facilitate VB VB O
arrangement NN NN O
of IN IN O
bx NN NN O
. . . O
   
Atypical NNP NNP O
nevus NN NN O
: : : O
dnka NN NN O
appt NN NN O
w/derm NN NN O
for IN IN O
eval NN NN O
in IN IN O
march NN NN I-DATE
. . . O
   
will MD MD O
rerefer VB VB O
at IN IN O
future JJ JJ O
visit NN NN O
. . . O
   
copays NNS NNS O
$35 NN NN O
for IN IN O
nonpcp NN NN O
visit NN NN O
- : : O
difficult JJ JJ O
for IN IN O
him PRP PRP O
. . . O
   
Hyperlipidemia NNP NNP O
: : : O
has VBZ VBZ O
low JJ JJ O
hdl NN NN O
33 CD CD O
in IN IN O
6/94 CD CD I-DATE
, , , O
reviewed VBN VBN O
today NN NN O
& CC CC O
rec NN NN O
'd MD MD O
exercise VB VB O
. . . O
   
ldl NN NN O
119 CD CD O
on IN IN O
pravastatin NN NN O
-- : : O
inc NN NN O
to TO TO O
40 CD CD O
mg NN NN O
. . . O
   
lfts NNS NNS O
nl NN NN O
6/94 CD CD I-DATE
. . . O
   
recheck NN NN O
lipids/lfts NNS NNS O
on IN IN O
inc NN NN O
prava NN NN O
next JJ JJ O
visit NN NN O
. . . O
   
HM NNP NNP O
: : : O
lipids NNS NNS O
as IN IN O
above IN IN O
. . . O
   
had VBD VBD O
Td NNP NNP O
booster NN NN O
2089 CD CD I-DATE
. . . O
   
re NN NN O
: : : O
tob NN NN O
cessation/cutting VBG VBG O
down RB RB O
- : : O
he PRP PRP O
remains VBZ VBZ O
precontemplative JJ JJ O
. . . O
   
tried VBD VBD O
wellbutrin NN NN O
in IN IN O
past JJ JJ O
w/no NN NN O
effect NN NN O
. . . O
   
gave VBD VBD O
him PRP PRP O
# # # O
for IN IN O
pharm NN NN O
to TO TO O
consider VB VB O
Rx NNP NNP O
assistance NN NN O
progs NNS NNS O
, , , O
as IN IN O
he PRP PRP O
has VBZ VBZ O
been VBN VBN O
interested VBN VBN O
in IN IN O
this DT DT O
, , , O
filled VBN VBN O
out IN IN O
some DT DT O
paperwork NN NN O
for IN IN O
cheaper JJR JJR O
meds NNS NNS O
in IN IN O
past JJ JJ O
. . . O
   
also RB RB O
offered VBN VBN O
to TO TO O
switch VB VB O
back RB RB O
to TO TO O
nph VB VB O
for IN IN O
cost NN NN O
reasons NNS NNS O
today NN NN O
, , , O
but CC CC O
he PRP PRP O
declined VBD VBD O
. . . O
   
rtc NN NN O
2-3mos JJ JJ O
f/u NN NN O
dm NN NN O
, , , O
hcv NN NN O
, , , O
check NN NN O
lipids/lfts NNS NNS O
, , , O
umalb NN NN O
_____________________________ NN NN O
_ NN NN O
Kari NNP NNP I-DOCTOR
Marlene NNP NNP I-DOCTOR
Pryor NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2094-03-14 JJ JJ I-DATE
Youssef NNP NNP I-DOCTOR
Null NNP NNP I-DOCTOR
Ludlow NNP NNP I-HOSPITAL
Medical NNP NNP I-HOSPITAL
Center NNP NNP I-HOSPITAL
82 CD CD I-STREET
Manatee NNP NNP I-STREET
Street NNP NNP I-STREET
Post NNP NNP I-CITY
, , , O
IN IN IN I-STATE
86454 CD CD I-ZIP
Dear RB RB O
Dr NNP NNP O
. . . O
Null NNP NNP I-DOCTOR
, , , O
I PRP PRP O
had VBD VBD O
the DT DT I-LOCATION-OTHER
pleasure NN NN O
of IN IN O
seeing VBG VBG O
Nick NNP NNP I-PATIENT
Hall NNP NNP I-PATIENT
in IN IN O
WSH NNP NNP I-HOSPITAL
cardiology NN NN O
clinic NN NN O
today NN NN O
in IN IN O
follow-up NN NN O
of IN IN O
his PRP$ PRP$ O
recent JJ JJ O
admission NN NN O
to TO TO O
the DT DT I-LOCATION-OTHER
ICMA NNP NNP I-HOSPITAL
. . . O
   
While IN IN O
I PRP PRP O
know VBP VBP O
that IN IN O
you PRP PRP O
are VBP VBP O
familiar JJ JJ O
with IN IN O
his PRP$ PRP$ O
history NN NN O
, , , O
please VB VB O
allow VB VB O
me PRP PRP O
to TO TO O
briefly VB VB O
review NN NN O
it PRP PRP O
for IN IN O
my PRP$ PRP$ O
records NNS NNS O
. . . O
   
He PRP PRP O
is VBZ VBZ O
a DT DT O
lovely JJ JJ O
53 CD CD I-AGE
year NN NN O
old JJ JJ O
gentleman NN NN O
whose WP$ WP$ O
history NN NN O
is VBZ VBZ O
remarkable JJ JJ O
for IN IN O
Hodgkins NNP NNP O
, , , O
status NN NN O
post NN NN O
mantle JJ JJ O
radiation NN NN O
in IN IN O
the DT DT I-LOCATION-OTHER
early JJ JJ O
70's; CD CD O
   
coronary JJ JJ O
artery NN NN O
disease NN NN O
, , , O
status NN NN O
post-PCI NN NN O
to TO TO O
the DT DT I-LOCATION-OTHER
LAD NNP NNP O
and CC CC O
RCA NNP NNP O
in IN IN O
' POS POS O
90 CD CD O
and CC CC O
' POS POS O
87 CD CD O
, , , O
respectively RB RB O
, , , O
and CC CC O
recently RB RB O
diagnosed VBD VBD O
squamous JJ JJ O
cell NN NN O
lung NN NN O
cancer NN NN O
. . . O
   
MIBI NNP NNP O
done VBN VBN O
at IN IN O
LMC NNP NNP I-HOSPITAL
1/24/94 CD CD I-DATE
showed VBD VBD O
normal JJ JJ O
EF NNP NNP O
without IN IN O
perfusion NN NN O
defects NNS NNS O
( ( ( O
no DT DT O
scar NN NN O
or CC CC O
ischemia NN NN O
) ) ) O
; : : O
   
he PRP PRP O
exercised VBD VBD O
10:30 NN NN O
on IN IN O
a DT DT O
standard JJ JJ O
Bruce NNP NNP O
iwthout NN NN O
symptoms NNS NNS O
. . . O
   
He PRP PRP O
was VBD VBD O
admitted VBN VBN O
2/94 CD CD I-DATE
for IN IN O
elective NN NN O
left VBD VBD O
upper JJ JJ O
lobectomy NN NN O
for IN IN O
his PRP$ PRP$ O
squamous JJ JJ O
cell NN NN O
lung NN NN O
cancer NN NN O
( ( ( O
ASA NNP NNP O
was VBD VBD O
stopped VBN VBN O
1 CD CD O
week NN NN O
prior RB RB O
to TO TO O
surgery NN NN O
; : : O
   
he PRP PRP O
was VBD VBD O
not RB RB O
on IN IN O
plavix NN NN O
preop NN NN O
) ) ) O
; : : O
   
in IN IN O
PACU NNP NNP O
following VBG VBG O
resection NN NN O
, , , O
he PRP PRP O
had VBD VBD O
a DT DT O
VT/VF NNP NNP O
arrest NN NN O
and CC CC O
was VBD VBD O
taken VBN VBN O
emergently RB RB O
to TO TO O
the DT DT I-LOCATION-OTHER
cardiac JJ JJ O
catheterization NN NN O
lab NN NN O
, , , O
where WRB WRB O
he PRP PRP O
was VBD VBD O
found VBN VBN O
to TO TO O
have VB VB O
a DT DT O
massive JJ JJ O
volume NN NN O
of IN IN O
thrombus NN NN O
extending VBG VBG O
throughout IN IN O
his PRP$ PRP$ O
RCA NNP NNP O
. . . O
   
After IN IN O
extensive JJ JJ O
suction NN NN O
catheter NN NN O
use NN NN O
and CC CC O
POBA NNP NNP O
, , , O
a DT DT O
good JJ JJ O
angiographic JJ JJ O
result NN NN O
was VBD VBD O
obtained VBN VBN O
; : : O
   
no DT DT O
stents NNS NNS O
were VBD VBD O
placed VBN VBN O
due JJ JJ O
to TO TO O
the DT DT I-LOCATION-OTHER
heightened JJ JJ O
thrombotic JJ JJ O
state NN NN O
that IN IN O
he PRP PRP O
was VBD VBD O
in IN IN O
. . . O
   
Remarkably RB RB O
, , , O
echocardiogram NN NN O
revealed VBD VBD O
normal JJ JJ O
LV NNP NNP O
systolic JJ JJ O
function NN NN O
, , , O
with IN IN O
basal NN NN O
inferoposterior NN NN O
HK NNP NNP O
noted VBD VBD O
. . . O
   
His PRP$ PRP$ O
peak NN NN O
TnI NNP NNP O
was VBD VBD O
33.6 CD CD O
, , , O
his PRP$ PRP$ O
peak NN NN O
CK NNP NNP O
was VBD VBD O
1710 CD CD O
, , , O
and CC CC O
his PRP$ PRP$ O
peak NN NN O
MB NNP NNP O
was VBD VBD O
87.2 CD CD O
. . . O
   
He PRP PRP O
had VBD VBD O
a DT DT O
relatively RB RB O
unremarkable JJ JJ O
course NN NN O
post-catheterization NN NN O
; : : O
   
plavix NN NN O
initiation NN NN O
was VBD VBD O
delayed VBN VBN O
until IN IN O
his PRP$ PRP$ O
chest NN NN O
tube NN NN O
was VBD VBD O
removed VBN VBN O
, , , O
after IN IN O
which WDT WDT O
it PRP PRP O
was VBD VBD O
started VBN VBN O
without IN IN O
incident NN NN O
. . . O
   
He PRP PRP O
was VBD VBD O
discharged VBN VBN O
2/11/94 CD CD I-DATE
, , , O
and CC CC O
returns NNS NNS O
today NN NN O
for IN IN O
routine JJ JJ O
follow-up JJ JJ O
. . . O
   
Regarding VBG VBG O
his PRP$ PRP$ O
squamous JJ JJ O
cell NN NN O
lung NN NN O
cancer NN NN O
, , , O
it PRP PRP O
is VBZ VBZ O
my PRP$ PRP$ O
understanding NN NN O
that IN IN O
he PRP PRP O
had VBD VBD O
no DT DT O
evidence NN NN O
of IN IN O
metastatic JJ JJ O
disease NN NN O
and CC CC O
that IN IN O
margins NNS NNS O
were VBD VBD O
negative JJ JJ O
; : : O
   
he PRP PRP O
is VBZ VBZ O
not RB RB O
currently RB RB O
planned VBN VBN O
for IN IN O
any DT DT O
adjuvant NN NN O
therapy NN NN O
, , , O
but CC CC O
will MD MD O
be VB VB O
closely RB RB O
followed VBN VBN O
. . . O
   
Regarding VBG VBG O
his PRP$ PRP$ O
remote JJ JJ O
history NN NN O
of IN IN O
Hodgkins NNP NNP O
, , , O
he PRP PRP O
is VBZ VBZ O
followed VBN VBN O
at IN IN O
RFPC NNP NNP I-HOSPITAL
, , , O
and CC CC O
is VBZ VBZ O
due JJ JJ O
for IN IN O
an DT DT O
annual JJ JJ O
visit NN NN O
there RB RB O
in IN IN O
the DT DT I-LOCATION-OTHER
next JJ JJ O
1-2 JJ JJ O
months NNS NNS O
. . . O
   
He PRP PRP O
has VBZ VBZ O
been VBN VBN O
walking VBG VBG O
outside IN IN O
for IN IN O
the DT DT I-LOCATION-OTHER
past NN NN O
~ NN NN O
2 CD CD O
weeks NNS NNS O
( ( ( O
since IN IN O
the DT DT I-LOCATION-OTHER
weather NN NN O
improved VBN VBN O
) ) ) O
, , , O
walking VBG VBG O
about IN IN O
2 CD CD O
miles NNS NNS O
in IN IN O
around IN IN O
30 CD CD O
minutes NNS NNS O
. . . O
   
He PRP PRP O
feels VBZ VBZ O
well RB RB O
, , , O
and CC CC O
has VBZ VBZ O
had VBN VBN O
no DT DT O
problems NNS NNS O
. . . O
   
He PRP PRP O
notes VBZ VBZ O
some DT DT O
mild JJ JJ O
dyspnea NN NN O
with IN IN O
increased VBN VBN O
exertion NN NN O
( ( ( O
climbing VBG VBG O
hills NNS NNS O
) ) ) O
, , , O
but CC CC O
denies NNS NNS O
any DT DT O
unusual JJ JJ O
dyspnea NN NN O
. . . O
   
He PRP PRP O
denies VBZ VBZ O
chest NN NN O
pain NN NN O
, , , O
SOB NNP NNP O
at IN IN O
rest NN NN O
, , , O
orthopnea NN NN O
( ( ( O
stable JJ JJ O
2 CD CD O
pillow NN NN O
use NN NN O
) ) ) O
, , , O
PND NNP NNP O
, , , O
edema NN NN O
, , , O
palpitaitons NNS NNS O
, , , O
or CC CC O
claudication NN NN O
. . . O
   
He PRP PRP O
brings VBZ VBZ O
with IN IN O
him PRP PRP O
a DT DT O
handwritten NN NN O
record NN NN O
of IN IN O
his PRP$ PRP$ O
recent JJ JJ O
hemodynamics NNS NNS O
- : : O
his PRP$ PRP$ O
BP NNP NNP O
runs VBZ VBZ O
in IN IN O
the DT DT I-LOCATION-OTHER
100-120's/60-80's, JJ JJ O
with IN IN O
rare JJ JJ O
systolics NNS NNS O
in IN IN O
the DT DT I-LOCATION-OTHER
130's. CD CD O
   
His PRP$ PRP$ O
heart NN NN O
rate NN NN O
has VBZ VBZ O
been VBN VBN O
in IN IN O
the DT DT I-LOCATION-OTHER
70-80's. JJ JJ O
   
His PRP$ PRP$ O
past JJ JJ O
medical JJ JJ O
history NN NN O
includes VBZ VBZ O
: : : O
CAD NNP NNP O
s/p NN NN O
IMI NNP NNP O
' POS POS O
88 CD CD O
( ( ( O
totally RB RB O
occluded VBD VBD O
RCA NNP NNP O
with IN IN O
good JJ JJ O
collaterals NNS NNS O
, , , O
revascularized VBN VBN O
with IN IN O
3 CD CD O
stents NNS NNS O
to TO TO O
the DT DT I-LOCATION-OTHER
RCA NNP NNP O
) ) ) O
, , , O
MI NNP NNP O
' POS POS O
90 CD CD O
( ( ( O
LAD NNP NNP O
stent NN NN O
) ) ) O
, , , O
inferior JJ JJ O
STEMI NNP NNP O
2/94 CD CD I-DATE
as IN IN O
above IN IN O
s/p NN NN O
POBA NNP NNP O
VF NNP NNP O
arrest NN NN O
in IN IN O
setting VBG VBG O
of IN IN O
STEMI NNP NNP O
Hodgkin NNP NNP O
's POS POS O
' POS POS O
81 CD CD O
- : : O
splenectomy NN NN O
, , , O
XRT NNP NNP O
LUL NNP NNP O
squamous JJ JJ O
cell NN NN O
cancer NN NN O
s/p NN NN O
L NNP NNP O
upper JJ JJ O
lobectomy NN NN O
2/94 CD CD I-DATE
hyperlipidemia NN NN O
( ( ( O
low JJ JJ O
HDL NNP NNP O
and CC CC O
high JJ JJ O
LDL NNP NNP O
- : : O
tried VBD VBD O
niaspan NN NN O
in IN IN O
the DT DT I-LOCATION-OTHER
past JJ JJ O
without IN IN O
much JJ JJ O
benefit NN NN O
) ) ) O
hypothyroid NN NN O
basal NN NN O
cell NN NN O
skin NN NN O
CA NNP NNP O
nephrolithiasis NN NN O
His PRP$ PRP$ O
medications NNS NNS O
include VBP VBP O
: : : O
Lipitor NNP NNP O
80 CD CD O
mg NN NN O
Plavix NNP NNP O
75 CD CD O
mg NN NN O
ASA NNP NNP O
325 CD CD O
mg NN NN O
po NN NN O
QD NNP NNP O
Lopressor NNP NNP O
200 CD CD O
mg NN NN O
po NN NN O
BID NNP NNP O
Prilosec NNP NNP O
20 CD CD I-AGE
mg NN NN O
He PRP PRP O
has VBZ VBZ O
a DT DT O
history NN NN O
of IN IN O
intolerance NN NN O
   
( ( ( O
dizziness NN NN O
) ) ) O
with IN IN O
lisinopril NN NN O
. . . O
   
His PRP$ PRP$ O
family NN NN O
history NN NN O
is VBZ VBZ O
notable JJ JJ O
for IN IN O
hyperlipidemia NN NN O
and CC CC O
hypertension NN NN O
, , , O
but CC CC O
negative JJ JJ O
for IN IN O
CAD NNP NNP O
. . . O
   
He PRP PRP O
works VBZ VBZ O
in IN IN O
consulting VBG VBG I-PROFESSION
, , , O
and CC CC O
travels VBZ VBZ O
around IN IN O
the DT DT I-LOCATION-OTHER
Midwest NNP NNP I-LOCATION-OTHER
as IN IN O
part NN NN O
of IN IN O
his PRP$ PRP$ O
job NN NN O
. . . O
   
He PRP PRP O
is VBZ VBZ O
now RB RB O
back RB RB O
at IN IN O
work NN NN O
. . . O
   
He PRP PRP O
is VBZ VBZ O
married VBN VBN O
, , , O
and CC CC O
lives NNS NNS O
in IN IN O
Lincoln NNP NNP I-CITY
City NNP NNP I-CITY
. . . O
   
He PRP PRP O
and CC CC O
his PRP$ PRP$ O
wife NN NN O
have VBP VBP O
4 CD CD O
children NNS NNS O
, , , O
ages NNS NNS O
15 CD CD I-AGE
/ NN NN O
17 CD CD I-AGE
/ NN NN O
20 CD CD I-AGE
/ NN NN O
24 CD CD I-AGE
; : : O
   
they PRP PRP O
have VBP VBP O
no DT DT O
pets NNS NNS O
. . . O
   
He PRP PRP O
has VBZ VBZ O
never RB RB O
smoked VBN VBN O
cigarettes NNS NNS O
. . . O
   
He PRP PRP O
drinks NNS NNS O
3 CD CD O
glasses NNS NNS O
of IN IN O
wine/week NN NN O
, , , O
and CC CC O
a DT DT O
cup NN NN O
of IN IN O
coffee NN NN O
qam NN NN O
. . . O
   
On IN IN O
physical JJ JJ O
exam NN NN O
today NN NN O
, , , O
he PRP PRP O
has VBZ VBZ O
a DT DT O
heart NN NN O
rate NN NN O
of IN IN O
68 CD CD O
and CC CC O
a DT DT O
blood NN NN O
pressure NN NN O
of IN IN O
134/75 CD CD O
. . . O
   
He PRP PRP O
is VBZ VBZ O
a DT DT O
well RB RB O
developed VBN VBN O
well RB RB O
nourished VBN VBN O
gentleman NN NN O
in IN IN O
no DT DT O
apparent JJ JJ O
distress NN NN O
. . . O
   
His PRP$ PRP$ O
JVP NNP NNP O
is VBZ VBZ O
flat JJ JJ O
sitting VBG VBG O
at IN IN O
90 CD CD O
degrees NNS NNS O
, , , O
and CC CC O
he PRP PRP O
has VBZ VBZ O
no DT DT O
carotid NN NN O
bruits NNS NNS O
. . . O
   
His PRP$ PRP$ O
lungs NNS NNS O
are VBP VBP O
clear JJ JJ O
to TO TO O
auscultation NN NN O
bilaterally RB RB O
. . . O
   
He PRP PRP O
has VBZ VBZ O
a DT DT O
regular JJ JJ O
rate NN NN O
and CC CC O
rhythm NN NN O
with IN IN O
a DT DT O
normal JJ JJ O
S1 NNP NNP O
S2 NNP NNP O
, , , O
and CC CC O
no DT DT O
murmurs NNS NNS O
, , , O
rubs NNS NNS O
, , , O
or CC CC O
gallups NNS NNS O
. . . O
   
His PRP$ PRP$ O
abdomen NN NN O
is VBZ VBZ O
benign NN NN O
. . . O
   
He PRP PRP O
is VBZ VBZ O
warm JJ JJ O
and CC CC O
well RB RB O
perfused VBN VBN O
peripherally RB RB O
without IN IN O
significant JJ JJ O
edema NN NN O
, , , O
and CC CC O
with IN IN O
2 CD CD O
+ NN NN O
PT NNP NNP O
pulses NNS NNS O
bilaterally RB RB O
. . . O
   
His PRP$ PRP$ O
EKG NNP NNP O
in IN IN O
clinic NN NN O
today NN NN O
is VBZ VBZ O
NSR NNP NNP O
at IN IN O
68 CD CD O
, , , O
with IN IN O
possible JJ JJ O
LAE NNP NNP O
, , , O
a DT DT O
nonspeciifc NN NN O
IVCD NNP NNP O
, , , O
and CC CC O
inferior JJ JJ O
Q NNP NNP O
waves NNS NNS O
in IN IN O
III/F NNP NNP O
, , , O
consistent JJ JJ O
with IN IN O
an DT DT O
inferior JJ JJ O
MI NNP NNP O
. . . O
   
He PRP PRP O
has VBZ VBZ O
increased VBN VBN O
voltages NNS NNS O
consistent JJ JJ O
with IN IN O
LVH NNP NNP O
. . . O
   
His PRP$ PRP$ O
recent JJ JJ O
cardiac JJ JJ O
tests NNS NNS O
include VBP VBP O
: : : O
- : : O
echo NN NN O
2/94 CD CD I-DATE
- : : O
EF NNP NNP O
60 CD CD O
% NN NN O
, , , O
basal NN NN O
inferoposterior NN NN O
HK NNP NNP O
, , , O
normal JJ JJ O
atrai NN NN O
, , , O
no DT DT O
significant JJ JJ O
valvular NN NN O
disease NN NN O
- : : O
cath NN NN O
2/94 CD CD I-DATE
- : : O
right JJ JJ O
dominant JJ JJ O
system NN NN O
, , , O
patent NN NN O
LAD NNP NNP O
stent NN NN O
, , , O
proximal NN NN O
60 CD CD O
% NN NN O
LCx NNP NNP O
, , , O
proximal NN NN O
90 CD CD O
% NN NN O
thrombotic JJ JJ O
RCA NNP NNP O
occlusion NN NN O
( ( ( O
in-stent JJ JJ O
) ) ) O
with IN IN O
100 CD CD O
% NN NN O
ostial JJ JJ O
R-PDA NNP NNP O
thrombotic JJ JJ O
lesion NN NN O
s/p NN NN O
Angiojet/POBA NNP NNP O
with IN IN O
TIMI-3 NNP NNP O
excellent JJ JJ O
angiographic JJ JJ O
result NN NN O
In IN IN O
summary NN NN O
, , , O
this DT DT O
is VBZ VBZ O
a DT DT O
53 CD CD I-AGE
year NN NN O
old JJ JJ O
man NN NN O
who WP WP O
had VBD VBD O
a DT DT O
VF NNP NNP O
arrest NN NN O
in IN IN O
the DT DT I-LOCATION-OTHER
setting VBG VBG O
of IN IN O
perioperative JJ JJ O
inferior JJ JJ O
STEMI NNP NNP O
, , , O
status NN NN O
post NN NN O
extensive JJ JJ O
angiojet NN NN O
and CC CC O
POBA NNP NNP O
of IN IN O
acute JJ JJ O
in-stent JJ JJ O
thrombosis NN NN O
of IN IN O
presumed JJ JJ O
bare JJ JJ O
metal NN NN O
stents NNS NNS O
in IN IN O
his PRP$ PRP$ O
RCA NNP NNP O
. . . O
   
He PRP PRP O
is VBZ VBZ O
asymptomatic JJ JJ O
from IN IN O
a DT DT O
cardiovascular JJ JJ O
standpoint NN NN O
, , , O
and CC CC O
somewhat RB RB O
remarkably RB RB O
did VBD VBD O
not RB RB O
take VB VB O
a DT DT O
large JJ JJ O
myocardial NN NN O
hit VBD VBD O
from IN IN O
this DT DT O
life-threatening JJ JJ O
event NN NN O
. . . O
   
Our PRP$ PRP$ O
attention NN NN O
now RB RB O
shifts VBZ VBZ O
to TO TO O
the DT DT I-LOCATION-OTHER
prevention NN NN O
of IN IN O
future JJ JJ O
events NNS NNS O
. . . O
   
Given VBN VBN O
the DT DT I-LOCATION-OTHER
degree NN NN O
of IN IN O
thrombus NN NN O
burden NN NN O
in IN IN O
his PRP$ PRP$ O
RCA NNP NNP O
at IN IN O
the DT DT I-LOCATION-OTHER
time NN NN O
of IN IN O
cath NN NN O
, , , O
he PRP PRP O
is VBZ VBZ O
someone NN NN O
for IN IN O
whom WP WP O
we PRP PRP O
would MD MD O
strongly RB RB O
advise VB VB O
lifelong JJ JJ O
plavix NN NN O
and CC CC O
aspirin NN NN O
. . . O
   
Furthermore RB RB O
, , , O
he PRP PRP O
is VBZ VBZ O
not RB RB O
someone NN NN O
for IN IN O
whom WP WP O
I PRP PRP O
would MD MD O
be VB VB O
comfortable JJ JJ O
with IN IN O
even RB RB O
temporary JJ JJ O
discontinuation NN NN O
of IN IN O
one CD CD O
of IN IN O
these DT DT O
agents NNS NNS O
- : : O
we PRP PRP O
would MD MD O
advise VB VB O
that IN IN O
ANY DT DT O
future NN NN O
procedures NNS NNS O
be VB VB O
done VBN VBN O
on IN IN O
aspirin NN NN O
and CC CC O
plavix NN NN O
. . . O
   
His PRP$ PRP$ O
blood NN NN O
pressure NN NN O
and CC CC O
heart NN NN O
rate NN NN O
are VBP VBP O
well RB RB O
controlled VBN VBN O
on IN IN O
his PRP$ PRP$ O
current JJ JJ O
regimen NNS NNS O
, , , O
as IN IN O
demonstrated VBN VBN O
by IN IN O
his PRP$ PRP$ O
home NN NN O
records NNS NNS O
. . . O
   
I PRP PRP O
have VBP VBP O
taken VBN VBN O
the DT DT I-LOCATION-OTHER
liberty NN NN O
today NN NN O
of IN IN O
changing VBG VBG O
him PRP PRP O
from IN IN O
lopressor NN NN O
200 CD CD O
bid NN NN O
to TO TO O
toprol NN NN O
200 CD CD O
bid NN NN O
to TO TO O
minimize VB VB O
any DT DT O
ups NNS NNS O
and CC CC O
downs NNS NNS O
in IN IN O
his PRP$ PRP$ O
beta NN NN O
blockade NN NN O
, , , O
but CC CC O
otherwise RB RB O
, , , O
would MD MD O
not RB RB O
make VB VB O
any DT DT O
changes NNS NNS O
to TO TO O
his PRP$ PRP$ O
regimen NN NN O
at IN IN O
this DT DT O
time NN NN O
. . . O
   
We PRP PRP O
will MD MD O
check VB VB O
a DT DT O
full JJ JJ O
set NN NN O
of IN IN O
labs NNS NNS O
today NN NN O
, , , O
but CC CC O
I PRP PRP O
suspect VBP VBP O
that IN IN O
no DT DT O
further JJ JJ O
changes NNS NNS O
will MD MD O
be VB VB O
required VBN VBN O
at IN IN O
this DT DT O
time NN NN O
. . . O
   
Given VBN VBN O
his PRP$ PRP$ O
history NN NN O
of IN IN O
Hodgkin NNP NNP O
's POS POS O
, , , O
as RB RB O
well RB RB O
as IN IN O
his PRP$ PRP$ O
known VBN VBN O
CAD NNP NNP O
, , , O
he PRP PRP O
is VBZ VBZ O
clearly RB RB O
at IN IN O
risk NN NN O
for IN IN O
future JJ JJ O
events NNS NNS O
, , , O
and CC CC O
I PRP PRP O
suspect VBP VBP O
that IN IN O
we PRP PRP O
will MD MD O
take VB VB O
a DT DT O
rather RB RB O
aggressive JJ JJ O
stance NN NN O
in IN IN O
terms NNS NNS O
of IN IN O
monitoring VBG VBG O
for IN IN O
ischemia NN NN O
. . . O
   
Certainly RB RB O
, , , O
if IN IN O
he PRP PRP O
has VBZ VBZ O
any DT DT O
concerning VBG VBG O
symptoms NNS NNS O
, , , O
we PRP PRP O
would MD MD O
have VB VB O
a DT DT O
low JJ JJ O
threshold NN NN O
to TO TO O
pursue VB VB O
an DT DT O
aggressive JJ JJ O
course NN NN O
. . . O
   
At IN IN O
present JJ JJ O
, , , O
however RB RB O
, , , O
I PRP PRP O
am VBP VBP O
delighted VBN VBN O
with IN IN O
how WRB WRB O
well RB RB O
he PRP PRP O
is VBZ VBZ O
doing VBG VBG O
. . . O
   
It PRP PRP O
was VBD VBD O
a DT DT O
pleasure NN NN O
to TO TO O
see VB VB O
Mr NNP NNP O
. . . O
Hall NNP NNP I-PATIENT
in IN IN O
cardiology NN NN O
clinic NN NN O
today NN NN O
. . . O
   
I PRP PRP O
will MD MD O
plan VB VB O
to TO TO O
see VB VB O
him PRP PRP O
in IN IN O
follow-up JJ JJ O
in IN IN O
6 CD CD O
months NNS NNS O
time NN NN O
, , , O
but CC CC O
he PRP PRP O
knows VBZ VBZ O
to TO TO O
call VB VB O
sooner RBR RBR O
should MD MD O
he PRP PRP O
have VB VB O
any DT DT O
problems NNS NNS O
or CC CC O
concerns NNS NNS O
. . . O
   
Regards NNP NNP O
, , , O
____________________________________________ NN NN O
_ NN NN O
Florence NNP NNP I-DOCTOR
Heather NNP NNP I-DOCTOR
Gil NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
, , , O
Ph.D NNP NNP O
. . . O
   
CC NNP NNP O
: : : O
Dr NNP NNP O
. . . O
Nick NNP NNP I-PATIENT
Golden NNP NNP I-DOCTOR
Thoracic NNP NNP O
Surgery NNP NNP O
Wytheville NNP NNP I-HOSPITAL
South NNP NNP I-HOSPITAL
Hospital NNP NNP I-HOSPITAL
Dr NNP NNP O
. . . O
Paul NNP NNP I-DOCTOR
Reilly NNP NNP I-DOCTOR
Riverside NNP NNP I-HOSPITAL
Family NNP NNP I-HOSPITAL
Practice NNP NNP I-HOSPITAL
Center NNP NNP I-HOSPITAL
   
-DOCSTART- -X- -X- O
   
Record NNP NNP O
date NN NN O
: : : O
2111-09-26 NN NN I-DATE
CC NNP NNP O
: : : O
Ear NNP NNP O
pain NN NN O
, , , O
cough NN NN O
HPI NNP NNP O
: : : O
49 CD CD I-AGE
y.o. NN NN O
female JJ JJ O
c/o NN NN O
cough NN NN O
with IN IN O
clear JJ JJ O
mucus NN NN O
, , , O
left VBD VBD O
ear JJ JJ O
pain NN NN O
and CC CC O
nasal NN NN O
congestion NN NN O
for IN IN O
the DT DT O
past JJ JJ O
week NN NN O
. . . O
   
She PRP PRP O
denies VBZ VBZ O
any DT DT O
chest NN NN O
pain NN NN O
, , , O
shortness NN NN O
of IN IN O
breath NN NN O
, , , O
fever NN NN O
, , , O
chills NNS NNS O
or CC CC O
sweat NN NN O
. . . O
   
No DT DT O
sore NN NN O
throat NN NN O
. . . O
   
She PRP PRP O
does VBZ VBZ O
smoke NN NN O
about IN IN O
one CD CD O
pack/day NN NN O
for IN IN O
25 CD CD O
years NNS NNS O
and CC CC O
does VBZ VBZ O
not RB RB O
want VB VB O
to TO TO O
quit VB VB O
. . . O
   
She PRP PRP O
also RB RB O
notes VBZ VBZ O
problems NNS NNS O
with IN IN O
bending VBG VBG O
her PRP$ PRP$ O
right JJ JJ O
thumb NN NN O
without IN IN O
h/o NN NN O
trauma NN NN O
, , , O
pain NN NN O
, , , O
parathesias NN NN O
or CC CC O
numbness NN NN O
. . . O
   
Symptoms NNP NNP O
present JJ JJ O
for IN IN O
past JJ JJ O
3 CD CD O
months NNS NNS O
. . . O
   
Allergies NNP NNP O
NKA NNP NNP O
Health NNP NNP O
Maint NNP NNP O
Cholesterol NNP NNP O
03/10/01 CD CD I-DATE
222 CD CD O
Mammogram NNP NNP O
11/02/97 CD CD I-DATE
see VB VB O
report NN NN O
in IN IN O
Results NNS NNS O
Pap NNP NNP O
Smear NNP NNP O
09/28/99 CD CD I-DATE
see VB VB O
report NN NN O
in IN IN O
Results NNS NNS O
HbA1c NNP NNP O
08/22/2106 CD CD I-DATE
10.70 CD CD O
Procedures NNP NNP O
Hysterectomy NNP NNP O
Flowsheets NNP NNP O
BLOOD NNP NNP O
PRESSURE NN NN O
110/70 CD CD O
WEIGHT NNP NNP O
206 CD CD O
lb NN NN O
HENT NNP NNP O
: : : O
PERRLA NNP NNP O
, , , O
oral JJ JJ O
w/out NN NN O
lesions NNS NNS O
, , , O
neck NN NN O
supple NN NN O
, , , O
nasal NN NN O
turbinates NNS NNS O
mildly RB RB O
enlarged VBN VBN O
with IN IN O
no DT DT O
sinus NN NN O
tenderness NN NN O
. . . O
   
No DT DT O
lymphadenopathy NN NN O
and CC CC O
TMs NNP NNP O
clear JJ JJ O
. . . O
   
LUNGS NNP NNP O
: : : O
CTA NNP NNP O
EXT NNP NNP O
: : : O
Inability NNP NNP O
to TO TO O
bend VB VB O
right NN NN O
thumb NN NN O
without IN IN O
tenderness NN NN O
, , , O
warmth NN NN O
or CC CC O
swelling VBG VBG O
. . . O
   
A/P NNP NNP O
: : : O
   
1 CD CD O
. . . O
Allergies NNP NNP O
with IN IN O
cough NN NN O
. . . O
   
Claritin NNP NNP O
and CC CC O
robitussin NN NN O
for IN IN O
cough NN NN O
and CC CC O
given VBN VBN O
smoking NN NN O
history NN NN O
will MD MD O
check VB VB O
chest NN NN O
xray NN NN O
. . . O
   
2 CD CD O
. . . O
Right RB RB O
thumb NN NN O
stiffness NN NN O
. . . O
   
Check NNP NNP O
xray NN NN O
and CC CC O
referral NN NN O
to TO TO O
orthopedics NNS NNS O
. . . O
   
3 CD CD O
. . . O
Health NN NN O
maint NN NN O
. . . O
   
Pt NNP NNP O
. . . O
   
declined VBD VBD O
physical JJ JJ O
and CC CC O
on IN IN O
reviewing VBG VBG O
chart NN NN O
noted VBD VBD O
to TO TO O
have VB VB O
diabetes NNS NNS O
. . . O
   
Recommend NNP NNP O
f/u NN NN O
for IN IN O
physical JJ JJ O
and CC CC O
assessment NN NN O
of IN IN O
diabetes NN NN O
. . . O
   
____________________________________________ NN NN O
_ NN NN O
Grace NNP NNP I-DOCTOR
C. NN NN I-DOCTOR
Valerie-Yun NNP NNP I-DOCTOR
, , , O
M.D. NNP NNP O
